PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kular, J; Tickner, JC; Pavlos, NJ; Viola, HM; Abel, T; Lim, BS; Yang, XH; Chen, HH; Cook, R; Hool, LC; Zheng, MH; Xu, JK				Kular, Jasreen; Tickner, Jennifer C.; Pavlos, Nathan J.; Viola, Helena M.; Abel, Tamara; Lim, Bay Sie; Yang, Xiaohong; Chen, Honghui; Cook, Robert; Hool, Livia C.; Zheng, Ming Hao; Xu, Jiake			Choline Kinase beta Mutant Mice Exhibit Reduced Phosphocholine, Elevated Osteoclast Activity, and Low Bone Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; PHOSPHATIDYLCHOLINE METABOLISM; CHOLINE/ETHANOLAMINE KINASE; SIGNALING PATHWAY; MINERAL DENSITY; RANKL; LIGAND; DIFFERENTIATION; INVOLVEMENT; DISRUPTION	The maintenance of bone homeostasis requires tight coupling between bone-forming osteoblasts and bone-resorbing osteoclasts. However, the precise molecular mechanism(s) underlying the differentiation and activities of these specialized cells are still largely unknown. Here, we identify choline kinase beta (CHKB), a kinase involved in the biosynthesis of phosphatidylcholine, as a novel regulator of bone homeostasis. Choline kinase beta mutant mice (flp/flp) exhibit a systemic low bone mass phenotype. Consistently, osteoclast numbers and activity are elevated in flp/flp mice. Interestingly, osteoclasts derived from flp/flp mice exhibit reduced sensitivity to excessive levels of extracellular calcium, which could account for the increased bone resorption. Conversely, supplementation of cytidine 5'-diphosphocholine in vivo and in vitro, a regimen that bypasses CHKB deficiency, restores osteoclast numbers to physiological levels. Finally, we demonstrate that, in addition to modulating osteoclast formation and function, loss of CHKB corresponds with a reduction in bone formation by osteoblasts. Taken together, these data posit CHKB as a new modulator of bone homeostasis.	[Kular, Jasreen; Tickner, Jennifer C.; Lim, Bay Sie; Cook, Robert; Xu, Jiake] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Pavlos, Nathan J.; Zheng, Ming Hao] Univ Western Australia, Ctr Orthopaed Res, Sch Surg, Nedlands, WA 6009, Australia; [Viola, Helena M.; Hool, Livia C.] Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA 6009, Australia; [Abel, Tamara] Univ Western Australia, Ctr Microscopy Characterizat & Anal, Nedlands, WA 6009, Australia; [Yang, Xiaohong; Chen, Honghui] Jinan Univ, Guangzhou Inst Traumat Surg, Affiliated Hosp 4, Coll Med, Guangzhou 510182, Guangdong, Peoples R China	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Jinan University	Xu, JK (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia.	jiake.xu@uwa.edu.au	Hool, Livia C/H-5059-2014; Tickner, Jennifer/H-5965-2014	Hool, Livia C/0000-0001-7758-5252; Tickner, Jennifer/0000-0002-5020-0671; Pavlos, Nathan/0000-0001-7003-188X; Zheng, Minghao/0000-0003-1185-4768; Xu, Jiake/0000-0003-2021-8309	National Health and Medical Research Council; National Natural Science Foundation of China [81228013]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Health and Medical Research Council and by Grant 81228013 from the National Natural Science Foundation of China.	Adibhatla R, 2005, NEUROCHEM RES, V30, P15, DOI 10.1007/s11064-004-9681-8; Amblard D, 2003, J BONE MINER RES, V18, P561, DOI 10.1359/jbmr.2003.18.3.561; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 1998, BBA-LIPID LIPID MET, V1390, P1, DOI 10.1016/S0005-2760(97)00177-X; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chaves Neto Antonio Hernandes, 2011, J Cell Biochem, V112, P71, DOI 10.1002/jcb.22763; Chim SM, 2011, J BIOL CHEM, V286, P22035, DOI 10.1074/jbc.M110.187633; Concepcion D, 2004, GENETICS, V168, P953, DOI 10.1534/genetics.104.029843; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; Fagone P, 2009, J BIOL CHEM, V284, P6847, DOI 10.1074/jbc.M807338200; Feng HT, 2009, J BIOL CHEM, V284, P14667, DOI 10.1074/jbc.M901670200; Hill P A, 1998, Br J Orthod, V25, P101; Ishidate K, 1997, BBA-LIPID LIPID MET, V1348, P70, DOI 10.1016/S0005-2760(97)00118-5; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Judex S, 2004, J BONE MINER RES, V19, P607, DOI 10.1359/JBMR.040110; Khor EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070815; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Larson CM, 2000, J PEDIATR ORTHOPED, V20, P71, DOI 10.1097/00004694-200001000-00016; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Li Z, 2014, BBA-GEN SUBJECTS, V1840, P2112, DOI 10.1016/j.bbagen.2014.03.008; Li Z, 2014, BBA-MOL CELL BIOL L, V1841, P859, DOI 10.1016/j.bbalip.2014.02.004; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mitsuhashi S, 2013, CURR OPIN NEUROL, V26, P536, DOI 10.1097/WCO.0b013e328364c82d; Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Morgan EF, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P3; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; Ng PY, 2013, J BONE MINER RES, V28, P119, DOI 10.1002/jbmr.1725; Pearce JM, 2013, MAGN RESON MATER PHY, V26, P337, DOI 10.1007/s10334-012-0349-0; Quinlivan R, 2013, NEUROMUSCULAR DISORD, V23, P549, DOI 10.1016/j.nmd.2013.04.002; Ramirez de Molina A, 2005, CANCER RES, V65, P5647, DOI 10.1158/0008-5472.CAN-04-4416; Ramirez de Molina A, 2008, INT J BIOCHEM CELL B, V40, P1753, DOI 10.1016/j.biocel.2008.01.013; Rios PG, 2012, ARCH NEUROL-CHICAGO, V69, P657, DOI 10.1001/archneurol.2011.2333; Roberts S, 2007, J BONE MINER RES, V22, P617, DOI 10.1359/JBMR.070108; Roberts SJ, 2004, BIOCHEM J, V382, P59, DOI 10.1042/BJ20040511; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAW NJ, 1994, ARCH DIS CHILD, V71, P235, DOI 10.1136/adc.71.3.235; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; Shuaib A, 2000, EXP NEUROL, V161, P733, DOI 10.1006/exnr.1999.7314; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Tasdemir HA, 2001, PEDIATR INT, V43, P157, DOI 10.1046/j.1442-200x.2001.01352.x; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; UCHIDA T, 1994, J BIOCHEM-TOKYO, V116, P1241, DOI 10.1093/oxfordjournals.jbchem.a124670; UCHIDA T, 1992, J BIOL CHEM, V267, P10156; VANCE DE, 1990, BIOCHEM CELL BIOL, V68, P1151, DOI 10.1139/o90-172; Viola HM, 2007, CIRC RES, V100, P1036, DOI 10.1161/01.RES.0000263010.19273.48; WITTENBERG J, 1953, J BIOL CHEM, V202, P431; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Wu GS, 2009, BBA-MOL CELL BIOL L, V1791, P347, DOI 10.1016/j.bbalip.2009.02.006; Xu JK, 2005, J CELL PHYSIOL, V202, P554, DOI 10.1002/jcp.20159; Yadav MC, 2011, J BONE MINER RES, V26, P286, DOI 10.1002/jbmr.195; Yamashita T, 2008, BIOCHEM BIOPH RES CO, V365, P252, DOI 10.1016/j.bbrc.2007.10.169; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zaidi M, 2004, BIOL REV, V79, P79, DOI 10.1017/S1464793103006262	59	22	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1729	1742		10.1074/jbc.M114.567966	http://dx.doi.org/10.1074/jbc.M114.567966			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451916	hybrid, Green Published			2022-12-28	WOS:000348056400038
J	Lee, A; Wang, SY; Williams, B; Hagen, J; Scheetz, TE; Haeseleer, F				Lee, Amy; Wang, Shiyi; Williams, Brittany; Hagen, Jussara; Scheetz, Todd E.; Haeseleer, Francoise			Characterization of Ca(v)1.4 Complexes (alpha(1) 1.4, beta(2), and alpha(2)delta(4)) in HEK293T Cells and in the Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNELS; STATIONARY NIGHT BLINDNESS; DEPENDENT INACTIVATION; CONE PHOTORECEPTORS; CACNA1F MUTATIONS; CA2+ CHANNELS; SUBUNIT; EXPRESSION; MOUSE; GENE	In photoreceptor synaptic terminals, voltage-gated Ca(v)1.4 channels mediate Ca2+ signals required for transmission of visual stimuli. Like other high voltage-activated Ca-v channels, Ca(v)1.4 channels are composed of a main pore-forming Ca(v)1.4 alpha(1) subunit and auxiliary beta and alpha(2)delta subunits. Of the four distinct classes of beta and alpha(2)delta, beta(2) and alpha(2)delta(4) are thought to co-assemble with Ca(v)1.4 alpha(1) subunits in photoreceptors. However, an understanding of the functional properties of this combination of Ca-v subunits is lacking. Here, we provide evidence that Ca(v)1.4 alpha(1), beta(2), and alpha(2)delta(4) contribute to Ca(v)1.4 channel complexes in the retina and describe their properties in electrophysiological recordings. In addition, we identified a variant of beta(2), named here beta(2X13), which, along with beta(2a), is present in photoreceptor terminals. Ca(v)1.4 alpha(1), beta(2), and alpha(2)delta(4) were coimmunoprecipitated from lysates of transfected HEK293 cells and mouse retina and were found to interact in the outer plexiform layer of the retina containing the photoreceptor synaptic terminals, by proximity ligation assays. In whole-cell patch clamp recordings of transfected HEK293T cells, channels (Ca(v)1.4 alpha(1) + beta(2X13)) containing alpha(2)delta(4) exhibited weaker voltage-dependent activation than those with alpha(2)delta(1). Moreover, compared with channels (Ca(v)1.4 alpha(1) + alpha(2)delta(4)) with beta(2a), beta(2X13)-containing channels exhibited greater voltage-dependent inactivation. The latter effect was specific to Ca(v)1.4 because it was not seen for Ca(v)1.2 channels. Our results provide the first detailed functional analysis of the Ca(v)1.4 subunits that form native photoreceptor Ca(v)1.4 channels and indicate potential heterogeneity in these channels conferred by beta(2a) and beta(2X13) variants.	[Lee, Amy; Wang, Shiyi; Williams, Brittany; Hagen, Jussara] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Lee, Amy; Wang, Shiyi; Williams, Brittany; Hagen, Jussara] Univ Iowa, Dept Otolaryngol Head Neck Surg, Iowa City, IA 52242 USA; [Lee, Amy; Wang, Shiyi; Williams, Brittany; Hagen, Jussara] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Scheetz, Todd E.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Scheetz, Todd E.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Haeseleer, Francoise] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Washington; University of Washington Seattle	Haeseleer, F (corresponding author), Univ Washington, Dept Physiol & Biophys, 1705 NE Pacific St,Box 357290, Seattle, WA 98195 USA.	fanfan@u.washington.edu	Wang, Shiyi/AAC-9354-2019	Lee, Amy/0000-0001-8021-0443; williams, brittany/0000-0002-6597-619X; Wang, Shiyi/0000-0003-3433-3025; Scheetz, Todd/0000-0002-1965-5811	National Institutes of Health (NIH), NEI [R01-EY020850]; NIH [DC009433, NS084190, T32 NS007421]; NIH, NCRR [S10 RR025429]; Carver Research Program of Excellence Award; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025429] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY020850, P30EY001730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084190, T32NS007421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC009433, R01DC009433] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Carver Research Program of Excellence Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NEI, Grant R01-EY020850 (to F. H.); NIH Grants DC009433 and NS084190 (to A. L.); NIH Grant T32 NS007421 (to B. W.); and NIH, NCRR, Grant S10 RR025429 (to Sharona Gordon). This work was also supported by a Carver Research Program of Excellence Award (to A. L.).	Ball SL, 2011, BRAIN RES, V1412, P1, DOI 10.1016/j.brainres.2011.07.033; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Bernstein GM, 2007, CELL CALCIUM, V41, P27, DOI 10.1016/j.ceca.2006.04.010; Berntson A, 2003, J NEUROSCI RES, V71, P146, DOI 10.1002/jnr.10459; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boycott KM, 2001, HUM GENET, V108, P91, DOI 10.1007/s004390100461; Buraei Z, 2013, BBA-BIOMEMBRANES, V1828, P1530, DOI 10.1016/j.bbamem.2012.08.028; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Busquet P, 2010, INT J NEUROPSYCHOPH, V13, P499, DOI 10.1017/S1461145709990368; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chaudhuri D, 2007, J GEN PHYSIOL, V129, P385, DOI 10.1085/jgp.200709749; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Chu PJ, 2004, J MOL CELL CARDIOL, V36, P423, DOI 10.1016/j.yjmcc.2003.12.012; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; Doering CJ, 2005, BIOPHYS J, V89, P3042, DOI 10.1529/biophysj.105.067124; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Ebert AM, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-38; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Felix R, 1997, J NEUROSCI, V17, P6884; Ferreira G, 1997, J GEN PHYSIOL, V109, P449, DOI 10.1085/jgp.109.4.449; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Knoflach D, 2013, CHANNELS, V7, P503, DOI 10.4161/chan.26368; Ko ML, 2007, J NEUROCHEM, V103, P784, DOI 10.1111/j.1471-4159.2007.04816.x; Koschak A, 2003, J NEUROSCI, V23, P6041, DOI 10.1523/JNEUROSCI.23-14-06041.2003; Krizaj D, 2002, FRONT BIOSCI-LANDMRK, V7, pD2023, DOI 10.2741/krizaj; Kurshan PT, 2009, NAT NEUROSCI, V12, P1415, DOI 10.1038/nn.2417; Lipscombe D, 2013, BBA-BIOMEMBRANES, V1828, P1522, DOI 10.1016/j.bbamem.2012.09.018; Liu XN, 2013, CHANNELS, V7, P514, DOI 10.4161/chan.26376; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyford GL, 2002, AM J PHYSIOL-CELL PH, V283, pC1001, DOI 10.1152/ajpcell.00140.2002; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Mercer AJ, 2011, J NEUROSCI, V31, P4397, DOI 10.1523/JNEUROSCI.5921-10.2011; Morgans CW, 1999, EUR J NEUROSCI, V11, P2989, DOI 10.1046/j.1460-9568.1999.00719.x; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Muller LPD, 2013, J COMP NEUROL, V521, P2486, DOI 10.1002/cne.23294; Peloquin JB, 2008, NEUROSCIENCE, V151, P1066, DOI 10.1016/j.neuroscience.2007.11.053; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Qin N, 2002, MOL PHARMACOL, V62, P485, DOI 10.1124/mol.62.3.485; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; Roberts-Crowley ML, 2009, J GEN PHYSIOL, V133, P387, DOI 10.1085/jgp.200810047; Sandoval A, 2004, FEBS LETT, V576, P21, DOI 10.1016/j.febslet.2004.08.054; Schlick B, 2010, NEUROSCIENCE, V167, P786, DOI 10.1016/j.neuroscience.2010.02.037; Shaltiel L, 2012, J BIOL CHEM, V287, P36312, DOI 10.1074/jbc.M112.392811; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Taylor WR, 1998, VISUAL NEUROSCI, V15, P541; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vellani V, 2000, J PHYSIOL-LONDON, V529, P333, DOI 10.1111/j.1469-7793.2000.00333.x; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Whitmore SS, 2014, EXP EYE RES, V129, P93, DOI 10.1016/j.exer.2014.11.001; Wutz K, 2002, EUR J HUM GENET, V10, P449, DOI 10.1038/sj.ejhg.5200828; Wycisk KA, 2006, INVEST OPHTH VIS SCI, V47, P3523, DOI 10.1167/iovs.06-0271; Wycisk KA, 2006, AM J HUM GENET, V79, P973, DOI 10.1086/508944; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Zabouri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063853	71	39	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1505	1521		10.1074/jbc.M114.607465	http://dx.doi.org/10.1074/jbc.M114.607465			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25468907	Green Published, hybrid			2022-12-28	WOS:000348056400021
J	Watanabe, T; Ito, T; Goda, HM; Ishibashi, Y; Miyamoto, T; Ikeda, K; Taguchi, R; Okino, N; Ito, M				Watanabe, Takashi; Ito, Tomoharu; Goda, Hatsumi M.; Ishibashi, Yohei; Miyamoto, Tomofumi; Ikeda, Kazutaka; Taguchi, Ryo; Okino, Nozomu; Ito, Makoto			Sterylglucoside Catabolism in Cryptococcus neoformans with Endoglycoceramidase-related Protein 2 (EGCrP2), the First Steryl-beta-glucosidase Identified in Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; PICHIA-PASTORIS; GENE; GLUCOSYLCERAMIDE; VIRULENCE; PURIFICATION; SEQUENCE; CLONING; VACUOLE	Cryptococcosis is an infectious disease caused by pathogenic fungi, such as Cryptococcus neoformans and Cryptococcus gattii. The ceramide structure (methyl-d18: 2/h18: 0) of C. neoformans glucosylceramide (GlcCer) is characteristic and strongly related to its pathogenicity. We recently identified endoglycoceramidase-related protein 1 (EGCrP1) as a glucocerebrosidase in C. neoformans and showed that it was involved in the quality control of GlcCer by eliminating immature GlcCer during the synthesis of GlcCer (Ishibashi, Y., Ikeda, K., Sakaguchi, K., Okino, N., Taguchi, R., and Ito, M. (2012) Quality control of fungus-specific glucosylceramide in Cryptococcus neoformans by endoglycoceramidase-related protein 1 (EGCrP1). J. Biol. Chem. 287, 368-381). We herein identified and characterized EGCrP2, a homologue of EGCrP1, as the enzyme responsible for sterylglucoside catabolism in C. neoformans. In contrast to EGCrP1, which is specific to GlcCer, EGCrP2 hydrolyzed various beta-glucosides, including GlcCer, cholesteryl-beta-glucoside, ergosteryl-beta-glucoside, sitosteryl-beta-glucoside, and para-nitrophenyl-beta-glucoside, but not beta-glucosides or beta-galactosides, under acidic conditions. Disruption of the EGCrP2 gene (egcrp2) resulted in the accumulation of a glycolipid, the structure of which was determined following purification to ergosteryl-3 beta-glucoside, a major sterylglucoside in fungi, by mass spectrometric and two-dimensional nuclear magnetic resonance analyses. This glycolipid accumulated in vacuoles and EGCrP2 was detected in vacuole-enriched fraction. These results indicated that EGCrP2 was involved in the catabolism of ergosteryl-beta-glucoside in the vacuoles of C. neoformans. Distinct growth arrest, a dysfunction in cell budding, and an abnormal vacuole morphology were detected in the egcrp2-disrupted mutants, suggesting that EGCrP2 may be a promising target for anti-cryptococcal drugs. EGCrP2, classified into glycohydrolase family 5, is the first steryl-beta-glucosidase identified as well as a missing link in sterylglucoside metabolism in fungi.	[Watanabe, Takashi; Ito, Tomoharu; Goda, Hatsumi M.; Ishibashi, Yohei; Okino, Nozomu; Ito, Makoto] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka 8128581, Japan; [Miyamoto, Tomofumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan; [Ikeda, Kazutaka] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970052, Japan; [Taguchi, Ryo] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan	Kyushu University; Kyushu University; Keio University; Chubu University	Ito, M (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	makotoi@agr.kyushu-u.ac.jp	Ito, Makoto/Q-6164-2019; Okino, Nozomu/AAY-2635-2021	ito, Makoto/0000-0003-3159-7818	Japanese Ministry of Education, Culture, Science, and Technology [24380058]; Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research [24619007] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Basic Research B Grant 24380058 from the Japanese Ministry of Education, Culture, Science, and Technology and the Japan Foundation for Applied Enzymology (to M. I.).	Aguirre A, 2014, APPL MICROBIOL BIOT, V98, P4033, DOI 10.1007/s00253-013-5345-4; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Cabrera M, 2008, METHOD ENZYMOL, V451, P177, DOI 10.1016/S0076-6879(08)03213-8; Caines MEC, 2007, J BIOL CHEM, V282, P14300, DOI 10.1074/jbc.M611455200; Cao Y, 2007, AUTOPHAGY, V3, P17, DOI 10.4161/auto.3371; Cornet M, 2005, INFECT IMMUN, V73, P7977, DOI 10.1128/IAI.73.12.7977-7987.2005; COX GM, 1995, J MED VET MYCOL, V33, P261; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Franke K, 2006, MICROBIOL-SGM, V152, P3111, DOI 10.1099/mic.0.29115-0; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Grille S, 2010, PROG LIPID RES, V49, P262, DOI 10.1016/j.plipres.2010.02.001; Harrison TS, 2002, MED MYCOL, V40, P329, DOI 10.1080/mmy.40.3.329.332; Hayashi Y, 2008, ANAL BIOCHEM, V383, P122, DOI 10.1016/j.ab.2008.07.024; Idnurm A, 2003, PHYSIOL MOL PLANT P, V62, P305, DOI 10.1016/S0885-5765(03)00074-2; Ishibashi Y, 2012, J BIOL CHEM, V287, P368, DOI 10.1074/jbc.M111.311340; ITO M, 1986, J BIOL CHEM, V261, P14278; Izu H, 1997, J BIOL CHEM, V272, P19846, DOI 10.1074/jbc.272.32.19846; Johnston DA, 2009, INFECT IMMUN, V77, P2343, DOI 10.1128/IAI.01458-08; KALINOWSKA M, 1978, PHYTOCHEMISTRY, V17, P1533, DOI 10.1016/S0031-9422(00)94637-5; Kim MS, 2009, BIOCHEM BIOPH RES CO, V390, P983, DOI 10.1016/j.bbrc.2009.10.089; Kim YK, 2002, PLANT J, V30, P177, DOI 10.1046/j.1365-313X.2002.01284.x; Kunimoto S, 2002, CELL STRUCT FUNCT, V27, P157, DOI 10.1247/csf.27.157; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Nakagawa T, 1999, J BIOCHEM, V126, P604, DOI 10.1093/oxfordjournals.jbchem.a022492; Oku M, 2003, EMBO J, V22, P3231, DOI 10.1093/emboj/cdg331; Oura T, 2008, MICROBIOL-SGM, V154, P3795, DOI 10.1099/mic.0.2008/018788-0; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PERFECT JR, 1992, GENE, V122, P213, DOI 10.1016/0378-1119(92)90053-R; Poltermann S, 2005, MICROBIOL-SGM, V151, P1645, DOI 10.1099/mic.0.27505-0; Rhome R, 2007, EUKARYOT CELL, V6, P1715, DOI 10.1128/EC.00208-07; Richards A, 2012, J MICROBIOL METH, V91, P155, DOI 10.1016/j.mimet.2012.08.002; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; Singh A, 2012, CELL MICROBIOL, V14, P500, DOI 10.1111/j.1462-5822.2011.01735.x; Stasyk OV, 2003, CELL BIOL INT, V27, P947, DOI 10.1016/j.cellbi.2003.08.004; Ternes P, 2006, J BIOL CHEM, V281, P5582, DOI 10.1074/jbc.M512864200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Warnecke D, 1999, J BIOL CHEM, V274, P13048, DOI 10.1074/jbc.274.19.13048; Zhang YQ, 2012, CURR PROTEIN PEPT SC, V13, P134, DOI 10.2174/138920312800493205; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993	44	27	29	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1005	1019		10.1074/jbc.M114.616300	http://dx.doi.org/10.1074/jbc.M114.616300			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25361768	Green Published, hybrid			2022-12-28	WOS:000347778200034
J	Yap, TL; Jiang, ZP; Heinrich, F; Gruschus, JM; Pfefferkorn, CM; Barros, M; Curtis, JE; Sidransky, E; Lee, JC				Yap, Thai Leong; Jiang, Zhiping; Heinrich, Frank; Gruschus, James M.; Pfefferkorn, Candace M.; Barros, Marilia; Curtis, Joseph E.; Sidransky, Ellen; Lee, Jennifer C.			Structural Features of Membrane-bound Glucocerebrosidase and alpha-Synuclein Probed by Neutron Reflectometry and Fluorescence Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILAYER-LIPID MEMBRANES; ACID-BETA-GLUCOSIDASE; SAPOSIN-C; PARKINSONS-DISEASE; GAUCHER-DISEASE; LYSOSOMAL DEGRADATION; DEFECTIVE ENZYME; PROTEIN; MUTATIONS; BINDING	Mutations in glucocerebrosidase (GCase), the enzyme deficient in Gaucher disease, are a common genetic risk factor for the development of Parkinson disease and related disorders, implicating the role of this lysosomal hydrolase in the disease etiology. A specific physical interaction exists between the Parkinson disease-related protein alpha-synuclein (alpha-syn) and GCase both in solution and on the lipid membrane, resulting in efficient enzyme inhibition. Here, neutron reflectometry was employed as a first direct structural characterization of GCase and alpha-syn.GCase complex on a sparsely-tethered lipid bilayer, revealing the orientation of the membrane-bound GCase. GCase binds to and partially inserts into the bilayer with its active site most likely lying just above the membrane-water interface. The interaction was further characterized by intrinsic Trp fluorescence, circular dichroism, and surface plasmon resonance spectroscopy. Both Trp fluorescence and neutron reflectometry results suggest a rearrangement of loops surrounding the catalytic site, where they extend into the hydrocarbon chain region of the outer leaflet. Taking advantage of contrasting neutron scattering length densities, the use of deuterated alpha-syn versus protiated GCase showed a large change in the membrane-bound structure of alpha-syn in the complex. We propose a model of alpha-syn.GCase on the membrane, providing structural insights into inhibition of GCase by alpha-syn. The interaction displaces GCase away from the membrane, possibly impeding substrate access and perturbing the active site. GCase greatly alters membrane-bound alpha-syn, moving helical residues away from the bilayer, which could impact the degradation of alpha-syn in the lysosome where these two proteins interact.	[Yap, Thai Leong; Jiang, Zhiping; Gruschus, James M.; Pfefferkorn, Candace M.; Lee, Jennifer C.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Sidransky, Ellen] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Heinrich, Frank; Barros, Marilia] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Heinrich, Frank; Curtis, Joseph E.] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Carnegie Mellon University; National Institute of Standards & Technology (NIST) - USA	Lee, JC (corresponding author), NHLBI, Lab Mol Biophys, NIH, 50 South Dr,Bldg 50 Rm 3513, Bethesda, MD 20892 USA.	leej4@mail.nih.gov	Lee, Jennifer/E-9658-2015; Barros, Marilia/I-7772-2019; Heinrich, Frank/A-5339-2010	Lee, Jennifer/0000-0003-0506-8349; Heinrich, Frank/0000-0002-8579-553X; Barros, Marilia/0000-0002-4628-3048	Intramural Research Program at the National Institutes of Health; NHLBI; NHGRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006144] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200336] Funding Source: NIH RePORTER	Intramural Research Program at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research Program at the National Institutes of Health, NHLBI, and NHGRI. Research was performed in part at the NIST Center for Nanoscale Science and Technology and by the NIST IMS program "Precision Measurements for Integral Membrane Proteins."	Alattia JR, 2007, P NATL ACAD SCI USA, V104, P17394, DOI 10.1073/pnas.0704998104; ANKNER JF, 1992, P SOC PHOTO-OPT INS, V1738, P260, DOI 10.1117/12.130637; Atrian S, 2008, PROTEINS, V70, P882, DOI 10.1002/prot.21554; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Brumshtein B, 2006, ACTA CRYSTALLOGR D, V62, P1458, DOI 10.1107/S0907444906038303; Budvytyte R, 2013, LANGMUIR, V29, P8645, DOI 10.1021/la401132c; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi JH, 2011, MOL GENET METAB, V104, P185, DOI 10.1016/j.ymgme.2011.06.008; Clifton Luke A, 2013, Methods Mol Biol, V974, P119, DOI 10.1007/978-1-62703-275-9_7; Clifton LA, 2012, J BIOL CHEM, V287, P337, DOI 10.1074/jbc.M111.302901; Dura JA, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2219744; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Fiaux J, 2004, J BIOMOL NMR, V29, P289, DOI 10.1023/B:JNMR.0000032523.00554.38; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Goker-Alpan O, 2010, ACTA NEUROPATHOL, V120, P641, DOI 10.1007/s00401-010-0741-7; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hatty CR, 2014, BBA-BIOMEMBRANES, V1838, P1019, DOI 10.1016/j.bbamem.2013.12.013; Heinrich F, 2014, BBA-BIOMEMBRANES, V1838, P2341, DOI 10.1016/j.bbamem.2014.03.007; Heinrich F, 2014, J BIOL CHEM, V289, P9683, DOI 10.1074/jbc.M113.543561; Heinrich F, 2009, LANGMUIR, V25, P4219, DOI 10.1021/la8033275; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; Jiang ZP, 2013, J AM CHEM SOC, V135, P15970, DOI 10.1021/ja405993r; Kirby BJ, 2012, CURR OPIN COLLOID IN, V17, P44, DOI 10.1016/j.cocis.2011.11.001; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Ladokhin AS, 1999, BIOPHYS J, V76, P946, DOI 10.1016/S0006-3495(99)77258-9; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Lieberman Raquel L, 2011, Enzyme Res, V2011, P973231, DOI 10.4061/2011/973231; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; McGillivray DJ, 2007, BIOINTERPHASES, V2, P21, DOI 10.1116/1.2709308; McGillivray DJ, 2009, BIOPHYS J, V96, P1547, DOI 10.1016/j.bpj.2008.11.020; McGlinchey RP, 2013, BIOCHEM SOC T, V41, P1509, DOI 10.1042/BST20130158; MCINTOSH TJ, 1987, BIOCHEMISTRY-US, V26, P1783, DOI 10.1021/bi00380a042; MORIMOTO S, 1990, J BIOL CHEM, V265, P1933; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Nalls MA, 2013, JAMA NEUROL, V70, P727, DOI 10.1001/jamaneurol.2013.1925; Nanda H, 2010, BIOPHYS J, V99, P2516, DOI 10.1016/j.bpj.2010.07.062; Pfefferkorn CM, 2012, BIOPHYS J, V102, P613, DOI 10.1016/j.bpj.2011.12.051; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Qi XY, 1998, BIOCHEMISTRY-US, V37, P11544, DOI 10.1021/bi980785+; Sardi SP, 2013, P NATL ACAD SCI USA, V110, P3537, DOI 10.1073/pnas.1220464110; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Shaaltiel Y, 2007, PLANT BIOTECHNOL J, V5, P579, DOI 10.1111/j.1467-7652.2007.00263.x; Shekhar P, 2011, J APPL PHYS, V110, DOI 10.1063/1.3661986; Shenoy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032591; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Tanner DE, 2011, J CHEM THEORY COMPUT, V7, P3635, DOI 10.1021/ct200563j; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; VACCARO AM, 1993, FEBS LETT, V336, P159, DOI 10.1016/0014-5793(93)81631-9; Wilkening G, 1998, J BIOL CHEM, V273, P30271, DOI 10.1074/jbc.273.46.30271; Xilouri M, 2013, MOL NEUROBIOL, V47, P537, DOI 10.1007/s12035-012-8341-2; Yap TL, 2013, BIOCHEMISTRY-US, V52, P7161, DOI 10.1021/bi401191v; Yap TL, 2013, MOL GENET METAB, V108, P56, DOI 10.1016/j.ymgme.2012.11.010; Yap TL, 2011, J BIOL CHEM, V286, P28080, DOI 10.1074/jbc.M111.237859	59	33	33	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					744	754		10.1074/jbc.M114.610584	http://dx.doi.org/10.1074/jbc.M114.610584			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25429104	Green Published, hybrid			2022-12-28	WOS:000347778200005
J	Liu, JC; Ferreira, CG; Yusufzai, T				Liu, Jessica C.; Ferreira, Catarina G.; Yusufzai, Timur			Human CHD2 Is a Chromatin Assembly ATPase Regulated by Its Chromo- and DNA-binding Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; Chromatin Remodeling; DNA-binding Protein; Epilepsy; Nucleosome; CHD2; Chromodomains	REMODELING FACTOR; MOUSE DEVELOPMENT; SNF2 FAMILY; ISWI; ACF; NUCLEOSOMES; MUTATIONS; HELICASE; PROTEIN; IDENTIFICATION	Background: CHD2 is a conserved ATPase and deletions of CHD2 have been linked to developmental and neurological disorders. Results: The regions flanking the ATPase domain of CHD2 confer substrate specificity and couple ATP hydrolysis to remodeling. Conclusion: CHD2 possesses nucleosome assembly activity regulated by its accessory domains. Significance: Understanding the mechanisms of chromatin remodeling is crucial for delineating how remodeling defects contribute to human diseases. Chromodomain helicase DNA-binding protein 2 (CHD2) is an ATPase and a member of the SNF2-like family of helicase-related enzymes. Although deletions of CHD2 have been linked to developmental defects in mice and epileptic disorders in humans, little is known about its biochemical and cellular activities. In this study, we investigate the ATP-dependent activity of CHD2 and show that CHD2 catalyzes the assembly of chromatin into periodic arrays. We also show that the N-terminal region of CHD2, which contains tandem chromodomains, serves an auto-inhibitory role in both the DNA-binding and ATPase activities of CHD2. While loss of the N-terminal region leads to enhanced chromatin-stimulated ATPase activity, the N-terminal region is required for ATP-dependent chromatin remodeling by CHD2. In contrast, the C-terminal region, which contains a putative DNA-binding domain, selectively senses double-stranded DNA of at least 40 base pairs in length and enhances the ATPase and chromatin remodeling activities of CHD2. Our study shows that the accessory domains of CHD2 play central roles in both regulating the ATPase domain and conferring selectivity to chromatin substrates.	[Liu, Jessica C.; Ferreira, Catarina G.; Yusufzai, Timur] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Liu, Jessica C.; Ferreira, Catarina G.; Yusufzai, Timur] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA; [Liu, Jessica C.] Harvard Univ, Dept Mol & Cellular Biol, Grad Program Mol Cells & Organisms, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University	Yusufzai, T (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,JF520, Boston, MA 02215 USA.	timur_yusufzai@dfci.harvard.edu	Ferreira, Carlos Gil/AAD-4104-2020; Ferreira, Carlos Gil/G-4957-2013	Ferreira, Carlos Gil/0000-0002-7228-7018; 				Alexiadis V, 2004, J BIOL CHEM, V279, P27824, DOI 10.1074/jbc.M402648200; Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Boyer LA, 2000, J BIOL CHEM, V275, P11545, DOI 10.1074/jbc.275.16.11545; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Chenier S, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-9; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Courage C, 2014, EUR J MED GENET, V57, P520, DOI 10.1016/j.ejmg.2014.06.003; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Fan HY, 2003, MOL CELL, V11, P1311, DOI 10.1016/S1097-2765(03)00192-8; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Harada A, 2012, EMBO J, V31, P2994, DOI 10.1038/emboj.2012.136; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; HENIKOFF S, 1993, TRENDS BIOCHEM SCI, V18, P291, DOI 10.1016/0968-0004(93)90037-N; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kulkarni S, 2008, AM J MED GENET A, V146A, P1117, DOI 10.1002/ajmg.a.32178; Lake RJ, 2010, MOL CELL, V37, P235, DOI 10.1016/j.molcel.2009.10.027; Lund C, 2014, EPILEPSY BEHAV, V33, P18, DOI 10.1016/j.yebeh.2014.02.005; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Marfella CGA, 2006, J CELL PHYSIOL, V209, P162, DOI 10.1002/jcp.20718; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P82, DOI 10.1038/nsmb.2457; Nakagawa T, 2001, J BIOL CHEM, V276, P27384, DOI 10.1074/jbc.M101331200; Quan JH, 2014, J BIOL CHEM, V289, P20717, DOI 10.1074/jbc.M114.568568; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Robinson KM, 2003, MOL CELL BIOL, V23, P7937, DOI 10.1128/MCB.23.22.7937-7946.2003; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Suls A, 2013, AM J HUM GENET, V93, P967, DOI 10.1016/j.ajhg.2013.09.017; Torigoe SE, 2013, ELIFE, V2, DOI 10.7554/eLife.00863; Torigoe SE, 2011, MOL CELL, V43, P638, DOI 10.1016/j.molcel.2011.07.017; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233	43	27	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					25	34		10.1074/jbc.M114.609156	http://dx.doi.org/10.1074/jbc.M114.609156			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25384982	Green Published, hybrid			2022-12-28	WOS:000347231200003
J	Raspelli, E; Cassani, C; Chiroli, E; Fraschini, R				Raspelli, Erica; Cassani, Corinne; Chiroli, Elena; Fraschini, Roberta			Budding Yeast Swe1 Is Involved in the Control of Mitotic Spindle Elongation and Is Regulated by Cdc14 Phosphatase during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclin-dependent Kinase (Cdk); Mitosis; Mitotic Spindle; Phosphorylation; Yeast	MORPHOGENESIS CHECKPOINT; SACCHAROMYCES-CEREVISIAE; TYROSINE PHOSPHORYLATION; PROTEIN-KINASE; POLO KINASE; CELL-CYCLE; ANAPHASE; DEGRADATION; EXIT; WEE1	Background: Timely mitotic spindle elongation ensures correct chromosome segregation, which is crucial for genetic stability. Results: The protein kinase Swe1 contributes to restraining anaphase progression and is regulated by the protein phosphatase Cdc14. Conclusion: Swe1 plays a role in the control of mitotic spindle elongation. Significance: Swe1 regulation by Cdc14 allows proper coordination of spindle elongation with mitotic progression. Cyclin-dependent kinase (Cdk1) activity is required for mitotic entry, and this event is restrained by an inhibitory phosphorylation of the catalytic subunit Cdc28 on a conserved tyrosine (Tyr(19)). This modification is brought about by the protein kinase Swe1 that inhibits Cdk1 activation thus blocking mitotic entry. Swe1 levels are regulated during the cell cycle, and they decrease during G(2)/M concomitantly to Cdk1 activation, which drives entry into mitosis. However, after mitotic entry, a pool of Swe1 persists, and we collected evidence that it is involved in controlling mitotic spindle elongation. We also describe that the protein phosphatase Cdc14 is implicated in Swe1 regulation; in fact, we observed that Swe1 dephosphorylation in vivo depends on Cdc14 that, in turn, is able to control its subcellular localization. In addition we show that the lack of Swe1 causes premature mitotic spindle elongation and that high levels of Swe1 block mitotic spindle elongation, indicating that Swe1 inhibits this process. Importantly, these effects are not dependent upon the role of in Cdk1 inhibition. These data fit into a model in which Cdc14 binds and inhibits Swe1 to allow timely mitotic spindle elongation.	[Raspelli, Erica; Cassani, Corinne; Fraschini, Roberta] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, I-20126 Milan, Italy; [Chiroli, Elena] FIRC, Inst Mol Oncol, IFOM, I-20139 Milan, Italy	University of Milano-Bicocca; IFOM - FIRC Institute of Molecular Oncology	Fraschini, R (corresponding author), Univ Milano Bicocca, Dipt Biotecnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy.	roberta.fraschini@unimib.it	fraschini, roberta/G-5680-2015	Chiroli, Elena/0000-0001-8668-0657; Raspelli, Erica/0000-0002-0937-0521	Fondazione Buzzati-Traverso; Fondazione Confalonieri; Fondazione Veronesi	Fondazione Buzzati-Traverso; Fondazione Confalonieri; Fondazione Veronesi(Fondazione Umberto Veronesi)	Supported by a fellowship from Fondazione Buzzati-Traverso.; Supported by a fellowship from Fondazione Confalonieri.; Supported by a Young Investigator Programme 2013 fellowship from Fondazione Veronesi.	AMON A, 1992, NATURE, V355, P368, DOI 10.1038/355368a0; Asano S, 2005, EMBO J, V24, P2194, DOI 10.1038/sj.emboj.7600683; Bembenek J, 2005, CELL CYCLE, V4, P961, DOI 10.4161/cc.4.7.1798; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; de Gramont A, 2005, TRENDS BIOCHEM SCI, V30, P559, DOI 10.1016/j.tibs.2005.08.008; Fraschini R, 2006, J CELL BIOL, V172, P335, DOI 10.1083/jcb.200507162; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Fraschini R, 1999, J CELL BIOL, V145, P979, DOI 10.1083/jcb.145.5.979; Garcia K, 2009, CURR BIOL, V19, P1670, DOI 10.1016/j.cub.2009.08.013; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Howell AS, 2012, GENETICS, V190, P51, DOI 10.1534/genetics.111.128314; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Keaton MA, 2006, CURR OPIN MICROBIOL, V9, P540, DOI 10.1016/j.mib.2006.10.004; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; King K, 2013, MOL BIOL CELL, V24, P914, DOI 10.1091/mbc.E12-11-0812; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Lim HH, 1996, MOL CELL BIOL, V16, P6385; Maniatis T., 1992, MOL CLONING LAB MANU; McMillan JN, 2002, MOL BIOL CELL, V13, P3560, DOI 10.1091/mbc.E02-05-0283; McMillan JN, 1999, MOL CELL BIOL, V19, P5981; McMillan JN, 1998, J CELL BIOL, V142, P1487, DOI 10.1083/jcb.142.6.1487; Merlini L, 2012, PLOS GENET, V8, P531, DOI 10.1371/journal.pgen.1002670; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Raspelli E, 2011, MOL BIOL CELL, V22, P2185, DOI 10.1091/mbc.E11-02-0127; RUSSELL P, 1989, CELL, V57, P295, DOI 10.1016/0092-8674(89)90967-7; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shou WY, 2001, MOL CELL, V8, P45, DOI 10.1016/S1097-2765(01)00291-X; Sia RAL, 1998, EMBO J, V17, P6678, DOI 10.1093/emboj/17.22.6678; Sia RAL, 1996, MOL BIOL CELL, V7, P1657, DOI 10.1091/mbc.7.11.1657; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Visintin C, 2008, GENE DEV, V22, P79, DOI 10.1101/gad.1601308; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687	43	10	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					1	12		10.1074/jbc.M114.590984	http://dx.doi.org/10.1074/jbc.M114.590984			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25406317	Green Published, hybrid			2022-12-28	WOS:000347231200001
J	da Palma, JR; Burri, DJ; Oppliger, J; Salamina, M; Cendron, L; de Laureto, PP; Seidah, NG; Kunz, S; Pasquato, A				da Palma, Joel Ramos; Burri, Dominique Julien; Oppliger, Joel; Salamina, Marco; Cendron, Laura; de Laureto, Patrizia Polverino; Seidah, Nabil Georges; Kunz, Stefan; Pasquato, Antonella			Zymogen Activation and Subcellular Activity of Subtilisin Kexin Isozyme 1/Site 1 Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEINS; CHORIOMENINGITIS VIRUS GLYCOPROTEIN; PROPROTEIN CONVERTASE SKI-1/S1P; CHOLESTEROL-METABOLISM; SUBTILASE SKI-1/S1P; SITE-1 PROTEASE; CLEAVAGE; BIOSYNTHESIS; PROPEPTIDE; PRECURSOR	The proprotein convertase subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P) plays crucial roles in cellular homeostatic functions and is hijacked by pathogenic viruses for the processing of their envelope glycoproteins. Zymogen activation of SKI1/S1P involves sequential autocatalytic processing of its N-terminal prodomain at sites B'/B followed by the herein newly identified C'/C sites. We found that SKI-1/S1P autoprocessing results in intermediates whose catalytic domain remains associated with prodomain fragments of different lengths. In contrast to other zymogen proprotein convertases, all incompletely matured intermediates of SKI-1/S1P showed full catalytic activity toward cellular substrates, whereas optimal cleavage of viral glycoproteins depended on B'/B processing. Incompletely matured forms of SKI-1/S1P further process cellular and viral substrates in distinct subcellular compartments. Using a cell-based sensor for SKI-1/S1P activity, we found that 9 amino acid residues at the cleavage site (P1-P8) and P1' are necessary and sufficient to define the subcellular location of processing and to determine to what extent processing of a substrate depends on SKI-1/S1P maturation. In sum, our study reveals novel and unexpected features of SKI-1/S1P zymogen activation and subcellular specificity of activity toward cellular and pathogen-derived substrates.	[da Palma, Joel Ramos; Burri, Dominique Julien; Oppliger, Joel; Kunz, Stefan; Pasquato, Antonella] Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland; [da Palma, Joel Ramos; Burri, Dominique Julien; Oppliger, Joel; Kunz, Stefan; Pasquato, Antonella] Univ Lausanne, CH-1011 Lausanne, Switzerland; [Salamina, Marco; Cendron, Laura] Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, Dept Biol, I-35121 Padua, Italy; [de Laureto, Patrizia Polverino] Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, Dept Pharmaceut Sci, I-35121 Padua, Italy; [Seidah, Nabil Georges] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	University of Lausanne; University of Padua; University of Padua; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Kunz, S (corresponding author), Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland.	Stefan.Kunz@chuv.ch; Antonella.Pasquato@chuv.ch	Seidah, Nabil/I-3596-2013; Kunz, Stefan/K-5840-2017	Seidah, Nabil/0000-0001-6503-9342; Pasquato, Antonella/0000-0002-9428-0722; Cendron, Laura/0000-0002-0125-0461; Kunz, Stefan/0000-0001-6030-9550	Swiss National Science Foundation [FN 31003A-135536]; University of Lausanne; Canadian Institutes of Health Research Grant [93792]; Canada Chair Grant [216684]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Lausanne; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canada Chair Grant	This work was supported by Swiss National Science Foundation Grant FN 31003A-135536 (to S. K.), funds from the University of Lausanne (to S. K.), Canadian Institutes of Health Research Grant 93792 (to N. G. S.), and Canada Chair Grant 216684 (to N. G. S.). The authors declare that the cell-based sensor SS-LASV is patented.	Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Beyer WR, 2003, J VIROL, V77, P2866, DOI 10.1128/JVI.77.5.2866-2872.2003; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Burri DJ, 2013, J VIROL, V87, P6406, DOI 10.1128/JVI.00072-13; Burri DJ, 2012, J VIROL, V86, P4935, DOI 10.1128/JVI.00024-12; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; Elagoz A, 2002, J BIOL CHEM, V277, P11265, DOI 10.1074/jbc.M109011200; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Goerke AR, 2008, METAB ENG, V10, P187, DOI 10.1016/j.ymben.2008.04.001; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Kunz S, 2003, VIROLOGY, V314, P168, DOI 10.1016/S0042-6822(03)00421-5; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; OHTA Y, 1991, MOL MICROBIOL, V5, P1507, DOI 10.1111/j.1365-2958.1991.tb00797.x; OHTA Y, 1991, MOL MICROBIOL, V5, P3090; Pasquato A, 2006, J BIOL CHEM, V281, P23471, DOI 10.1074/jbc.M513675200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Pullikotil P, 2004, J BIOL CHEM, V279, P17338, DOI 10.1074/jbc.M313764200; Pullikotil P, 2007, J BIOL CHEM, V282, P27402, DOI 10.1074/jbc.M703200200; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; REHEMTULLA A, 1992, P NATL ACAD SCI USA, V89, P8235, DOI 10.1073/pnas.89.17.8235; Reiling JH, 2013, NAT CELL BIOL, V15, P1473, DOI 10.1038/ncb2865; Rojek JM, 2008, J VIROL, V82, P6045, DOI 10.1128/JVI.02392-07; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Sone M, 2005, BBA-PROTEINS PROTEOM, V1749, P15, DOI 10.1016/j.bbapap.2005.01.011; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.77.16.8640-8649.2003; WEBER EL, 1988, VIROLOGY, V164, P30, DOI 10.1016/0042-6822(88)90616-2; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zandberg WF, 2011, GLYCOBIOLOGY, V21, P1290, DOI 10.1093/glycob/cwr060	39	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35743	35756		10.1074/jbc.M114.588525	http://dx.doi.org/10.1074/jbc.M114.588525			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378398	hybrid, Green Published			2022-12-28	WOS:000346897900007
J	Ramon, E; Cordomi, A; Aguila, M; Srinivasan, S; Dong, XY; Moore, AT; Webster, AR; Cheetham, ME; Garriga, P				Ramon, Eva; Cordomi, Arnau; Aguila, Monica; Srinivasan, Sundaramoorthy; Dong, Xiaoyun; Moore, Anthony T.; Webster, Andrew R.; Cheetham, Michael E.; Garriga, Pere			Differential Light-induced Responses in Sectorial Inherited Retinal Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; RHODOPSIN RETINITIS-PIGMENTOSA; INTERNAL WATER-MOLECULES; CRYSTAL-STRUCTURE; CONFORMATIONAL STABILITY; FRIEDENWALD-LECTURE; METARHODOPSIN-II; BOVINE RHODOPSIN; CELL-DEATH; ACTIVATION	Retinitis pigmentosa (RP) is a group of genetically and clinically heterogeneous inherited degenerative retinopathies caused by abnormalities of photoreceptors or retinal pigment epithelium in the retina leading to progressive sight loss. Rhodopsin is the prototypical G-protein-coupled receptor located in the vertebrate retina and is responsible for dim light vision. Here, novel M39R and N55K variants were identified as causing an intriguing sector phenotype of RP in affected patients, with selective degeneration in the inferior retina. To gain insights into the molecular aspects associated with this sector RP phenotype, whose molecular mechanism remains elusive, the mutations were constructed by site-directed mutagenesis, expressed in heterologous systems, and studied by biochemical, spectroscopic, and functional assays. M39R and N55K opsins had variable degrees of chromophore regeneration when compared with WT opsin but showed no gross structural misfolding or altered trafficking. M39R showed a faster rate for transducin activation than WT rhodopsin with a faster metarhodopsinII decay, whereas N55K presented a reduced activation rate and an altered photobleaching pattern. N55K also showed an altered retinal release from the opsin binding pocket upon light exposure, affecting its optimal functional response. Our data suggest that these sector RP mutations cause different protein phenotypes that may be related to their different clinical progression. Overall, these findings illuminate the molecular mechanisms of sector RP associated with rhodopsin mutations.	[Ramon, Eva; Srinivasan, Sundaramoorthy; Dong, Xiaoyun; Garriga, Pere] Univ Politecn Cataluna, Dept Engn Quim, Ctr Biotecnol Mol, Terrassa 08222, Spain; [Cordomi, Arnau] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Cerdanyola Del Valles 08193, Spain; [Aguila, Monica; Moore, Anthony T.; Webster, Andrew R.; Cheetham, Michael E.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Moore, Anthony T.; Webster, Andrew R.] Moorfields Eye Hosp, London EC1V 2PD, England	Universitat Politecnica de Catalunya; Autonomous University of Barcelona; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Garriga, P (corresponding author), Univ Politecn Cataluna, Dept Engn Quim, Ctr Biotecnol Mol, Rambla St Nebridi 22, Terrassa 08222, Spain.	pere.garriga@upc.edu	Srinivasan, Sundaramoorthy/A-2753-2016; Cordomí, Arnau/A-1686-2009; Garriga, Pere/C-1949-2017	Cordomí, Arnau/0000-0002-3848-2928; Garriga, Pere/0000-0003-4234-8382; Srinivasan, Sundaramoorthy/0000-0003-4750-0478; Cheetham, Michael/0000-0001-6429-654X	Ministerio de Ciencia e Innovacion [SAF2011-30216-C02-01]; Grups de Recerca Consolidats de la Generalitat de Catalunya Grants [2009 SGR 1402]; RP Fighting Blindness; Wellcome Trust; Beatriu de Pinos Fellowship from Agencia de Gestio d'Ajuts Universitaris i de Recerca; Instituto de Salud Carlos III; Formacio d'Investigadors from Agencia de Gestio d'Ajuts Universitaris i de Recerca; Chinese Scholarship Council; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; National Institute for Health Research [NF-SI-0507-10204] Funding Source: researchfish	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Grups de Recerca Consolidats de la Generalitat de Catalunya Grants; RP Fighting Blindness; Wellcome Trust(Wellcome Trust); Beatriu de Pinos Fellowship from Agencia de Gestio d'Ajuts Universitaris i de Recerca; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Formacio d'Investigadors from Agencia de Gestio d'Ajuts Universitaris i de Recerca; Chinese Scholarship Council(China Scholarship Council); National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported in part by Grant SAF2011-30216-C02-01 from Ministerio de Ciencia e Innovacion and Grups de Recerca Consolidats de la Generalitat de Catalunya Grants 2009 SGR 1402 (to P. G.), and the RP Fighting Blindness and Wellcome Trust (to M. E. C.).; Recipient of Beatriu de Pinos Fellowship from Agencia de Gestio d'Ajuts Universitaris i de Recerca.; Recipient of a contract grant from the Instituto de Salud Carlos III.; Recipient of a predoctoral scholarship Formacio d'Investigadors from Agencia de Gestio d'Ajuts Universitaris i de Recerca.; Recipient of a predoctoral fellowship from the Chinese Scholarship Council.; Supported by the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Audo I, 2010, ARCH OPHTHALMOL-CHIC, V128, P1036, DOI 10.1001/archophthalmol.2010.162; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Bessant D A, 1999, Hum Mutat, V13, P83, DOI 10.1002/(SICI)1098-1004(1999)13:1<83::AID-HUMU12>3.0.CO;2-5; Bosch-Presegue L, 2011, FEBS J, V278, P1493, DOI 10.1111/j.1742-4658.2011.08066.x; Cabana J, 2013, J BIOL CHEM, V288, P2593, DOI 10.1074/jbc.M112.395939; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Ciarkowski J, 2001, ACTA BIOCHIM POL, V48, P1203; Cideciyan AV, 2005, P NATL ACAD SCI USA, V102, P5233, DOI 10.1073/pnas.0408892102; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Fain GL, 1999, INVEST OPHTH VIS SCI, V40, P2770; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Hargrave PA, 2001, INVEST OPHTH VIS SCI, V42, P3; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Hwa J, 1997, P NATL ACAD SCI USA, V94, P10571, DOI 10.1073/pnas.94.20.10571; Jastrzebska B, 2010, BIOCHEM J, V428, P1, DOI 10.1042/BJ20100270; Sanchez-Martin MJ, 2013, CHEMBIOCHEM, V14, P639, DOI 10.1002/cbic.201200687; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; LISMAN J, 1995, NAT MED, V1, P1254, DOI 10.1038/nm1295-1254; Majumder A, 2013, P NATL ACAD SCI USA, V110, P12468, DOI 10.1073/pnas.1222666110; Matsuyama T, 2010, J BIOL CHEM, V285, P8114, DOI 10.1074/jbc.M109.063875; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; MOORE AT, 1992, BRIT J OPHTHALMOL, V76, P465, DOI 10.1136/bjo.76.8.465; Naash ML, 1996, INVEST OPHTH VIS SCI, V37, P775; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Orisme W, 2010, CELL SIGNAL, V22, P447, DOI 10.1016/j.cellsig.2009.10.016; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Paskowitz DM, 2006, BRIT J OPHTHALMOL, V90, P1060, DOI 10.1136/bjo.2006.097436; Perusek L, 2013, NUTRIENTS, V5, P2646, DOI 10.3390/nu5072646; Petrs-Silva H, 2014, CLIN OPHTHALMOL, V8, P127, DOI 10.2147/OPTH.S38041; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reyes-Alcaraz A, 2011, BIOPHYS J, V101, P2798, DOI 10.1016/j.bpj.2011.09.049; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz L, 2003, MED HYPOTHESES, V60, P644, DOI 10.1016/S0306-9877(02)00391-2; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Surguchev A, 2010, BRAIN RES BULL, V81, P12, DOI 10.1016/j.brainresbull.2009.09.015; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tam BM, 2014, J NEUROSCI, V34, P13336, DOI 10.1523/JNEUROSCI.1655-14.2014; Tesmer JJG, 2010, NAT STRUCT MOL BIOL, V17, P650, DOI 10.1038/nsmb0610-650; Tikhonova IG, 2008, J AM CHEM SOC, V130, P10141, DOI 10.1021/ja0765520; Toledo D, 2011, J BIOL CHEM, V286, P39993, DOI 10.1074/jbc.M110.201517; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772; Van Woerkom Craig, 2005, Optometry, V76, P309; Vaughan DK, 2003, INVEST OPHTH VIS SCI, V44, P848, DOI 10.1167/iovs.02-0709; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230	62	28	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35918	35928		10.1074/jbc.M114.609958	http://dx.doi.org/10.1074/jbc.M114.609958			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25359768	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000346897900023
J	Macauley, MS; Arlian, BM; Rillahan, CD; Pang, PC; Bortell, N; Marcondes, MCG; Haslam, SM; Dell, A; Paulson, JC				Macauley, Matthew S.; Arlian, Britni M.; Rillahan, Cory D.; Pang, Poh-Choo; Bortell, Nikki; Marcondes, Maria Cecilia G.; Haslam, Stuart M.; Dell, Anne; Paulson, James C.			Systemic Blockade of Sialylation in Mice with a Global Inhibitor of Sialyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycosylation Inhibitor; Glycosyltransferase; Kidney; Podocyte; Sialic Acid; Sialyltransferase	TISSUE-SPECIFIC EXPRESSION; SIALIC-ACID; POLYSIALIC ACID; CELL-ADHESION; SELECTIN; GLYCOSYLTRANSFERASES; BIOSYNTHESIS; LIGANDS; GLYCANS; ALPHA	Sialic acid terminates glycans of glycoproteins and glycolipids that play numerous biological roles in health and disease. Although genetic tools are available for interrogating the effects of decreased or abolished sialoside expression in mice, pharmacological inhibition of the sialyltransferase family has, to date, not been possible. We have recently shown that a sialic acid analog, 2,4,7,8,9-pentaacetyl-3F(ax)-Neu5Ac-CO2Me (3F-NeuAc), added to the media of cultured cells shuts down sialylation by a mechanism involving its intracellular conversion to CMP-3F-NeuAc, a competitive inhibitor of all sialyltransferases. Here we show that administering 3F-NeuAc to mice dramatically decreases sialylated glycans in cells of all tissues tested, including blood, spleen, liver, brain, lung, heart, kidney, and testes. A single dose results in greatly decreased sialoside expression for over 7 weeks in some tissues. Although blockade of sialylation with 3F-NeuAc does not affect viability of cultured cells, its use in vivo has a deleterious on target effect on liver and kidney function. After administration of 3F-NeuAc, liver enzymes in the blood are dramatically altered, and mice develop proteinuria concomitant with dramatic loss of sialic acid in the glomeruli within 4 days, leading to irreversible kidney dysfunction and failure to thrive. These results confirm a critical role for sialosides in liver and kidney function and document the feasibility of pharmacological inhibition of sialyltransferases for in vivo modulation of sialoside expression.	[Macauley, Matthew S.; Arlian, Britni M.; Rillahan, Cory D.; Paulson, James C.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Macauley, Matthew S.; Arlian, Britni M.; Rillahan, Cory D.; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Macauley, Matthew S.; Arlian, Britni M.; Rillahan, Cory D.; Paulson, James C.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Bortell, Nikki; Marcondes, Maria Cecilia G.] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Rillahan, Cory D.] Mem Sloan Kettering Canc Ctr, Div Canc Biol & Genet, New York, NY 10065 USA; [Pang, Poh-Choo; Haslam, Stuart M.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, London SW7 2AZ, England	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Memorial Sloan Kettering Cancer Center; Imperial College London	Paulson, JC (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jpaulson@scripps.edu	Paulson, James/AAG-3565-2019	Dell, Anne/0000-0003-1380-2347; Macauley, Matthew/0000-0003-4579-1048	National Institutes of Health [HL107151]; Johnson and Johnson; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1]; Human Frontiers Fellowship; BBSRC [BB/F008309/1, BB/K016164/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Human Frontiers Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant HL107151 (to J. C. P.). This work was also supported by grants from Johnson and Johnson (to J. C. P.), Biotechnology and Biological Sciences Research Council Grants BB/K016164/1 and BB/F008309/1 (to A. D. and S. M. H.), and a Human Frontiers Fellowship (to M. S. M.).	Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Barthel SR, 2011, J BIOL CHEM, V286, P21717, DOI 10.1074/jbc.M110.194597; Bull C, 2013, MOL CANCER THER, V12, P1935, DOI 10.1158/1535-7163.MCT-13-0279; Burkart MD, 1997, J AM CHEM SOC, V119, P11743, DOI 10.1021/ja9723904; Burkart MD, 2000, BIOORGAN MED CHEM, V8, P1937, DOI 10.1016/S0968-0896(00)00139-5; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Frommhold D, 2008, J EXP MED, V205, P1435, DOI 10.1084/jem.20070846; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Gelberg H, 1996, LAB INVEST, V74, P907; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hildebrandt H., 2013, TOP CURR CH IN PRESS; Ito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029873; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; Krocher T., 2013, BRAIN STRUC IN PRESS; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Nagafuku M, 2012, P NATL ACAD SCI USA, V109, pE336, DOI 10.1073/pnas.1114965109; Neu U, 2011, CURR OPIN STRUC BIOL, V21, P610, DOI 10.1016/j.sbi.2011.08.009; Nicholls JM, 2013, ANTIVIR RES, V98, P401, DOI 10.1016/j.antiviral.2013.04.012; North SJ, 2010, METHOD ENZYMOL, V478, P27, DOI 10.1016/S0076-6879(10)78002-2; Okada M, 2002, J BIOL CHEM, V277, P1633, DOI 10.1074/jbc.C100395200; Okeley NM, 2013, P NATL ACAD SCI USA, V110, P5404, DOI 10.1073/pnas.1222263110; Orr SL, 2013, GLYCOBIOLOGY, V23, P363, DOI 10.1093/glycob/cws150; Orth SR, 1998, NEW ENGL J MED, V338, P1202, DOI 10.1056/NEJM199804233381707; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; Paulson JC, 2009, NAT STRUCT MOL BIOL, V16, P1121, DOI 10.1038/nsmb1109-1121; PAULSON JC, 1989, J BIOL CHEM, V264, P10931; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Quaggin SE, 2007, J CLIN INVEST, V117, P1480, DOI 10.1172/JCI32482; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Weinhold B, 2012, J AM SOC NEPHROL, V23, P1319, DOI 10.1681/ASN.2011090947; Yang WH, 2012, BLOOD, V120, P1015, DOI 10.1182/blood-2012-04-424366; Yoshikawa M, 2009, P NATL ACAD SCI USA, V106, P9483, DOI 10.1073/pnas.0903279106; Zandberg WF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.403568	47	64	64	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35149	35158		10.1074/jbc.M114.606517	http://dx.doi.org/10.1074/jbc.M114.606517			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25368325	Green Published, hybrid			2022-12-28	WOS:000346660200009
J	Chekan, JR; Kwon, IH; Agarwal, V; Dodd, D; Revindran, V; Mackie, RI; Cann, I; Nair, SK				Chekan, Jonathan R.; Kwon, In Hyuk; Agarwal, Vinayak; Dodd, Dylan; Revindran, Vanessa; Mackie, Roderick I.; Cann, Isaac; Nair, Satish K.			Structural and Biochemical Basis for Mannan Utilization by Caldanaerobius polysaccharolyticus Strain ATCC BAA-17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Biofuel; Cellulose; Crystal Structure; Plant Cell Wall	THERMOANAEROBACTERIUM-POLYSACCHAROLYTICUM; THERMOPHILIC BACTERIUM; PHOSPHORYLASES; EXPRESSION; DIVERSITY; SOFTWARE; CHECKING; SYSTEMS; PHENIX; ZEAE	Background: The thermophilic bacterium Caldanaerobius polysaccharolyticus can utilize mannan polysaccharides found in plant hemicellulose. Results: The mannan degradation gene cluster contains a solute-binding protein with an unexpected tolerance for linear and branched manno-oligosaccharides. Conclusion: Structural studies reveal a binding site optimized for linear and branched mannotriose. Significance: The self-contained mannan-utilizing cluster can be utilized for engineering efforts for the conversion of mannan-containing hemicellulose into cellulosic biofuels. Hemicelluloses, the polysaccharide component of plant cell walls, represent one of the most abundant biopolymers in nature. The most common hemicellulosic constituents of softwoods, such as conifers and cycads, are mannans consisting of a 1,4-linked -mannopyranosyl main chain with branch decorations. Efforts toward the utilization of hemicellulose for bioconversion into cellulosic biofuels have resulted in the identification of several families of glycoside hydrolases that can degrade mannan. However, effective biofermentation of manno-oligosaccharides is limited by a lack of appropriate uptake route in ethanologenic organisms. Here, we used transcriptome sequencing to gain insights into mannan degradation by the thermophilic anaerobic bacterium Caldanaerobius polysaccharolyticus. The most highly up-regulated genes during mannan fermentation occur in a cluster containing several genes encoding enzymes for efficient mannan hydrolysis as well as a solute-binding protein (CpMnBP1) that exhibits specificity for short mannose polymers but exhibited the flexibility to accommodate branched polysaccharide decorations. Co-crystal structures of CpMnBP1 in complex with mannobiose (1.4-angstrom resolution) and mannotriose (2.2-angstrom resolution) revealed the molecular rationale for chain length and oligosaccharide specificity. Calorimetric analysis of several active site variants confirmed the roles of residues critical to the function of CpMnBP1. This work represents the first biochemical characterization of a mannose-specific solute-binding protein and provides a framework for engineering mannan utilization capabilities for microbial fermentation.	[Chekan, Jonathan R.; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Kwon, In Hyuk; Mackie, Roderick I.; Cann, Isaac] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Dodd, Dylan; Cann, Isaac] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Chekan, Jonathan R.; Dodd, Dylan; Revindran, Vanessa; Mackie, Roderick I.; Cann, Isaac; Nair, Satish K.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Agarwal, Vinayak; Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Dodd, Dylan; Revindran, Vanessa; Mackie, Roderick I.; Cann, Isaac] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cann, I (corresponding author), Univ Illinois, Inst Genom Biol 3408, Energy Biosci Inst, Urbana, IL 61801 USA.	icann@illinois.edu; snair@illinois.edu	Nair, Satish/AAY-2510-2021; Agarwal, Vinayak/L-5688-2017; Chekan, Jonathan/AAN-8499-2020	Chekan, Jonathan/0000-0003-4651-0594; Dodd, Dylan/0000-0001-6210-6239	Energy Biosciences Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER	Energy Biosciences Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Energy Biosciences Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Cann IKO, 1999, J BACTERIOL, V181, P1643, DOI 10.1128/JB.181.5.1643-1651.1999; Cann IKO, 2001, INT J SYST EVOL MICR, V51, P293, DOI 10.1099/00207713-51-2-293; Chauhan PS, 2012, APPL MICROBIOL BIOT, V93, P1817, DOI 10.1007/s00253-012-3887-5; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Du J, 2011, J IND MICROBIOL BIOT, V38, P873, DOI 10.1007/s10295-011-0970-3; Du J, 2010, MOL BIOSYST, V6, P2150, DOI 10.1039/c0mb00007h; Ebringerova A, 2005, ADV POLYM SCI, V186, P1, DOI 10.1007/b136816; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Han YJ, 2012, J BIOL CHEM, V287, P34946, DOI 10.1074/jbc.M112.391532; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hong KK, 2012, CELL MOL LIFE SCI, V69, P2671, DOI 10.1007/s00018-012-0945-1; Jang YS, 2012, BIOTECHNOL ADV, V30, P989, DOI 10.1016/j.biotechadv.2011.08.015; Kawahara R, 2012, J BIOL CHEM, V287, P42389, DOI 10.1074/jbc.M112.390336; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Ladeveze S, 2013, J BIOL CHEM, V288, P32370, DOI 10.1074/jbc.M113.483628; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee SJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00092; Lee YJ, 2008, INT J SYST EVOL MICR, V58, P666, DOI 10.1099/ijs.0.65329-0; Mizutani K, 2012, APPL ENVIRON MICROB, V78, P4781, DOI 10.1128/AEM.07457-11; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Oyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080448; Popper ZA, 2003, ANN BOT-LONDON, V91, P1, DOI 10.1093/aob/mcg013; Popper ZA, 2008, CURR OPIN PLANT BIOL, V11, P286, DOI 10.1016/j.pbi.2008.02.012; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Sanchez C, 2009, BIOTECHNOL ADV, V27, P185, DOI 10.1016/j.biotechadv.2008.11.001; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; St John FJ, 2006, APPL ENVIRON MICROB, V72, P1496, DOI 10.1128/AEM.72.2.1496-1506.2006; van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	38	12	12	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34965	34977		10.1074/jbc.M114.579904	http://dx.doi.org/10.1074/jbc.M114.579904			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342756	Green Published, hybrid			2022-12-28	WOS:000346260800045
J	Hart, GW				Hart, Gerald W.			Minireview Series on the Thirtieth Anniversary of Research on O-GlcNAcylation of Nuclear and Cytoplasmic Proteins: Nutrient Regulation of Cellular Metabolism and Physiology by O-GlcNAcylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Alzheimer Disease; Cancer; Diabetes; Gene Transcription; O-GlcNAcylation; O-Linked N-Acetylglucosamine (O-GlcNAc)	LINKED GLCNAC; TRANSCRIPTION	The dynamic cycling of N-acetylglucosamine (termed O-GlcNAcylation) on serine or threonine residues of nuclear or cytoplasmic proteins serves as a nutrient sensor, both independently and also via its interplay with other post-translational modifications, to regulate signaling, transcription, and cellular physiology. Emerging evidence suggests that dysregulation of this ubiquitous post-translational modification contributes to the etiology of some the most important human chronic diseases.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	ghart@asbmb.org		Hart, Gerald/0000-0001-7812-4351	NHLBI NIH HHS [P01 HL107153] Funding Source: Medline; NIDDK NIH HHS [P30 DK079637] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alonso J, 2014, J BIOL CHEM, V289, P34433, DOI 10.1074/jbc.R114.609198; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HOLT GD, 1986, J BIOL CHEM, V261, P8049; Janetzko J, 2014, J BIOL CHEM, V289, P34424, DOI 10.1074/jbc.R114.604405; Lewis BA, 2014, J BIOL CHEM, V289, P34440, DOI 10.1074/jbc.R114.595439; Ma ZY, 2014, J BIOL CHEM, V289, P34457, DOI 10.1074/jbc.R114.577718; Marsh SA, 2014, J BIOL CHEM, V289, P34449, DOI 10.1074/jbc.R114.585984; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vaidyanathan K, 2014, J BIOL CHEM, V289, P34466, DOI 10.1074/jbc.R114.591560; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	11	37	39	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34422	34423		10.1074/jbc.R114.609776	http://dx.doi.org/10.1074/jbc.R114.609776			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25336646	hybrid, Green Published			2022-12-28	WOS:000346260800001
J	Burress, H; Taylor, M; Banerjee, T; Tatulian, SA; Teter, K				Burress, Helen; Taylor, Michael; Banerjee, Tuhina; Tatulian, Suren A.; Teter, Ken			Co- and Post-translocation Roles for HSP90 in Cholera Intoxication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN A1 SUBUNIT; RETICULUM-ASSOCIATED DEGRADATION; CELL CHAPERONE HSP90; ENDOPLASMIC-RETICULUM; RETRO-TRANSLOCATION; ADP-RIBOSYLATION; MEMBRANE TRANSLOCATION; ENDOGENOUS INHIBITOR; MAMMALIAN-CELLS; TARGET-CELLS	Cholera toxin (CT) moves from the cell surface to the endoplasmic reticulum (ER) where the catalytic CTA1 subunit separates from the rest of the toxin. CTA1 then unfolds and passes through an ER translocon pore to reach its cytosolic target. Due to its intrinsic instability, cytosolic CTA1 must be refolded to achieve an active conformation. The cytosolic chaperone Hsp90 is involved with the ER to cytosol export of CTA1, but the mechanistic role of Hsp90 in CTA1 translocation remains unknown. Moreover, potential post-translocation roles for Hsp90 in modulating the activity of cytosolic CTA1 have not been explored. Here, we show by isotope-edited Fourier transform infrared spectroscopy that Hsp90 induces a gain-of-structure in disordered CTA1 at physiological temperature. Only the ATP-bound form of Hsp90 interacts with disordered CTA1, and refolding of CTA1 by Hsp90 is dependent upon ATP hydrolysis. In vitro reconstitution of the CTA1 translocation event likewise required ATP hydrolysis by Hsp90. Surface plasmon resonance experiments found that Hsp90 does not release CTA1, even after ATP hydrolysis and the return of CTA1 to a folded conformation. The interaction with Hsp90 allows disordered CTA1 to attain an active state, which is further enhanced by ADP-ribosylation factor 6, a host cofactor for CTA1. Our data indicate CTA1 translocation involves a process that couples the Hsp90-mediated refolding of CTA1 with CTA1 extraction from the ER. The molecular basis for toxin translocation elucidated in this study may also apply to several ADP-ribosylating toxins that move from the endosomes to the cytosol in an Hsp90-dependent process.	[Burress, Helen; Taylor, Michael; Banerjee, Tuhina; Teter, Ken] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA; [Tatulian, Suren A.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Teter, K (corresponding author), Biomol Res Annex, 12722 Res Pkwy, Orlando, FL 32826 USA.	kteter@mail.ucf.edu		Teter, Ken/0000-0003-4176-9361	National Institutes of Health from the NIAID [R01AI099493]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099493] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI099493 from the NIAID (to K. T.).	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Ampapathi RS, 2008, J MOL BIOL, V377, P748, DOI 10.1016/j.jmb.2007.12.075; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Banerjee T, 2014, MOL MICROBIOL, V94, P898, DOI 10.1111/mmi.12807; Banerjee T, 2010, BIOCHEMISTRY-US, V49, P8839, DOI 10.1021/bi101201c; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Bernardi KM, 2013, MOL BIOL CELL, V24, P3545, DOI 10.1091/mbc.E13-06-0332; Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; Dixit G, 2008, EXP BIOL MED, V233, P163, DOI 10.3181/0705-RM-132; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Haug G, 2004, INFECT IMMUN, V72, P3066, DOI 10.1128/IAI.72.5.3066-3068.2004; Haug G, 2003, J BIOL CHEM, V278, P32266, DOI 10.1074/jbc.M303980200; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; KAHN RA, 1984, J BIOL CHEM, V259, P6228; Kaiser E, 2011, INFECT IMMUN, V79, P3913, DOI 10.1128/IAI.05372-11; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Lang AE, 2014, CELL MICROBIOL, V16, P490, DOI 10.1111/cmi.12228; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Marshall RS, 2008, J BIOL CHEM, V283, P15869, DOI 10.1074/jbc.M709316200; Massey S, 2011, INFECT IMMUN, V79, P4739, DOI 10.1128/IAI.05503-11; Massey S, 2009, J MOL BIOL, V393, P1083, DOI 10.1016/j.jmb.2009.09.013; McConnell E, 2007, BIOCHEM BIOPH RES CO, V355, P1087, DOI 10.1016/j.bbrc.2007.02.077; Moore P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075801; MURAYAMA T, 1993, BIOCHEMISTRY-US, V32, P561, DOI 10.1021/bi00053a022; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; O'Neal CJ, 2004, BIOCHEMISTRY-US, V43, P3772, DOI 10.1021/bi0360152; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Ozdemir SK, 2003, J LIGHTWAVE TECHNOL, V21, P805, DOI 10.1109/JLT.2003.809552; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Ratts R, 2003, J CELL BIOL, V160, P1139, DOI 10.1083/jcb.200210028; Ray S, 2012, J BIOL CHEM, V287, P30395, DOI 10.1074/jbc.M112.385575; Reddy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073390; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; SOMAN G, 1986, BIOCHEMISTRY-US, V25, P4113, DOI 10.1021/bi00362a019; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Sreedhar AS, 2004, FEBS LETT, V562, P11; Tatulian Suren A, 2013, Methods Mol Biol, V974, P177, DOI 10.1007/978-1-62703-275-9_9; Tatulian SA, 2010, SPECTROSC-INT J, V24, P37, DOI 10.1155/2010/634831; Taylor M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003925; Taylor M, 2011, J BIOL CHEM, V286, P22090, DOI 10.1074/jbc.M111.237966; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Taylor ME, 2011, APPL MATH SCI, V116, P1, DOI 10.1007/978-1-4419-7052-7_1; Teter K, 2006, INFECT IMMUN, V74, P2259, DOI 10.1128/IAI.74.4.2259-2267.2006; Teter K, 2004, INFECT IMMUN, V72, P6826, DOI 10.1128/IAI.72.12.6826-6835.2004; Teter K, 2003, TRAFFIC, V4, P232, DOI 10.1034/j.1600-0854.2003.00070.x; Teter K, 2002, INFECT IMMUN, V70, P6172, DOI 10.1128/IAI.70.11.6172-6179.2002; Teter K., 2013, MOONLIGHTING CELL ST, P323; Teter K, 2013, BIOMOLECULES, V3, P997, DOI 10.3390/biom3040997; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; TSUBUKI S, 1994, FEBS LETT, V344, P229, DOI 10.1016/0014-5793(94)00388-2; WAGNER BJ, 1995, ARCH BIOCHEM BIOPHYS, V323, P455, DOI 10.1006/abbi.1995.0067; WELSH CF, 1994, MOL CELL BIOCHEM, V138, P157, DOI 10.1007/BF00928458; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Worthington ZEV, 2007, INFECT IMMUN, V75, P2946, DOI 10.1128/IAI.02011-06; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456	67	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33644	33654		10.1074/jbc.M114.609800	http://dx.doi.org/10.1074/jbc.M114.609800			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25320090	Green Published, hybrid			2022-12-28	WOS:000345636600049
J	Kondrikov, D; Gross, C; Black, SM; Su, YC				Kondrikov, Dmitry; Gross, Christine; Black, Stephen M.; Su, Yunchao			Novel Peptide for Attenuation of Hyperoxia-induced Disruption of Lung Endothelial Barrier and Pulmonary Edema via Modulating Peroxynitrite Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; OXYGEN-INDUCED RETINOPATHY; INJURY; APOPTOSIS; ENOS; PERMEABILITY; MONOLAYERS; TOXICITY; CELLS; NO	Pulmonary damages of oxygen toxicity include vascular leakage and pulmonary edema. We have previously reported that hyperoxia increases the formation of NO and peroxynitrite in lung endothelial cells via increased interaction of endothelial nitric oxide (eNOS) with beta-actin. A peptide (P326TAT) with amino acid sequence corresponding to the actin binding region of eNOS residues 326-333 has been shown to reduce the hyperoxia-induced formation of NO and peroxynitrite in lung endothelial cells. In the present study, we found that exposure of pulmonary artery endothelial cells to hyperoxia (95% oxygen and 5% CO2) for 48 h resulted in disruption of monolayer barrier integrity in two phases, and apoptosis occurred in the second phase. NOS inhibitor NG-nitro-L-arginine methyl ester attenuated the endothelial barrier disruption in both phases. Peroxynitrite scavenger uric acid did not affect the first phase but ameliorated the second phase of endothelial barrier disruption and apoptosis. P326TAT inhibited hyperoxia-induced disruption of monolayer barrier integrity in two phases and apoptosis in the second phase. More importantly, injection of P326TAT attenuated vascular leakage, pulmonary edema, and endothelial apoptosis in the lungs of mice exposed to hyperoxia. P326TAT also significantly reduced the increase in eNOS-beta-actin association and protein tyrosine nitration. Together, these results indicate that peptide P326TAT ameliorates barrier dysfunction of hyperoxic lung endothelial monolayer and attenuates eNOS-beta-actin association, peroxynitrite formation, endothelial apoptosis, and pulmonary edema in lungs of hyperoxic mice. P326TAT can be a novel therapeutic agent to treat or prevent acute lung injury in oxygen toxicity.	[Kondrikov, Dmitry; Su, Yunchao] Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Su, Yunchao] Georgia Regents Univ, Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Gross, Christine; Black, Stephen M.; Su, Yunchao] Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Su, Yunchao] Georgia Regents Univ, Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Su, YC (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, 1120 15th St, Augusta, GA 30912 USA.	ysu@gru.edu			National Institutes of Health [HL088261, HL115078, HL0101902]; Flight Attendants Medical Research Institute [113018_CIA]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088261, R03HL115078, P01HL101902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendants Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL088261 and HL115078 (to Y. S.) and HL0101902 (to S. M. B.). This work was also supported by Flight Attendants Medical Research Institute Grant 113018_CIA (to Y. S.).	Abdelsaid MA, 2010, J PHARMACOL EXP THER, V332, P125, DOI 10.1124/jpet.109.157941; Allen BW, 2009, J APPL PHYSIOL, V106, P662, DOI 10.1152/japplphysiol.91109.2008; Beauchamp MH, 2004, FREE RADICAL BIO MED, V37, P1885, DOI 10.1016/j.freeradbiomed.2004.09.008; Bhandari V, 2006, FREE RADICAL BIO MED, V41, P4, DOI 10.1016/j.freeradbiomed.2006.01.027; Bove K, 2001, AM J PHYSIOL-LUNG C, V280, pL914, DOI 10.1152/ajplung.2001.280.5.L914; BRASCH RC, 1993, PEDIATR RADIOL, V23, P495, DOI 10.1007/BF02012128; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Christofidou-Solomidou Melpo, 2006, Treat Respir Med, V5, P47, DOI 10.2165/00151829-200605010-00004; Delavallee L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432; Gu XL, 2003, AM J PHYSIOL-CELL PH, V285, pC546, DOI 10.1152/ajpcell.00424.2002; Gustafsson AB, 2005, METH MOLEC MED, V112, P81; Klings ES, 2009, AM J PATHOL, V175, P2309, DOI 10.2353/ajpath.2009.081017; Kondrikov D, 2011, FREE RADICAL BIO MED, V50, P1689, DOI 10.1016/j.freeradbiomed.2011.03.020; Kondrikov D, 2010, J BIOL CHEM, V285, P35479, DOI 10.1074/jbc.M110.140269; Kondrikov D, 2010, J BIOL CHEM, V285, P4319, DOI 10.1074/jbc.M109.063172; Li LF, 2007, CRIT CARE, V11, DOI 10.1186/cc6101; McGrath-Morrow SA, 2001, AM J RESP CELL MOL, V25, P150, DOI 10.1165/ajrcmb.25.2.4362; Modol T, 2011, BIOCHEM PHARMACOL, V81, P451, DOI 10.1016/j.bcp.2010.10.017; NOZIK ES, 1995, RESP PHYSIOL, V100, P63, DOI 10.1016/0034-5687(94)00116-H; Payne DK, 1996, FREE RADICAL RES, V25, P229, DOI 10.3109/10715769609149048; PHILLIPS PG, 1988, J APPL PHYSIOL, V64, P1196, DOI 10.1152/jappl.1988.64.3.1196; Radomski A, 1998, BRIT J PHARMACOL, V125, P1455, DOI 10.1038/sj.bjp.0702216; Sanchez FA, 2009, P NATL ACAD SCI USA, V106, P6849, DOI 10.1073/pnas.0812694106; Su YC, 2003, AM J PHYSIOL-CELL PH, V284, pC1542, DOI 10.1152/ajpcell.00248.2002; Veress LA, 2010, AM J RESP CRIT CARE, V182, P1352, DOI 10.1164/rccm.200910-1618OC; WEIR KLI, 1994, AM J RESP CRIT CARE, V150, P784, DOI 10.1164/ajrccm.150.3.8087353	26	10	10	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33355	33363		10.1074/jbc.M114.585356	http://dx.doi.org/10.1074/jbc.M114.585356			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25315770	Green Published, hybrid			2022-12-28	WOS:000345636600026
J	Secondo, A; Esposito, A; Sirabella, R; Boscia, F; Pannaccione, A; Molinaro, P; Cantile, M; Ciccone, R; Sisalli, MJ; Scorziello, A; Di Renzo, G; Annunziato, L				Secondo, Agnese; Esposito, Alba; Sirabella, Rossana; Boscia, Francesca; Pannaccione, Anna; Molinaro, Pasquale; Cantile, Maria; Ciccone, Roselia; Sisalli, Maria Jose; Scorziello, Antonella; Di Renzo, Gianfranco; Annunziato, Lucio			Involvement of the Na+/Ca2+ exchanger isoform 1 (NCX1) in Neuronal Growth Factor (NGF)-induced Neuronal Differentiation through Ca2+-dependent Akt Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; NEURITE OUTGROWTH; PC12 CELLS; FUNCTIONAL EXPRESSION; NA+-CA2+ EXCHANGER; ACTIVATION; PROTEIN; CLONING; DEPOLARIZATION; INHIBITION	NGF induces neuronal differentiation by modulating [Ca2+](i). However, the role of the three isoforms of the main Ca2+-extruding system, the Na+/Ca2+ exchanger (NCX), in NGF-induced differentiation remains unexplored. We investigated whether NCX1, NCX2, and NCX3 isoforms could play a relevant role in neuronal differentiation through the modulation of [Ca2+](i) and the Akt pathway. NGF caused progressive neurite elongation; a significant increase of the well known marker of growth cones, GAP-43; and an enhancement of endoplasmic reticulum (ER) Ca2+ content and of Akt phosphorylation through an early activation of ERK1/2. Interestingly, during NGF-induced differentiation, the NCX1 protein level increased, NCX3 decreased, and NCX2 remained unaffected. At the same time, NCX total activity increased. Moreover, NCX1 colocalized and coimmunoprecipitated with GAP-43, and NCX1 silencing prevented NGF-induced effects on GAP-43 expression, Akt phosphorylation, and neurite outgrowth. On the other hand, the overexpression of its neuronal splicing isoform, NCX1.4, even in the absence of NGF, induced an increase in Akt phosphorylation and GAP-43 protein expression. Interestingly, tetrodotoxin-sensitive Na+ currents and 1,3-benzenedicarboxylic acid, 4,4'-[1,4,10-trioxa-7,13-diazacyclopentadecane-7,13-diylbis(5-methoxy-6,12-benzofurandiyl)]bis-, tetrakis[(acetyloxy)methyl] ester-detected [Na+](i) significantly increased in cells overexpressing NCX1.4 as well as ER Ca2+ content. This latter effect was prevented by tetrodotoxin. Furthermore, either the [Ca2+](i) chelator (1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid) (BAPTA-AM) or the PI3K inhibitor LY 294002 prevented Akt phosphorylation and GAP-43 protein expression rise in NCX1.4 overexpressing cells. Moreover, in primary cortical neurons, NCX1 silencing prevented Akt phosphorylation, GAP-43 and MAP2 overexpression, and neurite elongation. Collectively, these data show that NCX1 participates in neuronal differentiation through the modulation of ER Ca2+ content and PI3K signaling.	[Secondo, Agnese; Esposito, Alba; Boscia, Francesca; Pannaccione, Anna; Molinaro, Pasquale; Cantile, Maria; Ciccone, Roselia; Sisalli, Maria Jose; Scorziello, Antonella; Di Renzo, Gianfranco; Annunziato, Lucio] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Sch Med, I-80131 Naples, Italy; [Sirabella, Rossana; Annunziato, Lucio] Fdn Ist Ricovero & Cura Carattere Sci IRCCN SDN, I-80143 Naples, Italy	University of Naples Federico II	Annunziato, L (corresponding author), Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Sch Med, Via Sergio Pansini 5, I-80131 Naples, Italy.	lannunzi@unina.it	Molinaro, Pasquale/J-4754-2012; sisalli, maria jose/AAC-2928-2019; Secondo, Agnese/AAA-3407-2022; Di Renzo, Gian C./P-3819-2017; Ciccone, Roselia/AAA-6045-2020; Pannaccione, Anna/Q-7629-2019; Scorziello, Antonella/K-6131-2018	Di Renzo, Gian C./0000-0003-4467-240X; Ciccone, Roselia/0000-0003-1495-1264; Cantile, Monica/0000-0001-7840-3369; SISALLI, MARIA JOSE/0000-0002-0734-1751; Molinaro, Pasquale/0000-0003-2770-2267	Ministero della Salute [RF-FSL352059]; Progetto Giovani Ricercatori Grant from the Ministero della Salute [GR-2010-2318138]; Federazione Italiana Sclerosi Multipla progetto [R/01]	Ministero della Salute(Ministry of Health, Italy); Progetto Giovani Ricercatori Grant from the Ministero della Salute; Federazione Italiana Sclerosi Multipla progetto	This work was supported by Grant COFIN 2008, Ricerca-Sanitaria Grant RF-FSL352059, Ricerca Finalizzata (2006), Progetto-Strategico (2007), Progetto Ordinario (2007), Ricerca Finalizzata (2009), Ricerca-Sanitaria Progetto Ordinario (2008) from the Ministero della Salute (to L. A.) and by Progetto Giovani Ricercatori Grant GR-2010-2318138 from the Ministero della Salute (to A. S.), and Federazione Italiana Sclerosi Multipla progetto R/01 (to F. B.).	Annunziato L, 2004, PHARMACOL REV, V56, P633, DOI 10.1124/pr.56.4.5; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bouron A, 1999, N-S ARCH PHARMACOL, V359, P370, DOI 10.1007/PL00005363; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cardenas C, 2004, J BIOL CHEM, V279, P39122, DOI 10.1074/jbc.M401044200; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Ciccolini F, 2003, J NEUROSCI, V23, P103; Drummond HA, 2006, AM J PHYSIOL-CELL PH, V290, pC404, DOI 10.1152/ajpcell.00210.2005; Formisano L, 2008, MOL PHARMACOL, V73, P727, DOI 10.1124/mol.107.042549; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hardingham GE, 1998, CELL CALCIUM, V23, P131, DOI 10.1016/S0143-4160(98)90111-7; He LP, 2003, J PHYSIOL-LONDON, V548, P677, DOI 10.1113/jphysiol.2002.036426; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; KATER SB, 1991, J NEUROSCI, V11, P891; Kolb B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00204; Larbig R, 2010, J PHYSIOL-LONDON, V588, P3266, DOI 10.1113/jphysiol.2010.187708; LI ZP, 1994, J BIOL CHEM, V269, P17434; Molinaro P, 2008, J NEUROSCI, V28, P1179, DOI 10.1523/JNEUROSCI.4671-07.2008; Musatov S, 2004, P NATL ACAD SCI USA, V101, P3627, DOI 10.1073/pnas.0308289101; Neri LM, 2002, BBA-MOL CELL BIOL L, V1584, P73, DOI 10.1016/S1388-1981(02)00300-1; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Oda T, 2011, J PHARMACOL SCI, V116, P128, DOI 10.1254/jphs.11011SC; Pannaccione A, 2012, J NEUROSCI, V32, P10609, DOI 10.1523/JNEUROSCI.6429-11.2012; Salinas M, 2000, MOL CELL NEUROSCI, V15, P156, DOI 10.1006/mcne.1999.0813; Secondo A, 2007, CELL CALCIUM, V42, P521, DOI 10.1016/j.ceca.2007.01.006; Secondo A, 2011, MOL PHARMACOL, V79, P558, DOI 10.1124/mol.110.069658; Secondo A, 2009, J PHARMACOL EXP THER, V331, P212, DOI 10.1124/jpet.109.152132; Shibata A, 2003, CELL SIGNAL, V15, P279, DOI 10.1016/S0898-6568(02)00089-X; Sirabella R, 2012, J NEUROCHEM, V122, P911, DOI 10.1111/j.1471-4159.2012.07838.x; Sirabella R, 2009, STROKE, V40, P922, DOI 10.1161/STROKEAHA.108.531962; SOLEM M, 1995, J NEUROSCI, V15, P5966; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Urbanczyk J, 2006, J PHYSIOL-LONDON, V575, P693, DOI 10.1113/jphysiol.2006.113910; Valsecchi V, 2011, STROKE, V42, P754, DOI 10.1161/STROKEAHA.110.597583; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vojtek AB, 2003, MOL CELL BIOL, V23, P4417, DOI 10.1128/MCB.23.13.4417-4427.2003; Wang ZY, 2011, INT J DEV NEUROSCI, V29, P415, DOI 10.1016/j.ijdevneu.2011.03.001; Zheng F, 2008, J NEUROCHEM, V106, P1259, DOI 10.1111/j.1471-4159.2008.05478.x	39	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1319	1331		10.1074/jbc.M114.555516	http://dx.doi.org/10.1074/jbc.M114.555516			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25416782	Green Published, hybrid			2022-12-28	WOS:000348056400003
J	Wang, H; Zhou, TT; Peng, JH; Xu, P; Dong, NZ; Chen, SH; Wu, QY				Wang, Hao; Zhou, Tiantian; Peng, Jianhao; Xu, Ping; Dong, Ningzheng; Chen, Shenghan; Wu, Qingyu			Distinct Roles of N-Glycosylation at Different Sites of Corin in Cell Membrane Targeting and Ectodomain Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; TRANSMEMBRANE SERINE-PROTEASE; EXPERIMENTAL HEART-FAILURE; ZYMOGEN ACTIVATION; BLOOD-PRESSURE; HYPERTENSION; SURFACE; GENE; EXPRESSION; DOMAINS	Corin is a membrane-bound protease essential for activating natriuretic peptides and regulating blood pressure. Human corin has 19 predicted N-glycosylation sites in its extracellular domains. It has been shown that N-glycans are required for corin cell surface expression and zymogen activation. It remains unknown, however, how N-glycans at different sites may regulate corin biosynthesis and processing. In this study, we examined corin mutants, in which each of the 19 predicted N-glycosylation sites was mutated individually. By Western analysis of corin proteins in cell lysate and conditioned medium from transfected HEK293 cells and HL-1 cardiomyocytes, we found that N-glycosylation at Asn-80 inhibited corin shedding in the juxtamembrane domain. Similarly, N-glycosylation at Asn-231 protected corin from autocleavage in the frizzled-1 domain. Moreover, N-glycosylation at Asn-697 in the scavenger receptor domain and at Asn-1022 in the protease domain is important for corin cell surface targeting and zymogen activation. We also found that the location of the N-glycosylation site in the protease domain was not critical. N-Glycosylation at Asn-1022 may be switched to different sites to promote corin zymogen activation. Together, our results show that N-glycans at different sites may play distinct roles in regulating the cell membrane targeting, zymogen activation, and ectodomain shedding of corin.	[Wang, Hao; Peng, Jianhao; Xu, Ping; Chen, Shenghan; Wu, Qingyu] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Wang, Hao; Wu, Qingyu] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Zhou, Tiantian; Dong, Ningzheng; Wu, Qingyu] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou 215123, Peoples R China; [Zhou, Tiantian; Dong, Ningzheng; Wu, Qingyu] Soochow Univ, Collaborat Innovat Ctr Hematol, Suzhou 215123, Peoples R China	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Soochow University - China; Soochow University - China	Wu, QY (corresponding author), Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wuq@ccf.org		Wu, Qingyu/0000-0003-0561-9315; Wang, Hao/0000-0001-6881-9977	National Institutes of Health [HL089298, HD064634]; National Natural Science Foundation of China [81370718]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Danish-Chinese Center for Protease and Cancer [31161130356]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064634] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Danish-Chinese Center for Protease and Cancer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089298 and HD064634. This work was also supported by National Natural Science Foundation of China Grant 81370718, a grant from the Priority Academic Program Development of Jiangsu Higher Education Institutions, and Danish-Chinese Center for Protease and Cancer Grant 31161130356.	Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Armaly Z, 2013, CURR OPIN NEPHROL HY, V22, P713, DOI 10.1097/01.mnh.0000435609.35789.32; Armstrong DWJ, 2013, REGUL PEPTIDES, V186, P108, DOI 10.1016/j.regpep.2013.08.006; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Cannone V, 2013, HYPERTENSION, V62, P860, DOI 10.1161/HYPERTENSIONAHA.113.01344; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dong NZ, 2014, J BIOL CHEM, V289, P17909, DOI 10.1074/jbc.M114.551424; Dong NZ, 2013, J BIOL CHEM, V288, P7867, DOI 10.1074/jbc.M112.411512; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Gladysheva IP, 2008, BIOCHEM BIOPH RES CO, V373, P130, DOI 10.1016/j.bbrc.2008.05.181; Gladysheva IP, 2008, J MOL CELL CARDIOL, V44, P131, DOI 10.1016/j.yjmcc.2007.10.002; Haga Y, 2011, J BIOL CHEM, V286, P31320, DOI 10.1074/jbc.M111.253955; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Hooper JD, 2000, EUR J BIOCHEM, V267, P6931, DOI 10.1046/j.1432-1327.2000.01806.x; Ichiki T, 2013, AM J PHYSIOL-REG I, V304, pR102, DOI 10.1152/ajpregu.00233.2012; Ichiki T, 2011, CLIN CHEM, V57, P40, DOI 10.1373/clinchem.2010.153908; Jiang J, 2014, J BIOL CHEM, V289, P19500, DOI 10.1074/jbc.M114.555110; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Kaitu'u-Lino TJ, 2013, HUM REPROD, V28, P1172, DOI 10.1093/humrep/det028; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; Klein JD, 2010, KIDNEY INT, V78, P635, DOI 10.1038/ki.2010.223; Langenickel TH, 2004, AM J PHYSIOL-HEART C, V287, pH1516, DOI 10.1152/ajpheart.00947.2003; Liao X, 2007, J BIOL CHEM, V282, P27728, DOI 10.1074/jbc.M703687200; Lynch AI, 2009, CURR HYPERTENS REP, V11, P35, DOI 10.1007/s11906-009-0008-7; Martinez-Maza R, 2001, J BIOL CHEM, V276, P2168, DOI 10.1074/jbc.M006774200; Miller GS, 2013, CELL TISSUE RES, V351, P245, DOI 10.1007/s00441-012-1348-1; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Qi XF, 2011, J BIOL CHEM, V286, P20963, DOI 10.1074/jbc.M110.217570; Rame JE, 2007, HYPERTENSION, V49, P857, DOI 10.1161/01.HYP.0000258566.95867.9e; REISS K, 2009, CELL DEV BIOL, V20, P126; Rubattu S, 2014, CLIN SCI, V127, P1, DOI 10.1042/CS20130427; Schlondorff J, 1999, J CELL SCI, V112, P3603; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sciarretta S, 2013, CIRC RES, V112, P1355, DOI 10.1161/CIRCRESAHA.113.301325; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Webb SL, 2011, FRONT BIOSCI-LANDMRK, V16, P539, DOI 10.2741/3704; Wu F, 2002, J BIOL CHEM, V277, P16900, DOI 10.1074/jbc.M201503200; Wu QY, 2007, FRONT BIOSCI-LANDMRK, V12, P4179, DOI 10.2741/2379; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Yamaguchi N, 2002, J BIOL CHEM, V277, P6806, DOI 10.1074/jbc.M103645200; Yan W, 1999, J BIOL CHEM, V274, P14926, DOI 10.1074/jbc.274.21.14926; Yan W, 2000, P NATL ACAD SCI USA, V97, P8525, DOI 10.1073/pnas.150149097; Zheng XL, 1999, J BIOL CHEM, V274, P1596, DOI 10.1074/jbc.274.3.1596; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583; Zhou Y, 2013, PLACENTA, V34, P89, DOI 10.1016/j.placenta.2012.11.016; Zhou YQ, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-013-0415-7	54	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1654	1663		10.1074/jbc.M114.606442	http://dx.doi.org/10.1074/jbc.M114.606442			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451932	hybrid, Green Published			2022-12-28	WOS:000348056400032
J	Wu, Q; Liu, HO; Liu, YD; Liu, WS; Pan, D; Zhang, WJ; Yang, L; Fu, Q; Xu, JJ; Gu, JX				Wu, Qian; Liu, Hai-Ou; Liu, Yi-Dong; Liu, Wei-Si; Pan, Deng; Zhang, Wei-Juan; Yang, Liu; Fu, Qiang; Xu, Jie-Jie; Gu, Jian-Xin			Decreased Expression of Hepatocyte Nuclear Factor 4 alpha (Hnf4 alpha)/MicroRNA-122 (miR-122) Axis in Hepatitis B Virus-associated Hepatocellular Carcinoma Enhances Potential Oncogenic GALNT10 Protein Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; GALNAC-TRANSFERASE; O-GLYCOSYLATION; N-ACETYLGLUCOSAMINYLTRANSFERASE; SURFACE-PROTEINS; GENE-EXPRESSION; P53 ACTIVITY; CANCER; LIVER; CELLS	MicroRNA-122 (miR-122), a mammalian liver-specific miRNA, has been reported to play crucial roles in the control of diverse aspects of hepatic function and dysfunction, including viral infection and hepatocarcinogenesis. In this study, we explored the clinical significance, transcriptional regulation, and direct target of miR-122 in hepatitis B virus (HBV)-associated hepatocellular carcinoma. Reduced expression of miR-122 in patients with HBV-associated hepatocellular carcinoma was correlated with venous invasion and poor prognosis. Furthermore, UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetyl-galactosaminyltransferase-10 (GALNT10) was identified as a bona fide target of miR-122 in hepatoma cells. Ectopic expression and knockdown studies showed thatGALNT10 indeed promotes proliferation and apoptosis resistance of hepatoma cells in a glycosyltransferase-dependent manner. Critically, adverse correlation between miR-122 and GALNT10, a poor prognosticator of clinical outcome, was demonstrated in hepatoma patients. Hepatocyte nuclear factor 4 alpha (Hnf4 alpha), a liver-enriched transcription factor that activates miR-122 gene transcription, was suppressed in HBV-infected hepatoma cells. Chromatin immunoprecipitation assay showed significantly reduced association of Hnf4 alpha with the miR-122 promoter in HBV-infected hepatoma cells. Moreover, GALNT10 was found to intensify O-glycosylation following signal activation of the epidermal growth factor receptor. In addition, in a therapeutic perspective, we proved that GALNT10 silencing increases sensitivity to sorafenib and doxorubicin challenge. In summary, our results reveal a novel Hnf4 alpha/miR-122/GALNT10 regulatory pathway that facilitates EGF miR-122 activation and hepatoma growth in HBV-associated hepatocarcinogenesis.	Fudan Univ, Minist Hlth, Dept Biochem & Mol Biol, Key Lab Glycoconjugate Res, Shanghai 200032, Peoples R China; [Zhang, Wei-Juan] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Dept Immunol, Shanghai 200032, Peoples R China	Fudan University; Fudan University		jjxufdu@fudan.edu.cn; jxgu@shmu.edu.cn	Zhang, Weijuan/Q-1645-2019	Zhang, Weijuan/0000-0003-3494-3114	National Basic Research Program of China [2012CB822104]; National Key Projects for Infectious Diseases of China [2012ZX10002-012]; National Natural Science Foundation of China [31100629, 31270863, 81471621, 81472227]; Program for New Century Excellent Talents in University [NCET-13-0146]; Shanghai Rising-Star Program Grant [13QA1400300]	National Basic Research Program of China(National Basic Research Program of China); National Key Projects for Infectious Diseases of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Rising-Star Program Grant	This work was supported by National Basic Research Program of China Grant 2012CB822104, National Key Projects for Infectious Diseases of China Grant 2012ZX10002-012, National Natural Science Foundation of China Grants 31100629, 31270863, 81471621, and 81472227, Program for New Century Excellent Talents in University Grant NCET-13-0146, and Shanghai Rising-Star Program Grant 13QA1400300.	Agrawal P, 2014, P NATL ACAD SCI USA, V111, P4338, DOI 10.1073/pnas.1321524111; Asghar U, 2012, J HEPATOL, V56, P686, DOI 10.1016/j.jhep.2011.07.031; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bernardi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076540; Bishayee S, 2000, BIOCHEM PHARMACOL, V60, P1217, DOI 10.1016/S0006-2952(00)00425-1; Blivet-Van Eggelpoel MJ, 2012, J HEPATOL, V57, P108, DOI 10.1016/j.jhep.2012.02.019; Blomme B, 2009, J HEPATOL, V50, P592, DOI 10.1016/j.jhep.2008.12.010; Bozkaya G, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-64; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Cao Y, 1999, VIRCHOWS ARCH, V434, P503, DOI 10.1007/s004280050375; Cheng AL, 2012, EUR J CANCER, V48, P1452, DOI 10.1016/j.ejca.2011.12.006; Cheng LM, 2002, FEBS LETT, V531, P115, DOI 10.1016/S0014-5793(02)03399-9; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Fan CG, 2011, ONCOL REP, V26, P1281, DOI 10.3892/or.2011.1375; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Fukuda M, 1996, CANCER RES, V56, P2237; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; HAKOMORI S, 1985, CANCER RES, V45, P2405; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Huang S, 2011, CANCER RES, V71, P7071, DOI 10.1158/0008-5472.CAN-11-0128; Ito Y, 2001, INT J CANCER, V91, P631, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1118>3.3.CO;2-6; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kasper BT, 2014, BIOCHEM BIOPH RES CO, V445, P774, DOI 10.1016/j.bbrc.2014.01.034; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Li C, 2005, PROTEOMICS, V5, P1125, DOI 10.1002/pmic.200401141; Li CF, 2013, J VIROL, V87, P2193, DOI 10.1128/JVI.02831-12; Li W, 2014, MOL MED REP, V9, P1293, DOI 10.3892/mmr.2014.1929; Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023; Liu HO, 2011, CANCER RES, V71, P7547, DOI 10.1158/0008-5472.CAN-11-2260; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Noda K, 1998, HEPATOLOGY, V28, P944, DOI 10.1002/hep.510280408; Okabe H, 2001, CANCER RES, V61, P2129; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Ruan YY, 2012, J CLIN INVEST, V122, P2554, DOI 10.1172/JCI58488; Sasaki M, 1999, PATHOL INT, V49, P325, DOI 10.1046/j.1440-1827.1999.00867.x; Schiffer E, 2005, HEPATOLOGY, V41, P307, DOI 10.1002/hep.20538; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schmitt S, 2004, J GEN VIROL, V85, P2045, DOI 10.1099/vir.0.79932-0; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Shan SW, 2013, J CELL SCI, V126, P1517, DOI 10.1242/jcs.122895; Song KS, 2013, FASEB J, V27; Song K, 2013, HEPATOLOGY, V58, P1681, DOI 10.1002/hep.26514; Su MC, 2005, CANCER LETT, V224, P117, DOI 10.1016/j.canlet.2004.10.010; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Tian XC, 2010, J VIROL, V84, P3373, DOI 10.1128/JVI.02555-09; Tolle TK, 1998, J VIROL, V72, P9978, DOI 10.1128/JVI.72.12.9978-9985.1998; Varki A., 2009, ESSENTIALS GLYCOBIOL, P120; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wei YY, 2008, J HEPATOL, V49, P1029, DOI 10.1016/j.jhep.2008.09.003; Werr M, 1998, J VIROL, V72, P778, DOI 10.1128/JVI.72.1.778-782.1998; Wu YM, 2013, CANCER RES, V73, P5580, DOI 10.1158/0008-5472.CAN-13-0869; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Xiang WQ, 2011, J HEPATOL, V54, P26, DOI 10.1016/j.jhep.2010.08.006; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Xu JJ, 2012, GASTROENTEROLOGY, V143, P199, DOI 10.1053/j.gastro.2012.03.053; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Yanagi M, 2001, J GASTROEN HEPATOL, V16, P1282, DOI 10.1046/j.1440-1746.2001.02612.x; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zhang WJ, 2013, J BIOL CHEM, V288, P13534, DOI 10.1074/jbc.M113.457218; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016	75	68	72	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1170	1185		10.1074/jbc.M114.601203	http://dx.doi.org/10.1074/jbc.M114.601203			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25422324	Green Published, hybrid			2022-12-28	WOS:000347778200047
J	Kuznetsov, NA; Faleev, NG; Kuznetsova, AA; Morozova, EA; Revtovich, SV; Anufrieva, NV; Nikulin, AD; Fedorova, OS; Demidkina, TV				Kuznetsov, Nikita A.; Faleev, Nicolai G.; Kuznetsova, Alexandra A.; Morozova, Elena A.; Revtovich, Svetlana V.; Anufrieva, Natalya V.; Nikulin, Alexei D.; Fedorova, Olga S.; Demidkina, Tatyana V.			Pre-steady-state Kinetic and Structural Analysis of Interaction of Methionine gamma-Lyase from Citrobacter freundii with Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitor; Enzyme Structure; Pre-steady-state Kinetics; Pyridoxal Phosphate; Substrate Specificity; Methionine -Lyase; Structure of Pyridoxal 5-Phosphate-Cycloserine Derivative	FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE; CRYSTAL-STRUCTURES; THERAPEUTIC APPLICATIONS; CONFORMATIONAL DYNAMICS; ACID AMINOTRANSFERASE; MERCAPTOMETHANE-LYASE; PSEUDOMONAS-PUTIDA; REACTION-MECHANISM; METHYL MERCAPTAN; ENZYME	Methionine gamma-lyase (MGL) catalyzes the gamma-elimination of l-methionine and its derivatives as well as the beta-elimination of l-cysteine and its analogs. These reactions yield alpha-keto acids and thiols. The mechanism of chemical conversion of amino acids includes numerous reaction intermediates. The detailed analysis of MGL interaction with glycine, l-alanine, l-norvaline, and l-cycloserine was performed by pre-steady-state stopped-flow kinetics. The structure of side chains of the amino acids is important both for their binding with enzyme and for the stability of the external aldimine and ketimine intermediates. X-ray structure of the MGLl-cycloserine complex has been solved at 1.6 angstrom resolution. The structure models the ketimine intermediate of physiological reaction. The results elucidate the mechanisms of the intermediate interconversion at the stages of external aldimine and ketimine formation.	[Kuznetsov, Nikita A.; Kuznetsova, Alexandra A.; Fedorova, Olga S.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk 630090, Russia; [Kuznetsov, Nikita A.; Kuznetsova, Alexandra A.; Fedorova, Olga S.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk 630090, Russia; [Faleev, Nicolai G.] Russian Acad Sci, Nesmeyanov Inst Organoelement Cpds, Moscow 119991, Russia; [Morozova, Elena A.; Revtovich, Svetlana V.; Anufrieva, Natalya V.; Demidkina, Tatyana V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Nikulin, Alexei D.] Russian Acad Sci, Inst Prot Res, Pushchino 142290, Moscow Region, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Russian Academy of Sciences; Nesmeyanov Institute of Organoelement Compounds; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences	Fedorova, OS (corresponding author), Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk 630090, Russia.	fedorova@niboch.nsc.ru; tvd@eimb.ru	Fedorova, Olga/ABE-6637-2020; Kuznetsov, Nikita A/F-3245-2011; Fedorova, Olga S./E-1291-2013; Demidkina, Tatyana/AAD-9427-2019; Nikulin, Alexey/B-8226-2011; Kuznetsov, Nikita/CAA-3889-2022; Kuznetsov, Nikita/AFU-9897-2022; Anufrieva, Natalya V/B-5794-2016; Kuznetsova, Aleksandra A/G-5119-2013; Morozova, Elena/B-5849-2016; Revtovich, Svetlana V/F-9646-2015	Fedorova, Olga/0000-0002-4001-7187; Kuznetsov, Nikita A/0000-0002-4016-198X; Fedorova, Olga S./0000-0002-4001-7187; Nikulin, Alexey/0000-0001-5391-6184; Kuznetsov, Nikita/0000-0002-4016-198X; Kuznetsov, Nikita/0000-0002-4016-198X; Anufrieva, Natalya V/0000-0002-6611-8840; Morozova, Elena/0000-0003-2922-2793; Revtovich, Svetlana V/0000-0003-1594-9334; Kuznetsova, Aleksandra/0000-0002-9805-7050	Russian Academy of Sciences Program [6.11]; Russian Foundation for Basic Researches [14-04-00349]; Russian Scientific Foundation [14-14-00063]; Russian Federation for State Support of the Leading Scientific Schools [SS-2064.2014.4, SS-1205.2014.4]; Russian Ministry of Education and Science [SP-4012.2013.4]	Russian Academy of Sciences Program(Russian Academy of Sciences); Russian Foundation for Basic Researches(Russian Foundation for Basic Research (RFBR)); Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Federation for State Support of the Leading Scientific Schools; Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	This work was supported by Russian Academy of Sciences Program "Molecular & Cell Biology" (6.11), Russian Foundation for Basic Researches Grant 14-04-00349, Russian Scientific Foundation Grant 14-14-00063, President of the Russian Federation for State Support of the Leading Scientific Schools Grants SS-2064.2014.4 and SS-1205.2014.4, and Russian Ministry of Education and Science Grant SP-4012.2013.4.	BRZOVIC P, 1990, BIOCHEMISTRY-US, V29, P442, DOI 10.1021/bi00454a020; BUTTERWORTH PJ, 1972, BIOCHIM BIOPHYS ACTA, V289, P251, DOI 10.1016/0005-2744(72)90074-5; DAVIS L, 1971, ADV ENZYMOL, V35, P33; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; El-Sayed AS, 2010, APPL MICROBIOL BIOT, V86, P445, DOI 10.1007/s00253-009-2303-2; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Friedemann TE, 1943, J BIOL CHEM, V147, P415; Fukamachi H, 2005, BIOCHEM BIOPH RES CO, V331, P127, DOI 10.1016/j.bbrc.2005.03.139; Hoffman R M, 1997, Hum Cell, V10, P69; ITO S, 1976, J BIOCHEM-TOKYO, V79, P1263, DOI 10.1093/oxfordjournals.jbchem.a131180; JOHNSON GF, 1970, J BIOL CHEM, V245, P5560; KOCHETKOV NK, 1959, DOKLADY AKAD NAYK SS, V129, P1132; Koulikova VV, 2011, AMINO ACIDS, V41, P1247, DOI 10.1007/s00726-010-0802-1; Koval VV, 2010, MUTAT RES-FUND MOL M, V685, P3, DOI 10.1016/j.mrfmmm.2009.08.018; KREIS W, 1973, CANCER RES, V33, P1862; Kudou D, 2007, J BIOCHEM, V141, P535, DOI 10.1093/jb/mvm055; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuznetsov NA, 2012, DNA REPAIR, V11, P884, DOI 10.1016/j.dnarep.2012.08.004; Kuznetsov NA, 2012, NUCLEIC ACIDS RES, V40, P7384, DOI 10.1093/nar/gks423; Kuznetsov NA, 2009, BIOCHEMISTRY-US, V48, P11335, DOI 10.1021/bi901100b; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LOCKWOOD BC, 1991, BIOCHEM J, V279, P675, DOI 10.1042/bj2790675; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malashkevich VN, 1999, J MOL BIOL, V294, P193, DOI 10.1006/jmbi.1999.3254; Mamaeva DV, 2005, ACTA CRYSTALLOGR F, V61, P546, DOI 10.1107/S1744309105015447; Manukhov IV, 2005, J BACTERIOL, V187, P3889, DOI 10.1128/JB.187.11.3889-3893.2005; Morozova EA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1272, DOI 10.1134/S0006297910100093; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NAKAYAMA T, 1984, AGR BIOL CHEM TOKYO, V48, P2367, DOI 10.1080/00021369.1984.10866502; Nikulin A, 2008, ACTA CRYSTALLOGR D, V64, P211, DOI 10.1107/S0907444907065390; Olson GT, 1998, J AM CHEM SOC, V120, P2256, DOI 10.1021/ja972907b; Peisach D, 1998, J AM CHEM SOC, V120, P2268, DOI 10.1021/ja973353f; Rebeille F, 2006, P NATL ACAD SCI USA, V103, P15687, DOI 10.1073/pnas.0606195103; Revtovich SV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P564, DOI 10.1134/S0006297911050063; Revtovich SV, 2014, BIOCHIMIE, V101, P161, DOI 10.1016/j.biochi.2014.01.007; Ronda L, 2011, BBA-PROTEINS PROTEOM, V1814, P834, DOI 10.1016/j.bbapap.2010.06.017; Sato D, 2009, IUBMB LIFE, V61, P1019, DOI 10.1002/iub.255; SHALTIEL S, 1970, BIOCHEM BIOPH RES CO, V41, P594, DOI 10.1016/0006-291X(70)90054-9; Steegborn C, 2001, J MOL BIOL, V311, P789, DOI 10.1006/jmbi.2001.4880; Tan YY, 2010, ANTICANCER RES, V30, P1041; TANAKA H, 1977, BIOCHEMISTRY-US, V16, P100, DOI 10.1021/bi00620a016; TANAKA H, 1985, ENZYME MICROB TECH, V7, P530, DOI 10.1016/0141-0229(85)90094-8; Tokoro M, 2003, J BIOL CHEM, V278, P42717, DOI 10.1074/jbc.M212414200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshimura M, 2000, INFECT IMMUN, V68, P6912, DOI 10.1128/IAI.68.12.6912-6916.2000	45	15	16	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					671	681		10.1074/jbc.M114.586511	http://dx.doi.org/10.1074/jbc.M114.586511			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25398880	hybrid, Green Published			2022-12-28	WOS:000347231200057
J	Eltit, JM; Franzini-Armstrong, C; Perez, CF				Eltit, Jose M.; Franzini-Armstrong, Clara; Perez, Claudio F.			Amino Acid Residues 489-503 of Dihydropyridine Receptor (DHPR) beta(1a) Subunit Are Critical for Structural Communication between the Skeletal Muscle DHPR Complex and Type 1 Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLOW CALCIUM CURRENT; C-TERMINAL TAIL; II-III-LOOP; BETA-1A SUBUNIT; CA2+ CHANNEL; CHARGE MOVEMENTS; MUSCULAR DYSGENESIS; CARBOXYL-TERMINUS; MYOTUBES; MUTATION	The beta(1a) subunit is a cytoplasmic component of the dihydropyridine receptor (DHPR) complex that plays an essential role in skeletal muscle excitation-contraction (EC) coupling. Here we investigate the role of the C-terminal end of this auxiliary subunit in the functional and structural communication between the DHPR and the Ca2+ release channel (RyR1). Progressive truncation of the beta(1a) C terminus showed that deletion of amino acid residues Gln(489) to Trp(503) resulted in a loss of depolarization-induced Ca2+ release, a severe reduction of L-type Ca2+ currents, and a lack of tetrad formation as evaluated by freeze-fracture analysis. However, deletion of this domain did not affect expression/targeting or density (Q(max)) of the DHPR-alpha(1S) subunit to the plasma membrane. Within this motif, triple alanine substitution of residues Leu(496), Leu(500), and Trp(503), which are thought to mediate direct beta(1a)-RyR1 interactions, weakened EC coupling but did not replicate the truncated phenotype. Therefore, these data demonstrate that an amino acid segment encompassing sequence (489)QVQVLTSLRRNLSFW(503) of beta(1a) contains critical determinant(s) for the physical link of DHPR and RyR1, further confirming a direct correspondence between DHPR positioning and DHPR/RyR functional interactions. In addition, our data strongly suggest that the motif Leu(496)-Leu(500)-Trp(503) within the beta(1a) C-terminal tail plays a nonessential role in the bidirectional DHPR/RyR1 signaling that supports skeletal-type EC coupling.	[Perez, Claudio F.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Eltit, Jose M.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Franzini-Armstrong, Clara] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Virginia Commonwealth University; University of Pennsylvania	Perez, CF (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 20 Shattuck St, Boston, MA 02115 USA.	cperez@zeus.bwh.harvard.edu			National Institutes of Health [R03AR066359, R01 HL48093, 2P01AR052354]; William S. Milton Fund/Harvard Medical School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR066359, P01AR052354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William S. Milton Fund/Harvard Medical School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R03AR066359 (to C. F. P.) and R01 HL48093 and 2P01AR052354 (to C. F. A.). This work was also supported by fund from the William S. Milton Fund/Harvard Medical School (to C. F. P.).	ADAMS BA, 1990, NATURE, V346, P569, DOI 10.1038/346569a0; Ahern CA, 2001, P NATL ACAD SCI USA, V98, P6935, DOI 10.1073/pnas.111001898; Avila G, 2005, CELL CALCIUM, V38, P35, DOI 10.1016/j.ceca.2005.05.001; Avila G, 2001, J BIOL CHEM, V276, P17732, DOI 10.1074/jbc.M009685200; Bannister RA, 2010, J GEN PHYSIOL, V135, P629, DOI 10.1085/jgp.200910329; BEAM KG, 1986, NATURE, V320, P168, DOI 10.1038/320168a0; Beurg M, 1997, BIOPHYS J, V73, P807, DOI 10.1016/S0006-3495(97)78113-X; Beurg M, 1999, BIOPHYS J, V77, P2953, DOI 10.1016/S0006-3495(99)77128-6; CHAUDHARI N, 1989, DEV BIOL, V133, P456, DOI 10.1016/0012-1606(89)90049-3; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; Coronado R, 2004, BIOL RES, V37, P565; Dayal A, 2013, P NATL ACAD SCI USA, V110, P7488, DOI 10.1073/pnas.1301087110; Dayal A, 2010, CELL CALCIUM, V47, P500, DOI 10.1016/j.ceca.2010.04.003; Eltit JM, 2011, P NATL ACAD SCI USA, V108, P7046, DOI 10.1073/pnas.1018380108; Flucher BE, 2005, J MUSCLE RES CELL M, V26, P1, DOI 10.1007/s10974-005-9000-2; Gach MP, 2008, BIOPHYS J, V94, P3023, DOI 10.1529/biophysj.107.118893; GARCIA J, 1994, J GEN PHYSIOL, V103, P125, DOI 10.1085/jgp.103.1.125; GARCIA J, 1994, J GEN PHYSIOL, V103, P107, DOI 10.1085/jgp.103.1.107; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Hernandez-Ochoa EO, 2014, BIOPHYS J, V106, P535, DOI 10.1016/j.bpj.2013.11.4503; Karunasekara Y, 2012, FASEB J, V26, P5049, DOI 10.1096/fj.12-211334; KNUDSON CM, 1989, J BIOL CHEM, V264, P1345; Lee DY, 2008, BLOOD, V111, P2280, DOI 10.1182/blood-2007-07-100032; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Nakai J, 1997, P NATL ACAD SCI USA, V94, P1019, DOI 10.1073/pnas.94.3.1019; Paolini C, 2004, J MOL BIOL, V342, P145, DOI 10.1016/j.jmb.2004.07.035; Protasi F, 1997, J CELL BIOL, V137, P859, DOI 10.1083/jcb.137.4.859; Protasi F, 1998, J CELL BIOL, V140, P831, DOI 10.1083/jcb.140.4.831; Rebbeck RT, 2011, BIOPHYS J, V100, P922, DOI 10.1016/j.bpj.2011.01.022; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Schredelseker J, 2009, J BIOL CHEM, V284, P1242, DOI 10.1074/jbc.M807767200; Sheridan DC, 2006, P NATL ACAD SCI USA, V103, P19760, DOI 10.1073/pnas.0609473103; Sheridan DC, 2012, CHANNELS, V6, P26, DOI 10.4161/chan.18916; Sheridan DC, 2004, BIOPHYS J, V87, P929, DOI 10.1529/biophysj.104.043810; Sheridan DC, 2003, BIOPHYS J, V84, P220, DOI 10.1016/S0006-3495(03)74844-9; TAKEKURA H, 1994, BIOPHYS J, V67, P793, DOI 10.1016/S0006-3495(94)80539-9; Takekura H, 2004, MOL BIOL CELL, V15, P5408, DOI 10.1091/mbc.E04-05-0414; TAKEKURA H, 1995, P NATL ACAD SCI USA, V92, P3381, DOI 10.1073/pnas.92.8.3381; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Westerman KA, 2010, EXP CELL RES, V316, P1966, DOI 10.1016/j.yexcr.2010.03.022	44	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36116	36124		10.1074/jbc.M114.615526	http://dx.doi.org/10.1074/jbc.M114.615526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25384984	hybrid, Green Published			2022-12-28	WOS:000346897900038
J	Matsumoto, N; Suzuki, E; Ishikawa, M; Shirafuji, T; Hasumi, K				Matsumoto, Naoki; Suzuki, Eriko; Ishikawa, Makoto; Shirafuji, Takumi; Hasumi, Keiji			Soluble Epoxide Hydrolase as an Anti-inflammatory Target of the Thrombolytic Stroke Drug SMTP-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; ACUTE ISCHEMIC-STROKE; MICROSPORA TRIPRENYL PHENOL-7; EPOXYEICOSATRIENOIC ACIDS; CEREBRAL INFARCTION; LYSOPHOSPHATIDIC ACIDS; PHOSPHATASE-ACTIVITY; GENE DELETION; SIDE-CHAIN; INHIBITORS	Although ischemic stroke is a major cause of death and disability worldwide, only a small fraction of patients benefit from the current thrombolytic therapy due to a risk of cerebral hemorrhage caused by inflammation. Thus, the development of a new strategy to combat inflammation during thrombolysis is an urgent demand. The small molecule thrombolytic SMTP-7 effectively treats ischemic stroke in several animal models with reducing cerebral hemorrhage. Here we revealed that SMTP-7 targeted soluble epoxide hydrolase (sEH) to suppress inflammation. SMTP-7 inhibited both of the two sEH enzyme activities: epoxide hydrolase (which inactivates anti-inflammatory epoxy-fatty acids) and lipid phosphate phosphatase. SMTP-7 suppressed epoxy-fatty acid hydrolysis in HepG2 cells in culture, implicating the sEH inhibition in the anti-inflammatory mechanism. The sEH inhibition by SMTP-7 was independent of its thrombolytic activity. The simultaneous targeting of thrombolysis and sEH by a single molecule is a promising strategy to revolutionize the current stroke therapy.	[Matsumoto, Naoki; Suzuki, Eriko; Hasumi, Keiji] Tokyo Noko Univ, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan; [Ishikawa, Makoto; Shirafuji, Takumi] Nihon Pharmaceut, Pharmaceut Res Lab, Chiba 2860825, Japan; [Hasumi, Keiji] TMS Co Ltd, Fuchu, Tokyo 1830055, Japan	Tokyo University of Agriculture & Technology	Hasumi, K (corresponding author), Tokyo Noko Univ, Dept Appl Biol Sci, 3-5-8 Saiwaicho, Fuchu, Tokyo 1838509, Japan.	hasumi@cc.tuat.ac.jp	Hasumi, Keiji/C-2372-2013; SUZUKI, Eriko/G-1082-2013	Hasumi, Keiji/0000-0002-3340-7312; 	Japan Science and Technology Agency [AS2316911G]; Ministry of Education, Culture, Sports, Science and Technology (Translational Research Network Program) [C7]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology (Translational Research Network Program)	This work was supported in part by Japan Science and Technology Agency Grant AS2316911G (to K. H.) a grant from the Ministry of Education, Culture, Sports, Science and Technology (Translational Research Network Program C7; to K. H.).	Akamatsu Y, 2011, NEUROSCI LETT, V503, P110, DOI 10.1016/j.neulet.2011.08.018; Argiriadi MA, 1999, P NATL ACAD SCI USA, V96, P10637, DOI 10.1073/pnas.96.19.10637; Bettaieb A, 2013, J BIOL CHEM, V288, P14189, DOI 10.1074/jbc.M113.458414; COOPER HS, 1993, LAB INVEST, V69, P238; Dieleman LA, 1997, SCAND J GASTROENTERO, V32, P99; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Donnan GA, 2011, NAT REV NEUROL, V7, P400, DOI 10.1038/nrneurol.2011.89; Gomez GA, 2006, PROTEIN SCI, V15, P58, DOI 10.1110/ps.051720206; Gomez GA, 2004, BIOCHEMISTRY-US, V43, P4716, DOI 10.1021/bi036189j; Hasegawa K, 2010, J ANTIBIOT, V63, P589, DOI 10.1038/ja.2010.101; Hashimoto T, 2010, J PHARMACOL SCI, V114, P41, DOI 10.1254/jphs.10131FP; Hasumi K, 2007, J ANTIBIOT, V60, P463, DOI 10.1038/ja.2007.60; Hasumi K, 2010, FEBS J, V277, P3675, DOI 10.1111/j.1742-4658.2010.07783.x; Hu WM, 2012, THROMB J, V10, DOI 10.1186/1477-9560-10-2; Hu WM, 2003, J ANTIBIOT, V56, P832, DOI 10.7164/antibiotics.56.832; Hu WM, 2000, J ANTIBIOT, V53, P241, DOI 10.7164/antibiotics.53.241; Iliff JJ, 2010, PROSTAG OTH LIPID M, V91, P68, DOI 10.1016/j.prostaglandins.2009.06.004; Inceoglu B, 2008, P NATL ACAD SCI USA, V105, P18901, DOI 10.1073/pnas.0809765105; Jiang HL, 2008, J PHARMACOL EXP THER, V326, P330, DOI 10.1124/jpet.107.134858; Jouihan SA, 2013, J CEREBR BLOOD F MET, V33, P1650, DOI 10.1038/jcbfm.2013.130; Jung O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011979; Kleindorfer D, 2008, STROKE, V39, P924, DOI 10.1161/STROKEAHA.107.490375; Kleinig TJ, 2009, CURR OPIN NEUROL, V22, P294, DOI 10.1097/WCO.0b013e32832b4db3; Koide H, 2012, J ANTIBIOT, V65, P361, DOI 10.1038/ja.2012.29; Koide H, 2012, J ANTIBIOT, V65, P91, DOI 10.1038/ja.2011.108; Koyanagi K, 2014, BLOOD COAGUL FIBRIN, V25, P316, DOI 10.1097/MBC.0000000000000032; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Li LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094092; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039165; Luo PC, 2010, J PHARMACOL EXP THER, V334, P430, DOI 10.1124/jpet.110.167544; Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108; Marowsky A, 2009, NEUROSCIENCE, V163, P646, DOI 10.1016/j.neuroscience.2009.06.033; Michaelis UR, 2006, PHARMACOL THERAPEUT, V111, P584, DOI 10.1016/j.pharmthera.2005.11.003; Miyazaki T, 2011, STROKE, V42, P1097, DOI 10.1161/STROKEAHA.110.598359; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Morisseau C, 2012, BIOCHEM BIOPH RES CO, V419, P796, DOI 10.1016/j.bbrc.2012.02.108; Motoki A, 2008, AM J PHYSIOL-HEART C, V295, pH2128, DOI 10.1152/ajpheart.00428.2008; Nadeau JO, 2005, CAN J NEUROL SCI, V32, P433, DOI 10.1017/S0317167100004418; Newman JW, 2005, PROG LIPID RES, V44, P1, DOI 10.1016/j.plipres.2004.10.001; Nishimura Y, 2012, J ANTIBIOT, V65, P483, DOI 10.1038/ja.2012.47; Oguro A, 2012, J LIPID RES, V53, P505, DOI 10.1194/jlr.M022319; Qiu H, 2011, CARDIOVASC THER, V29, P99, DOI 10.1111/j.1755-5922.2010.00150.x; ROSTAMI A, 1990, J NEUROIMMUNOL, V30, P145, DOI 10.1016/0165-5728(90)90098-8; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Sanders WG, 2012, AM J PHYSIOL-CELL PH, V303, pC278, DOI 10.1152/ajpcell.00386.2011; Sasaki M, 2003, FREE RADICAL BIO MED, V35, P1679, DOI 10.1016/j.freeradbiomed.2003.09.016; Sawada H, 2014, J CEREBR BLOOD F MET, V34, P235, DOI 10.1038/jcbfm.2013.191; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Shibata K, 2011, N-S ARCH PHARMACOL, V384, P103, DOI 10.1007/s00210-011-0642-x; Shibata K, 2010, N-S ARCH PHARMACOL, V382, P245, DOI 10.1007/s00210-010-0542-5; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Strauss KI, 2013, PROSTAG OTH LIPID M, V104, P18, DOI 10.1016/j.prostaglandins.2012.07.005; Thomson SJ, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/605101; Tran KL, 2005, BIOCHEMISTRY-US, V44, P12179, DOI 10.1021/bi050842g; Ulu A, 2008, J CARDIOVASC PHARM, V52, P314, DOI 10.1097/FJC.0b013e318185fa3c; Ulu A, 2013, J CARDIOVASC PHARM, V62, P285, DOI 10.1097/FJC.0b013e318298e460; Velde AAT, 2006, INFLAMM BOWEL DIS, V12, P995, DOI 10.1097/01.mib.0000227817.54969.5e; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; Zeldin DC, 1996, ARCH BIOCHEM BIOPHYS, V330, P87, DOI 10.1006/abbi.1996.0229; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V316, P443, DOI 10.1006/abbi.1995.1059; Zhang WY, 2012, DIGEST DIS SCI, V57, P2580, DOI 10.1007/s10620-012-2217-1; Zhang WR, 2008, STROKE, V39, P2073, DOI 10.1161/STROKEAHA.107.508325; Zhang WR, 2007, J CEREBR BLOOD F MET, V27, P1931, DOI 10.1038/sj.jcbfm.9600494	65	29	32	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35826	35838		10.1074/jbc.M114.588087	http://dx.doi.org/10.1074/jbc.M114.588087			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25361765	hybrid, Green Published			2022-12-28	WOS:000346897900014
J	Diner, I; Hales, CM; Bishof, I; Rabenold, L; Duong, DM; Yi, H; Laur, O; Gearing, M; Troncoso, J; Thambisetty, M; Lah, JJ; Levey, AI; Seyfried, NT				Diner, Ian; Hales, Chadwick M.; Bishof, Isaac; Rabenold, Lake; Duong, Duc M.; Yi, Hong; Laur, Oskar; Gearing, Marla; Troncoso, Juan; Thambisetty, Madhav; Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.			Aggregation Properties of the Small Nuclear Ribonucleoprotein U1-70K in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Neurodegenerative Disease; Protein Aggregation; RNA; Spliceosome; Tau Protein (Tau)	FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; CELL-FREE FORMATION; PRION-LIKE DOMAINS; NEURODEGENERATIVE DISEASE; PROTEIN AGGREGATION; CORTICOBASAL DEGENERATION; TDP-43; GRANULES; PHOSPHORYLATION	Recent evidence indicates that U1-70K and other U1 small nuclear ribonucleoproteins are Sarkosyl-insoluble and associate with Tau neurofibrillary tangles selectively in Alzheimer disease (AD). Currently, the mechanisms underlying the conversion of soluble nuclear U1 small nuclear ribonucleoproteins into insoluble cytoplasmic aggregates remain elusive. Based on the biochemical and subcellular distribution properties of U1-70K in AD, we hypothesized that aggregated U1-70K itself or other biopolymers (e.g. proteins or nucleic acids) interact with and sequester natively folded soluble U1-70K into insoluble aggregates. Here, we demonstrate that total homogenates from AD brain induce soluble U1-70K from control brain or recombinant U1-70K to become Sarkosyl-insoluble. This effect was not dependent on RNA and did not correlate with detergent-insoluble Tau levels as AD homogenates with reduced levels of these components were still capable of inducing U1-70K aggregation. In contrast, proteinase K-treated AD homogenates and Sarkosyl-soluble AD fractions were unable to induce U1-70K aggregation, indicating that aggregated proteins in AD brain are responsible for inducing soluble U1-70K aggregation. It was determined that the C terminus of U1-70K, which harbors two disordered low complexity (LC) domains, is necessary for U1-70K aggregation. Moreover, both LC1 and LC2 domains were sufficient for aggregation. Finally, protein cross-linking and mass spectrometry studies demonstrated that a U1-70K fragment harboring the LC1 domain directly interacts with aggregated U1-70K in AD brain. Our results support a hypothesis that aberrant forms of U1-70K in AD can directly sequester soluble forms of U1-70K into insoluble aggregates.	[Diner, Ian; Bishof, Isaac; Rabenold, Lake; Duong, Duc M.; Seyfried, Nicholas T.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Hales, Chadwick M.; Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Yi, Hong] Emory Univ, Robert P Apkarian Integrated Electron Microscopy, Atlanta, GA 30322 USA; [Laur, Oskar] Emory Univ, Div Microbiol, Atlanta, GA 30322 USA; [Laur, Oskar] Emory Univ, Yerkes Res Ctr, Atlanta, GA 30322 USA; [Gearing, Marla] Johns Hopkins Sch Med, Dept Expt Pathol, Baltimore, MD 21205 USA; [Troncoso, Juan] Johns Hopkins Sch Med, Dept Pathol & Neurol, Baltimore, MD 21205 USA; [Thambisetty, Madhav] NIA, NIH, Baltimore, MD 21224 USA; [Diner, Ian; Hales, Chadwick M.; Bishof, Isaac; Rabenold, Lake; Duong, Duc M.; Gearing, Marla; Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.] Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Diner, Ian; Hales, Chadwick M.; Bishof, Isaac; Rabenold, Lake; Duong, Duc M.; Yi, Hong; Laur, Oskar; Gearing, Marla; Lah, James J.; Levey, Allan I.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Emory University	Seyfried, NT (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	nseyfri@emory.edu	Levey, Allan/F-2104-2011	Levey, Allan/0000-0002-3153-502X; Duong, Duc/0000-0001-5880-1888	National Institutes of Health [P50AG025688, P30NS055077, 5T32GM008367]; National Institutes of Health Intramural Research Program; National Institute on Aging; Alzheimer's Association New Investigator Research Award [NIRG-12-242297]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, T32NS007480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014449, P50AG025688, ZIAAG000200, P50AG005146, R01AG043375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association New Investigator Research Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P50AG025688 (to the Emory Alzheimer's Disease Center) and Grant P30NS055077 (to the Emory Neuroscience NINDS Core Facilities), the National Institutes of Health Intramural Research Program, and the National Institute on Aging. This work was also supported by Alzheimer's Association New Investigator Research Award NIRG-12-242297 (to N. T. S.).; Supported by National Institutes of Health Grant 5T32GM008367.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bai B, 2013, P NATL ACAD SCI USA, V110, P16562, DOI 10.1073/pnas.1310249110; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRIDGE E, 1993, J VIROL, V67, P5792, DOI 10.1128/JVI.67.10.5792-5802.1993; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Dammer EB, 2015, PROTEOMICS, V15, P508, DOI 10.1002/pmic.201400189; Dammer EB, 2013, J PROTEOME RES, V12, P3193, DOI 10.1021/pr400246t; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Dickson DW, 2002, J NEUROPATH EXP NEUR, V61, P935, DOI 10.1093/jnen/61.11.935; Driscoll I, 2011, CURR ALZHEIMER RES, V8, P330, DOI 10.2174/156720511795745348; Ferguson SM, 2003, J NEUROSCI, V23, P9697; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hales CM, 2014, BRAIN PATHOL, V24, P344, DOI 10.1111/bpa.12133; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Herskowitz JH, 2010, J PROTEOME RES, V9, P6368, DOI 10.1021/pr100666c; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Korneta I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002641; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Mahapatra RK, 2004, LANCET NEUROL, V3, P736, DOI 10.1016/S1474-4422(04)00936-6; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; O'Brien RJ, 2009, J ALZHEIMERS DIS, V18, P665, DOI 10.3233/JAD-2009-1179; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; ROGERS J, 1980, P NATL ACAD SCI-BIOL, V77, P1877, DOI 10.1073/pnas.77.4.1877; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Seyfried NT, 2008, ANAL CHEM, V80, P4161, DOI 10.1021/ac702516a; Seyfried NT, 2012, J PROTEOME RES, V11, P2721, DOI 10.1021/pr2010814; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Sinz A, 2007, ANGEW CHEM INT EDIT, V46, P660, DOI 10.1002/anie.200602549; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; Vanderweyde T, 2012, J NEUROSCI, V32, P8270, DOI 10.1523/JNEUROSCI.1592-12.2012; Wang IF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1766; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Yi H, 2001, J HISTOCHEM CYTOCHEM, V49, P279, DOI 10.1177/002215540104900301	49	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35296	35313		10.1074/jbc.M114.562959	http://dx.doi.org/10.1074/jbc.M114.562959			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25355317	Green Published, hybrid			2022-12-28	WOS:000346660200022
J	Wi, SM; Moon, G; Kim, J; Kim, ST; Shim, JH; Chun, E; Lee, KY				Wi, Sae Mi; Moon, Gyuyoung; Kim, Juhong; Kim, Seong-Tae; Shim, Jae-Hyuck; Chun, Eunyoung; Lee, Ki-Young			TAK1-ECSIT-TRAF6 Complex Plays a Key Role in the TLR4 Signal to Activate NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Inflammation; Innate Immunity; NF-kappaB; Signal Transduction; ECSIT; TNF Receptor-associated Factor 6; Toll-like Receptors; Transforming Growth Factor--activated Kinase 1	TRANSDUCTION PATHWAY; OXIDATIVE STRESS; ADAPTER PROTEIN; INNATE IMMUNITY; KINASE KINASE; TAK1; RECOGNITION; UBIQUITIN; ECSIT; TAB2	ECSIT (evolutionarily conserved signaling intermediate in Toll pathways) is known as a multifunctional regulator in different signals, including Toll-like receptors (TLRs), TGF-, and BMP. Here, we report a new regulatory role of ECSIT in TLR4-mediated signal. By LPS stimulation, ECSIT formed a high molecular endogenous complex including TAK1 and TRAF6, in which ECSIT interacted with each protein and regulated TAK1 activity, leading to the activation of NF-B. ECSIT-knockdown THP-1 (ECSITKD THP-1) cells exhibited severe impairments in NF-B activity, cytokine production, and NF-B-dependent gene expression, whereas those were dramatically restored by reintroduction of wild type (WT) ECSIT gene. Interestingly, ECSIT mutants, which lack a specific interacting domain for either TAK1 or TRAF6, could not restore these activities. Moreover, no significant changes in both NF-B activity and cytokine production induced by TLR4 could be seen in TAK1(KD) or TRAF6(KD) THP-1 cells transduced by WT ECSIT, strongly suggesting the essential requirement of TAK1-ECSIT-TRAF6 complex in TLR4 signaling. Taken together, our data demonstrate that the ECSIT complex, including TAK1 and TRAF6, plays a pivotal role in TLR4-mediated signals to activate NF-kappa B.	[Wi, Sae Mi; Moon, Gyuyoung; Kim, Juhong; Kim, Seong-Tae; Lee, Ki-Young] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Wi, Sae Mi; Moon, Gyuyoung; Kim, Juhong; Kim, Seong-Tae; Lee, Ki-Young] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, South Korea; [Shim, Jae-Hyuck] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Chun, Eunyoung] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Chun, Eunyoung] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Cornell University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Chun, E (corresponding author), 665 Huntington Ave,Bldg 1,Rm 904, Boston, MA 02115 USA.	echun@hsph.harvard.edu; thylee@skku.edu		Shim, Jae-Hyuck/0000-0002-4947-3293	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2012R1A2A2A01005659]; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A111636]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (2012R1A2A2A01005659) and Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea, Grant A111636.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Irrinki KM, 2011, MOL CELL BIOL, V31, P3745, DOI 10.1128/MCB.05303-11; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Kim SY, 2014, MOL CELL BIOL, V34, P510, DOI 10.1128/MCB.01225-13; Kim SY, 2012, J BIOL CHEM, V287, P3381, DOI 10.1074/jbc.M111.317875; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Soler-Lopez M, 2012, BIOESSAYS, V34, P532, DOI 10.1002/bies.201100193; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Xiao CC, 2003, GENE DEV, V17, P2933, DOI 10.1101/gad.1145603	22	60	67	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35205	35214		10.1074/jbc.M114.597187	http://dx.doi.org/10.1074/jbc.M114.597187			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25371197	Green Published, hybrid			2022-12-28	WOS:000346660200014
J	Olausson, KH; Nister, M; Lindstrom, MS				Olausson, Karl Holmberg; Nister, Monica; Lindstrom, Mikael S.			Loss of Nucleolar Histone Chaperone NPM1 Triggers Rearrangement of Heterochromatin and Synergizes with a Deficiency in DNA Methyltransferase DNMT3A to Drive Ribosomal DNA Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Methyltransferase; Heterochromatin; Histone; Histone Chaperone; Histone Modification; Nucleolus; p53; Ribosome Assembly	TUMOR-SUPPRESSOR; RNA GENES; ACTINOMYCIN-D; PROTEIN; NUCLEOPHOSMIN; ARF; B23; METHYLATION; CHROMATIN; BIOGENESIS	Background: NPM1 is a nucleolar histone chaperone mutated in cancer. Results: NPM1-deficient cells display rearrangement of perinucleolar heterochromatin, and simultaneous knockdown of NPM1 and DNMT3A enhances transcription of ribosomal DNA. Conclusion: NPM1 loss disrupts heterochromatin organization around the nucleolus. Significance: Rearrangement of heterochromatin in NPM1-deficient cells may be of importance in tumor development. Nucleoli are prominent nuclear structures assembled and organized around actively transcribed ribosomal DNA (rDNA). The nucleolus has emerged as a platform for the organization of chromatin enriched for repressive histone modifications associated with repetitive DNA. NPM1 is a nucleolar protein required for the maintenance of genome stability. However, the role of NPM1 in nucleolar chromatin dynamics and ribosome biogenesis remains unclear. We found that normal fibroblasts and cancer cells depleted of NPM1 displayed deformed nucleoli and a striking rearrangement of perinucleolar heterochromatin, as identified by immunofluorescence staining of trimethylated H3K9, trimethylated H3K27, and heterochromatin protein 1 (HP1/CBX3). By co-immunoprecipitation we found NPM1 associated with HP1 and core and linker histones. Moreover, NPM1 was required for efficient tethering of HP1-enriched chromatin to the nucleolus. We next tested whether the alterations in perinucleolar heterochromatin architecture correlated with a difference in the regulation of rDNA. U1242MG glioma cells depleted of NPM1 presented with altered silver staining of nucleolar organizer regions, coupled to a modest decrease in H3K9 di- and trimethylation at the rDNA promoter. rDNA transcription and cell proliferation were sustained in these cells, indicating that altered organization of heterochromatin was not secondary to inhibition of rDNA transcription. Furthermore, knockdown of DNA methyltransferase DNMT3A markedly enhanced rDNA transcription in NPM1-depleted U1242MG cells. In summary, this study highlights a function of NPM1 in the spatial organization of nucleolus-associated heterochromatin.	[Olausson, Karl Holmberg; Nister, Monica; Lindstrom, Mikael S.] Karolinska Inst, Karolinska Univ Hosp, Dept Oncol Pathol, Canc Ctr Karolinska, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Lindstrom, MS (corresponding author), Karolinska Inst, Karolinska Univ Hosp Solna, Dept Oncol Pathol, Canc Ctr Karolinska, CCK R8 05, SE-17176 Stockholm, Sweden.	mikael.lindstrom@ki.se	Lindström, Mikael S/AAA-1451-2019	Lindström, Mikael S/0000-0003-1148-8497	Karolinska Institutet; Ake Wiberg Foundation; Magnus Bergvall Foundation; VR-MH from the Swedish Research Council [K2012-99X-21969-01-3]; Swedish Cancer Society; Cancer Society in Stockholm; Swedish Research Council; Stockholm County Council	Karolinska Institutet(Karolinska Institutet); Ake Wiberg Foundation; Magnus Bergvall Foundation; VR-MH from the Swedish Research Council(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council)	This work was supported by the Karolinska Institutet, the Ake Wiberg Foundation, the Magnus Bergvall Foundation, and VR-MH Project K2012-99X-21969-01-3 from the Swedish Research Council (to M. S. L.).; Supported by grants from Karolinska Institutet, the Swedish Cancer Society, the Cancer Society in Stockholm, the Swedish Research Council, and the Stockholm County Council.	Amin MA, 2008, BIOCHEM J, V415, P345, DOI 10.1042/BJ20081411; Apicelli AJ, 2008, MOL CELL BIOL, V28, P1068, DOI 10.1128/MCB.00484-07; Ayrault O, 2006, ONCOGENE, V25, P7577, DOI 10.1038/sj.onc.1209743; Bartova E, 2010, J HISTOCHEM CYTOCHEM, V58, P391, DOI 10.1369/jhc.2009.955435; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bonetti P, 2008, J CELL BIOL, V182, P19, DOI 10.1083/jcb.200711040; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Burns KH, 2003, SCIENCE, V300, P633, DOI 10.1126/science.1081813; Canudas S, 2011, GENE DEV, V25, P1807, DOI 10.1101/gad.17325211; Cheng K, 2007, ONCOGENE, V26, P7391, DOI 10.1038/sj.onc.1210549; Choong ML, 2009, CELL CYCLE, V8, P2810, DOI 10.4161/cc.8.17.9503; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Cong R, 2012, NUCLEIC ACIDS RES, V40, P9441, DOI 10.1093/nar/gks720; Enomoto T, 2006, J BIOL CHEM, V281, P18463, DOI 10.1074/jbc.M602788200; Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118; Fawal M, 2006, BLOOD, V108, P2780, DOI 10.1182/blood-2006-04-014902; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Gadad SS, 2011, BIOCHEMISTRY-US, V50, P2780, DOI 10.1021/bi101835J; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Galetzka D, 2006, J CELL BIOCHEM, V98, P885, DOI 10.1002/jcb.20798; Gao Q, 2011, P NATL ACAD SCI USA, V108, P18061, DOI 10.1073/pnas.1114946108; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Guerrero PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016401; Guetg C, 2012, EPIGENETICS-US, V7, P811, DOI 10.4161/epi.21072; Hamperl S, 2013, BBA-GENE REGUL MECH, V1829, P405, DOI 10.1016/j.bbagrm.2012.12.007; Hernandez-Hernandez A, 2012, CYTOGENET GENOME RES, V136, P89, DOI 10.1159/000335752; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Horakova AH, 2010, CHROMOSOMA, V119, P227, DOI 10.1007/s00412-009-0252-2; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Kalashnikova AA, 2013, NUCLEIC ACIDS RES, V41, P4026, DOI 10.1093/nar/gkt104; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Kwon SH, 2008, MOL CELLS, V26, P217; Larson K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002473; Lee SY, 2005, BIOCHEM J, V388, P7, DOI 10.1042/BJ20042033; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li KK, 2013, SEMIN HEMATOL, V50, P48, DOI 10.1053/j.seminhematol.2013.01.005; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Lindstrom MS, 2007, CELL CYCLE, V6, P434, DOI 10.4161/cc.6.4.3861; Lindstrom MS, 2006, CELL BIOCHEM BIOPHYS, V46, P79, DOI 10.1385/CBB:46:1:79; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Lu XW, 2009, GENE DEV, V23, P452, DOI 10.1101/gad.1749309; LUBITZ W, 1980, INT J CANCER, V25, P53, DOI 10.1002/ijc.2910250107; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Majumder S, 2006, J BIOL CHEM, V281, P22062, DOI 10.1074/jbc.M601155200; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Nemeth A, 2011, TRENDS GENET, V27, P149, DOI 10.1016/j.tig.2011.01.002; NISTER M, 1986, CANCER RES, V46, P332; O'Donohue MF, 2010, J CELL BIOL, V190, P853, DOI 10.1083/jcb.201005117; Ochs RL, 1998, METHOD CELL BIOL, V53, P303; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Padeken J, 2013, CELL CYCLE, V12, P3455, DOI 10.4161/cc.26697; Padeken J, 2013, MOL CELL, V50, P236, DOI 10.1016/j.molcel.2013.03.002; Park G, 2010, PROTEIN J, V29, P213, DOI 10.1007/s10930-010-9242-8; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Percipalle P, 2012, METHODS MOL BIOL, V809, P519, DOI 10.1007/978-1-61779-376-9_34; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Rickards B, 2007, MOL CELL BIOL, V27, P937, DOI 10.1128/MCB.01584-06; ROUSSEL P, 1994, EXP CELL RES, V214, P465, DOI 10.1006/excr.1994.1283; Roy DM, 2014, PROTEIN CELL, V5, P265, DOI 10.1007/s13238-014-0031-6; Salminen A, 2009, BIOCHEM BIOPH RES CO, V378, P6, DOI 10.1016/j.bbrc.2008.11.023; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Sportoletti P, 2008, BLOOD, V111, P3859, DOI 10.1182/blood-2007-06-098251; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Takada Y, 2011, DEVELOPMENT, V138, P4207, DOI 10.1242/dev.064444; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Yao Z, 2010, ONCOGENE, V29, P1821, DOI 10.1038/onc.2009.473; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhou Xiang, 2012, Genes Cancer, V3, P298, DOI 10.1177/1947601912455200; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	84	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34601	34619		10.1074/jbc.M114.569244	http://dx.doi.org/10.1074/jbc.M114.569244			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25349213	hybrid, Green Published			2022-12-28	WOS:000346260800019
J	Montigny, C; Decottignies, P; Le Marechal, P; Capy, P; Bublitz, M; Olesen, C; Moller, JV; Nissen, P; le Maire, M				Montigny, Cedric; Decottignies, Paulette; Le Marechal, Pierre; Capy, Pierre; Bublitz, Maike; Olesen, Claus; Moller, Jesper Vuust; Nissen, Poul; le Maire, Marc			S-Palmitoylation and S-Oleoylation of Rabbit and Pig Sarcolipin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium ATPase; Mass Spectrometry (MS); Membrane Protein; Protein Acylation; Protein Palmitoylation; Sarcoplasmic Reticulum (SR); Protein Oleoylation; Sarcolipin	SARCOPLASMIC-RETICULUM CA2+-ATPASE; HELICAL TRANSMEMBRANE PROTEINS; SKELETAL-MUSCLE; MEMBRANE-PROTEINS; CALCIUM-PUMP; PHYLOGENETIC TREES; DETERGENT BINDING; ATPASE SERCA; CA2+; SITES	Background: Many functions are subjected to regulation by protein-protein interactions. An example is the SERCA1a-SLN8 complex. Results: Rabbit and pig SLN have two types of fatty acid anchors (palmitic and oleic acid) attached to an intramembranous cysteine residue. Conclusion: A role and evolutionary significance of these S-acylations are suggested. Significance: First demonstration of SLN S-acylation and of the intramembranous S-oleoylation of a membrane protein. Sarcolipin (SLN) is a regulatory peptide present in sarcoplasmic reticulum (SR) from skeletal muscle of animals. We find that native rabbit SLN is modified by a fatty acid anchor on Cys-9 with a palmitic acid in about 60% and, surprisingly, an oleic acid in the remaining 40%. SLN used for co-crystallization with SERCA1a (Winther, A. M., Bublitz, M., Karlsen, J. L., Moller, J. V., Hansen, J. B., Nissen, P., and Buch-Pedersen, M. J. (2013) Nature 495, 265-2691; Ref. 1) is also palmitoylated/oleoylated, but is not visible in crystal structures, probably due to disorder. Treatment with 1 m hydroxylamine for 1 h removes the fatty acids from a majority of the SLN pool. This treatment did not modify the SERCA1a affinity for Ca2+ but increased the Ca2+-dependent ATPase activity of SR membranes indicating that the S-acylation of SLN or of other proteins is required for this effect on SERCA1a. Pig SLN is also fully palmitoylated/oleoylated on its Cys-9 residue, but in a reverse ratio of about 40/60. An alignment of 67 SLN sequences from the protein databases shows that 19 of them contain a cysteine and the rest a phenylalanine at position 9. Based on a cladogram, we postulate that the mutation from phenylalanine to cysteine in some species is the result of an evolutionary convergence. We suggest that, besides phosphorylation, S-acylation/deacylation also regulates SLN activity.	[Montigny, Cedric; le Maire, Marc] Univ Paris 11, CEA, UMR 8221, Lab Prot Membranaires, F-91191 Gif Sur Yvette, France; [Montigny, Cedric; le Maire, Marc] CENS, Lab Leon Brillouin, CNRS, F-91191 Gif Sur Yvette, France; [Decottignies, Paulette; Le Marechal, Pierre] Univ Paris 11, CNRS, UMR 8619, Inst Biochim & Biophys Mol & Cellulaire, F-91400 Orsay, France; [Capy, Pierre] Ctr Rech Gif, CNRS, UPR 9034, Lab Evolut Genomes & Speciat, F-91190 Gif Sur Yvette, France; [Capy, Pierre] Univ Paris 11, F-91190 Gif Sur Yvette, France; [Bublitz, Maike; Olesen, Claus; Moller, Jesper Vuust; Nissen, Poul] Danish Natl Res Fdn, PUMPKIN, Ctr Membrane Pumps Cells & Dis, DK-8000 Aarhus, Denmark; [Bublitz, Maike; Olesen, Claus; Moller, Jesper Vuust; Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Olesen, Claus] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Danmarks Grundforskningsfond; Aarhus University; Aarhus University	le Maire, M (corresponding author), CEA, UMR 8221, F-91191 Gif Sur Yvette, France.	marc.lemaire@cea.fr	MONTIGNY, Cédric/AAH-4216-2021	Nissen, Poul/0000-0003-0948-6628; Bublitz, Maike/0000-0003-3161-418X; Olesen, Claus/0000-0002-0462-1686	Agence Nationale de la Recherche; Domaines d'Interet Majeur Maladies Infectieuses Region Ile de France	Agence Nationale de la Recherche(French National Research Agency (ANR)); Domaines d'Interet Majeur Maladies Infectieuses Region Ile de France(Region Ile-de-France)	This work was supported by grants from the Agence Nationale de la Recherche (to M. l. M. and C. M.) and the Domaines d'Interet Majeur Maladies Infectieuses Region Ile de France (to M. l. M. and C. M.).	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSEN JP, 1977, BIOCHIM BIOPHYS ACTA, V485, P188, DOI 10.1016/0005-2744(77)90206-6; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Bhupathy P, 2009, J MOL CELL CARDIOL, V47, P723, DOI 10.1016/j.yjmcc.2009.07.014; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Buffy JJ, 2006, BIOCHEMISTRY-US, V45, P10939, DOI 10.1021/bi060728d; Buffy JJ, 2006, J MOL BIOL, V358, P420, DOI 10.1016/j.jmb.2006.02.005; CHAMPEIL P, 1985, BIOCHEMISTRY-US, V24, P69, DOI 10.1021/bi00322a012; Champeil P, 1998, J BIOL CHEM, V273, P6619, DOI 10.1074/jbc.273.12.6619; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Chaube R, 2014, J BIOL CHEM, V289, P8612, DOI 10.1074/jbc.M114.548925; DONNELLY D, 1993, PROTEIN SCI, V2, P55; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; Kazmin D, 2002, ANAL BIOCHEM, V301, P91, DOI 10.1006/abio.2001.5488; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; Lee AG, 2002, CURR OPIN STRUC BIOL, V12, P547, DOI 10.1016/S0959-440X(02)00360-3; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; MACLENNAN DH, 1973, COLD SPRING HARB SYM, V37, P469, DOI 10.1101/SQB.1973.037.01.058; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; Mascioni A, 2002, BIOCHEMISTRY-US, V41, P475, DOI 10.1021/bi011243m; MEIS LD, 1971, J BIOL CHEM, V246, P4759; MEISSNER G, 1973, BIOCHEM BIOPH RES CO, V52, P913, DOI 10.1016/0006-291X(73)91024-3; Mokrab Y, 2010, PROTEINS, V78, P2895, DOI 10.1002/prot.22809; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Montigny C, 2004, J BIOL CHEM, V279, P43971, DOI 10.1074/jbc.M407142200; Montigny C, 2008, BIOCHEMISTRY-US, V47, P12159, DOI 10.1021/bi8006498; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Musgaard M, 2012, BIOPHYS J, V102, P268, DOI 10.1016/j.bpj.2011.12.009; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Picard M, 2006, J BIOL CHEM, V281, P3360, DOI 10.1074/jbc.M511385200; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Resh MD, 2013, CURR BIOL, V23, pR431, DOI 10.1016/j.cub.2013.04.024; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schey KL, 2010, BIOCHEMISTRY-US, V49, P9858, DOI 10.1021/bi101415w; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Stevens TJ, 2001, PROTEIN SCI, V10, P2507, DOI 10.1110/ps.ps.10501; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; TONG SW, 1977, BIOCHEM BIOPH RES CO, V74, P1242, DOI 10.1016/0006-291X(77)91651-5; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Tulloch LB, 2011, J BIOL CHEM, V286, P36020, DOI 10.1074/jbc.M111.282145; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; WAWRZYNOW A, 1992, ARCH BIOCHEM BIOPHYS, V298, P620, DOI 10.1016/0003-9861(92)90457-8; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900	59	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33850	33861		10.1074/jbc.M114.590307	http://dx.doi.org/10.1074/jbc.M114.590307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25301946	hybrid, Green Published			2022-12-28	WOS:000346077600012
J	Torii, T; Miyamoto, Y; Tago, K; Sango, K; Nakamura, K; Sanbe, A; Tanoue, A; Yamauchi, J				Torii, Tomohiro; Miyamoto, Yuki; Tago, Kenji; Sango, Kazunori; Nakamura, Kazuaki; Sanbe, Atsushi; Tanoue, Akito; Yamauchi, Junji			Arf6 Guanine Nucleotide Exchange Factor Cytohesin-2 Binds to CCDC120 and Is Transported Along Neurites to Mediate Neurite Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP Ribosylation Factor (ARF); GTPase; Guanine Nucleotide Exchange Factor (GEF); Neurite Outgrowth; Vesicles	DOMAIN-CONTAINING PROTEIN; STABILIZER VALPROIC ACID; RIBOSYLATION FACTOR 6; ACTIN CYTOSKELETON; SIGNALING COMPLEXES; MEMBRANE-TRANSPORT; NEURONAL POLARITY; PLASMA-MEMBRANE; N1E-115 CELLS; EFA6 FAMILY	Background: The Arf6 activator, cytohesin-2, is involved in neurite growth. Results: Cytohesin-2 binds to CCDC120 and is transported along growing neurites. Conclusion: This interaction is required for Arf6 activation and neurite growth. Significance: The previously unknown functional CCDC120 is a new cytohesin adaptor protein, which regulates neurite growth. The mechanism of neurite growth is complicated, involving continuous cytoskeletal rearrangement and vesicular trafficking. Cytohesin-2 is a guanine nucleotide exchange factor for Arf6, an Arf family molecular switch protein, controlling cell morphological changes such as neuritogenesis. Here, we show that cytohesin-2 binds to a protein with a previously unknown function, CCDC120, which contains three coiled-coil domains, and is transported along neurites in differentiating N1E-115 cells. Transfection of the small interfering RNA (siRNA) specific for CCDC120 into cells inhibits neurite growth and Arf6 activation. When neurites start to extend, vesicles containing CCDC120 and cytohesin-2 are transported in an anterograde manner rather than a retrograde one. As neurites continue extension, anterograde vesicle transport decreases. CCDC120 knockdown inhibits cytohesin-2 localization into vesicles containing CCDC120 and diffuses cytohesin-2 in cytoplasmic regions, illustrating that CCDC120 determines cytohesin-2 localization in growing neurites. Reintroduction of the wild type CCDC120 construct into cells transfected with CCDC120 siRNA reverses blunted neurite growth and Arf6 activity, whereas the cytohesin-2-binding CC1 region-deficient CCDC120 construct does not. Thus, cytohesin-2 is transported along neurites by vesicles containing CCDC120, and it mediates neurite growth. These results suggest a mechanism by which guanine nucleotide exchange factor for Arf6 is transported to mediate neurite growth.	[Torii, Tomohiro; Miyamoto, Yuki; Nakamura, Kazuaki; Tanoue, Akito; Yamauchi, Junji] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Setagaya Ku, Tokyo 1578535, Japan; [Tago, Kenji] Jichi Med Univ, Grad Sch Med, Shimotsuke, Tochigi 3290498, Japan; [Sango, Kazunori] Tokyo Metropolitan Inst Med Sci, Amyotroph Lateral Sclerosis Neuropathy Project, Setagaya Ku, Tokyo 1568506, Japan; [Sanbe, Atsushi] Iwate Med Univ, Sch Pharm, Morioka, Iwate 0200023, Japan; [Yamauchi, Junji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138510, Japan	National Center for Child Health & Development - Japan; Jichi Medical University; Tokyo Metropolitan Institute of Medical Science; Iwate Medical University; Tokyo Medical & Dental University (TMDU)	Torii, T (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	torii-t@ncchd.go.jp; yamauchi-j@ncchd.go.jp		Torii, Tomohiro/0000-0002-0039-923X	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Ministry of Health, Labour, and Welfare; Takeda Science Foundation; Uehara Science Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Science Foundation(Uehara Memorial Foundation)	This work has been supported by grants-in-aid for young scientists, Scientific Research B, and Scientific Research on Innovative Areas, "Glial Assembly: A New Regulatory Machinery of Brain Function and Disorders" from the Japanese Ministry of Education, Culture, Sports, Science, and Technology and the Japanese Ministry of Health, Labour, and Welfare, and in part by grants from the Takeda Science Foundation and the Uehara Science Foundation.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Attar MA, 2012, EXP CELL RES, V318, P228, DOI 10.1016/j.yexcr.2011.10.018; Boehm T, 2003, EMBO J, V22, P1014, DOI 10.1093/emboj/cdg101; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; BRAY D, 1970, P NATL ACAD SCI USA, V65, P905, DOI 10.1073/pnas.65.4.905; Burgo A, 2012, DEV CELL, V23, P166, DOI 10.1016/j.devcel.2012.04.019; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Deretic D, 2012, VISION RES, V75, P5, DOI 10.1016/j.visres.2012.07.015; Derrien V, 2002, J CELL SCI, V115, P2867; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; DiNitto JP, 2010, BIOCHEMISTRY-US, V49, P6083, DOI 10.1021/bi1000454; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Ikenouchi J, 2010, P NATL ACAD SCI USA, V107, P748, DOI 10.1073/pnas.0908423107; Jaworski J, 2007, EUR J CELL BIOL, V86, P513, DOI 10.1016/j.ejcb.2007.04.007; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Klarlund JK, 2001, J BIOL CHEM, V276, P40065, DOI 10.1074/jbc.M105260200; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mansour M, 2002, J BIOL CHEM, V277, P32302, DOI 10.1074/jbc.M202898200; Matsuya S, 2005, J NEUROCHEM, V93, P674, DOI 10.1111/j.1471-4159.2005.03072.x; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Murphy JA, 2006, BRAIN RES, V1120, P35, DOI 10.1016/j.brainres.2006.08.096; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sakagami H, 2004, EUR J NEUROSCI, V19, P863, DOI 10.1111/j.0953-816X.2004.03195.x; Sakagami H, 2006, BRAIN RES, V1093, P1, DOI 10.1016/j.brainres.2006.02.058; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Sironi C, 2009, J CELL SCI, V122, P2108, DOI 10.1242/jcs.042325; Tang PT, 2002, P NATL ACAD SCI USA, V99, P2625, DOI 10.1073/pnas.052712999; Torii T., 2012, ADV BIOL CHEM, V02, P291, DOI [10.4236/abc.2012.23037, DOI 10.4236/ABC.2012.23037]; Torii T, 2012, CELL SIGNAL, V24, P1872, DOI 10.1016/j.cellsig.2012.05.016; Torii T, 2010, J BIOL CHEM, V285, P24270, DOI 10.1074/jbc.M110.125658; van den Bosch MTJ, 2014, J THROMB HAEMOST, V12, P726, DOI 10.1111/jth.12542; Venkateswarlu K, 2003, J BIOL CHEM, V278, P43460, DOI 10.1074/jbc.M304078200; Wang J, 2012, EMBO J, V31, P4057, DOI 10.1038/emboj.2012.253; Yamauchi J, 2008, EXP CELL RES, V314, P2279, DOI 10.1016/j.yexcr.2008.03.019; Yamauchi J, 2007, EXP CELL RES, V313, P1886, DOI 10.1016/j.yexcr.2007.02.019; Yamauchi J, 2006, EXP CELL RES, V312, P2954, DOI 10.1016/j.yexcr.2006.05.016; Yamauchi J, 2010, J NEUROSCI RES, V88, P3189, DOI 10.1002/jnr.22460; Yamauchi J, 2009, EXP CELL RES, V315, P2043, DOI 10.1016/j.yexcr.2009.03.012	58	14	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33887	33903		10.1074/jbc.M114.575787	http://dx.doi.org/10.1074/jbc.M114.575787			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25326380	Green Published, hybrid			2022-12-28	WOS:000346077600019
J	Yu, TZ; Wang, L; Lee, H; O'Brien, DK; Bronk, SF; Gores, GJ; Yoon, Y				Yu, Tianzheng; Wang, Li; Lee, Hakjoo; O'Brien, Dawn K.; Bronk, Steven F.; Gores, Gregory J.; Yoon, Yisang			Decreasing Mitochondrial Fission Prevents Cholestatic Liver Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bile Acid; Cell Death; Liver; Mitochondria; Reactive Oxygen Species (ROS); DLP1; Drp1; Cholestasis; Mitochondrial Fission; Mitochondrial Fusion	BILE-DUCT LIGATION; ISOLATED RAT HEPATOCYTES; ACID-INDUCED APOPTOSIS; OXYGEN SPECIES PRODUCTION; DYNAMIN-RELATED PROTEIN-1; DOMINANT OPTIC ATROPHY; SALT-INDUCED APOPTOSIS; PERMEABILITY TRANSITION; OXIDATIVE STRESS; MAMMALIAN-CELLS	Background: Bile acid-induced hepatocyte injury causes cholestatic liver disease. Results: Inhibiting mitochondrial fission prevents bile acid-induced hepatocyte death, and liver-specific decrease of mitochondrial fission in vivo limits bile duct ligation-induced liver injury and fibrosis. Conclusion: Controlling mitochondrial morphology is an effective strategy to decrease bile acid-induced liver injury. Significance: Mitochondrial fission is a new target to control cholestatic liver disease. Mitochondria frequently change their shape through fission and fusion in response to physiological stimuli as well as pathological insults. Disrupted mitochondrial morphology has been observed in cholestatic liver disease. However, the role of mitochondrial shape change in cholestasis is not defined. In this study, using in vitro and in vivo models of bile acid-induced liver injury, we investigated the contribution of mitochondrial morphology to the pathogenesis of cholestatic liver disease. We found that the toxic bile salt glycochenodeoxycholate (GCDC) rapidly fragmented mitochondria, both in primary mouse hepatocytes and in the bile transporter-expressing hepatic cell line McNtcp.24, leading to a significant increase in cell death. GCDC-induced mitochondrial fragmentation was associated with an increase in reactive oxygen species (ROS) levels. We found that preventing mitochondrial fragmentation in GCDC by inhibiting mitochondrial fission significantly decreased not only ROS levels but also cell death. We also induced cholestasis in mouse livers via common bile duct ligation. Using a transgenic mouse model inducibly expressing a dominant-negative fission mutant specifically in the liver, we demonstrated that decreasing mitochondrial fission substantially diminished ROS levels, liver injury, and fibrosis under cholestatic conditions. Taken together, our results provide new evidence that controlling mitochondrial fission is an effective strategy for ameliorating cholestatic liver injury.	[Yu, Tianzheng; Wang, Li; Lee, Hakjoo; O'Brien, Dawn K.; Yoon, Yisang] Georgia Regents Univ, Dept Physiol, Med Coll Georgia, Augusta, GA 30912 USA; [Bronk, Steven F.; Gores, Gregory J.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	University System of Georgia; Augusta University; Mayo Clinic	Yoon, Y (corresponding author), Georgia Regents Univ, Dept Physiol, Med Coll Georgia, 1120 15th St, Augusta, GA 30912 USA.	yyoon@gru.edu	Yoon, Yisang/AAJ-7910-2020	Yoon, Yisang/0000-0002-1618-5439	National Institutes of Health [DK061991, DK41876]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK041876, R01DK061991, P30DK084567, R01DK041876, R37DK041876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grants DK061991 (to Y. Y.) and DK41876 (to G. J. G.).	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; ANWER MS, 1988, HEPATOLOGY, V8, P887, DOI 10.1002/hep.1840080430; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; BEUERS U, 1993, GASTROENTEROLOGY, V104, P604, DOI 10.1016/0016-5085(93)90433-D; Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065455; Copple BL, 2010, SEMIN LIVER DIS, V30, P195, DOI 10.1055/s-0030-1253228; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Fang YW, 2004, HEPATOLOGY, V40, P961, DOI 10.1002/hep.20385; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Fickert P, 2005, J HEPATOL, V42, P378, DOI 10.1016/j.jhep.2004.10.016; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Galloway CA, 2012, DIABETES, V61, P2093, DOI 10.2337/db11-1640; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Georgiev P, 2008, BRIT J SURG, V95, P646, DOI 10.1002/bjs.6050; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gujral JS, 2004, HEPATOLOGY, V40, P998, DOI 10.1002/hep.20380; Gupta S, 2004, J BIOL CHEM, V279, P5821, DOI 10.1074/jbc.M310979200; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Hom JR, 2007, J CELL PHYSIOL, V212, P498, DOI 10.1002/jcp.21051; Jhun BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060810; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; KWO P, 1995, AM J PHYSIOL-GASTR L, V268, pG613, DOI 10.1152/ajpgi.1995.268.4.G613; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lin TK, 2012, APOPTOSIS, V17, P871, DOI 10.1007/s10495-012-0732-3; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Mitchell C, 2011, LAB INVEST, V91, P273, DOI 10.1038/labinvest.2010.163; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Qi X, 2011, MOL BIOL CELL, V22, P256, DOI 10.1091/mbc.E10-06-0551; Rehman H, 2008, J PHARMACOL EXP THER, V327, P699, DOI 10.1124/jpet.108.143578; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Roberts LR, 1997, GASTROENTEROLOGY, V113, P1714, DOI 10.1053/gast.1997.v113.pm9352877; Rodrigues CMP, 1998, MOL MED, V4, P165, DOI 10.1007/BF03401914; Rolo AP, 2000, TOXICOL SCI, V57, P177, DOI 10.1093/toxsci/57.1.177; SCHAFFNER F, 1971, GASTROENTEROLOGY, V60, P888; Serviddio G, 2004, HEPATOLOGY, V39, P711, DOI 10.1002/hep.20101; SOKOL RJ, 1995, GASTROENTEROLOGY, V109, P1249, DOI 10.1016/0016-5085(95)90585-5; Sokol RJ, 2001, PEDIATR RES, V49, P519, DOI 10.1203/00006450-200104000-00014; SPIVEY JR, 1993, J CLIN INVEST, V92, P17, DOI 10.1172/JCI116546; Strack S, 2013, J CELL BIOL, V201, P1037, DOI 10.1083/jcb.201210045; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; THIBAULT N, 1993, BIOCHEM PHARMACOL, V45, P289, DOI 10.1016/0006-2952(93)90063-3; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Webster CRL, 1998, HEPATOLOGY, V27, P1324, DOI 10.1002/hep.510270519; Yerushalmi B, 2001, HEPATOLOGY, V33, P616, DOI 10.1053/jhep.2001.22702; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu HMI, 2005, P NATL ACAD SCI USA, V102, P8615, DOI 10.1073/pnas.0500124102; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Yu TZ, 2011, ANTIOXID REDOX SIGN, V14, P425, DOI 10.1089/ars.2010.3284; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	65	28	29	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34074	34088		10.1074/jbc.M114.588616	http://dx.doi.org/10.1074/jbc.M114.588616			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25342755	Green Published, hybrid			2022-12-28	WOS:000346077600033
J	Hryniuk, A; Grainger, S; Savory, JGA; Lohnes, D				Hryniuk, Alexa; Grainger, Stephanie; Savory, Joanne G. A.; Lohnes, David			Cdx1 and Cdx2 Function as Tumor Suppressors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE INTESTINAL NEOPLASIA; COLORECTAL-CANCER PROGRESSION; TRANSCRIPTION FACTOR CDX2; COMPOUND MUTANT MICE; FACTOR-BETA-RECEPTOR; HOMEOBOX GENE; TGF-BETA; COLON-CANCER; CHROMOSOMAL INSTABILITY; GUT DEVELOPMENT	In humans, colorectal cancer is often initiated through APC loss of function, which leads to crypt hyperplasia and polyposis driven by unrestricted canonical Wnt signaling. Such polyps typically arise in the colorectal region and are at risk of transforming to invasive adenocarcinomas. Although colorectal cancer is the third most common cause of cancer-related death worldwide, the processes impacting initiation, transformation, and invasion are incompletely understood. Murine APC(Min/+) mutants are often used to model colorectal cancers; however, they develop nonmetastatic tumors confined largely to the small intestine and are thus not entirely representative of the human disease. APC(Min/+) alleles can collaborate with mutations impacting other pathways to recapitulate some aspects of human colorectal cancer. To this end, we assessed APC(Min/+)-induced polyposis following somatic loss of the homeodomain transcription factor Cdx2, alone or with a Cdx1 null allele, in the adult gastrointestinal tract. APC(Min/+)-Cdx2 mutants recapitulated several aspects of human colorectal cancer, including an invasive phenotype. Notably, the concomitant loss of Cdx1 led to a significant increase in the incidence of tumors in the distal colon, relative to APC(Min/+)-Cdx2 offspring, demonstrating a previously unrecognized role for this transcription factor in colorectal tumorigenesis. These findings underscore previously unrecognized roles for Cdx members in intestinal tumorigenesis.	[Hryniuk, Alexa; Grainger, Stephanie; Savory, Joanne G. A.; Lohnes, David] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Lohnes, D (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	dlohnes@uottawa.ca	Grainger, Stephanie/AAT-4518-2020	Grainger, Stephanie/0000-0001-6889-7174; , Alexa/0000-0002-6778-2006				Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Baba Y, 2009, CLIN CANCER RES, V15, P4665, DOI 10.1158/1078-0432.CCR-09-0401; Bakaris S, 2008, HISTOL HISTOPATHOL, V23, P1043, DOI 10.14670/HH-23.1043; Bakkebo M, 2012, FEBS LETT, V586, P3367, DOI 10.1016/j.febslet.2012.07.027; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Beck F, 2003, DEV BIOL, V255, P399, DOI 10.1016/S0012-1606(02)00096-9; Bonhomme C, 2008, ONCOGENE, V27, P4497, DOI 10.1038/onc.2008.78; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Brown JD, 1999, J BIOL CHEM, V274, P8797, DOI 10.1074/jbc.274.13.8797; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Cho NL, 2007, CANCER RES, V67, P2366, DOI 10.1158/0008-5472.CAN-06-3026; Chung DC, 2000, GASTROENTEROLOGY, V119, P854, DOI 10.1053/gast.2000.16507; Clevers H, 2006, CANCER RES, V66, P2, DOI 10.1158/0008-5472.CAN-05-3849; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Domon-Dell C, 2003, ONCOGENE, V22, P7913, DOI 10.1038/sj.onc.1206756; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Funaba M, 2002, J BIOL CHEM, V277, P41361, DOI 10.1074/jbc.M204597200; Funakoshi S, 2010, AM J PHYSIOL-GASTR L, V299, pG1054, DOI 10.1152/ajpgi.00297.2010; GALANDIUK S, 1987, AM J SURG, V153, P41, DOI 10.1016/0002-9610(87)90199-1; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Grainger S, 2012, DEV BIOL, V361, P1, DOI 10.1016/j.ydbio.2011.09.034; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Guo RJ, 2004, J BIOL CHEM, V279, P36865, DOI 10.1074/jbc.M405213200; Halberg RB, 2000, P NATL ACAD SCI USA, V97, P3461, DOI 10.1073/pnas.050585597; Hamamoto T, 2002, CANCER RES, V62, P5955; Hasson RM, 2014, CARCINOGENESIS, V35, P96, DOI 10.1093/carcin/bgt323; Hinoi T, 2001, AM J PATHOL, V159, P2239, DOI 10.1016/S0002-9440(10)63074-X; Hong KD, 2013, AM SURGEON, V79, P353; Hryniuk A, 2012, DEV BIOL, V363, P426, DOI 10.1016/j.ydbio.2012.01.010; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Kaimaktchiev V, 2004, MODERN PATHOL, V17, P1392, DOI 10.1038/modpathol.3800205; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Ku JL, 2007, CANCER LETT, V247, P283, DOI 10.1016/j.canlet.2006.05.008; Lorentz O, 1997, J CELL BIOL, V139, P1553, DOI 10.1083/jcb.139.6.1553; Lugli A, 2008, MODERN PATHOL, V21, P1403, DOI 10.1038/modpathol.2008.117; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pilozzi E, 2004, J PATHOL, V204, P289, DOI 10.1002/path.1641; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Porsch H, 2014, J BIOL CHEM, V289, P19747, DOI 10.1074/jbc.M114.547273; Rubio D, 2008, EXP CELL RES, V314, P691, DOI 10.1016/j.yexcr.2007.11.017; Runyan CE, 2009, J BIOL CHEM, V284, P25181, DOI 10.1074/jbc.M109.032847; Salari K, 2012, P NATL ACAD SCI USA, V109, pE3196, DOI 10.1073/pnas.1206004109; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Sipos F, 2012, WORLD J GASTROENTERO, V18, P601, DOI 10.3748/wjg.v18.i7.601; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sodir NM, 2006, CANCER RES, V66, P8430, DOI 10.1158/0008-5472.CAN-06-1437; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Subtil C, 2007, CANCER LETT, V247, P197, DOI 10.1016/j.canlet.2006.04.004; Suh ER, 2002, J BIOL CHEM, V277, P35795, DOI 10.1074/jbc.M205567200; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Takayama T, 2006, J GASTROENTEROL, V41, P185, DOI 10.1007/s00535-006-1801-6; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Verzi MP, 2011, MOL CELL BIOL, V31, P2026, DOI 10.1128/MCB.01250-10; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Witek ME, 2005, CLIN CANCER RES, V11, P8549, DOI 10.1158/1078-0432.CCR-05-1624; Wong NACS, 2004, P NATL ACAD SCI USA, V101, P574, DOI 10.1073/pnas.0307190101; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	75	57	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33343	33354		10.1074/jbc.M114.583823	http://dx.doi.org/10.1074/jbc.M114.583823			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25320087	Green Published, hybrid			2022-12-28	WOS:000345636600025
J	Ronzone, E; Wesolowski, J; Bauler, LD; Bhardwaj, A; Hackstadt, T; Paumet, F				Ronzone, Erik; Wesolowski, Jordan; Bauler, Laura D.; Bhardwaj, Anshul; Hackstadt, Ted; Paumet, Fabienne			An alpha-Helical Core Encodes the Dual Functions of the Chlamydial Protein IncA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION; SNARE COMPLEX; COILED-COIL; INCLUSION MEMBRANE; CRYSTAL-STRUCTURE; TRACHOMATIS; PSITTACI; MODEL; GENES; SPECIFICITY	Chlamydia is an intracellular bacterium that establishes residence within parasitophorous compartments (inclusions) inside host cells. Chlamydial inclusions are uncoupled from the endolysosomal pathway and undergo fusion with cellular organelles and with each other. To do so, Chlamydia expresses proteins on the surface of the inclusion using a Type III secretion system. These proteins, termed Incs, are located at the interface between host and pathogen and carry out the functions necessary for Chlamydia survival. Among these Incs, IncA plays a critical role in both protecting the inclusion from lysosomal fusion and inducing the homotypic fusion of inclusions. Within IncA are two regions homologous to eukaryotic SNARE (soluble N-ethylmaleimide-sensitive factor attachment receptor) domains referred to as SNARE-like domain 1 (SLD1) and SNARE-like domain 2 (SLD2). Using a multidisciplinary approach, we have discovered the functional core of IncA that retains the ability to both inhibit SNARE-mediated fusion and promote the homotypic fusion of Chlamydia inclusions. Circular dichroism and analytical ultracentrifugation experiments show that this core region is composed almost entirely of alpha-helices and assembles into stable homodimers in solution. Altogether, we propose that both IncA functions are encoded in a structured core domain that encompasses SLD1 and part of SLD2.	[Ronzone, Erik; Wesolowski, Jordan; Paumet, Fabienne] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Bhardwaj, Anshul] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Bauler, Laura D.; Hackstadt, Ted] NIAID, Host Parasite Interact Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA	Jefferson University; Jefferson University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Paumet, F (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, 233 S 10th St,BLSB Rm 750, Philadelphia, PA 19107 USA.	fabienne.paumet@jefferson.edu	Bauler, Laura/AAX-1686-2021	Bauler, Laura/0000-0001-6508-1938; Bhardwaj, Anshul/0000-0002-0897-979X; Hackstadt, Ted/0000-0003-1367-5528; Wesolowski, Jordan/0000-0002-4439-385X; Paumet, Fabienne/0000-0003-4466-6966	National Institutes of Health, NCI, Cancer Center Support Grant [P30 CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073486, ZIAAI000567] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Drs. Gino Cingolani, John Pascal, and Michael Root for critical discussion and advice during the course of this study. Research in this paper includes work carried out at the Sydney Kimmel Cancer Center X-ray Crystallography and Molecular Interaction Facility and Nucleic Acid Facility, which are supported in part by National Institutes of Health, NCI, Cancer Center Support Grant P30 CA56036.	Almeida F, 2012, J BACTERIOL, V194, P6574, DOI 10.1128/JB.01428-12; Alzhanov D, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-24; Antonin W, 2002, J BIOL CHEM, V277, P36449, DOI 10.1074/jbc.M204369200; Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Bauler LD, 2014, J BACTERIOL, V196, P1325, DOI 10.1128/JB.01290-13; Bhardwaj A, 2014, ACTA CRYSTALLOGR D, V70, P342, DOI 10.1107/S1399004713027685; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; Delevoye C, 2004, J BIOL CHEM, V279, P46896, DOI 10.1074/jbc.M407227200; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; EDMAN P, 1949, ARCH BIOCHEM, V22, P475; FRIIS RR, 1972, J BACTERIOL, V110, P706, DOI 10.1128/JB.110.2.706-721.1972; Geisler WM, 2001, J INFECT DIS, V184, P879, DOI 10.1086/323340; GRADDIS TJ, 1993, BIOCHEMISTRY-US, V32, P12664, DOI 10.1021/bi00210a015; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Hayes D., 1995, SEDNTERP SEDIMENTATI; HODGES R S, 1988, Peptide Research, V1, P19; Hsia RC, 1997, MOL MICROBIOL, V25, P351, DOI 10.1046/j.1365-2958.1997.4701834.x; JANCSO A, 1991, J BIOL CHEM, V266, P5891; Johnson CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083989; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LAU SYM, 1984, J BIOL CHEM, V259, P3253; LAWN AM, 1973, J HYG-CAMBRIDGE, V71, P515, DOI 10.1017/S0022172400046507; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Rockey DD, 2002, MICROBIOL-SGM, V148, P2497, DOI 10.1099/00221287-148-8-2497; ROCKEY DD, 1995, MOL MICROBIOL, V15, P617, DOI 10.1111/j.1365-2958.1995.tb02371.x; Ronzone E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069769; Schuck P, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P26; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Subtil A, 2004, CURR OPIN MICROBIOL, V7, P85, DOI 10.1016/j.mib.2003.12.012; Subtil A, 2001, MOL MICROBIOL, V39, P792, DOI 10.1046/j.1365-2958.2001.02272.x; Suchland RJ, 2000, INFECT IMMUN, V68, P360, DOI 10.1128/IAI.68.1.360-367.2000; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tsui MMK, 2000, J CELL SCI, V113, P145; Varlamov O, 2004, J CELL BIOL, V164, P79, DOI 10.1083/jcb.200307066; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weir E, 2004, CAN MED ASSOC J, V170, P1225, DOI 10.1503/cmaj.1040286; Wesolowski J, 2014, TRAFFIC, V15, P516, DOI 10.1111/tra.12159; Wesolowski J, 2010, VIRULENCE, V1, P319, DOI 10.4161/viru.1.4.12195; WYRICK PB, 1978, INFECT IMMUN, V19, P1054, DOI 10.1128/IAI.19.3.1054-1060.1978; WYRICK PB, 1978, INFECT IMMUN, V19, P1061, DOI 10.1128/IAI.19.3.1061-1067.1978; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; ZHOU NE, 1993, BIOCHEMISTRY-US, V32, P6190, DOI 10.1021/bi00075a011; ZHOU NE, 1992, BIOPOLYMERS, V32, P419, DOI 10.1002/bip.360320419	52	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33469	33480		10.1074/jbc.M114.592063	http://dx.doi.org/10.1074/jbc.M114.592063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25324548	Green Published, hybrid			2022-12-28	WOS:000345636600035
J	Sun, J; Narayanasamy, S; Curley, RW; Harrison, EH				Sun, Jian; Narayanasamy, Sureshbabu; Curley, Robert W., Jr.; Harrison, Earl H.			beta-Apo-13-carotenone Regulates Retinoid X Receptor Transcriptional Activity through Tetramerization of the Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CAROTENE; 9-CIS-RETINOIC ACID; RXR; LIGAND; MODULATORS; CLEAVAGE; GROWTH; SUPPRESSION; ABSORPTION; PROTEIN	Retinoid X receptor (RXR alpha) is activated by 9-cis-retinoic acid (9cRA) and regulates transcription as a homodimer or as a heterodimer with other nuclear receptors. We have previously demonstrated that beta-apo-13-carotenone, an eccentric cleavage product of beta-carotene, antagonizes the activation of RXR alpha by 9cRA in mammalian cells overexpressing this receptor. However, the molecular mechanism of beta-apo-13-carotenone's modulation on the transcriptional activity of RXR alpha is not understood and is the subject of this report. We performed transactivation assays using full-length RXR alpha and reporter gene constructs (RXRE-Luc) transfected into COS-7 cells, and luciferase activity was examined. beta-Apo-13-carotenone was compared with the RXR alpha antagonist UVI3003. The results showed that both beta-apo-13-carotenone and UVI3003 shifted the dose-dependentRXR alpha activation by 9cRA. In contrast, the results of assays using a hybrid Gal4-DBD: RXR alpha LBD receptor reporter cell assay that detects 9cRA-induced coactivator binding to the ligand binding domain demonstrated that UVI3003 significantly inhibited 9cRA-induced coactivator binding to RXR alpha LBD, but beta-apo-13-carotenone did not. However, both beta-apo-13-carotenone and UVI3003 inhibited 9-cRA induction of caspase 9 gene expression in the mammary carcinoma cell line MCF-7. Toresolve this apparent contradiction, we investigated the effect of beta-apo-13-carotenone on the oligomeric state of purified recombinant RXR alpha LBD. beta-Apo-13-carotenone induces tetramerization of the RXR alpha LBD, although UVI3003 had no effect on the oligomeric state. These observations suggest that beta-apo-13-carotenoneregulates RXR alpha transcriptional activity by inducing the formation of the "transcriptionally silent" RXR alpha tetramer.	[Sun, Jian; Narayanasamy, Sureshbabu; Harrison, Earl H.] Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA; [Narayanasamy, Sureshbabu; Curley, Robert W., Jr.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Harrison, EH (corresponding author), 314 Campbell Hall,1787 Neil Ave, Columbus, OH 43210 USA.	harrison.304@osu.edu	NARAYANASAMY, SURESHBABU/AAN-6604-2021; Harrison, Earl H/AAN-5378-2021	Narayanasamy, Sureshbabu/0000-0002-5846-3230	National Institutes of Health, NHLBI [R01-HL049879]; Office of Dietary Supplements; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049879] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL049879 from NHLBI and the Office of Dietary Supplements.	BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Carter CJ, 2010, DEV BIOL, V343, P124, DOI 10.1016/j.ydbio.2010.03.023; Dawson MI, 2012, BBA-MOL CELL BIOL L, V1821, P21, DOI 10.1016/j.bbalip.2011.09.014; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; Donato LJ, 2007, CANCER RES, V67, P609, DOI 10.1158/0008-5472.CAN-06-0989; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; Eroglu A, 2012, J BIOL CHEM, V287, P15886, DOI 10.1074/jbc.M111.325142; Eroglu A, 2010, ARCH BIOCHEM BIOPHYS, V504, P11, DOI 10.1016/j.abb.2010.07.025; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fleshman MK, 2011, J AGR FOOD CHEM, V59, P4448, DOI 10.1021/jf200416a; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Harrison EH, 2005, ANNU REV NUTR, V25, P87, DOI 10.1146/annurev.nutr.25.050304.092614; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Ho CC, 2007, AM J CLIN NUTR, V85, P770, DOI 10.1093/ajcn/85.3.770; Kersten S, 1998, J MOL BIOL, V284, P21, DOI 10.1006/jmbi.1998.2168; KERSTEN S, 1995, BIOCHEMISTRY-US, V34, P13717, DOI 10.1021/bi00042a001; KERSTEN S, 1995, P NATL ACAD SCI USA, V92, P8645, DOI 10.1073/pnas.92.19.8645; Kersten S, 1997, J BIOL CHEM, V272, P29759, DOI 10.1074/jbc.272.47.29759; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Olson JA, 1995, FASEB J, V9, P1547, DOI 10.1096/fasebj.9.15.8529833; Parker RS, 1996, FASEB J, V10, P542, DOI 10.1096/fasebj.10.5.8621054; PIJNAPPEL WWM, 1993, NATURE, V366, P340, DOI 10.1038/366340a0; Qian LX, 2010, J LIPID RES, V51, P1781, DOI 10.1194/jlr.M002840; ROBERTSON KA, 1992, MOL CELL BIOL, V12, P3743, DOI 10.1128/MCB.12.9.3743; SAKASHITA A, 1993, BLOOD, V81, P1009; Sanz MJ, 2012, J IMMUNOL, V189, P411, DOI 10.4049/jimmunol.1102942; Shmarakov I, 2010, ARCH BIOCHEM BIOPHYS, V504, P3, DOI 10.1016/j.abb.2010.05.010; THALLER C, 1993, DEVELOPMENT, V118, P957; Yasmin R, 2010, J MOL BIOL, V397, P1121, DOI 10.1016/j.jmb.2010.02.030; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	34	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33118	33124		10.1074/jbc.M114.610501	http://dx.doi.org/10.1074/jbc.M114.610501			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25324544	Green Published, hybrid			2022-12-28	WOS:000345636600006
J	Yu, HJ; Zhou, JJ; Takahashi, H; Yao, W; Suzuki, Y; Yuan, X; Yoshimura, SH; Zhang, Y; Liu, Y; Emmett, N; Bond, V; Wang, DM; Ding, X; Takeyasu, K; Yao, XB				Yu, Huijuan; Zhou, Jiajia; Takahashi, Hirohide; Yao, William; Suzuki, Yuki; Yuan, Xiao; Yoshimura, Shige H.; Zhang, Yin; Liu, Ya; Emmett, Nerimiah; Bond, Vincent; Wang, Dongmei; Ding, Xia; Takeyasu, Kunio; Yao, Xuebiao			Spatial Control of Proton Pump H,K-ATPase Docking at the Apical Membrane by Phosphorylation-coupled Ezrin-Syntaxin 3 Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC PARIETAL-CELLS; BIOCHEMICAL-CHARACTERIZATION; ACTIN INTERACTION; ACID-SECRETION; ERM PROTEINS; FERM DOMAIN; ACTIVATION; LOCALIZATION; TUBULOVESICLES; RADIXIN	The digestive function of the stomach depends on acidification of the gastric lumen. Acid secretion into the lumen is triggered by activation of a cAMP-dependent protein kinase (PKA) cascade, which ultimately results in the insertion of gastric H,K-ATPases into the apical plasma membranes of parietal cells. A coupling protein is ezrin whose phosphorylation at Ser-66 by PKA is required for parietal cell activation. However, little is known regarding the molecular mechanism(s) by which ezrin operates in gastric acid secretion. Here we show that phosphorylation of Ser-66 induces a conformational change of ezrin that enables its association with syntaxin 3 (Stx3) and provides a spatial cue for H, K-ATPase trafficking. This conformation-dependent association is specific for Stx3, and the binding interface is mapped to the N-terminal region. Biochemical analyses show that inhibition of ezrin phosphorylation at Ser-66 prevents ezrin-Stx3 association and insertion of H, K-ATPase into the apical plasma membrane of parietal cells. Using atomic force microscopic analyses, our study revealed that phosphorylation of Ser-66 induces unfolding of ezrin molecule to allow Stx3 binding to its N terminus. Given the essential role of Stx3 in polarized secretion, our study presents the first evidence in which phosphorylation-induced conformational rearrangement of the ezrin molecule provides a spatial cue for polarized membrane trafficking in epithelial cells.	[Yu, Huijuan; Zhou, Jiajia; Yuan, Xiao; Zhang, Yin; Liu, Ya; Wang, Dongmei; Yao, Xuebiao] Univ Sci & Technol China, Sch Life Sci, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Takahashi, Hirohide; Suzuki, Yuki; Yoshimura, Shige H.; Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane, Kyoto 6068502, Japan; [Zhou, Jiajia; Yao, William; Emmett, Nerimiah; Bond, Vincent] Morehouse Sch Med, Atlanta, GA 30310 USA; [Zhang, Yin; Ding, Xia] Beijing Univ Chinese Med, Grad Sch, Beijing 100086, Peoples R China; [Yao, William] Amer Digest Hlth Fdn, Cincinnati, OH USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Kyoto University; Morehouse School of Medicine; Beijing University of Chinese Medicine	Takeyasu, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane, Kyoto 6068502, Japan.	takeyasu@kyoto.ac.jp; yaoxb@ustc.edu.cn	Yoshimura, Shige H./AAF-5463-2019; Yao, Xuebiao/P-5771-2014; Suzuki, Yuki/H-9950-2015	Yoshimura, Shige H./0000-0001-6033-1301; Suzuki, Yuki/0000-0003-1848-0105; Takahashi, Hirohide/0000-0002-2553-8806	National Institutes of Health [CA164133, DK56292, G12RR03034]; Chinese 973 Projects [2012CB945002, 2012CB917204, 2010CB912103]; MOST [2009DFA31010]; Ministry of Education [20113402130010]; Anhui Project [08040102005]; Chinese Natural Science Foundation [31320103904, 31430054, 31271518, 91313303, 91129714, 81270466, 31301105]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101, G12MD007602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Projects(National Basic Research Program of China); MOST; Ministry of Education; Anhui Project; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants CA164133, DK56292, and G12RR03034. This work was also supported by Chinese 973 Projects 2012CB945002, 2012CB917204, and 2010CB912103, MOST 2009DFA31010, Ministry of Education 20113402130010, Anhui Project 08040102005, Chinese Natural Science Foundation Grants 31320103904, 31430054, 31271518, 91313303, 91129714, 81270466, and 31301105.	Ammar DA, 2002, AM J PHYSIOL-GASTR L, V282, pG23, DOI 10.1152/ajpgi.00277.2002; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Calhoun BC, 1997, BIOCHEM J, V325, P559, DOI 10.1042/bj3250559; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Ding X, 2010, J BIOL CHEM, V285, P18769, DOI 10.1074/jbc.M110.129007; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; HANZEL DK, 1989, AM J PHYSIOL, V256, pG1082, DOI 10.1152/ajpgi.1989.256.6.G1082; Ishikawa H, 2001, J MOL BIOL, V310, P973, DOI 10.1006/jmbi.2001.4818; Karvar S, 2005, TRAFFIC, V6, P654, DOI 10.1111/j.1600-0854.2005.00306.x; Karvar S, 2002, J BIOL CHEM, V277, P50030, DOI 10.1074/jbc.M207694200; Karvar S, 2002, GASTROENTEROLOGY, V123, P281, DOI 10.1053/gast.2002.34217; Liu D, 2007, FEBS LETT, V581, P3563, DOI 10.1016/j.febslet.2007.06.071; Liu Y, 2007, FEBS LETT, V581, P4318, DOI 10.1016/j.febslet.2007.07.083; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Peng XR, 1997, MOL BIOL CELL, V8, P399, DOI 10.1091/mbc.8.3.399; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; Wang FS, 2008, J BIOL CHEM, V283, P26714, DOI 10.1074/jbc.M800527200; Xia P, 2014, MOL BIOL CELL, V25, P4166, DOI 10.1091/mbc.E14-06-1133; YAO X, 1995, MOL BIOL CELL, V6, P140; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; Zhou RH, 2005, J CELL SCI, V118, P4381, DOI 10.1242/jcs.02559; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200	29	15	16	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33333	33342		10.1074/jbc.M114.581280	http://dx.doi.org/10.1074/jbc.M114.581280			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25301939	hybrid, Green Published			2022-12-28	WOS:000345636600024
J	Zhang, J; Xu, D; Nie, J; Han, RL; Zhai, YG; Shi, YG				Zhang, Jun; Xu, Dan; Nie, Jia; Han, Ruili; Zhai, Yonggong; Shi, Yuguang			Comparative Gene Identification-58 (CGI-58) Promotes Autophagy as a Putative Lysophosphatidylglycerol Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANARIN-DORFMAN-SYNDROME; ADIPOSE TRIGLYCERIDE LIPASE; LIPID STORAGE DISEASE; HIGH-FAT DIET; INSULIN-RESISTANCE; HEPATIC STEATOSIS; ER STRESS; CARDIOLIPIN; MICE; OBESITY	CGI-58 is a lipid droplet-associated protein that, when mutated, causes Chanarin-Dorfman syndrome in humans, which is characterized by excessive storage of triglyceride in various tissues. However, the molecular mechanisms underlying the defect remain elusive. CGI-58 was previously reported to catalyze the resynthesis of phosphatidic acid as a lysophosphatidic acid acyltransferase. In addition to triglyceride, phosphatidic acid is also used a substrate for the synthesis of various mitochondrial phospholipids. In this report, we investigated the propensity of CGI-58 in the remodeling of various phospholipids. We found that the recombinant CGI-58 overexpressed in mammalian cells or purified from Sf9 insect cells catalyzed efficiently the reacylation of lysophosphatidylglycerol to phosphatidylglycerol (PG), which requires acyl-CoA as the acyl donor. In contrast, the recombinant CGI-58 was devoid of acyltransferase activity toward other lysophospholipids. Accordingly, overexpression and knockdown of CGI-58 adversely affected the endogenous PG level in C2C12 cells. PG is a substrate for the synthesis of cardiolipin, which is required for mitochondrial oxidative phosphorylation and mitophagy. Consequently, overexpression and knockdown of CGI-58 adversely affected autophagy and mitophagy in C2C12 cells. In support for a key role of CGI-58 in mitophagy, overexpression of CGI-58 significantly stimulated mitochondrial fission and translocation of PINK1 to mitochondria, key steps involved in mitophagy. Furthermore, overexpression of CGI-58 promoted mitophagic initiation through activation of 5'-AMP-activated protein kinase and inhibition of mTORC1 mammalian target of rapamycin complex 1 signaling, the positive and negative regulators of autophagy, respectively. Together, these findings identified novel molecular mechanisms by which CGI-58 regulates lipid homeostasis, because defective autophagy is implicated in dyslipidemia and fatty liver diseases.	[Zhang, Jun; Zhai, Yonggong] Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China; [Zhang, Jun; Zhai, Yonggong] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Zhang, Jun; Xu, Dan; Nie, Jia; Han, Ruili; Shi, Yuguang] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Beijing Normal University; Beijing Normal University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Zhai, YG (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China.	ygzhai@bnu.edu.cn; yus11@psu.edu	Zhang, Jun/W-5146-2019; nie, jia/AAE-8355-2019	Zhang, Jun/0000-0002-8489-3699; nie, jia/0000-0001-9085-7224	National Institutes of Health [DK076685]; NSFC of China [31271207]; 973 Project [2011CB915504]; Chinese National Scholarship Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076685, R56DK076685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China); Chinese National Scholarship Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076685 (to Y. S.). This work was also supported by grants from NSFC of China (Grant 31271207 to Y. Z.), 973 Project (Grant 2011CB915504 to Y. Z.) and a scholarship from the Chinese National Scholarship Council (to D. X.).	Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Caviglia JM, 2011, J LIPID RES, V52, P2032, DOI 10.1194/jlr.M019117; Chen DH, 2006, BIOCHEM J, V398, P169, DOI 10.1042/BJ20060303; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; Chu CT, 2014, AUTOPHAGY, V10, P376, DOI 10.4161/auto.27191; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Codogno P, 2010, CELL METAB, V11, P449, DOI 10.1016/j.cmet.2010.05.006; Coupe B, 2012, CELL METAB, V15, P247, DOI 10.1016/j.cmet.2011.12.016; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Ghosh AK, 2008, J BIOL CHEM, V283, P24525, DOI 10.1074/jbc.M801783200; Goldman S, 2010, AUTOPHAGY, V6, P179, DOI 10.4161/auto.6.1.10814; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Guo F, 2013, J LIPID RES, V54, P2109, DOI 10.1194/jlr.M035519; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Huang WJ, 2012, CELL RES, V22, P473, DOI 10.1038/cr.2012.24; Igal RA, 1998, J LIPID RES, V39, P31; Kawasaki K, 1999, J BIOL CHEM, V274, P1828, DOI 10.1074/jbc.274.3.1828; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Li J, 2012, P NATL ACAD SCI USA, V109, P6975, DOI 10.1073/pnas.1120043109; Montero-Moran G, 2010, J LIPID RES, V51, P709, DOI 10.1194/jlr.M001917; MUSUMECI S, 1988, AM J MED GENET, V29, P377, DOI 10.1002/ajmg.1320290219; Nie J, 2010, BBA-MOL CELL BIOL L, V1801, P438, DOI 10.1016/j.bbalip.2009.12.002; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yang XY, 2010, FEBS LETT, V584, P903, DOI 10.1016/j.febslet.2009.12.058; Yang YZ, 2004, J BIOL CHEM, V279, P55866, DOI 10.1074/jbc.M406710200; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhao T, 2012, J BIOL CHEM, V287, P23615, DOI 10.1074/jbc.M112.379164; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200; Zhou LJ, 2010, AUTOPHAGY, V6, P1196, DOI 10.4161/auto.6.8.13478	47	21	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.573857	http://dx.doi.org/10.1074/jbc.M114.573857			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25315780	hybrid, Green Published			2022-12-28	WOS:000345335000054
J	Zhang, Z; Yang, HR; Wang, HB				Zhang, Zhuo; Yang, Huirong; Wang, Hengbin			The Histone H2A Deubiquitinase USP16 Interacts with HERC2 and Fine-tunes Cellular Response to DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; UBIQUITIN LIGASES; REPAIR PROTEINS; RNF168; RNF8; UBIQUITYLATION; CHROMOSOMES; COUNTERACTS; RECRUITMENT; PROGRESSION	Histone ubiquitination at DNA double strand breaks facilitates the recruitment of downstream repair proteins; however, how the ubiquitination is dynamically regulated during repair and terminated after repair is not well understood. Here we report that the histone H2A deubiquitinase USP16 interacts with HERC2, fine-tunes the ubiquitin signal during repair, and importantly, is required for terminating the ubiquitination signal after repair. HERC2 interacts with the coiled-coil domain of USP16 through its C-terminal HECT domain. HERC2 knockdown affects the levels of ubiquitinated H2A through the action of USP16. In response to DNA damage, USP16 levels increase, and this increase is dependent on HERC2. Increased USP16 serves as a negative regulator for DNA damage-induced ubiquitin foci formation and affects downstream factor recruitment and DNA damage response. The functional significance of USP16 is further manifested in human Down syndrome patient cells, which contain three copies of USP16 genes and have altered cellular response to DNA damage. Finally, we demonstrated that USP16 could deubiquitinate both H2A Lys-119 and H2A Lys-15 ubiquitination in vitro. Therefore, this study identifies USP16 as a critical regulator of DNA damage response and H2A Lys-15 ubiquitination as a potential target of USP16.	[Zhang, Zhuo; Yang, Huirong; Wang, Hengbin] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Stem Cell Inst, Birmingham, AL 35294 USA; [Yang, Huirong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	University of Alabama System; University of Alabama Birmingham; Fudan University	Wang, HB (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Stem Cell Inst, Kaul Human Genet Bldg 402A,720 20th St S, Birmingham, AL 35294 USA.	hbwang@uab.edu		Wang, Hengbin/0000-0003-2414-0609	National Institutes of Health [GM081489]; University of Alabama Comprehensive Cancer Center Junior Faculty Development Grant Program [CA13148-39]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama Comprehensive Cancer Center Junior Faculty Development Grant Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081489 (to H. W.).; Supported in part by University of Alabama Comprehensive Cancer Center Junior Faculty Development Grant Program CA13148-39.	Adorno M, 2013, NATURE, V501, P380, DOI 10.1038/nature12530; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Cao J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00026; Danielsen JR, 2012, J CELL BIOL, V197, P179, DOI 10.1083/jcb.201106152; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gatti M, 2012, CELL CYCLE, V11, P2538, DOI 10.4161/cc.20919; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Hiom K, 2009, CURR BIOL, V19, pR331, DOI 10.1016/j.cub.2009.03.024; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Jones A, 2011, METHODS, V54, P315, DOI 10.1016/j.ymeth.2011.03.003; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Mendez-Acuna L, 2010, CYTOGENET GENOME RES, V128, P28, DOI 10.1159/000296275; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Pinder Jordan B., 2013, Frontiers in Genetics, V4, P45, DOI 10.3389/fgene.2013.00045; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Rando OJ, 2012, CURR OPIN GENET DEV, V22, P148, DOI 10.1016/j.gde.2012.02.013; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sharma N, 2014, CELL CYCLE, V13, P106, DOI 10.4161/cc.26814; Sirbu BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012724; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Wu JX, 2009, MOL CELL BIOL, V29, P849, DOI 10.1128/MCB.01302-08; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470	37	46	49	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.599605	http://dx.doi.org/10.1074/jbc.M114.599605			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25305019	Green Published, hybrid			2022-12-28	WOS:000345335000041
J	Xiao, H; Bid, HK; Jou, D; Wu, XJ; Yu, WY; Li, CL; Houghton, PJ; Lin, JY				Xiao, Hui; Bid, Hemant Kumar; Jou, David; Wu, Xiaojuan; Yu, Wenying; Li, Chenglong; Houghton, Peter J.; Lin, Jiayuh			A Novel Small Molecular STAT3 Inhibitor, LY5, Inhibits Cell Viability, Cell Migration, and Angiogenesis in Medulloblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; NON-HODGKINS-LYMPHOMA; DNA-BINDING ACTIVITY; SIGNAL TRANSDUCER; PROSTATE-CANCER; GENE-REGULATION; GROWTH-FACTOR; TUMOR-CELLS; POSSIBLE MECHANISM; MULTIPLE-MYELOMA	Signal transducers and activators of transcription 3 (STAT3) signaling is persistently activated and could contribute to tumorigenesis of medulloblastoma. Numerous studies have demonstrated that inhibition of the persistent STAT3 signaling pathway results in decreased proliferation and increased apoptosis in human cancer cells, indicating that STAT3 is a viable molecular target for cancer therapy. In this study, we investigated a novel non-peptide, cell-permeable small molecule, named LY5, to target STAT3 in medulloblastoma cells. LY5 inhibited persistent STAT3 phosphorylation and induced apoptosis in human medulloblastoma cell lines expressing constitutive STAT3 phosphorylation. The inhibition of STAT3 signaling by LY5 was confirmed by down-regulating the expression of the downstream targets of STAT3, including cyclin D1, bcl-XL, survivin, and micro-RNA-21. LY5 also inhibited the induction of STAT3 phosphorylation by interleukin-6 (IL-6), insulin-like growth factor (IGF)-1, IGF-2, and leukemia inhibitory factor in medulloblastoma cells, but did not inhibit STAT1 and STAT5 phosphorylation stimulated by interferon-gamma (IFN-gamma) and EGF, respectively. In addition, LY5 blocked the STAT3 nuclear localization induced by IL-6, but did not block STAT1 and STAT5 nuclear translocation mediated by IFN-gamma and EGF, respectively. A combination of LY5 with cisplatin or x-ray radiation also showed more potent effects than single treatment alone in the inhibition of cell viability in human medulloblastoma cells. Furthermore, LY5 demonstrated a potent inhibitory activity on cell migration and angiogenesis. Taken together, these findings indicate LY5 inhibits persistent and inducible STAT3 phosphorylation and suggest that LY5 is a promising therapeutic drug candidate for medulloblastoma by inhibiting persistent STAT3 signaling.	[Xiao, Hui; Bid, Hemant Kumar; Jou, David; Wu, Xiaojuan; Houghton, Peter J.; Lin, Jiayuh] Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Dept Pediat,Coll Med,Ctr Childhood Canc & Blood D, Columbus, OH 43205 USA; [Yu, Wenying; Li, Chenglong] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Lin, JY (corresponding author), 700 Childrens Dr, Columbus, OH 43205 USA.	lin.674@osu.edu	Li, Chenglong/E-7182-2010; Lin, Jiayuh/E-3515-2011	Li, Chenglong/0000-0003-3174-8719; 	Alex's Lemonade Stand Foundation; Research Institute at Nationwide Children's Hospital	Alex's Lemonade Stand Foundation; Research Institute at Nationwide Children's Hospital(Ohio State University)	This work was supported by Alex's Lemonade Stand Foundation and the Technology Development Fund from The Research Institute at Nationwide Children's Hospital.	Alas S, 2003, CLIN CANCER RES, V9, P316; Amin HM, 2004, ONCOGENE, V23, P5426, DOI 10.1038/sj.onc.1207703; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Badr G, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-236; Barton BE, 2004, MOL CANCER THER, V3, P11; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buettner R, 2002, CLIN CANCER RES, V8, P945; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Cheng JG, 2001, P NATL ACAD SCI USA, V98, P8680, DOI 10.1073/pnas.151180898; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Clark J, 2003, ONCOGENE, V22, P1247, DOI 10.1038/sj.onc.1206247; Connolly E, 2008, AM J PATHOL, V173, P856, DOI 10.2353/ajpath.2008.080096; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Fu XY, 2006, CELL RES, V16, P214, DOI 10.1038/sj.cr.7310029; Grunder E, 2011, EUR J CANCER, V47, P2479, DOI 10.1016/j.ejca.2011.06.041; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Huang SL, 2012, CANCER LETT, V315, P198, DOI 10.1016/j.canlet.2011.10.011; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kato K, 2000, BBA-GENE STRUCT EXPR, V1493, P91, DOI 10.1016/S0167-4781(00)00168-8; Kuropatwinski KK, 1997, J BIOL CHEM, V272, P15135, DOI 10.1074/jbc.272.24.15135; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Liu Y, 2010, J BIOL CHEM, V285, P27429, DOI 10.1074/jbc.M110.142752; Miklossy G, 2013, NAT REV DRUG DISCOV, V12, P611, DOI 10.1038/nrd4088; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Osugi T, 2002, J BIOL CHEM, V277, P6676, DOI 10.1074/jbc.M108246200; Packer R J, 1999, Neuro Oncol, V1, P232, DOI 10.1093/neuonc/1.3.232; Packer RJ, 2006, J CLIN ONCOL, V24, P4202, DOI 10.1200/JCO.2006.06.4980; Paydas S, 2003, ANN ONCOL, V14, P1045, DOI 10.1093/annonc/mdg277; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Rebbaa A, 2001, MOL MED, V7, P393, DOI 10.1007/BF03402185; Rossi A, 2008, CLIN CANCER RES, V14, P971, DOI 10.1158/1078-0432.CCR-07-2072; Schlessinger K, 2005, CANCER RES, V65, P5828, DOI 10.1158/0008-5472.CAN-05-0317; Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198; SHIMONOVITZ S, 1994, AM J OBSTET GYNECOL, V171, P832, DOI 10.1016/0002-9378(94)90107-4; Shiota M, 2013, CANCER RES, V73, P3109, DOI 10.1158/0008-5472.CAN-12-3979; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Thaloor D, 1998, CELL GROWTH DIFFER, V9, P305; Tian XC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-58; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Vogel S, 2010, J BIOL CHEM, V285, P33756, DOI 10.1074/jbc.M110.132985; Wang L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-14; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yamaguchi H, 2002, AM J HEMATOL, V69, P74, DOI 10.1002/ajh.10030; Yang F, 2010, MOL CANCER RES, V8, P35, DOI 10.1158/1541-7786.MCR-09-0220; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu WY, 2013, J MED CHEM, V56, P4402, DOI 10.1021/jm400080c; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zong CS, 1998, J BIOL CHEM, V273, P28065, DOI 10.1074/jbc.273.43.28065	69	54	56	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3418	3429		10.1074/jbc.M114.616748	http://dx.doi.org/10.1074/jbc.M114.616748			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25313399	Green Published, hybrid			2022-12-28	WOS:000349456000018
J	Englert, NA; Luo, G; Goldstein, JA; Surapureddi, S				Englert, Neal A.; Luo, George; Goldstein, Joyce A.; Surapureddi, Sailesh			Epigenetic Modification of Histone 3 Lysine 27 MEDIATOR SUBUNIT MED25 IS REQUIRED FOR THE DISSOCIATION OF POLYCOMB REPRESSIVE COMPLEX 2 FROM THE PROMOTER OF CYTOCHROME P450 2C9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; RNA-POLYMERASE-II; HEPATIC NUCLEAR FACTOR-4-ALPHA; REPRESSIVE COMPLEX 2; GENOME-WIDE ANALYSIS; PREGNANE-X-RECEPTOR; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; HUMAN HEPATOCYTES; MEDIATOR COMPLEX	The Mediator complex is vital for the transcriptional regulation of eukaryotic genes. Mediator binds to nuclear receptors at target response elements and recruits chromatin-modifying enzymes and RNA polymerase II. Here, we examine the involvement of Mediator subunit MED25 in the epigenetic regulation of human cytochrome P450 2C9 (CYP2C9). MED25 is recruited to the CYP2C9 promoter through association with liver-enriched HNF4 alpha, and we show that MED25 influences the H3K27 status of the HNF4 alpha binding region. This region was enriched for the activating marker H3K27ac and histone acetyltransferase CREBBP after MED25 overexpression but was trimethylated when MED25 expression was silenced. The epigenetic regulator Polycomb repressive complex (PRC2), which represses expression by methylating H3K27, plays an important role in target gene regulation. Silencing MED25 correlated with increased association of PRC2 not only with the promoter region chromatin but with HNF4 alpha itself. We confirmed the involvement of MED25 for fully functional preinitiation complex recruitment and transcriptional output in vitro. Formaldehyde-assisted isolation of regulatory elements (FAIRE) revealed chromatin conformation changes that were reliant on MED25, indicating that MED25 induced a permissive chromatin state that reflected increases in CYP2C9 mRNA. For the first time, we showed evidence that a functionally relevant human gene is transcriptionally regulated by HNF4 alpha via MED25 and PRC2. CYP2C9 is important for the metabolism of many exogenous chemicals including pharmaceutical drugs as well as endogenous substrates. Thus, MED25 is important for regulating the epigenetic landscape resulting in transcriptional activation of a highly inducible gene, CYP2C9.	[Englert, Neal A.; Luo, George; Goldstein, Joyce A.; Surapureddi, Sailesh] NIEHS, Lab Toxicol & Pharmacol, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Goldstein, JA (corresponding author), NIEHS, Lab Toxicol & Pharmacol, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	goldste1@niehs.nih.gov			National Institutes of Health Intramural Research Program, NIEHS [ES021024-32]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES021024] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIEHS Project ES021024-32.	Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Beck DB, 2010, COLD SH Q B, V75, P11, DOI 10.1101/sqb.2010.75.052; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Caron S, 2013, MOL CELL BIOL, V33, P2202, DOI 10.1128/MCB.01004-12; Chen YP, 2005, J PHARMACOL EXP THER, V314, P1125, DOI 10.1124/jpet.105.087072; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Corvetta D, 2013, J BIOL CHEM, V288, P8332, DOI 10.1074/jbc.M113.454280; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; Dannenberg LO, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-181; Delest A, 2012, CURR OPIN CELL BIOL, V24, P405, DOI 10.1016/j.ceb.2012.01.008; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ferguson SS, 2005, MOL PHARMACOL, V68, P747, DOI 10.1124/mol.105.013169; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gomez A, 2009, PHARMACOGENOMICS, V10, P1067, DOI [10.2217/pgs.09.56, 10.2217/PGS.09.56]; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Holmqvist PH, 2013, TRANSCR-AUSTIN, V4, P18, DOI 10.4161/trns.22601; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kurzawski M, 2012, PHARMACOL REP, V64, P927, DOI 10.1016/S1734-1140(12)70888-5; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lee HK, 2007, EMBO J, V26, P3545, DOI 10.1038/sj.emboj.7601797; Lee JY, 2012, BBA-PROTEINS PROTEOM, V1824, P974, DOI 10.1016/j.bbapap.2012.05.006; Lehmann L, 2012, J BIOL CHEM, V287, P35784, DOI 10.1074/jbc.M112.397430; Li TG, 2010, J LIPID RES, V51, P832, DOI 10.1194/jlr.M002782; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Miura H, 2009, NUCLEIC ACIDS RES, V37, P778, DOI 10.1093/nar/gkn978; Neri F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r91; Pascussi JM, 2000, MOL PHARMACOL, V58, P1441, DOI 10.1124/mol.58.6.1441; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Paul DS, 2013, GENOME RES, V23, P1130, DOI 10.1101/gr.155127.113; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; Rana R, 2011, MOL CELL BIOL, V31, P466, DOI 10.1128/MCB.00847-10; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sela D, 2013, J BIOL CHEM, V288, P26179, DOI 10.1074/jbc.M113.496968; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Sugathan A, 2013, MOL CELL BIOL, V33, P3594, DOI 10.1128/MCB.00280-13; Surapureddi S, 2002, P NATL ACAD SCI USA, V99, P11836, DOI 10.1073/pnas.182426699; Surapureddi S, 2008, MOL PHARMACOL, V74, P913, DOI 10.1124/mol.108.048983; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Thomas M, 2013, MOL PHARMACOL, V83, P709, DOI 10.1124/mol.112.082503; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Viswakarma N, 2013, J BIOL CHEM, V288, P27898, DOI 10.1074/jbc.M113.486696; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Weng Y, 2005, J BIOL CHEM, V280, P31686, DOI 10.1074/jbc.M504447200; Wortham M, 2007, DRUG METAB DISPOS, V35, P1700, DOI 10.1124/dmd.107.016436; Wu SY, 2003, MOL CELL BIOL, V23, P6229, DOI 10.1128/MCB.23.17.6229-6242.2003; Xu CR, 2009, MOL CANCER RES, V7, P1937, DOI 10.1158/1541-7786.MCR-09-0333; Yang H, 2010, EXP BIOL MED, V235, P32, DOI 10.1258/ebm.2009.009252; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007	62	19	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2264	2278		10.1074/jbc.M114.579474	http://dx.doi.org/10.1074/jbc.M114.579474			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25391650	Green Published, hybrid			2022-12-28	WOS:000348588000030
J	Fresques, T; Niles, B; Aronova, S; Mogri, H; Rakhshandehroo, T; Powers, T				Fresques, Tara; Niles, Brad; Aronova, Sofia; Mogri, Huzefa; Rakhshandehroo, Taha; Powers, Ted			Regulation of Ceramide Synthase by Casein Kinase 2-dependent Phosphorylation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOLIPID METABOLISM; ENDOPLASMIC-RETICULUM; PROTEINS; CK2; BIOSYNTHESIS; ACTIVATION; SYSTEM; TARGET; YPK1	Complex sphingolipids are important components of eukaryotic cell membranes and, together with their biosynthetic precursors, including sphingoid long chain bases and ceramides, have important signaling functions crucial for cell growth and survival. Ceramides are produced at the endoplasmic reticulum (ER) membrane by a multicomponent enzyme complex termed ceramide synthase (CerS). In budding yeast, this complex is composed of two catalytic subunits, Lac1 and Lag1, as well as an essential regulatory subunit, Lip1. Proper formation of ceramides by CerS has been shown previously to require the Cka2 subunit of casein kinase 2 (CK2), a ubiquitous enzyme with multiple cellular functions, but the precise mechanism involved has remained unidentified. Here we present evidence that Lac1 and Lag1 are direct targets for CK2 and that phosphorylation at conserved positions within the C-terminal cytoplasmic domain of each protein is required for optimal CerS activity. Our data suggest that phosphorylation of Lac1 and Lag1 is important for proper localization and distribution of CerS within the ER membrane and that phosphorylation of these sites is functionally linked to the COP I-dependent C-terminal dilysine ER retrieval pathway. Together, our data identify CK2 as an important regulator of sphingolipid metabolism, and additionally, because both ceramides and CK2 have been implicated in the regulation of cancer, our findings may lead to an enhanced understanding of their relationship in health and disease.	[Fresques, Tara; Niles, Brad; Aronova, Sofia; Mogri, Huzefa; Rakhshandehroo, Taha; Powers, Ted] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Powers, T (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, One Shields Ave, Davis, CA 95616 USA.	tpowers@ucdavis.edu			National Institutes of Health [GM086387]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM086387 (to T. P.).	Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Dilova I, 2004, J BIOL CHEM, V279, P46527, DOI 10.1074/jbc.M409012200; Faust M, 2001, MOL CELL BIOCHEM, V227, P73, DOI 10.1023/A:1013129410551; Furuya H, 2011, CANCER METAST REV, V30, P567, DOI 10.1007/s10555-011-9304-1; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gietz D, 1998, METHOD MICROBIOL, V26, P53; Hannich JT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004762; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Homma MK, 2008, MOL CELL BIOCHEM, V316, P49, DOI 10.1007/s11010-008-9823-4; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Kobayashi SD, 2003, EUKARYOT CELL, V2, P284, DOI 10.1128/EC.2.2.284-294.2003; Koyanagi S, 2003, INT J CANCER, V105, P1, DOI 10.1002/ijc.11024; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; Leroy D, 1999, MOL CELL BIOCHEM, V191, P85, DOI 10.1023/A:1006858210835; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maiti T, 2003, YEAST, V20, P97, DOI 10.1002/yea.937; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Muir A, 2014, ELIFE, V3, DOI 10.7554/eLife.03779; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUNSTERMANN U, 1990, EUR J BIOCHEM, V189, P251, DOI 10.1111/j.1432-1033.1990.tb15484.x; Niles BJ, 2014, CELL REP, V6, P541, DOI 10.1016/j.celrep.2013.12.040; Niles BJ, 2012, P NATL ACAD SCI USA, V109, P1536, DOI 10.1073/pnas.1117563109; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Russo GL, 2000, BIOCHEM J, V351, P143, DOI 10.1042/0264-6021:3510143; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Sarno S, 2008, MOL BIOSYST, V4, P889, DOI 10.1039/b805534c; Schiffmann S, 2009, CARCINOGENESIS, V30, P745, DOI 10.1093/carcin/bgp061; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Sims KJ, 2004, BIOCHEM CELL BIOL, V82, P45, DOI 10.1139/o03-086; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562	44	21	21	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1395	1403		10.1074/jbc.M114.621086	http://dx.doi.org/10.1074/jbc.M114.621086			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25429105	Green Published, hybrid			2022-12-28	WOS:000348056400009
J	Martinelli, L; Lalli, D; Garcia-Morales, L; Ratera, M; Querol, E; Pinol, J; Fita, I; Calisto, BM				Martinelli, Luca; Lalli, Daniela; Garcia-Morales, Luis; Ratera, Merce; Querol, Enrique; Pinol, Jaume; Fita, Ignacio; Calisto, Barbara M.			A Major Determinant for Gliding Motility in Mycoplasma genitalium THE INTERACTION BETWEEN THE TERMINAL ORGANELLE PROTEINS MG200 AND MG491	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR-SPECTROSCOPY; ATTACHMENT ORGANELLE; MINIMAL BACTERIUM; BINDING SURFACE; PNEUMONIAE; CYTADHERENCE; DOMAIN; CELL; EVOLUTION; GENES	Several mycoplasmas, such as the emergent human pathogen Mycoplasma genitalium, developed a complex polar structure, known as the terminal organelle (TO), responsible for a new type of cellular motility, which is involved in a variety of cell functions: cell division, adherence to host cells, and virulence. The TO cytoskeleton is organized as a multisubunit dynamic motor, including three main ultrastructures: the terminal button, the electrodense core, and the wheel complex. Here, we describe the interaction between MG200 and MG491, two of the main components of the TO wheel complex that connects the TO with the cell body and the cell membrane. The interaction between MG200 and MG491 has a K-D in the 80 nM range, as determined by surface plasmon resonance. The interface between the two partners was confined to the "enriched in aromatic and glycine residues" (EAGR) box of MG200, previously described as a protein-protein interaction domain, and to a 25-residue-long peptide from the C-terminal region of MG491 by surface plasmon resonance and NMR spectroscopy studies. An atomic description of the MG200 EAGR box binding surface was also provided by solution NMR. An M. genitalium mutant lacking the MG491 segment corresponding to the peptide reveals specific alterations in cell motility and cell morphology indicating that the MG200-MG491 interaction plays a key role in the stability and functioning of the TO.	[Martinelli, Luca; Fita, Ignacio] Inst Biol Mol Barcelona IBMB CSIC, Barcelona 08028, Spain; [Lalli, Daniela] Univ Florence, Magnet Resonance Ctr, I-50019 Sesto Fiorentino, Italy; [Lalli, Daniela] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, Italy; [Garcia-Morales, Luis; Ratera, Merce; Querol, Enrique; Pinol, Jaume] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Garcia-Morales, Luis; Ratera, Merce; Querol, Enrique; Pinol, Jaume] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Calisto, Barbara M.] European Synchrotron Radiat Facil, Struct Biol Grp, F-38043 Grenoble, France; [Calisto, Barbara M.] Univ Porto, Inst Biol Mol & Celular IBMC, P-4150180 Oporto, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Florence; University of Florence; Autonomous University of Barcelona; Autonomous University of Barcelona; European Synchrotron Radiation Facility (ESRF); Universidade do Porto	Calisto, BM (corresponding author), European Synchrotron Radiat Facil, Struct Biol Grp, CS 40220, F-38043 Grenoble, France.	barbara.calisto@esrf.fr	Garcia-Morales, Luis/Q-7461-2018; Fita, Ignasi/R-4515-2019	Garcia-Morales, Luis/0000-0002-3037-4519; Fita, Ignasi/0000-0002-7521-2679; Martinelli, Luca/0000-0003-2004-3932; Calisto, Barbara/0000-0003-1732-571X; Pinol, Jaume/0000-0002-9055-8934; Ratera, Merce/0000-0001-5224-9172	FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]	FRISBI; GRAL	We especially thank the Instruct Centre CERM (Italy) for access to the NMR Research Infrastructure. We also acknowledge Isabel Bally from the Institut de Biologie Structurale (CEA, CNRS, Universite Joseph Fourier, Grenoble, France) for access to the SPR technical platform of the Grenoble Partnership for Structural Biology (PSB) and Nicole Thielens (CEA, CNRS, Universite Joseph Fourier, Grenoble, France) for help in the acquisition and interpretation of SPR data. This work used the platforms of the Grenoble Instruct Centre (ISBG; UMS, 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble PSB. Many thanks are given to M. Pons (BioNMR Group, Facultat de Quimica, UB, Spain) and Daniele de Sanctis (Structural Biology Group, ESRF, France) for helpful scientific discussions.	Balish MF, 2001, J BACTERIOL, V183, P3680, DOI 10.1128/JB.183.12.3680-3688.2001; Balish MF, 2006, J MOL MICROB BIOTECH, V11, P244, DOI 10.1159/000094058; Blanchard A, 2011, ANN NY ACAD SCI, V1230, pE61, DOI 10.1111/j.1749-6632.2011.06418.x; Burgos R, 2008, MOL MICROBIOL, V69, P1029, DOI 10.1111/j.1365-2958.2008.06343.x; Burgos R, 2006, J BACTERIOL, V188, P8627, DOI 10.1128/JB.00978-06; Calisto BM, 2012, MOL MICROBIOL, V86, P382, DOI 10.1111/j.1365-2958.2012.08200.x; Catrein I, 2011, PROTEOMICS, V11, P3614, DOI 10.1002/pmic.201100076; Citti C, 2013, TRENDS MICROBIOL, V21, P196, DOI 10.1016/j.tim.2013.01.003; Cloward JM, 2010, MOL MICROBIOL, V77, P158, DOI 10.1111/j.1365-2958.2010.07196.x; Cloward JM, 2009, MOL MICROBIOL, V71, P1296, DOI 10.1111/j.1365-2958.2009.06602.x; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hasselbring BM, 2007, J BACTERIOL, V189, P7442, DOI 10.1128/JB.00867-07; Hasselbring BM, 2007, MOL MICROBIOL, V63, P44, DOI 10.1111/j.1365-2958.2006.05507.x; Hatchel JM, 2008, MICROBIOL-SGM, V154, P286, DOI 10.1099/mic.0.2007/012765-0; Hegermann J, 2002, NATURWISSENSCHAFTEN, V89, P453, DOI 10.1007/s00114-002-0359-2; Henderson GP, 2006, MOL MICROBIOL, V60, P376, DOI 10.1111/j.1365-2958.2006.05113.x; Johansson K.E., 2002, MOL BIOL PATHOGENICI; Jordan JL, 2007, INFECT IMMUN, V75, P518, DOI 10.1128/IAI.01344-06; Kay Lewis E, 2011, J Magn Reson, V213, P423, DOI 10.1016/j.jmr.2011.09.004; Kenri T, 2004, J BACTERIOL, V186, P6944, DOI 10.1128/JB.186.20.6944-6955.2004; KIRCHHOFF H, 1992, INT J SYST BACTERIOL, V42, P506, DOI 10.1099/00207713-42-3-506; KIRCHHOFF H, 1984, ISRAEL J MED SCI, V20, P848; Krause DC, 1997, J BACTERIOL, V179, P2668, DOI 10.1128/jb.179.8.2668-2677.1997; Lluch-Senar M, 2010, MOL MICROBIOL, V78, P278, DOI 10.1111/j.1365-2958.2010.07306.x; McGowin CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001324; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Miyata M, 2008, TRENDS MICROBIOL, V16, P6, DOI 10.1016/j.tim.2007.11.002; Pich OQ, 2006, MICROBIOL-SGM, V152, P519, DOI 10.1099/mic.0.28287-0; Pich OQ, 2006, MOL MICROBIOL, V60, P1509, DOI 10.1111/j.1365-2958.2006.05187.x; Proft T, 1996, GENE, V171, P79, DOI 10.1016/0378-1119(96)00014-5; Sambrook J., 2001, MOL CLONING LAB MANU; Seybert A, 2006, J STRUCT BIOL, V156, P342, DOI 10.1016/j.jsb.2006.04.010; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sirand-Pugnet P, 2007, RES MICROBIOL, V158, P754, DOI 10.1016/j.resmic.2007.09.007; Sweet RL, 2012, CURR INFECT DIS REP, V14, P194, DOI 10.1007/s11908-012-0243-y; Taylor-Robinson D, 1997, J ANTIMICROB CHEMOTH, V40, P622, DOI 10.1093/jac/40.5.622; TULLY JG, 1979, J INFECT DIS, V139, P478, DOI 10.1093/infdis/139.4.478; Wider G, 1999, CURR OPIN STRUC BIOL, V9, P594, DOI 10.1016/S0959-440X(99)00011-1; WUTHRICH K, 1990, J BIOL CHEM, V265, P22059	43	7	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1699	1711		10.1074/jbc.M114.594762	http://dx.doi.org/10.1074/jbc.M114.594762			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25471372	Green Published, hybrid			2022-12-28	WOS:000348056400036
J	Stephenson, R; Hosler, MR; Gavande, NS; Ghosh, AK; Weake, VM				Stephenson, Robert; Hosler, Marcus R.; Gavande, Navnath S.; Ghosh, Arun K.; Weake, Vikki M.			Characterization of a Drosophila Ortholog of the Cdc7 Kinase A ROLE FOR Cdc7 IN ENDOREPLICATION INDEPENDENT OF CHIFFON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE CDC7; CHORION GENE AMPLIFICATION; CELL-CYCLE REGULATION; HUMAN CDC7-RELATED KINASE; IN-VITRO PHOSPHORYLATION; S-PHASE; DNA-REPLICATION; PROTEIN-KINASE; CHROMOSOMAL LOCALIZATION; REGULATORY SUBUNIT	Cdc7 is a serine-threonine kinase that phosphorylates components of the pre-replication complex during DNA replication initiation. Cdc7 is highly conserved, and Cdc7 orthologs have been characterized in organisms ranging from yeast to humans. Cdc7 is activated specifically during late G1/S phase by binding to its regulatory subunit, Dbf4. Drosophila melanogaster contains a Dbf4 ortholog, Chiffon, which is essential for chorion amplification in Drosophila egg chambers. However, no Drosophila ortholog of Cdc7 has yet been characterized. Here, we report the functional and biochemical characterization of a Drosophila ortholog of Cdc7. Co-expression of Drosophila Cdc7 and Chiffon is able to complement a growth defect in yeast containing a temperature-sensitive Cdc7 mutant. Cdc7 and Chiffon physically interact and can be co-purified from insect cells. Cdc7 phosphorylates the known Cdc7 substrates Mcm2 and histone H3 in vitro, and Cdc7 kinase activity is stimulated by Chiffon and inhibited by the Cdc7-specific inhibitor XL413. Drosophila egg chamber follicle cells deficient for Cdc7 have a defect in two types of DNA replication, endoreplication and chorion gene amplification. However, follicle cells deficient for Chiffon have a defect in chorion gene amplification but still undergo endocycling. Our results show that Cdc7 interacts with Chiffon to form a functional Dbf4-dependent kinase complex and that Cdc7 is necessary for DNA replication in Drosophila egg chamber follicle cells. Additionally, we show that Chiffon is a member of an expanding subset of DNA replication initiation factors that are not strictly required for endoreplication in Drosophila.	[Stephenson, Robert; Hosler, Marcus R.; Weake, Vikki M.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Gavande, Navnath S.; Ghosh, Arun K.] Purdue Univ, Dept Chem & Med Chem, W Lafayette, IN 47907 USA; [Ghosh, Arun K.; Weake, Vikki M.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Weake, VM (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	vweake@purdue.edu	Weake, Vikki/A-5722-2018	Weake, Vikki/0000-0002-5933-9952; Gavande, Navnath/0000-0002-2413-0235	National Institutes of Health [P40OD018537, OD010949-10, P30 CA023168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053386] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949, P40OD018537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The chif<SUP>ETBE3</SUP> flies were kindly provided by John Tower, and the cdc7-90 yeast strain was kindly provided by Ann Kirchmaier. We thank Jie Li and Xiaoqi Liu for assistance with the kinase assays. Fly stocks were from the Bloomington Drosophila Stock Center (supported by National Institutes of Health Grant P40OD018537); plasmids were from the Drosophila Genomics Resource Center (supported by National Institutes of Health Grant OD010949-10), and information was from FlyBase and FlyMine. NMR, mass spectrometry, and DNA sequencing data were acquired by core facilities supported by National Institutes of Health Grant P30 CA023168.	AXELROD A, 1991, MOL CELL BIOL, V11, P1080, DOI 10.1128/MCB.11.2.1080; BAHMAN M, 1988, BIOCHIM BIOPHYS ACTA, V951, P335, DOI 10.1016/0167-4781(88)90104-2; Baker SP, 2010, NAT CELL BIOL, V12, P294, DOI 10.1038/ncb2030; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Brown GW, 1998, J BIOL CHEM, V273, P22083, DOI 10.1074/jbc.273.34.22083; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Bunt SM, 2012, GENESIS, V50, P914, DOI 10.1002/dvg.22341; Calvi BR, 1999, METHODS, V18, P407, DOI 10.1006/meth.1999.0799; Calvi BR, 1998, GENE DEV, V12, P734, DOI 10.1101/gad.12.5.734; CHAPMAN JW, 1989, EXP CELL RES, V180, P419, DOI 10.1016/0014-4827(89)90068-2; Cheng LA, 1999, MOL CELL BIOL, V19, P4270; Clontech Laboratories Inc., 2007, BACPAK BAC EXPR SYST; Davey MJ, 2011, G3-GENES GENOM GENET, V1, P317, DOI 10.1534/g3.111.000430; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; DePamphilis ML, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00368; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Faul T, 1999, CHROMOSOMA, V108, P26, DOI 10.1007/s004120050348; FEGER G, 1995, EMBO J, V14, P5387, DOI 10.1002/j.1460-2075.1995.tb00223.x; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Follette PJ, 1998, CURR BIOL, V8, P235, DOI 10.1016/S0960-9822(98)70089-2; Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Furukohri A, 2003, J BIOCHEM, V134, P447, DOI 10.1093/jb/mvg163; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Guo BQ, 1999, SOMAT CELL MOLEC GEN, V25, P159, DOI 10.1023/A:1018841506868; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hess GF, 1998, GENE, V211, P133, DOI 10.1016/S0378-1119(98)00094-8; HOLLINGSWORTH RE, 1990, P NATL ACAD SCI USA, V87, P6272, DOI 10.1073/pnas.87.16.6272; Hong A, 2007, EMBO J, V26, P2071, DOI 10.1038/sj.emboj.7601648; Hughes S, 2012, NAT STRUCT MOL BIOL, V19, P1101, DOI 10.1038/nsmb.2404; Hughes S, 2010, J BIOL CHEM, V285, P541, DOI 10.1074/jbc.M109.036491; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; Jares P, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-5; Jares P, 2000, GENE DEV, V14, P1528; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; JOHNSTON LH, 1982, MOL GEN GENET, V186, P445, DOI 10.1007/BF00729467; Kim JM, 1998, J BIOL CHEM, V273, P23248, DOI 10.1074/jbc.273.36.23248; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; KITADA K, 1992, GENETICS, V131, P21; Kitamura R, 2011, J BIOL CHEM, V286, P23031, DOI 10.1074/jbc.M111.243311; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Koltun ES, 2012, BIOORG MED CHEM LETT, V22, P3727, DOI 10.1016/j.bmcl.2012.04.024; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lake CM, 2007, GENETICS, V176, P2151, DOI 10.1534/genetics.107.073551; Landis G, 1999, DEVELOPMENT, V126, P4281; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Lepke M, 1999, MOL GEN GENET, V262, P220, DOI 10.1007/s004380051078; Lilly MA, 1996, GENE DEV, V10, P2514, DOI 10.1101/gad.10.19.2514; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Marston AL, 2009, CURR BIOL, V19, pR74, DOI 10.1016/j.cub.2008.12.003; Masai H, 2000, BIOCHEM BIOPH RES CO, V275, P228, DOI 10.1006/bbrc.2000.3281; MASAI H, 1995, EMBO J, V14, P3094, DOI 10.1002/j.1460-2075.1995.tb07312.x; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Matthews LA, 2013, CELL CYCLE, V12, P1180, DOI 10.4161/cc.24416; Montagnoli A, 2002, EMBO J, V21, P3171, DOI 10.1093/emboj/cdf290; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Nakamura T, 2000, GENES CELLS, V5, P463, DOI 10.1046/j.1365-2443.2000.00343.x; Nakamura T, 2002, MOL CELL BIOL, V22, P309, DOI 10.1128/MCB.22.1.309-320.2002; Ogino K, 2001, J BIOL CHEM, V276, P31376, DOI 10.1074/jbc.M102197200; Park SY, 2008, P NATL ACAD SCI USA, V105, P12343, DOI 10.1073/pnas.0805189105; PATTERSON M, 1986, MOL CELL BIOL, V6, P1590, DOI 10.1128/MCB.6.5.1590; Perrimon N, 1998, INT J DEV BIOL, V42, P243; Peter A, 2002, EMBO REP, V3, P34, DOI 10.1093/embo-reports/kvf012; Ramer MD, 2013, J BIOL CHEM, V288, P14926, DOI 10.1074/jbc.M112.392910; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Roberts BT, 1999, P NATL ACAD SCI USA, V96, P2800, DOI 10.1073/pnas.96.6.2800; Sacco E, 2012, BIOTECHNOL ADV, V30, P73, DOI 10.1016/j.biotechadv.2011.09.009; Sato N, 2003, GENES CELLS, V8, P451, DOI 10.1046/j.1365-2443.2003.00647.x; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; Schwed G, 2002, MOL BIOL CELL, V13, P607, DOI 10.1091/mbc.01-08-0400; Sclafani RA, 2000, J CELL SCI, V113, P2111; Sher N, 2012, GENOME RES, V22, P64, DOI 10.1101/gr.126003.111; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shi N, 2012, J BIOL CHEM, V287, P6860, DOI 10.1074/jbc.M111.306209; SIKORSKI RS, 1989, GENETICS, V122, P19; Silva T, 2006, J BIOL CHEM, V281, P11569, DOI 10.1074/jbc.M510278200; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Su TT, 1998, J CELL BIOL, V140, P451, DOI 10.1083/jcb.140.3.451; Su TT, 1996, MOL BIOL CELL, V7, P319, DOI 10.1091/mbc.7.2.319; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Takeda T, 1999, MOL CELL BIOL, V19, P5535; Tanaka S, 2010, CHROMOSOMA, V119, P565, DOI 10.1007/s00412-010-0291-8; Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591; Tower J, 2004, ANNU REV GENET, V38, P273, DOI 10.1146/annurev.genet.37.110801.143851; TREISMAN JE, 1995, GENE DEV, V9, P1709, DOI 10.1101/gad.9.14.1709; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Weiss A, 1998, CURR BIOL, V8, P239, DOI 10.1016/S0960-9822(98)70090-9; Yanow SK, 2003, J BIOL CHEM, V278, P41083, DOI 10.1074/jbc.M307144200; YOON HJ, 1993, MOL BIOL CELL, V4, P195, DOI 10.1091/mbc.4.2.195; Yoshizawa-Sugata N, 2005, J BIOL CHEM, V280, P13062, DOI 10.1074/jbc.M411653200; Zhang HJ, 2004, DEVELOPMENT, V131, P2089, DOI 10.1242/dev.01064	101	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1332	1347		10.1074/jbc.M114.597948	http://dx.doi.org/10.1074/jbc.M114.597948			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451925	hybrid, Green Published			2022-12-28	WOS:000348056400004
J	Wetzel, J; Herrmann, S; Swapna, LS; Prusty, D; Peter, ATJ; Kono, M; Saini, S; Nellimarla, S; Wong, TWY; Wilcke, L; Ramsay, O; Cabrera, A; Biller, L; Heincke, D; Mossman, K; Spielmann, T; Ungermann, C; Parkinson, J; Gilberger, TW				Wetzel, Johanna; Herrmann, Susann; Swapna, Lakshmipuram Seshadri; Prusty, Dhaneswar; Peter, Arun T. John; Kono, Maya; Saini, Sidharth; Nellimarla, Srinivas; Wong, Tatianna Wai Ying; Wilcke, Louisa; Ramsay, Olivia; Cabrera, Ana; Biller, Laura; Heincke, Dorothee; Mossman, Karen; Spielmann, Tobias; Ungermann, Christian; Parkinson, John; Gilberger, Tim W.			The Role of Palmitoylation for Protein Recruitment to the Inner Membrane Complex of the Malaria Parasite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-CELL INVASION; MULTIPLE SEQUENCE ALIGNMENT; PLASMODIUM-FALCIPARUM; S-ACYLTRANSFERASES; TOXOPLASMA-GONDII; GLOBAL ANALYSIS; GLIDEOSOME; MECHANISM; YEAST; IDENTIFICATION	To survive and persist within its human host, the malaria parasite Plasmodium falciparum utilizes a battery of lineage-specific innovations to invade and multiply in human erythrocytes. With central roles in invasion and cytokinesis, the inner membrane complex, a Golgi-derived double membrane structure underlying the plasma membrane of the parasite, represents a unique and unifying structure characteristic to all organisms belonging to a large phylogenetic group called Alveolata. More than 30 structurally and phylogenetically distinct proteins are embedded in the IMC, where a portion of these proteins displays N-terminal acylation motifs. Although N-terminal myristoylation is catalyzed co-translationally within the cytoplasm of the parasite, palmitoylation takes place at membranes and is mediated by palmitoyl acyltransferases (PATs). Here, we identify a PAT (PfDHHC1) that is exclusively localized to the IMC. Systematic phylogenetic analysis of the alveolate PAT family reveals PfDHHC1 to be a member of a highly conserved, apicomplexan-specific clade of PATs. We show that during schizogony this enzyme has an identical distribution like two dual-acylated, IMC-localized proteins (PfISP1 and PfISP3). We used these proteins to probe into specific sequence requirements for IMC-specific membrane recruitment and their interaction with differentially localized PATs of the parasite.	[Wetzel, Johanna; Herrmann, Susann; Prusty, Dhaneswar; Saini, Sidharth; Nellimarla, Srinivas; Wong, Tatianna Wai Ying; Wilcke, Louisa; Ramsay, Olivia; Cabrera, Ana; Heincke, Dorothee; Mossman, Karen; Gilberger, Tim W.] McMaster Univ, Dept Pathol & Mol Med, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Swapna, Lakshmipuram Seshadri; Parkinson, John] Univ Toronto, Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [Swapna, Lakshmipuram Seshadri; Parkinson, John] Univ Toronto, Dept Biochem, Toronto, ON M5G 0A4, Canada; [Swapna, Lakshmipuram Seshadri; Parkinson, John] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 0A4, Canada; [Peter, Arun T. John; Ungermann, Christian] Univ Osnabruck, Biochem Sect, Dept Biol Chem, D-49076 Osnabruck, Germany; [Kono, Maya; Wilcke, Louisa; Biller, Laura; Heincke, Dorothee; Spielmann, Tobias; Gilberger, Tim W.] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Gilberger, Tim W.] Ctr Struct Syst Biol, D-22607 Hamburg, Germany	McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Osnabruck; Bernhard Nocht Institut fur Tropenmedizin	Gilberger, TW (corresponding author), McMaster Univ, Dept Pathol & Mol Med, 1200 Main St West,MDCL 2306, Hamilton, ON L8N 3Z5, Canada.	tgilber@mcmaster.ca	Parkinson, John/A-4424-2008; Cabrera, Ana/AES-5002-2022; Prusty, Dhaneswar/S-6908-2019	Parkinson, John/0000-0001-9815-1189; Cabrera, Ana/0000-0003-2246-3471; Prusty, Dhaneswar/0000-0003-0788-5473; Spielmann, Tobias/0000-0002-3968-4601; Gilberger, Tim-Wolf/0000-0002-7965-8272; HERRMANN, SUSANN/0000-0002-4953-5685; Seshadri, Swapna/0000-0001-5906-7574; John Peter, Arun T./0000-0001-8356-5469	Hamilton Health Sciences McMaster Hospital Transfusion Medicine	Hamilton Health Sciences McMaster Hospital Transfusion Medicine	We are grateful for WR99210 provided by Jacobus Pharmaceuticals and the support of the Hamilton Health Sciences McMaster Hospital Transfusion Medicine. We thank Drs C. Daubenberger and P. Sharma for providing antibodies against GAPDH and GAP45.	Aurrecoechea C, 2013, NUCLEIC ACIDS RES, V41, pD684, DOI 10.1093/nar/gks1113; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Beck JR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003162; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Cabrera A, 2012, TRAFFIC, V13, P1335, DOI 10.1111/j.1600-0854.2012.01394.x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; Flueck C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000784; Frenal K, 2013, TRAFFIC, V14, P895, DOI 10.1111/tra.12081; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Fung CN, 2012, MOL BIOCHEM PARASIT, V184, P99, DOI 10.1016/j.molbiopara.2012.05.002; Gonzalez Montoro A, 2013, BIOCHEM J, V454, P427, DOI 10.1042/BJ20121693; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Gunaratne RS, 2000, BIOCHEM J, V348, P459, DOI 10.1042/0264-6021:3480459; Haase S, 2008, INFECT IMMUN, V76, P879, DOI 10.1128/IAI.00144-07; Harding CR, 2014, CELL MICROBIOL, V16, P632, DOI 10.1111/cmi.12285; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Keeley A, 2004, TRENDS CELL BIOL, V14, P528, DOI 10.1016/j.tcb.2004.08.002; Kono M, 2013, FRONT BIOSCI-LANDMRK, V18, P982, DOI 10.2741/4157; Kono M, 2012, MOL BIOL EVOL, V29, P2113, DOI 10.1093/molbev/mss081; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Linder ME, 2013, BIOCHEM SOC T, V41, P29, DOI 10.1042/BST20120328; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Magrane M, 2011, UNIPROT KNOWLEDGEBAS; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; MESZOELY CAM, 1987, EXP PARASITOL, V64, P300, DOI 10.1016/0014-4894(87)90040-3; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; Mueller C, 2013, CELL HOST MICROBE, V13, P289, DOI 10.1016/j.chom.2013.02.001; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Planey SL, 2009, MOL MEMBR BIOL, V26, P14, DOI 10.1080/09687680802646703; Poulin B, 2013, BIOL OPEN, V2, P1160, DOI 10.1242/bio.20136163; Ridzuan MAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033845; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shetty P, 2012, NATURE, V484, pS14, DOI 10.1038/484S14a; Struck NS, 2005, J CELL SCI, V118, P5603, DOI 10.1242/jcs.02673; Tonkin ML, 2012, ACTA CRYSTALLOGR F, V68, P832, DOI 10.1107/S174430911202297X; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2006, J BIOL CHEM, V281, P31995, DOI 10.1074/jbc.M606717200; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wasmuth J, 2009, GENOME RES, V19, P1202, DOI 10.1101/gr.083386.108; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yeoman JA, 2011, EUKARYOT CELL, V10, P556, DOI 10.1128/EC.00244-10; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	67	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1712	1728		10.1074/jbc.M114.598094	http://dx.doi.org/10.1074/jbc.M114.598094			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25425642	Green Published, hybrid			2022-12-28	WOS:000348056400037
J	Crowe, AM; Stogios, PJ; Casabon, I; Evdokimova, E; Savchenko, A; Eltis, LD				Crowe, Adam M.; Stogios, Peter J.; Casabon, Israel; Evdokimova, Elena; Savchenko, Alexei; Eltis, Lindsay D.			Structural and Functional Characterization of a Ketosteroid Transcriptional Regulator of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETR FAMILY; 3-KETOSTEROID 9-ALPHA-HYDROXYLASE; SIDE-CHAIN; DEGRADATION; CATABOLISM; REPRESSOR; BINDING; CONSERVATION; SMEGMATIS; PROTEINS	Catabolism of host cholesterol is critical to the virulence of Mycobacterium tuberculosis and is a potential target for novel therapeutics. KstR2, a TetR family repressor (TFR), regulates the expression of 15 genes encoding enzymes that catabolize the last half of the cholesterol molecule, represented by 3a alpha-H-4 alpha(3'-propanoate)-7a beta -methylhexahydro-1,5-indane-dione (HIP). Binding of KstR2 to its operator sequences is relieved upon binding of HIP-CoA. A 1.6-angstrom resolution crystal structure of the KstR2(Mtb)center dot HIP-CoA complex reveals that the KstR2(Mtb) dimer accommodates two molecules of HIP-CoA. Each ligand binds in an elongated cleft spanning the dimerization interface such that the HIP and CoA moieties interact with different KstR2(Mtb) protomers. In isothermal titration calorimetry studies, the dimer bound 2 eq of HIP-CoA with high affinity (K-d = 80 +/- 10 n(M)) but bound neither HIP nor CoASH. Substitution of Arg-162 or Trp-166, residues that interact, respectively, with the diphosphate and HIP moieties of HIP-CoA, dramatically decreased the affinity of KstR2(Mtb) for HIP-CoA but not for its operator sequence. The variant of R162M that decreased the affinity for HIP-CoA (Delta Delta G = 13 kJ mol(-1)) is consistent with the loss of three hydrogen bonds as indicated in the structural data. A 24-bp operator sequence bound two dimers of KstR2. Structural comparisons with a ligand-free rhodococcal homologue and a DNA-bound homologue suggest that HIP-CoA induces conformational changes of the DNA-binding domains of the dimer that preclude their proper positioning in the major groove of DNA. The results provide insight into KstR2-mediated regulation of expression of steroid catabolic genes and the determinants of ligand binding in TFRs.	[Crowe, Adam M.; Eltis, Lindsay D.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Casabon, Israel; Eltis, Lindsay D.] Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Stogios, Peter J.; Evdokimova, Elena; Savchenko, Alexei] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada; [Evdokimova, Elena; Savchenko, Alexei] Argonne Natl Lab, MCSG, Argonne, IL 60439 USA	University of British Columbia; University of British Columbia; University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory	Savchenko, A (corresponding author), Univ Toronto, 200 Coll St,Rm 420B, Toronto, ON M5S 3E5, Canada.	alexei.savchenko@utoronto.ca; leltis@mail.ubc.ca	Eltis, Lindsay D/J-8272-2015	Eltis, Lindsay D/0000-0002-6774-8158; Stogios, Peter/0000-0001-8663-1425; Crowe, Adam/0000-0002-5487-2520	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, U54GM074942] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Hiroshi Otani is thanked for critical comments. Members of the Structural Biology Center at Argonne National Laboratory assisted with conducting data collection and structure determination experiments. Veronica Yim provided technical assistance. The structure of KstR2<INF>Mtb</INF> was determined by the Midwest Centre for Structural Genomics as target APC111849. Argonne National Laboratory is operated by University of Chicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Agari Y, 2011, MICROBIOL-SGM, V157, P1589, DOI 10.1099/mic.0.048017-0; Anand S, 2012, FEBS J, V279, P3214, DOI 10.1111/j.1742-4658.2012.08707.x; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Barrientos A, 2015, ENVIRON MICROBIOL, V17, P47, DOI 10.1111/1462-2920.12395; Bhukya H, 2014, NUCLEIC ACIDS RES, V42, P10122, DOI 10.1093/nar/gku587; Bolla JR, 2012, NUCLEIC ACIDS RES, V40, P9340, DOI 10.1093/nar/gks677; Capyk JK, 2011, J BIOL CHEM, V286, P40717, DOI 10.1074/jbc.M111.289975; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Casabon I, 2014, J BACTERIOL, V196, P579, DOI 10.1128/JB.01012-13; Casabon I, 2013, MOL MICROBIOL, V89, P1201, DOI 10.1111/mmi.12340; Casabon I, 2013, MOL MICROBIOL, V87, P269, DOI 10.1111/mmi.12095; Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujihashi M, 2014, PROTEINS, V82, P1301, DOI 10.1002/prot.24496; Garcia-Fernandez E, 2014, J BIOL CHEM, V289, P17576, DOI 10.1074/jbc.M113.545715; HILLEN W, 1982, J BIOL CHEM, V257, P6605; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horinouchi M, 2012, J STEROID BIOCHEM, V129, P4, DOI 10.1016/j.jsbmb.2010.10.008; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEE SS, 1967, BIOCHEMISTRY-US, V6, P1395, DOI 10.1021/bi00857a023; Luengo JM, 2001, MOL MICROBIOL, V39, P1434, DOI 10.1046/j.1365-2958.2001.02344.x; Mehrotra P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004265; Miller DJ, 2010, NAT STRUCT MOL BIOL, V17, P971, DOI 10.1038/nsmb.1847; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mohn WW, 2012, J BACTERIOL, V194, P6712, DOI 10.1128/JB.01169-12; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Reichheld SE, 2009, P NATL ACAD SCI USA, V106, P22263, DOI 10.1073/pnas.0911566106; Sambrook J., 2001, MOL CLONING LAB MANU; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Tonthat NK, 2013, P NATL ACAD SCI USA, V110, P10586, DOI 10.1073/pnas.1221036110; van der Geize R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002181; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang SF, 2013, J BIOL CHEM, V288, P23687, DOI 10.1074/jbc.M113.468694; Yu Z, 2010, J MOL BIOL, V400, P847, DOI 10.1016/j.jmb.2010.05.062	46	22	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					872	882		10.1074/jbc.M114.607481	http://dx.doi.org/10.1074/jbc.M114.607481			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25406313	hybrid, Green Published			2022-12-28	WOS:000347778200017
J	Li, Z; Hwang, S; Ericson, J; Bowler, K; Bar-Peled, M				Li, Zi; Hwang, Soyoun; Ericson, Jaime; Bowler, Kyle; Bar-Peled, Maor			Pen and Pal Are Nucleotide-Sugar Dehydratases That Convert UDP-GlcNAc to UDP-6-Deoxy-D-GlcNAc-5,6-ene and Then to UDP-4-Keto-6-deoxy-L-AltNAc for CMP-Pseudaminic Acid Synthesis in Bacillus thuringiensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAGELLIN GLYCOSYLATION; HELICOBACTER-PYLORI; INSECTICIDAL ACTIVITY; CAMPYLOBACTER-JEJUNI; N-ACETYLGLUCOSAMINE; C-6 DEHYDRATASE; IDENTIFICATION; CEREUS; BIOSYNTHESIS; 4,6-DEHYDRATASE	CMP-pseudaminic acid is a precursor required for the O-glycosylation of flagellin in some pathogenic Gram-negative bacteria, a process known to be critical in bacterial motility and infection. However, little is known about flagellin glycosylation in Gram-positive bacteria. Here, we identified and functionally characterized an operon, named Bti_pse, in Bacillus thuringiensis israelensis ATCC 35646, which encodes seven different enzymes that together convert UDP-GlcNAc to CMP-pseudaminic acid. In contrast, Gram-negative bacteria complete this reaction with six enzymes. The first enzyme, which we named Pen, converts UDP-D-GlcNAc to an uncommon UDP-sugar, UDP-6-deoxy-D-GlcNAc-5,6-ene. Pen contains strongly bound NADP(+) and has distinct UDP-GlcNAc 4-oxidase, 5,6-dehydratase, and 4-reductase activities. The second enzyme, which we named Pal, converts UDP-6-deoxy-D-GlcNAc-5,6-ene to UDP4-keto-6-deoxy-L-AltNAc. Pal is NAD(+)-dependent and has distinct UDP-6-deoxy-D-GlcNAc-5,6-ene 4-oxidase, 5,6-reductase, and 5-epimerase activities. We also show here using NMR spectroscopy and mass spectrometry that in B. thuringiensis, the enzymatic product of Pen and Pal, UDP-4-keto-6-deoxy-L-AltNAc, is converted to CMP-pseudaminic acid by the sequential activities of a C4(+)-transaminase (Pam), a 4-N-acetyltransferase (Pdi), a UDP-hydrolase (Phy), an enzyme (Ppa) that adds phosphoenolpyruvate to form pseudaminic acid, and finally a cytidylyltransferase that condenses CTP to generate CMP-pseudaminic acid. Knowledge of the distinct dehydratase-like enzymes Pen and Pal and their role in CMP-pseudaminic acid biosynthesis in Gram-positive bacteria provides a foundation to investigate the role of pseudaminic acid and flagellin glycosylation in Bacillus and their involvement in bacterial motility and pathogenicity.	[Li, Zi; Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Li, Zi; Hwang, Soyoun; Ericson, Jaime; Bowler, Kyle; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu		Bowler, Kyle/0000-0001-5375-0356	BioEnergy Science Center - Office of Biological and Environmental Research in the Department of Energy Office of Science [DE-PS02-06ER64304]	BioEnergy Science Center - Office of Biological and Environmental Research in the Department of Energy Office of Science	This work was supported by BioEnergy Science Center Grant DE-PS02-06ER64304, which is supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science.	ALY C, 1985, J INVERTEBR PATHOL, V46, P251, DOI 10.1016/0022-2011(85)90066-7; Assaeedi ASA, 2011, AUST J CROP SCI, V5, P1185; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Creuzenet C, 2000, J BIOL CHEM, V275, P34873, DOI 10.1074/jbc.M006369200; Creuzenet C, 2004, FEBS LETT, V559, P136, DOI 10.1016/S0014-5793(04)00057-2; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gillis A, 2012, NANOSCALE, V4, P1585, DOI 10.1039/c1nr11161b; Gu XG, 2010, J BIOL CHEM, V285, P24825, DOI 10.1074/jbc.M110.125872; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; GUNTHER H, 1977, CHEM REV, V77, P599; Hayakawa J, 2009, BIOSCI BIOTECH BIOCH, V73, P1450, DOI 10.1271/bbb.90092; Ibrahim MA, 2013, EXP BIOL MED, V238, P350, DOI 10.1177/1535370213477973; Ichimatsu T, 2000, CURR MICROBIOL, V40, P217, DOI 10.1007/s002849910044; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; LOVGREN A, 1993, J GEN MICROBIOL, V139, P21, DOI 10.1099/00221287-139-1-21; Maki-Yonekura S, 2003, P NATL ACAD SCI USA, V100, P15528, DOI 10.1073/pnas.2534343100; Margulis L, 1998, P NATL ACAD SCI USA, V95, P1236, DOI 10.1073/pnas.95.3.1236; Mizuki E, 1999, J APPL MICROBIOL, V86, P979, DOI 10.1046/j.1365-2672.1999.00778.x; Morrison JP, 2008, BIOORG CHEM, V36, P312, DOI 10.1016/j.bioorg.2008.08.004; NAMBA K, 1989, NATURE, V342, P648, DOI 10.1038/342648a0; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Parker JL, 2012, MICROBIOLOGYOPEN, V1, P149, DOI 10.1002/mbo3.19; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Schirm M, 2005, ANAL CHEM, V77, P7774, DOI 10.1021/ac051316y; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schoenhofen IC, 2006, GLYCOBIOLOGY, V16, p8C, DOI 10.1093/glycob/cwl010; Schunemann Rogerio, 2014, ISRN Microbiol, V2014, P135675, DOI 10.1155/2014/135675; Shen A, 2006, PLOS PATHOG, V2, P282, DOI 10.1371/journal.ppat.0020030; Soufiane B, 2007, ANTON LEEUW INT J G, V92, P449, DOI 10.1007/s10482-007-9173-3; Swiecicka I, 2006, FEMS MICROBIOL ECOL, V56, P132, DOI 10.1111/j.1574-6941.2006.00063.x; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Wyszynski FJ, 2012, NAT CHEM, V4, P539, DOI [10.1038/NCHEM.1351, 10.1038/nchem.1351]; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	38	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					691	704		10.1074/jbc.M114.612747	http://dx.doi.org/10.1074/jbc.M114.612747			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25414257	Green Published, hybrid			2022-12-28	WOS:000347778200001
J	Zhang, H; Chi, Y; Gao, K; Zhang, XL; Yao, J				Zhang, Hui; Chi, Yuan; Gao, Kun; Zhang, Xiling; Yao, Jian			p53 Protein-mediated Up-regulation of MAP Kinase Phosphatase 3 (MKP-3) Contributes to the Establishment of the Cellular Senescent Phenotype through Dephosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-DIPLOID FIBROBLASTS; HUMAN-CELLS; REPLICATIVE SENESCENCE; PREMATURE SENESCENCE; FEEDBACK-REGULATION; TUMOR SUPPRESSION; ONCOGENIC RAS; EXPRESSION; DUSP6; DEATH	Growth arrest is one of the essential features of cellular senescence. At present, the precise mechanisms responsible for the establishment of the senescence-associated arrested phenotype are still incompletely understood. Given that ERK1/2 is one of the major kinases controlling cell growth and proliferation, we examined the possible implication of ERK1/2. Exposure of normal rat epithelial cells to etoposide caused cellular senescence, as manifested by enlarged cell size, a flattened cell body, reduced cell proliferation, enhanced beta-galactosidase activity, and elevated p53 and p21. Senescent cells displayed a blunted response to growth factor-induced cell proliferation, which was preceded by impaired ERK1/2 activation. Further analysis revealed that senescent cells expressed a significantly higher level of mitogen-activated protein phosphatase 3 (MKP-3, a cytosolic ERK1/2targeted phosphatase), which was suppressed by blocking the transcriptional activity of the tumor suppressor p53 with pifithrin-alpha. Inhibition of MKP-3 activity with a specific inhibitor or siRNA enhanced basal ERK1/2 phosphorylation and promoted cell proliferation. Apart from its role in growth arrest, impairment of ERK1/2 also contributed to the resistance of senescent cells to oxidant-elicited cell injury. These results therefore indicate that p53-mediated up-regulation of MKP-3 contributes to the establishment of the senescent cellular phenotype through dephosphorylating ERK1/2. Impairment of ERK1/2 activation could be an important mechanism by which p53 controls cellular senescence.	[Zhang, Hui; Chi, Yuan; Gao, Kun; Zhang, Xiling; Yao, Jian] Univ Yamanashi, Dept Mol Signaling, Yamanashi 4093898, Japan; [Zhang, Hui] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Trauma Res Ctr, Beijing 100037, Peoples R China	University of Yamanashi; Chinese People's Liberation Army General Hospital	Yao, J (corresponding author), Univ Yamanashi, Dept Mol Signaling, Chuo Ku, Shimokato1110, Yamanashi, Japan.	yao@yamanashi.ac.jp		Yao, Jian/0000-0003-2622-0215	Ministry of Education, Culture, Sports, Science, and Technology, Japan [26461219]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology, Japan Grant-in-Aid for Scientific Research 26461219 (to J. Y.).	Becker T., 2013, SENESCENCE SENESCENC, P25; Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750; BOND JA, 1994, ONCOGENE, V9, P1885; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Furukawa T, 2008, BIOCHEM BIOPH RES CO, V377, P317, DOI 10.1016/j.bbrc.2008.10.003; Gu LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052305; HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y; HARPER JW, 1993, CELL, V75, P805; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Komarova EA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P41; Kondoh K, 2007, BBA-MOL CELL RES, V1773, P1227, DOI 10.1016/j.bbamcr.2006.12.002; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee WC, 2005, NEUROCHEM RES, V30, P263, DOI 10.1007/s11064-005-2449-y; Lents NH, 2002, J BIOL CHEM, V277, P47469, DOI 10.1074/jbc.M207425200; Leontieva OV, 2010, AGING-US, V2, P924, DOI 10.18632/aging.100265; Li GJ, 2012, NAT MED, V18, P1518, DOI 10.1038/nm.2963; Mallette FA, 2007, CELL CYCLE, V6, P1831, DOI 10.4161/cc.6.15.4516; Martin P, 2010, FEBS J, V277, P39, DOI 10.1111/j.1742-4658.2009.07369.x; Menendez D, 2010, DISCOV MED, V10, P94; Molina G, 2009, NAT CHEM BIOL, V5, P680, DOI 10.1038/nchembio.190; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Piya S, 2012, FEBS LETT, V586, P4233, DOI 10.1016/j.febslet.2012.10.031; Pognonec P, 2010, FEBS J, V277, P1, DOI 10.1111/j.1742-4658.2009.07365.x; Pouyssegur J, 2003, EUR J BIOCHEM, V270, P3291, DOI 10.1046/j.1432-1033.2003.03707.x; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Qian YJ, 2010, HISTOL HISTOPATHOL, V25, P515, DOI 10.14670/HH-25.515; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Schonn I, 2010, APOPTOSIS, V15, P162, DOI 10.1007/s10495-009-0440-9; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Shay JW, 2004, MOL CELL, V14, P420, DOI 10.1016/S1097-2765(04)00269-2; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; Tresini M, 2007, J BIOL CHEM, V282, P4136, DOI 10.1074/jbc.M604955200; Vaziri H, 1996, EXP GERONTOL, V31, P295, DOI 10.1016/0531-5565(95)02025-X; Walsh S, 2003, MOL CANCER RES, V1, P280; Wang YC, 1998, ONCOGENE, V17, P1923, DOI 10.1038/sj.onc.1202113; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yao J, 2006, AM J PHYSIOL-RENAL, V290, pF1083, DOI 10.1152/ajprenal.00134.2005; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020; Zhu Y, 2013, CANCER SCI, V104, P1052, DOI 10.1111/cas.12176; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	59	16	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1129	1140		10.1074/jbc.M114.590943	http://dx.doi.org/10.1074/jbc.M114.590943			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25414256	Green Published, hybrid			2022-12-28	WOS:000347778200044
J	Yoshida, A; Tomita, T; Fujimura, T; Nishiyama, C; Kuzuyama, T; Nishiyama, M				Yoshida, Ayako; Tomita, Takeo; Fujimura, Tsutomu; Nishiyama, Chiharu; Kuzuyama, Tomohisa; Nishiyama, Makoto			Structural Insight into Amino Group-carrier Protein-mediated Lysine Biosynthesis CRYSTAL STRUCTURE OF THE LYSZ.LYSW COMPLEX FROM THERMUS THERMOPHILUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosynthesis; Crystal Structure; Evolution; Isothermal Titration Calorimetry (ITC); Thermophile; Carrier Protein; Lysine Biosynthesis	FATTY-ACID SYNTHASE; MYCOBACTERIUM-TUBERCULOSIS; ARGININE-BIOSYNTHESIS; ALPHA-AMINOADIPATE; CYSTEINE SYNTHASE; GLUTAMATE KINASE; BACTERIUM; ASPARTOKINASE; PURIFICATION; PATHWAY	Background: The amino group-carrier protein TtLysW is required for the biosynthesis of lysine by T. thermophilus. Results: The crystal structure of the lysine biosynthetic enzyme TtLysZ was determined in a complex with TtLysW. Conclusion: The two proteins interacted with each other through electrostatic interactions. Significance: Elucidating the mechanisms by which TtLysW is recognized by enzymes is crucial for understanding the evolution of lysine biosynthesis. In the biosynthesis of lysine by Thermus thermophilus, the metabolite -ketoglutarate is converted to the intermediate -aminoadipate (AAA), which is protected by the 54-amino acid acidic protein LysW. In this study, we determined the crystal structure of LysZ from T. thermophilus (TtLysZ), an amino acid kinase that catalyzes the second step in the AAA to lysine conversion, which was in a complex with LysW at a resolution of 1.85 . A crystal analysis coupled with isothermal titration calorimetry of the TtLysZ mutants for TtLysW revealed tight interactions between LysZ and the globular and C-terminal extension domains of the LysW protein, which were mainly attributed to electrostatic forces. These results provided structural evidence for LysW acting as a protecting molecule for the -amino group of AAA and also as a carrier protein to guarantee better recognition by biosynthetic enzymes for the efficient biosynthesis of lysine.	[Yoshida, Ayako; Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; [Fujimura, Tsutomu] Juntendo Univ, Sch Med, Cent Lab Med Sci, Div Biochem Anal,Bunkyo Ku, Tokyo 1138421, Japan; [Nishiyama, Chiharu] Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 1258585, Japan	University of Tokyo; Juntendo University; Tokyo University of Science	Nishiyama, M (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	umanis@mail.ecc.u-tokyo.ac.jp	Nishiyama, Chiharu/GPW-9372-2022	Yoshida, Ayako/0000-0002-3668-9001; Kuzuyama, Tomohisa/0000-0002-7221-5858; Fujimura, Tsutomu/0000-0003-1744-7725; Nishiyama, Makoto/0000-0001-8143-8052				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLACK S, 1955, J BIOL CHEM, V213, P27; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gil-Ortiz F, 2003, J MOL BIOL, V331, P231, DOI 10.1016/S0022-2836(03)00716-2; Gill DJ, 2007, EMBO J, V26, P600, DOI 10.1038/sj.emboj.7601501; GILSON MK, 1988, PROTEINS, V4, P7, DOI 10.1002/prot.340040104; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAAS D, 1975, EUR J BIOCHEM, V52, P365, DOI 10.1111/j.1432-1033.1975.tb04004.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Jia YH, 2006, BIOCHEM J, V396, P479, DOI 10.1042/BJ20051711; Jurgenson CT, 2008, BIOCHEMISTRY-US, V47, P10354, DOI 10.1021/bi800915j; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Kumaran S, 2009, J BIOL CHEM, V284, P10268, DOI 10.1074/jbc.M900154200; Liu XY, 2008, J BIOL CHEM, V283, P16216, DOI 10.1074/jbc.M800760200; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; MAJERUS PW, 1964, P NATL ACAD SCI USA, V51, P1231, DOI 10.1073/pnas.51.6.1231; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyazaki J, 2003, J BIOL CHEM, V278, P1864, DOI 10.1074/jbc.M205133200; Miyazaki J, 2002, FEBS LETT, V512, P269, DOI 10.1016/S0014-5793(02)02290-1; Miyazaki J, 2001, J BACTERIOL, V183, P5067, DOI 10.1128/JB.183.17.5067-5073.2001; Miyazaki T, 2004, MICROBIOL-SGM, V150, P2327, DOI 10.1099/mic.0.27037-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; O'Leary SE, 2008, BIOCHEMISTRY-US, V47, P11606, DOI 10.1021/bi8013664; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouchi T, 2013, NAT CHEM BIOL, V9, P277, DOI [10.1038/NCHEMBIO.1200, 10.1038/nchembio.1200]; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Stachelhaus T, 1996, CHEM BIOL, V3, P913, DOI 10.1016/S1074-5521(96)90180-5; STRASSMAN M, 1953, J AM CHEM SOC, V75, P1680, DOI 10.1021/ja01103a049; Sundaresan R, 2012, BIOCHEM BIOPH RES CO, V420, P692, DOI 10.1016/j.bbrc.2012.03.072; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; Wulandari AP, 2002, FEBS LETT, V522, P35, DOI 10.1016/S0014-5793(02)02877-6; Yi H, 2013, J BIOL CHEM, V288, P36463, DOI 10.1074/jbc.M113.527143	45	9	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					435	447		10.1074/jbc.M114.595983	http://dx.doi.org/10.1074/jbc.M114.595983			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25392000	hybrid, Green Published			2022-12-28	WOS:000347231200038
J	Levy-Apter, E; Finkelshtein, E; Vemulapalli, V; Li, SSC; Bedford, MT; Elson, A				Levy-Apter, Einat; Finkelshtein, Eynat; Vemulapalli, Vidyasiri; Li, Shawn S. -C.; Bedford, Mark T.; Elson, Ari			Adaptor Protein GRB2 Promotes Src Tyrosine Kinase Activation and Podosomal Organization by Protein-tyrosine Phosphatase epsilon in Osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR CELLS; PTP-ALPHA; SH3 DOMAINS; IN-VIVO; RECEPTOR; PHOSPHORYLATION; ASSOCIATION; NEU; CYTOSKELETON; ADHESIONS	The non-receptor isoform of protein-tyrosine phosphatase epsilon (cyt-PTPe) supports adhesion of bone-resorbing osteoclasts by activating Src downstream of integrins. Loss of cyt-PTPe reduces Src activity in osteoclasts, reduces resorption of mineralized matrix both in vivo and in cell culture, and induces mild osteopetrosis in young female PTPe KO mice. Activation of Src by cyt-PTPe is dependent upon this phosphatase undergoing phosphorylation at its C-terminal Tyr-638 by partially active Src. To understand how cyt-PTPe activates Src, we screened 73 Src homology 2 (SH2) domains for binding to Tyr(P)-638 of cyt-PTPe. The SH2 domain of GRB2 bound Tyr(P)-638 of cyt-PTPe most prominently, whereas the Src SH2 domain did not bind at all, suggesting that GRB2 may link PTPe with downstream molecules. Further studies indicated that GRB2 is required for activation of Src by cyt-PTPe in osteoclast-like cells (OCLs) in culture. Overexpression of GRB2 in OCLs increased activating phosphorylation of Src at Tyr-416 and of cyt-PTPe at Tyr-638; opposite results were obtained when GRB2 expression was reduced by shRNA or by gene inactivation. Phosphorylation of cyt-PTPe at Tyr-683 and its association with GRB2 are integrin-driven processes in OCLs, and cyt-PTPe undergoes autodephosphorylation at Tyr-683, thus limiting Src activation by integrins. Reduced GRB2 expression also reduced the ability of bone marrow precursors to differentiate into OCLs and reduced the fraction of OCLs in which podosomal adhesion structures assume organization typical of active, resorbing cells. We conclude that GRB2 physically links cyt-PTPe with Src and enables cyt-PTPe to activate Src downstream of activated integrins in OCLs.	[Levy-Apter, Einat; Finkelshtein, Eynat; Elson, Ari] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Vemulapalli, Vidyasiri; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA; [Li, Shawn S. -C.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada; [Li, Shawn S. -C.] Univ Western Ontario, Schulich Sch Med & Dent, Siebens Drake Med Res Inst, London, ON N6A 5C1, Canada	Weizmann Institute of Science; University of Texas System; UTMD Anderson Cancer Center; Western University (University of Western Ontario); Western University (University of Western Ontario)	Elson, A (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	ari.elson@weizmann.ac.il		Elson, Ari/0000-0001-9808-9135	Israel Science Foundation; Kekst Family Institute for Medical Genetics, Weizmann Institute; David and Fella Shapell Family Center for Genetic Disorders Research, Weizmann Institute; Cancer Prevention Research Institute of Texas Grant [RP130432]; Centre for Environmental and Molecular Carcinogenesis at M. D. Anderson	Israel Science Foundation(Israel Science Foundation); Kekst Family Institute for Medical Genetics, Weizmann Institute; David and Fella Shapell Family Center for Genetic Disorders Research, Weizmann Institute; Cancer Prevention Research Institute of Texas Grant; Centre for Environmental and Molecular Carcinogenesis at M. D. Anderson	This work was supported by the Israel Science Foundation and by the Kekst Family Institute for Medical Genetics and the David and Fella Shapell Family Center for Genetic Disorders Research, both of the Weizmann Institute (to A. E.).; Directs the Protein Array Core, which is supported by Cancer Prevention Research Institute of Texas Grant RP130432 and by the Centre for Environmental and Molecular Carcinogenesis at M. D. Anderson.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Berman-Golan D, 2007, ONCOGENE, V26, P7028, DOI 10.1038/sj.onc.1210505; Bisson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050996; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Cheng SYS, 2014, MOL CELL BIOL, V34, P348, DOI 10.1128/MCB.00825-13; Chiusaroli R, 2004, MOL BIOL CELL, V15, P234, DOI 10.1091/mbc.e03-04-0207; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; denHertog J, 1996, EMBO J, V15, P3016, DOI 10.1002/j.1460-2075.1996.tb00665.x; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; ELSON A, 1995, J BIOL CHEM, V270, P26116, DOI 10.1074/jbc.270.44.26116; Espejo A, 2002, BIOCHEM J, V367, P697, DOI 10.1042/BJ20020860; Finkelshtein E, 2014, MOL BIOL CELL, V25, P1808, DOI 10.1091/mbc.E14-03-0788; Georgess D, 2014, CELL ADHES MIGR, V8, P192, DOI 10.4161/cam.27840; Gil-Henn H, 2003, J BIOL CHEM, V278, P15579, DOI 10.1074/jbc.M210273200; Granot-Attas S, 2009, MOL BIOL CELL, V20, P4324, DOI 10.1091/mbc.E08-11-1158; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Lin CC, 2012, CELL, V149, P1514, DOI 10.1016/j.cell.2012.04.033; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Luxenburg C, 2006, EUR J CELL BIOL, V85, P203, DOI 10.1016/j.ejcb.2005.11.002; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Rousso-Noori L, 2011, CELL METAB, V13, P562, DOI 10.1016/j.cmet.2011.02.017; Sines T, 2007, MOL CELL BIOL, V27, P7102, DOI 10.1128/MCB.02096-06; SU J, 1994, J BIOL CHEM, V269, P18731; Sun GB, 2012, MOL CELL BIOL, V32, P3776, DOI 10.1128/MCB.00214-12; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Toledano-Katchalski H, 1999, ONCOGENE, V18, P5024, DOI 10.1038/sj.onc.1202883; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037	36	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36048	36058		10.1074/jbc.M114.603548	http://dx.doi.org/10.1074/jbc.M114.603548			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25381250	hybrid, Green Published			2022-12-28	WOS:000346897900033
J	Miszta, A; Pelkmans, L; Lindhout, T; Krishnamoorthy, G; de Groot, PG; Hemker, CH; Heemskerk, JWM; Kelchtermans, H; de Laat, B				Miszta, Adam; Pelkmans, Leonie; Lindhout, Theo; Krishnamoorthy, Ganeshram; de Groot, Philip G.; Hemker, Coenraad H.; Heemskerk, Johan W. M.; Kelchtermans, Hilde; de Laat, Bas			Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ADHESION; VONWILLEBRAND-FACTOR; POLYMERIZING FIBRIN; FACTOR-XIII; SHEAR; ELLIPSOMETRY; ACTIVATION; DOMAIN; BLOOD; AGGREGATION	Attachment of platelets from the circulation onto a growing thrombus is a process involving multiple platelet receptors, endothelial matrix components, and coagulation factors. It has been indicated previously that during a transglutaminase reaction activated factor XIII (FXIIIa) covalently cross-links von Willebrand factor (VWF) to polymerizing fibrin. Bound VWF further recruits and activates platelets via interactions with the platelet receptor complex glycoprotein Ib (GPIb). In the present study we found proof for binding of VWF to a fibrin monomer layer during the process of fibrinogen-to-fibrin conversion in the presence of thrombin, arvin, or a snake venom from Crotalus atrox. Using a domain deletion mutant we demonstrated the involvement of the C domains of VWF in this binding. Substantial binding of VWF to fibrin monomers persisted in the presence of the FXIIIa inhibitor K9-DON, illustrating that cross-linking via factor XIII is not essential for this phenomenon and suggesting the identification of a second mechanism through which VWF multimers incorporate into a fibrin network. Under high shear conditions, platelets were shown to adhere to fibrin only if VWF had been incorporated. In conclusion, our experiments show that the C domains of VWF and the E domain of fibrin monomers are involved in the incorporation of VWF during the polymerization of fibrin and that this incorporation fosters binding and activation of platelets. Fibrin thus is not an inert end product but partakes in further thrombus growth. Our findings help to elucidate the mechanism of thrombus growth and platelet adhesion under conditions of arterial shear rate.	[Miszta, Adam; Pelkmans, Leonie; Lindhout, Theo; Krishnamoorthy, Ganeshram; Hemker, Coenraad H.; Heemskerk, Johan W. M.; Kelchtermans, Hilde; de Laat, Bas] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6229 EV Maastricht, Netherlands; [Miszta, Adam; Pelkmans, Leonie; Lindhout, Theo; Hemker, Coenraad H.; Kelchtermans, Hilde; de Laat, Bas] Synapse BV, NL-6229 EV Maastricht, Netherlands; [de Groot, Philip G.] Univ Med Ctr Utrecht, NL-3584 CX Utrecht, Netherlands	Maastricht University; Utrecht University; Utrecht University Medical Center	Miszta, A (corresponding author), Synapse BV, Oxfordlaan 70, NL-6229 EV Maastricht, Netherlands.	adam.miszta@thrombin.com	Miszta, Adam/M-6183-2013; Heemskerk, Johan/AAM-8323-2021; Miszta, Adam/K-3545-2019	Heemskerk, Johan/0000-0002-2848-5121; Hemker, Coen/0000-0003-1669-2358; Kelchtermans, Hilde/0000-0002-2724-3438	Netherlands Heart Foundation Project [2006T5301]	Netherlands Heart Foundation Project	This work was supported by The Netherlands Heart Foundation Project 2006T5301.	Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; BAILEY K, 1951, NATURE, V167, P233, DOI 10.1038/167233a0; Beguin S, 2004, J THROMB HAEMOST, V2, P170, DOI 10.1111/j.1538-7836.2004.00558.x; Beguin S, 1999, BLOOD, V93, P564, DOI 10.1182/blood.V93.2.564; Benes M, 2004, LANGMUIR, V20, P10129, DOI 10.1021/la048811u; BUNCE LA, 1992, J CLIN INVEST, V89, P842, DOI 10.1172/JCI115663; CHURCH FC, 1986, ANAL BIOCHEM, V157, P77, DOI 10.1016/0003-2697(86)90198-3; COLLER BS, 1995, THROMB HAEMOSTASIS, V74, P302; Cosemans JMEM, 2011, BLOOD, V117, P651, DOI 10.1182/blood-2010-01-262683; CUYPERS PA, 1983, J BIOL CHEM, V258, P2426; CUYPERS PA, 1978, ANAL BIOCHEM, V84, P56, DOI 10.1016/0003-2697(78)90483-9; ENDENBURG SC, 1995, BLOOD, V86, P4158, DOI 10.1182/blood.V86.11.4158.bloodjournal86114158; HADA M, 1986, BLOOD, V68, P95; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Keuren JFW, 2004, BLOOD, V103, P1741, DOI 10.1182/blood-2003-07-2267; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; La Corte ALC, 2011, ADV PROTEIN CHEM STR, V83, P75, DOI 10.1016/B978-0-12-381262-9.00003-3; LOSCALZO J, 1986, J CLIN INVEST, V78, P1112, DOI 10.1172/JCI112668; Machan R, 2010, CHEM PHYS LIPIDS, V163, P200, DOI 10.1016/j.chemphyslip.2009.11.005; Matlung HL, 2010, ATHEROSCLEROSIS, V213, P77, DOI 10.1016/j.atherosclerosis.2010.07.054; Miszta A, 2008, J PEPT SCI, V14, P503, DOI 10.1002/psc.938; NIEWIAROWSKI S, 1972, J CLIN INVEST, V51, P685, DOI 10.1172/JCI106857; RIBES JA, 1987, J CLIN INVEST, V79, P117, DOI 10.1172/JCI112771; RIBES JA, 1990, BLOOD, V75, P1460; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Sabo TM, 2007, BIOCHEMISTRY-US, V46, P10089, DOI 10.1021/bi700579z; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Smith EL, 2013, J THROMB HAEMOST, V11, P993, DOI 10.1111/jth.12174; TURITTO VT, 1984, J CLIN INVEST, V74, P1730, DOI 10.1172/JCI111591; Van Kruchten R, 2012, PLATELETS, V23, P229, DOI 10.3109/09537104.2011.630848; Weisel JW, 2013, BLOOD, V121, P1712, DOI 10.1182/blood-2012-09-306639; WEISEL JW, 1986, BIOPHYS J, V50, P1079, DOI 10.1016/S0006-3495(86)83552-4; Zhou YF, 2014, BLOOD, V123, P1785, DOI 10.1182/blood-2013-11-523639; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134	36	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35979	35986		10.1074/jbc.M114.591677	http://dx.doi.org/10.1074/jbc.M114.591677			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25381443	hybrid, Green Published			2022-12-28	WOS:000346897900028
J	Watson, HA; Holley, RJ; Langford-Smith, KJ; Wilkinson, FL; van Kuppevelt, TH; Wynn, RF; Wraith, JE; Merry, CLR; Bigger, BW				Watson, H. Angharad; Holley, Rebecca J.; Langford-Smith, Kia J.; Wilkinson, Fiona L.; van Kuppevelt, Toin H.; Wynn, Robert F.; Wraith, J. Edmond; Merry, Catherine L. R.; Bigger, Brian W.			Heparan Sulfate Inhibits Hematopoietic Stem and Progenitor Cell Migration and Engraftment in Mucopolysaccharidosis I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME REPLACEMENT THERAPY; RISK-FACTOR ANALYSIS; GLYCOSAMINOGLYCAN-BINDING; HURLERS-SYNDROME; TRANSPLANTATION; INDUCTION; IMPROVES; CORRECTS; OUTCOMES; DOMAINS	Mucopolysaccharidosis I Hurler (MPSI-H) is a pediatric lysosomal storage disease caused by genetic deficiencies in IDUA, coding for alpha-L-iduronidase. Idua(-/-) mice share similar clinical pathology with patients, including the accumulation of the undegraded glycosaminoglycans (GAGs) heparan sulfate (HS), and dermatan sulfate (DS), progressive neurodegeneration, and dysostosis multiplex. Hematopoietic stem cell transplantation (HSCT) is the most effective treatment for Hurler patients, but reduced intensity conditioning is a risk factor in transplantation, suggesting an underlying defect in hematopoietic cell engraftment. HS is a co-receptor in the CXCL12/CXCR4 axis of hematopoietic stem and progenitor cell (HSPC) migration to the bone marrow (BM), but the effect of HS alterations on HSPC migration, or the functional role of HS in MPSI-H are unknown. We demonstrate defective WT HSPC engraftment and migration in Idua(-/-) recipient BM, particularly under reduced intensity conditioning. Both intra-but especially extracellular Idua(-/-) BM HS was significantly increased and abnormally sulfated. Soluble heparinase-sensitive GAGs from Idua(-/-) BM and specifically 2-O-sulfated HS, elevated in Idua(-/-) BM, both inhibited CXCL12-mediated WT HSPC transwell migration, while DS had no effect. Thus we have shown that excess overly sulfated extracellular HS binds, and sequesters CXCL12, limiting hematopoietic migration and providing a potential mechanism for the limited scope of HSCT in Hurler disease.	[Watson, H. Angharad; Holley, Rebecca J.; Langford-Smith, Kia J.; Wilkinson, Fiona L.; Bigger, Brian W.] Univ Manchester, Fac Med & Human Sci, Stem Cell & Neurotherapies Grp, Manchester M13 9PT, Lancs, England; [Holley, Rebecca J.; Merry, Catherine L. R.] Univ Manchester, Fac Phys & Engn Sci, Stem Cell Glycobiol Grp, Manchester M13 9PL, Lancs, England; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, Matrix Biochem Grp, NL-6500 HB Nijmegen, Netherlands; [Wynn, Robert F.] Royal Manchester Childrens Hosp, Bone Marrow Transplantat Unit, Manchester M13 9WL, Lancs, England; [Wraith, J. Edmond] St Marys Hosp, Biochem Genet Unit, Manchester M13 9WL, Lancs, England	University of Manchester; University of Manchester; Radboud University Nijmegen; Royal Manchester Children's Hospital; University of Manchester	Bigger, BW (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England.	Brian.bigger@manchester.ac.uk	van Kuppevelt, A.H.M.S.M./L-4463-2015; Bigger, Brian/I-3553-2012	Wilkinson, Fiona/0000-0002-0358-3489; merry, catherine/0000-0002-3490-2809; Wynn, robert/0000-0002-6046-8428; Watson, Angharad/0000-0003-4356-6891; Bigger, Brian/0000-0002-9708-1112	BBSRC; Wellcome; University of Manchester; MRC [G0701165, G0902170] Funding Source: UKRI; Medical Research Council [G0902170, G0701165] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome; University of Manchester; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We gratefully acknowledge the help and assistance of the staff at the Manchester BSU. The Bioimaging Facility microscopes used in this study were purchased with grants from BBSRC, Wellcome, and the University of Manchester Strategic Fund. Special thanks go to Robert Fernandez for help with the microscopy and image processing.	Albanese P, 2009, EXP HEMATOL, V37, P1072, DOI 10.1016/j.exphem.2009.06.005; Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311; Baxter MA, 2005, J INHERIT METAB DIS, V28, P1045, DOI 10.1007/s10545-005-0136-4; Boelens JJ, 2007, BONE MARROW TRANSPL, V40, P225, DOI 10.1038/sj.bmt.1705718; Boelens JJ, 2009, BIOL BLOOD MARROW TR, V15, P618, DOI 10.1016/j.bbmt.2009.01.020; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Clarke LA, 1997, HUM MOL GENET, V6, P503, DOI 10.1093/hmg/6.4.503; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; de Ru MH, 2013, J INHERIT METAB DIS, V36, P247, DOI 10.1007/s10545-012-9538-2; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; Fuller M, 2004, GLYCOBIOLOGY, V14, P443, DOI 10.1093/glycob/cwh049; Gupta P, 2006, THESCIENTIFICWORLDJO, V6, P452, DOI 10.1100/tsw.2006.83; Holley RJ, 2011, J BIOL CHEM, V286, P37515, DOI 10.1074/jbc.M111.287474; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Khan SA, 2008, AM J PHYSIOL-CELL PH, V294, pC1387, DOI 10.1152/ajpcell.00346.2007; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Langford-Smith A, 2012, MOL THER, V20, P1610, DOI 10.1038/mt.2012.82; Langford-Smith K, 2010, MOL GENET METAB, V99, P269, DOI 10.1016/j.ymgme.2009.10.175; Langford-Smith KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077632; Langford-Smith KJ, 2011, J INHERIT METAB DIS, V34, P499, DOI 10.1007/s10545-010-9254-8; Lawrence R, 2012, NAT CHEM BIOL, V8, P197, DOI 10.1038/nchembio.766; Lensen JFM, 2005, J AM SOC NEPHROL, V16, P1279, DOI 10.1681/ASN.2004050413; Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455; Muenzer J, 2009, PEDIATRICS, V123, P19, DOI 10.1542/peds.2008-0416; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Netelenbos T, 2002, J LEUKOCYTE BIOL, V72, P353; O'Boyle G, 2009, FASEB J, V23, P3906, DOI 10.1096/fj.09-134643; Pan CD, 2005, BLOOD, V106, P1956, DOI 10.1182/blood-2005-02-0657; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Rueda P, 2012, CIRCULATION, V126, P1882, DOI 10.1161/CIRCULATIONAHA.112.113290; Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Saif MA, 2012, HAEMATOL-HEMATOL J, V97, P1320, DOI 10.3324/haematol.2011.058644; Sergijenko A, 2013, MOL THER, V21, P1938, DOI 10.1038/mt.2013.141; Siapati EK, 2005, MOL THER, V12, P537, DOI 10.1016/j.ymthe.2005.01.022; Sweeney EA, 2001, ANN NY ACAD SCI, V938, P48; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Wilkinson FL, 2013, MOL THER, V21, P868, DOI 10.1038/mt.2013.29; Wilkinson FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035787; Wilson S, 2009, AM J PATHOL, V175, P2053, DOI 10.2353/ajpath.2009.090211; Wraith JE, 2006, J INHERIT METAB DIS, V29, P442, DOI 10.1007/s10545-006-0239-6; Wraith JE, 2005, EXPERT OPIN PHARMACO, V6, P489, DOI 10.1517/14656566.6.3.489; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284	45	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36194	36203		10.1074/jbc.M114.599944	http://dx.doi.org/10.1074/jbc.M114.599944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25359774	Green Published, hybrid			2022-12-28	WOS:000346897900045
J	Keire, PA; Bressler, SL; Lemire, JM; Edris, B; Rubin, BP; Rahmani, M; McManus, BM; van de Rijn, M; Wight, TN				Keire, Paul A.; Bressler, Steven L.; Lemire, Joan M.; Edris, Badreddin; Rubin, Brian P.; Rahmani, Maziar; McManus, Bruce M.; van de Rijn, Matt; Wight, Thomas N.			A Role for Versican in the Development of Leiomyosarcoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Cell Proliferation; Extracellular Matrix; Hyaluronan; Small Interfering RNA (siRNA); Leiomyosarcoma; Tumor Growth; Versican	SMOOTH-MUSCLE-CELLS; RICH PERICELLULAR MATRIX; PROSTATE-CANCER CELLS; SOFT-TISSUE SARCOMA; GROWTH-FACTOR; CHONDROITIN SULFATE; UTERINE LEIOMYOSARCOMAS; SUBSTRATUM ADHESION; OSTEOSARCOMA CELLS; TUMOR-GROWTH	Background: The cause of leiomyosarcoma (LMS) is unknown. Results: Experimental modulation of versican levels in LMS cells resulted in altered cell proliferation, adhesion, migration, and tumor growth. Conclusion: Versican regulates the growth of LMS tumors in a mouse model. Significance: Collectively, these results suggest targeting versican in the treatment of LMS. Leiomyosarcoma (LMS) is a mesenchymal cancer that occurs throughout the body. Although LMS is easily recognized histopathologically, the cause of the disease remains unknown. Versican, an extracellular matrix proteoglycan, increases in LMS. Microarray analyses of 80 LMSs and 24 leiomyomas showed a significant elevated expression of versican in human LMS versus benign leiomyomas. To explore the importance of versican in this smooth muscle cell tumor, we used versican-directed siRNA to knock down versican expression in a LMS human cell line, SK-LMS-1. Decreased versican expression was accompanied by slower rates of LMS cell proliferation and migration, increased adhesion, and decreased accumulation of the extracellular matrix macromolecule hyaluronan. Addition of purified versican to cells expressing versican siRNA restored cell proliferation to the level of LMS controls, increased the pericellular coat and the retention of hyaluronan, and decreased cell adhesion in a dose-dependent manner. The presence of versican was not only synergistic with hyaluronan in increasing cell proliferation, but the depletion of versican decreased hyaluronan synthase expression and decreased the retention of hyaluronan. When LMS cells stably expressing versican siRNA were injected into nude mice, the resulting tumors displayed significantly less versican and hyaluronan staining, had lower volumes, and had reduced levels of mitosis as compared with controls. Collectively, these results suggest a role for using versican as a point of control in the management and treatment of LMS.	[Keire, Paul A.; Bressler, Steven L.; Wight, Thomas N.] Virginia Mason, Benaroya Res Inst, Matrix Biol Program, Seattle, WA 98101 USA; [Keire, Paul A.; Lemire, Joan M.; Rubin, Brian P.; Wight, Thomas N.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Edris, Badreddin; van de Rijn, Matt] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Rahmani, Maziar; McManus, Bruce M.] St Pauls Hosp, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Vancouver, BC V6Z 1Y6, Canada; [Rahmani, Maziar; McManus, Bruce M.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2A1, Canada	Benaroya Research Institute; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; Stanford University; St. Paul's Hospital; University of Saskatchewan; University of British Columbia	Wight, TN (corresponding author), Virginia Mason, Benaroya Res Inst, Matrix Biol Program, 1201 Ninth Ave, Seattle, WA 98101 USA.	twight@benaroyaresearch.org		van de Rijn, Matt/0000-0002-1909-9739	National Institutes of Health [HL098067, 5 T32 HG00044, CA112270]; American Heart Association [0310062Z]; National Science Foundation; National Leiomyosarcoma Foundation; Leiomyosarcoma Direct Research Foundation; NATIONAL CANCER INSTITUTE [R01CA112270] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098067] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); National Leiomyosarcoma Foundation; Leiomyosarcoma Direct Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL098067 (to T. N. W.), 5 T32 HG00044 (a training grant through the Stanford Genome Training Program to B. E.), and CA112270 (for work in the van de Rijn laboratory). This work was also supported by American Heart Association Pre-Doctoral Fellowship 0310062Z (to P. A. K.), a National Science Foundation graduate research fellowship (to B. E.), and the National Leiomyosarcoma Foundation and Leiomyosarcoma Direct Research Foundation (for work in the van de Rijn laboratory).	Arslan AA, 2005, HUM REPROD, V20, P852, DOI 10.1093/humrep/deh698; Beck AH, 2010, ONCOGENE, V29, P845, DOI 10.1038/onc.2009.381; BodeLesniewska B, 1996, J HISTOCHEM CYTOCHEM, V44, P303, DOI 10.1177/44.4.8601689; Bogels M, 2012, ONCOIMMUNOLOGY, V1, P798, DOI 10.4161/onci.20427; Bu PY, 2014, EXP THER MED, V8, P309, DOI 10.3892/etm.2014.1708; Cattaruzza S, 2005, MATRIX BIOL, V24, P400, DOI 10.1016/j.matbio.2005.06.005; Cattaruzza S, 2004, FASEB J, V18, P779, DOI 10.1096/fj.03-0660fje; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Du WW, 2013, HISTOL HISTOPATHOL, V28, P701, DOI 10.14670/HH-28.701; DUCROS DL, 1995, J INVEST DERMATOL, V105, P426, DOI 10.1111/1523-1747.ep12321131; Eskander RN, 2012, J OBSTET GYNAECOL RE, V38, P1086, DOI 10.1111/j.1447-0756.2011.01841.x; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Fletcher C., 2002, WHO CLASSIFICATION T, V4, P130; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; Gao CF, 2009, MOL CANCER THER, V8, P2803, DOI 10.1158/1535-7163.MCT-09-0125; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Guillou L, 1997, J CLIN ONCOL, V15, P350, DOI 10.1200/JCO.1997.15.1.350; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; HASCALL VC, 1994, METHOD ENZYMOL, V230, P390; Havre PA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-517; Hernandez D, 2011, INT J MOL MED, V27, P269, DOI 10.3892/ijmm.2010.577; Horiuchi A, 2000, INT J CANCER, V88, P640, DOI 10.1002/1097-0215(20001115)88:4<640::AID-IJC19>3.0.CO;2-K; Hyacinthe M, 1999, CANCER-AM CANCER SOC, V85, P409, DOI 10.1002/(SICI)1097-0142(19990115)85:2<409::AID-CNCR19>3.0.CO;2-I; JONES MW, 1995, INT J GYNECOL PATHOL, V14, P243, DOI 10.1097/00004347-199507000-00008; Kastner S, 2007, AM J PATHOL, V171, P1811, DOI 10.2353/ajpath.2007.070085; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kodama J, 2007, EUR J CANCER, V43, P1460, DOI 10.1016/j.ejca.2007.02.007; Kosaki R, 1999, CANCER RES, V59, P1141; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Labropoulou VT, 2006, HISTOPATHOLOGY, V49, P582, DOI 10.1111/j.1365-2559.2006.02558.x; Lemire JM, 1999, ARTERIOSCL THROM VAS, V19, P1630, DOI 10.1161/01.ATV.19.7.1630; Lemire JM, 2007, J CELL BIOCHEM, V101, P753, DOI 10.1002/jcb.21235; Li D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056616; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Li Y, 2001, BRIT J CANCER, V85, P600, DOI 10.1054/bjoc.2001.1922; Liu NF, 2001, CANCER RES, V61, P5207; MAJOR FJ, 1993, CANCER-AM CANCER SOC, V71, P1702, DOI 10.1002/cncr.2820710440; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Mitropoulou TN, 2001, BIOCHIMIE, V83, P529, DOI 10.1016/S0300-9084(01)01281-0; Moinfar F, 2007, PATHOLOGY, V39, P55, DOI 10.1080/00313020601136146; Myslinski E, 2001, NUCLEIC ACIDS RES, V29, P2502, DOI 10.1093/nar/29.12.2502; Nikitovic D, 2006, IUBMB LIFE, V58, P47, DOI 10.1080/15216540500531713; Olin KL, 1999, J BIOL CHEM, V274, P34629, DOI 10.1074/jbc.274.49.34629; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PERRONE T, 1988, AM J SURG PATHOL, V12, P1, DOI 10.1097/00000478-198801000-00001; Ra HJ, 2009, J BIOL CHEM, V284, P27924, DOI 10.1074/jbc.M109.035147; Rahmani M, 2006, CAN J PHYSIOL PHARM, V84, P77, DOI 10.1139/Y05-154; RANCHOD M, 1977, CANCER, V39, P255, DOI 10.1002/1097-0142(197701)39:1<255::AID-CNCR2820390139>3.0.CO;2-H; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Robboy SJ, 2000, ENVIRON HEALTH PERSP, V108, P779, DOI 10.2307/3454306; Said N, 2012, J CLIN INVEST, V122, P1503, DOI 10.1172/JCI61392; Sakko AJ, 2003, CANCER RES, V63, P4786; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Schonherr E, 1997, ARCH BIOCHEM BIOPHYS, V339, P353, DOI 10.1006/abbi.1996.9854; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; SHMOOKLER BM, 1983, AM J SURG PATHOL, V7, P269; Skandalis SS, 2006, BIOCHIMIE, V88, P1135, DOI 10.1016/j.biochi.2006.03.011; SOBUE M, 1987, CANCER RES, V47, P160; Subramaniam V, 2007, EXP MOL PATHOL, V83, P207, DOI 10.1016/j.yexmp.2007.04.008; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Theocharis AD, 2003, INT J BIOCHEM CELL B, V35, P376, DOI 10.1016/S1357-2725(02)00264-9; Tofuku K, 2006, INT J ONCOL, V29, P175; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032; Weiss S., 2001, ENZINGER WEISSS SOFT, P695; Wight TN, 2014, BBA-GEN SUBJECTS, V1840, P2441, DOI 10.1016/j.bbagen.2013.12.028; Wight TN, 2014, MATRIX BIOL, V35, P152, DOI 10.1016/j.matbio.2014.01.015; Wilkinson TS, 2004, AM J RESP CELL MOL, V31, P92, DOI 10.1165/rcmb.2003-0380OC; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; YAMAGATA M, 1993, J CELL SCI, V106, P55; YAMAGATA M, 1994, J CELL SCI, V107, P2581; Yang JL, 2010, MOL CELL PROTEOMICS, V9, P2405, DOI 10.1074/mcp.M110.000240; Yeung TL, 2013, CANCER RES, V73, P5016, DOI 10.1158/0008-5472.CAN-13-0023; YU Q, 1995, BIOTECHNIQUES, V19, P122; ZAKO M, 1995, J BIOL CHEM, V270, P3914, DOI 10.1074/jbc.270.8.3914; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	79	25	25	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34089	34103		10.1074/jbc.M114.607168	http://dx.doi.org/10.1074/jbc.M114.607168			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25320080	hybrid, Green Published			2022-12-28	WOS:000346077600034
J	Mao, Y; Huang, Y; Buczek-Thomas, JA; Ethen, CM; Nugent, MA; Wu, ZLL; Zaia, J				Mao, Yang; Huang, Yu; Buczek-Thomas, Jo Ann; Ethen, Cheryl M.; Nugent, Matthew A.; Wu, Zhengliang L.; Zaia, Joseph			A Liquid Chromatography-Mass Spectrometry-based Approach to Characterize the Substrate Specificity of Mammalian Heparanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycosaminoglycan; Glycosylation; Heparan Sulfate; Heparanase; Heparin; Heparin-binding Protein	FIBROBLAST-GROWTH-FACTOR; SULFATE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; MAKEUP FLOW; CANCER; METASTASIS; GLYCOSAMINOGLYCANS; OLIGOSACCHARIDES; DEGRADATION; MEMBRANE	Background: Heparanase remodels ECM and is associated with cancer metastasis and angiogenesis. Results: An LC-MS-based approach was developed to profile the structures of the heparanase cleavage sites in heterogeneous HS chains. Conclusion: Heparanase cleaves at the non-reducing side of highly sulfated HS domains. Significance: The results suggest a mechanism for heparanase to activate nascent growth factor binding domains within HS. Extracellular heparanase activity releases growth factors and angiogenic factors from heparan sulfate (HS) storage sites and alters the integrity of the extracellular matrix. These activities lead to a loss of normal cell matrix adherent junctions and correlate with invasive cellular phenotypes. Elevated expression of heparanase is associated with several human cancers and with vascular remodeling. Heparanase cleaves only a limited fraction of glucuronidic linkages in HS. There have been few investigations of the functional consequences of heparanase activity, largely due to the heterogeneity and complexity of HS. Here, we report a liquid chromatography-mass spectrometry (LC-MS)-based approach to profile the terminal structures created by heparanase digestion and reconstruct the heparanase cleavage sites from the products. Using this method, we demonstrate that heparanase cleaves at the non-reducing side of highly sulfated HS domains, exposing cryptic growth factor binding sites. This cleavage pattern is observed in HS from several tissue sources, regardless of overall sulfation degree, indicating a common recognition pattern. We further demonstrate that heparanase cleavage of HS chains leads to increased ability to support FGF2-dependent cell proliferation. These results suggest a new mechanism to explain how heparanase might potentiate the uncontrolled cell proliferation associated with cancer through its ability to activate nascent growth factor-promoting domains within HS.	[Mao, Yang; Huang, Yu; Buczek-Thomas, Jo Ann; Nugent, Matthew A.; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Ethen, Cheryl M.; Wu, Zhengliang L.] R&D Syst, Minneapolis, MN 55413 USA	Boston University	Zaia, J (corresponding author), Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, 670 Albany St,Rm 509, Boston, MA 02118 USA.	jzaia@bu.edu	Zaia, Joseph/U-7850-2019	Zaia, Joseph/0000-0001-9497-8701; Wu, Zhengliang/0000-0002-0700-0906; Mao, Yang/0000-0002-9674-1158	National Institutes of Health [P41 GM104603, R01 HL098950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098950, R21HL131554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41 GM104603 and R01 HL098950 (to J. Z.).	Bai XM, 1997, J BIOL CHEM, V272, P23172, DOI 10.1074/jbc.272.37.23172; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dowd CJ, 1999, J BIOL CHEM, V274, P5236, DOI 10.1074/jbc.274.8.5236; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; GILAT D, 1995, J EXP MED, V181, P1929, DOI 10.1084/jem.181.5.1929; Goldshmidt O, 2002, EXP CELL RES, V281, P50, DOI 10.1006/excr.2002.5651; Horowitz A, 2002, J CELL BIOL, V157, P715, DOI 10.1083/jcb.200112145; Huang Y, 2011, ANAL CHEM, V83, P8222, DOI 10.1021/ac201964n; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; ISHAIMICHAELI R, 1990, CELL REGUL, V1, P833, DOI 10.1091/mbc.1.11.833; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Maxwell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045474; Nadir Y, 2008, SEMIN THROMB HEMOST, V34, P187, DOI 10.1055/s-2008-1079259; Naimy H, 2011, J BIOL CHEM, V286, P19311, DOI 10.1074/jbc.M110.204693; NAKAJIMA M, 1983, SCIENCE, V220, P611, DOI 10.1126/science.6220468; NAKAJIMA M, 1984, J BIOL CHEM, V259, P2283; Okada Y, 2002, J BIOL CHEM, V277, P42488, DOI 10.1074/jbc.M206510200; Peterson S, 2012, J BIOL CHEM, V287, P34836, DOI 10.1074/jbc.M112.390161; Peterson SB, 2010, J BIOL CHEM, V285, P14504, DOI 10.1074/jbc.M110.104166; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Podyma-Inoue KA, 2002, J BIOL CHEM, V277, P32459, DOI 10.1074/jbc.M203282200; Purushothaman A, 2011, J BIOL CHEM, V286, P30377, DOI 10.1074/jbc.M111.254789; Ramani VC, 2013, FEBS J, V280, P2294, DOI 10.1111/febs.12168; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Staples GO, 2010, ANAL CHEM, V82, P516, DOI 10.1021/ac901706f; Staples GO, 2009, PROTEOMICS, V9, P686, DOI 10.1002/pmic.200701008; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Wu ZLL, 2005, J BIOL CHEM, V280, P33749, DOI 10.1074/jbc.M505677200; YAMADA S, 1994, GLYCOBIOLOGY, V4, P69, DOI 10.1093/glycob/4.1.69; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200	43	29	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34141	34151		10.1074/jbc.M114.589630	http://dx.doi.org/10.1074/jbc.M114.589630			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25336655	Green Published, hybrid			2022-12-28	WOS:000346077600038
J	Srinivasan, S; Romagnoli, M; Bohm, A; Sonenshein, GE				Srinivasan, Srimathi; Romagnoli, Mathilde; Bohm, Andrew; Sonenshein, Gail E.			N-Glycosylation Regulates ADAM8 Processing and Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOPROTEASE-DISINTEGRIN ADAM8; E-CADHERIN; CELL CARCINOMA; LINKED GLYCANS; LUNG-CANCER; EXPRESSION; ADHESION; INVASIVENESS; TRANSPORT; ISOFORMS	The transmembrane ADAM8 (A Disintegrin And Metalloproteinase 8) protein is abundantly expressed in human breast tumors and derived metastases compared with normal breast tissue, and plays critical roles in aggressive Triple-Negative breast cancers (TNBCs). During ADAM8 maturation, the inactive proform dimerizes or multimerizes and autocatalytically removes the prodomain leading to the formation of the active, processed form. ADAM8 is a glycoprotein; however, little was known about the structure or functional role of these sugar moieties. Here, we report that in estrogen receptor (ER)alpha-negative, but not-positive, breast cancer cells ADAM8 contains N-glycosylation, which is required for its correct processing and activation. Consistently ADAM8 dimers were detected on the surface of ER alpha-negative breast cancer cells but not on ER alpha-positive ones. Site-directed mutagenesis confirmed four N-glycosylazhytion sites (Asn-67, Asn-91, Asn-436, and Asn-612) in human ADAM8. The Asn-67 and Asn-91 prodomain sites contained high mannose, whereas complex type N-glycosylation was observed on Asn-436 and Asn-612 in the active and remnant forms. The Asn-91 and Asn-612 sites were essential for its correct processing and cell surface localization, in particular its exit from the Golgi and endoplasmic reticulum, respectively. The N436Q mutation led to decreased ADAM8 stability due to enhanced lysosomal degradation. In contrast, mutation of the Asn-67 site had only modest effects on enzyme stability and processing. Thus, N-glycosylation is essential for processing, localization, stability, and activity of ADAM8.	[Srinivasan, Srimathi; Romagnoli, Mathilde; Bohm, Andrew; Sonenshein, Gail E.] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA	Tufts University	Sonenshein, GE (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, J808,150 Harrison Ave, Boston, MA 02111 USA.	Gail.Sonenshein@tufts.edu			National Institutes of Health [R01 CA129129, P01 ES01124]; Dept. of Defense (DOD) postdoctoral fellowship [W81XWH-10-1-1003]; NATIONAL CANCER INSTITUTE [R01CA129129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Defense (DOD) postdoctoral fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by grants from the National Institutes of Health (R01 CA129129 and P01 ES01124, to G. E. S.) and the Dept. of Defense (DOD) postdoctoral fellowship W81XWH-10-1-1003 (to M. R.).	Bartsch JW, 2010, J NEUROSCI, V30, P12210, DOI 10.1523/JNEUROSCI.1520-10.2010; Calle Y, 2000, CHEMOTHERAPY, V46, P408, DOI 10.1159/000007322; Chavaroche A, 2014, ANAL BIOCHEM, V449, P68, DOI 10.1016/j.ab.2013.12.018; Choi SJ, 2001, J BONE MINER RES, V16, P814, DOI 10.1359/jbmr.2001.16.5.814; Cooper AM, 2012, J IMMUNOL, V188, P3199, DOI 10.4049/jimmunol.1102689; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Escrevente C., 2008, BIOCH BIOPHYS ACTA; Forozan F, 1999, BRIT J CANCER, V81, P1328, DOI 10.1038/sj.bjc.6695007; Fourie AM, 2003, J BIOL CHEM, V278, P30469, DOI 10.1074/jbc.M213157200; Fritzsche FR, 2006, VIRCHOWS ARCH, V449, P628, DOI 10.1007/s00428-006-0315-1; Fry JL, 2010, CANCER RES, V70, P8187, DOI 10.1158/0008-5472.CAN-09-4231; Geng F, 2012, J CELL SCI, V125, P2615, DOI 10.1242/jcs.096735; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Guo NX, 2005, CLIN BIOCHEM, V38, P149, DOI 10.1016/j.clinbiochem.2004.10.002; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hernandez I, 2010, ONCOGENE, V29, P3758, DOI 10.1038/onc.2010.130; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Ishikawa N, 2004, CLIN CANCER RES, V10, P8363, DOI 10.1158/1078-0432.CCR-04-1436; Kelly K, 2005, DEV DYNAM, V232, P221, DOI 10.1002/dvdy.20221; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Koller G, 2009, CURR PHARM DESIGN, V15, P2272, DOI 10.2174/138161209788682361; Kophengnavong T, 2000, MOL CELL BIOL, V20, P261, DOI 10.1128/MCB.20.1.261-272.2000; Liu HL, 2009, J BIOL CHEM, V284, P29077, DOI 10.1074/jbc.M109.014258; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Matsuno O, 2010, RESP MED, V104, P34, DOI 10.1016/j.rmed.2009.06.018; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Nita-Lazar M, 2009, CANCER RES, V69, P5673, DOI 10.1158/0008-5472.CAN-08-4512; Roemer A, 2004, J UROLOGY, V172, P2162, DOI 10.1097/01.ju.0000144602.01322.49; Romagnoli M, 2014, EMBO MOL MED, V6, P278, DOI 10.1002/emmm.201303373; Romagnoli M, 2012, CANCER RES, V72, P6268, DOI 10.1158/0008-5472.CAN-12-2270; Schlomann U, 2002, J BIOL CHEM, V277, P48210, DOI 10.1074/jbc.M203355200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Valkovskaya N, 2007, J CELL MOL MED, V11, P1162, DOI 10.1111/j.1582-4934.2007.00082.x; Varki A., 2009, ESSENTIALS GLYCOBIOL; VONLAMPE B, 1993, GUT, V34, P829, DOI 10.1136/gut.34.6.829; Wildeboer D, 2006, J NEUROPATH EXP NEUR, V65, P516, DOI 10.1097/01.jnen.0000229240.51490.d3; Wu Guo-Cheng, 2008, Ai Zheng, V27, P874; Yoshiyama K, 1997, GENOMICS, V41, P56, DOI 10.1006/geno.1997.4607; Zack MD, 2009, ARTHRITIS RHEUM-US, V60, P2704, DOI 10.1002/art.24753; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zhu WJ, 2001, EMBO J, V20, P5999, DOI 10.1093/emboj/20.21.5999; Zielinski V, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-76	45	14	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33676	33688		10.1074/jbc.M114.594242	http://dx.doi.org/10.1074/jbc.M114.594242			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25336660	Green Published, hybrid			2022-12-28	WOS:000345636600052
J	Ahles, A; Rodewald, F; Rochais, F; Bunemann, M; Engelhardt, S				Ahles, Andrea; Rodewald, Fabian; Rochais, Francesca; Buenemann, Moritz; Engelhardt, Stefan			Interhelical Interaction and Receptor Phosphorylation Regulate the Activation Kinetics of Different Human beta(1)-Adrenoceptor Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; NERVOUS-SYSTEM; BLOOD-PRESSURE; BETA-ARRESTIN; POLYMORPHISM; MECHANISM; PHARMACOGENOMICS; HYPERTENSION	G protein-coupled receptors represent the largest class of drug targets, but genetic variation within G protein-coupled receptors leads to variable drug responses and, thereby, compromises their therapeutic application. One of the most intensely studied examples is a hyperfunctional variant of the human beta(1)-adrenoceptor that carries an arginine at position 389 in helix 8 (Arg-389-ADRB1). However, the mechanism underlying the higher efficacy of the Arg-389 variant remained unclear to date. Despite its hyperfunctionality, we found the Arg-389 variant of ADRB1 to be hyperphosphorylated upon continuous stimulation with norepinephrine compared with the Gly-389 variant. Using ADRB1 sensors to monitor activation kinetics by fluorescence resonance energy transfer, Arg-389-ADRB1 exerted faster activation speed and arrestin recruitment than the Gly-389 variant. Both activation speed and arrestin recruitment depended on phosphorylation of the receptor, as shown by knockdown of G protein-coupled receptor kinases and phosphorylation-deficient ADRB1 mutants. Structural modeling of the human beta(1)-adrenoceptor suggested interaction of the side chain of Arg-389 with opposing amino acid residues in helix 1. Site-directed mutagenesis of Lys-85 and Thr-86 in helix 1 revealed that this interaction indeed determined ADRB1 activation kinetics. Taken together, these findings indicate that differences in interhelical interaction regulate the different activation speed and efficacy of ADRB1 variants.	[Ahles, Andrea; Rodewald, Fabian; Engelhardt, Stefan] Tech Univ Munich, Inst Pharmacol & Toxicol, D-80802 Munich, Germany; [Rochais, Francesca] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Buenemann, Moritz] Univ Marburg, Inst Pharmacol & Clin Pharm, D-35043 Marburg, Germany; [Engelhardt, Stefan] German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, D-80802 Munich, Germany	Technical University of Munich; University of Wurzburg; Philipps University Marburg; German Centre for Cardiovascular Research; Munich Heart Alliance	Engelhardt, S (corresponding author), Tech Univ Munich, Inst Pharmacol & Toxicol, Biedersteiner Str 29, D-80802 Munich, Germany.	stefan.engelhardt@tum.de	Rochais, Francesca/ABF-4675-2021; Engelhardt, Stefan/AAA-9329-2019; Rochais, Francesca/A-5326-2017	Rochais, Francesca/0000-0001-9355-8916; Engelhardt, Stefan/0000-0001-5378-8661; Rochais, Francesca/0000-0001-9355-8916				Ahles A, 2014, PHARMACOL REV, V66, P598, DOI 10.1124/pr.113.008219; Ahles A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001681; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Gjesing AP, 2007, DIABETIC MED, V24, P392, DOI 10.1111/j.1464-5491.2006.02031.x; Johnson AD, 2011, HYPERTENSION, V57, P903, DOI 10.1161/HYPERTENSIONAHA.110.158667; Joseph SS, 2004, BRIT J PHARMACOL, V142, P51, DOI 10.1038/sj.bjp.0705753; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Kim IM, 2014, CIRC RES, V114, P833, DOI 10.1161/CIRCRESAHA.114.302766; Kirstein SL, 2004, PHARMACOL REV, V56, P31, DOI 10.1124/pr.56.1.2; Liang W, 2003, J BIOL CHEM, V278, P39773, DOI 10.1074/jbc.M304482200; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rochais F, 2007, J CLIN INVEST, V117, P229, DOI 10.1172/JCI30012; Rosskopf D, 2008, PHARMACOL REV, V60, P513, DOI 10.1124/pr.108.000612; Tesson F, 1999, J MOL CELL CARDIOL, V31, P1025, DOI 10.1006/jmcc.1999.0947; Tikhonoff V, 2008, J HUM HYPERTENS, V22, P864, DOI 10.1038/jhh.2008.73; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Zhang F, 2013, PHYSIOL GENOMICS, V45, P1186, DOI 10.1152/physiolgenomics.00087.2013	34	10	10	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1760	1769		10.1074/jbc.M114.607333	http://dx.doi.org/10.1074/jbc.M114.607333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451930	Green Published, hybrid			2022-12-28	WOS:000348056400041
J	Richarme, G; Mihoub, M; Dairou, J; Bui, LC; Leger, T; Lamouri, A				Richarme, Gilbert; Mihoub, Mouadh; Dairou, Julien; Bui, Linh Chi; Leger, Thibaut; Lamouri, Aazdine			Parkinsonism-associated Protein DJ-1/Park7 Is a Major Protein Deglycase That Repairs Methylglyoxal- and Glyoxal-glycated Cysteine, Arginine, and Lysine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HSP31; PROKARYOTIC HOMOLOG; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; HUMAN DJ-1; YAJL; BINDING; STRESS; CELLS; THIOREDOXIN	Glycation is an inevitable nonenzymatic covalent reaction between proteins and endogenous reducing sugars or dicarbonyls (methylglyoxal, glyoxal) that results in protein inactivation. DJ-1 was reported to be a multifunctional oxidative stress response protein with poorly defined function. Here, we show that human DJ-1 is a protein deglycase that repairs methylglyoxal- and glyoxal-glycated amino acids and proteins by acting on early glycation intermediates and releases repaired proteins and lactate or glycolate, respectively. DJ-1 deglycates cysteines, arginines, and lysines (the three major glycated amino acids) of serum albumin, glyceraldehyde-3-phosphate dehydrogenase, aldolase, and aspartate aminotransferase and thus reactivates these proteins. DJ-1 prevented protein glycation in an Escherichia coli mutant deficient in the DJ-1 homolog YajL and restored cell viability in glucose-containing media. These results suggest that DJ-1-associated Parkinsonism results from excessive protein glycation and establishes DJ-1 as a major antiglycation and anti-aging protein.	[Richarme, Gilbert; Mihoub, Mouadh] Univ Paris 07, Inst Jacques Monod, CNRS UMR 7592, F-75013 Paris, France; [Dairou, Julien; Bui, Linh Chi] Univ Paris Diderot, Sorbonne Paris Cite, Unite Biol Fonct & Adaptat UMR CNRS 8251, Bioprofiler Facil, F-75205 Paris, France; [Leger, Thibaut] Univ Paris 07, Prote Facil, Inst Jacques Monod, CNRS,UMR 7592, F-75013 Paris, France; [Lamouri, Aazdine] Univ Paris Diderot, Sorbonne Paris Cite, ITODYS, UMR CNRS 7086, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Richarme, G (corresponding author), Univ Paris 07, Inst Jacques Monod, CNRS UMR 7592, 15 Rue Helene Brion, F-75013 Paris, France.	richarme@paris7.jussieu.fr	Léger, Thibaut/GPP-5828-2022	Leger, Thibaut/0000-0002-6304-3433				Abdallah J, 2007, J BACTERIOL, V189, P9140, DOI 10.1128/JB.01208-07; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Bretes H, 2014, NUCLEIC ACIDS RES, V42, P5043, DOI 10.1093/nar/gku124; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Gautier V, 2012, J MOL BIOL, V421, P662, DOI 10.1016/j.jmb.2012.01.047; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Le HT, 2012, J BIOL CHEM, V287, P5861, DOI 10.1074/jbc.M111.299198; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hesterkamp T, 1996, FEBS LETT, V389, P32, DOI 10.1016/0014-5793(96)00582-0; Huyen NTT, 2009, MOL MICROBIOL, V71, P876, DOI 10.1111/j.1365-2958.2008.06568.x; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Kern R, 2003, BIOCHEM J, V371, P965, DOI 10.1042/BJ20030093; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kthiri F, 2010, J BIOL CHEM, V285, P10328, DOI 10.1074/jbc.M109.077529; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; LEONCINI G, 1980, ITAL J BIOCHEM, V29, P289; Li JL, 2012, J NEUROL SCI, V317, P1, DOI 10.1016/j.jns.2012.02.018; LO TWC, 1994, J BIOL CHEM, V269, P32299; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66; Malki A, 2005, J BIOL CHEM, V280, P14420, DOI 10.1074/jbc.M408296200; Malki A, 2003, BIOCHEM BIOPH RES CO, V301, P430, DOI 10.1016/S0006-291X(02)03053-X; MCLAUGHLIN JA, 1980, P NATL ACAD SCI-BIOL, V77, P949, DOI 10.1073/pnas.77.2.949; Messaoudi N, 2013, J BACTERIOL, V195, P1167, DOI 10.1128/JB.02202-12; Mironova R, 2001, MOL MICROBIOL, V39, P1061, DOI 10.1046/j.1365-2958.2001.02304.x; Morgan PE, 2002, ARCH BIOCHEM BIOPHYS, V403, P259, DOI 10.1016/S0003-9861(02)00222-9; Neuberg C, 1913, BIOCHEM Z, V49, P502; PATTHY L, 1975, J BIOL CHEM, V250, P565; Pepper ED, 2010, APPL ENVIRON MICROB, V76, P7925, DOI 10.1128/AEM.01369-10; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; Rabbani N, 2012, AMINO ACIDS, V42, P1133, DOI 10.1007/s00726-010-0783-0; RAHBAR S, 1968, CLIN CHIM ACTA, V22, P296, DOI 10.1016/0009-8981(68)90372-0; RICHARME G, 1983, BIOCHIM BIOPHYS ACTA, V748, P99, DOI 10.1016/0167-4838(83)90032-8; Sastry MSR, 2002, J BIOL CHEM, V277, P46026, DOI 10.1074/jbc.M205800200; Seidler NW, 2003, ARCH BIOCHEM BIOPHYS, V410, P149, DOI 10.1016/S0003-9861(02)00662-8; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Smitherman PK, 2004, J PHARMACOL EXP THER, V308, P260, DOI 10.1124/jpet.103.057729; Szwergold BS, 2005, ANN NY ACAD SCI, V1043, P845, DOI 10.1196/annals.1333.097; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Thornalley PJ, 2014, BBA-GEN SUBJECTS, V1840, P818, DOI 10.1016/j.bbagen.2013.03.025; Thornalley PJ, 2011, SEMIN CELL DEV BIOL, V22, P318, DOI 10.1016/j.semcdb.2011.02.006; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Van Schaftingen E, 2012, AMINO ACIDS, V42, P1143, DOI 10.1007/s00726-010-0780-3; Vicente Miranda H, 2010, J PATHOL, V221, P13, DOI 10.1002/path.2682; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481; Yamagishi S, 2012, REJUV RES, V15, P564, DOI 10.1089/rej.2012.1335; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	55	170	174	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1885	1897		10.1074/jbc.M114.597815	http://dx.doi.org/10.1074/jbc.M114.597815			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25416785	Green Published, hybrid			2022-12-28	WOS:000348056400052
J	Deng, GJ; Shen, JQ; Yin, M; McManus, J; Mathieu, M; Gee, P; He, T; Shi, CM; Bedel, O; McLean, LR; Le-Strat, F; Zhang, Y; Marquette, JP; Gao, Q; Zhang, BL; Rak, A; Hoffmann, D; Rooney, E; Vassort, A; Englaro, W; Li, Y; Patel, V; Adrian, F; Gross, S; Wiederschain, D; Cheng, H; Licht, S				Deng, Gejing; Shen, Junqing; Yin, Ming; McManus, Jessica; Mathieu, Magali; Gee, Patricia; He, Timothy; Shi, Chaomei; Bedel, Olivier; McLean, Larry R.; Le-Strat, Frank; Zhang, Ying; Marquette, Jean-Pierre; Gao, Qiang; Zhang, Bailin; Rak, Alexey; Hoffmann, Dietmar; Rooney, Eamonn; Vassort, Aurelie; Englaro, Walter; Li, Yi; Patel, Vinod; Adrian, Francisco; Gross, Stefan; Wiederschain, Dmitri; Cheng, Hong; Licht, Stuart			Selective Inhibition of Mutant Isocitrate Dehydrogenase 1 (IDH1) via Disruption of a Metal Binding Network by an Allosteric Small Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ONCOMETABOLITE 2-HYDROXYGLUTARATE; MUTATIONS; DIFFERENTIATION; MECHANISM; GLIOMA; TRANSFORMATION; SWITCH; R132H; CELLS	Cancer-associated point mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) confer a neomorphic enzymatic activity: the reduction of alpha-ketoglutarate to D-2-hydroxyglutaric acid, which is proposed to act as an oncogenic metabolite by inducing hypermethylation of histones and DNA. Although selective inhibitors of mutant IDH1 and IDH2 have been identified and are currently under investigation as potential cancer therapeutics, the mechanistic basis for their selectivity is not yet well understood. A high throughput screen for selective inhibitors of IDH1 bearing the oncogenic mutation R132H identified compound 1, a bis-imidazole phenol that inhibits D-2-hydroxyglutaric acid production in cells. We investigated the mode of inhibition of compound 1 and a previously published IDH1 mutant inhibitor with a different chemical scaffold. Steady-state kinetics and biophysical studies show that both of these compounds selectively inhibit mutant IDH1 by binding to an allosteric site and that inhibition is competitive with respect to Mg2+. A crystal structure of compound 1 complexed with R132H IDH1 indicates that the inhibitor binds at the dimer interface and makes direct contact with a residue involved in binding of the catalytically essential divalent cation. These results show that targeting a divalent cation binding residue can enable selective inhibition of mutant IDH1 and suggest that differences in magnesium binding between wild-type and mutant enzymes may contribute to the inhibitors' selectivity for the mutant enzyme.	[Deng, Gejing; Shen, Junqing; Yin, Ming; McManus, Jessica; Gee, Patricia; He, Timothy; Shi, Chaomei; Bedel, Olivier; Gao, Qiang; Zhang, Bailin; Hoffmann, Dietmar; Adrian, Francisco; Gross, Stefan; Wiederschain, Dmitri; Cheng, Hong; Licht, Stuart] Sanofi, Div Oncol Drug Discovery & Preclin Dev, Cambridge, MA 02139 USA; [Mathieu, Magali; Marquette, Jean-Pierre; Rak, Alexey; Rooney, Eamonn; Vassort, Aurelie; Englaro, Walter] Sanofi, Div Lead Generat & Compound Realizat, F-94403 Vitry Sur Seine, France; [McLean, Larry R.; Zhang, Ying; Li, Yi; Patel, Vinod] Sanofi, Div Lead Generat & Compound Realizat, Waltham, MA 02452 USA; [Le-Strat, Frank] Sanofi, Dept Disposit Safety & Anim Res, F-91385 Chilly Mazarin, France	Sanofi-Aventis; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi-Aventis; Sanofi France	Deng, GJ (corresponding author), Sanofi Oncol, 640 Mem Dr, Cambridge, MA 02139 USA.	gejing.deng@sanofi.com						ALBERT R, 1987, SYNTHESIS-STUTTGART, P635; Ceccarelli C, 2002, J BIOL CHEM, V277, P43454, DOI 10.1074/jbc.M207306200; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davis MI, 2014, J BIOL CHEM, V289, P13717, DOI 10.1074/jbc.M113.511030; Deechongkit S, 2004, ORG LETT, V6, P497, DOI 10.1021/ol036102m; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Geisbrecht BV, 1999, J BIOL CHEM, V274, P30527, DOI 10.1074/jbc.274.43.30527; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Jin GL, 2013, CANCER RES, V73, P496, DOI 10.1158/0008-5472.CAN-12-2852; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Liu RC, 2009, TETRAHEDRON LETT, V50, P4046, DOI 10.1016/j.tetlet.2009.04.097; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Popovici-Muller J., 2012, Preparation of Cycloalkylheteroarylacetylphenylaminopheny-lacetamide Derivatives and Analogs for Use as Antitumor Agents, Patent No. [WO 2012009678A1, 2012009678]; Popovici-Muller J, 2012, ACS MED CHEM LETT, V3, P850, DOI 10.1021/ml300225h; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Segel IH, 1975, ENZYME KINETICS BEHA; Soundar S, 1996, PROTEIN EXPRES PURIF, V8, P305, DOI 10.1006/prep.1996.0105; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Thol F, 2010, BLOOD, V116, P614, DOI 10.1182/blood-2010-03-272146; Wagner K, 2010, J CLIN ONCOL, V28, P2356, DOI 10.1200/JCO.2009.27.6899; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; YAN JM, 1994, SYNTHETIC COMMUN, V24, P47, DOI 10.1080/00397919408012624; Yang B, 2010, CELL RES, V20, P1188, DOI 10.1038/cr.2010.145; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zheng BS, 2013, ACS MED CHEM LETT, V4, P542, DOI 10.1021/ml400036z	37	96	103	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					762	774		10.1074/jbc.M114.608497	http://dx.doi.org/10.1074/jbc.M114.608497			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25391653	hybrid, Green Published			2022-12-28	WOS:000347778200007
J	Ermolova, N; Kramerova, I; Spencer, MJ				Ermolova, Natalia; Kramerova, Irina; Spencer, Melissa J.			Autolytic Activation of Calpain 3 Proteinase Is Facilitated by Calmodulin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; MUSCLE-SPECIFIC CALPAIN; CRYSTAL-STRUCTURE; IN-VIVO; P94; MUTATIONS; EXPRESSION; DOMAIN; 2A	Calpains are broadly distributed, calcium-dependent enzymes that induce limited proteolysis in a wide range of substrates. Mutations in the gene encoding the muscle-specific family member calpain 3 (CAPN3) underlie limb-girdle muscular dystrophy 2A. We have shown previously that CAPN3 knockout muscles exhibit attenuated calcium release, reduced calmodulin kinase (CaMKII) signaling, and impaired muscle adaptation to exercise. However, neither the precise role of CAPN3 in these processes nor the mechanisms of CAPN3 activation in vivo have been fully elucidated. In this study, we identify calmodulin (CaM), a known transducer of the calcium signal, as the first positive regulator of CAPN3 autolytic activity. CaM was shown to bind CAPN3 at two sites located in the C2L domain. Biochemical studies using muscle extracts from transgenic mice overexpressing CAPN3 or its inactive mutant revealed that CaM binding enhanced CAPN3 autolytic activation. Furthermore, CaM facilitated CAPN3-mediated cleavage of its in vivo substrate titin in tissue extracts. Therefore, these studies reveal a novel interaction between CAPN3 and CaM and identify CaM as the first positive regulator of CAPN3 activity.	Univ Calif Los Angeles, Dept Neurol, Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Ctr Duchenne Muscular Dystrophy, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Spencer, MJ (corresponding author), Univ Calif Los Angeles, Dept Neurol, Neurosci Res Bldg,635 Charles Young Dr S, Los Angeles, CA 90095 USA.	mspencer@mednet.ucla.edu			NIAMS/National Institutes of Health [U54AR052646, 2RO1AR048177, 2 P30 AR057230-06]; Muscular Dystrophy Association of America [MDA241489]; Coalition to Cure Calpain 3; Crystal Ball Fund; My Directives; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048177, P30AR057230, U54AR052646] Funding Source: NIH RePORTER	NIAMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Muscular Dystrophy Association of America(Muscular Dystrophy Association); Coalition to Cure Calpain 3; Crystal Ball Fund; My Directives; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported, in whole or in part, by NIAMS/National Institutes of Health GrantsU54AR052646, 2RO1AR048177, and 2 P30 AR057230-06 (to M. S.). This work was also supported by Muscular Dystrophy Association of America Grant MDA241489 (to M. S.), by the Coalition to Cure Calpain 3, by the Crystal Ball Fund, and by My Directives.	Anderson LVB, 1998, AM J PATHOL, V153, P1169, DOI 10.1016/S0002-9440(10)65661-1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Bossuyt J, 2013, J MOL MED, V91, P907, DOI 10.1007/s00109-013-1060-y; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; Diaz BEG, 2006, BIOCHEMISTRY-US, V45, P3714, DOI 10.1021/bi051917j; Ermolova N, 2011, HUM MOL GENET, V20, P3331, DOI 10.1093/hmg/ddr239; Fanin M, 2003, AM J PATHOL, V163, P1929, DOI 10.1016/S0002-9440(10)63551-1; Garnham CP, 2009, BIOCHEMISTRY-US, V48, P3457, DOI 10.1021/bi900130u; Garvey SM, 2002, GENOMICS, V79, P146, DOI 10.1006/geno.2002.6685; Gautel M, 2011, PFLUG ARCH EUR J PHY, V462, P119, DOI 10.1007/s00424-011-0946-1; Hanna RA, 2007, FEBS LETT, V581, P2894, DOI 10.1016/j.febslet.2007.05.035; Haravuori H, 2001, NEUROLOGY, V56, P869, DOI 10.1212/WNL.56.7.869; Huebsch KA, 2005, HUM MOL GENET, V14, P2801, DOI 10.1093/hmg/ddi313; Jia ZC, 2001, BIOPHYS J, V80, P2590, DOI 10.1016/S0006-3495(01)76229-7; Jia Zongchao, 2002, Methods Mol Biol, V172, P51; Kichard I., 1999, AM J HUM GENET, V64, P1524; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kinbara K, 1998, BIOCHEM J, V335, P589, DOI 10.1042/bj3350589; Kramerova I, 2007, HUM MOL GENET, V16, P1006, DOI 10.1093/hmg/ddm044; Kramerova I, 2005, HUM MOL GENET, V14, P2125, DOI 10.1093/hmg/ddi217; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kramerova I, 2012, HUM MOL GENET, V21, P3193, DOI 10.1093/hmg/dds144; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ono Y, 2013, J MOL BIOL, V425, P2955, DOI 10.1016/j.jmb.2013.05.009; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Partha SK, 2014, FEBS J, V281, P3138, DOI 10.1111/febs.12849; PEITSCH MC, 1995, TRENDS BIOCHEM SCI, V20, P82, DOI 10.1016/S0968-0004(00)88963-X; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Ravulapalli R, 2005, BIOCHEM J, V388, P585, DOI 10.1042/BJ20041821; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Spencer MJ, 2002, P NATL ACAD SCI USA, V99, P8874, DOI 10.1073/pnas.132269299	36	12	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					996	1004		10.1074/jbc.M114.588780	http://dx.doi.org/10.1074/jbc.M114.588780			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25389288	Green Published, hybrid			2022-12-28	WOS:000347778200033
J	Kiesel, S; Watzlich, D; Lange, C; Reijerse, E; Brocker, MJ; Rudiger, W; Lubitz, W; Scheer, H; Moser, J; Jahn, D				Kiesel, Svenja; Waetzlich, Denise; Lange, Christiane; Reijerse, Edward; Broecker, Markus J.; Ruediger, Wolfhart; Lubitz, Wolfgang; Scheer, Hugo; Moser, Juergen; Jahn, Dieter			Iron-Sulfur Cluster-dependent Catalysis of Chlorophyllide a Oxidoreductase from Roseobacter denitrificans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATIVE PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; ELECTRON-PARAMAGNETIC-RES; BACTERIOCHLOROPHYLL BIOSYNTHESIS; AZOTOBACTER-VINELANDII; FE PROTEIN; NITROGENASE; REDUCTASE; SUBSTRATE; PURIFICATION; RECONSTITUTION	Bacteriochlorophyll a biosynthesis requires the stereo-and regiospecific two electron reduction of the C7-C8 double bond of chlorophyllide a by the nitrogenase-like multisubunit metalloenzyme, chlorophyllide a oxidoreductase (COR). ATP-dependent COR catalysis requires interaction of the protein subcomplex (BchX)(2) with the catalytic (BchY/BchZ)(2) protein to facilitate substrate reduction via two redox active iron-sulfur centers. The ternary COR enzyme holocomplex comprising subunits BchX, BchY, and BchZ from the purple bacterium Roseobacter denitrificans was trapped in the presence of the ATP transition state analog ADP.AlF4-. Electron paramagnetic resonance experiments revealed a [4Fe-4S] cluster of subcomplex (BchX)(2). Asecond [4Fe-4S] cluster was identified on (BchY/BchZ)(2). Mutagenesis experiments indicated that the latter is ligated by four cysteines, which is in contrast to the three cysteine/ one aspartate ligation pattern of the closely related darkoperative protochlorophyllide a oxidoreductase (DPOR). In subsequent mutagenesis experiments a DPOR-like aspartate ligation pattern was implemented for the catalytic [4Fe-4S] cluster of COR. Artificial cluster formation for this inactive COR variant was demonstrated spectroscopically. A series of chemically modified substrate molecules with altered substituents on the individual pyrrole rings and the isocyclic ring were tested as COR substrates. The COR enzyme was still able to reduce the B ring of substrates carrying modified substituents on ring systems A, C, and E. However, substrates with a modification of the distantly located propionate side chain were not accepted. A tentative substrate binding mode was concluded in analogy to the related DPOR system.	[Kiesel, Svenja; Waetzlich, Denise; Lange, Christiane; Moser, Juergen; Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Reijerse, Edward; Lubitz, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany; [Broecker, Markus J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Ruediger, Wolfhart; Scheer, Hugo] Univ Munich, Dept Biol 1, D-80638 Munich, Germany	Braunschweig University of Technology; Max Planck Society; Yale University; University of Munich	Moser, J (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	j.moser@tu-bs.de		Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft [JA 470/9-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant JA 470/9-2.	BIEL AJ, 1983, J BACTERIOL, V156, P686, DOI 10.1128/JB.156.2.686-694.1983; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; BRODY SS, 1968, BIOPHYS J, V8, P210, DOI 10.1016/S0006-3495(68)86486-0; Brocker MJ, 2008, J BIOL CHEM, V283, P29873, DOI 10.1074/jbc.M805206200; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; Broecker MJ, 2010, J BIOL CHEM, V285, P27336, DOI 10.1074/jbc.M110.126698; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; BURKE DH, 1993, J BACTERIOL, V175, P2407, DOI 10.1128/JB.175.8.2407-2413.1993; Busch AWU, 2011, BIOCHEM J, V439, P257, DOI 10.1042/BJ20110814; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; CONOVER RC, 1990, J BIOL CHEM, V265, P8533; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V64, P823, DOI 10.1111/j.1751-1097.1996.tb01842.x; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; FUJITA Y, 1993, PLANT CELL PHYSIOL, V34, P305; Gough SP, 2007, PLANT PHYSIOL BIOCH, V45, P932, DOI 10.1016/j.plaphy.2007.09.001; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GRIFFITHS WT, 1980, BIOCHEM J, V186, P267, DOI 10.1042/bj1860267; Guigliarelli B, 1999, ADV INORG CHEM, V47, P421, DOI 10.1016/S0898-8838(08)60084-7; HAGEN WR, 1985, FEBS LETT, V189, P250, DOI 10.1016/0014-5793(85)81033-4; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; HELFRICH M, 1994, EUR J BIOCHEM, V219, P267, DOI 10.1111/j.1432-1033.1994.tb19938.x; HENDRY GAF, 1987, NEW PHYTOL, V107, P255, DOI 10.1111/j.1469-8137.1987.tb00181.x; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Hu YL, 2011, COORDIN CHEM REV, V255, P1218, DOI 10.1016/j.ccr.2010.11.018; Huberman A, 2002, ANAL BIOCHEM, V307, P375, DOI 10.1016/S0003-2697(02)00047-7; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Jung YS, 2000, J BIOL CHEM, V275, P36974, DOI 10.1074/jbc.M004947200; Kim EJ, 2008, J BIOL CHEM, V283, P3718, DOI 10.1074/jbc.M707774200; Klement H, 1999, EUR J BIOCHEM, V265, P862, DOI 10.1046/j.1432-1327.1999.00627.x; Kondo T, 2011, FEBS LETT, V585, P214, DOI 10.1016/j.febslet.2010.11.044; Kurnikov IV, 2001, J PHYS CHEM B, V105, P5359, DOI 10.1021/jp002540o; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latimer MT, 1996, J BIOL CHEM, V271, P24023, DOI 10.1074/jbc.271.39.24023; LINDAHL PA, 1985, J BIOL CHEM, V260, P1160; MAY HD, 1991, BIOCHEM J, V277, P457, DOI 10.1042/bj2770457; MCFEETERS RF, 1971, PLANT PHYSIOL, V47, P609, DOI 10.1104/pp.47.5.609; Moser J, 2013, P NATL ACAD SCI USA, V110, P2094, DOI 10.1073/pnas.1218303110; Mouesca JM, 1998, COORDIN CHEM REV, V178, P1573, DOI 10.1016/S0010-8545(98)00155-6; Muraki N, 2010, NATURE, V465, P110, DOI 10.1038/nature08950; Nomata J, 2005, BBA-BIOENERGETICS, V1708, P229, DOI 10.1016/j.bbabio.2005.02.002; Nomata J, 2006, FEBS LETT, V580, P6151, DOI 10.1016/j.febslet.2006.10.014; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Nomata J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05455; ONATE YA, 1993, BIOCHIM BIOPHYS ACTA, V1164, P113, DOI 10.1016/0167-4838(93)90237-L; Rudiger W, 2005, BIOCHEMISTRY-US, V44, P10864, DOI 10.1021/bi0504198; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schmid B, 2002, BIOCHEMISTRY-US, V41, P15557, DOI 10.1021/bi026642b; Shen G, 2007, J BIOL CHEM, V282, P31909, DOI 10.1074/jbc.M705554200; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; Tsukatani Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01217; Watzlich D, 2009, J BIOL CHEM, V284, P15530, DOI 10.1074/jbc.M901331200; WHERLAND S, 1981, BIOCHEMISTRY-US, V20, P5132, DOI 10.1021/bi00521a006; Wiig JA, 2011, METHODS MOL BIOL, V766, P93, DOI 10.1007/978-1-61779-194-9_7	56	14	14	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1141	1154		10.1074/jbc.M114.617761	http://dx.doi.org/10.1074/jbc.M114.617761			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25422320	hybrid, Green Published			2022-12-28	WOS:000347778200045
J	Yang, SG; Wang, YY; Mei, KR; Zhang, S; Sun, XJ; Ren, FL; Liu, SH; Yang, Z; Wang, XQ; Qin, ZH; Chang, ZJ				Yang, Shigao; Wang, Yinyin; Mei, Kunrong; Zhang, Sen; Sun, Xiaojun; Ren, Fangli; Liu, Sihan; Yang, Zi; Wang, Xinquan; Qin, Zhihai; Chang, Zhijie			Tumor Necrosis Factor Receptor 2 (TNFR2)center dot Interleukin-17 Receptor D (IL-17RD) Heteromerization Reveals a Novel Mechanism for NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF RECEPTOR; LIGAND; KIDNEY; CELLS; HSEF; SEF; LOCALIZATION; EXPRESSION; APOPTOSIS; ALPHA	TNF receptor 2 (TNFR2) exerts diverse roles in the pathogenesis of inflammatory and autoimmune diseases. Here, we report that TNFR2 but not TNFR1 forms a heteromer with interleukin-17 receptor D (IL-17RD), also named Sef, to activate NF-kappa B signaling. TNFR2 associates with IL-17RD, leading to mutual receptor aggregation and TRAF2 recruitment, which further activate the downstream cascade of NF-kappa B signaling. Depletion of IL-17RD impaired TNFR2-mediated activation of NF-kappa B signaling. Importantly, IL-17RD was markedly increased in renal tubular epithelial cells in nephritis rats, and a strong interaction of TNFR2 and IL-17RD was observed in the renal epithelia. The IL-17RD center dot TNFR2 complex in activation of NF-kappa B may explain the role of TNFR2 in inflammatory diseases including nephritis.	[Yang, Shigao; Wang, Yinyin; Sun, Xiaojun; Ren, Fangli; Liu, Sihan; Yang, Zi; Chang, Zhijie] Tsinghua Univ, Sch Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Yang, Shigao; Wang, Yinyin; Sun, Xiaojun; Ren, Fangli; Liu, Sihan; Yang, Zi; Chang, Zhijie] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China; [Yang, Shigao] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China; [Mei, Kunrong; Wang, Xinquan] Tsinghua Univ, Struct Biol Ctr, Sch Life Sci, Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Zhang, Sen] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Zhang, Sen] Peking Union Med Coll, Beijing 100050, Peoples R China; [Qin, Zhihai] Chinese Acad Sci, Key Lab Prot & Peptide Pharmaceut, Chinese Acad Sci Univ Tokyo Joint Lab Struct Viro, Inst Biophys, Beijing 100101, Peoples R China	Tsinghua University; Sichuan University; Chinese Academy of Sciences; Institute of Process Engineering, CAS; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chang, ZJ (corresponding author), Tsinghua Univ, Sch Med, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	zhijiec@tsinghua.edu.cn	SUN, XIAOJUN/I-8018-2014; Mei, Kunrong/F-4553-2019; Chang, Zhijie/AAH-8109-2019	SUN, XIAOJUN/0000-0003-3710-8560; Mei, Kunrong/0000-0001-7827-2944; Chang, Zhijie/0000-0003-1567-3227; Qin, Zhihai/0000-0001-9793-7964; Yang, Shigao/0000-0003-2717-6914	973 Project [2011CB910502]; National Natural Science Foundation of China [30871286, 31071225, 31030040, 91229203]; Tsinghua Science Foundation [20121080018]; Natural Science Foundation of Beijing [511003]; Major Program [2013ZX08011-006]; 863 project in China [2012AA021703]	973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua Science Foundation; Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Major Program; 863 project in China(National High Technology Research and Development Program of China)	This work was supported by grants from the 973 Project (2011CB910502), the National Natural Science Foundation of China (30871286, 31071225, 31030040, and 91229203), the Tsinghua Science Foundation (20121080018), the Natural Science Foundation of Beijing (511003), the Major Program (2013ZX08011-006), and the 863 project (2012AA021703) in China.	Ait-Ali D, 2008, ENDOCRINOLOGY, V149, P2840, DOI 10.1210/en.2007-1192; Akassoglou K, 2003, P NATL ACAD SCI USA, V100, P709, DOI 10.1073/pnas.0236046100; Al-Lamki RS, 2005, FASEB J, V19, P1637, DOI 10.1096/fj.05-3841com; Al-Lamki RS, 2001, LAB INVEST, V81, P1503, DOI 10.1038/labinvest.3780364; Aten J, 2000, J AM SOC NEPHROL, V11, P1426, DOI 10.1681/ASN.V1181426; Bruggeman LA, 2011, LAB INVEST, V91, P413, DOI 10.1038/labinvest.2010.199; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; de Haij S, 2005, J AM SOC NEPHROL, V16, P1603, DOI 10.1681/ASN.2004090781; Douni E, 1998, J EXP MED, V188, P1343, DOI 10.1084/jem.188.7.1343; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; Fuchs Y, 2012, DEV CELL, V23, P611, DOI 10.1016/j.devcel.2012.07.013; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Haridas V, 1998, J IMMUNOL, V160, P3152; Horiuchi T, 2007, ANN RHEUM DIS, V66, P320, DOI 10.1136/ard.2006.058917; Ozcan A, 2012, AM J NEPHROL, V35, P356, DOI 10.1159/000337918; Pinckard JK, 1997, J BIOL CHEM, V272, P10784; Ramesh G, 2003, AM J PHYSIOL-RENAL, V285, pF610, DOI 10.1152/ajprenal.00101.2003; Ren YM, 2008, CELL SIGNAL, V20, P518, DOI 10.1016/j.cellsig.2007.11.010; Ren YM, 2007, BIOCHEM BIOPH RES CO, V354, P741, DOI 10.1016/j.bbrc.2007.01.037; Rodriguez M, 2011, J BIOL CHEM, V286, P22814, DOI 10.1074/jbc.M111.225631; Rong ZL, 2009, CELL RES, V19, P208, DOI 10.1038/cr.2008.320; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vielhauer V, 2005, J CLIN INVEST, V115, P1199, DOI 10.1172/JCI200523348; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Xiong SQ, 2003, J BIOL CHEM, V278, P50273, DOI 10.1074/jbc.M306936200; Yang RB, 2003, J BIOL CHEM, V278, P33232, DOI 10.1074/jbc.M305022200; Zhang S, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/819296	30	20	21	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					861	871		10.1074/jbc.M114.586560	http://dx.doi.org/10.1074/jbc.M114.586560			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25378394	Green Published, hybrid			2022-12-28	WOS:000347778200016
J	Bradley, EW; Carpio, LR; Olson, EN; Westendorf, JJ				Bradley, Elizabeth W.; Carpio, Lomeli R.; Olson, Eric N.; Westendorf, Jennifer J.			Histone Deacetylase 7 (Hdac7) Suppresses Chondrocyte Proliferation and beta-Catenin Activity during Endochondral Ossification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-catenin (-catenin); Cartilage; Growth Plate; Histone Deacetylase (HDAC); Insulin; ATDC5 Cells; Histone Deacetylase 7 (Hdac7)	PROTEIN-KINASE-D; GROWTH-PLATE; ARTICULAR-CARTILAGE; NUCLEAR EXPORT; IN-VIVO; DIFFERENTIATION; HYPERTROPHY; EXPRESSION; OSTEOBLAST; MICE	Background: Hdac7 is a transcriptional co-repressor in skeletal tissues, but its role in chondrocytes is undefined. Results: Proteasomal degradation reduced Hdac7 levels during chondrogenic maturation and conditional deletion of Hdac7 in chondrocytes increased proliferation and -catenin levels. Conclusion: Hdac7 degradation enhances -catenin transcriptional activity in growth plate chondrocytes. Significance: Suppressing Hdac7 levels increases chondrocyte proliferation and promotes cartilage formation and regeneration. Histone deacetylases (Hdacs) regulate endochondral ossification by suppressing gene transcription and modulating cellular responses to growth factors and cytokines. We previously showed that Hdac7 suppresses Runx2 activity and osteoblast differentiation. In this study, we examined the role of Hdac7 in postnatal chondrocytes. Hdac7 was highly expressed in proliferating cells within the growth plate. Postnatal tissue-specific ablation of Hdac7 with a tamoxifen-inducible collagen type 2a1-driven Cre recombinase increased proliferation and -catenin levels in growth plate chondrocytes and expanded the proliferative zone. Similar results were obtained in primary chondrocyte cultures where Hdac7 was deleted with adenoviral-Cre. Hdac7 bound -catenin in proliferating chondrocytes, but stimulation of chondrocyte maturation promoted the translocation of Hdac7 to the cytoplasm where it was degraded by the proteasome. As a result, -catenin levels and transcription activity increased in the nucleus. These data demonstrate that Hdac7 suppresses proliferation and -catenin activity in chondrocytes. Reducing Hdac7 levels in early chondrocytes may promote the expansion and regeneration of cartilage tissues.	[Bradley, Elizabeth W.; Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Carpio, Lomeli R.] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA; [Westendorf, Jennifer J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Southwestern Medical Center Dallas	Westendorf, JJ (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu		Bradley, Elizabeth/0000-0002-8814-5524; Shull, Lomeli/0000-0001-7537-8516	National Institutes of Health [AR056950, AR61873, AR65397, GM055252]; MayoClinic; Mayo Graduate School; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056950, K01AR065397, F32AR061873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MayoClinic; Mayo Graduate School; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR056950, AR61873, AR65397, and GM055252, MayoClinic, and the Mayo Graduate School.	Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Bradley EW, 2013, J BIOL CHEM, V288, P9572, DOI 10.1074/jbc.M112.423723; Bradley EW, 2010, MOL ENDOCRINOL, V24, P1581, DOI 10.1210/me.2010-0037; Chagin AS, 2007, BONE, V40, P1415, DOI 10.1016/j.bone.2006.12.066; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen M, 2008, J CELL SCI, V121, P1455, DOI 10.1242/jcs.020362; Dao DY, 2012, J BONE MINER RES, V27, P1680, DOI 10.1002/jbmr.1639; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jensen ED, 2009, J BIOL CHEM, V284, P2225, DOI 10.1074/jbc.M800586200; Kolettas E, 2001, RHEUMATOLOGY, V40, P1146, DOI 10.1093/rheumatology/40.10.1146; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; McGee-Lawrence ME, 2013, BONE, V52, P296, DOI 10.1016/j.bone.2012.10.015; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Nixon AJ, 1999, J ORTHOPAED RES, V17, P475, DOI 10.1002/jor.1100170404; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Schmidt MB, 2006, OSTEOARTHR CARTILAGE, V14, P403, DOI 10.1016/j.joca.2005.10.011; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Staines KA, 2013, J ENDOCRINOL, V219, pR1, DOI 10.1530/JOE-13-0276; Talwar RM, 2006, J ORAL MAXIL SURG, V64, P600, DOI 10.1016/j.joms.2005.12.006; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang BL, 2014, ARTHRITIS RHEUMATOL, V66, P107, DOI 10.1002/art.38195; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Wang YM, 2011, J BONE MINER RES, V26, P1437, DOI 10.1002/jbmr.359; Yuasa T, 2009, AM J PATHOL, V175, P1993, DOI 10.2353/ajpath.2009.081173; Zhu M, 2008, ARTHRITIS RHEUM-US, V58, P2053, DOI 10.1002/art.23614; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	40	37	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					118	126		10.1074/jbc.M114.596247	http://dx.doi.org/10.1074/jbc.M114.596247			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25389289	Green Published, hybrid			2022-12-28	WOS:000347231200011
J	Lee, EF; Dewson, G; Evangelista, M; Pettikiriarachchi, A; Gold, GJ; Zhu, HR; Colman, PM; Fairlie, WD				Lee, Erinna F.; Dewson, Grant; Evangelista, Marco; Pettikiriarachchi, Anne; Gold, Grace J.; Zhu, Haoran; Colman, Peter M.; Fairlie, W. Douglas			The Functional Differences between Pro-survival and Pro-apoptotic B Cell Lymphoma 2 (Bcl-2) Proteins Depend on Structural Differences in Their Bcl-2 Homology 3 (BH3) Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PERMEABILIZATION; PEPTIDE COMPLEX; CRYSTAL-STRUCTURE; BH3-ONLY LIGANDS; FAMILY-MEMBERS; SWAPPED DIMER; HIGH-AFFINITY; X-RAY; BAX; MCL-1	Bcl-2 homology 3 (BH3) domains are short sequence motifs that mediate nearly all protein-protein interactions between B cell lymphoma 2 (Bcl-2) family proteins in the intrinsic apoptotic cell death pathway. These sequences are found on both prosurvival and pro-apoptotic members, although their primary function is believed to be associated with induction of cell death. Here, we identify critical features of the BH3 domains of prosurvival proteins that distinguish them functionally from their pro-apoptotic counterparts. Biochemical and x-ray crystallographic studies demonstrate that these differences reduce the capacity of most pro-survival proteins to form high affinity "BH3-in-groove" complexes that are critical for cell death induction. Switching these residues for the corresponding residues in Bcl-2 homologous antagonist/killer (Bak) increases the binding affinity of isolated BH3 domains for pro-survival proteins; however, their exchange in the context of the parental protein causes rapid proteasomal degradation due to protein destabilization. This is supported by further x-ray crystallographic studies that capture elements of this destabilization in one pro-survival protein, Bcl-w. In pro-apoptotic Bak, we demonstrate that the corresponding distinguishing residues are important for its cell-killing capacity and antagonism by prosurvival proteins.	[Lee, Erinna F.; Dewson, Grant; Evangelista, Marco; Pettikiriarachchi, Anne; Gold, Grace J.; Zhu, Haoran; Colman, Peter M.; Fairlie, W. Douglas] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Lee, Erinna F.; Dewson, Grant; Gold, Grace J.; Zhu, Haoran; Colman, Peter M.; Fairlie, W. Douglas] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Fairlie, WD (corresponding author), Walter & Eliza Hall Inst Med Res, Struct Biol Div, 1G Royal Pde, Parkville, Vic 3052, Australia.	fairlie@wehi.edu.au	Fairlie, Walter/M-8401-2015; Lee, Erinna/N-1523-2015; dewson, grant/C-7646-2013	Fairlie, Walter/0000-0002-2498-1160; Lee, Erinna/0000-0003-1255-9808; dewson, grant/0000-0003-4251-8898	National Health and Medical Research Council (NHMRC) of Australia [1016701, 1041936, 1008329, 1024620, SPRF 1022618]; Australian Research Council Fellowship [FT100100791]; Cancer Council of Victoria [1057949]; NHMRC IRIISS Grant [361646]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Fellowship(Australian Research Council); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NHMRC IRIISS Grant(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants and fellowships from the National Health and Medical Research Council (NHMRC) of Australia (Program Grant 1016701 (to P. M. C.), Project Grants 1041936 and 1008329 (to W. D. F. and P. M. C.), Career Development Fellowship 1024620 (to E. F. L.), and SPRF 1022618 (to P. M. C.)), Australian Research Council Fellowship FT100100791 (to G. D.), and Cancer Council of Victoria Grant-in-aid 1057949. Infrastructure support was provided by NHMRC IRIISS Grant 361646 and the Victorian State Government OIS grant.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bingle CD, 2000, J BIOL CHEM, V275, P22136, DOI 10.1074/jbc.M909572199; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Brouwer JM, 2014, MOL CELL, V55, P938, DOI 10.1016/j.molcel.2014.07.016; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chang BS, 1999, MOL CELL BIOL, V19, P6673; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen TS, 2013, J MOL BIOL, V425, P171, DOI 10.1016/j.jmb.2012.11.009; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; CLARKE MF, 1995, P NATL ACAD SCI USA, V92, P11024, DOI 10.1073/pnas.92.24.11024; Cosulich SC, 1997, CURR BIOL, V7, P913, DOI 10.1016/S0960-9822(06)00410-6; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Denisov AY, 2003, J BIOL CHEM, V278, P21124, DOI 10.1074/jbc.M301798200; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Dutta S, 2013, ACS CHEM BIOL, V8, P778, DOI 10.1021/cb300679a; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foight GW, 2014, ACS CHEM BIOL, V9, P1962, DOI 10.1021/cb500340w; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Hinds MG, 2003, EMBO J, V22, P1497, DOI 10.1093/emboj/cdg144; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Ku B, 2011, CELL RES, V21, P627, DOI 10.1038/cr.2010.149; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Lee EF, 2008, J CELL BIOL, V180, P341, DOI 10.1083/jcb.200708096; Lee EF, 2011, STRUCTURE, V19, P1467, DOI 10.1016/j.str.2011.07.015; Lee EF, 2009, ANGEW CHEM INT EDIT, V48, P4318, DOI 10.1002/anie.200805761; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindenboim L, 2005, CELL DEATH DIFFER, V12, P713, DOI 10.1038/sj.cdd.4401638; Lindenboim L, 2001, CELL DEATH DIFFER, V8, P933, DOI 10.1038/sj.cdd.4400888; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Ma S, 2013, J BIOL CHEM, V288, P26027, DOI 10.1074/jbc.M113.490094; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Minn AJ, 1996, J BIOL CHEM, V271, P6306, DOI 10.1074/jbc.271.11.6306; Mitra RS, 2001, NEOPLASIA, V3, P437, DOI 10.1038/sj.neo.7900181; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Ofengeim D, 2012, NAT NEUROSCI, V15, P574, DOI 10.1038/nn.3054; Oh KJ, 2006, J BIOL CHEM, V281, P36999, DOI 10.1074/jbc.M602341200; Oh KJ, 2010, J BIOL CHEM, V285, P28924, DOI 10.1074/jbc.M110.135293; Otwinowski Z, 1997, METHODS ENZYMOL, V276, P307; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Smith BJ, 2013, CHEMBIOCHEM, V14, P1564, DOI 10.1002/cbic.201300351; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Weber A, 2013, APOPTOSIS, V18, P1093, DOI 10.1007/s10495-013-0868-9; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	73	27	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36001	36017		10.1074/jbc.M114.610758	http://dx.doi.org/10.1074/jbc.M114.610758			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25371206	hybrid, Green Published			2022-12-28	WOS:000346897900030
J	Tucker, AC; Taylor, KC; Rank, KC; Rayment, I; Escalante-Semerena, JC				Tucker, Alex C.; Taylor, Keenan C.; Rank, Katherine C.; Rayment, Ivan; Escalante-Semerena, Jorge C.			Insights into the Specificity of Lysine Acetyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA SYNTHETASE; PROTEIN ACETYLTRANSFERASE; SUBSTRATE-SPECIFICITY; COENZYME-A; IDENTIFICATION; DEACETYLATION; RECOGNITION; VECTORS; HISTONE; CLUSPRO	Reversible lysine acetylation by protein acetyltransferases is a conserved regulatory mechanism that controls diverse cellular pathways. Gcn5-related N-acetyltransferases (GNATs), named after their founding member, are found in all domains of life. GNATs are known for their role as histone acetyltransferases, but non-histone bacterial protein acetytransferases have been identified. Only structures of GNAT complexes with short histone peptide substrates are available in databases. Given the biological importance of this modification and the abundance of lysine in polypeptides, how specificity is attained for larger protein substrates is central to understanding acetyl-lysine-regulated networks. Here we report the structure of a GNAT in complex with a globular protein substrate solved to 1.9 angstrom. GNAT binds the protein substrate with extensive surface interactions distinct from those reported for GNAT-peptide complexes. Our data reveal determinants needed for the recognition of a protein substrate and provide insight into the specificity of GNATs.	[Tucker, Alex C.; Escalante-Semerena, Jorge C.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Taylor, Keenan C.; Rank, Katherine C.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University System of Georgia; University of Georgia; University of Wisconsin System; University of Wisconsin Madison	Escalante-Semerena, JC (corresponding author), Univ Georgia, Dept Microbiol, 212C Biol Sci Bldg,120 Cedar St, Athens, GA 30602 USA.	jcescala@uga.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083987, T32GM007215, R01GM062203] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Simon Dove for plasmids and strains. Part of the results shown in this report were obtained at the Argonne National Laboratory Structural Biology Center at the Advanced Photon Source. The University of Chicago Argonne, LLC operates Argonne National Laboratory for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERKOWIT.D, 1968, J BACTERIOL, V96, P215, DOI 10.1128/JB.96.1.215-220.1968; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Castang S, 2010, MOL MICROBIOL, V78, P916, DOI 10.1111/j.1365-2958.2010.07378.x; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Crosby HA, 2014, J BACTERIOL, V196, P1496, DOI 10.1128/JB.00004-14; Crosby HA, 2012, J BIOL CHEM, V287, P41392, DOI 10.1074/jbc.M112.417360; Crosby HA, 2012, J BIOL CHEM, V287, P15590, DOI 10.1074/jbc.M112.352104; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; Elion E. A., 2007, CURRENT PROTOCOLS MO; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedmann DR, 2013, FEBS J, V280, P5570, DOI 10.1111/febs.12373; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Griffith KL, 2002, BIOCHEM BIOPH RES CO, V290, P397, DOI 10.1006/bbrc.2001.6152; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Rayment I, 2002, STRUCTURE, V10, P147, DOI 10.1016/S0969-2126(02)00711-6; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Sasse J., 1991, CURRENT PROTOCOLS MO; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Thao S, 2011, CURR OPIN MICROBIOL, V14, P200, DOI 10.1016/j.mib.2010.12.013; Tucker AC, 2013, MOL MICROBIOL, V87, P152, DOI 10.1111/mmi.12088; Tucker AC, 2010, J BACTERIOL, V192, P6200, DOI 10.1128/JB.00874-10; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181	45	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36249	36262		10.1074/jbc.M114.613901	http://dx.doi.org/10.1074/jbc.M114.613901			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25381442	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000346897900049
J	Zhao, BZ; Shah, P; Budanov, AV; Qiang, L; Ming, M; Aplin, A; Sims, DM; He, YY				Zhao, Baozhong; Shah, Palak; Budanov, Andrei V.; Qiang, Lei; Ming, Mei; Aplin, Andrew; Sims, Diane M.; He, Yu-Ying			Sestrin2 Protein Positively Regulates AKT Enzyme Signaling and Survival in Human Squamous Cell Carcinoma and Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; P53 TUMOR-SUPPRESSOR; DNA-DAMAGE; GENOTOXIC STRESS; NRF2; SKIN; MUTATIONS; APOPTOSIS; AUTOPHAGY; TARGET	Skin cancer is the most common cancer in the United States and is mainly caused by environmental UV radiation. Reducing skin cancer incidence is becoming an urgent issue. The stress-inducible protein Sestrin2 (Sesn2) plays an important role in maintaining redox and metabolic homeostasis and their related pathologies. However, the role of Sesn2 in cancer remains unclear. Here we show that UVB radiation induces Sesn2 expression in normal human keratinocytes, mouse skin, normal human melanocytes, and melanoma cells. In addition, Sesn2 promotes AKT activation through a PTEN-dependent mechanism. Sesn2 deletion or knockdown sensitizes squamous cell carcinoma (SCC) cells to 5-fluorouracil-induced apoptosis and melanoma cells to UVB- and vemurafenib-induced apoptosis. In mice Sesn2 knockdown suppresses tumor growth from injected human SCC and melanoma cells. Last, as compared with normal skin, Sesn2 is up-regulated in both human skin SCC and melanoma. Our findings demonstrate that Sesn2 promotes AKT activation and survival in response to UVB stress and chemotherapeutics and suggest that Sesn2 is oncogenic in skin SCC and melanoma.	[Zhao, Baozhong; Shah, Palak; Qiang, Lei; Ming, Mei; Sims, Diane M.; He, Yu-Ying] Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA; [Budanov, Andrei V.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Aplin, Andrew] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; [Aplin, Andrew] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA	University of Chicago; Virginia Commonwealth University; Jefferson University; Jefferson University	He, YY (corresponding author), Univ Chicago, Dept Med, Dermatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu	Budanov, Andrei V/HGD-5487-2022; Qiang, Lei/B-2763-2012	Budanov, Andrei V/0000-0002-7943-1000; Qiang, Lei/0000-0002-7164-3164	National Institutes of Health (NIEHS) [ES016936]; National Institutes of Health (NCI) [CA172660]; National Institutes of Health (NIGMS) [GM067983]; National Institutes of Health (University of Chicago Cancer Research Center) [P30 CA014599]; National Institutes of Health [UL1 TR000430]; American Cancer Society Grant [RSG-13-078-01]; University of Chicago Friends of Dermatology Endowment Fund; NATIONAL CANCER INSTITUTE [R01CA172660, P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016936] Funding Source: NIH RePORTER	National Institutes of Health (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (University of Chicago Cancer Research Center); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Grant(American Cancer Society); University of Chicago Friends of Dermatology Endowment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES016936 (NIEHS; to Y.-Y. H.), CA172660 (NCI; to A. B.), GM067983 (NIGMS; to A. A.), P30 CA014599 (University of Chicago Cancer Research Center, and UL1 TR000430 (Clinical and Translational Science Award). This work was also supported by American Cancer Society Grant RSG-13-078-01 (to Y.-Y. H.) and the University of Chicago Friends of Dermatology Endowment Fund.	Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Ben-Sahra I, 2013, CELL DEATH DIFFER, V20, P611, DOI 10.1038/cdd.2012.157; Budanou AV, 2010, EMBO MOL MED, V2, P388, DOI 10.1002/emmm.201000097; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2011, ANTIOXID REDOX SIGN, V15, P1679, DOI 10.1089/ars.2010.3530; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Cam M, 2014, J BIOL CHEM, V289, P4083, DOI 10.1074/jbc.M113.530303; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Claerhout S, 2010, INT J CANCER, V127, P2790, DOI 10.1002/ijc.25300; D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Han WN, 2012, J BIOL CHEM, V287, P18788, DOI 10.1074/jbc.M112.363614; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018; Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Lee SO, 2012, ONCOGENE, V31, P3265, DOI 10.1038/onc.2011.504; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Marionnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012059; Ming M, 2011, CANCER RES, V71, P5287, DOI 10.1158/0008-5472.CAN-10-4614; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; Miura S, 2014, J INVEST DERMATOL, V134, P553, DOI 10.1038/jid.2013.343; Qiang L, 2014, AUTOPHAGY, V10, P1864, DOI 10.4161/auto.32171; Qiang L, 2013, J BIOL CHEM, V288, P1603, DOI 10.1074/jbc.M112.415224; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Ragnarsson G, 1999, BRIT J CANCER, V79, P1468, DOI 10.1038/sj.bjc.6690234; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sanli T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032035; Schwab M, 1996, GENE CHROMOSOME CANC, V16, P211, DOI 10.1002/(SICI)1098-2264(199608)16:4<211::AID-GCC1>3.0.CO;2-0; Shao YP, 2010, CANCER RES, V70, P6670, DOI 10.1158/0008-5472.CAN-09-4471; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu CL, 2013, ONCOGENE, V32, P2682, DOI 10.1038/onc.2012.279; Yang YL, 2013, EXP GERONTOL, V48, P371, DOI 10.1016/j.exger.2012.12.011	40	36	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35806	35814		10.1074/jbc.M114.595397	http://dx.doi.org/10.1074/jbc.M114.595397			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378405	Green Published, hybrid			2022-12-28	WOS:000346897900012
J	Long, J; Li, B; Rodriguez-Blanco, J; Pastori, C; Volmar, CH; Wahlestedt, C; Capobianco, A; Bai, F; Pei, XH; Ayad, NG; Robbins, DJ				Long, Jun; Li, Bin; Rodriguez-Blanco, Jezabel; Pastori, Chiara; Volmar, Claude-Henry; Wahlestedt, Claes; Capobianco, Anthony; Bai, Feng; Pei, Xin-Hai; Ayad, Nagi G.; Robbins, David J.			The BET Bromodomain Inhibitor I-BET151 Acts Downstream of Smoothened Protein to Abrogate the Growth of Hedgehog Protein-driven Cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bromodomain-containing Protein 4 (BRD4); Drug Screening; Epigenetics; Hedgehog Signaling Pathway; Medulloblastoma; Gli; I-BET151	MEDULLOBLASTOMA; PATHWAY; EPIGENETICS; ACTIVATION; SUPPRESSOR; CHROMATIN; BRAIN	Epigenetic enzymes modulate signal transduction pathways in different biological contexts. We reasoned that epigenetic regulators might modulate the Hedgehog (HH) signaling pathway, a main driver of cell proliferation in various cancers including medulloblastoma. To test this hypothesis, we performed an unbiased small-molecule screen utilizing an HH-dependent reporter cell line (Light2 cells). We incubated Light2 cells with small molecules targeting different epigenetic modulators and identified four histone deacetylase inhibitors and a bromodomain and extra terminal domain (BET) protein inhibitor (I-BET151) that attenuate HH activity. I-BET151 was also able to inhibit the expression of HH target genes in Sufu(-/-) mouse embryonic fibroblasts, in which constitutive Gli activity is activated in a Smoothened (Smo)-independent fashion, consistent with it acting downstream of Smo. Knockdown of Brd4 (which encodes one of the BET proteins) phenocopies I-BET151 treatment, suggesting that Brd4 is a regulator of the HH signaling pathway. Consistent with this suggestion, Brd4 associates with the proximal promoter region of the Gli1 locus, and does so in a manner that can be reversed by I-BET151. Importantly, I-BET151 also suppressed the HH activity-dependent growth of medulloblastoma cells, in vitro and in vivo. These studies suggest that BET protein modulation may be an attractive therapeutic strategy for attenuating the growth of HH-dependent cancers, such as medulloblastoma.	[Long, Jun; Li, Bin; Rodriguez-Blanco, Jezabel; Capobianco, Anthony; Bai, Feng; Pei, Xin-Hai; Robbins, David J.] Univ Miami, Miller Sch Med, DeWitt Daughtry Family Dept Surg, Mol Oncol Program, Miami, FL 33136 USA; [Pastori, Chiara; Volmar, Claude-Henry; Wahlestedt, Claes; Ayad, Nagi G.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Ctr Therapeut Innovat, Miami, FL 33136 USA; [Wahlestedt, Claes; Capobianco, Anthony; Pei, Xin-Hai; Ayad, Nagi G.; Robbins, David J.] Univ Miami, Sylvester Canc Ctr, Miami, FL 33136 USA; [Capobianco, Anthony; Robbins, David J.] Univ Miami, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Ayad, NG (corresponding author), Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Ctr Therapeut Innovat,LPLC, 1095 NW 14th Terrace,R48, Miami, FL 33136 USA.	nayad@med.miami.edu; drobbins@med.miami.edu	Long, Jun/S-2382-2019; Volmar, C H/AFR-7749-2022; LONG, JUN/N-7270-2015; Rodriguez, Jezabel/B-7613-2019	Long, Jun/0000-0002-8229-9653; Volmar, C H/0000-0001-9437-051X; Rodriguez, Jezabel/0000-0003-1839-6181; Li, Bin/0000-0001-9341-4672; pei, xin-hai/0000-0001-6441-1691	National Institutes of Health [RO1CA082628, RO1NS067289]; NATIONAL CANCER INSTITUTE [R01CA082628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA082628 (to D. J. R.) and RO1NS067289 (to N. G. A.).	Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Arzate-Mejia RG, 2011, IUBMB LIFE, V63, P881, DOI 10.1002/iub.557; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281; Batora NV, 2014, NEUROSCIENCE, V264, P171, DOI 10.1016/j.neuroscience.2013.07.030; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Chaidos A, 2014, BLOOD, V123, P697, DOI 10.1182/blood-2013-01-478420; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gilbertson RJ, 2004, LANCET ONCOL, V5, P209, DOI 10.1016/S1470-2045(04)01424-X; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Henssen A, 2013, ONCOTARGET, V4, DOI 10.18632/oncotarget.1534; Itzen F, 2014, NUCLEIC ACIDS RES, V42, P7577, DOI 10.1093/nar/gku449; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Lee SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071455; Lin TL, 2012, ONCOTARGETS THER, V5, P47, DOI 10.2147/OTT.S21957; Malatesta M, 2013, CANCER RES, V73, P6323, DOI 10.1158/0008-5472.CAN-12-4660; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Pastori C, 2014, EPIGENETICS-US, V9, P611, DOI 10.4161/epi.27906; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Singh S, 2009, HUM GENET, V125, P95, DOI 10.1007/s00439-008-0599-0; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tang YJ, 2014, NAT MED, V20, P732, DOI 10.1038/nm.3613; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Venkataraman S, 2014, ONCOTARGET, V5, P2355; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Weaver KL, 2014, CANCER RES, V74, P4741, DOI 10.1158/0008-5472.CAN-14-1547; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	37	86	89	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35494	35502		10.1074/jbc.M114.595348	http://dx.doi.org/10.1074/jbc.M114.595348			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25355313	hybrid, Green Published			2022-12-28	WOS:000346660200038
J	Lewis, BA; Hanover, JA				Lewis, Brian A.; Hanover, John A.			O-GlcNAc and the Epigenetic Regulation of Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Epigenetics; Glycobiology; O-GlcNAcylation; Polycomb; RNA Polymerase II; Signaling; Histones; O-GlcNAc; Transcription	RNA-POLYMERASE-II; CARBOXYL-TERMINAL DOMAIN; N-ACETYLGLUCOSAMINE TRANSFERASE; TRITHORAX-GROUP PROTEIN; EMBRYONIC STEM-CELLS; HISTONE H3; TETRATRICOPEPTIDE REPEATS; TYROSINE PHOSPHORYLATION; TRANSCRIPTION ELONGATION; MESSENGER-RNA	O-GlcNAcylation is an abundant nutrient-driven modification linked to cellular signaling and regulation of gene expression. Utilizing precursors derived from metabolic flux, O-GlcNAc functions as a homeostatic regulator. The enzymes of O-GlcNAc cycling, OGT and O-GlcNAcase, act in mitochondria, the cytoplasm, and the nucleus in association with epigenetic writers and erasers of the histone code. Both O-GlcNAc and O-phosphate modify repeats within the RNA polymerase II C-terminal domain (CTD). By communicating with the histone and CTD codes, O-GlcNAc cycling provides a link between cellular metabolic status and the epigenetic machinery. Thus, O-GlcNAcylation is poised to influence trans-generational epigenetic inheritance.	[Lewis, Brian A.] NCI, NIH, Bethesda, MD 20892 USA; [Hanover, John A.] NIDDK, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Lewis, BA (corresponding author), NCI, Lymphoid Malignancies Branch, NIH, Bldg 10,Rm 6B05,10 Ctr Dr, Bethesda, MD 20814 USA.	lewisbri@mail.nih.gov; jah@helix.nih.gov		Lewis, Brian/0000-0002-8321-0665	National Institutes of Health from NCI; NIDDK; NATIONAL CANCER INSTITUTE [ZIABC011223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060103, ZIADK060101, ZIADK060102] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health intramural grants from the NCI (to B. A. L.) and NIDDK (to J. A. H.). This is the third article in the Minireview Series on the Thirtieth Anniversary of Research on O-GlcNAcylation of Nuclear and Cytoplasmic Proteins: Nutrient Regulation of Cellular Metabolism and Physiology by O-GlcNAcylation.	Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Bartkowiak B, 2011, TRANSCR-AUSTIN, V2, P115, DOI 10.4161/trns.2.3.15004; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Baskaran R, 1996, MOL CELL BIOL, V16, P3361; Baskaran R, 1997, J BIOL CHEM, V272, P18905, DOI 10.1074/jbc.272.30.18905; Baskaran R, 1999, CELL GROWTH DIFFER, V10, P387; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Cameron EA, 2007, AM J HUM BIOL, V19, P593, DOI 10.1002/ajhb.20639; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; CHESNUT JD, 1992, J BIOL CHEM, V267, P10500; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Corden JL, 2013, CHEM REV, V113, P8423, DOI 10.1021/cr400158h; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109; Dias WB, 2012, BIOCHEM BIOPH RES CO, V422, P224, DOI 10.1016/j.bbrc.2012.04.124; Egloff S, 2010, J BIOL CHEM, V285, P20564, DOI 10.1074/jbc.M110.132530; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Fletcher BS, 2002, LEUKEMIA, V16, P1507, DOI 10.1038/sj.leu.2402557; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Hagemann R, 2010, MOL GENET GENOMICS, V283, P199, DOI 10.1007/s00438-010-0521-z; Hanes SD, 2014, BBA-GENE REGUL MECH, V1839, P316, DOI 10.1016/j.bbagrm.2014.02.001; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hanover JA, 2010, CHEM BIOL, V17, P1272, DOI 10.1016/j.chembiol.2010.12.001; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Harwood KR, 2014, J CELL SCI, V127, P1857, DOI 10.1242/jcs.113233; Hascall VC, 2014, MATRIX BIOL, V35, P14, DOI 10.1016/j.matbio.2014.01.014; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hintermair C, 2012, EMBO J, V31, P2784, DOI 10.1038/emboj.2012.123; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Howerton CL, 2014, P NATL ACAD SCI USA, V111, P9639, DOI 10.1073/pnas.1401203111; Hsin JP, 2011, SCIENCE, V334, P683, DOI 10.1126/science.1206034; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; Ito R, 2014, GENES CELLS, V19, P52, DOI 10.1111/gtc.12107; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jeronimo C, 2013, CHEM REV, V113, P8491, DOI 10.1021/cr4001397; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kang ES, 2008, EXP CELL RES, V314, P2238, DOI 10.1016/j.yexcr.2008.04.014; Kassis JA, 2010, MOL CELL BIOL, V30, P2581, DOI 10.1128/MCB.00231-10; KEARSE KP, 1991, P NATL ACAD SCI USA, V88, P1701, DOI 10.1073/pnas.88.5.1701; Keembiyehetty CN, 2011, J CELL SCI, V124, P2851, DOI 10.1242/jcs.083287; KELLY WG, 1993, J BIOL CHEM, V268, P10416; KORNFELD S, 1964, P NATL ACAD SCI USA, V52, P371, DOI 10.1073/pnas.52.2.371; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; LAZAROWSKI ER, 1994, J BIOL CHEM, V269, P11830; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Liu JX, 2013, J BIOL CHEM, V288, P10890, DOI 10.1074/jbc.M113.460238; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Marz P, 2006, J BIOL CHEM, V281, P20263, DOI 10.1074/jbc.M601563200; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Ono R, 2002, CANCER RES, V62, P4075; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Qian H, 2007, ANNU REV PHYS CHEM, V58, P113, DOI 10.1146/annurev.physchem.58.032806.104550; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Rao FV, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130021; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Schroder S, 2013, MOL CELL, V52, P314, DOI 10.1016/j.molcel.2013.10.009; Sekine O, 2010, J BIOL CHEM, V285, P38684, DOI 10.1074/jbc.M110.155192; Shi FT, 2013, J BIOL CHEM, V288, P20776, DOI 10.1074/jbc.M113.460386; Shin SH, 2011, AMINO ACIDS, V40, P885, DOI 10.1007/s00726-010-0719-8; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Smolle M, 2013, BBA-GENE REGUL MECH, V1829, P84, DOI 10.1016/j.bbagrm.2012.08.008; Solary E, 2014, LEUKEMIA, V28, P485, DOI 10.1038/leu.2013.337; Tanaka Y, 2007, GENE, V397, P161, DOI 10.1016/j.gene.2007.04.027; Tarrant MK, 2012, NAT CHEM BIOL, V8, P262, DOI [10.1038/NCHEMBIO.771, 10.1038/nchembio.771]; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; WALDMAN BC, 1990, BIOCHEMISTRY-US, V29, P44, DOI 10.1021/bi00453a006; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zhang Q, 2014, J BIOL CHEM, V289, P5986, DOI 10.1074/jbc.M113.524140; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885	101	97	98	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34440	34448		10.1074/jbc.R114.595439	http://dx.doi.org/10.1074/jbc.R114.595439			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25336654	hybrid, Green Published			2022-12-28	WOS:000346260800004
J	Yang, X; Trehan, SK; Guan, YJ; Sun, CQ; Moore, DC; Jayasuriya, CT; Chen, Q				Yang, Xu; Trehan, Samir K.; Guan, Yingjie; Sun, Changqi; Moore, Douglas C.; Jayasuriya, Chathuraka T.; Chen, Qian			Matrilin-3 Inhibits Chondrocyte Hypertrophy as a Bone Morphogenetic Protein-2 Antagonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone Morphogenetic Protein (BMP); Cartilage; Cartilage Biology; Chondrocyte; Extracellular Matrix; Extracellular Matrix protein	OLIGOMERIC MATRIX PROTEIN; FUNCTIONAL-CHARACTERIZATION; INCREASED EXPRESSION; ARTICULAR-CARTILAGE; TGF-BETA; A-DOMAIN; DIFFERENTIATION; BMP; PROLIFERATION; MUTATION	Background: Matrilin-3-deficient mice exhibit increased chondrocyte hypertrophy and early osteoarthritis. Results: Matrilin-3 binds bone morphogenetic factor-2 (BMP-2) and inhibits downstream BMP-2 signaling. Conclusion: The biological function of matrilin-3 involves modulating BMP-2 pathway activity. Significance: This is the first demonstration that matrilin-3 regulates chondrocyte hypertrophy as a BMP-2 antagonist in cartilage. Increased chondrocyte hypertrophy is often associated with cartilage joint degeneration in human osteoarthritis patients. Matrilin-3 knock-out (Matn3 KO) mice exhibit these features. However, the underlying mechanism is unknown. In this study, we sought a molecular explanation for increased chondrocyte hypertrophy in the mice prone to cartilage degeneration. We analyzed the effects of Matn3 on chondrocyte hypertrophy and bone morphogenetic protein (Bmp) signaling by quantifying the hypertrophic marker collagen type X (Col X) gene expression and Smad1 activity in Matn3 KO mice in vivo and in Matn3-overexpressing chondrocytes in vitro. The effect of Matn3 and its specific domains on BMP activity were quantified by Col X promoter activity containing the Bmp-responsive element. Binding of MATN3 with BMP-2 was determined by immunoprecipitation, solid phase binding, and surface plasmon resonance assays. In Matn3 KO mice, Smad1 activity was increased more in growth plate chondrocytes than in wild-type mice. Conversely, Matn3 overexpression in hypertrophic chondrocytes led to inhibition of Bmp-2-stimulated, BMP-responsive element-dependent Col X expression and Smad1 activity. MATN3 bound BMP-2 in a dose-dependent manner. Multiple epidermal growth factor (EGF)-like domains clustered together by the coiled coil of Matn3 is required for Smad1 inhibition. Hence, as a novel BMP-2-binding protein and antagonist in the cartilage extracellular matrix, MATN3 may have the inherent ability to inhibit premature chondrocyte hypertrophy by suppressing BMP-2/Smad1 activity.	[Yang, Xu; Trehan, Samir K.; Guan, Yingjie; Sun, Changqi; Moore, Douglas C.; Jayasuriya, Chathuraka T.; Chen, Qian] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Cell & Mol Biol Lab,Dept Orthopaed, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Chen, Q (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Orthopaed, 1 Hoppin St,Ste 402A, Providence, RI 02903 USA.	Qian_chen@Brown.edu	Chen, Qian/C-4354-2011	Chen, Qian/0000-0003-4406-5618; Jayasuriya, Chathuraka/0000-0002-2705-0679	National Institutes of Health from NCRR [P20 GM104937, P20 RR024484]; National Institutes of Health from NIAMS [AG017021, AG 014399]; National Science Foundation of China [81271978]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG014399, R01AG014399, R01AG017021] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 GM104937 and P20 RR024484 from NCRR and AG017021 and AG 014399 from NIAMS. This work was also supported by National Science Foundation of China Grant 81271978.	Albilia JB, 2013, J ORTHOP RES, V31, P44, DOI 10.1002/jor.22182; Borochowitz ZU, 2004, J MED GENET, V41, P366, DOI 10.1136/jmg.2003.013342; Caron MMJ, 2013, OSTEOARTHR CARTILAGE, V21, P604, DOI 10.1016/j.joca.2013.01.009; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; CHEN Q, 1995, DEV BIOL, V172, P293, DOI 10.1006/dbio.1995.0024; Davidson ENB, 2015, ANN RHEUM DIS, V74, P1257, DOI 10.1136/annrheumdis-2013-204528; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; Fisher MC, 2006, MATRIX BIOL, V25, P27, DOI 10.1016/j.matbio.2005.07.008; Fresquet M, 2007, J BIOL CHEM, V282, P34634, DOI 10.1074/jbc.M705301200; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Huang QY, 2008, J HUM GENET, V53, P644, DOI 10.1007/s10038-008-0295-x; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Ishida K, 2013, BONE, V55, P23, DOI 10.1016/j.bone.2013.03.007; Jackson GC, 2004, J MED GENET, V41, P52, DOI 10.1136/jmg.2003.011429; Jayasuriya CT, 2014, INT J MOL SCI, V15, P14555, DOI 10.3390/ijms150814555; Jayasuriya CT, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4033; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Ko YP, 2004, MOL CELL BIOL, V24, P1691, DOI 10.1128/MCB.24.4.1691-1699.2004; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kugimiya F, 2005, J BIOL CHEM, V280, P35704, DOI 10.1074/jbc.M505166200; Li XF, 2003, ENDOCRINOLOGY, V144, P2514, DOI 10.1210/en.2002-220969; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Mabuchi Akihiko, 2004, Hum Mutat, V24, P439, DOI 10.1002/humu.9286; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, GENE DEV, V14, P627; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Minina E, 2001, DEVELOPMENT, V128, P4523; Mostert AK, 2003, AM J MED GENET A, V120A, P490, DOI 10.1002/ajmg.a.20034; PARALKAR VM, 1992, J CELL BIOL, V119, P1721, DOI 10.1083/jcb.119.6.1721; Pei M, 2008, OSTEOARTHR CARTILAGE, V16, P1110, DOI 10.1016/j.joca.2007.12.011; Pullig O, 2002, OSTEOARTHR CARTILAGE, V10, P253, DOI 10.1053/joca.2001.0508; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Shen BJ, 2010, J CELL BIOCHEM, V109, P406, DOI 10.1002/jcb.22412; Stefansson SE, 2003, AM J HUM GENET, V72, P1448, DOI 10.1086/375556; Tsuchida Kunihiro, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P157, DOI 10.2174/1568008043339901; Tsumaki N, 2002, J BONE MINER RES, V17, P898, DOI 10.1359/jbmr.2002.17.5.898; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; van der Weyden L, 2006, AM J PATHOL, V169, P515, DOI 10.2353/ajpath.2006.050981; Vincourt JB, 2008, ARTHRITIS RHEUM, V58, P2798, DOI 10.1002/art.23761; Volk SW, 1998, J BONE MINER RES, V13, P1521, DOI 10.1359/jbmr.1998.13.10.1521; Wagener R, 1997, FEBS LETT, V413, P129, DOI 10.1016/S0014-5793(97)00895-8; Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200; Zhang Yue, 2008, J Orthop Surg Res, V3, P21, DOI 10.1186/1749-799X-3-21; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	47	33	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34768	34779		10.1074/jbc.M114.583104	http://dx.doi.org/10.1074/jbc.M114.583104			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25331953	Green Published, hybrid			2022-12-28	WOS:000346260800030
J	Fedosejevs, ET; Ying, S; Park, J; Anderson, EM; Mullen, RT; She, YM; Plaxton, WC				Fedosejevs, Eric T.; Ying, Sheng; Park, Joonho; Anderson, Erin M.; Mullen, Robert T.; She, Yi-Min; Plaxton, William C.			Biochemical and Molecular Characterization of RcSUS1, a Cytosolic Sucrose Synthase Phosphorylated in Vivo at Serine 11 in Developing Castor Oil Seeds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYLASE; BACTERIAL-TYPE; MEMBRANE ASSOCIATION; PROTEIN-KINASE; CELL-WALL; REGULATORY PHOSPHORYLATION; VITRO PHOSPHORYLATION; CELLULOSE SYNTHESIS; COTTON FIBER; MAIZE	Sucrose synthase (SUS) catalyzes the UDP-dependent cleavage of sucrose into UDP-glucose and fructose and has become an important target for improving seed crops via metabolic engineering. A UDP-specific SUS homotetramer composed of 93-kDa subunits was purified to homogeneity from the triacylglyceride-rich endosperm of developing castor oil seeds (COS) and identified as RcSUS1 by mass spectrometry. RcSUS1 transcripts peaked during early development, whereas levels of SUS activity and immunoreactive 93-kDa SUS polypeptides maximized during mid-development, becoming undetectable in fully mature COS. The cytosolic location of the enzyme was established following transient expression of RcSUS1-enhanced YFP in tobacco suspension cells and fluorescence microscopy. Immunological studies using anti-phosphosite-specific antibodies revealed dynamic and high stoichiometric in vivo phosphorylation of RcSUS1 at its conserved Ser-11 residue during COSdevelopment. Incorporation of P-32(i) from [gamma-P-32]ATP into a RcSUS1 peptide substrate, alongside a phosphosite-specific ELISA assay, established the presence of calcium-dependent RcSUS1 (Ser-11) kinase activity. Approximately 10% of RcSUS1 was associated with COS microsomal membranes and was hypophosphorylated relative to the remainder of RcSUS1 that partitioned into the soluble, cytosolic fraction. Elimination of sucrose supply caused by excision of intact pods of developing COS abolished RcSUS1 transcription while triggering the progressive dephosphorylation of RcSUS1 in planta. This did not influence the proportion of RcSUS1 associated with microsomal membranes but instead correlated with a subsequent marked decline in SUS activity and immunoreactive RcSUS1 polypeptides. Phosphorylation at Ser-11 appears to protect RcSUS1 from proteolysis, rather than influence its kinetic properties or partitioning between the soluble cytosol and microsomal membranes.	[Fedosejevs, Eric T.; Ying, Sheng; Plaxton, William C.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Plaxton, William C.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Park, Joonho] Seoul Natl Univ Sci & Technol, Dept Fine Chem, Seoul 139743, South Korea; [Anderson, Erin M.; Mullen, Robert T.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [She, Yi-Min] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Shanghai 201602, Peoples R China	Queens University - Canada; Queens University - Canada; Seoul National University of Science & Technology; University of Guelph; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Plaxton, WC (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	plaxton@queensu.ca	Plaxton, William C/O-3353-2013	Plaxton, William C/0000-0002-8447-7249; She, Yi-Min/0000-0002-0571-4630	Natural Sciences and Engineering Research Council of Canada; Queen's Research Chairs program; University of Guelph Research Chairs program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Queen's Research Chairs program; University of Guelph Research Chairs program	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (to W. C. P. and R. T. M.), the Queen's Research Chairs program (to W. C. P.), and the University of Guelph Research Chairs program (to R. T. M.).	Alexander RD, 2006, PROTEOMICS, V6, P1886, DOI 10.1002/pmic.200500548; Anguenot R, 1999, ARCH BIOCHEM BIOPHYS, V365, P163, DOI 10.1006/abbi.1999.1146; Asano T, 2002, PLANT CELL, V14, P619, DOI 10.1105/tpc.010454; Bahaji A, 2014, BIOTECHNOL ADV, V32, P87, DOI 10.1016/j.biotechadv.2013.06.006; Baud S, 2004, J EXP BOT, V55, P397, DOI 10.1093/jxb/erh047; Baud S, 2010, PROG LIPID RES, V49, P235, DOI 10.1016/j.plipres.2010.01.001; Bieniawska Z, 2007, PLANT J, V49, P810, DOI 10.1111/j.1365-313X.2006.03011.x; Brill E, 2011, PLANT PHYSIOL, V157, P40, DOI 10.1104/pp.111.178574; Brown AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030100; Coleman HD, 2009, P NATL ACAD SCI USA, V106, P13118, DOI 10.1073/pnas.0900188106; Dalziel KJ, 2012, FEBS LETT, V586, P1049, DOI 10.1016/j.febslet.2012.02.054; Duncan KA, 2007, PLANT CELL PHYSIOL, V48, P1612, DOI 10.1093/pcp/pcm133; Duncan KA, 2006, PLANT CELL PHYSIOL, V47, P959, DOI 10.1093/pcp/pcj068; Etxeberria E, 2003, J EXP BOT, V54, P1407, DOI 10.1093/jxb/erg148; Fallahi H, 2008, J EXP BOT, V59, P3283, DOI 10.1093/jxb/ern180; Fujii S, 2010, PLANT CELL PHYSIOL, V51, P294, DOI 10.1093/pcp/pcp190; Angeles-Nunez JG, 2010, PLANTA, V232, P701, DOI 10.1007/s00425-010-1207-9; Gennidakis S, 2007, PLANT J, V52, P839, DOI 10.1111/j.1365-313X.2007.03274.x; GREENWOOD JS, 1982, CAN J BOT, V60, P1751, DOI 10.1139/b82-222; Haigler CH, 2001, PLANT MOL BIOL, V47, P29, DOI 10.1023/A:1010615027986; Hardin SC, 2004, PLANT PHYSIOL, V134, P1427, DOI 10.1104/pp.103.036780; Hardin SC, 2006, PLANT PHYSIOL, V141, P1106, DOI 10.1104/pp.106.078006; Hennen-Bierwagen TA, 2009, PLANT PHYSIOL, V149, P1541, DOI 10.1104/pp.109.135293; Hill AT, 2014, BIOCHEM J, V458, P109, DOI 10.1042/BJ20131191; Houston NL, 2009, PLANT PHYSIOL, V151, P857, DOI 10.1104/pp.109.141622; Huber C, 1996, PLANT PHYSIOL, V112, P793, DOI 10.1104/pp.112.2.793; Jiang YJ, 2012, PLANT BIOTECHNOL J, V10, P301, DOI 10.1111/j.1467-7652.2011.00662.x; King SP, 1997, PLANT PHYSIOL, V114, P153, DOI 10.1104/pp.114.1.153; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Komina O, 2002, PLANT PHYSIOL, V129, P1664, DOI 10.1104/pp.002360; Li J, 2013, PLANT CELL PHYSIOL, V54, P282, DOI 10.1093/pcp/pcs180; Li RJ, 2006, PLANTA, V224, P952, DOI 10.1007/s00425-006-0266-4; Lu YQ, 2012, PLANT METHODS, V8, DOI [10.1186/1746-4811-8-9, 10.1371/journal.ppat.1002663]; Moorhead G, 1996, CURR BIOL, V6, P1104, DOI 10.1016/S0960-9822(02)70677-5; Moorhead G, 1999, PLANT J, V18, P1, DOI 10.1046/j.1365-313X.1999.00417.x; Murmu J, 2007, PLANTA, V226, P1299, DOI 10.1007/s00425-007-0551-x; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nakai T, 1998, PLANT CELL PHYSIOL, V39, P1337, DOI 10.1093/oxfordjournals.pcp.a029339; Neuhaus HE, 2005, TRENDS PLANT SCI, V10, P154, DOI 10.1016/j.tplants.2005.02.002; Nunez JGA, 2008, PLANT CELL PHYSIOL, V49, P1621, DOI 10.1093/pcp/pcn117; O'Leary B, 2011, BIOCHEM J, V433, P65, DOI 10.1042/BJ20101361; Park J, 2012, PLANT J, V71, P251, DOI 10.1111/j.1365-313X.2012.04985.x; Persia D, 2008, PLANT PHYSIOL, V147, P1603, DOI 10.1104/pp.108.115956; PLAXTON WC, 1991, PLANT PHYSIOL, V97, P1334, DOI 10.1104/pp.97.4.1334; Rolletschek H, 2002, J EXP BOT, V53, P1099, DOI 10.1093/jexbot/53.371.1099; Ruan YL, 2008, FUNCT PLANT BIOL, V35, P382, DOI 10.1071/FP08017; SIMCOX PD, 1979, CAN J BOT, V57, P1008, DOI 10.1139/b79-125; Subbaiah CC, 2006, J BIOL CHEM, V281, P15625, DOI 10.1074/jbc.M600355200; Swatek KN, 2011, J PROTEOME RES, V10, P4076, DOI 10.1021/pr200263m; Tanase K, 2002, PHYSIOL PLANTARUM, V114, P21, DOI 10.1046/j.0031-9317.2001.10137.x; Tripodi KE, 2005, PLANT PHYSIOL, V139, P969, DOI 10.1104/pp.105.066647; Troncoso-Ponce MA, 2011, PLANT J, V68, P1014, DOI 10.1111/j.1365-313X.2011.04751.x; Winter H, 1997, FEBS LETT, V420, P151, DOI 10.1016/S0014-5793(97)01506-8; Winter H, 1998, FEBS LETT, V430, P205, DOI 10.1016/S0014-5793(98)00659-0; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; Zhang XQ, 1999, ARCH BIOCHEM BIOPHYS, V371, P70, DOI 10.1006/abbi.1999.1415	56	19	20	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33412	33424		10.1074/jbc.M114.585554	http://dx.doi.org/10.1074/jbc.M114.585554			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25313400	Green Published, hybrid			2022-12-28	WOS:000345636600031
J	Li, L; Yao, YC; Gu, XQ; Che, D; Ma, CQ; Dai, ZY; Li, C; Zhou, T; Cai, WB; Yang, ZH; Yang, X; Gao, GQ				Li, Lei; Yao, Ya-Chao; Gu, Xiao-Qiong; Che, Di; Ma, Cai-Qi; Dai, Zhi-Yu; Li, Cen; Zhou, Ti; Cai, Wei-Bin; Yang, Zhong-Han; Yang, Xia; Gao, Guo-Quan			Plasminogen Kringle 5 Induces Endothelial Cell Apoptosis by Triggering a Voltage-dependent Anion Channel 1 (VDAC1) Positive Feedback Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; PROTEIN; GROWTH; NEOVASCULARIZATION; RECEPTOR; PATHWAY; ANGIOGENESIS; PERMEABILITY; PLASMALEMMA; EXPRESSION	Human plasminogen kringle 5 (K5) is known to display its potent anti-angiogenesis effect through inducing endothelial cell (EC) apoptosis, and the voltage-dependent anion channel 1 (VDAC1) has been identified as a receptor of K5. However, the exact role and underlying mechanisms of VDAC1 in K5-induced EC apoptosis remain elusive. In the current study, we showed that K5 increased the protein level of VDAC1, which initiated the mitochondrial apoptosis pathway of ECs. Our findings also showed that K5 inhibited the ubiquitin-dependent degradation of VDAC1 by promoting the phosphorylation of VDAC1, possibly at Ser-12 and Thr-107. The phosphorylated VDAC1 was attenuated by the AKT agonist, glycogen synthase kinase (GSK) 3 beta inhibitor, and siRNA, suggesting that K5 increased VDAC1 phosphorylation via the AKT-GSK3 beta pathway. Furthermore, K5 promoted cell surface translocation of VDAC1, and binding between K5 and VDAC1 was observed on the plasma membrane. HKI protein blocked the impact of K5 on the AKT-GSK3 beta pathway by competitively inhibiting the interaction of K5 and cell surface VDAC1. Moreover, K5-induced EC apoptosis was suppressed by VDAC1 antibody. These data show for the first time that K5-induced EC apoptosis is mediated by the positive feedback loop of "VDAC1-AKT-GSK3 beta-VDAC1," which may provide new perspectives on the mechanisms of K5-induced apoptosis.	[Li, Lei; Che, Di; Ma, Cai-Qi; Dai, Zhi-Yu; Li, Cen; Zhou, Ti; Cai, Wei-Bin; Yang, Zhong-Han; Yang, Xia; Gao, Guo-Quan] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China; [Li, Lei] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Reprod Med Guangdong Prov, Dept Reprod Med Ctr, Guangzhou 510150, Guangdong, Peoples R China; [Yao, Ya-Chao] Guangdong 2 Prov Peoples Hosp, Lab Ctr, Guangzhou 510317, Guangdong, Peoples R China; [Gu, Xiao-Qiong] Guangzhou Women & Childrens Med Ctr, Dept Lab, Guangzhou 510623, Guangdong, Peoples R China; [Yang, Xia] Sun Yat Sen Univ, Minist Educ, China Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China; [Gao, Guo-Quan] Sun Yat Sen Univ, Dept Educ Guangdong Prov, Key Lab Funct Mol Marine Microorganisms, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University	Yang, X (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China.	yangxia@mail.sysu.edu.cn; gaogq@mail.sysu.edu.cn	Dai, Zhiyu/H-3453-2019	Dai, Zhiyu/0000-0002-2945-7923	National Nature Science Foundation of China [30973449, 81172163, 81272515, 81272338, 81200706, 81471033, 81400639]; National Key Sci-Tech Special Project of China [2009ZX09103-642, 2013ZX09102053]; Program for Doctoral Station in University [20120171110053, 20130171110053]; Key Project of Nature Science Foundation of Guangdong Province [10251008901000009]; Key Sci-tech Research Project of Guangdong Province [2011B031200006]; Guandong Natural Science Fund [S2012010009250, S2012040006986]; Key Sci-tech Research Project of Guangzhou Municipality [2011Y1-00017-8, 12A52061519]; Innovative talents project of doctoral candidates of Sun Yat-sen University	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China; Program for Doctoral Station in University; Key Project of Nature Science Foundation of Guangdong Province; Key Sci-tech Research Project of Guangdong Province; Guandong Natural Science Fund; Key Sci-tech Research Project of Guangzhou Municipality; Innovative talents project of doctoral candidates of Sun Yat-sen University	This work was supported by National Nature Science Foundation of China Grants 30973449, 81172163, 81272515, 81272338, 81200706, 81471033, and 81400639, National Key Sci-Tech Special Project of China Grant 2009ZX09103-642, 2013ZX09102053, Program for Doctoral Station in University Grants 20120171110053 and 20130171110053, Key Project of Nature Science Foundation of Guangdong Province, Grant 10251008901000009, Key Sci-tech Research Project of Guangdong Province, Grant 2011B031200006, Guandong Natural Science Fund Grants S2012010009250 and S2012040006986, Key Sci-tech Research Project of Guangzhou Municipality Grants 2011Y1-00017-8 and 12A52061519, and the Innovative talents project of doctoral candidates of Sun Yat-sen University.	Adachi M, 2004, AM J PHYSIOL-GASTR L, V287, pG695, DOI 10.1152/ajpgi.00415.2003; Adham SAI, 2009, BIOCHEM BIOPH RES CO, V390, P130, DOI 10.1016/j.bbrc.2009.09.081; Barash S, 2002, BIOCHEM BIOPH RES CO, V294, P835, DOI 10.1016/S0006-291X(02)00566-1; Bathori G, 1999, J BIOL CHEM, V274, P29607, DOI 10.1074/jbc.274.42.29607; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Buettner R, 2000, P NATL ACAD SCI USA, V97, P3201, DOI 10.1073/pnas.060242297; Cai WB, 2005, J CELL BIOCHEM, V96, P1254, DOI 10.1002/jcb.20601; Cai WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053152; Campochiaro PA, 2004, EXPERT OPIN BIOL TH, V4, P1395, DOI 10.1517/14712598.4.9.1395; Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; De Pinto Vito, 2003, Ital J Biochem, V52, P17; EARP HS, 1986, J BIOL CHEM, V261, P4777; ERIKSSON A, 1991, J BIOL CHEM, V266, P21138; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gao LJ, 2011, INT J ONCOL, V39, P1265, DOI 10.3892/ijo.2011.1108; Gonzalez-Gronow M, 2003, J BIOL CHEM, V278, P27312, DOI 10.1074/jbc.M303172200; Gonzalez-Gronow M, 2007, J BIOL CHEM, V282, P32811, DOI 10.1074/jbc.M703342200; Green DR, 2006, CANCER CELL, V9, P328, DOI 10.1016/j.ccr.2006.05.004; Gu XQ, 2011, APOPTOSIS, V16, P846, DOI 10.1007/s10495-011-0618-9; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kerner J, 2012, BBA-BIOMEMBRANES, V1818, P1520, DOI 10.1016/j.bbamem.2011.11.013; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Lin CS, 2010, CLIN VACCINE IMMUNOL, V17, P1548, DOI 10.1128/CVI.00064-10; Liu XY, 2005, MOL THER, V11, P531, DOI 10.1016/j.ymthe.2004.12.003; Lu H, 1999, BIOCHEM BIOPH RES CO, V258, P668, DOI 10.1006/bbrc.1999.0612; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Perri SR, 2005, CANCER RES, V65, P8359, DOI 10.1158/0008-5472.CAN-05-0508; Schwarzer C, 2000, INT J BIOCHEM CELL B, V32, P1075, DOI 10.1016/S1357-2725(00)00047-9; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; THINNES FP, 1989, BIOL CHEM H-S, V370, P1253; Wang RQ, 2011, J IMMUNOL, V187, P5964, DOI 10.4049/jimmunol.1101205; Xu G, 2010, ALLERGY, V65, P581, DOI 10.1111/j.1398-9995.2009.02252.x; Xu G, 2007, LARYNGOSCOPE, V117, P960, DOI 10.1097/mlg.0b013e318041549c; Yamamoto Y, 2004, DIABETES, V53, P1831, DOI 10.2337/diabetes.53.7.1831; Yanamandra N, 2011, J PHARMACOL EXP THER, V337, P636, DOI 10.1124/jpet.110.172809; Yang Y, 2006, CANCER BIOL THER, V5, P399; Yuan SP, 2008, FASEB J, V22, P2809, DOI 10.1096/fj.08-107417; Zhang ZH, 2005, INVEST OPHTH VIS SCI, V46, P4062, DOI 10.1167/iovs.04-1330; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205	45	30	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.567792	http://dx.doi.org/10.1074/jbc.M114.567792			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25296756	Green Published, hybrid			2022-12-28	WOS:000345335000021
J	Huynh, MH; Liu, B; Henry, M; Liew, L; Matthews, SJ; Carruthers, VB				Huynh, My-Hang; Liu, Bing; Henry, Maud; Liew, Lloyd; Matthews, Stephen J.; Carruthers, Vern B.			Structural Basis of Toxoplasma gondii MIC2-associated Protein Interaction with MIC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION COMPLEX; HOST-CELLS; INVASION; RECOGNITION; DOMAIN; ASSIGNMENT; SECRETION; INFECTION; TRANSPORT; ORGANELLE	Toxoplasma gondii parasites must actively invade host cells to propagate. Secretory microneme proteins have been shown to be important for both gliding motility and active invasion. MIC2-M2AP is a protein complex that is essential for productive motility and rapid invasion by binding to host cell surface receptors. To investigate the architecture of the MIC2 and M2AP complex, we identified the minimal domains sufficient for interaction and solved the NMR solution structure of the globular domain of M2AP. We found that M2AP adopts a modified galectin fold similar to the C-terminal domain of another microneme protein, MIC1. NMR and immunoprecipitation analyses implicated hydrophobic residues on one face of the M2AP galectin fold in binding to the membrane proximal sixth thrombospondin type I repeat domain of MIC2. Our findings provide a second example of a galectin fold adapted for microneme protein-protein interactions and suggest a conserved strategy for the assembly and folding of diverse protein complexes.	[Huynh, My-Hang; Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Liu, Bing; Henry, Maud; Liew, Lloyd; Matthews, Stephen J.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	University of Michigan System; University of Michigan; Imperial College London	Matthews, SJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, South Kensington Campus, London SW7 2AZ, England.	s.j.matthews@imperial.ac.uk; vcarruth@umich.edu		Matthews, Steve/0000-0003-0676-0927; Carruthers, Vern/0000-0001-6859-8895; Liu, Bing/0000-0003-1670-6115	National Institutes of Health [AI063263]; UK Medical Research Council [G0800038]; Wellcome Trust [085464]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063263, R01AI046675] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E02520X/1] Funding Source: researchfish; Medical Research Council [G0400423, G0800038] Funding Source: researchfish; BBSRC [BB/E02520X/1] Funding Source: UKRI; MRC [MR/J006874/1, G0800038, G0400423] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant AI063263 (to V. B. C.). This work was also supported by UK Medical Research Council Grant G0800038 (to S. J. M) and by Wellcome Trust Grant 085464 (to S. J. M.).	Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Blumenschein TMA, 2007, EMBO J, V26, P2808, DOI 10.1038/sj.emboj.7601704; Gaji RY, 2011, TRAFFIC, V12, P840, DOI 10.1111/j.1600-0854.2011.01192.x; Halonen Sandra K, 2013, Handb Clin Neurol, V114, P125, DOI 10.1016/B978-0-444-53490-3.00008-X; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huynh MH, 2004, CELL MICROBIOL, V6, P771, DOI 10.1111/j.1462-5822.2004.00403.x; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Liu B, 2009, BIOMOL NMR ASSIGN, V3, P81, DOI 10.1007/s12104-009-9146-8; Marchant J, 2012, J BIOL CHEM, V287, P16720, DOI 10.1074/jbc.M111.325928; Marchant J, 2008, BIOMOL NMR ASSIGN, V2, P119, DOI 10.1007/s12104-008-9100-1; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Rabenau KE, 2001, MOL MICROBIOL, V41, P537, DOI 10.1046/j.1365-2958.2001.02513.x; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Saouros S, 2005, J BIOL CHEM, V280, P38583, DOI 10.1074/jbc.C500365200; Sawmynaden K, 2008, EMBO REP, V9, P1149, DOI 10.1038/embor.2008.179; Shen B, 2014, P NATL ACAD SCI USA, V111, P3567, DOI 10.1073/pnas.1315156111; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sloves PJ, 2012, CELL HOST MICROBE, V11, P515, DOI 10.1016/j.chom.2012.03.006; Song GJ, 2014, P NATL ACAD SCI USA, V111, P4862, DOI 10.1073/pnas.1403059111; Tonkin ML, 2010, PROTEIN SCI, V19, P1985, DOI 10.1002/pro.477; Wan KL, 1997, MOL BIOCHEM PARASIT, V84, P203, DOI 10.1016/S0166-6851(96)02796-X	24	15	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1432	1441		10.1074/jbc.M114.613646	http://dx.doi.org/10.1074/jbc.M114.613646			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25411252	hybrid, Green Published			2022-12-28	WOS:000348056400013
J	Yan, S; Zhang, HL; Hou, GJ; Ahmed, S; Williams, JC; Polenova, T				Yan, Si; Zhang, Huilan; Hou, Guangjin; Ahmed, Shubbir; Williams, John C.; Polenova, Tatyana			Internal Dynamics of Dynactin CAP-Gly Is Regulated by Microtubules and Plus End Tracking Protein EB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINNING NMR-SPECTROSCOPY; SOLID-STATE; MAMMALIAN DYNACTIN; ORDER PARAMETERS; CHEMICAL-SHIFTS; P150(GLUED); DOMAIN; RELAXATION; TRANSPORT; BINDING	CAP-Gly domain of dynactin, a microtubule-associated activator of dynein motor, participates in multiple cellular processes, and its point mutations are associated with neurodegenerative diseases. Recently, we have demonstrated that conformational plasticity is an intrinsic property of CAP-Gly. To understand its origin, we addressed internal dynamics of CAP-Gly assembled on polymeric microtubules, bound to end-binding protein EB1 and free, by magic angle spinning NMR and molecular dynamics simulations. The analysis of residue-specific dynamics of CAP-Gly on time scales spanning nano-through milliseconds reveals its unusually high mobility, both free and assembled on polymeric microtubules. On the contrary, CAP-Gly bound to EB1 is significantly more rigid. Molecular dynamics simulations indicate that these motions are strongly temperature-dependent, and loop regions are surprisingly mobile. These findings establish the connection between conformational plasticity and internal dynamics in CAP-Gly, which is essential for the biological functions of CAP-Gly and its ability to bind to polymeric microtubules and multiple binding partners. In this work, we establish an approach, for the first time, to probe atomic resolution dynamic profiles of a microtubule-associated protein assembled on polymeric microtubules. More broadly, the methodology established here can be applied for atomic resolution analysis of dynamics in other microtubule-associated protein assemblies, including but not limited to dynactin, dynein, and kinesin motors assembled on microtubules.	[Yan, Si; Zhang, Huilan; Hou, Guangjin; Polenova, Tatyana] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Ahmed, Shubbir; Williams, John C.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA	University of Delaware; City of Hope; Beckman Research Institute of City of Hope	Polenova, T (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	tpolenov@udel.edu	Ahmed, Shubbir/AAC-4289-2019; Hou, Guangjin/AAW-6736-2021	Ahmed, Shubbir/0000-0003-1655-6735; 	National Institutes of Health [R01GM085306, P30GM103519]; National Science Foundation [CHE0959496]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103519, R01GM085306] Funding Source: NIH RePORTER; Office of Integrative Activities [1301765] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM085306 and P30GM103519. This work was also supported in part by National Science Foundation Grant CHE0959496 (to the University of Delaware).	Ahmed S, 2010, BIOCHEMISTRY-US, V49, P5083, DOI 10.1021/bi100235z; AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; CARLIER MF, 1984, P NATL ACAD SCI-BIOL, V81, P771, DOI 10.1073/pnas.81.3.771; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chevelkov V, 2010, J AM CHEM SOC, V132, P5015, DOI 10.1021/ja100645k; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2007, NAT STRUCT MOL BIOL, V14, P980, DOI 10.1038/nsmb1299; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Hou GJ, 2013, J AM CHEM SOC, V135, P1358, DOI 10.1021/ja3084972; Hou GJ, 2011, J AM CHEM SOC, V133, P18646, DOI 10.1021/ja203771a; Li K, 2014, J AM CHEM SOC, V136, P11402, DOI 10.1021/ja504677d; Li SL, 2002, J BIOL CHEM, V277, P48596, DOI 10.1074/jbc.M208512200; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Puls I, 2005, ANN NEUROL, V57, P687, DOI 10.1002/ana.20468; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sparky D. G., 2000, J MAGN RESON, V147, P296; Sun SJ, 2009, J AM CHEM SOC, V131, P10113, DOI 10.1021/ja902003u; Thurber KR, 2009, J MAGN RESON, V196, P84, DOI 10.1016/j.jmr.2008.09.019; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Yan S, 2013, J MOL BIOL, V425, P4249, DOI 10.1016/j.jmb.2013.04.027; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; Yang J, 2009, J AM CHEM SOC, V131, P13690, DOI 10.1021/ja9037802	35	10	10	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1607	1622		10.1074/jbc.M114.603118	http://dx.doi.org/10.1074/jbc.M114.603118			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451937	Green Published, hybrid			2022-12-28	WOS:000348056400029
J	Lee, S; Zhang, CG; Liu, XD				Lee, Schuyler; Zhang, Conggang; Liu, Xuedong			Role of Glucose Metabolism and ATP in Maintaining PINK1 Levels during Parkin-mediated Mitochondrial Damage Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOPHAGY; PROTEASOME; GENE; DEGRADATION; RECRUITMENT; ACTIVATION; MECHANISMS; MUTATIONS; NEURONS; OCCURS	Mutations in several genes, including PINK1 and Parkin, are known to cause autosomal recessive cases of Parkinson disease in humans. These genes operate in the same pathway and play a crucial role in mitochondrial dynamics and maintenance. PINK1 is required to recruit Parkin to mitochondria and initiate mitophagy upon mitochondrial depolarization. In this study, we show that PINK1-dependent Parkin mitochondrial recruitment in response to global mitochondrial damage by carbonyl cyanide m-chlorophenylhydrazine (CCCP) requires active glucose metabolism. Parkin accumulation on mitochondria and subsequent Parkin-dependent mitophagy is abrogated in glucose-free medium or in the presence of 2-deoxy-D-glucose upon CCCP treatment. The defects in Parkin recruitment correlate with intracellular ATP levels and can be attributed to suppression of PINK1 up-regulation in response to mitochondria depolarization. Low levels of ATP appear to prevent PINK1 translation instead of affecting PINK1 mRNA expression or reducing its stability. Consistent with a requirement of ATP for elevated PINK1 levels and Parkin mitochondrial recruitment, local or individual mitochondrial damage via photoirradiation does not affect Parkin recruitment to damaged mitochondria as long as a pool of functional mitochondria is present in the photoirradiated cells even in glucose-free or 2-deoxy-D-glucose-treated conditions. Thus, our data identify ATP as a key regulator for Parkin mitochondrial translocation and sustaining elevated PINK1 levels during mitophagy. PINK1 functions as an AND gate and a metabolic sensor coupling biogenetics of cells and stress signals to mitochondria dynamics.	[Lee, Schuyler; Zhang, Conggang; Liu, Xuedong] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA	University of Colorado System; University of Colorado Boulder	Liu, XD (corresponding author), Univ Colorado, Dept Chem & Biochem, JSCBB, 3415 Colorado Ave, Boulder, CO 80303 USA.	Xuedong.Liu@colorado.edu	Core, BioFrontiers Advanced Light Microscopy/O-6175-2019; , tanglang/AAD-3372-2020	LIU, XUEDONG/0000-0001-7209-4964	National Institutes of Health [CA107098, S10 RR026680]; Butch Award of University of Colorado; Cancer League of Colorado; NATIONAL CANCER INSTITUTE [R01CA107098] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Butch Award of University of Colorado; Cancer League of Colorado; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA107098 (to X. L.) and S10 RR026680 (to ImageXpress MicroXL). This work was also supported by the Butch Award of University of Colorado and a grant from the Cancer League of Colorado (to X. L.).	AGGARWAL BB, 1978, BIOCHIM BIOPHYS ACTA, V502, P367, DOI 10.1016/0005-2728(78)90057-9; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Ashrafi G, 2014, J CELL BIOL, V206, P655, DOI 10.1083/jcb.201401070; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Gogvadze V, 2010, MOL ASPECTS MED, V31, P60, DOI 10.1016/j.mam.2009.12.004; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ihrlund LS, 2008, MOL ONCOL, V2, P94, DOI 10.1016/j.molonc.2008.01.003; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McCoy MK, 2014, HUM MOL GENET, V23, P145, DOI 10.1093/hmg/ddt407; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Peng XY, 2005, J BIOL CHEM, V280, P13148, DOI 10.1074/jbc.M410838200; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rogaeva E, 2004, ARCH NEUROL-CHICAGO, V61, P1898, DOI 10.1001/archneur.61.12.1898; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Trempe JF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00038; Vadlakonda L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00165; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yang JY, 2011, AUTOPHAGY, V7, P1230, DOI 10.4161/auto.7.10.16626; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang C., 2014, CELL RES IN PRESS; Zhang CG, 2014, CURR BIOL, V24, P1854, DOI 10.1016/j.cub.2014.07.014	49	31	31	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					904	917		10.1074/jbc.M114.606798	http://dx.doi.org/10.1074/jbc.M114.606798			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25404737	hybrid, Green Published			2022-12-28	WOS:000347778200025
J	Singh, S; Simpson, RL; Bennett, RG				Singh, Sudhir; Simpson, Ronda L.; Bennett, Robert G.			Relaxin Activates Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) through a Pathway Involving PPAR gamma Coactivator 1 alpha ( PGC1 alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY PEPTIDE RECEPTORS; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); PARENCHYMAL ARTERIOLES; INTERNATIONAL-UNION; SIGNALING PATHWAYS; HORMONE; LIGANDS; CELLS; GLUCONEOGENESIS; ROSIGLITAZONE	Relaxin activation of its receptor RXFP1 triggers multiple signaling pathways. Previously, we have shown that relaxin activates PPAR gamma transcriptional activity in a ligand-independent manner, but the mechanism for this effect was unknown. In this study, we examined the signaling pathways of downstream of RXFP1 leading to PPAR gamma activation. Using cells stably expressing RXFP1, we found that relaxin regulation of PPAR gamma activity requires accumulation of cAMP and subsequent activation of cAMP-dependent protein kinase (PKA). The activated PKA subsequently phosphorylated cAMP response element-binding protein (CREB) at Ser-133 to activate it directly, as well as indirectly through mitogen activated protein kinase p38 MAPK. Activated CREB was required for relaxin stimulation of PPAR gamma activity, while there was no evidence for a role of the nitric oxide or ERK MAPK pathways. Relaxin increased the mRNA and protein levels of the coactivator protein PGC1 alpha, and this effect was dependent on PKA, and was completely abrogated by a dominant-negative form of CREB. This mechanism was confirmed in a hepatic stellate cell line stably that endogenously expresses RXFP1. Reduction of PGC1 alpha levels using siRNA diminished the regulation of PPAR gamma by relaxin. These results suggest that relaxin activates the cAMP/PKA and p38 MAPK pathways to phosphorylate CREB, resulting in increased PGC1 alpha levels. This provides a mechanism for the ligand-independent activation of PPAR gamma in response to relaxin.	[Singh, Sudhir; Simpson, Ronda L.; Bennett, Robert G.] Nebraska Western Iowa Hlth Care Syst, Dept Vet Affairs, Med Res Serv, Omaha, NE 68105 USA; [Singh, Sudhir; Simpson, Ronda L.; Bennett, Robert G.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Singh, Sudhir; Simpson, Ronda L.; Bennett, Robert G.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA; [Singh, Sudhir; Simpson, Ronda L.; Bennett, Robert G.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Bennett, RG (corresponding author), Dept Med Res 151, 4101 Woolworth Ave, Omaha, NE 68105 USA.	rgbennet@unmc.edu			Dept. of Veterans Affairs Biomedical Laboratory Research & Development Program [BX000849]; National Institutes of Health NIAAA [R01 AA015509]; Bly Memorial Research Fund; University of Nebraska Medical Center Graduate College Fellowship; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015509] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000849] Funding Source: NIH RePORTER	Dept. of Veterans Affairs Biomedical Laboratory Research & Development Program; National Institutes of Health NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Bly Memorial Research Fund; University of Nebraska Medical Center Graduate College Fellowship; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by funding through the Dept. of Veterans Affairs Biomedical Laboratory Research & Development Program (BX000849), National Institutes of Health NIAAA (R01 AA015509), the Bly Memorial Research Fund (to R. G. B.), and by a University of Nebraska Medical Center Graduate College Fellowship (to S. S.).	Baccari MC, 2008, CURR PROTEIN PEPT SC, V9, P638, DOI 10.2174/138920308786733921; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bennett RG, 2003, BIOCHEM PHARMACOL, V66, P867, DOI 10.1016/S0006-2952(03)00403-9; Bennett RG, 2007, BIOCHEM PHARMACOL, V73, P1033, DOI 10.1016/j.bcp.2006.12.007; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Chan SL, 2013, FASEB J, V27, P3917, DOI 10.1096/fj.13-230797; Chan SL, 2011, FASEB J, V25, P3229, DOI 10.1096/fj.10-175471; Chow BSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042714; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; DAY RN, 1989, J BIOL CHEM, V264, P431; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Dschietzig T, 2003, CIRC RES, V92, P32, DOI 10.1161/01.RES.0000051884.27117.7E; Fallowfield JA, 2014, HEPATOLOGY, V59, P1492, DOI 10.1002/hep.26627; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Genovese T, 2005, EUR RESPIR J, V25, P225, DOI 10.1183/09031936.05.00049704; Halls ML, 2007, BRIT J PHARMACOL, V150, P677, DOI 10.1038/sj.bjp.0707140; Halls ML, 2009, ANN NY ACAD SCI, V1160, P108, DOI 10.1111/j.1749-6632.2008.03814.x; Halls ML, 2006, MOL PHARMACOL, V70, P214, DOI 10.1124/mol.105.021691; Halls ML, 2007, J PHARMACOL EXP THER, V320, P281, DOI 10.1124/jpet.106.113225; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hirate Y, 2012, CONNECT TISSUE RES, V53, P207, DOI 10.3109/03008207.2011.628060; Hong T, 2011, AM J PHYSIOL-ENDOC M, V300, pE500, DOI 10.1152/ajpendo.00225.2010; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Iglarz M, 2003, HYPERTENSION, V42, P737, DOI 10.1161/01.HYP.0000083511.91817.B1; Ivell R, 2005, ANN NY ACAD SCI, V1041, P280, DOI 10.1196/annals.1282.041; Ivell R, 2007, ADV EXP MED BIOL, V612, P26; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Moon JS, 2014, J BONE MINER RES, V29, P1586, DOI 10.1002/jbmr.2197; Nguyen BT, 2005, ANN NY ACAD SCI, V1041, P296, DOI 10.1196/annals.1282.044; Nguyen BT, 2003, MOL ENDOCRINOL, V17, P1075, DOI 10.1210/me.2002-0284; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Sasser JM, 2013, AM J PHYSIOL-REG I, V305, pR559, DOI 10.1152/ajpregu.00528.2012; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Sime PJ, 2008, J INVEST MED, V56, P534, DOI 10.2310/JIM.0b013e31816464e9; Singh S, 2010, MOL CELL ENDOCRINOL, V315, P239, DOI 10.1016/j.mce.2009.08.014; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tsukamoto H, 2006, J GASTROEN HEPATOL, V21, pS102, DOI 10.1111/j.1440-1746.2006.04573.x; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Wu MH, 2009, AM J PATHOL, V174, P519, DOI 10.2353/ajpath.2009.080574; Wu YF, 2003, J BIOL CHEM, V278, P8637, DOI 10.1074/jbc.M210910200; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Zhang Q, 2002, J CELL BIOCHEM, V85, P536, DOI 10.1002/jcb.10150	52	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					950	959		10.1074/jbc.M114.589325	http://dx.doi.org/10.1074/jbc.M114.589325			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25389293	hybrid, Green Published			2022-12-28	WOS:000347778200029
J	Roche, CJ; Talwar, A; Palmer, AF; Cabrales, P; Gerfen, G; Friedman, JM				Roche, Camille J.; Talwar, Abhinav; Palmer, Andre F.; Cabrales, Pedro; Gerfen, Gary; Friedman, Joel M.			Evaluating the Capacity to Generate and Preserve Nitric Oxide Bioactivity in Highly Purified Earthworm Erythrocruorin A GIANT POLYMERIC HEMOGLOBIN WITH POTENTIAL BLOOD SUBSTITUTE PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hemoglobin; Myoglobin; Nitric Oxide; Oxidation-Reduction (Redox); Reductase; Dinitrogen Trioxide; Erythrocruorin; Nitrite Anhydrase; Nitrite Reductase	LUMBRICUS-TERRESTRIS HEMOGLOBIN; CELL-FREE HEMOGLOBIN; REDUCTASE-ACTIVITY; EXTRACELLULAR HEMOGLOBIN; SUSTAINED-RELEASE; OXYGEN CARRIERS; INVERTEBRATE HEMOGLOBINS; S-NITROSOHEMOGLOBIN; LINKER CHAINS; HEME REDOX	Background: Earthworm hemoglobin (LtHb) is a potential blood substitute. Results: LtHb can generate nitric oxide (NO) and preserve NO bioactivity. Conclusion: LtHb reactions with nitrite and NO are indicative of therapeutic possibilities. Significance: The results further highlight the potential role of hemoglobins in NO homeostasis. The giant extracellular hemoglobin (erythrocruorin) from the earth worm (Lumbricus terrestris) has shown promise as a potential hemoglobin-based oxygen carrier (HBOC) in in vivo animal studies. An important beneficial characteristic of this hemoglobin (LtHb) is the large number of heme-based oxygen transport sites that helps overcome issues of osmotic stress when attempting to provide enough material for efficient oxygen delivery. A potentially important additional property is the capacity of the HBOC either to generate nitric oxide (NO) or to preserve NO bioactivity to compensate for decreased levels of NO in the circulation. The present study compares the NO-generating and NO bioactivity-preserving capability of LtHb with that of human adult hemoglobin (HbA) through several reactions including the nitrite reductase, reductive nitrosylation, and still controversial nitrite anhydrase reactions. An assignment of a heme-bound dinitrogen trioxide as the stable intermediate associated with the nitrite anhydrase reaction in both LtHb and HbA is supported based on functional and EPR spectroscopic studies. The role of the redox potential as a factor contributing to the NO-generating activity of these two proteins is evaluated. The results show that LtHb undergoes the same reactions as HbA and that the reduced efficacy for these reactions for LtHb relative to HbA is consistent with the much higher redox potential of LtHb. Evidence of functional heterogeneity in LtHb is explained in terms of the large difference in the redox potential of the isolated subunits.	[Roche, Camille J.; Talwar, Abhinav; Gerfen, Gary; Friedman, Joel M.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Talwar, Abhinav] Herricks High Sch, New Hyde Pk, NY 11040 USA; [Palmer, Andre F.] Ohio State Univ, William G Lawrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Cabrales, Pedro] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Yeshiva University; Albert Einstein College of Medicine; University System of Ohio; Ohio State University; University of California System; University of California San Diego	Friedman, JM (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	joel.friedman@einstein.yu.edu	Cabrales, Pedro/A-1930-2014	Cabrales, Pedro/0000-0002-8794-2839	National Institutes of Health [P01HL110900-01A1, P01HL071064, R56HL123015, R01HL052684, R01HL62354, R01HL078840, R01DK070862]; FJC, a foundation of philanthropic funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078840, R01HL062354, R56HL123015, P01HL110900, P01HL071064, R01HL052684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FJC, a foundation of philanthropic funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL110900-01A1 and P01HL071064 (to J. M. F.), R56HL123015 and R01HL052684 (to P. C.), R01HL62354, R01HL078840, and R01DK070862. This work was also supported by FJC, a foundation of philanthropic funds.	Alayash AI, 2014, TRENDS BIOTECHNOL, V32, P177, DOI 10.1016/j.tibtech.2014.02.006; Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Balcerczyk A, 2005, FREE RADICAL BIO MED, V39, P327, DOI 10.1016/j.freeradbiomed.2005.03.017; Barghaus O., 1992, MEAS SCI TECHNOL, V3, P765; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Buehler PW, 2008, BBA-PROTEINS PROTEOM, V1784, P1378, DOI 10.1016/j.bbapap.2007.12.009; Buerk DG, 2011, ADV EXP MED BIOL, V701, P271, DOI 10.1007/978-1-4419-7756-4_36; Cabrales P, 2013, ANTIOXID REDOX SIGN, V18, P2284, DOI 10.1089/ars.2012.5099; Cabrales P, 2011, AM J PHYSIOL-HEART C, V300, pH49, DOI 10.1152/ajpheart.00665.2010; Cabrales P, 2010, FREE RADICAL BIO MED, V49, P530, DOI 10.1016/j.freeradbiomed.2010.04.034; Cantu-Medellin N, 2011, NITRIC OXIDE-BIOL CH, V25, P59, DOI 10.1016/j.niox.2011.01.006; Corti P, 2013, FREE RADICAL BIO MED, V65, P1518, DOI 10.1016/j.freeradbiomed.2013.09.020; DAVID MM, 1974, J MOL BIOL, V87, P89, DOI 10.1016/0022-2836(74)90561-0; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Dorman SC, 2004, J INORG BIOCHEM, V98, P185, DOI 10.1016/j.jinorgbio.2003.10.004; Dorman SC, 2002, ARTIF CELL BLOOD SUB, V30, P39, DOI 10.1081/BIO-120002726; Elmer J, 2012, LIFE SCI, V91, P852, DOI 10.1016/j.lfs.2012.08.036; Elmer J, 2012, TRANSFUSION, V52, P1729, DOI 10.1111/j.1537-2995.2011.03523.x; FAULKNER KM, 1995, J BIOL CHEM, V270, P13604, DOI 10.1074/jbc.270.23.13604; Fernandez BO, 2003, J AM CHEM SOC, V125, P10510, DOI 10.1021/ja036693b; Ford PC, 2010, INORG CHEM, V49, P6226, DOI 10.1021/ic902073z; Friedman AJ, 2008, NITRIC OXIDE-BIOL CH, V19, P12, DOI 10.1016/j.niox.2008.04.003; FUSHITANI K, 1986, J BIOL CHEM, V261, P8414; FUSHITANI K, 1991, J BIOL CHEM, V266, P10275; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; Gow AJ, 1999, P NATL ACAD SCI USA, V96, P9027, DOI 10.1073/pnas.96.16.9027; Gow AJ, 2005, J INORG BIOCHEM, V99, P903, DOI 10.1016/j.jinorgbio.2004.12.001; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Han TH, 2002, P NATL ACAD SCI USA, V99, P7763, DOI 10.1073/pnas.122118299; Harrington JP, 2007, ARTIF CELL BLOOD SUB, V35, P53, DOI 10.1080/10731190600974491; Hirsch RE, 1997, ARTIF CELL BLOOD SUB, V25, P429, DOI 10.3109/10731199709118932; Hopmann KH, 2011, CHEM-EUR J, V17, P6348, DOI 10.1002/chem.201003578; Itoh Y, 2000, ANAL BIOCHEM, V287, P203, DOI 10.1006/abio.2000.4859; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; KAPP OH, 1981, BIOCHEM BIOPH RES CO, V101, P509, DOI 10.1016/0006-291X(81)91289-4; Kim-Shapiro DB, 2014, NITRIC OXIDE-BIOL CH, V38, P58, DOI 10.1016/j.niox.2013.11.002; Kojima H, 1998, CHEM PHARM BULL, V46, P373; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Koppenol WH, 2012, INORG CHEM, V51, P5637, DOI 10.1021/ic202561f; KRISTENSEN EW, 1991, J ELECTROANAL CHEM, V309, P61, DOI 10.1016/0022-0728(91)87004-N; Liochev SI, 1996, ARCH BIOCHEM BIOPHYS, V330, P281, DOI 10.1006/abbi.1996.0254; Luchsinger BP, 2003, P NATL ACAD SCI USA, V100, P461, DOI 10.1073/pnas.0233287100; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; Minning DM, 1999, NATURE, V401, P497, DOI 10.1038/46822; Mouche F, 2001, J STRUCT BIOL, V133, P176, DOI 10.1006/jsbi.2001.4362; Nachuraju P, 2011, RESUSCITATION, V82, P607, DOI 10.1016/j.resuscitation.2010.12.025; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nagababu E, 2006, NITRIC OXIDE-BIOL CH, V15, P20, DOI 10.1016/j.niox.2006.01.012; Navati MS, 2009, J AM CHEM SOC, V131, P12273, DOI 10.1021/ja903364h; OWNBY DW, 1993, J BIOL CHEM, V268, P13539; Planchet E, 2006, J EXP BOT, V57, P3043, DOI 10.1093/jxb/erl070; Roche CJ, 2006, J BIOL CHEM, V281, P36874, DOI 10.1074/jbc.M603914200; Roche CJ, 2013, J BIOL CHEM, V288, P22408, DOI 10.1074/jbc.M113.482679; Roche CJ, 2012, NITRIC OXIDE-BIOL CH, V27, P32, DOI 10.1016/j.niox.2012.04.002; Roche CJ, 2011, J BIOL CHEM, V286, P23452, DOI 10.1074/jbc.M110.183186; Roche CJ, 2010, NITRIC OXIDE-BIOL CH, V22, P180, DOI 10.1016/j.niox.2009.11.003; Rohlfs RJ, 1998, J BIOL CHEM, V273, P12128, DOI 10.1074/jbc.273.20.12128; Rousselot Morgane, 2006, Biotechnology Journal, V1, P333, DOI 10.1002/biot.200500049; Sheng JZ, 2005, J PHARMACOL EXP THER, V315, P931, DOI 10.1124/jpet.105.087932; Srihirun S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030380; Stamler JS, 2008, NAT MED, V14, P1008, DOI 10.1038/nm1008-1008; SZABO A, 1976, BIOCHEMISTRY-US, V15, P4427, DOI 10.1021/bi00665a013; Tejero J, 2012, J BIOL CHEM, V287, P18262, DOI 10.1074/jbc.M111.298927; Wust PK, 2009, APPL ENVIRON MICROB, V75, P1852, DOI 10.1128/AEM.02745-08; Yi J, 2009, J AM CHEM SOC, V131, P18119, DOI 10.1021/ja904726q; Yonetani T, 1998, J BIOL CHEM, V273, P20323, DOI 10.1074/jbc.273.32.20323; Zhu H, 1996, J BIOL CHEM, V271, P30007, DOI 10.1074/jbc.271.47.30007	69	9	9	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					99	117		10.1074/jbc.M114.583260	http://dx.doi.org/10.1074/jbc.M114.583260			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25371199	Green Published, hybrid			2022-12-28	WOS:000347231200010
J	Bukiya, AN; McMillan, J; Liu, JX; Shivakumar, B; Parrill, AL; Dopico, AM				Bukiya, Anna N.; McMillan, Jacob; Liu, Jianxi; Shivakumar, Bangalore; Parrill, Abby L.; Dopico, Alex M.			Activation of Calcium- and Voltage-gated Potassium Channels of Large Conductance by Leukotriene B4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Drug Design; Ion Channel; Leukotriene; Patch Clamp	CA2+-ACTIVATED K+ CHANNELS; SMOOTH-MUSCLE; BK CHANNELS; BILE-ACIDS; TRANSMEMBRANE DOMAIN; ARACHIDONIC-ACID; BETA-1 SUBUNIT; MAXIK CHANNEL; FATTY-ACIDS; MODULATION	Calcium/voltage-gated, large conductance potassium (BK) channels control numerous physiological processes, including myogenic tone. BK channel regulation by direct interaction between lipid and channel protein sites has received increasing attention. Leukotrienes (LTA4, LTB4, LTC4, LTD4, and LTE4) are inflammatory lipid mediators. We performed patch clamp studies in Xenopus oocytes that co-expressed BK channel-forming (cbv1) and accessory 1 subunits cloned from rat cerebral artery myocytes. Leukotrienes were applied at 0.1 nm-10 m to either leaflet of cell-free membranes at a wide range of [Ca2+](i) and voltages. Only LTB4 reversibly increased BK steady-state activity (EC50 = 1 nm; E-max reached at 10 nm), with physiological [Ca2+](i) and voltages favoring this activation. Homomeric cbv1 or cbv1-2 channels were LTB4-resistant. Computational modeling predicted that LTB4 docked onto the cholane steroid-sensing site in the BK 1 transmembrane domain 2 (TM2). Co-application of LTB4 and cholane steroid did not further increase LTB4-induced activation. LTB4 failed to activate 1 subunit-containing channels when 1 carried T169A, A176S, or K179I within the docking site. Co-application of LTB4 with LTA4, LTC4, LTD4, or LTE4 suppressed LTB4-induced activation. Inactive leukotrienes docked onto a portion of the site, probably preventing tight docking of LTB4. In summary, we document the ability of two endogenous lipids from different chemical families to share their site of action on a channel accessory subunit. Thus, cross-talk between leukotrienes and cholane steroids might converge on regulation of smooth muscle contractility via BK 1. Moreover, the identification of LTB4 as a highly potent ligand for BK channels is critical for the future development of 1-specific BK channel activators.	[Bukiya, Anna N.; Liu, Jianxi; Shivakumar, Bangalore; Dopico, Alex M.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [McMillan, Jacob; Parrill, Abby L.] Univ Memphis, Dept Chem, Memphis, TN 38152 USA; [McMillan, Jacob; Parrill, Abby L.] Univ Memphis, Computat Res Mat Inst CROMIUM, Memphis, TN 38152 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Memphis	Bukiya, AN (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	abukiya@uthsc.edu; adopico@uthsc.edu	Bukiya, Anna/N-5361-2019	Parrill, Abby/0000-0003-1658-8497	National Institutes of Health [AA020184, HL10463-01, AA11560]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011560, R37AA011560, R29AA011560, R03AA020184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA020184 (to A. B.) and HL10463-01 and AA11560 (to A. D.).	Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Bukiya AN, 2008, J LIPID RES, V49, P2441, DOI 10.1194/jlr.M800286-JLR200; Bukiya AN, 2008, FEBS LETT, V582, P673, DOI 10.1016/j.febslet.2008.01.036; Bukiya AN, 2007, MOL PHARMACOL, V72, P359, DOI 10.1124/mol.107.034330; Bukiya AN, 2013, MOL PHARMACOL, V83, P1030, DOI 10.1124/mol.112.083519; Bukiya AN, 2011, P NATL ACAD SCI USA, V108, P20207, DOI 10.1073/pnas.1112901108; Bukiya AN, 2011, ARTERIOSCL THROM VAS, V31, P2410, DOI 10.1161/ATVBAHA.111.233965; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Bukiya AN, 2009, FEBS LETT, V583, P2779, DOI 10.1016/j.febslet.2009.07.019; CABRAL DJ, 1987, BIOCHEMISTRY-US, V26, P1801, DOI 10.1021/bi00381a002; Clarke AL, 2002, AM J PHYSIOL-CELL PH, V283, pC1441, DOI 10.1152/ajpcell.00035.2002; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Crowley JJ, 2005, MOL PHARMACOL, V68, P4, DOI 10.1124/mol.105.012971; Dopico AM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00312; Dopico AM, 2002, J GEN PHYSIOL, V119, P251, DOI 10.1085/jgp.119.3.251; Essin K, 2009, BLOOD, V113, P1326, DOI 10.1182/blood-2008-07-166660; Hoffmann EK, 1999, PFLUG ARCH EUR J PHY, V438, P263, DOI 10.1007/s004240050908; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4822, DOI 10.1073/pnas.1222003110; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Jaggar JH, 2005, CIRC RES, V97, P805, DOI 10.1161/01.RES.0000186180.47148.7b; King JT, 2006, J NEUROPHYSIOL, V95, P2878, DOI 10.1152/jn.01352.2005; KIRBER MT, 1992, FEBS LETT, V297, P24, DOI 10.1016/0014-5793(92)80319-C; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; Liu JX, 2008, MOL PHARMACOL, V74, P628, DOI 10.1124/mol.108.048694; Martin P, 2014, PFLUG ARCH EUR J PHY, V466, P1779, DOI 10.1007/s00424-013-1422-x; MCMANUS OB, 1993, BIOCHEMISTRY-US, V32, P6128, DOI 10.1021/bi00075a002; Meera P, 1996, FEBS LETT, V382, P84, DOI 10.1016/0014-5793(96)00151-2; Meng XJ, 1997, J CLIN INVEST, V99, P2915, DOI 10.1172/JCI119486; Morimoto T, 2007, MOL PHARMACOL, V71, P1075, DOI 10.1124/mol.106.031146; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Perez GJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1769, DOI 10.1152/ajpcell.2001.281.6.C1769; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Poveda JA, 2014, BBA-BIOMEMBRANES, V1838, P1560, DOI 10.1016/j.bbamem.2013.10.023; Sasagawa M, 1994, Arerugi, V43, P28; SCHERER RW, 1993, J GEN PHYSIOL, V102, P125, DOI 10.1085/jgp.102.1.125; SHINDO K, 1993, INT J TISSUE REACT, V15, P181; SHIRATSUKI N, 1990, PROSTAG LEUKOTR ESS, V40, P285, DOI 10.1016/0952-3278(90)90051-L; Singh AK, 2012, J BIOL CHEM, V287, P20509, DOI 10.1074/jbc.M112.356261; Snyder PW, 2011, P NATL ACAD SCI USA, V108, P17889, DOI 10.1073/pnas.1114107108; Striggow F, 1997, BIOCHEM BIOPH RES CO, V237, P413, DOI 10.1006/bbrc.1997.7152; Tanaka Y, 2004, J PHARMACOL SCI, V94, P339, DOI 10.1254/jphs.94.339; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; Valverde MA, 1999, SCIENCE, V285, P1929, DOI 10.1126/science.285.5435.1929; Vigna SR, 2011, PANCREAS, V40, P708, DOI 10.1097/MPA.0b013e318214c8df; Wang YW, 2002, J NEUROSCI, V22, P1550, DOI 10.1523/JNEUROSCI.22-05-01550.2002; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240	49	14	15	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35314	35325		10.1074/jbc.M114.577825	http://dx.doi.org/10.1074/jbc.M114.577825			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25371198	Green Published, hybrid			2022-12-28	WOS:000346660200023
J	Jolly, L; Stavrou, A; Vanderstoken, G; Meliopoulos, VA; Habgood, A; Tatler, AL; Porte, J; Knox, A; Weinreb, P; Violette, S; Hussell, T; Kolb, M; Stampfli, MR; Schultz-Cherry, S; Jenkins, G				Jolly, Lisa; Stavrou, Anastasios; Vanderstoken, Gilles; Meliopoulos, Victoria A.; Habgood, Anthony; Tatler, Amanda L.; Porte, Joanne; Knox, Alan; Weinreb, Paul; Violette, Shelia; Hussell, Tracy; Kolb, Martin; Stampfli, Martin R.; Schultz-Cherry, Stacey; Jenkins, Gisli			Influenza Promotes Collagen Deposition via alpha v beta 6 Integrin-mediated Transforming Growth Factor beta Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Influenza; Integrin; Pulmonary Fibrosis; Toll-like Receptor (TLR)	IDIOPATHIC PULMONARY-FIBROSIS; EPSTEIN-BARR-VIRUS; VIRAL GLYCOPROTEINS GHGL; LUNG EPITHELIAL-CELLS; MOUTH-DISEASE-VIRUS; NF-KAPPA-B; TGF-BETA; LATENT TGF-BETA-1; GENE-EXPRESSION; RNA VIRUSES	Influenza infection exacerbates chronic pulmonary diseases, including idiopathic pulmonary fibrosis. A central pathway in the pathogenesis of idiopathic pulmonary fibrosis is epithelial injury leading to activation of transforming growth factor (TGF). The mechanism and functional consequences of influenza-induced activation of epithelial TGF are unclear. Influenza stimulates toll-like receptor 3 (TLR3), which can increase RhoA activity, a key event prior to activation of TGF by the v6 integrin. We hypothesized that influenza would stimulate TLR3 leading to activation of latent TGF via v6 integrin in epithelial cells. Using H1152 (IC50 6.1 m) to inhibit Rho kinase and 6.3G9 to inhibit v6 integrins, we demonstrate their involvement in influenza (A/PR/8/34 H1N1) and poly(I:C)-induced TGF activation. We confirm the involvement of TLR3 in this process using chloroquine (IC50 11.9 m) and a dominant negative TLR3 construct (pZERO-hTLR3). Examination of lungs from influenza-infected mice revealed augmented levels of collagen deposition, phosphorylated Smad2/3, v6 integrin, and apoptotic cells. Finally, we demonstrate that v6 integrin-mediated TGF activity following influenza infection promotes epithelial cell death in vitro and enhanced collagen deposition in vivo and that this response is diminished in Smad3 knock-out mice. These data show that H1N1 and poly(I:C) can induce v6 integrin-dependent TGF activity in epithelial cells via stimulation of TLR3 and suggest a novel mechanism by which influenza infection may promote collagen deposition in fibrotic lung disease.	[Jolly, Lisa; Stavrou, Anastasios; Habgood, Anthony; Tatler, Amanda L.; Porte, Joanne; Knox, Alan; Jenkins, Gisli] Univ Nottingham, Univ Nottingham Hosp, Nottingham Resp Res Unit, Nottingham NG5 1PB, England; [Meliopoulos, Victoria A.; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Weinreb, Paul; Violette, Shelia] Biogen Idec Inc, Cambridge, MA 02142 USA; [Vanderstoken, Gilles; Kolb, Martin; Stampfli, Martin R.] McMaster Univ, St Josephs Hlth Care, McMaster Immunol Res Ctr, Hamilton, ON L8S 4L8, Canada; [Vanderstoken, Gilles; Kolb, Martin; Stampfli, Martin R.] McMaster Univ, St Josephs Hlth Care, Firestone Inst, Hamilton, ON L8S 4L8, Canada; [Hussell, Tracy] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9NT, Lancs, England	University of Nottingham; St Jude Children's Research Hospital; Biogen; McMaster University; McMaster University; University of Manchester	Jenkins, G (corresponding author), Univ Nottingham, Univ Nottingham Hosp, Nottingham Resp Res Unit, Clin Sci Bldg,City Hosp Campus, Nottingham NG5 1PB, England.	gisli.jenkins@nottingham.ac.uk	tatler, amanda/I-2620-2019; Schultz-Cherry, Stacey/N-2506-2018; Jenkins, Gisli/R-8143-2017; Hussell, Tracy/O-4630-2014	tatler, amanda/0000-0002-4644-4614; Jenkins, Gisli/0000-0002-7929-2119; Stampfli, Martin/0000-0003-4918-5889; Hussell, Tracy/0000-0001-7186-6141; Knox, Alan/0000-0002-5906-4143; Weinreb, Paul/0000-0002-0802-0052	National Institutes of Health from NIAID [HHSN266200700005C]; Asthma United Kingdom [07-026, 10-020]; American Lebanese Syrian Associated Charities; Medical Research Council [G0802752] Funding Source: researchfish; Asthma UK [07/026, 10/020] Funding Source: researchfish; MRC [G0802752] Funding Source: UKRI	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Asthma United Kingdom; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant HHSN266200700005C from NIAID. This work was also supported by Asthma United Kingdom Grants 07-026 and 10-020 and the American Lebanese Syrian Associated Charities (to S. S. C.). Dr. Gisli Jenkins has acted as a consultant for GlaxoSmithKline, Boehringer Ingelheim, Intermune, Medimmune, and Biogen Idec and has research contracts with GlaxoSmithKline, Novartis, and Biogen Idec. Drs. Paul Weinreb and Shelia Violette are employees and shareholders of Biogen Idec.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Berryman S, 2005, J VIROL, V79, P8519, DOI 10.1128/JVI.79.13.8519-8534.2005; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Brownh PD, 1990, GROWTH FACTORS, V3, DOI 10.3109/08977199009037500; Carlson CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001136; Chesnokova LS, 2011, J VIROL, V85, P13214, DOI 10.1128/JVI.05580-11; Chesnokova LS, 2009, P NATL ACAD SCI USA, V106, P20464, DOI 10.1073/pnas.0907508106; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Fujino N, 2013, J INFECT DIS, V207, P692, DOI 10.1093/infdis/jis739; Goodwin A, 2009, BIOCHEM SOC T, V37, P849, DOI 10.1042/BST0370849; Hagimoto N, 1997, AM J RESP CELL MOL, V16, P91, DOI 10.1165/ajrcmb.16.1.8998084; Hagimoto N, 1997, AM J RESP CELL MOL, V17, P272, DOI 10.1165/ajrcmb.17.3.2893; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Haidari M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021444; Horan GS, 2008, AM J RESP CRIT CARE, V177, P56, DOI 10.1164/rccm.200706-805OC; Hutt-Fletcher LM, 2010, VIRULENCE, V1, P395, DOI 10.4161/viru.1.5.12546; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; John AE, 2013, J NUCL MED, V54, P2146, DOI 10.2967/jnumed.113.120592; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KIRK JME, 1986, CLIN SCI, V70, P39, DOI 10.1042/cs0700039; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; Kovner AV, 2012, B EXP BIOL MED+, V153, P229, DOI 10.1007/s10517-012-1683-y; Kuwano K, 1999, J CLIN INVEST, V104, P13, DOI 10.1172/JCI5628; Kuwano Kazuyoshi, 2001, Current Molecular Medicine (Hilversum), V1, P551, DOI 10.2174/1566524013363401; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li P, 2012, BRIT J RADIOL, V85, P729, DOI 10.1259/bjr/85580974; Lin CB, 2001, VIROLOGY, V287, P202, DOI 10.1006/viro.2001.1010; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Luckhardt TR, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-18; Manukyan M, 2009, J IMMUNOL, V182, P3522, DOI 10.4049/jimmunol.0802280; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; MIYAZONO K, 1989, NATURE, V338, P158, DOI 10.1038/338158a0; Monaghan P, 2005, J GEN VIROL, V86, P2769, DOI 10.1099/vir.0.81172-0; MORI I, 1995, J GEN VIROL, V76, P2869, DOI 10.1099/0022-1317-76-11-2869; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Neubauer K, 1999, J HEPATOL, V31, P692, DOI 10.1016/S0168-8278(99)80350-X; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Qiao J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-107; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; REDLICH CA, 1995, AM J RESP CELL MOL, V12, P287, DOI 10.1165/ajrcmb.12.3.7873195; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Roberson EC, 2012, AM J RESP CELL MOL, V46, P573, DOI 10.1165/rcmb.2010-0460OC; SchultzCherry S, 1996, J VIROL, V70, P8624, DOI 10.1128/JVI.70.12.8624-8629.1996; Seitsonen J, 2010, J VIROL, V84, P8509, DOI 10.1128/JVI.02176-09; SHA X, 1991, J CELL BIOL, V114, P827, DOI 10.1083/jcb.114.4.827; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Singh V, 2012, LUNG INDIA, V29, P277, DOI 10.4103/0970-2113.99118; SPECKS U, 1995, AM J RESP CRIT CARE, V151, P1956, DOI 10.1164/ajrccm.151.6.7767545; SUBBARAO EK, 1992, J CLIN MICROBIOL, V30, P996, DOI 10.1128/JCM.30.4.996-999.1992; Tatler AL, 2008, BIOCHEM BIOPH RES CO, V370, P239, DOI 10.1016/j.bbrc.2008.03.064; Tatter AL, 2011, J IMMUNOL, V187, P6094, DOI 10.4049/jimmunol.1003507; Weinreb PH, 2004, J BIOL CHEM, V279, P17875, DOI 10.1074/jbc.M312103200; Williams AE, 2005, MICROBES INFECT, V7, P365, DOI 10.1016/j.micinf.2004.11.012; Williams CH, 2004, J VIROL, V78, P6967, DOI 10.1128/JVI.78.13.6967-6973.2004; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044	69	42	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35246	35263		10.1074/jbc.M114.582262	http://dx.doi.org/10.1074/jbc.M114.582262			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25339175	hybrid, Green Published			2022-12-28	WOS:000346660200018
J	Koenig, PA; Nicholls, PK; Schmidt, FI; Hagiwara, M; Maruyama, T; Frydman, GH; Watson, N; Page, DC; Ploegh, HL				Koenig, Paul-Albert; Nicholls, Peter K.; Schmidt, Florian I.; Hagiwara, Masatoshi; Maruyama, Takeshi; Frydman, Galit H.; Watson, Nicki; Page, David C.; Ploegh, Hidde L.			The E2 Ubiquitin-conjugating Enzyme UBE2J1 Is Required for Spermiogenesis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum-associated Protein Degradation (ERAD); ER Quality Control; Gene Knockout; Spermatogenesis; Ubiquitin-conjugating Enzyme (E2 enzyme); ERAD Tuning; Male Infertility; Mouse Model; Spermiogenesis	ENDOPLASMIC-RETICULUM; CYTOPLASMIC DROPLET; MISFOLDED PROTEINS; UNFOLDED PROTEIN; ER; DISLOCATION; SPERMATOGENESIS; DEGRADATION; MOUSE; MEMBRANE	Background: The physiological roles of many ER quality control components are unknown. Results: Male Ube2j1(-/-) mice are sterile with defects in flagella and acrosome function, and cytoplasm removal in sperm cells. Conclusion: Spermatogenesis is a previously unknown process requiring ER quality control. Significance: ER quality control components might serve as diagnostic or therapeutic targets for male infertility in the future. ER-resident proteins destined for degradation are dislocated into the cytosol by components of the ER quality control machinery for proteasomal degradation. Dislocation substrates are ubiquitylated in the cytosol by E2 ubiquitin-conjugating/E3 ligase complexes. UBE2J1 is one of the well-characterized E2 enzymes that participate in this process. However, the physiological function of Ube2j1 is poorly defined. We find that Ube2j1(-/-) mice have reduced viability and fail to thrive early after birth. Male Ube2j1(-/-) mice are sterile due to a defect in late spermatogenesis. Ultrastructural analysis shows that removal of the cytoplasm is incomplete in Ube2j1(-/-) elongating spermatids, compromising the release of mature elongate spermatids into the lumen of the seminiferous tubule. Our findings identify an essential function for the ubiquitin-proteasome-system in spermiogenesis and define a novel, non-redundant physiological function for the dislocation step of ER quality control.	[Koenig, Paul-Albert; Nicholls, Peter K.; Schmidt, Florian I.; Hagiwara, Masatoshi; Maruyama, Takeshi; Watson, Nicki; Page, David C.; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Frydman, Galit H.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Page, David C.; Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Page, David C.] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	Koenig, Paul-Albert/AAH-1595-2021; Maruyama, Takeshi/T-7568-2019; Schmidt, Florian/H-7372-2012; Schmidt, Florian Ingo/J-1672-2019; Nicholls, Peter/AAC-7137-2021	Koenig, Paul-Albert/0000-0001-5995-2557; Maruyama, Takeshi/0000-0003-0331-4702; Schmidt, Florian/0000-0002-9979-9769; Schmidt, Florian Ingo/0000-0002-9979-9769; Nicholls, Peter/0000-0002-5540-442X	National Institutes of Health; Cancer Center Support (core) Grant from the National Cancer Institute [P30-CA14051]; National Health and Medical Research Council (Australia) [1053776]; Swiss National Science Foundation (SNSF); Japan Society for the Promotion of Science; Japan Heart Foundation; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support (core) Grant from the National Cancer Institute; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Heart Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health and in part by the Cancer Center Support (core) Grant P30-CA14051 from the National Cancer Institute.; Recipient of a National Health and Medical Research Council (Australia) CJ Martin Fellowship 1053776.; Supported by an Early Postdoctoral Mobility Fellowship from the Swiss National Science Foundation (SNSF).; Supported by the Japan Society for the Promotion of Science and the Japan Heart Foundation.	Bao JQ, 2010, MOL CELL ENDOCRINOL, V327, P89, DOI 10.1016/j.mce.2010.06.006; Bernasconi R, 2013, MOL CELL, V52, P783, DOI 10.1016/j.molcel.2013.10.016; Bernasconi R, 2011, CURR OPIN CELL BIOL, V23, P176, DOI 10.1016/j.ceb.2010.10.002; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; CLERMONT Y, 1978, AM J ANAT, V151, P191, DOI 10.1002/aja.1001510204; De Rooij DG, 2000, J ANDROL, V21, P776; Dougan SK, 2011, MOL CELL BIOL, V31, P1145, DOI 10.1128/MCB.00967-10; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005; Gan HY, 2013, MOL CELL PROTEOMICS, V12, P1144, DOI 10.1074/mcp.M112.020123; Geiger R, 2011, NAT CELL BIOL, V13, P1305, DOI 10.1038/ncb2339; HESS R, 1994, PEPTIDE RES, V7, P146; Hoch RV, 2006, DEVELOPMENT, V133, P663, DOI 10.1242/dev.02242; Horimoto S, 2013, J BIOL CHEM, V288, P31517, DOI 10.1074/jbc.M113.476010; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Kumar TR, 2001, ENDOCRINOLOGY, V142, P3512, DOI 10.1210/en.142.8.3512; Lenk U, 2002, J CELL SCI, V115, P3007; Lester D, 2000, BIOCHEM BIOPH RES CO, V269, P474, DOI 10.1006/bbrc.2000.2302; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Meistrich ML, 2003, CHROMOSOMA, V111, P483, DOI 10.1007/s00412-002-0227-z; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; NAKAMOTO T, 1989, CELL TISSUE RES, V257, P279, DOI 10.1007/BF00261831; O'Donnell Liza, 2011, Spermatogenesis, V1, P14; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; Rengan AK, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-92; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; SMITH MH, 1986, MOL IMMUNOL, V23, P1077, DOI 10.1016/0161-5890(86)90006-4; Steger K, 1999, ANAT EMBRYOL, V199, P471, DOI 10.1007/s004290050245; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Xu H, 2013, ASIAN J ANDROL, V15, P799, DOI 10.1038/aja.2013.69; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zheng HL, 2007, P NATL ACAD SCI USA, V104, P6852, DOI 10.1073/pnas.0701669104	41	23	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34490	34502		10.1074/jbc.M114.604132	http://dx.doi.org/10.1074/jbc.M114.604132			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25320092	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000346260800010
J	Rossez, Y; Holmes, A; Lodberg-Pedersen, H; Birse, L; Marshall, J; Willats, WGT; Toth, IK; Holden, NJ				Rossez, Yannick; Holmes, Ashleigh; Lodberg-Pedersen, Henriette; Birse, Louise; Marshall, Jacqueline; Willats, William G. T.; Toth, Ian K.; Holden, Nicola J.			Escherichia coli Common Pilus (ECP) Targets Arabinosyl Residues in Plant Cell Walls to Mediate Adhesion to Fresh Produce Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesin; Bacterial Adhesion; Escherichia coli (E; coli); Glycobiology; Host-Pathogen Interaction; Ligand-binding Protein; Organelle; Plant Cell Wall; Arabinose; Glycan Array	BIOFILM FORMATION; UNITED-STATES; MONOCLONAL-ANTIBODIES; VIBRIO-CHOLERAE; ARABINOGALACTAN-PROTEINS; E. COLI; O157-H7; COLONIZATION; OUTBREAK; CONSUMPTION	Background: Bacterial fimbriae mediate binding to host tissue through specific interactions. Results: ECP interacts with arabinosyl residues in pectin and other plant cell wall components. Conclusion: ECP-arabinan interactions facilitate binding of E. coli to plant hosts. Significance: The prevalence of arabinan targets in produce plants together with ECP expression may explain the association of pathogenic bacteria in edible plants. Outbreaks of verotoxigenic Escherichia coli are often associated with fresh produce. However, the molecular basis to adherence is unknown beyond ionic lipid-flagellum interactions in plant cell membranes. We demonstrate that arabinans present in different constituents of plant cell walls are targeted for adherence by E. coli common pilus (ECP; or meningitis-associated and temperature-regulated (Mat) fimbriae) for E. coli serotypes O157:H7 and O18:K1:H7. l-Arabinose is a common constituent of plant cell wall that is rarely found in other organisms, whereas ECP is widespread in E. coli and other environmental enteric species. ECP bound to oligosaccharides of at least arabinotriose or longer in a glycan array, plant cell wall pectic polysaccharides, and plant glycoproteins. Recognition overlapped with the antibody LM13, which binds arabinanase-sensitive pectic epitopes, and showed a preferential affinity for (15)--linked l-arabinosyl residues and longer chains of arabinan as demonstrated with the use of arabinan-degrading enzymes. Functional adherence in planta was mediated by the adhesin EcpD in combination with the structural subunit, EcpA, and expression was demonstrated with an ecpR-GFP fusion and ECP antibodies. Spinach was found to be enriched for ECP/LM13 targets compared with lettuce. Specific recognition of arabinosyl residues may help explain the persistence of E. coli in the wider environment and association of verotoxigenic E. coli with some fresh produce plants by exploitation of a glycan found only in plant, not animal, cells.	[Rossez, Yannick; Holmes, Ashleigh; Birse, Louise; Marshall, Jacqueline; Toth, Ian K.; Holden, Nicola J.] James Hutton Inst, Dundee DD2 5DA, Scotland; [Lodberg-Pedersen, Henriette; Willats, William G. T.] Univ Copenhagen, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg Copenhagen, Denmark	James Hutton Institute; University of Copenhagen	Holden, NJ (corresponding author), James Hutton Inst, Dundee DD2 5DA, Scotland.	nicola.holden@hutton.ac.uk	Rossez, Yannick/AAP-3017-2021; Holden, Nicola/B-3038-2009; Holmes, Ashleigh/GYQ-7993-2022; Crozier, Louise/AAM-3490-2020; Holden, Nicola/L-1653-2019	Rossez, Yannick/0000-0001-5435-1373; Holden, Nicola/0000-0002-7904-4529; Holmes, Ashleigh/0000-0002-3627-667X; Holden, Nicola/0000-0002-7904-4529	Leverhulme Trust [RPG-096]; Biotechnology and Biological Sciences Research Council [BB/I014179/1]; BBSRC [BB/I014179/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Leverhulme Trust Grant RPG-096 and the Biotechnology and Biological Sciences Research Council Grant BB/I014179/1.	Alcantar-Curiel MD, 2013, VIRULENCE, V4, P129, DOI 10.4161/viru.22974; Avelino F, 2010, INT J MED MICROBIOL, V300, P440, DOI 10.1016/j.ijmm.2010.02.002; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Berger CN, 2009, ENV MICROBIOL REP, V1, P234, DOI 10.1111/j.1758-2229.2009.00037.x; BLAKE PA, 1980, NEW ENGL J MED, V302, P305, DOI 10.1056/NEJM198002073020601; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Calvin L., 2007, Amber Waves, V5, P24; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P1045; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Clausen MH, 2003, CARBOHYD RES, V338, P1797, DOI 10.1016/S0008-6215(03)00272-6; Collin B, 2012, J SHELLFISH RES, V31, P87, DOI 10.2983/035.031.0111; COLWELL RR, 1977, SCIENCE, V198, P394, DOI 10.1126/science.910135; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Delaquis P, 2007, J FOOD PROTECT, V70, P1966, DOI 10.4315/0362-028X-70.8.1966; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; Doyle MP, 2008, J APPL MICROBIOL, V105, P317, DOI 10.1111/j.1365-2672.2008.03746.x; Duncan MJ, 2005, J BIOL CHEM, V280, P37707, DOI 10.1074/jbc.M501249200; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Etzler M. E., 2009, VIRIDIPLANTAE ESSENT; Feng PCH, 2013, APPL ENVIRON MICROB, V79, P6917, DOI 10.1128/AEM.02455-13; Feng PCH, 2011, APPL ENVIRON MICROB, V77, P343, DOI 10.1128/AEM.01872-10; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Friedman M, 2000, J AGR FOOD CHEM, V48, P2101, DOI 10.1021/jf990489j; Garnett JA, 2012, P NATL ACAD SCI USA, V109, P3950, DOI 10.1073/pnas.1106733109; Grant J, 2008, EMERG INFECT DIS, V14, P1633, DOI 10.3201/eid1410.071341; Hanning IB, 2009, FOODBORNE PATHOG DIS, V6, P635, DOI 10.1089/fpd.2008.0232; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Holden N, 2007, INFECT IMMUN, V75, P3325, DOI 10.1128/IAI.01989-06; Holden N, 2009, FEMS MICROBIOL REV, V33, P689, DOI 10.1111/j.1574-6976.2008.00153.x; Horby PW, 2003, EPIDEMIOL INFECT, V130, P169, DOI 10.1017/S0950268802008063; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; Jones L, 2003, P NATL ACAD SCI USA, V100, P11783, DOI 10.1073/pnas.1832434100; Jones L, 2005, PLANTA, V221, P255, DOI 10.1007/s00425-004-1432-1; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; KIELISZEWSKI MJ, 1995, J BIOL CHEM, V270, P2541, DOI 10.1074/jbc.270.6.2541; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kisiela DI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002733; KNOX JP, 1990, PLANTA, V181, P512, DOI 10.1007/BF00193004; KORHONEN TK, 1980, INFECT IMMUN, V27, P569, DOI 10.1128/IAI.27.2.569-575.1980; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lasaro MA, 2009, APPL ENVIRON MICROB, V75, P246, DOI 10.1128/AEM.01144-08; Lee KJD, 2005, PLANT CELL, V17, P3051, DOI 10.1105/tpc.105.034413; Lehti TA, 2013, MOL MICROBIOL, V87, P1200, DOI 10.1111/mmi.12161; Lehti TA, 2012, MICROBIOL-SGM, V158, P1444, DOI 10.1099/mic.0.056499-0; Lehti TA, 2010, MICROBIOL-SGM, V156, P2408, DOI 10.1099/mic.0.039610-0; Levigne SV, 2004, PLANT PHYSIOL, V134, P1173, DOI 10.1104/pp.103.035311; Lutz C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00375; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; MCMICHAEL JC, 1979, J BACTERIOL, V138, P969, DOI 10.1128/JB.138.3.969-975.1979; Merlin C, 2002, J BACTERIOL, V184, P4573, DOI 10.1128/JB.184.16.4573-4581.2002; Mhedbi-Hajri N, 2011, ADV EXP MED BIOL, V715, P71, DOI 10.1007/978-94-007-0940-9_5; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Moller I, 2008, GLYCOCONJUGATE J, V25, P37, DOI 10.1007/s10719-007-9059-7; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Pouttu R, 2001, J BACTERIOL, V183, P4727, DOI 10.1128/JB.183.16.4727-4736.2001; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Rodriguez-Navarro DN, 2007, FEMS MICROBIOL LETT, V272, P127, DOI 10.1111/j.1574-6968.2007.00761.x; Ross HA, 2011, PLANT BIOTECHNOL J, V9, P848, DOI 10.1111/j.1467-7652.2011.00591.x; Rossez Y, 2014, ENVIRON MICROBIOL, V16, P2181, DOI 10.1111/1462-2920.12315; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Saldana Z, 2009, J BACTERIOL, V191, P3451, DOI 10.1128/JB.01539-08; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; SMALLWOOD M, 1995, PLANTA, V196, P510, DOI 10.1007/BF00203651; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Valentin-Bon I, 2008, APPL ENVIRON MICROB, V74, P1240, DOI 10.1128/AEM.02258-07; Verhertbruggen Y, 2009, PLANT J, V59, P413, DOI 10.1111/j.1365-313X.2009.03876.x; WEINSTEIN L, 1979, PLANT PHYSIOL, V63, P425, DOI 10.1104/pp.63.3.425; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399; Westerlund-Wikstrom B, 1997, PROTEIN ENG, V10, P1319, DOI 10.1093/protein/10.11.1319; Westphal Y, 2010, CARBOHYD RES, V345, P1180, DOI 10.1016/j.carres.2010.03.042; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Wright KM, 2013, PHYTOPATHOLOGY, V103, P333, DOI 10.1094/PHYTO-08-12-0209-FI; Yates EA, 1996, GLYCOBIOLOGY, V6, P131, DOI 10.1093/glycob/6.2.131	80	22	23	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34349	34365		10.1074/jbc.M114.587717	http://dx.doi.org/10.1074/jbc.M114.587717			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25320086	Green Published, hybrid			2022-12-28	WOS:000346077600055
J	Vreeland, AC; Levi, L; Zhang, W; Berry, DC; Noy, N				Vreeland, Amanda C.; Levi, Liraz; Zhang, Wei; Berry, Daniel C.; Noy, Noa			Cellular Retinoic Acid-binding Protein 2 Inhibits Tumor Growth by Two Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Nucleus; Retinoic Acid; Retinoid-binding Protein; RNA-binding Protein; HuR; Nuclear Import; Export	ACTIVATED RECEPTOR-BETA/DELTA; BREAST-CANCER CELLS; SIGNALING PATHWAY; STRUCTURAL BASIS; GENE-EXPRESSION; RAR AGONISTS; PPAR-BETA; HUR; SUPPRESSION; APOPTOSIS	Background: CRABP2 delivers RA to its cognate nuclear receptor RAR and regulates gene expression by cooperating with HuR in stabilizing mRNAs. Results: In conjunction with HuR, CRABP2 regulates the expression of multiple cancer-related genes and suppresses tumor growth. Conclusion: The anticarcinogenic activities of CRABP2 are mediated by both HuR and RAR. Significance: The data demonstrate a novel mechanism through which CRABP2 inhibits tumorigenesis. Cellular retinoic acid-binding protein 2 (CRABP2) potently suppresses the growth of various carcinomas, but the mechanism(s) that underlies this activity remains incompletely understood. CRABP2 displays two distinct functions. The classical function of this protein is to directly deliver retinoic acid (RA) to RA receptor (RAR), a nuclear receptor activated by this hormone, in turn inducing the expression of multiple antiproliferative genes. The other function of the protein is exerted in the absence of RA and mediated by the RNA-binding and stabilizing protein HuR. CRABP2 directly binds to HuR, markedly strengthens its interactions with target mRNAs, and thus increases their stability and up-regulates their expression. Here we show that the anticarcinogenic activities of CRABP2 are mediated by both of its functions. Transcriptome analyses revealed that, in the absence of RA, a large cohort of transcripts is regulated in common by CRABP2 and HuR, and many of these are involved in regulation of oncogenic properties. Furthermore, both in cultured cells and in vivo, CRABP2 or a CRABP2 mutant defective in its ability to cooperate with RAR but competent in interactions with HuR suppressed carcinoma growth and did so in the absence of RA. Hence, transcript stabilization by the CRABP2-HuR complex significantly contributes to the ability of CRABP2 to inhibit tumorigenesis. Surprisingly, the observations also revealed that HuR regulates the expression of multiple genes involved in nuclear pore formation and is required for nuclear import of CRABP2 and for transcriptional activation by RAR. The data thus point at a novel function for this important protein.	[Vreeland, Amanda C.; Levi, Liraz; Zhang, Wei; Berry, Daniel C.; Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44195 USA; [Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44195 USA; [Vreeland, Amanda C.; Levi, Liraz; Zhang, Wei; Noy, Noa] Cleveland Clin Fdn, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Noy, N (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Cellular & Mol Med, 9500 Euclid Ave NC10, Cleveland, OH 44195 USA.	nxn51@case.edu	Zhang, Wei/G-8229-2016	Levi, Liraz/0000-0001-7462-2396; Zhang, Wei/0000-0003-2691-2721	National Institutes of Health [P30CA43703]; National Institutes of Health Office of Research Infrastructure Programs [S10RR021228]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA166955] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Office of Research Infrastructure Programs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Cecile Rochette-Egly (Institut Genetique Biologie Moleculaire Cellulaire, Strasbourg, France) for CRABP2 antibodies. The core facilities of the Case Comprehensive Cancer Center are supported by National Institutes of Health Grant P30CA43703. The Imaging Core Facility, Department of Genetics and Genome Sciences, Case Western Reserve University, is supported by the National Institutes of Health Office of Research Infrastructure Programs under Award S10RR021228.	Afonja O, 2004, ONCOGENE, V23, P8135, DOI 10.1038/sj.onc.1207983; Afonja O, 2002, ONCOGENE, V21, P7850, DOI 10.1038/sj.onc.1205985; Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Armstrong EH, 2014, J BIOL CHEM, V289, P14941, DOI 10.1074/jbc.M113.514646; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Budhu A, 2001, J MOL BIOL, V305, P939, DOI 10.1006/jmbi.2000.4340; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Donato LJ, 2007, CANCER RES, V67, P609, DOI 10.1158/0008-5472.CAN-06-0989; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Gubin MM, 2010, CELL CYCLE, V9, P3337, DOI 10.4161/cc.9.16.12711; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Jing YK, 1997, CANCER RES, V57, P1668; Latorre E, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-13; Levi L, 2013, CANCER RES, V73, P4770, DOI 10.1158/0008-5472.CAN-13-0384; Manor D, 2003, CANCER RES, V63, P4426; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Montagner A, 2014, EMBO MOL MED, V6, P80, DOI 10.1002/emmm.201302666; Morgan E, 2010, PPAR RES, V2010, DOI 10.1155/2010/234629; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Venkitaraman AR, 2014, MOL CELLS, V37, P95, DOI 10.14348/molcells.2014.2346; Vreeland AC, 2014, MOL CELL BIOL, V34, P2135, DOI 10.1128/MCB.00281-14; Zacheis D, 1999, J MED CHEM, V42, P4434, DOI 10.1021/jm990292i	37	21	24	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34065	34073		10.1074/jbc.M114.604041	http://dx.doi.org/10.1074/jbc.M114.604041			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25320093	hybrid, Green Published			2022-12-28	WOS:000346077600032
J	Takatsu, H; Tanaka, G; Segawa, K; Suzuki, J; Nagata, S; Nakayama, K; Shin, HW				Takatsu, Hiroyuki; Tanaka, Gaku; Segawa, Katsumori; Suzuki, Jun; Nagata, Shigekazu; Nakayama, Kazuhisa; Shin, Hye-Won			Phospholipid Flippase Activities and Substrate Specificities of Human Type IV P-type ATPases Localized to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; BILE CANALICULAR MEMBRANE; AMINOPHOSPHOLIPID TRANSLOCASE; HEREDITARY CHOLESTASIS; SUBCELLULAR-LOCALIZATION; ATP8B1 DEFICIENCY; CDC50 PROTEINS; IN-VIVO; EXPRESSION; PHOSPHATIDYLSERINE	Type IV P-type ATPases (P4-ATPases) are believed to translocate aminophospholipids from the exoplasmic to the cytoplasmic leaflets of cellular membranes. The yeast P4-ATPases, Drs2p and Dnf1p/Dnf2p, flip nitrobenzoxadiazole-labeled phosphatidylserine at the Golgi complex and nitrobenzoxadiazole-labeled phosphatidylcholine (PC) at the plasma membrane, respectively. However, the flippase activities and substrate specificities of mammalian P4-ATPases remain incompletely characterized. In this study, we established an assay for phospholipid flippase activities of plasma membrane-localized P4-ATPases using human cell lines stably expressing ATP8B1, ATP8B2, ATP11A, and ATP11C. We found that ATP11A and ATP11C have flippase activities toward phosphatidylserine and phosphatidylethanolamine but not PC or sphingomyelin. By contrast, ATPase-deficient mutants of ATP11A and ATP11C did not exhibit any flippase activity, indicating that these enzymes catalyze flipping in an ATPase-dependent manner. Furthermore, ATP8B1 and ATP8B2 exhibited preferential flippase activities toward PC. Some ATP8B1 mutants found in patients of progressive familial intrahepatic cholestasis type 1 (PFIC1), a severe liver disease caused by impaired bile flow, failed to translocate PC despite their delivery to the plasma membrane. Moreover, incorporation of PC mediated by ATP8B1 can be reversed by simultaneous expression of ABCB4, a PC floppase mutated in PFIC3 patients. Our findings elucidate the flippase activities and substrate specificities of plasma membrane-localized human P4-ATPases and suggest that phenotypes of some PFIC1 patients result from impairment of the PC flippase activity of ATP8B1.	[Takatsu, Hiroyuki; Shin, Hye-Won] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto 6068501, Japan; [Takatsu, Hiroyuki; Tanaka, Gaku; Nakayama, Kazuhisa; Shin, Hye-Won] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Segawa, Katsumori; Suzuki, Jun; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Kyoto University	Shin, HW (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	shin@pharm.kyoto-u.ac.jp	Shin, Hye-Won/P-5398-2018; Nakayama, Kazuhisa/ABF-2924-2020; Nagata, Shigekazu/AAG-3203-2019	Shin, Hye-Won/0000-0002-9138-9554; Nagata, Shigekazu/0000-0001-9758-8426; Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science and Technology of Japan; Special Coordination Fund for Promoting Science and Technology; Takeda Science Foundation; Inamori Foundation; Grants-in-Aid for Scientific Research [22000013, 25113514] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Fund for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Inamori Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Special Coordination Fund for Promoting Science and Technology; the Takeda Science Foundation; and the Inamori Foundation.	Anthonisen AN, 2006, J BIOL CHEM, V281, P31572, DOI 10.1074/jbc.M605194200; Baldridge RD, 2013, J BIOL CHEM, V288, P19516, DOI 10.1074/jbc.M113.476911; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; BUSCHMAN E, 1992, J BIOL CHEM, V267, P18093; Cai SY, 2009, GASTROENTEROLOGY, V136, P1060, DOI 10.1053/j.gastro.2008.10.025; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Davit-Spraul A, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-1; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Folmer DE, 2009, HEPATOLOGY, V50, P1597, DOI 10.1002/hep.23158; FUKUNAGA R, 1990, J BIOL CHEM, V265, P14008; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Groen A, 2011, GASTROENTEROLOGY, V141, P1927, DOI 10.1053/j.gastro.2011.07.042; Jacquemin E, 2012, CLIN RES HEPATOL GAS, V36, pS26, DOI 10.1016/S2210-7401(12)70018-9; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morita S, 2007, HEPATOLOGY, V46, P188, DOI 10.1002/hep.21591; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Nicolaou M, 2012, J PATHOL, V226, P300, DOI 10.1002/path.3019; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pawlikowska L, 2004, HUM MOL GENET, V13, P881, DOI 10.1093/hmg/ddh100; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Ray NB, 2010, NAT MED, V16, P1120, DOI 10.1038/nm.2213; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Stone A, 2012, J BIOL CHEM, V287, P41139, DOI 10.1074/jbc.M112.413039; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Ujhazy P, 2001, HEPATOLOGY, V34, P768, DOI 10.1053/jhep.2001.27663; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; van der Velden LM, 2010, HEPATOLOGY, V51, P286, DOI 10.1002/hep.23268; Verhulst PM, 2010, HEPATOLOGY, V51, P2049, DOI 10.1002/hep.23586; Williamson P, 2002, BBA-MOL CELL BIOL L, V1585, P53, DOI 10.1016/S1388-1981(02)00324-4; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	46	76	77	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33543	33556		10.1074/jbc.M114.593012	http://dx.doi.org/10.1074/jbc.M114.593012			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25315773	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000345636600041
J	Tal, O; Trabelcy, B; Gerchman, Y; Adir, N				Tal, Ofir; Trabelcy, Beny; Gerchman, Yoram; Adir, Noam			Investigation of Phycobilisome Subunit Interaction Interfaces by Coupled Cross-linking and Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY-TRANSFER PATHWAYS; CRYSTAL-STRUCTURE; CYANOBACTERIAL PHYCOBILISOMES; C-PHYCOCYANIN; 2.2 ANGSTROM; WEB SERVER; MODEL; ALLOPHYCOCYANIN; PHYCOBILIPROTEINS; PHYCOERYTHRIN	The phycobilisome (PBS) is an extremely large light-harvesting complex, common in cyanobacteria and red algae, composed of rods and core substructures. These substructures are assembled from chromophore-bearing phycocyanin and allophycocyanin subunits, nonpigmented linker proteins and in some cases additional subunits. To date, despite the determination of crystal structures of isolated PBS components, critical questions regarding the interaction and energy flow between rods and core are still unresolved. Additionally, the arrangement of minor PBS components located inside the core cylinders is unknown. Different models of the general architecture of the PBS have been proposed, based on low resolution images from electron microscopy or high resolution crystal structures of isolated components. This work presents a model of the assembly of the rods onto the core arrangement and for the positions of inner core components, based on cross-linking and mass spectrometry analysis of isolated, functional intact Thermosynechococcus vulcanus PBS, as well as functional crosslinked adducts. The experimental results were utilized to predict potential docking interactions of different protein pairs. Combining modeling and cross-linking results, we identify specific interactions within the PBS subcomponents that enable us to suggest possible functional interactions between the chromophores of the rods and the core and improve our understanding of the assembly, structure, and function of PBS.	[Tal, Ofir; Adir, Noam] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel; [Trabelcy, Beny; Gerchman, Yoram] Univ Haifa, Fac Nat Sci, Dept Biol, IL-36006 Tivon, Israel	Technion Israel Institute of Technology; University of Haifa	Adir, N (corresponding author), Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel.	nadir@tx.technion.ac.il	Adir, Noam/ABE-6990-2020; Gerchman, Yoram/H-4698-2019; Gerchman, Yoram/F-5226-2015	Gerchman, Yoram/0000-0002-8637-9589	United States-Israel Binational Science Fund [2009406]; Israel Science Foundation [1576/12]; Nancy and Stephen Grand Technion Energy Program; Technion Russell Berrie Nanotechnology Institute	United States-Israel Binational Science Fund; Israel Science Foundation(Israel Science Foundation); Nancy and Stephen Grand Technion Energy Program; Technion Russell Berrie Nanotechnology Institute	This work was supported by United States-Israel Binational Science Fund Grant 2009406 and Israel Science Foundation Grant 1576/12. We also acknowledge the support from the Nancy and Stephen Grand Technion Energy Program and the Technion Russell Berrie Nanotechnology Institute.	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Adir N, 2003, J BIOL CHEM, V278, P25926, DOI 10.1074/jbc.M302838200; Adir N., 2008, PHOTOSYNTHETIC PROTE, P243, DOI DOI 10.1002/9783527623464.CH11; Adir N., 2006, COMPLEX INTRACELLULA, VVolume 2, P47; Anderson LK, 1998, MOL MICROBIOL, V30, P467, DOI 10.1046/j.1365-2958.1998.01081.x; APT KE, 1995, J MOL BIOL, V248, P79, DOI 10.1006/jmbi.1995.0203; Arteni AA, 2008, PHOTOSYNTH RES, V95, P169, DOI 10.1007/s11120-007-9264-z; Arteni AA, 2009, BBA-BIOENERGETICS, V1787, P272, DOI 10.1016/j.bbabio.2009.01.009; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BRYANT DA, 1979, ARCH MICROBIOL, V123, P113, DOI 10.1007/BF00446810; CAPUANO V, 1991, J BIOL CHEM, V266, P7239; Chen M, 2009, FEBS LETT, V583, P2535, DOI 10.1016/j.febslet.2009.07.012; Choi H, 2008, J PROTEOME RES, V7, P47, DOI 10.1021/pr700747q; Cogdell RJ, 2008, PHOTOCH PHOTOBIO SCI, V7, P1150, DOI 10.1039/b807201a; Cogdell RJ, 2004, PHOTOSYNTH RES, V81, P207, DOI 10.1023/B:PRES.0000036883.56959.a9; Collins AM, 2012, PLANT PHYSIOL, V158, P1600, DOI 10.1104/pp.111.192849; Croce R, 2013, PHOTOSYNTH RES, V116, P153, DOI 10.1007/s11120-013-9838-x; Curutchet C, 2011, J AM CHEM SOC, V133, P3078, DOI 10.1021/ja110053y; David L, 2014, BBA-BIOENERGETICS, V1837, P385, DOI 10.1016/j.bbabio.2013.12.014; David L, 2011, J MOL BIOL, V405, P201, DOI 10.1016/j.jmb.2010.10.036; de Marsac NT, 2003, PHOTOSYNTH RES, V76, P197; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dong CX, 2009, BBA-BIOENERGETICS, V1787, P1122, DOI 10.1016/j.bbabio.2009.04.007; EDWARDS MR, 1971, J CELL BIOL, V50, P896, DOI 10.1083/jcb.50.3.896; FICNER R, 1992, J MOL BIOL, V228, P935, DOI 10.1016/0022-2836(92)90876-L; Figueroa M, 2012, PROTEIN SCI, V21, P1921, DOI 10.1002/pro.2176; Fournier CT, 2012, J PROTEOME RES, V11, P5712, DOI 10.1021/pr300538f; GANTT E, 1966, J CELL BIOL, V29, P423, DOI 10.1083/jcb.29.3.423; Gao X, 2012, MOL MICROBIOL, V85, P907, DOI 10.1111/j.1365-2958.2012.08152.x; Gao X, 2011, MOL MICROBIOL, V82, P698, DOI 10.1111/j.1365-2958.2011.07844.x; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GLAZER AN, 1983, ANN INST PASTEUR MIC, VB134, P159, DOI 10.1016/S0769-2609(83)80103-3; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; HOLZWARTH AR, 1990, BIOPHYS J, V57, P133, DOI 10.1016/S0006-3495(90)82514-5; Jallet D, 2012, BBA-BIOENERGETICS, V1817, P1418, DOI 10.1016/j.bbabio.2011.11.020; Jiang T, 1999, PROTEINS, V34, P224; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Kondo K, 2005, PHOTOSYNTH RES, V84, P269, DOI 10.1007/s11120-004-7762-9; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krogmann DW, 2007, PHOTOSYNTH RES, V93, P27, DOI 10.1007/s11120-007-9133-9; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Liu HJ, 2013, SCIENCE, V342, P1104, DOI 10.1126/science.1242321; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Marx A, 2013, BBA-BIOENERGETICS, V1827, P311, DOI 10.1016/j.bbabio.2012.11.006; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Matamala AR, 2007, J COMPUT CHEM, V28, P1200, DOI 10.1002/jcc.20628; McGregor A, 2008, J MOL BIOL, V384, P406, DOI 10.1016/j.jmb.2008.09.018; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Mullineaux CW, 2008, PHOTOSYNTH RES, V95, P175, DOI 10.1007/s11120-007-9249-y; Noy D, 2008, PHOTOSYNTH RES, V95, P23, DOI 10.1007/s11120-007-9269-7; Ren YL, 2013, J COMPUT CHEM, V34, P1005, DOI 10.1002/jcc.23221; Reuter W, 1999, P NATL ACAD SCI USA, V96, P1363, DOI 10.1073/pnas.96.4.1363; SAUER K, 1988, BIOCHIM BIOPHYS ACTA, V936, P157, DOI 10.1016/0005-2728(88)90232-0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SUTER GW, 1987, BIOPHYS J, V52, P673, DOI 10.1016/S0006-3495(87)83262-9; Tian LJ, 2012, BIOPHYS J, V102, P1692, DOI 10.1016/j.bpj.2012.03.008; Tian LJ, 2011, J AM CHEM SOC, V133, P18304, DOI 10.1021/ja206414m; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; van Amerongen H, 2013, PHOTOSYNTH RES, V116, P251, DOI 10.1007/s11120-013-9824-3; Watanabe M, 2013, PHOTOSYNTH RES, V116, P265, DOI 10.1007/s11120-013-9905-3; Womick JM, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3457378; Xu H, 2009, BIOINFORMATICS, V25, P1341, DOI 10.1093/bioinformatics/btp155; Zhang H, 2014, BIOCHEMISTRY-US, V53, P13, DOI 10.1021/bi401539w	64	15	16	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33084	33097		10.1074/jbc.M114.595942	http://dx.doi.org/10.1074/jbc.M114.595942			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25296757	hybrid, Green Published			2022-12-28	WOS:000345636600003
J	Grey, M; Dunning, CJ; Gaspar, R; Grey, C; Brundin, P; Sparr, E; Linse, S				Grey, Marie; Dunning, Christopher J.; Gaspar, Ricardo; Grey, Carl; Brundin, Patrik; Sparr, Emma; Linse, Sara			Acceleration of alpha-Synuclein Aggregation by Exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						{alpha}-Synuclein; Amyloid; Exosome; Fibril; Fluorescence; Lipid; Mass Spectrometry (MS); Membrane; Parkinson Disease; Protein Aggregation	PARKINSONS-DISEASE; GM1 GANGLIOSIDE; BETA-PROTEIN; ALZHEIMERS-DISEASE; LYSOSOMAL DYSFUNCTION; LEWY BODY; IN-VIVO; NUCLEATION; MECHANISM; BINDING	Background: Cell-to-cell transmission of -syn via exosomes has been proposed to propagate Parkinson disease pathology. Results: Exosomes contain gangliosides, several other lipid classes, and proteins. Exosomes and ganglioside vesicles accelerate -syn aggregation. Vesicles made of other membrane lipids do not. Conclusion: Exosomes provide catalytic environments for nucleation of -syn aggregation. Significance: Revealing factors that promote -syn aggregation may provide insight into Parkinson disease pathogenesis. Exosomes are small vesicles released from cells into extracellular space. We have isolated exosomes from neuroblastoma cells and investigated their influence on the aggregation of -synuclein, a protein associated with Parkinson disease pathology. Using cryo-transmission electron microscopy of exosomes, we found spherical unilamellar vesicles with a significant protein content, and Western blot analysis revealed that they contain, as expected, the proteins Flotillin-1 and Alix. Using thioflavin T fluorescence to monitor aggregation kinetics, we found that exosomes catalyze the process in a similar manner as a low concentration of preformed -synuclein fibrils. The exosomes reduce the lag time indicating that they provide catalytic environments for nucleation. The catalytic effects of exosomes derived from naive cells and cells that overexpress -synuclein do not differ. Vesicles prepared from extracted exosome lipids accelerate aggregation, suggesting that the lipids in exosomes are sufficient for the catalytic effect to arise. Using mass spectrometry, we found several phospholipid classes in the exosomes, including phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine, phosphatidylinositol, and the gangliosides GM2 and GM3. Within each class, several species with different acyl chains were identified. We then prepared vesicles from corresponding pure lipids or defined mixtures, most of which were found to retard -synuclein aggregation. As a striking exception, vesicles containing ganglioside lipids GM1 or GM3 accelerate the process. Understanding how -synuclein interacts with biological membranes to promote neurological disease might lead to the identification of novel therapeutic targets.	[Grey, Marie; Gaspar, Ricardo; Sparr, Emma] Lund Univ, Wallenberg Neurosci Ctr, Dept Phys Chem, SE-22100 Lund, Sweden; [Dunning, Christopher J.; Gaspar, Ricardo; Linse, Sara] Lund Univ, Wallenberg Neurosci Ctr, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden; [Grey, Carl] Lund Univ, Wallenberg Neurosci Ctr, Dept Biotechnol, SE-22100 Lund, Sweden; [Brundin, Patrik] Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, SE-22100 Lund, Sweden; [Brundin, Patrik] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI 49503 USA	Lund University; Lund University; Lund University; Lund University; Van Andel Institute	Brundin, P (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, SE-22100 Lund, Sweden.	patrik.brundin@vai.org; emma.sparr@fkem1.lu.se; sara.linse@biochemistry.lu.se	Dunning, Christopher/A-5503-2015	Dunning, Christopher/0000-0002-2101-030X; Sparr, Emma/0000-0001-8343-9657; Linse, Sara/0000-0001-9629-7109; Gaspar, Ricardo/0000-0002-6454-7633	Swedish Research Council, Linneaus Center for Organizing Molecular Matter; Swedish Research Council, Linneaus Center for Bagadilico; European Research Council; Parkinsonfonden; Crafoord Foundation; Hjarnfonden; Swedish Foundation for Strategic Research; Strong Research Environment Multipark (Multidisciplinary Research in Parkinson Disease at Lund University)	Swedish Research Council, Linneaus Center for Organizing Molecular Matter(Swedish Research Council); Swedish Research Council, Linneaus Center for Bagadilico(Swedish Research Council); European Research Council(European Research Council (ERC)European Commission); Parkinsonfonden; Crafoord Foundation; Hjarnfonden; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Strong Research Environment Multipark (Multidisciplinary Research in Parkinson Disease at Lund University)	This work was supported by the Swedish Research Council and its Linneaus Centers for Organizing Molecular Matter (to E. S. and S. L.) and Bagadilico (to M. G., C. J. D., and P. B.), the European Research Council Advanced Awards (to S. L. and P. B.), Parkinsonfonden (to C. J. D.), the Crafoord Foundation (to C. J. D.), Swedish Research Council (to S. L., E. S., and P. B.), Hjarnfonden (to P. B.), the Swedish Foundation for Strategic Research (E. S.), and by the Strong Research Environment Multipark (Multidisciplinary Research in Parkinson Disease at Lund University).	Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Arosio P, 2014, J AM CHEM SOC, V136, P219, DOI 10.1021/ja408765u; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonini NM, 2005, CELL, V123, P359, DOI 10.1016/j.cell.2005.10.017; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cabaleiro-Lago C, 2010, ACS CHEM NEUROSCI, V1, P279, DOI 10.1021/cn900027u; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chang CW, 2013, NEUROSCI LETT, V548, P190, DOI 10.1016/j.neulet.2013.06.009; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chivet M, 2013, BIOCHEM SOC T, V41, P241, DOI 10.1042/BST20120266; Chivet M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00145; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cole NB, 2008, EXP CELL RES, V314, P2076, DOI 10.1016/j.yexcr.2008.03.012; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Dehay B, 2012, AUTOPHAGY, V8, P1389, DOI 10.4161/auto.21011; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Dunning CJR, 2013, PRION, V7, P92, DOI 10.4161/pri.23806; Dunning CJR, 2012, PROG NEUROBIOL, V97, P205, DOI 10.1016/j.pneurobio.2011.11.003; Ejlerskov P, 2013, J BIOL CHEM, V288, P17313, DOI 10.1074/jbc.M112.401174; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Graham JM, 1999, MOVEMENT DISORD, V14, P10; Grey M, 2011, J PARKINSON DIS, V1, P359, DOI 10.3233/JPD-2011-11067; Halliday GM, 2011, ACTA NEUROPATHOL, V122, P187, DOI 10.1007/s00401-011-0852-9; Halliday GM, 2005, BRAIN, V128, P2654, DOI 10.1093/brain/awh584; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Harrower TP, 2005, EXP NEUROL, V195, P1, DOI 10.1016/j.expneurol.2005.06.002; Hellstrand E, 2013, ACS CHEM NEUROSCI, V4, P1339, DOI 10.1021/cn400066t; Hellstrand E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077235; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Hoshino T, 2013, J PHYS CHEM B, V117, P8085, DOI 10.1021/jp4029062; Jaspard F, 2003, PHYSIOL MEAS, V24, P137, DOI 10.1088/0967-3334/24/1/310; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Keilani S, 2012, J NEUROSCI, V32, P5223, DOI 10.1523/JNEUROSCI.4860-11.2012; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; Meisl G, 2014, P NATL ACAD SCI USA, V111, P9384, DOI 10.1073/pnas.1401564111; Michel CH, 2014, J BIOL CHEM, V289, P956, DOI 10.1074/jbc.M113.515445; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Okada T, 2008, J MOL BIOL, V382, P1066, DOI 10.1016/j.jmb.2008.07.072; Olofsson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073040; Pan-Montojo F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00898; Pfefferkorn CM, 2012, BIOPHYS J, V102, P613, DOI 10.1016/j.bpj.2011.12.051; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rabe M, 2013, ACS CHEM NEUROSCI, V4, P408, DOI 10.1021/cn3001312; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sani MA, 2011, FEBS LETT, V585, P749, DOI 10.1016/j.febslet.2011.02.011; Schapira AHV, 2009, TRENDS PHARMACOL SCI, V30, P41, DOI 10.1016/j.tips.2008.10.005; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Vingtdeux V, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00229; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Ximerakis M, 2014, FASEB J, V28, P3146, DOI 10.1096/fj.13-245852; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	85	245	250	8	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2969	2982		10.1074/jbc.M114.585703	http://dx.doi.org/10.1074/jbc.M114.585703			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25425650	Green Published, hybrid			2022-12-28	WOS:000349310700035
J	Dellero, Y; Mauve, C; Boex-Fontvieille, E; Flesch, V; Jossier, M; Tcherkez, G; Hodges, M				Dellero, Younes; Mauve, Caroline; Boex-Fontvieille, Edouard; Flesch, Valerie; Jossier, Mathieu; Tcherkez, Guillaume; Hodges, Michael			Experimental Evidence for a Hydride Transfer Mechanism in Plant Glycolate Oxidase Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE STRUCTURE; ACTIVE-SITE; FLAVOCYTOCHROME B(2); LACTATE OXIDASE; ACID OXIDASE; DEUTERIUM; PURIFICATION; OXIDATION; SOLVENT; BINDING	In plants, glycolate oxidase is involved in the photorespiratory cycle, one of the major fluxes at the global scale. To clarify both the nature of the mechanism and possible differences in glycolate oxidase enzyme chemistry from C-3 and C-4 plant species, we analyzed kinetic parameters of purified recombinant C-3 (Arabidopsis thaliana) and C-4 (Zea mays) plant enzymes and compared isotope effects using natural and deuterated glycolate in either natural or deuterated solvent. The C-12/C-13 isotope effect was also investigated for each plant glycolate oxidase protein by measuring the C-13 natural abundance in glycolate using natural or deuterated glycolate as a substrate. Our results suggest that several elemental steps were associated with an hydrogen/deuterium isotope effect and that glycolate alpha-deprotonation itself was only partially rate-limiting. Calculations of commitment factors from observed kinetic isotope effect values support a hydride transfer mechanism. No significant differences were seen between C-3 and C-4 enzymes.	[Dellero, Younes; Mauve, Caroline; Boex-Fontvieille, Edouard; Flesch, Valerie; Jossier, Mathieu; Tcherkez, Guillaume; Hodges, Michael] Univ Paris 11, Inst Biol Plantes, CNRS, UMR8618, F-91405 Orsay, France; [Mauve, Caroline; Tcherkez, Guillaume] Inst Biol Plantes, F-91405 Orsay, France; [Tcherkez, Guillaume] Inst Univ France, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut Universitaire de France	Hodges, M (corresponding author), Univ Paris 11, Inst Biol Plantes, CNRS, UMR8618, Batiment 630, F-91405 Orsay, France.	michael.hodges@u-psud.fr	Hodges, Michael/A-8883-2008; Jossier, Mathieu/K-3375-2013; Tcherkez, Guillaume/L-1300-2015; mauve, caroline/ABF-8601-2021	Dellero, Younes/0000-0001-6038-8199	French State Grants [ANR-10-LABX-0040-SPS, ANR-11-IDEX-0003-02]; ANR [JC 12-0001-01]; CNRS; Universite Paris Sud; French Ministry of Higher Education and Research	French State Grants; ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Sud; French Ministry of Higher Education and Research	This work was supported in part by French State Grants ANR-10-LABX-0040-SPS (managed by the French National Research Agency under the Investments for the Future Program ANR-11-IDEX-0003-02) and ANR JC 12-0001-01 (to G. T.), the CNRS, and the Universite Paris Sud.; Supported by a Ph.D. grant from the French Ministry of Higher Education and Research.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5627, DOI 10.1021/bi00670a031; Bourhis JM, 2009, ACTA CRYSTALLOGR F, V65, P1246, DOI 10.1107/S1744309109041670; Cleland WW, 2005, ARCH BIOCHEM BIOPHYS, V433, P2, DOI 10.1016/j.abb.2004.08.027; Devi MT, 1996, PHOTOSYNTH RES, V47, P231, DOI 10.1007/BF02184284; Diep Le K. H., 1991, J BIOL CHEM, V266, P20877; Esser C, 2014, MOL BIOL EVOL, V31, P1089, DOI 10.1093/molbev/msu041; FENDRICH G, 1982, BIOCHIM BIOPHYS ACTA, V702, P242, DOI 10.1016/0167-4838(82)90509-X; Fitzpatrick PF, 2007, J LABELLED COMPD RAD, V50, P1016, DOI 10.1002/jlcr.1400; Friend AD, 2010, J EXP BOT, V61, P1293, DOI 10.1093/jxb/erq019; Furuichi M, 2008, J MOL BIOL, V378, P436, DOI 10.1016/j.jmb.2008.02.062; GHISLA S, 1977, J BIOL CHEM, V252, P6729; Gluza K., 2013, DRUG DISCOVERY, P325, DOI [10.5772/52504, DOI 10.5772/52504]; Hackenberg C, 2011, PLANT CELL, V23, P2978, DOI 10.1105/tpc.111.088070; HARDY RC, 1949, J RES NAT BUR STAND, V42, P573, DOI 10.6028/jres.042.049; HERMES JD, 1984, BIOCHEMISTRY-US, V23, P5479, DOI 10.1021/bi00318a016; Hodges M, 2013, PLANT BIOLOGY, V15, P694, DOI 10.1111/j.1438-8677.2012.00719.x; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; Kurtz KA, 2000, J AM CHEM SOC, V122, P12896, DOI 10.1021/ja002528+; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDQVIST Y, 1989, J BIOL CHEM, V264, P3624; MACHEROUX P, 1993, EUR J BIOCHEM, V213, P1047, DOI 10.1111/j.1432-1033.1993.tb17852.x; MACHEROUX P, 1991, BIOCHEMISTRY-US, V30, P4612, DOI 10.1021/bi00232a036; MUH U, 1994, J BIOL CHEM, V269, P7989; NISHIMURA M, 1983, ARCH BIOCHEM BIOPHYS, V222, P397, DOI 10.1016/0003-9861(83)90536-2; Nolke G, 2014, PLANT BIOTECHNOL J, V12, P734, DOI 10.1111/pbi.12178; Ortega-Galisteo AP, 2012, J EXP BOT, V63, P2089, DOI 10.1093/jxb/err414; Pennati A, 2011, BIOCHEMISTRY-US, V50, P1, DOI 10.1021/bi101387w; Pennati A, 2009, J BIOL CHEM, V284, P31214, DOI 10.1074/jbc.M109.040063; Peterhansel C, 2013, PLANT BIOLOGY, V15, P754, DOI 10.1111/j.1438-8677.2012.00681.x; Pollegioni L, 1997, J BIOL CHEM, V272, P4924, DOI 10.1074/jbc.272.8.4924; Popov VN, 2003, J PLANT PHYSIOL, V160, P851, DOI 10.1078/0176-1617-01105; Quaye O, 2008, BIOCHEMISTRY-US, V47, P243, DOI 10.1021/bi7017943; Ralph EC, 2007, BIOCHEMISTRY-US, V46, P7655, DOI 10.1021/bi700482h; Ralph EC, 2006, BIOCHEMISTRY-US, V45, P15844, DOI 10.1021/bi061894o; RENDINA AR, 1984, BIOCHEMISTRY-US, V23, P6257, DOI 10.1021/bi00320a056; RICHARDSON K, 1961, J BIOL CHEM, V236, P1280; Rocha Maria Joao, 2003, BMC Biochem, V4, P2, DOI 10.1186/1471-2091-4-2; SCHARSCHMIDT M, 1984, BIOCHEMISTRY-US, V23, P5471, DOI 10.1021/bi00318a015; Sobrado P, 2003, BIOCHEMISTRY-US, V42, P15208, DOI 10.1021/bi035546n; Sobrado P, 2001, BIOCHEMISTRY-US, V40, P994, DOI 10.1021/bi002283d; Stenberg K, 1997, PROTEIN SCI, V6, P1009, DOI 10.1002/pro.5560060506; STENBERG K, 1995, EUR J BIOCHEM, V228, P408; Takeda M, 2009, J AM CHEM SOC, V131, P18556, DOI 10.1021/ja907911y; Tcherkez G, 2011, TRENDS PLANT SCI, V16, P499, DOI 10.1016/j.tplants.2011.05.010; Tcherkez GGB, 2013, BIOCHEMISTRY-US, V52, P869, DOI 10.1021/bi300933u; Timm S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042809; Tsai CL, 2007, BIOCHEMISTRY-US, V46, P7844, DOI 10.1021/bi7005543; Vignaud C, 2007, ARCH BIOCHEM BIOPHYS, V465, P410, DOI 10.1016/j.abb.2007.06.021; WILLIAMS HE, 1968, AM J MED, V45, P715, DOI 10.1016/0002-9343(68)90207-6; WILLIAMS HWR, 1983, J MED CHEM, V26, P1196, DOI 10.1021/jm00362a020; Zelitch I, 2009, PLANT PHYSIOL, V149, P195, DOI 10.1104/pp.108.128439	51	22	23	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1689	1698		10.1074/jbc.M114.618629	http://dx.doi.org/10.1074/jbc.M114.618629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25416784	Green Published, hybrid			2022-12-28	WOS:000348056400035
J	Fan, AL; Zocher, G; Stec, E; Stehle, T; Li, SM				Fan, Aili; Zocher, Georg; Stec, Edyta; Stehle, Thilo; Li, Shu-Ming			Site-directed Mutagenesis Switching a Dimethylallyl Tryptophan Synthase to a Specific Tyrosine C-3-Prenylating Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-FUMIGATUS; INDOLE PRENYLTRANSFERASES; BIOCHEMICAL-CHARACTERIZATION; PRENYLATION; DERIVATIVES; CATALYZES; HYDROXYNAPHTHALENES; OVERPRODUCTION; REARRANGEMENT; BIOSYNTHESIS	The tryptophan prenyltransferases FgaPT2 and 7-DMATS (7-dimethylallyl tryptophan synthase) from Aspergillus fumigatus catalyze C-4- and C-7-prenylation of the indole ring, respectively. 7-DMATS was found to accept L-tyrosine as substrate as well and converted it to an O-prenylated derivative. An acceptance of L-tyrosine by FgaPT2 was also observed in this study. Interestingly, isolation and structure elucidation revealed the identification of a C-3-prenylated L-tyrosine as enzyme product. Molecular modeling and site-directed mutagenesis led to creation of a mutant FgaPT2_K174F, which showed much higher specificity toward L-tyrosine than L-tryptophan. Its catalytic efficiency toward L-tyrosine was found to be 4.9-fold in comparison with that of non-mutated FgaPT2, whereas the activity toward L-tryptophan was less than 0.4% of that of the wild-type. To the best of our knowledge, this is the first report on an enzymatic C-prenylation of L-tyrosine as free amino acid and altering the substrate preference of a prenyltransferase by mutagenesis.	[Fan, Aili; Stec, Edyta; Li, Shu-Ming] Univ Marburg, Inst Pharmazeut Biol & Biotechnol, D-35037 Marburg, Germany; [Zocher, Georg; Stehle, Thilo] Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany	Philipps University Marburg; Eberhard Karls University of Tubingen	Li, SM (corresponding author), Univ Marburg, Inst Pharmazeut Biol & Biotechnol, D-35037 Marburg, Germany.	shuming.li@staff.uni-marburg.de	Fan, Aili/X-3185-2019	Fan, Aili/0000-0003-4738-0517	Deutsche Forschungsgemeinschaft [Li844/4-1, SFB766]; China Scholarship Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council)	This work was supported in part by Deutsche Forschungsgemeinschaft Grants Li844/4-1 (to S.-M. L.) and SFB766 (to G. Z. and T. S.).; Recipient of a scholarship from the China Scholarship Council.	Ahmed F, 2008, J NAT PROD, V71, P1963, DOI 10.1021/np8004248; Bonitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027336; Botta B, 2005, CURR MED CHEM, V12, P713, DOI 10.2174/0929867053202241; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; El-Seedi HR, 2009, CURR MED CHEM, V16, P2581, DOI 10.2174/092986709788682056; Fan AL, 2014, APPL MICROBIOL BIOT, V98, P10119, DOI 10.1007/s00253-014-5872-7; Fan AL, 2014, TETRAHEDRON LETT, V55, P5199, DOI 10.1016/j.tetlet.2014.07.080; Gardiner DM, 2004, MOL MICROBIOL, V53, P1307, DOI 10.1111/j.1365-2958.2004.04215.x; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Jain HD, 2008, BIOORGAN MED CHEM, V16, P4626, DOI 10.1016/j.bmc.2008.02.050; Jost M, 2010, J AM CHEM SOC, V132, P17849, DOI 10.1021/ja106817c; Karamat F, 2014, PLANT J, V77, P627, DOI 10.1111/tpj.12409; Kremer A, 2007, MICROBIOL-SGM, V153, P3409, DOI 10.1099/mic.0.2007/009019-0; Kremer A, 2010, MICROBIOL-SGM, V156, P278, DOI 10.1099/mic.0.033886-0; Li SM, 2010, NAT PROD REP, V27, P57, DOI 10.1039/b909987p; Li SM, 2009, APPL MICROBIOL BIOT, V84, P631, DOI 10.1007/s00253-009-2128-z; Liebhold M, 2013, ORG LETT, V15, P5834, DOI 10.1021/ol4029012; Liebhold M, 2012, ORG LETT, V14, P4882, DOI 10.1021/ol302207r; Lindel T, 2012, TOP CURR CHEM, V309, P67, DOI 10.1007/128_2011_204; Lu YP, 2009, BIOCHEM BIOPH RES CO, V379, P351, DOI 10.1016/j.bbrc.2008.12.061; Luk LYP, 2011, J AM CHEM SOC, V133, P12342, DOI 10.1021/ja2034969; Luk LYP, 2009, J AM CHEM SOC, V131, P13932, DOI 10.1021/ja906485u; Majmudar JD, 2011, CHEMBIOCHEM, V12, P2723, DOI 10.1002/cbic.201100612; McIntosh JA, 2013, ACS CHEM BIOL, V8, P877, DOI 10.1021/cb300614c; McIntosh JA, 2011, J AM CHEM SOC, V133, P13698, DOI 10.1021/ja205458h; McIntosh JA, 2009, NAT PROD REP, V26, P537, DOI 10.1039/b714132g; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pockrandt D, 2014, APPL MICROBIOL BIOT, V98, P4987, DOI 10.1007/s00253-014-5509-x; Pockrandt D, 2012, CHEMBIOCHEM, V13, P2764, DOI 10.1002/cbic.201200545; Rudolf JD, 2013, ACS CHEM BIOL, V8, P2707, DOI 10.1021/cb400691z; Stec E, 2008, CHEMBIOCHEM, V9, P2055, DOI 10.1002/cbic.200800237; Steffan N, 2007, CHEMBIOCHEM, V8, P1298, DOI 10.1002/cbic.200700107; Tarcz S, 2014, CHEMBIOCHEM, V15, P108, DOI 10.1002/cbic.201300610; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; Wallwey C, 2011, NAT PROD REP, V28, P496, DOI 10.1039/c0np00060d; Wessjohann LA, 2013, CURR OPIN CHEM BIOL, V17, P229, DOI 10.1016/j.cbpa.2013.02.016; Williams RM, 2000, TOP CURR CHEM, V209, P97; Winkelblech J, 2014, CHEMBIOCHEM, V15, P1030, DOI 10.1002/cbic.201400046; Wollinsky B, 2012, BIOORG MED CHEM LETT, V22, P3866, DOI 10.1016/j.bmcl.2012.04.119; WOODSIDE AB, 1988, ORG SYNTH, V66, P211; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; Yin WB, 2013, J AM CHEM SOC, V135, P2064, DOI 10.1021/ja311145n; Yu X, 2012, METHOD ENZYMOL, V516, P259, DOI 10.1016/B978-0-12-394291-3.00005-8; Yu X, 2012, J BIOL CHEM, V287, P1371, DOI 10.1074/jbc.M111.317982; Yu X, 2011, CHEMBIOCHEM, V12, P2280, DOI 10.1002/cbic.201100413; Yu X, 2011, APPL MICROBIOL BIOT, V92, P737, DOI 10.1007/s00253-011-3351-y; Zou HX, 2011, APPL MICROBIOL BIOT, V89, P1443, DOI 10.1007/s00253-010-2956-x	48	15	16	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1364	1373		10.1074/jbc.M114.623413	http://dx.doi.org/10.1074/jbc.M114.623413			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25477507	Green Published, hybrid			2022-12-28	WOS:000348056400006
J	Katsuyama, E; Miyamoto, H; Kobayashi, T; Sato, Y; Hao, W; Kanagawa, H; Fujie, A; Tando, T; Watanabe, R; Morita, M; Miyamoto, K; Niki, Y; Morioka, H; Matsumoto, M; Toyama, Y; Miyamoto, T				Katsuyama, Eri; Miyamoto, Hiroya; Kobayashi, Tami; Sato, Yuiko; Hao, Wu; Kanagawa, Hiroya; Fujie, Atsuhiro; Tando, Toshimi; Watanabe, Ryuichi; Morita, Mayu; Miyamoto, Kana; Niki, Yasuo; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi			Interleukin-1 Receptor-associated Kinase-4 (IRAK4) Promotes Inflammatory Osteolysis by Activating Osteoclasts and Inhibiting Formation of Foreign Body Giant Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE POLARIZATION; DC-STAMP; FUSION; BISPHOSPHONATES; OSTEOPETROSIS; OSTEONECROSIS; CHEMOKINES; PLASTICITY; FRACTURES; RESPONSES	Formation of foreign body giant cells (FBGCs) occurs following implantation of medical devices such as artificial joints and is implicated in implant failure associated with inflammation or microbial infection. Two major macrophage subpopulations, M1 and M2, play different roles in inflammation and wound healing, respectively. Therefore, M1/M2 polarization is crucial for the development of various inflammation-related diseases. Here, we show that FBGCs do not resorb bone but rather express M2 macrophage-like wound healing and inflammation-terminating molecules in vitro. We also found that FBGC formation was significantly inhibited by inflammatory cytokines or infection mimetics in vitro. Interleukin-1 receptor-associated kinase-4 (IRAK4) deficiency did not alter osteoclast formation in vitro, and IRAK4-deficient mice showed normal bone mineral density in vivo. However, IRAK4-deficient mice were protected from excessive osteoclastogenesis induced by IL-1 beta in vitro or by LPS, an infection mimetic of Gram-negative bacteria, in vivo. Furthermore, IRAK4 deficiency restored FBGC formation and expression of M2 macrophage markers inhibited by inflammatory cytokines in vitro or by LPS in vivo. Our results demonstrate that osteoclasts and FBGCs are reciprocally regulated and identify IRAK4 as a potential therapeutic target to inhibit stimulated osteoclastogenesis and rescue inhibited FBGC formation under inflammatory and infectious conditions without altering physiological bone resorption.	[Katsuyama, Eri; Miyamoto, Hiroya; Kobayashi, Tami; Sato, Yuiko; Hao, Wu; Kanagawa, Hiroya; Fujie, Atsuhiro; Tando, Toshimi; Watanabe, Ryuichi; Miyamoto, Kana; Niki, Yasuo; Morioka, Hideo; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Kobayashi, Tami; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Integrated Bone Metab & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Sato, Yuiko] Keio Univ, Sch Med, Dept Musculoskeletal Reconstruct & Regenerat Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Morita, Mayu] Keio Univ, Sch Med, Dept Dent & Oral Surg, Shinjuku Ku, Tokyo 1608582, Japan	Keio University; Keio University; Keio University; Keio University	Miyamoto, T (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	miyamoto@z5.keio.jp	hao, wu/HDM-1705-2022	NIKI, YASUO/0000-0002-0197-5171				Amano S, 1996, J IMMUNOL, V156, P1931; Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; ARONSON M, 1962, NATURE, V193, P399, DOI 10.1038/193399a0; Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Biteman B, 2007, FASEB J, V21, P2257, DOI 10.1096/fj.06-7918com; Borromeo GL, 2014, J BONE MINER RES, V29, P1363, DOI 10.1002/jbmr.2179; Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902; Edwards BJ, 2013, J BONE JOINT SURG AM, V95A, P297, DOI 10.2106/JBJS.K.01181; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Hoshi H, 2012, J BONE MINER RES, V27, P2015, DOI 10.1002/jbmr.1634; Iglesias JE, 2015, GERODONTOLOGY, V32, P169, DOI 10.1111/ger.12093; Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035; Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221; Khan AA, 2009, J RHEUMATOL, V36, P478, DOI 10.3899/jrheum.080759; Khan UA, 2014, J CELL BIOCHEM, V115, P1290, DOI 10.1002/jcb.24781; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lin T, 2012, OSTEOPOROSIS INT, V23, P1823, DOI 10.1007/s00198-011-1797-5; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955; MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Marwick C, 2000, JAMA-J AM MED ASSOC, V283, P869, DOI 10.1001/jama.283.7.869; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Miyamoto T, 2000, BLOOD, V96, P4335, DOI 10.1182/blood.V96.13.4335.h8004335_4335_4343; Miyauchi Y, 2012, J BIOL CHEM, V287, P28508, DOI 10.1074/jbc.M112.356634; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakanishi-Matsui M, 2013, BIOCHEM BIOPH RES CO, V440, P611, DOI 10.1016/j.bbrc.2013.09.109; NAWROTH PP, 1986, J EXP MED, V163, P1363, DOI 10.1084/jem.163.6.1363; Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599; Okada Y, 2000, J CLIN INVEST, V105, P823, DOI 10.1172/JCI8195; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Rao AJ, 2013, J BIOMED MATER RES A, V101, P1925, DOI 10.1002/jbm.a.34486; Rao AJ, 2012, ACTA BIOMATER, V8, P2815, DOI 10.1016/j.actbio.2012.03.042; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sterling H, 1998, J CELL BIOL, V143, P837, DOI 10.1083/jcb.143.3.837; Suratwala SJ, 2008, J BONE JOINT SURG AM, V90A, P2189, DOI 10.2106/JBJS.G.00409; Suzuki N, 2006, SCIENCE, V311, P1927, DOI 10.1126/science.1124256; Suzuki N, 2003, J IMMUNOL, V171, P6065, DOI 10.4049/jimmunol.171.11.6065; Suzuki N, 2003, J IMMUNOL, V170, P4031, DOI 10.4049/jimmunol.170.8.4031; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124; TANG LP, 1995, AM J CLIN PATHOL, V103, P466; Uderhardt S, 2012, J MOL MED, V90, P1247, DOI 10.1007/s00109-012-0954-4; Visekruna M, 2008, J CLIN ENDOCR METAB, V93, P2948, DOI 10.1210/jc.2007-2803; Whyte MP, 2008, J BONE MINER RES, V23, P1698, DOI [10.1359/jbmr.080511, 10.1359/JBMR.080511]; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yagi M, 2007, J BONE MINER RES, V22, P992, DOI 10.1359/JBMR.070401; Yang SY, 2007, J ORTHOP RES, V25, P603, DOI 10.1002/jor.20342; ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205	58	23	24	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					716	726		10.1074/jbc.M114.568360	http://dx.doi.org/10.1074/jbc.M114.568360			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25404736	Green Published, hybrid			2022-12-28	WOS:000347778200003
J	Sato, T; Akasu, H; Shimono, W; Matsu, C; Fujiwara, Y; Shibagaki, Y; Heard, JJ; Tamanoi, F; Hattori, S				Sato, Tatsuhiro; Akasu, Hitomi; Shimono, Wataru; Matsu, Chisa; Fujiwara, Yuki; Shibagaki, Yoshio; Heard, Jeffrey J.; Tamanoi, Fuyuhiko; Hattori, Seisuke			Rheb Protein Binds CAD (Carbamoyl-phosphate Synthetase 2, Aspartate Transcarbamoylase, and Dihydroorotase) Protein in a GTP-and Effector Domain-dependent Manner and Influences Its Cellular Localization and Carbamoyl-phosphate Synthetase (CPSase) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOVO PYRIMIDINE SYNTHESIS; TUBEROUS SCLEROSIS COMPLEX; NUCLEOTIDE BIOSYNTHESIS; MULTIFUNCTIONAL PROTEIN; MAMMALIAN-CELLS; DIRECT TARGET; ACTIVATION; MTOR; GROWTH; MECHANISM	Rheb small GTPases, which consist of Rheb1 and Rheb2 (also known as RhebL1) in mammalian cells, are unique members of the Ras superfamily and play central roles in regulating protein synthesis and cell growth by activating mTOR. To gain further insight into the function of Rheb, we carried out a search for Rheb-binding proteins and found that Rheb binds to CAD protein (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, and dihydroorotase), a multifunctional enzyme required for the de novo synthesis of pyrimidine nucleotides. CAD binding is more pronounced with Rheb2 than with Rheb1. Rheb binds CAD in a GTP-and effector domain-dependent manner. The region of CAD where Rheb binds is located at the C-terminal region of the carbamoyl-phosphate synthetase domain and not in the dihydroorotase and aspartate transcarbamoylase domains. Rheb stimulated carbamoyl-phosphate synthetase activity of CAD in vitro. In addition, an elevated level of intracellular UTP pyrimidine nucleotide was observed in Tsc2-deficient cells, which was attenuated by knocking down of Rheb. Immunostaining analysis showed that expression of Rheb leads to increased accumulation of CAD on lysosomes. Both a farnesyltransferase inhibitor that blocks membrane association of Rheb and knockdown of Rheb mislocalized CAD. These results establish CAD as a downstream effector of Rheb and suggest a possible role of Rheb in regulating de novo pyrimidine nucleotide synthesis.	[Sato, Tatsuhiro; Akasu, Hitomi; Shimono, Wataru; Matsu, Chisa; Fujiwara, Yuki; Shibagaki, Yoshio; Hattori, Seisuke] Kitasato Univ, Sch Pharmaceut Sci, Div Biochem, Tokyo 1088641, Japan; [Heard, Jeffrey J.; Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Inst Mol Biol, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	Kitasato University; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Sato, T (corresponding author), Kitasato Univ, Sch Pharmaceut Sci, Div Biochem, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	satot@pharm.kitasato-u.ac.jp			National Institutes of Health [CA41996];  [23790345];  [23510261]; NATIONAL CANCER INSTITUTE [R01CA041996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA41996 (to F. T.). This work was also supported by Grant-in-aid for Young Scientists B 23790345 (to T. S.) and for Scientific Research C 23510261 (to S. H.).	Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CARREY EA, 1985, EMBO J, V4, P3735, DOI 10.1002/j.1460-2075.1985.tb04142.x; Clark GJ, 1997, J BIOL CHEM, V272, P10608; COLEMAN PF, 1977, J BIOL CHEM, V252, P6379; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Heard JJ, 2014, CELL SIGNAL, V26, P1950, DOI 10.1016/j.cellsig.2014.05.011; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Iwahana H, 1996, BIOCHEM BIOPH RES CO, V219, P249, DOI 10.1006/bbrc.1996.0213; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LIU X, 1994, J BIOL CHEM, V269, P27747; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Piao XH, 2009, BIOCHEM BIOPH RES CO, V389, P16, DOI 10.1016/j.bbrc.2009.08.070; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Takahashi K, 2005, J BIOL CHEM, V280, P32768, DOI 10.1074/jbc.M506280200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; van Eeghen AM, 2012, EUR J HUM GENET, V20, P510, DOI 10.1038/ejhg.2011.241; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Yang WL, 2001, MOL MICROBIOL, V41, P1339, DOI 10.1046/j.1365-2958.2001.02599.x; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	33	17	18	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1096	1105		10.1074/jbc.M114.592402	http://dx.doi.org/10.1074/jbc.M114.592402			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25422319	Green Published, hybrid			2022-12-28	WOS:000347778200041
J	Terakawa, MS; Yagi, H; Adachi, M; Lee, YH; Goto, Y				Terakawa, Mayu S.; Yagi, Hisashi; Adachi, Masayuki; Lee, Young-Ho; Goto, Yuji			Small Liposomes Accelerate the Fibrillation of Amyloid beta (1-40)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; A-BETA; MEMBRANE DISRUPTION; LIPID-MEMBRANES; PROTEIN; FIBRILS; PEPTIDE; AGGREGATION; MECHANISM	The deposition of amyloid beta (A beta) peptides is a pathological hallmark of Alzheimer disease. A beta peptides were previously considered to interact specifically with ganglioside-containing membranes. Several studies have suggested that A beta peptides also bind to phosphatidylcholine membranes, which lead to deformation of membranes and fibrillation of A beta. Moreover, the role of membrane curvature, one type of deformation produced by binding of proteins to a membrane, in the binding and fibrillation of A beta remains unclear. To clearly understand the relationship between the binding, consequent membrane deformation, and fibrillation of A beta, we examined the amyloid fibrillation of A beta-(1-40) in the presence of liposomes of various sizes. Membrane curvature increased with a decrease in the size of the liposomes. We used liposomes made of 1,2-dioleoyl-sn-glycero-3-phosphocholine to eliminate electrostatic effects. The results obtained showed that liposomes of smaller sizes (<= 50 nm) significantly accelerated the nucleation step, thereby shortening the lag time of fibrillation. On the other hand, liposomes of larger sizes decreased the amount of fibrils but did not notably affect the lag time. The morphologies of fibrils, which were monitored by total internal reflection fluorescence microscopy, atomic force microscopy, and transmission electron microscopy, revealed that the length of A beta -(1-40) fibrils became shorter and the amount of amorphous aggregates became larger as liposomes increased in size. These results suggest that the curvature of membranes coupled with an increase in water-accessible hydrophobic regions is important for binding and concentrating A beta monomers, leading to amyloid nucleation. Furthermore, amyloid fibrillation on membranes may compete with non-productive binding to produce amorphous aggregates.	[Terakawa, Mayu S.; Yagi, Hisashi; Adachi, Masayuki; Lee, Young-Ho; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp			Ministry of Education, Science, Sports, and Culture, Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [25870407, 13J03790] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Science, Sports, and Culture, Japan, a grant-in-aid for scientific research (to Y. G.), and a grantin-aid for the Japan Society for the Promotion of Science Fellows (to M. S. T.). We acknowledge financial support from Takeda Science Foundation (to H. Y.).	Aisenbrey C, 2008, EUR BIOPHYS J BIOPHY, V37, P247, DOI 10.1007/s00249-007-0237-0; Ambroggio EE, 2005, BIOPHYS J, V88, P2706, DOI 10.1529/biophysj.104.055582; [Anonymous], 2010, INT J ALZHEIMERS DIS; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Ban T, 2006, METHOD ENZYMOL, V413, P91, DOI 10.1016/S0076-6879(06)13005-0; Ban T, 2006, J BIOL CHEM, V281, P33677, DOI 10.1074/jbc.M606072200; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Bokvist M, 2007, J AM CHEM SOC, V129, P14848, DOI 10.1021/ja076059o; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Chauhan A, 2000, NEUROCHEM RES, V25, P423, DOI 10.1023/A:1007509608440; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Gellermann GP, 2005, P NATL ACAD SCI USA, V102, P6297, DOI 10.1073/pnas.0407035102; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HALVERSON K, 1990, BIOCHEMISTRY-US, V29, P2639, DOI 10.1021/bi00463a003; Hamada T, 2010, J PHYS CHEM LETT, V1, P170, DOI 10.1021/jz900106z; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jiang ZP, 2013, J AM CHEM SOC, V135, P15970, DOI 10.1021/ja405993r; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Kotler SA, 2014, CHEM SOC REV, V43, P6692, DOI 10.1039/c3cs60431d; KREMER JMH, 1977, BIOCHEMISTRY-US, V16, P3932, DOI 10.1021/bi00636a033; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lorenzen N, 2014, J BIOL CHEM, V289, P21299, DOI 10.1074/jbc.M114.554667; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Morita M, 2012, SOFT MATTER, V8, P2816, DOI 10.1039/c2sm07185a; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Pannuzzo M, 2013, PHYS CHEM CHEM PHYS, V15, P8940, DOI 10.1039/c3cp44539a; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Pfefferkorn CM, 2012, BIOPHYS J, V102, P613, DOI 10.1016/j.bpj.2011.12.051; Platt GW, 2008, J MOL BIOL, V378, P251, DOI 10.1016/j.jmb.2008.01.092; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Qu L, 2009, J COMP NEUROL, V514, P343, DOI 10.1002/cne.22007; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/603052, DOI 10.4061/2011/603052]; Sasahara K, 2012, BIOCHEMISTRY-US, V51, P6908, DOI 10.1021/bi300542g; Sciacca MFM, 2012, BIOPHYS J, V103, P702, DOI 10.1016/j.bpj.2012.06.045; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Shimanouchi T, 2011, COLLOID SURFACE B, V88, P221, DOI 10.1016/j.colsurfb.2011.06.036; Smith PES, 2009, J AM CHEM SOC, V131, P4470, DOI 10.1021/ja809002a; So M, 2011, J MOL BIOL, V412, P568, DOI 10.1016/j.jmb.2011.07.069; Sun Y, 2010, BIOPHYS J, V99, P544, DOI 10.1016/j.bpj.2010.04.045; Tomas S, 2010, NAT CHEM, V2, P1077, DOI 10.1038/NCHEM.892; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Yagi H, 2007, BIOCHEMISTRY-US, V46, P15009, DOI 10.1021/bi701842n; Yagi H, 2013, BBA-PROTEINS PROTEOM, V1834, P2480, DOI 10.1016/j.bbapap.2013.08.013; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yoshimura Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HA01; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109	63	61	62	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					815	826		10.1074/jbc.M114.592527	http://dx.doi.org/10.1074/jbc.M114.592527			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25406316	hybrid, Green Published			2022-12-28	WOS:000347778200012
J	Tillgren, V; Ho, JCS; Onnerfjord, P; Kalamajski, S				Tillgren, Viveka; Ho, James C. S.; Onnerfjord, Patrik; Kalamajski, Sebastian			The Novel Small Leucine-rich Protein Chondroadherin-like (CHADL) Is Expressed in Cartilage and Modulates Chondrocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN FIBRILLOGENESIS; TARGETED DISRUPTION; MATRIX PROTEIN; FIBROMODULIN; LUMICAN; DECORIN; DEFICIENT; SEQUENCE; RECEPTOR; LEADS	The constitution and biophysical properties of extracellular matrices can dramatically influence cellular phenotype during development, homeostasis, or pathogenesis. These effects can be signaled through a differentially regulated assembly of collagen fibrils, orchestrated by a family of collagen-associated small leucine-rich proteins (SLRPs). In this report, we describe the tissue-specific expression and function of a previously uncharacterized SLRP, chondroadherin-like (CHADL). We developed antibodies against CHADL and, by immunohistochemistry, detected CHADL expression mainly in skeletal tissues, particularly in fetal cartilage and in the pericellular space of adult chondrocytes. In situ hybridizations and immunoblots on tissue lysates confirmed this tissue-specific expression pattern. Recombinant CHADL bound collagen in cell culture and inhibited in vitro collagen fibrillogenesis. After Chadl shRNA knockdown, chondrogenic ATDC5 cells increased their differentiation, indicated by increased transcript levels of Sox9, Ihh, Col2a1, and Col10a1. The knockdown increased collagen II and aggrecan deposition in the cell layers. Microarray analysis of the knockdown samples suggested collagen receptor-related changes, although other upstream effects could not be excluded. Together, our data indicate that the novel SLRP CHADL is expressed in cartilaginous tissues, influences collagen fibrillogenesis, and modulates chondrocyte differentiation. CHADL appears to have a negative regulatory role, possibly ensuring the formation of a stable extracellular matrix.	[Tillgren, Viveka; Onnerfjord, Patrik; Kalamajski, Sebastian] Lund Univ, Dept Clin Sci, S-22184 Lund, Sweden; [Ho, James C. S.] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden	Lund University; Lund University	Kalamajski, S (corresponding author), Lund Univ, Dept Clin Sci, BMC C12,Klinikgatan 28, S-22184 Lund, Sweden.	Sebastian.Kalamajski@med.lu.se	Ho, James CS/ADQ-2735-2022; Ho, James CS/AAF-8197-2022; Onnerfjord, Patrik/R-3131-2019	Ho, James CS/0000-0002-6131-1297; Ho, James CS/0000-0002-6131-1297; Onnerfjord, Patrik/0000-0002-2345-2937; Kalamajski, Sebastian/0000-0002-6600-9302	Swedish Research Council; Crafoord Foundation; Magnus Bergvall Foundation; Ake Wiberg Foundation; Greta and Johan Kock Foundation; Alfred Osterlund Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Magnus Bergvall Foundation; Ake Wiberg Foundation; Greta and Johan Kock Foundation; Alfred Osterlund Foundation	This study was supported by grants from the Swedish Research Council, the Crafoord Foundation, the Magnus Bergvall Foundation, the Ake Wiberg Foundation, the Greta and Johan Kock Foundation, and the Alfred Osterlund Foundation.	Calamajski S., 2007, J BIOL CHEM, V282, P6740; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; Caron MMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033467; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Haglund L, 2011, J BIOL CHEM, V286, P3925, DOI 10.1074/jbc.M110.161141; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; Hessle L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063080; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; LARSSON T, 1991, J BIOL CHEM, V266, P20428; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209; Xu L, 2007, ARTHRITIS RHEUM, V56, P2663, DOI 10.1002/art.22761; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200	27	15	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					918	925		10.1074/jbc.M114.593541	http://dx.doi.org/10.1074/jbc.M114.593541			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451920	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000347778200026
J	Homer-Bouthiette, C; Doetschman, T; Xiao, LP; Hurley, MM				Homer-Bouthiette, Collin; Doetschman, Thomas; Xiao, Liping; Hurley, Marja M.			Knockout of Nuclear High Molecular Weight FGF2 Isoforms in Mice Modulates Bone and Phosphate Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; MATRIX PROTEIN; EXPRESSION; RECEPTOR; GENE; MINERALIZATION; MASS; HYPOPHOSPHATEMIA; DIVERSITY	We previously reported that targeted overexpression of the fibroblast growth factor 2 (FGF2) high molecular weight (HMW) isoforms in osteoblastic lineage cells in mice resulted in phenotypic changes, including dwarfism, rickets, osteomalacia, hypophosphatemia, increased serum parathyroid hormone, and increased levels of the phosphatonin FGF23 in serum and bone. This study examined the effects of genetically knocking out the FGF2HMW isoforms (HMWKO) on bone and phosphate homeostasis. HMWKO mice were not dwarfed and had significantly increased bone mineral density and bone mineral content in femurs and lumbar vertebrae when compared with the wild-type (WT) littermates. Micro-computed tomography analysis of femurs revealed increased trabecular bone volume, thickness, number, and connective tissue density with decreased trabecular spacing compared with WT. In addition, there was significantly decreased cortical porosity and increased cortical thickness and sub-periosteal area in femurs of HMWKO. Histomorphometric analysis demonstrated increased osteoblast activity and diminished osteoclast activity in the HMWKO. In vitro bone marrow stromal cell cultures showed there was a significant increase in alkaline phosphatase-positive colony number at 1 week in HMWKO. At 3 weeks of culture, the mineralized area was also significantly increased. There was increased expression of osteoblast differentiation marker genes and reduced expression of genes associated with impaired mineralization, including a significant reduction in Fgf23 and Sost mRNA. Normal serum phosphate and parathyroid hormone were observed in HMWKO mice. This study demonstrates a significant negative impact of HMWFGF2 on biological functions in bone and phosphate homeostasis in mice.	[Homer-Bouthiette, Collin; Xiao, Liping; Hurley, Marja M.] Univ Connecticut, Ctr Hlth, Dept Med, Inst Syst Genom, Farmington, CT 06030 USA; [Doetschman, Thomas] Univ Arizona, Inst B105, Tucson, AZ 85724 USA; [Doetschman, Thomas] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA	University of Connecticut; University of Arizona; University of Arizona	Xiao, LP (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, 263 Farmington Ave, Farmington, CT 06030 USA.	xiao@uchc.edu; hurley@nso1.uchc.edu			National Institutes of Health [DK098566-01-A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK098566-01-A1 (to M. M. H. and L. X.).	Ammann P, 2003, OSTEOPOROSIS INT, V14, pS13, DOI 10.1007/s00198-002-1345-4; Arnaud E, 1999, MOL CELL BIOL, V19, P505; Atkins GJ, 2011, J BONE MINER RES, V26, P1425, DOI 10.1002/jbmr.345; Azhar M, 2009, DEV DYNAM, V238, P351, DOI 10.1002/dvdy.21835; Beck L, 1997, J CLIN INVEST, V99, P1200, DOI 10.1172/JCI119276; Butler JS, 2011, J ORTHOP RES, V29, P414, DOI 10.1002/jor.21260; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; Delrieu I, 2000, FEBS LETT, V468, P6, DOI 10.1016/S0014-5793(00)01189-3; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; GOSPODAROWICZ D, 1990, CLIN ORTHOP RELAT R, P231; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; Hurley MM, 1999, J BONE MINER RES, V14, P776, DOI 10.1359/jbmr.1999.14.5.776; Juppner H, 2011, KIDNEY INT, V79, pS24, DOI 10.1038/ki.2011.27; Kardami E, 2004, CARDIOVASC RES, V63, P458, DOI 10.1016/j.cardiores.2004.04.024; Kumar J, 2011, BONE, V49, P343, DOI 10.1016/j.bone.2011.05.018; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Liao SY, 2010, J MOL CELL CARDIOL, V48, P1245, DOI 10.1016/j.yjmcc.2010.01.014; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lu Yongbo, 2011, Curr Osteoporos Rep, V9, P103, DOI 10.1007/s11914-011-0053-4; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Masuda M, 2010, BIOCHEM J, V429, P583, DOI 10.1042/BJ20100484; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Okada-Ban M, 2000, INT J BIOCHEM CELL B, V32, P263, DOI 10.1016/S1357-2725(99)00133-8; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRATS H, 1989, P NATL ACAD SCI USA, V86, P1836, DOI 10.1073/pnas.86.6.1836; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Sapir-Koren R, 2011, IBMS BONEKEY, V8, P286, DOI [10.1138/20110516, DOI 10.1138/20110516]; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; Sobue T, 2005, J CELL BIOCHEM, V95, P83, DOI 10.1002/jcb.20389; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang H, 2008, J BONE MINER RES, V23, P939, DOI 10.1359/JBMR.080220; Xiao LP, 2013, J BONE MINER RES, V28, P35, DOI 10.1002/jbmr.1721; Xiao LP, 2010, BONE, V47, P360, DOI 10.1016/j.bone.2010.05.021; Xiao LP, 2010, J BIOL CHEM, V285, P2834, DOI 10.1074/jbc.M109.030577; Xiao LP, 2009, J BIOL CHEM, V284, P3170, DOI 10.1074/jbc.M804900200; Yu XJ, 2005, CYTOKINE GROWTH F R, V16, P221, DOI 10.1016/j.cytogfr.2005.01.002; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200	44	22	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36303	36314		10.1074/jbc.M114.619569	http://dx.doi.org/10.1074/jbc.M114.619569			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25389287	hybrid, Green Published			2022-12-28	WOS:000346897900053
J	McCorvie, TJ; Kopec, J; Hyung, SJ; Fitzpatrick, F; Feng, XD; Termine, D; Strain-Damerell, C; Vollmar, M; Fleming, J; Janz, JM; Bulawa, C; Yue, WW				McCorvie, Thomas J.; Kopec, Jolanta; Hyung, Suk-Joon; Fitzpatrick, Fiona; Feng, Xidong; Termine, Daniel; Strain-Damerell, Claire; Vollmar, Melanie; Fleming, James; Janz, Jay M.; Bulawa, Christine; Yue, Wyatt W.			Inter-domain Communication of Human Cystathionine beta-Synthase STRUCTURAL BASIS OF S-ADENOSYL-L-METHIONINE ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY DOMAIN; HEME PROTEIN; CBS DOMAINS; INTRASTERIC INHIBITION; ALLOSTERIC ACTIVATION; BINDING-SITES; STABILITY; HOMOCYSTINURIA; ADENOSYLMETHIONINE; TRANSSULFURATION	Cystathionine beta-synthase (CBS) is a key enzyme in sulfur metabolism, and its inherited deficiency causes homocystinuria. Mammalian CBS is modulated by the binding of S-adenosyl-L-methionine (AdoMet) to its regulatory domain, which activates its catalytic domain. To investigate the underlying mechanism, we performed x-ray crystallography, mutagenesis, and mass spectrometry (MS) on human CBS. The 1.7 angstrom structure of a AdoMet-bound CBS regulatory domain shows one AdoMet molecule per monomer, at the interface between two constituent modules (CBS-1, CBS-2). AdoMet binding is accompanied by a reorientation between the two modules, relative to the AdoMet-free basal state, to form interactions with AdoMet via residues verified by mutagenesis to be important for AdoMet binding (Phe(443), Asp(444), Gln(445), and Asp(538)) and for AdoMet-driven inter-domain communication (Phe(443), Asp(538)). The observed structural change is further supported by ion mobility MS, showing that as-purified CBS exists in two conformational populations, which converged to one in the presence of AdoMet. We therefore propose that AdoMet-induced conformational change alters the interface and arrangement between the catalytic and regulatory domains within the CBS oligomer, thereby increasing the accessibility of the enzyme active site for catalysis.	[Strain-Damerell, Claire; Vollmar, Melanie; Yue, Wyatt W.] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7DQ, England; [Hyung, Suk-Joon; Feng, Xidong] Pfizer Inc, Worldwide Res & Dev, Groton, CT 06340 USA; [Termine, Daniel; Fleming, James; Janz, Jay M.; Bulawa, Christine] Pfizer Inc, Pfizer Rare Dis Res Unit, Worldwide Res & Dev, Cambridge, MA 02140 USA	University of Oxford; Pfizer; Pfizer	Bulawa, C (corresponding author), Pfizer Inc, Pfizer Rare Dis Res Unit, Worldwide Res & Dev, Cambridge, MA 02140 USA.	christine.bulawa@pfizer.com; wyatt.yue@sgc.ox.ac.uk	Kopec, Jolanta/E-7117-2010; Hyung, Suk-Joon/N-6449-2014	Kopec, Jolanta/0000-0002-0889-9845; McCorvie, Thomas/0000-0002-1502-7113; Fitzpatrick, Fiona/0000-0002-1634-7733; Hyung, Suk-Joon/0000-0001-6759-4219; Vollmar, Melanie/0000-0002-9162-9159	AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]	AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust (092809/Z/10/Z).	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ereno-Orbea J, 2014, P NATL ACAD SCI USA, V111, pE3845, DOI 10.1073/pnas.1414545111; Ereno-Orbea J, 2013, ARCH BIOCHEM BIOPHYS, V540, P70, DOI 10.1016/j.abb.2013.10.008; Ereno-Orbea J, 2013, P NATL ACAD SCI USA, V110, pE3790, DOI 10.1073/pnas.1313683110; Evande R, 2002, BIOCHEMISTRY-US, V41, P11832, DOI 10.1021/bi026248d; Frank N, 2006, BIOCHEMISTRY-US, V45, P11021, DOI 10.1021/bi060737m; Froese DS, 2010, MOL GENET METAB, V100, P29, DOI 10.1016/j.ymgme.2010.02.005; Gomez-Garcia I, 2010, J MOL BIOL, V399, P53, DOI 10.1016/j.jmb.2010.03.045; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hnizda A, 2012, BIOCHEMISTRY-US, V51, P4755, DOI 10.1021/bi300435e; Hnizda A, 2010, BIOCHEMISTRY-US, V49, P10526, DOI 10.1021/bi101384m; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Janosik M, 2001, AM J HUM GENET, V68, P1506, DOI 10.1086/320597; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; KERY V, 1994, J BIOL CHEM, V269, P25283; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Kraus JP, 1999, HUM MUTAT, V13, P362; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; Majtan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105290; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Mendes MIS, 2014, HUM MUTAT, V35, P1195, DOI 10.1002/humu.22616; MUDD SH, 1985, AM J HUM GENET, V37, P1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oyenarte I, 2012, ACTA CRYSTALLOGR F, V68, P1318, DOI 10.1107/S1744309112037219; Pey AL, 2014, BBA-MOL BASIS DIS, V1842, P2163, DOI 10.1016/j.bbadis.2014.08.011; Pey AL, 2014, BBA-PROTEINS PROTEOM, V1844, P1453, DOI 10.1016/j.bbapap.2014.04.015; Pey AL, 2013, BIOCHEM J, V449, P109, DOI 10.1042/BJ20120731; Sen S, 2005, BIOCHEMISTRY-US, V44, P14210, DOI 10.1021/bi051046d; Shan XY, 2001, HUM MOL GENET, V10, P635, DOI 10.1093/hmg/10.6.635; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Taoka S, 1999, BIOCHEMISTRY-US, V38, P13155, DOI 10.1021/bi990865t; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d	37	39	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36018	36030		10.1074/jbc.M114.610782	http://dx.doi.org/10.1074/jbc.M114.610782			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25336647	hybrid, Green Published			2022-12-28	WOS:000346897900031
J	Essig, A; Hofmann, D; Munch, D; Gayathri, S; Kunzler, M; Kallio, PT; Sahl, HG; Wider, G; Schneider, T; Aebi, M				Essig, Andreas; Hofmann, Daniela; Muench, Daniela; Gayathri, Savitha; Kuenzler, Markus; Kallio, Pauli T.; Sahl, Hans-Georg; Wider, Gerhard; Schneider, Tanja; Aebi, Markus			Copsin, a Novel Peptide-based Fungal Antibiotic Interfering with the Peptidoglycan Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotic Resistance; Antibiotics; Antimicrobial Peptide (AMP); Fungi; Lipid II; Bacterial-Fungal Interaction (BFI); Fungal Secretome	CELL-WALL BIOSYNTHESIS; PRECURSOR LIPID II; PROTEIN STRUCTURES; PICHIA-PASTORIS; DEFENSIN; FOOD; VANCOMYCIN; EXPRESSION; PLECTASIN; BINDING	Background: Secreted antibacterial substances of fungi provide a rich source for new antibiotics. Results: Copsin is a novel fungal antimicrobial peptide that binds in a unique manner to the cell wall precursor lipid II. Conclusion: As part of the defense strategy of a mushroom, copsin kills bacteria by inhibiting the cell wall synthesis. Significance: Copsin provides a novel highly stabilized scaffold for antibiotics. Fungi and bacteria compete with an arsenal of secreted molecules for their ecological niche. This repertoire represents a rich and inexhaustible source for antibiotics and fungicides. Antimicrobial peptides are an emerging class of fungal defense molecules that are promising candidates for pharmaceutical applications. Based on a co-cultivation system, we studied the interaction of the coprophilous basidiomycete Coprinopsis cinerea with different bacterial species and identified a novel defensin, copsin. The polypeptide was recombinantly produced in Pichia pastoris, and the three-dimensional structure was solved by NMR. The cysteine stabilized /-fold with a unique disulfide connectivity, and an N-terminal pyroglutamate rendered copsin extremely stable against high temperatures and protease digestion. Copsin was bactericidal against a diversity of Gram-positive bacteria, including human pathogens such as Enterococcus faecium and Listeria monocytogenes. Characterization of the antibacterial activity revealed that copsin bound specifically to the peptidoglycan precursor lipid II and therefore interfered with the cell wall biosynthesis. In particular, and unlike lantibiotics and other defensins, the third position of the lipid II pentapeptide is essential for effective copsin binding. The unique structural properties of copsin make it a possible scaffold for new antibiotics.	[Essig, Andreas; Gayathri, Savitha; Kuenzler, Markus; Kallio, Pauli T.; Aebi, Markus] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Hofmann, Daniela; Wider, Gerhard] ETH, Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Muench, Daniela; Sahl, Hans-Georg; Schneider, Tanja] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-53115 Bonn, Germany; [Schneider, Tanja] Partner Site Bonn Cologne, German Ctr Infect Res, D-53115 Bonn, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bonn; German Center for Infection Research	Aebi, M (corresponding author), ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch	Schneider, Tanja/L-8049-2013	Kunzler, Markus/0000-0003-1275-0629; Schneider, Tanja/0000-0001-7269-4716; Rausch, Daniela/0000-0003-3211-5745; Hofmann, Daniela/0000-0001-7073-0744; Wider, Gerhard/0000-0001-9366-7645	ETH Zurich	ETH Zurich(ETH Zurich)	This work was supported by the ETH Zurich.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; ARTHUR M, 1993, ANTIMICROB AGENTS CH, V37, P1563, DOI 10.1128/AAC.37.8.1563; BLOMBERG F, 1977, J AM CHEM SOC, V99, P8149, DOI 10.1021/ja00467a005; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Brotz H, 1997, EUR J BIOCHEM, V246, P193, DOI 10.1111/j.1432-1033.1997.t01-1-00193.x; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; de Kruijff B, 2008, PROSTAG LEUKOTR ESS, V79, P117, DOI 10.1016/j.plefa.2008.09.020; Dingley AJ, 2008, NAT PROTOC, V3, P242, DOI 10.1038/nprot.2007.497; Dix N. J., 1995, FUNGAL ECOL, P203; Fant F, 1998, J MOL BIOL, V279, P257, DOI 10.1006/jmbi.1998.1767; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Franzenburg S, 2013, P NATL ACAD SCI USA, V110, pE3730, DOI 10.1073/pnas.1304960110; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HEITZ A, 1989, BIOCHEMISTRY-US, V28, P2392, DOI 10.1021/bi00432a009; KLAUS W, 1993, J MOL BIOL, V232, P897, DOI 10.1006/jmbi.1993.1438; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Motyl M., 2005, CURR PROTOC PHARM, V31, p13A, DOI [10.1002/0471141755.ph13a03s31, DOI 10.1002/0471141755.PH13A03S31]; Muller A, 2012, MICROB DRUG RESIST, V18, P261, DOI 10.1089/mdr.2011.0242; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Nagorska K, 2007, ACTA BIOCHIM POL, V54, P495; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; Oeemig JS, 2012, J BIOL CHEM, V287, P42361, DOI 10.1074/jbc.M112.382028; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Rick PD, 1998, GLYCOBIOLOGY, V8, P557, DOI 10.1093/glycob/8.6.557; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sambrook J., 2001, MOL CLONING; Scherlach K, 2013, ANNU REV MICROBIOL, V67, P375, DOI 10.1146/annurev-micro-092412-155702; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schneider T, 2010, INT J MED MICROBIOL, V300, P161, DOI 10.1016/j.ijmm.2009.10.005; SHELDRICK GM, 1978, NATURE, V271, P223, DOI 10.1038/271223a0; Sugiki T, 2012, METHODS MOL BIOL, V831, P19, DOI 10.1007/978-1-61779-480-3_2; van Scholl L, 2006, NEW PHYTOL, V170, P153, DOI 10.1111/j.1469-8137.2006.01649.x; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354; Zhu SY, 2012, P NATL ACAD SCI USA, V109, P8495, DOI 10.1073/pnas.1201263109	49	94	101	0	59	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34953	34964		10.1074/jbc.M114.599878	http://dx.doi.org/10.1074/jbc.M114.599878			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342741	Green Published, hybrid			2022-12-28	WOS:000346260800044
J	Frasdorf, B; Radon, C; Leimkuhler, S				Fraesdorf, Benjamin; Radon, Christin; Leimkuehler, Silke			Characterization and Interaction Studies of Two Isoforms of the Dual Localized 3-Mercaptopyruvate Sulfurtransferase TUM1 from Humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence; Mitochondria; Molybdenum; Sulfur; Transfer RNA (tRNA)	MOLYBDENUM COFACTOR BIOSYNTHESIS; HUMAN MERCAPTOPYRUVATE SULFURTRANSFERASE; BOVINE LIVER RHODANESE; CYTOSOLIC TRANSFER-RNA; AMINO-ACID-SEQUENCE; ESCHERICHIA-COLI; HYDROGEN-SULFIDE; MOLYBDOPTERIN BIOSYNTHESIS; THIO-MODIFICATION; SULFUR CARRIER	Background: Localization and identification of interaction partners of two splice variants of the human 3-mercaptopyruvate sulfurtransferase TUM1. Results: We show that TUM1 interacts with proteins involved in Moco and FeS cluster biosynthesis. Conclusion: Human TUM1 is a dual localized protein in the cytosol and mitochondria with distinct roles in sulfur transfer and interaction partners. Significance: The study contributes to the sulfur transfer pathway for the biosynthesis of sulfur-containing biofactors. The human tRNA thiouridine modification protein (TUM1), also designated as 3-mercaptopyruvate sulfurtransferase (MPST), has been implicated in a wide range of physiological processes in the cell. The roles range from an involvement in thiolation of cytosolic tRNAs to the generation of H2S as signaling molecule both in mitochondria and the cytosol. TUM1 is a member of the sulfurtransferase family and catalyzes the conversion of 3-mercaptopyruvate to pyruvate and protein-bound persulfide. Here, we purified and characterized two novel TUM1 splice variants, designated as TUM1-Iso1 and TUM1-Iso2. The purified proteins showed similar kinetic behavior and comparable pH and temperature dependence. Cellular localization studies, however, showed a different localization pattern between the isoforms. TUM1-Iso1 is exclusively localized in the cytosol, whereas TUM1-Iso2 showed a dual localization both in the cytosol and mitochondria. Interaction studies were performed with the isoforms both in vitro using the purified proteins and in vivo by fluorescence analysis in human cells, using the split-EGFP system. The studies showed that TUM1 interacts with the l-cysteine desulfurase NFS1 and the rhodanese-like protein MOCS3, suggesting a dual function of TUM1 both in sulfur transfer for the biosynthesis of the molybdenum cofactor, and for the thiolation of tRNA. Our studies point to distinct roles of each TUM1 isoform in the sulfur transfer processes in the cell, with different compartmentalization of the two splice variants of TUM1.	[Fraesdorf, Benjamin; Radon, Christin; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany	University of Potsdam	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany.	sleim@uni-potsdam.de		Leimkuhler, Silke/0000-0003-3238-2122	Deutsche Forschungsgemeinschaft [LE1171/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant LE1171/9-1.	Billaut-Laden I, 2006, TOXICOL LETT, V165, P101, DOI 10.1016/j.toxlet.2006.02.002; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; CANNELLA C, 1986, BIOCHEMISTRY-US, V25, P7319, DOI 10.1021/bi00371a012; Chowdhury MM, 2012, J BIOL CHEM, V287, P17297, DOI 10.1074/jbc.M112.351429; Colnaghi R, 2001, FEBS LETT, V500, P153, DOI 10.1016/S0014-5793(01)02610-2; CRAWHALL JC, 1968, SCIENCE, V160, P419, DOI 10.1126/science.160.3826.419; Dahl JU, 2011, J BIOL CHEM, V286, P35801, DOI 10.1074/jbc.M111.282368; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HANNESTAD U, 1981, BIOCHEM MED METAB B, V26, P106, DOI 10.1016/0006-2944(81)90035-1; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Hille R, 2011, COORDIN CHEM REV, V255, P1179, DOI 10.1016/j.ccr.2010.11.034; HOROWITZ P, 1983, J BIOL CHEM, V258, P7894; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; KEYSE SM, 1993, TRENDS BIOCHEM SCI, V18, P377, DOI 10.1016/0968-0004(93)90092-2; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Leimkuhler S, 2003, J BIOL CHEM, V278, P26127, DOI 10.1074/jbc.M303092200; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Marelja Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060869; Matthies A, 2005, BIOCHEMISTRY-US, V44, P7912, DOI 10.1021/bi0503448; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Mikami Y, 2011, BIOCHEM J, V439, P479, DOI 10.1042/BJ20110841; Miyamoto R, 2014, J NEUROCHEM, V130, P29, DOI 10.1111/jnc.12698; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Nagahara N, 2005, J BIOL CHEM, V280, P34569, DOI 10.1074/jbc.M505643200; NAGAHARA N, 1995, J BIOL CHEM, V270, P16230, DOI 10.1074/jbc.270.27.16230; Nagahara N, 1998, HISTOCHEM CELL BIOL, V110, P243, DOI 10.1007/s004180050286; Nagahara N, 1999, HISTOL HISTOPATHOL, V14, P1277, DOI 10.14670/HH-14.1277; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Pandurangappa M, 2010, ANAL SCI, V26, P83, DOI 10.2116/analsci.26.83; PLOEGMAN JH, 1978, J MOL BIOL, V123, P557, DOI 10.1016/0022-2836(78)90207-3; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; Qiu R, 2012, PROTEIN PEPTIDE LETT, V19, P1139, DOI 10.2174/092986612803217060; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Sass E, 2003, J BIOL CHEM, V278, P45109, DOI 10.1074/jbc.M302344200; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Schmitz J, 2007, BIOCHEMISTRY-US, V46, P909, DOI 10.1021/bi062011w; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; SORBO B, 1957, BIOCHIM BIOPHYS ACTA, V23, P412, DOI 10.1016/0006-3002(57)90346-3; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TANIGUCHI T, 1974, BIOCHIM BIOPHYS ACTA, V364, P284, DOI 10.1016/0005-2744(74)90014-X; Toohey JI, 2011, ANAL BIOCHEM, V413, P1, DOI 10.1016/j.ab.2011.01.044; UBUKA T, 1992, Amino Acids (Vienna), V2, P143, DOI 10.1007/BF00806085; Van der Veen AG, 2011, P NATL ACAD SCI USA, V108, P1763, DOI 10.1073/pnas.1014402108; Westley J, 1989, SULPHUR CONTAINING D, P87; Westrop GD, 2009, J BIOL CHEM, V284, P33485, DOI 10.1074/jbc.M109.054320; Williams RAM, 2003, J BIOL CHEM, V278, P1480, DOI 10.1074/jbc.M209395200; Wuebbens MM, 2003, J BIOL CHEM, V278, P14523, DOI 10.1074/jbc.M300453200; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yogev O, 2011, FEBS J, V278, P4230, DOI 10.1111/j.1742-4658.2011.08359.x	56	42	43	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34543	34556		10.1074/jbc.M114.605733	http://dx.doi.org/10.1074/jbc.M114.605733			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25336638	Green Published, hybrid			2022-12-28	WOS:000346260800014
J	van Schouwenburg, PA; Kruithof, S; Votsmeier, C; van Schie, K; Hart, MH; de Jong, RN; van Buren, EEL; van Ham, M; Aarden, L; Wolbink, G; Wouters, D; Rispens, T				van Schouwenburg, Pauline A.; Kruithof, Simone; Votsmeier, Christian; van Schie, Karin; Hart, Margreet H.; de Jong, Rob N.; van Buren, Esther E. L.; van Ham, Marieke; Aarden, Lucien; Wolbink, Gertjan; Wouters, Diana; Rispens, Theo			Functional Analysis of the Anti-adalimumab Response Using Patient-derived Monoclonal Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; Autoimmune Disease; Biotechnology; Humoral Response; Monoclonal Antibody; Tumor Necrosis Factor (TNF); Adalimumab; Immunogenicity	RHEUMATOID-ARTHRITIS PATIENTS; LONG-TERM TREATMENT; CLINICAL-RESPONSE; NECROSIS-FACTOR; IGG SUBCLASSES; RA PATIENTS; IMMUNOGENICITY; INFLIXIMAB; AFFINITY; GENES	Background: Therapeutic antibodies such as adalimumab can elicit anti-drug antibodies. Results: Monoclonal patient-derived antibodies were generated and found to compete for binding to adalimumab and are neutralizing, but they show markedly different fine-specificity. Conclusion: Anti-adalimumab antibodies bind to overlapping but distinct epitopes on adalimumab. Significance: Even for a fully human therapeutic antibody, there may be multiple determinants that contribute to immunogenicity. The production of antibodies to adalimumab in autoimmune patients treated with adalimumab is shown to diminish treatment efficacy. We previously showed that these antibodies are almost exclusively neutralizing, indicating a restricted response. Here, we investigated the characteristics of a panel of patient-derived monoclonal antibodies for binding to adalimumab. Single B-cells were isolated from two patients, cultured, and screened for adalimumab specificity. Analysis of variable region sequences of 16 clones suggests that the immune response against adalimumab is broad, involving multiple B-cell clones each using different combinations of V(D)J segments. A strong bias for replacement mutations in the complementarity determining regions was found, indicating an antigen-driven response. We recombinantly expressed 11 different monoclonal antibodies and investigated their affinity and specificity. All clones except one are of high affinity (K-d between 0.6 and 233 pm) and compete with TNF as well as each other for binding to adalimumab. However, binding to a panel of single-point mutants of adalimumab indicates markedly different fine specificities that also result in a differential tendency of each clone to form dimeric and multimeric immune complexes. We conclude that although all anti-adalimumab antibodies compete for binding to TNF, the response is clonally diverse and involves multiple epitopes on adalimumab. These results are important for understanding the relationship between self and non-self or idiotypic determinants on therapeutic antibodies and their potential immunogenicity.	[van Schouwenburg, Pauline A.; Kruithof, Simone; van Schie, Karin; Hart, Margreet H.; van Ham, Marieke; Aarden, Lucien; Wolbink, Gertjan; Wouters, Diana; Rispens, Theo] Sanquin Res, Dept Immunopathol, NL-1105 AZ Amsterdam, Netherlands; [van Schouwenburg, Pauline A.; Kruithof, Simone; van Schie, Karin; Hart, Margreet H.; van Ham, Marieke; Aarden, Lucien; Wolbink, Gertjan; Wouters, Diana; Rispens, Theo] Landsteiner Lab Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Wolbink, Gertjan] Jan van Breemen Res Inst Reade, NL-1056 AB Amsterdam, Netherlands; [Votsmeier, Christian] Bayer HealthCare, Global Biol, Global Drug Discovery, D-51061 Cologne, Germany; [de Jong, Rob N.; van Buren, Esther E. L.] Genmab BV, NL-3584 BV Utrecht, Netherlands	Bayer AG; Bayer Healthcare Pharmaceuticals; Genmab	Rispens, T (corresponding author), Sanquin Blood Supply, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	t.rispens@sanquin.nl		de Jong, Rob N./0000-0002-9300-6633; Wolbink, Gerrit Jan/0000-0003-1924-7460; van Schouwenburg, Pauline/0000-0003-2779-1415				Amara K, 2013, J EXP MED, V210, P445, DOI 10.1084/jem.20121486; Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; de Jong Rob N., 2006, Journal of Structural and Functional Genomics, V7, P109, DOI 10.1007/s10969-006-9014-z; de Vries MK, 2009, ANN RHEUM DIS, V68, P1787, DOI 10.1136/ard.2009.109702; Dohmen SE, 2006, TRANSFUSION, V46, P2162, DOI 10.1111/j.1537-2995.2006.01047.x; FONTIJN R, 1995, EXP CELL RES, V216, P199, DOI 10.1006/excr.1995.1025; HACK CE, 1992, INFECT IMMUN, V60, P2835, DOI 10.1128/IAI.60.7.2835-2842.1992; INSEL RA, 1994, INT IMMUNOL, V6, P1437, DOI 10.1093/intimm/6.9.1437; Pascual-Salcedo D, 2011, RHEUMATOLOGY, V50, P1445, DOI 10.1093/rheumatology/ker124; Poulsen TR, 2007, J IMMUNOL, V179, P3841, DOI 10.4049/jimmunol.179.6.3841; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Rispens T, 2014, J BIOL CHEM, V289, P6098, DOI 10.1074/jbc.M113.541813; Rispens T, 2013, ANAL BIOCHEM, V437, P118, DOI 10.1016/j.ab.2013.02.027; Roux KH, 1997, J IMMUNOL, V159, P3372; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; Svenson M, 2007, RHEUMATOLOGY, V46, P1828, DOI 10.1093/rheumatology/kem261; Uduman M, 2011, NUCLEIC ACIDS RES, V39, pW499, DOI 10.1093/nar/gkr413; van Schie KA, 2015, ANN RHEUM DIS, V74, P311, DOI 10.1136/annrheumdis-2014-206237; van Schouwenburg PA, 2013, ANN RHEUM DIS, V72, P104, DOI 10.1136/annrheumdis-2012-201445; van Schouwenburg PA, 2012, J CLIN IMMUNOL, V32, P1000, DOI 10.1007/s10875-012-9705-0; van Schouwenburg PA, 2010, J IMMUNOL METHODS, V362, P82, DOI 10.1016/j.jim.2010.09.005; Votsmeier C, 2012, MABS-AUSTIN, V4, P341, DOI 10.4161/mabs.19981; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Wolbink GJ, 2006, ARTHRITIS RHEUM-US, V54, P711, DOI 10.1002/art.21671	25	50	52	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34482	34488		10.1074/jbc.M114.615500	http://dx.doi.org/10.1074/jbc.M114.615500			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25326381	Green Published, hybrid			2022-12-28	WOS:000346260800009
J	Bray, L; Froment, C; Pardo, P; Candotto, C; Burlet-Schiltz, O; Zajac, JM; Mollereau, C; Mouledous, L				Bray, Lauriane; Froment, Carine; Pardo, Pierre; Candotto, Cedric; Burlet-Schiltz, Odile; Zajac, Jean-Marie; Mollereau, Catherine; Mouledous, Lionel			Identification and Functional Characterization of the Phosphorylation Sites of the Neuropeptide FF2 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptor (GPCR); Mass Spectrometry (MS); Phosphorylation; Post-translational Modification (PTM); Signaling; Desensitization; Internalization; Mass Spectrometry; Neuropeptide FF	PROTEIN-COUPLED RECEPTORS; MU-OPIOID RECEPTORS; NPFF2 RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; DISTINCT DOMAINS; DESENSITIZATION; INTERNALIZATION; SIGNAL; TRAFFICKING; ANTAGONIST	Background: G protein-coupled receptor functions are regulated by phosphorylation. Results: Mass spectrometry was used to map the phosphorylation sites of the NPFF2 neuropeptide FF receptor, and site-directed mutagenesis permitted the identification of their role in receptor regulation. Conclusion: Sites involved in desensitization and internalization do not fully overlap. Significance: This is the first mapping of NPFF2 receptor phosphorylation. The neuropeptide FF2 (NPFF2) receptor belongs to the rhodopsin family of G protein-coupled receptors and mediates the effects of several related RFamide neuropeptides. One of the main pharmacological interests of this system resides in its ability to regulate endogenous opioid systems, making it a potential target to reduce the negative effects of chronic opioid use. Phosphorylation of intracellular residues is the most extensively studied post-translational modification regulating G protein-coupled receptor activity. However, until now, no information concerning NPFF2 receptor phosphorylation is available. In this study, we combined mass spectrometric analysis and site-directed mutagenesis to analyze for the first time the phosphorylation pattern of the NPFF2 receptor and the role of the various phosphorylation sites in receptor signaling, desensitization, and trafficking in a SH-SY5Y model cell line. We identified the major, likely GRK-dependent, phosphorylation cluster responsible for acute desensitization, (TNST415)-T-412 at the end of the C terminus of the receptor, and additional sites involved in desensitization ((TS373)-T-372) and internalization (Ser(395)). We thus demonstrate the key role played by phosphorylation in the regulation of NPFF2 receptor activity and trafficking. Our data also provide additional evidence supporting the concept that desensitization and internalization are partially independent processes relying on distinct phosphorylation patterns.	[Bray, Lauriane; Froment, Carine; Pardo, Pierre; Candotto, Cedric; Burlet-Schiltz, Odile; Zajac, Jean-Marie; Mollereau, Catherine; Mouledous, Lionel] Univ Toulouse, CNRS, UMR5089, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Mollereau, C (corresponding author), Univ Toulouse, CNRS, UMR5089, Inst Pharmacol & Biol Struct, 205 Route Narbonne BP64182, F-31077 Toulouse, France.	catherine.mollereau-manaute@ipbs.fr; Lionel.mouledous@ipbs.fr	Zajac, jean-marie/E-5129-2010	Mouledous, Lionel/0000-0002-7675-3493; Schiltz, Odile/0000-0002-3606-2356; Mollereau, Catherine/0000-0003-1543-5624	Fondation pour la Recherche Medicale (programme Grands Equipements); Region Midi-Pyrenees, Infrastructures en Biologie, Sante et Agronomie; Fonds Europeens de Developpement Regional	Fondation pour la Recherche Medicale (programme Grands Equipements)(Fondation pour la Recherche Medicale); Region Midi-Pyrenees, Infrastructures en Biologie, Sante et Agronomie(Region Occitanie); Fonds Europeens de Developpement Regional(European Commission)	This work was supported in part by grants from the Fondation pour la Recherche Medicale (programme Grands Equipements), the Region Midi-Pyrenees, Infrastructures en Biologie, Sante et Agronomie, and Fonds Europeens de Developpement Regional.	Anko ML, 2006, J NEUROCHEM, V96, P573, DOI 10.1111/j.1471-4159.2005.03581.x; Asai D, 2014, FEBS LETT, V588, P2129, DOI 10.1016/j.febslet.2014.04.038; Bonini JA, 2000, J BIOL CHEM, V275, P39324, DOI 10.1074/jbc.M004385200; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Butcher AJ, 2014, J BIOL CHEM, V289, P18451, DOI 10.1074/jbc.M114.568816; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Celver J, 2004, MOL PHARMACOL, V65, P528, DOI 10.1124/mol.65.3.528; Chuang TT, 1996, TRENDS PHARMACOL SCI, V17, P416, DOI 10.1016/S0165-6147(96)10048-1; Daaka Y, 1997, P NATL ACAD SCI USA, V94, P2180, DOI 10.1073/pnas.94.6.2180; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Elhabazi K, 2012, BRIT J PHARMACOL, V165, P424, DOI 10.1111/j.1476-5381.2011.01563.x; Elshourbagy NA, 2000, J BIOL CHEM, V275, P25965, DOI 10.1074/jbc.M004515200; Gartner F, 2013, J BIOL CHEM, V288, P32138, DOI 10.1074/jbc.M113.461566; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gautier V, 2012, MOL CELL PROTEOMICS, V11, P527, DOI 10.1074/mcp.M111.015230; GICQUEL S, 1992, EUR J PHARMACOL, V222, P61, DOI 10.1016/0014-2999(92)90463-E; Gluck L., 2014, BIOL PSYCHIAT, V2014; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Jin WZ, 1999, J NEUROSCI, V19, P3773; Kotani M, 2001, BRIT J PHARMACOL, V133, P138, DOI 10.1038/sj.bjp.0704038; Lau EK, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001748; Liggett SB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002331; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; Maletinska L, 2013, BRAIN RES, V1498, P33, DOI 10.1016/j.brainres.2012.12.037; Mollereau C, 2005, CURR TOP MED CHEM, V5, P341, DOI 10.2174/1568026053544515; Mollereau C, 2005, MOL PHARMACOL, V67, P965, DOI 10.1124/mol.104.004614; Mollereau C, 2002, EUR J PHARMACOL, V451, P245, DOI 10.1016/S0014-2999(02)02224-0; Mollereau C, 2007, PEPTIDES, V28, P1125, DOI 10.1016/j.peptides.2007.03.001; Mollereau C, 2011, PHARMACOL REP, V63, P1061, DOI 10.1016/S1734-1140(11)70623-5; Mouledous L, 2008, BIOCHEM BIOPH RES CO, V373, P80, DOI 10.1016/j.bbrc.2008.05.174; Mouledous L, 2012, J BIOL CHEM, V287, P12736, DOI 10.1074/jbc.M111.314617; Mouledous L, 2010, BIOFACTORS, V36, P423, DOI 10.1002/biof.116; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Ouedraogo M, 2008, TRAFFIC, V9, P305, DOI 10.1111/j.1600-0854.2007.00691.x; Panula P, 1996, PROG NEUROBIOL, V48, P461, DOI 10.1016/0301-0082(96)00001-9; Pertovaara A, 2005, NEUROSCIENCE, V134, P1023, DOI 10.1016/j.neuroscience.2005.04.050; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Simonin F, 2006, P NATL ACAD SCI USA, V103, P466, DOI 10.1073/pnas.0502090103; Singh V, 2014, J IMMUNOL, V192, P2186, DOI 10.4049/jimmunol.1301875; Sun YL, 2012, PEPTIDES, V38, P110, DOI 10.1016/j.peptides.2012.08.019; Talmont F, 2010, PEPTIDES, V31, P215, DOI 10.1016/j.peptides.2009.11.020; Talmont F, 2009, NEUROCHEM INT, V55, P815, DOI 10.1016/j.neuint.2009.08.004; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yang HYT, 2008, NEUROPEPTIDES, V42, P1, DOI 10.1016/j.npep.2007.06.004; Zajac JM, 2001, TRENDS PHARMACOL SCI, V22, P63, DOI 10.1016/S0165-6147(00)01610-2	50	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33754	33766		10.1074/jbc.M114.612614	http://dx.doi.org/10.1074/jbc.M114.612614			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25326382	Green Published, hybrid			2022-12-28	WOS:000346077600004
J	Edwards, DJ; Streich, FC; Ronchi, VP; Todaro, DR; Haas, AL				Edwards, Daniel J.; Streich, Frederick C., Jr.; Ronchi, Virginia P.; Todaro, Dustin R.; Haas, Arthur L.			Convergent Evolution in the Assembly of Polyubiquitin Degradation Signals by the Shigella flexneri IpaH9.8 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cooperativity; E3 Ubiquitin Ligase; Enzyme Mechanism; Polyubiquitin Chain; Protein Degradation; Virulence Factor; IpaH; Ubc5; Conjugation; Oligomer	E3 UBIQUITIN LIGASES; III SECRETION; MULTIUBIQUITIN CHAIN; PROTEIN; MECHANISM; INVASION; CELLS; VIRULENCE; EFFECTORS; REVEALS	Background: IpaH bacterial ubiquitin ligases show no homology with eukaryotic ligases, and their mechanism is speculative. Results: IpaH9.8 functions as a cooperative allosteric dimer with two Ubc5 approximate to ubiquitin binding sites per subunit. Conclusion: Kinetic parallels between IpaH and eukaryotic HECT ligases suggest convergent catalytic cycle evolution. Significance: These are the first mechanistic details of the IpaH enzyme catalytic mechanism. The human pathogen Shigella flexneri subverts host function and defenses by deploying a cohort of effector proteins via a type III secretion system. The IpaH family of 10 such effectors mimics ubiquitin ligases but bears no sequence or structural homology to their eukaryotic counterpoints. Using rates of I-125-polyubiquitin chain formation as a functional read out, IpaH9.8 displays V-type positive cooperativity with respect to varying concentrations of its Ubc5B approximate to I-125-ubiquitin thioester co-substrate in the nanomolar range ([S](1/2) = 140 +/- 32 nm; n = 1.8 +/- 0.1) and cooperative substrate inhibition at micromolar concentrations ([S](1/2) = 740 +/- 240 nm; n = 1.7 +/- 0.2), requiring ordered binding to two functionally distinct sites per subunit. The isosteric substrate analog Ubc5BC85S-ubiquitin oxyester acts as a competitive inhibitor of wild-type Ubc5B approximate to I-125-ubiquitin thioester (K-i = 117 +/- 29 nm), whereas a Ubc5BC85A product analog shows noncompetitive inhibition (K-i = 2.2 +/- 0.5 m), consistent with the two-site model. Re-evaluation of a related IpaH3 crystal structure (PDB entry 3CVR) identifies a symmetric dimer consistent with the observed cooperativity. Genetic disruption of the predicted IpaH9.8 dimer interface reduces the solution molecular weight and significantly ablates the k(cat) but not [S](1/2) for polyubiquitin chain formation. Other studies demonstrate that cooperativity requires the N-terminal leucine-rich repeat-targeting domain and is transduced through Phe(395). Additionally, these mechanistic features are conserved in a distantly related SspH2 Salmonella enterica ligase. Kinetic parallels between IpaH9.8 and the recently revised mechanism for E6AP/UBE3A (Ronchi, V. P., Klein, J. M., and Haas, A. L. (2013) E6AP/UBE3A ubiquitin ligase harbors two E2 approximate to ubiquitin binding sites. J. Biol. Chem. 288, 10349-10360) suggest convergent evolution of the catalytic mechanisms for prokaryotic and eukaryotic ligases.	[Edwards, Daniel J.; Streich, Frederick C., Jr.; Ronchi, Virginia P.; Todaro, Dustin R.; Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Haas, AL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu		Streich Jr, Frederick/0000-0002-7549-424X	National Institutes of Health [GM034009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM034009 (to A. L. H.).	Ashida H, 2007, MOL MICROBIOL, V63, P680, DOI 10.1111/j.1365-2958.2006.05547.x; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chou YC, 2012, J BIOL CHEM, V287, P268, DOI 10.1074/jbc.M111.316265; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Diao J, 2008, NAT STRUCT MOL BIOL, V15, P65, DOI 10.1038/nsmb1346; GOLDBERG MB, 1995, P NATL ACAD SCI USA, V92, P6572, DOI 10.1073/pnas.92.14.6572; Grau-Bove X, 2013, GENOME BIOL EVOL, V5, P833, DOI 10.1093/gbe/evt052; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haas Arthur L., 2005, V301, P23; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; HIGH N, 1992, EMBO J, V11, P1991, DOI 10.1002/j.1460-2075.1992.tb05253.x; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Lee H, 2005, EPIDEMIOL INFECT, V133, P469, DOI 10.1017/S0950268804003590; Lin DYW, 2011, J BIOL CHEM, V286, P441, DOI 10.1074/jbc.M110.167643; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Okuda J, 2005, BIOCHEM BIOPH RES CO, V333, P531, DOI 10.1016/j.bbrc.2005.05.145; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; PERDOMO JJ, 1994, J CLIN INVEST, V93, P633, DOI 10.1172/JCI117015; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Ronchi VP, 2012, METHODS MOL BIOL, V832, P197, DOI 10.1007/978-1-61779-474-2_14; Sack RB, 1997, CLIN INFECT DIS, V24, pS102, DOI 10.1093/clinids/24.Supplement_1.S102; Sansonetti PJ, 2001, FEMS MICROBIOL REV, V25, P3, DOI 10.1111/j.1574-6976.2001.tb00569.x; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Seyedarabi A, 2010, FEBS LETT, V584, P4163, DOI 10.1016/j.febslet.2010.09.006; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Stoll KE, 2011, J BIOL CHEM, V286, P15165, DOI 10.1074/jbc.M110.203968; Streich FC, 2013, J BIOL CHEM, V288, P8209, DOI 10.1074/jbc.M113.451567; Sur D, 2004, INDIAN J MED RES, V120, P454; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Townes JM, 2010, CLIN INFECT DIS, V50, P247, DOI 10.1086/649540; Wang F, 2013, CELL MICROBIOL, V15, P474, DOI 10.1111/cmi.12052; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; WASSEF JS, 1989, INFECT IMMUN, V57, P858, DOI 10.1128/IAI.57.3.858-863.1989; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wu B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000960; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	55	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34114	34128		10.1074/jbc.M114.609164	http://dx.doi.org/10.1074/jbc.M114.609164			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25342744	Green Published, hybrid			2022-12-28	WOS:000346077600036
J	Englund, PT				Englund, Paul T.			A Passion for Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Trypanosoma brucei; Mitochondrial DNA; DNA Replication; DNA Topoisomerase	KINETOPLAST DNA-REPLICATION; VARIANT SURFACE GLYCOPROTEIN; TRYPANOSOMATID CRITHIDIA-FASCICULATA; UNIVERSAL MINICIRCLE SEQUENCE; FATTY-ACID SYNTHESIS; MITOCHONDRIAL-DNA; BINDING-PROTEIN; LEISHMANIA-TARENTOLAE; AFRICAN TRYPANOSOMES; RNA INTERFERENCE	I knew nothing and had thought nothing about parasites until 1971. In fact, if you had asked me before then, I might have commented that parasites were rather disgusting. I had been at the Johns Hopkins School of Medicine for three years, and I was on the lookout for a new project. In 1971, I came across a paper in the Journal of Molecular Biology by Larry Simpson, a classmate of mine in graduate school. Larry's paper described a remarkable DNA structure known as kinetoplast DNA (kDNA), isolated from a parasite. kDNA, the mitochondrial genome of trypanosomatids, is a DNA network composed of several thousand interlocked DNA rings. Almost nothing was known about it. I was looking for a project on DNA replication, and I wanted it to be both challenging and important. I had no doubt that working with kDNA would be a challenge, as I would be exploring uncharted territory. I was also sure that the project would be important when I learned that parasites with kDNA threaten huge populations in underdeveloped tropical countries. Looking again at Larry's paper, I found the electron micrographs of the kDNA networks to be rather beautiful. I decided to take a chance on kDNA. Little did I know then that I would devote the next forty years of my life to studying kDNA replication.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Englund, PT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	penglund@jhmi.edu			NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I thank many wonderful collaborators throughout the years on the kDNA project: the late Nick Cozzarelli, the late Don Crothers, Jack Griffith, Keith Gull, Rob Jensen, Tom Kunkel, Leroy Liu, Terry Shapiro, Yossi Shlomai, Larry Simpson, Dave Ward, and Bob Wells. On the GPI project, I thank mainly Jerry Hart and Dan Raben. I thank the NIH for supporting me so generously throughout my whole career. I thank Dan Goldberg, Ann Hubbard, Michele Klingbeil, Steve Levene, Dan Ray, Terry Shapiro, Yossi Shlomai, Larry Simpson, and Dyann Wirth for helpful discussions and comments on the manuscript. I thank my wife, Christy, for her encouragement over many years and her astute critique of this paper. Finally, I dedicate this paper to the memory of two brilliant scientists: Dan Lane, who was a fantastic department chair and my very close friend, and Elisabetta Ullu, who was in my opinion the best molecular biologist working on African trypanosomes. Elisabetta died much too young on September 8, 2014.	Abu-Elneel K, 2001, J CELL BIOL, V153, P725, DOI 10.1083/jcb.153.4.725; Acosta-Serrano A, 2001, P NATL ACAD SCI USA, V98, P1513, DOI 10.1073/pnas.041611698; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; AVRAHAMI D, 1995, P NATL ACAD SCI USA, V92, P10511, DOI 10.1073/pnas.92.23.10511; BANGS JD, 1985, P NATL ACAD SCI USA, V82, P3207, DOI 10.1073/pnas.82.10.3207; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; BORST P, 1977, EXP CELL RES, V110, P167, DOI 10.1016/0014-4827(77)90283-X; BORST P, 1991, TRENDS GENET, V7, P139, DOI 10.1016/0168-9525(91)90374-Y; BRIDGEN PJ, 1976, NATURE, V263, P613, DOI 10.1038/263613a0; Buxbaum LU, 1996, P NATL ACAD SCI USA, V93, P1178, DOI 10.1073/pnas.93.3.1178; CARPENTER LR, 1995, MOL CELL BIOL, V15, P6794; Chen JH, 1995, EMBO J, V14, P6339, DOI 10.1002/j.1460-2075.1995.tb00325.x; CHEN JH, 1995, CELL, V80, P61, DOI 10.1016/0092-8674(95)90451-4; Chowdhury AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001226; Concepcion-Acevedo J, 2012, EUKARYOT CELL, V11, P844, DOI 10.1128/EC.05291-11; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Craig LC, 1943, J BIOL CHEM, V150, P33; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Dean S, 2013, P NATL ACAD SCI USA, V110, P14741, DOI 10.1073/pnas.1305404110; DOERING TL, 1991, SCIENCE, V252, P1851, DOI 10.1126/science.1829548; Downey N, 2005, EUKARYOT CELL, V4, P765, DOI 10.1128/EC.4.4.765-774.2005; Drew ME, 2003, J BIOL CHEM, V278, P46596, DOI 10.1074/jbc.M309320200; Drew ME, 2001, J CELL BIOL, V153, P735, DOI 10.1083/jcb.153.4.735; ENGLUND PT, 1977, J BIOL CHEM, V252, P6208; ENGLUND PT, 1978, CELL, V14, P157, DOI 10.1016/0092-8674(78)90310-0; ENGLUND PT, 1979, J BIOL CHEM, V254, P4895; FERGUSON M, 1992, CELL, V70, P621, DOI 10.1016/0092-8674(92)90431-B; FERGUSON ML, 1994, J CELL BIOL, V126, P631, DOI 10.1083/jcb.126.3.631; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; GRIFFITH J, 1986, CELL, V46, P717, DOI 10.1016/0092-8674(86)90347-8; Guilbride DL, 1998, J CELL SCI, V111, P675; HAJDUK SL, 1984, CELL, V36, P483, DOI 10.1016/0092-8674(84)90241-1; HERELD D, 1988, P NATL ACAD SCI USA, V85, P8914, DOI 10.1073/pnas.85.23.8914; HERELD D, 1986, J BIOL CHEM, V261, P3813; Hines JC, 2011, EUKARYOT CELL, V10, P445, DOI 10.1128/EC.00308-10; Hines JC, 2010, MOL CELL BIOL, V30, P1319, DOI 10.1128/MCB.01231-09; HOEIJMAKERS JHJ, 1980, PLASMID, V4, P97, DOI 10.1016/0147-619X(80)90086-4; HOEIJMAKERS JHJ, 1980, NATURE, V284, P78, DOI 10.1038/284078a0; HOGAN M, 1978, P NATL ACAD SCI USA, V75, P195, DOI 10.1073/pnas.75.1.195; Hwa KY, 1999, GLYCOBIOLOGY, V9, P181, DOI 10.1093/glycob/9.2.181; Jensen RE, 2008, TRENDS PARASITOL, V24, P428, DOI 10.1016/j.pt.2008.06.007; Jiang DW, 2001, BIOCHEM J, V358, P757, DOI 10.1042/0264-6021:3580757; Johnson CE, 1999, MOL BIOCHEM PARASIT, V102, P205, DOI 10.1016/S0166-6851(99)00082-1; Johnson CE, 1998, J CELL BIOL, V143, P911, DOI 10.1083/jcb.143.4.911; Kapeller K, 2011, J BIOL CHEM, V286, P40566, DOI 10.1074/jbc.M111.270322; KITCHIN PA, 1986, J BIOL CHEM, V261, P1302; KITCHIN PA, 1984, J BIOL CHEM, V259, P5532; Klingbeil MM, 2002, MOL CELL, V10, P175, DOI 10.1016/S1097-2765(02)00571-3; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; KRAKOW JL, 1986, J BIOL CHEM, V261, P2147; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Li CJ, 1997, J BIOL CHEM, V272, P20787, DOI 10.1074/jbc.272.33.20787; Li ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000048; Lindsay ME, 2008, MOL MICROBIOL, V70, P1465, DOI 10.1111/j.1365-2958.2008.06493.x; Liu BY, 2010, J BIOL CHEM, V285, P7056, DOI 10.1074/jbc.M109.084038; Liu BY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000589; Liu BY, 2009, MOL CELL, V35, P490, DOI 10.1016/j.molcel.2009.07.004; LIU LF, 1980, CELL, V19, P697, DOI 10.1016/S0092-8674(80)80046-8; Liu YN, 2007, MOL MICROBIOL, V64, P676, DOI 10.1111/j.1365-2958.2007.05686.x; MARINI JC, 1980, J BIOL CHEM, V255, P4976; MARINI JC, 1982, COLD SPRING HARB SYM, V47, P279; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MASTERSON WJ, 1990, CELL, V62, P73, DOI 10.1016/0092-8674(90)90241-6; MELENDY T, 1988, CELL, V55, P1083, DOI 10.1016/0092-8674(88)90252-8; MELENDY T, 1989, J BIOL CHEM, V264, P1870; MENSAWILMOT K, 1990, MOL CELL BIOL, V10, P720, DOI 10.1128/MCB.10.2.720; Milman N, 2007, P NATL ACAD SCI USA, V104, P19250, DOI 10.1073/pnas.0706858104; Milne KG, 1999, J BIOL CHEM, V274, P1465, DOI 10.1074/jbc.274.3.1465; Morita YS, 2000, SCIENCE, V288, P140, DOI 10.1126/science.288.5463.140; Morris JC, 2002, EMBO J, V21, P4429, DOI 10.1093/emboj/cdf474; NTAMBI JM, 1985, J BIOL CHEM, V260, P5574; NTAMBI JM, 1986, J BIOL CHEM, V261, P1890; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Onn I, 2004, EUKARYOT CELL, V3, P277, DOI 10.1128/EC.3.2.277-287.2004; Paul KS, 2004, EUKARYOT CELL, V3, P855, DOI 10.1128/EC.3.4.855-861.2004; PEREZMORGA DL, 1993, CELL, V74, P703, DOI 10.1016/0092-8674(93)90517-T; RAUCH CA, 1993, EMBO J, V12, P403, DOI 10.1002/j.1460-2075.1993.tb05672.x; ROBINSON DR, 1994, J CELL BIOL, V126, P641, DOI 10.1083/jcb.126.3.641; RYAN KA, 1989, MOL CELL BIOL, V9, P3212, DOI 10.1128/MCB.9.8.3212; RYAN KA, 1988, P NATL ACAD SCI USA, V85, P5844, DOI 10.1073/pnas.85.16.5844; Saxowsky TT, 2003, J BIOL CHEM, V278, P49095, DOI 10.1074/jbc.M308565200; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Shapiro TA, 1999, METH MOL B, V94, P61; SHAPIRO TA, 1989, J BIOL CHEM, V264, P4173; Sharma MR, 2009, P NATL ACAD SCI USA, V106, P9637, DOI 10.1073/pnas.0901631106; Shlomai J, 2004, CURR MOL MED, V4, P623, DOI 10.2174/1566524043360096; SIMPSON AM, 1976, J PROTOZOOL, V23, P583, DOI 10.1111/j.1550-7408.1976.tb03846.x; Simpson L, 2000, P NATL ACAD SCI USA, V97, P6986, DOI 10.1073/pnas.97.13.6986; SIMPSON L, 1971, J MOL BIOL, V56, P443, DOI 10.1016/0022-2836(71)90394-9; SIMPSON L, 1978, CELL, V14, P169, DOI 10.1016/0092-8674(78)90311-2; SIMPSON L, 1974, BIOCHIM BIOPHYS ACTA, V349, P161, DOI 10.1016/0005-2787(74)90077-X; Stephens JL, 2007, J BIOL CHEM, V282, P4427, DOI 10.1074/jbc.M609037200; STURM NR, 1990, CELL, V61, P879, DOI 10.1016/0092-8674(90)90198-N; STURM NR, 1990, CELL, V61, P871, DOI 10.1016/0092-8674(90)90197-M; TORRI AF, 1995, J BIOL CHEM, V270, P3495, DOI 10.1074/jbc.270.8.3495; TORRI AF, 1992, J BIOL CHEM, V267, P4786; TORRI AF, 1994, J BIOL CHEM, V269, P8165; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TZFATI Y, 1995, J BIOL CHEM, V270, P21339, DOI 10.1074/jbc.270.36.21339; Wang JY, 2012, MOL MICROBIOL, V83, P471, DOI 10.1111/j.1365-2958.2011.07938.x; Wang ZF, 2001, EMBO J, V20, P4674, DOI 10.1093/emboj/20.17.4674; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Werbovetz KA, 1996, BIOCHEM J, V318, P575, DOI 10.1042/bj3180575; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Zhao Z, 2008, EMBO J, V27, P143, DOI 10.1038/sj.emboj.7601956	110	6	6	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33712	33729		10.1074/jbc.X114.620666	http://dx.doi.org/10.1074/jbc.X114.620666			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25336639	Green Published, hybrid			2022-12-28	WOS:000346077600001
J	Behrmann, H; Lurick, A; Kuhlee, A; Balderhaar, HK; Brocker, C; Kummel, D; Engelbrecht-Vandre, S; Gohlke, U; Raunser, S; Heinemann, U; Ungermann, C				Behrmann, Heide; Luerick, Anna; Kuhlee, Anne; Balderhaar, Henning Kleine; Broecker, Cornelia; Kuemmel, Daniel; Engelbrecht-Vandre, Siegfried; Gohlke, Ulrich; Raunser, Stefan; Heinemann, Udo; Ungermann, Christian			Structural Identification of the Vps18 beta-Propeller Reveals a Critical Role in the HOPS Complex Stability and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETHERING COMPLEX; MACROMOLECULAR CRYSTALLOGRAPHY; FUSION; MEMBRANE; ENDOSOME; SITES; PHOSPHORYLATION; PURIFICATION; REFINEMENT; PROTEINS	Membrane fusion at the vacuole, the lysosome equivalent in yeast, requires the HOPS tethering complex, which is recruited by the Rab7 GTPase Ypt7. HOPS provides a template for the assembly of SNAREs and thus likely confers fusion at a distinct position on vacuoles. Five of the six subunits in HOPS have a similar domain prediction with strong similarity to COPII subunits and nuclear porins. Here, we show that Vps18 indeed has a seven-bladed beta-propeller as its N-terminal domain by revealing its structure at 2.14 angstrom. The Vps18 N-terminal domain can interact with the N-terminal part of Vps11 and also binds to lipids. Although deletion of the Vps18 N-terminal domain does not preclude HOPS assembly, as revealed by negative stain electron microscopy, the complex is instable and cannot support membrane fusion in vitro. We thus conclude that the beta-propeller of Vps18 is required for HOPS stability and function and that it can serve as a starting point for further structural analyses of the HOPS tethering complex.	[Behrmann, Heide; Gohlke, Ulrich; Heinemann, Udo] Max Delbruck Ctr Mol Med, Macromol Struct & Interact Grp, D-13125 Berlin, Germany; [Behrmann, Heide; Heinemann, Udo] Free Univ Berlin, Chem & Biochem Inst, D-14195 Berlin, Germany; [Luerick, Anna; Balderhaar, Henning Kleine; Broecker, Cornelia; Engelbrecht-Vandre, Siegfried; Ungermann, Christian] Univ Osnabruck, Biochem Sect, Dept Biol Chem, D-49076 Osnabruck, Germany; [Kuhlee, Anne; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany; [Kuemmel, Daniel] Univ Osnabruck, Struct Biol Sect, Dept Biol Chem, D-49076 Osnabruck, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; University Osnabruck; Max Planck Society; University Osnabruck	Heinemann, U (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	heinemann@mdc-berlin.de; cu@uos.de	Gohlke, Ulrich/B-8641-2016; Raunser, Stefan/AHE-1573-2022; Heinemann, Udo/S-3379-2016; Heinemann, Udo/AAH-4766-2019	Heinemann, Udo/0000-0002-8191-3850; Heinemann, Udo/0000-0002-8191-3850; Raunser, Stefan/0000-0001-9373-3016; Behrmann, Heide/0000-0002-1769-7049	Deutsche Forschungsgemeinschaft [UN111/5-3, RA1781/2-3]; Hans-Muhlenhoff foundation; Leibniz Graduate School of Molecular Biophysics, Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hans-Muhlenhoff foundation; Leibniz Graduate School of Molecular Biophysics, Berlin	This work was supported by the Deutsche Forschungsgemeinschaft (UN111/5-3 (to C. U.) and RA1781/2-3 (to S. R.)), by the Hans-Muhlenhoff foundation (to C. U.), and the Leibniz Graduate School of Molecular Biophysics, Berlin (to H. B. and U. H.).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baker RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067409; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Epp N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067307; FOLCH J, 1957, J BIOL CHEM, V226, P497; Graham SC, 2013, P NATL ACAD SCI USA, V110, P13345, DOI 10.1073/pnas.1307074110; Guo Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081534; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Klinger CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076278; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kummel D, 2014, CURR OPIN CELL BIOL, V29, P61, DOI 10.1016/j.ceb.2014.04.007; Lachmann Jens, 2011, Small GTPases, V2, P182; LaGrassa TJ, 2005, J CELL BIOL, V168, P401, DOI 10.1083/jcb.200407141; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Narayan K, 2006, METHODS, V39, P122, DOI 10.1016/j.ymeth.2006.05.006; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; Richardson BC, 2009, P NATL ACAD SCI USA, V106, P13329, DOI 10.1073/pnas.0901966106; Rieter E, 2013, J CELL SCI, V126, P593, DOI 10.1242/jcs.115725; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Solinger JA, 2013, FEBS J, V280, P2743, DOI 10.1111/febs.12151; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810	42	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33503	33512		10.1074/jbc.M114.602714	http://dx.doi.org/10.1074/jbc.M114.602714			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25324549	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000345636600038
J	Drew, BG; Hamidi, H; Zhou, ZQ; Villanueva, CJ; Krum, SA; Calkin, AC; Parks, BW; Ribas, V; Kalajian, NY; Phun, J; Daraei, P; Christofk, HR; Hewitt, SC; Korach, KS; Tontonoz, P; Lusis, AJ; Slamon, DJ; Hurvitz, SA; Hevener, AL				Drew, Brian G.; Hamidi, Habib; Zhou, Zhenqi; Villanueva, Claudio J.; Krum, Susan A.; Calkin, Anna C.; Parks, Brian W.; Ribas, Vicent; Kalajian, Nareg Y.; Phun, Jennifer; Daraei, Pedram; Christofk, Heather R.; Hewitt, Sylvia C.; Korach, Kenneth S.; Tontonoz, Peter; Lusis, Aldons J.; Slamon, Dennis J.; Hurvitz, Sara A.; Hevener, Andrea L.			Estrogen Receptor (ER)alpha-regulated Lipocalin 2 Expression in Adipose Tissue Links Obesity with Breast Cancer Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ALPHA GENE; METABOLIC SYNDROME; LUNG METASTASIS; INFLAMMATION; CELLS; MICE; FAT; ADIPOCYTES; BINDING	Obesity is associated with increased breast cancer (BrCA) incidence. Considering that inactivation of estrogen receptor (ER)alpha promotes obesity and metabolic dysfunction in women and female mice, understanding the mechanisms and tissue-specific sites of ER alpha action to combat metabolic-related disease, including BrCA, is of clinical importance. To study the role of ERa in adipose tissue we generated fat-specific ERa knock-out (FERKO) 'mice. Herein we show that ERa deletion increased adipocyte size, fat pad weight, and tissue expression and circulating levels of the secreted glycoprotein, lipocalin 2 (Lcn2), an adipokine previously associated with BrCA development. Chromatin immunoprecipitation and luciferase reporter studies showed that ER alpha binds the Lcn2 promoter to repress its expression. Because adipocytes constitute an important cell type of the breast microenvironment, we examined the impact of adipocyte ERa deletion on cancer cell behavior. Conditioned medium from ER alpha-null adipocytes and medium containing pure Lcn2 increased proliferation and migration of a subset of BrCA cells in culture. The proliferative and promigratory effects of ER alpha-deficient adipocyte-conditioned medium on BrCA cells was reversed by Lcn2 deletion. BrCA cell responsiveness to exogenous Lcn2 was heightened in cell types where endogenous Lcn2 expression was minimal, but components of the Lcn2 signaling pathway were enriched, i.e. SLC22A17 and 3 -hydroxybutyrate dehydrogenase (BDH2). In breast tumor biopsies from women diagnosed with BrCA we found that BDH2 expression was positively associated with adiposity and circulating Lcn2 levels. Collectively these data suggest that reduction of ERa expression in adipose tissue promotes adiposity and is linked with the progression and severity of BrCA via increased adipocyte-specific Lcn2 production and enhanced tumor cell Lcn2 sensitivity.	[Drew, Brian G.; Zhou, Zhenqi; Ribas, Vicent; Kalajian, Nareg Y.; Phun, Jennifer; Daraei, Pedram; Hevener, Andrea L.] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Dept Med, Los Angeles, CA 90095 USA; [Hamidi, Habib; Slamon, Dennis J.; Hurvitz, Sara A.] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Hamidi, Habib; Christofk, Heather R.; Slamon, Dennis J.; Hurvitz, Sara A.; Hevener, Andrea L.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Villanueva, Claudio J.; Calkin, Anna C.; Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Krum, Susan A.] Univ Calif Los Angeles, Dept Orthopaed Surg, Orthopaed Hosp, Los Angeles, CA 90095 USA; [Krum, Susan A.] Univ Calif Los Angeles, Orthopaed Hosp, Res Ctr, Los Angeles, CA 90095 USA; [Parks, Brian W.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Christofk, Heather R.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Hewitt, Sylvia C.; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, Reprod & Dev Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Slamon, Dennis J.; Hurvitz, Sara A.] Translat Res Oncol US, Los Angeles, CA 90095 USA; [Hevener, Andrea L.] Iiris Cantor UCLA Womens Hlth Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hevener, AL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, 900 Vet Ave,Warren Hall Suite 24-130, Los Angeles, CA 90095 USA.	ahevener@mednet.ucla.edu	Krum, Susan A./D-7282-2013; Hamidi, Habib/H-8030-2016; Ribas, Vicent/K-1390-2014; Hewitt, Sylvia/W-8752-2019	Krum, Susan A./0000-0002-6414-6397; Hamidi, Habib/0000-0003-0196-9852; Ribas, Vicent/0000-0003-3380-2256; Hewitt, Sylvia/0000-0001-7713-0805; Christofk, Heather/0000-0002-8662-4425; Korach, Kenneth/0000-0002-7765-418X; Calkin, Anna/0000-0002-9861-0602; Villanueva, Claudio/0000-0002-9731-7463	UCLA Jonsson Comprehensive Cancer Center; UCLA Iris Cantor Women's Health Foundation; UCSD-UCLA Diabetes Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007228] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL123021, P01HL090553, K99HL123021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, K01DK060484, R21DK073227, P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES070065, ZIAES070065] Funding Source: NIH RePORTER	UCLA Jonsson Comprehensive Cancer Center; UCLA Iris Cantor Women's Health Foundation; UCSD-UCLA Diabetes Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We are grateful for the continued support of our research from the UCLA Jonsson Comprehensive Cancer Center, the UCLA Iris Cantor Women's Health Foundation, and the UCSD-UCLA Diabetes Research Center. Intellectual contributions by Richard Finn, Jerrold Olefsky, Ronald Evans, Hussy Cohen, and Chris Glass were also helpful in advancing this research. We are grateful for the technical support from Rima Boyadjian (UCLA Inflammation Core), the UCLA Tissue Procurement and Histology Core, and the UCSD Moores Cancer Center Histology and Immunohistochemistry Shared Resource directed by Nissi Varki.	Ahlbory-Dieker DL, 2009, MOL ENDOCRINOL, V23, P1544, DOI 10.1210/me.2009-0045; Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Berger T, 2010, P NATL ACAD SCI USA, V107, P2995, DOI 10.1073/pnas.1000101107; Boruk M, 1998, MOL ENDOCRINOL, V12, P1749, DOI 10.1210/me.12.11.1749; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Carter JC, 2012, EXP MOL PATHOL, V92, P312, DOI 10.1016/j.yexmp.2012.03.005; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Dahlman I, 2008, PHARMACOGENET GENOM, V18, P967, DOI 10.1097/FPC.0b013e32831101ef; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Harima S, 2013, HEPATO-GASTROENTEROL, V60, P733, DOI 10.5754/hge12895; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hewitt SC, 2014, MOL ENDOCRINOL, V28, P899, DOI 10.1210/me.2014-1051; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Hewitt SC, 2010, J BIOL CHEM, V285, P2676, DOI 10.1074/jbc.M109.043471; Hurvitz SA, 2010, CLIN BREAST CANCER, V10, P307, DOI 10.3816/CBC.2010.n.040; Iyengar P, 2003, ONCOGENE, V22, P6408, DOI 10.1038/sj.onc.1206737; Jiralerspong S, 2013, ANN ONCOL, V24, P2506, DOI 10.1093/annonc/mdt224; Lee YH, 2010, ATHEROSCLEROSIS, V213, P592, DOI 10.1016/j.atherosclerosis.2010.09.012; Leng XH, 2011, J CELL PHYSIOL, V226, P309, DOI 10.1002/jcp.22403; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Maccio A, 2009, OBES REV, V10, P660, DOI 10.1111/j.1467-789X.2009.00592.x; Murray D, 2008, BRIT J CANCER, V99, P1322, DOI 10.1038/sj.bjc.6604688; NECHAD M, 1983, EXP CELL RES, V149, P119, DOI 10.1016/0014-4827(83)90385-3; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nilsson M, 2007, INT J OBESITY, V31, P900, DOI 10.1038/sj.ijo.0803528; Okura T, 2003, INT J OBESITY, V27, P1020, DOI 10.1038/sj.ijo.0802378; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Panidis D, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-151; Park J, 2012, J CLIN INVEST, V122, P4243, DOI 10.1172/JCI63930; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Park J, 2011, ENDOCR-RELAT CANCER, V18, pC25, DOI 10.1530/ERC-11-0163; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Reimann M, 2006, CLIMACTERIC, V9, P215, DOI 10.1080/13697130600733758; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Ribas V, 2011, P NATL ACAD SCI USA, V108, P16457, DOI 10.1073/pnas.1104533108; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Rodriguez-Cuenca S, 2007, CELL PHYSIOL BIOCHEM, V20, P877, DOI 10.1159/000110448; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Seth P, 2002, CANCER RES, V62, P4540; Shi H, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-83; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Sparano JA, 2012, CANCER-AM CANCER SOC, V118, P5937, DOI 10.1002/cncr.27527; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Stoesz SP, 1995, ONCOGENE, V11, P2233; Tan JX, 2011, INT J DEV BIOL, V55, P851, DOI 10.1387/ijdb.113365jt; Turati F, 2013, BRIT J CANCER, V108, P222, DOI 10.1038/bjc.2012.492; Villanueva CJ, 2011, CELL METAB, V13, P413, DOI 10.1016/j.cmet.2011.02.014; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; Wang YY, 2012, CANCER LETT, V324, P142, DOI 10.1016/j.canlet.2012.05.019; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang J, 2009, CELL CYCLE, V8, P2347, DOI 10.4161/cc.8.15.9224; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zhang SQ, 2014, ONCOL LETT, V7, P1375, DOI 10.3892/ol.2014.1918	61	52	54	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5566	5581		10.1074/jbc.M114.606459	http://dx.doi.org/10.1074/jbc.M114.606459			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25468909	Green Published, hybrid			2022-12-28	WOS:000350044200028
J	Jin, Y; Liu, YS; Nelin, LD				Jin, Yi; Liu, Yusen; Nelin, Leif D.			Extracellular Signal-regulated Kinase Mediates Expression of Arginase II but Not Inducible Nitric-oxide Synthase in Lipopolysaccharide-stimulated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TOLL-LIKE RECEPTOR; NEGATIVE REGULATION; PATHWAY; P38; RAS; INVOLVEMENT; INDUCTION; APOPTOSIS; ABILITY	The mitogen-activated protein kinases (MAPK) have been shown to participate in iNOS induction following lipopolysaccharide (LPS) stimulation, while the role of MAPKs in the regulation of arginase remains unclear. We hypothesized that different MAPK family members are involved in iNOS and arginase expression following LPS stimulation. LPS-stimulated RAW 264.7 cells exhibited increased protein and mRNA levels for iNOS, arginase I, and arginase II; although the induction of arginase II was more robust than that for arginase I. A p38 inhibitor completely prevented iNOS expression while it only attenuated arginase II induction. In contrast, a MEK1/2 inhibitor (ERK pathway) completely abolished arginase II expression while actually enhancing iNOS induction in LPS-stimulated cells. Arginase II promoter activity was increased by similar to 4-fold following LPS-stimulation, which was prevented by the ERK pathway inhibitor. Arginase II promoter activity was unaffected by a p38 inhibitor or JNK pathway interference. Transfection with a construct expressing a constitutively active RAS mutant increased LPS-induced arginase II promoter activity, while transfection with a vector expressing a dominant negative ERK2 mutant or a vector expressing MKP-3 inhibited the arginase II promoter activity. LPS-stimulated nitric oxide (NO) production was increased following siRNA-mediated knockdown of arginase II and decreased when arginase II was overexpressed. Our results demonstrate that while both the ERK and p38 pathways regulate arginase II induction in LPS-stimulated macrophages, iNOS induction by LPS is dependent on p38 activation. These results suggest that differential inhibition of the MAPK pathway may be a potential therapeutic strategy to regulate macrophage phenotype.	[Jin, Yi; Liu, Yusen; Nelin, Leif D.] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Pulm Hypertens Grp, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Nelin, LD (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, 575 Childrens Crossrd, Columbus, OH 43205 USA.	Leif.Nelin@nationwidechildrens.org	Liu, Yusen/E-3527-2011; Nelin, Leif/AAC-8475-2020	Liu, Yusen/0000-0002-0994-0109	NHLBI [R01HL075261]; NIAID, National Institutes of Health [R01AI068956]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068956] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Grant Number R01HL075261 from the NHLBI and Grant Number R01AI068956 from the NIAID, National Institutes of Health.	Barra V, 2011, CELL MOL LIFE SCI, V68, P1815, DOI 10.1007/s00018-010-0537-x; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Chang CI, 2000, J IMMUNOL, V165, P2134, DOI 10.4049/jimmunol.165.4.2134; Chen CC, 1999, MOL PHARMACOL, V55, P481; Chen PL, 2001, J BIOL CHEM, V276, P29440, DOI 10.1074/jbc.M103463200; Chen PL, 2002, PROTEIN EXPRES PURIF, V24, P481, DOI 10.1006/prep.2001.1599; Das P., 2010, PLANT SIGNAL BEHAV, V6, P1; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Deng QD, 2004, J BIOL CHEM, V279, P1050, DOI 10.1074/jbc.M308644200; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Douda D.N., 2010, OPEN NITRIC OXIDE J, V12, P69; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Foxwell B, 1998, P NATL ACAD SCI USA, V95, P8211, DOI 10.1073/pnas.95.14.8211; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Gotoh T, 1999, J CELL BIOL, V144, P427, DOI 10.1083/jcb.144.3.427; Johann AM, 2007, FASEB J, V21, P2704, DOI 10.1096/fj.06-7815com; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Lang T, 2007, IMMUNOL CELL BIOL, V85, P425, DOI 10.1038/sj.icb.7100094; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lee TY, 2009, BIOCHEM BIOPH RES CO, V382, P134, DOI 10.1016/j.bbrc.2009.02.160; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Monick MM, 2002, J BIOL CHEM, V277, P32992, DOI 10.1074/jbc.M203218200; Mori M, 2007, J NUTR, V137, p1616S, DOI 10.1093/jn/137.6.1616S; Morris MC, 2014, J BIOL CHEM, V289, P21584, DOI 10.1074/jbc.M114.583518; Nelin LD, 2007, AM J PHYSIOL-CELL PH, V293, pC632, DOI 10.1152/ajpcell.00137.2006; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; ROSSOMANDO A, 1992, P NATL ACAD SCI USA, V89, P5221, DOI 10.1073/pnas.89.12.5221; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052	35	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2099	2111		10.1074/jbc.M114.599985	http://dx.doi.org/10.1074/jbc.M114.599985			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25451938	Green Published, hybrid			2022-12-28	WOS:000348588000016
J	Liu, ZY; Zhang, WC; Zhang, M; Zhu, HP; Moriasi, C; Zou, MH				Liu, Zhaoyu; Zhang, Wencheng; Zhang, Miao; Zhu, Huaiping; Moriasi, Cate; Zou, Ming-Hui			Liver Kinase B1 Suppresses Lipopolysaccharide-induced Nuclear Factor kappa B (NF-kappa B) Activation in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; INFLAMMATORY MEDIATORS; GLUCOSE-HOMEOSTASIS; INNOCENT BYSTANDER; C-ZETA; LKB1; PHOSPHORYLATION; RECEPTOR; SERINE-428; IMPROVES	Liver kinase B1 (LKB1), a serine/threonine kinase, is a tumor suppressor and metabolic regulator. Recent data suggest that LKB1 is essential in regulating homeostasis of hematopoietic cells and immune responses. However, its role in macrophages and innate immune system remains unclear. Here we report that macrophage LKB1 inhibits pro-inflammatory signaling in response to LPS. LPS-induced pro-inflammatory cytokines and pro-inflammatory enzymes were monitored in bone marrow-derived macrophages isolated from myeloid cell-specific LKB1 knock out mice and their wild type littermate control mice. LPS induced higher levels of pro-inflammatory cytokines and pro-inflammatory enzymes in bone marrow-derived macrophages from LKB1 KO than those from wild type mice. Consistently, LPS induced higher levels of NF-kappa B activation in LKB1-deficient macrophages than those in wild type. Further, LPS stimulation significantly increased LKB1 phosphorylation at serine 428, which promoted its binding to I kappa B kinase beta (IKK beta), resulting in the inhibition of NF-kappa B. Finally, LPS injection caused higher levels of cytokine release and more severe tissue injury in the lung tissues of LKB1 KO mice than in those of control mice. We conclude that LKB1 inhibits LPS-induced NF-kappa B activation in macrophages.	[Liu, Zhaoyu; Zhang, Wencheng; Zhang, Miao; Zhu, Huaiping; Moriasi, Cate; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, 941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	mzou@ouhsc.edu	liu, zhao/GXV-6141-2022; Zhang, Wencheng/AAO-8445-2020		National Institutes of Health [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488, AG047776]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074399, R01HL110488, R01HL096032, R01HL089920, R01HL079584, R01HL105157, R01HL080499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488, and AG047776 (to M. H. Z.).; A recipient of the National Established Investigator Award of the American Heart Association.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Chen F, 2005, BIOCHEM BIOPH RES CO, V332, P1, DOI 10.1016/j.bbrc.2005.03.075; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; De Castro C, 2010, METHOD ENZYMOL, V480, P89, DOI 10.1016/S0076-6879(10)80005-9; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Filippov S, 2013, J LIPID RES, V54, P2095, DOI 10.1194/jlr.M035212; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He JL, 2013, ARTERIOSCL THROM VAS, V33, P1297, DOI 10.1161/ATVBAHA.113.301296; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim MJ, 2014, MOL PHARMACOL, V86, P284, DOI 10.1124/mol.114.093039; Kita Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043056; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Morio LA, 2001, TOXICOL APPL PHARM, V177, P188, DOI 10.1006/taap.2001.9316; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; NEWMAN JH, 1985, CLIN CHEST MED, V6, P371; Ohashi K, 2010, J BIOL CHEM, V285, P22291, DOI 10.1074/jbc.M110.123794; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; SAUKKONEN K, 1990, J EXP MED, V171, P439, DOI 10.1084/jem.171.2.439; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Tamas P, 2010, EUR J IMMUNOL, V40, P242, DOI 10.1002/eji.200939677; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074	45	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2312	2320		10.1074/jbc.M114.616441	http://dx.doi.org/10.1074/jbc.M114.616441			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25451940	Green Published, hybrid			2022-12-28	WOS:000348588000036
J	Bellmann-Sickert, K; Stone, TA; Poulsen, BE; Deber, CM				Bellmann-Sickert, Kathrin; Stone, Tracy A.; Poulsen, Bradley E.; Deber, Charles M.			Efflux by Small Multidrug Resistance Proteins Is Inhibited by Membrane-interactive Helix-stapled Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; TRANSMEMBRANE PEPTIDE; DRUG EFFLUX; TRANSPORTER; EMRE; PRINCIPLES; TOPOLOGY; RECEPTOR; TARGETS; RESIDUE	Bacterial cell membranes contain several protein pumps that resist the toxic effects of drugs by efficiently extruding them. One family of these pumps, the small multidrug resistance proteins (SMRs), consists of proteins of about 110 residues that need to oligomerize to form a structural pathway for substrate extrusion. As such, SMR oligomerization sites should constitute viable targets for efflux inhibition, by disrupting protein-protein interactions between helical segments. To explore this proposition, we are using Hsmr, an SMR from Halobacter salinarum that dimerizes to extrude toxicants. Our previous work established that (i) Hsmr dimerization is mediated by a helix-helix interface in Hsmr transmembrane (TM) helix 4 (residues (90)GLALIVAGV(98)); and (ii) a peptide comprised of the full TM4(85-105) sequence inhibits Hsmr-mediated ethidium bromide efflux from bacterial cells. Here we define the minimal linear sequence for inhibitor activity (determined as TM4(88100), and then "staple" this sequence via Grubbs metathesis to produce peptides typified by acetyl-A-(Sar)(3)-(88)VVGLXL-I (Z) under bar XGVVV(100)-KKK-NH2 (X = 2-(4'-pentenyl)alanine at positions 92 and 96; (Z) under bar Val, Gly, or Asn at position 95)). The Asn(95) peptide displayed specific efflux inhibition and resensitization of Hsmr-expressing cells to ethidium bromide; and was non-hemolytic to human red blood cells. Stapling essentially prevented peptide degradation in blood plasma and liver homogenates versus an unstapled counterpart. The overall results confirm that the stapled analog of TM4(88-100) retains the structural complementarity required to disrupt the Hsmr TM4-TM4 locus in Hsmr, and portend the general validity of stapled peptides as therapeutics for the disruption of functional protein-protein interactions in membranes.	[Bellmann-Sickert, Kathrin; Stone, Tracy A.; Poulsen, Bradley E.; Deber, Charles M.] Hosp Sick Children, Div Mol Struct & Funct, Res Inst, Toronto, ON M5G 0A4, Canada; [Stone, Tracy A.; Poulsen, Bradley E.; Deber, Charles M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Deber, CM (corresponding author), Hosp Sick Children, Div Mol Struct & Funct, Res Inst, 686 Bay St, Toronto, ON M5G 0A4, Canada.	deber@sickkids.ca	Stone, Tracy/AAR-5337-2021; Poulsen, Bradley/AAW-9750-2020; Bellmann-Sickert, Kathrin/AFP-0609-2022	Bellmann-Sickert, Kathrin/0000-0002-0007-008X; Stone, Tracy/0000-0002-5689-5232	Canadian Institutes of Health Research Grant [CIHR FRN-5810]; CIHR Master's Canada Graduate Scholarship; Research Training Committee at the Hospital for Sick Children	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); CIHR Master's Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Research Training Committee at the Hospital for Sick Children	This work was supported, in part, by Canadian Institutes of Health Research Grant CIHR FRN-5810 (to C. M. D.).; Recipient of a CIHR Master's Canada Graduate Scholarship and an award from the Research Training Committee at the Hospital for Sick Children. Present address: Dept. of Molecular Biology, Simches Research Center, MA General Hospital, 185 Cambridge St., Boston, MA 02114.	Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015; Bellmann-Sickert K, 2011, J MED CHEM, V54, P2658, DOI 10.1021/jm101357e; Bellmann-Sickert K, 2011, CHEMMEDCHEM, V6, P193, DOI 10.1002/cmdc.201000403; Chang YS, 2013, P NATL ACAD SCI USA, V110, pE3445, DOI 10.1073/pnas.1303002110; Chapuis H, 2012, AMINO ACIDS, V43, P2047, DOI 10.1007/s00726-012-1283-1; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Glukhov E, 2008, BIOPOLYMERS, V89, P360, DOI 10.1002/bip.20917; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Higueruelo AP, 2013, CURR OPIN PHARMACOL, V13, P791, DOI 10.1016/j.coph.2013.05.009; Johnson RM, 2007, BIOCHEMISTRY-US, V46, P9208, DOI 10.1021/bi7008773; Kim YW, 2011, NAT PROTOC, V6, P761, DOI 10.1038/nprot.2011.324; Kolbusz MA, 2012, BIOCHEMISTRY-US, V51, P8867, DOI 10.1021/bi300854c; Kunjachan S, 2013, ADV DRUG DELIVER REV, V65, P1852, DOI 10.1016/j.addr.2013.09.018; Maurya IK, 2013, J BIOL CHEM, V288, P16775, DOI 10.1074/jbc.M113.467159; Melnyk RA, 2003, BIOPOLYMERS, V71, P675, DOI 10.1002/bip.10595; Melnyk RA, 2002, J MOL BIOL, V315, P63, DOI 10.1006/jmbi.2001.5214; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Nasie I, 2012, J BACTERIOL, V194, P6766, DOI 10.1128/JB.01318-12; Ng DP, 2012, BBA-BIOMEMBRANES, V1818, P1115, DOI 10.1016/j.bbamem.2011.07.046; Ninio S, 2003, J BIOL CHEM, V278, P12000, DOI 10.1074/jbc.M213119200; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poulsen BE, 2012, ANTIMICROB AGENTS CH, V56, P3911, DOI 10.1128/AAC.00158-12; Poulsen BE, 2009, J BIOL CHEM, V284, P9870, DOI 10.1074/jbc.M900182200; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Pham TK, 2013, BIOORG MED CHEM LETT, V23, P6717, DOI 10.1016/j.bmcl.2013.10.031; Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X; Walensky LD, 2014, J MED CHEM, V57, P6275, DOI 10.1021/jm4011675; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Yewale C, 2013, BIOMATERIALS, V34, P8690, DOI 10.1016/j.biomaterials.2013.07.100; Yin LM, 2012, J BIOL CHEM, V287, P7738, DOI 10.1074/jbc.M111.303602	35	19	21	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1752	1759		10.1074/jbc.M114.616185	http://dx.doi.org/10.1074/jbc.M114.616185			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25425644	hybrid, Green Published			2022-12-28	WOS:000348056400040
J	Joshi, J; Mueller-Cajar, O; Tsai, YCC; Hartl, FU; Hayer-Hartl, M				Joshi, Jidnyasa; Mueller-Cajar, Oliver; Tsai, Yi-Chin C.; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Role of Small Subunit in Mediating Assembly of Red-type Form I Rubisco	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE/OXYGENASE; CRYSTAL-STRUCTURE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; PROTEIN; OXYGENASE; CHAPERONE; INTERFACE; MECHANISM; EVOLUTION	Ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) is the key enzyme involved in photosynthetic carbon fixation, converting atmospheric CO2 to organic compounds. Form I Rubisco is a cylindrical complex composed of eight large (RbcL) subunits that are capped by four small subunits (RbcS) at the top and four at the bottom. Form I Rubiscos are phylogenetically divided into green-and red-type. Some red-type enzymes have catalytically superior properties. Thus, understanding their folding and assembly is of considerable biotechnological interest. Folding of the green-type RbcL subunits in cyanobacteria is mediated by the GroEL/ES chaperonin system, and assembly to holoenzyme requires specialized chaperones such as RbcX and RAF1. Here, we show that the red-type RbcL subunits in the proteobacterium Rhodobacter sphaeroides also fold with GroEL/ES. However, assembly proceeds in a chaperone-independent manner. We find that the C-terminal beta-hairpin extension of red-type RbcS, which is absent in green-type RbcS, is critical for efficient assembly. The beta-hairpins of four RbcS subunits form an eight-stranded beta-barrel that protrudes into the central solvent channel of the RbcL core complex. The two beta-barrels stabilize the complex through multiple interactions with the RbcL subunits. A chimeric green-type RbcS carrying the C-terminal beta-hairpin renders the assembly of a cyanobacterial Rubisco independent of RbcX. Our results may facilitate the engineering of crop plants with improved growth properties expressing red-type Rubisco.	[Joshi, Jidnyasa; Mueller-Cajar, Oliver; Tsai, Yi-Chin C.; Hartl, F. Ulrich; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	mhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017; Mueller-Cajar, Oliver/A-7237-2018	Hayer-Hartl, Manajit/0000-0001-8213-6742; Mueller-Cajar, Oliver/0000-0003-2866-5963				Allen JF, 2011, TRENDS PLANT SCI, V16, P645, DOI 10.1016/j.tplants.2011.10.004; Alonso H, 2009, J BIOL CHEM, V284, P33876, DOI 10.1074/jbc.M109.050989; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; Andrews TJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P159, DOI 10.1016/S0003-9861(03)00100-0; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; Bhattacharya D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2931; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bracher A, 2011, NAT STRUCT MOL BIOL, V18, P875, DOI 10.1038/nsmb.2090; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Feiz L, 2014, PLANT J, V80, P862, DOI 10.1111/tpj.12686; Feiz L, 2012, PLANT CELL, V24, P3435, DOI 10.1105/tpc.112.102012; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; Hansen S, 1999, J MOL BIOL, V288, P609, DOI 10.1006/jmbi.1999.2701; HARTMAN FC, 1994, ANNU REV BIOCHEM, V63, P197, DOI 10.1146/annurev.biochem.63.1.197; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Hill JE, 2001, CELL STRESS CHAPERON, V6, P190, DOI 10.1379/1466-1268(2001)006<0190:ATTIAI>2.0.CO;2; Horken KM, 1999, ARCH BIOCHEM BIOPHYS, V361, P183, DOI 10.1006/abbi.1998.0979; Kanevski I, 1999, PLANT PHYSIOL, V119, P133, DOI 10.1104/pp.119.1.133; Karkehabadi S, 2005, BIOCHEMISTRY-US, V44, P9851, DOI 10.1021/bi050537v; Kolesinski P, 2014, FEBS J, V281, P3920, DOI 10.1111/febs.12928; Kolesinski P, 2011, PLANT MOL BIOL, V77, P447, DOI 10.1007/s11103-011-9823-8; Kontur WS, 2012, J BACTERIOL, V194, P7016, DOI 10.1128/JB.01214-12; LARIMER FW, 1993, GENE, V126, P85, DOI 10.1016/0378-1119(93)90593-R; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Mueller-Cajar O, 2008, BIOCHEM J, V414, P205, DOI 10.1042/BJ20080668; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; NEWMAN J, 1993, ACTA CRYSTALLOGR D, V49, P548, DOI 10.1107/S090744499300530X; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; READ BA, 1992, BIOCHEMISTRY-US, V31, P5553, DOI 10.1021/bi00139a018; REITH M, 1995, ANNU REV PLANT PHYS, V46, P549, DOI 10.1146/annurev.arplant.46.1.549; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; Spreitzer RJ, 2005, P NATL ACAD SCI USA, V102, P17225, DOI 10.1073/pnas.0508042102; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Sugawara H, 1999, J BIOL CHEM, V274, P15655, DOI 10.1074/jbc.274.22.15655; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Tsai YCC, 2012, J BIOL CHEM, V287, P20471, DOI 10.1074/jbc.M112.365411; van Lun M, 2011, J MOL BIOL, V411, P1083, DOI 10.1016/j.jmb.2011.06.052; Weiss C, 2009, PLANT MOL BIOL, V69, P227, DOI 10.1007/s11103-008-9432-3; Wheatley NM, 2014, J BIOL CHEM, V289, P7973, DOI 10.1074/jbc.M113.531236; Whitney SM, 2001, PLANT J, V26, P535, DOI 10.1046/j.1365-313x.2001.01056.x; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814	47	24	24	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1066	1074		10.1074/jbc.M114.613091	http://dx.doi.org/10.1074/jbc.M114.613091			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25371207	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000347778200038
J	Sandoval, D; Hill, S; Ziemba, A; Lewis, S; Kuhlman, B; Kleiger, G				Sandoval, Daniella; Hill, Spencer; Ziemba, Amy; Lewis, Steven; Kuhlman, Brian; Kleiger, Gary			Ubiquitin-conjugating Enzyme Cdc34 and Ubiquitin Ligase Skp1-Cullin-F-box Ligase (SCF) Interact through Multiple Conformations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULLIN-RING LIGASES; STRUCTURAL INSIGHTS; COMPLEX; NEDD8; ACTIVATION; MECHANISM; BINDING; DOMAIN	In the ubiquitin-proteasome system, protein substrates are degraded via covalent modification by a polyubiquitin chain. The polyubiquitin chain must be assembled rapidly in cells, because a chain of at least four ubiquitins is required to signal for degradation, and chain-editing enzymes in the cell may cleave premature polyubiquitin chains before achieving this critical length. The ubiquitin-conjugating enzyme Cdc34 and ubiquitin ligase SCF are capable of building polyubiquitin chains onto protein substrates both rapidly and processively; this may be explained at least in part by the atypically fast rate of Cdc34 and SCF association. This rapid association has been attributed to electrostatic interactions between the acidic C-terminal tail of Cdc34 and a feature on SCF called the basic canyon. However, the structural aspects of the Cdc34-SCF interaction and how they permit rapid complex formation remain elusive. Here, we use protein cross-linking to demonstrate that the Cdc34-SCF interaction occurs in multiple conformations, where several residues from the Cdc34 acidic tail are capable of contacting a broad region of the SCF basic canyon. Similar patterns of cross-linking are also observed between Cdc34 and the Cul1 paralog Cul2, implicating the same mechanism for the Cdc34-SCF interaction in other members of the cullin-RING ubiquitin ligases. We discuss how these results can explain the rapid association of Cdc34 and SCF.	[Sandoval, Daniella; Hill, Spencer; Ziemba, Amy; Kleiger, Gary] Univ Nevada, Dept Chem & Biochem, Las Vegas, NV 89154 USA; [Lewis, Steven; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of North Carolina; University of North Carolina Chapel Hill	Kleiger, G (corresponding author), Univ Nevada, Dept Chem & Biochem, 4505 S Maryland Pkwy, Las Vegas, NV 89154 USA.	gary.kleiger@unlv.edu			National Institutes of Health, NIGMS [P20 GM103440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073960, P20GM103440] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant P20 GM103440.	Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; den Besten W, 2012, NAT STRUCT MOL BIOL, V19, P511, DOI 10.1038/nsmb.2269; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; FERSHT A, 1985, ENZYME STRUCTURE MEC, P147; GILL G, 1990, P NATL ACAD SCI USA, V87, P2127, DOI 10.1073/pnas.87.6.2127; GILL G, 1987, CELL, V51, P121, DOI 10.1016/0092-8674(87)90016-X; Kaiser SE, 2012, NAT STRUCT MOL BIOL, V19, P1242, DOI 10.1038/nsmb.2415; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Kleiger G, 2009, J BIOL CHEM, V284, P36012, DOI 10.1074/jbc.M109.058529; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Mathias N, 1998, J BIOL CHEM, V273, P4040, DOI 10.1074/jbc.273.7.4040; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Ziemba A, 2013, J BIOL CHEM, V288, P34882, DOI 10.1074/jbc.M113.509190	29	13	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1106	1118		10.1074/jbc.M114.615559	http://dx.doi.org/10.1074/jbc.M114.615559			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25425648	Green Published, hybrid			2022-12-28	WOS:000347778200042
J	Dkhar, HK; Gopalsamy, A; Loharch, S; Kaur, A; Bhutani, I; Saminathan, K; Bhagyaraj, E; Chandra, V; Swaminathan, K; Agrawal, P; Parkesh, R; Gupta, P				Dkhar, Hedwin Kitdorlang; Gopalsamy, Anupriya; Loharch, Saurabh; Kaur, Amandeep; Bhutani, Isha; Saminathan, Kanmani; Bhagyaraj, Ella; Chandra, Vemika; Swaminathan, Kunchithapadam; Agrawal, Pushpa; Parkesh, Raman; Gupta, Pawan			Discovery of Mycobacterium tuberculosis alpha-1,4-Glucan Branching Enzyme (GlgB) Inhibitors by Structure- and Ligand-based Virtual Screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Docking; Molecular Docking; Mycobacterium tuberculosis; Pathogenesis; Small Molecule	MOLECULAR-FORCE FIELD; ALPHA-GLUCAN PATHWAY; ALAMAR BLUE ASSAY; IN-VIVO; ENRICHMENT FACTORS; ACCURATE DOCKING; PROTEIN; EXPRESSION; GLYCOGEN; H37RV	Background:M. tuberculosis GlgB is essential for the biosynthesis of branched glucan and modulates pathogenesis and survival. Results: Two novel small molecules demonstrated significant inhibition of M. tuberculosis GlgB enzyme activity, growth and survival. Conclusion: Small molecules with diverse scaffolds but similar three-dimensional-structures show a similar biological effect. Significance: Deriving scaffolds from docking and similarity search is a successful design strategy for difficult targets. GlgB (-1,4-glucan branching enzyme) is the key enzyme involved in the biosynthesis of -glucan, which plays a significant role in the virulence and pathogenesis of Mycobacterium tuberculosis. Because -glucans are implicated in the survival of both replicating and non-replicating bacteria, there exists an exigent need for the identification and development of novel inhibitors for targeting enzymes, such as GlgB, involved in this pathway. We have used the existing structural information of M. tuberculosis GlgB for high throughput virtual screening and molecular docking. A diverse database of 330,000 molecules was used for identifying novel and efficacious therapeutic agents for targeting GlgB. We also used three-dimensional shape as well as two-dimensional similarity matrix methods to identify diverse molecular scaffolds that inhibit M. tuberculosis GlgB activity. Virtual hits were generated after structure and ligand-based screening followed by filters based on interaction with human GlgB and in silico pharmacokinetic parameters. These hits were experimentally evaluated and resulted in the discovery of a number of structurally diverse chemical scaffolds that target M. tuberculosis GlgB. Although a number of inhibitors demonstrated in vitro enzyme inhibition, two compounds in particular showed excellent inhibition of in vivo M. tuberculosis survival and its ability to get phagocytosed. This work shows that in silico docking and three-dimensional chemical similarity could be an important therapeutic approach for developing inhibitors to specifically target the M. tuberculosis GlgB enzyme.	[Dkhar, Hedwin Kitdorlang; Loharch, Saurabh; Kaur, Amandeep; Bhutani, Isha; Bhagyaraj, Ella; Chandra, Vemika; Agrawal, Pushpa; Parkesh, Raman; Gupta, Pawan] Inst Microbial Technol, Council Sci & Ind Res, Chandigarh 160036, India; [Gopalsamy, Anupriya; Saminathan, Kanmani; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); National University of Singapore	Parkesh, R (corresponding author), Inst Microbial Technol, Council Sci & Ind Res, Chandigarh 160036, India.	rparkesh@imtech.res.in; pawan@imtech.res.in	Agrawal, Pushpa/P-2282-2016; Chandra, Vemika/AAK-6997-2020	Agrawal, Pushpa/0000-0003-3568-8119; Chandra, Vemika/0000-0001-5360-7875; Loharch, Saurabh/0000-0002-5496-8784; Ella, Bhagyaraj/0000-0002-5887-9228; Gopalsamy, Anupriya/0000-0002-2774-5454	Council of Scientific and Industrial Research (CSIR) 12th Plan project Infectious Disease [BSC0210]; Genesis [BSC0121]; OLP projects; CSIR-UGC junior research fellowship; Institute of Microbial Technology research internship	Council of Scientific and Industrial Research (CSIR) 12th Plan project Infectious Disease; Genesis; OLP projects; CSIR-UGC junior research fellowship; Institute of Microbial Technology research internship(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research (CSIR) 12th Plan project Infectious Disease (BSC0210), Genesis (BSC0121), and OLP projects (to P. G., R. P., and P. A.).; Supported by a CSIR-UGC junior research fellowship.; Recipient of an Institute of Microbial Technology research internship.	Agrawal P, 2014, CURR MED CHEM, V21, P4074, DOI 10.2174/0929867321666140826120449; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bittencourt VCB, 2006, J BIOL CHEM, V281, P22614, DOI 10.1074/jbc.M511417200; Chandra V, 2013, J BIOL CHEM, V288, P10692, DOI 10.1074/jbc.M113.455915; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Cowley SC, 2001, GENE, V264, P225, DOI 10.1016/S0378-1119(01)00336-5; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Duffy EM, 2000, J AM CHEM SOC, V122, P2878, DOI 10.1021/ja993663t; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gagliardi MC, 2007, CELL MICROBIOL, V9, P2081, DOI 10.1111/j.1462-5822.2007.00940.x; Garg S, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-1; Garg SK, 2007, PROTEIN EXPRES PURIF, V51, P198, DOI 10.1016/j.pep.2006.08.005; Geurtsen J, 2009, J IMMUNOL, V183, P5221, DOI 10.4049/jimmunol.0900768; Haigh JA, 2005, J CHEM INF MODEL, V45, P673, DOI 10.1021/ci049651v; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Halgren TA, 1996, J COMPUT CHEM, V17, P616, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hevener KE, 2012, J MED CHEM, V55, P268, DOI 10.1021/jm201168g; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jones SA, 2008, INFECT IMMUN, V76, P2531, DOI 10.1128/IAI.00096-08; Jorgensen WL, 2000, BIOORG MED CHEM LETT, V10, P1155, DOI 10.1016/S0960-894X(00)00172-4; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kalscheuer R, 2010, DRUG NEWS PERSPECT, V23, P619, DOI 10.1358/dnp.2010.23.10.1534855; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; Krieger IV, 2012, CHEM BIOL, V19, P1556, DOI 10.1016/j.chembiol.2012.09.018; Kruger DM, 2010, CHEMMEDCHEM, V5, P148, DOI 10.1002/cmdc.200900314; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lombardo MJ, 2007, P NATL ACAD SCI USA, V104, P18229, DOI 10.1073/pnas.0705636104; Martin A, 2003, ANTIMICROB AGENTS CH, V47, P3616, DOI 10.1128/AAC.47.11.3616-3619.2003; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; Mitchison DA, 2005, AM J RESP CRIT CARE, V171, P699, DOI 10.1164/rccm.200411-1603OE; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Pal K, 2010, J BIOL CHEM, V285, P20897, DOI 10.1074/jbc.M110.121707; Petsko G. A., 2004, PROTEIN STRUCTURE FU, P50; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Schwebach JR, 2001, INFECT IMMUN, V69, P5671, DOI 10.1128/IAI.69.9.5671-5678.2001; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; SPATAFORA G, 1995, INFECT IMMUN, V63, P2556, DOI 10.1128/IAI.63.7.2556-2563.1995; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	47	15	16	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					76	89		10.1074/jbc.M114.589200	http://dx.doi.org/10.1074/jbc.M114.589200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25384979	Green Published, hybrid			2022-12-28	WOS:000347231200008
J	Zhang, ML; Zhu, B; Davie, J				Zhang, Meiling; Zhu, Bo; Davie, Judith			Alternative Splicing of MEF2C pre-mRNA Controls Its Activity in Normal Myogenesis and Promotes Tumorigenicity in Rhabdomyosarcoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Histone Deacetylase (HDAC); Myogenesis; Rhabdomyosarcoma (RMS); Tumor Cell Biology; Tumor Immunology; MEF2C; SRPK3	MYOCYTE ENHANCER FACTOR-2; TUMOR ALVEOLAR RHABDOMYOSARCOMA; SKELETAL-MUSCLE DIFFERENTIATION; HELIX-LOOP-HELIX; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MADS-BOX; HISTONE DEACETYLASES; FACTOR 2C; ACTIVATION	Background: MEF2C is an important regulator of many developmental programs. Results: Alternative splicing of the exon of MEF2C regulates myogenesis. Loss of SRPK3 in rhabdomyosarcoma cells inhibits this splicing and blocks differentiation. Conclusion: MEF2C2 promotes myogenesis, and restoration of MEF2C2 in rhabdomyosarcoma cells inhibits growth. Significance: Defining the function and deregulation of MEF2C2 enhances the understanding of normal myogenesis and RMS tumorigenesis. Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. Many cellular disruptions contribute to the progression of this pediatric cancer, including aberrant alternative splicing. The MEF2 family of transcription factors regulates many developmental programs, including myogenesis. MEF2 gene transcripts are subject to alternate splicing to generate protein isoforms with divergent functions. We found that MEF2C1 was the ubiquitously expressed isoform that exhibited no myogenic activity and that MEF2C2, the muscle-specific MEF2C isoform, was required for efficient differentiation. We showed that exon in MEF2C was aberrantly alternatively spliced in RMS cells, with the ratio of 2/1 highly down-regulated in RMS cells compared with normal myoblasts. Compared with MEF2C2, MEF2C1 interacted more strongly with and recruited HDAC5 to myogenic gene promoters to repress muscle-specific genes. Overexpression of the MEF2C2 isoform in RMS cells increased myogenic activity and promoted differentiation in RMS cells. We also identified a serine protein kinase, SRPK3, that was down-regulated in RMS cells and found that expression of SRPK3 promoted the splicing of the MEF2C2 isoform and induced differentiation. Restoration of either MEF2C2 or SPRK3 inhibited both proliferation and anchorage-independent growth of RMS cells. Together, our findings indicate that the alternative splicing of MEF2C plays an important role in normal myogenesis and RMS development. An improved understanding of alternative splicing events in RMS cells will potentially reveal novel therapeutic targets for RMS treatment.	[Davie, Judith] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA; So Illinois Univ, Simmons Canc Inst, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Davie, J (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, 229 Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA.	jdavie@siumed.edu			NIAMS/National Institutes of Health [RAR 060017A]; American Cancer Society, Illinois Division [159609]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R15AR060017] Funding Source: NIH RePORTER	NIAMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Cancer Society, Illinois Division(American Cancer Society); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by NIAMS/National Institutes of Health Grant RAR 060017A. This work was also supported by Grant 159609 from the American Cancer Society, Illinois Division (to J. D.).	Ab Hakim NH, 2010, GENES CELLS, V15, P255, DOI 10.1111/j.1365-2443.2009.01378.x; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bachinski LL, 2010, MUSCLE NERVE, V42, P856, DOI 10.1002/mus.21789; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chen SL, 2000, GENE DEV, V14, P1209; D'Andrea M, 2006, J CELL PHYSIOL, V207, P379, DOI 10.1002/jcp.20585; Das S, 2014, MOL CANCER RES, V12, P1195, DOI 10.1158/1541-7786.MCR-14-0131; Davie JK, 2007, DEV BIOL, V311, P650, DOI 10.1016/j.ydbio.2007.08.014; Dodou E, 1997, MOL CELL BIOL, V17, P1848, DOI 10.1128/MCB.17.4.1848; Du M, 2008, MOL CELL BIOL, V28, P2952, DOI 10.1128/MCB.00248-08; Du SY, 2005, INT J CANCER, V115, P85, DOI 10.1002/ijc.20844; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Infantino V, 2013, GENE, V531, P355, DOI 10.1016/j.gene.2013.08.044; Jacob AG, 2013, NEOPLASIA, V15, P1049, DOI 10.1593/neo.13286; Kablar B, 2000, HISTOL HISTOPATHOL, V15, P649, DOI 10.14670/HH-15.649; Kalsotra A, 2014, CELL REP, V6, P336, DOI 10.1016/j.celrep.2013.12.025; Kasukawa Y, 2002, J BONE MINER RES, V17, P1579, DOI 10.1359/jbmr.2002.17.9.1579; Keller C, 2013, FEBS J, V280, P4323, DOI 10.1111/febs.12421; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Londhe P, 2011, MOL CELL BIOL, V31, P2854, DOI 10.1128/MCB.05397-11; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; MacQuarrie KL, 2013, MOL CELL BIOL, V33, P773, DOI 10.1128/MCB.00916-12; MARTIN JF, 1994, MOL CELL BIOL, V14, P1647, DOI 10.1128/MCB.14.3.1647; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Nadruz W, 2003, CIRC RES, V92, P243, DOI 10.1161/01.RES.0000053184.94618.97; Nakagawa O, 2005, GENE DEV, V19, P2066, DOI 10.1101/gad.1338705; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Raimondi L, 2012, CELL DEATH DIFFER, V19, P871, DOI 10.1038/cdd.2011.171; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Sartori F, 2006, CANCER, V106, P1766, DOI 10.1002/cncr.21772; Sebastian S, 2013, GENE DEV, V27, P1247, DOI 10.1101/gad.215400.113; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang ML, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-150; Zhu BM, 2005, J BIOL CHEM, V280, P28749, DOI 10.1074/jbc.M502491200; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004; Zhu B, 2014, INT J CANCER, V135, P785, DOI 10.1002/ijc.28721	54	43	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					310	324		10.1074/jbc.M114.606277	http://dx.doi.org/10.1074/jbc.M114.606277			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25404735	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000347231200028
J	Jones, A; Kainz, D; Khan, F; Lee, C; Carrithers, MD				Jones, Alexis; Kainz, Danielle; Khan, Faatima; Lee, Cara; Carrithers, Michael D.			Human Macrophage SCN5A Activates an Innate Immune Signaling Pathway for Antiviral Host Defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenylate Cyclase; Double-stranded RNA (dsRNA); Innate Immunity; Interferon; Sodium Channel	SODIUM-CHANNEL NAV1.5; EXPRESSION; PROTEIN; RECOGNITION; INFECTION; NUCLEAR; BINDING; SYSTEM; CELLS	Pattern recognition receptors contain a binding domain for pathogen-associated molecular patterns coupled to a signaling domain that regulates transcription of host immune response genes. Here, a novel mechanism that links pathogen recognition to channel activation and downstream signaling is proposed. We demonstrate that an intracellular sodium channel variant, human macrophage SCN5A, initiates signaling and transcription through a calcium-dependent isoform of adenylate cyclase, ADCY8, and the transcription factor, ATF2. Pharmacological stimulation with a channel agonist or treatment with cytoplasmic poly(I:C), a mimic of viral dsRNA, activates this pathway to regulate expression of SP100-related genes and interferon . Electrophysiological analysis reveals that the SCN5A variant mediates nonselective outward currents and a small, but detectable, inward current. Intracellular poly(I:C) markedly augments an inward voltage-sensitive sodium current and inhibits the outward nonselective current. These results suggest human macrophage SCN5A initiates signaling in an innate immune pathway relevant to antiviral host defense. It is postulated that SCN5A is a novel pathogen sensor and that this pathway represents a channel activation-dependent mechanism of transcriptional regulation.	[Jones, Alexis; Kainz, Danielle; Khan, Faatima; Lee, Cara; Carrithers, Michael D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, Madison, WI 53706 USA; [Jones, Alexis; Kainz, Danielle; Khan, Faatima; Lee, Cara; Carrithers, Michael D.] Univ Wisconsin, Sch Med & Publ Hlth, Program Cellular & Mol Pathol, Madison, WI 53706 USA; [Carrithers, Michael D.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Carrithers, MD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, 1300 Univ Ave,Rm 2679, Madison, WI 53706 USA.	carrithers@neurology.wisc.edu	Lee, Cara/E-5157-2016	Lee, Cara/0000-0003-0614-9060	Department of Veterans Affairs; University of Wisconsin at Madison; Veterans Affairs [I01BX000467] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); University of Wisconsin at Madison; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit Award from the Department of Veterans Affairs and the University of Wisconsin at Madison.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; CALI JJ, 1994, J BIOL CHEM, V269, P12190; Carrithers LM, 2011, FEMS IMMUNOL MED MIC, V63, P319, DOI 10.1111/j.1574-695X.2011.00853.x; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; DU W, 1992, P NATL ACAD SCI USA, V89, P2150, DOI 10.1073/pnas.89.6.2150; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Guldner HH, 1999, J CELL SCI, V112, P733; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; Lau E, 2012, J CELL SCI, V125, P2815, DOI 10.1242/jcs.095000; Liao H, 2010, J BIOL CHEM, V285, P14791, DOI 10.1074/jbc.M110.116905; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mott KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-56; Nikolaeva MA, 2005, J NEUROSCI, V25, P9960, DOI 10.1523/JNEUROSCI.2003-05.2005; Ou YJ, 2003, J BIOL CHEM, V278, P1915, DOI 10.1074/jbc.M209938200; Rahgozar K, 2013, J NEUROPATH EXP NEUR, V72, P489, DOI 10.1097/NEN.0b013e318293eb08; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Ronai Z, 1998, ONCOGENE, V16, P523, DOI 10.1038/sj.onc.1201566; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Schroeter A, 2010, J MOL CELL CARDIOL, V49, P16, DOI 10.1016/j.yjmcc.2010.04.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Weiser T, 2002, MOL PHARMACOL, V62, P433, DOI 10.1124/mol.62.3.433; Willoughby D, 2008, NAT METHODS, V5, P29, DOI 10.1038/NMETH1135	24	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35326	35340		10.1074/jbc.M114.611962	http://dx.doi.org/10.1074/jbc.M114.611962			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25368329	hybrid, Green Published			2022-12-28	WOS:000346660200024
J	Pelissier, MC; Sebban-Kreuzer, C; Guerlesquin, F; Brannigan, JA; Bourne, Y; Vincent, F				Pelissier, Marie-Cecile; Sebban-Kreuzer, Corinne; Guerlesquin, Francoise; Brannigan, James A.; Bourne, Yves; Vincent, Florence			Structural and Functional Characterization of the Clostridium perfringens N-Acetylmannosamine-6-phosphate 2-Epimerase Essential for the Sialic Acid Salvage Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate; Enzyme Mechanism; Mutagenesis; Sialic Acid; X-ray Crystallography; H-1 NMR Spectroscopy; Sugar 2-Epimerase; Sugar Phosphate	LIGATION-INDEPENDENT CLONING; N-ACETYLNEURAMINIC ACID; ESCHERICHIA-COLI; CELLOBIOSE 2-EPIMERASE; MOUSE INTESTINE; CATABOLISM; SEQUENCE; PROTEINS; INSIGHTS; ACETYLMANNOSAMINE	Pathogenic bacteria are endowed with an arsenal of specialized enzymes to convert nutrient compounds from their cell hosts. The essential N-acetylmannosamine-6-phosphate 2-epimerase (NanE) belongs to a convergent glycolytic pathway for utilization of the three amino sugars, GlcNAc, ManNAc, and sialic acid. The crystal structure of ligand-free NanE from Clostridium perfringens reveals a modified triose-phosphate isomerase (/)(8) barrel in which a stable dimer is formed by exchanging the C-terminal helix. By retaining catalytic activity in the crystalline state, the structure of the enzyme bound to the GlcNAc-6P product identifies the topology of the active site pocket and points to invariant residues Lys(66) as a putative single catalyst, supported by the structure of the catalytically inactive K66A mutant in complex with substrate ManNAc-6P. H-1 NMR-based time course assays of native NanE and mutated variants demonstrate the essential role of Lys(66) for the epimerization reaction with participation of neighboring Arg(43), Asp(126), and Glu(180) residues. These findings unveil a one-base catalytic mechanism of C2 deprotonation/reprotonation via an enolate intermediate and provide the structural basis for the development of new antimicrobial agents against this family of bacterial 2-epimerases.	[Pelissier, Marie-Cecile; Bourne, Yves; Vincent, Florence] Aix Marseille Univ, AFMB UMR7257, F-13288 Marseille, France; [Pelissier, Marie-Cecile; Bourne, Yves; Vincent, Florence] CNRS, AFMB UMR7257, F-13288 Marseille, France; [Sebban-Kreuzer, Corinne; Guerlesquin, Francoise] Aix Marseille Univ, CNRS UMR7255, Lab Ingn Syst Macromol, F-13402 Marseille 20, France; [Brannigan, James A.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of York - UK	Vincent, F (corresponding author), CNRS, Lab AFMB, 163 Ave Luminy, F-13288 Marseille, France.	florence.vincent@afmb.univ-mrs.fr	Vincent, Florence/F-7137-2016; Bourne, Yves/AAC-4635-2022	Bourne, Yves/0000-0003-3850-0548; vincent, Florence/0000-0002-8564-4184	CNRS; French Infrastructure for Integrated Structural Biology (FRISBI) Grant [ANR-10-INSB-05-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Infrastructure for Integrated Structural Biology (FRISBI) Grant	This work was supported in part by the CNRS and French Infrastructure for Integrated Structural Biology (FRISBI) Grant ANR-10-INSB-05-01.	Allard STM, 2001, CELL MOL LIFE SCI, V58, P1650, DOI 10.1007/PL00000803; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beebe JA, 2003, BIOCHEMISTRY-US, V42, P4414, DOI 10.1021/bi020639a; Bonsor D, 2006, ORG BIOMOL CHEM, V4, P1252, DOI 10.1039/b517338h; Brigham C, 2009, J BACTERIOL, V191, P3629, DOI 10.1128/JB.00811-08; Brynestad S, 2002, INT J FOOD MICROBIOL, V74, P195, DOI 10.1016/S0168-1605(01)00680-8; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujiwara T, 2014, J BIOL CHEM, V289, P3405, DOI 10.1074/jbc.M113.531251; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; GHOSH S, 1965, J BIOL CHEM, V240, P1531; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Hwang J, 2013, P NATL ACAD SCI USA, V110, pE2829, DOI 10.1073/pnas.1302859110; Ito S, 2009, BIOTECHNOL LETT, V31, P1065, DOI 10.1007/s10529-009-9979-3; Ito S, 2009, APPL MICROBIOL BIOT, V84, P1053, DOI 10.1007/s00253-009-2179-1; Jeong HG, 2009, INFECT IMMUN, V77, P3209, DOI 10.1128/IAI.00109-09; JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636; Kowatz T, 2010, PROTEIN SCI, V19, P1337, DOI 10.1002/pro.410; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEES S, 1976, H-S Z PHYSIOL CHEM, V357, P839, DOI 10.1515/bchm2.1976.357.1.839; Ochoa-Leyva A, 2011, J MOL BIOL, V411, P143, DOI 10.1016/j.jmb.2011.05.027; Olson ME, 2013, J BACTERIOL, V195, P1779, DOI 10.1128/JB.02294-12; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Plumbridge J, 1999, J BACTERIOL, V181, P47, DOI 10.1128/JB.181.1.47-54.1999; Ringenberg MA, 2003, MOL MICROBIOL, V50, P961, DOI 10.1046/j.1365-2958.2003.03741.x; ROGGENTIN P, 1995, BIOL CHEM H-S, V376, P569; ROGGENTIN P, 1989, GLYCOCONJUGATE J, V6, P349, DOI 10.1007/BF01047853; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Samuel J, 2002, NAT PROD REP, V19, P261, DOI 10.1039/b100492l; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SEEHOLZER SH, 1993, P NATL ACAD SCI USA, V90, P1237, DOI 10.1073/pnas.90.4.1237; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Smith H, 2000, PHILOS T R SOC B, V355, P551, DOI 10.1098/rstb.2000.0597; Steenbergen SM, 2005, INFECT IMMUN, V73, P1284, DOI 10.1128/IAI.73.3.1284-1294.2005; Takahashi S, 2001, J BIOCHEM, V130, P815, DOI 10.1093/oxfordjournals.jbchem.a003053; Tanner ME, 2008, CURR OPIN CHEM BIOL, V12, P532, DOI 10.1016/j.cbpa.2008.06.016; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Vincent F, 2005, J BIOL CHEM, V280, P19649, DOI 10.1074/jbc.M502131200; Vincent F, 2004, J BIOL CHEM, V279, P2809, DOI 10.1074/jbc.M310165200; Walters DM, 1999, J BACTERIOL, V181, P4526, DOI 10.1128/JB.181.15.4526-4532.1999	57	13	13	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35215	35224		10.1074/jbc.M114.604272	http://dx.doi.org/10.1074/jbc.M114.604272			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25320079	Green Published, hybrid			2022-12-28	WOS:000346660200015
J	Alonso, J; Schimpl, M; van Aalten, DMF				Alonso, Jana; Schimpl, Marianne; van Aalten, Daan M. F.			O-GlcNAcase: Promiscuous Hexosaminidase or Key Regulator of O-GlcNAc Signaling?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Cell Signaling; Enzyme Inhibitor; Epigenetics; Genetics; Glycobiology; Protein Structure	BETA-N-ACETYLGLUCOSAMINIDASE; EMBRYONIC STEM-CELLS; TAY-SACHS-DISEASE; INSULIN-RESISTANCE; SUBSTRATE RECOGNITION; PROTEIN MODIFICATION; STRUCTURAL INSIGHTS; CYTOSOLIC PROTEINS; 3T3-L1 ADIPOCYTES; KINETIC-ANALYSIS	O-GlcNAc signaling is regulated by an opposing pair of enzymes: O-GlcNAc transferase installs and O-GlcNAcase (OGA) removes the modification from proteins. The dynamics and regulation of this process are only beginning to be understood as the physiological functions of both enzymes are being probed using genetic and pharmacological approaches. This minireview charts the discovery and functional and structural analysis of OGA and summarizes the insights gained from recent studies using OGA inhibition, gene knock-out, and overexpression. We identify several areas of known unknowns that would benefit from future research, such as the enigmatic C-terminal domain of OGA.	[Alonso, Jana; Schimpl, Marianne; van Aalten, Daan M. F.] Univ Dundee, MRC, Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [van Aalten, Daan M. F.] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland	University of Dundee; University of Dundee	van Aalten, DMF (corresponding author), Univ Dundee, MRC, Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland.	dmfvanaalten@dundee.ac.uk	Lorenzo, Jana Alonso/B-2869-2012	Lorenzo, Jana Alonso/0000-0002-2304-8715; Schimpl, Marianne/0000-0003-2284-5250; van Aalten, Daan/0000-0002-1499-6908	Medical Research Council [G0900138] Funding Source: Medline; Wellcome Trust [087590] Funding Source: Medline; MRC [G0900138] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Banerjee PS, 2013, CHEM SOC REV, V42, P4345, DOI 10.1039/c2cs35412h; Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; Butkinaree C, 2008, J BIOL CHEM, V283, P23557, DOI 10.1074/jbc.M804116200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cecioni S, 2013, CURR OPIN CHEM BIOL, V17, P719, DOI 10.1016/j.cbpa.2013.06.030; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dorfmueller HC, 2010, CHEM BIOL, V17, P1250, DOI 10.1016/j.chembiol.2010.09.014; Dorfmueller HC, 2009, BIOCHEM J, V420, P221, DOI 10.1042/BJ20090110; Drougat L, 2012, BBA-GEN SUBJECTS, V1820, P1839, DOI 10.1016/j.bbagen.2012.08.024; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Francisco H, 2009, DEV NEUROBIOL, V69, P162, DOI 10.1002/dneu.20695; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gong CX, 2012, P NATL ACAD SCI USA, V109, P17319, DOI 10.1073/pnas.1215395109; Graham DL, 2014, NEUROPHARMACOLOGY, V79, P307, DOI 10.1016/j.neuropharm.2013.11.025; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hayakawa K, 2013, J BIOL CHEM, V288, P17099, DOI 10.1074/jbc.M113.455899; He Y, 2014, ACTA CRYSTALLOGR D, V70, P186, DOI 10.1107/S1399004713029155; He Y, 2010, J AM CHEM SOC, V132, P1807, DOI 10.1021/ja9086769; Heckel D, 1998, HUM MOL GENET, V7, P1859, DOI 10.1093/hmg/7.12.1859; Hilgers RHP, 2012, AM J PHYSIOL-HEART C, V303, pH513, DOI 10.1152/ajpheart.01175.2011; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Howerton CL, 2013, P NATL ACAD SCI USA, V110, P5169, DOI 10.1073/pnas.1300065110; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Keembiyehetty CN, 2011, J CELL SCI, V124, P2851, DOI 10.1242/jcs.083287; Knapp S, 2007, ORG LETT, V9, P2321, DOI 10.1021/ol0706814; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Lepage SE, 2010, INT J DEV BIOL, V54, P1213, DOI 10.1387/ijdb.093028sl; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Macauley MS, 2012, J BIOL CHEM, V287, P28882, DOI 10.1074/jbc.M112.363721; Macauley MS, 2010, CHEM BIOL, V17, P937, DOI 10.1016/j.chembiol.2010.07.006; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Macauley MS, 2009, CARBOHYD RES, V344, P1079, DOI 10.1016/j.carres.2009.04.017; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; Martin JC, 2014, GLYCOBIOLOGY, V24, P85, DOI 10.1093/glycob/cwt094; MINAMI R, 1981, TOHOKU J EXP MED, V133, P175, DOI 10.1620/tjem.133.175; Muller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062835; Nagel AK, 2014, AMINO ACIDS, V46, P2305, DOI 10.1007/s00726-014-1827-7; Olszewski NE, 2010, BBA-GEN SUBJECTS, V1800, P49, DOI 10.1016/j.bbagen.2009.11.016; Ostrowski A, 2013, BIOCHEM J, V456, P1, DOI [10.1042/BJ20131081, 10.1042/BJ201301081]; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; PENTON E, 1975, BIOCHIM BIOPHYS ACTA, V391, P162, DOI 10.1016/0005-2744(75)90162-X; Radermacher PT, 2014, P NATL ACAD SCI USA, V111, P5592, DOI 10.1073/pnas.1322396111; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Rao FV, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130021; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Robinson KA, 2007, AM J PHYSIOL-ENDOC M, V292, pE884, DOI 10.1152/ajpendo.00569.2006; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Schimpl M, 2012, CHEM BIOL, V19, P173, DOI 10.1016/j.chembiol.2012.01.011; Schimpl M, 2010, BIOCHEM J, V432, P1, DOI 10.1042/BJ20101338; Schultz J, 2002, FEBS LETT, V529, P179, DOI 10.1016/S0014-5793(02)03322-7; Sekine O, 2010, J BIOL CHEM, V285, P38684, DOI 10.1074/jbc.M110.155192; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Speakman CM, 2014, STEM CELLS, V32, P2605, DOI 10.1002/stem.1761; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; SWALLOW DM, 1976, ANN HUM GENET, V40, P55, DOI 10.1111/j.1469-1809.1976.tb00164.x; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Toleman CA, 2006, J BIOL CHEM, V281, P3918, DOI 10.1074/JBC.m510485200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Wang P, 2013, AUTOPHAGY, V9, P604, DOI 10.4161/auto.23459; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Whisenhunt TR, 2006, GLYCOBIOLOGY, V16, P551, DOI 10.1093/glycob/cwj096; Whitworth GE, 2007, J AM CHEM SOC, V129, P635, DOI 10.1021/ja065697o; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035277; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/nchembio.797, 10.1038/NCHEMBIO.797]; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	83	38	38	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34433	34439		10.1074/jbc.R114.609198	http://dx.doi.org/10.1074/jbc.R114.609198			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25336650	hybrid, Green Published			2022-12-28	WOS:000346260800003
J	Lacek, K; Urbanowicz, RA; Troise, F; De Lorenzo, C; Severino, V; Di Maro, A; Tarr, AW; Ferrara, F; Ploss, A; Temperton, N; Ball, JK; Nicosia, A; Cortese, R; Pessi, A				Lacek, Krzysztof; Urbanowicz, Richard A.; Troise, Fulvia; De Lorenzo, Claudia; Severino, Valeria; Di Maro, Antimo; Tarr, Alexander W.; Ferrara, Francesca; Ploss, Alexander; Temperton, Nigel; Ball, Jonathan K.; Nicosia, Alfredo; Cortese, Riccardo; Pessi, Antonello			Dramatic Potentiation of the Antiviral Activity of HIV Antibodies by Cholesterol Conjugation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; Cholesterol; Human Immunodeficiency Virus (HIV); Lipid Raft; Membrane Fusion; Molecular Evolution; Viral Immunology; Virus Entry	IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; SITE-SPECIFIC CONJUGATION; MEMBRANE-PROXIMAL REGION; INFLUENZA HEMAGGLUTININ; FUSION PORE; NEUTRALIZING ANTIBODIES; ENTRY INHIBITORS; GP41 EPITOPE; LIPID RAFTS	Background: Some HIV-neutralizing antibodies have an antigen-binding site with dual specificity, for the plasma membrane and a viral epitope. Results: We engineered membrane affinity outside the antigen-binding site by conjugating cholesterol, with concomitantly increased antiviral potency. Conclusion: A natural mechanism dependent on affinity maturation is mimicked by conjugation of a lipid. Significance: This is a general strategy to boost the potency of antiviral antibodies. The broadly neutralizing antibodies HIV 2F5 and 4E10, which bind to overlapping epitopes in the membrane-proximal external region of the fusion protein gp41, have been proposed to use a two-step mechanism for neutralization; first, they bind and preconcentrate at the viral membrane through their long, hydrophobic CDRH3 loops, and second, they form a high affinity complex with the protein epitope. Accordingly, mutagenesis of the CDRH3 can abolish their neutralizing activity, with no change in the affinity for the peptide epitope. We show here that we can mimic this mechanism by conjugating a cholesterol group outside of the paratope of an antibody. Cholesterol-conjugated antibodies bind to lipid raft domains on the membrane, and because of this enrichment, they show increased antiviral potency. In particular, we find that cholesterol conjugation (i) rescues the antiviral activity of CDRH3-mutated 2F5, (ii) increases the antiviral activity of WT 2F5, (iii) potentiates the non-membrane-binding HIV antibody D5 10-100-fold (depending on the virus strain), and (iv) increases synergy between 2F5 and D5. Conjugation can be made at several positions, including variable and constant domains. Cholesterol conjugation therefore appears to be a general strategy to boost the potency of antiviral antibodies, and, because membrane affinity is engineered outside of the antibody paratope, it can complement affinity maturation strategies.	[Lacek, Krzysztof; Troise, Fulvia; De Lorenzo, Claudia; Nicosia, Alfredo; Cortese, Riccardo; Pessi, Antonello] Ceinge Biotecnol Avanzate SCRL, I-80145 Naples, NA, Italy; [Lacek, Krzysztof] Univ Gdansk, Lab Virus Mol Biol, PL-80822 Gdansk, Poland; [Urbanowicz, Richard A.; Tarr, Alexander W.; Ball, Jonathan K.] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Nottingham NG7 2UH, England; [Urbanowicz, Richard A.; Tarr, Alexander W.; Ball, Jonathan K.] Univ Nottingham, Queens Med Ctr, Nottingham Digest Dis Ctr, Biomed Res Unit, Nottingham NG7 2UH, England; [De Lorenzo, Claudia; Nicosia, Alfredo] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, I-80131 Naples, NA, Italy; [Severino, Valeria; Di Maro, Antimo] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, I-81100 Caserta, CE, Italy; [Ferrara, Francesca; Temperton, Nigel] Univ Kent, Sch Pharm, Infect Dis & Allergy Grp, Viral Pseudotype Unit, Chatham ME4 4TB, Kent, England; [Ploss, Alexander] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Pessi, Antonello] JV Bio, I-80145 Naples, NA, Italy	CEINGE Biotecnologie Avanzate; Fahrenheit Universities; University of Gdansk; University of Nottingham; University of Nottingham; University of Naples Federico II; Universita della Campania Vanvitelli; University of Kent; Princeton University	Pessi, A (corresponding author), JV Bio, Via Gaetano Salvatore 486, I-80145 Naples, NA, Italy.	a.pessi@jvbio.com	Tarr, Alexander W/B-7953-2008; Temperton, Nigel James/M-1164-2019; Ferrara, Francesca/I-3686-2014; Ploss, Alexander/ABG-2330-2020; Urbanowicz, Richard Antoni/M-3354-2019; Ball, Jonathan/HGU-3130-2022; Temperton, Nigel James/K-5158-2013	Tarr, Alexander W/0000-0003-1009-0823; Temperton, Nigel James/0000-0002-7978-3815; Ferrara, Francesca/0000-0002-4973-1520; Ploss, Alexander/0000-0001-9322-7252; Urbanowicz, Richard Antoni/0000-0002-2461-4993; Temperton, Nigel James/0000-0002-7978-3815; De Lorenzo, Claudia/0000-0002-6195-5631; ball, jonathan/0000-0001-5773-8733	National Science Centre [UMO-2012/04/A/NZ1/00056]; Ministry of Science and Higher Education [0330/IP1/2013/72]; Medical Research Council [G0801169]; MRC [G0801169] Funding Source: UKRI	National Science Centre(National Science Centre, Poland); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by National Science Centre Grant UMO-2012/04/A/NZ1/00056 and Ministry of Science and Higher Education Grant 0330/IP1/2013/72 (to K. L.) and by Medical Research Council Grant G0801169 (to J. K. B. and R. A. U.).	Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Ashkenazi A, 2012, FASEB J, V26, P4628, DOI 10.1096/fj.12-215111; Barman S, 2007, J VIROL, V81, P12169, DOI 10.1128/JVI.00835-07; Bentz J, 2000, BIOPHYS J, V78, P886, DOI 10.1016/S0006-3495(00)76646-X; Bentz J, 2000, BIOPHYS J, V78, P227, DOI 10.1016/S0006-3495(00)76587-8; Brown RJP, 2011, J VIROL, V85, P6024, DOI 10.1128/JVI.00131-11; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Francis JN, 2012, BIOCONJUGATE CHEM, V23, P1252, DOI 10.1021/bc300076f; Guenaga J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002806; He Y, 2007, PROTEINS, V69, P75, DOI 10.1002/prot.21478; Hrin R, 2008, AIDS RES HUM RETROV, V24, P1537, DOI 10.1089/aid.2008.0129; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Ingallinella P, 2009, P NATL ACAD SCI USA, V106, P5801, DOI 10.1073/pnas.0901007106; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Junutula JR, 2008, J IMMUNOL METHODS, V332, P41, DOI 10.1016/j.jim.2007.12.011; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Lee KK, 2011, J BIOL CHEM, V286, P42141, DOI 10.1074/jbc.M111.254243; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; Montgomery DL, 2009, MABS, V1, P462, DOI 10.4161/mabs.1.5.9214; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Ono A, 2005, ADV VIRUS RES, V64, P311, DOI 10.1016/S0065-3527(05)64010-9; Persic L, 1997, GENE, V187, P9, DOI 10.1016/S0378-1119(96)00628-2; Pessi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036833; Pocai A, 2009, DIABETES, V58, P2258, DOI 10.2337/db09-0278; Porotto M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001168; Porotto M, 2010, J VIROL, V84, P6760, DOI 10.1128/JVI.00135-10; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Santoprete A, 2011, J PEPT SCI, V17, P270, DOI 10.1002/psc.1328; SHARPLES.NE, 1966, BIOCHEMISTRY-US, V5, P2963, DOI 10.1021/bi00873a028; Stimmel JB, 2000, J BIOL CHEM, V275, P30445, DOI 10.1074/jbc.M001672200; Teruya K, 2010, PROTEIN J, V29, P493, DOI 10.1007/s10930-010-9278-9; Voynov V, 2010, BIOCONJUGATE CHEM, V21, P385, DOI 10.1021/bc900509s; Welsch JC, 2013, J VIROL, V87, P13785, DOI 10.1128/JVI.02436-13; Xu HY, 2010, J VIROL, V84, P1076, DOI 10.1128/JVI.02113-09; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zolot RS, 2013, NAT REV DRUG DISCOV, V12, P259, DOI 10.1038/nrd3980	53	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					35015	35028		10.1074/jbc.M114.591826	http://dx.doi.org/10.1074/jbc.M114.591826			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342747	hybrid, Green Published			2022-12-28	WOS:000346260800049
J	Wu, MV; Bikopoulos, G; Hung, S; Ceddia, RB				Wu, Michelle V.; Bikopoulos, George; Hung, Steven; Ceddia, Rolando B.			Thermogenic Capacity Is Antagonistically Regulated in Classical Brown and White Subcutaneous Fat Depots by High Fat Diet and Endurance Training in Rats IMPACT ON WHOLE-BODY ENERGY EXPENDITURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue Metabolism; AMP-activated Kinase (AMPK); Exercise; Obesity; Peroxisome Proliferator-activated Receptor Coactivator 1-(PGC-1a) (PPARGC1A); UCP-1; FNDC5; Irisin; Brown Adipocytes; ATGL	NERVOUS-SYSTEM ACTIVITY; MESSENGER-RNA EXPRESSION; ADIPOSE-TISSUE; SKELETAL-MUSCLE; COLD-EXPOSURE; EXHAUSTIVE EXERCISE; GENE-EXPRESSION; IRISIN; ADIPOCYTES; OBESITY	Background: Brown adipose tissue (BAT) is important for cold- and diet-induced thermogenesis. Results: Obesity and chronic exercise antagonistically regulate thermogenic capacity of BAT and subcutaneous white fat (SC WAT). Conclusion: Endurance exercise reduces thermogenic capacity in classical BAT while increasing it in the SC WAT. Significance: Browning of the SC WAT may be potentially used to treat obesity. This study investigated the regulation of thermogenic capacity in classical brown adipose tissue (BAT) and subcutaneous inguinal (SC Ing) white adipose tissue (WAT) and how it affects whole-body energy expenditure in sedentary and endurance-trained rats fed ad libitum either low fat or high fat (HF) diets. Analysis of tissue mass, PGC-1 and UCP-1 content, the presence of multilocular adipocytes, and palmitate oxidation revealed that a HF diet increased the thermogenic capacity of the interscapular and aortic brown adipose tissues, whereas exercise markedly suppressed it. Conversely, exercise induced browning of the SC Ing WAT. This effect was attenuated by a HF diet. Endurance training neither affected skeletal muscle FNDC5 content nor circulating irisin, but it increased FNDC5 content in SC Ing WAT. This suggests that locally produced FNDC5 rather than circulating irisin mediated the exercise-induced browning effect on this fat tissue. Importantly, despite reducing the thermogenic capacity of classical BAT, exercise increased whole-body energy expenditure during the dark cycle. Therefore, browning of subcutaneous WAT likely exerted a compensatory effect and raised whole-body energy expenditure in endurance-trained rats. Based on these novel findings, we propose that exercise-induced browning of the subcutaneous WAT provides an alternative mechanism that reduces thermogenic capacity in core areas and increases it in peripheral body regions. This could allow the organism to adjust its metabolic rate to accommodate diet-induced thermogenesis while simultaneously coping with the stress of chronically increased heat production through exercise.	[Wu, Michelle V.; Bikopoulos, George; Hung, Steven; Ceddia, Rolando B.] York Univ, Sch Kinesiol & Hlth Sci, Muscle Hlth Res Ctr, N York, ON M3J 1P3, Canada	York University - Canada	Ceddia, RB (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Muscle Hlth Res Ctr, 4700 Keele St, N York, ON M3J 1P3, Canada.	roceddia@yorku.ca			Natural Sciences and Engineering Research Council of Canada [311818-2011]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant 311818-2011 (to R. B. C.).	Araujo RL, 2010, ENDOCRINOLOGY, V151, P3460, DOI 10.1210/en.2010-0026; ARNOLD J, 1987, J PHYSIOL-LONDON, V390, P45, DOI 10.1113/jphysiol.1987.sp016685; Aydin S, 2014, PEPTIDES, V52, P68, DOI 10.1016/j.peptides.2013.11.024; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brenmoehl J, 2014, INT J BIOL SCI, V10, P338, DOI 10.7150/ijbs.7972; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; De Matteis R, 2013, NUTR METAB CARDIOVAS, V23, P582, DOI 10.1016/j.numecd.2012.01.013; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Gaidhu MP, 2011, J LIPID RES, V52, P1702, DOI 10.1194/jlr.M015354; GOHIL K, 1984, BIOSCIENCE REP, V4, P987, DOI 10.1007/BF01116898; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Kraemer RR, 2014, HORM METAB RES, V46, P150, DOI 10.1055/s-0033-1355381; LANDSBERG L, 1981, LIFE SCI, V28, P1801, DOI 10.1016/0024-3205(81)90352-0; LARUEACHAGIOTIS C, 1995, PHYSIOL BEHAV, V57, P1013, DOI 10.1016/0031-9384(94)00005-P; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Lowell BB, 2003, J BIOL CHEM, V278, P29385, DOI 10.1074/jbc.R300011200; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Pekkala S, 2013, J PHYSIOL-LONDON, V591, P5393, DOI 10.1113/jphysiol.2013.263707; PERONNET F, 1981, J APPL PHYSIOL, V51, P812, DOI 10.1152/jappl.1981.51.4.812; Pescatello LS, 2014, AM COLL SPORTS MED G, P162; RAPPAPORT EB, 1982, METABOLISM, V31, P143, DOI 10.1016/0026-0495(82)90126-3; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073680; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641; SCHWARTZ JH, 1983, J CLIN INVEST, V72, P361, DOI 10.1172/JCI110976; Terblanche SE, 2001, COMP BIOCHEM PHYS A, V128, P889, DOI 10.1016/S1095-6433(00)00344-5; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vitzel KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062190; Vosselman MJ, 2013, AM J CLIN NUTR, V98, P57, DOI 10.3945/ajcn.113.059022; WINDER WW, 1978, J APPL PHYSIOL, V45, P370, DOI 10.1152/jappl.1978.45.3.370; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; YAMASHITA H, 1993, INT J BIOMETEOROL, V37, P61, DOI 10.1007/BF01212769; YOUNG JB, 1982, J CLIN INVEST, V69, P1061, DOI 10.1172/JCI110541; YOUNG JB, 1983, AM J PHYSIOL, V245, pE148, DOI 10.1152/ajpendo.1983.245.2.E148; Zhang YY, 2014, J BIOL CHEM, V289, P22063, DOI 10.1074/jbc.M114.559104	45	121	128	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34129	34140		10.1074/jbc.M114.591008	http://dx.doi.org/10.1074/jbc.M114.591008			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25344623	Green Published, hybrid			2022-12-28	WOS:000346077600037
J	Wu, RTY; Cao, L; Chen, BPC; Cheng, WH				Wu, Ryan T. Y.; Cao, Lei; Chen, Benjamin P. C.; Cheng, Wen-Hsing			Selenoprotein H Suppresses Cellular Senescence through Genome Maintenance and Redox Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ataxia Telangiectasia; p53; Reactive Oxygen Species (ROS); Selenium; Senescence	DNA-DAMAGE-RESPONSE; DOUBLE-STRAND BREAKS; FREE-RADICAL THEORY; OXIDATIVE STRESS; SELENIUM DEFICIENCY; ATM ACTIVATION; HUMAN-CELLS; REPLICATIVE SENESCENCE; NF-E2-RELATED FACTOR-2; GLUTATHIONE SYNTHESIS	Background: Selenoprotein H (SelH), a proposed redox-responsive DNA-binding protein, is little-studied. Results: SelH shRNA cells display severe proliferation defects and accelerated senescence with abnormal responses to DNA damage and oxidative stress. Conclusion: SelH suppresses senescence and may have important roles in gatekeeping genomic integrity. Significance: Learning how SelH keeps senescence in check is crucial for advancing our understanding linking selenium and aging intervention. Oxidative stress and persistent DNA damage response contribute to cellular senescence, a degeneration process critically involving ataxia telangiectasia-mutated (ATM) and p53. Selenoprotein H (SelH), a nuclear selenoprotein, is proposed to carry redox and transactivation domains. To determine the role of SelH in genome maintenance, shRNA knockdown was employed in human normal and immortalized cell lines. SelH shRNA MRC-5 diploid fibroblasts under ambient O-2 displayed a distinct profile of senescence including -galactosidase expression, autofluorescence, growth inhibition, and ATM pathway activation. Such senescence phenotypes were alleviated in the presence of ATM kinase inhibitors, by p53 shRNA knockdown, or by maintaining the cells under 3% O-2. During the course of 5-day recovery, the induction of phospho-ATM on Ser-1981 and H2AX by H2O2 treatment (20 m) subsided in scrambled shRNA but exacerbated in SelH shRNA MRC-5 cells. Results from clonogenic assays demonstrated hypersensitivity of SelH shRNA HeLa cells to paraquat and H2O2, but not to hydroxyurea, neocarzinostatin, or camptothecin. While SelH mRNA expression was induced by H2O2 treatment, SelH-GFP did not mobilize to sites of oxidative DNA damage. The glutathione level was lower in SelH shRNA than scrambled shRNA HeLa cells, and the H2O2-induced cell death was rescued in the presence of N-acetylcysteine, a glutathione precursor. Altogether, SelH protects against cellular senescence to oxidative stress through a genome maintenance pathway involving ATM and p53.	[Wu, Ryan T. Y.; Cheng, Wen-Hsing] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Cao, Lei; Cheng, Wen-Hsing] Mississippi State Univ, Dept Food Sci Nutr & Hlth Promot, Mississippi State, MS 39762 USA; [Chen, Benjamin P. C.] Univ Texas Dallas, Div Mol Radiat Biol, Dept Radiat Oncol, SW Med Ctr Dallas, Dallas, TX 75390 USA	University System of Maryland; University of Maryland College Park; Mississippi State University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cheng, WH (corresponding author), Mississippi State Univ, Dept Food Sci Nutr & Hlth Promot, Mississippi State, MS 39762 USA.	wc523@msstate.edu						Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Balajee AS, 2001, NUCLEIC ACIDS RES, V29, P1341, DOI 10.1093/nar/29.6.1341; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Ben Jilani KE, 2007, INT J BIOL SCI, V3, P198; Burk RF, 2008, FREE RADICAL BIO MED, V44, P1617, DOI 10.1016/j.freeradbiomed.2008.01.016; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Di Micco R, 2008, CELL CYCLE, V7, P3601, DOI 10.4161/cc.7.22.7152; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Downey CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000616; Franco R, 2006, J BIOL CHEM, V281, P29542, DOI 10.1074/jbc.M602500200; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Garm C, 2013, AGING CELL, V12, P58, DOI 10.1111/acel.12019; Gladyshev VN, 2014, ANTIOXID REDOX SIGN, V20, P727, DOI 10.1089/ars.2013.5228; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Han X, 2013, IUBMB LIFE, V65, P951, DOI 10.1002/iub.1220; HARMAN D, 1960, J GERONTOL, V15, P38, DOI 10.1093/geronj/15.1.38; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; Kim JW, 2002, ARCH GERONTOL GERIAT, V34, P9, DOI 10.1016/S0167-4943(01)00178-9; Kimoto-Kinoshita S, 1999, NEUROSCI LETT, V273, P41, DOI 10.1016/S0304-3940(99)00623-0; Kipp A, 2009, MOL NUTR FOOD RES, V53, P1561, DOI 10.1002/mnfr.200900105; Kipp AP, 2012, J NUTR BIOCHEM, V23, P1170, DOI 10.1016/j.jnutbio.2011.06.011; KOI M, 1994, CANCER RES, V54, P4308; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lawless C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032117; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Legrain Y, 2014, J BIOL CHEM, V289, P6299, DOI 10.1074/jbc.M113.526863; Lewinska A, 2010, REDOX REP, V15, P87, DOI 10.1179/174329210X12650506623366; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Mallette FA, 2007, CELL CYCLE, V6, P1831, DOI 10.4161/cc.6.15.4516; Maude SL, 2005, CANCER RES, V65, P780; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; McCann JC, 2011, FASEB J, V25, P1793, DOI 10.1096/fj.11-180885; Mendelev N, 2011, MITOCHONDRION, V11, P76, DOI 10.1016/j.mito.2010.07.007; Mendelev N, 2009, EXP NEUROL, V220, P328, DOI 10.1016/j.expneurol.2009.09.008; Moinova HR, 1999, BIOCHEM BIOPH RES CO, V261, P661, DOI 10.1006/bbrc.1999.1109; Morozova N, 2003, GENES CELLS, V8, P963, DOI 10.1046/j.1365-2443.2003.00687.x; Mortusewicz O, 2011, NUCLEIC ACIDS RES, V39, P5045, DOI 10.1093/nar/gkr099; Moussavi-Harami Farid, 2004, Iowa Orthop J, V24, P15; Novoselov SV, 2007, J BIOL CHEM, V282, P11960, DOI 10.1074/jbc.M701605200; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Panee J, 2007, J BIOL CHEM, V282, P23759, DOI 10.1074/jbc.M702267200; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; PEREZ R, 1991, FREE RADICAL BIO MED, V10, P35, DOI 10.1016/0891-5849(91)90019-Y; Pieri C, 2001, GERONTOLOGY, V47, P88, DOI 10.1159/000052779; Poulios E, 2007, ANN NY ACAD SCI, V1119, P9, DOI 10.1196/annals.1404.025; Qi YM, 2010, J BIOL CHEM, V285, P33010, DOI 10.1074/jbc.M110.137406; Raines AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-26; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Richter T, 2007, EXP GERONTOL, V42, P1043, DOI 10.1016/j.exger.2007.08.004; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sakurai A, 2005, J CELL PHYSIOL, V203, P529, DOI 10.1002/jcp.20246; Sebastia J, 2003, CYTOM PART A, V51A, P16, DOI 10.1002/cyto.a.10003; Sengupta A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012249; Singh A, 2006, AM J RESP CELL MOL, V35, P639, DOI 10.1165/rcmb.2005-0325OC; Sivonova M, 2007, PHYSIOL RES, V56, P757, DOI 10.33549/physiolres.931094; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Sunde RA, 2010, EXP BIOL MED, V235, P1046, DOI 10.1258/ebm.2010.010111; Suzuki M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/310534; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Voghel G, 2007, MECH AGEING DEV, V128, P662, DOI 10.1016/j.mad.2007.09.006; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Wilhelm J, 2009, MOL CELL BIOCHEM, V328, P167, DOI 10.1007/s11010-009-0086-5; Williams JB, 2008, EXP GERONTOL, V43, P538, DOI 10.1016/j.exger.2008.02.001; Wu M, 2011, J AGR FOOD CHEM, V59, P11882, DOI 10.1021/jf203012a; Wu M, 2010, J BIOL CHEM, V285, P12055, DOI 10.1074/jbc.M109.088781; Yanamadala S, 2003, MOL CANCER RES, V1, P747; Zhan H, 2010, J BIOL CHEM, V285, P29662, DOI 10.1074/jbc.M110.125138	82	30	32	5	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34378	34388		10.1074/jbc.M114.611970	http://dx.doi.org/10.1074/jbc.M114.611970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25336634	Green Published, hybrid			2022-12-28	WOS:000346077600057
J	Nyman, E; Rajan, MR; Fagerholm, S; Brannmark, C; Cedersund, G; Stralfors, P				Nyman, Elin; Rajan, Meenu Rohini; Fagerholm, Siri; Brannmark, Cecilia; Cedersund, Gunnar; Stralfors, Peter			A Single Mechanism Can Explain Network-wide Insulin Resistance in Adipocytes from Obese Patients with Type 2 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SKELETAL-MUSCLE; RECEPTOR SUBSTRATE-1; SIGNAL-TRANSDUCTION; NEGATIVE-FEEDBACK; MAP KINASE; IN-VIVO; TUBEROUS SCLEROSIS; SCAFFOLD PROTEINS; SYSTEMS-BIOLOGY	The response to insulin is impaired in type 2 diabetes. Much information is available about insulin signaling, but understanding of the cellular mechanisms causing impaired signaling and insulin resistance is hampered by fragmented data, mainly obtained from different cell lines and animals. We have collected quantitative and systems-wide dynamic data on insulin signaling in primary adipocytes and compared cells isolated from healthy and diabetic individuals. Mathematical modeling and experimental verification identified mechanisms of insulin control of the MAPKs ERK1/2. We found that in human adipocytes, insulin stimulates phosphorylation of the ribosomal protein S6 and hence protein synthesis about equally via ERK1/2 and mTORC1. Using mathematical modeling, we examined the signaling network as a whole and show that a single mechanism can explain the insulin resistance of type 2 diabetes throughout the network, involving signaling both through IRS1, PKB, and mTOR and via ERK1/2 to the nuclear transcription factor Elk1. The most important part of the insulin resistance mechanism is an attenuated feedback from the protein kinase mTORC1 to IRS1, which spreads signal attenuation to all parts of the insulin signaling network. Experimental inhibition of mTORC1 using rapamycin in adipocytes from non-diabetic individuals induced and thus confirmed the predicted network-wide insulin resistance.	[Nyman, Elin; Rajan, Meenu Rohini; Fagerholm, Siri; Brannmark, Cecilia; Cedersund, Gunnar; Stralfors, Peter] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Cedersund, Gunnar] Linkoping Univ, Dept Biomed Engn, SE-58185 Linkoping, Sweden	Linkoping University; Linkoping University	Stralfors, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.	peter.stralfors@liu.se	Nyman, Elin/I-3363-2019	Nyman, Elin/0000-0002-4261-0291; Stralfors, Peter/0000-0002-1196-1806	Swedish Diabetes Fund; University of Linkoping; Swedish Research Council; Novo Nordisk Fonden [NNF12OC1016434] Funding Source: researchfish	Swedish Diabetes Fund; University of Linkoping; Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Swedish Diabetes Fund, University of Linkoping, and the Swedish Research Council.	Ahmed S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134708; Aldridge BB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000340; Aokia K, 2011, P NATL ACAD SCI USA, V108, P12675, DOI 10.1073/pnas.1104030108; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Brannmark C, 2010, J BIOL CHEM, V285, P20171, DOI 10.1074/jbc.M110.106849; Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634; Cedersund G, 2012, FEBS J, V279, P3513, DOI 10.1111/j.1742-4658.2012.08725.x; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; Danielsson A, 2009, MOL MED, V15, P228, DOI 10.2119/molmed.2009.00037; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Gogg S, 2002, J BIOL CHEM, V277, P36045, DOI 10.1074/jbc.M200575200; Hao N, 2012, MOL BIOL CELL, V23, P3899, DOI 10.1091/mbc.E12-04-0333; HONNOR RC, 1985, J BIOL CHEM, V260, P5122; Huang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022933; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kondoh K, 2005, CHROMOSOMA, V114, P86, DOI 10.1007/s00412-005-0341-9; Kreutz C, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-120; Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Leng Y, 2004, DIABETES, V53, P1436, DOI 10.2337/diabetes.53.6.1436; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lin Tai-An, 1994, Journal of Biological Chemistry, V269, P21255; Locasale JW, 2007, P NATL ACAD SCI USA, V104, P13307, DOI 10.1073/pnas.0706311104; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mut M, 2012, INT J BIOCHEM CELL B, V44, P302, DOI 10.1016/j.biocel.2011.10.025; Nijhout HF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00245; Nyman E, 2012, TRENDS ENDOCRIN MET, V23, P107, DOI 10.1016/j.tem.2011.12.007; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; Osman AA, 2001, J APPL PHYSIOL, V90, P454, DOI 10.1152/jappl.2001.90.2.454; Ost A, 2007, FASEB J, V21, P3696, DOI 10.1096/fj.07-8173com; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Pearce LR, 2013, CELL, V155, P765, DOI 10.1016/j.cell.2013.09.058; Pereira MJ, 2012, MOL CELL ENDOCRINOL, V355, P96, DOI 10.1016/j.mce.2012.01.024; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Rajan MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059725; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Schmidt H, 2007, BIOINFORMATICS, V23, P646, DOI 10.1093/bioinformatics/btl668; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Stenkula KG, 2004, MOL CELL ENDOCRINOL, V221, P1, DOI 10.1016/j.mce.2004.04.011; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; Volmat V, 2001, J CELL SCI, V114, P3433; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; Witzel F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00475; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	63	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33215	33230		10.1074/jbc.M114.608927	http://dx.doi.org/10.1074/jbc.M114.608927			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25320095	Green Published, hybrid			2022-12-28	WOS:000345636600015
J	Schalk, AM; Nguyen, HA; Rigouin, C; Lavie, A				Schalk, Amanda M.; Hien-Anh Nguyen; Rigouin, Coraline; Lavie, Arnon			Identification and Structural Analysis of an L-Asparaginase Enzyme from Guinea Pig with Putative Tumor Cell Killing Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI L-ASPARAGINASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; GLUTAMINASE ACTIVITY; REFINEMENT; CHILDREN; SERUM; PURIFICATION; REINDUCTION	The initial observation that guinea pig serum kills lymphoma cells marks the serendipitous discovery of a new class of anticancer agents. The serum cell killing factor was shown to be an enzyme with L-asparaginase (ASNase) activity. As a direct result of this observation, several bacterial L-asparaginases were developed and are currently approved by the Food and Drug Administration for the treatment of the subset of hematological malignancies that are dependent on the extracellular pool of the amino acid asparagine. As drugs, these enzymes act to hydrolyze asparagine to aspartate, thereby starving the cancer cells of this amino acid. Prior to the work presented here, the precise identity of this guinea pig enzyme has not been reported in the peer-reviewed literature. We discovered that the guinea pig enzyme annotated as H0W0T5_CAVPO, which we refer to as gpASNase1, has the required low Km property consistent with that possessed by the cell-killing guinea pig serum enzyme. Elucidation of the ligand-free and aspartate complex gpASNase1 crystal structures allows a direct comparison with the bacterial enzymes and serves to explain the lack of L-glutaminase activity in the guinea pig enzyme. The structures were also used to generate a homology model for the human homolog hASNase1 and to help explain its vastly different kinetic properties compared with gpASNase1, despite a 70% sequence identity. Given that the bacterial enzymes frequently present immunogenic and other toxic side effects, this work suggests that gpASNase1 could be a promising alternative to these bacterial enzymes.	[Schalk, Amanda M.; Hien-Anh Nguyen; Rigouin, Coraline; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lavie, A (corresponding author), Dept Biochem & Mol Genet, 900 S Ashland Ave,Mol Biol Res Bldg,Rm 1108, Chicago, IL 60607 USA.	lavie@uic.edu		Lavie, Arnon/0000-0001-5591-8722	National Institutes of Health [R21 CA155424, T32 HL0507692]; NATIONAL CANCER INSTITUTE [R21CA155424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 CA155424 and T32 HL0507692 (to A. M. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aghaiypour K, 2001, BIOCHEMISTRY-US, V40, P5655, DOI 10.1021/bi0029595; Ario T., 2003, U. S. Patent, Patent No. [6,537,547 B1, 6537547]; Armstrong JK, 2007, CANCER-AM CANCER SOC, V110, P103, DOI 10.1002/cncr.22739; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avramis VI, 2005, CLIN PHARMACOKINET, V44, P367, DOI 10.2165/00003088-200544040-00003; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boos J, 1996, EUR J CANCER, V32A, P1544, DOI 10.1016/0959-8049(96)00131-1; BROOME JD, 1963, J EXP MED, V118, P99, DOI 10.1084/jem.118.1.99; Chan WK, 2014, BLOOD, V123, P3596, DOI 10.1182/blood-2013-10-535112; COONEY DA, 1970, CANCER RES, V30, P929; DELLINGER CT, 1976, CANCER, V38, P1843, DOI 10.1002/1097-0142(197610)38:4<1843::AID-CNCR2820380463>3.0.CO;2-J; Derst C, 2000, PROTEIN SCI, V9, P2009, DOI 10.1110/ps.9.10.2009; DISTASIO JA, 1982, INT J CANCER, V30, P343, DOI 10.1002/ijc.2910300314; DOLOWY WC, 1966, CANCER, V19, P1813, DOI 10.1002/1097-0142(196612)19:12<1813::AID-CNCR2820191208>3.0.CO;2-E; DURDEN DL, 1983, CANCER RES, V43, P1602; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez CA, 2013, INT J CLIN EXP MED, V6, P478; HALEY EE, 1961, CANCER RES, V21, P532; Hejazi M, 2002, BIOCHEM J, V364, P129, DOI 10.1042/bj3640129; HO PPK, 1970, J BIOL CHEM, V245, P3708; Joosten RP, 2009, J APPL CRYSTALLOGR, V42, P376, DOI 10.1107/S0021889809008784; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karamitros CS, 2014, J BIOL CHEM, V289, P12962, DOI 10.1074/jbc.M113.545038; KIDD JG, 1953, J EXP MED, V98, P565, DOI 10.1084/jem.98.6.565; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Muller HJ, 2000, BRIT J HAEMATOL, V110, P379, DOI 10.1046/j.1365-2141.2000.02187.x; Muller HJ, 2002, CANCER CHEMOTH PHARM, V49, P149, DOI 10.1007/s00280-001-0391-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; NEUMAN RE, 1956, SCIENCE, V124, P124, DOI 10.1126/science.124.3212.124; OHNUMA T, 1967, BIOCHEM J, V103, P238, DOI 10.1042/bj1030238; OLLENSCHLAGER G, 1988, EUR J CLIN INVEST, V18, P512, DOI 10.1111/j.1365-2362.1988.tb01049.x; Palm GJ, 1996, FEBS LETT, V390, P211, DOI 10.1016/0014-5793(96)00660-6; Papageorgiou AC, 2008, FEBS J, V275, P4306, DOI 10.1111/j.1742-4658.2008.06574.x; Salzer WL, 2014, ANN NY ACAD SCI, V1329, P81, DOI 10.1111/nyas.12496; Schalk AM, 2014, BIOCHEMISTRY-US, V53, P2318, DOI 10.1021/bi401692v; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; SWAIN AL, 1993, P NATL ACAD SCI USA, V90, P1474, DOI 10.1073/pnas.90.4.1474; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wriston Jr JC, 1070, METHODS ENZYMOLOGY A, VXVII, P732; YELLIN TO, 1966, BIOCHEMISTRY-US, V5, P1605, DOI 10.1021/bi00869a022; Yun MK, 2007, J MOL BIOL, V369, P794, DOI 10.1016/j.jmb.2007.03.061	44	35	36	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33175	33186		10.1074/jbc.M114.609552	http://dx.doi.org/10.1074/jbc.M114.609552			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25320094	hybrid, Green Published			2022-12-28	WOS:000345636600012
J	Sea, K; Sohn, SH; Durazo, A; Sheng, YW; Shaw, BF; Cao, XH; Taylor, AB; Whitson, LJ; Holloway, SP; Hart, PJ; Cabelli, DE; Gralla, EB; Valentine, JS				Sea, Kevin; Sohn, Se Hui; Durazo, Armando; Sheng, Yuewei; Shaw, Bryan F.; Cao, Xiaohang; Taylor, Alexander B.; Whitson, Lisa J.; Holloway, Stephen P.; Hart, P. John; Cabelli, Diane E.; Gralla, Edith Butler; Valentine, Joan Selverstone			Insights into the Role of the Unusual Disulfide Bond in Copper-Zinc Superoxide Dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU,ZN-SUPEROXIDE DISMUTASE; ATOMIC-RESOLUTION; METAL; YEAST; AGGREGATION; SOD1; MUTATIONS; BINDING; APOPROTEIN; MECHANISM	The functional and structural significance of the intrasubunit disulfide bond in copper-zinc superoxide dismutase (SOD1) was studied by characterizing mutant forms of human SOD1 (hSOD) and yeast SOD1 lacking the disulfide bond. We determined x-ray crystal structures of metal-bound and metal-deficient hC57S SOD1. C57S hSOD1 isolated from yeast contained four zinc ions per protein dimer and was structurally very similar to wild type. The addition of copper to this four-zinc protein gave properly reconstituted 2Cu, 2Zn C57S hSOD, and its spectroscopic properties indicated that the coordination geometry of the copper was remarkably similar to that of holo wild type hSOD1. In contrast, the addition of copper and zinc ions to apo C57S human SOD1 failed to give proper reconstitution. Using pulse radiolysis, we determined SOD activities of yeast and human SOD1s lacking disulfide bonds and found that they were enzymatically active at similar to 10% of the wild type rate. These results are contrary to earlier reports that the intrasubunit disulfide bonds in SOD1 are essential for SOD activity. Kinetic studies revealed further that the yeast mutant SOD1 had less ionic attraction for superoxide, possibly explaining the lower rates. Saccharomyces cerevisiae cells lacking the sod1 gene do not grow aerobically in the absence of lysine, but expression of C57S SOD1 increased growth to 30-50% of the growth of cells expressing wild type SOD1, supporting that C57S SOD1 retained a significant amount of activity.	[Sea, Kevin; Sohn, Se Hui; Durazo, Armando; Sheng, Yuewei; Shaw, Bryan F.; Gralla, Edith Butler; Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sea, Kevin] Santa Rosa Jr Coll, Dept Wine Studies, 1501 Mendocino Ave, Santa Rosa, CA 95401 USA; [Sohn, Se Hui] LG Chem Ltd, Taejon 305380, South Korea; [Durazo, Armando] Univ Arizona, Dept Chem & Environm Engn, Tucson, AZ 85721 USA; [Cabelli, Diane E.] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA; [Shaw, Bryan F.] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA; [Cao, Xiaohang; Taylor, Alexander B.; Whitson, Lisa J.; Holloway, Stephen P.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Hart, P. John] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX 78229 USA; [Valentine, Joan Selverstone] Ewha Womans Univ, Dept Bioinspired Sci, Seoul 120750, South Korea	University of California System; University of California Los Angeles; LG Chem; University of Arizona; United States Department of Energy (DOE); Brookhaven National Laboratory; Baylor University; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Ewha Womans University	Sea, K (corresponding author), Santa Rosa Jr Coll, Dept Wine Studies, 1501 Mendocino Ave, Santa Rosa, CA 95401 USA.	kevinsea@yahoo.com; jsv@chem.ucla.edu	Valentine, Joan S/B-6665-2008; Shaw, Bryan/A-7001-2008	Valentine, Joan S/0000-0002-7174-925X; Taylor, Alexander/0000-0003-3517-6033	National Institutes of Health [DK46828, GM28222, GM08496, NS39112]; Veterans Affairs [VA 101 BX00506]; U.S. Department of Energy Division of Chemical Sciences, Geosciences, and Biosciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028222, T32GM008496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039112] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000506] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1352122] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); U.S. Department of Energy Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK46828 and GM28222 (to J. S. V.), GM08496 (to K. S.), and NS39112 (to P. J. H.). This work was also supported by Veterans Affairs Grant VA 101 BX00506 (to P. J. H.) and Contract DE-AC02-98CH10886 from the U.S. Department of Energy Division of Chemical Sciences, Geosciences, and Biosciences (to Brookhaven National Laboratory).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banci L, 2006, J BIOL CHEM, V281, P2333, DOI 10.1074/jbc.M506497200; Banci L, 2013, NAT CHEM BIOL, V9, P297, DOI [10.1038/NCHEMBIO.1202, 10.1038/nchembio.1202]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertini I, 1998, ADV INORG CHEM, V45, P127, DOI 10.1016/S0898-8838(08)60026-4; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Das A, 2013, P NATL ACAD SCI USA, V110, P3871, DOI 10.1073/pnas.1216597110; Doucette P, 2004, THESIS; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; DUNBAR JC, 1981, CLIN RES PROC, V17, P51; Durazo A., 2007, THESIS; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraroni M, 1999, J MOL BIOL, V288, P413, DOI 10.1006/jmbi.1999.2681; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Ghosh S, 2013, ANTIOXID REDOX SIGN, V18, P412, DOI 10.1089/ars.2012.4566; Goto JJ, 1998, J BIOL CHEM, V273, P30104, DOI 10.1074/jbc.273.46.30104; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; Hart PJ, 2006, CURR OPIN CHEM BIOL, V10, P131, DOI 10.1016/j.cbpa.2006.02.034; Hart PJ, 1998, PROTEIN SCI, V7, P545; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Le Moan N, 2006, J BIOL CHEM, V281, P10420, DOI 10.1074/jbc.M513346200; Liba A, 2000, THESIS; Liba A., 2003, THESIS; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; LIU XF, 1992, J BIOL CHEM, V267, P18298; Lyons TJ, 2000, J BIOL INORG CHEM, V5, P189, DOI 10.1007/s007750050363; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; MING LJ, 1988, INORG CHEM, V27, P728, DOI 10.1021/ic00277a029; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANTOLIANO MW, 1982, J AM CHEM SOC, V104, P6310, DOI 10.1021/ja00387a027; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROE JA, 1988, BIOCHEMISTRY-US, V27, P950, DOI 10.1021/bi00403a017; Sea KW, 2013, J BIOL INORG CHEM, V18, P985, DOI 10.1007/s00775-013-1047-8; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Sheng YW, 2012, CURR TOP MED CHEM, V12, P2560; SIKORSKI RS, 1989, GENETICS, V122, P19; Sohn S. H., 2006, THESIS; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; TAINER JA, 1983, NATURE, V306, P284, DOI 10.1038/306284a0; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valentine J. S., 1981, METAL IONS BIOL, P291; VONPIECHOWSKI M, 1993, BER BUNSEN PHYS CHEM, V97, P762; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x	63	54	55	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2405	2418		10.1074/jbc.M114.588798	http://dx.doi.org/10.1074/jbc.M114.588798			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25433341	hybrid, Green Published			2022-12-28	WOS:000348588000043
J	Hense, A; Herman, E; Oldemeyer, S; Kottke, T				Hense, Anika; Herman, Elena; Oldemeyer, Sabine; Kottke, Tilman			Proton Transfer to Flavin Stabilizes the Signaling State of the Blue Light Receptor Plant Cryptochrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED ELECTRON-TRANSFER; COLI DNA PHOTOLYASE; ARABIDOPSIS CRYPTOCHROME; ATP-BINDING; PHOTOACTIVATION MECHANISM; DROSOPHILA CRYPTOCHROME; INFRARED-SPECTROSCOPY; AQUEOUS-SOLUTION; RADICAL-PAIRS; IN-VIVO	Plant cryptochromes regulate the circadian rhythm, flowering time, and photomorphogenesis in higher plants as responses to blue light. In the dark, these photoreceptors bind oxidized FAD in the photolyase homology region (PHR). Upon blue light absorption, FAD is converted to the neutral radical state, the likely signaling state, by electron transfer via a conserved tryptophan triad and proton transfer from a nearby aspartic acid. Here we demonstrate, by infrared and time-resolved UV-visible spectroscopy on the PHR domain, that replacement of the aspartic acid Asp-396 with cysteine prevents proton transfer. The lifetime of the radical is decreased by 6 orders of magnitude. This short lifetime does not permit to drive conformational changes in the C-terminal extension that have been associated with signal transduction. Only in the presence of ATP do both the wild type and mutant form a long-lived radical state. However, in the mutant, an anion radical is formed instead of the neutral radical, as found previously in animal type I cryptochromes. Infrared spectroscopic experiments demonstrate that the light-induced conformational changes of the PHR domain are conserved in the mutant despite the lack of proton transfer. These changes are not detected in the photoreduction of the non-photosensory D-amino acid oxidase to the anion radical. In conclusion, formation of the anion radical is sufficient to generate a protein response in plant cryptochromes. Moreover, the intrinsic proton transfer is required for stabilization of the signaling state in the absence of ATP.	[Hense, Anika; Herman, Elena; Oldemeyer, Sabine; Kottke, Tilman] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany	University of Bielefeld	Kottke, T (corresponding author), Univ Bielefeld, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany.	tilman.kottke@uni-bielefeld.de	Kottke, Tilman/B-7102-2011	Kottke, Tilman/0000-0001-8080-9579	Deutsche Forschungsgemeinschaft [KO3580/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant KO3580/2-1. Part of these results were presented at the 16th International Congress on Photobiology held in Cordoba, Argentina, in 2014.	AHMAD M, 1995, PLANT J, V8, P653, DOI 10.1046/j.1365-313X.1995.08050653.x; Balland V, 2009, J AM CHEM SOC, V131, P426, DOI 10.1021/ja806540j; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bauer C, 2011, PHOTOCHEM PHOTOBIOL, V87, P548, DOI 10.1111/j.1751-1097.2011.00901.x; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Biskup T, 2013, J BIOL CHEM, V288, P9249, DOI 10.1074/jbc.M112.417725; Biskup T, 2011, ANGEW CHEM INT EDIT, V50, P12647, DOI 10.1002/anie.201104321; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Bouly JP, 2003, EUR J BIOCHEM, V270, P2921, DOI 10.1046/j.1432-1033.2003.03691.x; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Brazard J, 2010, J AM CHEM SOC, V132, P4935, DOI 10.1021/ja1002372; Burney S, 2012, ANGEW CHEM INT EDIT, V51, P9356, DOI 10.1002/anie.201203476; Burney S, 2009, FEBS LETT, V583, P1427, DOI 10.1016/j.febslet.2009.03.040; Cailliez F, 2014, J AM CHEM SOC, V136, P12974, DOI 10.1021/ja506084f; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Damiani MJ, 2011, J BIOL CHEM, V286, P4382, DOI 10.1074/jbc.M110.194696; Danon A, 2006, P NATL ACAD SCI USA, V103, P17036, DOI 10.1073/pnas.0608139103; Forbes-Stovall J, 2014, PLANT PHYSIOL BIOCH, V75, P14, DOI 10.1016/j.plaphy.2013.12.002; Giovani B, 2003, NAT STRUCT BIOL, V10, P489, DOI 10.1038/nsb933; Goormaghtigh E, 2006, BIOPHYS J, V90, P2946, DOI 10.1529/biophysj.105.072017; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Henbest KB, 2008, P NATL ACAD SCI USA, V105, P14395, DOI 10.1073/pnas.0803620105; Herbel V, 2013, PLANT J, V74, P583, DOI 10.1111/tpj.12144; Hughes RM, 2012, J BIOL CHEM, V287, P22165, DOI 10.1074/jbc.M112.360545; Immeln D, 2007, J BIOL CHEM, V282, P21720, DOI 10.1074/jbc.M700849200; Immeln D, 2012, J AM CHEM SOC, V134, P12536, DOI 10.1021/ja302121z; Immeln D, 2010, J PHYS CHEM B, V114, P17155, DOI 10.1021/jp1076388; Iwata T, 2010, BIOCHEMISTRY-US, V49, P8882, DOI 10.1021/bi1009979; JORNS MS, 1990, BIOCHEMISTRY-US, V29, P552, DOI 10.1021/bi00454a032; Kondoh M, 2011, J MOL BIOL, V413, P128, DOI 10.1016/j.jmb.2011.08.031; KOTAKI A, 1970, J BIOCHEM-TOKYO, V68, P287, DOI 10.1093/oxfordjournals.jbchem.a129358; Kottke T, 2006, BIOCHEMISTRY-US, V45, P2472, DOI 10.1021/bi051964b; Langenbacher T, 2009, J AM CHEM SOC, V131, P14274, DOI 10.1021/ja901628y; Li X, 2011, P NATL ACAD SCI USA, V108, P20844, DOI 10.1073/pnas.1114579108; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Liu B, 2010, CURR OPIN PLANT BIOL, V13, P578, DOI 10.1016/j.pbi.2010.09.005; Maeda K, 2012, P NATL ACAD SCI USA, V109, P4774, DOI 10.1073/pnas.1118959109; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Muller P, 2014, SCI REP-UK, V4, DOI 10.1038/srep05175; Muller P, 2011, J BIOL CHEM, V286, P21033, DOI 10.1074/jbc.M111.228940; MULLER F, 1987, FREE RADICAL BIO MED, V3, P215, DOI 10.1016/0891-5849(87)90009-8; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; Raffelberg S, 2013, BIOL CHEM, V394, P1517, DOI 10.1515/hsz-2013-0163; Reisdorph NA, 2004, PLANT PHYSIOL, V134, P1546, DOI 10.1104/pp.103.031930; Salzmann S, 2008, J PHOTOCH PHOTOBIO A, V198, P221, DOI 10.1016/j.jphotochem.2008.03.015; Schleicher E, 2007, J BIOL CHEM, V282, P4738, DOI 10.1074/jbc.M604734200; Sellaro R, 2010, PLANT PHYSIOL, V154, P401, DOI 10.1104/pp.110.160820; Solov'yov IA, 2012, J AM CHEM SOC, V134, P18046, DOI 10.1021/ja3074819; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Vaidya AT, 2013, P NATL ACAD SCI USA, V110, P20455, DOI 10.1073/pnas.1313336110; Weber S, 2010, J PHYS CHEM B, V114, P14745, DOI 10.1021/jp103401u; Wille G, 2003, BIOCHEMISTRY-US, V42, P14814, DOI 10.1021/bi035219f; Yamada D, 2012, BIOCHEMISTRY-US, V51, P5774, DOI 10.1021/bi300530x; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yu XH, 2007, P NATL ACAD SCI USA, V104, P7289, DOI 10.1073/pnas.0701912104; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200	60	40	41	0	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1743	1751		10.1074/jbc.M114.606327	http://dx.doi.org/10.1074/jbc.M114.606327			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25471375	Green Published, hybrid			2022-12-28	WOS:000348056400039
J	Ruan, ZR; Fang, ZP; Ye, Q; Lei, HY; Eriani, G; Zhou, XL; Wang, ED				Ruan, Zhi-Rong; Fang, Zhi-Peng; Ye, Qing; Lei, Hui-Yan; Eriani, Gilbert; Zhou, Xiao-Long; Wang, En-Duo			Identification of Lethal Mutations in Yeast Threonyl-tRNA Synthetase Revealing Critical Residues in Its Human Homolog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; ESCHERICHIA-COLI; AMINO-ACID; ACTIVE-SITE; RANDOM MUTAGENESIS; ZINC ION; AMINOACYLATION; BINDING; PROTEIN; ATP	Aminoacyl-tRNA synthetases (aaRSs) are a group of ancient enzymes catalyzing aminoacylation and editing reactions for protein biosynthesis. Increasing evidence suggests that these critical enzymes are often associated with mammalian disorders. Therefore, complete determination of the enzymes functions is essential for informed diagnosis and treatment. Here, we show that a yeast knock-out strain for the threonyl-tRNA synthetase (ThrRS) gene is an excellent platform for such an investigation. Saccharomyces cerevisiae ThrRS has a unique modular structure containing four structural domains and a eukaryote-specific N-terminal extension. Using randomly mutated libraries of the ThrRS gene (thrS) and a genetic screen, a set of loss-of-function mutants were identified. The mutations affected the synthetic and editing activities and influenced the dimer interface. The results also highlighted the role of the N-terminal extension for enzymatic activity and protein stability. To gain insights into the pathological mechanisms induced by mutated aaRSs, we systematically introduced the loss-of-function mutations into the human cytoplasmic ThrRS gene. All mutations induced similar detrimental effects, showing that the yeast model could be used to study pathology-associated point mutations in mammalian aaRSs.	[Ruan, Zhi-Rong; Fang, Zhi-Peng; Ye, Qing; Lei, Hui-Yan; Zhou, Xiao-Long; Wang, En-Duo] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Ctr RNA Res,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Eriani, Gilbert] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Zhou, XL (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Ctr RNA Res,Shanghai Inst Biol Sci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	xlzhou@sibcb.ac.cn; edwang@sibcb.ac.cn	Ruan, Zhi-Rong/GYI-8935-2022	Ruan, Zhi-Rong/0000-0002-1806-2942; Eriani, Gilbert/0000-0002-8518-4675; Fang, Zhipeng/0000-0001-5720-1709	National Key Basic Research Foundation of China [2012CB911000]; Natural Science Foundation of China [31130064]; Committee of Science and Technology in Shanghai [12JC1409700]	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology in Shanghai(Shanghai Science & Technology Committee)	This work was supported by National Key Basic Research Foundation of China Grant 2012CB911000, Natural Science Foundation of China Grant 31130064, and Committee of Science and Technology in Shanghai Grant 12JC1409700.	Ador L, 1999, J MOL BIOL, V288, P231, DOI 10.1006/jmbi.1999.2679; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Arnez JG, 1997, P NATL ACAD SCI USA, V94, P7144, DOI 10.1073/pnas.94.14.7144; Arnez JG, 1997, TRENDS BIOCHEM SCI, V22, P211, DOI 10.1016/S0968-0004(97)01052-9; Banks GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006218; Beebe K, 2004, P NATL ACAD SCI USA, V101, P5958, DOI 10.1073/pnas.0401530101; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Caillet J, 2003, MOL MICROBIOL, V47, P961, DOI 10.1046/j.1365-2958.2003.03364.x; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; COMMANS S, 1995, BIOCHEMISTRY-US, V34, P8180, DOI 10.1021/bi00025a025; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; de Pouplana LR, 2001, TRENDS BIOCHEM SCI, V26, P591, DOI 10.1016/S0968-0004(01)01932-6; Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; ERIANI G, 1995, J MOL EVOL, V40, P499; ERIANI G, 1993, P NATL ACAD SCI USA, V90, P10816, DOI 10.1073/pnas.90.22.10816; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; HASEGAWA T, 1992, BIOCHEM BIOPH RES CO, V184, P478, DOI 10.1016/0006-291X(92)91219-G; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Hu QH, 2013, NUCLEIC ACIDS RES, V41, P1859, DOI 10.1093/nar/gks1307; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; JAZWINSKI SM, 1990, METHOD ENZYMOL, V182, P154; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Korencic D, 2004, P NATL ACAD SCI USA, V101, P10260, DOI 10.1073/pnas.0403926101; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; LEE ML, 1969, J BIOL CHEM, V244, P223; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Montanari A, 2008, RNA, V14, P275, DOI 10.1261/rna.740108; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Rasila TS, 2009, ANAL BIOCHEM, V388, P71, DOI 10.1016/j.ab.2009.02.008; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Rinaldi T, 2010, FEMS YEAST RES, V10, P1006, DOI 10.1111/j.1567-1364.2010.00685.x; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; SANNI A, 1991, P NATL ACAD SCI USA, V88, P8387, DOI 10.1073/pnas.88.19.8387; Shimizu S, 2009, J MOL BIOL, V394, P286, DOI 10.1016/j.jmb.2009.09.018; SPRINGER M, 1989, EMBO J, V8, P2417, DOI 10.1002/j.1460-2075.1989.tb08372.x; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Torres-Larios A, 2003, J MOL BIOL, V331, P201, DOI 10.1016/S0022-2836(03)00719-8; Wang CC, 1999, J BIOL CHEM, V274, P16508, DOI 10.1074/jbc.274.23.16508; Wong TS, 2006, J MOL BIOL, V355, P858, DOI 10.1016/j.jmb.2005.10.082; YARUS M, 1970, ANAL BIOCHEM, V35, P450, DOI 10.1016/0003-2697(70)90207-1; Zhou XL, 2013, NUCLEIC ACIDS RES, V41, P302, DOI 10.1093/nar/gks982; Zhou XL, 2011, NUCLEIC ACIDS RES, V39, P8857, DOI 10.1093/nar/gkr595; Zhou XL, 2013, SCI CHINA LIFE SCI, V56, P921, DOI 10.1007/s11427-013-4542-9	56	10	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1664	1678		10.1074/jbc.M114.599886	http://dx.doi.org/10.1074/jbc.M114.599886			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25416776	Green Published, hybrid			2022-12-28	WOS:000348056400033
J	Hsu, SH; Lo, YY; Liu, TH; Pan, YJ; Huang, YT; Sun, YJ; Hung, CC; Tseng, FG; Yang, CW; Pan, RL				Hsu, Shen-Hsing; Lo, Yueh-Yu; Liu, Tseng-Huang; Pan, Yih-Jiuan; Huang, Yun-Tzu; Sun, Yuh-Ju; Hung, Cheng-Chieh; Tseng, Fan-Gang; Yang, Chih-Wei; Pan, Rong-Long			Substrate-induced Changes in Domain Interaction of Vacuolar H+-Pyrophosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; 2-DIMENSIONAL CRYSTALLIZATION; INORGANIC PYROPHOSPHATASE; MEMBRANE-PROTEINS; LIPID LAYER; RECEPTOR 2; PURIFICATION; RESIDUES; BINDING; ROLES	Single molecule atomic force microscopy (smAFM) was employed to unfold transmembrane domain interactions of a unique vacuolar H+-pyrophosphatase (EC 3.6.1.1) from Vigna radiata. H+-Pyrophosphatase is a membrane-embedded homodimeric protein containing a single type of polypeptide and links PPi hydrolysis to proton translocation. Each subunit consists of 16 transmembrane domains with both ends facing the lumen side. In this investigation, H+-pyrophosphatase was reconstituted into the lipid bilayer in the same orientation for efficient fishing out of the membrane by smAFM. The reconstituted H+-pyrophosphatase in the lipid bilayer showed an authentically dimeric structure, and the size of each monomer was similar to 4 nm in length,similar to 2 nm in width, and+1 nm in protrusion height. Upon extracting the H+-pyrophosphatase out of the membrane, force-distance curves containing 10 peaks were obtained and assigned to distinct domains. In the presence of pyrophosphate, phosphate, and imidodiphosphate, the numbers of interaction curves were altered to 7, 8, and 10, respectively, concomitantly with significant modification in force strength. The substrate-binding residues were further replaced to verify these domain changes upon substrate binding. A working model is accordingly proposed to show the interactions between transmembrane domains of H+-pyrophosphatase in the presence and absence of substrate and its analog.	[Hsu, Shen-Hsing; Lo, Yueh-Yu; Hung, Cheng-Chieh; Yang, Chih-Wei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Nephrol,Kidney Res Ctr, Taoyuan 33333, Taiwan; [Liu, Tseng-Huang; Pan, Yih-Jiuan; Huang, Yun-Tzu; Sun, Yuh-Ju; Pan, Rong-Long] Natl Tsing Hua Univ, Coll Life Sci, Dept Life Sci, Hsinchu 30013, Taiwan; [Liu, Tseng-Huang; Pan, Yih-Jiuan; Huang, Yun-Tzu; Sun, Yuh-Ju; Pan, Rong-Long] Natl Tsing Hua Univ, Coll Life Sci, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Tseng, Fan-Gang] Natl Tsing Hua Univ, Coll Nucl Sci, Dept Engn & Syst Sci, Hsinchu 30013, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Yang, CW (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Nephrol,Kidney Res Ctr, Taoyuan 33333, Taiwan.	cwyang@ms1.hinet.net; rlpan@life.nthu.edu.tw		Tseng, Fan-Gang/0000-0001-7654-6905	Chang Gung Memorial Hospital-National Tsing Hua University Joint Research Grants [101N2748E1, CMRPG3D0641]; National Science Council, Republic of China [NSC 101-2627-M-007-008, NSC 102-2321-B-007-005, NSC 102-2311-B-007-001-MY3, NSC 102-2314-B-182-031-MY3, NSC102-2811-B-182-028]	Chang Gung Memorial Hospital-National Tsing Hua University Joint Research Grants; National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by Chang Gung Memorial Hospital-National Tsing Hua University Joint Research Grants 101N2748E1 (to R.-L. P.) and CMRPG3D0641 (to C.-C. H.), National Science Council, Republic of China, Grants NSC 101-2627-M-007-008, NSC 102-2321-B-007-005, and NSC 102-2311-B-007-001-MY3 (to R.-L. P.), NSC 102-2314-B-182-031-MY3 (to C.-W. Y.), and NSC102-2811-B-182-028 (to Y.-Y. L.).	Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRITTEN CJ, 1992, J BIOL CHEM, V267, P21850; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Damaghi M, 2010, J MOL BIOL, V397, P878, DOI 10.1016/j.jmb.2010.02.023; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; Drozdowicz YM, 2000, PLANT PHYSIOL, V123, P353, DOI 10.1104/pp.123.1.353; Frederix PLTM, 2009, BIOPHYS J, V96, P329, DOI 10.1016/j.bpj.2008.09.046; Hertadi R, 2003, J MOL BIOL, V333, P993, DOI 10.1016/j.jmb.2003.09.010; Hsiao YY, 2007, BBA-BIOENERGETICS, V1767, P965, DOI 10.1016/j.bbabio.2007.04.007; Hsiao YY, 2004, BBA-BIOENERGETICS, V1608, P190, DOI 10.1016/j.bbabio.2004.01.001; Hsu SH, 2010, BIOCHEMISTRY-US, V49, P5408, DOI 10.1021/bi100058w; Hsu SH, 2009, BOT STUD, V50, P291; Huang YT, 2010, J BIOL CHEM, V285, P23655, DOI 10.1074/jbc.M110.134916; Janovjak H, 2003, EMBO J, V22, P5220, DOI 10.1093/emboj/cdg509; Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640; Kellosalo J, 2012, SCIENCE, V337, P473, DOI 10.1126/science.1222505; Kessler M, 2006, STRUCTURE, V14, P521, DOI 10.1016/j.str.2005.11.023; Lee CH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.190215; Levy D, 2001, FEBS LETT, V504, P187, DOI 10.1016/S0014-5793(01)02748-X; Levy D, 1999, J STRUCT BIOL, V127, P44, DOI 10.1006/jsbi.1999.4155; Lin HH, 2005, ARCH BIOCHEM BIOPHYS, V442, P206, DOI 10.1016/j.abb.2005.08.010; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; Liu TH, 2009, FEBS J, V276, P4381, DOI 10.1111/j.1742-4658.2009.07146.x; Lo YY, 2013, J BIOL CHEM, V288, P12335, DOI 10.1074/jbc.M112.418699; Lopez-Marques RL, 2005, BBA-BIOMEMBRANES, V1716, P69, DOI 10.1016/j.bbamem.2005.08.004; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; McIntosh MT, 2001, MOL BIOCHEM PARASIT, V114, P183, DOI 10.1016/S0166-6851(01)00251-1; Mimura H, 2004, J BIOL CHEM, V279, P35106, DOI 10.1074/jbc.M406264200; Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309; Pan YJ, 2011, BBA-BIOENERGETICS, V1807, P59, DOI 10.1016/j.bbabio.2010.10.006; SARAFIAN V, 1992, BIOCHEM J, V283, P493, DOI 10.1042/bj2830493; SATO MH, 1994, J BIOL CHEM, V269, P6725; Tzeng CM, 1996, BIOCHEM J, V316, P143, DOI 10.1042/bj3160143; Van RC, 2005, BBA-BIOENERGETICS, V1709, P84, DOI 10.1016/j.bbabio.2005.05.011	35	3	4	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1197	1209		10.1074/jbc.M114.568139	http://dx.doi.org/10.1074/jbc.M114.568139			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451931	Green Published, hybrid			2022-12-28	WOS:000347778200049
J	Cho, YL; Hur, SM; Kim, JY; Kim, JH; Lee, DK; Choe, J; Won, MH; Ha, KS; Jeoung, D; Han, S; Ryoo, S; Lee, H; Min, JK; Kwon, YG; Kim, DH; Kim, YM				Cho, Young-Lai; Hur, Sung-Mo; Kim, Ji-Yoon; Kim, Ji-Hee; Lee, Dong-Keon; Choe, Jongeon; Won, Moo-Ho; Ha, Kwon-Soo; Jeoung, Dooil; Han, Sanghwa; Ryoo, Sungwoo; Lee, Hansoo; Min, Jeong-Ki; Kwon, Young-Guen; Kim, Dong-Hyun; Kim, Young-Myeong			Specific Activation of Insulin-like Growth Factor-1 Receptor by Ginsenoside Rg5 Promotes Angiogenesis and Vasorelaxation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Endothelial Cell; Insulin-like Growth Factor (IGF); Nitric Oxide; Vascular Biology; Insulin-like Growth Factor-1 Receptor; Vascular Function	NITRIC-OXIDE SYNTHASE; VASCULAR-PERMEABILITY; SIGNAL PATHWAYS; PROTEIN-KINASE; MICE; DIMERIZATION; CELLS; PHOSPHORYLATION; INFLAMMATION; CONTRIBUTES	Background: The mechanism by which ginsenoside Rg5 regulates vascular function remains unclear. Results: Rg5 increases angiogenesis and vasorelxation by activating multiple signal transduction pathways downstream of insulin-like growth fastor-1 receptor (IGF-1R). Conclusion: Rg5 promotes endothelial cell function through activation of IGF-1R. Significance: These findings reveal a mechanism for the positive regulation of vascular function by Rg5-mediated IGF-1R activation. Ginsenoside Rg5 is a compound newly synthesized during the steaming process of ginseng; however, its biological activity has not been elucidated with regard to endothelial function. We found that Rg5 stimulated in vitro angiogenesis of human endothelial cells, consistent with increased neovascularization and blood perfusion in a mouse hind limb ischemia model. Rg5 also evoked vasorelaxation in aortic rings isolated from wild type and high cholesterol-fed ApoE(-/-) mice but not from endothelial nitric-oxide synthase (eNOS) knock-out mice. Angiogenic activity of Rg5 was highly associated with a specific increase in insulin-like growth factor-1 receptor (IGF-1R) phosphorylation and subsequent activation of multiple angiogenic signals, including ERK, FAK, Akt/eNOS/NO, and G(i)-mediated phospholipase C/Ca2+/eNOS dimerization pathways. The vasodilative activity of Rg5 was mediated by the eNOS/NO/cGMP axis. IGF-1R knockdown suppressed Rg5-induced angiogenesis and vasorelaxation by inhibiting key angiogenic signaling and NO/cGMP pathways. In silico docking analysis showed that Rg5 bound with high affinity to IGF-1R at the same binding site of IGF. Rg5 blocked binding of IGF-1 to its receptor with an IC50 of approximate to 90 nmol/liter. However, Rg5 did not induce vascular inflammation and permeability. These data suggest that Rg5 plays a novel role as an IGF-1R agonist, promoting therapeutic angiogenesis and improving hypertension without adverse effects in the vasculature.	[Cho, Young-Lai; Hur, Sung-Mo; Kim, Ji-Yoon; Kim, Ji-Hee; Lee, Dong-Keon; Ha, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Dept Mol & Cellular Biochem, Sch Med, Chunchon 200701, Gangwon Do, South Korea; [Choe, Jongeon] Kangwon Natl Univ, Dept Immunol, Sch Med, Chunchon 200701, Gangwon Do, South Korea; [Won, Moo-Ho] Kangwon Natl Univ, Dept Neurobiol, Sch Med, Chunchon 200701, Gangwon Do, South Korea; [Jeoung, Dooil; Han, Sanghwa] Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Chunchon 200701, Gangwon Do, South Korea; [Ryoo, Sungwoo; Lee, Hansoo] Kangwon Natl Univ, Coll Nat Sci, Dept Life Sci, Chunchon 200701, Gangwon Do, South Korea; [Min, Jeong-Ki; Kwon, Young-Guen] Yonsei Univ, Dept Biochem, Coll Sci & Biotechnol, Seoul 120749, South Korea; [Kim, Dong-Hyun] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Coll Pharm, Seoul 130701, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Yonsei University; Kyung Hee University	Kim, YM (corresponding author), Kangwon Natl Univ, Dept Mol & Cellular Biochem, Sch Med, Chunchon 200701, Gangwon Do, South Korea.	ymkim@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Ha, Kwon-Soo/0000-0002-4219-1787; Min, Jeong-Ki/0000-0003-4924-8739	National Research Foundation of Korea - Korean government (Ministry of Science, ICT and Future Planning) [NRF-2011-0028790, NRF-2013M3A9B6046563]; Kangwon National University	National Research Foundation of Korea - Korean government (Ministry of Science, ICT and Future Planning); Kangwon National University	This work was supported by Grants NRF-2011-0028790 and NRF-2013M3A9B6046563 from the National Research Foundation of Korea, funded by the Korean government (Ministry of Science, ICT and Future Planning), and a research grant from Kangwon National University.	Aghdam SY, 2012, BIOCHEM BIOPH RES CO, V421, P197, DOI 10.1016/j.bbrc.2012.03.134; Baek YY, 2012, EUR J PHARMACOL, V674, P188, DOI 10.1016/j.ejphar.2011.11.022; Cheung LWT, 2011, CARDIOVASC RES, V89, P419, DOI 10.1093/cvr/cvq300; Choi YK, 2010, J BIOL CHEM, V285, P32116, DOI 10.1074/jbc.M110.131284; Chung BH, 2012, EXP MOL MED, V44, P191, DOI 10.3858/emm.2012.44.3.014; Chung BH, 2010, BIOCHEM BIOPH RES CO, V391, P254, DOI 10.1016/j.bbrc.2009.11.045; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; Conti E, 2004, CIRCULATION, V110, P2260, DOI 10.1161/01.CIR.0000144309.87183.FB; Fan RS, 2005, J BIOL CHEM, V280, P24212, DOI 10.1074/jbc.M500716200; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GRANT MB, 1993, ANN NY ACAD SCI, V692, P230; Han RNN, 2003, AM J RESP CELL MOL, V28, P159, DOI 10.1165/rcmb.4764; Handa P, 2011, ARTERIOSCL THROM VAS, V31, P2827, DOI 10.1161/ATVBAHA.111.236554; Hartnett L, 2010, INT J DEV BIOL, V54, P573, DOI 10.1387/ijdb.092922lh; Hellermann GR, 1997, J BIOL CHEM, V272, P12030, DOI 10.1074/jbc.272.18.12030; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Hwang YP, 2010, TOXICOL APPL PHARM, V242, P18, DOI 10.1016/j.taap.2009.09.009; Imrie H, 2012, DIABETES, V61, P2359, DOI 10.2337/db11-1494; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; Kim CK, 2010, MOL PHARMACOL, V78, P142, DOI 10.1124/mol.110.063586; Kim TW, 2012, INT IMMUNOPHARMACOL, V12, P110, DOI 10.1016/j.intimp.2011.10.023; Lee KS, 2012, BIOCHEM BIOPH RES CO, V418, P49, DOI 10.1016/j.bbrc.2011.12.123; Lee ZW, 2000, CELL SIGNAL, V12, P91, DOI 10.1016/S0898-6568(99)00069-8; Lyons-Darden T, 2004, J MOL ENDOCRINOL, V33, P165, DOI 10.1677/jme.0.0330165; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Moser C, 2008, EUR J CANCER, V44, P1577, DOI 10.1016/j.ejca.2008.04.003; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Perrault R, 2013, BIOCHEM J, V450, P209, DOI 10.1042/BJ20112158; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piecewicz SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032191; Poiraudeau S, 1997, J CELL BIOCHEM, V64, P414; Pyun BJ, 2008, CANCER RES, V68, P227, DOI 10.1158/0008-5472.CAN-07-2799; Sengupta S, 2004, CIRCULATION, V110, P1219, DOI 10.1161/01.CIR.0000140676.88412.CF; Sukhanov S, 2007, ARTERIOSCL THROM VAS, V27, P2684, DOI 10.1161/ATVBAHA.107.156257	37	36	38	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					467	477		10.1074/jbc.M114.603142	http://dx.doi.org/10.1074/jbc.M114.603142			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25391655	Green Published, hybrid			2022-12-28	WOS:000347231200041
J	Dahl, JU; Koldewey, P; Salmon, L; Horowitz, S; Bardwell, JCA; Jakob, U				Dahl, Jan-Ulrik; Koldewey, Philipp; Salmon, Loic; Horowitz, Scott; Bardwell, James C. A.; Jakob, Ursula			HdeB Functions as an Acid-protective Chaperone in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Chaperone; Protein Aggregation; Protein Folding; Stress Response	ESCHERICHIA-COLI; PERIPLASMIC PROTEIN; SHIGELLA-FLEXNERI; ENTERIC BACTERIA; INTERNAL PH; RESISTANCE; DISORDER; NMR; SPECTROSCOPY; EXPRESSION	Background: Periplasmic chaperones HdeA and HdeB are involved in the acid stress response in Escherichia coli. Results: HdeB requires its folded and dimeric state to protect E. coli from protein aggregation at pH 4. Conclusion: HdeA and HdeB use different mechanisms to prevent periplasmic protein aggregation, allowing them to function over a broad pH range. Significance: This study furthers the understanding of how enteric bacteria counteract acid stress. Enteric bacteria such as Escherichia coli utilize various acid response systems to counteract the acidic environment of the mammalian stomach. To protect their periplasmic proteome against rapid acid-mediated damage, bacteria contain the acid-activated periplasmic chaperones HdeA and HdeB. Activation of HdeA at pH 2 was shown to correlate with its acid-induced dissociation into partially unfolded monomers. In contrast, HdeB, which has high structural similarities to HdeA, shows negligible chaperone activity at pH 2 and only modest chaperone activity at pH 3. These results raised intriguing questions concerning the physiological role of HdeB in bacteria, its activation mechanism, and the structural requirements for its function as a molecular chaperone. In this study, we conducted structural and biochemical studies that revealed that HdeB indeed works as an effective molecular chaperone. However, in contrast to HdeA, whose chaperone function is optimal at pH 2, the chaperone function of HdeB is optimal at pH 4, at which HdeB is still fully dimeric and largely folded. NMR, analytical ultracentrifugation, and fluorescence studies suggest that the highly dynamic nature of HdeB at pH 4 alleviates the need for monomerization and partial unfolding. Once activated, HdeB binds various unfolding client proteins, prevents their aggregation, and supports their refolding upon subsequent neutralization. Overexpression of HdeA promotes bacterial survival at pH 2 and 3, whereas overexpression of HdeB positively affects bacterial growth at pH 4. These studies demonstrate how two structurally homologous proteins with seemingly identical in vivo functions have evolved to provide bacteria with the means for surviving a range of acidic protein-unfolding conditions.	[Dahl, Jan-Ulrik; Koldewey, Philipp; Salmon, Loic; Horowitz, Scott; Bardwell, James C. A.; Jakob, Ursula] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Koldewey, Philipp; Salmon, Loic; Horowitz, Scott; Bardwell, James C. A.; Jakob, Ursula] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Bardwell, JCA (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	jbardwel@umich.edu; ujakob@umich.edu	Dahl, Jan-Ulrik/J-1893-2019; Dahl, Jan-Ulrik/J-4970-2017; Salmon, Loic/C-9162-2018	Dahl, Jan-Ulrik/0000-0001-8597-7416; Dahl, Jan-Ulrik/0000-0002-4164-6129; Salmon, Loic/0000-0002-0249-6279; Horowitz, Scott/0000-0002-1148-0105	National Institutes of Health [GM102829]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM102829 (to J. C. A. B. and U. J.). This work was also supported by the Howard Hughes Medical Institute (to J. C. A. B.).	Bardwell JCA, 2012, TRENDS BIOCHEM SCI, V37, P517, DOI 10.1016/j.tibs.2012.08.006; Baryshnikova OK, 2008, J BIOMOL NMR, V41, P5, DOI 10.1007/s10858-008-9234-6; CHUANG SE, 1993, J BACTERIOL, V175, P5242, DOI 10.1128/JB.175.16.5242-5252.1993; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fan Yao, 2010, Journal of Structural and Functional Genomics, V11, P101, DOI 10.1007/s10969-010-9079-6; Foit L, 2013, P NATL ACAD SCI USA, V110, pE1254, DOI 10.1073/pnas.1222458110; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; Goddard T. D., 2008, SPARKY3; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hong WZ, 2012, TRENDS MICROBIOL, V20, P328, DOI 10.1016/j.tim.2012.03.001; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Jakob U, 2014, CHEM REV, V114, P6779, DOI 10.1021/cr400459c; Kern R, 2007, J BACTERIOL, V189, P603, DOI 10.1128/JB.01522-06; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Malki A, 2008, J BIOL CHEM, V283, P13679, DOI 10.1074/jbc.M800869200; Parker BW, 2013, J BIOL CHEM, V288, P32574, DOI 10.1074/jbc.M113.503516; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Smith JL, 2003, J FOOD PROTECT, V66, P1292, DOI 10.4315/0362-028X-66.7.1292; Szakacs Z, 2004, ANAL CHIM ACTA, V522, P247, DOI 10.1016/j.aca.2004.07.005; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002; Valderas MW, 2005, VET MICROBIOL, V107, P307, DOI 10.1016/j.vetmic.2005.01.018; Wang WJ, 2012, J MOL BIOL, V415, P538, DOI 10.1016/j.jmb.2011.11.026; WARD FW, 1987, LAB ANIM, V21, P216, DOI 10.1258/002367787781268693; Waterman SR, 1996, MOL MICROBIOL, V21, P925, DOI 10.1046/j.1365-2958.1996.00058.x; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zhang BW, 2011, J AM CHEM SOC, V133, P19393, DOI 10.1021/ja2060066; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]	36	38	40	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					65	75		10.1074/jbc.M114.612986	http://dx.doi.org/10.1074/jbc.M114.612986			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25391835	Green Published, hybrid			2022-12-28	WOS:000347231200007
J	Ham, H; Woolery, AR; Tracy, C; Stenesen, D; Kramer, H; Orth, K				Ham, Hyeilin; Woolery, Andrew R.; Tracy, Charles; Stenesen, Drew; Kraemer, Helmut; Orth, Kim			Unfolded Protein Response-regulated Drosophila Fic (dFic) Protein Reversibly AMPylates BiP Chaperone during Endoplasmic Reticulum Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ADP-RIBOSYLATION; MOLECULAR CHAPERONES; BINDING-PROTEIN; ATPASE ACTIVITY; NEUROLOGICAL DISORDERS; GLUTAMINE-SYNTHETASE; STRESS INDUCTION; QUALITY CONTROL; DNAJ HOMOLOG	Drosophila Fic (dFic) mediates AMPylation, a covalent attachment of adenosine monophosphate (AMP) from ATP to hydroxyl side chains of protein substrates. Here, we identified the endoplasmic reticulum (ER) chaperone BiP as a substrate for dFic and mapped the modification site to Thr-366 within the ATPase domain. The level of AMPylated BiP in Drosophila S2 cells is high during homeostasis, whereas the level of AMPylated BiP decreases upon the accumulation of misfolded proteins in the ER. Both dFic and BiP are transcriptionally activated upon ER stress, supporting the role of dFic in the unfolded protein response pathway. The inactive conformation of BiP is the preferred substrate for dFic, thus endorsing a model whereby AMPylation regulates the function of BiP as a chaperone, allowing acute activation of BiP by deAMPylation during an ER stress response. These findings not only present the first substrate of eukaryotic AMPylator but also provide a target for regulating the unfolded protein response, an emerging avenue for cancer therapy.	[Ham, Hyeilin; Woolery, Andrew R.; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Tracy, Charles; Stenesen, Drew; Kraemer, Helmut] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Kramer, Helmut/0000-0002-1167-2676	Cancer Prevention and Research Institute of Texas Grant [RP120613]; NATIONAL EYE INSTITUTE [R01EY021922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Orth laboratory and Lawrence Lum for helpful discussion and assistance. We acknowledge the services of the UT Southwestern Proteomics Core, supported by Cancer Prevention and Research Institute of Texas Grant RP120613 (to Drs. David Trudgian and Hamid Mirzaei).	Andreasson C, 2010, J BIOL CHEM, V285, P12445, DOI 10.1074/jbc.M109.096735; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CARLSSON L, 1983, P NATL ACAD SCI-BIOL, V80, P4664, DOI 10.1073/pnas.80.15.4664; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Ceriani M Fernanda, 2007, Methods Mol Biol, V362, P415; Chambers JE, 2012, J CELL BIOL, V198, P371, DOI 10.1083/jcb.201202005; Chevalier M, 2000, J BIOL CHEM, V275, P19620, DOI 10.1074/jbc.M001333200; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Cruz JW, 2014, J BIOL CHEM, V289, P7788, DOI 10.1074/jbc.M113.544429; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Garcia-Pino A, 2014, TRENDS BIOCHEM SCI, V39, P121, DOI 10.1016/j.tibs.2014.01.001; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gaut JR, 1997, CELL STRESS CHAPERON, V2, P252, DOI 10.1379/1466-1268(1997)002<0252:IVTPOI>2.3.CO;2; GAUT JR, 1993, J BIOL CHEM, V268, P12691; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; HAAS IG, 1994, EXPERIENTIA, V50, P1012, DOI 10.1007/BF01923455; Hao YH, 2011, J BIOTECHNOL, V151, P251, DOI 10.1016/j.jbiotec.2010.12.013; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; KINGDON HS, 1967, P NATL ACAD SCI USA, V58, P1703, DOI 10.1073/pnas.58.4.1703; KOCH GLE, 1990, BIOESSAYS, V12, P527, DOI 10.1002/bies.950121105; LEDFORD BE, 1994, MOL CELL BIOCHEM, V138, P141, DOI 10.1007/BF00928456; LENO GH, 1990, FEBS LETT, V276, P29, DOI 10.1016/0014-5793(90)80499-9; LEUSTEK T, 1991, ARCH BIOCHEM BIOPHYS, V289, P256, DOI 10.1016/0003-9861(91)90469-Y; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; Mei Y., 2013, J PHARMACEUT BIOMED, V1; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rahman M, 2012, NAT NEUROSCI, V15, P871, DOI 10.1038/nn.3102; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; SHAPIRO BM, 1967, P NATL ACAD SCI USA, V58, P642, DOI 10.1073/pnas.58.2.642; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Tan YH, 2011, NATURE, V475, P506, DOI 10.1038/nature10307; Vandewynckel YP, 2013, ANTICANCER RES, V33, P4683; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Weng WC, 2011, J FORMOS MED ASSOC, V110, P428, DOI 10.1016/S0929-6646(11)60064-8; Woolery AR, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.601310; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	60	73	74	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36059	36069		10.1074/jbc.M114.612515	http://dx.doi.org/10.1074/jbc.M114.612515			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25395623	Green Published, hybrid			2022-12-28	WOS:000346897900034
J	Shin, B; Yu, J; Park, ES; Choi, S; Yu, J; Hwang, JM; Yun, H; Chung, YH; Hong, KS; Choi, JS; Takami, M; Rho, J				Shin, Bongjin; Yu, Jungeun; Park, Eui-Soon; Choi, Seunga; Yu, Jiyeon; Hwang, Jung Me; Yun, Hyeongseok; Chung, Young-Ho; Hong, Kwan Soo; Choi, Jong-Soon; Takami, Masamichi; Rho, Jaerang			Secretion of a Truncated Osteopetrosis-associated Transmembrane Protein 1 (OSTM1) Mutant Inhibits Osteoclastogenesis through Down-regulation of the B Lymphocyte-induced Maturation Protein 1 (BLIMP1)-Nuclear Factor of Activated T Cells c1 (NFATc1) Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE OSTEOPETROSIS; SEVERE MALIGNANT OSTEOPETROSIS; INFANTILE OSTEOPETROSIS; BONE METABOLISM; DIFFERENTIATION; MUTATION; OSTEOIMMUNOLOGY; SUBUNIT; IMMUNE; MOUSE	Genetic mutations in osteoclastogenic genes are closely associated with osteopetrotic bone diseases. Genetic defects in OSTM1 (osteopetrosis-associated transmembrane protein 1) cause autosomal recessive osteopetrosis in humans. In particular, OSTM1 mutations that exclude the transmembrane domain might lead to the production of a secreted form of truncated OSTM1. However, the precise role of the secreted form of truncated OSTM1 remains unknown. In this study, we analyzed the functional role of truncated OSTM1 in osteoclastogenesis. Here, we showed that a secreted form of truncated OSTM1 binds to the cell surface of osteoclast (OC) precursors and inhibits the formation of multinucleated OCs through the reduction of cell fusion and survival. Truncated OSTM1 significantly inhibited the expression of OC marker genes through the downregulation of the BLIMP1 (B lymphocyte-induced maturation protein 1)-NFATc1 (nuclear factor of activated T cells c1) axis. Finally, we demonstrated that truncated OSTM1 reduces lipopolysaccharide-induced bone destruction in vivo. Thus, these findings suggest that autosomal recessive osteopetrosis patients with an OSTM1 gene mutation lacking the transmembrane domain produce a secreted form of truncated OSTM1 that inhibits osteoclastogenesis.	[Shin, Bongjin; Yu, Jungeun; Park, Eui-Soon; Choi, Seunga; Yu, Jiyeon; Hwang, Jung Me; Yun, Hyeongseok; Rho, Jaerang] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Taejon 305764, South Korea; [Hong, Kwan Soo; Choi, Jong-Soon; Rho, Jaerang] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol GRAST, Taejon 305764, South Korea; [Chung, Young-Ho; Hong, Kwan Soo; Choi, Jong-Soon] Korea Basic Sci Inst, Div Life Sci, Taejon 305806, South Korea; [Takami, Masamichi] Showa Univ, Sch Dent, Dept Biochem, Shinagawaku 1428555, Japan	Chungnam National University; Chungnam National University; Korea Basic Science Institute (KBSI); Showa University	Rho, J (corresponding author), Chungnam Natl Univ, Dept Microbiol & Mol Biol, 99 Daehak Ro, Taejon 305764, South Korea.	jrrho@cnu.ac.kr	HONG, Kwan Soo/GXF-6397-2022	HONG, Kwan Soo/0000-0003-4342-5183; Rho, Jaerang/0000-0002-0019-4939; Takami, Masamichi/0000-0002-4506-3975	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [NRF-2011-0021771]; Korea Basic Science Institute Grant [D33400]; Chungnam National University; Ministry of National Defense Foundation [ADD 14-01-06-06]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education; Korea Basic Science Institute Grant; Chungnam National University; Ministry of National Defense Foundation	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education Grant NRF-2011-0021771, Korea Basic Science Institute Grant D33400, the research fund of Chungnam National University, and Ministry of National Defense Foundation Grant ADD 14-01-06-06.	Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Del Fattore A, 2008, BONE, V42, P19, DOI 10.1016/j.bone.2007.08.029; Feigin ME, 2008, CELL SIGNAL, V20, P949, DOI 10.1016/j.cellsig.2008.01.009; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; Kim H, 2013, CELL METAB, V17, P249, DOI 10.1016/j.cmet.2013.01.002; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kim T, 2009, J BIOL CHEM, V284, P15308, DOI 10.1074/jbc.M807722200; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lee SH, 2008, BIOCHEM BIOPH RES CO, V369, P320, DOI 10.1016/j.bbrc.2008.01.168; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Maranda B, 2008, J BONE MINER RES, V23, P296, DOI 10.1359/JBMR.071015; Miyamoto Takeshi, 2011, Keio Journal of Medicine, V60, P101; Miyauchi Y, 2010, J EXP MED, V207, P751, DOI 10.1084/jem.20091957; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Ott CE, 2013, BONE, V55, P292, DOI 10.1016/j.bone.2013.04.007; Pangrazio A, 2006, J BONE MINER RES, V21, P1098, DOI 10.1359/JBMR.060403; Pata M, 2008, J BIOL CHEM, V283, P30522, DOI 10.1074/jbc.M805242200; Prinetti A, 2009, GLYCOCONJUGATE J, V26, P623, DOI 10.1007/s10719-008-9179-8; Quarello P, 2004, J BONE MINER RES, V19, P1194, DOI 10.1359/JBMR.040407; Rajapurohitam V, 2001, BONE, V28, P513, DOI 10.1016/S8756-3282(01)00416-1; Ramirez A, 2004, HUM MUTAT, V23, P471, DOI 10.1002/humu.20028; Rho J, 2004, MOL CELLS, V17, P1; Rho J, 2001, MOL CELL BIOL, V21, P8365, DOI 10.1128/MCB.21.24.8365-8370.2001; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Segovia-Silvestre T, 2009, HUM GENET, V124, P561, DOI 10.1007/s00439-008-0583-8; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; WALKER DG, 1975, SCIENCE, V190, P784, DOI 10.1126/science.1105786; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Yasuda T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001592; Yu J, 2012, J CLIN IMMUNOL, V32, P1360, DOI 10.1007/s10875-012-9722-z; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	35	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35868	35881		10.1074/jbc.M114.589614	http://dx.doi.org/10.1074/jbc.M114.589614			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25359771	Green Published, hybrid			2022-12-28	WOS:000346897900019
J	Park, SY; Waheed, AA; Zhang, ZR; Freed, EO; Bonifacino, JS				Park, Sang Yoon; Waheed, Abdul A.; Zhang, Zai-Rong; Freed, Eric O.; Bonifacino, Juan S.			HIV-1 Vpu Accessory Protein Induces Caspase-mediated Cleavage of IRF3 Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Caspase; Cellular Immune Response; Human Immunodeficiency Virus (HIV); Innate Immunity; Vpu; Interferon Regulatory Factor 3	VIRUS TYPE-1 NEF; BETA-TRCP; ANTIVIRAL RESPONSE; DENDRITIC CELLS; RESTRICTS HIV-1; DOWN-REGULATION; IMMUNODEFICIENCY; APOPTOSIS; DEGRADATION; EXPRESSION	Vpu is an accessory protein encoded by HIV-1 that interferes with multiple host-cell functions. Herein we report that expression of Vpu by transfection into 293T cells causes partial proteolytic cleavage of interferon regulatory factor 3 (IRF3), a key transcription factor in the innate anti-viral response. Vpu-induced IRF3 cleavage is mediated by caspases and occurs mainly at Asp-121. Cleavage produces a C-terminal fragment of approximate to 37 kDa that comprises the IRF dimerization and transactivation domains but lacks the DNA-binding domain. A similar cleavage is observed upon infection of the Jurkat T-cell line with vesicular stomatitis virus G glycoprotein (VSV-G)-pseudotyped HIV-1. Two other HIV-1 accessory proteins, Vif and Vpr, also contribute to the induction of IRF3 cleavage in both the transfection and the infection systems. The C-terminal IRF3 fragment interferes with the transcriptional activity of full-length IRF3. Cleavage of IRF3 under all of these conditions correlates with cleavage of poly(ADP-ribose) polymerase, an indicator of apoptosis. We conclude that Vpu contributes to the attenuation of the anti-viral response by partial inactivation of IRF3 while host cells undergo apoptosis.	[Park, Sang Yoon; Zhang, Zai-Rong; Bonifacino, Juan S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Waheed, Abdul A.; Freed, Eric O.] NCI, HIV Drug Resistance Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bonifacino, JS (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	bonifacinoj@helix.nih.gov		Bonifacino, Juan S./0000-0002-5673-6370; ZHANG, ZAIRONG/0000-0001-9768-0548	NICHD; NCI; Intramural AIDS Targeted Antiviral Program (IATAP), National Institutes of Health; National Institutes of Health [IATAP-ZIA HD008909, NICHD DIR-ZIA HD001607]; NATIONAL CANCER INSTITUTE [ZIABC010776] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural AIDS Targeted Antiviral Program (IATAP), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Intramural Programs of the NICHD and NCI and the Intramural AIDS Targeted Antiviral Program (IATAP), National Institutes of Health, and by National Institutes of Health Grants IATAP-ZIA HD008909 and NICHD DIR-ZIA HD001607 (to J. S. B.).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Akari H, 2001, J EXP MED, V194, P1299, DOI 10.1084/jem.194.9.1299; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Best SM, 2004, VIROLOGY, V320, P191, DOI 10.1016/j.virol.2003.11.025; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; Casella CR, 1999, J VIROL, V73, P92, DOI 10.1128/JVI.73.1.92-100.1999; Chaipan C, 2013, J VIROL, V87, P444, DOI 10.1128/JVI.00676-12; Doehle BP, 2012, J VIROL, V86, P8367, DOI 10.1128/JVI.00423-12; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Dube M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-114; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Garcia S, 1997, IMMUNOL LETT, V57, P53, DOI 10.1016/S0165-2478(97)00070-9; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Harman AN, 2011, BLOOD, V118, P298, DOI 10.1182/blood-2010-07-297721; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Hotter D, 2013, J VIROL, V87, P7160, DOI 10.1128/JVI.00526-13; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Li Y, 2011, BBA-GENE REGUL MECH, V1809, P166, DOI 10.1016/j.bbagrm.2011.01.006; Magadan JG, 2012, J VIROL, V86, P757, DOI 10.1128/JVI.05933-11; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Matusali G, 2012, J VIROL, V86, P4496, DOI 10.1128/JVI.05788-11; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Moll M, 2010, BLOOD, V116, P1876, DOI 10.1182/blood-2009-09-243667; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Ockenhouse CF, 2005, J INFECT DIS, V191, P2064, DOI 10.1086/430321; Okumura A, 2008, VIROLOGY, V373, P85, DOI 10.1016/j.virol.2007.10.042; Sastry KJ, 1996, ONCOGENE, V13, P487; Schaeffer E, 2001, J VIROL, V75, P2993, DOI 10.1128/JVI.75.6.2993-3000.2001; Sears N, 2011, J BIOL CHEM, V286, P33037, DOI 10.1074/jbc.M111.257022; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Verma S, 2011, BLOOD, V117, P6600, DOI 10.1182/blood-2011-01-333427; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Yoneyama M, 1996, J BIOCHEM-TOKYO, V120, P160; Zhang ZR, 2013, CELL, V154, P609, DOI 10.1016/j.cell.2013.06.038	43	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35102	35110		10.1074/jbc.M114.597062	http://dx.doi.org/10.1074/jbc.M114.597062			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25352594	hybrid, Green Published			2022-12-28	WOS:000346660200005
J	Marsh, SA; Collins, HE; Chatham, JC				Marsh, Susan A.; Collins, Helen E.; Chatham, John C.			Protein O-GlcNAcylation and Cardiovascular (Patho)physiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Calcium; Cardiac Hypertrophy; Cardiovascular; Epigenetics; O-Linked N-Acetylglucosamine (O-GlcNAc)	LINKED N-ACETYLGLUCOSAMINE; CAPACITATIVE CALCIUM-ENTRY; NITRIC-OXIDE SYNTHASE; HEXOSAMINE BIOSYNTHESIS PATHWAY; ISCHEMIA-REPERFUSION INJURY; RHOA/RHO-KINASE PATHWAY; NEONATAL CARDIOMYOCYTES; CARDIAC-HYPERTROPHY; GLCNAC TRANSFERASE; POSTTRANSLATIONAL MODIFICATION	Our understanding of the role of protein O-GlcNAcylation in the regulation of the cardiovascular system has increased rapidly in recent years. Studies have linked increased O-GlcNAc levels to glucose toxicity and diabetic complications; conversely, acute activation of O-GlcNAcylation has been shown to be cardioprotective. However, it is also increasingly evident that O-GlcNAc turnover plays a central role in the delicate regulation of the cardiovascular system. Therefore, the goals of this minireview are to summarize our current understanding of how changes in O-GlcNAcylation influence cardiovascular pathophysiology and to highlight the evidence that O-GlcNAc cycling is critical for normal function of the cardiovascular system.	[Marsh, Susan A.] Washington State Univ, Sect Expt & Syst Pharmacol, Coll Pharm, Spokane, WA 99210 USA; [Collins, Helen E.; Chatham, John C.] Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA	Washington State University; University of Alabama System; University of Alabama Birmingham	Chatham, JC (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA.	jchatham@uab.edu	Collins, Helen E/AEC-0560-2022		National Institutes of Health [HL-104549, HL-101192, HL-110366]; Washington State University College of Pharmacy; University of Alabama at Birmingham Comprehensive Cardiovascular Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL104549, R01HL101192, R21HL110366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington State University College of Pharmacy; University of Alabama at Birmingham Comprehensive Cardiovascular Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL-104549 (to S. A. M.) and Grants HL-101192 and HL-110366 (to J. C. C.). This work was also supported by the Washington State University College of Pharmacy (to S. A. M.). This is the fourth article in the Minireview Series on the Thirtieth Anniversary of Research on O-GlcNAcylation of Nuclear and Cytoplasmic Proteins: Nutrient Regulation of Cellular Metabolism and Physiology by O-GlcNAcylation.; Recipient of the William W. Featheringill Postdoctoral Fellowship from the University of Alabama at Birmingham Comprehensive Cardiovascular Center.	Beleznai T, 2012, VASC PHARMACOL, V56, P115, DOI 10.1016/j.vph.2011.11.003; Bennett CE, 2013, LIFE SCI, V92, P657, DOI 10.1016/j.lfs.2012.09.007; Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; Chatham JC, 2010, BBA-GEN SUBJECTS, V1800, P57, DOI 10.1016/j.bbagen.2009.07.004; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Cox EJ, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-101; Darley-Usmar VM, 2012, J MOL CELL CARDIOL, V52, P538, DOI 10.1016/j.yjmcc.2011.08.009; Dassanayaka S, 2014, PHARMACOL THERAPEUT, V142, P62, DOI 10.1016/j.pharmthera.2013.11.005; Davidoff AJ, 1997, AM J PHYSIOL-HEART C, V272, pH159, DOI 10.1152/ajpheart.1997.272.1.H159; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Durgan DJ, 2011, J BIOL CHEM, V286, P44606, DOI 10.1074/jbc.M111.278903; Dutta K, 2002, J MOL CELL CARDIOL, V34, P985, DOI 10.1006/jmcc.2002.2035; Erickson JR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00059; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Facundo HT, 2012, AM J PHYSIOL-HEART C, V302, pH2122, DOI 10.1152/ajpheart.00775.2011; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Fricovsky ES, 2012, AM J PHYSIOL-REG I, V303, pR689, DOI 10.1152/ajpregu.00548.2011; Fulop N, 2007, AM J PHYSIOL-CELL PH, V292, pC1370, DOI 10.1152/ajpcell.00422.2006; Gawlowski T, 2012, J BIOL CHEM, V287, P30024, DOI 10.1074/jbc.M112.390682; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Heath JM, 2014, CIRC RES, V114, P1094, DOI 10.1161/CIRCRESAHA.114.302968; Hilgers RHP, 2012, AM J PHYSIOL-HEART C, V303, pH513, DOI 10.1152/ajpheart.01175.2011; Hirose K, 2011, ANESTHESIOLOGY, V115, P955, DOI 10.1097/ALN.0b013e31822fcede; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; Hunton DL, 2002, J BIOL CHEM, V277, P14266, DOI 10.1074/jbc.M107167200; Ito R, 2014, GENES CELLS, V19, P52, DOI 10.1111/gtc.12107; Jensen RV, 2013, CARDIOVASC RES, V97, P369, DOI 10.1093/cvr/cvs337; Jensen RV, 2013, SCAND CARDIOVASC J, V47, P168, DOI 10.3109/14017431.2012.756984; Johnsen VL, 2013, PHYSIOL GENOMICS, V45, P17, DOI 10.1152/physiolgenomics.00111.2012; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; Kim DH, 2011, BMB REP, V44, P415, DOI 10.5483/BMBRep.2011.44.6.415; Kim HS, 2009, FEBS LETT, V583, P2474, DOI 10.1016/j.febslet.2009.06.052; Laczy B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018417; Laczy B, 2009, AM J PHYSIOL-HEART C, V296, pH13, DOI 10.1152/ajpheart.01056.2008; Lima VV, 2011, CARDIOVASC RES, V89, P614, DOI 10.1093/cvr/cvq338; Lima VV, 2008, J AM SOC HYPERTENS, V2, P410, DOI 10.1016/j.jash.2008.06.001; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Liu J, 2007, FASEB J, V21, pA865; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Liu J, 2007, J MOL CELL CARDIOL, V42, P177, DOI 10.1016/j.yjmcc.2006.09.015; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; Luo B, 2007, J BIOL CHEM, V282, P7172, DOI 10.1074/jbc.M607362200; Luo X, 2012, J MOL CELL CARDIOL, V52, P136, DOI 10.1016/j.yjmcc.2011.11.003; Marsh SA, 2013, LIFE SCI, V92, P648, DOI 10.1016/j.lfs.2012.06.011; Marsh SA, 2011, AMINO ACIDS, V40, P819, DOI 10.1007/s00726-010-0699-8; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Mathiyalagan P, 2014, CARDIOVASC RES, V103, P7, DOI 10.1093/cvr/cvu122; McLarty JL, 2013, LIFE SCI, V92, P621, DOI 10.1016/j.lfs.2012.08.006; Medford HM, 2014, AM J PHYSIOL-REG I, V306, pR519, DOI 10.1152/ajpregu.00253.2013; Medford HM, 2013, AM J PHYSIOL-HEART C, V305, pH114, DOI 10.1152/ajpheart.00135.2013; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; Nagy T, 2006, AM J PHYSIOL-CELL PH, V290, pC57, DOI 10.1152/ajpcell.00263.2005; Ngoh GA, 2008, J PHARMACOL EXP THER, V327, P602, DOI 10.1124/jpet.108.143263; Ngoh GA, 2011, AMINO ACIDS, V40, P895, DOI 10.1007/s00726-010-0728-7; Ngoh GA, 2010, CIRC RES, V107, P171, DOI 10.1161/CIRCRESAHA.110.224675; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Palaniappan KK, 2013, CELL REP, V5, P546, DOI 10.1016/j.celrep.2013.08.048; Pang Y, 2002, DIABETES, V51, P3461, DOI 10.2337/diabetes.51.12.3461; Patti ME, 1999, DIABETES, V48, P1562, DOI 10.2337/diabetes.48.8.1562; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Ren J, 1997, AM J PHYSIOL-HEART C, V272, pH148, DOI 10.1152/ajpheart.1997.272.1.H148; Ren J, 1997, AM J PHYSIOL-HEART C, V273, pH2876, DOI 10.1152/ajpheart.1997.273.6.H2876; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Voelkers M, 2010, J MOL CELL CARDIOL, V48, P1329, DOI 10.1016/j.yjmcc.2010.01.020; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Wu TJ, 2009, EUR J PHARMACOL, V613, P93, DOI 10.1016/j.ejphar.2009.04.012; Xing DQ, 2008, AM J PHYSIOL-HEART C, V295, pH335, DOI 10.1152/ajpheart.01259.2007; Xing DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024021; Yang SL, 2006, SHOCK, V25, P600, DOI 10.1097/01.shk.0000209563.07693.db; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; YkiJarvinen H, 1997, DIABETOLOGIA, V40, P76, DOI 10.1007/s001250050645; Yokoe S, 2010, GLYCOBIOLOGY, V20, P1217, DOI 10.1093/glycob/cwq071; Young ME, 2007, GENE REGUL SYST BIO, V1, P251; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885; Zhu-Mauldin X, 2012, J BIOL CHEM, V287, P39094, DOI 10.1074/jbc.M112.383778; Zou LY, 2007, SHOCK, V27, P402, DOI 10.1097/01.shk.0000245031.31859.29; Zou LY, 2012, J BIOL CHEM, V287, P34419, DOI 10.1074/jbc.M112.393207	99	58	59	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34449	34456		10.1074/jbc.R114.585984	http://dx.doi.org/10.1074/jbc.R114.585984			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25336635	Green Published, hybrid			2022-12-28	WOS:000346260800005
J	Norwood, J; Franklin, JM; Sharma, D; D'Mello, SR				Norwood, Jordan; Franklin, Jade M.; Sharma, Dharmendra; D'Mello, Santosh R.			Histone Deacetylase 3 Is Necessary for Proper Brain Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain; Cerebellum; Glial Cell; Histone Deacetylase 3 (HDAC3); Neurodevelopment; Neuron; Cortex	CENTRAL-NERVOUS-SYSTEM; HDAC1; MICE; DIFFERENTIATION; MYELINATION; NEOCORTEX; SURVIVAL; IDENTITY; NEURONS; ROLES	Background: The molecular mechanisms regulating brain development are unclear. Results: HDAC3 deletion disrupts the organization of certain neuronal cell types and the proportions of some glial cell types in the cortex and cerebellum. Conclusion: HDAC3 regulates brain development, and other HDACs cannot compensate for its function. Significance: Our study identifies a key player in the regulation of brain development. The functional role of histone deacetylase 3 (HDAC3) in the developing brain has yet to be elucidated. We show that mice lacking HDAC3 in neurons and glia of the central nervous system, Nes-Cre/HDAC3 conditional KO mice, show major abnormalities in the cytoarchitecture of the neocortex and cerebellum and die within 24 h of birth. Later-born neurons do not localize properly in the cortex. A similar mislocalization is observed with cerebellar Purkinje neurons. Although the proportion of astrocytes is higher than normal, the numbers of oligodendrocytes are reduced. In contrast, conditional knockout of HDAC3 in neurons of the forebrain and certain other brain regions, using Thy1-Cre and calcium/calmodulin dependent protein kinase II -Cre for ablation, produces no overt abnormalities in the organization of cells within the cortex or of cerebellar Purkinje neurons at birth. However, both lines of conditional knockout mice suffer from progressive hind limb paralysis and ataxia and die around 6 weeks after birth. The mice display an increase in overall numbers of cells, higher numbers of astrocytes, and Purkinje neuron degeneration. Taken together, our results demonstrate that HDAC3 plays an essential role in regulating brain development, with effects on both neurons and glia in different brain regions.	[Norwood, Jordan; Franklin, Jade M.; Sharma, Dharmendra; D'Mello, Santosh R.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA	Southern Methodist University	D'Mello, SR (corresponding author), So Methodist Univ, Dept Biol Sci, Dedman Life Sci Bldg,6501 Airline Rd, Dallas, TX 75275 USA.	sdmello@smu.edu	D'Mello, Santosh/AAM-3644-2020; D'Mello, Santosh/AAO-7192-2020	D'Mello, Santosh/0000-0002-7652-1334; Norwood, Jordan/0000-0001-8093-5938	National Institutes of Health [NS40408, NS058462]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058462, R01NS040408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS40408 and NS058462.	Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Bardai FH, 2013, J NEUROSCI, V33, P11833, DOI 10.1523/JNEUROSCI.5831-12.2013; Bardai FH, 2012, J BIOL CHEM, V287, P35444, DOI 10.1074/jbc.M112.394544; Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Chen Y, 2011, NAT NEUROSCI, V14, P437, DOI 10.1038/nn.2780; Chin PC, 2004, J NEUROCHEM, V90, P595, DOI 10.1111/j.1471-4159.2004.02530.x; Cvetanovic M, 2011, NAT MED, V17, P1445, DOI 10.1038/nm.2494; Dewachter I, 2002, J NEUROSCI, V22, P3445; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hevner RF, 2007, J NEUROPATH EXP NEUR, V66, P101, DOI 10.1097/nen.0b013e3180301c06; Jacob C, 2011, NAT NEUROSCI, V14, P429, DOI 10.1038/nn.2762; Kim MS, 2012, J NEUROSCI, V32, P10879, DOI 10.1523/JNEUROSCI.2089-12.2012; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005; Mendez-Gomez HR, 2011, MOL CELL NEUROSCI, V46, P108, DOI 10.1016/j.mcn.2010.08.011; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Morris MJ, 2013, INT J DEV NEUROSCI, V31, P370, DOI 10.1016/j.ijdevneu.2013.02.005; Price V, 2013, J NEUROSCI RES, V91, P407, DOI 10.1002/jnr.23170; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333	24	48	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34569	34582		10.1074/jbc.M114.576397	http://dx.doi.org/10.1074/jbc.M114.576397			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25339172	Green Published, hybrid			2022-12-28	WOS:000346260800016
J	Pauker, MH; Reicher, B; Joseph, N; Wortzel, I; Jakubowicz, S; Noy, E; Perl, O; Barda-Saad, M				Pauker, Maor H.; Reicher, Barak; Joseph, Noah; Wortzel, Inbal; Jakubowicz, Shlomi; Noy, Elad; Perl, Orly; Barda-Saad, Mira			WASp Family Verprolin-homologous Protein-2 (WAVE2) and Wiskott-Aldrich Syndrome Protein (WASp) Engage in Distinct Downstream Signaling Interactions at the T Cell Antigen Receptor Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Adaptor Protein; Cytoskeleton; Lymphocyte; Molecular Dynamics; T Cell Receptor (TCR); T Cell Signaling; WASp; WAVE2	APC CONTACT SITE; ACTIN CYTOSKELETON; ARP2/3 COMPLEX; TYROSINE KINASE; ADAPTER PROTEINS; LIVE CELLS; ACTIVATION; SLP-76; NCK; PHOSPHORYLATION	Background: The regulatory mechanisms and potential redundancy of the structurally related actin nucleation promoting factors, WAVE2 and WASp, are poorly understood. Results: Following T cell activation, WAVE2 and WASp are recruited to the TCR site and then dissociate. Conclusion: WAVE2 and WASp share similar recruitment mechanisms but differ in their subsequent molecular interactions and dynamics. Significance: These differences may explain their distinct functions in regulating actin-dependent processes. T cell antigen receptor (TCR) engagement has been shown to activate pathways leading to actin cytoskeletal polymerization and reorganization, which are essential for lymphocyte activation and function. Several actin regulatory proteins were implicated in regulating the actin machinery, such as members of the Wiskott-Aldrich syndrome protein (WASp) family. These include WASp and the WASp family verprolin-homologous protein-2 (WAVE2). Although WASp and WAVE2 share several structural features, the precise regulatory mechanisms and potential redundancy between them have not been fully characterized. Specifically, unlike WASp, the dynamic molecular interactions that regulate WAVE2 recruitment to the cell membrane and specifically to the TCR signaling complex are largely unknown. Here, we identify the molecular mechanism that controls the recruitment of WAVE2 in comparison with WASp. Using fluorescence resonance energy transfer (FRET) and novel triple-color FRET (3FRET) technology, we demonstrate how WAVE2 signaling complexes are dynamically regulated during lymphocyte activation in vivo. We show that, similar to WASp, WAVE2 recruitment to the TCR site depends on protein-tyrosine kinase, ZAP-70, and the adaptors LAT, SLP-76, and Nck. However, in contrast to WASp, WAVE2 leaves this signaling complex and migrates peripherally together with vinculin to the membrane leading edge. Our experiments demonstrate that WASp and WAVE2 differ in their dynamics and their associated proteins. Thus, this study reveals the differential mechanisms regulating the function of these cytoskeletal proteins.	[Pauker, Maor H.; Reicher, Barak; Joseph, Noah; Wortzel, Inbal; Jakubowicz, Shlomi; Noy, Elad; Perl, Orly; Barda-Saad, Mira] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel	Bar Ilan University	Barda-Saad, M (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel.	Mira.Barda-Saad@biu.ac.il			Israeli Ministry of Health through the Office of the Chief Scientist; Israel Science Foundation	Israeli Ministry of Health through the Office of the Chief Scientist; Israel Science Foundation(Israel Science Foundation)	This work was supported, in part, by the Israeli Ministry of Health through the Office of the Chief Scientist, and by the Israel Science Foundation.	Badour K, 2007, P NATL ACAD SCI USA, V104, P1593, DOI 10.1073/pnas.0610543104; Balagopalan L, 2007, MOL CELL BIOL, V27, P8622, DOI 10.1128/MCB.00467-07; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Barda-Saad M, 2010, EMBO J, V29, P2315, DOI 10.1038/emboj.2010.133; Barr VA, 2006, TRAFFIC, V7, P1143, DOI 10.1111/j.1600-0854.2006.00464.x; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; Bonello G, 2004, J CELL SCI, V117, P1009, DOI 10.1242/jcs.00968; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Danson CM, 2007, J CELL SCI, V120, P4144, DOI 10.1242/jcs.013714; Derivery E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002462; Ditlev JA, 2012, J CELL BIOL, V197, P643, DOI 10.1083/jcb.201111113; Gomez TS, 2008, ADV IMMUNOL, V97, P1, DOI 10.1016/S0065-2776(08)00001-1; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; Huang YP, 2008, BLOOD, V112, P111, DOI 10.1182/blood-2007-10-118232; Jordan MS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002501; Jordan MS, 2006, J IMMUNOL, V176, P2430, DOI 10.4049/jimmunol.176.4.2430; Kitamura T, 1996, BIOCHEM BIOPH RES CO, V219, P509, DOI 10.1006/bbrc.1996.0264; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Lettau M, 2010, PROTEIN SCI, V19, P658, DOI 10.1002/pro.334; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Matalon O, 2013, IMMUNOL REV, V256, P10, DOI 10.1111/imr.12112; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Nakanishi O, 2007, J BIOCHEM, V141, P319, DOI 10.1093/jb/mvm034; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; Nolz JC, 2007, MOL CELL BIOL, V27, P5986, DOI 10.1128/MCB.00136-07; Pauker MH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002423; Pauker MH, 2011, MOL CELL BIOL, V31, P2653, DOI 10.1128/MCB.01358-10; Reicher B, 2012, MOL CELL BIOL, V32, P3153, DOI 10.1128/MCB.00161-12; Reicher B, 2010, FEBS LETT, V584, P4858, DOI 10.1016/j.febslet.2010.09.002; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Sechi AS, 2002, IMMUNOL REV, V189, P98, DOI 10.1034/j.1600-065X.2002.18909.x; Singh S, 2007, P NATL ACAD SCI USA, V104, P20043, DOI 10.1073/pnas.0709999104; Spear M, 2014, J BIOL CHEM, V289, P6949, DOI 10.1074/jbc.M113.492132; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Wu JN, 2004, SEMIN IMMUNOL, V16, P379, DOI 10.1016/j.smim.2004.08.018; Wunderlich L, 1999, EUR J IMMUNOL, V29, P1068, DOI 10.1002/(SICI)1521-4141(199904)29:04<1068::AID-IMMU1068>3.0.CO;2-P; Xu XP, 2012, EMBO J, V31, P236, DOI 10.1038/emboj.2011.343; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311; Yu Y, 2013, J CELL SCI, V126, P1049, DOI 10.1242/jcs.098210; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zipfel PA, 2006, CURR BIOL, V16, P35, DOI 10.1016/j.cub.2005.12.024	58	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34503	34519		10.1074/jbc.M114.591685	http://dx.doi.org/10.1074/jbc.M114.591685			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342748	Green Published, hybrid			2022-12-28	WOS:000346260800011
J	DiStefano, PV; Kuebel, JM; Sarelius, IH; Glading, AJ				DiStefano, Peter V.; Kuebel, Julia M.; Sarelius, Ingrid H.; Glading, Angela J.			KRIT1 Protein Depletion Modifies Endothelial Cell Behavior via Increased Vascular Endothelial Growth Factor (VEGF) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; BETA-CATENIN; TYROSINE PHOSPHORYLATION; RHO KINASE; IN-VIVO; C-JUN; PERMEABILITY; ANGIOGENESIS; MUTATIONS; CCM1	Disruption of endothelial cell-cell contact is a key event in many cardiovascular diseases and a characteristic of pathologically activated vascular endothelium. The CCM (cerebral cavernous malformation) family of proteins (KRIT1 (Krev-interaction trapped 1), PDCD10, and CCM2) are critical regulators of endothelial cell-cell contact and vascular homeostasis. Here we show novel regulation of vascular endothelial growth factor (VEGF) signaling in KRIT1-depleted endothelial cells. Loss of KRIT1 and PDCD10, but not CCM2, increases nuclear beta-catenin signaling and up-regulates VEGF-A protein expression. In KRIT1-depleted cells, increased VEGF-A levels led to increased VEGF receptor 2 (VEGFR2) activation and subsequent alteration of cytoskeletal organization, migration, and barrier function and to in vivo endothelial permeability in KRIT1-deficient animals. VEGFR2 activation also increases beta-catenin phosphorylation but is only partially responsible for KRIT1 depletion-dependent disruption of cell-cell contacts. Thus, VEGF signaling contributes to modifying endothelial function in KRIT1-deficient cells and microvessel permeability in Krit1(+/-) mice; however, VEGF signaling is likely not the only contributor to disrupted endothelial cell-cell contacts in the absence of KRIT1.	[DiStefano, Peter V.; Kuebel, Julia M.; Sarelius, Ingrid H.; Glading, Angela J.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester	Glading, AJ (corresponding author), Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	angela_glading@urmc.rochester.edu	Glading, Angela/AAI-3455-2020	Glading, Angela/0000-0002-1830-6601	National Institutes of Health [HL117885-01]; American Heart Association [0930071N]; American Heart Association Predoctoral Fellowship [14PRE2038009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL117885-01 (to A. J. G.). This work was also supported by American Heart Association Grant 0930071N (to A. J. G.) and American Heart Association Predoctoral Fellowship 14PRE2038009 (to P. V. D.).	Abe T, 2009, ACTA NEUROCHIR, V151, P855, DOI 10.1007/s00701-009-0410-6; Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Bernatchez PN, 1999, J BIOL CHEM, V274, P31047, DOI 10.1074/jbc.274.43.31047; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Chan AC, 2011, J CLIN INVEST, V121, P1871, DOI 10.1172/JCI44393; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; Corr M, 2012, ARTERIOSCL THROM VAS, V32, P2702, DOI 10.1161/ATVBAHA.112.300115; Duval M, 2003, J BIOL CHEM, V278, P20091, DOI 10.1074/jbc.M301410200; Easwaran V, 2003, CANCER RES, V63, P3145; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; Esser S, 1998, J CELL SCI, V111, P1853; Fahmy RG, 2006, NAT BIOTECHNOL, V24, P856, DOI 10.1038/nbt1225; Faurobert E, 2013, J CELL BIOL, V202, P545, DOI 10.1083/jcb.201303044; Fischer A, 2013, TRENDS MOL MED, V19, P302, DOI 10.1016/j.molmed.2013.02.004; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gault J, 2005, STROKE, V36, P872, DOI 10.1161/01.STR.0000157586.20479.fd; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Goitre L, 2014, FREE RADICAL BIO MED, V68, P134, DOI 10.1016/j.freeradbiomed.2013.11.020; Goitre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011786; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; HUXLEY VH, 1987, AM J PHYSIOL, V252, pH188, DOI 10.1152/ajpheart.1987.252.1.H188; Jung KH, 2003, ARCH NEUROL-CHICAGO, V60, P1613, DOI 10.1001/archneur.60.11.1613; Kaplan JB, 1997, GROWTH FACTORS, V14, P243, DOI 10.3109/08977199709021523; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lal BK, 2001, MICROVASC RES, V62, P252, DOI 10.1006/mvre.2001.2338; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038/sj.onc.1201928; Lee Yong C, 2005, Curr Opin Investig Drugs, V6, P1124; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Liu JJ, 2011, MOL BIOL CELL, V22, P2509, DOI 10.1091/mbc.E11-02-0157; Liu WZ, 2013, MOL CELL, V49, P719, DOI 10.1016/j.molcel.2012.12.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Mammoto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2774; Marchuk DA, 2003, HUM MOL GENET, V12, pR97, DOI 10.1093/hmg/ddg103; Middleton J, 2004, ARTHRITIS RES THER, V6, P60, DOI 10.1186/ar1156; Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894; Orr AW, 2007, J CELL BIOL, V176, P719, DOI 10.1083/jcb.200609008; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Sarelius IH, 2006, AM J PHYSIOL-HEART C, V290, pH474, DOI 10.1152/ajpheart.00655.2005; Spilsbury K, 2000, AM J PATHOL, V157, P135, DOI 10.1016/S0002-9440(10)64525-7; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wang YM, 2007, J NEUROSCI RES, V85, P740, DOI 10.1002/jnr.21169; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Xie H, 1998, J CELL SCI, V111, P615; Yoruk B, 2012, DEV BIOL, V362, P121, DOI 10.1016/j.ydbio.2011.12.006; Zeng HY, 2001, J BIOL CHEM, V276, P32714, DOI 10.1074/jbc.M103130200; Zhu YA, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.5.FOCUS1090	68	44	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.582304	http://dx.doi.org/10.1074/jbc.M114.582304			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25320085	Green Published, hybrid			2022-12-28	WOS:000345335000055
J	Forster, A; Planamente, S; Manoli, E; Lossi, NS; Freemont, PS; Filloux, A				Foerster, Andreas; Planamente, Sara; Manoli, Eleni; Lossi, Nadine S.; Freemont, Paul S.; Filloux, Alain			Coevolution of the ATPase ClpV, the Sheath Proteins TssB and TssC, and the Accessory Protein TagJ/HsiE1 Distinguishes Type VI Secretion Classes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TN-SEQ; SYSTEM; EFFECTOR; IDENTIFICATION; COMPLEXES; REQUIRES; MACHINE; TOXIN	The type VI secretion system (T6SS) is a bacterial nanomachine for the transport of effector molecules into prokaryotic and eukaryotic cells. It involves the assembly of a tubular structure composed of TssB and TssC that is similar to the tail sheath of bacteriophages. The sheath contracts to provide the energy needed for effector delivery. The AAA(+) ATPase ClpV disassembles the contracted sheath, which resets the systems for reassembly of an extended sheath that is ready to fire again. This mechanism is crucial for T6SS function. In Vibrio cholerae, ClpV binds the N terminus of TssC within a hydrophobic groove. In this study, we resolved the crystal structure of the N-terminal domain of Pseudomonas aeruginosa ClpV1 and observed structural alterations in the hydrophobic groove. The modification in the ClpV1 groove is matched by a change in the N terminus of TssC, suggesting the existence of distinct T6SS classes. An accessory T6SS component, TagJ/HsiE, exists predominantly in one of the classes. Using bacterial two-hybrid approaches, we showed that the P. aeruginosa homolog HsiE1 interacts strongly with ClpV1. We then resolved the crystal structure of HsiE1 in complex with the N terminus of HsiB1, a TssB homolog and component of the contractile sheath. Phylogenetic analysis confirmed that these differences distinguish T6SS classes that resulted from a functional co-evolution between TssB, TssC, TagJ/HsiE, and ClpV. The interaction of TagJ/HsiE with the sheath as well as with ClpV suggests an alternative mode of disassembly in which HsiE recruits the ATPase to the sheath.	[Foerster, Andreas; Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Struct Biol Ctr, London SW7 2AZ, England; [Planamente, Sara; Manoli, Eleni; Lossi, Nadine S.; Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Med Res Council, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England	Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Freemont, PS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Struct Biol Ctr, London SW7 2AZ, England.	p.freemont@imperial.ac.uk; a.filloux@imperial.ac.uk	Planamente, Sara/ABB-4551-2020	Planamente, Sara/0000-0003-2778-1356; Forster, Andreas/0000-0003-1472-3990; Freemont, Paul/0000-0002-5658-8486; Filloux, Alain/0000-0003-1307-0289	Medical Research Council (MRC) [MR/K001930/1, G0800171/ID86344]; Wellcome Trust [WT091939]; Medical Research Council [G0800171, MR/K001930/1] Funding Source: researchfish; MRC [MR/J006874/1, MR/K001930/1, G0800171] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council (MRC) Program Grant MR/K001930/1.; Supported in part by Wellcome Trust Grant WT091939.; Supported by Medical Research Council (MRC) Grant G0800171/ID86344.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aksyuk AA, 2009, EMBO J, V28, P821, DOI 10.1038/emboj.2009.36; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; Brooks TM, 2013, J BIOL CHEM, V288, P7618, DOI 10.1074/jbc.M112.436725; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Coulthurst SJ, 2013, RES MICROBIOL, V164, P640, DOI 10.1016/j.resmic.2013.03.017; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Forouhar Farhad, 2007, Journal of Structural and Functional Genomics, V8, P37, DOI 10.1007/s10969-007-9018-3; Fu Y, 2013, CELL HOST MICROBE, V14, P652, DOI 10.1016/j.chom.2013.11.001; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kapitein N, 2013, MOL MICROBIOL, V87, P1013, DOI 10.1111/mmi.12147; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kube S, 2014, CELL REP, V8, P20, DOI 10.1016/j.celrep.2014.05.034; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; Lossi NS, 2012, MOL MICROBIOL, V86, P437, DOI 10.1111/j.1365-2958.2012.08204.x; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma LS, 2014, CELL HOST MICROBE, V16, P94, DOI 10.1016/j.chom.2014.06.002; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MILLER JH, 1992, SHORT COURSE BACTERI, P71; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Whitney JC, 2013, J BIOL CHEM, V288, P26616, DOI 10.1074/jbc.M113.488320; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081074; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	48	37	39	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.600510	http://dx.doi.org/10.1074/jbc.M114.600510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25305017	Green Published, hybrid			2022-12-28	WOS:000345335000053
J	Woolery, AR; Yu, XB; LaBaer, J; Orth, K				Woolery, Andrew R.; Yu, Xiaobo; LaBaer, Joshua; Orth, Kim			AMPylation of Rho GTPases Subverts Multiple Host Signaling Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIBRIO EFFECTOR PROTEIN; NADPH OXIDASE; RAC; ACTIVATION; COMPLEMENT; KINASES; BINDING; FAMILY; ARRAYS; DOMAIN	Rho GTPases are frequent targets of virulence factors as they are keystone signaling molecules. Herein, we demonstrate that AMPylation of Rho GTPases by VopS is a multifaceted virulence mechanism that counters several host immunity strategies. Activation of NF kappa B, Erk, and JNK kinase signaling pathways were inhibited in a VopS-dependent manner during infection with Vibrio parahaemolyticus. Phosphorylation and degradation of IKB alpha were inhibited in the presence of VopS as was nuclear translocation of the NF kappa B subunit p65. AMPylation also prevented the generation of superoxide by the phagocytic NADPH oxidase complex, potentially by inhibiting the interaction of Rac and p67. Furthermore, the interaction of GTPases with the E3 ubiquitin ligases cIAP1 and XIAP was hindered, leading to decreased degradation of Rac and RhoA during infection. Finally, we screened for novel Rac1 interactions using a nucleic acid programmable protein array and discovered that Rac1 binds to the protein C1QA, a protein known to promote immune signaling in the cytosol. Interestingly, this interaction was disrupted by AMPylation. We conclude that AMPylation of Rho Family GTPases by VopS results in diverse inhibitory consequences during infection beyond the most obvious phenotype, the collapse of the actin cytoskeleton.	[Woolery, Andrew R.; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Yu, Xiaobo; LaBaer, Joshua] Arizona State Univ, Biodesign Inst, Virginia G Piper Ctr Personalized Diagnost, Tempe, AZ 85287 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Arizona State University; Arizona State University-Tempe	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Kim.Orth@utsouthwestern.edu	Yu, Xiaobo/F-5997-2015; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; yu, xiaobo/0000-0003-2352-9866	National Institutes of Health [R01-AI087808]; Early Detection Research Network Grant [5U01CA117374]; Welch Foundation [I-1561]; Cell and Molecular Biology Training Grant [5T32GM008203]; NATIONAL CANCER INSTITUTE [U01CA117374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network Grant; Welch Foundation(The Welch Foundation); Cell and Molecular Biology Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI087808 (to K. O.) and Early Detection Research Network Grant 5U01CA117374 (to J. L.). This work was also supported by the Welch Foundation (Grant I-1561 to K. O.).; Supported by Cell and Molecular Biology Training Grant 5T32GM008203.	Anderson KS, 2011, J PROTEOME RES, V10, P85, DOI 10.1021/pr100686b; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Broberg CA, 2010, SCIENCE, V329, P1660, DOI 10.1126/science.1192850; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Estornes Y, 2015, SEMIN CELL DEV BIOL, V39, P106, DOI 10.1016/j.semcdb.2014.03.035; Frost JA, 1996, MOL CELL BIOL, V16, P3707, DOI 10.1128/mcb.16.7.3707; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Hao YH, 2011, J BIOTECHNOL, V151, P251, DOI 10.1016/j.jbiotec.2010.12.013; Higa N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003142; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Lerm M, 1999, INFECT IMMUN, V67, P496, DOI 10.1128/IAI.67.2.496-503.1999; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Miersch S, 2013, J PROTEOMICS, V94, P486, DOI 10.1016/j.jprot.2013.10.018; Nasu H, 2000, J CLIN MICROBIOL, V38, P2156; Nayak A, 2012, INNATE IMMUN-LONDON, V18, P350, DOI 10.1177/1753425910396252; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Ramachandran N, 2008, NAT METHODS, V5, P535, DOI 10.1038/NMETH.1210; Reddick LE, 2014, MOL CELL, V54, P321, DOI 10.1016/j.molcel.2014.03.010; Roos D, 2014, CLIN EXP IMMUNOL, V175, P139, DOI 10.1111/cei.12202; Salomon D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3973; Salomon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061086; Salomon D, 2013, CURR OPIN MICROBIOL, V16, P213, DOI 10.1016/j.mib.2013.01.013; Sareila O, 2011, ANTIOXID REDOX SIGN, V15, P2197, DOI 10.1089/ars.2010.3635; Sreelatha A, 2013, P NATL ACAD SCI USA, V110, P11559, DOI 10.1073/pnas.1307032110; Wang YT, 2012, IMMUNOLOGY, V136, P78, DOI 10.1111/j.1365-2567.2012.03561.x; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Yu XB, 2014, MOL CELL PROTEOMICS, V13, P3164, DOI 10.1074/mcp.M114.041103; Yu XB, 2014, THERANOSTICS, V4, P808, DOI 10.7150/thno.8255; Zhang LL, 2013, CURR OPIN MICROBIOL, V16, P70, DOI 10.1016/j.mib.2013.02.002; Zhang LL, 2012, CELL REP, V1, P453, DOI 10.1016/j.celrep.2012.04.004	40	27	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.601310	http://dx.doi.org/10.1074/jbc.M114.601310			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25301945	Green Published, hybrid			2022-12-28	WOS:000345335000048
J	Ding, Y; Dellisanti, CD; Ko, MH; Czajkowski, C; Puglielli, L				Ding, Yun; Dellisanti, Cosma D.; Ko, Mi Hee; Czajkowski, Cynthia; Puglielli, Luigi			The Endoplasmic Reticulum-based Acetyltransferases, ATase1 and ATase2, Associate with the Oligosaccharyltransferase to Acetylate Correctly Folded Polypeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A (acetyl-CoA); Acetyltransferase; Endoplasmic Reticulum (ER); Oligosaccharyltransferase; Post-translational Modification (PTM)	BETA-SECRETASE BACE1; LYSINE ACETYLATION; THERAPEUTIC TARGET; COA TRANSPORTER; QUALITY-CONTROL; PROTEIN; MEMBRANE; GOLGI; PATHWAY; LUMEN	Background: The acetyltransferases ATase1 and ATase2 acetylate ER-transiting and -resident proteins. Results: ATase1 and ATase2 form homo- and heterodimers, associate with the oligosaccharyltransferase (OST) complex, and modify correctly folded polypetides. Conclusion: The ATases are novel members of the broad ER translocation machinery. Significance: The ATases act in concert with (and perhaps sequentially to) the OST to mark correctly folded glycoproteins. The endoplasmic reticulum (ER) has two membrane-bound acetyltransferases responsible for the endoluminal N-E-lysine acetylation of ER-transiting and -resident proteins. Mutations that impair the ER-based acetylation machinery are associated with developmental defects and a familial form of spastic paraplegia. Deficient ER acetylation in the mouse leads to defects of the immune and nervous system. Here, we report that both ATase1 and ATase2 form homo- and heterodimers and associate with members of the oligosaccharyltransferase (OST) complex. In contrast to the OST, the ATases only modify correctly folded polypetides. Collectively, our studies suggest that one of the functions of the ATases is to work in concert with the OST and select correctly folded from unfolded/misfolded transiting polypeptides.	[Ding, Yun; Ko, Mi Hee; Puglielli, Luigi] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Dellisanti, Cosma D.; Czajkowski, Cynthia] Univ Wisconsin, Dept Neurosci, Madison, WI 53705 USA; [Ding, Yun; Czajkowski, Cynthia; Puglielli, Luigi] Univ Wisconsin, Neurosci Training Program, Madison, WI 53705 USA; [Puglielli, Luigi] Vet Affairs Med Ctr, Geriatr Res Educ Clin Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Puglielli, L (corresponding author), Univ Wisconsin, Dept Med, VAH GRECC, 2500 Overlook Terrace, Madison, WI 53705 USA.	lp1@medicine.wisc.edu			National Institutes of Health [AG033514, NS34727]; Veterans Affairs Merit Award [BX001638]; Thome Memorial Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034727, R56NS034727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG033514] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); Thome Memorial Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants AG033514 (to L. P.) and NS34727 (to C. C.). This work was also supported by Veterans Affairs Merit Award BX001638 (to L. P.) and funds from the Thome Memorial Foundation (to L. P.).	Chen XM, 2001, J BIOL CHEM, V276, P2411, DOI 10.1074/jbc.M007723200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Dempski RE, 2002, CURR OPIN CHEM BIOL, V6, P844, DOI 10.1016/S1367-5931(02)00390-3; Ding Y, 2012, J BIOL CHEM, V287, P8424, DOI 10.1074/jbc.M111.310136; Ferrandina G, 2009, EXPERT OPIN THER TAR, V13, P823, DOI 10.1517/14728220903005616; Huppke P, 2012, AM J HUM GENET, V90, P61, DOI 10.1016/j.ajhg.2011.11.030; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Jonas MC, 2010, J CELL SCI, V123, P3378, DOI 10.1242/jcs.068841; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; KUMAR V, 1994, J BIOL CHEM, V269, P13451; Lalioti VS, 2013, J CELL PHYSIOL, V228, P1907, DOI 10.1002/jcp.24355; Lin PF, 2008, AM J HUM GENET, V83, P752, DOI 10.1016/j.ajhg.2008.11.003; Mak AB, 2014, J MOL BIOL, V426, P2175, DOI 10.1016/j.jmb.2014.02.012; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Pehar M, 2013, BBA-MOL CELL RES, V1833, P686, DOI 10.1016/j.bbamcr.2012.12.004; Pehar M, 2012, J BIOL CHEM, V287, P29921, DOI 10.1074/jbc.M112.363911; Pehar M, 2012, J BIOL CHEM, V287, P22436, DOI 10.1074/jbc.C112.362871; Peng YJ, 2014, J NEUROSCI, V34, P6772, DOI 10.1523/JNEUROSCI.0077-14.2014; Pfeffer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4072; Puglielli L, 1999, J BIOL CHEM, V274, P12665, DOI 10.1074/jbc.274.18.12665; Puglielli L, 1999, J BIOL CHEM, V274, P4474, DOI 10.1074/jbc.274.7.4474; Rappa G, 2008, STEM CELLS, V26, P3008, DOI 10.1634/stemcells.2008-0601; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Wang HB, 2013, TRENDS PHARMACOL SCI, V34, P215, DOI 10.1016/j.tips.2013.01.008; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X; Yang XJ, 2007, EMBO REP, V8, P556, DOI 10.1038/sj.embor.7400977; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	36	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32044	32055		10.1074/jbc.M114.585547	http://dx.doi.org/10.1074/jbc.M114.585547			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25301944	Green Published, hybrid			2022-12-28	WOS:000345314700033
J	Lin, Y; Li, DJ; Liang, Q; Liu, SQ; Zuo, XL; Li, L; Sun, XM; Li, WX; Guo, MX; Huang, Z				Lin, Yi; Li, Dengju; Liang, Qing; Liu, Shangqing; Zuo, Xuelan; Li, Lin; Sun, Xuemei; Li, Wenxin; Guo, Mingxiong; Huang, Zan			miR-638 Regulates Differentiation and Proliferation in Leukemic Cells by Targeting Cyclin-dependent Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; BINDING-PROTEIN-ALPHA; DOWN-REGULATION; TERMINAL DIFFERENTIATION; STEM-CELLS; EXPRESSION; MICRORNA-223; GENES	MicroRNAs have been extensively studied as regulators of hematopoiesis and leukemogenesis. We identified miR-638 as a novel regulator in myeloid differentiation and proliferation of leukemic cells. We found that miR-638 was developmentally up-regulated in cells of myeloid but not lymphoid lineage. Furthermore, significant miR-638 down-regulation was observed in primary acute myeloid leukemia (AML) blasts, whereas miR-638 expression was dramatically up-regulated in primary AML blasts and leukemic cell lines undergoing forced myeloid differentiation. These observations suggest that miR-638 might play a role in myeloid differentiation, and its dysregulation may contribute to leukemogenesis. Indeed, ectopic expression of miR-638 promoted phorbol 12-myristate 13-acetate- or all-transretinoic acid-induced differentiation of leukemic cell lines and primary AML blasts, whereas miR-638 inhibition caused an opposite phenotype. Consistently, miR-638 overexpression induced G(1) cell cycle arrest and reduced colony formation in soft agar. Cyclin-dependent kinase 2 (CDK2) was found to be a target gene of miR-638. CDK2 inhibition phenotypically mimicked the overexpression of miR-638. Moreover, forced expression of CDK2 restored the proliferation and the colony-forming ability inhibited by miR-638. Our data suggest that miR-638 regulates proliferation and myeloid differentiation by targeting CDK2 and may serve as a novel target for leukemia therapy or marker for AML diagnosis and prognosis.	[Lin, Yi; Li, Wenxin; Guo, Mingxiong; Huang, Zan] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Li, Dengju] Huazhong Technol Univ, Tongji Hosp, Dept Hematol, Wuhan 430030, Hubei, Peoples R China; [Liang, Qing; Liu, Shangqing; Zuo, Xuelan] Wuhan Univ, Dept Hematol, Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China; [Li, Lin; Sun, Xuemei] Nanjing Univ Chinese Med, Dept Hematol, Jiangsu Prov Hosp Tradit Chinese Med TCM, Nanjing 210029, Jiangsu, Peoples R China	Wuhan University; Huazhong University of Science & Technology; Wuhan University; Nanjing University of Chinese Medicine	Guo, MX (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	guomx@whu.edu.cn; z-huang@whu.edu.cn	LIN, YI/AAC-3335-2020	LIN, YI/0000-0001-8209-1185; Huang, Zan/0000-0001-5623-6950	National Natural Science Foundation of China [31371481, 81000201, 31271511, 81272627]; Ph.D. Programs Foundation of the Ministry of Education of China [20110141110016]; New Century Excellent Talents in University (NCET) of the Ministry of Education of China [NCET-12-0422]; Fundamental Research Funds for the Central Universities [2042014KF0243]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); New Century Excellent Talents in University (NCET) of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31371481 (to Z. H.), 81000201 (to L. L.), 31271511 (to M. G.), and 81272627 (to S. L.); Ph.D. Programs Foundation of the Ministry of Education of China Grant 20110141110016 (to Z. H.); New Century Excellent Talents in University (NCET) of the Ministry of Education of China Grant NCET-12-0422 (to Z. H.), and Fundamental Research Funds for the Central Universities Grant 2042014KF0243 (to M. G.).	Aref S, 2006, HEMATOLOGY, V11, P31, DOI 10.1080/10245330500322321; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benedetti L, 1996, BLOOD, V87, P1939; Buschges R, 1999, BRAIN PATHOL, V9, P435; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dobashi Y, 2000, J BIOL CHEM, V275, P12572, DOI 10.1074/jbc.275.17.12572; DUBOIS C, 1994, BLOOD, V83, P3264; Duprez E, 1997, ONCOGENE, V14, P1563, DOI 10.1038/sj.onc.1200995; Eyholzer M, 2010, BRIT J CANCER, V103, P275, DOI 10.1038/sj.bjc.6605751; Favreau AJ, 2012, AM J HEMATOL, V87, P442, DOI 10.1002/ajh.23129; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; GALLAGHER R, 1979, BLOOD, V54, P713; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Hackanson B, 2008, CANCER RES, V68, P3142, DOI 10.1158/0008-5472.CAN-08-0483; Jaiswal R, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-37; Jiang X, 2012, P NATL ACAD SCI USA, V109, P19397, DOI 10.1073/pnas.1217519109; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kharfan-Dabaja MA, 2005, CANCER IMMUNOL IMMUN, V54, P25, DOI 10.1007/s00262-004-0562-4; Klausen P, 2004, J LEUKOCYTE BIOL, V75, P569, DOI 10.1189/jlb.1003474; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li DC, 2012, TOXICOL SCI, V125, P382, DOI 10.1093/toxsci/kfr299; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Li P, 2013, CARDIOVASC RES, V99, P185, DOI 10.1093/cvr/cvt082; Lim S, 2012, STEM CELLS, V30, P1509, DOI 10.1002/stem.1114; Lin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069230; Liu L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.512; Ma KL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-118; Martinez LA, 1999, ONCOGENE, V18, P397, DOI 10.1038/sj.onc.1202300; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Mukai HY, 2006, MOL CELL BIOL, V26, P7953, DOI 10.1128/MCB.00718-06; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Palma CA, 2012, J CELL MOL MED, V16, P978, DOI 10.1111/j.1582-4934.2011.01514.x; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Salvatori Beatrice, 2011, Genes Cancer, V2, P585, DOI 10.1177/1947601911416357; Schmitz NMR, 2005, LEUKEMIA, V19, P1783, DOI 10.1038/sj.leu.2403900; Seca H, 2010, EUR J CANCER, V46, P1520, DOI 10.1016/j.ejca.2010.03.031; Subramanian S, 2010, J PATHOL, V220, P58, DOI 10.1002/path.2633; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Tikoo R, 1997, J BIOL CHEM, V272, P442; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Wang J, 2011, J CELL BIOCHEM, V112, P2443, DOI 10.1002/jcb.23165; Wang K, 2015, TUMOR BIOL, V36, P393, DOI 10.1007/s13277-014-2655-9; Wang XS, 2012, BLOOD, V119, P4992, DOI 10.1182/blood-2011-10-385716; Wang XN, 2009, CELL CYCLE, V8, P736, DOI 10.4161/cc.8.5.7870; WEIL SC, 1987, P NATL ACAD SCI USA, V84, P2057, DOI 10.1073/pnas.84.7.2057; Wessendorf S, 2003, ONCOGENE, V22, P1425, DOI 10.1038/sj.onc.1206297; Zhao LY, 2014, DIGEST DIS SCI, V59, P1743, DOI 10.1007/s10620-014-3087-5; Zhu DX, 2012, CARCINOGENESIS, V33, P1294, DOI 10.1093/carcin/bgs179	57	43	44	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1818	1828		10.1074/jbc.M114.599191	http://dx.doi.org/10.1074/jbc.M114.599191			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451924	Green Published, hybrid			2022-12-28	WOS:000348056400046
J	Kompella, SN; Hung, A; Clark, RJ; Mar, F; Adams, DJ				Kompella, Shiva N.; Hung, Andrew; Clark, Richard J.; Mar, Frank; Adams, David J.			Alanine Scan of alpha-Conotoxin RegIIA Reveals a Selective alpha 3 beta 4 Nicotinic Acetylcholine Receptor Antagonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL SENSITIVITY; MOLECULAR-DYNAMICS; AUTONOMIC GANGLIA; CRYSTAL-STRUCTURE; HOMOLOG ACHBP; LUNG-CANCER; ALPHA-9-ALPHA-10; RAT; SUBUNIT; BINDING	Activation of the alpha 3 beta 4 nicotinic acetylcholine receptor (nAChR) subtype has recently been implicated in the pathophysiology of various conditions, including development and progression of lung cancer and in nicotine addiction. As selective alpha 3 beta 4 nAChR antagonists, alpha-conotoxins are valuable tools to evaluate the functional roles of this receptor subtype. We previously reported the discovery of a new beta 4/7-conotoxin, RegIIA. RegIIA was isolated from Conus regius and inhibits acetylcholine (ACh)-evoked currents mediated by alpha 3 beta 4, alpha 3 beta 2, and alpha 7 nAChR subtypes. The current study used alanine scanning mutagenesis to understand the selectivity profile of RegIIA at the alpha 3 beta 4 nAChR subtype. [N11A] and [N12A] RegIIA analogs exhibited 3-fold more selectivity for the alpha 3 beta 4 than the alpha 3 beta 2 nAChR subtype. We also report synthesis of [N11A, N12A] RegIIA, a selective alpha 3 beta 4 nAChR antagonist (IC50 of 370 nM) that could potentially be used in the treatment of lung cancer and nicotine addiction. Molecular dynamics simulations of RegIIA and [N11A, N12A] RegIIA bound to alpha 3 beta 4 and alpha 3 beta 2 suggest that destabilization of toxin contacts with residues at the principal and complementary faces of alpha 3 beta 2 (alpha 3-Tyr(92), Ser(149), Tyr(189), Cys(192), and Tyr(196); beta 2-Trp(57), Arg(81), and Phe(119)) may form the molecular basis for the selectivity shift.	[Kompella, Shiva N.; Hung, Andrew; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia; [Clark, Richard J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Mar, Frank] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA	Royal Melbourne Institute of Technology (RMIT); University of Queensland; State University System of Florida; Florida Atlantic University	Adams, DJ (corresponding author), RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia.	david.adams@rmit.edu.au	Adams, David John/K-3578-2019; Clark, Richard J/G-8848-2012	Adams, David John/0000-0002-7030-2288; Clark, Richard J/0000-0002-6807-5426; Hung, Andrew/0000-0003-3569-2951; Kompella, Shiva/0000-0001-5625-2491	Australian Research Council (ARC) Discovery Project Grant; Victorian Life Sciences Computation Initiative (VLSCI) [VR0009, NCq75]	Australian Research Council (ARC) Discovery Project Grant(Australian Research Council); Victorian Life Sciences Computation Initiative (VLSCI)	This work was supported in part by an Australian Research Council (ARC) Discovery Project Grant (to D. J. A. and F. M.) and the Victorian Life Sciences Computation Initiative (VLSCI) for provision of computational resources (project grants VR0009 and NCq75 to A. H. and D. J. A.).	Akondi KB, 2014, CHEM REV, V114, P5815, DOI 10.1021/cr400401e; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Armishaw CJ, 2010, TOXINS, V2, P1471, DOI 10.3390/toxins2061471; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Azam L, 2012, J NEUROCHEM, V122, P1137, DOI 10.1111/j.1471-4159.2012.07867.x; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Chang YP, 2014, J MED CHEM, V57, P3511, DOI 10.1021/jm500183r; Chernyavsky AI, 2004, J CELL SCI, V117, P5665, DOI 10.1242/jcs.01492; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dowell C, 2003, J NEUROSCI, V23, P8445; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; Essack M, 2012, MAR DRUGS, V10, P1244, DOI 10.3390/md10061244; Franco A, 2006, PROG MOLEC, V43, P83, DOI 10.1007/978-3-540-30880-5_4; Franco A, 2012, BIOCHEM PHARMACOL, V83, P419, DOI 10.1016/j.bcp.2011.11.006; GALZI JL, 1990, J BIOL CHEM, V265, P10430; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Grishin AA, 2013, J BIOL CHEM, V288, P34428, DOI 10.1074/jbc.M113.512582; Grishin AA, 2010, J BIOL CHEM, V285, P22254, DOI 10.1074/jbc.M110.111880; Halai R, 2009, J BIOL CHEM, V284, P20275, DOI 10.1074/jbc.M109.015339; Hogg RC, 2003, J BIOL CHEM, V278, P26908, DOI 10.1074/jbc.M212628200; Hogg RC, 1999, J BIOL CHEM, V274, P36559, DOI 10.1074/jbc.274.51.36559; Huk KH, 2002, MOL NEUROBIOL, V25, P79; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Improgo MRD, 2010, PROG NEUROBIOL, V92, P212, DOI 10.1016/j.pneurobio.2010.05.003; Inserra MC, 2013, BIOCHEM PHARMACOL, V86, P791, DOI 10.1016/j.bcp.2013.07.016; Kamendi HW, 2009, J NEUROPHYSIOL, V101, P1141, DOI 10.1152/jn.90680.2008; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lebbe EKM, 2014, MAR DRUGS, V12, P2970, DOI 10.3390/md12052970; Lee C, 2012, BMB REP, V45, P275, DOI 10.5483/BMBRep.2012.45.5.275; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Luo SQ, 1998, J NEUROSCI, V18, P8571; Luo SL, 2013, J MED CHEM, V56, P9655, DOI 10.1021/jm401254c; McCallum SE, 2012, NEUROPHARMACOLOGY, V63, P434, DOI 10.1016/j.neuropharm.2012.04.015; McIntosh JM, 2005, J BIOL CHEM, V280, P30107, DOI 10.1074/jbc.M504102200; McIntosh JM, 2002, J BIOL CHEM, V277, P33610, DOI 10.1074/jbc.M205102200; Millard EL, 2004, EUR J BIOCHEM, V271, P2320, DOI 10.1111/j.1432-1033.2004.04148.x; Muldoon PP, 2014, BRIT J PHARMACOL, V171, P3845, DOI 10.1111/bph.12741; Nevin ST, 2007, MOL PHARMACOL, V72, P1406, DOI 10.1124/mol.107.040568; Park KS, 2006, PFLUG ARCH EUR J PHY, V452, P775, DOI 10.1007/s00424-006-0086-1; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peng C, 2010, ACTA BIOCH BIOPH SIN, V42, P745, DOI 10.1093/abbs/gmq074; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHULLER HM, 1989, BIOCHEM PHARMACOL, V38, P3439, DOI 10.1016/0006-2952(89)90112-3; Shiembob DL, 2006, BIOCHEMISTRY-US, V45, P11200, DOI 10.1021/bi0611715; Skok VI, 2002, AUTON NEUROSCI-BASIC, V97, P1, DOI 10.1016/S1566-0702(01)00386-1; Stoker AK, 2013, CURR OPIN NEUROBIOL, V23, P493, DOI 10.1016/j.conb.2013.02.013; Talley TT, 2006, J BIOL CHEM, V281, P24678, DOI 10.1074/jbc.M602969200; Thunnissen FB, 2009, J THORAC ONCOL, V4, P943, DOI 10.1097/JTO.0b013e3181ad83fc; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Lierop BJ, 2013, ACS CHEM BIOL, V8, P1815, DOI 10.1021/cb4002393; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; Wang NS, 2002, PROG NEUROBIOL, V68, P341, DOI 10.1016/S0301-0082(02)00106-5; Whiteaker P, 2007, BIOCHEMISTRY-US, V46, P6628, DOI 10.1021/bi7004202	62	33	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1039	1048		10.1074/jbc.M114.605592	http://dx.doi.org/10.1074/jbc.M114.605592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25411242	Green Published, hybrid			2022-12-28	WOS:000347778200036
J	Tan, Z; Xie, N; Banerjee, S; Cui, HC; Fu, MG; Thannickal, VJ; Liu, G				Tan, Zheng; Xie, Na; Banerjee, Sami; Cui, Huachun; Fu, Mingui; Thannickal, Victor J.; Liu, Gang			The Monocarboxylate Transporter 4 Is Required for Glycolytic Reprogramming and Inflammatory Response in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycolysis; Inflammation; Lipopolysaccharide (LPS); Macrophage; Toll-like Receptor (TLR); MCT4	TOLL-LIKE RECEPTOR; PATTERN-RECOGNITION RECEPTORS; LACTIC-ACID; EFFECTOR FUNCTION; LACTATE; METABOLISM; HYPOXIA; ACTIVATION; CANCER; CELLS	Background: Glycolysis has an important role in inflammation. Results: MCT4 is up-regulated in inflammatorily activated macrophages and required for innate immune response. Conclusion: MCT4 up-regulation represents a positive feedback mechanism in inflammation. Significance: Delineation of the role of MCT4 provides further insight into the regulation of inflammation by glycolysis. There has been fast growing evidence showing that glycolysis plays a critical role in the activation of immune cells. Enhanced glycolysis leads to increased formation of intracellular lactate that is exported to the extracellular environment by monocarboxylate transporter 4 (MCT4). Although the biological activities of extracellular lactate have been well studied, it is less understood how the lactate export is regulated or whether lactate export affects glycolysis during inflammatory activation. In this study, we found that MCT4 is up-regulated by TLR2 and TLR4, but not TLR3 agonists in a variety of macrophages. The increased expression of MCT4 was mediated by MYD88 in a NF-B-dependent manner. Furthermore, we found that MCT4 is required for macrophage activation upon TLR2 and TLR4 stimulations, as evidenced by attenuated expression of proinflammatory mediators in macrophages with MCT4 knockdown. Mechanistically, we found that MCT4 knockdown leads to enhanced intracellular accumulation of lactate and decreased glycolysis in LPS-treated macrophages. We found that LPS-induced expression of key glycolytic enzymes hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 is diminished in macrophages with MCT4 knockdown. Our data suggest that MCT4 up-regulation represents a positive feedback mechanism in macrophages to maintain a high glycolytic rate that is essential to a fully activated inflammatory response.	[Tan, Zheng; Xie, Na; Banerjee, Sami; Cui, Huachun; Thannickal, Victor J.; Liu, Gang] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Tan, Zheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Immunol, Wuhan 430030, Peoples R China; [Fu, Mingui] Univ Missouri, Dept Basic Med Sci, Kansas City, MO 64108 USA	University of Alabama System; University of Alabama Birmingham; Huazhong University of Science & Technology; University of Missouri System; University of Missouri Kansas City	Liu, G (corresponding author), Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Dept Med, 901 19th St So,BMR II 233, Birmingham, AL 35294 USA.	gliu@uab.edu		, Gang/0000-0002-6999-7633; Liu, Gang/0000-0003-2615-131X	National Institutes of Health [HL105473, HL076206, HL114470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114470, R01HL105473, R01HL076206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL105473 and HL076206 (to G. L.) and HL114470 (to V.J.T.).	Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC; Banerjee S, 2013, J IMMUNOL, V190, P6542, DOI 10.4049/jimmunol.1202496; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Dietl K, 2010, J IMMUNOL, V184, P1200, DOI 10.4049/jimmunol.0902584; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hoque R, 2014, GASTROENTEROLOGY, V146, P1763, DOI 10.1053/j.gastro.2014.03.014; Jeannin P, 2008, CURR OPIN IMMUNOL, V20, P530, DOI 10.1016/j.coi.2008.04.013; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lama S, 2014, J BIOL CHEM, V289, P20200, DOI 10.1074/jbc.M114.570978; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lim KS, 2014, ONCOGENE, V33, P4433, DOI 10.1038/onc.2013.390; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; McBrian MA, 2013, MOL CELL, V49, P310, DOI 10.1016/j.molcel.2012.10.025; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Samuvel DJ, 2009, J IMMUNOL, V182, P2476, DOI 10.4049/jimmunol.0802059; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Shime H, 2008, J IMMUNOL, V180, P7175, DOI 10.4049/jimmunol.180.11.7175; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Yoshimura A, 1999, J IMMUNOL, V163, P1	51	101	102	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					46	55		10.1074/jbc.M114.603589	http://dx.doi.org/10.1074/jbc.M114.603589			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25406319	Green Published, hybrid			2022-12-28	WOS:000347231200005
J	Nguyen, Y; Sugiman-Marangos, S; Harvey, H; Bell, SD; Charlton, CL; Junop, MS; Burrows, LL				Ylan Nguyen; Sugiman-Marangos, Seiji; Harvey, Hanjeong; Bell, Stephanie D.; Charlton, Carmen L.; Junop, Murray S.; Burrows, Lori L.			Pseudomonas aeruginosa Minor Pilins Prime Type IVa Pilus Assembly and Promote Surface Display of the PilY1 Adhesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesin; Bacterial Adhesion; Crystal Structure; Pseudomonas aeruginosa (P; aeruginosa); Type II Secretion System (T2SS); Type IV Pili; Pilin; Pseudopilin; Twitching Motility	II SECRETION SYSTEM; NEISSERIA-MENINGITIDIS; PROTEIN-SECRETION; FIMBRIAL BIOGENESIS; AMINO-ACID; TWITCHING MOTILITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PSEUDOPILIN EPSH; ANALYSIS REVEALS	Background: Type IV pili (T4P) are virulence factors composed of major and minor pilins. Results: Minor pilins prime pilus assembly and traffic anti-retraction protein PilY1 to the surface; FimU and GspH are structurally similar. Conclusion: Minor pilins are essential for pilus assembly and function. Significance: This work expands the structural and functional similarities between the T4P and T2S systems. Type IV pili (T4P) contain hundreds of major subunits, but minor subunits are also required for assembly and function. Here we show that Pseudomonas aeruginosa minor pilins prime pilus assembly and traffic the pilus-associated adhesin and anti-retraction protein, PilY1, to the cell surface. PilV, PilW, and PilX require PilY1 for inclusion in surface pili and vice versa, suggestive of complex formation. PilE requires PilVWXY1 for inclusion, suggesting that it binds a novel interface created by two or more components. FimU is incorporated independently of the others and is proposed to couple the putative minor pilin-PilY1 complex to the major subunit. The production of small amounts of T4P by a mutant lacking the minor pilin operon was traced to expression of minor pseudopilins from the P. aeruginosa type II secretion (T2S) system, showing that under retraction-deficient conditions, T2S minor subunits can prime T4P assembly. Deletion of all minor subunits abrogated pilus assembly. In a strain lacking the minor pseudopilins, PilVWXY1 and either FimU or PilE comprised the minimal set of components required for pilus assembly. Supporting functional conservation of T2S and T4P minor components, our 1.4 crystal structure of FimU revealed striking architectural similarity to its T2S ortholog GspH, despite minimal sequence identity. We propose that PilVWXY1 form a priming complex for assembly and that PilE and FimU together stably couple the complex to the major subunit. Trafficking of the anti-retraction factor PilY1 to the cell surface allows for production of pili of sufficient length to support adherence and motility.	[Ylan Nguyen; Sugiman-Marangos, Seiji; Harvey, Hanjeong; Bell, Stephanie D.; Burrows, Lori L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Ylan Nguyen; Sugiman-Marangos, Seiji; Harvey, Hanjeong; Bell, Stephanie D.; Burrows, Lori L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Charlton, Carmen L.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2R3, Canada; [Charlton, Carmen L.] Prov Lab Publ Hlth, Edmonton, AB T6G 2J2, Canada; [Junop, Murray S.] Univ Western Ontario, Dept Biochem, London, ON N6A 3K7, Canada	McMaster University; McMaster University; University of Alberta; Western University (University of Western Ontario)	Burrows, LL (corresponding author), 4H18 Hlth Sci Ctr, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada.	burrowl@mcmaster.ca	Junop, Murray S/E-4160-2015	Junop, Murray S/0000-0001-6676-5717; Sugiman-Marangos, Seiji/0000-0002-8475-5456; Charlton, Carmen/0000-0002-9129-5136	Canadian Institutes of Health Research [MOP 93585, MOP 89903]; Cystic Fibrosis Canada; Banting Scholarship from the Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Banting Scholarship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by Canadian Institutes of Health Research Grants MOP 93585 (to L. L. B.) and MOP 89903 (to M. S. J.).; Recipient of a graduate studentship from Cystic Fibrosis Canada and a Banting Scholarship from the Canadian Institutes of Health Research.	Aas FE, 2002, MOL MICROBIOL, V46, P749, DOI 10.1046/j.1365-2958.2002.03193.x; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALM RA, 1995, MOL MICROBIOL, V16, P485, DOI 10.1111/j.1365-2958.1995.tb02413.x; Alm RA, 1996, J BACTERIOL, V178, P3809, DOI 10.1128/jb.178.13.3809-3817.1996; Alm RA, 1996, MOL MICROBIOL, V22, P161; Arts J, 2007, J BACTERIOL, V189, P2069, DOI 10.1128/JB.01236-06; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; Belete B, 2008, J BACTERIOL, V190, P2023, DOI 10.1128/JB.01623-07; Bleves S, 1998, MOL MICROBIOL, V27, P31, DOI 10.1046/j.1365-2958.1998.00653.x; Bohn YST, 2009, MOL MICROBIOL, V71, P730, DOI 10.1111/j.1365-2958.2008.06559.x; Brissac T, 2012, INFECT IMMUN, V80, P3297, DOI 10.1128/IAI.00369-12; Brown DR, 2010, INFECT IMMUN, V78, P3053, DOI 10.1128/IAI.00099-10; Burrows LL, 2012, MOL MICROBIOL, V86, P765, DOI 10.1111/mmi.12034; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Cisneros DA, 2012, MOL MICROBIOL, V86, P805, DOI 10.1111/mmi.12033; Cisneros DA, 2012, EMBO J, V31, P1041, DOI 10.1038/emboj.2011.454; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; de Bentzmann S, 2006, J BACTERIOL, V188, P4851, DOI 10.1128/JB.00345-06; DeLano WL, 2002, PYMOL USERS MANUAL; Douzi B, 2009, J BIOL CHEM, V284, P34580, DOI 10.1074/jbc.M109.042366; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forest KT, 2008, NAT STRUCT MOL BIOL, V15, P428, DOI 10.1038/nsmb0508-428; Francetic O, 2007, J BACTERIOL, V189, P1783, DOI 10.1128/JB.01230-06; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Giltner CL, 2011, ENVIRON MICROBIOL, V13, P250, DOI 10.1111/j.1462-2920.2010.02327.x; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; Heiniger RW, 2010, CELL MICROBIOL, V12, P1158, DOI 10.1111/j.1462-5822.2010.01461.x; Helaine S, 2005, MOL MICROBIOL, V55, P65, DOI 10.1111/j.1365-2958.2004.04372.x; Helaine S, 2007, P NATL ACAD SCI USA, V104, P15888, DOI 10.1073/pnas.0707581104; Imhaus AF, 2014, EMBO J, V33, P1767, DOI 10.15252/embj.201488031; Johnson MDL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029629; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Kuchma SL, 2012, J BACTERIOL, V194, P5388, DOI 10.1128/JB.00899-12; Kuchma SL, 2010, J BACTERIOL, V192, P2950, DOI 10.1128/JB.01642-09; Kuo WW, 2005, J BIOMED SCI, V12, P587, DOI 10.1007/s11373-005-7372-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; Lu HM, 1997, MOL MICROBIOL, V25, P247, DOI 10.1046/j.1365-2958.1997.4561818.x; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mattick JS, 1996, GENE, V179, P147, DOI 10.1016/S0378-1119(96)00441-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NUNN DN, 1991, P NATL ACAD SCI USA, V88, P3281, DOI 10.1073/pnas.88.8.3281; NUNN DN, 1993, J BACTERIOL, V175, P4375, DOI 10.1128/JB.175.14.4375-4382.1993; Orans J, 2010, P NATL ACAD SCI USA, V107, P1065, DOI 10.1073/pnas.0911616107; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Raghunathan K, 2014, BBA-PROTEINS PROTEOM, V1844, P406, DOI 10.1016/j.bbapap.2013.11.013; RUDEL T, 1995, P NATL ACAD SCI USA, V92, P7986, DOI 10.1073/pnas.92.17.7986; RUSSELL MA, 1994, MOL MICROBIOL, V13, P973, DOI 10.1111/j.1365-2958.1994.tb00489.x; SASTRY PA, 1985, J BACTERIOL, V164, P571, DOI 10.1128/JB.164.2.571-577.1985; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; STROM MS, 1991, J BIOL CHEM, V266, P1656; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; Vignon G, 2003, J BACTERIOL, V185, P3416, DOI 10.1128/JB.185.11.3416-3428.2003; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winther-Larsen HC, 2005, MOL MICROBIOL, V56, P903, DOI 10.1111/j.1365-2958.2005.04591.x; Winther-Larsen HC, 2001, P NATL ACAD SCI USA, V98, P15276, DOI 10.1073/pnas.261574998; Yanez ME, 2008, J MOL BIOL, V377, P91, DOI 10.1016/j.jmb.2007.08.041; Yanez ME, 2008, J MOL BIOL, V375, P471, DOI 10.1016/j.jmb.2007.10.035	68	67	71	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					601	611		10.1074/jbc.M114.616904	http://dx.doi.org/10.1074/jbc.M114.616904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25389296	Green Published, hybrid			2022-12-28	WOS:000347231200052
J	Masjkur, J; Arps-Forker, C; Poser, SW; Nikolakopoulou, P; Toutouna, L; Chenna, R; Chavakis, T; Chatzigeorgiou, A; Chen, LS; Dubrovska, A; Choudhary, P; Uphues, I; Mark, M; Bornstein, SR; Androutsellis-Theotokis, A				Masjkur, Jimmy; Arps-Forker, Carina; Poser, Steven W.; Nikolakopoulou, Polyxeni; Toutouna, Louiza; Chenna, Ramu; Chavakis, Triantafyllos; Chatzigeorgiou, Antonios; Chen, Lan-Sun; Dubrovska, Anna; Choudhary, Pratik; Uphues, Ingo; Mark, Michael; Bornstein, Stefan R.; Androutsellis-Theotokis, Andreas			Hes3 Is Expressed in the Adult Pancreatic Islet and Regulates Gene Expression, Cell Growth, and Insulin Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta Cell (B-cell); Cell Culture; Islet; Neural Stem Cell (NSC); Neurodegenerative Disease; Neuroprogenitor Cell; Notch Pathway; Pancreas; Parkinson Disease; Signal Transduction	NEURAL STEM-CELLS; BETA-CELLS; NOTCH; ACTIVATION; RECEPTOR; FATE; PDX1; DIFFERENTIATION; PROLIFERATION; STIMULATION	The transcription factor Hes3 is a component of a signaling pathway that supports the growth of neural stem cells with profound consequences in neurodegenerative disease models. Here we explored whether Hes3 also regulates pancreatic islet cells. We showed that Hes3 is expressed in human and rodent pancreatic islets. In mouse islets it co-localizes with alpha and beta cell markers. We employed the mouse insulinoma cell line MIN6 to perform in vitro characterization and functional studies in conditions known to modulate Hes3 based upon our previous work using neural stem cell cultures. In these conditions, cells showed elevated Hes3 expression and nuclear localization, grew efficiently, and showed higher evoked insulin release responses, compared with serum-containing conditions. They also exhibited higher expression of the transcription factor Pdx1 and insulin. Furthermore, they were responsive to pharmacological treatments with the GLP-1 analog Exendin-4, which increased nuclear Hes3 localization. We employed a transfection approach to address specific functions of Hes3. Hes3 RNA interference opposed cell growth and affected gene expression as revealed by DNA microarrays. Western blotting and PCR approaches specifically showed that Hes3 RNA interference opposes the expression of Pdx1 and insulin. Hes3 overexpression (using a Hes3-GFP fusion construct) confirmed a role of Hes3 in regulating Pdx1 expression. Hes3 RNA interference reduced evoked insulin release. Mice lacking Hes3 exhibited increased islet damage by streptozotocin. These data suggest roles of Hes3 in pancreatic islet function.	[Masjkur, Jimmy; Arps-Forker, Carina; Poser, Steven W.; Nikolakopoulou, Polyxeni; Toutouna, Louiza; Bornstein, Stefan R.; Androutsellis-Theotokis, Andreas] Univ Dresden, Dept Med, D-01307 Dresden, Germany; [Chenna, Ramu] Univ Dresden, BioInnovat Zentrum, Appl Bioinformat Grp, D-01307 Dresden, Germany; [Chavakis, Triantafyllos; Chatzigeorgiou, Antonios; Chen, Lan-Sun] Tech Univ Dresden, Inst Clin Chem & Lab Med, Dept Clin Pathobiochem, D-01307 Dresden, Germany; [Dubrovska, Anna] Tech Univ Dresden, Dept Med, OncoRay Natl Ctr Radiat Res Oncol, Med Fac Carl Gustav Carus, D-01307 Dresden, Germany; [Choudhary, Pratik] Kings Coll London, Diabet Res Grp, London SE5 9RS, England; [Uphues, Ingo; Mark, Michael] Boehringer Ingelheim Pharma GmbH & Co KG, Dept CardioMetab Dis Res, D-88400 Biberach, Germany; [Androutsellis-Theotokis, Andreas] Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of London; King's College London; Boehringer Ingelheim; Technische Universitat Dresden	Androutsellis-Theotokis, A (corresponding author), Univ Dresden, Dept Med, Fetscherstr 74, D-01307 Dresden, Germany.	andreas.theotokis@uniklinikum-dresden.de	Chavakis, Triantafyllos/ABE-8845-2020; Nikolakopoulou, Polyxeni/GOV-7024-2022; Choudhary, Pratik/D-7701-2015; Masjkur, Jimmy/CAF-9054-2022; Dubrovska, Anna/AAE-8514-2019	Nikolakopoulou, Polyxeni/0000-0002-1695-9545; Dubrovska, Anna/0000-0002-3375-1500; Choudhary, Pratik/0000-0001-7635-4735; Androutsellis-Theotokis, Andreas/0000-0002-1985-4589; Chen, Lan-Sun/0000-0002-5917-3083; Chatzigeorgiou, Antonios/0000-0002-7039-4223	Boehringer Ingelheim; Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases through Initiative and Network Fund of Helmholtz Association [051_40001]; Deutsche Forschungsgemeinschaft [SFB 655]	Boehringer Ingelheim(Boehringer Ingelheim); Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases through Initiative and Network Fund of Helmholtz Association; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Boehringer Ingelheim and in part by the Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of Helmholtz Association Grant 051_40001 and Deutsche Forschungsgemeinschaft Grant SFB 655, "Cells into tissues," Project A24. Ingo Uphues and Michael Mark are employees of Boehringer Ingelheim and thus contributed to study design, data analysis, and preparation of the manuscript.	Androutsellis-Theotokis A, 2008, COLD SH Q B, V73, P403, DOI 10.1101/sqb.2008.73.018; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010841; Androutsellis-Theotokis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009414; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; D'Amico E, 2005, J MOL ENDOCRINOL, V34, P377, DOI 10.1677/jme.1.01655; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Fujimoto K, 2009, DIABETES OBES METAB, V11, P30, DOI 10.1111/j.1463-1326.2009.01121.x; Gigoux V, 2008, REGUL PEPTIDES, V146, P88, DOI 10.1016/j.regpep.2007.08.020; GOKE R, 1993, J BIOL CHEM, V268, P19650; Gouti M, 2008, STEM CELLS, V26, P1985, DOI 10.1634/stemcells.2008-0182; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Hirata H, 2000, J BIOL CHEM, V275, P19083, DOI 10.1074/jbc.M001075200; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hirata H, 2001, EMBO J, V20, P4454, DOI 10.1093/emboj/20.16.4454; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Imayoshi I, 2011, MOL NEUROBIOL, V44, P7, DOI 10.1007/s12035-011-8186-0; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kageyama R, 2010, CURR TOP DEV BIOL, V92, P311, DOI 10.1016/S0070-2153(10)92010-3; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Kwon G, 2004, DIABETES, V53, pS225, DOI 10.2337/diabetes.53.suppl_3.S225; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li YH, 2005, DIABETES, V54, P482, DOI 10.2337/diabetes.54.2.482; Ludwig B, 2013, P NATL ACAD SCI USA, V110, P19054, DOI 10.1073/pnas.1317561110; Masjkur J, 2012, CNS NEUROL DISORD-DR, V11, P805, DOI 10.2174/1871527311201070805; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Norquay LD, 2009, ENDOCRINOLOGY, V150, P4531, DOI 10.1210/en.2009-0395; Ohta S, 2012, J CELL SCI, V125, P3210, DOI 10.1242/jcs.102210; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Oya S, 2008, NEUROREPORT, V19, P805, DOI 10.1097/WNR.0b013e3282ff8641; Pacioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051630; Park DM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01095; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Phieler J, 2013, J IMMUNOL, V191, P4367, DOI 10.4049/jimmunol.1300038; Poser SW, 2013, JOVE-J VIS EXP, DOI 10.3791/50880; Poser SW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00273; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Rooman I, 2002, DIABETES, V51, P686, DOI 10.2337/diabetes.51.3.686; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Salewski RP, 2013, STEM CELLS DEV, V22, P383, DOI 10.1089/scd.2012.0218; Suarez-Pinzon WL, 2005, J CLIN ENDOCR METAB, V90, P3401, DOI 10.1210/jc.2004-0761; Tanabe K, 1997, BIOCHEM BIOPH RES CO, V241, P765, DOI 10.1006/bbrc.1997.7894; Ueo T, 2012, DEVELOPMENT, V139, P1071, DOI 10.1242/dev.069070; Van de Velde S, 2011, P NATL ACAD SCI USA, V108, P16876, DOI 10.1073/pnas.1114228108; WANG TC, 1993, J CLIN INVEST, V92, P1349, DOI 10.1172/JCI116708; Zhang CC, 2012, CLIN CANCER RES, V18, P5008, DOI 10.1158/1078-0432.CCR-12-1379	51	7	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35503	35516		10.1074/jbc.M114.590687	http://dx.doi.org/10.1074/jbc.M114.590687			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25371201	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000346660200039
J	Hilwi, M; Dayan, O; Kanner, BI				Hilwi, Maram; Dayan, Oshrat; Kanner, Baruch I.			Conformationally Sensitive Proximity of Extracellular Loops 2 and 4 of the gamma-Aminobutyric Acid (GABA) Transporter GAT-1 Inferred from Paired Cysteine Mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Conformational Change; Cysteine-mediated Cross-linking; Disulfide; Neurotransmitter Transport; Sulfhydryl; GABA	NEURONAL GLUTAMATE TRANSPORTER; DOPAMINE TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; SEROTONIN TRANSPORTER; XENOPUS OOCYTES; RAT-BRAIN; SUBSTRATE; SITE; IDENTIFICATION; EQUILIBRIUM	Background: Extracellular loop 2 of GAT-1 contains two conserved cysteines. Results: Transport by an extracellular loop 4 cysteine mutant is inhibited under oxidizing conditions. Conclusion: Transport is accompanied by proximity changes between extracellular loops 2 and 4. Significance: This work provides new insights into the molecular mechanism of neurotransmitter transport. The sodium- and chloride-coupled GABA transporter GAT-1 is a member of the neurotransmitter:sodium:symporters, which are crucial for synaptic transmission. Structural work on the bacterial homologue LeuT suggests that extracellular loop 4 closes the extracellular solvent pathway when the transporter becomes inward-facing. To test whether this model can be extrapolated to GAT-1, cysteine residues were introduced at positions 359 and 448 of extracellular loop 4 and transmembrane helix 10, respectively. Treatment of HeLa cells, expressing the double cysteine mutant S359C/K448C with the oxidizing reagent copper(II)(1,10-phenantroline)(3), resulted in a significant inhibition of [H-3]GABA transport. However, transport by the single cysteine mutant S359C was also inhibited by the oxidant, whereas its activity was almost 4-fold stimulated by dithiothreitol. Both effects were attenuated when the conserved cysteine residues, Cys-164 and/or Cys-173, were replaced by serine. These cysteines are located in extracellular loop 2, the role of which in the structure and function of the eukaryotic neurotransmitter:sodium:symporters remains unknown. The inhibition of transport of S359C by the oxidant was markedly reduced under conditions expected to increase the proportion of inward-facing transporters, whereas the reactivity of the mutants to a membrane-impermeant sulfhydryl reagent was not conformationally sensitive. Our data suggest that extracellular loops 2 and 4 come into close proximity to each other in the outward-facing conformation of GAT-1.	[Hilwi, Maram; Dayan, Oshrat; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, POB 12272, IL-91120 Jerusalem, Israel.	baruch.kanner@mail.huji.ac.il			Israel Science Foundation [804/11]; Rosetrees Trust	Israel Science Foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust)	This work was supported by Israel Science Foundation Grant 804/11 and by a grant from the Rosetrees Trust.	Ben-Yona A, 2012, J BIOL CHEM, V287, P7159, DOI 10.1074/jbc.M111.323634; Ben-Yona A, 2011, J BIOL CHEM, V286, P2826, DOI 10.1074/jbc.M110.149732; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen R, 2007, MOL CELL BIOCHEM, V298, P41, DOI 10.1007/s11010-006-9348-7; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KANNER BI, 1994, J EXP BIOL, V196, P237; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Nelson N, 1998, J NEUROCHEM, V71, P1785; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Shabaneh M, 2014, J BIOL CHEM, V289, P11175, DOI 10.1074/jbc.M114.550277; Stockner T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002909; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zomot E, 2005, J BIOL CHEM, V280, P25512, DOI 10.1074/jbc.M503864200	32	2	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34258	34266		10.1074/jbc.M114.593061	http://dx.doi.org/10.1074/jbc.M114.593061			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25339171	hybrid, Green Published			2022-12-28	WOS:000346077600048
J	Izaguirre, G; Aguila, S; Qi, LX; Swanson, R; Roth, R; Rezaie, AR; Gettins, PGW; Olson, ST				Izaguirre, Gonzalo; Aguila, Sonia; Qi, Lixin; Swanson, Richard; Roth, Ryan; Rezaie, Alireza R.; Gettins, Peter G. W.; Olson, Steven T.			Conformational Activation of Antithrombin by Heparin Involves an Altered Exosite Interaction with Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Antithrombin (AT); Heparin; Protease; Serpin; Anticoagulant; Blood Coagulation; Exosite	FACTOR-XA; FACTOR-IXA; TERNARY COMPLEX; INHIBITOR SPECIFICITY; ALLOSTERIC MECHANISM; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; RAPID INHIBITION; BASIC RESIDUES; AUTOLYSIS LOOP	Background: Exosites are known to mediate heparin allosteric activation of antithrombin. Results: Mutagenesis revealed that an exosite differentially contributes to antithrombin reactivity with factors Xa/IXa in unactivated and heparin-activated states. Conclusion: Heparin allosteric activation of antithrombin results from alterations in an exosite interaction with protease induced by core conformational changes. Significance: The findings support our recently proposed model of antithrombin allosteric activation. Heparin allosterically activates antithrombin as an inhibitor of factors Xa and IXa by enhancing the initial Michaelis complex interaction of inhibitor with protease through exosites. Here, we investigate the mechanism of this enhancement by analyzing the effects of alanine mutations of six putative antithrombin exosite residues and three complementary protease exosite residues on antithrombin reactivity with these proteases in unactivated and heparin-activated states. Mutations of antithrombin Tyr(253) and His(319) exosite residues produced massive 10-200-fold losses in reactivity with factors Xa and IXa in both unactivated and heparin-activated states, indicating that these residues made critical attractive interactions with protease independent of heparin activation. By contrast, mutations of Asn(233), Arg(235), Glu(237), and Glu(255) exosite residues showed that these residues made both repulsive and attractive interactions with protease that depended on the activation state and whether the critical Tyr(253)/His(319) residues were mutated. Mutation of factor Xa Arg(143), Lys(148), and Arg(150) residues that interact with the exosite in the x-ray structure of the Michaelis complex confirmed the importance of all residues for heparin-activated antithrombin reactivity and Arg(150) for native serpin reactivity. These results demonstrate that the exosite is a key determinant of antithrombin reactivity with factors Xa and IXa in the native as well as the heparin-activated state and support a new model of allosteric activation we recently proposed in which a balance between attractive and repulsive exosite interactions in the native state is shifted to favor the attractive interactions in the activated state through core conformational changes induced by heparin binding.	[Izaguirre, Gonzalo; Qi, Lixin; Swanson, Richard; Roth, Ryan; Olson, Steven T.] Univ Illinois, Dept Periodont, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA; [Aguila, Sonia] Univ Murcia, Ctr Reg Hemodonac, Murcia 30003, Spain; [Rezaie, Alireza R.] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Murcia; Saint Louis University	Izaguirre, G (corresponding author), 801 S Paulina St,MC 860, Chicago, IL 60612 USA.	goniza@uic.edu	Aguila, Sonia/Q-2822-2019	Aguila, Sonia/0000-0001-5794-5177	National Institutes of Health [R37 HL39888, R01 HL62565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888, R01HL062565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 HL39888 (to S. T. O.) and R01 HL62565 (to A. R. R.).	Backovic M, 2002, J PROTEOME RES, V1, P367, DOI 10.1021/pr025515z; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Chuang YJ, 2001, J BIOL CHEM, V276, P14961, DOI 10.1074/jbc.M011550200; Chuang YJ, 2001, BIOCHEMISTRY-US, V40, P6670, DOI 10.1021/bi002933d; DEAGOSTINI AI, 1990, J CELL BIOL, V111, P1293, DOI 10.1083/jcb.111.3.1293; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Dementiev A, 2013, J BIOL CHEM, V288, P33611, DOI 10.1074/jbc.M113.510727; Futamura A, 2000, J BIOL CHEM, V275, P4092, DOI 10.1074/jbc.275.6.4092; Gettins PGW, 2009, FEBS LETT, V583, P3397, DOI 10.1016/j.febslet.2009.10.005; GRAHAM JA, 1992, J CLIN PATHOL, V45, P921, DOI 10.1136/jcp.45.10.921; Ishiguro K, 2000, J CLIN INVEST, V106, P873, DOI 10.1172/JCI10489; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Izaguirre G, 2009, J BIOL CHEM, V284, P1550, DOI 10.1074/jbc.M807340200; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2006, J BIOL CHEM, V281, P35478, DOI 10.1074/jbc.M607204200; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; Johnson DJD, 2003, BIOCHEMISTRY-US, V42, P8712, DOI 10.1021/bi034524y; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langdown J, 2009, J MOL BIOL, V386, P1278, DOI 10.1016/j.jmb.2009.01.028; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Liu Y, 2014, BLOOD, V124, P142, DOI 10.1182/blood-2014-03-561027; Manithody C, 2002, BIOCHEMISTRY-US, V41, P6780, DOI 10.1021/bi0255367; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; MILLAR DS, 1994, HUM GENET, V94, P509; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Olson ST, 2010, BIOCHIMIE, V92, P1587, DOI 10.1016/j.biochi.2010.05.011; Petitou M, 2003, BIOCHIMIE, V85, P83, DOI 10.1016/S0300-9084(03)00078-6; Pike RN, 1997, J BIOL CHEM, V272, P19652, DOI 10.1074/jbc.272.32.19652; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; vanBoven HH, 1997, SEMIN HEMATOL, V34, P188; Whisstock JC, 2000, J MOL BIOL, V301, P1287, DOI 10.1006/jmbi.2000.3982; Yang LK, 2003, J BIOL CHEM, V278, P25032, DOI 10.1074/jbc.M302174200	37	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34049	34064		10.1074/jbc.M114.611707	http://dx.doi.org/10.1074/jbc.M114.611707			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25331949	Green Published, hybrid			2022-12-28	WOS:000346077600031
J	Ginsburg, DS; Anlembom, TE; Wang, JN; Patel, SR; Li, B; Hinnebusch, AG				Ginsburg, Daniel S.; Anlembom, Timi Elvuchio; Wang, Jianing; Patel, Sanket R.; Li, Bing; Hinnebusch, Alan G.			NuA4 Links Methylation of Histone H3 Lysines 4 and 36 to Acetylation of Histones H4 and H3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR GCN4P; POL II CTD; SACCHAROMYCES-CEREVISIAE; SAGA COMPLEX; GENOME-WIDE; H2B MONOUBIQUITINATION; CRYPTIC TRANSCRIPTION; DEACETYLASE COMPLEX; CODING REGIONS; GENE DELETION	Cotranscriptional methylation of histone H3 lysines 4 and 36 by Set1 and Set2, respectively, stimulates interaction between nucleosomes and histone deacetylase complexes to block cryptic transcription in budding yeast. We previously showed that loss of all H3K4 and H3K36 methylation in a set1 Delta set2 Delta mutant reduces interaction between native nucleosomes and the NuA4 lysine acetyltransferase (KAT) complex. We now provide evidence that NuA4 preferentially binds H3 tails mono- and dimethylated on H3K4 and di- and trimethylated on H3K36, an H3 methylation pattern distinct from that recognized by the RPD3C(S) and Hos2/Set3 histone deacetylase complexes (HDACs). Loss of H3K4 or H3K36 methylation in set1 Delta or set2 Delta mutants reduces NuA4 interaction with bulk nucleosomes in vitro and in vivo, and reduces NuA4 occupancy of transcribed coding sequences at particular genes. We also provide evidence that NuA4 acetylation of lysine residues in the histone H4 tail stimulates SAGA interaction with nucleosomes and its recruitment to coding sequences and attendant acetylation of histone H3 in vivo. Thus, H3 methylation exerts opposing effects of enhancing nucleosome acetylation by both NuA4 and SAGA as well as stimulating nucleosome deacetylation by multiple HDACs to maintain the proper level of histone acetylation in transcribed coding sequences.	[Ginsburg, Daniel S.; Anlembom, Timi Elvuchio; Wang, Jianing; Patel, Sanket R.] LIU Post, Dept Biomed Sci, Brookville, NY 11548 USA; [Li, Bing] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Hinnebusch, Alan G.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ginsburg, DS (corresponding author), Dept Biomed Sci, 720 Northern Blvd, Brookville, NY 11548 USA.	daniel.ginsburg@liu.edu		wang, jianing/0000-0002-2191-5627	National Institutes of Health Intramural Research Program; LIU Post Campus Faculty Research Committee; National Institutes of Health [R01GM090077]; Welch Foundation [I-1713]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090077] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LIU Post Campus Faculty Research Committee; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program and the LIU Post Campus Faculty Research Committee.; W.A. "Tex" Moncrief, Jr. Scholar in Medical Research and supported by National Institutes of Health Grant R01GM090077 and Welch Foundation Grant I-1713.	Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Biswas D, 2008, MOL CELL BIOL, V28, P4445, DOI 10.1128/MCB.00164-08; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brower-Toland B, 2005, J MOL BIOL, V346, P135, DOI 10.1016/j.jmb.2004.11.056; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Hassan AH, 2007, BIOCHEM J, V402, P125, DOI 10.1042/BJ20060907; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Li SS, 2009, J BIOL CHEM, V284, P9411, DOI 10.1074/jbc.M809617200; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Nourani A, 2001, MOL CELL BIOL, V21, P7629, DOI 10.1128/MCB.21.22.7629-7640.2001; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Qiu HF, 2005, MOL CELL BIOL, V25, P3461, DOI 10.1128/MCB.25.9.3461-3474.2005; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Rasband W., 2006, IMAGEJ; REID GA, 1982, J BIOL CHEM, V257, P3056; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Smolle M, 2013, BBA-GENE REGUL MECH, V1829, P84, DOI 10.1016/j.bbagrm.2012.08.008; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	54	25	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.585588	http://dx.doi.org/10.1074/jbc.M114.585588			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25301943	Green Published, hybrid			2022-12-28	WOS:000345335000023
J	Choi, YS; Lee, YJ; Lee, SY; Shi, L; Ha, JH; Cheong, HK; Cheong, C; Cohen, RE; Ryu, KS				Choi, Yun-Seok; Lee, Yun-Ju; Lee, Seo-Yeon; Shi, Lei; Ha, Jung-Hye; Cheong, Hae-Kap; Cheong, Chaejoon; Cohen, Robert E.; Ryu, Kyoung-Seok			Differential Ubiquitin Binding by the Acidic Loops of Ube2g1 and Ube2r1 Enzymes Distinguishes Their Lys-48-ubiquitylation Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYME; CRYSTAL-STRUCTURE; HUMAN CDC34; MECHANISM; REVEALS; COMPLEX; SYSTEM; INTERMEDIATE; SUBSTRATE; E2	The ubiquitin E2 enzymes, Ube2g1 and Ube2r1, are able to synthesize Lys-48-linked polyubiquitins without an E3 ligase but how that is accomplished has been unclear. Although both E2s contain essential acidic loops, only Ube2r1 requires an additional C-terminal extension (184-196) for efficient Lys-48-ubiquitylation activity. The presence of Tyr-102 and Tyr-104 in the Ube2g1 acidic loop enhanced both ubiquitin binding and Lys-48-ubiquitylation and distinguished Ube2g1 from the otherwise similar truncated Ube2r1(1-183) (Ube2r1C). Replacement of Gln-105-Ser-106-Gly-107 in the acidic loop of Ube2r1C (Ube2r1C(YGY)) by the corresponding residues from Ube2g1 (Tyr-102-Gly-103-Tyr-104) increased Lys-48-ubiquitylation activity and ubiquitin binding. Two E2 similar to UB thioester mimics (oxyester and disulfide) were prepared to characterize the ubiquitin binding activity of the acidic loop. The oxyester but not the disulfide derivative was found to be a functional equivalent of the E2 similar to UB thioester. The ubiquitin moiety of the Ube2r1C(C93S)-[N-15]UBK48R oxyester displayed two-state conformational exchange, whereas the Ube2r1C(C93S/YGY)-[N-15]UBK48R oxyester showed predominantly one state. Together with NMR studies that compared UBK48R oxyesters of the wild-type and the acidic loop mutant (Y102G/Y104G) forms of Ube2g1, in vitro ubiquitylation assays with various mutation forms of the E2s revealed how the intramolecular interaction between the acidic loop and the attached donor ubiquitin regulates Lys-48-ubiquitylation activity.	[Choi, Yun-Seok; Lee, Yun-Ju; Lee, Seo-Yeon; Ha, Jung-Hye; Cheong, Hae-Kap; Cheong, Chaejoon; Ryu, Kyoung-Seok] Korea Basic Sci Inst, Div Magnet Resonance, Chungcheongbuk Do 363883, South Korea; [Choi, Yun-Seok; Ha, Jung-Hye; Cheong, Chaejoon; Ryu, Kyoung-Seok] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon 305333, South Korea; [Shi, Lei] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Choi, Yun-Seok; Cohen, Robert E.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80521 USA	Korea Basic Science Institute (KBSI); University of Washington; University of Washington Seattle; Colorado State University	Ryu, KS (corresponding author), Korea Basic Sci Inst, Div Magnet Resonance, Ochang Campus,Yangcheong Ri 804-1, Chungcheongbuk Do 363883, South Korea.	ksryu@kbsi.re.kr	Cheong, Chaejoon/GWC-3135-2022		National Institutes of Health [GM097452]; Korea Basic Science Institute (KBSI); KBSI [T33410]; University of Science and Technology Post-Doc research program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Basic Science Institute (KBSI); KBSI; University of Science and Technology Post-Doc research program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM097452 (to R. E. C.). This study was also supported by the high-field NMR research program from Korea Basic Science Institute (KBSI; to K.-S. R.) and KBSI Grant T33410 (to H.-K. C.).; Supported by University of Science and Technology Post-Doc research program.	Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Choi YS, 2010, J BIOL CHEM, V285, P17754, DOI 10.1074/jbc.M109.090621; Choi YS, 2009, FEBS LETT, V583, P3323, DOI 10.1016/j.febslet.2009.09.034; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Fiaux J, 2004, J BIOMOL NMR, V29, P289, DOI 10.1023/B:JNMR.0000032523.00554.38; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; Goddard T. D., SPARKY 3; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Houben K, 2004, J MOL BIOL, V344, P513, DOI 10.1016/j.jmb.2004.09.054; Ju TT, 2010, PROTEINS, V78, P1291, DOI 10.1002/prot.22648; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Liu WX, 2014, EMBO J, V33, P46, DOI 10.1002/embj.201385315; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Merkley N, 2005, J BIOL CHEM, V280, P31732, DOI 10.1074/jbc.M505205200; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Ryu KS, 2008, BMB REP, V41, P852, DOI 10.5483/BMBRep.2008.41.12.852; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shekhtman A, 2002, FEBS LETT, V524, P177, DOI 10.1016/S0014-5793(02)03051-X; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Spratt DE, 2011, J MOL BIOL, V407, P425, DOI 10.1016/j.jmb.2011.01.047; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501	39	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2251	2263		10.1074/jbc.M114.624809	http://dx.doi.org/10.1074/jbc.M114.624809			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25471371	hybrid, Green Published			2022-12-28	WOS:000348588000029
J	McGillivray, A; Golden, NA; Kaushal, D				McGillivray, Amanda; Golden, Nadia A.; Kaushal, Deepak			The Mycobacterium tuberculosis Clp Gene Regulator Is Required for in Vitro Reactivation from Hypoxia-induced Dormancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN-ANTITOXIN SYSTEMS; SIGMA-FACTOR; PROTEOLYTIC COMPLEXES; PROTEASE; SUSCEPTIBILITY; VIRULENCE; DOSR	Mycobacterium tuberculosis (Mtb) is the leading cause of death from an infectious disease worldwide and is the causative agent of tuberculosis (Chao, M. C., and Rubin, E. J. (2010) Annu. Rev. Microbiol. 64, 293-311). Throughout infection, Mtb encounters a variety of host pressures. Thus, responding to these host stresses via the induction of multiple regulatory networks is needed for survival within the host. The Clp protease gene regulator, Rv2745c (clgR), is induced in response to environmental stress conditions, implicating its potential role in Mtb pathogenesis. Transcriptional activation of genes downstream of Rv2745c occurs in a condition-dependent manner. Our isogenic Mtb:Delta Rv2745c mutant expresses a significantly different phenotype upon reaeration conditions. Transcriptional analysis revealed differential gene expression profiles relative to wild-type Mtb. Rv2745c is strongly induced in response to hypoxic and reaeration conditions, implicating a role of Rv2745c in vivo during both establishment of infection and reactivation. We found dysregulation of downstream genes within both the sigma(H)/sigma(E) regulon as well as the dosR regulon in the isogenic mutant, Mtb:Delta Rv2745c. Upon hypoxic and reaeration conditions, Clp protease induction occurred within wild-type Mtb, indicating that activation of clgR, which subsequently leads to Clp protease induction, is crucial for degradation of misfolded proteins and ultimately survival of Mtb upon specific stress conditions. Our data indicate the diverse response of Rv2745c, sigma(H) and sigma(E) in response to a variety of stress conditions. Activation of Rv2745c in response to various stress conditions leads to differential activation of downstream genes, indicating the diverse role of Rv2745c and its importance for Mtb survival in vivo.	[McGillivray, Amanda; Golden, Nadia A.; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, Covington, LA 70433 USA	Tulane University	Kaushal, D (corresponding author), Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, 18703 Three Rivers Rd, Covington, LA 70433 USA.	dkaushal@tulane.edu			National Institutes of Health [R01AI089323]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089323] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI089323.	Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Bhat SA, 2012, FREE RADICAL BIO MED, V53, P1625, DOI 10.1016/j.freeradbiomed.2012.08.008; Bretl DJ, 2011, MICROBIOL MOL BIOL R, V75, P566, DOI 10.1128/MMBR.05004-11; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Chauhan S, 2009, J BACTERIOL, V191, P6075, DOI 10.1128/JB.00310-09; Chen T, 2013, J CELL BIOCHEM, V114, P1, DOI 10.1002/jcb.24302; Choudhary E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089759; Cilfone NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068680; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; Dutta NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010069; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gautam US, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095220; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Katti MK, 2008, CELL MICROBIOL, V10, P1286, DOI 10.1111/j.1462-5822.2008.01126.x; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Lee ASG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031934; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; McGillivray A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093604; McGillivray SM, 2012, ANTIMICROB AGENTS CH, V56, P1854, DOI 10.1128/AAC.05131-11; Mehra S, 2010, J INFECT DIS, V202, P943, DOI 10.1086/654820; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Ocheretina O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090569; Ollinger J, 2012, J BACTERIOL, V194, P663, DOI 10.1128/JB.06142-11; Parish T, 2014, CHEM BIOL, V21, P437, DOI 10.1016/j.chembiol.2014.04.002; Personne Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060228; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Raju RM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003994; Raju RM, 2012, NAT REV DRUG DISCOV, V11, P777, DOI 10.1038/nrd3846; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russell DG, 2013, CURR OPIN MICROBIOL, V16, P78, DOI 10.1016/j.mib.2012.11.007; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Sachdeva P, 2010, FEBS J, V277, P605, DOI 10.1111/j.1742-4658.2009.07479.x; Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002; Sala A, 2013, CELL STRESS CHAPERON, V18, P129, DOI 10.1007/s12192-012-0396-5; Sherrid AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011622; Singh S, 2014, VACCINE, V32, P712, DOI 10.1016/j.vaccine.2013.11.065; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	46	30	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2351	2367		10.1074/jbc.M114.615534	http://dx.doi.org/10.1074/jbc.M114.615534			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25422323	hybrid, Green Published			2022-12-28	WOS:000348588000039
J	Chen, ZH; Yu, YP; Michalopoulos, G; Nelson, J; Luo, JH				Chen, Zhang-Hui; Yu, Yan P.; Michalopoulos, George; Nelson, Joel; Luo, Jian-Hua			The DNA Replication Licensing Factor Miniature Chromosome Maintenance 7 Is Essential for RNA Splicing of Epidermal Growth Factor Receptor, c-Met, and Platelet-derived Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER GROWTH; CELL-DEATH; HELICASE ACTIVITY; PROTEIN COMPLEX; MCM7; INTERACTS; BINDING; IDENTIFICATION; METASTASIS; FAMILY	Miniature chromosome maintenance 7 (MCM7) is an essential component of DNA replication licensing complex. Recent studies indicate that MCM7 is amplified and overexpressed in a variety of human malignancies. In this report, we show that MCM7 binds SF3B3. The binding motif is located in the N terminus (amino acids 221-248) of MCM7. Knockdown of MCM7 or SF3B3 significantly increased unspliced RNA of epidermal growth factor receptor, platelet-derived growth factor receptor, and c-Met. A dramatic drop of reporter gene expression of the oxytocin exon 1-intron-exon 2-EGFP construct was also identified in SF3B3 and MCM7 knockdown PC3 and DU145 cells. The MCM7 or SF3B3 depleted cell extract failed to splice reporter RNA in in vitro RNA splicing analyses. Knockdown of SF3B3 and MCM7 leads to an increase of cell death of both PC3 and DU145 cells. Such cell death induction is partially rescued by expressing spliced c-Met. To our knowledge, this is the first report suggesting that MCM7 is a critical RNA splicing factor, thus giving significant new insight into the oncogenic activity of this protein.	[Chen, Zhang-Hui; Yu, Yan P.; Michalopoulos, George; Luo, Jian-Hua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [Nelson, Joel] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Luo, JH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Scaife Hall S-728, Pittsburgh, PA 15261 USA.	luoj@msx.upmc.edu	Luo, jian/HGE-7331-2022		National Cancer Institute [RO1 CA098249]; American Cancer Society [RSG-08-137-01-CNE]; NATIONAL CANCER INSTITUTE [R01CA098249] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Grant RO1 CA098249 (to J.-H. L.) and American Cancer Society Grant RSG-08-137-01-CNE (to Y. P. Y.).	Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Brake T, 2003, CANCER RES, V63, P8173; Brand M, 2001, EMBO J, V20, P3187, DOI 10.1093/emboj/20.12.3187; Chong JPJ, 1996, TRENDS BIOCHEM SCI, V21, P102, DOI 10.1016/0968-0004(96)10013-X; COXON A, 1992, NUCLEIC ACIDS RES, V20, P5571, DOI 10.1093/nar/20.21.5571; DALTON S, 1995, P NATL ACAD SCI USA, V92, P2514, DOI 10.1073/pnas.92.7.2514; Das BK, 1999, MOL CELL BIOL, V19, P6796; Gladden AB, 2003, J BIOL CHEM, V278, P9754, DOI 10.1074/jbc.M212088200; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Han YC, 2010, CANCER RES, V70, P4375, DOI 10.1158/0008-5472.CAN-09-4403; Honeycutt KA, 2006, ONCOGENE, V25, P4027, DOI 10.1038/sj.onc.1209435; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Kearsey SE, 1996, BIOESSAYS, V18, P183, DOI 10.1002/bies.950180305; Luo JH, 2011, WORLD J CLIN ONCOL, V2, P120, DOI 10.5306/wjco.v2.i2.120; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Masuhiro Y, 2005, P NATL ACAD SCI USA, V102, P8126, DOI 10.1073/pnas.0503197102; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Romanowski P, 1996, P NATL ACAD SCI USA, V93, P10189, DOI 10.1073/pnas.93.19.10189; Shi YK, 2010, CANCER GENE THER, V17, P694, DOI 10.1038/cgt.2010.25; Shi YK, 2008, AM J PATHOL, V173, P1758, DOI 10.2353/ajpath.2008.080363; Wang H, 2012, J BIOL CHEM, V287, P16890, DOI 10.1074/jbc.M111.322636; You ZY, 1999, MOL CELL BIOL, V19, P8003; Yu YP, 2007, CANCER RES, V67, P8043, DOI 10.1158/0008-5472.CAN-07-0648; Yu YP, 2006, CANCER RES, V66, P7414, DOI 10.1158/0008-5472.CAN-06-0227; Zhang XY, 2013, AM J PATHOL, V182, P796, DOI 10.1016/j.ajpath.2012.11.020; Zhu ZH, 2009, ONCOGENE, V28, P41, DOI 10.1038/onc.2008.359; Zhu ZH, 2010, AM J PATHOL, V177, P1176, DOI 10.2353/ajpath.2010.091026	30	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1404	1411		10.1074/jbc.M114.622761	http://dx.doi.org/10.1074/jbc.M114.622761			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25425645	hybrid, Green Published			2022-12-28	WOS:000348056400010
J	White, MR; Khan, MM; Deredge, D; Ross, CR; Quintyn, R; Zucconi, BE; Wysocki, VH; Wintrode, PL; Wilson, GM; Garcin, ED				White, Michael R.; Khan, Mohd M.; Deredge, Daniel; Ross, Christina R.; Quintyn, Royston; Zucconi, Beth E.; Wysocki, Vicki H.; Wintrode, Patrick L.; Wilson, Gerald M.; Garcin, Elsa D.			A Dimer Interface Mutation in Glyceraldehyde-3-Phosphate Dehydrogenase Regulates Its Binding to AU-rich RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN-CANCER CELLS; ALPHA MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; HIGH-RESOLUTION; 3-PHOSPHATE DEHYDROGENASE; REVERSIBLE DISSOCIATION; ADENOSINE-TRIPHOSPHATE; NUCLEAR TRANSLOCATION; FUNCTIONAL DIVERSITY; MASS-SPECTROMETRY	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an enzyme best known for its role in glycolysis. However, extra-glycolytic functions of GAPDH have been described, including regulation of protein expression via RNA binding. GAPDH binds to numerous adenine-uridine rich elements (AREs) from various mRNA 3'-untranslated regions in vitro and in vivo despite its lack of a canonical RNA binding motif. How GAPDH binds to these AREs is still unknown. Here we discovered that GAPDH binds with high affinity to the core ARE from tumor necrosis factor-alpha mRNA via a two-step binding mechanism. We demonstrate that a mutation at the GAPDH dimer interface impairs formation of the second RNA-GAPDH complex and leads to changes in the RNA structure. We investigated the effect of this interfacial mutation on GAPDH oligomerization by crystallography, small-angle x-ray scattering, nano-electrospray ionization native mass spectrometry, and hydrogen-deuterium exchange mass spectrometry. We show that the mutation does not significantly affect GAPDH tetramerization as previously proposed. Instead, the mutation promotes short-range and long-range dynamic changes in regions located at the dimer and tetramer interface and in the NAD+ binding site. These dynamic changes are localized along the P axis of the GAPDH tetramer, suggesting that this region is important for RNA binding. Based on our results, we propose a model for sequential GAPDH binding to RNA via residues located at the dimer and tetramer interfaces.	[White, Michael R.; Khan, Mohd M.; Garcin, Elsa D.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA; [Deredge, Daniel; Wintrode, Patrick L.] Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 21201 USA; [Ross, Christina R.; Zucconi, Beth E.; Wilson, Gerald M.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA; [Quintyn, Royston; Wysocki, Vicki H.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Ohio; Ohio State University	Garcin, ED (corresponding author), Univ Maryland Baltimore Cty, Dept Chem & Biochem, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	egarcin@umbc.edu	Garcin, Elsa D/C-1556-2013; Wilson, Gerald/AAF-3874-2019; Khan, Mohd M./D-4451-2015	Garcin, Elsa D/0000-0003-0501-8421; Khan, Mohd M./0000-0003-2793-1705; Wilson, Gerald/0000-0002-1273-7507; Wysocki, Vicki/0000-0003-0495-2538	National Institutes of Health [R01 CA102428, T32 GM066706]; National Science Foundation [DBI 0923551]; American Heart Association [PRE6900008]; NATIONAL CANCER INSTITUTE [R01CA102428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 CA102428 (to G. M. W.). This work was also supported in part by National Science Foundation Grant DBI 0923551 (to V. H. W.) and the American Heart Association Grant PRE6900008 (to B. E. Z.).; Supported in part by National Institutes of Health Grant T32 GM066706.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Backlund M, 2009, NUCLEIC ACIDS RES, V37, P2346, DOI 10.1093/nar/gkp098; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; BAXI MD, 1995, BIOCHEMISTRY-US, V34, P9700, DOI 10.1021/bi00030a007; Bonafe N, 2005, CANCER RES, V65, P3762, DOI 10.1158/0008-5472.CAN-04-3954; Brewer G, 2003, J INTERF CYTOK RES, V23, P553, DOI 10.1089/107999003322485053; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Carmona P, 1999, BBA-PROTEIN STRUCT M, V1432, P222, DOI 10.1016/S0167-4838(99)00113-2; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Chang BS, 1996, J PHARM SCI, V85, P1325, DOI 10.1021/js960080y; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; CONSTANTINIDES SM, 1969, J BIOL CHEM, V244, P5695; De BP, 1996, J BIOL CHEM, V271, P24728, DOI 10.1074/jbc.271.40.24728; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evguenieva-Hackenberg E, 2002, J BIOL CHEM, V277, P46145, DOI 10.1074/jbc.M208717200; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Galhena AS, 2008, ANAL CHEM, V80, P1425, DOI 10.1021/ac701782q; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; GRIKO YV, 1988, P NATL ACAD SCI USA, V85, P3343, DOI 10.1073/pnas.85.10.3343; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HOAGLAND VD, 1969, BIOCHEMISTRY-US, V8, P594, DOI 10.1021/bi00830a020; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Huang QJ, 2011, J BIOL CHEM, V286, P42211, DOI 10.1074/jbc.M111.296905; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; Jia J, 2012, MOL CELL, V47, P656, DOI 10.1016/j.molcel.2012.06.006; KARPEL RL, 1981, BIOCHIM BIOPHYS ACTA, V654, P256, DOI 10.1016/0005-2787(81)90180-5; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kramer K, 2014, NAT METHODS, V11, P1064, DOI [10.1038/NMETH.3092, 10.1038/nmeth.3092]; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; Mazzola JL, 2002, MOL BRAIN RES, V100, P95, DOI 10.1016/S0169-328X(02)00160-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MURONETZ VI, 1994, ARCH BIOCHEM BIOPHYS, V313, P253, DOI 10.1006/abbi.1994.1385; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Nagy E, 2000, BIOCHEM BIOPH RES CO, V275, P253, DOI 10.1006/bbrc.2000.3246; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nicholls C, 2012, P NATL ACAD SCI USA, V109, P13308, DOI 10.1073/pnas.1206672109; Norman DG, 2000, BIOCHEMISTRY-US, V39, P6317, DOI 10.1021/bi992944a; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park J, 2009, BBA-PROTEINS PROTEOM, V1794, P254, DOI 10.1016/j.bbapap.2008.10.003; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; PERUCHO M, 1977, EUR J BIOCHEM, V81, P557, DOI 10.1111/j.1432-1033.1977.tb11982.x; PERUCHO M, 1980, BIOCHIM BIOPHYS ACTA, V606, P181, DOI 10.1016/0005-2787(80)90028-3; Rodriguez-Pascual F, 2008, MOL CELL BIOL, V28, P7139, DOI 10.1128/MCB.01145-08; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Schultz DE, 1996, J BIOL CHEM, V271, P14134, DOI 10.1074/jbc.271.24.14134; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Shim J, 2002, MOL CELLS, V14, P323; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; STANCEL GM, 1969, BIOCHEMISTRY-US, V8, P4005, DOI 10.1021/bi00838a017; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Ventura M, 2010, INT J BIOCHEM CELL B, V42, P1672, DOI 10.1016/j.biocel.2010.06.014; Wang EH, 1997, CANCER RES, V57, P5426; Wang RYL, 2008, CELL HOST MICROBE, V3, P178, DOI 10.1016/j.chom.2008.02.005; White EJF, 2013, BBA-GENE REGUL MECH, V1829, P680, DOI 10.1016/j.bbagrm.2012.12.002; Wilson GM, 1999, J BIOL CHEM, V274, P33374, DOI 10.1074/jbc.274.47.33374; Wilson GM, 2001, J BIOL CHEM, V276, P38400, DOI 10.1074/jbc.M106509200; Wilson GM, 1999, PROG NUCLEIC ACID RE, V62, P257; Wilson GM, 2001, J BIOL CHEM, V276, P8695, DOI 10.1074/jbc.M009848200; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Yogalingam G, 2013, J BIOL CHEM, V288, P18947, DOI 10.1074/jbc.M113.466870; Zhang A, 2012, PHARM RES-DORDR, V29, P236, DOI 10.1007/s11095-011-0538-y; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; Zhou MW, 2012, ANGEW CHEM INT EDIT, V51, P4336, DOI 10.1002/anie.201108700; Zhou Y, 2008, MOL CANCER RES, V6, P1375, DOI 10.1158/1541-7786.MCR-07-2170; Zucconi BE, 2010, J BIOL CHEM, V285, P39127, DOI 10.1074/jbc.M110.180182	73	28	28	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1770	1785		10.1074/jbc.M114.618165	http://dx.doi.org/10.1074/jbc.M114.618165			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451934	Green Published, hybrid			2022-12-28	WOS:000348056400042
J	Zhao, XM; Liu, C; Jiang, LJ; Li, QY; Zhou, MT; Cheng, TC; Mita, K; Xia, QY				Zhao, Xiao-Ming; Liu, Chun; Jiang, Li-Jun; Li, Qiong-Yan; Zhou, Meng-Ting; Cheng, Ting-Cai; Mita, Kazuei; Xia, Qing-You			A Juvenile Hormone Transcription Factor Bmdimm-Fibroin H Chain Pathway Is Involved in the Synthesis of Silk Protein in Silkworm, Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL HOMOLOG 1; FORK HEAD; GENE-TRANSCRIPTION; GLAND DEVELOPMENT; CRYSTAL-STRUCTURE; DNA-BINDING; DROSOPHILA; EXPRESSION; METAMORPHOSIS; TISSUE	The genes responsible for silk biosynthesis are switched on and off at particular times in the silk glands of Bombyx mori. This switch appears to be under the control of endogenous and exogenous hormones. However, the molecular mechanisms by which silk protein synthesis is regulated by the juvenile hormone (JH) are largely unknown. Here, we report a basic helix-loop-helix transcription factor, Bmdimm, its silk gland-specific expression, and its direct involvement in the regulation of fibroin H-chain (fib-H) by binding to an E-box (CAAATG) element of the fib-H gene promoter. Far-Western blots, enzyme-linked immunosorbent assays, and co-immunoprecipitation assays revealed that Bmdimm protein interacted with another basic helix-loop-helix transcription factor, Bmsage. Immunostaining revealed that Bmdimm and Bmsage proteins are co-localized in nuclei. Bmdimm expression was induced in larval silk glands in vivo, in silk glands cultured in vitro, and in B. mori cell lines after treatment with a JH analog. The JH effect on Bmdimm was mediated by the JH-Met-Kr-h1 signaling pathway, and Bmdimm expression did not respond to JH by RNA interference with double-stranded BmKr-h1 RNA. These data suggest that the JH regulatory pathway, the transcription factor Bmdimm, and the targeted fib-H gene contribute to the synthesis of fibroin H-chain protein in B. mori.	[Zhao, Xiao-Ming; Liu, Chun; Jiang, Li-Jun; Li, Qiong-Yan; Zhou, Meng-Ting; Cheng, Ting-Cai; Mita, Kazuei; Xia, Qing-You] Southwest Univ, Coll Biotechnol, Minist Agr, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China; [Zhao, Xiao-Ming; Liu, Chun; Jiang, Li-Jun; Li, Qiong-Yan; Zhou, Meng-Ting; Cheng, Ting-Cai; Xia, Qing-You] Southwest Univ, Key Sericultural Lab, Minist Agr, Coll Biotechnol, Chongqing 400716, Peoples R China; [Zhao, Xiao-Ming] Shanxi Univ, Res Inst Appl Biol, Taiyuan 030006, Shanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Southwest University - China; Ministry of Agriculture & Rural Affairs; Southwest University - China; Shanxi University	Liu, C (corresponding author), Southwest Univ, Coll Biotechnol, Minist Agr, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.	mlliuchun@163.com; xiaqy@swu.edu.cn	zhao, xiaoming/GNM-5551-2022	cheng, tingcai/0000-0002-3862-0817; Zhao, Xiaoming/0000-0003-2237-3417	National Basic Research Program of China [2012CB114600]; National Hi-Tech Research and Development Program of China [2011AA100306]; Program for New Century Excellent Talents [NCET-11-0699]; National Natural Science Foundation of China [31372380]	National Basic Research Program of China(National Basic Research Program of China); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2012CB114600, National Hi-Tech Research and Development Program of China Grant 2011AA100306, Program for New Century Excellent Talents NCET-11-0699, and the National Natural Science Foundation of China 31372380.	Abrams EW, 2006, DEVELOPMENT, V133, P3517, DOI 10.1242/dev.02525; Aslam AFM, 2011, ZOOL SCI, V28, P609, DOI 10.2108/zsj.28.609; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; Bobrovnik SA, 2003, J BIOCHEM BIOPH METH, V57, P213, DOI 10.1016/S0165-022X(03)00145-3; Chaitanya RK, 2013, GEN COMP ENDOCR, V181, P10, DOI 10.1016/j.ygcen.2012.08.014; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; DAILLIE J, 1979, BIOCHIMIE, V61, P275, DOI 10.1016/S0300-9084(79)80072-3; DURAND B, 1992, MOL CELL BIOL, V12, P5768, DOI 10.1128/MCB.12.12.5768; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Fox RM, 2013, DEVELOPMENT, V140, P2160, DOI 10.1242/dev.092924; GRZELAK K, 1982, MOL CELL ENDOCRINOL, V26, P341, DOI 10.1016/0303-7207(82)90122-8; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; ISHIZAKI H, 1994, INT J DEV BIOL, V38, P301; Kayukawa T, 2014, DEV BIOL, V388, P48, DOI 10.1016/j.ydbio.2014.01.022; Kayukawa T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01570; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kethidi DR, 2004, J BIOL CHEM, V279, P19634, DOI 10.1074/jbc.M311647200; Kimoto M, 2012, DEV GENES EVOL, V222, P351, DOI 10.1007/s00427-012-0418-4; Kokubo H, 1996, DEV GENES EVOL, V206, P80, DOI 10.1007/s004270050033; KURATA K, 1984, Journal of Sericultural Science of Japan, V53, P421; KURATA SI, 1978, CHROMOSOMA, V68, P313, DOI 10.1007/BF00327166; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin Y, 2013, J BIOL CHEM, V288, P13345, DOI 10.1074/jbc.M113.462556; Liu QX, 2000, DEV BIOL, V225, P437, DOI 10.1006/dbio.2000.9836; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; MACH V, 1995, J BIOL CHEM, V270, P9340, DOI 10.1074/jbc.270.16.9340; MAEKAWA H, 1980, DEV BIOL, V78, P394, DOI 10.1016/0012-1606(80)90343-7; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Ohno K, 2013, J BIOL CHEM, V288, P31581, DOI 10.1074/jbc.M113.514471; OHTA S, 1988, DEV GROWTH DIFFER, V30, P293; Pan MH, 2007, IN VITRO CELL DEV-AN, V43, P101, DOI 10.1007/s11626-006-9009-x; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Park D, 2008, MOL CELL BIOL, V28, P410, DOI 10.1128/MCB.01104-07; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; SEHNAL F, 1990, INT J INSECT MORPHOL, V19, P79, DOI 10.1016/0020-7322(90)90022-H; SUZUKI Y, 1986, P NATL ACAD SCI USA, V83, P9522, DOI 10.1073/pnas.83.24.9522; Takiya S, 1997, BIOCHEM J, V321, P645, DOI 10.1042/bj3210645; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRIPOULAS NA, 1986, DEV BIOL, V116, P328, DOI 10.1016/0012-1606(86)90136-3; Wang Y, 2007, DEV GENES EVOL, V217, P715, DOI 10.1007/s00427-007-0184-x; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Xia QY, 2014, ANNU REV ENTOMOL, V59, P513, DOI 10.1146/annurev-ento-011613-161940; XU PX, 1994, J BIOL CHEM, V269, P2733; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]; Zhao XM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094091	54	29	35	3	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					972	986		10.1074/jbc.M114.606921	http://dx.doi.org/10.1074/jbc.M114.606921			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25371208	Green Published, hybrid			2022-12-28	WOS:000347778200031
J	Huang, JY; Sun, YT; Zhang, JJ; Huang, XY				Huang, Jianyun; Sun, Yutong; Zhang, J. Jillian; Huang, Xin-Yun			Pivotal Role of Extended Linker 2 in the Activation of G alpha by G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Signaling; Second Messenger; Signal Transduction; Signaling	GUANINE-NUCLEOTIDE EXCHANGE; HETEROTRIMERIC G-PROTEIN; BETA(2) ADRENERGIC-RECEPTOR; GAMMA-SUBUNIT COMPLEX; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ADENYLYL-CYCLASE; SIGNAL-TRANSDUCTION; MECHANISM; SWITCH	Background: G protein-coupled receptors mainly signal through heterotrimeric G-proteins. Results: We have demonstrated that mutations in the extended Linker 2 impaired the activation of G(s) by -adrenergic receptors. Conclusion: We have proposed a potential novel conduit from -adrenergic receptors to the helical domain of G(s) subunit via the extended Linker 2. Significance: Our systematic mutagenesis studies provide insights into the activation mechanism of G-proteins by receptors. G protein-coupled receptors (GPCRs) relay extracellular signals mainly to heterotrimeric G-proteins (G) and they are the most successful drug targets. The mechanisms of G-protein activation by GPCRs are not well understood. Previous studies have revealed a signal relay route from a GPCR via the C-terminal 5-helix of G to the guanine nucleotide-binding pocket. Recent structural and biophysical studies uncover a role for the opening or rotating of the -helical domain of G during the activation of G by a GPCR. Here we show that -adrenergic receptors activate eight G(s) mutant proteins (from a screen of 66 G(s) mutants) that are unable to bind G subunits in cells. Five of these eight mutants are in the F/Linker 2/2 hinge region (extended Linker 2) that connects the Ras-like GTPase domain and the -helical domain of G(s). This extended Linker 2 is the target site of a natural product inhibitor of G(q). Our data show that the extended Linker 2 is critical for G activation by GPCRs. We propose that a GPCR via its intracellular loop 2 directly interacts with the (2)/(3) loop of G to communicate to Linker 2, resulting in the opening and closing of the -helical domain and the release of GDP during G-protein activation.	[Huang, Jianyun; Sun, Yutong; Zhang, J. Jillian; Huang, Xin-Yun] Cornell Univ, Dept Physiol, Weill Med Coll, New York, NY 10065 USA	Cornell University	Huang, XY (corresponding author), Cornell Univ, Dept Physiol, Weill Med Coll, New York, NY 10065 USA.	xyhuang@med.cornell.edu		Sun, Yutong/0000-0002-9368-2957	National Institutes of Health [HL 91525]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 91525 (to X.-Y. H.).	Bastepe M, 2002, MOL ENDOCRINOL, V16, P1912, DOI 10.1210/me.2002-0054; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; Choe HW, 2011, NEUROPHARMACOLOGY, V60, P52, DOI 10.1016/j.neuropharm.2010.07.018; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; FLORIO VA, 1989, J BIOL CHEM, V264, P3909; FUNG BKK, 1983, J BIOL CHEM, V258, P495; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Grishina G, 2000, MOL PHARMACOL, V57, P1081; Herrmann R, 2006, J BIOL CHEM, V281, P30234, DOI 10.1074/jbc.M600797200; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; Jones JC, 2012, P NATL ACAD SCI USA, V109, P7275, DOI 10.1073/pnas.1202943109; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kolesnikov AV, 2011, J NEUROSCI, V31, P8067, DOI 10.1523/JNEUROSCI.0174-11.2011; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Nikonov SS, 2013, J NEUROSCI, V33, P5182, DOI 10.1523/JNEUROSCI.5204-12.2013; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Oldham WM, 2007, P NATL ACAD SCI USA, V104, P7927, DOI 10.1073/pnas.0702623104; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; PEDERSEN SE, 1982, P NATL ACAD SCI-BIOL, V79, P7228, DOI 10.1073/pnas.79.23.7228; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17040; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Ramachandran S, 2006, NAT STRUCT MOL BIOL, V13, P756, DOI 10.1038/nsmb0906-756; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Rondard P, 2001, P NATL ACAD SCI USA, V98, P6150, DOI 10.1073/pnas.101136198; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Schwartz TW, 2011, NATURE, V477, P540, DOI 10.1038/477540a; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Singh G, 2012, BIOCHEMISTRY-US, V51, P3232, DOI 10.1021/bi3001984; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; Steegborn C, 2005, J BIOL CHEM, V280, P31754, DOI 10.1074/jbc.M507144200; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 2010, NAT STRUCT MOL BIOL, V17, P650, DOI 10.1038/nsmb0610-650; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Zhang ZX, 2004, J BIOL CHEM, V279, P33937, DOI 10.1074/jbc.M403404200	53	7	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					272	283		10.1074/jbc.M114.608661	http://dx.doi.org/10.1074/jbc.M114.608661			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25414258	Green Published, hybrid			2022-12-28	WOS:000347231200025
J	Kadare, G; Gervasi, N; Brami-Cherrier, K; Blockus, H; El Messari, S; Arold, ST; Girault, JA				Kadare, Gress; Gervasi, Nicolas; Brami-Cherrier, Karen; Blockus, Heike; El Messari, Said; Arold, Stefan T.; Girault, Jean-Antoine			Conformational Dynamics of the Focal Adhesion Targeting Domain Control Specific Functions of Focal Adhesion Kinase in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Conformational Change; Focal Adhesions; Protein Kinase; Protein Structure; Tyrosine-Protein Kinase (Tyrosine Kinase)	SRC FAMILY KINASES; FAK PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; DEPENDENT FUNCTIONS; STRUCTURAL BASIS; ERK ACTIVATION; LD MOTIFS; PAXILLIN; BINDING; LOCALIZATION	Background: Focal adhesion kinase (FAK) is enriched at focal adhesions through its focal adhesion targeting (FAT) domain, a four-helix bundle. Results: Mutations that facilitate or prevent opening of the first helix have profound consequences on the biochemical properties of FAK and its function in cells. Conclusion: The ability of FAT to open and close is essential for FAK function. Significance: This provides evidence for the functional importance of the conformational dynamics of FAT. Focal adhesion (FA) kinase (FAK) regulates cell survival and motility by transducing signals from membrane receptors. The C-terminal FA targeting (FAT) domain of FAK fulfils multiple functions, including recruitment to FAs through paxillin binding. Phosphorylation of FAT on Tyr(925) facilitates FA disassembly and connects to the MAPK pathway through Grb2 association, but requires dissociation of the first helix (H1) of the four-helix bundle of FAT. We investigated the importance of H1 opening in cells by comparing the properties of FAK molecules containing wild-type or mutated FAT with impaired or facilitated H1 openings. These mutations did not alter the activation of FAK, but selectively affected its cellular functions, including self-association, Tyr(925) phosphorylation, paxillin binding, and FA targeting and turnover. Phosphorylation of Tyr(861), located between the kinase and FAT domains, was also enhanced by the mutation that opened the FAT bundle. Similarly phosphorylation of Ser(910) by ERK in response to bombesin was increased by FAT opening. Although FAK molecules with the mutation favoring FAT opening were poorly recruited at FAs, they efficiently restored FA turnover and cell shape in FAK-deficient cells. In contrast, the mutation preventing H1 opening markedly impaired FAK function. Our data support the biological importance of conformational dynamics of the FAT domain and its functional interactions with other parts of the molecule.	[Kadare, Gress; Gervasi, Nicolas; Brami-Cherrier, Karen; Blockus, Heike; El Messari, Said; Girault, Jean-Antoine] INSERM, UMR S 839, F-75005 Paris, France; [Kadare, Gress; Gervasi, Nicolas; Brami-Cherrier, Karen; Blockus, Heike; El Messari, Said; Girault, Jean-Antoine] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France; [Kadare, Gress; Gervasi, Nicolas; Brami-Cherrier, Karen; Blockus, Heike; El Messari, Said; Girault, Jean-Antoine] Inst Fer Moulin, F-75005 Paris, France; [Arold, Stefan T.] King Abdullah Univ Sci & Technol KAUST, Div Biol & Environm Sci & Engn, Computat Biosci Res Ctr CBRC, Thuwal, Saudi Arabia; [Arold, Stefan T.] Univ Montpellier I & II, CNRS, Ctr Biochim Struct, INSERM,U1054,UMR5048, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; King Abdullah University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Girault, JA (corresponding author), UPMC, INSERM, UMR S 839, Inst Fer Moulin, 17 Rue Fer Moulin, F-75005 Paris, France.	jean-antoine.girault@inserm.fr	Gervasi, Nicolas/P-6047-2017; Girault, Jean-Antoine/F-7518-2013; brami-cherrier, karen/I-9263-2014; Arold, Stefan/T-2612-2019	Gervasi, Nicolas/0000-0002-1924-2443; Girault, Jean-Antoine/0000-0002-7900-1705; brami-cherrier, karen/0000-0002-3009-3821; Blockus, Heike/0000-0001-5274-2805; Arold, Stefan T/0000-0001-5278-0668; Kadare, Gress/0000-0002-8865-5743	Agence Nationale de la Recherche [ANR-05-2_42589]; Association pour la Recherche sur le Cancer (ARC) [A05/3/3138]; Fondation pour la Recherche Medicale; European Research Council; Inserm; UPMC; King Abdullah University of Science and Technology (KAUST); Paris School of Neuroscience (ENP)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Research Council(European Research Council (ERC)European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC; King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); Paris School of Neuroscience (ENP)	This work was supported in part by Agence Nationale de la Recherche Grant ANR-05-2_42589, Association pour la Recherche sur le Cancer (ARC) Grant A05/3/3138, Fondation pour la Recherche Medicale, European Research Council, Inserm, UPMC, and King Abdullah University of Science and Technology (KAUST).; Undergraduate funded by the Paris School of Neuroscience (ENP). Present address: Institut de la Vision, UMR-S 968 Inserm/UPMC/CNRS 7210, 75012 Paris, France.	Alam T, 2014, BIOCHEM J, V460, P317, DOI 10.1042/BJ20140298; Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Arold ST, 2011, CURR OPIN STRUC BIOL, V21, P808, DOI 10.1016/j.sbi.2011.09.008; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; Bertolucci CM, 2005, PROTEIN SCI, V14, P644, DOI 10.1110/ps.041107205; BOURNE Y, 1995, P NATL ACAD SCI USA, V92, P10232, DOI 10.1073/pnas.92.22.10232; Brami-Cherrier K, 2014, EMBO J, V33, P356, DOI 10.1002/embj.201386399; Burgaya F, 1996, MOL BRAIN RES, V37, P63, DOI 10.1016/0169-328X(95)00273-U; Cable J, 2012, BIOCHEMISTRY-US, V51, P2213, DOI 10.1021/bi300123a; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Cooley MA, 2000, MOL BIOL CELL, V11, P3247, DOI 10.1091/mbc.11.9.3247; Corsi JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-198; Corsi JM, 2009, J BIOL CHEM, V284, P34769, DOI 10.1074/jbc.M109.067280; Deramaudt TB, 2011, MOL BIOL CELL, V22, P964, DOI 10.1091/mbc.E10-08-0725; Dixon RDS, 2004, STRUCTURE, V12, P2161, DOI 10.1016/j.str.2004.09.011; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; Gao GH, 2004, J BIOL CHEM, V279, P8441, DOI 10.1074/jbc.M309808200; Garron ML, 2008, J MOL BIOL, V375, P1320, DOI 10.1016/j.jmb.2007.11.040; Girault JA, 1999, TRENDS BIOCHEM SCI, V24, P54, DOI 10.1016/S0968-0004(98)01331-0; Grigera PR, 2005, J CELL SCI, V118, P4931, DOI 10.1242/jcs.02696; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hamadi A, 2010, J ONCOL, V2010, DOI 10.1155/2010/932803; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Hunger-Glaser I, 2004, J CELL PHYSIOL, V200, P213, DOI 10.1002/jcp.20018; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Jiang XH, 2007, CELL SIGNAL, V19, P1000, DOI 10.1016/j.cellsig.2006.11.004; Kadare G, 2003, J BIOL CHEM, V278, P47434, DOI 10.1074/jbc.M308562200; Katz BZ, 2003, J BIOL CHEM, V278, P29115, DOI 10.1074/jbc.M212396200; Ladbury JE, 2012, TRENDS BIOCHEM SCI, V37, P173, DOI 10.1016/j.tibs.2012.01.001; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Lim YM, 2004, J BIOL CHEM, V279, P29060, DOI 10.1074/jbc.M401183200; Liu GH, 2002, MOL CELL BIOL, V22, P2751, DOI 10.1128/MCB.22.8.2751-2760.2002; Ma A, 2001, MOL BIOL CELL, V12, P1; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; OWENS LV, 1995, CANCER RES, V55, P2752; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Prutzman KC, 2004, STRUCTURE, V12, P881, DOI 10.1016/S0969-2126(04)00097-8; Rousseau F, 2001, P NATL ACAD SCI USA, V98, P5596, DOI 10.1073/pnas.101542098; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; TACHIBANA K, 1995, J EXP MED, V182, P1089, DOI 10.1084/jem.182.4.1089; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P; Zhou Z, 2006, PROTEINS, V65, P259, DOI 10.1002/prot.21107	56	23	24	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					478	491		10.1074/jbc.M114.593632	http://dx.doi.org/10.1074/jbc.M114.593632			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25391654	Green Published, hybrid			2022-12-28	WOS:000347231200042
J	Li, Z; Lee, ASE; Bracher, S; Jung, H; Paz, A; Kumar, JP; Abramson, J; Quick, M; Shi, L				Li, Zheng; Lee, Ashley S. E.; Bracher, Susanne; Jung, Heinrich; Paz, Aviv; Kumar, Jay P.; Abramson, Jeff; Quick, Matthias; Shi, Lei			Identification of a Second Substrate-binding Site in Solute-Sodium Symporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; Computational Biology; Galactose; Membrane Transport; Molecular Dynamics; Transporter; Equilibrium Binding; Scintillation Proximity Assay; Solute-Sodium Symporter; Structural Alignment	NA+/PROLINE TRANSPORTER PUTP; TRANSMEMBRANE DOMAIN-IX; AMINO-ACID ANTIPORTER; ESCHERICHIA-COLI; MEMBRANE-TRANSPORT; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; NEUROTRANSMITTER TRANSPORTERS; NA+/GLUCOSE COTRANSPORTER; GALACTOSE TRANSPORTER	Background: Although the solute-sodium symporter (SSS) vSGLT and the neurotransmitter-sodium symporter (NSS) LeuT have similar structural folds, their crystallographically identified substrate sites diverge in location and composition. Results: We identified second substrate sites in two SSSs that align with the crystallographically identified site in LeuT. Conclusion: Substrate transport by SSSs involves two substrate sites. Significance: NSS and SSS share common mechanistic features. The structure of the sodium/galactose transporter (vSGLT), a solute-sodium symporter (SSS) from Vibrio parahaemolyticus, shares a common structural fold with LeuT of the neurotransmitter-sodium symporter family. Structural alignments between LeuT and vSGLT reveal that the crystallographically identified galactose-binding site in vSGLT is located in a more extracellular location relative to the central substrate-binding site (S1) in LeuT. Our computational analyses suggest the existence of an additional galactose-binding site in vSGLT that aligns to the S1 site of LeuT. Radiolabeled galactose saturation binding experiments indicate that, like LeuT, vSGLT can simultaneously bind two substrate molecules under equilibrium conditions. Mutating key residues in the individual substrate-binding sites reduced the molar substrate-to-protein binding stoichiometry to approximate to 1. In addition, the related and more experimentally tractable SSS member PutP (the Na+/proline transporter) also exhibits a binding stoichiometry of 2. Targeting residues in the proposed sites with mutations results in the reduction of the binding stoichiometry and is accompanied by severely impaired translocation of proline. Our data suggest that substrate transport by SSS members requires both substrate-binding sites, thereby implying that SSSs and neurotransmitter-sodium symporters share common mechanistic elements in substrate transport.	[Li, Zheng; Shi, Lei] Cornell Univ, Dept Physiol & Biophys, Weill Cornell Med Coll, New York, NY 10065 USA; [Lee, Ashley S. E.; Quick, Matthias] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Lee, Ashley S. E.; Quick, Matthias] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Bracher, Susanne; Jung, Heinrich] Univ Munich, Bioctr, D-82152 Martinsried, Germany; [Paz, Aviv; Abramson, Jeff] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Kumar, Jay P.; Abramson, Jeff] Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Shi, Lei] Cornell Univ, Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10021 USA	Cornell University; Columbia University; Columbia University; University of Munich; University of California System; University of California Los Angeles; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; New York State Psychiatry Institute; Cornell University	Quick, M (corresponding author), New York State Psychiat Inst & Hosp, 1051 Riverside Dr,Unit 25, New York, NY 10032 USA.	mq2102@columbia.edu; les2007@med.cornell.edu	Paz, Aviv/AAN-3966-2021; Jung, Heinrich/K-3790-2014; Shi, Lei/AAV-1321-2020	Jung, Heinrich/0000-0002-5450-3063; Shi, Lei/0000-0002-4137-096X; Paz, Aviv/0000-0003-0792-492X; Kumar, Jay Prakash/0000-0003-4488-0292	National Science Foundation [TG-MCB090022]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000606] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Computations were performed on Ranger at the Texas Advanced Computing Center (National Science Foundation Grant TG-MCB090022) and the David A. Cofrin computational infrastructure of the Institute for Computational Biomedicine at Weill Cornell Medical College. We thank Drs. Jonathan Javitch and Harel Weinstein for helpful discussions, MiEstrella Miller-Cruz and Trang Nguyen for technical assistance, and Dr. Ernest Wright for critical reading of the manuscript.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bowers K. J., 2006, P ACM IEEE SC 2006 C, P43; Cheng MH, 2013, BIOPHYS J, V105, P630, DOI 10.1016/j.bpj.2013.06.032; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De la Vieja A, 2007, J BIOL CHEM, V282, P25290, DOI 10.1074/jbc.M700147200; Diez-Sampedro A, 2001, J BIOL CHEM, V276, P49188, DOI 10.1074/jbc.M108286200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P237, DOI 10.1113/jphysiol.1967.sp008298; Hilger D, 2008, J BIOL CHEM, V283, P4921, DOI 10.1074/jbc.M706741200; Hirayama BA, 2007, BIOCHEMISTRY-US, V46, P13391, DOI 10.1021/bi701562k; Jorgensen WL, 2005, P NATL ACAD SCI USA, V102, P6665, DOI 10.1073/pnas.0408037102; Jung H, 1998, J BIOL CHEM, V273, P26400, DOI 10.1074/jbc.273.41.26400; Jung H, 1998, BIOCHEMISTRY-US, V37, P11083, DOI 10.1021/bi980684b; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; Kalayil S, 2013, P NATL ACAD SCI USA, V110, P17296, DOI 10.1073/pnas.1309071110; Khelashvili G, 2013, J AM CHEM SOC, V135, P14266, DOI 10.1021/ja405984v; Korkmaz F, 2013, BBA-BIOMEMBRANES, V1828, P1181, DOI 10.1016/j.bbamem.2013.01.004; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li J, 2012, BBA-BIOMEMBRANES, V1818, P263, DOI 10.1016/j.bbamem.2011.09.011; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mazier S, 2011, J BIOL CHEM, V286, P29347, DOI 10.1074/jbc.M111.263327; Menke M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040010; MOGI T, 1984, J BIOL CHEM, V259, P7797; Nasr ML, 2014, BIOCHEMISTRY-US, V53, P4, DOI 10.1021/bi401412e; OHSAWA M, 1988, J BACTERIOL, V170, P5185, DOI 10.1128/jb.170.11.5185-5191.1988; Olkhova E, 2011, J MOL BIOL, V406, P59, DOI 10.1016/j.jmb.2010.11.045; Penheiter AR, 2012, CURR GENE THER, V12, P33; Perez C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5231; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Perez C, 2011, EMBO J, V30, P1221, DOI 10.1038/emboj.2011.46; Pirch T, 2003, J BIOL CHEM, V278, P42942, DOI 10.1074/jbc.M308253200; Pirch T, 2002, J BIOL CHEM, V277, P8790, DOI 10.1074/jbc.M111008200; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Pohlenz J, 1999, BIOCHIMIE, V81, P469, DOI 10.1016/S0300-9084(99)80097-2; Quick M, 1998, BIOCHEMISTRY-US, V37, P13800, DOI 10.1021/bi980562j; Quick M, 1996, EUR J BIOCHEM, V239, P732, DOI 10.1111/j.1432-1033.1996.0732u.x; Quick M, 1997, BIOCHEMISTRY-US, V36, P4631, DOI 10.1021/bi963063w; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Raba M, 2008, J MOL BIOL, V382, P884, DOI 10.1016/j.jmb.2008.07.070; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schulze JM, 2010, EPIGENETICS-US, V5, P573, DOI 10.4161/epi.5.7.12856; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Simmons KJ, 2014, EMBO J, V33, P1831, DOI 10.15252/embj.201387557; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Tang L, 2010, NAT STRUCT MOL BIOL, V17, P492, DOI 10.1038/nsmb.1788; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Xie ZY, 2000, J BIOL CHEM, V275, P25959, DOI 10.1074/jbc.M002687200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; YAMATO I, 1988, J BIOL CHEM, V263, P16055; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zomot E, 2010, MOL BIOSYST, V6, P1040, DOI 10.1039/b927492h	73	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					127	141		10.1074/jbc.M114.584383	http://dx.doi.org/10.1074/jbc.M114.584383			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25398883	Green Published, hybrid			2022-12-28	WOS:000347231200012
J	Godoy, JA; Arrazola, MS; Ordenes, D; Silva-Alvarez, C; Braidy, N; Inestrosa, NC				Godoy, Juan A.; Arrazola, Macarena S.; Ordenes, Daniela; Silva-Alvarez, Carmen; Braidy, Nady; Inestrosa, Nibaldo C.			Wnt-5a Ligand Modulates Mitochondrial Fission-Fusion in Rat Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN-KINASE; NMDA-RECEPTOR; DRP1; PHOSPHORYLATION; TRANSPORT; DYNAMICS; WNTS; COLOCALIZATION; TRANSMISSION	The Wnt signaling pathway plays an important role in developmental processes, including embryonic patterning, cell specification, and cell polarity. Wnt components participate in the development of the central nervous system, and growing evidence indicates that this pathway also regulates the function of the adult nervous system. In this study, we report that Wnt-5a, a noncanonical Wnt ligand, is a potent activator of mitochondrial dynamics and induces acute fission and fusion events in the mitochondria of rat hippocampal neurons. The effect of Wnt-5a was inhibited in the presence of sFRP, a Wnt scavenger. Similarly, the canonical Wnt-3a ligand had no effect on mitochondrial fission-fusion events, suggesting that this effect is specific for Wnt-5a alone. We also show that the Wnt-5a effects on mitochondrial dynamics occur with an increase in both intracellular and mitochondrial calcium (Ca2+), which was correlated with an increased phosphorylation of Drp1(Ser-616) and a decrease of Ser-637 phosphorylation, both indicators of mitochondrial dynamics. Electron microscope analysis of hippocampal tissues in the CA1 region showed an increase in the number of mitochondria present in the postsynaptic region, and this finding correlated with a change in mitochondrial morphology. We conclude that Wnt-5a/Ca2+ signaling regulates the mitochondrial fission-fusion process in hippocampal neurons, a feature that might help to further understand the role of Wnt-related pathologies, including neuro-degenerative diseases associated with mitochondrial dysfunction, and represents a potentially important link between impaired metabolic function and degenerative disorders.	[Godoy, Juan A.; Arrazola, Macarena S.; Ordenes, Daniela; Silva-Alvarez, Carmen; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac, Santiago 8331150, Chile; [Braidy, Nady; Inestrosa, Nibaldo C.] Univ New S Wales, Fac Med, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW 2031, Australia; [Inestrosa, Nibaldo C.] Univ Magallanes, Ctr Excelencia Biomed Magallanes, Punta Arenas 6200000, Chile	Pontificia Universidad Catolica de Chile; University of New South Wales Sydney; Universidad de Magallanes	Inestrosa, NC (corresponding author), Pontificia Univ Catolica Chile, CARE Biomed Ctr, Ave Alameda 340, Santiago 8331150, Chile.	ninestrosa@bio.puc.cl	Godoy, Juan A/F-5398-2018	Godoy, Juan A/0000-0001-9920-6698; Arrazola, Macarena S./0000-0002-0840-8997; Braidy, Nady/0000-0002-0497-5572	Basal Centre for Excellence in Science and Technology [PFB 12/2007]; FONDECYT [1120156, 11130529]; Alzheimer's Australia; NHMRC at the University of New South Wales, Sydney, Australia	Basal Centre for Excellence in Science and Technology(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Alzheimer's Australia; NHMRC at the University of New South Wales, Sydney, Australia	This work was supported in part by Grants PFB 12/2007 from the Basal Centre for Excellence in Science and Technology and FONDECYT 1120156 (to N. C. I.) and FONDECYT 11130529 (to C. S. A.).; Recipient of the Alzheimer's Australia and NHMRC Early Career, Postdoctoral Research Fellowship at the University of New South Wales, Sydney, Australia.	Billups B, 2002, J NEUROSCI, V22, P5840; Brooks C, 2011, AM J PHYSIOL-CELL PH, V300, pC447, DOI 10.1152/ajpcell.00402.2010; Brustovetsky T, 2009, CELL CALCIUM, V46, P18, DOI 10.1016/j.ceca.2009.03.017; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Cai Q, 2011, NEUROSCI RES, V70, P9, DOI 10.1016/j.neures.2011.02.005; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cerpa W, 2011, J NEUROSCI, V31, P9466, DOI 10.1523/JNEUROSCI.6311-10.2011; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chen H, 2010, ANN NY ACAD SCI, V1201, P21, DOI 10.1111/j.1749-6632.2010.05615.x; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Cho Bongki, 2013, Exp Neurobiol, V22, P149, DOI 10.5607/en.2013.22.3.149; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Dedov VN, 2000, IUBMB LIFE, V49, P549; Farias GG, 2009, J BIOL CHEM, V284, P15857, DOI 10.1074/jbc.M808986200; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Holmstrom MH, 2012, AM J PHYSIOL-ENDOC M, V302, pE731, DOI 10.1152/ajpendo.00159.2011; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Inestrosa NC, 2014, J MOL CELL BIOL, V6, P64, DOI 10.1093/jmcb/mjt051; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Munoz FJ, 2014, BIOCHEM BIOPH RES CO, V444, P189, DOI 10.1016/j.bbrc.2014.01.031; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Oliva CA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00224; Oliva CA, 2013, AGEING RES REV, V12, P786, DOI 10.1016/j.arr.2013.03.006; Park M, 2012, EMBO J, V31, P2697, DOI 10.1038/emboj.2012.145; Perkins Edward M, 2007, Methods Mol Biol, V372, P467, DOI 10.1007/978-1-59745-365-3_33; Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012; Qi X, 2011, MOL BIOL CELL, V22, P256, DOI 10.1091/mbc.E10-06-0551; Quintanilla RA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-45; Rosso SB, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00103; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Silva-Alvarez C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00097; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Slater PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078892; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Su B, 2010, MOL NEUROBIOL, V41, P87, DOI 10.1007/s12035-009-8095-7; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Vos Melissa, 2010, Front Synaptic Neurosci, V2, P139, DOI 10.3389/fnsyn.2010.00139; Wang HJ, 2000, J CELL BIOL, V150, P1489, DOI 10.1083/jcb.150.6.1489; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286; Zolezzi JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064019	68	44	45	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36179	36193		10.1074/jbc.M114.557009	http://dx.doi.org/10.1074/jbc.M114.557009			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25336659	Green Published, hybrid			2022-12-28	WOS:000346897900044
J	Wang, RS; Chen, RD; Li, JH; Liu, X; Xie, KB; Chen, DW; Yin, YZ; Tao, XY; Xie, D; Zou, JH; Yang, L; Dai, JG				Wang, Ruishan; Chen, Ridao; Li, Jianhua; Liu, Xiao; Xie, Kebo; Chen, Dawei; Yin, Yunze; Tao, Xiaoyu; Xie, Dan; Zou, Jianhua; Yang, Lin; Dai, Jungui			Molecular Characterization and Phylogenetic Analysis of Two Novel Regio-specific Flavonoid Prenyltransferases from Morus alba and Cudrania tricuspidata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SUSPENSION-CULTURES; ISOPRENYLATED FLAVONOIDS; PRENYLATED ISOFLAVONOIDS; REGIOSELECTIVE SYNTHESIS; GLYCYRRHIZA-URALENSIS; DITERPENE METABOLISM; BIOSYNTHESIS; CLONING; PLANT; CHALCONES	Prenylated flavonoids are attractive specialized metabolites with a wide range of biological activities and are distributed in several plant families. The prenylation catalyzed by prenyltransferases represents a Friedel-Crafts alkylation of the flavonoid skeleton in the biosynthesis of natural prenylated flavonoids and contributes to the structural diversity and biological activities of these compounds. To date, all identified plant flavonoid prenyltransferases (FPTs) have been identified in Leguminosae. In the present study two new FPTs, Morus alba isoliquiritigenin 3'-dimethylallyltransferase (MaIDT) and Cudrania tricuspidata isoliquiritigenin 3'-dimethylallyltransferase (CtIDT), were identified from moraceous plants M. alba and C. tricuspidata, respectively. MaIDT and CtIDT shared low levels of homology with the leguminous FPTs. MaIDT and CtIDT are predicted to be membrane-bound proteins with predicted transit peptides, seven transmembrane regions, and conserved functional domains that are similar to other homogentisate prenyltransferases. Recombinant MaIDT and CtIDT were able to regioselectively introduce dimethylallyl diphosphate into the A ring of three flavonoids with different skeleton types (chalcones, isoflavones, and flavones). Phylogenetic analysis revealed thatMaIDT and CtIDT are distantly related to their homologs in Leguminosae, which suggests that FPTs in Moraceae and Leguminosae might have evolved independently. MaIDT and CtIDT represent the first two non-Leguminosae FPTs to be identified in plants and could thus lead to the identification of additional evolutionarily varied FPTs in other non-Leguminosae plants and could elucidate the biosyntheses of prenylated flavonoids in various plants. Furthermore, MaIDT and CtIDT might be used for regiospecific prenylation of flavonoids to produce bioactive compounds for potential therapeutic applications due to their high efficiency and catalytic promiscuity.	[Wang, Ruishan; Chen, Ridao; Li, Jianhua; Liu, Xiao; Xie, Kebo; Chen, Dawei; Yin, Yunze; Tao, Xiaoyu; Xie, Dan; Zou, Jianhua; Yang, Lin; Dai, Jungui] Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Wang, Ruishan; Chen, Ridao; Li, Jianhua; Liu, Xiao; Xie, Kebo; Chen, Dawei; Yin, Yunze; Tao, Xiaoyu; Xie, Dan; Zou, Jianhua; Yang, Lin; Dai, Jungui] Chinese Acad Med Sci, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Dai, JG (corresponding author), Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, 1 Xian Nong Tan St, Beijing 100050, Peoples R China.	jgdai@imm.ac.cn			National Natural Science Foundation of China [81273405]; Fundamental Research Funds for the Central Universities [2012N06]; Program for Doctorate Education Grant [20111106110029]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing," China [2012X09301002-001-005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for Doctorate Education Grant; National Science and Technology Major Project "Key New Drug Creation and Manufacturing," China	The study was supported by National Natural Science Foundation of China Grant 81273405, Fundamental Research Funds for the Central Universities Grant 2012N06, Program for Doctorate Education Grant 20111106110029, and National Science and Technology Major Project "Key New Drug Creation and Manufacturing," China Grant 2012X09301002-001-005.	Akashi T, 2009, PLANT PHYSIOL, V149, P683, DOI 10.1104/pp.108.123679; Barron D, 1996, PHYTOCHEMISTRY, V43, P921, DOI 10.1016/S0031-9422(96)00344-5; Boland GM, 1998, NAT PROD REP, V15, P241; Borges-Argaez R, 2002, PHYTOCHEMISTRY, V60, P533, DOI 10.1016/S0031-9422(02)00131-0; Botta B, 2005, TRENDS PHARMACOL SCI, V26, P606, DOI 10.1016/j.tips.2005.09.012; Botta B, 2005, CURR MED CHEM, V12, P713, DOI 10.2174/0929867053202241; Botta B, 2009, CURR MED CHEM, V16, P3414, DOI 10.2174/092986709789057662; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt DR, 2013, TETRAHEDRON, V69, P9994, DOI 10.1016/j.tet.2013.09.068; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; Chen QianQian, 2011, Plant Physiology Communications, V47, P575; Chen RD, 2013, ADV SYNTH CATAL, V355, P1817, DOI 10.1002/adsc.201300196; Crowell AL, 2002, ARCH BIOCHEM BIOPHYS, V405, P112, DOI 10.1016/S0003-9861(02)00348-X; DAVISSON VJ, 1985, METHOD ENZYMOL, V110, P130; DELLEMONACHE G, 1995, PHYTOCHEMISTRY, V39, P575, DOI 10.1016/0031-9422(94)00971-U; Hamberger B, 2011, PLANT PHYSIOL, V157, P1677, DOI 10.1104/pp.111.185843; HANO Y, 1990, J CHEM SOC CHEM COMM, P610, DOI 10.1039/c39900000610; He NJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3445; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Hossain MM, 2006, TETRAHEDRON, V62, P8625, DOI 10.1016/j.tet.2006.06.066; Juvale K, 2012, BIOORGAN MED CHEM, V20, P346, DOI 10.1016/j.bmc.2011.10.074; Karamat F, 2014, PLANT J, V77, P627, DOI 10.1111/tpj.12409; Khatib S, 2005, BIOORGAN MED CHEM, V13, P433, DOI 10.1016/j.bmc.2004.10.010; KOBAYASHI M, 1985, CHEM PHARM BULL, V33, P3811; Kremer A, 2008, APPL MICROBIOL BIOT, V79, P951, DOI 10.1007/s00253-008-1505-3; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; LAFLAMME P, 1993, PHYTOCHEMISTRY, V34, P147, DOI 10.1016/S0031-9422(00)90796-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JH, 2014, CHEMBIOCHEM, V15, P1672, DOI 10.1002/cbic.201402160; Li Tian, 2014, Database (Oxford), V2014, DOI 10.1093/database/bau054; Munakata R, 2014, PLANT PHYSIOL, V166, P80, DOI 10.1104/pp.114.246892; NOMURA T, 1994, NAT PROD REP, V11, P205, DOI 10.1039/np9941100205; Nomura T, 1988, Fortschr Chem Org Naturst, V53, P87; Nomura T, 2009, P JPN ACAD B-PHYS, V85, P391, DOI 10.2183/pjab.85.391; Ozaki T, 2009, J ANTIBIOT, V62, P385, DOI 10.1038/ja.2009.48; Page J. E., 2012, U. S. Patent, Patent No. 8884100; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Sasaki K, 2008, PLANT PHYSIOL, V146, P1075, DOI 10.1104/pp.107.110544; Sasaki K, 2011, J BIOL CHEM, V286, P24125, DOI 10.1074/jbc.M111.244426; Shen GA, 2012, PLANT PHYSIOL, V159, P70, DOI 10.1104/pp.112.195271; TAHARA S, 1995, PHYTOCHEMISTRY, V38, P1073, DOI 10.1016/0031-9422(94)00788-U; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tao Xiao-Yu, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3738; Tsukayama M, 2004, CHEM PHARM BULL, V52, P1285, DOI 10.1248/cpb.52.1285; Tsurumaru Y, 2012, BIOCHEM BIOPH RES CO, V417, P393, DOI 10.1016/j.bbrc.2011.11.125; VELIKY IA, 1970, CAN J MICROBIOL, V16, P223, DOI 10.1139/m70-041; Vitali A, 2004, FEBS LETT, V557, P33, DOI 10.1016/S0014-5793(03)01398-X; Vitali A, 2001, PLANTA MED, V67, P475, DOI 10.1055/s-2001-15814; Wang HM, 2014, TETRAHEDRON LETT, V55, P897, DOI 10.1016/j.tetlet.2013.12.044; Yamamoto H, 2000, PHYTOCHEMISTRY, V54, P649, DOI 10.1016/S0031-9422(00)00198-9; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; Yin S, 2004, BIOORGAN MED CHEM, V12, P4387, DOI 10.1016/j.bmc.2004.06.014; Yin Yun-Ze, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3734; Yin YZ, 2013, J MOL CATAL B-ENZYM, V89, P28, DOI 10.1016/j.molcatb.2012.12.009; Yu X, 2011, CHEMBIOCHEM, V12, P2280, DOI 10.1002/cbic.201100413; Zerbe P, 2013, PLANT PHYSIOL, V162, P1073, DOI 10.1104/pp.113.218347; Zhang SD, 2011, MOL PHYLOGENET EVOL, V60, P21, DOI [10.1016/j.ympev.2011.04.008, 10.1016/j.ympev.2011.09.018]	58	35	36	5	71	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35815	35825		10.1074/jbc.M114.608265	http://dx.doi.org/10.1074/jbc.M114.608265			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25361766	Green Published, hybrid			2022-12-28	WOS:000346897900013
J	Zhang, J; Lu, AR; Kong, LL; Zhang, QL; Ling, EJ				Zhang, Jie; Lu, Anrui; Kong, Lulu; Zhang, Qiaoli; Ling, Erjun			Functional Analysis of Insect Molting Fluid Proteins on the Protection and Regulation of Ecdysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; MANDUCA-SEXTA; BOMBYX-MORI; CAENORHABDITIS-ELEGANS; SUPEROXIDE-DISMUTASE; TRIBOLIUM-CASTANEUM; BEAUVERIA-BASSIANA; RNA INTERFERENCE; INNATE IMMUNITY; DUAL OXIDASE	Molting fluid accumulates between the old and new cuticles during periodical ecdysis in Ecdysozoa. Natural defects in insect ecdysis are frequently associated with melanization (an immunity response) occurring primarily in molting fluids, suggesting that molting fluid may impact immunity as well as affect ecdysis. To address this hypothesis, proteomic analysis of molting fluids from Bombyx mori during three different types of ecdysis was performed. Many proteins were newly identified, including immunity-related proteins, in each molting fluid. Molting fluids inhibited the growth of bacteria in vitro. The entomopathogenic fungi Beauveria bassiana, which can escape immune responses in feeding larvae, is quickly recognized by larvae during ecdysis, followed by melanization in molting fluid and old cuticle. Fungal conidia germination was delayed, and no hyphae were detected in the hemocoels of pharate instar insects. Molting fluids protect the delicate pharate instar insects with extremely thin cuticles against microorganisms. To explore the function of molting fluids in ecdysis regulation, based on protein similarity, 32 genes were selected for analysis in ecdysis regulation through RNAi in Tribolium castaneum, a model commonly used to study integument development because RNAi is difficult to achieve in B. mori. We identified 24 molting proteins that affected ecdysis after knockdown, with different physiological functions, including old cuticle protein recycling, molting fluid pressure balance, detoxification, and signal detection and transfer of molting fluids. We report that insects secrete molting fluid for protection and regulation of ecdysis, which indicates a way to develop new pesticides through interrupting insect ecdysis in the future.	[Zhang, Jie; Lu, Anrui; Zhang, Qiaoli; Ling, Erjun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Kong, Lulu] Shanghai Jiao Tong Univ, Coll Agr & Biol, Shanghai 200240, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Ling, EJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China.	erjunling@sippe.ac.cn			National Basic Research Program of China [2012CB114605]; National Natural Science Foundation of China [31172151]; Ministry of Agriculture of China [2011ZX08009-003]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by National Basic Research Program of China Grant 2012CB114605, National Natural Science Foundation of China Grant 31172151, and Ministry of Agriculture of China Grant 2011ZX08009-003.	Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; Asano T, 2009, INSECT MOL BIOL, V18, P223, DOI 10.1111/j.1365-2583.2008.00858.x; Ashida Masaaki, 1998, P135; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaudhari SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003268; Chaudhari SS, 2011, P NATL ACAD SCI USA, V108, P17028, DOI 10.1073/pnas.1112288108; Corsi AK, 2006, ANAL BIOCHEM, V359, P1, DOI 10.1016/j.ab.2006.07.033; Denys A, 1997, IMMUNOLOGY, V91, P609, DOI 10.1046/j.1365-2567.1997.00296.x; Diaz-Albiter H, 2012, J BIOL CHEM, V287, P23995, DOI 10.1074/jbc.M112.376095; Ewer J, 2005, PLOS BIOL, V3, P1696, DOI 10.1371/journal.pbio.0030349; FIRSTENCEL H, 1990, J INVERTEBR PATHOL, V55, P258, DOI 10.1016/0022-2011(90)90061-A; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; He FJ, 2003, J RENIN-ANGIO-ALDO S, V4, P11, DOI 10.3317/jraas.2003.001; He NJ, 2007, INSECT BIOCHEM MOLEC, V37, P135, DOI 10.1016/j.ibmb.2006.10.011; Hogenkamp DG, 2008, INSECT BIOCHEM MOLEC, V38, P478, DOI 10.1016/j.ibmb.2007.08.002; Jebara S, 2005, J PLANT PHYSIOL, V162, P929, DOI 10.1016/j.jplph.2004.10.005; Ji MM, 2013, INSECT MOL BIOL, V22, P273, DOI 10.1111/imb.12019; Jiang HB, 2004, INSECT BIOCHEM MOLEC, V34, P89, DOI 10.1016/j.ibmb.2003.09.006; Kaji K, 2009, INSECT BIOCHEM MOLEC, V39, P207, DOI 10.1016/j.ibmb.2008.12.001; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; KATZENELLENBOGEN BS, 1971, J INSECT PHYSIOL, V17, P1139, DOI 10.1016/0022-1910(71)90016-3; Ken CF, 2005, J AGR FOOD CHEM, V53, P1470, DOI 10.1021/jf048269f; KUWANO E, 1985, AGR BIOL CHEM TOKYO, V49, P483, DOI 10.1080/00021369.1985.10866750; Li YS, 2012, INSECT BIOCHEM MOLEC, V42, P766, DOI 10.1016/j.ibmb.2012.07.004; Ling Erjun, 2003, Journal of Insect Biotechnology and Sericology, V72, P101; Martin RM, 2005, CYTOM PART A, V67A, P45, DOI 10.1002/cyto.a.20172; Muthukrishnan S, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P193, DOI 10.1016/B978-0-12-384747-8.10007-8; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; OHNISHI E, 1970, ARCH BIOCHEM BIOPHYS, V139, P143, DOI 10.1016/0003-9861(70)90055-X; Reynolds SE, 1996, ADV INSECT PHYSIOL, V26, P157, DOI 10.1016/S0065-2806(08)60031-4; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Sabotic J, 2012, APPL MICROBIOL BIOT, V93, P1351, DOI 10.1007/s00253-011-3834-x; SAMUELS RI, 1993, J INSECT PHYSIOL, V39, P633, DOI 10.1016/0022-1910(93)90068-3; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Shang YF, 2012, J INVERTEBR PATHOL, V109, P105, DOI 10.1016/j.jip.2011.10.004; Shao QM, 2012, J BIOL CHEM, V287, P14270, DOI 10.1074/jbc.M112.354548; Shen CR, 2010, J BIOMOL SCREEN, V15, P213, DOI 10.1177/1087057109355057; St Leger RJ, 2010, APPL MICROBIOL BIOT, V85, P901, DOI 10.1007/s00253-009-2306-z; Stenvall J, 2011, P NATL ACAD SCI USA, V108, P1064, DOI 10.1073/pnas.1006328108; Suzuki Y, 2013, P NATL ACAD SCI USA, V110, P12518, DOI 10.1073/pnas.1311405110; Tan A, 2008, INSECT BIOCHEM MOLEC, V38, P430, DOI 10.1016/j.ibmb.2007.09.012; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thein MC, 2009, J BIOL CHEM, V284, P17549, DOI 10.1074/jbc.M900831200; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; Wang P, 2000, INSECT BIOCHEM MOLEC, V30, P135, DOI 10.1016/S0965-1748(99)00108-3; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Weers PMM, 2006, INSECT BIOCHEM MOLEC, V36, P231, DOI 10.1016/j.ibmb.2006.01.001; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xu QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043769; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-553; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Zdybicka-Barabas A, 2011, COMP BIOCHEM PHYS B, V158, P90, DOI 10.1016/j.cbpb.2010.10.001; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105	61	71	76	5	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35891	35906		10.1074/jbc.M114.599597	http://dx.doi.org/10.1074/jbc.M114.599597			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25368323	hybrid, Green Published			2022-12-28	WOS:000346897900021
J	Del Nagro, C; Xiao, Y; Rangell, L; Reichelt, M; O'Brien, T				Del Nagro, Christopher; Xiao, Yang; Rangell, Linda; Reichelt, Mike; O'Brien, Thomas			Depletion of the Central Metabolite NAD Leads to Oncosis-mediated Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; ATP; Cell Death; Cell Metabolism; Nicotinamide Adenine Dinucleotide (NAD); GNE-617; NAMPT; Oncosis	NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE NAMPT; POLY(ADP-RIBOSE) SYNTHESIS; APOPTOSIS; NECROSIS; SIRT1; DEACETYLASE; INHIBITORS; CHROMATIN; CANCER; ACID	Depletion of the central metabolite NAD in cells results in broad metabolic defects leading to cell death and is a proposed novel therapeutic strategy in oncology. There is, however, a limited understanding of the underlying mechanisms that connect disruption of this central metabolite with cell death. Here we utilize GNE-617, a small molecule inhibitor of NAMPT, a rate-limiting enzyme required for NAD generation, to probe the pathways leading to cell death following NAD depletion. In all cell lines examined, NAD was rapidly depleted (average t(1/2) of 8.1 h) following NAMPT inhibition. Concurrent with NAD depletion, there was a decrease in both cell proliferation and motility, which we attribute to reduced activity of NAD-dependent deacetylases because cells fail to deacetylate -tubulin-K40 and histone H3-K9. Following depletion of NAD by >95%, cells lose the ability to regenerate ATP. Cell lines with a slower rate of ATP depletion (average t(1/2) of 45 h) activate caspase-3 and show evidence of apoptosis and autophagy, whereas cell lines with rapid depletion ATP (average t(1/2) of 32 h) do not activate caspase-3 or show signs of apoptosis or autophagy. However, the predominant form of cell death in all lines is oncosis, which is driven by the loss of plasma membrane homeostasis once ATP levels are depleted by >20-fold. Thus, our work illustrates the sequence of events that occurs in cells following depletion of a key metabolite and reveals that cell death caused by a loss of NAD is primarily driven by the inability of cells to regenerate ATP.	[Del Nagro, Christopher; Xiao, Yang; O'Brien, Thomas] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Rangell, Linda; Reichelt, Mike] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	O'Brien, T (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	Obrien.tom@gene.com		O'Brien, Thomas/0000-0002-9161-8070				Berger N A, 1986, Basic Life Sci, V38, P357; Berger N A, 1983, Princess Takamatsu Symp, V13, P219; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Bi TQ, 2011, ONCOL REP, V26, P1251, DOI 10.3892/or.2011.1378; Billington RA, 2008, J BIOL CHEM, V283, P6367, DOI 10.1074/jbc.M706204200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bowlby SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040195; CARSON DA, 1987, J IMMUNOL, V138, P1904; Cea M, 2012, BLOOD, V120, P3519, DOI 10.1182/blood-2012-03-416776; Cerna D, 2012, J BIOL CHEM, V287, P22408, DOI 10.1074/jbc.M112.357301; CHATTERJEE S, 1989, EXP CELL RES, V184, P1, DOI 10.1016/0014-4827(89)90358-3; Chiarugi A, 2005, FASEB J, V19, P1783, DOI 10.1096/fj.05-4200rev; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Garcia-Saez AJ, 2012, CELL DEATH DIFFER, V19, P1733, DOI 10.1038/cdd.2012.105; Hasmann M, 2003, CANCER RES, V63, P7436; Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382; Jeong YS, 2010, GENES CELLS, V15, P181, DOI 10.1111/j.1365-2443.2009.01375.x; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JURKOWITZALEXANDER MS, 1992, J NEUROCHEM, V59, P344, DOI 10.1111/j.1471-4159.1992.tb08910.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Knight JRP, 2012, CURR OPIN ONCOL, V24, P68, DOI 10.1097/CCO.0b013e32834d813b; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; MAJNO G, 1995, AM J PATHOL, V146, P3; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013; Nicotera P, 2004, ONCOGENE, V23, P2757, DOI 10.1038/sj.onc.1207559; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; O'Brien T, 2013, NEOPLASIA, V15, P1314, DOI [10.1593/neo.131184, 10.1593/neo.131718]; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Orlov SN, 2004, ADV EXP MED BIOL, V559, P219; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Trump BF, 1997, TOXICOL PATHOL, V25, P82, DOI 10.1177/019262339702500116; van Horssen R, 2013, CELL MOL LIFE SCI, V70, P2175, DOI 10.1007/s00018-012-1249-1; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Weerasinghe P, 2012, EXP MOL PATHOL, V93, P302, DOI 10.1016/j.yexmp.2012.09.018; Xiao Y, 2013, NEOPLASIA, V15, P1137, DOI 10.1593/neo.131304; Yin H, 2012, J CELL SCI, V125, P5770, DOI 10.1242/jcs.110262; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zheng XZ, 2013, J MED CHEM, V56, P6413, DOI 10.1021/jm4008664	48	51	52	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35182	35192		10.1074/jbc.M114.580159	http://dx.doi.org/10.1074/jbc.M114.580159			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25355314	Green Published, hybrid			2022-12-28	WOS:000346660200012
J	Komaniecka, I; Choma, A; Mazur, A; Duda, KA; Lindner, B; Schwudke, D; Holst, O				Komaniecka, Iwona; Choma, Adam; Mazur, Andrzej; Duda, Katarzyna A.; Lindner, Buko; Schwudke, Dominik; Holst, Otto			Occurrence of an Unusual Hopanoid-containing Lipid A Among Lipopolysaccharides from Bradyrhizobium Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycoconjugate; Lipid A; Lipopolysaccharide (LPS); Mass Spectrometry (MS); Nuclear Magnetic Resonance (NMR); Bradyrhizobium; Hopanoid; Long Chain Fatty Acids	D-GALACTURONIC ACID; PHOSPHATE RESIDUES; RHIZOBIUM-ETLI; A COMPONENT; BACTERIAL LIPOPOLYSACCHARIDES; RHODOMICROBIUM-VANNIELII; MESORHIZOBIUM; TRITERPENOIDS; SINORHIZOBIUM; SERIES	The chemical structures of the unusual hopanoid-containing lipid A samples of the lipopolysaccharides (LPS) from three strains of Bradyrhizobium (slow-growing rhizobia) have been established. They differed considerably from other Gram-negative bacteria in regards to the backbone structure, the number of ester-linked long chain hydroxylated fatty acids, as well as the presence of a tertiary residue that consisted of at least one molecule of carboxyl-bacteriohopanediol or its 2-methyl derivative. The structural details of this type of lipid A were established using one- and two-dimensional NMR spectroscopy, chemical composition analyses, and mass spectrometry techniques (electrospray ionization Fourier-transform ion cyclotron resonance mass spectrometry and MALDI-TOF-MS). In these lipid A samples the glucosamine disaccharide characteristic for enterobacterial lipid A was replaced by a 2,3-diamino-2,3-dideoxy-d-glucopyranosyl-(GlcpN3N) disaccharide, deprived of phosphate residues, and substituted by an -d-Manp-(16)--d-Manp disaccharide substituting C-4 of the non-reducing (distal) GlcpN3N, and one residue of galacturonic acid (d-GalpA) -(11)-linked to the reducing (proximal) amino sugar residue. Amide-linked 12:0(3-OH) and 14:0(3-OH) were identified. Some hydroxy groups of these fatty acids were further esterified by long (-1)-hydroxylated fatty acids comprising 26-34 carbon atoms. As confirmed by mass spectrometry techniques, these long chain fatty acids could form two or three acyloxyacyl residues. The triterpenoid derivatives were identified as 34-carboxyl-bacteriohopane-32,33-diol and 34-carboxyl-2-methyl-bacteriohopane-32,33-diol and were covalently linked to the (-1)-hydroxy group of very long chain fatty acid in bradyrhizobial lipid A. Bradyrhizobium japonicum possessed lipid A species with two hopanoid residues.	[Komaniecka, Iwona; Choma, Adam; Mazur, Andrzej] Marie Curie Sklodowska Univ, Dept Genet & Microbiol, PL-20033 Lublin, Poland; [Duda, Katarzyna A.; Holst, Otto] Leibniz Ctr Med & Biosci, Div Struct Biochem, Res Ctr Borstel, PL-23845 Borstel, Poland; [Lindner, Buko; Schwudke, Dominik] Leibniz Ctr Med & Biosci, Div Bioanalyt Chem, Res Ctr Borstel, PL-23845 Borstel, Poland	Maria Curie-Sklodowska University	Komaniecka, I (corresponding author), Marie Curie Sklodowska Univ, Dept Genet & Microbiol, PL-20033 Lublin, Poland.	ikoma@hektor.umcs.lublin.pl	Schwudke, Dominik/B-3478-2013; Duda, Katarzyna/M-5274-2018	Schwudke, Dominik/0000-0002-1379-9451; Duda, Katarzyna/0000-0001-7701-3262; Komaniecka, Iwona/0000-0003-0807-8083; Choma, Adam/0000-0002-5454-8640	Polish Ministry of Science and Higher Education Grants [303 109 32/3593, N N303 822840]	Polish Ministry of Science and Higher Education Grants	This work was supported by Polish Ministry of Science and Higher Education Grants 303 109 32/3593 and N N303 822840 (to A. Ch. and I. K.).	Albus U, 2001, NEW PHYTOL, V151, P597, DOI 10.1046/j.0028-646x.2001.00214.x; BERRY AM, 1993, P NATL ACAD SCI USA, V90, P6091, DOI 10.1073/pnas.90.13.6091; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; BHAT UR, 1991, J BACTERIOL, V173, P2155, DOI 10.1128/JB.173.7.2155-2159.1991; BHAT UR, 1994, J BIOL CHEM, V269, P14402; BHAT UR, 1991, INT J SYST BACTERIOL, V41, P213; Bravo JM, 2001, EUR J BIOCHEM, V268, P1323, DOI 10.1046/j.1432-1327.2001.01998.x; Brewin NJ, 1993, ADV MOL GENETICS PLA, V2, P369; Brown DB, 2013, GLYCOBIOLOGY, V23, P546, DOI 10.1093/glycob/cws223; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; Choma A, 2004, EUR J BIOCHEM, V271, P1310, DOI 10.1111/j.1432-1033.2004.04038.x; Choma A, 2008, CARBOHYD RES, V343, P799, DOI 10.1016/j.carres.2008.01.006; Choma A, 2012, CARBOHYD RES, V352, P126, DOI 10.1016/j.carres.2012.03.003; Choma A, 2011, ACTA BIOCHIM POL, V58, P51; DEMAAGD RA, 1989, J BACTERIOL, V171, P1143, DOI 10.1128/jb.171.2.1143-1150.1989; Dow M, 2000, ANNU REV PHYTOPATHOL, V38, P241, DOI 10.1146/annurev.phyto.38.1.241; Fraysse N, 2002, GLYCOBIOLOGY, V12, P741, DOI 10.1093/glycob/cwf078; GILSERRANO AM, 1994, J BACTERIOL, V176, P2454, DOI 10.1128/JB.176.8.2454-2457.1994; HOLST O, 1983, EUR J BIOCHEM, V137, P325, DOI 10.1111/j.1432-1033.1983.tb07832.x; JOHNSON KG, 1976, CAN J MICROBIOL, V22, P29, DOI 10.1139/m76-004; KANNENBERG EL, 1995, FEMS MICROBIOL LETT, V127, P255; Komaniecka I, 2010, MICROBIOL IMMUNOL, V54, P717, DOI 10.1111/j.1348-0421.2010.00269.x; Komaniecka I, 2010, CHEM-EUR J, V16, P2922, DOI 10.1002/chem.200902390; Mathis R, 2005, P NATL ACAD SCI USA, V102, P2655, DOI 10.1073/pnas.0409816102; MORAN AP, 1991, EUR J BIOCHEM, V198, P459, DOI 10.1111/j.1432-1033.1991.tb16036.x; MORENO E, 1990, J BACTERIOL, V172, P3569, DOI 10.1128/jb.172.7.3569-3576.1990; NEUNLIST S, 1985, EUR J BIOCHEM, V147, P561, DOI 10.1111/j.0014-2956.1985.00561.x; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Plotz BM, 2000, J BIOL CHEM, V275, P11222, DOI 10.1074/jbc.275.15.11222; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Que NLS, 2000, J BIOL CHEM, V275, P28006; Que-Gewirth NLS, 2004, J BIOL CHEM, V279, P25420, DOI 10.1074/jbc.M400598200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reitz M, 2000, APPL ENVIRON MICROB, V66, P3515, DOI 10.1128/AEM.66.8.3515-3518.2000; ROHMER M, 1984, J GEN MICROBIOL, V130, P1137; ROHMER M, 1979, P NATL ACAD SCI USA, V76, P847, DOI 10.1073/pnas.76.2.847; ROPPEL J, 1975, CARBOHYD RES, V40, P31, DOI 10.1016/S0008-6215(00)82666-X; RUSSA R, 1995, ARCH MICROBIOL, V163, P345, DOI 10.1007/BF00404207; Schwudke D, 2003, J BIOL CHEM, V278, P27502, DOI 10.1074/jbc.M303012200; Silipo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6106; Simonin P, 1996, EUR J BIOCHEM, V241, P865, DOI 10.1111/j.1432-1033.1996.00865.x; SIMONIN P, 1994, EUR J BIOCHEM, V225, P765, DOI 10.1111/j.1432-1033.1994.00765.x; Smit J, 2008, INNATE IMMUN-LONDON, V14, P25, DOI 10.1177/1753425907087588; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Tsukushi Y, 2004, J ENDOTOXIN RES, V10, P25, DOI 10.1179/096805104225003799; Urbanik-Sypniewska T, 2000, IMMUNOBIOLOGY, V202, P408, DOI 10.1016/S0171-2985(00)80043-1; Vincent M., 1970, HANDBOOK, V15; Welander PV, 2009, J BACTERIOL, V191, P6145, DOI 10.1128/JB.00460-09; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; YOKOTA A, 1987, ARCH MICROBIOL, V149, P106, DOI 10.1007/BF00425074; YOUNG JPW, 1991, J BACTERIOL, V173, P2271; Zahringer U, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P93	52	25	25	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35644	35655		10.1074/jbc.M114.614529	http://dx.doi.org/10.1074/jbc.M114.614529			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25371196	Green Published, hybrid			2022-12-28	WOS:000346660200050
J	Raddatz, N; Castillo, JP; Gonzalez, C; Alvarez, O; Latorre, R				Raddatz, Natalia; Castillo, Juan P.; Gonzalez, Carlos; Alvarez, Osvaldo; Latorre, Ramon			Temperature and Voltage Coupling to Channel Opening in Transient Receptor Potential Melastatin 8 (TRPM8)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Calcium Channel; Gating; Ion Channel; Thermodynamics; TRPM8; Allosteric Model; Deactivation Processes; Temperature Coefficient	SHAKER POTASSIUM CHANNELS; SQUID GIANT-AXON; ION CHANNELS; COLD SENSATION; PORE TURRET; SODIUM-CHANNELS; HEAT ACTIVATION; GATING CHARGE; K+ CHANNELS; REVEALS	Expressed in somatosensory neurons of the dorsal root and trigeminal ganglion, the transient receptor potential melastatin 8 (TRPM8) channel is a Ca2+-permeable cation channel activated by cold, voltage, phosphatidylinositol 4,5-bisphosphate, and menthol. Although TRPM8 channel gating has been characterized at the single channel and macroscopic current levels, there is currently no consensus regarding the extent to which temperature and voltage sensors couple to the conduction gate. In this study, we extended the range of voltages where TRPM8-induced ionic currents were measured and made careful measurements of the maximum open probability the channel can attain at different temperatures by means of fluctuation analysis. The first direct measurements of TRPM8 channel temperature-driven conformational rearrangements provided here suggest that temperature alone is able to open the channel and that the opening reaction is voltage-independent. Voltage is a partial activator of TRPM8 channels, because absolute open probability values measured with fully activated voltage sensors are less than 1, and they decrease as temperature rises. By unveiling the fast temperature-dependent deactivation process, we show that TRPM8 channel deactivation is well described by a double exponential time course. The fast and slow deactivation processes are temperature-dependent with enthalpy changes of 27.2 and 30.8 kcal mol(-1). The overall Q(10) for the closing reaction is about 33. A three-tiered allosteric model containing four voltage sensors and four temperature sensors can account for the complex deactivation kinetics and coupling between voltage and temperature sensor activation and channel opening.	[Raddatz, Natalia; Castillo, Juan P.; Gonzalez, Carlos; Alvarez, Osvaldo; Latorre, Ramon] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso 2366103, Chile; [Alvarez, Osvaldo] Univ Chile, Fac Ciencias, Dept Biol, Santiago 7800003, Chile	Universidad de Valparaiso; Universidad de Chile	Alvarez, O (corresponding author), Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso 2366103, Chile.	oalvarez@uchile.cl; ramon.latorre@uv.cl	Gonzalez, Carlos/V-7628-2019	Raddatz, Natalia/0000-0002-1801-4131	FONDECYT [1110430, 1120802, Anillo ACT-1104]; Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo (Chilean Government)	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo (Chilean Government)	This work was supported by Grants FONDECYT 1110430 (to R. L.) and 1120802 (to C. G.) and Anillo ACT-1104 (to C. G.). The Centro Interdisciplinario de Neurociencia de Valparaiso is a Millennium Institute supported by the Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo (Chilean Government).	Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Ashour SK, 2010, J ADV RES, V1, P341, DOI 10.1016/j.jare.2010.06.004; AZZALINI A, 1985, SCAND J STAT, V12, P171; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chowdhury S, 2014, CELL, V158, P1148, DOI 10.1016/j.cell.2014.07.026; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; COLE KS, 1960, BIOPHYS J, V1, P1, DOI 10.1016/S0006-3495(60)86871-3; CORREA AM, 1992, BIOPHYS J, V61, P1332, DOI 10.1016/S0006-3495(92)81941-0; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Cui YY, 2012, J GEN PHYSIOL, V139, P273, DOI 10.1085/jgp.201110724; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Fernandez JA, 2011, J GEN PHYSIOL, V137, P173, DOI 10.1085/jgp.201010498; FITZHUGH R, 1983, MATH BIOSCI, V64, P75, DOI 10.1016/0025-5564(83)90028-7; GOLDMAN L, 1991, BIOPHYS J, V60, P519, DOI 10.1016/S0006-3495(91)82080-X; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Hirschberg B, 1995, J GEN PHYSIOL, V106, P1053, DOI 10.1085/jgp.106.6.1053; HORN R, 1984, BIOPHYS J, V45, P323, DOI 10.1016/S0006-3495(84)84158-2; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Jara-Oseguera A, 2013, BIOPHYS J, V104, P2160, DOI 10.1016/j.bpj.2013.03.055; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2013, ACS CHEM NEUROSCI, V4, P238, DOI 10.1021/cn300193h; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nieto-Posadas A, 2011, CURR TOP MED CHEM, V11, P2131, DOI 10.2174/156802611796904870; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Rodriguez BM, 1998, J GEN PHYSIOL, V112, P223, DOI 10.1085/jgp.112.2.223; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Salazar M, 2011, J NEUROSCI, V31, P5554, DOI 10.1523/JNEUROSCI.6775-10.2011; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Sigg D, 1997, J GEN PHYSIOL, V109, P27, DOI 10.1085/jgp.109.1.27; SIGG D, 1994, SCIENCE, V264, P578, DOI 10.1126/science.8160016; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Stewart AP, 2010, BIOCHEM BIOPH RES CO, V394, P383, DOI 10.1016/j.bbrc.2010.03.027; STUHMER W, 1987, EUR BIOPHYS J BIOPHY, V14, P131, DOI 10.1007/BF00253837; VILLARROEL A, 1988, PFLUG ARCH EUR J PHY, V413, P118, DOI 10.1007/BF00582521; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Voets T, 2012, REV PHYSIOL BIOCH P, V162, P91, DOI 10.1007/112_2011_5; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Yao J, 2010, P NATL ACAD SCI USA, V107, pE125, DOI 10.1073/pnas.1008272107; YELLEN G, 1984, J GEN PHYSIOL, V84, P187, DOI 10.1085/jgp.84.2.187; Yudin Y, 2012, MOL CELL ENDOCRINOL, V353, P68, DOI 10.1016/j.mce.2011.10.023; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010	60	40	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35438	35454		10.1074/jbc.M114.612713	http://dx.doi.org/10.1074/jbc.M114.612713			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25352597	Green Published, hybrid			2022-12-28	WOS:000346660200034
J	Smulik, R; Debski, D; Zielonka, J; Michalowski, B; Adamus, J; Marcinek, A; Kalyanaraman, B; Sikora, A				Smulik, Renata; Debski, Dawid; Zielonka, Jacek; Michalowski, Bartosz; Adamus, Jan; Marcinek, Andrzej; Kalyanaraman, Balaraman; Sikora, Adam			Nitroxyl (HNO) Reacts with Molecular Oxygen and Forms Peroxynitrite at Physiological pH BIOLOGICAL IMPLICATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiovascular; Ischemia; Nitric Oxide; Oxidative Stress; Vascular; Angeli's Salt; Boronate Probes; Cardioprotection; Nitroxyl; Peroxynitrite	NITRIC-OXIDE; ANGELIS SALT; SODIUM TRIOXODINITRATE; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; ARYLBORONIC ACID; NITROSYL HYDRIDE; L-ARGININE; ANION; NO	Nitroxyl (HNO), the protonated one-electron reduction product of NO, remains an enigmatic reactive nitrogen species. Its chemical reactivity and biological activity are still not completely understood. HNO donors show biological effects different from NO donors. Although HNO reactivity with molecular oxygen is described in the literature, the product of this reaction has not yet been unambiguously identified. Here we report that the decomposition of HNO donors under aerobic conditions in aqueous solutions at physiological pH leads to the formation of peroxynitrite (ONOO-) as a major intermediate. We have specifically detected and quantified ONOO- with the aid of boronate probes, e.g. coumarin-7-boronic acid or 4-boronobenzyl derivative of fluorescein methyl ester. In addition to the major phenolic products, peroxynitrite-specific minor products of oxidation of boronate probes were detected under these conditions. Using the competition kinetics method and a set of HNO scavengers, the value of the second order rate constant of the HNO reaction with oxygen (k = 1.8 x 10(4) m(-1) s(-1)) was determined. The rate constant (k = 2 x 10(4) m(-1) s(-1)) was also determined using kinetic simulations. The kinetic parameters of the reactions of HNO with selected thiols, including cysteine, dithiothreitol, N-acetylcysteine, captopril, bovine and human serum albumins, and hydrogen sulfide, are reported. Biological and cardiovascular implications of nitroxyl reactions are discussed.	[Sikora, Adam] Lodz Univ Technol, Inst Appl Radiat Chem, PL-90924 Lodz, Poland; [Zielonka, Jacek; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Zielonka, Jacek; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA	Lodz University of Technology; Medical College of Wisconsin; Medical College of Wisconsin	Kalyanaraman, B (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	balarama@mcw.edu; adam.sikora@p.lodz.pl	Smulik-Izydorczyk, Renata/T-9352-2019; Sikora, Adam B/I-2756-2014; Zielonka, Jacek/N-9546-2014; Marcinek, Andrzej/M-1775-2018; Michalowski, Bartosz/AAN-3737-2020	Smulik-Izydorczyk, Renata/0000-0002-6509-404X; Sikora, Adam B/0000-0002-4962-8945; Zielonka, Jacek/0000-0002-2524-0145; Marcinek, Andrzej/0000-0002-9852-7593; Michalowski, Bartosz/0000-0002-3955-2924	National Institutes of Health Grant [R01 HL073056]; Polish Ministry of Higher Education within the Iuventus Plus program [IP2011049271]; Jagiellonian Centre for Experimental Therapeutics - European Union [POIG.01.01.02-00-069/09]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073056] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Higher Education within the Iuventus Plus program; Jagiellonian Centre for Experimental Therapeutics - European Union; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL073056 (to B. K.). This work was also supported by Grant IP2011049271 from the Polish Ministry of Higher Education within the Iuventus Plus program and by Grant POIG.01.01.02-00-069/09 from Jagiellonian Centre for Experimental Therapeutics(supported by the European Union from the resources of the European Regional Development Fund under the Innovative Economy Programme).	Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Augustyniak A, 2013, CHEM-BIOL INTERACT, V206, P262, DOI 10.1016/j.cbi.2013.09.019; BAZYLINSKI DA, 1985, J AM CHEM SOC, V107, P7982, DOI 10.1021/ja00312a031; Bohle DS, 1996, METHOD ENZYMOL, V269, P302; Chazotte-Aubert L, 1999, J BIOL CHEM, V274, P20909, DOI 10.1074/jbc.274.30.20909; Chin KY, 2014, BRIT J PHARMACOL, V171, P1722, DOI 10.1111/bph.12568; Cline MR, 2011, FREE RADICAL BIO MED, V50, P1274, DOI 10.1016/j.freeradbiomed.2011.02.008; DONALD CE, 1986, INORG CHEM, V25, P2676, DOI 10.1021/ic00236a004; DOYLE MP, 1988, J AM CHEM SOC, V110, P593, DOI 10.1021/ja00210a047; Ellis A, 2000, BRIT J PHARMACOL, V129, P315, DOI 10.1038/sj.bjp.0703058; ELLIS AJ, 1967, GEOCHIM COSMOCHIM AC, V31, P615, DOI 10.1016/0016-7037(67)90038-5; Favaloro JL, 2007, CARDIOVASC RES, V73, P587, DOI 10.1016/j.cardiores.2006.11.018; Fukuto JM, 2005, CHEM RES TOXICOL, V18, P790, DOI 10.1021/tx0496800; FUKUTO JM, 1992, J PHARMACOL EXP THER, V263, P546; Fukuto JM, 2013, J INORG BIOCHEM, V118, P201, DOI 10.1016/j.jinorgbio.2012.08.027; Fukuto JM, 2009, FREE RADICAL BIO MED, V47, P1318, DOI 10.1016/j.freeradbiomed.2009.06.014; Goss SPA, 1997, J BIOL CHEM, V272, P21647, DOI 10.1074/jbc.272.34.21647; Gupta D, 2009, DALTON T, P5730, DOI 10.1039/b905535e; Hewett SJ, 2005, FREE RADICAL BIO MED, V39, P1478, DOI 10.1016/j.freeradbiomed.2005.07.007; HOBBS AJ, 1994, P NATL ACAD SCI USA, V91, P10992, DOI 10.1073/pnas.91.23.10992; HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030; Hughes MN, 1999, METHOD ENZYMOL, V301, P279; Ianni JC, 2003, COMPUTATIONAL FLUID AND SOLID MECHANICS 2003, VOLS 1 AND 2, PROCEEDINGS, P1368; Irvine JC, 2003, HYPERTENSION, V41, P1301, DOI 10.1161/01.HYP.0000072010.54901.DE; Irvine JC, 2007, HYPERTENSION, V49, P885, DOI 10.1161/01.HYP.0000259328.04159.90; Irvine JC, 2008, TRENDS PHARMACOL SCI, V29, P601, DOI 10.1016/j.tips.2008.08.005; JOSEPH J, 1994, FASEB J, V8, pA313; Joseph J., 1996, BIOCHEMISTRY-US, V35, P9287; Kirsch M, 2002, J BIOL CHEM, V277, P13379, DOI 10.1074/jbc.M108079200; Kirsch M, 2003, ARCH BIOCHEM BIOPHYS, V418, P133, DOI 10.1016/j.abb.2003.07.002; Kirsch M, 2009, ORG BIOMOL CHEM, V7, P1954, DOI 10.1039/b901046g; Liochev SI, 2003, FREE RADICAL BIO MED, V34, P1399, DOI 10.1016/S0891-5849(03)00111-4; Liochev SI, 2002, ARCH BIOCHEM BIOPHYS, V402, P166, DOI 10.1016/S0003-9861(02)00074-7; Liochev SI, 2001, J BIOL CHEM, V276, P35253, DOI 10.1074/jbc.M104237200; Lippert AR, 2011, ACCOUNTS CHEM RES, V44, P793, DOI 10.1021/ar200126t; Mao GJ, 2014, CHEM COMMUN, V50, P5790, DOI 10.1039/c4cc01440e; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; Miranda KM, 2005, COORDIN CHEM REV, V249, P433, DOI 10.1016/j.ccr.2004.08.010; Miranda KM, 2001, J BIOL CHEM, V276, P1720, DOI 10.1074/jbc.M006174200; Miranda KM, 2003, P NATL ACAD SCI USA, V100, P9196, DOI 10.1073/pnas.1430507100; Miranda KM, 2002, ARCH BIOCHEM BIOPHYS, V401, P134, DOI 10.1016/S0003-9861(02)00031-0; Morrison DE, 2010, J BIOL INORG CHEM, V15, P1305, DOI 10.1007/s00775-010-0690-6; MURPHY ME, 1991, P NATL ACAD SCI USA, V88, P10860, DOI 10.1073/pnas.88.23.10860; Pagliaro P, 2003, LIFE SCI, V73, P2137, DOI 10.1016/S0024-3205(03)00593-9; Poderoso JJ, 1999, FREE RADICAL BIO MED, V26, P925, DOI 10.1016/S0891-5849(98)00277-9; PUFAHL RA, 1995, BIOCHEMISTRY-US, V34, P1930, DOI 10.1021/bi00006a014; RADI R, 1991, J BIOL CHEM, V266, P4244; Sabbah HN, 2013, CIRC-HEART FAIL, V6, P1250, DOI 10.1161/CIRCHEARTFAILURE.113.000632; Saleem M, 2004, BIOCHEM BIOPH RES CO, V315, P455, DOI 10.1016/j.bbrc.2004.01.081; Samuni A, 2011, J PHYS CHEM A, V115, P3022, DOI 10.1021/jp201796q; Samuni U, 2010, J AM CHEM SOC, V132, P8428, DOI 10.1021/ja101945j; Samuni Y, 2013, J INORG BIOCHEM, V118, P155, DOI 10.1016/j.jinorgbio.2012.10.002; Shafirovich V, 2002, P NATL ACAD SCI USA, V99, P7340, DOI 10.1073/pnas.112202099; Shafirovich V, 2003, J AM CHEM SOC, V125, P6547, DOI 10.1021/ja034378j; Sharpe MA, 1998, BIOCHEM J, V332, P9, DOI 10.1042/bj3320009; Sieracki NA, 2013, FREE RADICAL BIO MED, V61, P40, DOI 10.1016/j.freeradbiomed.2013.02.020; Sikora A, 2013, CHEM RES TOXICOL, V26, P856, DOI 10.1021/tx300499c; Sikora A, 2011, CHEM RES TOXICOL, V24, P687, DOI 10.1021/tx100439a; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Stoyanovsky DA, 2004, J MED CHEM, V47, P210, DOI 10.1021/jm030192j; Suarez SA, 2007, POLYHEDRON, V26, P4673, DOI 10.1016/j.poly.2007.05.040; Switzer CH, 2009, BBA-BIOENERGETICS, V1787, P835, DOI 10.1016/j.bbabio.2009.04.015; Wanstall JC, 2001, BRIT J PHARMACOL, V134, P463, DOI 10.1038/sj.bjp.0704269; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Wong PSY, 1998, BIOCHEMISTRY-US, V37, P5362, DOI 10.1021/bi973153g; Wrobel AT, 2014, J AM CHEM SOC, V136, P4697, DOI 10.1021/ja500315x; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080	70	55	55	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35570	35581		10.1074/jbc.M114.597740	http://dx.doi.org/10.1074/jbc.M114.597740			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25378389	Green Published, hybrid			2022-12-28	WOS:000346660200044
J	Zearfoss, NR; Deveau, LM; Clingman, CC; Schmidt, E; Johnson, ES; Massi, F; Ryder, SP				Zearfoss, N. Ruth; Deveau, Laura M.; Clingman, Carina C.; Schmidt, Eric; Johnson, Emily S.; Massi, Francesca; Ryder, Sean P.			A Conserved Three-nucleotide Core Motif Defines Musashi RNA Binding Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Fluorescence Anisotropy; RNA; RNA-binding Protein; RNA-Protein Interaction; Binding Specificity; RNA Recognition; RRM	MESSENGER-RNA; MYELOID-LEUKEMIA; STEM-CELLS; TRANSLATIONAL REPRESSION; PROTEIN MUSASHI-1; PROGENITOR CELLS; MOLECULAR-BASIS; MAMMALIAN CNS; EXPRESSION; RECOGNITION	Musashi (MSI) family proteins control cell proliferation and differentiation in many biological systems. They are overexpressed in tumors of several origins, and their expression level correlates with poor prognosis. MSI proteins control gene expression by binding RNA and regulating its translation. They contain two RNA recognition motif (RRM) domains, which recognize a defined sequence element. The relative contribution of each nucleotide to the binding affinity and specificity is unknown. We analyzed the binding specificity of three MSI family RRM domains using a quantitative fluorescence anisotropy assay. We found that the core element driving recognition is the sequence UAG. Nucleotides outside of this motif have a limited contribution to binding free energy. For mouse MSI1, recognition is determined by the first of the two RRM domains. The second RRM adds affinity but does not contribute to binding specificity. In contrast, the recognition element for Drosophila MSI is more extensive than the mouse homolog, suggesting functional divergence. The short nature of the binding determinant suggests that protein-RNA affinity alone is insufficient to drive target selection by MSI family proteins.	[Zearfoss, N. Ruth; Deveau, Laura M.; Clingman, Carina C.; Schmidt, Eric; Johnson, Emily S.; Massi, Francesca; Ryder, Sean P.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Ryder, SP (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 364 Plantation St, Worcester, MA 01605 USA.	Sean.Ryder@umassmed.edu			National Institutes of Health [GM098763, GM081422, GM098643]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098763, R01GM098643, R01GM081422, T32GM107000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM098763 (to F. M.) and GM081422 and GM098643 (to S. P. R.).	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asai R, 2005, DEV GROWTH DIFFER, V47, P501, DOI 10.1111/j.1440-169X.2005.00825.x; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Byers RJ, 2011, BLOOD, V118, P2857, DOI 10.1182/blood-2011-04-346767; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Clingman CC, 2014, ELIFE, V3, DOI 10.7554/eLife.02848; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dobson NR, 2008, GLIA, V56, P318, DOI 10.1002/glia.20615; Goddard D., 2008, SPARKY 3; Horisawa K, 2009, FEBS LETT, V583, P2429, DOI 10.1016/j.febslet.2009.06.045; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Jenkins HT, 2011, P NATL ACAD SCI USA, V108, P18266, DOI 10.1073/pnas.1105211108; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kurihara Y, 1997, GENE, V186, P21, DOI 10.1016/S0378-1119(96)00673-7; Kuwako K, 2010, NEURON, V67, P407, DOI 10.1016/j.neuron.2010.07.005; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Miyanoiri Y, 2003, J BIOL CHEM, V278, P41309, DOI 10.1074/jbc.M306210200; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Ohyama T, 2012, NUCLEIC ACIDS RES, V40, P3218, DOI 10.1093/nar/gkr1139; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Pagano JM, 2011, RNA, V17, P14, DOI 10.1261/rna.2428111; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; RICHTER K, 1990, New Biologist, V2, P556; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; Siddall NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049810; Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053540; Vo DT, 2012, AM J PATHOL, V181, P1762, DOI 10.1016/j.ajpath.2012.07.031; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yoda A, 2000, GENES CELLS, V5, P885, DOI 10.1046/j.1365-2443.2000.00378.x	41	49	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35530	35541		10.1074/jbc.M114.597112	http://dx.doi.org/10.1074/jbc.M114.597112			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25368328	Green Published, hybrid			2022-12-28	WOS:000346660200041
J	Hock, AK; Vigneron, AM; Vousden, KH				Hock, Andreas K.; Vigneron, Arnaud M.; Vousden, Karen H.			Ubiquitin-specific Peptidase 42 (USP42) Functions to Deubiquitylate Histones and Regulate Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Deubiquitylation (Deubiquitination); Histone; RNA Polymerase II; Transcription; USP42	DEUBIQUITINATING ENZYMES; P53 STABILITY; PATHWAY; MDM2; DEGRADATION; PROMOTES; LIGASE	Background: Ubiquitin modification of histones regulates gene expression. Results: USP42 targets histone H2B at promoters, leading to decreased ubiquitylation. This correlates with the regulation of transcription driven by a number of transcription factors. Conclusion: USP42 contributes to the modulation of transcription. Significance: The identification of histone H2B as a target for USP42 extends our understanding of the factors that can regulate gene expression. Ubiquitin-specific peptidase 42 (USP42) is a deubiquitylating enzyme that can target p53 and contribute to the stabilization of p53 in response to stress. We now show that USP42 can also regulate transcription independently of p53. USP42 co-localized with RNA polymerase II (RNA Pol II) in nuclear foci, bound to histone H2B, and deubiquitylated H2B. Depletion of USP42 increased H2B ubiquitylation at a model promoter and decreased both basal and induced transcription from a number of promoters. These results are consistent with a role for USP42 in regulating transcription by deubiquitylating histones.	[Hock, Andreas K.; Vigneron, Arnaud M.; Vousden, Karen H.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Vousden, KH (corresponding author), Canc Res UK Beatson Inst, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.vousden@beatson.gla.ac.uk	Vigneron, Arnaud/ABC-7306-2021	Vigneron, Arnaud/0000-0003-4161-0676	Cancer Research UK [C596/A10419]; Cancer Research UK [18274] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK Grant C596/A10419.	Atanassov BS, 2011, FEBS LETT, V585, P2016, DOI 10.1016/j.febslet.2010.10.042; Chandrasekharan MB, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12314; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Choong ML, 2009, CELL CYCLE, V8, P2810, DOI 10.4161/cc.8.17.9503; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hock AK, 2014, BBA-MOL CELL RES, V1843, P137, DOI 10.1016/j.bbamcr.2013.05.022; Hock AK, 2011, EMBO J, V30, P4921, DOI 10.1038/emboj.2011.419; Joo HY, 2011, J BIOL CHEM, V286, P7190, DOI 10.1074/jbc.M110.158311; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Liu JH, 2011, EMBO J, V30, P846, DOI 10.1038/emboj.2011.11; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Muller PAJ, 2013, ONCOGENE, V32, P1252, DOI 10.1038/onc.2012.148; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tsou WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043112; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zou Q, 2014, NAT IMMUNOL, V15, P562, DOI 10.1038/ni.2885	31	28	28	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34862	34870		10.1074/jbc.M114.589267	http://dx.doi.org/10.1074/jbc.M114.589267			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25336640	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000346260800037
J	Miao, HF; Jia, YY; Xie, SC; Wang, X; Zhao, JF; Chu, YJ; Zhou, ZL; Shi, ZB; Song, XM; Li, L				Miao, Haofei; Jia, Yingying; Xie, Sichun; Wang, Xin; Zhao, Jianfei; Chu, Youjun; Zhou, Zhilei; Shi, Zhubing; Song, Xiaomin; Li, Lin			Structural Insights into the C1q Domain of Caprin-2 in Canonical Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium-binding Protein; Crystal Structure; Mutagenesis; Wnt Pathway; Wnt Signaling; C1q; Caprin-2	CRYSTAL-STRUCTURE; RNA GRANULES; PROTEIN; MOLECULE; FEATURES; FAMILY	Background: Caprin-2 is a newly identified regulator in canonical Wnt signaling. Results: Mutants targeting trimer contacts of Caprin-2 CRD rather than calcium-binding sites affect the function of Caprin-2 in canonical Wnt signaling. Conclusion: Caprin-2 CRD forms a flexible homotrimer mediated by calcium, and this trimeric assembly is required for the function of Caprin-2. Significance: This work facilitates our understanding of how Caprin-2 functions in canonical Wnt signaling. Previously, we have identified Caprin-2 as a new regulator in canonical Wnt signaling through a mechanism of facilitating LRP5/6 phosphorylation; moreover, we found that its C-terminal C1q-related domain (Cap2_CRD) is required for this process. Here, we determined the crystal structures of Cap2_CRD from human and zebrafish, which both associate as a homotrimer with calcium located at the symmetric center. Surprisingly, the calcium binding-deficient mutant exists as a more stable trimer than its wild-type counterpart. Further studies showed that this Caprin-2 mutant disabled in binding calcium maintains the activity of promoting LRP5/6 phosphorylation, whereas the mutations disrupting Cap2_CRD homotrimer did impair such activity. Together, our findings suggested that the C-terminal CRD domain of Caprin-2 forms a flexible homotrimer mediated by calcium and that such trimeric assembly is required for Caprin-2 to regulate canonical Wnt signaling.	[Miao, Haofei; Jia, Yingying; Xie, Sichun; Wang, Xin; Zhao, Jianfei; Chu, Youjun; Zhou, Zhilei; Shi, Zhubing; Song, Xiaomin; Li, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, XM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	xmsong01@sibcb.ac.cn; lli@sibs.ac.cn	LI, LI/GVS-5344-2022; zhou, zhou/HCH-1084-2022; Li, Li/AEM-3636-2022; Shi, Zhubing/F-9490-2010; li, li/HII-4157-2022	Shi, Zhubing/0000-0002-9624-4960; 	Ministry of Science and Technology of China [2010CB912100, 2011CD966300]; National Natural Science Foundation of China [31230044, 30930052, 91213304, 31100532]; Sanofi-Arentis; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sanofi-Arentis; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology of China Grants 2010CB912100 (to L. L.) and 2011CD966300 (to X. S.) and National Natural Science Foundation of China Grants 31230044, 30930052, and 91213304 (to L. L.) and 31100532 (to X. S.).; Supported by the Sanofi-Arentis and Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences scholarship program. To whom correspondence may be addressed. E-mail: xmsong01@sibcb.ac.cn.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4; Carland TM, 2010, DEV COMP IMMUNOL, V34, P785, DOI 10.1016/j.dci.2010.02.014; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Ding Y, 2008, J CELL BIOL, V182, P865, DOI 10.1083/jcb.200803147; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Garlatti V, 2010, J IMMUNOL, V185, P808, DOI 10.4049/jimmunol.1000184; Ghai R, 2007, IMMUNOBIOLOGY, V212, P253, DOI 10.1016/j.imbio.2006.11.001; Grill B, 2004, J IMMUNOL, V172, P2389, DOI 10.4049/jimmunol.172.4.2389; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kojouharova MS, 2004, J IMMUNOL, V172, P4351, DOI 10.4049/jimmunol.172.7.4351; Kvansakul M, 2003, MATRIX BIOL, V22, P145, DOI 10.1016/S0945-053X(02)00119-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oren DA, 2002, NAT STRUCT BIOL, V9, P288, DOI 10.1038/nsb769; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Roumenina LT, 2005, BIOCHEMISTRY-US, V44, P14097, DOI 10.1021/bi051186n; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Shiina N, 2010, J BIOL CHEM, V285, P24260, DOI 10.1074/jbc.M110.108944; SMITH RA, 1987, J BIOL CHEM, V262, P6951; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhou ZC, 2008, P NATL ACAD SCI USA, V105, P5465, DOI 10.1073/pnas.0711350105	32	14	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34104	34113		10.1074/jbc.M114.591636	http://dx.doi.org/10.1074/jbc.M114.591636			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25331957	Green Published, hybrid			2022-12-28	WOS:000346077600035
J	Skala, W; Utzschneider, DT; Magdolen, V; Debela, M; Guo, SH; Craik, CS; Brandstetter, H; Goettig, P				Skala, Wolfgang; Utzschneider, Daniel T.; Magdolen, Viktor; Debela, Mekdes; Guo, Shihui; Craik, Charles S.; Brandstetter, Hans; Goettig, Peter			Structure-Function Analyses of Human Kallikrein-related Peptidase 2 Establish the 99-Loop as Master Regulator of Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Crystallography; Enzyme Kinetics; Kallikrein; Prostate Cancer; Serine Protease; Substrate Specificity; 99-Loop; Autolytic Cleavage; Conformational Selection; Zinc Inhibition	HUMAN GLANDULAR KALLIKREIN; PROSTATE-SPECIFIC ANTIGEN; RAY CRYSTAL-STRUCTURE; SERINE-PROTEASE; SUBSTRATE-SPECIFICITY; ELECTROSTATIC PROPERTIES; GROWTH-FACTOR; BINDING SITE; HK2; TRYPSIN	Background: Serine proteases KLK2 and KLK3 clear the way for spermatozoa before impregnation. Results: Enzymatic assays and structures of KLK2 elucidate its catalytic action, especially when compared with conformations of similar proteases. Conclusion: Flexible loops around the active site of serine proteases open concertedly upon substrate binding. Significance: This mechanistic model will stimulate the design of pharmaceutical inhibitors. Human kallikrein-related peptidase 2 (KLK2) is a tryptic serine protease predominantly expressed in prostatic tissue and secreted into prostatic fluid, a major component of seminal fluid. Most likely it activates and complements chymotryptic KLK3 (prostate-specific antigen) in cleaving seminal clotting proteins, resulting in sperm liquefaction. KLK2 belongs to the classical KLKs 1-3, which share an extended 99- or kallikrein loop near their non-primed substrate binding site. Here, we report the 1.9 crystal structures of two KLK2-small molecule inhibitor complexes. In both structures discontinuous electron density for the 99-loop indicates that this loop is largely disordered. We provide evidence that the 99-loop is responsible for two biochemical peculiarities of KLK2, i.e. reversible inhibition by micromolar Zn2+ concentrations and permanent inactivation by autocatalytic cleavage. Indeed, several 99-loop mutants of KLK2 displayed an altered susceptibility to Zn2+, which located the Zn2+ binding site at the 99-loop/active site interface. In addition, we identified an autolysis site between residues 95e and 95f in the 99-loop, whose elimination prevented the mature enzyme from limited autolysis and irreversible inactivation. An exhaustive comparison of KLK2 with related structures revealed that in the KLK family the 99-, 148-, and 220-loop exist in open and closed conformations, allowing or preventing substrate access, which extends the concept of conformational selection in trypsin-related proteases. Taken together, our novel biochemical and structural data on KLK2 identify its 99-loop as a key player in activity regulation.	[Skala, Wolfgang; Guo, Shihui; Brandstetter, Hans; Goettig, Peter] Salzburg Univ, Div Struct Biol, Dept Mol Biol, A-5020 Salzburg, Austria; [Utzschneider, Daniel T.; Magdolen, Viktor] Tech Univ Munich, Klinikum Rechts Isar, Klin Forschergrp, Frauenklin, D-81675 Munich, Germany; [Debela, Mekdes] Max Planck Inst Biochem, Proteinase Res Grp, D-82152 Martinsried, Germany; [Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	Salzburg University; Technical University of Munich; Max Planck Society; University of California System; University of California San Francisco	Goettig, P (corresponding author), Salzburg Univ, Div Struct Biol, Dept Mol Biol, Billrothstr 11, A-5020 Salzburg, Austria.	peter.goettig@sbg.ac.at	guo, shihui/GPX-4901-2022; Brandstetter, Hans/E-6754-2011; Guo, shihui/AAT-2810-2021; Goettig, Peter/R-7996-2017; Goettig, Peter/K-4508-2019; Utzschneider, Daniel/D-5855-2016; Esser-Skala, Wolfgang/L-9370-2017	guo, shihui/0000-0002-0542-1221; Brandstetter, Hans/0000-0002-6089-3045; Guo, shihui/0000-0002-0542-1221; Goettig, Peter/0000-0002-2430-1970; Goettig, Peter/0000-0002-2430-1970; Utzschneider, Daniel/0000-0003-2205-9057; Esser-Skala, Wolfgang/0000-0002-7350-4045	Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung) [I631-B11]; German Research Association (Deutsche Forschungsgemeinschaft) [MA1236/7-1]; United States Department of Defense [PC111318]; Austrian Science Fund (FWF) [I 631] Funding Source: researchfish	Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); German Research Association (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); United States Department of Defense(United States Department of Defense); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung project I631-B11), the German Research Association (Deutsche Forschungsgemeinschaft, MA1236/7-1), and the United States Department of Defense Grant PC111318).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bax B, 1997, STRUCTURE, V5, P1275, DOI 10.1016/S0969-2126(97)00280-3; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Bernett MJ, 2002, J BIOL CHEM, V277, P24562, DOI 10.1074/jbc.M202392200; BODE W, 1975, FEBS LETT, V56, P139, DOI 10.1016/0014-5793(75)80128-1; BODE W, 1983, J MOL BIOL, V164, P237, DOI 10.1016/0022-2836(83)90077-3; BODE W, 1992, PROTEIN SCI, V1, P426; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; Bourgeois L, 1997, J BIOL CHEM, V272, P29590, DOI 10.1074/jbc.272.47.29590; Carvalho AL, 2002, J MOL BIOL, V322, P325, DOI 10.1016/S0022-2836(02)00705-2; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHEN ZG, 1983, J MOL BIOL, V164, P283, DOI 10.1016/0022-2836(83)90078-5; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Cloutier SM, 2002, EUR J BIOCHEM, V269, P2747, DOI 10.1046/j.1432-1033.2002.02960.x; CRAIK CS, 1985, SCIENCE, V228, P291, DOI 10.1126/science.3838593; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Debela M, 2008, BIOL CHEM, V389, P623, DOI 10.1515/BC.2008.075; Debela M, 2007, J MOL BIOL, V373, P1017, DOI 10.1016/j.jmb.2007.08.042; Debela M, 2007, P NATL ACAD SCI USA, V104, P16086, DOI 10.1073/pnas.0707811104; Debela M, 2006, J MOL BIOL, V362, P1094, DOI 10.1016/j.jmb.2006.08.003; Denmeade SR, 2001, PROSTATE, V48, P122, DOI 10.1002/pros.1088; Deperthes D, 1996, J ANDROL, V17, P659; Deperthes D, 1995, BBA-GEN SUBJECTS, V1245, P311, DOI 10.1016/0304-4165(95)00118-2; Einspahr H. M., 2012, INT TABLES CRYSTALLO, VF, P64; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Felsenstein J., 2005, PHYLIP PHYLOGENY INT; Fenner G, 1931, NATURWISSENSCHAFTEN, V19, P310; Fernandez IS, 2008, J MOL BIOL, V377, P1488, DOI 10.1016/j.jmb.2008.01.089; Frenette G, 1997, BBA-GEN SUBJECTS, V1334, P109, DOI 10.1016/S0304-4165(96)00080-3; Frenette G, 1997, INT J CANCER, V71, P897, DOI 10.1002/(SICI)1097-0215(19970529)71:5<897::AID-IJC31>3.0.CO;2-2; Frey EK, 1926, H-S Z PHYSIOL CHEM, V157, P32; FUJINAGA M, 1987, J MOL BIOL, V195, P373, DOI 10.1016/0022-2836(87)90658-9; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Goettig P, 2010, BIOCHIMIE, V92, P1546, DOI 10.1016/j.biochi.2010.06.022; Gomis-Ruth FX, 2002, J BIOL CHEM, V277, P27273, DOI 10.1074/jbc.M201534200; Grauer LS, 1998, J ANDROL, V19, P407; Harding MM, 2014, METHODS MOL BIOL, V1091, P333, DOI 10.1007/978-1-62703-691-7_23; HARTLEY BS, 1970, PHILOS T ROY SOC B, V257, P77, DOI 10.1098/rstb.1970.0010; Hekim C, 2006, J BIOL CHEM, V281, P12555, DOI 10.1074/jbc.M600014200; Hopfner KP, 1999, STRUCTURE, V7, P989, DOI 10.1016/S0969-2126(99)80125-7; Jansen FH, 2009, EUR UROL, V55, P563, DOI 10.1016/j.eururo.2008.11.040; Janssen S, 2006, PROSTATE, V66, P358, DOI 10.1002/pros.20348; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kellermann J, 1988, Protein Seq Data Anal, V1, P177; Kishi A, 1999, J BIOL CHEM, V274, P4220, DOI 10.1074/jbc.274.7.4220; Kontos CK, 2012, CLIN CHEM LAB MED, V50, P1877, DOI 10.1515/cclm-2012-0247; Kraut H, 1930, H-S Z PHYSIOL CHEM, V189, P97, DOI 10.1515/bchm2.1930.189.3-4.97; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; KREUTTER K, 1994, BIOCHEMISTRY-US, V33, P13792, DOI 10.1021/bi00250a033; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lansdown ABG, 2007, WOUND REPAIR REGEN, V15, P2, DOI 10.1111/j.1524-475X.2006.00179.x; Laxmikanthan G, 2005, PROTEINS, V58, P802, DOI 10.1002/prot.20368; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Liang GY, 2012, BIOORG MED CHEM LETT, V22, P2450, DOI 10.1016/j.bmcl.2012.02.014; Lovgren J, 1999, EUR J BIOCHEM, V262, P781, DOI 10.1046/j.1432-1327.1999.00433.x; Lovgren J, 1999, EUR J BIOCHEM, V266, P1050, DOI 10.1046/j.1432-1327.1999.00946.x; Lovgren J, 1997, BIOCHEM BIOPH RES CO, V238, P549, DOI 10.1006/bbrc.1997.7333; Lundwall A, 2008, CELL MOL LIFE SCI, V65, P2019, DOI 10.1007/s00018-008-8024-3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonald MR, 1941, J GEN PHYSIOL, V25, P53, DOI 10.1085/jgp.25.1.53; MCGEE RS, 1988, BIOL REPROD, V39, P499, DOI 10.1095/biolreprod39.2.499; Menez R, 2008, J MOL BIOL, V376, P1021, DOI 10.1016/j.jmb.2007.11.052; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; Mikolajczyk SD, 1999, CANCER RES, V59, P3927; Mikolajczyk SD, 1999, INT J CANCER, V81, P438, DOI 10.1002/(SICI)1097-0215(19990505)81:3<438::AID-IJC18>3.3.CO;2-L; Mikolajczyk SD, 1998, PROSTATE, V34, P44; Mittl PRE, 1997, STRUCTURE, V5, P253, DOI 10.1016/S0969-2126(97)00183-4; Mize GJ, 2008, MOL CANCER RES, V6, P1043, DOI 10.1158/1541-7786.MCR-08-0096; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nelson PS, 1999, P NATL ACAD SCI USA, V96, P3114, DOI 10.1073/pnas.96.6.3114; Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q; Niu WL, 2011, BIOCHEMISTRY-US, V50, P6301, DOI 10.1021/bi200878c; Ota N, 1999, PROTEINS, V37, P641, DOI 10.1002/(SICI)1097-0134(19991201)37:4<641::AID-PROT14>3.0.CO;2-W; Pavlopoulou A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013781; Pozharski E, 2013, ACTA CRYSTALLOGR D, V69, P150, DOI 10.1107/S0907444912044423; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Rao AR, 2008, BJU INT, V101, P5, DOI 10.1111/j.1464-410X.2007.07138.x; Rehault S, 2001, EUR J BIOCHEM, V268, P2960, DOI 10.1046/j.1432-1327.2001.02185.x; Rupp B, 2012, ACTA CRYSTALLOGR F, V68, P366, DOI 10.1107/S1744309112008421; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHEDLICH LJ, 1987, DNA-J MOLEC CELL BIO, V6, P429, DOI 10.1089/dna.1987.6.429; Schrodinger L, 2012, PYMOL MOL GRAPHICS S; SEGAL DM, 1971, BIOCHEMISTRY-US, V10, P3728; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Sichler K, 2002, FEBS LETT, V530, P220, DOI 10.1016/S0014-5793(02)03495-6; Skala W, 2013, J BIOTECHNOL, V168, P421, DOI 10.1016/j.jbiotec.2013.10.022; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Stura EA, 2011, J MOL BIOL, V414, P530, DOI 10.1016/j.jmb.2011.10.007; TENEYCK LF, 1973, ACTA CRYSTALLOGR A, VA 29, P183, DOI 10.1107/S0567739473000458; Timm DE, 1997, PROTEIN SCI, V6, P1418, DOI 10.1002/pro.5560060706; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vasilief, 2011, QTIPLOT DATA ANAL SC; VILLOUTREIX BO, 1994, PROTEINS, V19, P230, DOI 10.1002/prot.340190307; VILLOUTREIX BO, 1994, PROTEIN SCI, V3, P2033, DOI 10.1002/pro.5560031116; Weichenberger CX, 2007, NUCLEIC ACIDS RES, V35, pW403, DOI 10.1093/nar/gkm263; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200	105	24	25	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34267	34283		10.1074/jbc.M114.598201	http://dx.doi.org/10.1074/jbc.M114.598201			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25326387	Green Published, hybrid			2022-12-28	WOS:000346077600049
J	Hooper, C; Jackson, SS; Coughlin, EE; Coon, JJ; Miyamoto, S				Hooper, Christopher; Jackson, Shawn S.; Coughlin, Emma E.; Coon, Joshua J.; Miyamoto, Shigeki			Covalent Modification of the NF-kappa B Essential Modulator (NEMO) by a Chemical Compound Can Regulate Its Ubiquitin Binding Properties in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANHIDROTIC ECTODERMAL DYSPLASIA; ZINC-FINGER; IKK ACTIVATION; TNF-ALPHA; WITHAFERIN; CHAINS; DOMAIN; POLYUBIQUITIN; INHIBITION; COMPLEX	Post-translational modification by ubiquitin plays important roles in multiple physiological and pathological processes. Ubiquitin-binding proteins play a critical role in recognizing and relaying polyubiquitin-based signaling. NEMO (NF-kappa B Essential Modulator) is a central player in canonical NF-kappa B signaling whose major function is to bind to Lys-63-and/or M1- (or linear) linked polyubiquitin chains generated in response to cell stimulation. Here we show that Withaferin A (WA), a steroidal lactone, causes a change in NEMO's interaction with specific types of polyubiquitin chains in vitro. WA induces full-length recombinant NEMO to bind to long Lys-48-linked polyubiquitin chains but not tetra-ubiquitin species. Significantly, the UBAN (ubiquitin binding in ABIN and NEMO) domain, essential for the ability of NEMO to bind M1/Lys-63-linked polyubiquitin, is dispensable for the WA-induced gain-of-function activity. Mass spectrometric analysis demonstrated that WA covalently modifies NEMO on a cysteine residue within the C-terminal zinc finger (ZF) domain. Point mutations to the ZF can reverse the WA-induced Lys-48-polyubiquitin binding phenotype. Our study demonstrates the feasibility of directly altering the ubiquitin interaction properties of an ubiquitin-binding protein by a chemical compound, thereby shedding light on a novel drug class to potentially alter polyubiquitin-based cellular processes.	[Hooper, Christopher; Jackson, Shawn S.; Coon, Joshua J.; Miyamoto, Shigeki] Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Madison, WI 53705 USA; [Jackson, Shawn S.; Miyamoto, Shigeki] Univ Wisconsin, Med Scientist Training Program, Madison, WI 53705 USA; [Hooper, Christopher; Jackson, Shawn S.; Miyamoto, Shigeki] Univ Wisconsin, Cellular & Mol Biol Program, Madison, WI 53705 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Coughlin, Emma E.; Coon, Joshua J.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Miyamoto, S (corresponding author), Univ Wisconsin, Wisconsin Inst Med Res 6159, McArdle Lab Canc Res, Dept Oncol, 1111 Highland Ave, Madison, WI 53705 USA.	smiyamot@wisc.edu		Coughlin, Emma/0000-0001-8774-7876	National Institutes of Health [R01 GM083681, R01 CA077474]; NATIONAL CANCER INSTITUTE [R01CA077474, F31CA186551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692, R01GM083681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM083681 and R01 CA077474.	Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Chen JQ, 2013, CURR OPIN IMMUNOL, V25, P4, DOI 10.1016/j.coi.2012.12.005; Chiaravalli J, 2011, BIOCHEM PHARMACOL, V82, P1163, DOI 10.1016/j.bcp.2011.07.083; Clark K, 2013, NAT REV MOL CELL BIO, V14, P673, DOI 10.1038/nrm3644; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; Cordier F, 2009, J BIOL CHEM, V284, P2902, DOI 10.1074/jbc.M806655200; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Grover A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S25; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kensche T, 2012, J BIOL CHEM, V287, P23626, DOI 10.1074/jbc.M112.347195; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ngadjeua F, 2013, J BIOL CHEM, V288, P33722, DOI 10.1074/jbc.M113.483305; Ozorowski G, 2012, BIOL CHEM, V393, P1151, DOI 10.1515/hsz-2012-0184; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wijeratne EMK, 2014, J MED CHEM, V57, P2851, DOI 10.1021/jm401279n; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yoshikawa A, 2009, FEBS LETT, V583, P3317, DOI 10.1016/j.febslet.2009.09.028	37	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33161	33174		10.1074/jbc.M114.582478	http://dx.doi.org/10.1074/jbc.M114.582478			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25296760	hybrid, Green Published			2022-12-28	WOS:000345636600011
J	Hariharan, P; Guan, L				Hariharan, Parameswaran; Guan, Lan			Insights into the Inhibitory Mechanisms of the Regulatory Protein IIA(Glc) on Melibiose Permease Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE PHOSPHOTRANSFERASE SYSTEMS; ESCHERICHIA-COLI; LACTOSE PERMEASE; CATABOLITE REPRESSION; MEMBRANE-VESICLES; SUGAR-TRANSPORT; NA+; PHOSPHOENOLPYRUVATE; ACTIVATION; COMPLEX	The phosphotransfer protein IIA(Glc) of the bacterial phosphoenolpyruvate: carbohydrate phosphotransferase system plays a key role in the regulation of carbohydrate metabolism. Melibiose permease (MelB) is one among several permeases subject to IIA(Glc) regulation. The regulatory mechanisms are poorly understood; in addition, thermodynamic features of IIA(Glc) binding to other proteins are also unknown. Applying isothermal titration calorimetry and amine-specificcross-linking, we show that IIA(Glc) directly binds to MelB of Salmonella typhimurium (MelB(St)) and Escherichia coli MelB (MelB(Ec)) at a stoichiometry of unity in the absence or presence of melibiose. The dissociation constant values are 3-10 mu M for MelBSt and 25 mu M for MelB(Ec). All of the binding is solely driven by favorable enthalpy forces. IIA(Glc) binding to MelB(St) in the absence or presence of melibiose yields a large negative heat capacity change; in addition, the conformational entropy is constrained upon the binding. We further found that the IIA(Glc)-bound MelB(St) exhibits a decreased binding affinity for melibiose or nitrophenyl-alpha-galactoside. It is believed that sugar binding to the permease is involved in an induced fit mechanism, and the transport process requires conformational cycling between different states. Thus, the thermodynamic data are consistent with the interpretation that IIA(Glc) inhibits the induced fit process and restricts the conformational dynamics of MelB(St).	[Hariharan, Parameswaran; Guan, Lan] Texas Tech Univ Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University Health Science Center	Guan, L (corresponding author), Texas Tech Univ Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, 3601 4th St,STOP 6551, Lubbock, TX 79430 USA.	Lan.Guan@ttuhsc.edu	Parameswaran, Hariharan/P-2496-2015	Parameswaran, Hariharan/0000-0002-6020-1547	National Science Foundation [MCB-1158085]; National Institutes of Health [R01 GM095538]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095538] Funding Source: NIH RePORTER; Direct For Biological Sciences [1158085] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB-1158085 (to L. G.) and the National Institutes of Health Grant R01 GM095538 (to L. G.).	BASSILANA M, 1987, J BIOL CHEM, V262, P16865; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chaptal V, 2011, P NATL ACAD SCI USA, V108, P9361, DOI 10.1073/pnas.1105687108; Chen SS, 2013, NATURE, V499, P364, DOI 10.1038/nature12232; Dayem MA, 2003, J BIOL CHEM, V278, P1518, DOI 10.1074/jbc.M210053200; Deutscher J, 2014, MICROBIOL MOL BIOL R, V78, P231, DOI 10.1128/MMBR.00001-14; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Feese MD, 1997, BIOCHEMISTRY-US, V36, P16087, DOI 10.1021/bi971999e; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Grainger DC, 2003, MOL MICROBIOL, V48, P335, DOI 10.1046/j.1365-2958.2003.t01-1-03434.x; Granell M, 2010, P NATL ACAD SCI USA, V107, P22078, DOI 10.1073/pnas.1008649107; Guan L, 2013, ENCY BIOL CHEM, P387; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Guan L, 2012, BIOCHEMISTRY-US, V51, P2950, DOI 10.1021/bi300230h; Guan L, 2011, J BIOL CHEM, V286, P6367, DOI 10.1074/jbc.M110.206227; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Kahramanoglou C, 2006, J BACTERIOL, V188, P3199, DOI 10.1128/JB.188.9.3199-3207.2006; Kumar H, 2014, P NATL ACAD SCI USA, V111, P1784, DOI 10.1073/pnas.1324141111; KURODA M, 1992, CHEM PHARM BULL, V40, P1637, DOI 10.1248/cpb.40.1637; KURODA M, 1992, J BIOL CHEM, V267, P18336; Kuroda M, 2001, J MOL MICROB BIOTECH, V3, P381; Lengeler JW, 2009, CONTRIB MICROBIOL, V16, P65, DOI 10.1159/000219373; MEADOW ND, 1982, J BIOL CHEM, V257, P4526; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Nie YL, 2006, J BIOL CHEM, V281, P35779, DOI 10.1074/jbc.M607232200; OSUMI T, 1982, ANN INST PASTEUR MIC, VA133, P269; Peterkofsky A, 2001, J MOL MICROB BIOTECH, V3, P347; Pickering BS, 2012, MBIO, V3, DOI 10.1128/mBio.00228-12; Poolman B, 1996, MOL MICROBIOL, V19, P911, DOI 10.1046/j.1365-2958.1996.397949.x; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; POURCHER T, 1991, BIOCHEM BIOPH RES CO, V178, P1176, DOI 10.1016/0006-291X(91)91016-6; POURCHER T, 1995, BIOCHEMISTRY-US, V34, P4412, DOI 10.1021/bi00013a033; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; SAIER MH, 1989, MICROBIOL REV, V53, P109, DOI 10.1128/MMBR.53.1.109-120.1989; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Sondej M, 2003, BIOCHEMISTRY-US, V42, P9153, DOI 10.1021/bi034406a; Sondej M, 2002, BIOCHEMISTRY-US, V41, P5556, DOI 10.1021/bi011990j; TOKUDA H, 1977, BIOCHEMISTRY-US, V16, P2130, DOI 10.1021/bi00629a013; TSUCHIYA T, 1977, BIOCHEM BIOPH RES CO, V76, P26, DOI 10.1016/0006-291X(77)91663-1; WILSON DM, 1987, BIOCHIM BIOPHYS ACTA, V904, P191, DOI 10.1016/0005-2736(87)90368-3; Wilson TH, 2001, BBA-BIOENERGETICS, V1505, P121, DOI 10.1016/S0005-2728(00)00282-6; Yousef MS, 2009, P NATL ACAD SCI USA, V106, P15291, DOI 10.1073/pnas.0905516106; Zakariassen H, 2007, THERMOCHIM ACTA, V464, P24, DOI 10.1016/j.tca.2007.07.021; ZANI ML, 1994, J BIOL CHEM, V269, P24883	47	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.609255	http://dx.doi.org/10.1074/jbc.M114.609255			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25296751	hybrid, Green Published			2022-12-28	WOS:000345335000051
J	Ortogero, N; Schuster, AS; Oliver, DK; Riordan, CR; Hong, AS; Hennig, GW; Luong, D; Bao, JQ; Bhetwal, BP; Ro, S; McCarrey, JR; Yan, W				Ortogero, Nicole; Schuster, Andrew S.; Oliver, Daniel K.; Riordan, Connor R.; Hong, Annie S.; Hennig, Grant W.; Luong, Dickson; Bao, Jianqiang; Bhetwal, Bhupal P.; Ro, Seungil; McCarrey, John R.; Yan, Wei			A Novel Class of Somatic Small RNAs Similar to Germ Cell Pachytene PIWI-interacting Small RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOGENOUS SIRNAS; PIRNA BIOGENESIS; NONCODING RNAS; MOUSE GERMLINE; IDENTIFICATION; DATABASE; PROTEIN; TESTES; SPERMATOGENESIS; EXPRESSION	PIWI-interacting RNAs (piRNAs) are small noncoding RNAs that bind PIWI family proteins exclusively expressed in the germ cells of mammalian gonads. MIWI2-associated piRNAs are essential for silencing transposons during primordial germ cell development, and MIWI-bound piRNAs are required for normal spermatogenesis during adulthood in mice. Although piRNAs have long been regarded as germ cell-specific, increasing lines of evidence suggest that somatic cells also express piRNA-like RNAs (pilRNAs). Here, we report the detection of abundant pilRNAs in somatic cells, which are similar to MIWI-associated piRNAs mainly expressed in pachytene spermatocytes and round spermatids in the testis. Based on small RNA deep sequencing and quantitative PCR analyses, pilRNA expression is dynamic and displays tissue specificity. Although pilRNAs are similar to pachytene piRNAs in both size and genomic origins, they have a distinct ping-pong signature. Furthermore, pilRNA biogenesis appears to utilize a yet to be identified pathway, which is different from all currently known small RNA biogenetic pathways. In addition, pilRNAs appear to preferentially target the 3'-UTRs of mRNAs in a partially complementary manner. Our data suggest that pilRNAs, as an integral component of the small RNA transcriptome in somatic cell lineages, represent a distinct population of small RNAs that may have functions similar to germ cell piRNAs.	[Ortogero, Nicole; Schuster, Andrew S.; Oliver, Daniel K.; Riordan, Connor R.; Hong, Annie S.; Hennig, Grant W.; Luong, Dickson; Bao, Jianqiang; Bhetwal, Bhupal P.; Ro, Seungil; Yan, Wei] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [McCarrey, John R.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Texas System; University of Texas at San Antonio (UTSA)	Yan, W (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Ctr Mol Med, Rm 207B,1664 N Virginia St,MS 0575, Reno, NV 89557 USA.	wyan@medicine.nevada.edu	Yan, Wei/AAH-7943-2019; Bao, Jianqiang/T-7299-2019; Bao, Jianqiang/G-9184-2016	Bao, Jianqiang/0000-0003-1248-2687; Ro, Seungil/0000-0003-0861-8334	National Institutes of Health [HD060858, HD071736, HD074573]; COBRE [P20-RR18751]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD071736, R01HD060858, R03HD074573] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD060858, HD071736, and HD074573 (to W. Y.) and COBRE Grant P20-RR18751 (to the University of Nevada Genetic Engineering Center).	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bao J, 2014, CELL DEATH DIFFER, V21, P783, DOI 10.1038/cdd.2014.5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beyret E, 2012, CELL RES, V22, P1429, DOI 10.1038/cr.2012.120; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Frost RJA, 2010, P NATL ACAD SCI USA, V107, P11847, DOI 10.1073/pnas.1007158107; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Hertel J, 2008, BIOINFORMATICS, V24, P158, DOI 10.1093/bioinformatics/btm464; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Liu CN, 2005, NUCLEIC ACIDS RES, V33, pD112, DOI 10.1093/nar/gki041; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000635; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ortogero N, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.102269; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Park C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018628; Ro S, 2007, RNA, V13, P1693, DOI 10.1261/rna.640307; Ro S, 2013, CELL RES, V23, P759, DOI 10.1038/cr.2013.37; Ro S, 2010, METHODS MOL BIOL, V629, P271, DOI 10.1007/978-1-60761-657-3_17; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Unhavaithaya Y, 2009, J BIOL CHEM, V284, P6507, DOI 10.1074/jbc.M809104200; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei ZL, 2012, MAR BIOTECHNOL, V14, P459, DOI 10.1007/s10126-011-9426-z; Wu QX, 2012, J BIOL CHEM, V287, P25173, DOI 10.1074/jbc.M112.362053; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Zheng K, 2010, P NATL ACAD SCI USA, V107, P11841, DOI 10.1073/pnas.1003953107	45	22	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.613232	http://dx.doi.org/10.1074/jbc.M114.613232			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25320077	Green Published, hybrid			2022-12-28	WOS:000345335000036
J	Tanaka, N; Takahashi, S; Matsubara, T; Jiang, CT; Sakamoto, W; Chanturiya, T; Teng, RF; Gavrilova, O; Gonzalez, FJ				Tanaka, Naoki; Takahashi, Shogo; Matsubara, Tsutomu; Jiang, Changtao; Sakamoto, Wataru; Chanturiya, Tatyana; Teng, Ruifeng; Gavrilova, Oksana; Gonzalez, Frank J.			Adipocyte-specific Disruption of Fat-specific Protein 27 Causes Hepatosteatosis and Insulin Resistance in High-fat Diet-fed Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue; Diabetes; Hepatocyte; Insulin Resistance; Lipid; Mouse	HEPATIC STEATOSIS; LIPID DROPLETS; GENERALIZED LIPODYSTROPHY; METABOLIC DISEASE; DEFICIENT MICE; FSP27; LIVER; SENSITIVITY; STORAGE; GENE	Background: FSP27 contributes to unilocular lipid droplet formation in adipocytes. Results: Adipocyte-specific FSP27 disruption in mice produced small white adipose mass, hepatosteatosis, and insulin resistance upon high-fat diet feeding. Conclusion: Adipose FSP27 plays a critical role in minimizing ectopic fat accumulation. Significance: This mouse model is useful for understanding the significance of fat storage in adipose tissue. White adipose tissue (WAT) functions as an energy reservoir where excess circulating fatty acids are transported to WAT, converted to triglycerides, and stored as unilocular lipid droplets. Fat-specific protein 27 (FSP27, CIDEC in humans) is a lipid-coating protein highly expressed in mature white adipocytes that contributes to unilocular lipid droplet formation. However, the influence of FSP27 in adipose tissue on whole-body energy homeostasis remains unclear. Mice with adipocyte-specific disruption of the Fsp27 gene (Fsp27(Ad)) were generated using an aP2-Cre transgene with the Cre/LoxP system. Upon high-fat diet feeding, Fsp27(Ad) mice were resistant to weight gain. In the small WAT of these mice, small adipocytes containing multilocular lipid droplets were dispersed. The expression levels of the genes associated with mitochondrial abundance and brown adipocyte identity were increased, and basal lipolytic activities were significantly augmented in adipocytes isolated from Fsp27(Ad) mice compared with the Fsp27(F/F) counterparts. The impaired fat-storing function in Fsp27(Ad) adipocytes and the resultant lipid overflow from WAT led to marked hepatosteatosis, dyslipidemia, and systemic insulin resistance in high-fat diet-treated Fsp27(Ad) mice. These results demonstrate a critical role for FSP27 in the storage of excess fat in WAT with minimizing ectopic fat accumulation that causes insulin-resistant diabetes and non-alcoholic fatty liver disease. This mouse model may be useful for understanding the significance of fat-storing properties of white adipocytes and the role of local FSP27 in whole-body metabolism and estimating the pathogenesis of human partial lipodystrophy caused by CIDEC mutations.	[Tanaka, Naoki; Takahashi, Shogo; Matsubara, Tsutomu; Jiang, Changtao; Gonzalez, Frank J.] NCI, Ctr Canc Res, Lab Metab, NIH, Bethesda, MD 20892 USA; [Sakamoto, Wataru] NIDDK, Mol Signaling Sect, NIH, Bethesda, MD 20892 USA; [Chanturiya, Tatyana; Teng, Ruifeng; Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gonzalez, FJ (corresponding author), NCI, Ctr Canc Res, Lab Metab, NIH, Bethesda, MD 20892 USA.	gonzalef@mail.nih.gov	Teng, Ruifeng/U-8318-2019; Takahashi, Shogo/GVS-9010-2022	Takahashi, Shogo/0000-0002-3831-5353; Tanaka, Naoki/0000-0002-3212-3836; Jiang, Changtao/0000-0002-5206-2372	National Institutes of Health Intramural Research Program (NCI) [U54 ES16015]; NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK070002] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program (NCI) and Grant U54 ES16015 (to F. J. G.).	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kim JY, 2008, AM J PHYSIOL-ENDOC M, V294, pE654, DOI 10.1152/ajpendo.00104.2007; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Puri V, 2008, J CLIN INVEST, V118, P2693, DOI 10.1172/JCI36554; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Ravussin Y, 2013, INT J OBESITY, V37, P399, DOI 10.1038/ijo.2012.105; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Savage DB, 2009, DIS MODEL MECH, V2, P554, DOI 10.1242/dmm.002907; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Tanaka N, 2014, BBA-MOL CELL BIOL L, V1841, P1596, DOI 10.1016/j.bbalip.2014.08.015; Tanaka N, 2012, HEPATOLOGY, V56, P118, DOI 10.1002/hep.25630; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371; You Y, 1998, MAMM GENOME, V9, P232, DOI 10.1007/s003359900731; Zadeh ES, 2013, J HEPATOL, V59, P131, DOI 10.1016/j.jhep.2013.02.007; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611	31	64	68	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3092	3105		10.1074/jbc.M114.605980	http://dx.doi.org/10.1074/jbc.M114.605980			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25477509	Green Published, hybrid			2022-12-28	WOS:000349310700045
J	Bernatchez, JA; Paul, R; Tchesnokov, EP; Ngure, M; Beilhartz, GL; Berghuis, AM; Lavoie, R; Li, LH; Auger, A; Melnyk, RA; Grobler, JA; Miller, MD; Hazuda, DJ; Hecht, SM; Gotte, M				Bernatchez, Jean A.; Paul, Rakesh; Tchesnokov, Egor P.; Ngure, Marianne; Beilhartz, Greg L.; Berghuis, Albert M.; Lavoie, Rico; Li, Lianhai; Auger, Anick; Melnyk, Roman A.; Grobler, Jay A.; Miller, Michael D.; Hazuda, Daria J.; Hecht, Sidney M.; Goette, Matthias			Derivatives of Mesoxalic Acid Block Translocation of HIV-1 Reverse Transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; STRAND TRANSFER-REACTIONS; DNA-POLYMERASE; NONNUCLEOSIDE INHIBITORS; DRUG-RESISTANCE; RATCHET MODEL; MECHANISM; MUTATIONS; PHOSPHONOFORMATE; NUCLEOTIDES	The pyrophosphate mimic and broad spectrum antiviral phosphonoformic acid (PFA, foscarnet) was shown to freeze the pre-translocational state of the reverse transcriptase (RT) complex of the human immunodeficiency virus type 1 (HIV-1). However, PFA lacks a specificity domain, which is seen as a major reason for toxic side effects associated with the clinical use of this drug. Here, we studied the mechanism of inhibition of HIV-1 RT by the 4-chlorophenylhydrazone of mesoxalic acid (CPHM) and demonstrate that this compound also blocks RT translocation. Hot spots for inhibition with PFA or CPHM occur at template positions with a bias toward pre-translocation. Mutations at active site residue Asp-185 compromise binding of both compounds. Moreover, divalent metal ions are required for the formation of ternary complexes with either of the two compounds. However, CPHM contains both an anchor domain that likely interacts with the catalytic metal ions and a specificity domain. Thus, although the inhibitor binding sites may partly overlap, they are not identical. The K65R mutation in HIV-1 RT, which reduces affinity to PFA, increases affinity to CPHM. Details with respect to the binding sites of the two inhibitors are provided on the basis of mutagenesis studies, structure-activity relationship analyses with newly designed CPHM derivatives, and in silico docking experiments. Together, these findings validate the pre-translocated complex of HIV-1 RT as a specific target for the development of novel classes of RT inhibitors.	[Bernatchez, Jean A.; Berghuis, Albert M.; Goette, Matthias] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Paul, Rakesh; Hecht, Sidney M.] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Paul, Rakesh; Hecht, Sidney M.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Tchesnokov, Egor P.; Ngure, Marianne; Beilhartz, Greg L.; Berghuis, Albert M.; Goette, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Lavoie, Rico; Li, Lianhai; Auger, Anick; Melnyk, Roman A.; Grobler, Jay A.; Miller, Michael D.; Hazuda, Daria J.] Merck Res Labs, West Point, PA 19486 USA; [Goette, Matthias] McGill Univ, Div Expt Med, Dept Med, Montreal, PQ H3A 1A3, Canada	McGill University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; McGill University; Merck & Company; McGill University	Gotte, M (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, 6-020 Katz Grp Ctr, Edmonton, AB T6G 2E1, Canada.	gotte@ualberta.ca	Melnyk, Roman/GQA-9908-2022	Berghuis, Albert/0000-0002-2663-025X; Bernatchez, Jean/0000-0002-8309-1627; Paul, Rakesh/0000-0002-9651-1555	Canadian Institutes of Health Research; Quebec Consortium for Drug Discovery; Merck; Fonds de la Recherche en Sante du Quebec; Chemical Biology Training Program Scholarship from the Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Quebec Consortium for Drug Discovery; Merck(Merck & Company); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Chemical Biology Training Program Scholarship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Canadian Institutes of Health Research, the Quebec Consortium for Drug Discovery, and Merck (to M. G.).; Recipient of a doctoral training scholarship from the Fonds de la Recherche en Sante du Quebec and a Chemical Biology Training Program Scholarship from the Canadian Institutes of Health Research.	Beilhartz GL, 2009, J MOL BIOL, V388, P462, DOI 10.1016/j.jmb.2009.03.025; Chowers M, 2010, EUR J CLIN MICROBIOL, V29, P779, DOI 10.1007/s10096-010-0926-y; Cihlar T, 1998, J VIROL, V72, P5927, DOI 10.1128/JVI.72.7.5927-5936.1998; Cruchaga C, 2006, J BIOL CHEM, V281, P27744, DOI 10.1074/jbc.M603360200; Das K, 2013, CURR OPIN VIROL, V3, P111, DOI 10.1016/j.coviro.2013.03.012; Davis WR, 2000, BIOCHEMISTRY-US, V39, P14279, DOI 10.1021/bi0015764; De Clercq Erik, 2005, Expert Opin Emerg Drugs, V10, P241, DOI 10.1517/14728214.10.2.241; Ehteshami M, 2008, J BIOL CHEM, V283, P29904, DOI 10.1074/jbc.M804882200; Ehteshami M, 2013, J BIOL CHEM, V288, P17336, DOI 10.1074/jbc.M112.433441; Freisz S, 2010, ANGEW CHEM INT EDIT, V49, P1805, DOI 10.1002/anie.200905651; Gabbara S, 1999, BIOCHEMISTRY-US, V38, P13070, DOI 10.1021/bi991085n; Gotte M, 2006, CURR PHARM DESIGN, V12, P1867, DOI 10.2174/138161206776873626; Gotte M, 2001, J BIOL CHEM, V276, P6711, DOI 10.1074/jbc.M009097200; Hammond JL, 2001, ANTIMICROB AGENTS CH, V45, P1621, DOI 10.1128/AAC.45.6.1621-1628.2001; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jochmans D, 2006, J VIROL, V80, P12283, DOI 10.1128/JVI.00889-06; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kawamoto A, 2008, INT J BIOCHEM CELL B, V40, P2410, DOI 10.1016/j.biocel.2008.04.007; Kirby KA, 2011, CELL MOL BIOL, V57, P40, DOI 10.1170/T900; Lai MT, 2009, ANTIMICROB AGENTS CH, V53, P2424, DOI 10.1128/AAC.01559-08; Le Grice SFJ, 2012, J BIOL CHEM, V287, P40850, DOI 10.1074/jbc.R112.389056; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Maga G, 2007, ANGEW CHEM INT EDIT, V46, P1810, DOI 10.1002/anie.200604165; Marchand B, 2004, INT J BIOCHEM CELL B, V36, P1823, DOI 10.1016/j.biocel.2004.02.029; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Meyer PR, 2003, J VIROL, V77, P6127, DOI 10.1128/JVI.77.11.6127-6137.2003; Michailidis E, 2012, CELL MOL BIOL, V58, P187, DOI 10.1170/T940; Michailidis E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-65; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; OBERG B, 1982, PHARMACOL THERAPEUT, V19, P387, DOI 10.1016/0163-7258(82)90074-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radi M, 2008, CHEMMEDCHEM, V3, P573, DOI 10.1002/cmdc.200700198; Rajotte D, 2013, ANTIMICROB AGENTS CH, V57, P2712, DOI 10.1128/AAC.00113-13; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Shaw-Reid CA, 2003, J BIOL CHEM, V278, P2777, DOI 10.1074/jbc.C200621200; Sluis-Cremer N, 2000, BIOCHEM J, V348, P77, DOI 10.1042/0264-6021:3480077; Spence RA, 1996, BIOCHEMISTRY-US, V35, P1054, DOI 10.1021/bi952058+; TACHEDJIAN G, 1995, VIROLOGY, V212, P58, DOI 10.1006/viro.1995.1453; Torres-Madriz G, 2008, CLIN INFECT DIS, V47, P702, DOI 10.1086/590934; Zahn KE, 2011, J BIOL CHEM, V286, P25246, DOI 10.1074/jbc.M111.248864; Zhan P, 2013, MED RES REV, V33, pE1, DOI 10.1002/med.20241; Zhang ZJ, 2006, ANTIMICROB AGENTS CH, V50, P2772, DOI 10.1128/AAC.00127-06	47	14	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1474	1484		10.1074/jbc.M114.614305	http://dx.doi.org/10.1074/jbc.M114.614305			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25355312	Green Published, hybrid			2022-12-28	WOS:000348056400018
J	Liston, SD; Clarke, BR; Greenfield, LK; Richards, MR; Lowary, TL; Whitfield, C				Liston, Sean D.; Clarke, Bradley R.; Greenfield, Laura K.; Richards, Michele R.; Lowary, Todd L.; Whitfield, Chris			Domain Interactions Control Complex Formation and Polymerase Specificity in the Biosynthesis of the Escherichia coli O9a Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE O-ANTIGENS; 2 ACTIVE-SITES; CHAIN-LENGTH; CHONDROITIN POLYMERASE; HYALURONAN SYNTHASE; STRUCTURAL BASIS; SINGLE; POLYSACCHARIDE; TRANSPORTER; BINDING	The Escherichia coli O9a O-polysaccharide (O-PS) is a prototype for bacterial glycan synthesis and export by an ATP-binding cassette transporter-dependent pathway. The O9a O-PS possesses a tetrasaccharide repeat unit comprising two alpha-(1 -> 2)and two alpha-(1 -> 3)-linked mannose residues and is extended on a polyisoprenoid lipid carrier by the action of a polymerase (WbdA) containing two glycosyltransferase active sites. The N-terminal domain of WbdA possesses alpha-(1 -> 2)-mannosyl-transferase activity, and we demonstrate in this study that the C-terminal domain is an alpha-(1 -> 3)-mannosyltransferase. Previous studies established that the size of the O9a polysaccharide is determined by the chain-terminating dual kinase/methyltransferase (WbdD) that is tethered to the membrane and recruits WbdA into an active enzyme complex by protein-protein interactions. Here, we used bacterial two-hybrid analysis to identify a surface-exposed alpha-helix in the C-terminal mannosyltransferase domain of WbdA as the site of interaction with WbdD. However, the C-terminal domain was unable to interact with WbdD in the absence of its N-terminal partner. Through deletion analysis, we demonstrated that the alpha-(1 -> 2)-mannosyltransferase activity of the N-terminal domain is regulated by the activity of the C-terminal alpha-(1 -> 3)-mannosyltransferase. In mutants where the C-terminal catalytic site was deleted but the WbdD-interaction site remained, the N-terminal mannosyltransferase became an unrestricted polymerase, creating a novel polymer comprising only alpha-(1 -> 2)-linked mannose residues. The WbdD protein therefore orchestrates critical localization and coordination of activities involved in chain extension and termination. Complex domain interactions are needed to position the polymerase components appropriately for assembly into a functional complex located at the cytoplasmic membrane.	[Liston, Sean D.; Clarke, Bradley R.; Greenfield, Laura K.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Richards, Michele R.; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Richards, Michele R.; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Guelph; University of Alberta; University of Alberta	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Richards, Mickey/E-8140-2011; Lowary, Todd L/F-9608-2019	Richards, Mickey/0000-0002-1973-5678; Lowary, Todd L/0000-0002-8331-8211; Liston, Sean/0000-0002-6218-2247	Natural Sciences and Engineering Research Council; Alberta Glycomics Centre; Alberta Innovates Health Solutions Ph.D. Studentship	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Glycomics Centre; Alberta Innovates Health Solutions Ph.D. Studentship	This work was supported in part by grants from the Natural Sciences and Engineering Research Council (to C. W. and T. L. L.) and by the Alberta Glycomics Centre (to T. L. L.).; Recipient of an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council. Present address: Cell Biology Program, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada.; Recipient of an Alberta Innovates Health Solutions Ph.D. Studentship.	Baker JL, 2013, TRENDS BIOTECHNOL, V31, P49, DOI 10.1016/j.tibtech.2013.03.003; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Chavaroche AAE, 2012, APPL MICROBIOL BIOT, V95, P1199, DOI 10.1007/s00253-011-3813-2; Chavaroche AAE, 2011, J BIOL CHEM, V286, P1777, DOI 10.1074/jbc.M110.136754; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Clarke BR, 2011, J BIOL CHEM, V286, P41391, DOI 10.1074/jbc.M111.295857; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; DeAngelis PL, 2013, GLYCOBIOLOGY, V23, P764, DOI 10.1093/glycob/cwt016; Fiebig T, 2014, GLYCOBIOLOGY, V24, P150, DOI 10.1093/glycob/cwt102; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; Greenfield LK, 2012, J BIOL CHEM, V287, P35078, DOI 10.1074/jbc.M112.401000; Greenfield LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/j.carres.2012.02.027; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hagelueken G, 2015, NAT STRUCT MOL BIOL, V22, P50, DOI 10.1038/nsmb.2935; Hagelueken G, 2012, MOL MICROBIOL, V86, P730, DOI 10.1111/mmi.12014; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; JANN K, 1982, EUR J BIOCHEM, V127, P157, DOI 10.1111/j.1432-1033.1982.tb06850.x; Jansson PE, 2006, CARBOHYD RES, V341, P1003, DOI 10.1016/j.carres.2006.02.034; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Keys TG, 2014, NAT CHEM BIOL, V10, P437, DOI 10.1038/nchembio.1501; Keys TG, 2013, GLYCOBIOLOGY, V23, P613, DOI 10.1093/glycob/cwt003; Kido N, 2000, J BACTERIOL, V182, P2567, DOI 10.1128/JB.182.9.2567-2573.2000; King JD, 2014, P NATL ACAD SCI USA, V111, P6407, DOI 10.1073/pnas.1400814111; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Levengood MR, 2011, J AM CHEM SOC, V133, P12758, DOI 10.1021/ja204448t; Lindhout T, 2011, P NATL ACAD SCI USA, V108, P7397, DOI 10.1073/pnas.1019266108; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Miller J. H., 1972, EXPT MOL GENETICS, P432; Miller J. H, 1972, EXPT MOL GENETICS; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; PAROLIS LAS, 1986, CARBOHYD RES, V155, P272, DOI 10.1016/S0008-6215(00)90158-7; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RICK PD, 1994, J BACTERIOL, V176, P2877, DOI 10.1128/JB.176.10.2877-2884.1994; Roslund MU, 2011, CARBOHYD RES, V346, P1311, DOI 10.1016/j.carres.2011.04.033; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Sobhany M, 2012, J BIOL CHEM, V287, P36022, DOI 10.1074/jbc.M112.375873; Troutman JM, 2009, BIOCHEMISTRY-US, V48, P2807, DOI 10.1021/bi802284d; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600	54	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1075	1085		10.1074/jbc.M114.622480	http://dx.doi.org/10.1074/jbc.M114.622480			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25422321	Green Published, hybrid			2022-12-28	WOS:000347778200039
J	Wu, HY; Rong, YQ; Correia, K; Min, JK; Morgan, JI				Wu, Hui-Yuan; Rong, Yongqi; Correia, Kristen; Min, Jaeki; Morgan, James I.			Comparison of the Enzymatic and Functional Properties of Three Cytosolic Carboxypeptidase Family Members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURKINJE-CELL DEGENERATION; ALPHA-TUBULIN; BETA-TUBULIN; POSTTRANSLATIONAL MODIFICATIONS; GENE-EXPRESSION; PCD MICE; MOUSE; NNA1; POLYGLUTAMYLATION; BRAIN	Nna1 (CCP1) defines a subfamily of M14 metallocarboxypeptidases (CCP1-6) and is mutated in pcd (Purkinje cell degeneration) mice. Nna1, CCP4, and CCP6 are involved in the post-translational process of polyglutamylation, where they catalyze the removal of polyglutamate side chains. However, it is unknown whether these three cytosolic carboxypeptidases share identical enzymatic properties and redundant biological functions. We show that like Nna1, purified recombinant CCP4 and CCP6 deglutamylate tubulin, but unlike Nna1, neither rescues Purkinje cell degeneration in pcd mice, indicating that they do not have identical functions. Using biotin-based synthetic substrates, we established that the three enzymes are distinguishable based upon individual preferences for glutamate chain length, the amino acid immediately adjacent to the glutamate chain, and whether their activity is enhanced by nearby acidic amino acids. Nna1 and CCP4 remove the C-terminal glutamate from substrates with two or more glutamates, whereas CCP6 requires four or more glutamates. CCP4 behaves as a promiscuous glutamase, with little preference for chain length or neighboring amino acid composition. Besides glutamate chain length dependence, Nna1 and CCP6 exhibit higher k(cat)/K-m when substrates contain nearby acidic amino acids. All cytosolic carboxypeptidases exhibit a monoglutamase activity when aspartic acid precedes a single glutamate, which, together with their other individual preferences for flanking amino acids, greatly increases the potential substrates for these enzymes and the biological processes in which they act. Additionally, Nna1 metabolized substrates mimicking the C terminus of tubulin in a way suggesting that the tyrosinated form of tubulin will accumulate in pcd mice.	[Wu, Hui-Yuan; Rong, Yongqi; Correia, Kristen; Morgan, James I.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Min, Jaeki] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Morgan, JI (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	jim.morgan@stjude.org	Morgan, James/GRO-2905-2022; Morgan, James/N-8104-2018	Morgan, James/0000-0002-8920-1065; Min, Jaeki/0000-0002-0083-3198	National Institutes of Health Cancer Center from NCI [CA 21765]; American Lebanese Syrian Associated Charities;  [NS051537]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051537] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center from NCI; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Cancer Center Support Grant CA 21765 from NCI and Grant NS051537 (to J.I.M.). This work was also supported by the American Lebanese Syrian Associated Charities.	ALEXANDER JE, 1991, P NATL ACAD SCI USA, V88, P4685, DOI 10.1073/pnas.88.11.4685; Berezniuk I, 2012, J BIOL CHEM, V287, P6503, DOI 10.1074/jbc.M111.309138; Buitrago MM, 2004, BEHAV BRAIN RES, V155, P249, DOI 10.1016/j.bbr.2004.04.025; Chakrabarti L, 2008, VISION RES, V48, P1999, DOI 10.1016/j.visres.2008.05.026; COOMBS TL, 1962, BIOCHEMISTRY-US, V1, P899, DOI 10.1021/bi00911a024; DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5; EDDE B, 1992, BIOCHEMISTRY-US, V31, P403, DOI 10.1021/bi00117a014; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Gagnon C, 1996, J CELL SCI, V109, P1545; Guide for Care and Use of Laboratory Animals, 1996, NIH PUBLICATION, V80-23; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; IACOPINO AM, 1990, MOL BRAIN RES, V8, P283, DOI 10.1016/0169-328X(90)90041-B; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Janke C, 2008, EMBO REP, V9, P636, DOI 10.1038/embor.2008.114; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Mathews C. K., 2000, BIOCHEMISTRY-US, P375; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; PATURLELAFANECHERE L, 1991, BIOCHEMISTRY-US, V30, P10523, DOI 10.1021/bi00107a022; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; Regnard C, 2000, J BIOL CHEM, V275, P15969, DOI 10.1074/jbc.M000045200; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Rong YQ, 2004, MOL BRAIN RES, V132, P128, DOI 10.1016/j.molbrainres.2004.10.015; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; VALLEE BL, 1955, J BIOL CHEM, V217, P253; Van Dijk J, 2008, J BIOL CHEM, V283, P3915, DOI 10.1074/jbc.M705813200; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Wang TY, 2006, MOL CELL NEUROSCI, V33, P200, DOI 10.1016/j.mcn.2006.07.009; Wei P, 2011, MOL CELL BIOL, V31, P2838, DOI 10.1128/MCB.05208-11; Wu HY, 2012, FASEB J, V26, P4468, DOI 10.1096/fj.12-205047; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620; Zhao X, 2012, HEREDITY, V109, P156, DOI 10.1038/hdy.2012.23	34	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1222	1232		10.1074/jbc.M114.604850	http://dx.doi.org/10.1074/jbc.M114.604850			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25416787	Green Published, hybrid			2022-12-28	WOS:000347778200051
J	Fujita, M; Zhu, K; Fujita, CK; Zhao, M; Lam, KS; Kurth, MJ; Takada, YK; Takada, Y				Fujita, Masaaki; Zhu, Kan; Fujita, Chitose K.; Zhao, Min; Lam, Kit S.; Kurth, Mark J.; Takada, Yoko K.; Takada, Yoshikazu			Proinflammatory Secreted Phospholipase A2 Type IIA (sPLA-IIA) Induces Integrin Activation through Direct Binding to a Newly Identified Binding Site (Site 2) in Integrins alpha v beta 3, alpha 4 beta 1, and alpha 5 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Allosteric Regulation; Inflammation; Integrin; Peptides; Docking Simulation; Fractalkine; Integrin Activation; Secreted Phospholipase A2 Type IIA	TERNARY COMPLEX-FORMATION; CRYSTAL-STRUCTURE; RECEPTOR IGF1R; EXTRACELLULAR SEGMENT; MEMBRANE-RECEPTOR; DEFECTIVE MUTANT; FIBRINOGEN GAMMA; TERMINAL DOMAINS; ONCOGENIC ACTION; STRUCTURAL BASIS	Background: Besides inside-out signaling, integrins are activated by the binding of fractalkine to a newly identified binding site (site 2). Results: sPLA2-IIA induced integrin activation through site 2. A peptide from site 2 or a small compound that binds to sPLA2-IIA suppressed the activation. Conclusion: sPLA2-IIA activates integrins through direct binding to site 2. Significance: Integrin activation through site 2 may be a potential therapeutic target in inflammation. Integrins are activated by signaling from inside the cell (inside-out signaling) through global conformational changes of integrins. We recently discovered that fractalkine activates integrins in the absence of CX3CR1 through the direct binding of fractalkine to a ligand-binding site in the integrin headpiece (site 2) that is distinct from the classical RGD-binding site (site 1). We propose that fractalkine binding to the newly identified site 2 induces activation of site 1 though conformational changes (in an allosteric mechanism). We reasoned that site 2-mediated activation of integrins is not limited to fractalkine. Human secreted phospholipase A2 type IIA (sPLA2-IIA), a proinflammatory protein, binds to integrins v3 and 41 (site 1), and this interaction initiates a signaling pathway that leads to cell proliferation and inflammation. Human sPLA2-IIA does not bind to M-type receptor very well. Here we describe that sPLA2-IIA directly activated purified soluble integrin v3 and transmembrane v3 on the cell surface. This activation did not require catalytic activity or M-type receptor. Docking simulation predicted that sPLA2-IIA binds to site 2 in the closed-headpiece of v3. A peptide from site 2 of integrin 1 specifically bound to sPLA2-IIA and suppressed sPLA2-IIA-induced integrin activation. This suggests that sPLA2-IIA activates v3 through binding to site 2. sPLA2-IIA also activated integrins 41 and 51 in a site 2-mediated manner. We recently identified small compounds that bind to sPLA2-IIA and suppress integrin-sPLA2-IIA interaction (e.g. compound 21 (Cmpd21)). Cmpd21 effectively suppressed sPLA2-IIA-induced integrin activation. These results define a novel mechanism of proinflammatory action of sPLA2-IIA through integrin activation.	[Fujita, Masaaki; Zhu, Kan; Zhao, Min; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Fujita, Masaaki; Lam, Kit S.; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Kurth, Mark J.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Fujita, Chitose K.] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Clin Immunol & Rheumatol, Osaka 5308480, Japan	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Kitano Hospital	Takada, Y (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu	Zhu, Kan/AAJ-7450-2021	Zhu, Kan/0000-0002-1146-8130; takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health [CA13015]; TRDRP (Tobacco-related Disease Research Program) Grant [18XT-0169]; Department of Defense [W81XWH-10-1-0312]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TRDRP (Tobacco-related Disease Research Program) Grant; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA13015. This work was also supported by TRDRP (Tobacco-related Disease Research Program) Grant 18XT-0169 and Department of Defense Grant W81XWH-10-1-0312 (to Y. T.).	Aho HJ, 1996, INVEST OPHTH VIS SCI, V37, P1826; Birts CN, 2010, TRENDS BIOCHEM SCI, V35, P28, DOI 10.1016/j.tibs.2009.08.003; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; Bowton DL, 2005, J ASTHMA, V42, P65, DOI 10.1081/JAS-200044748; Bradley JD, 2005, J RHEUMATOL, V32, P417; Cierniewski CS, 1999, J BIOL CHEM, V274, P16923, DOI 10.1074/jbc.274.24.16923; Cupillard L, 1999, J BIOL CHEM, V274, P7043, DOI 10.1074/jbc.274.11.7043; Dong QH, 2006, CANCER LETT, V240, P9, DOI 10.1016/j.canlet.2005.08.012; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Fujita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096372; Fujita M, 2013, J BIOL CHEM, V288, P19593, DOI 10.1074/jbc.M113.470872; Fujita M, 2013, J BIOL CHEM, V288, P3059, DOI 10.1074/jbc.M112.412536; Fujita M, 2012, J IMMUNOL, V189, P5809, DOI 10.4049/jimmunol.1200889; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; Hu DD, 1999, J BIOL CHEM, V274, P4633, DOI 10.1074/jbc.274.8.4633; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Jaross W, 2002, EUR J CLIN INVEST, V32, P383, DOI 10.1046/j.1365-2362.2002.01000.x; Jiang JZ, 2002, AM J PATHOL, V160, P667, DOI 10.1016/S0002-9440(10)64886-9; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Legler DF, 2001, J CELL SCI, V114, P1545; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Mori S., 2013, MED SCI, V1, P20; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Mori S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057927; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; NEVALAINEN TJ, 1994, INVEST OPHTH VIS SCI, V35, P417; NICOLAS JP, 1995, J BIOL CHEM, V270, P28869, DOI 10.1074/jbc.270.48.28869; Niessen HWM, 2003, CARDIOVASC RES, V60, P68, DOI 10.1016/S0008-6363(03)00324-9; Qu XD, 1998, INFECT IMMUN, V66, P2791, DOI 10.1128/IAI.66.6.2791-2797.1998; Saari KM, 2001, INVEST OPHTH VIS SCI, V42, P318; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Sved P, 2004, CANCER RES, V64, P6934, DOI 10.1158/0008-5472.CAN-03-3018; Tada K, 1998, J IMMUNOL, V161, P5008; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Triggiani M, 2003, J IMMUNOL, V170, P3279, DOI 10.4049/jimmunol.170.6.3279; VADAS P, 1985, LIFE SCI, V36, P579, DOI 10.1016/0024-3205(85)90640-X; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yamaji S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010273; Ye L, 2013, BIOORG MED CHEM LETT, V23, P340, DOI 10.1016/j.bmcl.2012.10.080; Yokoyama K, 2000, J BIOL CHEM, V275, P16891, DOI 10.1074/jbc.M000610200; Yokoyama K, 1999, BIOCHEMISTRY-US, V38, P5872, DOI 10.1021/bi9827619; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037	50	28	37	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					259	271		10.1074/jbc.M114.579946	http://dx.doi.org/10.1074/jbc.M114.579946			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25398877	Green Published, hybrid			2022-12-28	WOS:000347231200024
J	Goncalves, RLS; Quinlan, CL; Perevoshchikova, IV; Hey-Mogensen, M; Brand, MD				Goncalves, Renata L. S.; Quinlan, Casey L.; Perevoshchikova, Irina V.; Hey-Mogensen, Martin; Brand, Martin D.			Sites of Superoxide and Hydrogen Peroxide Production by Muscle Mitochondria Assessed ex Vivo under Conditions Mimicking Rest and Exercise	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Exercise; Hydrogen Peroxide; Mitochondria; Mitochondrial Respiratory Chain Complex; Reactive Oxygen Species (ROS); Rat Skeletal Muscle; Superoxide	RAT SKELETAL-MUSCLE; AMINO-ACID-METABOLISM; OXYGEN SPECIES PRODUCTION; OXIDOREDUCTASE COMPLEX-I; BRANCHED-CHAIN AMINO; EXPERIMENTAL CHRONIC UREMIA; NUCLEAR-MAGNETIC-RESONANCE; DIGITORUM LONGUS MUSCLES; ELECTRON-TRANSPORT CHAIN; PURINE-NUCLEOTIDE CYCLE	Background: Ten mitochondrial sites of superoxide/H2O2 generation are known, but their contributions in vivo are undefined. Results: We assessed their rates ex vivo in conditions mimicking rest and exercise. Conclusion: Sites I-Q and IIF generated half the signal at rest. During exercise, rates were lower, and site I-F dominated. Significance: Contributing sites ex vivo probably reflect those in vivo. The sites and rates of mitochondrial production of superoxide and H(2)O(2)in vivo are not yet defined. At least 10 different mitochondrial sites can generate these species. Each site has a different maximum capacity (e.g. the outer quinol site in complex III (site IIIQo) has a very high capacity in rat skeletal muscle mitochondria, whereas the flavin site in complex I (site I-F) has a very low capacity). The maximum capacities can greatly exceed the actual rates observed in the absence of electron transport chain inhibitors, so maximum capacities are a poor guide to actual rates. Here, we use new approaches to measure the rates at which different mitochondrial sites produce superoxide/H2O2 using isolated muscle mitochondria incubated in media mimicking the cytoplasmic substrate and effector mix of skeletal muscle during rest and exercise. We find that four or five sites dominate during rest in this ex vivo system. Remarkably, the quinol site in complex I (site I-Q) and the flavin site in complex II (site IIF) each account for about a quarter of the total measured rate of H2O2 production. Site I-F, site IIIQo, and perhaps site E-F in the -oxidation pathway account for most of the remainder. Under conditions mimicking mild and intense aerobic exercise, total production is much less, and the low capacity site I-F dominates. These results give novel insights into which mitochondrial sites may produce superoxide/H(2)O(2)in vivo.	[Goncalves, Renata L. S.; Quinlan, Casey L.; Perevoshchikova, Irina V.; Hey-Mogensen, Martin; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Goncalves, RLS (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	rgoncalves@buckinstitute.org	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Quinlan, Casey/0000-0002-7808-8271	National Institutes of Health [TL1 AG032116]; Brazilian Government through the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) e ao Conselho de Nacional de Desenvolvimento Cientifico e Tecnologico programa Ciencias Sem Fronteiras (CNPq-CSF); Glenn Foundation; Carlsberg Foundation; NATIONAL INSTITUTE ON AGING [TL1AG032116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brazilian Government through the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) e ao Conselho de Nacional de Desenvolvimento Cientifico e Tecnologico programa Ciencias Sem Fronteiras (CNPq-CSF)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Glenn Foundation; Carlsberg Foundation(Carlsberg Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant TL1 AG032116 (to C. L. Q.). This work was also supported by the Brazilian Government through the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) e ao Conselho de Nacional de Desenvolvimento Cientifico e Tecnologico programa Ciencias Sem Fronteiras (CNPq-CSF) (to R. L. S. G.), the Glenn Foundation (to R. L. S. G. and I. V. P.), and the Carlsberg Foundation (to M. H.-M.).	ADIBI SA, 1971, AM J PHYSIOL, V221, P829; Affourtit C, 2012, METHODS MOL BIOL, V810, P165, DOI 10.1007/978-1-61779-382-0_11; AKERBOOM TPM, 1978, EUR J BIOCHEM, V84, P413, DOI 10.1111/j.1432-1033.1978.tb12182.x; ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; ARAGON JJ, 1980, EUR J BIOCHEM, V110, P371, DOI 10.1111/j.1432-1033.1980.tb04877.x; ARDAWI MSM, 1990, CLIN SCI, V79, P139, DOI 10.1042/cs0790139; Ariza Ana Carolina, 2012, Front Endocrinol (Lausanne), V3, P22, DOI 10.3389/fendo.2012.00022; ARNOLD H, 1970, EUR J BIOCHEM, V15, P360, DOI 10.1111/j.1432-1033.1970.tb01016.x; AWAPARA J, 1956, J BIOL CHEM, V218, P571; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baraban SC, 1997, J PHYSIOL-LONDON, V498, P679, DOI 10.1113/jphysiol.1997.sp021892; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BERGER M, 1976, BIOCHEM J, V158, P191, DOI 10.1042/bj1580191; Bertocci LA, 1999, J APPL PHYSIOL, V86, P2077, DOI 10.1152/jappl.1999.86.6.2077; BHUIYAN AKMJ, 1988, BIOCHEM J, V253, P337, DOI 10.1042/bj2530337; Borsheim E, 2006, AM J PHYSIOL-ENDOC M, V290, pE643, DOI 10.1152/ajpendo.00267.2005; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; BRASS EP, 1978, J BIOL CHEM, V253, P2688; BROCKS DG, 1980, BIOCHEM J, V188, P207, DOI 10.1042/bj1880207; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; Bruton J, 2003, J PHYSIOL-LONDON, V551, P179, DOI 10.1113/jphysiol.2003.043927; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Callahan LA, 2001, J APPL PHYSIOL, V90, P45, DOI 10.1152/jappl.2001.90.1.45; CHALLISS RAJ, 1989, AM J PHYSIOL, V256, pE129, DOI 10.1152/ajpendo.1989.256.1.E129; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; CHEN V, 1984, DIABETES, V33, P1078, DOI 10.2337/diabetes.33.11.1078; Chung YR, 1998, AM J PHYSIOL-CELL PH, V274, pC846, DOI 10.1152/ajpcell.1998.274.3.C846; Cieslar J, 1998, AM J PHYSIOL-REG I, V275, pR1530, DOI 10.1152/ajpregu.1998.275.5.R1530; Cieslar JH, 2000, J BIOL CHEM, V275, P6129, DOI 10.1074/jbc.275.9.6129; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; DALE RA, 1965, J PHYSIOL-LONDON, V181, P701, DOI 10.1113/jphysiol.1965.sp007792; Damink SWMO, 1999, CLIN SCI, V96, P639, DOI 10.1042/CS19980389; Dawson KD, 2005, J PHYSIOL-LONDON, V565, P637, DOI 10.1113/jphysiol.2004.079939; DESPLANCHES D, 1990, J APPL PHYSIOL, V69, P504, DOI 10.1152/jappl.1990.69.2.504; DOHM GL, 1981, J APPL PHYSIOL, V50, P41, DOI 10.1152/jappl.1981.50.1.41; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Dumas JF, 2005, DIABETOLOGIA, V48, P328, DOI 10.1007/s00125-004-1631-0; ELSE PL, 1985, AM J PHYSIOL, V248, pR415, DOI 10.1152/ajpregu.1985.248.4.R415; Essen-Gustavsson B, 2002, ACTA PHYSIOL SCAND, V174, P275, DOI 10.1046/j.1365-201x.2002.00942.x; FELLENIU.E, 1973, ACTA CHEM SCAND, V27, P2361, DOI 10.3891/acta.chem.scand.27-2361; GARBER AJ, 1976, J BIOL CHEM, V251, P826; GARBER AJ, 1978, J CLIN INVEST, V62, P633, DOI 10.1172/JCI109170; GARBER AJ, 1978, J CLIN INVEST, V62, P623, DOI 10.1172/JCI109169; GEERS C, 1990, J PHYSIOL-LONDON, V423, P279, DOI 10.1113/jphysiol.1990.sp018022; GILLIN AG, 1992, AM J PHYSIOL, V262, pF1061; GOLDSTEIN L, 1983, BIOCHEM J, V214, P757, DOI 10.1042/bj2140757; GOODMAN MN, 1974, DIABETES, V23, P881, DOI 10.2337/diab.23.11.881; GOODMAN MN, 1977, J BIOL CHEM, V252, P5054; GOODMAN MN, 1978, DIABETES, V27, P1065, DOI 10.2337/diab.27.11.1065; HAGG SA, 1976, BIOCHEM J, V158, P203, DOI 10.1042/bj1580203; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; HENSGENS HESJ, 1978, BIOCHEM J, V170, P699, DOI 10.1042/bj1700699; Hey-Mogensen M, 2014, FREE RADICAL BIO MED, V72, P149, DOI 10.1016/j.freeradbiomed.2014.04.007; HEYMSFIELD SB, 1982, AM J CLIN NUTR, V36, P131, DOI 10.1093/ajcn/36.1.131; HINKLE PC, 1967, J BIOL CHEM, V242, P5169; HINTZ CS, 1982, AM J PHYSIOL, V242, pC218, DOI 10.1152/ajpcell.1982.242.3.C218; Hitchins S, 2001, AM J PHYSIOL-HEART C, V281, pH882, DOI 10.1152/ajpheart.2001.281.2.H882; Horska A, 1999, AM J PHYSIOL-ENDOC M, V276, pE766, DOI 10.1152/ajpendo.1999.276.4.E766; Howarth KR, 2004, J APPL PHYSIOL, V97, P579, DOI 10.1152/japplphysiol.01344.2003; HOWARTH RE, 1971, J NUTR, V101, P485, DOI 10.1093/jn/101.4.485; HULTMAN E, 1986, J PHYSIOL-LONDON, V374, P493, DOI 10.1113/jphysiol.1986.sp016093; HUTSON SM, 1981, AM J CLIN NUTR, V34, P173, DOI 10.1093/ajcn/34.2.173; HUTSON SM, 1980, J BIOL CHEM, V255, P2418; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Ingalls CP, 1999, J APPL PHYSIOL, V87, P386, DOI 10.1152/jappl.1999.87.1.386; KARL IE, 1976, J BIOL CHEM, V251, P844; KASPEREK GJ, 1989, AM J PHYSIOL, V256, pE186, DOI 10.1152/ajpendo.1989.256.1.E186; KAUPPINEN RA, 1982, BIOCHIM BIOPHYS ACTA, V681, P286, DOI 10.1016/0005-2728(82)90033-0; KIRKWOOD SP, 1986, AM J PHYSIOL, V251, pC395, DOI 10.1152/ajpcell.1986.251.3.C395; KLINGENBERG M, 1960, ANNU REV BIOCHEM, V29, P669, DOI 10.1146/annurev.bi.29.070160.003321; KONDOH Y, 1992, RES EXP MED, V192, P407, DOI 10.1007/BF02576298; KONIJN AM, 1976, J NUTR, V106, P1507, DOI 10.1093/jn/106.10.1507; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; KUSHMERICK MJ, 1985, AM J PHYSIOL, V248, pC542, DOI 10.1152/ajpcell.1985.248.5.C542; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lee S, 2011, CELL RES, V21, P817, DOI 10.1038/cr.2011.55; LEE SH, 1979, J BIOL CHEM, V254, P420; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Loffler M, 1996, HISTOCHEM CELL BIOL, V105, P119, DOI 10.1007/BF01696151; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; MACDERMOTT M, 1990, EXP PHYSIOL, V75, P763, DOI 10.1113/expphysiol.1990.sp003458; MAIZELS EZ, 1977, BIOCHEM J, V162, P557, DOI 10.1042/bj1620557; Makara JK, 2000, ENDOCRINOLOGY, V141, P1705, DOI 10.1210/en.141.5.1705; MANCHESTER KL, 1963, BIOCHEM J, V89, P202, DOI 10.1042/bj0890202; MARQUIS NR, 1964, J LIPID RES, V5, P184; Mathieu-Costello O, 2005, J APPL PHYSIOL, V99, P281, DOI 10.1152/japplphysiol.00750.2004; MAY RC, 1987, AM J PHYSIOL, V252, pE712, DOI 10.1152/ajpendo.1987.252.6.E712; MILLWARD DJ, 1974, BRIT J NUTR, V32, P127, DOI 10.1079/BJN19740063; MINATOGAWA Y, 1984, BIOCHEM J, V223, P73, DOI 10.1042/bj2230073; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; Munkvik M, 2009, AM J PHYSIOL-REG I, V297, pR900, DOI 10.1152/ajpregu.91043.2008; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakamura K, 2001, J BIOL CHEM, V276, P34402, DOI 10.1074/jbc.M103766200; Nicholls D. G., 2002, BIOENERGETICS, V3, P105; Noland RC, 2009, J BIOL CHEM, V284, P22840, DOI 10.1074/jbc.M109.032888; Orr AL, 2013, FREE RADICAL BIO MED, V65, P1047, DOI 10.1016/j.freeradbiomed.2013.08.170; Orr AL, 2012, J BIOL CHEM, V287, P42921, DOI 10.1074/jbc.M112.397828; OWEN OE, 1973, BIOCHEM J, V134, P499, DOI 10.1042/bj1340499; PARRILLA R, 1978, PFLUG ARCH EUR J PHY, V374, P9, DOI 10.1007/BF00585691; PASTORIS O, 1995, NEUROCHEM RES, V20, P143, DOI 10.1007/BF00970538; PAUL HS, 1978, METABOLISM, V27, P185, DOI 10.1016/0026-0495(78)90164-6; PEARSON DJ, 1967, BIOCHEM J, V105, P953, DOI 10.1042/bj1050953; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; PETERSON RD, 1964, AM J PHYSIOL, V206, P599, DOI 10.1152/ajplegacy.1964.206.3.599; PICHARD C, 1988, J CLIN INVEST, V82, P895, DOI 10.1172/JCI113695; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Quinlan CL, 2013, METHOD ENZYMOL, V526, P189, DOI 10.1016/B978-0-12-405883-5.00012-0; Quinlan CL, 2012, FREE RADICAL BIO MED, V53, P1807, DOI 10.1016/j.freeradbiomed.2012.08.015; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; RENNIE MJ, 1976, BIOCHEM J, V156, P647, DOI 10.1042/bj1560647; RUDERMAN NB, 1977, AM J PHYSIOL, V233, pE109, DOI 10.1152/ajpendo.1977.233.2.E109; SACKTOR B, 1965, J BIOL CHEM, V240, P2678; Saha AK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1030, DOI 10.1152/ajpendo.1999.276.6.E1030; Sakellariou GK, 2014, FREE RADICAL RES, V48, P12, DOI 10.3109/10715762.2013.830718; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; SCHARFF R, 1966, BIOCHEM J, V99, P173, DOI 10.1042/bj0990173; SCHIAFFINO S, 1970, J CELL BIOL, V47, P107, DOI 10.1083/jcb.47.1.107; Sies H, 2014, J BIOL CHEM, V289, P8735, DOI 10.1074/jbc.R113.544635; SIESS EA, 1977, BIOCHEM J, V166, P225, DOI 10.1042/bj1660225; SOBOLL S, 1992, BIOCHEM J, V281, P171, DOI 10.1042/bj2810171; SPYDEVOLD O, 1976, EUR J BIOCHEM, V71, P155, DOI 10.1111/j.1432-1033.1976.tb11101.x; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; SUNDQVIST KE, 1987, BIOCHEM J, V243, P853, DOI 10.1042/bj2430853; Thyfault JP, 2010, AM J PHYSIOL-REG I, V299, pR926, DOI 10.1152/ajpregu.00093.2010; TISCHLER ME, 1988, MUSCLE NERVE, V11, P752, DOI 10.1002/mus.880110711; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; TURINSKY J, 1990, AM J PHYSIOL, V258, pE485, DOI 10.1152/ajpendo.1990.258.3.E485; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; VANEKEREN GJ, 1992, INT J EXP PATHOL, V73, P51; VEECH RL, 1969, BIOCHEM J, V115, P837, DOI 10.1042/bj1150837; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Vinnakota KC, 2004, AM J PHYSIOL-HEART C, V286, pH1742, DOI 10.1152/ajpheart.00478.2003; WALSER M, 1973, J CLIN INVEST, V52, P2865, DOI 10.1172/JCI107483; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; WESTERBLAD H, 1993, J PHYSIOL-LONDON, V468, P729, DOI 10.1113/jphysiol.1993.sp019797; WIESNER RJ, 1988, BIOCHIM BIOPHYS ACTA, V936, P114, DOI 10.1016/0005-2728(88)90258-7; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; WILLIAMS JA, 1971, J PHYSIOL-LONDON, V212, P101, DOI 10.1113/jphysiol.1971.sp009312; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; ZORZANO A, 1985, BIOCHEM J, V232, P585, DOI 10.1042/bj2320585	159	203	205	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					209	227		10.1074/jbc.M114.619072	http://dx.doi.org/10.1074/jbc.M114.619072			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25389297	hybrid, Green Published			2022-12-28	WOS:000347231200018
J	Cutting, AS; Del Rosario, Y; Mu, R; Rodriguez, A; Till, A; Subramani, S; Gottlieb, RA; Doran, KS				Cutting, Andrew S.; Del Rosario, Yvette; Mu, Rong; Rodriguez, Anthony; Till, Andreas; Subramani, Suresh; Gottlieb, Roberta A.; Doran, Kelly S.			The Role of Autophagy during Group B Streptococcus Infection of Blood-Brain Barrier Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG EPITHELIAL-CELLS; GROUP-A STREPTOCOCCUS; BETA-HEMOLYSIN/CYTOLYSIN; STAPHYLOCOCCUS-AUREUS; LC3-ASSOCIATED PHAGOCYTOSIS; INTRACELLULAR BACTERIA; TRANSGENIC MICE; INVASION; PROTEIN; IMMUNITY	Bacterial meningitis occurs when bloodborne pathogens invade and penetrate the blood-brain barrier (BBB), provoking inflammation and disease. Group B Streptococcus (GBS), the leading cause of neonatal meningitis, can enter human brain microvascular endothelial cells (hBMECs), but the host response to intracellular GBS has not been characterized. Here we sought to determine whether antibacterial autophagy, which involves selective recognition of intracellular organisms and their targeting to autophagosomes for degradation, is activated in BBB endothelium during bacterial infection. GBS infection resulted in increased punctate distribution of GFP-microtubule- associated protein 1 light chain 3 (LC3) and increased levels of endogenous LC3-II and p62 turnover, two hallmark indicators of active autophagic flux. Infection with GBS mutants revealed that bacterial invasion and the GBS pore-forming beta-hemolysin/cytolysin (beta-h/c) trigger autophagic activation. Cell-free bacterial extracts containing beta-h/c activity induced LC3-II conversion, identifying this toxin as a principal provocative factor for autophagy activation. These results were confirmed in vivo using a mouse model of GBS meningitis as infection with WT GBS induced autophagy in brain tissue more frequently than a beta-h/c-deficient mutant. Elimination of autophagy using Atg5-deficient fibroblasts or siRNA-mediated impairment of autophagy in hBMECs led to increased recovery of intracellular GBS. However, electron microscopy revealed that GBS was rarely found within double membrane autophagic structures even though we observed GBS-LC3 co-localization. These results suggest that although autophagy may act as a BBB cellular defense mechanism in response to invading and toxin-producing bacteria, GBS may actively thwart the autophagic pathway.	[Cutting, Andrew S.; Del Rosario, Yvette; Mu, Rong; Rodriguez, Anthony; Doran, Kelly S.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Gottlieb, Roberta A.] San Diego State Univ, Donald P Shiley BioSci Ctr, San Diego, CA 92182 USA; [Till, Andreas; Subramani, Suresh] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Till, Andreas; Subramani, Suresh] Univ Calif San Diego, San Diego Ctr Syst Biol, La Jolla, CA 92093 USA; [Till, Andreas] Univ Bonn, Life & Brain Ctr, Stem Cell Pathol Grp, D-53127 Bonn, Germany; [Doran, Kelly S.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA	California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Bonn; University of California System; University of California San Diego	Doran, KS (corresponding author), San Diego State Univ, Dept Biol, 5500 Campanile Dr,NLS 317, San Diego, CA 92182 USA.	kdoran@mail.sdsu.edu	Till, Andreas/AAO-6375-2021; Till, Andreas/E-9661-2013	Till, Andreas/0000-0002-0139-9143	National Institutes of Health [GM069373, R01-NS051247]; NINDS; seed grant from the San Diego Center for Systems Biology [GM085764]; Rees-Stealy Research Foundation/San Diego State University Heart Institute fellowship; Deutsche Forschungsgemeinschaft (German Research Foundation) [Ti-640 1-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, R01GM069373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); seed grant from the San Diego Center for Systems Biology; Rees-Stealy Research Foundation/San Diego State University Heart Institute fellowship; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM069373 (to S. S.), R01-NS051247 and associated supplement from the NINDS (to A. R. and K. S. D.), and GM085764, a seed grant from the San Diego Center for Systems Biology (to A. T. and S. S.). This work was also supported by a Rees-Stealy Research Foundation/San Diego State University Heart Institute fellowship (to A. S. C.) and Deutsche Forschungsgemeinschaft (German Research Foundation) Fellowship Ti-640 1-1.	Banerjee A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1474; Barnett TC, 2013, CELL HOST MICROBE, V14, P675, DOI 10.1016/j.chom.2013.11.003; Mestre MB, 2010, AUTOPHAGY, V6, P110, DOI 10.4161/auto.6.1.10698; BETZ AL, 1986, ANNU REV PHYSIOL, V48, P241; BETZ AL, 1985, FED PROC, V44, P2614; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Cai Z, 2012, J NEUROSCI RES, V90, P1105, DOI 10.1002/jnr.23011; CATALDI A, 1990, MOL MICROBIOL, V4, P1111, DOI 10.1111/j.1365-2958.1990.tb00685.x; Lerena MC, 2011, CELL MICROBIOL, V13, P814, DOI 10.1111/j.1462-5822.2011.01581.x; Chang YC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002082; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Doran KS, 2002, J INFECT DIS, V185, P196, DOI 10.1086/338475; Duclos S, 2000, CELL MICROBIOL, V2, P365, DOI 10.1046/j.1462-5822.2000.00066.x; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Ebrahimi CM, 2011, INFECT IMMUN, V79, P2510, DOI 10.1128/IAI.00006-11; Ebrahimi CM, 2009, J BACTERIOL, V191, P7165, DOI 10.1128/JB.00903-09; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Gong L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017852; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Huang J, 2009, CURR TOP MICROBIOL, V335, P189, DOI 10.1007/978-3-642-00302-8_9; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Knodler LA, 2011, CELL MICROBIOL, V13, P1319, DOI 10.1111/j.1462-5822.2011.01632.x; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lai Shu-Chin, 2012, Cells, V1, P396, DOI 10.3390/cells1030396; Lembo A, 2010, MOL MICROBIOL, V77, P431, DOI 10.1111/j.1365-2958.2010.07215.x; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li XL, 2013, INFECT IMMUN, V81, P271, DOI 10.1128/IAI.00834-12; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Maisey HC, 2008, FASEB J, V22, P1715, DOI 10.1096/fj.07-093963; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Maisey Heather C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000811; Mehta P, 2014, CURR OPIN IMMUNOL, V26, P69, DOI 10.1016/j.coi.2013.10.012; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Mostowy S, 2013, CELL MICROBIOL, V15, P395, DOI 10.1111/cmi.12063; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Nizet V, 1996, INFECT IMMUN, V64, P3818, DOI 10.1128/IAI.64.9.3818-3826.1996; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; O'Seaghdha M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003394; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; PATTEE PA, 1981, J BACTERIOL, V145, P479, DOI 10.1128/JB.145.1.479-488.1981; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Romao S, 2014, AUTOPHAGY, V10, P526, DOI 10.4161/auto.27606; Sagar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060160; Sakurai A, 2010, J BIOL CHEM, V285, P22666, DOI 10.1074/jbc.M109.100131; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Seo HS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002947; Sheen TR, 2010, J MOL MED, V88, P633, DOI 10.1007/s00109-010-0630-5; Stins MF, 1997, IN VITRO CELL DEV-AN, V33, P243; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Tenenbaum T, 2005, INFECT IMMUN, V73, P4404, DOI 10.1128/IAI.73.7.4404-4409.2005; Tenenbaum T, 2007, MICROBES INFECT, V9, P714, DOI 10.1016/j.micinf.2007.02.015; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; Whidbey C, 2013, J EXP MED, V210, P1265, DOI 10.1084/jem.20122753; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; WILKINSON HW, 1977, J CLIN MICROBIOL, V6, P183; WILSON CB, 1985, J INFECT DIS, V152, P323, DOI 10.1093/infdis/152.2.323; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yitzhaki S, 2009, BASIC RES CARDIOL, V104, P157, DOI 10.1007/s00395-009-0006-6; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	81	43	45	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35711	35723		10.1074/jbc.M114.588657	http://dx.doi.org/10.1074/jbc.M114.588657			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25371213	Green Published, hybrid			2022-12-28	WOS:000346897900004
J	Wang, Y; Yago, T; Zhang, N; Abdisalaam, S; Alexandrakis, G; Rodgers, W; McEver, RP				Wang, Ying; Yago, Tadayuki; Zhang, Nan; Abdisalaam, Salim; Alexandrakis, George; Rodgers, William; McEver, Rodger P.			Cytoskeletal Regulation of CD44 Membrane Organization and Interactions with E-selectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Cytoskeleton; Fluorescence Recovery after Photobleaching (FRAP); Fluorescence Resonance Energy Transfer (FRET); Neutrophil; Signal Transduction	EZRIN/RADIXIN/MOESIN ERM PROTEINS; ANKYRIN-BINDING DOMAIN; HYALURONAN-BINDING; P-SELECTIN; CORRELATION SPECTROSCOPY; CYTOPLASMIC DOMAINS; LEUKOCYTE ADHESION; TYROSINE KINASES; LIVE CELLS; NEUTROPHILS	Interactions of CD44 on neutrophils with E-selectin on activated endothelial cells mediate rolling under flow, a prerequisite for neutrophil arrest and migration into perivascular tissues. How CD44 functions as a rolling ligand despite its weak affinity for E-selectin is unknown. We examined the nanometer scale organization of CD44 on intact cells. CD44 on leukocytes and transfected K562 cells was cross-linked within a 1.14-nm spacer. Depolymerizing actin with latrunculin B reduced cross-linking. Fluorescence resonance energy transfer (FRET) revealed tight co-clustering between CD44 fused to yellow fluorescent protein (YFP) and CD44 fused to cyan fluorescent protein on K562 cells. Latrunculin B reduced FRET-reported co-clustering. Number and brightness analysis confirmed actin-dependent CD44-YFP clusters on living cells. CD44 lacking binding sites for ankyrin and for ezrin/radixin/moesin (ERM) proteins on its cytoplasmic domain (ANKERM) did not cluster. Unexpectedly, CD44 lacking only the ankyrin-binding site (ANK) formed larger but looser clusters. Fluorescence recovery after photobleaching demonstrated increased CD44 mobility by latrunculin B treatment or by deleting the cytoplasmic domain. ANKERM mobility increased only modestly, suggesting that the cytoplasmic domain engages the cytoskeleton by an additional mechanism. Ex vivo differentiated CD44-deficient neutrophils expressing exogenous CD44 rolled on E-selectin and activated Src kinases after binding anti-CD44 antibody. In contrast, differentiated neutrophils expressing ANK had impaired rolling and kinase activation. These data demonstrate that spectrin and actin networks regulate CD44 clustering and suggest that ankyrin enhances CD44-mediated neutrophil rolling and signaling.	[Yago, Tadayuki; McEver, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Wang, Ying; Zhang, Nan; Rodgers, William; McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Abdisalaam, Salim; Alexandrakis, George] Univ Texas Arlington, Dept Biomed Engn, Arlington, TX 76010 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; University of Texas Arlington	McEver, RP (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	rodger-mcever@omrf.org		Zhang, Nan/0000-0002-6736-2781	National Institutes of Health [HL03463, HL085607]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034363, K08HL003463, P01HL085607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL03463 and HL085607.	Abdisalaam S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt908; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Damjanovich S., 1994, MOBILITY PROXIMITY B; DELAAT SW, 1980, P NATL ACAD SCI-BIOL, V77, P1526; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Gal I, 2003, J BIOL CHEM, V278, P11150, DOI 10.1074/jbc.M210661200; Gimferrer I, 2011, J IMMUNOL, V186, P3892, DOI 10.4049/jimmunol.1003505; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Hellriegel C, 2011, FASEB J, V25, P2883, DOI 10.1096/fj.11-181537; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Ilangumaran S, 1998, BLOOD, V91, P3901; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; Lefebvre DC, 2010, MOL IMMUNOL, V47, P1882, DOI 10.1016/j.molimm.2010.03.018; Lefort CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00157; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Lesley J, 2000, EUR J IMMUNOL, V30, P245, DOI 10.1002/1521-4141(200001)30:1<245::AID-IMMU245>3.3.CO;2-O; Levi M, 2003, J AM SOC NEPHROL, V14, P1949, DOI 10.1097/01.ASN.0000078768.86317.31; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li RH, 1998, EUR J IMMUNOL, V28, P1745, DOI 10.1002/(SICI)1521-4141(199806)28:06<1745::AID-IMMU1745>3.0.CO;2-5; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Nacher M, 2011, AM J PATHOL, V178, P2437, DOI 10.1016/j.ajpath.2011.01.039; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; NEAME SJ, 1995, J CELL SCI, V108, P3127; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; PERSCHL A, 1995, J CELL SCI, V108, P1033; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Protin U, 1999, J IMMUNOL, V163, P4917; Rossow MJ, 2010, NAT PROTOC, V5, P1761, DOI 10.1038/nprot.2010.122; Shao BJ, 2012, J BIOL CHEM, V287, P19585, DOI 10.1074/jbc.M112.361519; Sreeramkumar V, 2013, BLOOD, V122, P3993, DOI 10.1182/blood-2013-07-514497; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Xia LJ, 2002, J CLIN INVEST, V109, P939; Yago T, 2002, J CELL BIOL, V158, P787, DOI 10.1083/jcb.200204041; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Yago T, 2010, P NATL ACAD SCI USA, V107, P9204, DOI 10.1073/pnas.1003110107; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zhu D, 1998, CELL MOTIL CYTOSKEL, V39, P209, DOI 10.1002/(SICI)1097-0169(1998)39:3<209::AID-CM4>3.0.CO;2-#	53	30	30	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35159	35171		10.1074/jbc.M114.600767	http://dx.doi.org/10.1074/jbc.M114.600767			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25359776	Green Published, hybrid			2022-12-28	WOS:000346660200010
J	Yamaguchi, S; Tanimoto, A; Otsuguro, K; Hibino, H; Ito, S				Yamaguchi, Soichiro; Tanimoto, Akira; Otsuguro, Ken-ichi; Hibino, Hiroshi; Ito, Shigeo			Negatively Charged Amino Acids Near and in Transient Receptor Potential (TRP) Domain of TRPM4 Channel Are One Determinant of Its Ca2+ Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Electrophysiology; Ion Channel; Manganese; Molecular Biology; Phosphoinositide; Physiology; Site-directed Mutagenesis; Transient Receptor Potential Channels (TRP Channels)	NONSELECTIVE CATION; CL-CHANNELS; ION-CHANNEL; ACTIVATION; CALMODULIN; MECHANISM; MEMBRANE; BINDING; BRAIN; DEPENDENCE	Transient receptor potential (TRP) channel melastatin subfamily member 4 (TRPM4) is a broadly expressed nonselective monovalent cation channel. TRPM4 is activated by membrane depolarization and intracellular Ca2+, which is essential for the activation. The Ca2+ sensitivity is known to be regulated by calmodulin and membrane phosphoinositides, such as phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2). Although these regulators must play important roles in controlling TRPM4 activity, mutation analyses of the calmodulin-binding sites have suggested that Ca2+ binds to TRPM4 directly. However, the intrinsic binding sites in TRPM4 remain to be elucidated. Here, by using patch clamp and molecular biological techniques, we show that there are at least two functionally different divalent cation-binding sites, and the negatively charged amino acids near and in the TRP domain in the C-terminal tail of TRPM4 (Asp-1049 and Glu-1062 of rat TRPM4) are required for maintaining the normal Ca2+ sensitivity of one of the binding sites. Applications of Co2+, Mn2+, or Ni2+ to the cytosolic side potentiated TRPM4 currents, increased the Ca2+ sensitivity, but were unable to evoke TRPM4 currents without Ca2+. Mutations of the acidic amino acids near and in the TRP domain, which are conserved in TRPM2, TRPM5, and TRPM8, deteriorated the Ca2+ sensitivity in the presence of Co2+ or PI(4,5)P-2 but hardly affected the sensitivity to Co2+ and PI(4,5)P-2. These results suggest a novel role of the TRP domain in TRPM4 as a site responsible for maintaining the normal Ca2+ sensitivity. These findings provide more insights into the molecular mechanisms of the regulation of TRPM4 by Ca2+.	[Yamaguchi, Soichiro; Tanimoto, Akira; Otsuguro, Ken-ichi; Ito, Shigeo] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Pharmacol Lab, Sapporo, Hokkaido 0600818, Japan; [Yamaguchi, Soichiro; Hibino, Hiroshi] Niigata Univ, Sch Med, Dept Mol Physiol, Niigata 9518510, Japan	Hokkaido University; Niigata University	Yamaguchi, S (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Pharmacol Lab, Sapporo, Hokkaido 0600818, Japan.	souya@vetmed.hokudai.ac.jp	Otsuguro, Ken-ichi/A-4840-2012; Yamaguchi, Soichiro/Q-8563-2019	Otsuguro, Ken-ichi/0000-0002-2481-5592; 	Takeda Science Foundation; Tsukada grant for Niigata University Medical Research	Takeda Science Foundation(Takeda Science Foundation (TSF)); Tsukada grant for Niigata University Medical Research	This work was supported by a grant from the Takeda Science Foundation (to S. Y.) and a Tsukada grant for Niigata University Medical Research (to S. Y.).	Almaraz L, 2014, HANDB EXP PHARMACOL, V222, P547, DOI 10.1007/978-3-642-54215-2_22; Amarouch MY, 2013, NEUROSCI LETT, V541, P105, DOI 10.1016/j.neulet.2013.02.011; Avila Daiana Silva, 2013, Met Ions Life Sci, V13, P199, DOI 10.1007/978-94-007-7500-8_7; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Earley S, 2007, AM J PHYSIOL-HEART C, V292, pH2613, DOI 10.1152/ajpheart.01286.2006; Faouzi M, 2014, HANDB EXP PHARMACOL, V222, P403, DOI 10.1007/978-3-642-54215-2_16; Forrer R, 2001, BIOL TRACE ELEM RES, V80, P77, DOI 10.1385/BTER:80:1:77; Gregorio-Teruel L, 2014, J GEN PHYSIOL, V143, P361, DOI 10.1085/jgp.201311070; Guinamard R, 2011, ADV EXP MED BIOL, V704, P147, DOI 10.1007/978-94-007-0265-3_8; HABERMANN E, 1983, ARCH TOXICOL, V54, P61, DOI 10.1007/BF00277816; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Liu P, 2004, BIOMETALS, V17, P157, DOI 10.1023/B:BIOM.0000018373.85342.36; Liu Y, 2011, ADV EXP MED BIOL, V704, P185, DOI 10.1007/978-94-007-0265-3_10; Mathar I, 2014, HANDB EXP PHARMACOL, V222, P461, DOI 10.1007/978-3-642-54215-2_18; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; MILOS M, 1989, J INORG BIOCHEM, V36, P11, DOI 10.1016/0162-0134(89)80009-1; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; OBERHAUSER A, 1988, J GEN PHYSIOL, V92, P67, DOI 10.1085/jgp.92.1.67; PALLEN CJ, 1984, J BIOL CHEM, V259, P6134; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sakuraba M, 2014, J NEUROSCI RES, V92, P1409, DOI 10.1002/jnr.23410; Schattling B, 2012, NAT MED, V18, P1805, DOI 10.1038/nm.3015; Shimizu T, 2009, CELL CALCIUM, V45, P226, DOI 10.1016/j.ceca.2008.10.005; Simon F, 2010, J BIOL CHEM, V285, P37150, DOI 10.1074/jbc.M110.155390; Stallmeyer B, 2012, HUM MUTAT, V33, P109, DOI 10.1002/humu.21599; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; SUNOSE H, 1993, AM J PHYSIOL, V265, pC72, DOI 10.1152/ajpcell.1993.265.1.C72; SUZUKI K, 1968, J INORG NUCL CHEM, V30, P161, DOI 10.1016/0022-1902(68)80075-2; TAKEUCHI S, 1992, HEARING RES, V61, P86, DOI 10.1016/0378-5955(92)90039-P; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; WEDLER FC, 1982, BIOCHEMISTRY-US, V21, P6389, DOI 10.1021/bi00268a011; WOLFF DJ, 1985, J BIOL CHEM, V260, P4195; WOLFF DJ, 1977, J BIOL CHEM, V252, P4108; Yamada Kazuhiro, 2013, Met Ions Life Sci, V13, P295, DOI 10.1007/978-94-007-7500-8_9; Yoo JC, 2010, BIOCHEM BIOPH RES CO, V391, P806, DOI 10.1016/j.bbrc.2009.11.142; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zheng J, 2013, COMPR PHYSIOL, V3, P221, DOI 10.1002/cphy.c120001; Zhou Y, 2012, P NATL ACAD SCI USA, V109, P11413, DOI 10.1073/pnas.1204444109	54	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35265	35282		10.1074/jbc.M114.606087	http://dx.doi.org/10.1074/jbc.M114.606087			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25378404	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000346660200020
J	Brett, K; Kordyukova, LV; Serebryakova, MV; Mintaev, RR; Alexeevski, AV; Veit, M				Brett, Katharina; Kordyukova, Larisa V.; Serebryakova, Marina V.; Mintaev, Ramil R.; Alexeevski, Andrei V.; Veit, Michael			Site-specific S-Acylation of Influenza Virus Hemagglutinin THE LOCATION OF THE ACYLATION SITE RELATIVE TO THE MEMBRANE BORDER IS THE DECISIVE FACTOR FOR ATTACHMENT OF STEARATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fatty Acid; Glycoprotein; Influenza Virus; Mass Spectrometry (MS); Protein Acylation; Protein Palmitoylation; Transmembrane Domain; Hemagglutinin; Palmitate; Stearate	FUSION PORE FORMATION; MULTIPLE SEQUENCE ALIGNMENT; FATTY-ACID SELECTION; CYTOPLASMIC TAIL; MASS-SPECTROMETRY; PROTEIN PALMITOYLATION; LIPID MODIFICATIONS; A HEMAGGLUTININ; INSECT CELLS; RAFTS	Background:S-Acylation of hemagglutinin with stearate and palmitate is essential for influenza virus replication. Results: Mass spectrometry showed that shifting a cysteine from the transmembrane region to a cytoplasmic position eliminates attachment of stearate. Conclusion: The location of the acylation site is the decisive factor for site-specific acylation. Significance: Similar differential acylation might occur in cellular transmembrane proteins. S-Acylation of hemagglutinin (HA), the main glycoprotein of influenza viruses, is an essential modification required for virus replication. Using mass spectrometry, we have previously demonstrated specific attachment of acyl chains to individual acylation sites. Whereas the two cysteines in the cytoplasmic tail of HA contain only palmitate, stearate is exclusively attached to a cysteine positioned at the end of the transmembrane region (TMR). Here we analyzed recombinant viruses containing HA with exchange of conserved amino acids adjacent to acylation sites or with a TMR cysteine shifted to a cytoplasmic location to identify the molecular signal that determines preferential attachment of stearate. We first developed a new protocol for sample preparation that requires less material and might thus also be suitable to analyze cellular proteins. We observed cell type-specific differences in the fatty acid pattern of HA: more stearate was attached if human viruses were grown in mammalian compared with avian cells. No underacylated peptides were detected in the mass spectra, and even mutations that prevented generation of infectious virus particles did not abolish acylation of expressed HA as demonstrated by metabolic labeling experiments with [H-3]palmitate. Exchange of conserved amino acids in the vicinity of an acylation site had a moderate effect on the stearate content. In contrast, shifting the TMR cysteine to a cytoplasmic location virtually eliminated attachment of stearate. Thus, the location of an acylation site relative to the transmembrane span is the main signal for stearate attachment, but the sequence context and the cell type modulate the fatty acid pattern.	[Brett, Katharina; Veit, Michael] Free Univ Berlin, Inst Virol, D-14163 Berlin, Germany; [Kordyukova, Larisa V.; Serebryakova, Marina V.; Mintaev, Ramil R.; Alexeevski, Andrei V.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Serebryakova, Marina V.] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Mintaev, Ramil R.] Russian Acad Med Sci, II Mechnikov Res Inst Vaccines & Sera, Moscow 105064, Russia; [Alexeevski, Andrei V.] Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Moscow 119234, Russia	Free University of Berlin; Lomonosov Moscow State University; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Medical Sciences; Research Institute of Vaccines and Sera Mechnikov, RAMS; Lomonosov Moscow State University	Veit, M (corresponding author), Free Univ Berlin, Inst Virol, Fachbereich Vet Med, Zentrum Infekt Med Robert von Ostertag Haus, Robert von Ostertag Str 7-13, D-14163 Berlin, Germany.	mveit@zedat.fu-berlin.de	Mintaev, Ramil/AAE-3303-2019; Serebryakova, Marina/E-2986-2012; Kordyukova, Larisa V./D-6547-2012	Serebryakova, Marina/0000-0002-5402-8215; Kordyukova, Larisa V./0000-0002-6089-1103; Mintaev, Ramil/0000-0001-5398-3627; Veit, Michael/0000-0002-7638-1829	Deutsche Forschungsgemeinschaft [Ve 141/10]; Priority Program 1175; Russian Foundation for Basic Research [13-04-00290, 14-04-01693]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Priority Program 1175; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Deutsche Forschungsgemeinschaft Grant Ve 141/10 and Priority Program 1175 and Russian Foundation for Basic Research Grants 13-04-00290 and 14-04-01693.	Chen BJ, 2005, J VIROL, V79, P13673, DOI 10.1128/JVI.79.21.13673-13684.2005; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engel S, 2010, BIOCHEM J, V425, P567, DOI 10.1042/BJ20091388; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hernandez R., 2010, CURR PROTOC MICROBIO, V4, P41; Hutchinson EC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5816; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kordyukova LV, 2008, J VIROL, V82, P9288, DOI 10.1128/JVI.00704-08; Kordyukova LV, 2011, BBA-BIOMEMBRANES, V1808, P1843, DOI 10.1016/j.bbamem.2011.03.005; Kordyukova LV, 2010, VIROLOGY, V398, P49, DOI 10.1016/j.virol.2009.11.039; Kordyukova LV, 2004, PROTEIN PEPTIDE LETT, V11, P385, DOI 10.2174/0929866043406850; Kummel D, 2006, P NATL ACAD SCI USA, V103, P12701, DOI 10.1073/pnas.0603513103; KURODA K, 1991, VIROLOGY, V180, P159, DOI 10.1016/0042-6822(91)90019-8; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Liang XQ, 2002, J BIOL CHEM, V277, P33032, DOI 10.1074/jbc.M204607200; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Melikyan GB, 1997, VIROLOGY, V235, P118, DOI 10.1006/viro.1997.8686; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; NAEVE CW, 1990, EMBO J, V9, P3857, DOI 10.1002/j.1460-2075.1990.tb07604.x; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Reverey H, 1996, J BIOL CHEM, V271, P23607, DOI 10.1074/jbc.271.39.23607; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; RODRIGUEZBOULAN E, 1984, J CELL BIOL, V98, P308, DOI 10.1083/jcb.98.1.308; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Sakai T, 2002, J VIROL, V76, P4603, DOI 10.1128/JVI.76.9.4603-4611.2002; SCHMIDT MFG, 1984, EMBO J, V3, P2295, DOI 10.1002/j.1460-2075.1984.tb02129.x; Serebryakova MV, 2013, ARCH VIROL, V158, P467, DOI 10.1007/s00705-012-1510-9; Serebryakova MV, 2011, VIRUS RES, V160, P294, DOI 10.1016/j.virusres.2011.07.002; Serebryakova MV, 2006, EUR J MASS SPECTROM, V12, P51, DOI 10.1255/ejms.792; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Simonsen AC, 2003, FEBS LETT, V552, P253, DOI 10.1016/S0014-5793(03)00970-0; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; STEINHAUER DA, 1991, VIROLOGY, V184, P445, DOI 10.1016/0042-6822(91)90867-B; Sugita Y, 2011, J GEN VIROL, V92, P2485, DOI 10.1099/vir.0.036715-0; Ujike M, 2004, J VIROL, V78, P11536, DOI 10.1128/JVI.78.21.11536-11543.2004; VEIT M, 1991, J VIROL, V65, P2491, DOI 10.1128/JVI.65.5.2491-2500.1991; VEIT M, 1993, FEBS LETT, V336, P243, DOI 10.1016/0014-5793(93)80812-9; VEIT M, 1990, VIROLOGY, V177, P807, DOI 10.1016/0042-6822(90)90554-5; Veit M, 1996, BIOCHEM J, V318, P163, DOI 10.1042/bj3180163; Veit M, 2013, BIOCHEM SOC T, V41, P50, DOI 10.1042/BST20120210; Veit Michael, 2008, V446, P163, DOI 10.1007/978-1-60327-084-7_12; Wagner R, 2005, J VIROL, V79, P6449, DOI 10.1128/JVI.79.10.6449-6458.2005; ZURCHER T, 1994, J VIROL, V68, P5748, DOI 10.1128/JVI.68.9.5748-5754.1994	49	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34978	34989		10.1074/jbc.M114.586180	http://dx.doi.org/10.1074/jbc.M114.586180			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25349209	Green Published, hybrid			2022-12-28	WOS:000346260800046
J	Jin, HJ; Kanthasamy, A; Harischandra, DS; Kondru, N; Ghosh, A; Panicker, N; Anantharam, V; Rana, A; Kanthasamy, AG				Jin, Huajun; Kanthasamy, Arthi; Harischandra, Dilshan S.; Kondru, Naveen; Ghosh, Anamitra; Panicker, Nikhil; Anantharam, Vellareddy; Rana, Ajay; Kanthasamy, Anumantha G.			Histone Hyperacetylation Up-regulates Protein Kinase C delta in Dopaminergic Neurons to Induce Cell Death RELEVANCE TO EPIGENETIC MECHANISMS OF NEURODEGENERATION IN PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Epigenetics; Histone Deacetylase Inhibitor (HDAC Inhibitor); Neurodegeneration; Oxidative Stress; Parkinson Disease; PKC; Histone Acetylation	ALPHA-SYNUCLEIN OLIGOMERS; PKC-DELTA; PROTEOLYTIC ACTIVATION; DEACETYLASE INHIBITOR; OXIDATIVE-STRESS; DIFFERENTIAL ACTIVATION; SODIUM-BUTYRATE; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; REPRESS TRANSCRIPTION	Background: Dysregulation of neuronal acetylation homeostasis promotes neurodegeneration. Results: Histone hyperacetylation up-regulates PKC in dopaminergic neurons and augments susceptibility to oxidative damage. Conclusion: Epigenetic regulation of PKC plays a proapoptotic role in neuronal cell death. Significance: The up-regulation of PKC expression by hyperacetylation provides an epigenetic molecular basis of neurodegenerative disease. The oxidative stress-sensitive protein kinase C (PKC) has been implicated in dopaminergic neuronal cell death. However, little is known about the epigenetic mechanisms regulating PKC expression in neurons. Here, we report a novel mechanism by which the PKC gene can be regulated by histone acetylation. Treatment with histone deacetylase (HDAC) inhibitor sodium butyrate (NaBu) induced PKC expression in cultured neurons, brain slices, and animal models. Several other HDAC inhibitors also mimicked NaBu. The chromatin immunoprecipitation analysis revealed that hyperacetylation of histone H4 by NaBu is associated with the PKC promoter. Deletion analysis of the PKC promoter mapped the NaBu-responsive element to an 81-bp minimal promoter region. Detailed mutagenesis studies within this region revealed that four GC boxes conferred hyperacetylation-induced PKC promoter activation. Cotransfection experiments and Sp inhibitor studies demonstrated that Sp1, Sp3, and Sp4 regulated NaBu-induced PKC up-regulation. However, NaBu did not alter the DNA binding activities of Sp proteins or their expression. Interestingly, a one-hybrid analysis revealed that NaBu enhanced transcriptional activity of Sp1/Sp3. Overexpression of the p300/cAMP-response element-binding protein-binding protein (CBP) potentiated the NaBu-mediated transactivation potential of Sp1/Sp3, but expressing several HDACs attenuated this effect, suggesting that p300/CBP and HDACs act as coactivators or corepressors in histone acetylation-induced PKC up-regulation. Finally, using genetic and pharmacological approaches, we showed that NaBu up-regulation of PKC sensitizes neurons to cell death in a human dopaminergic cell model and brain slice cultures. Together, these results indicate that histone acetylation regulates PKC expression to augment nigrostriatal dopaminergic cell death, which could contribute to the progressive neuropathogenesis of Parkinson disease.	[Jin, Huajun; Kanthasamy, Arthi; Harischandra, Dilshan S.; Kondru, Naveen; Ghosh, Anamitra; Panicker, Nikhil; Anantharam, Vellareddy; Kanthasamy, Anumantha G.] Iowa State Univ, Dept Biomed Sci, Iowa Ctr Adv Neurotoxicol, Ames, IA 50011 USA; [Rana, Ajay] Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Rana, Ajay] Hines Vet Affairs Med Ctr, Hines, IL 60141 USA	Iowa State University; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Kanthasamy, AG (corresponding author), Iowa State Univ, Dept Biomed Sci, 2062 Coll Vet Med Bldg, Ames, IA 50011 USA.	akanthas@iastate.edu	Kondru, Naveen/AAM-9444-2021; Kondru, Naveen/AAB-7468-2020; Panicker, Nikhil/A-2770-2019; Rana, Ajay/ABE-3739-2020; Kondru, Naveen/P-9687-2019; Ghosh, Anamitra/C-5118-2015	Kondru, Naveen/0000-0002-1433-6336; Kondru, Naveen/0000-0002-1433-6336; Panicker, Nikhil/0000-0003-1752-4284; Rana, Ajay/0000-0003-0951-2566; Kanthasamy, Anumantha/0000-0002-6454-4264; Kanthasamy, Arthi/0000-0003-4654-9907; Harischandra, Dilshan/0000-0003-3220-8765; Ghosh, Anamitra/0000-0001-9740-2070	National Institutes of Health RO1 [ES10586, NS074443, NS65167, GM055835]; W. Eugene and Linda Lloyd Endowed Chair Professorship; Dean Professorship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074443, R01NS065167] Funding Source: NIH RePORTER	National Institutes of Health RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. Eugene and Linda Lloyd Endowed Chair Professorship; Dean Professorship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health RO1 Grants ES10586 and NS074443 (to A. G. K.), NS65167 (to A. K.), and GM055835 (to A. R.). This work was also supported by the W. Eugene and Linda Lloyd Endowed Chair Professorship (to A. G. K.) and the Dean Professorship (to A. K.).	Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Anantharam V, 2004, ANN NY ACAD SCI, V1035, P271, DOI 10.1196/annals.1332.017; Anantharam V, 2002, J NEUROSCI, V22, P1738, DOI 10.1523/JNEUROSCI.22-05-01738.2002; Asaithambi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096947; Azadi S, 2006, MOL CELL NEUROSCI, V31, P759, DOI 10.1016/j.mcn.2006.01.001; Bardai FH, 2012, J BIOL CHEM, V287, P35444, DOI 10.1074/jbc.M112.394544; Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Barrasa JI, 2012, BBA-MOL CELL RES, V1823, P570, DOI 10.1016/j.bbamcr.2011.12.010; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Boutillier AL, 2003, J NEUROCHEM, V84, P814, DOI 10.1046/j.1471-4159.2003.01581.x; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Camarero N, 2003, NUCLEIC ACIDS RES, V31, P1693, DOI 10.1093/nar/gkg262; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Chou CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018087; Chou WH, 2005, TRENDS CARDIOVAS MED, V15, P47, DOI 10.1016/j.tcm.2005.01.003; Chu SJ, 2012, GENE, V508, P1, DOI 10.1016/j.gene.2012.07.022; D'Costa AM, 2006, ONCOGENE, V25, P378, DOI 10.1038/sj.onc.1209065; D'Mello SR, 2009, DRUG NEWS PERSPECT, V22, P513, DOI [10.1358/dnp.2009.22.9.1437959, 10.1358/dnp.2009.9.1428871]; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Dennig J, 1996, EMBO J, V15, P5659, DOI 10.1002/j.1460-2075.1996.tb00950.x; Dietz KC, 2010, PHARMACOL RES, V62, P11, DOI 10.1016/j.phrs.2010.01.011; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Ghosh A, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.444224; Ghosh A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-241; Goldberg M, 1996, BIOCHEM PHARMACOL, V51, P1089, DOI 10.1016/0006-2952(96)00046-9; Gordon R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-82; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Han JW, 2001, J BIOL CHEM, V276, P42084, DOI 10.1074/jbc.M106688200; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; Hanrott K, 2008, EUR J NEUROSCI, V27, P1086, DOI 10.1111/j.1460-9568.2008.06097.x; Harischandra DS, 2014, PRION, V8, P142, DOI 10.4161/pri.28369; Hou LF, 2012, INT J EPIDEMIOL, V41, P79, DOI 10.1093/ije/dyr154; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Jin HJ, 2011, J BIOL CHEM, V286, P19840, DOI 10.1074/jbc.M110.203687; Jin HJ, 2011, J NEUROSCI, V31, P2035, DOI 10.1523/JNEUROSCI.5634-10.2011; Kanthasamy AG, 2005, NEUROTOXICOLOGY, V26, P701, DOI 10.1016/j.neuro.2004.07.010; Kanthasamy A, 2012, NEUROTOXICOLOGY, V33, P833, DOI 10.1016/j.neuro.2012.01.011; Kanthasamy A, 2010, NEUROTOXICOLOGY, V31, P555, DOI 10.1016/j.neuro.2009.12.003; Kanthasamy AG, 2006, FREE RADICAL BIO MED, V41, P1578, DOI 10.1016/j.freeradbiomed.2006.08.016; Kaul S, 2003, EUR J NEUROSCI, V18, P1387, DOI 10.1046/j.1460-9568.2003.02864.x; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kim JH, 2010, AM J PATHOL, V176, P1517, DOI 10.2353/ajpath.2010.090398; Konduri S, 2009, MOL CANCER THER, V8, P533, DOI 10.1158/1535-7163.MCT-08-0405; Koponen S, 2000, J CEREBR BLOOD F MET, V20, P93, DOI 10.1097/00004647-200001000-00013; Kuehn HS, 2013, BLOOD, V121, P3117, DOI 10.1182/blood-2012-12-469544; Kurkinen KMA, 2000, GENE, V242, P115, DOI 10.1016/S0378-1119(99)00539-9; Latchoumycandane C, 2011, TOXICOL APPL PHARM, V256, P314, DOI 10.1016/j.taap.2011.07.021; Lee HH, 2008, J GEN VIROL, V89, P878, DOI 10.1099/vir.0.83533-0; Leitges M, 2001, J CLIN INVEST, V108, P1505; Lemercier C, 2002, J BIOL CHEM, V277, P22045, DOI 10.1074/jbc.M201736200; Li J, 2003, J BIOL CHEM, V278, P13183, DOI 10.1074/jbc.M300269200; Lin KT, 2012, CLIN CANCER RES, V18, P4691, DOI 10.1158/1078-0432.CCR-12-0633; Lin M, 2012, NEUROSCIENCE, V210, P308, DOI 10.1016/j.neuroscience.2012.03.004; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Marinova Z, 2009, J NEUROCHEM, V111, P976, DOI 10.1111/j.1471-4159.2009.06385.x; Markova NG, 2007, J INVEST DERMATOL, V127, P1126, DOI 10.1038/sj.jid.5700684; Marks PA, 2003, CURR OPIN PHARMACOL, V3, P344, DOI 10.1016/S1471-4892(03)00084-5; McMillan L, 2003, BRIT J CANCER, V88, P748, DOI 10.1038/sj.bjc.6600793; Miettinen S, 1996, J NEUROSCI, V16, P6236; Min BW, 2008, EXP MOL MED, V40, P699, DOI 10.3858/emm.2008.40.6.699; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; Mottet D, 2009, ONCOGENE, V28, P243, DOI 10.1038/onc.2008.371; MURATA Y, 1994, J BIOL CHEM, V269, P20674; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Palaniyandi SS, 2009, CARDIOVASC RES, V82, P229, DOI 10.1093/cvr/cvp001; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pirooznia SK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00030; Pirooznia SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041776; Ponassi R, 2006, BIOCHEM PHARMACOL, V72, P1417, DOI 10.1016/j.bcp.2006.07.031; PONGRACZ J, 1995, INT J CANCER, V61, P35, DOI 10.1002/ijc.2910610107; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Ramirez T, 2008, CHROMOSOMA, V117, P147, DOI 10.1007/s00412-007-0133-5; RAY R, 1989, J CLIN INVEST, V83, P2003, DOI 10.1172/JCI114110; Reno EM, 2008, HUM PATHOL, V39, P21, DOI 10.1016/j.humpath.2007.05.023; Saha RN, 2006, CELL DEATH DIFFER, V13, P539, DOI 10.1038/sj.cdd.4401769; Salminen A, 1998, MOL BRAIN RES, V61, P203, DOI 10.1016/S0169-328X(98)00210-1; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Schildknecht S, 2009, TOXICOL APPL PHARM, V241, P23, DOI 10.1016/j.taap.2009.07.027; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Scholz D, 2011, J NEUROCHEM, V119, P957, DOI 10.1111/j.1471-4159.2011.07255.x; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Shin EJ, 2012, BEHAV BRAIN RES, V232, P98, DOI 10.1016/j.bbr.2012.04.001; Shin EJ, 2011, NEUROCHEM INT, V59, P39, DOI 10.1016/j.neuint.2011.03.022; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Song C, 2011, NEUROTOXICOLOGY, V32, P586, DOI 10.1016/j.neuro.2011.05.018; Song C, 2010, MOL PHARMACOL, V77, P621, DOI 10.1124/mol.109.062174; Sowa Y, 1999, CANCER RES, V59, P4266; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Suh KS, 2003, GENOMICS, V82, P57, DOI 10.1016/S0888-7543(03)00072-7; Sun JM, 2002, J BIOL CHEM, V277, P35783, DOI 10.1074/jbc.C200378200; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Valor LM, 2013, CURR PHARM DESIGN, V19, P5051, DOI 10.2174/13816128113199990382; Varga A, 2004, EUR UROL, V46, P462, DOI 10.1016/j.eururo.2004.04.014; Walker GE, 2001, ENDOCRINOLOGY, V142, P3817, DOI 10.1210/en.142.9.3817; Wang Y, 2009, NEUROSCI LETT, V467, P212, DOI 10.1016/j.neulet.2009.10.037; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Won J, 2002, J BIOL CHEM, V277, P38230, DOI 10.1074/jbc.M206064200; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yang YJ, 2004, MOL CELL NEUROSCI, V25, P406, DOI 10.1016/j.mcn.2003.11.011; Yokota T, 2004, ONCOGENE, V23, P5340, DOI 10.1038/sj.onc.1207689; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669; Zhang DH, 2007, J NEUROSCI, V27, P5349, DOI 10.1523/JNEUROSCI.4107-06.2007; Zhu WG, 2001, CANCER RES, V61, P1327	120	50	54	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34743	34767		10.1074/jbc.M114.576702	http://dx.doi.org/10.1074/jbc.M114.576702			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342743	Green Published, hybrid			2022-12-28	WOS:000346260800029
J	Yeo, GC; Baldock, C; Wise, SG; Weiss, AS				Yeo, Giselle C.; Baldock, Clair; Wise, Steven G.; Weiss, Anthony S.			A Negatively Charged Residue Stabilizes the Tropoelastin N-terminal Region for Elastic Fiber Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aspartate (Aspartic Acid); Elastin; Protein Self-assembly; Small Angle X-ray Scattering; Tertiary Structure; Domain 6; Elastic Fiber Assembly; N-terminal Region; Tropoelastin	RECOMBINANT HUMAN TROPOELASTIN; HUMAN SKIN ELASTIN; SMALL-ANGLE SCATTERING; CROSS-LINKING DOMAIN; LYSYL OXIDASE; IN-VITRO; COACERVATION; ASSOCIATION; PEPTIDES; SEQUENCES	Background: Negative residues are rare in human tropoelastin, and their contributions to protein structure and function are unknown. Results: Mutating aspartate 72 reduces coacervation, cross-linking, and elastogenesis and alters the N-terminal conformation. Conclusion: Aspartate 72 residue stabilizes the N-terminal structure for functional assembly into elastic fibers. Significance: This work provides the first direct evidence of the importance of the tropoelastin N-terminal structure in elastic fiber assembly. Tropoelastin is an extracellular matrix protein that assembles into elastic fibers that provide elasticity and strength to vertebrate tissues. Although the contributions of specific tropoelastin regions during each stage of elastogenesis are still not fully understood, studies predominantly recognize the central hinge/bridge and C-terminal foot as the major participants in tropoelastin assembly, with a number of interactions mediated by the abundant positively charged residues within these regions. However, much less is known about the importance of the rarely occurring negatively charged residues and the N-terminal coil region in tropoelastin assembly. The sole negatively charged residue in the first half of human tropoelastin is aspartate 72. In contrast, the same region comprises 17 positively charged residues. We mutated this aspartate residue to alanine and assessed the elastogenic capacity of this novel construct. We found that D72A tropoelastin has a decreased propensity for initial self-association, and it cross-links aberrantly into denser, less porous hydrogels with reduced swelling properties. Although the mutant can bind cells normally, it does not form elastic fibers with human dermal fibroblasts and forms fewer atypical fibers with human retinal pigmented epithelial cells. This impaired functionality is associated with conformational changes in the N-terminal region. Our results strongly point to the role of the Asp-72 site in stabilizing the N-terminal segment of human tropoelastin and the importance of this region in facilitating elastic fiber assembly.	[Yeo, Giselle C.; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Yeo, Giselle C.; Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Baldock, Clair] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Wise, Steven G.] Heart Res Inst, Sydney, NSW 2042, Australia; [Wise, Steven G.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Weiss, Anthony S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Manchester; University of Sydney; Heart Research Institute; University of Sydney; University of Sydney	Weiss, AS (corresponding author), Univ Sydney, Charles Perkins Ctr, Bldg D17, Sydney, NSW 2006, Australia.	tony.weiss@sydney.edu.au	Wise, Steven G/G-2630-2018; Weiss, Anthony S/GYV-0157-2022; Wise, Steven/AAB-8170-2021; Weiss, Anthony S/F-8103-2010; Wise, Steven/B-1858-2009	Weiss, Anthony S/0000-0002-8106-4836; Yeo, Giselle/0000-0001-6071-8899; Wise, Steven/0000-0001-7964-819X; Baldock, Clair/0000-0003-3497-1959	European Radiation Synchrotron Fund (ESRF) [MX-1483]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014283] Funding Source: NIH RePORTER	European Radiation Synchrotron Fund (ESRF); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank the European Radiation Synchrotron Fund (ESRF) for access to beamline BM29 (Midland BAG Proposal MX-1483) and Dr. Benoit Maillot for assistance during data collection.	Akhtart K, 2011, J BIOL CHEM, V286, P13574, DOI 10.1074/jbc.M110.192088; Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108; BASHIR MM, 1989, J BIOL CHEM, V264, P8887; Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525; BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345; Bochicchio B, 2011, CHIRALITY, V23, P694, DOI 10.1002/chir.20979; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149; BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778; Clarke AW, 2005, BIOCHEMISTRY-US, V44, P10271, DOI 10.1021/bi050530d; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; DOIG AJ, 1995, PROTEIN SCI, V4, P1325, DOI 10.1002/pro.5560040708; Dyksterhuis LB, 2007, MATRIX BIOL, V26, P125, DOI 10.1016/j.matbio.2006.10.002; Dyksterhuis LB, 2009, ARCH BIOCHEM BIOPHYS, V487, P79, DOI 10.1016/j.abb.2009.06.001; Getie M, 2005, PROTEINS, V61, P649, DOI 10.1002/prot.20643; GROSSO LE, 1993, BIOCHEMISTRY-US, V32, P13369, DOI 10.1021/bi00211a052; Heinz A, 2010, FEBS J, V277, P1939, DOI 10.1111/j.1742-4658.2010.07616.x; Jensen SA, 2000, J BIOL CHEM, V275, P28449, DOI 10.1074/jbc.M004265200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; Lee P, 2014, J BIOL CHEM, V289, P1467, DOI 10.1074/jbc.M113.518381; Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0; Megarbane H, 2009, J INVEST DERMATOL, V129, P1650, DOI 10.1038/jid.2008.450; Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200; Mithieux SM, 2005, J STRUCT BIOL, V149, P282, DOI 10.1016/j.jsb.2004.11.005; Muiznieks LD, 2007, BIOCHEMISTRY-US, V46, P8196, DOI 10.1021/bi700139k; Ostuni A, 2007, BIOPHYS J, V93, P3640, DOI 10.1529/biophysj.107.110809; PasqualiRonchetti I, 1997, MICROSC RES TECHNIQ, V38, P428, DOI 10.1002/(SICI)1097-0029(19970815)38:4<428::AID-JEMT10>3.0.CO;2-L; Piontkivska H, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-31; Sato F, 2007, J MOL BIOL, V369, P841, DOI 10.1016/j.jmb.2007.03.060; Schmelzer CEH, 2005, J CHROMATOGR A, V1083, P120, DOI 10.1016/j.chroma.2005.06.034; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stone PJ, 2001, AM J RESP CELL MOL, V24, P733, DOI 10.1165/ajrcmb.24.6.4304; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Taddese S, 2008, MATRIX BIOL, V27, P420, DOI 10.1016/j.matbio.2008.02.001; Tamburro AM, 2006, BIOCHEMISTRY-US, V45, P9518, DOI 10.1021/bi060289i; Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200; UITTO J, 1979, J INVEST DERMATOL, V72, P1, DOI 10.1111/1523-1747.ep12530093; Urry DW, 2004, CHEM PHYS LETT, V399, P177, DOI 10.1016/j.cplett.2004.09.137; URRY DW, 1979, BIOCHEM BIOPH RES CO, V90, P194, DOI 10.1016/0006-291X(79)91608-5; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x; Wang HW, 2008, PROC SPIE, V6860, DOI 10.1117/12.763604; Waterhouse A, 2011, PHARM RES-DORDR, V28, P1415, DOI 10.1007/s11095-010-0327-z; Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006; Wu WJ, 1999, EUR J BIOCHEM, V266, P308, DOI 10.1046/j.1432-1327.1999.00891.x; Yeo GC, 2012, P NATL ACAD SCI USA, V109, P2878, DOI 10.1073/pnas.1111615108	47	18	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34815	34826		10.1074/jbc.M114.606772	http://dx.doi.org/10.1074/jbc.M114.606772			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342751	Green Published, hybrid			2022-12-28	WOS:000346260800033
J	Yoon, J; Feng, XX; Kim, YS; Shin, DM; Hatzi, K; Wang, HS; Morse, HC				Yoon, Jeongheon; Feng, Xianxum; Kim, Yong-Soo; Shin, Dong-Mi; Hatzi, Katerina; Wang, Hongsheng; Morse, Herbert C., III			Interferon Regulatory Factor 8 (IRF8) Interacts with the B Cell Lymphoma 6 (BCL6) Corepressor BCOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Expression; Immunology; Lymphocyte; Protein Complex; Protein-Protein Interaction; Transcription Repressor	SEQUENCE-BINDING-PROTEIN; GERMINAL-CENTER; COMPLEX-FORMATION; PROGENITOR CELLS; GENE-EXPRESSION; DENDRITIC CELLS; ICSBP; DOMAIN; ACTIVATION; LINEAGE	Background: Protein partnerships regulate specific functions of cells. BCOR protein-protein interactions are critical to aspects of B cell biology. Results: IRF8 pairs with BCOR in the nucleus to enhance its transcriptional repressive activity. Conclusion: Partnering of IRF8 with BCOR defines a novel mechanism for controlling B cell gene expression. Significance: Understanding gene regulation in specific cell types requires identification of protein complexes that modulate expression. B cell lymphoma 6 (BCL6) corepressor (BCOR) was discovered as a BCL6-interacting corepressor, but little is known about its other biological activities in normal B cell development and function. Previously, we found that interferon regulatory factor 8 (IRF8), also known as interferon consensus sequence-binding protein, directly targets a large number of genes in germinal center B cells including BCL6. In this study, we screened potential binding partners of IRF8 using a retrovirus-based protein complementation assay screen in a mouse pre-B cell line. We found that IRF8 interacts directly with BCOR and that the -helical region of IRF8 and the BCL6 binding domain of BCOR are required for this interaction. In addition, IRF8 protein interacts directly with BCL6. Using an siRNA-mediated IRF8 knockdown mouse B cell lymphoma cell line, we showed that IRF8 represses Bcor and enhances Bcl6 transcription. Taken together, these data suggest that a complex comprising BCOR-BCL6-IRF8 modulates BCL6-associated transcriptional regulation of germinal center B cell function.	[Yoon, Jeongheon; Feng, Xianxum; Kim, Yong-Soo; Shin, Dong-Mi; Wang, Hongsheng; Morse, Herbert C., III] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Hatzi, Katerina] Weill Cornell Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY 10065 USA; [Hatzi, Katerina] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cornell University; Cornell University	Morse, HC (corresponding author), NIAID, Virol & Cellular Immunol Sect, Immunogenet Lab, NIH, 5640 Fisher Lane, Rockville, MD 20852 USA.	hmorse@niaid.nih.gov		Morse, Herbert/0000-0002-9331-3705	National Institutes of Health Intramural Research Program of the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001057] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIAID.	Baccala R, 2013, P NATL ACAD SCI USA, V110, P2940, DOI 10.1073/pnas.1222798110; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Bouamar H, 2013, BLOOD, V122, P726, DOI 10.1182/blood-2013-04-495804; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Cattoretti G, 2006, J IMMUNOL, V177, P6930, DOI 10.4049/jimmunol.177.10.6930; Chrabot BS, 2013, GENES IMMUN, V14, P471, DOI 10.1038/gene.2013.42; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Dror N, 2007, J BIOL CHEM, V282, P5633, DOI 10.1074/jbc.M607825200; Feng JX, 2011, J IMMUNOL, V186, P1458, DOI 10.4049/jimmunol.1001950; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Ghetu AF, 2008, MOL CELL, V29, P384, DOI 10.1016/j.molcel.2007.12.026; Gobin SJP, 2003, BLOOD, V101, P3058, DOI 10.1182/blood-2002-09-2924; Hatzi K, 2014, TRENDS MOL MED, V20, P343, DOI 10.1016/j.molmed.2014.03.001; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Huynh KD, 2000, GENE DEV, V14, P1810; Kuwata T, 2002, MOL CELL BIOL, V22, P7439, DOI 10.1128/MCB.22.21.7439-7448.2002; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma SB, 2006, J IMMUNOL, V177, P7898, DOI 10.4049/jimmunol.177.11.7898; Martinez A, 2008, AM J SURG PATHOL, V32, P1190, DOI 10.1097/PAS.0b013e318166f46a; Nakano N, 2005, IMMUNOGENETICS, V56, P871, DOI 10.1007/s00251-004-0754-2; Pathak S, 2013, J IMMUNOL, V191, P6222, DOI 10.4049/jimmunol.1301169; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Shin DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027384; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tsujimura H, 2003, BLOOD, V101, P961, DOI 10.1182/blood-2002-05-1327; Tsujimura H, 2002, J IMMUNOL, V169, P1261, DOI 10.4049/jimmunol.169.3.1261; Wamstad JA, 2007, GENE EXPR PATTERNS, V7, P550, DOI 10.1016/j.modgep.2007.01.006; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Wei F, 2009, MOL CELL BIOL, V29, P4612, DOI 10.1128/MCB.00234-09; Yang DF, 2007, J IMMUNOL, V179, P4775, DOI 10.4049/jimmunol.179.7.4775; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110; Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200	41	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34250	34257		10.1074/jbc.M114.571182	http://dx.doi.org/10.1074/jbc.M114.571182			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25331958	Green Published, hybrid			2022-12-28	WOS:000346077600047
J	Bultema, JJ; Boyle, JA; Malenke, PB; Martin, FE; Dell'Angelica, EC; Cheney, RE; Di Pietro, SM				Bultema, Jarred J.; Boyle, Judith A.; Malenke, Parker B.; Martin, Faye E.; Dell'Angelica, Esteban C.; Cheney, Richard E.; Di Pietro, Santiago M.			Myosin Vc Interacts with Rab32 and Rab38 Proteins and Works in the Biogenesis and Secretion of Melanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOME-RELATED ORGANELLES; HERMANSKY-PUDLAK-SYNDROME; AP-3 ADAPTER COMPLEX; UNCONVENTIONAL MYOSIN; MEMBRANE-PROTEINS; MELANIN TRANSFER; STRUCTURAL BASIS; TRAFFICKING; MELANOCYTES; MICE	Class V myosins are actin-based motors with conserved functions in vesicle and organelle trafficking. Herein we report the discovery of a function for Myosin Vc in melanosome biogenesis as an effector of melanosome-associated Rab GTPases. We isolated Myosin Vc in a yeast two-hybrid screening for proteins that interact with Rab38, a Rab protein involved in the biogenesis of melanosomes and other lysosome-related organelles. Rab38 and its close homolog Rab32 bind to Myosin Vc but not to Myosin Va or Myosin Vb. Binding depends on residues in the switch II region of Rab32 and Rab38 and regions of the Myosin Vc coiled-coil tail domain. Myosin Vc also interacts with Rab7a and Rab8a but not with Rab11, Rab17, and Rab27. Although Myosin Vc is not particularly abundant on pigmented melanosomes, its knockdown in MNT-1 melanocytes caused defects in the trafficking of integral membrane proteins to melanosomes with substantially increased surface expression of Tyrp1, nearly complete loss of Tyrp2, and significant Vamp7 mislocalization. Knockdown of Myosin Vc in MNT-1 cells more than doubled the abundance of pigmented melanosomes but did not change the number of unpigmented melanosomes. Together the data demonstrate a novel role for Myosin Vc in melanosome biogenesis and secretion.	[Bultema, Jarred J.; Boyle, Judith A.; Malenke, Parker B.; Martin, Faye E.; Di Pietro, Santiago M.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Bultema, Jarred J.] Univ Colorado, Dept Chem & Biochem, Colorado Springs, CO 80907 USA; [Dell'Angelica, Esteban C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Cheney, Richard E.] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	Colorado State University; University of Colorado System; University of Colorado at Colorado Springs; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Di Pietro, SM (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	santiago.dipietro@colostate.edu	di pietro, santiago/AAR-6899-2020	Cheney, Richard/0000-0001-6565-7888	Colorado State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC003299, R01DC003299] Funding Source: NIH RePORTER	Colorado State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Thomas Giddings (University of Colorado, Boulder, CO) for high pressure freezing and Andrea Ambrosio for invaluable help with figure preparation. Microscopes used in this work were supported in part by the Microscope Imaging Network core infrastructure grant from Colorado State University.	Ambrosio AL, 2012, BLOOD, V120, P4072, DOI 10.1182/blood-2012-04-420745; Ando H, 2012, J INVEST DERMATOL, V132, P1222, DOI 10.1038/jid.2011.413; Ando Hideya, 2011, Cell Logist, V1, P12, DOI 10.4161/cl.1.1.13638; Beaumont KA, 2011, TRAFFIC, V12, P627, DOI 10.1111/j.1600-0854.2011.01172.x; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brooks BP, 2007, INVEST OPHTH VIS SCI, V48, P3905, DOI 10.1167/iovs.06-1464; Bultema Jarred J, 2013, Small GTPases, V4, P16, DOI 10.4161/sgtp.22349; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Chabrillat ML, 2005, MOL BIOL CELL, V16, P1640, DOI 10.1091/mbc.e04-09-0770; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Cohen-Solal KA, 2003, BBA-PROTEINS PROTEOM, V1651, P68, DOI 10.1016/S1570-9639(03)00236-X; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 2000, J BIOL CHEM, V275, P1300, DOI 10.1074/jbc.275.2.1300; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Di Pietro SM, 2005, TRAFFIC, V6, P525, DOI 10.1111/j.1600-0854.2005.00299.x; Di Pietro SM, 2004, TRAFFIC, V5, P276, DOI 10.1111/j.1600-0854.2004.0171.x; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Harper DC, 2008, J BIOL CHEM, V283, P2307, DOI 10.1074/jbc.M708007200; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x; Jacobs DT, 2009, MOL BIOL CELL, V20, P4471, DOI 10.1091/mbc.E08-08-0865; JENKINS NA, 1981, NATURE, V293, P370, DOI 10.1038/293370a0; Jordens I, 2006, PIGM CELL RES, V19, P412, DOI 10.1111/j.1600-0749.2006.00329.x; Kent HM, 2012, DEV CELL, V22, P979, DOI 10.1016/j.devcel.2012.01.018; Kloer DP, 2010, J BIOL CHEM, V285, P7794, DOI 10.1074/jbc.M109.069088; Kondo Taisuke, 2011, Expert Rev Dermatol, V6, P97, DOI 10.1586/edm.10.70; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lee MTG, 2009, TRAFFIC, V10, P1377, DOI 10.1111/j.1600-0854.2009.00942.x; Lindsay AJ, 2013, MOL BIOL CELL, V24, P3420, DOI 10.1091/mbc.E13-05-0236; Loftus SK, 2002, P NATL ACAD SCI USA, V99, P4471, DOI 10.1073/pnas.072087599; Lopes VS, 2007, MOL BIOL CELL, V18, P3914, DOI 10.1091/mbc.E07-03-0268; Marchelletta RR, 2008, AM J PHYSIOL-CELL PH, V295, pC13, DOI 10.1152/ajpcell.00330.2007; Meehl JB, 2009, METHODS MOL BIOL, V586, P227, DOI 10.1007/978-1-60761-376-3_12; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; Ninkovic I, 2008, J THROMB HAEMOST, V6, P2143, DOI 10.1111/j.1538-7836.2008.03178.x; Oiso N, 2004, MAMM GENOME, V15, P307, DOI 10.1007/s00335-004-2337-9; Osanai K, 2008, AM J PATHOL, V173, P1265, DOI 10.2353/ajpath.2008.080056; OZEKI H, 1995, J INVEST DERMATOL, V105, P361, DOI 10.1111/1523-1747.ep12320792; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Provance DW, 1996, P NATL ACAD SCI USA, V93, P14554, DOI 10.1073/pnas.93.25.14554; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Rodriguez OC, 2002, J CELL SCI, V115, P991; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Roland JT, 2009, J BIOL CHEM, V284, P1213, DOI 10.1074/jbc.M805957200; Ryder PV, 2013, MOL BIOL CELL, V24, P2269, DOI 10.1091/mbc.E13-02-0088; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Schafer IB, 2012, NAT STRUCT MOL BIOL, V19, P1300, DOI 10.1038/nsmb.2414; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Singh SK, 2010, FASEB J, V24, P3756, DOI 10.1096/fj.10-159046; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Tamura K, 2011, J BIOL CHEM, V286, P7507, DOI 10.1074/jbc.M110.191205; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Tarafder AK, 2014, J INVEST DERMATOL, V134, P1056, DOI 10.1038/jid.2013.432; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667; Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XF, 1997, J CELL SCI, V110, P847; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Wu XF, 2001, J CELL SCI, V114, P1091; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Wu XFS, 2012, P NATL ACAD SCI USA, V109, pE2101, DOI 10.1073/pnas.1209397109	81	43	44	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33513	33528		10.1074/jbc.M114.578948	http://dx.doi.org/10.1074/jbc.M114.578948			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25324551	hybrid, Green Published			2022-12-28	WOS:000345636600039
J	Hu, LX; Huang, HL; Li, JH; Yin, MX; Lu, Y; Wu, WQ; Zeng, R; Jiang, J; Zhao, Y; Zhang, L				Hu, Lianxin; Huang, Hongling; Li, Jinhui; Yin, Meng-Xin; Lu, Yi; Wu, Wenqing; Zeng, Rong; Jiang, Jin; Zhao, Yun; Zhang, Lei			Drosophila Casein Kinase 2 (CK2) Promotes Warts Protein to Suppress Yorkie Protein Activity for Growth Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPO SIGNALING PATHWAY; ORGAN SIZE CONTROL; CELL-CYCLE EXIT; TUMOR-SUPPRESSOR; IN-VIVO; PROLIFERATION ARREST; TEAD/TEF FAMILY; BANTAM MICRORNA; BETA-SUBUNIT; APOPTOSIS	Drosophila Hippo signaling regulates Wts activity to phosphorylate and inhibit Yki in order to control tissue growth. CK2 is widely expressed and involved in a variety of signaling pathways. In this study we report that Drosophila CK2 promotes Wts activity to phosphorylate and inhibit Yki activity, which is independent of Hpo-induced Wts promotion. In vivo, CK2 overexpression suppresses hpo mutant-induced expanded (Ex) up-regulation and overgrowth phenotype, whereas it cannot affect wts mutant. Consistent with this, knockdown of CK2 up-regulates Hpo pathway target expression. We also found that Drosophila CK2 is essential for tissue growth as a cell death inhibitor as knockdown of CK2 in the developing disc induces severe growth defects as well as caspase3 signals. Taken together, our results uncover a dual role of CK2; although its major role is promoting cell survive, it may potentially be a growth inhibitor as well.	[Hu, Lianxin; Huang, Hongling; Li, Jinhui; Yin, Meng-Xin; Lu, Yi; Wu, Wenqing; Zhao, Yun; Zhang, Lei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Zeng, Rong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai 200031, Peoples R China; [Jiang, Jin] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Yue Yang Rd, Shanghai 200031, Peoples R China.	rayzhang@sibcb.ac.cn		Hu, Lianxin/0000-0001-5600-5634	National Basic Research Program of China (973 Program) [2010CB912101, 2012CB945001, 2011CB943902]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA01010406]; National Natural Science Foundation of China [31171394, 31371462]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (973 Program 2010CB912101, 2012CB945001, and 2011CB943902), the "Strategic Priority Research Program" of the Chinese Academy of Sciences (Grant XDA01010406), and National Natural Science Foundation of China Grants 31171394 and 31371462.	Ahmad KA, 2008, ADV ENZYME REGUL, V48, P179, DOI 10.1016/j.advenzreg.2008.04.002; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Dominguez I, 2009, CELL MOL LIFE SCI, V66, P1850, DOI 10.1007/s00018-009-9153-z; Genevet A, 2009, J CELL SCI, V122, P2360, DOI 10.1242/jcs.041806; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang HL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001620; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jauch E, 2002, GENE, V298, P29, DOI 10.1016/S0378-1119(02)00921-6; Jia HG, 2010, J BIOL CHEM, V285, P37218, DOI 10.1074/jbc.M110.174565; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Jin YY, 2012, J BIOL CHEM, V287, P5784, DOI 10.1074/jbc.M111.310334; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Marin O, 1999, BIOCHEM BIOPH RES CO, V256, P442, DOI 10.1006/bbrc.1999.0348; MEGGIO F, 1992, EUR J BIOCHEM, V204, P293, DOI 10.1111/j.1432-1033.1992.tb16636.x; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Oh H, 2009, DEV BIOL, V335, P188, DOI 10.1016/j.ydbio.2009.08.026; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Penner CG, 1997, J CELL BIOCHEM, V64, P525; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Ren FF, 2010, DEV BIOL, V337, P303, DOI 10.1016/j.ydbio.2009.10.046; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Seldin DC, 2005, MOL CELL BIOCHEM, V274, P63, DOI 10.1007/s11010-005-3078-0; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Turowec JP, 2011, MOL CELL BIOCHEM, V356, P159, DOI 10.1007/s11010-011-0972-5; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Verghese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047173; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wang S, 2006, CURR BIOL, V16, P2239, DOI 10.1016/j.cub.2006.09.034; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XU TA, 1995, DEVELOPMENT, V121, P1053; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yin MX, 2011, J GENET GENOMICS, V38, P471, DOI 10.1016/j.jgg.2011.09.009; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Yue T, 2012, DEV CELL, V22, P255, DOI 10.1016/j.devcel.2011.12.011; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	57	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33598	33607		10.1074/jbc.M114.580456	http://dx.doi.org/10.1074/jbc.M114.580456			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25320084	hybrid, Green Published			2022-12-28	WOS:000345636600045
J	Davis, AL; Qiao, SX; Lesson, JL; de la Vega, MR; Park, SL; Seanez, CM; Gokhale, V; Cabello, CM; Wondrak, GT				Davis, Angela L.; Qiao, Shuxi; Lesson, Jessica L.; de la Vega, Montserrat Rojo; Park, Sophia L.; Seanez, Carol M.; Gokhale, Vijay; Cabello, Christopher M.; Wondrak, Georg T.			The Quinone Methide Aurin Is a Heat Shock Response Inducer That Causes Proteotoxic Stress and Noxa-dependent Apoptosis in Malignant Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRAF INHIBITOR RESISTANCE; HSP90 INHIBITOR; AURINTRICARBOXYLIC ACID; COMBINATION-THERAPY; CANCER; ACTIVATION; AUTOPHAGY; CHAPERONE; PROTEASOME; EXPRESSION	Pharmacological induction of proteotoxic stress is rapidly emerging as a promising strategy for cancer cell-directed chemotherapeutic intervention. Here, we describe the identification of a novel drug-like heat shock response inducer for the therapeutic induction of proteotoxic stress targeting malignant human melanoma cells. Screening a focused library of compounds containing redox-directed electrophilic pharmacophores employing the Stress & Toxicity PathwayFinder (TM) PCR Array technology as a discovery tool, a drug-like triphenylmethane-derivative (aurin; 4-[bis(p-hydroxyphenyl)methylene]-2,5-cyclohexadien-1-one) was identified as an experimental cell stress modulator that causes (i) heat shock factor transcriptional activation, (ii) up-regulation of heat shock response gene expression (HSPA6, HSPA1A, DNAJB4, HMOX1), (iii) early unfolded protein response signaling (phospho-PERK, phospho-eIF2 alpha, CHOP (CCAAT/enhancer-binding protein homologous protein)), (iv) proteasome impairment with increased protein-ubiquitination, and (v) oxidative stress with glutathione depletion. Fluorescence polarization-based experiments revealed that aurin displays activity as a geldanamycin-competitive Hsp90 alpha-antagonist, a finding further substantiated by molecular docking and ATPase inhibition analysis. Aurin exposure caused caspase-dependent cell death in a panel of human malignant melanoma cells (A375, G361, LOX-IMVI) but not in nonmalignant human skin cells (Hs27 fibroblasts, HaCaT keratinocytes, primary melanocytes) undergoing the aurin-induced heat shock response without impairment of viability. Aurin-induced melanoma cell apoptosis depends on Noxa up-regulation as confirmed by siRNA rescue experiments demonstrating that siPMAIP1-based target down-regulation suppresses aurin-induced cell death. Taken together, our data suggest feasibility of apoptotic elimination of malignant melanoma cells using the quinone methide-derived heat shock response inducer aurin.	Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85724 USA; [Wondrak, Georg T.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA	University of Arizona; Arizona Center Cancer Care; University of Arizona	Wondrak, GT (corresponding author), Univ Arizona, Coll Pharm, 1515 North Campbell Ave, Tucson, AZ 85724 USA.	wondrak@pharmacy.arizona.edu		Park, Sophia L/0000-0002-1615-1749	National Institutes of Health [R01CA122484, R03CA167580, R21CA166926, ES007091, ES006694]; Arizona Cancer Center [CA023074]; NATIONAL CANCER INSTITUTE [R21CA166926, R03CA167580, R01CA122484, P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007091, P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA122484, R03CA167580, R21CA166926, ES007091, ES006694, and Arizona Cancer Center Support Grant CA023074. Preliminary data from this research were part of an oral presentation at the 19th Annual Meeting of the Society for Free Radical Biology and Medicine, November 17, 2012, San Diego, CA.	Acquaviva J, 2014, MOL CANCER THER, V13, P353, DOI 10.1158/1535-7163.MCT-13-0481; Armstrong JL, 2011, CLIN CANCER RES, V17, P2216, DOI 10.1158/1078-0432.CCR-10-3003; Bair WB, 2010, MELANOMA RES, V20, P85, DOI 10.1097/CMR.0b013e3283364903; Cabello CM, 2012, INVEST NEW DRUG, V30, P1289, DOI 10.1007/s10637-011-9676-7; Cabello CM, 2009, BIOCHEM PHARMACOL, V78, P344, DOI 10.1016/j.bcp.2009.04.016; Cabello CM, 2009, BIOCHEM PHARMACOL, V77, P1125, DOI 10.1016/j.bcp.2008.12.002; Carta F, 2005, MELANOMA RES, V15, P235, DOI 10.1097/00008390-200508000-00002; Catalanotti F, 2012, CLIN CANCER RES, V18, P2420, DOI 10.1158/1078-0432.CCR-12-0626; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Coss RA, 2003, MOL CANCER THER, V2, P383; Dai CK, 2012, J CELL PHYSIOL, V227, P2982, DOI 10.1002/jcp.24017; Davis AL, 2013, INT J MOL SCI, V14, P4185, DOI 10.3390/ijms14024185; De Raedt T, 2011, CANCER CELL, V20, P400, DOI 10.1016/j.ccr.2011.08.014; de Ridder GG, 2012, MELANOMA RES, V22, P225, DOI 10.1097/CMR.0b013e32835312fd; Deichmann M, 2004, INT J ONCOL, V25, P259; Dobbelstein M, 2014, NAT REV DRUG DISCOV, V13, P179, DOI 10.1038/nrd4201; Flemming A, 2011, NAT REV DRUG DISCOV, V10, P491, DOI 10.1038/nrd3482; Foresti R, 2005, J PHARMACOL EXP THER, V312, P686, DOI 10.1124/jpet.104.074153; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Garbe C, 2011, ONCOLOGIST, V16, P5, DOI 10.1634/theoncologist.2010-0190; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Hassan M, 2008, ONCOGENE, V27, P4557, DOI 10.1038/onc.2008.90; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Howes R, 2006, ANAL BIOCHEM, V350, P202, DOI 10.1016/j.ab.2005.12.023; Hughes D, 2008, CANCER PREV RES, V1, P485, DOI 10.1158/1940-6207.CAPR-08-0149; Kalogeraki A, 2006, ANTICANCER RES, V26, P3551; Kandela IK, 2002, PHOTOCH PHOTOBIO SCI, V1, P309, DOI 10.1039/b110572h; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Klaic L, 2011, J AM CHEM SOC, V133, P19634, DOI 10.1021/ja208359a; Kudchadkar R, 2012, CANCER J, V18, P124, DOI 10.1097/PPO.0b013e31824b436e; Kwong LN, 2014, ONCOGENE, V33, P1, DOI 10.1038/onc.2013.34; Laufenberg LJ, 2014, SHOCK, V41, P420, DOI 10.1097/SHK.0000000000000128; Llauger-Bufi L, 2003, BIOORG MED CHEM LETT, V13, P3975, DOI 10.1016/j.bmcl.2003.08.065; Lu HF, 2008, J NEUROSCI RES, V86, P2925, DOI 10.1002/jnr.21733; Luke JJ, 2013, ONCOLOGIST, V18, P717, DOI 10.1634/theoncologist.2012-0391; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Ma XH, 2011, CLIN CANCER RES, V17, P3478, DOI 10.1158/1078-0432.CCR-10-2372; Marino ML, 2012, J BIOL CHEM, V287, P30664, DOI 10.1074/jbc.M112.339127; McCollum AK, 2008, MOL CANCER THER, V7, P3256, DOI 10.1158/1535-7163.MCT-08-0157; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Paraiso KHT, 2012, CLIN CANCER RES, V18, P2502, DOI 10.1158/1078-0432.CCR-11-2612; Peng B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-79; PHILLIPS MD, 1988, BLOOD, V72, P1898; Qiao SX, 2013, AUTOPHAGY, V9, P2087, DOI 10.4161/auto.26506; Qiao SX, 2012, APOPTOSIS, V17, P1079, DOI 10.1007/s10495-012-0746-x; Qiao SX, 2012, BIOCHEM PHARMACOL, V83, P1229, DOI 10.1016/j.bcp.2012.01.027; Selimovic D, 2013, CELL SIGNAL, V25, P308, DOI 10.1016/j.cellsig.2012.10.004; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Straume O, 2012, P NATL ACAD SCI USA, V109, P8699, DOI 10.1073/pnas.1017909109; STRONY J, 1990, CIRCULATION, V81, P1106, DOI 10.1161/01.CIR.81.3.1106; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Wang WB, 2012, J CELL PHYSIOL, V227, P2196, DOI 10.1002/jcp.22956; Wondrak GT, 2007, FREE RADICAL BIO MED, V43, P178, DOI 10.1016/j.freeradbiomed.2007.03.035; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Xie XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055096; Xu WP, 2011, CANCER CELL, V20, P281, DOI 10.1016/j.ccr.2011.08.020; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang X, 2011, FREE RADICAL BIO MED, V50, P811, DOI 10.1016/j.freeradbiomed.2010.12.036; Zhu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052333; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	70	20	22	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1623	1638		10.1074/jbc.M114.592626	http://dx.doi.org/10.1074/jbc.M114.592626			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25477506	hybrid, Green Published			2022-12-28	WOS:000348056400030
J	Matsuda, H; Yamada, T; Yoshida, M; Nishimura, T				Matsuda, Hiroko; Yamada, Takayuki; Yoshida, Miki; Nishimura, Takashi			Flies without Trehalose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; INSULIN-SECRETION; LIPID-METABOLISM; FAT-BODY; GROWTH; CELLS; GLUCOSE; HOMEOSTASIS; EXPRESSION; NEURONS	Living organisms adapt to environmental changes through metabolic homeostasis. Sugars are used primarily for the metabolic production of ATP energy and carbon sources. Trehalose is a nonreducing disaccharide that is present in many organisms. In insects, the principal hemolymph sugar is trehalose instead of glucose. As in mammals, hemolymph sugar levels in Drosophila are regulated by the action of endocrine hormones. Therefore, the mobilization of trehalose to glucose is thought to be critical for metabolic homeostasis. However, the physiological role of trehalose as a hemolymph sugar during insect development remains largely unclear. Here, we demonstrate that mutants of the trehalose-synthesizing enzyme Tps1 failed to produce trehalose as expected but survived into the late pupal period and died before eclosion. Larvae without trehalose grew normally, with a slight reduction in body size, under normal food conditions. However, these larvae were extremely sensitive to starvation, possibly due to a local defect in the central nervous system. Furthermore, Tps1 mutant larvae failed to grow on a low-sugar diet and exhibited severe growth defects on a low-protein diet. These diet-dependent phenotypes of Tps1 mutants demonstrate the critical role of trehalose during development in Drosophila and reveal how animals adapt to changes in nutrient availability.	[Matsuda, Hiroko; Yamada, Takayuki; Yoshida, Miki; Nishimura, Takashi] RIKEN Ctr Dev Biol, Lab Growth Control Signaling, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Yoshida, Miki; Nishimura, Takashi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	RIKEN; Nara Institute of Science & Technology	Nishimura, T (corresponding author), RIKEN Ctr Dev Biol, Lab Growth Control Signaling, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	t-nishimura@cdb.riken.jp	Nishimura, Takashi/AAQ-9299-2020; Nishimura, Takashi/D-7672-2017	Nishimura, Takashi/0000-0002-6773-0302; Nishimura, Takashi/0000-0002-6773-0302	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by scientific research grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT; to T. N.).	Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Bharucha KN, 2008, J EXP BIOL, V211, P3103, DOI 10.1242/jeb.016451; CANDY DJ, 1959, NATURE, V183, P1594, DOI 10.1038/1831594a0; Chen QF, 2002, J BIOL CHEM, V277, P3274, DOI 10.1074/jbc.M109479200; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; Davis MM, 2007, DEVELOPMENT, V134, P4395, DOI 10.1242/dev.009902; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Havula E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003438; Havula E, 2012, SEMIN CELL DEV BIOL, V23, P640, DOI 10.1016/j.semcdb.2012.02.007; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; Muller YL, 2013, HUM GENET, V132, P697, DOI 10.1007/s00439-013-1278-3; MURPHY TA, 1965, J BIOL CHEM, V240, P1500; Okamoto N, 2013, GENE DEV, V27, P87, DOI 10.1101/gad.204479.112; Okamoto N, 2012, P NATL ACAD SCI USA, V109, P2406, DOI 10.1073/pnas.1116050109; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; An PNT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099519; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Ruaud AF, 2011, MOL ENDOCRINOL, V25, P83, DOI 10.1210/me.2010-0337; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Tennessen JM, 2014, G3-GENES GENOM GENET, V4, P839, DOI 10.1534/g3.114.010652; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; WYATT GR, 1957, J GEN PHYSIOL, V40, P833, DOI 10.1085/jgp.40.6.833; Zirin J, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001708	35	77	81	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1244	1255		10.1074/jbc.M114.619411	http://dx.doi.org/10.1074/jbc.M114.619411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451929	Green Published, hybrid			2022-12-28	WOS:000347778200053
J	Ishio, A; Sasamura, T; Ayukawa, T; Kuroda, J; Ishikawa, HO; Aoyama, N; Matsumoto, K; Gushiken, T; Okajima, T; Yamakawa, T; Matsuno, K				Ishio, Akira; Sasamura, Takeshi; Ayukawa, Tomonori; Kuroda, Junpei; Ishikawa, Hiroyuki O.; Aoyama, Naoki; Matsumoto, Kenjiroo; Gushiken, Takuma; Okajima, Tetsuya; Yamakawa, Tomoko; Matsuno, Kenji			O-Fucose Monosaccharide of Drosophila Notch Has a Temperature-sensitive Function and Cooperates with O-Glucose Glycan in Notch Transport and Notch Signaling Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Drosophila; Endoplasmic Reticulum (ER); Glycosylation; Trafficking; Notch; O-Fucose; O-Fucosyltransferase 1; O-Glucose; Rumi	SENSORY ORGAN DEVELOPMENT; MAMMALIAN NOTCH; PROTEIN O-FUCOSYL-TRANSFERASE-1; ENDOPLASMIC-RETICULUM; DELTA INTERACTIONS; ENDOCYTIC PATHWAY; MODIFIES NOTCH; NERVOUS-SYSTEM; IMAGINAL DISC; VENTRAL CELLS	Background: The requirement of O-fucose monosaccharide on Notch is not fully understood. Results: Loss of O-fucose monosaccharide on Notch caused temperature-sensitive loss of Notch signaling. Conclusion:O-Fucose monosaccharide of Notch has a temperature-sensitive function and cooperates with O-glucose glycan in Notch signal activation. Significance: Our findings elucidate how different forms of glycosylation on a protein influence protein functions. Notch (N) is a transmembrane receptor that mediates the cell-cell interactions necessary for many cell fate decisions. N has many epidermal growth factor-like repeats that are O-fucosylated by the protein O-fucosyltransferase 1 (O-Fut1), and the O-fut1 gene is essential for N signaling. However, the role of the monosaccharide O-fucose on N is unclear, because O-Fut1 also appears to have O-fucosyltransferase activity-independent functions, including as an N-specific chaperon. Such an enzymatic activity-independent function could account for the essential role of O-fut1 in N signaling. To evaluate the role of the monosaccharide O-fucose modification in N signaling, here we generated a knock-in mutant of O-fut1 (O-fut1(R245A knock-in)), which expresses a mutant protein that lacks O-fucosyltransferase activity but maintains the N-specific chaperon activity. Using O-fut1(R245A knock-in) and other gene mutations that abolish the O-fucosylation of N, we found that the monosaccharide O-fucose modification of N has a temperature-sensitive function that is essential for N signaling. The O-fucose monosaccharide and O-glucose glycan modification, catalyzed by Rumi, function redundantly in the activation of N signaling. We also showed that the redundant function of these two modifications is responsible for the presence of N at the cell surface. Our findings elucidate how different forms of glycosylation on a protein can influence the protein's functions.	[Ishio, Akira; Ayukawa, Tomonori; Aoyama, Naoki; Gushiken, Takuma] Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 1251500, Japan; [Ishio, Akira; Sasamura, Takeshi; Kuroda, Junpei; Matsumoto, Kenjiroo; Gushiken, Takuma; Yamakawa, Tomoko; Matsuno, Kenji] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan; [Ishikawa, Hiroyuki O.] Tokyo Univ Sci, Genome & Drug Res Ctr, Noda, Chiba 2788510, Japan; [Ishikawa, Hiroyuki O.] Chiba Univ, Grad Sch Sci, Inage Ku, Chiba, Japan; [Okajima, Tetsuya] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, Nagoya, Aichi 4660065, Japan	Tokyo University of Science; Osaka University; Tokyo University of Science; Chiba University; Nagoya University	Matsuno, K (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	kmatsuno@bio.sci.osaka-u.ac.jp	Tomoko, Yamakawa/GXG-9619-2022; Okajima, Tetsuya/I-7332-2014	Tomoko, Yamakawa/0000-0002-6590-6183; Okajima, Tetsuya/0000-0002-3677-648X	Japanese Ministry of Education, Culture, Sports and Science; PRESTO, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25840031, 25670140] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Japanese Ministry of Education, Culture, Sports and Science (to K. M. and T. A.) and grants from PRESTO, Japan Science and Technology Agency (to K. M.).	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ayukawa T, 2012, P NATL ACAD SCI USA, V109, P15318, DOI 10.1073/pnas.1202369109; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chou TB, 1996, GENETICS, V144, P1673; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Delgehyr N, 2012, P NATL ACAD SCI USA, V109, P5729, DOI 10.1073/pnas.1108537109; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fuerstenberg S, 1998, DEV BIOL, V201, P66, DOI 10.1006/dbio.1998.8944; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; Glavic A, 2011, BIOL RES, V44, P25, DOI 10.4067/S0716-97602011000100004; Go MJ, 1998, DEVELOPMENT, V125, P2031; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hiruma-Shimizu K, 2010, J AM CHEM SOC, V132, P14857, DOI 10.1021/ja105216u; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Ishikawa HO, 2005, P NATL ACAD SCI USA, V102, P18532, DOI 10.1073/pnas.0504115102; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Matsuno K, 2002, DEVELOPMENT, V129, P1049; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Perdigoto CN, 2011, DEVELOPMENT, V138, P4585, DOI 10.1242/dev.065292; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Roos C, 2002, J BIOL CHEM, V277, P3168, DOI 10.1074/jbc.m107927200; RULIFSON EJ, 1995, DEVELOPMENT, V121, P2813; Sasaki N, 2007, GENES CELLS, V12, P89, DOI 10.1111/j.1365-2443.2007.01037.x; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; SIMPSON P, 1990, DEVELOPMENT, V109, P509; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Takeuchi H, 2011, P NATL ACAD SCI USA, V108, P16600, DOI 10.1073/pnas.1109696108; Tanaka T, 2008, DEVELOPMENT, V135, P1107, DOI 10.1242/dev.017293; Tonetti M, 1998, BIOCHIMIE, V80, P923, DOI 10.1016/S0300-9084(00)88889-6; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Weng AP, 2004, CURR OPIN GENET DEV, V14, P48, DOI 10.1016/j.gde.2003.11.004; Whitworth GE, 2010, GLYCOBIOLOGY, V20, P287, DOI 10.1093/glycob/cwp173; WILDER EL, 1995, DEVELOPMENT, V121, P477; Windler SL, 2010, CURR BIOL, V20, P538, DOI 10.1016/j.cub.2010.01.049; XU T, 1993, DEVELOPMENT, V117, P1223; Yamakawa T, 2012, DEVELOPMENT, V139, P558, DOI 10.1242/dev.073858	73	36	36	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					505	519		10.1074/jbc.M114.616847	http://dx.doi.org/10.1074/jbc.M114.616847			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25378397	Green Published, hybrid			2022-12-28	WOS:000347231200044
J	Pandey, A; Pain, J; Ghosh, AK; Dancis, A; Pain, D				Pandey, Alok; Pain, Jayashree; Ghosh, Arnab K.; Dancis, Andrew; Pain, Debkumar			Fe-S Cluster Biogenesis in Isolated Mammalian Mitochondria COORDINATED USE OF PERSULFIDE SULFUR AND IRON AND REQUIREMENTS FOR GTP, NADH, AND ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Friedreich Ataxia; Iron; Iron Metabolism; Iron-Sulfur Protein; Metal Homeostasis; Mitochondria; Mitochondrial Aconitase; Mitochondrial Metabolism; Sulfur; Yeast	SUCCINYL-COA SYNTHETASES; SACCHAROMYCES-CEREVISIAE; SCAFFOLD PROTEIN; CYSTEINE DESULFURASE; INTACT MITOCHONDRIA; INTERACTING PROTEIN; YEAST FRATAXIN; HUMAN-DISEASE; IDENTIFICATION; CELLS	Background: Fe-S cluster assembly in mitochondria involves generation of an activated form of sulfur called persulfide. Results: A novel experimental system tracks new Fe-S cluster synthesis in isolated mammalian mitochondria. Conclusion: The use of persulfide sulfur and iron for Fe-S cluster biogenesis is tightly coordinated by processes requiring GTP, NADH, and ATP. Significance: These cofactor targets can now be defined. Iron-sulfur (Fe-S) clusters are essential cofactors, and mitochondria contain several Fe-S proteins, including the [4Fe-4S] protein aconitase and the [2Fe-2S] protein ferredoxin. Fe-S cluster assembly of these proteins occurs within mitochondria. Although considerable data exist for yeast mitochondria, this biosynthetic process has never been directly demonstrated in mammalian mitochondria. Using [S-35]cysteine as the source of sulfur, here we show that mitochondria isolated from Cath.A-derived cells, a murine neuronal cell line, can synthesize and insert new Fe-S-35 clusters into aconitase and ferredoxins. The process requires GTP, NADH, ATP, and iron, and hydrolysis of both GTP and ATP is necessary. Importantly, we have identified the S-35-labeled persulfide on the NFS1 cysteine desulfurase as a genuine intermediate en route to Fe-S cluster synthesis. In physiological settings, the persulfide sulfur is released from NFS1 and transferred to a scaffold protein, where it combines with iron to form an Fe-S cluster intermediate. We found that the release of persulfide sulfur from NFS1 requires iron, showing that the use of iron and sulfur for the synthesis of Fe-S cluster intermediates is a highly coordinated process. The release of persulfide sulfur also requires GTP and NADH, probably mediated by a GTPase and a reductase, respectively. ATP, a cofactor for a multifunctional Hsp70 chaperone, is not required at this step. The experimental system described here may help to define the biochemical basis of diseases that are associated with impaired Fe-S cluster biogenesis in mitochondria, such as Friedreich ataxia.	[Pandey, Alok; Pain, Jayashree; Ghosh, Arnab K.; Pain, Debkumar] Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07101 USA; [Dancis, Andrew] Univ Penn, Div Hematol Oncol, Dept Med, Philadelphia, PA 19104 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania	Pain, D (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave,MSB 1-669, Newark, NJ 07101 USA.	painde@njms.rutgers.edu		Ghosh, Arnab/0000-0002-6962-1935	National Institutes of Health [R01GM107542, R37DK053953]; Friedreich's Ataxia Research Alliance grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friedreich's Ataxia Research Alliance grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM107542 (to D. P.) and R37DK053953 (to A. D.). The work was also supported by a Friedreich's Ataxia Research Alliance grant.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Amutha B, 2008, J BIOL CHEM, V283, P1362, DOI 10.1074/jbc.M706808200; Amutha B, 2009, METHOD ENZYMOL, V456, P247, DOI 10.1016/S0076-6879(08)04414-5; Beilschmidt LK, 2014, BIOCHIMIE, V100, P48, DOI 10.1016/j.biochi.2014.01.009; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Dolle C, 2013, FEBS J, V280, P3530, DOI 10.1111/febs.12304; Holmes-Hampton GP, 2010, BIOCHEMISTRY-US, V49, P4227, DOI 10.1021/bi1001823; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Johnson JD, 1998, J BIOL CHEM, V273, P27580, DOI 10.1074/jbc.273.42.27580; Johnson JD, 1998, J BIOL CHEM, V273, P27573, DOI 10.1074/jbc.273.42.27573; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Lacour T, 1998, J BIOL CHEM, V273, P23984, DOI 10.1074/jbc.273.37.23984; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Maio N, 2014, CELL METAB, V19, P445, DOI 10.1016/j.cmet.2014.01.015; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Monne M, 2013, J BIOENERG BIOMEMBR, V45, P1, DOI 10.1007/s10863-012-9475-7; Ohashi K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2262; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Pain D., 2014, IRON SULFUR CLUSTERS, P367; Pain J, 2010, J BIOL CHEM, V285, P39409, DOI 10.1074/jbc.M110.178947; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Pandey A, 2012, BIOCHEM J, V448, P171, DOI 10.1042/BJ20120951; Pandey A, 2012, MITOCHONDRION, V12, P539, DOI 10.1016/j.mito.2012.07.103; Pandey BN, 2006, ANTIOXID REDOX SIGN, V8, P1253, DOI 10.1089/ars.2006.8.1253; Pasuit JB, 2004, J NEUROCHEM, V89, P1508, DOI 10.1111/j.1471-4159.2004.02450.x; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Ruprecht JJ, 2014, P NATL ACAD SCI USA, V111, pE426, DOI 10.1073/pnas.1320692111; Rustin P, 1996, J BIOL CHEM, V271, P14785, DOI 10.1074/jbc.271.25.14785; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Sepuri NBV, 1998, J BIOL CHEM, V273, P1420, DOI 10.1074/jbc.273.3.1420; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Shi Y, 2012, INT J INF TECH DECIS, V11, P1, DOI 10.1142/S0219622012010018; Stehling O, 2004, HUM MOL GENET, V13, P3007, DOI 10.1093/hmg/ddh324; Stehling O, 2014, BIOCHIMIE, V100, P61, DOI 10.1016/j.biochi.2014.01.010; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200; Walden WE, 2002, P NATL ACAD SCI USA, V99, P4138, DOI 10.1073/pnas.082108799; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; Yoon H, 2014, BIOCHEM J, V459, P71, DOI 10.1042/BJ20131273; Yoon H, 2012, BIOCHEM J, V441, P473, DOI 10.1042/BJ20111637; Zhang R, 2013, BIOL OPEN, V2, P432, DOI 10.1242/bio.20134259; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	65	24	25	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					640	657		10.1074/jbc.M114.610402	http://dx.doi.org/10.1074/jbc.M114.610402			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25398879	hybrid, Green Published			2022-12-28	WOS:000347231200055
J	Riffo-Campos, AL; Castillo, J; Tur, G; Gonzalez-Figueroa, P; Georgieva, EI; Rodriguez, JL; Lopez-Rodas, G; Rodrigo, MI; Franco, L				Riffo-Campos, Angela L.; Castillo, Josefa; Tur, Gema; Gonzalez-Figueroa, Paula; Georgieva, Elena I.; Rodriguez, Jose L.; Lopez-Rodas, Gerardo; Rodrigo, M. Isabel; Franco, Luis			Nucleosome-specific, Time-dependent Changes in Histone Modifications during Activation of the Early Growth Response 1 (Egr1) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Remodeling; Histone Modification; Liver; Mouse; Small Interfering RNA (siRNA); Transcription Regulation	H3 LYSINE-9 METHYLATION; RNA-POLYMERASE-II; HUMAN GENOME; TRANSCRIPTIONAL ACTIVATION; CANCER-CELLS; CHROMATIN; PROMOTER; PHOSPHORYLATION; ACETYLATION; RESOLUTION	Background: Chromatin structure and histone modifications regulate transcription in eukaryotes. Results: Activation of the early growth response gene 1 involves sliding and/or eviction of nucleosomes around the transcription start site and nucleosome-specific, time-dependent changes in histone modifications. Conclusion: Remodeling mechanisms and histone modifications are specific for each nucleosome. Significance: Mononucleosomal level studies give unique information on chromatin functions. Histone post-translational modifications and nucleosome remodeling are coordinate events involved in eukaryotic transcriptional regulation. There are relatively few data on the time course with which these events occur in individual nucleosomes. As a contribution to fill this gap, we first describe the nature and time course of structural changes in the nucleosomes -2, -1, and +1 of the murine Egr1 gene upon induction. To initiate the transient activation of the gene, we used the stimulation of MLP29 cells with phorbol esters and the in vivo activation after partial hepatectomy. In both models, nucleosomes -1 and +1 are partially evicted, whereas nucleosomes +1 and -2 slide downstream during transcription. The sliding of the latter nucleosome allows the EGR1 protein to bind its site, resulting in the repression of the gene. To decide whether EGR1 is involved in the sliding of nucleosome -2, Egr1 was knocked down. In the absence of detectable EGR1, the nucleosome still slides and remains downstream longer than in control cells, suggesting that the product of the gene may be rather involved in the returning of the nucleosome to the basal position. Moreover, the presence of eight epigenetic histone marks has been determined at a mononucleosomal level in that chromatin region. H3S10phK14ac, H3K4me3, H3K9me3, and H3K27me3 are characteristic of nucleosome +1, and H3K9ac and H4K16ac are mainly found in nucleosome -1, and H3K27ac predominates in nucleosomes -2 and -1. The temporal changes in these marks suggest distinct functions for some of them, although changes in H3K4me3 may result from histone turnover.	[Riffo-Campos, Angela L.; Castillo, Josefa; Tur, Gema; Gonzalez-Figueroa, Paula; Georgieva, Elena I.; Rodriguez, Jose L.; Lopez-Rodas, Gerardo; Rodrigo, M. Isabel; Franco, Luis] Univ Valencia, Dept Biochem & Mol Biol, E-46100 Burjassot, Spain; [Riffo-Campos, Angela L.; Castillo, Josefa; Lopez-Rodas, Gerardo; Rodrigo, M. Isabel; Franco, Luis] Inst Hlth Res INCLIVA, Valencia 46010, Spain	University of Valencia	Franco, L (corresponding author), Univ Valencia, Dept Biochem & Mol Biol, Dr Moliner 50, E-46100 Burjassot, Spain.	luis.franco@uv.es	Riffo-Campos, Angela L./AAX-8637-2021; Georgieva, Elena/O-1674-2019; Gonzalez-Figueroa, Paula/W-3654-2018; LOPEZ-RODAS, GERARDO/I-1349-2015	Riffo-Campos, Angela L./0000-0001-6300-3338; Gonzalez-Figueroa, Paula/0000-0001-8270-552X; Castillo Aliaga, Josefa/0000-0002-4092-0085; Franco, Luis/0000-0001-9610-6448; LOPEZ-RODAS, GERARDO/0000-0001-8367-653X	FISS Grant [FIS PI12/02110]	FISS Grant	This work was supported in part by FISS Grant FIS PI12/02110 (to G.L.-R.).	Aicher WK, 1999, RHEUMATOL INT, V18, P207, DOI 10.1007/s002960050086; Alkhatib SG, 2011, FEBS LETT, V585, P3197, DOI 10.1016/j.febslet.2011.09.003; ARENTS G, 1993, P NATL ACAD SCI USA, V90, P10489, DOI 10.1073/pnas.90.22.10489; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Chen SZ, 2012, GENE DEV, V26, P1364, DOI 10.1101/gad.186056.111; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Du Z, 2013, MOL PLANT, V6, P1463, DOI 10.1093/mp/sst018; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hondele M, 2013, NUCLEUS-AUSTIN, V4, P443, DOI 10.4161/nucl.27235; Horikoshi Nobuo, 2013, Genome Integr, V4, P3, DOI 10.1186/2041-9414-4-3; Hsieh FK, 2013, P NATL ACAD SCI USA, V110, P7654, DOI 10.1073/pnas.1222198110; JANSSENTIMMEN U, 1989, GENE, V80, P325, DOI 10.1016/0378-1119(89)90296-5; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kimura H, 2013, J HUM GENET, V58, P439, DOI 10.1038/jhg.2013.66; Kulaeva OI, 2013, BBA-GENE REGUL MECH, V1829, P76, DOI 10.1016/j.bbagrm.2012.08.015; Kulaeva OI, 2010, P NATL ACAD SCI USA, V107, P11325, DOI 10.1073/pnas.1001148107; Kumari Sujata, 2013, Subcell Biochem, V61, P3, DOI 10.1007/978-94-007-4525-4_1; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Lee ER, 2006, J BIOL CHEM, V281, P21162, DOI 10.1074/jbc.M602734200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; LOIDL P, 1988, FEBS LETT, V227, P91, DOI 10.1016/0014-5793(88)80874-3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Murawska M, 2011, TRANSCR-AUSTIN, V2, P244, DOI 10.4161/trns.2.6.17840; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Nozaki T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-416; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Poirier MG, 2009, NAT STRUCT MOL BIOL, V16, P938, DOI 10.1038/nsmb.1650; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Sacilotto N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023318; Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Simboeck E, 2010, J BIOL CHEM, V285, P41062, DOI 10.1074/jbc.M110.184481; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Szerlong HJ, 2010, J BIOL CHEM, V285, P31954, DOI 10.1074/jbc.M110.148718; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tur G, 2010, CELL MOL LIFE SCI, V67, P4065, DOI 10.1007/s00018-010-0426-3; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wiencke JK, 2008, ONCOGENE, V27, P2412, DOI 10.1038/sj.onc.1210895; Xi LQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-346; Zheng CG, 2009, CANCER RES, V69, P2324, DOI 10.1158/0008-5472.CAN-08-4113	60	16	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					197	208		10.1074/jbc.M114.579292	http://dx.doi.org/10.1074/jbc.M114.579292			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25378406	Green Published, hybrid			2022-12-28	WOS:000347231200017
J	Rizzardi, LF; Coleman, KE; Varma, D; Matson, JP; Oh, S; Cook, JG				Rizzardi, Lindsay F.; Coleman, Kate E.; Varma, Dileep; Matson, Jacob P.; Oh, Seeun; Cook, Jeanette Gowen			CDK1-dependent Inhibition of the E3 Ubiquitin Ligase CRL4(CDT2) Ensures Robust Transition from S Phase to Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Cyclin-dependent Kinase (CDK); DNA Replication; E3 Ubiquitin Ligase; Mitosis; CDT1; CDT2; p21; PCNA; SET8	CELL NUCLEAR ANTIGEN; THYMINE DNA GLYCOSYLASE; MAMMALIAN-CELLS; RE-REPLICATION; HUMAN CDT1; HISTONE METHYLTRANSFERASE; PREVENTS REREPLICATION; MULTIPLE MECHANISMS; KINASE ACTIVATION; CYCLE PROGRESSION	Background: CRL4(CDT2) mediates replication-coupled destruction during S phase. CRL4(CDT2) substrates reaccumulate by an unexplored mechanism. Results: CDK1 activity blocks CRL4(CDT2) by preventing chromatin recruitment of the substrate receptor, CDT2. Conclusion: CDK1 activity facilitates CRL4(CDT2) substrate reaccumulation upon S phase exit; several of these substrates are then required for normal mitotic progression. Significance: We provide the first evidence that CDK1 regulates the activity of CRL4(CDT2). Replication-coupled destruction of a cohort of cell cycle proteins ensures efficient and precise genome duplication. Three proteins destroyed during replication via the CRL4(CDT2) ubiquitin E3 ligase, CDT1, p21, and SET8 (PR-SET7), are also essential or important during mitosis, making their reaccumulation after S phase a critical cell cycle event. During early and mid-S phase and during DNA repair, proliferating cell nuclear antigen (PCNA) loading onto DNA (PCNA(DNA)) triggers the interaction between CRL4(CDT2) and its substrates, resulting in their degradation. We have discovered that, beginning in late S phase, PCNA(DNA) is no longer sufficient to trigger CRL4(CDT2)-mediated degradation. A CDK1-dependent mechanism that blocks CRL4(CDT2) activity by interfering with CDT2 recruitment to chromatin actively protects CRL4(CDT2) substrates. We postulate that deliberate override of replication-coupled destruction allows anticipatory accumulation in late S phase. We further show that (as for CDT1) de novo SET8 reaccumulation is important for normal mitotic progression. In this manner, CDK1-dependent CRL4(CDT2) inactivation contributes to efficient transition from S phase to mitosis.	[Rizzardi, Lindsay F.; Coleman, Kate E.; Cook, Jeanette Gowen] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Varma, Dileep; Matson, Jacob P.; Oh, Seeun; Cook, Jeanette Gowen] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cook, JG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, 120 Mason Farm Rd,Campus Box 7260, Chapel Hill, NC 27599 USA.	jgcook@email.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022	Cook, Jeanette/0000-0003-0849-7405; Matson, Jacob/0000-0002-9375-1676; Rizzardi, Lindsay/0000-0002-2866-9625	National Institutes of Health [R01GM102413A, K99CA178177, F31CA165891]; University of North Carolina (UNC) Chapel Hill dissertation completion fellowship; National Institutes of Health, NCI, Center Core Support Grant [P30CA016086]; NATIONAL CANCER INSTITUTE [R00CA178188, P30CA016086, F31CA165891, K99CA178177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092, R01GM102413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina (UNC) Chapel Hill dissertation completion fellowship; National Institutes of Health, NCI, Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM102413A (to J. G. C.), K99CA178177 (to D. V.), and F31CA165891 (to K. C.). This work was also supported by a University of North Carolina (UNC) Chapel Hill dissertation completion fellowship (to L. F. R.). The UNC Flow Cytometry Core Facility is supported in part by National Institutes of Health, NCI, Center Core Support Grant P30CA016086 to the UNC Lineberger Comprehensive Cancer Center.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2013, MOL CELL, V49, P1147, DOI 10.1016/j.molcel.2013.02.003; Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Ballabeni A, 2013, P NATL ACAD SCI USA, V110, pE2848, DOI 10.1073/pnas.1310677110; Ballabeni A, 2011, P NATL ACAD SCI USA, V108, P19252, DOI 10.1073/pnas.1116794108; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chandrasekaran S, 2011, MOL CELL BIOL, V31, P4405, DOI 10.1128/MCB.06163-11; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Dar A, 2014, MOL CELL BIOL, V34, P4049, DOI 10.1128/MCB.00838-14; Debatisse M, 2012, TRENDS GENET, V28, P22, DOI 10.1016/j.tig.2011.10.003; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dimitrova DS, 2002, J CELL SCI, V115, P51; Dorn ES, 2009, NUCLEIC ACIDS RES, V37, P60, DOI 10.1093/nar/gkn912; Ersoy I, 2009, LECT NOTES COMPUT SC, V5762, P617, DOI 10.1007/978-3-642-04271-3_75; Grant GD, 2013, MOL BIOL CELL, V24, P3634, DOI 10.1091/mbc.E13-05-0264; Greulich H, 2012, P NATL ACAD SCI USA, V109, P14476, DOI 10.1073/pnas.1203201109; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; Hall JR, 2008, J BIOL CHEM, V283, P25356, DOI 10.1074/jbc.M802667200; Havens CG, 2012, J BIOL CHEM, V287, P11410, DOI 10.1074/jbc.M111.337683; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hodeify R, 2011, AM J PHYSIOL-RENAL, V300, pF1171, DOI 10.1152/ajprenal.00507.2010; Hori T, 2014, DEV CELL, V29, P740, DOI 10.1016/j.devcel.2014.05.001; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kerns SL, 2007, J BIOL CHEM, V282, P5514, DOI 10.1074/jbc.M609289200; Kim GY, 2002, J BIOL CHEM, V277, P29792, DOI 10.1074/jbc.M201299200; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kreis NN, 2014, ONCOGENE, V33, P5716, DOI 10.1038/onc.2013.518; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Miotto B, 2011, MOL CELL, V44, P62, DOI 10.1016/j.molcel.2011.06.021; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Rossi M, 2013, MOL CELL, V49, P1159, DOI 10.1016/j.molcel.2013.02.004; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shibata E, 2014, J BIOL CHEM, V289, P23056, DOI 10.1074/jbc.M114.574210; Slenn TJ, 2014, J BIOL CHEM, V289, P23043, DOI 10.1074/jbc.M114.574194; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Takenaka K, 1998, SCIENCE, V280, P599, DOI 10.1126/science.280.5363.599; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Teer JK, 2006, J BIOL CHEM, V281, P6253, DOI 10.1074/jbc.M507150200; Terai K, 2013, J BIOL CHEM, V288, P30509, DOI 10.1074/jbc.C113.505586; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Tsunematsu T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2859; Varma D, 2012, NAT CELL BIOL, V14, P593, DOI 10.1038/ncb2489; Vassilev LT, 2006, CELL CYCLE, V5, P2555, DOI 10.4161/cc.5.22.3463; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wheeler LW, 2008, CELL CYCLE, V7, P2179, DOI 10.4161/cc.7.14.6270; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Widrow RJ, 1998, P NATL ACAD SCI USA, V95, P11246, DOI 10.1073/pnas.95.19.11246; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yoshida K, 2005, GENES CELLS, V10, P63, DOI 10.1111/j.1365-2443.2005.00815.x; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605; Zhang SF, 2013, J BIOL CHEM, V288, P29550, DOI 10.1074/jbc.M113.490466	80	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					556	567		10.1074/jbc.M114.614701	http://dx.doi.org/10.1074/jbc.M114.614701			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25411249	Green Published, hybrid			2022-12-28	WOS:000347231200048
J	Vivet-Boudou, V; Isel, C; El Safadi, Y; Smyth, RP; Laumond, G; Moog, C; Paillart, JC; Marquet, R				Vivet-Boudou, Valerie; Isel, Catherine; El Safadi, Yazan; Smyth, Redmond P.; Laumond, Geraldine; Moog, Christiane; Paillart, Jean-Christophe; Marquet, Roland			Evaluation of Anti-HIV-1 Mutagenic Nucleoside Analogues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antiviral Agent; Human Immunodeficiency Virus (HIV); Mutagenesis; Nucleoside; Nucleotide Analogue; Reverse Transcription; Lethal	IMMUNODEFICIENCY-VIRUS TYPE-1; HEPATITIS-C VIRUS; HIV-1 REVERSE-TRANSCRIPTASE; MOUTH-DISEASE VIRUS; DEFICIENCY SYNDROME AIDS; LETHAL MUTAGENESIS; ERROR CATASTROPHE; RNA VIRUS; RIBONUCLEOSIDE ANALOGS; REPLICATION FIDELITY	Background: Lethal mutagenesis is an antiviral strategy. Results: Nucleoside analogue mutagenicity is correlated to base pair stability and the ability to function as a template during reverse transcription. Conclusion: Two simple biophysical/biochemical assays predict mutagenicity of nucleoside analogues. Significance: Mutagenicity of anti-HIV-1 compounds can be reliably predicted in vitro without labor-intensive and costly in cellula tests. Because of their high mutation rates, RNA viruses and retroviruses replicate close to the threshold of viability. Their existence as quasi-species has pioneered the concept of lethal mutagenesis that prompted us to synthesize pyrimidine nucleoside analogues with antiviral activity in cell culture consistent with an accumulation of deleterious mutations in the HIV-1 genome. However, testing all potentially mutagenic compounds in cell-based assays is tedious and costly. Here, we describe two simple in vitro biophysical/biochemical assays that allow prediction of the mutagenic potential of deoxyribonucleoside analogues. The first assay compares the thermal stabilities of matched and mismatched base pairs in DNA duplexes containing or not the nucleoside analogues as follows. A promising candidate should display a small destabilization of the matched base pair compared with the natural nucleoside and the smallest gap possible between the stabilities of the matched and mismatched base pairs. From this assay, we predicted that two of our compounds, 5-hydroxymethyl-2-deoxyuridine and 5-hydroxymethyl-2-deoxycytidine, should be mutagenic. The second in vitro reverse transcription assay assesses DNA synthesis opposite nucleoside analogues inserted into a template strand and subsequent extension of the newly synthesized base pairs. Once again, only 5-hydroxymethyl-2-deoxyuridine and 5-hydroxymethyl-2-deoxycytidine are predicted to be efficient mutagens. The predictive potential of our fast and easy first line screens was confirmed by detailed analysis of the mutation spectrum induced by the compounds in cell culture because only compounds 5-hydroxymethyl-2-deoxyuridine and 5-hydroxymethyl-2-deoxycytidine were found to increase the mutation frequency by 3.1- and 3.4-fold, respectively.	[Vivet-Boudou, Valerie; Isel, Catherine; El Safadi, Yazan; Smyth, Redmond P.; Paillart, Jean-Christophe; Marquet, Roland] Univ Strasbourg, Architecture & React ARN, CNRS, IBMC, F-67084 Strasbourg, France; [Laumond, Geraldine; Moog, Christiane; Marquet, Roland] Univ Strasbourg, Inst Virol, INSERM, U748, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vivet-Boudou, V (corresponding author), Univ Strasbourg, Architecture & React ARN, CNRS, IBMC, F-67084 Strasbourg, France.	v.vivet@ibmc-cnrs.unistra.fr; c.isel@ibmc-cnrs.unistra.fr; r.marquet@ibmc-cnrs.unistra.fr	Paillart, Jean-Christophe/A-4171-2010; C, Moog/E-3962-2016; Smyth, Redmond/AAP-1637-2020; Isel, Catherine/B-9406-2015; Isel, Catherine/AAH-2174-2020	Paillart, Jean-Christophe/0000-0003-1647-8917; C, Moog/0000-0002-0916-156X; Isel, Catherine/0000-0001-7258-869X; Isel, Catherine/0000-0002-8014-7525; Smyth, Redmond/0000-0002-1580-0671; LAUMOND, Geraldine/0000-0003-1867-0734; Marquet, Roland/0000-0002-4209-3976	CNRS; Agence Nationale de Recherche sur le SIDA et les Hepatites Virales; SIDACTION; Strasbourg University; Centre National de la Recherche Scientifique	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de Recherche sur le SIDA et les Hepatites Virales(ANRSFrench National Research Agency (ANR)); SIDACTION; Strasbourg University; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by CNRS, the Agence Nationale de Recherche sur le SIDA et les Hepatites Virales, SIDACTION, and the Strasbourg University. Funding for open access charges: Centre National de la Recherche Scientifique.	ABOULELA F, 1985, NUCLEIC ACIDS RES, V13, P4811, DOI 10.1093/nar/13.13.4811; Abram ME, 2010, J VIROL, V84, P9864, DOI 10.1128/JVI.00915-10; Agudo R, 2008, J MOL BIOL, V382, P652, DOI 10.1016/j.jmb.2008.07.033; Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Armitage AE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002550; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Biebricher CK, 2005, VIRUS RES, V107, P117, DOI 10.1016/j.virusres.2004.11.002; Chelico L, 2009, NAT STRUCT MOL BIOL, V16, P454, DOI 10.1038/nsmb0509-454; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Chung DH, 2007, J VIROL, V81, P11722, DOI 10.1128/JVI.00874-07; Contreras AM, 2002, J VIROL, V76, P8505, DOI 10.1128/JVI.76.17.8505-8517.2002; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Dahl C, 2011, CLIN CHIM ACTA, V412, P831, DOI 10.1016/j.cca.2011.02.013; Daifuku R, 2003, BIODRUGS, V17, P169, DOI 10.2165/00063030-200317030-00003; Dapp MJ, 2014, J VIROL, V88, P354, DOI 10.1128/JVI.02444-13; Dapp MJ, 2009, J VIROL, V83, P11950, DOI 10.1128/JVI.01406-09; Davis GL, 1998, NEW ENGL J MED, V339, P1493, DOI 10.1056/NEJM199811193392102; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; Eigen M, 2002, P NATL ACAD SCI USA, V99, P13374, DOI 10.1073/pnas.212514799; EIGEN M, 1988, J PHYS CHEM-US, V92, P6881, DOI 10.1021/j100335a010; El Safadi Y, 2007, APPL MICROBIOL BIOT, V75, P723, DOI 10.1007/s00253-007-0919-7; El Safadi Y, 2010, J MED CHEM, V53, P1534, DOI 10.1021/jm901758f; Ferrer-Orta C, 2010, J VIROL, V84, P6188, DOI 10.1128/JVI.02420-09; GAFFNEY BL, 1989, BIOCHEMISTRY-US, V28, P5881, DOI 10.1021/bi00440a026; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Grande-Perez A, 2005, P NATL ACAD SCI USA, V102, P4448, DOI 10.1073/pnas.0408871102; Harris KS, 2005, ANTIVIR RES, V67, P1, DOI 10.1016/j.antiviral.2005.03.004; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Henriet S, 2009, MICROBIOL MOL BIOL R, V73, P211, DOI 10.1128/MMBR.00040-08; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HOLLAND JJ, 1990, J VIROL, V64, P3960, DOI 10.1128/JVI.64.8.3960-3962.1990; HOLLAND JJ, 1992, CURR TOP MICROBIOL, V176, P1; Hu WS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006882; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kriukiene E, 2012, CHEM SOC REV, V41, P6916, DOI 10.1039/c2cs35104h; Li DY, 2014, P NATL ACAD SCI USA, V111, pE3252, DOI 10.1073/pnas.1405635111; Lindberg J, 2002, EUR J BIOCHEM, V269, P1670, DOI 10.1046/j.1432-1327.2002.02811.x; Loeb LA, 2000, AIDS RES HUM RETROV, V16, P1, DOI 10.1089/088922200309539; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Menendez-Arias L, 2002, PROG NUCLEIC ACID RE, V71, P91, DOI 10.1016/S0079-6603(02)71042-8; Menendez-Arias L., 2013, HUMAN IMMUNODEFICIEN, P225; Menendez-Arias L, 2009, VIRUSES-BASEL, V1, P1137, DOI 10.3390/v1031137; Mercenne G, 2010, NUCLEIC ACIDS RES, V38, P633, DOI 10.1093/nar/gkp1009; Mikkelsen JG, 2000, J BIOMED SCI, V7, P77, DOI 10.1159/000025434; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; MIZRAHI V, 1994, J BIOL CHEM, V269, P19245; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mullins JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015135; O'Neil PK, 2002, J BIOL CHEM, V277, P38053, DOI 10.1074/jbc.M204774200; Pariente N, 2003, J VIROL, V77, P7131, DOI 10.1128/JVI.77.12.7131-7138.2003; PATHAK VK, 1992, J VIROL, V66, P3093, DOI 10.1128/JVI.66.5.3093-3100.1992; Perales C, 2012, TRENDS MICROBIOL, V20, P595, DOI 10.1016/j.tim.2012.08.010; Perales C, 2011, CURR OPIN VIROL, V1, P419, DOI 10.1016/j.coviro.2011.09.001; Perales C, 2011, J MOL BIOL, V407, P60, DOI 10.1016/j.jmb.2011.01.026; Perales C, 2010, FUTURE VIROL, V5, P679, DOI 10.2217/FVL.10.61; Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, J VIROL, V79, P2346, DOI 10.1128/JVI.79.4.2346-2355.2005; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Rosenberg Brad R, 2007, Adv Immunol, V94, P215, DOI 10.1016/S0065-2776(06)94007-3; Sadeghipour S, 2013, J VIROL, V87, P1759, DOI 10.1128/JVI.02139-12; Severson WE, 2003, J VIROL, V77, P481, DOI 10.1128/JVI.77.1.481-488.2003; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sierra S, 2000, J VIROL, V74, P8316, DOI 10.1128/JVI.74.18.8316-8323.2000; Smyth RP, 2014, J VIROL, V88, P2891, DOI 10.1128/JVI.03014-13; Smyth RP, 2012, VIRUS RES, V169, P415, DOI 10.1016/j.virusres.2012.06.015; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tapia N, 2005, VIROLOGY, V338, P1, DOI 10.1016/j.virol.2005.05.008; Vivet-Boudou V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027456; Waters L, 2007, INT J CLIN PRACT, V61, P105, DOI 10.1111/j.1742-1241.2006.01146.x; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; WERNTGES H, 1986, NUCLEIC ACIDS RES, V14, P3773, DOI 10.1093/nar/14.9.3773; Young KC, 2003, HEPATOLOGY, V38, P869, DOI 10.1053/jhep.2003.50445; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1	84	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					371	383		10.1074/jbc.M114.616383	http://dx.doi.org/10.1074/jbc.M114.616383			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25398876	Green Published, hybrid			2022-12-28	WOS:000347231200033
J	Huang, BF; Yang, CS; Wojton, J; Huang, NJ; Chen, C; Soderblom, EJ; Zhang, LG; Kornbluth, S				Huang, Bofu; Yang, Chih-Sheng; Wojton, Jeffrey; Huang, Nai-Jia; Chen, Chen; Soderblom, Erik J.; Zhang, Liguo; Kornbluth, Sally			Metabolic Control of Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII)-mediated Caspase-2 Suppression by the B55 beta/Protein Phosphatase 2A (PP2A)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCED APOPTOSIS; LAEVIS EGG EXTRACTS; CAM KINASE; CALMODULIN-BINDING; SMOOTH-MUSCLE; AUTOPHOSPHORYLATION; ACTIVATION; PHOSPHORYLATION; IDENTIFICATION; DOMAINS	High levels of metabolic activity confer resistance to apoptosis. Caspase-2, an apoptotic initiator, can be suppressed by high levels of nutrient flux through the pentose phosphate pathway. This metabolic control is exerted via inhibitory phosphorylation of the caspase-2 prodomain by activated Ca2+/calmodulin-dependent protein kinase II (CaMKII). We show here that this activation of CaMKII depends, in part, on dephosphorylation of CaMKII at novel sites (Thr393/Ser395) and that this is mediated by metabolic activation of protein phosphatase 2A in complex with the B55 beta targeting subunit. This represents a novel locus of CaMKII control and also provides a mechanism contributing to metabolic control of apoptosis. These findings may have implications for metabolic control of the many CaMKII-controlled and protein phosphatase 2A-regulated physiological processes, because both enzymes appear to be responsive to alterations in glucose metabolized via the pentose phosphate pathway.	[Huang, Bofu; Yang, Chih-Sheng; Wojton, Jeffrey; Huang, Nai-Jia; Chen, Chen; Kornbluth, Sally] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27705 USA; [Soderblom, Erik J.] Duke Univ, Med Ctr, Prote & Metabol Core Facil, Durham, NC 27705 USA; [Zhang, Liguo] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27705 USA	Duke University; Duke University; Duke University	Zhang, LG (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27705 USA.	liguo.zhang@duke.edu; sally.kornbluth@duke.edu			National Institutes of Health [RO1 GM080333]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM080333.	Andersen JL, 2011, MOL CELL, V43, P834, DOI 10.1016/j.molcel.2011.07.028; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Cheung HH, 2006, EXP CELL RES, V312, P2347, DOI 10.1016/j.yexcr.2006.03.027; COLBRAN RJ, 1988, J BIOL CHEM, V263, P18145; COLBRAN RJ, 1989, J BIOL CHEM, V264, P4800; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Kolb SJ, 1998, J BIOL CHEM, V273, P31555, DOI 10.1074/jbc.273.47.31555; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Marganski WA, 2005, CIRC RES, V97, P541, DOI 10.1161/01.RES.0000182630.29093.0d; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Mccoy F, 2013, MOL CELL, V52, P325, DOI 10.1016/j.molcel.2013.08.043; McCoy F, 2013, J BIOL CHEM, V288, P8838, DOI 10.1074/jbc.M112.437186; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Parsons MJ, 2013, CELL DEATH DIFFER, V20, P1174, DOI 10.1038/cdd.2013.38; PATTON BL, 1990, J BIOL CHEM, V265, P11204; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Rokolya A, 2000, AM J PHYSIOL-CELL PH, V278, pC537, DOI 10.1152/ajpcell.2000.278.3.C537; Shen K, 1998, J NEUROCHEM, V70, P96; SHIELDS SM, 1985, J NEUROSCI, V5, P3414; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; WAXHAM MN, 1993, BRAIN RES, V609, P1	31	9	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35882	35890		10.1074/jbc.M114.585844	http://dx.doi.org/10.1074/jbc.M114.585844			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378403	hybrid, Green Published			2022-12-28	WOS:000346897900020
J	Kondoh, D; Tateno, H; Hirabayashi, J; Yasumoto, Y; Nakao, R; Oishi, K				Kondoh, Daisuke; Tateno, Hiroaki; Hirabayashi, Jun; Yasumoto, Yuki; Nakao, Reiko; Oishi, Katsutaka			Molecular Clock Regulates Daily alpha 1-2-Fucosylation of the Neural Cell Adhesion Molecule (NCAM) within Mouse Secondary Olfactory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; FIRING-RATE; N-GLYCANS; IN-VITRO; RAT; EXPRESSION; RHYTHMS; FUCOSE	The circadian clock regulates various behavioral and physiological rhythms in mammals. Circadian changes in olfactory functions such as neuronal firing in the olfactory bulb (OB) and olfactory sensitivity have recently been identified, although the underlying molecular mechanisms remain unknown. We analyzed the temporal profiles of glycan structures in the mouseOB using a high-density microarray that includes 96 lectins, because glycoconjugates play important roles in the nervous system such as neurite outgrowth and synaptogenesis. Sixteen lectin signals significantly fluctuated in the OB, and the intensity of all three that had high affinity for alpha 1-2-fucose (alpha 1-2Fuc) glycan in the microarray was higher during the nighttime. Histochemical analysis revealed that alpha 1-2Fuc glycan is located in a diurnal manner in the lateral olfactory tract that comprises axon bundles of secondary olfactory neurons. The amount of alpha 1-2Fuc glycan associated with the major target glycoprotein neural cell adhesion molecule (NCAM) varied in a diurnal fashion, although the mRNA and protein expression of Ncam1 did not. The mRNA and protein expression of Fut1, a alpha 1-2-specific fucosyltransferase gene, was diurnal in the OB. Daily fluctuation of the alpha 1-2Fuc glycan was obviously damped in homozygous Clock mutant mice with disrupted diurnal Fut1 expression, suggesting that the molecular clock governs rhythmic alpha 1-2-fucosylation in secondary olfactory neurons. These findings suggest the possibility that the molecular clock is involved in the diurnal regulation of olfaction via alpha 1-2-fucosylation in the olfactory system.	[Kondoh, Daisuke; Yasumoto, Yuki; Nakao, Reiko; Oishi, Katsutaka] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, Tsukuba, Ibaraki 3058566, Japan; [Kondoh, Daisuke] Obihiro Univ Agr & Vet Med, Lab Vet Anat, Dept Basic Vet Med, Obihiro, Hokkaido 0808555, Japan; [Tateno, Hiroaki; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058568, Japan; [Yasumoto, Yuki; Oishi, Katsutaka] Tokyo Univ Sci, Grad Sch Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan; [Oishi, Katsutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Obihiro University of Agriculture & Veterinary Medicine; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo University of Science; University of Tokyo	Oishi, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	k-ooishi@aist.go.jp	Hirabayashi, Jun/M-3998-2018; Kondoh, Daisuke/D-6312-2017; Tateno, Hiroaki/M-2706-2018; Oishi, Katsutaka/L-6906-2018	Hirabayashi, Jun/0000-0002-8571-359X; Kondoh, Daisuke/0000-0002-3015-5156; Tateno, Hiroaki/0000-0003-3006-1659; Oishi, Katsutaka/0000-0002-4870-0837	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25350179]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research (C) KAKENHI 25350179 (to K. O.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Aujard F, 2001, NEUROSCIENCE, V106, P255, DOI 10.1016/S0306-4522(01)00285-8; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Corthell JT, 2013, NEUROSCIENCE, V247, P234, DOI 10.1016/j.neuroscience.2013.05.040; Corthell JT, 2012, NEUROSCIENCE, V222, P38, DOI 10.1016/j.neuroscience.2012.06.070; DAMJANOV I, 1987, LAB INVEST, V57, P5; Glass JD, 2003, NEUROSCIENCE, V117, P203, DOI 10.1016/S0306-4522(02)00817-5; GOODRUM JF, 1984, J NEUROSCI, V4, P1830; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Granados-Fuentes D, 2011, J BIOL RHYTHM, V26, P552, DOI 10.1177/0748730411420247; Hirabayashi J, 2013, CHEM SOC REV, V42, P4443, DOI 10.1039/c3cs35419a; Kaasik K, 2013, CELL METAB, V17, P291, DOI 10.1016/j.cmet.2012.12.017; Kalovidouris SA, 2005, J AM CHEM SOC, V127, P1340, DOI 10.1021/ja044631v; Kondoh D, 2010, J MORPHOL, V271, P1197, DOI 10.1002/jmor.10864; KRUG M, 1994, BRAIN RES, V643, P130, DOI 10.1016/0006-8993(94)90018-3; KRUG M, 1991, BRAIN RES, V540, P237, DOI 10.1016/0006-8993(91)90513-U; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; Lorenzini CGA, 1997, NEUROBIOL LEARN MEM, V68, P317, DOI 10.1006/nlme.1997.3798; Matthies H, 1996, BRAIN RES, V725, P276, DOI 10.1016/0006-8993(96)00406-4; Mordel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058457; MULLER L, 1985, NEUROSCIENCE, V14, P875, DOI 10.1016/0306-4522(85)90150-2; Munn RGK, 2012, HIPPOCAMPUS, V22, P1325, DOI 10.1002/hipo.20969; Murrey HE, 2006, P NATL ACAD SCI USA, V103, P21, DOI 10.1073/pnas.0503381102; Murrey HE, 2009, BIOCHEMISTRY-US, V48, P7261, DOI 10.1021/bi900640x; Oishi K, 2002, BIOCHEM BIOPH RES CO, V298, P198, DOI 10.1016/S0006-291X(02)02427-0; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Perlson E, 2013, J BIOL CHEM, V288, P27812, DOI 10.1074/jbc.M113.465088; PESTEAN A, 1995, NEUROSCI LETT, V195, P117, DOI 10.1016/0304-3940(95)11795-X; Plendl J, 1998, ACTA ANAT, V161, P234; POHLE W, 1987, BRAIN RES, V410, P245, DOI 10.1016/0006-8993(87)90321-0; Prosser RA, 2003, J NEUROSCI, V23, P652, DOI 10.1523/JNEUROSCI.23-02-00652.2003; Ronn LCB, 1998, EXP GERONTOL, V33, P853, DOI 10.1016/S0531-5565(98)00040-0; Salazar I, 2003, BRAIN RES, V979, P15, DOI 10.1016/S0006-8993(03)02835-X; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Tisay KT, 2002, J COMP NEUROL, V443, P213, DOI 10.1002/cne.10107; Treloar H, 1997, J NEUROBIOL, V32, P643, DOI 10.1002/(SICI)1097-4695(19970620)32:7<643::AID-NEU1>3.0.CO;2-4; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Zamze S, 1998, EUR J BIOCHEM, V258, P243, DOI 10.1046/j.1432-1327.1998.2580243.x; Zhao H, 2005, NEUROSCIENCE, V132, P519, DOI 10.1016/j.neuroscience.2005.01.012	41	4	4	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36158	36165		10.1074/jbc.M114.571141	http://dx.doi.org/10.1074/jbc.M114.571141			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25384980	hybrid, Green Published			2022-12-28	WOS:000346897900042
J	Moustafa, IM; Korboukh, VK; Arnold, JJ; Smidansky, ED; Marcotte, LL; Gohara, DW; Yang, XR; Sanchez-Farran, MA; Filman, D; Maranas, JK; Boehr, DD; Hogle, JM; Colina, CM; Cameron, CE				Moustafa, Ibrahim M.; Korboukh, Victoria K.; Arnold, Jamie J.; Smidansky, Eric D.; Marcotte, Laura L.; Gohara, David W.; Yang, Xiaorong; Antonieta Sanchez-Farran, Maria; Filman, David; Maranas, Janna K.; Boehr, David D.; Hogle, James M.; Colina, Coray M.; Cameron, Craig E.			Structural Dynamics as a Contributor to Error-prone Replication by an RNA-dependent RNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE KINETIC-ANALYSIS; DISEASE VIRUS MUTANT; PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; RIBONUCLEOTIDE INCORPORATION; LETHAL MUTAGENESIS; MOTIF D; POLIOVIRUS; FIDELITY; RIBAVIRIN	RNA viruses encoding high- or low-fidelity RNA-dependent RNA polymerases (RdRp) are attenuated. The ability to predict residues of the RdRp required for faithful incorporation of nucleotides represents an essential step in any pipeline intended to exploit perturbed fidelity as the basis for rational design of vaccine candidates. We used x-ray crystallography, molecular dynamics simulations, NMRspectroscopy, and pre-steady-state kinetics to compare a mutator (H273R) RdRp from poliovirus to the wild-type (WT) enzyme. We show that the nucleotide-binding site toggles between the nucleotide binding-occluded and nucleotide binding-competent states. The conformational dynamics between these states were enhanced by binding to primed template RNA. For the WT, the occluded conformation was favored; for H273R, the competent conformation was favored. The resonance for Met-187 in our NMR spectra reported on the ability of the enzyme to check the correctness of the bound nucleotide. Kinetic experiments were consistent with the conformational dynamics contributing to the established pre-incorporation conformational change and fidelity checkpoint. For H273R, residues comprising the active site spent more time in the catalytically competent conformation and were more positively correlated than the WT. We propose that by linking the equilibrium between the binding-occluded and binding-competent conformations of the nucleotide-binding pocket and other active-site dynamics to the correctness of the bound nucleotide, faithful nucleotide incorporation is achieved. These studies underscore the need to apply multiple biophysical and biochemical approaches to the elucidation of the physical basis for polymerase fidelity.	[Moustafa, Ibrahim M.; Korboukh, Victoria K.; Arnold, Jamie J.; Smidansky, Eric D.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Yang, Xiaorong; Boehr, David D.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Antonieta Sanchez-Farran, Maria; Maranas, Janna K.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Colina, Coray M.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Marcotte, Laura L.; Gohara, David W.; Filman, David; Hogle, James M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard Medical School	Cameron, CE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 201, University Pk, PA 16802 USA.	cec9@psu.edu	Hogle, James/HIG-9121-2022	Gohara, David/0000-0001-8799-9125; filman, david/0000-0002-8714-1644; Hogle, James/0000-0002-3655-1504	National Institutes of Health from NIAID [R01 AI045818]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020566, R01AI045818, R01AI104878] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 AI045818 from NIAID (to C. E. C.).	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q; Bakhtina M, 2005, BIOCHEMISTRY-US, V44, P5177, DOI 10.1021/bi047664w; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bull JJ, 2007, J VIROL, V81, P2930, DOI 10.1128/JVI.01624-06; Cameron CE, 2009, CURR OPIN STRUC BIOL, V19, P768, DOI 10.1016/j.sbi.2009.10.012; Case D.A., 2012, AMBER; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Garriga D, 2013, J MOL BIOL, V425, P2279, DOI 10.1016/j.jmb.2013.03.034; Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109; Gohara DW, 2004, BIOCHEMISTRY-US, V43, P5149, DOI 10.1021/bi035429s; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Graci JD, 2008, FUTURE VIROL, V3, P553, DOI 10.2217/17460794.3.6.553; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Graham RL, 2012, NAT MED, V18, P1820, DOI 10.1038/nm.2972; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2014, ANGEW CHEM INT EDIT, V53, P9992, DOI 10.1002/anie.201403924; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Korboukh VK, 2014, J BIOL CHEM, V289, P29531, DOI 10.1074/jbc.M114.592303; Liu XR, 2013, J BIOL CHEM, V288, P32753, DOI 10.1074/jbc.M113.484428; Marcotte LL, 2007, J VIROL, V81, P3583, DOI 10.1128/JVI.02306-06; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moustafa IM, 2011, J MOL BIOL, V410, P159, DOI 10.1016/j.jmb.2011.04.078; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; R Development Core Team, 2009, R LANG ENV STAT COMP; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Shen HJ, 2012, J PHYS CHEM B, V116, P14515, DOI 10.1021/jp302709v; Sholders AJ, 2014, J MOL BIOL, V426, P1407, DOI 10.1016/j.jmb.2013.12.031; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; Smidansky ED, 2011, BIOCHEMISTRY-US, V50, P5016, DOI 10.1021/bi200350d; Smidansky ED, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P135, DOI 10.1016/B978-0-12-374153-0.00006-0; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003760; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2005, VIRUS RES, V107, P173, DOI 10.1016/j.virusres.2004.11.007; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Weeks SA, 2012, J BIOL CHEM, V287, P31618, DOI 10.1074/jbc.C112.401471; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012; Yang XR, 2010, BIOCHEMISTRY-US, V49, P9361, DOI 10.1021/bi100833r	66	25	26	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36229	36248		10.1074/jbc.M114.616193	http://dx.doi.org/10.1074/jbc.M114.616193			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378410	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000346897900048
J	Wolf, MTF; An, SW; Nie, MZ; Bal, MS; Huang, CL				Wolf, Matthias T. F.; An, Sung-Wan; Nie, Mingzhu; Bal, Manjot S.; Huang, Chou-Long			Klotho Up-regulates Renal Calcium Channel Transient Receptor Potential Vanilloid 5 (TRPV5) by Intra- and Extracellular N-glycosylation-dependent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTS ENCODING MEMBRANE; VITAMIN-D METABOLISM; FUNCTIONAL VARIANT; BREAST-CANCER; PROTEIN; MICE; GENE; IDENTIFICATION; TRAFFICKING; ENDOCYTOSIS	The anti-aging protein Klotho is a type 1 membrane protein produced predominantly in the distal convoluted tubule. The ectodomain of Klotho is cleaved and secreted into the urine to regulate several ion channels and transporters. Secreted Klotho (sKL) up-regulates the TRPV5 calcium channel from the cell exterior by removing sialic acids from N-glycan of the channel and inhibiting its endocytosis. Because TRPV5 and Klotho coexpress in the distal convoluted tubule, we investigated whether Klotho regulates TRPV5 action from inside the cell. Whole-cell TRPV5-mediated channel activity was recorded in HEK cells coexpressing TRPV5 and sKL or membranous Klotho (mKL). Transfection of sKL, but not mKL, produced detectable Klotho protein in cell culture media. As for sKL, mKL increased TRPV5 current density. The role of sialidase activity of mKL acting inside is supported by findings that mutations of putative sialidase activity sites in sKL and mKL abrogated the regulation of TRPV5 but that the extracellular application of a sialidase inhibitor prevented the regulation of TRPV5 by sKL only. Mechanistically, coexpression with a dominant-negative dynamin II prevented the regulation of TRPV5 by sKL but not by mKL. In contrast, blocking forward trafficking by brefeldin A prevented the effect with mKL but not with sKL. Therefore, Klotho up-regulates TRPV5 from both the inside and outside of cells. The intracellular action of Klotho is likely due to enhanced forward trafficking of channel proteins, whereas the extracellular action is due to inhibition of endocytosis. Both effects involve putative Klotho sialidase activity. These effects of Klotho may play important roles regarding calcium reabsorption in the kidney.	[Wolf, Matthias T. F.; Nie, Mingzhu; Bal, Manjot S.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [An, Sung-Wan; Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wolf, MTF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	matthias.wolf@utsouthwestern.edu; chou-long.huang@utsouthwestern.edu			National Institutes of Health [RO1-DK85726, K08-DK095994-02, K12-HD000850]; Children's Clinical Research Advisory Committee, Children's Medical Center, Dallas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085726, K08DK095994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Clinical Research Advisory Committee, Children's Medical Center, Dallas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK85726, K08-DK095994-02, and K12-HD000850. This work was also supported by the Children's Clinical Research Advisory Committee, Children's Medical Center, Dallas.	Andrukhova O, 2014, EMBO J, V33, P229, DOI 10.1002/embj.201284188; Arking DE, 2003, AM J HUM GENET, V72, P1154, DOI 10.1086/375035; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Carlsson MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026560; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Frick KK, 2003, J AM SOC NEPHROL, V14, P1082, DOI 10.1097/01.ASN.0000062960.26868.17; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 2008, PHYSIOLOGY, V23, P32, DOI 10.1152/physiol.00039.2007; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Huang CL, 2010, KIDNEY INT, V77, P855, DOI 10.1038/ki.2010.73; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Ito S, 2002, BBA-GENE STRUCT EXPR, V1576, P341, DOI 10.1016/S0167-4781(02)00281-6; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kuro-o M, 2008, TRENDS ENDOCRIN MET, V19, P239, DOI 10.1016/j.tem.2008.06.002; Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; KUROO M, 1995, CIRC RES, V76, P148, DOI 10.1161/01.RES.76.1.148; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Reynders E, 2011, GLYCOBIOLOGY, V21, P853, DOI 10.1093/glycob/cwq179; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vagin O, 2007, CELL BIOCHEM BIOPHYS, V47, P376, DOI 10.1007/s12013-007-0033-6; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; van de Graaf SFJ, 2008, J BIOL CHEM, V283, P4077, DOI 10.1074/jbc.M706959200; Wolf I, 2010, ONCOGENE, V29, P26, DOI 10.1038/onc.2009.301; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292	42	45	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35849	35857		10.1074/jbc.M114.616649	http://dx.doi.org/10.1074/jbc.M114.616649			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378396	Green Published, hybrid			2022-12-28	WOS:000346897900016
J	Zhen, Y; Knobel, PA; Stracker, TH; Reverter, D				Zhen, Yang; Knobel, Philip A.; Stracker, Travis H.; Reverter, David			Regulation of USP28 Deubiquitinating Activity by SUMO Conjugation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Proteolytic Enzyme; SUMO-interacting Motif (SIM); Sumoylation; Ubiquitin; Ubiquitin-dependent Protease	DNA-DAMAGE; CRYSTAL-STRUCTURE; UBIQUITIN LIGASE; ENZYME; SPECIFICITY; MECHANISMS; PROTEINS; DOMAINS; IDENTIFICATION; POLYUBIQUITIN	Background: USP28 is a deubiquitinating enzyme implicated in the DNA damage response, Myc stabilization, and cancer progression. Results: USP28 activity is regulated by SUMO conjugation on the N-terminal region. Conclusion: The N-terminal ubiquitin-binding domains of USP28 are not required for polyubiquitin processing. Significance: Cross-talk exists between SUMO and ubiquitin in the regulation of USP28 enzymatic activity. USP28 (ubiquitin-specific protease 28) is a deubiquitinating enzyme that has been implicated in the DNA damage response, the regulation of Myc signaling, and cancer progression. The half-life stability of major regulators of critical cellular pathways depends on the activities of specific ubiquitin E3 ligases that target them for proteosomal degradation and deubiquitinating enzymes that promote their stabilization. One function of the post-translational small ubiquitin modifier (SUMO) is the regulation of enzymatic activity of protein targets. In this work, we demonstrate that the SUMO modification of the N-terminal domain of USP28 negatively regulates its deubiquitinating activity, revealing a role for the N-terminal region as a regulatory module in the control of USP28 activity. Despite the presence of ubiquitin-binding domains in the N-terminal domain, its truncation does not impair deubiquitinating activity on diubiquitin or polyubiquitin chain substrates. In contrast to other characterized USP deubiquitinases, our results indicate that USP28 has a chain preference activity for Lys(11), Lys(48), and Lys(63) diubiquitin linkages.	[Zhen, Yang; Reverter, David] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Spain; [Zhen, Yang; Reverter, David] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra 08193, Spain; [Knobel, Philip A.; Stracker, Travis H.] Inst Res Biomed, Barcelona 08028, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Reverter, D (corresponding author), Univ Autonoma Barcelona, Bellaterra 08193, Spain.	david.reverter@uab.cat	Reverter, David/H-5360-2015; Stracker, Travis H/I-2815-2015	Reverter, David/0000-0002-5347-0992; Stracker, Travis H/0000-0002-8650-2081; Knobel, Philip/0000-0003-1587-1530	Ministerio de Economia y Competitividad of Spain [BFU2012-37116, BFU2012-39521]; Chinese government; Swiss National Science Foundation	Ministerio de Economia y Competitividad of Spain(Spanish Government); Chinese government; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grants BFU2012-37116 (to D. R.) and BFU2012-39521 (to T. H. S.) from the Ministerio de Economia y Competitividad of Spain.; Supported by a scholarship to the Chinese Research Council program from the Chinese government.; Supported by an Early Postdoc Mobility fellowship from the Swiss National Science Foundation.	Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Diefenbacher ME, 2014, J CLIN INVEST, V124, P3407, DOI 10.1172/JCI73733; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Flugel D, 2012, BLOOD, V119, P1292, DOI 10.1182/blood-2011-08-375014; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Jacq X, 2013, CELL BIOCHEM BIOPHYS, V67, P25, DOI 10.1007/s12013-013-9635-3; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knobel PA, 2014, MOL CELL BIOL, V34, P2062, DOI 10.1128/MCB.00197-14; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lemak A., 2012, NE STRUCTUR IN PRESS; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Popov N, 2007, CELL CYCLE, V6, P2327, DOI 10.4161/cc.6.19.4804; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tammsalu T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005146; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Valero R, 2001, GENOME BIOL, V2; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Wong BR, 2003, DRUG DISCOV TODAY, V8, P746, DOI 10.1016/S1359-6446(03)02780-6; Wu YD, 2013, CELL REP, V5, P224, DOI 10.1016/j.celrep.2013.08.030; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	48	17	17	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34838	34850		10.1074/jbc.M114.601849	http://dx.doi.org/10.1074/jbc.M114.601849			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25359778	Green Published, hybrid			2022-12-28	WOS:000346260800035
J	Dhall, A; Wei, SJ; Fierz, B; Woodcock, CL; Lee, TH; Chatterjee, C				Dhall, Abhinav; Wei, Sijie; Fierz, Beat; Woodcock, Christopher L.; Lee, Tae-Hee; Chatterjee, Champak			Sumoylated Human Histone H4 Prevents Chromatin Compaction by Inhibiting Long-range Internucleosomal Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemical Modification; Chromatin Structure; Disulfide; Histone; Intein; Post-translational Modification (PTM); Small Ubiquitin-like Modifier (SUMO); Sumoylation; Acetylation; Ligation	SELF-ASSOCIATION; FIBER; BINDING; TAIL; H3; IDENTIFICATION; ACETYLATION; METHYLATION; NUCLEOSOMES; RESOLUTION	Background: Human histone H4 is post-translationally modified at Lys-12 by the small ubiquitin-like modifier protein (SUMO-3). Results: Chemical sumoylation at H4 Lys-12 revealed the inhibition of chromatin compaction and oligomerization by SUMO-3. Conclusion: Sumoylation changes chromatin structure by inhibiting long-range internucleosomal interactions and decreasing the affinity between adjacent nucleosomes. Significance: Learning how sumoylation changes the structure of chromatin suggests that it may mediate gene repression without chromatin compaction. The structure of eukaryotic chromatin directly influences gene function, and is regulated by chemical modifications of the core histone proteins. Modification of the human histone H4 N-terminal tail region by the small ubiquitin-like modifier protein, SUMO-3, is associated with transcription repression. However, the direct effect of sumoylation on chromatin structure and function remains unknown. Therefore, we employed a disulfide-directed strategy to generate H4 homogenously and site-specifically sumoylated at Lys-12 (suH4(ss)). Chromatin compaction and oligomerization assays with nucleosomal arrays containing suH4(ss) established that SUMO-3 inhibits array folding and higher order oligomerization, which underlie chromatin fiber formation. Moreover, the effect of sumoylation differed from that of acetylation, and could be recapitulated with the structurally similar protein ubiquitin. Mechanistic studies at the level of single nucleosomes revealed that, unlike acetylation, the effect of SUMO-3 arises from the attenuation of long-range internucleosomal interactions more than from the destabilization of a compacted dinucleosome state. Altogether, our results present the first insight on the direct structural effects of histone H4 sumoylation and reveal a novel mechanism by which SUMO-3 inhibits chromatin compaction.	[Dhall, Abhinav; Chatterjee, Champak] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Wei, Sijie; Lee, Tae-Hee] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Fierz, Beat] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Woodcock, Christopher L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Massachusetts System; University of Massachusetts Amherst	Woodcock, CL (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	chris@bio.umass.edu; txl18@psu.edu; chatterjee@chem.washington.edu	Chatterjee, Champak/R-7214-2017; Fierz, Beat/H-3143-2012; Lee, Tae-Hee/A-1266-2010; Wei, Sijie/J-6678-2019	Fierz, Beat/0000-0002-2991-3044; Wei, Sijie/0000-0003-4882-9566; Chatterjee, Champak/0000-0001-5772-4438; Dhall, Abhinav/0000-0002-7590-2469	National Institutes of Health [1S10RR027217]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097286, R01GM110430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Professor Rachel Klevit for access to a Beckman XL-I Analytical Ultracentrifuge supported by National Institutes of Health Grant 1S10RR027217.	Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chatterjee C, 2010, NAT CHEM BIOL, V6, P267, DOI [10.1038/NCHEMBIO.315, 10.1038/nchembio.315]; Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]; Chen WT, 2013, MOL CELL BIOL, V33, P111, DOI 10.1128/MCB.01024-12; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Correll SJ, 2012, EMBO J, V31, P2416, DOI 10.1038/emboj.2012.80; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Dhall A, 2011, ACS CHEM BIOL, V6, P987, DOI 10.1021/cb200142c; Ding HS, 2005, BIOCHEMISTRY-US, V44, P2790, DOI 10.1021/bi0477586; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Flaus A, 1998, J MOL BIOL, V275, P427, DOI 10.1006/jmbi.1997.1464; Galisson F, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004796; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Garcia Benjamin A, 2009, Front Biosci (Schol Ed), V1, P142, DOI 10.2741/s14; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; He S, 2003, P NATL ACAD SCI USA, V100, P12033, DOI 10.1073/pnas.2035256100; Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924; Issar N, 2008, CELL MICROBIOL, V10, P1999, DOI 10.1111/j.1462-5822.2008.01183.x; Jason LJM, 2001, J BIOL CHEM, V276, P14597, DOI 10.1074/jbc.M011153200; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lee JY, 2011, J BIOL CHEM, V286, P11099, DOI 10.1074/jbc.M110.192047; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li FP, 2011, ANGEW CHEM INT EDIT, V50, P9611, DOI 10.1002/anie.201103754; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Matafora V, 2009, MOL CELL PROTEOMICS, V8, P2243, DOI 10.1074/mcp.M900079-MCP200; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Saracco SA, 2007, PLANT PHYSIOL, V145, P119, DOI 10.1104/pp.107.102285; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Szerlong HJ, 2011, BIOCHEM CELL BIOL, V89, P24, DOI 10.1139/O10-139; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Woodcock CL, 1998, METHOD CELL BIOL, V53, P167; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559; Zhou BO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001272	50	57	58	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33827	33837		10.1074/jbc.M114.591644	http://dx.doi.org/10.1074/jbc.M114.591644			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25294883	hybrid, Green Published			2022-12-28	WOS:000346077600010
J	Kirchhefer, U; Brekle, C; Eskandar, J; Isensee, G; Kucerova, D; Muller, FU; Pinet, F; Schulte, JS; Seidl, MD; Boknik, P				Kirchhefer, Uwe; Brekle, Christiane; Eskandar, John; Isensee, Gunnar; Kucerova, Dana; Mueller, Frank U.; Pinet, Florence; Schulte, Jan S.; Seidl, Matthias D.; Boknik, Peter			Cardiac Function Is Regulated by B56 alpha-mediated Targeting of Protein Phosphatase 2A (PP2A) to Contractile Relevant Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adrenergic Receptor; Cardiomyocyte; Contractile Protein; Protein Phosphatase 2 (PP2A); Protein Phosphorylation	FAILING HUMAN MYOCARDIUM; SARCOPLASMIC-RETICULUM; HEART-FAILURE; SERINE/THREONINE PHOSPHATASES; MYOFIBRILLAR PROTEINS; DIASTOLIC DYSFUNCTION; VENTRICULAR MYOCYTES; RYANODINE RECEPTOR; SUBUNIT B56-ALPHA; PHOSPHORYLATION	Background: PP2A is a regulator of cardiac excitation-contraction coupling. Results: Cardiomyocyte-directed overexpression of B56, the main cardiac PP2A regulatory subunit, results in the dephosphorylation of myofilament proteins, increased Ca2+ sensitivity, and higher contractility. Conclusion: This suggests an important role for B56 in regulating PP2A activity and thereby the contractile function. Significance: PP2A-B56 is a potential pharmacological target to improve cardiac performance in failing hearts. Dephosphorylation of important myocardial proteins is regulated by protein phosphatase 2A (PP2A), representing a heterotrimer that is comprised of catalytic, scaffolding, and regulatory (B) subunits. There is a multitude of B subunit family members directing the PP2A holoenzyme to different myocellular compartments. To gain a better understanding of how these B subunits contribute to the regulation of cardiac performance, we generated transgenic (TG) mice with cardiomyocyte-directed overexpression of B56, a phosphoprotein of the PP2A-B56 family. The 2-fold overexpression of B56 was associated with an enhanced PP2A activity that was localized mainly in the cytoplasm and myofilament fraction. Contractility was enhanced both at the whole heart level and in isolated cardiomyocytes of TG compared with WT mice. However, peak amplitude of [Ca](i) did not differ between TG and WT cardiomyocytes. The basal phosphorylation of cardiac troponin inhibitor (cTnI) and the myosin-binding protein C was reduced by 26 and 35%, respectively, in TG compared with WT hearts. The stimulation of -adrenergic receptors by isoproterenol (ISO) resulted in an impaired contractile response of TG hearts. At a depolarizing potential of -5 mV, the I-Ca,I-L current density was decreased by 28% after administration of ISO in TG cardiomyocytes. In addition, the ISO-stimulated phosphorylation of phospholamban at Ser(16) was reduced by 27% in TG hearts. Thus, the increased PP2A-B56 activity in TG hearts is localized to specific subcellular sites leading to the dephosphorylation of important contractile proteins. This may result in higher myofilament Ca2+ sensitivity and increased basal contractility in TG hearts. These effects were reversed by -adrenergic stimulation.	[Kirchhefer, Uwe; Brekle, Christiane; Eskandar, John; Isensee, Gunnar; Kucerova, Dana; Mueller, Frank U.; Schulte, Jan S.; Seidl, Matthias D.; Boknik, Peter] Univ Klinikum Munster, Inst Pharmakol & Toxikol, D-48149 Munster, Germany; [Pinet, Florence] Inst Pasteur, INSERM, U744, F-59019 Lille, France	University of Munster; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Kirchhefer, U (corresponding author), Univ Klinikum Munster, Inst Pharmakol & Toxikol, Domagkstr 12, D-48149 Munster, Germany.	kirchhef@uni-muenster.de	Pinet, Florence/F-2892-2013	Pinet, Florence/0000-0002-5471-1487; Schulte, Jan Sebastian/0000-0003-0336-2632	Innovative Medizinische Forschung Munster [KI 2 1 10 10]	Innovative Medizinische Forschung Munster	This work was supported by Innovative Medizinische Forschung Munster Grant KI 2 1 10 10.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; Belevych AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028324; Bhasin N, 2007, AM J PHYSIOL-HEART C, V293, pH109, DOI 10.1152/ajpheart.00059.2007; Boknik P, 2001, AM J PHYSIOL-HEART C, V280, pH786, DOI 10.1152/ajpheart.2001.280.2.H786; Boknik P, 2000, N-S ARCH PHARMACOL, V362, P222, DOI 10.1007/s002100000283; Cazorla O, 2006, CARDIOVASC RES, V69, P370, DOI 10.1016/j.cardiores.2005.11.009; Chen PP, 2010, J GEN PHYSIOL, V136, P615, DOI 10.1085/jgp.201010448; Davare MA, 2000, J BIOL CHEM, V275, P39710, DOI 10.1074/jbc.M005462200; DeGrande ST, 2013, J BIOL CHEM, V288, P1032, DOI 10.1074/jbc.M112.426957; Dodge-Kafka KL, 2010, J BIOL CHEM, V285, P11078, DOI 10.1074/jbc.M109.034868; Dubell WH, 2002, AM J PHYSIOL-HEART C, V282, pH38, DOI 10.1152/ajpheart.00536.2001; duBell WH, 1996, J PHYSIOL-LONDON, V493, P793, DOI 10.1113/jphysiol.1996.sp021423; Dubois E, 2011, EUR HEART J, V32, P115, DOI 10.1093/eurheartj/ehq108; Gergs U, 2004, J BIOL CHEM, V279, P40827, DOI 10.1074/jbc.M405770200; Gigena MS, 2005, AM J PHYSIOL-HEART C, V289, pH285, DOI 10.1152/ajpheart.01291.2004; Golden HB, 2013, INT J CARDIOL, V168, P3884, DOI 10.1016/j.ijcard.2013.06.050; GULICK J, 1991, J BIOL CHEM, V266, P9180; Hall DD, 2006, BIOCHEMISTRY-US, V45, P3448, DOI 10.1021/bi051593z; Hamdani N, 2013, CARDIOVASC RES, V97, P464, DOI 10.1093/cvr/cvs353; Heijman J, 2013, J MOL CELL CARDIOL, V64, P90, DOI 10.1016/j.yjmcc.2013.09.006; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jideama NM, 2006, INT J BIOL SCI, V2, P1; Kho C, 2012, NAT REV CARDIOL, V9, P717, DOI 10.1038/nrcardio.2012.145; Kirchhefer U, 1999, CARDIOVASC RES, V42, P254, DOI 10.1016/S0008-6363(98)00296-X; Kirchhefer U, 2001, J BIOL CHEM, V276, P4142, DOI 10.1074/jbc.M006443200; Kirchhefer U, 2014, J BIOL CHEM, V289, P163, DOI 10.1074/jbc.M113.507996; Kobayashi YM, 1999, J BIOL CHEM, V274, P28660, DOI 10.1074/jbc.274.40.28660; Kucerova D, 2012, AM J PHYSIOL-HEART C, V302, pH2008, DOI 10.1152/ajpheart.00457.2011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen KO, 2008, CARDIOVASC RES, V80, P47, DOI 10.1093/cvr/cvn180; Liu QH, 2002, AM J PHYSIOL-HEART C, V283, pH1314, DOI 10.1152/ajpheart.00343.2002; Marshall M, 2009, CARDIOVASC RES, V82, P67, DOI 10.1093/cvr/cvp037; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Moreno-Gonzalez A, 2009, J MOL CELL CARDIOL, V47, P603, DOI 10.1016/j.yjmcc.2009.07.030; Neumann J, 1999, J PHARMACOL EXP THER, V289, P188; NEUMANN J, 1993, AM J PHYSIOL, V265, pH257, DOI 10.1152/ajpheart.1993.265.1.H257; PORZIO MA, 1977, BIOCHIM BIOPHYS ACTA, V490, P27, DOI 10.1016/0005-2795(77)90102-7; RAPUNDALO ST, 1989, CIRC RES, V64, P104, DOI 10.1161/01.RES.64.1.104; Schulte JS, 2012, AM J PHYSIOL-HEART C, V302, pH1998, DOI 10.1152/ajpheart.00057.2011; Schwinger RHG, 1999, J MOL CELL CARDIOL, V31, P479, DOI 10.1006/jmcc.1998.0897; Slimane ZH, 2014, CARDIOVASC RES, V102, P97, DOI 10.1093/cvr/cvu029; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Wijnker PJM, 2011, J MUSCLE RES CELL M, V32, P221, DOI 10.1007/s10974-011-9261-x; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Yang F, 2008, BIOCHEM CELL BIOL, V86, P70, DOI [10.1139/O07-150, 10.1139/o07-150]; Yin XK, 2010, MOL CELL PROTEOMICS, V9, P497, DOI 10.1074/mcp.M900275-MCP200; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389	51	34	34	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33862	33873		10.1074/jbc.M114.598938	http://dx.doi.org/10.1074/jbc.M114.598938			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25320082	Green Published, hybrid			2022-12-28	WOS:000346077600013
J	Kobylarz, MJ; Grigg, JC; Sheldon, JR; Heinrichs, DE; Murphy, MEP				Kobylarz, Marek J.; Grigg, Jason C.; Sheldon, Jessica R.; Heinrichs, David E.; Murphy, Michael E. P.			SbnG, a Citrate Synthase in Staphylococcus aureus A NEW FOLD ON AN OLD ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Iron; Siderophore; Staphylococcus aureus (S; aureus); Tricarboxylic Acid Cycle (TCA Cycle) (Krebs Cycle); Citrate Synthase; Convergent Evolution	CLASS-II ALDOLASE; MALATE SYNTHASE; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; STAPHYLOFERRIN-B; IN-VITRO; IRON; SIDEROPHORE; ALIGNMENT; REFINEMENT	Background:Staphylococcus aureus contains a second, iron-regulated citrate synthase. Results: SbnG is a citrate synthase within the phosphoenolpyruvate/pyruvate superfamily. Conclusion: The structural similarity of the SbnG active site to TCA cycle citrate synthase active sites suggests convergent evolution. Significance: SbnG is defined as a new structural class of citrate synthase. In response to iron deprivation, Staphylococcus aureus produces staphyloferrin B, a citrate-containing siderophore that delivers iron back to the cell. This bacterium also possesses a second citrate synthase, SbnG, that is necessary for supplying citrate to the staphyloferrin B biosynthetic pathway. We present the structure of SbnG bound to the inhibitor calcium and an active site variant in complex with oxaloacetate. The overall fold of SbnG is structurally distinct from TCA cycle citrate synthases yet similar to metal-dependent class II aldolases. Phylogenetic analyses revealed that SbnG forms a separate clade with homologs from other siderophore biosynthetic gene clusters and is representative of a metal-independent subgroup in the phosphoenolpyruvate/pyruvate domain superfamily. A structural superposition of the SbnG active site to TCA cycle citrate synthases and site-directed mutagenesis suggests a case for convergent evolution toward a conserved catalytic mechanism for citrate production.	[Kobylarz, Marek J.; Grigg, Jason C.; Murphy, Michael E. P.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Sheldon, Jessica R.; Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Heinrichs, David E.] Univ Western Ontario, Ctr Human Immunol, London, ON N6A 5C1, Canada	University of British Columbia; Western University (University of Western Ontario); Western University (University of Western Ontario)	Murphy, MEP (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.	Michael.Murphy@ubc.ca	Sheldon, Jessica/AAX-3048-2020; Heinrichs, David/ABD-5702-2021; Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014; Sheldon, Jessica/0000-0002-1413-9404; Heinrichs, David/0000-0002-7217-2456	Canadian Institutes of Health Research [MOP-102596]; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; U.S. Department of Energy Office of Science; Department of Energy Office of Biological and Environmental Research, the National Institutes of Health, National Center for Research Resources Biomedical Technology Program [P41RR001209]; National Institute of General Medical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; U.S. Department of Energy Office of Science(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research, the National Institutes of Health, National Center for Research Resources Biomedical Technology Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Operating Grant MOP-102596 from the Canadian Institutes of Health Research (to M. E. P. M. and D. E. H.); by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan (to the Canadian Light Source); by the U.S. Department of Energy Office of Science (to the Stanford Synchrotron Radiation Lightsource); and by the Department of Energy Office of Biological and Environmental Research, the National Institutes of Health, National Center for Research Resources Biomedical Technology Program Grant P41RR001209, and the National Institute of General Medical Sciences (to the Stanford Synchrotron Radiation Laboratory Structural Molecular Biology Program).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allard M, 2006, MICROBES INFECT, V8, P1679, DOI 10.1016/j.micinf.2006.01.022; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anstrom DM, 2006, PROTEIN SCI, V15, P2002, DOI 10.1110/ps.062300206; Bateman BT, 2001, INFECT IMMUN, V69, P7851, DOI 10.1128/IAI.69.12.7851-7857.2001; Beasley FC, 2010, J INORG BIOCHEM, V104, P282, DOI 10.1016/j.jinorgbio.2009.09.011; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Ben Zakour NL, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00044; Cheung J, 2012, CHEM BIOL, V19, P1568, DOI 10.1016/j.chembiol.2012.10.003; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Cotton JL, 2009, BIOCHEMISTRY-US, V48, P1025, DOI 10.1021/bi801844c; DRECHSEL H, 1993, BIOMETALS, V6, P185; Dudev T, 2004, J PHYS CHEM B, V108, P4546, DOI 10.1021/jp0310347; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans CT, 1996, BIOCHEMISTRY-US, V35, P10661, DOI 10.1021/bi960336e; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fish D. C., 1966, METHOD ENZYMOL, V9, P529; Francois JA, 2006, BIOCHEMISTRY-US, V45, P13487, DOI 10.1021/bi061083k; Franza T, 2005, MOL MICROBIOL, V55, P261, DOI 10.1111/j.1365-2958.2004.04383.x; Friedman DB, 2006, PLOS PATHOG, V2, P777, DOI 10.1371/journal.ppat.0020087; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Goulding CW, 2007, J MOL BIOL, V365, P275, DOI 10.1016/j.jmb.2006.09.086; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Howard BR, 2000, BIOCHEMISTRY-US, V39, P3156, DOI 10.1021/bi992519h; Izard T, 2000, EMBO J, V19, P3849, DOI 10.1093/emboj/19.15.3849; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kobylarz MJ, 2014, CHEM BIOL, V21, P379, DOI 10.1016/j.chembiol.2013.12.011; KONETSCHNYRAPP S, 1990, EUR J BIOCHEM, V191, P65, DOI 10.1111/j.1432-1033.1990.tb19094.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MacPherson IS, 2010, PROTEIN ENG DES SEL, V23, P137, DOI 10.1093/protein/gzp084; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ose T, 2004, ACTA CRYSTALLOGR D, V60, P1187, DOI 10.1107/S0907444904008881; Ose T, 2003, NATURE, V422, P185, DOI 10.1038/nature01454; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Rea D, 2008, BIOCHEMISTRY-US, V47, P9955, DOI 10.1021/bi800943g; Rea D, 2007, J MOL BIOL, V373, P866, DOI 10.1016/j.jmb.2007.06.048; REMINGTON S, 1982, J MOL BIOL, V158, P111, DOI 10.1016/0022-2836(82)90452-1; Sebulsky MT, 2004, J BIOL CHEM, V279, P53152, DOI 10.1074/jbc.M409793200; Sheldon JR, 2014, MOL MICROBIOL, V92, P824, DOI 10.1111/mmi.12593; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith CV, 2003, J BIOL CHEM, V278, P1735, DOI 10.1074/jbc.M209248200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WEINBERG ED, 1974, SCIENCE, V184, P952, DOI 10.1126/science.184.4140.952; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	59	17	17	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33797	33807		10.1074/jbc.M114.603175	http://dx.doi.org/10.1074/jbc.M114.603175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25336653	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000346077600007
J	Abdul-Ridha, A; Lane, JR; Mistry, SN; Lopez, L; Sexton, PM; Scammells, PJ; Christopoulos, A; Canals, M				Abdul-Ridha, Alaa; Lane, J. Robert; Mistry, Shailesh N.; Lopez, Laura; Sexton, Patrick M.; Scammells, Peter J.; Christopoulos, Arthur; Canals, Meritxell			Mechanistic Insights into Allosteric Structure-Function Relationships at the M-1 Muscarinic Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; ALZHEIMERS-DISEASE; CNS DISORDERS; MOLECULAR-MECHANISMS; SELECTIVE ACTIVATION; MODULATION; SCHIZOPHRENIA; AGONISM; IDENTIFICATION; DETERMINANTS	Benzylquinolone carboxylic acid (BQCA) is the first highly selective positive allosteric modulator (PAM) for the M-1 muscarinic acetylcholine receptor (mAChR), but it possesses low affinity for the allosteric site on the receptor. More recent drug discovery efforts identified 3-((1S,2S)-2-hydroxycyclohexyl)-6-((6-(1-methyl-1H-pyrazol-4-yl) pyridin-3-yl) methyl) benzo[h]-quinazolin- 4(3H)-one (referred to herein as benzoquinazolinon e 12) as a more potent M1 mAChR PAM with a structural ancestry originating from BQCA and related compounds. In the current study, we optimized the synthesis of and fully characterized the pharmacology of benzoquinazolinone 12, finding that its improved potency derived from a 50-fold increase in allosteric site affinity as compared with BQCA, while retaining a similar level of positive cooperativity with acetylcholine. We then utilized site-directed mutagenesis and molecular modeling to validate the allosteric binding pocket we previously described for BQCA as a shared site for benzoquinazolinone 12 and provide a molecular basis for its improved activity at the M-1 mAChR. This includes a key role for hydrophobic and polar interactions with residues Tyr-179, in the second extracellular loop (ECL2) and Trp-400(7.35) in transmembrane domain (TM)7. Collectively, this study highlights how the properties of affinity and cooperativity can be differentially modified on a common structural scaffold and identifies molecular features that can be exploited to tailor the development of M1 mAChR-targeting PAMs.	[Abdul-Ridha, Alaa; Lane, J. Robert; Lopez, Laura; Sexton, Patrick M.; Christopoulos, Arthur; Canals, Meritxell] Monash Univ, Monash Inst Pharmaceut Sci, Dept Drug Discovery Biol, Parkville, Vic 3052, Australia; [Mistry, Shailesh N.; Scammells, Peter J.] Monash Univ, Monash Inst Pharmaceut Sci, Dept Med Chem, Parkville, Vic 3052, Australia; [Mistry, Shailesh N.; Scammells, Peter J.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia	Monash University; Monash University; Monash University	Christopoulos, A (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	arthur.christopoulos@monash.edu; meri.canals@monash.edu	Mistry, Shailesh/O-2697-2014; Sexton, Patrick M/B-1319-2008; Christopoulos, Arthur/B-6207-2013	Mistry, Shailesh/0000-0002-2252-1689; Sexton, Patrick M/0000-0001-8902-2473; Christopoulos, Arthur/0000-0003-4442-3294; Scammells, Peter/0000-0003-2930-895X; Abdul-Ridha, Alaa/0000-0002-1491-3818; Canals, Meritxell/0000-0002-7942-5006; Lane, J. Robert/0000-0002-7361-7875	National Health and Medical Research Council of Australia [APP1055134, APP1049564]; Victorian Life Sciences Computation Initiative on its Peak Computing Facility at the University of Melbourne [VR0024]; Australian Postgraduate Award scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Life Sciences Computation Initiative on its Peak Computing Facility at the University of Melbourne; Australian Postgraduate Award scholarship	This work was funded by National Health and Medical Research Council of Australia Program Grants APP1055134 (to A. C. and P. M. S.) and APP1049564 (to J. R. L.). The computational studies were supported by resource allocation scheme Grant VR0024 of the Victorian Life Sciences Computation Initiative on its Peak Computing Facility at the University of Melbourne.; Recipient of an Australian Postgraduate Award scholarship.	Abdul-Ridha A, 2014, J BIOL CHEM, V289, P6067, DOI 10.1074/jbc.M113.539080; Byun NE, 2014, NEUROPSYCHOPHARMACOL, V39, P1578, DOI 10.1038/npp.2014.2; Canals M, 2012, J BIOL CHEM, V287, P650, DOI 10.1074/jbc.M111.314278; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Foster DJ, 2014, NEUROPSYCH DIS TREAT, V10, P183, DOI 10.2147/NDT.S55104; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hulme EC, 2003, BIOCHEM SOC T, V31, P29, DOI 10.1042/bst0310029; Jones CK, 2012, NEUROPSYCHOPHARMACOL, V37, P16, DOI 10.1038/npp.2011.199; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kennedy DP, 2014, MOL PHARMACOL, V85, P301, DOI 10.1124/mol.113.088682; Keov P, 2014, J BIOL CHEM, V289, P23817, DOI 10.1074/jbc.M114.582874; Kruse AC, 2014, CURR OPIN PHARMACOL, V16, P24, DOI 10.1016/j.coph.2014.02.006; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kuduk S. D., 2010, U. S. Patent WO, Patent No. [2010/059773, 2010059773, WO/2010/059773]; Kuduk SD, 2014, BIOORG MED CHEM LETT, V24, P1417, DOI 10.1016/j.bmcl.2014.01.012; Kuduk SD, 2012, EXPERT OPIN THER PAT, V22, P1385, DOI 10.1517/13543776.2012.731395; Kuduk SD, 2011, BIOORG MED CHEM LETT, V21, P1710, DOI 10.1016/j.bmcl.2011.01.094; Lazareno S, 2004, MOL PHARMACOL, V65, P257, DOI 10.1124/mol.65.1.257; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; Lebois EP, 2010, ACS CHEM NEUROSCI, V1, P104, DOI 10.1021/cn900003h; Lebon G, 2009, MOL PHARMACOL, V75, P331, DOI 10.1124/mol.108.050963; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; MATSUI H, 1995, MOL PHARMACOL, V47, P88; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Melancon BJ, 2013, DRUG DISCOV TODAY, V18, P1185, DOI 10.1016/j.drudis.2013.09.005; Mistry SN, 2013, J MED CHEM, V56, P5151, DOI 10.1021/jm400540b; Nathan PJ, 2013, INT J NEUROPSYCHOPH, V16, P721, DOI 10.1017/S1461145712000752; Nawaratne V, 2010, J BIOL CHEM, V285, P19012, DOI 10.1074/jbc.M110.125096; Nickols HH, 2014, NEUROBIOL DIS, V61, P55, DOI 10.1016/j.nbd.2013.09.013; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ragnarsson L, 2013, J BIOL CHEM, V288, P1814, DOI 10.1074/jbc.M112.430785; Shirey JK, 2009, J NEUROSCI, V29, P14271, DOI 10.1523/JNEUROSCI.3930-09.2009; Shonberg J, 2013, J MED CHEM, V56, P9199, DOI 10.1021/jm401318w; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Tarr JC, 2012, ACS CHEM NEUROSCI, V3, P884, DOI 10.1021/cn300068s; Valant C, 2012, MOL PHARMACOL, V81, P41, DOI 10.1124/mol.111.074872; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896	44	41	48	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33701	33711		10.1074/jbc.M114.604967	http://dx.doi.org/10.1074/jbc.M114.604967			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25326383	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000345636600054
J	Iwama, R; Kobayashi, S; Ohta, A; Horiuchi, H; Fukuda, R				Iwama, Ryo; Kobayashi, Satoshi; Ohta, Akinori; Horiuchi, Hiroyuki; Fukuda, Ryouichi			Fatty Aldehyde Dehydrogenase Multigene Family Involved in the Assimilation of n-Alkanes in Yarrowia lipolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE CYTOCHROMES P450; SJOGREN-LARSSON SYNDROME; CANDIDA-TROPICALIS; ALCOHOL OXIDASE; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; DECANE ASSIMILATION; OXIDATIVE STRESS; YEAST; GENE	In the n-alkane assimilating yeast Yarrowia lipolytica, n-alkanes are oxidized to fatty acids via fatty alcohols and fatty aldehydes, after which they are utilized as carbon sources. Here, we show that four genes (HFD1-HFD4) encoding fatty aldehyde dehydrogenases (FALDHs) are involved in the metabolism of n-alkanes in Y. lipolytica. A mutant, in which all of four HFD genes are deleted (Delta hfd1-4 strain), could not grow on n-alkanes of 12-18 carbons; however, the expression of one of those HFD genes restored its growth on n-alkanes. Production of Hfd2Ap or Hfd2Bp, translation products of transcript variants generated from HFD2 by the absence or presence of splicing, also supported the growth of the Delta hfd1-4 strain on n-alkanes. The FALDH activity in the extract of the wild-type strain was increased when cells were incubated in the presence of n-decane, whereas this elevation in FALDH activity by n-decane was not observed in Delta hfd1-4 strain extract. Substantial FALDH activities were detected in the extracts of Escherichia coli cells expressing the HFD genes. Fluorescent microscopic observation suggests that Hfd3p and Hfd2Bp are localized predominantly in the peroxisome, whereas Hfd1p and Hfd2Ap are localized in both the endoplasmic reticulum and the peroxisome. These results suggest that the HFD multigene family is responsible for the oxidation of fatty aldehydes to fatty acids in the metabolism of n-alkanes, and raise the possibility that Hfd proteins have diversified by gene multiplication and RNA splicing to efficiently assimilate or detoxify fatty aldehydes in Y. lipolytica.	[Iwama, Ryo; Kobayashi, Satoshi; Horiuchi, Hiroyuki; Fukuda, Ryouichi] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Ohta, Akinori] Chubu Univ, Coll Biosci & Biotechnol, Dept Biol Chem, Kasugai, Aichi 4878501, Japan	University of Tokyo; Chubu University	Fukuda, R (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	afukuda@mail.ecc.u-tokyo.ac.jp	IWAMA, Ryo/AAY-4462-2021; Iwama, Ryo/W-2769-2017	IWAMA, Ryo/0000-0002-0466-6593; Iwama, Ryo/0000-0002-0466-6593	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ashibe B, 2007, J BIOL CHEM, V282, P20763, DOI 10.1074/jbc.M611853200; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Barth G, 1996, YARROWIA LIPOLYTICA, P313; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; DeLaurenzi V, 1996, NAT GENET, V12, P52; Demozay D, 2004, J BIOL CHEM, V279, P6261, DOI 10.1074/jbc.M312062200; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Endoh-Yamagami S, 2007, EUKARYOT CELL, V6, P734, DOI 10.1128/EC.00412-06; Eschenfeldt WH, 2003, APPL ENVIRON MICROB, V69, P5992, DOI 10.1128/AEM.69.10.5992-5999.2003; Fickers P, 2005, FEMS YEAST RES, V5, P527, DOI 10.1016/j.femsyr.2004.09.004; Fukuda R., 2013, YARROWIA LIPOLYTICA, P111, DOI 10.1007/978-3-642-38320-5_5; Fukuda R, 2013, BIOSCI BIOTECH BIOCH, V77, P1149, DOI 10.1271/bbb.130164; Gatter M, 2014, FEMS YEAST RES, V14, P858, DOI 10.1111/1567-1364.12176; Hirakawa K, 2009, J BIOL CHEM, V284, P7126, DOI 10.1074/jbc.M806864200; Iida T, 1998, YEAST, V14, P1387; Kelson TL, 1997, BBA-GEN SUBJECTS, V1335, P99, DOI 10.1016/S0304-4165(96)00126-2; KEMP GD, 1990, APPL MICROBIOL BIOT, V32, P461, DOI 10.1007/BF00903783; KEMP GD, 1994, APPL MICROBIOL BIOT, V40, P873, DOI 10.1007/s002530050083; Kim D, 2007, ARCH BIOCHEM BIOPHYS, V464, P213, DOI 10.1016/j.abb.2007.02.032; Kobayashi S, 2013, FUNGAL GENET BIOL, V61, P100, DOI 10.1016/j.fgb.2013.09.008; Lida T, 2000, YEAST, V16, P1077, DOI 10.1002/1097-0061(20000915)16:12<1077::AID-YEA601>3.0.CO;2-K; Lin ZL, 2000, MOL GENET METAB, V71, P496, DOI 10.1006/mgme.2000.3084; LIU CM, 1971, J BACTERIOL, V106, P830, DOI 10.1128/JB.106.3.830-834.1971; MASAKI R, 1994, J CELL BIOL, V126, P1407, DOI 10.1083/jcb.126.6.1407; Mori K, 2013, FEMS YEAST RES, V13, P233, DOI 10.1111/1567-1364.12025; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Navarro-Avino JP, 1999, YEAST, V15, P829, DOI 10.1002/(SICI)1097-0061(199907)15:10A<829::AID-YEA423>3.0.CO;2-9; Nelson David R., 2009, Human Genomics, V4, P59; Nicaud JM, 2012, YEAST, V29, P409, DOI 10.1002/yea.2921; Ohkuma M, 1998, J BIOL CHEM, V273, P3948, DOI 10.1074/jbc.273.7.3948; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; Poopanitpan N, 2010, BIOCHEM BIOPH RES CO, V402, P731, DOI 10.1016/j.bbrc.2010.10.096; Scheller U, 1998, J BIOL CHEM, V273, P32528, DOI 10.1074/jbc.273.49.32528; SEGHEZZI W, 1992, DNA CELL BIOL, V11, P767, DOI 10.1089/dna.1992.11.767; SEGHEZZI W, 1991, GENE, V106, P51, DOI 10.1016/0378-1119(91)90565-S; Seip J, 2013, APPL ENVIRON MICROB, V79, P7360, DOI 10.1128/AEM.02079-13; Smit MS, 2005, BIOTECHNOL LETT, V27, P859, DOI 10.1007/s10529-005-6719-1; Sumita T, 2002, BIOCHEM BIOPH RES CO, V294, P1071, DOI 10.1016/S0006-291X(02)00607-1; Takai H, 2012, FUNGAL GENET BIOL, V49, P58, DOI 10.1016/j.fgb.2011.11.003; UEDA M, 1990, METHOD ENZYMOL, V188, P176; Vasiliou V, 2000, PHARMACOLOGY, V61, P192, DOI 10.1159/000028400; Verhoeven NM, 1998, FEBS LETT, V429, P225, DOI 10.1016/S0014-5793(98)00574-2; YAMADA T, 1980, ARCH MICROBIOL, V128, P145, DOI 10.1007/BF00406151; Yamagami S, 2004, J BIOL CHEM, V279, P22183, DOI 10.1074/jbc.M313313200; Yamagami S, 2001, BIOCHEM BIOPH RES CO, V282, P832, DOI 10.1006/bbrc.2001.4653; Zimmer T, 1998, BIOCHEM BIOPH RES CO, V251, P244, DOI 10.1006/bbrc.1998.9450; Zimmer T, 1996, BIOCHEM BIOPH RES CO, V224, P784, DOI 10.1006/bbrc.1996.1100	47	24	30	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33275	33286		10.1074/jbc.M114.596890	http://dx.doi.org/10.1074/jbc.M114.596890			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25315778	Green Published, hybrid			2022-12-28	WOS:000345636600019
J	Ryan, AJ; Larson-Casey, JL; He, C; Murthy, S; Carter, AB				Ryan, Alan J.; Larson-Casey, Jennifer L.; He, Chao; Murthy, Shuhba; Carter, A. Brent			Asbestos-induced Disruption of Calcium Homeostasis Induces Endoplasmic Reticulum Stress in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; PULMONARY-FIBROSIS; M2 MACROPHAGES; CELL APOPTOSIS; TRANSLOCON; ACTIVATION; DEPLETION; SURVIVAL; DEATH	Although the mechanisms for fibrosis development remain largely unknown, recent evidence indicates that endoplasmic reticulum (ER) stress and activation of the unfolded protein response (UPR) may act as an important fibrotic stimulus in diseased lungs. ER stress is observed in lungs of patients with idiopathic pulmonary fibrosis. In this study we evaluated if ER stress and the UPR was present in macrophages exposed to chrysotile asbestos and if ER stress in macrophages was associated with asbestos-induced pulmonary fibrosis. Macrophages exposed to chrysotile had elevated transcript levels of several ER stress genes. Macrophages loaded with the Ca2+-sensitive dye Fura2-AM showed that cytosolic Ca(2+)increased significantly within minutes after chrysotile exposure and remained elevated for a prolonged time. Chrysotile-induced increases in cytosolic Ca2+ were partially inhibited by either anisomycin, an inhibitor of passive Ca2+ leak from the ER, or 1,2-bis(2-aminophenoxyl)ethane-N,N,N',N'-tetraacetic acid (BAPTA-AM), an intracellular Ca2+ chelator known to deplete ER Ca2+ stores. Anisomycin inhibited X-box-binding protein 1 (XBP1) mRNA splicing and reduced immunoglobulin-binding protein (BiP) levels, whereas BAPTA-AM increased XBP1 splicing and BiP expression, suggesting that ER calcium depletion may be one factor contributing to ER stress in cells exposed to chrysotile. To evaluate ER stress in vivo, asbestos-exposed mice showed fibrosis development, and alveolar macrophages from fibrotic mice showed increased expression of BiP. Bronchoalveolar macrophages from asbestosis patients showed increased expression of several ER stress genes compared with normal subjects. These findings suggest that alveolar macrophages undergo ER stress, which is associated with fibrosis development.	[Ryan, Alan J.; Murthy, Shuhba; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Larson-Casey, Jennifer L.; He, Chao; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Larson-Casey, Jennifer L.; He, Chao; Carter, A. Brent] Univ Iowa, Carver Coll Med, Program Free Rad & Radiat Biol, Iowa City, IA 52242 USA; [Carter, A. Brent] Univ Iowa, Coll Publ Hlth, Dept Human Toxicol, Iowa City, IA 52242 USA; [Carter, A. Brent] Iowa City Vet Adm Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Carter, AB (corresponding author), Univ Iowa, Carver Coll Med, C33 GH, Iowa City, IA 52242 USA.	brent-carter@uiowa.edu	Casey, Jennifer/N-8385-2019	Casey, Jennifer/0000-0001-7238-7986	National Institutes of Health [2 ROI ES 015981-08, P30 CA086862]; Department of Veteran Affairs, Office of Research and Development, Biomedical Laboratory Research and Development [1 BX001135-01]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015981, P30ES005605] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran Affairs, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants 2 ROI ES 015981-08 and P30 CA086862 and by Merit Review from the Department of Veteran Affairs, Office of Research and Development, Biomedical Laboratory Research and Development Grant 1 BX001135-01.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Baek HA, 2012, AM J RESP CELL MOL, V46, P731, DOI 10.1165/rcmb.2011-0121OC; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858; Cawley K, 2011, METHOD ENZYMOL, V490, P31, DOI 10.1016/B978-0-12-385114-7.00002-7; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Dejeans N, 2010, BIOCHEM PHARMACOL, V79, P1221, DOI 10.1016/j.bcp.2009.12.009; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Flourakis M, 2006, FASEB J, V20, P1215, DOI 10.1096/fj.05-5254fje; Guidotti TL, 2004, AM J RESP CRIT CARE, V170, P691, DOI 10.1164/rccm.200310-1436ST; Hammadi M, 2013, FASEB J, V27, P1600, DOI 10.1096/fj.12-218875; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; He C, 2013, J BIOL CHEM, V288, P20745, DOI 10.1074/jbc.M112.410720; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Kamp DW, 2013, AM J RESP CELL MOL, V49, P892, DOI 10.1165/rcmb.2013-0053OC; Kaplan P, 2003, MOL CELL BIOCHEM, V248, P41, DOI 10.1023/A:1024145212616; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kiviluoto S, 2013, BBA-MOL CELL RES, V1833, P1612, DOI 10.1016/j.bbamcr.2013.01.026; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Lenna S, 2012, CURR OPIN RHEUMATOL, V24, P663, DOI 10.1097/BOR.0b013e3283588dbb; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Liu G, 2010, CHEM-BIOL INTERACT, V188, P309, DOI 10.1016/j.cbi.2010.03.047; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Maguire JA, 2011, AM J RESP CELL MOL, V44, P404, DOI 10.1165/rcmb.2009-0382OC; Maitra M, 2010, J BIOL CHEM, V285, P22103, DOI 10.1074/jbc.M110.121467; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Nakano T, 2006, CARDIOVASC RES, V69, P908, DOI 10.1016/j.cardiores.2005.11.023; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673; Osborn-Heaford HL, 2012, J BIOL CHEM, V287, P3301, DOI 10.1074/jbc.M111.308387; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Tanjore H, 2012, AM J PHYSIOL-LUNG C, V302, pL721, DOI 10.1152/ajplung.00410.2011; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Torres-Gonzalez E, 2012, AM J RESP CELL MOL, V46, P748, DOI 10.1165/rcmb.2011-0224OC; Van Coppenolle F, 2004, J CELL SCI, V117, P4135, DOI 10.1242/jcs.01274; Weigert A, 2006, BLOOD, V108, P1635, DOI 10.1182/blood-2006-04-014852; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yoshida I, 2006, NEUROCHEM INT, V48, P696, DOI 10.1016/j.neuint.2005.12.012	50	29	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33391	33403		10.1074/jbc.M114.579870	http://dx.doi.org/10.1074/jbc.M114.579870			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25324550	hybrid, Green Published			2022-12-28	WOS:000345636600029
J	Zhang, C; Zhuo, Y; Moniz, HA; Wang, S; Moremen, KW; Prestegard, JH; Brown, EM; Yang, JJ				Zhang, Chen; Zhuo, You; Moniz, Heather A.; Wang, Shuo; Moremen, Kelley W.; Prestegard, James H.; Brown, Edward M.; Yang, Jenny J.			Direct Determination of Multiple Ligand Interactions with the Extracellular Domain of the Calcium-sensing Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; CELL-SURFACE EXPRESSION; CA2+-SENSING RECEPTOR; SIGNAL-TRANSDUCTION; CA2+-BINDING SITES; CA2+ OSCILLATIONS; STRUCTURAL BASIS; BINDING-SITE; IDENTIFICATION; PROTEIN	Numerous in vivo functional studies have indicated that the dimeric extracellular domain (ECD) of the CaSR plays a crucial role in regulating Ca2+ homeostasis by sensing Ca2+ and L-Phe. However, direct interaction of Ca2+ and Phe with the ECD of the receptor and the resultant impact on its structure and associated conformational changes have been hampered by the large size of the ECD, its high degree of glycosylation, and the lack of biophysical methods to monitor weak interactions in solution. In the present study, we purified the glycosylated extracellular domain of calcium-sensing receptor (CaSR) (ECD) (residues 20-612), containing either complex or high mannose N-glycan structures depending on the host cell line employed for recombinant expression. Both glycosylated forms of the CaSR ECD were purified as dimers and exhibit similar secondary structures with similar to 50% beta-helix, similar to 20% beta-sheet content, and a well buried Trp environment. Using various spectroscopic methods, we have shown that both protein variants bind Ca2+ with a K-d of 3.0-5.0 mM. The local conformational changes of the proteins induced by their interactions with Ca2+ were visualized by NMR with specific N-15 Phe-labeled forms of the ECD. Saturation transfer difference NMR approaches demonstrated for the first time a direct interaction between the CaSR ECD and L-Phe. We further demonstrated that L-Phe increases the binding affinity of the CaSR ECD for Ca2+. Our findings provide new insights into the mechanisms by which Ca2+ and amino acids regulate the CaSR and may pave the way for exploration of the structural properties of CaSR and other members of family C of the GPCR superfamily.	[Zhang, Chen; Zhuo, You; Yang, Jenny J.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Zhang, Chen; Yang, Jenny J.] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA; [Moniz, Heather A.; Wang, Shuo; Moremen, Kelley W.; Prestegard, James H.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Moniz, Heather A.; Wang, Shuo; Moremen, Kelley W.; Prestegard, James H.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Brown, Edward M.] Brigham & Womens Hosp, Dept Med, Div Endocrinol, Boston, MA 02115 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Harvard University; Brigham & Women's Hospital	Yang, JJ (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.	jenny@gsu.edu	Moremen, Kelley/AAD-4661-2019		National Institutes of Health [GM081749, EB007268, P41GM103390, S10RR027097]; Center for Diagnostics and Therapeutics; Georgia Research Alliance; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, R01GM081749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Diagnostics and Therapeutics; Georgia Research Alliance; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081749 and EB007268 (to J. J. Y.), P41GM103390 (to K. W. M.), National Institutes of Health Instrumentation Grant S10RR027097 (to J. H. P.), a Center for Diagnostics and Therapeutics fellowship (to C. Z.), and funds from the Georgia Research Alliance.	Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bai M, 2004, CELL CALCIUM, V35, P197, DOI 10.1016/j.ceca.2003.10.018; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Breitwieser GE, 2006, CURR TOP DEV BIOL, V73, P85, DOI 10.1016/S0070-2153(05)73003-9; BROWN EM, 1991, J BONE MINER RES, V6, P1217; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Brown EM, 1998, ANNU REV MED, V49, P15, DOI 10.1146/annurev.med.49.1.15; Chang YH, 1999, ENDOCRINOLOGY, V140, P5883, DOI 10.1210/en.140.12.5883; Chattopadhyay N, 1997, BIOL CHEM, V378, P759; Cheng I, 1998, J CLIN ENDOCR METAB, V83, P703, DOI 10.1210/jc.83.2.703; Claridge T, 2009, J CHEM INF MODEL, V49, P1136, DOI 10.1021/ci900090d; Conigrave AD, 2000, TRENDS PHARMACOL SCI, V21, P401, DOI 10.1016/S0165-6147(00)01546-7; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conigrave AD, 2002, EUR J CLIN NUTR, V56, P1072, DOI 10.1038/sj.ejcn.1601463; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fan GF, 1998, FEBS LETT, V436, P353, DOI 10.1016/S0014-5793(98)01165-X; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; Goldsmith PK, 1999, J BIOL CHEM, V274, P11303, DOI 10.1074/jbc.274.16.11303; Huang Y, 2007, J BIOL CHEM, V282, P19000, DOI 10.1074/jbc.M701096200; Huang Y, 2010, J BIOL CHEM, V285, P35919, DOI 10.1074/jbc.M110.147918; Huang Y, 2009, BIOCHEMISTRY-US, V48, P388, DOI 10.1021/bi8014604; Jiang YS, 2010, J BIOL CHEM, V285, P33463, DOI 10.1074/jbc.M110.147033; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Liu S, 2007, CHEM BIOL, V14, P409, DOI 10.1016/j.chembiol.2007.02.010; Magno AL, 2011, BIOCHEM BIOPH RES CO, V412, P584, DOI 10.1016/j.bbrc.2011.07.132; Maniccia AW, 2006, BIOCHEMISTRY-US, V45, P5848, DOI 10.1021/bi052508q; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Monleon Daniel, 2002, Journal of Structural and Functional Genomics, V2, P93, DOI 10.1023/A:1020499629298; Mun HC, 2005, J BIOL CHEM, V280, P29067, DOI 10.1074/jbc.M500002200; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Quinn SJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1315, DOI 10.1152/ajpcell.1997.273.4.C1315; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rey O, 2005, J BIOL CHEM, V280, P22875, DOI 10.1074/jbc.M503455200; Riccardi D, 2002, EXP PHYSIOL, V87, P403, DOI 10.1111/j.1469-445X.2002.tb00053.x; ROBERTSON MA, 1978, CELL, V13, P515, DOI 10.1016/0092-8674(78)90325-2; Ryan ZC, 2006, BIOCHEM BIOPH RES CO, V349, P339, DOI 10.1016/j.bbrc.2006.08.047; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; SLAVIK J, 1982, BIOCHIM BIOPHYS ACTA, V694, P1, DOI 10.1016/0304-4157(82)90012-0; Streiff JH, 2004, MOL PHARMACOL, V66, P929, DOI 10.1124/mol.66.4.929; Tfelt-Hansen J, 2005, CRIT REV CL LAB SCI, V42, P35, DOI 10.1080/10408360590886606; Tfelt-Hansen J, 2003, FRONT BIOSCI-LANDMRK, V8, pS377, DOI 10.2741/1068; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Viegas A, 2011, J MED CHEM, V54, P8555, DOI 10.1021/jm201090k; Yazici D, 2011, ENDOCRINE, V40, P250, DOI 10.1007/s12020-011-9478-x; Young SH, 2002, AM J PHYSIOL-CELL PH, V282, pC1414, DOI 10.1152/ajpcell.00432.2001; Zhang C, 2014, J BIOL CHEM, V289, P5296, DOI 10.1074/jbc.M113.537357; Zhang ZX, 2002, J BIOL CHEM, V277, P33727, DOI 10.1074/jbc.M200976200	53	18	21	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33529	33542		10.1074/jbc.M114.604652	http://dx.doi.org/10.1074/jbc.M114.604652			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25305020	Green Published, hybrid			2022-12-28	WOS:000345636600040
J	Borg, A; Holm, M; Shiroyama, I; Hauryliuk, V; Pavlov, M; Sanyal, S; Ehrenberg, M				Borg, Anneli; Holm, Mikael; Shiroyama, Ikue; Hauryliuk, Vasili; Pavlov, Michael; Sanyal, Suparna; Ehrenberg, Mans			Fusidic Acid Targets Elongation Factor G in Several Stages of Translocation on the Bacterial Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EF-G; RNA TRANSLOCATION; PROTEIN SYNTHESIS; ESCHERICHIA-COLI; RIBONUCLEIC-ACID; TRANSLATION; HYDROLYSIS; RELEASE; STATE; TRIPHOSPHATE	The antibiotic fusidic acid (FA) targets elongation factor G (EF-G) and inhibits ribosomal peptide elongation and ribosome recycling, but deeper mechanistic aspects of FA action have remained unknown. Using quench flow and stopped flow experiments in a biochemical system for protein synthesis and taking advantage of separate time scales for inhibited (10 s) and uninhibited (100 ms) elongation cycles, a detailed kinetic model of FA action was obtained. FA targets EF-G at an early stage in the translocation process (I), which proceeds unhindered by the presence of the drug to a later stage (II), where the ribosome stalls. Stalling may also occur at a third stage of translocation(III), just before release of EF-G from the post-translocation ribosome. We show that FA is a strong elongation inhibitor (K-50% approximate to 1 mu M), discuss the identity of the FA targeted states, and place existing cryo-EM and crystal structures in their functional context.	[Borg, Anneli; Holm, Mikael; Shiroyama, Ikue; Hauryliuk, Vasili; Pavlov, Michael; Ehrenberg, Mans] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; [Borg, Anneli] 3H Biomed AB, S-75183 Uppsala, Sweden	Uppsala University	Ehrenberg, M (corresponding author), Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden.	ehrenberg@xray.bmc.uu.se	Hauryliuk, Vasili/J-3930-2019	Hauryliuk, Vasili/0000-0003-2389-5057	Swedish Research Council; Knut and Alice Wallenberg Foundation, RiboCORE; European Regional Development Fund through Centre of Excellence in Chemical Biology; Estonian Science Foundation [ETF9012, PUT37]; Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation, RiboCORE; European Regional Development Fund through Centre of Excellence in Chemical Biology; Estonian Science Foundation; Umea University	This work was supported by the Swedish Research Council (to M. E., A. B., S. S., and V. H.); the Knut and Alice Wallenberg Foundation, RiboCORE (to M. E. and S. S.); the European Regional Development Fund through Centre of Excellence in Chemical Biology, Estonian Science Foundation, Grants ETF9012 and PUT37 (to V. H.); and Umea University (to V. H.).	Antoun Ayman, 2004, Biol Proced Online, V6, P35, DOI 10.1251/bpo71; BODLEY JW, 1970, J BIOL CHEM, V245, P5662; Bremer H., 1996, E COLI SALMONELLA CE, V2, P1553; Burdett V, 1996, J BACTERIOL, V178, P3246, DOI 10.1128/jb.178.11.3246-3251.1996; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; Chen J, 2013, NAT STRUCT MOL BIOL, V20, P718, DOI 10.1038/nsmb.2567; CUNDLIFF.E, 1972, BIOCHEM BIOPH RES CO, V46, P1794, DOI 10.1016/0006-291X(72)90053-8; Fange D, 2011, BIOCHIMIE, V93, P1623, DOI 10.1016/j.biochi.2011.05.031; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; HIRASHIM.A, 1973, J BIOL CHEM, V248, P7580; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Johansson M, 2008, MOL CELL, V30, P589, DOI 10.1016/j.molcel.2008.04.010; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Keilson J., 1979, MARKOV CHAIN MODELS, P57; Kelmers A., 1971, METHODS ENZYMOL, V20, P3; OKURA A, 1971, J ANTIBIOT, V24, P655, DOI 10.7164/antibiotics.24.655; Pavlov MY, 1996, ARCH BIOCHEM BIOPHYS, V328, P9, DOI 10.1006/abbi.1996.0136; PESTKA S, 1968, P NATL ACAD SCI USA, V61, P726, DOI 10.1073/pnas.61.2.726; Ramrath DJF, 2013, P NATL ACAD SCI USA, V110, P20964, DOI 10.1073/pnas.1320387110; Rao AR, 2001, EMBO J, V20, P2977, DOI 10.1093/emboj/20.11.2977; Savelsbergh A, 2009, RNA, V15, P772, DOI 10.1261/rna.1592509; Semenkov YP, 2000, NAT STRUCT BIOL, V7, P1027; Studer SM, 2003, J MOL BIOL, V327, P369, DOI 10.1016/S0022-2836(03)00146-3; TANAKA N, 1968, BIOCHEM BIOPH RES CO, V30, P278, DOI 10.1016/0006-291X(68)90447-6; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; WILLIE GR, 1975, BIOCHEMISTRY-US, V14, P1713, DOI 10.1021/bi00679a025; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016	31	31	31	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3440	3454		10.1074/jbc.M114.611608	http://dx.doi.org/10.1074/jbc.M114.611608			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25451927	Green Published, hybrid			2022-12-28	WOS:000349456000020
J	Di Nardo, G; Breitner, M; Bandino, A; Ghosh, D; Jennings, GK; Hackett, JC; Gilardi, G				Di Nardo, Giovanna; Breitner, Maximilian; Bandino, Andrea; Ghosh, Debashis; Jennings, Gareth K.; Hackett, John C.; Gilardi, Gianfranco			Evidence for an Elevated Aspartate pK(a) in the Active Site of Human Aromatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN CHARACTERIZATION; INTRACELLULAR ACIDIFICATION; CONFORMATIONAL-CHANGE; CYTOCHROME-P450 19A1; HIPPOCAMPAL-NEURONS; STEROID AROMATASE; STRUCTURAL BASIS; AROMATIZATION; PH; HYDROXYLATION	Aromatase (CYP19A1), the enzyme that converts androgens to estrogens, is of significant mechanistic and therapeutic interest. Crystal structures and computational studies of this enzyme shed light on the critical role of Asp(309) in substrate binding and catalysis. These studies predicted an elevated pK(a) for Asp(309) and proposed that protonation of this residue was required for function. In this study, UV-visible absorption, circular dichroism, resonance Raman spectroscopy, and enzyme kinetics were used to study the impact of pH on aromatase structure and androstenedione binding. Spectroscopic studies demonstrate that androstenedione binding is pH-dependent, whereas, in contrast, theD309Nmutant retains its ability to bind to androstenedione across the entire pH range studied. Neither pH nor mutation perturbed the secondary structure or heme environment. The origin of the observed pH dependence was further narrowed to the protonation equilibria of Asp(309) with a parallel set of spectroscopic studies using exemestane and anastrozole. Because exemestane interacts with Asp(309) based on its co-crystal structure with the enzyme, its binding is pH-dependent. Aromatase binding to anastrozole is pH-independent, consistent with the hypothesis that this ligand exploits a distinct set of interactions in the active site. In summary, we assign the apparent pKa of 8.2 observed for androstenedione binding to the side chain of Asp(309). To our knowledge, this work represents the first experimental assignment of a pKa value to a residue in a cytochrome P450. This value is in agreement with theoretical calculations (7.78.1) despite the reliance of the computational methods on the conformational snapshots provided by crystal structures.	[Di Nardo, Giovanna; Breitner, Maximilian; Bandino, Andrea; Gilardi, Gianfranco] Univ Turin, Dept Life Sci & Syst Biol, I-10123 Turin, Italy; [Ghosh, Debashis] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Jennings, Gareth K.; Hackett, John C.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23219 USA; [Jennings, Gareth K.; Hackett, John C.] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23219 USA	University of Turin; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Virginia Commonwealth University; Virginia Commonwealth University	Hackett, JC (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, 401 Coll St, Richmond, VA 23219 USA.	jchackett@vcu.edu; gianfranco.gilardi@unito.it	Gilardi, Gianfranco/B-4523-2010; Gilardi, Gianfranco/M-3748-2019; Hackett, John/J-3871-2019	Gilardi, Gianfranco/0000-0002-6559-276X; Gilardi, Gianfranco/0000-0002-6559-276X; Hackett, John/0000-0002-4923-2668; Di Nardo, Giovanna/0000-0002-4169-2635	National Institutes of Health [R01GM092827, R01GM086893]; Italian Ministry of Education, Universities, and Research FIRB [RBFR12FI27_004]; United States Office of Naval Research [N000141210773]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092827, R01GM086893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Education, Universities, and Research FIRB(Ministry of Education, Universities and Research (MIUR)); United States Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM092827 (to J. C. H.) and R01GM086893 (to D. G.). This work was also supported by an Italian Ministry of Education, Universities, and Research FIRB grant (Project RBFR12FI27_004) (to G. D.) and United States Office of Naval Research Grant N000141210773 (to J. C. H.).	AKHTAR M, 1982, BIOCHEM J, V201, P569, DOI 10.1042/bj2010569; Brueggemeier RW, 2005, ENDOCR REV, V26, P331, DOI 10.1210/er.2004-0015; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Denisov IG, 2008, J PHYS CHEM A, V112, P13172, DOI 10.1021/jp8017875; Di Nardo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082118; Eilers PHC., 2005, BASELINE CORRECTION; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; Ghosh D, 2012, J MED CHEM, V55, P8464, DOI 10.1021/jm300930n; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; HARTLEY Z, 1993, J NEUROSCI, V13, P4690; HU SZ, 1991, J AM CHEM SOC, V113, P2843, DOI 10.1021/ja00008a007; IRWIN RP, 1994, J NEUROSCI, V14, P1352, DOI 10.1523/JNEUROSCI.14-03-01352.1994; Khatri Y, 2014, FEBS LETT, V588, P3117, DOI 10.1016/j.febslet.2014.06.050; LEPHART ED, 1991, METHOD ENZYMOL, V206, P477; Lo J, 2013, BIOCHEMISTRY-US, V52, P5821, DOI 10.1021/bi400669h; Maurelli S, 2011, CHEM COMMUN, V47, P10737, DOI 10.1039/c1cc13872c; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; OMURA T, 1964, J BIOL CHEM, V239, P2370; OSAWA Y, 1993, J STEROID BIOCHEM, V44, P469, DOI 10.1016/0960-0760(93)90252-R; Santen RJ, 2009, ENDOCR REV, V30, P343, DOI 10.1210/er.2008-0016; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; SCHWIENING CJ, 1993, P ROY SOC B-BIOL SCI, V253, P285, DOI 10.1098/rspb.1993.0115; Sen K, 2012, BIOCHEMISTRY-US, V51, P3039, DOI 10.1021/bi300017p; Silverstein TP, 2012, J CHEM EDUC, V89, P1474, DOI 10.1021/ed3000028; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; SMULEVICH G, 1988, BIOCHEMISTRY-US, V27, P5477, DOI 10.1021/bi00415a014; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; Takahashi KI, 1996, NEUROSCI RES, V24, P109, DOI 10.1016/0168-0102(95)00989-2; THOMPSON EA, 1974, J BIOL CHEM, V249, P5364; THOMPSON EA, 1974, J BIOL CHEM, V249, P5373; WANG GJ, 1994, J NEUROPHYSIOL, V72, P2563, DOI 10.1152/jn.1994.72.6.2563; Yoshimoto FK, 2014, J AM CHEM SOC, V136, P15016, DOI 10.1021/ja508185d; Yun CH, 1998, ARCH BIOCHEM BIOPHYS, V356, P229, DOI 10.1006/abbi.1998.0759; Yun CH, 1996, J BIOL CHEM, V271, P31312, DOI 10.1074/jbc.271.49.31312; Zhan RZ, 1998, BRAIN RES, V780, P86, DOI 10.1016/S0006-8993(97)01149-9	38	42	42	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1186	1196		10.1074/jbc.M114.595108	http://dx.doi.org/10.1074/jbc.M114.595108			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25425647	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000347778200048
J	Carr, R; Du, Y; Quoyer, J; Panettieri, RA; Janz, JM; Bouvier, M; Kobilka, BK; Benovic, JL				Carr, Richard, III; Du, Yang; Quoyer, Julie; Panettieri, Reynold A., Jr.; Janz, Jay M.; Bouvier, Michel; Kobilka, Brian K.; Benovic, Jeffrey L.			Development and Characterization of Pepducins as G(s)-biased Allosteric Agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; BETA-ARRESTIN; CRYSTAL-STRUCTURE; INTRACELLULAR LOOP; LIGAND BIAS; PROTEIN; ACTIVATION; PHOSPHORYLATION; DESENSITIZATION; INTERNALIZATION	The beta(2)-adrenergic receptor (beta(2)AR) is a prototypical G protein-coupled receptor that mediates many hormonal responses, including cardiovascular and pulmonary function. beta-Agonists used to combat hypercontractility in airway smooth muscle stimulate beta(2)AR-dependent cAMP production that ultimately promotes airway relaxation. Chronic stimulation of the beta(2)ARby long acting beta-agonists used in the treatment of asthma can promote attenuated responsiveness to agonists and an increased frequency of fatal asthmatic attacks. beta(2)AR desensitization to beta-agonists is primarily mediated by G protein-coupled receptor kinases and beta-arrestins that attenuate receptor-G(s) coupling and promote beta(2)AR internalization and degradation. A biased agonist that can selectively stimulate G(s) signaling without promoting receptor interaction with G protein-coupled receptor kinases and beta-arrestins should serve as an advantageous asthma therapeutic. To identify such molecules, we screened similar to 50 lipidated peptides derived from the intracellular loops of the beta(2)AR, known as pepducins. This screen revealed two classes of G(s)-biased pepducins, receptor-independent and receptor-dependent, as well as several beta-arrestin-biased pepducins. The receptor-independent G(s)-biased pepducins operate by directly stimulating G protein activation. In contrast, receptor-dependent G(s)-biased pepducins appear to stabilize a G(s)-biased conformation of the beta(2)AR that couples to G(s) but does not undergo G protein-coupled receptor kinase-mediated phosphorylation or beta-arrestin-mediated internalization. Functional studies in primary human airway smooth muscle cells demonstrate that G(s)-biased pepducins are not subject to conventional desensitization and thus may be good candidates for the development of next generation asthma therapeutics. Our study reports the first G(s)-biased activator of the beta(2)AR and provides valuable tools for the study of beta(2)AR function.	[Carr, Richard, III; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Du, Yang; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Quoyer, Julie; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Quoyer, Julie; Bouvier, Michel] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Panettieri, Reynold A., Jr.] Univ Penn, Perelman Sch Med, Airways Biol Initiat, Dept Med,Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Janz, Jay M.] Anchor Therapeut, Cambridge, MA 02139 USA	Jefferson University; Stanford University; Universite de Montreal; Universite de Montreal; University of Pennsylvania; Pennsylvania Medicine	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St,926 BLSB, Philadelphia, PA 19107 USA.	jeffrey.benovic@jefferson.edu	panettieri, reynold/AAG-9485-2019; Bouvier, Michel/H-2758-2014	Bouvier, Michel/0000-0003-1128-0100; Kobilka, Brian/0000-0001-5958-3990	National Institutes of Health [R37 GM047417, R01 GM044944, P01 HL114471, P30 ES013508, T32 GM100836]; Canadian Institute for Health Research Grant [CIHR-11215]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM100836, R01GM044944, R37GM047417, R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Health Research Grant(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 GM047417 and R01 GM044944 (to J. L. B.), P01 HL114471 (to J. L. B. and R. A. P.), P30 ES013508 (to R. A. P.), and T32 GM100836 (to R. C.). This work was also supported by Canadian Institute for Health Research Grant CIHR-11215 (to M. B.).	Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2011, TRENDS PHARMACOL SCI, V32, P227, DOI 10.1016/j.tips.2011.02.010; Baltoumas FA, 2013, J STRUCT BIOL, V182, P209, DOI 10.1016/j.jsb.2013.03.004; BRIL A, 1992, CARDIOVASC RES, V26, P518, DOI 10.1093/cvr/26.5.518; Cazzola M, 2011, BRIT J PHARMACOL, V163, P4, DOI 10.1111/j.1476-5381.2011.01216.x; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHEUNG AH, 1991, FEBS LETT, V279, P277, DOI 10.1016/0014-5793(91)80167-2; CHIDIAC P, 1994, MOL PHARMACOL, V45, P490; Cooper PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010235; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Erickson CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071980; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Hamdan FF, 2005, J BIOMOL SCREEN, V10, P463, DOI 10.1177/1087057105275344; Hollingsworth JW, 2010, AM J RESP CELL MOL, V43, P269, DOI 10.1165/rcmb.2009-0198OC; January B, 1998, BRIT J PHARMACOL, V123, P701, DOI 10.1038/sj.bjp.0701658; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Kaneider NC, 2005, NAT MED, V11, P661, DOI 10.1038/nm1245; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Lee HY, 2010, FEBS LETT, V584, P4102, DOI 10.1016/j.febslet.2010.08.036; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Licht T, 2003, BLOOD, V102, P2099, DOI 10.1182/blood-2002-12-3634; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2014, MOL ENDOCRINOL, V28, P281, DOI 10.1210/me.2013-1314; McMahon AW, 2011, PEDIATRICS, V128, pE1147, DOI 10.1542/peds.2010-1720; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; O'Callaghan K, 2012, J BIOL CHEM, V287, P12787, DOI 10.1074/jbc.R112.355461; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Poirier L, 2014, CAN J CARDIOL, V30, pS9, DOI 10.1016/j.cjca.2013.12.001; Quoyer J, 2013, P NATL ACAD SCI USA, V110, pE5088, DOI 10.1073/pnas.1312515110; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Remsberg JR, 2007, J MED CHEM, V50, P4534, DOI 10.1021/jm0705657; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; RUFFOLO RR, 1993, CARDIOLOGY, V82, P24; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SAMAMA P, 1994, MOL PHARMACOL, V45, P390; Schellenberg R, 2008, HEADACHE, V48, P118, DOI 10.1111/j.1526-4610.2007.00785.x; Staus DP, 2014, MOL PHARMACOL, V85, P472, DOI 10.1124/mol.113.089516; Tchernychev B, 2010, P NATL ACAD SCI USA, V107, P22255, DOI 10.1073/pnas.1009633108; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zocher M, 2012, STRUCTURE, V20, P1391, DOI 10.1016/j.str.2012.05.010	59	55	56	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35668	35684		10.1074/jbc.M114.618819	http://dx.doi.org/10.1074/jbc.M114.618819			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25395624	Green Published, hybrid			2022-12-28	WOS:000346897900001
J	Jung, SK; Lee, MH; Lim, DY; Kim, JE; Singh, P; Lee, SY; Jeong, CH; Lim, TG; Chen, HY; Chi, YI; Kundu, JK; Lee, NH; Lee, CC; Cho, YY; Bode, AM; Lee, KW; Dong, ZG				Jung, Sung Keun; Lee, Mee-Hyun; Lim, Do Young; Kim, Jong Eun; Singh, Puja; Lee, Sung-Young; Jeong, Chul-Ho; Lim, Tae-Gyu; Chen, Hanyong; Chi, Young-In; Kundu, Joydeb Kumar; Lee, Nam Hyouck; Lee, Charles C.; Cho, Yong-Yeon; Bode, Ann M.; Lee, Ki Won; Dong, Zigang			Isoliquiritigenin Induces Apoptosis and Inhibits Xenograft Tumor Growth of Human Lung Cancer Cells by Targeting Both Wild Type and L858R/T790M Mutant EGFR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE INHIBITORS; MET AMPLIFICATION; RESISTANCE; PROLIFERATION; ANTIOXIDANT; EXPRESSION; GEFITINIB; MUTATION; PATHWAY; ROOTS	Non-small-cell lung cancer (NSCLC) is associated with diverse genetic alterations including mutation of epidermal growth factor receptor (EGFR). Isoliquiritigenin (ILQ), a chalcone derivative, possesses anticancer activities. In the present study, we investigated the effects of ILQ on the growth of tyrosine kinase inhibitor (TKI)-sensitive and -resistant NSCLC cells and elucidated its underlying mechanisms. Treatment with ILQ inhibited growth and induced apoptosis in both TKI-sensitive and -resistant NSCLC cells. ILQ-induced apoptosis was associated with the cleavage of caspase-3 and poly-(ADP-ribose)-polymerase, increased expression of Bim, and reduced expression of Bcl-2. In vitro kinase assay results revealed that ILQ inhibited the catalytic activity of both wild type and double mutant (L858R/T790M) EGFR. Treatment with ILQ inhibited the anchorage-independent growth of NIH3T3 cells stably transfected with either wild type or double-mutant EGFR with or without EGF stimulation. ILQ also reduced the phosphorylation of Akt and ERK1/2 in both TKI-sensitive and -resistant NSCLC cells, and attenuated the kinase activity of Akt1 and ERK2 in vitro. ILQ directly interacted with both wild type and double-mutant EGFR in an ATP-competitive manner. A docking model study showed that ILQ formed two hydrogen bonds (Glu-762 and Met-793) with wild type EGFR and three hydrogen bonds (Lys-745, Met-793, and Asp-855) with mutant EGFR. ILQ attenuated the xenograft tumor growth of H1975 cells, which was associated with decreased expression of Ki-67 and diminished phosphorylation of Akt and ERK1/2. Taken together, ILQ suppresses NSCLC cell growth by directly targeting wild type or mutant EGFR.	[Jung, Sung Keun; Lee, Mee-Hyun; Lim, Do Young; Kim, Jong Eun; Singh, Puja; Lee, Sung-Young; Jeong, Chul-Ho; Lim, Tae-Gyu; Chen, Hanyong; Chi, Young-In; Lee, Charles C.; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Jung, Sung Keun; Lee, Nam Hyouck] Korea Food Res Inst, Div Metab & Funct Res, Songnam 463746, Gyeonggi Do, South Korea; [Lee, Mee-Hyun; Cho, Yong-Yeon] Catholic Univ Korea, Coll Pharm, Puchon 420743, Gyeonggi Do, South Korea; [Kim, Jong Eun; Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, Gyeonggi Do, South Korea; [Jeong, Chul-Ho; Kundu, Joydeb Kumar] Keimyung Univ, Coll Pharm, Taegu 704701, South Korea; [Lim, Tae-Gyu; Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul 151921, South Korea; [Lim, Tae-Gyu; Lee, Ki Won] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 151742, South Korea; [Lee, Charles C.] Cornell Univ, Dept Food Sci, Ithaca, NY 14850 USA; [Lee, Ki Won] Seoul Natl Univ, Inst Green Bio Sci & Technol, Res Inst Bio Food Ind, Pyeongchang 232916, South Korea	University of Minnesota System; Korea Food Research Institute (KFRI); Catholic University of Korea; Seoul National University (SNU); Keimyung University; Seoul National University (SNU); Seoul National University (SNU); Cornell University; Seoul National University (SNU)	Lee, KW (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea.	kiwon@snu.ac.kr; zgdong@hi.umn.edu	Cho, Yong-Yeon/AAD-4263-2020; Lee, Ki Won/M-4114-2018; kim, jong-eun/B-3550-2017; Lim, Tae-Gyu/AAO-8475-2020	kim, jong-eun/0000-0002-5030-6126; Lim, Tae-Gyu/0000-0001-6930-9565; Cho, Yong-Yeon/0000-0003-1107-2651	National Institutes of Health [CA1669011, CA172457, R37 CA081064, ES016548]; National Research Foundation of Korea (NRF) grant - Korea government (MEST), Republic of Korea [2010-0029233]; Korea Food Research Institute, Republic of Korea; NATIONAL CANCER INSTITUTE [R37CA081064, R21CA172457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF) grant - Korea government (MEST), Republic of Korea(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); Korea Food Research Institute, Republic of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from National Institutes of Health CA1669011, CA172457, R37 CA081064, and ES016548, by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2010-0029233), Republic of Korea, and by the Korea Food Research Institute, Republic of Korea.	[Anonymous], 2011, SCHROD; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Carrera S, 2014, CLIN TRANSL ONCOL, V16, P339, DOI 10.1007/s12094-013-1143-9; Chen XZ, 2012, J MOL MED, V90, P1311, DOI 10.1007/s00109-012-0910-3; Chin YW, 2007, J AGR FOOD CHEM, V55, P4691, DOI 10.1021/jf0703553; Cuendet M, 2010, CANCER PREV RES, V3, P221, DOI 10.1158/1940-6207.CAPR-09-0049; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Haraguchi H, 1998, BIOORGAN MED CHEM, V6, P339, DOI 10.1016/S0968-0896(97)10034-7; Hsu YL, 2005, LIFE SCI, V77, P279, DOI 10.1016/j.lfs.2004.09.047; Hsu YL, 2004, CLIN EXP PHARMACOL P, V31, P414, DOI 10.1111/j.1440-1681.2004.04016.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Kim JY, 2008, EUR J PHARMACOL, V584, P175, DOI 10.1016/j.ejphar.2008.01.032; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwon GT, 2009, J NUTR BIOCHEM, V20, P663, DOI 10.1016/j.jnutbio.2008.06.005; Ladanyi M, 2008, MODERN PATHOL, V21, pS16, DOI 10.1038/modpathol.3801018; Li RC, 2014, INT J BIOL MARKER, V29, pE112, DOI 10.5301/jbm.5000059; Li T, 2004, CANCER LETT, V207, P27, DOI 10.1016/j.canlet.2003.10.023; Li Y, 2013, TOXICOL APPL PHARM, V272, P37, DOI 10.1016/j.taap.2013.05.031; Ma Chunyan, 2011, J Thorac Dis, V3, P10, DOI 10.3978/j.issn.2072-1439.2010.12.02; Nguyen TTT, 2004, CARCINOGENESIS, V25, P647, DOI 10.1093/carcin/bgh052; Pallis AG, 2013, LUNG CANCER, V80, P120, DOI 10.1016/j.lungcan.2012.12.025; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sacco PC, 2014, FRONT BIOSCI-LANDMRK, V19, P259, DOI 10.2741/4205; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wang KL, 2013, EXPERT OPIN THER TAR, V17, P337, DOI 10.1517/14728222.2013.756869; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056459; West L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031906; Yamazaki S, 2002, CANCER LETT, V183, P23, DOI 10.1016/S0304-3835(02)00113-1; Yuan X, 2012, J ASIAN NAT PROD RES, V14, P789, DOI 10.1080/10286020.2012.694873; Zhang XY, 2010, CLIN EXP PHARMACOL P, V37, P841, DOI 10.1111/j.1440-1681.2010.05395.x; Zhou GS, 2013, MOL MED REP, V7, P531, DOI 10.3892/mmr.2012.1218; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	37	75	81	1	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35839	35848		10.1074/jbc.M114.585513	http://dx.doi.org/10.1074/jbc.M114.585513			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25368326	hybrid, Green Published			2022-12-28	WOS:000346897900015
J	Terada, K; Horinouchi, T; Fujioka, Y; Higashi, T; Nepal, P; Horiguchi, M; Karki, S; Hatate, C; Hoshi, A; Harada, T; Mai, Y; Ohba, Y; Miwa, S				Terada, Koji; Horinouchi, Takahiro; Fujioka, Yoichiro; Higashi, Tsunehito; Nepal, Prabha; Horiguchi, Mika; Karki, Sarita; Hatate, Chizuru; Hoshi, Akimasa; Harada, Takuya; Mai, Yosuke; Ohba, Yusuke; Miwa, Soichi			Agonist-promoted Ubiquitination Differentially Regulates Receptor Trafficking of Endothelin Type A and Type B Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Endothelin; Lysosome; Trafficking; Ubiquitination	PROTEASE-ACTIVATED RECEPTOR-1; DOWN-REGULATION; BETA(2)-ADRENERGIC RECEPTOR; CARDIOVASCULAR-DISEASE; COUPLED RECEPTORS; ETA-RECEPTOR; DEGRADATION; EXPRESSION; SUBTYPE; CLONING	Two types of G protein-coupled receptors for endothelin-1 (ET-1), ET type A receptor (ETAR) and ETBR, closely resemble each other, but upon ET-1 stimulation, they follow totally different intracellular trafficking pathways; ETAR is recycled back to plasma membrane, whereas ETBR is targeted to lysosome for degradation. However, the mechanisms for such different fates are unknown. Here we demonstrated that ETBR but not ETAR was ubiquitinated on the cell surface following ET-1 stimulation and that ETBR was internalized and degraded in lysosome more rapidly than ETAR. The mutant ETBR (designated 5KR mutant) in which 5 lysine residues in the C-tail were substituted to arginine was not ubiquitinated, and its rates of internalization and degradation after ET-1 stimulation became slower, being comparable with those of ETAR. Confocal microscopic study showed that following ET-1 stimulation, ETAR and 5KR mutant of ETBR were co-localized mainly with Rab11, a marker of recycling endosome, whereas ETBR was co-localized with Rab7, a marker of late endosome/lysosome. In the 5KR mutant, ET-1-induced ERK phosphorylation and an increase in the intracellular Ca2+ concentration upon repetitive ET-1 stimulation were larger. A series of ETBR mutants (designated 4KR mutant), in which either one of 5 arginine residues of the 5KR mutant was reverted to lysine, were normally ubiquitinated, internalized, and degraded, with ERK phosphorylation being normalized. These results demonstrate that agonist-induced ubiquitination at either lysine residue in the C-tail of ETBR but not ETAR switches intracellular trafficking from recycling to plasma membrane to targeting to lysosome, causing decreases in the cell surface level of ETBR and intracellular signaling.	[Terada, Koji; Horinouchi, Takahiro; Higashi, Tsunehito; Nepal, Prabha; Horiguchi, Mika; Karki, Sarita; Hatate, Chizuru; Hoshi, Akimasa; Harada, Takuya; Mai, Yosuke; Miwa, Soichi] Hokkaido Univ, Grad Sch Med, Dept Cellular Pharmacol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Fujioka, Yoichiro; Ohba, Yusuke] Hokkaido Univ, Grad Sch Med, Dept Cell Physiol, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Hokkaido University; Hokkaido University	Miwa, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Cellular Pharmacol, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	smiwa@med.hokudai.ac.jp	洋輔, 眞井/GVS-5202-2022; Fujioka, Yoichiro/AAF-3313-2019	Fujioka, Yoichiro/0000-0002-5760-9357	Japan Society for the Promotion of Science [24390059, 25670123, 25460326]; Smoking Research Foundation of Japan; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research [25670184, 26293041] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation of Japan; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aids for Scientific Research (B) 24390059 (to S. M.), Challenging Exploratory Research 25670123 (to S. M.), and Scientific Research (C) 25460326 (to K. T.) from the Japan Society for the Promotion of Science and in part by grants from the Smoking Research Foundation of Japan (to S. M.) and the Suzuken Memorial Foundation (to K. T.).	Abe Y, 2000, J BIOL CHEM, V275, P8664, DOI 10.1074/jbc.275.12.8664; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; Bohm F, 2002, ARTERIOSCL THROM VAS, V22, P674, DOI 10.1161/01.ATV.0000012804.63152.60; Bremnes T, 2000, J BIOL CHEM, V275, P17596, DOI 10.1074/jbc.M000142200; Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776; Cottrell GS, 2006, J BIOL CHEM, V281, P27773, DOI 10.1074/jbc.M603369200; DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797; Fujioka Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3763; FUKURODA T, 1994, BIOCHEM BIOPH RES CO, V199, P1461, DOI 10.1006/bbrc.1994.1395; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Henry AG, 2012, DEV CELL, V23, P519, DOI 10.1016/j.devcel.2012.08.003; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Horinouchi T, 2007, EUR J PHARMACOL, V566, P28, DOI 10.1016/j.ejphar.2007.03.019; Horinouchi T, 2013, J PHARMACOL SCI, V123, P85, DOI 10.1254/jphs.13R02CR; Horinouchi T, 2012, BIOCHEM BIOPH RES CO, V428, P252, DOI 10.1016/j.bbrc.2012.10.034; Horinouchi T, 2012, J PHARMACOL EXP THER, V340, P143, DOI 10.1124/jpet.111.187500; Iwasa S, 1999, ATHEROSCLEROSIS, V146, P93, DOI 10.1016/S0021-9150(99)00134-3; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Kawanabe Y, 2002, MOL PHARMACOL, V61, P277, DOI 10.1124/mol.61.2.277; Kobayashi T, 2000, PATHOL INT, V50, P929, DOI 10.1046/j.1440-1827.2000.01152.x; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Li JG, 2008, MOL PHARMACOL, V73, P1319, DOI 10.1124/mol.107.042846; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Nishimoto A, 2010, BIOCHEM BIOPH RES CO, V391, P1616, DOI 10.1016/j.bbrc.2009.12.087; Nishiya T, 2011, J BIOL CHEM, V286, P9009, DOI 10.1074/jbc.M110.190678; Okamoto Y, 1997, J BIOL CHEM, V272, P21589, DOI 10.1074/jbc.272.34.21589; Oksche A, 2000, MOL PHARMACOL, V57, P1104; Paasche JD, 2001, J BIOL CHEM, V276, P34041, DOI 10.1074/jbc.M103243200; Sakai S, 1996, NATURE, V384, P353, DOI 10.1038/384353a0; SAKAMOTO A, 1991, BIOCHEM BIOPH RES CO, V178, P656, DOI 10.1016/0006-291X(91)90158-4; SAKAMOTO A, 1993, J BIOL CHEM, V268, P8547; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; TAKAGI Y, 1995, J BIOL CHEM, V270, P10072, DOI 10.1074/jbc.270.17.10072; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; YANAGISAWA M, 1989, BIOCHEM PHARMACOL, V38, P1877; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	45	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35283	35295		10.1074/jbc.M113.544171	http://dx.doi.org/10.1074/jbc.M113.544171			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25381251	hybrid, Green Published			2022-12-28	WOS:000346660200021
J	Sharma, J; Baker, ST; Turgeon, SM; Gurney, AM; Opperman, KJ; Grill, B				Sharma, Jaiprakash; Baker, Scott T.; Turgeon, Shane M.; Gurney, Allison M.; Opperman, Karla J.; Grill, Brock			Identification of a Peptide Inhibitor of the RPM-1.FSN-1 Ubiquitin Ligase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						axon; Caenorhabditis elegans (C; elegans); Cell Signaling; Neurodegeneration; Ubiquitin Ligase; F-box; FSN-1; Neuronal Development	REGULATES AXON TERMINATION; MAP KINASE PATHWAY; C-ELEGANS RPM-1; CAENORHABDITIS-ELEGANS; SYNAPSE FORMATION; REGENERATION REQUIRES; WALLENDA/DLK KINASE; FORMATION REVEALS; BINDING-PROTEIN; HIGHWIRE	Background: How RPM-1 interacts with FSN-1 remains unknown. Results: Structure-function and transgenic analysis define the biochemical relationship between RPM-1 and FSN-1. Conclusion: RPM-1 uses a conserved mechanism to bind FSN-1 that is independent of RPM-1 ubiquitin ligase activity. Significance: Our biochemical and genetic analysis has led to identification of RIP, an in vivo inhibitor of the RPM-1FSN-1 ubiquitin ligase complex. The Pam/Highwire/RPM-1 (PHR) proteins include: Caenorhabditis elegans RPM-1 (Regulator of Presynaptic Morphology 1), Drosophila Highwire, and murine Phr1. These important regulators of neuronal development function in synapse formation, axon guidance, and axon termination. In mature neurons the PHR proteins also regulate axon degeneration and regeneration. PHR proteins function, in part, through an ubiquitin ligase complex that includes the F-box protein FSN-1 in C. elegans and Fbxo45 in mammals. At present, the structure-function relationships that govern formation of this complex are poorly understood. We cloned 9 individual domains that compose the entire RPM-1 protein sequence and found a single domain centrally located in RPM-1 that is sufficient for binding to FSN-1. Deletion analysis further refined FSN-1 binding to a conserved 97-amino acid region of RPM-1. Mutagenesis identified several conserved motifs and individual amino acids that mediate this interaction. Transgenic overexpression of this recombinant peptide, which we refer to as the RPM-1FSN-1 complex inhibitory peptide (RIP), yields similar phenotypes and enhancer effects to loss of function in fsn-1. Defects caused by transgenic RIP were suppressed by loss of function in the dlk-1 MAP3K and were alleviated by point mutations that reduce binding to FSN-1. These findings suggest that RIP specifically inhibits the interaction between RPM-1 and FSN-1 in vivo, thereby blocking formation of a functional ubiquitin ligase complex. Our results are consistent with the FSN-1 binding domain of RPM-1 recruiting FSN-1 and a target protein, such as DLK-1, whereas the RING-H2 domain of RPM-1 ubiquitinates the target.	[Sharma, Jaiprakash; Baker, Scott T.; Turgeon, Shane M.; Opperman, Karla J.; Grill, Brock] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Baker, Scott T.; Gurney, Allison M.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	Scripps Research Institute; University of Minnesota System; University of Minnesota Twin Cities	Grill, B (corresponding author), Scripps Res Inst Florida, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA.	bgrill@scripps.edu		Grill, Brock/0000-0002-0379-3267	National Institutes of Health [R01 NS072129]; National Science Foundation [IOS-1121095]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS072129 (to B. G.). This work was also supported by National Science Foundation Grant IOS-1121095 (to B. G.).	Babetto E, 2013, CELL REP, V3, P1422, DOI 10.1016/j.celrep.2013.04.013; Baker ST, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004297; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Brace EJ, 2014, J NEUROSCI, V34, P8398, DOI 10.1523/JNEUROSCI.4715-13.2014; BRENNER S, 1974, GENETICS, V77, P71; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Ch'ng' Q, 2003, GENETICS, V164, P1355; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Culican SM, 2009, MOL CELL NEUROSCI, V41, P304, DOI 10.1016/j.mcn.2009.04.001; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Grill B, 2012, J NEUROSCI, V32, P2628, DOI 10.1523/JNEUROSCI.2901-11.2012; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Huntwork-Rodriguez S, 2013, J CELL BIOL, V202, P747, DOI 10.1083/jcb.201303066; Kim JH, 2013, NEURON, V78, P827, DOI 10.1016/j.neuron.2013.05.020; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Li DJ, 2005, J NEUROSCI, V25, P1914, DOI 10.1523/JNEUROSCI.4790-04.2005; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nix P, 2011, P NATL ACAD SCI USA, V108, P10738, DOI 10.1073/pnas.1104830108; Po MD, 2010, CURR OPIN NEUROBIOL, V20, P100, DOI 10.1016/j.conb.2009.12.007; Refai O, 2013, G3-GENES GENOM GENET, V3, P2015, DOI 10.1534/g3.113.008466; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Shin JE, 2011, J NEUROSCI, V31, P17689, DOI 10.1523/JNEUROSCI.3902-11.2011; Tian XL, 2011, NAT NEUROSCI, V14, P1267, DOI 10.1038/nn.2922; Tulgren ED, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004481; Tulgren ED, 2011, GENETICS, V189, P1297, DOI 10.1534/genetics.111.134791; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Xiong X, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001440; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	38	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34654	34666		10.1074/jbc.M114.614065	http://dx.doi.org/10.1074/jbc.M114.614065			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25326385	Green Published, hybrid			2022-12-28	WOS:000346260800023
J	Xie, R; Dong, X; Wong, C; Vallon, V; Tang, B; Sun, J; Yang, SM; Dong, H				Xie, Rui; Dong, Xiao; Wong, Chase; Vallon, Volker; Tang, Bo; Sun, Jun; Yang, Shiming; Dong, Hui			Molecular Mechanisms of Calcium-sensing Receptor-mediated Calcium Signaling in the Modulation of Epithelial Ion Transport and Bicarbonate Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bicarbonate; Calcium; Calcium Channel; Calcium Imaging; Epithelial Cell; G Protein-Coupled Receptor (GPCR); Calcium-sensing Receptor; Cytosolic Ca2+ Concentrations; Transepithelial HCO3-secretion; Receptor-Op	EXTRACELLULAR CA2+-SENSING RECEPTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; CA2+-DEPENDENT CL-SECRETION; CHLORIDE SECRETION; FLUID SECRETION; CYSTIC-FIBROSIS; HCO3-TRANSPORT; GASTRIC-ACID; MUCOSAL PROTECTION; COLONIC EPITHELIUM	Background: Calcium-sensing receptor (CaSR) plays a critical role in the regulation of epithelial ion transport. Results: CaSR activators induce Ca2+ signaling and duodenal bicarbonate secretion (DBS). Conclusion: CaSR triggers Ca2+-dependent DBS, likely through receptor-operated channels, intermediate conductance Ca2+-activated K+ channels, and the cystic fibrosis transmembrane conductance regulator. Significance: Dietary CaSR activators may modulate the physiological process of DBS that is critical for duodenal mucosal protection. Epithelial ion transport is mainly under the control of intracellular cAMP and Ca2+ signaling. Although the molecular mechanisms of cAMP-induced epithelial ion secretion are well defined, those induced by Ca2+ signaling remain poorly understood. Because calcium-sensing receptor (CaSR) activation results in an increase in cytosolic Ca2+ ([Ca2+](cyt)) but a decrease in cAMP levels, it is a suitable receptor for elucidating the mechanisms of [Ca2+](cyt)-mediated epithelial ion transport and duodenal bicarbonate secretion (DBS). CaSR proteins have been detected in mouse duodenal mucosae and human intestinal epithelial cells. Spermine and Gd3+, two CaSR activators, markedly stimulated DBS without altering duodenal short circuit currents in wild-type mice but did not affect DBS and duodenal short circuit currents in cystic fibrosis transmembrane conductance regulator (CFTR) knockout mice. Clotrimazole, a selective blocker of intermediate conductance Ca2+-activated K+ channels but not chromanol 293B, a selective blocker of cAMP-activated K+ channels (KCNQ1), significantly inhibited CaSR activator-induced DBS, which was similar in wild-type and KCNQ1 knockout mice. HCO<sub arrange="stack">3<sup arrange="stack">- fluxes across epithelial cells were activated by a CFTR activator, but blocked by a CFTR inhibitor. CaSR activators induced HCO<sub arrange="stack">3<sup arrange="stack">- fluxes, which were inhibited by a receptor-operated channel (ROC) blocker. Moreover, CaSR activators dose-dependently raised cellular [Ca2+](cyt), which was abolished in Ca2+-free solutions and inhibited markedly by selective CaSR antagonist calhex 231, and ROC blocker in both animal and human intestinal epithelial cells. Taken together, CaSR activation triggers Ca2+-dependent DBS, likely through the ROC, intermediate conductance Ca2+-activated K+ channels, and CFTR channels. This study not only reveals that [Ca2+](cyt) signaling is critical to modulate DBS but also provides novel insights into the molecular mechanisms of CaSR-mediated Ca2+-induced DBS.	[Xie, Rui; Tang, Bo; Yang, Shiming; Dong, Hui] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing 400037, Peoples R China; [Dong, Xiao; Wong, Chase; Vallon, Volker; Dong, Hui] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Vallon, Volker] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92161 USA; [Xie, Rui] Zunyi Med Coll, Affiliated Hosp, Dept Gastroenterol, Zunyi 563003, Peoples R China; [Sun, Jun] Rush Univ, Dept Biochem, Chicago, IL 60612 USA; [Sun, Jun] Rush Univ, Dept Internal Med GI, Chicago, IL 60612 USA; [Sun, Jun] Rush Univ, Dept Microbiol Immunol, Chicago, IL 60612 USA	Army Medical University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Zunyi Medical University; Rush University; Rush University; Rush University	Yang, SM (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing 400037, Peoples R China.	shimingyang@yahoo.com; h2dong@ucsd.ed	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133; Vallon, Volker/0000-0002-9211-2063	National Institutes of Health [HL094728]; National Natural Science Foundation of China [31371167]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL094728. This work was also supported by National Natural Science Foundation of China Grant 31371167 (to H. D.) and by the Department of Veterans Affairs (to V. V.).	Akiba Y, 2009, AM J PHYSIOL-GASTR L, V297, pG781, DOI 10.1152/ajpgi.90605.2008; Allen A, 2005, AM J PHYSIOL-CELL PH, V288, pC1, DOI 10.1152/ajpcell.00102.2004; Bachmann O, 2006, AM J PHYSIOL-GASTR L, V291, pG650, DOI 10.1152/ajpgi.00376.2005; Barrett KE, 1998, AM J PHYSIOL-CELL PH, V274, pC958, DOI 10.1152/ajpcell.1998.274.4.C958; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bett GCL, 2006, J PHYSIOL-LONDON, V576, P755, DOI 10.1113/jphysiol.2006.116012; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; BROWN EM, 1995, CELL, V83, P679, DOI 10.1016/0092-8674(95)90180-9; Bruce JIE, 1999, J BIOL CHEM, V274, P20561, DOI 10.1074/jbc.274.29.20561; Buresi MC, 2005, AM J PHYSIOL-GASTR L, V288, pG337, DOI 10.1152/ajpgi.00112.2004; Buresi MC, 2002, FASEB J, V16, P1515, DOI 10.1096/fj.02-0039com; Buresi MC, 2001, AM J PHYSIOL-GASTR L, V281, pG323, DOI 10.1152/ajpgi.2001.281.2.G323; Buret A, 2008, J PARASITOL, V94, P545, DOI 10.1645/GE-1395.1; Casimiro MC, 2001, P NATL ACAD SCI USA, V98, P2526, DOI 10.1073/pnas.041398998; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chattopadhyay N, 1998, AM J PHYSIOL-GASTR L, V274, pG122, DOI 10.1152/ajpgi.1998.274.1.G122; Cheng SX, 2012, AM J PHYSIOL-GASTR L, V303, pG60, DOI 10.1152/ajpgi.00425.2011; Cheng SX, 2002, AM J PHYSIOL-GASTR L, V283, pG240, DOI 10.1152/ajpgi.00500.2001; COHEN ME, 1991, J CLIN INVEST, V88, P855, DOI 10.1172/JCI115387; COHEN ME, 1990, P NATL ACAD SCI USA, V87, P8990, DOI 10.1073/pnas.87.22.8990; Condliffe SB, 2001, J PHYSIOL-LONDON, V530, P47, DOI 10.1111/j.1469-7793.2001.0047m.x; Devor DC, 1997, AM J PHYSIOL-CELL PH, V273, pC531, DOI 10.1152/ajpcell.1997.273.2.C531; Dong H, 2005, AM J PHYSIOL-GASTR L, V288, pG457, DOI 10.1152/ajpgi.00381.2004; Dong H, 2006, AM J PHYSIOL-GASTR L, V291, pG1120, DOI 10.1152/ajpgi.00566.2005; FLEMSTROM G, 1982, AM J PHYSIOL, V242, pG183, DOI 10.1152/ajpgi.1982.242.3.G183; Flemstrom G, 2001, NEWS PHYSIOL SCI, V16, P23; FLEMSTROM G, 1980, ACTA PHYSIOL SCAND, V110, P419, DOI 10.1111/j.1748-1716.1980.tb06689.x; GARNER A, 1978, AM J PHYSIOL, V234, pE535, DOI 10.1152/ajpendo.1978.234.6.E535; Geibel J, 2006, P NATL ACAD SCI USA, V103, P9390, DOI 10.1073/pnas.0602996103; Geibel JP, 2009, ANNU REV PHYSIOL, V71, P205, DOI 10.1146/annurev.physiol.010908.163128; Goebel SU, 2000, J CLIN ENDOCR METAB, V85, P4131, DOI 10.1210/jc.85.11.4131; HEBERT SC, 1995, CURR OPIN CELL BIOL, V7, P484, DOI 10.1016/0955-0674(95)80004-2; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; ISENBERG JI, 1987, NEW ENGL J MED, V316, P374, DOI 10.1056/NEJM198702123160704; Jepps TA, 2009, AM J PHYSIOL-GASTR L, V297, pG107, DOI 10.1152/ajpgi.00057.2009; Jung J, 2014, CELL CALCIUM, V55, P376, DOI 10.1016/j.ceca.2014.02.002; Lee RJ, 2014, CELL CALCIUM, V55, P325, DOI 10.1016/j.ceca.2014.02.001; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Lee WK, 2008, AM J PHYSIOL-CELL PH, V294, pC879, DOI 10.1152/ajpcell.00490.2007; Maleth J, 2014, CELL CALCIUM, V55, P337, DOI 10.1016/j.ceca.2014.02.004; Namkung W, 2003, J BIOL CHEM, V278, P200, DOI 10.1074/jbc.M207199200; NEGULESCU PA, 1990, METHOD ENZYMOL, V192, P38; Pang G, 1996, GASTROENTEROLOGY, V111, P8, DOI 10.1053/gast.1996.v111.pm8698229; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pratha VS, 2000, GASTROENTEROLOGY, V118, P1051, DOI 10.1016/S0016-5085(00)70358-1; Putney JW, 2007, CELL CALCIUM, V42, P103, DOI 10.1016/j.ceca.2007.01.011; Quinn SJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1315, DOI 10.1152/ajpcell.1997.273.4.C1315; RICCARDI D, 1995, P NATL ACAD SCI USA, V92, P131, DOI 10.1073/pnas.92.1.131; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; Seidler U, 1997, J PHYSIOL-LONDON, V505, P411, DOI 10.1111/j.1469-7793.1997.411bb.x; Seidler UE, 2013, CURR OPIN PHARMACOL, V13, P900, DOI 10.1016/j.coph.2013.10.001; Sheinin Y, 2000, J HISTOCHEM CYTOCHEM, V48, P595, DOI 10.1177/002215540004800503; Smith A, 2008, ENDOCRINOLOGY, V149, P4554, DOI 10.1210/en.2007-1597; Smith AJ, 2006, FASEB J, V20, P2486, DOI 10.1096/fj.06-6391com; Tuo BG, 2004, AM J PHYSIOL-GASTR L, V286, pG444, DOI 10.1152/ajpgi.00105.2003; Tuo BG, 2009, BRIT J PHARMACOL, V158, P1313, DOI 10.1111/j.1476-5381.2009.00398.x; Villalba N, 2007, AM J PHYSIOL-HEART C, V292, pH1157, DOI 10.1152/ajpheart.01034.2006; Weston AH, 2005, CIRC RES, V97, P391, DOI 10.1161/01.RES.0000178787.59594.a0	60	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34642	34653		10.1074/jbc.M114.592774	http://dx.doi.org/10.1074/jbc.M114.592774			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25331955	hybrid, Green Published			2022-12-28	WOS:000346260800022
J	Zhao, FP; Xu, G; Zhou, YQ; Wang, LY; Xie, JJ; Ren, S; Liu, S; Zhu, Y				Zhao, Fanpeng; Xu, Gang; Zhou, Yaqin; Wang, Lvyin; Xie, Jiajia; Ren, Sheng; Liu, Shi; Zhu, Ying			MicroRNA-26b Inhibits Hepatitis B Virus Transcription and Replication by Targeting the Host Factor CHORDC1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hepatitis Virus; Host-Pathogen Interaction; Infectious Disease; MicroRNA (miRNA); Viral Transcription; CHORDC1; Hepatitis B Virus; Host Factor; MicroRNA-26b; Viral Infection	GENE-EXPRESSION; CARCINOMA; DISEASE; CANCER; HETEROZYGOSITY; RESISTANCE; INFECTION; APOPTOSIS; SEQUENCE; ENHANCER	Background: Disordered miR-26b expression has been linked to the development of many diseases induced by hepatitis B virus (HBV). Results: miR-26b inhibits HBV replication, and HBV infection suppresses miR-26b expression. Conclusion: miR-26b acts as a host restriction factor to attenuate HBV transcription and replication. Significance: The functional interplay between HBV infection and miR-26b may influence the outcome of viral proliferation and virus-induced diseases. Hepatitis B virus (HBV) causes acute and chronic hepatitis in humans, and HBV infection is a major threat to global health. HBV replication is regulated by a series of host factors, including microRNAs (miRNAs), which are highly conserved small noncoding RNAs that participate in a variety of physiological and pathological processes. Here, we report that a chemically synthesized mimic of miR-26b inhibited HBV antigen expression, transcription, and replication, whereas antisense knockdown of endogenous miR-26b enhanced HBV replication in HepG2 cells. Overexpression and knockdown experiments showed that miR-26b significantly decreased HBV enhancer/promoter activities. We identified the cysteine- and histidine-rich domain containing 1 (CHORDC1) as a novel host factor target of miR-26b. CHORDC1 protein but not mRNA was markedly decreased by miR-26b overexpression via base-pairing with complementary sequences in the 3UTR of its mRNA. Overexpression and knockdown studies showed that CHORDC1 increased viral antigen expression, transcription, and replication by elevating HBV enhancer/promoter activities. Conversely, HBV infection suppressed miR-26b expression and increased CHORDC1 protein levels in human liver cells. Another mature miRNA of the hsa-miR-26 family, miR-26a, had a similar function as miR-26b in targeting CHORDC1 and affecting HBV production. These results suggest that suppression of miR-26b expression up-regulates its target gene CHORDC1, which increases HBV enhancer/promoter activities and promotes viral transcription, gene expression, and replication. Our study could provide new insights into miRNA expression and the persistence of HBV infection.	[Zhao, Fanpeng; Xu, Gang; Zhou, Yaqin; Wang, Lvyin; Xie, Jiajia; Ren, Sheng; Liu, Shi; Zhu, Ying] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Zhu, Y (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China.	yingzhu@whu.edu.cn	Zhao, Fanpeng/X-9816-2019		Major State Basic Research Development Program of China [2013CB911102]; National Natural Science Foundation of China [81461130019, 81271821]; National Mega Project on Major Infectious Diseases Prevention [2012ZX10004503-004]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Diseases Prevention	This work was supported by Major State Basic Research Development Program of China Grant 2013CB911102, National Natural Science Foundation of China Grants 81461130019 and 81271821, and National Mega Project on Major Infectious Diseases Prevention Grant 2012ZX10004503-004.	Absalon S, 2013, J NEUROSCI, V33, P14645, DOI 10.1523/JNEUROSCI.1327-13.2013; ANTONUCCI TK, 1989, J VIROL, V63, P579, DOI 10.1128/JVI.63.2.579-583.1989; Arora H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023802; Bakre A, 2012, J GEN VIROL, V93, P2346, DOI 10.1099/vir.0.044255-0; Brancaccio M, 2003, FEBS LETT, V551, P47, DOI 10.1016/S0014-5793(03)00892-5; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Doitsh G, 2004, MOL CELL BIOL, V24, P1799, DOI 10.1128/MCB.24.4.1799-1808.2004; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Ferretti R, 2010, DEV CELL, V18, P486, DOI 10.1016/j.devcel.2009.12.020; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Gao J, 2011, ONCOL LETT, V2, P1019, DOI 10.3892/ol.2011.413; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Guo HY, 2011, HEPATOLOGY, V54, P808, DOI 10.1002/hep.24441; Hong TJ, 2013, J BIOL CHEM, V288, P215, DOI 10.1074/jbc.M112.398636; Hoppe-Seyler K, 2012, HEPATOLOGY, V56, P9, DOI 10.1002/hep.25602; Hu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034165; Huang S, 2011, BRIT J CANCER, V104, P235, DOI 10.1038/sj.bjc.6606010; Jackson R. J., 2007, SCI STKE, V2007, pe1; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Li SP, 2001, J HEPATOL, V34, P840, DOI 10.1016/S0168-8278(01)00047-2; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu SC, 2002, MOL CARCINOGEN, V34, P131, DOI 10.1002/mc.10057; Liu XX, 2011, FEBS LETT, V585, P1363, DOI 10.1016/j.febslet.2011.04.018; Michowski W, 2010, BBA-MOL CELL RES, V1803, P1043, DOI 10.1016/j.bbamcr.2010.05.005; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shang LM, 2006, J BIOL CHEM, V281, P1876, DOI 10.1074/jbc.M509901200; Shirasu K, 1999, CELL, V99, P355, DOI 10.1016/S0092-8674(00)81522-6; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; SU H, 1992, P NATL ACAD SCI USA, V89, P2708, DOI 10.1073/pnas.89.7.2708; Thiagalingam S, 2002, CURR OPIN ONCOL, V14, P65, DOI 10.1097/00001622-200201000-00012; Thirion M, 2013, VIRUSES-BASEL, V5, P2690, DOI 10.3390/v5112690; Verghese ET, 2013, J PATHOL, V231, P388, DOI 10.1002/path.4248; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wang YL, 2013, J BIOL CHEM, V288, P18484, DOI 10.1074/jbc.M113.458158; WILL H, 1987, J VIROL, V61, P904, DOI 10.1128/JVI.61.3.904-911.1987; Wu JC, 2005, FEBS LETT, V579, P421, DOI 10.1016/j.febslet.2004.12.005; Wu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016264; Yue X, 2012, J IMMUNOL, V189, P279, DOI 10.4049/jimmunol.1103405; Zhang CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069963; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	46	37	40	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					35029	35041		10.1074/jbc.M114.589978	http://dx.doi.org/10.1074/jbc.M114.589978			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342750	hybrid, Green Published			2022-12-28	WOS:000346260800050
J	Li, SM; Wang, LR; Zhao, QW; Liu, Y; He, LJ; Xu, QQ; Sun, X; Teng, L; Cheng, HQ; Ke, YH				Li, Shuomin; Wang, Linrun; Zhao, Qingwei; Liu, Yu; He, Lingjuan; Xu, Qinqin; Sun, Xu; Teng, Li; Cheng, Hongqiang; Ke, Yuehai			SHP2 Positively Regulates TGF beta 1-induced Epithelial-Mesenchymal Transition Modulated by Its Novel Interacting Protein Hook1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epithelial to Mesenchymal Transition; Epithelial-Mesenchymal Transition (EMT); Metastasis; Protein Phosphatase; Protein-Protein Interaction; Hook1; Mesenchymal; Protein-tyrosine Phosphatase; shp2	TYROSINE-PHOSPHATASE SHP-2; CELL-DIFFERENTIATION; NOONAN-SYNDROME; CRYSTAL-STRUCTURE; PTPN11 MUTATIONS; CANCER CELLS; MUTANT MICE; GENE; METASTASIS; ACTIVATION	Background: SHP2 regulates cancer development and progression. Results: SHP2 promotes TGF1-induced EMT requiring its phosphatase activity. PTP and N-SH2 domains of SHP2 interact with Hook1, which negatively regulates TGF1-induced EMT. Conclusion: SHP2-Hook1 complex regulates TGF1-induced EMT. Significance: SHP2 plays important roles in tumor metastases due to promoting EMT in cancer cells. The epithelial-mesenchymal transition (EMT) is an essential process for embryogenesis. It also plays a critical role in the initiation of tumor metastasis. Src homology 2 (SH2)-domain containing protein-tyrosine phosphatase-2 (SHP2) is a ubiquitously expressed protein-tyrosine phosphatase and is mutated in many tumors. However, its functional role in tumor metastasis remains largely unknown. We found that TGF1-induced EMT in lung epithelial A549 cells was partially blocked when SHP2 was decreased by transfected siRNA. The constitutively active form (E76V) promoted EMT while the phosphatase-dead mutation (C459S) and the SHP2 inhibitor PHPS1 blocked EMT, which further demonstrated that the phosphatase activity of SHP2 was required for promoting TGF1-induced EMT. Using the protein-tyrosine phosphatase domain of SHP2 as bait, we identified a novel SHP2-interacting protein Hook1. Hook1 was down-regulated during EMT in A549 cells. Overexpression of Hook1 inhibited EMT while knockdown of Hook1 promoted EMT. Moreover, both the protein-tyrosine phosphatase domain and N-terminal SH2 domain of SHP2 directly interacted with Hook1. Down-regulation of Hook1 increased SHP2 activity. These results suggested that Hook1 was an endogenous negative regulator of SHP2 phosphatase activity. Our data showed that the protein-tyrosine phosphatase SHP2 was involved in the process of EMT and Hook1 repressed EMT by regulating the activation of SHP2. SHP2-Hook1 complex may play important roles in tumor metastases by regulating EMT in cancer cells.	[Li, Shuomin; Liu, Yu; Xu, Qinqin; Sun, Xu; Teng, Li; Cheng, Hongqiang; Ke, Yuehai] Zhejiang Univ, Sch Med, Program Mol Cell Biol, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Linrun; Zhao, Qingwei; He, Lingjuan] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Cheng, Hongqiang; Ke, Yuehai] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Cheng, HQ (corresponding author), Zhejiang Univ, Sch Med, Program Mol Cell Biol, Dept Pathol & Pathophysiol, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	hqcheng11@zju.edu.cn; yke@zju.edu.cn	Xu, Qinqin/I-2202-2019; li, shuomin/D-2019-2015		State Ministry of Science and Technology of China [2010CB912004]; National Natural Science Foundation of China [81101662, 81090421]	State Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major Research Program of the State Ministry of Science and Technology of China (2010CB912004, to Y. K.) and the National Natural Science Foundation of China (81101662, to Q. Z.; 81090421, to Y. K.).	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bowen ME, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002050; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chan RJ, 2003, BLOOD, V102, P2074, DOI 10.1182/blood-2003-04-1171; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; Cunnick JM, 2002, J BIOL CHEM, V277, P9498, DOI 10.1074/jbc.M110547200; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Feng GS, 2012, CANCER CELL, V21, P150, DOI 10.1016/j.ccr.2012.01.001; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Gaillard CLB, 2011, MOL BIOL CELL, V22, P4549, DOI 10.1091/mbc.E11-05-0405; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Inagaki K, 2000, ONCOGENE, V19, P75, DOI 10.1038/sj.onc.1203204; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Ke YH, 2006, J BIOL CHEM, V281, P34374, DOI 10.1074/jbc.M607325200; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kramer H, 1999, GENETICS, V151, P675; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; Li FF, 2012, J IMMUNOL, V189, P3159, DOI 10.4049/jimmunol.1200197; Li Shuangwei, 2012, Front Med, V6, P275, DOI 10.1007/s11684-012-0216-4; Martinelli S, 2008, HUM MOL GENET, V17, P2018, DOI 10.1093/hmg/ddn099; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; MEISTRICH ML, 1990, AM J ANAT, V188, P74, DOI 10.1002/aja.1001880109; MEISTRICH ML, 1994, MOL REPROD DEV, V37, P69, DOI 10.1002/mrd.1080370110; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Oyanagi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053209; Qin XJ, 2012, ALLERGY, V67, P1547, DOI 10.1111/all.12048; Qu CK, 1998, ONCOGENE, V17, P433, DOI 10.1038/sj.onc.1201920; Qu CK, 2002, BBA-MOL CELL RES, V1592, P297, DOI 10.1016/S0167-4889(02)00322-1; Qu CK, 2000, CELL RES, V10, P279, DOI 10.1038/sj.cr.7290055; Qu CK, 2001, BLOOD, V97, P911, DOI 10.1182/blood.V97.4.911; Sobreira NLM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000991; Tang YN, 2011, CELL RES, V21, P316, DOI 10.1038/cr.2010.126; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; Wright JH, 1997, MOL BIOL CELL, V8, P1575, DOI 10.1091/mbc.8.8.1575; Xu L, 2008, MOL BIOL CELL, V19, P5059, DOI 10.1091/mbc.E08-05-0473; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhou XD, 2008, CELL DEATH DIFFER, V15, P988, DOI 10.1038/cdd.2008.54	53	36	39	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34152	34160		10.1074/jbc.M113.546077	http://dx.doi.org/10.1074/jbc.M113.546077			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25331952	Green Published, hybrid			2022-12-28	WOS:000346077600039
J	Gahl, RF; He, Y; Yu, SQ; Tjandra, N				Gahl, Robert F.; He, Yi; Yu, Shiqin; Tjandra, Nico			Conformational Rearrangements in the Pro-apoptotic Protein, Bax, as It Inserts into Mitochondria A CELLULAR DEATH SWITCH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2; TRANSLOCATION; FAMILY; PORE; OLIGOMERIZE; MEMBRANES; BCL-X(L); CYTOSOL; HELIX	The B-cell lymphoma 2 (Bcl-2) family of proteins regulates the activation of apoptosis through the mitochondria pathway. Pro-and anti-apoptotic members of this family keep each other in check until the correct time to commit to apoptosis. The point of no return for this commitment is the permeabilization of the outer mitochondrial membrane. Translocation of the pro-apoptotic member, Bax, from the cytosol to the mitochondria is the molecular signature of this event. We employed a novel method to reliably detect Forster resonance energy transfer (FRET) between pairs of fluorophores to identify intra-molecular conformational changes and inter-molecular contacts in Bax as this translocation occurs in live cells. In the cytosol, our FRET measurement indicated that the C-terminal helix is exposed instead of tucked away in the core of the protein. In addition fluorescence correlation spectroscopy (FCS) showed that cytosolic Bax diffuses much slower than expected, suggesting possible complex formation or transient membrane interaction. Cross-linking the C-terminal helix (alpha 9) to helix alpha 4 reduced the potential of those interactions to occur. After translocation, our FRET measurements showed that Bax molecules form homo-oligomers in the mitochondria through two distinct interfaces involving the BH3 domain (helix alpha 2) and the C-terminal helix. These findings have implications for possible contacts with other Bcl-2 proteins necessary for the regulation of apoptosis.	[Gahl, Robert F.; He, Yi; Yu, Shiqin; Tjandra, Nico] NHLBI, Lab Mol Biophys, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tjandra, N (corresponding author), 50 South Dr,Bldg 50,Rm 3503, Bethesda, MD 20892 USA.	tjandran@nhlbi.nih.gov	He, Yi/AAL-5658-2020		Intramural Research Program of the National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006064] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the National Institutes of Health, NHLBI.	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Czabotar PE, 2011, J BIOL CHEM, V286, P7123, DOI 10.1074/jbc.M110.161281; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Ding JZ, 2014, J BIOL CHEM, V289, P11873, DOI 10.1074/jbc.M114.552562; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gahl RF, 2014, METHODS, V66, P180, DOI 10.1016/j.ymeth.2013.07.011; Garcia-Saez AJ, 2012, CELL DEATH DIFFER, V19, P1733, DOI 10.1038/cdd.2012.105; Garcia-Saez AJ, 2006, FEBS J, V273, P971, DOI 10.1111/j.1742-4658.2006.05123.x; Garcia-Saez AJ, 2005, BIOPHYS J, V88, P3976, DOI 10.1529/biophysj.104.058008; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Haustein E, 2003, METHODS, V29, P153, DOI 10.1016/S1046-2023(02)00306-7; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; Polster BM, 2003, J NEUROSCI, V23, P2735; Sassone J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.300; Schellenberg B, 2013, MOL CELL, V49, P959, DOI 10.1016/j.molcel.2012.12.022; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tait SWG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008706; Tatulian SA, 2012, BIOCHEMISTRY-US, V51, P9406, DOI 10.1021/bi301195f; Todt F, 2013, CELL DEATH DIFFER, V20, P333, DOI 10.1038/cdd.2012.131; Vogel S, 2012, J BIOL CHEM, V287, P9112, DOI 10.1074/jbc.M111.248906; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Walensky LD, 2011, TRENDS BIOCHEM SCI, V36, P642, DOI 10.1016/j.tibs.2011.08.009; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	36	51	52	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.593897	http://dx.doi.org/10.1074/jbc.M114.593897			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25315775	Green Published, hybrid			2022-12-28	WOS:000345335000040
J	Mansour, W; Nakasone, MA; von Delbruck, M; Yu, ZL; Krutauz, D; Reis, N; Kleifeld, O; Sommer, T; Fushman, D; Glickman, MH				Mansour, Wissam; Nakasone, Mark A.; von Delbrueck, Maximilian; Yu, Zanlin; Krutauz, Daria; Reis, Noa; Kleifeld, Oded; Sommer, Thomas; Fushman, David; Glickman, Michael H.			Disassembly of Lys(11) and Mixed Linkage Polyubiquitin Conjugates Provides Insights into Function of Proteasomal Deubiquitinases Rpn11 and Ubp6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; UBIQUITINATED PROTEINS ACTIVATE; 26S PROTEASOME; CRYSTAL-STRUCTURE; ENZYME USP14; REGULATORY PARTICLE; SUBUNIT RPN11; CHAINS; DEGRADATION; BINDING	Protein homeostasis is largely dependent on proteolysis by the ubiquitin-proteasome system. Diverse polyubiquitin modifications are reported to target cellular proteins to the proteasome. At the proteasome, deubiquitination is an essential preprocessing event that contributes to degradation efficiency. We characterized the specificities of two proteasome-associated deubiquitinases (DUBs), Rpn11 and Ubp6, and explored their impact on overall proteasome DUB activity. This was accomplished by constructing a panel of well defined ubiquitin (Ub) conjugates, including homogeneous linkages of varying lengths as well as a heterogeneously modified target. Rpn11 and Ubp6 processed Lys(11) and Lys(63) linkages with comparable efficiencies that increased with chain length. In contrast, processing of Lys(48) linkages by proteasome was inversely correlated to chain length. Fluorescently labeled tetra-Ub chains revealed endo-chain preference for Ubp6 acting on Lys(48) and random action for Rpn11. Proteasomes were more efficient at deconjugating identical substrates than their constituent DUBs by roughly 2 orders of magnitude. Incorporation into proteasomes significantly enhanced enzymatic efficiency of Rpn11, due in part to alleviation of the autoinhibitory role of its C terminus. The broad specificity of Rpn11 could explain how proteasomes were more effective at disassembling a heterogeneously modified conjugate compared with homogeneous Lys(48)-linked chains. The reduced ability to disassemble homogeneous Lys(48)-linked chains longer than 4 Ub units may prolong residency time on the proteasome.	[Mansour, Wissam; Nakasone, Mark A.; Yu, Zanlin; Krutauz, Daria; Reis, Noa; Glickman, Michael H.] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Nakasone, Mark A.; Fushman, David] Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA; [von Delbrueck, Maximilian; Sommer, Thomas] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Kleifeld, Oded] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia	Technion Israel Institute of Technology; University System of Maryland; University of Maryland College Park; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Monash University	Glickman, MH (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	glickman@tx.technion.ac.il	Nakasone, Mark A./ABD-2173-2021	Nakasone, Mark A./0000-0002-1362-191X; Glickman, Michael/0000-0002-1222-8104; Yu, Zanlin/0000-0001-8381-8788	National Institutes of Health [GM065334, GM095755]; USA-Israel Binational Science Foundation; Deutsch-Israel Program grant; ISF council for higher education outstanding minority (VATAT) fellowship; Fulbright postdoctoral fellowship; Aly Kaufman Fellowship Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095755, R01GM065334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USA-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Deutsch-Israel Program grant; ISF council for higher education outstanding minority (VATAT) fellowship; Fulbright postdoctoral fellowship; Aly Kaufman Fellowship Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM065334 (to D. F.) and GM095755 (to D. F. and M. H. G.). This work was also supported by a USA-Israel Binational Science Foundation grant (to D. F. and M. H. G.) and a Deutsch-Israel Program grant (to T. S. and M. H. G.).; Supported in part by an ISF council for higher education outstanding minority (VATAT) fellowship.; Supported in part by a Fulbright postdoctoral fellowship and the Aly Kaufman Fellowship Trust.	Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Bagola K, 2013, MOL CELL, V50, P528, DOI 10.1016/j.molcel.2013.04.005; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Berndsen CE, 2011, ANAL BIOCHEM, V418, P102, DOI 10.1016/j.ab.2011.06.034; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Butler LR, 2012, EMBO J, V31, P3918, DOI 10.1038/emboj.2012.232; Cannon J, 2012, ANAL CHEM, V84, P10121, DOI 10.1021/ac302675y; Castaneda CA, 2013, STRUCTURE, V21, P1168, DOI 10.1016/j.str.2013.04.029; Chandra A, 2010, CURR GENET, V56, P543, DOI 10.1007/s00294-010-0321-3; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; D'Arcy P, 2012, INT J BIOCHEM CELL B, V44, P1729, DOI 10.1016/j.biocel.2012.07.011; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Dammer EB, 2011, J BIOL CHEM, V286, P10457, DOI 10.1074/jbc.M110.149633; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; Dikic I, 2009, NAT STRUCT MOL BIOL, V16, P1208, DOI 10.1038/nsmb1209-1209; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Eletr ZM, 2014, BBA-MOL CELL RES, V1843, P114, DOI 10.1016/j.bbamcr.2013.06.027; Feng L, 2010, J BIOL CHEM, V285, P30982, DOI 10.1074/jbc.M110.135392; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Fushman David, 2011, F1000 Biol Rep, V3, P26, DOI 10.3410/B3-26; Gallery M, 2007, MOL CANCER THER, V6, P262, DOI 10.1158/1535-7163.MCT-06-0542; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 2004, PLOS BIOL, V2, P25, DOI 10.1371/journal.pbio.0020013; Glickman MH, 2000, MOL B INT U, V12, P71; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Jung H, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.28; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HT, 2009, EMBO J, V28, P1867, DOI 10.1038/emboj.2009.115; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Komander D, 2010, SUBCELL BIOCHEM, V54, P69, DOI 10.1007/978-1-4419-6676-6_6; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kraut DA, 2007, TRENDS CELL BIOL, V17, P419, DOI 10.1016/j.tcb.2007.06.008; Kravtsova-Ivantsiv Y, 2013, ANGEW CHEM INT EDIT, V52, P192, DOI 10.1002/anie.201205656; Krutauz D, 2014, NAT CHEM BIOL, V10, P664, DOI [10.1038/NCHEMBIO.1574, 10.1038/nchembio.1574]; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee Byung-Hoon, 2012, Curr Protoc Chem Biol, V4, P311, DOI 10.1002/9780470559277.ch120078; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lin DYW, 2011, J BIOL CHEM, V286, P441, DOI 10.1074/jbc.M110.167643; Lingaraju GM, 2014, NATURE, V512, P161, DOI 10.1038/nature13566; Liu NN, 2014, SCI REP-UK, V4, DOI 10.1038/srep05240; Locke M, 2014, BIOCHEM J, V459, P205, DOI 10.1042/BJ20120662; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Nag DK, 2012, VIRUS RES, V165, P103, DOI 10.1016/j.virusres.2012.01.009; Nakasone MA, 2013, STRUCTURE, V21, P727, DOI 10.1016/j.str.2013.02.019; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Qin S, 2009, NUCLEIC ACIDS RES, V37, P1843, DOI 10.1093/nar/gkn1049; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rinaldi T, 2004, BIOCHEM J, V381, P275, DOI 10.1042/BJ20040008; Rinaldi T, 2008, MOL BIOL CELL, V19, P1022, DOI 10.1091/mbc.E07-07-0717; Rogov VV, 2012, CHEMBIOCHEM, V13, P959, DOI 10.1002/cbic.201200045; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schaefer JB, 2011, J BIOL CHEM, V286, P45186, DOI 10.1074/jbc.M111.310094; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Tanaka K, 2012, BIOL CHEM, V393, P217, DOI 10.1515/hsz-2011-0285; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tian Z, 2014, BLOOD, V123, P706, DOI 10.1182/blood-2013-05-500033; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Volk S, 2005, METHOD ENZYMOL, V399, P3, DOI 10.1016/S0076-6879(05)99001-0; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Wu N, 2013, INT J MOL SCI, V14, P10749, DOI 10.3390/ijms140610749; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ziv I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009753	101	33	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4688	4704		10.1074/jbc.M114.568295	http://dx.doi.org/10.1074/jbc.M114.568295			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25389291	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000350042000013
J	Berkut, AA; Peigneur, S; Myshkin, MY; Paramonov, AS; Lyukmanova, EN; Arseniev, AS; Grishin, EV; Tytgat, J; Shenkarev, ZO; Vassilevski, AA				Berkut, Antonina A.; Peigneur, Steve; Myshkin, Mikhail Yu.; Paramonov, Alexander S.; Lyukmanova, Ekaterina N.; Arseniev, Alexander S.; Grishin, Eugene V.; Tytgat, Jan; Shenkarev, Zakhar O.; Vassilevski, Alexander A.			Structure of Membrane-active Toxin from Crab Spider Heriaeus melloteei Suggests Parallel Evolution of Sodium Channel Gating Modifiers in Araneomorphae and Mygalomorphae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Ion Channel; Neurotoxin; Nuclear Magnetic Resonance (NMR); Sodium Channel; Toxin; Channel Activation; Gating Modifiers; Inhibitor Cystine Knot; Spider Toxins	JINGZHAOTOXIN-III BETA-TRTX-CJ1-ALPHA; SCORPION ALPHA-TOXINS; VOLTAGE-SENSOR; HUWENTOXIN-IV; TARANTULA TOXINS; ION-CHANNEL; DOMAIN-II; FUNCTIONAL-CHARACTERIZATION; POTASSIUM CHANNEL; MOLECULAR-BASIS	Background: Several toxins from mygalomorph spiders are known to inhibit sodium channel activation. Results: Hm-3 toxin from the araneomorph spider Heriaeus melloteei inhibits mammalian and insect sodium channel activation and possesses membrane activity. Conclusion: Hm-3 binds to sodium channel voltage sensors through membrane access. Significance: The first sodium channel activation inhibitor from Araneomorphae points to parallel evolution of H. melloteei and its distant mygalomorph relatives. We present a structural and functional study of a sodium channel activation inhibitor from crab spider venom. Hm-3 is an insecticidal peptide toxin consisting of 35 amino acid residues from the spider Heriaeus melloteei (Thomisidae). We produced Hm-3 recombinantly in Escherichia coli and determined its structure by NMR spectroscopy. Typical for spider toxins, Hm-3 was found to adopt the so-called inhibitor cystine knot or knottin fold stabilized by three disulfide bonds. Its molecule is amphiphilic with a hydrophobic ridge on the surface enriched in aromatic residues and surrounded by positive charges. Correspondingly, Hm-3 binds to both neutral and negatively charged lipid vesicles. Electrophysiological studies showed that at a concentration of 1 m Hm-3 effectively inhibited a number of mammalian and insect sodium channels. Importantly, Hm-3 shifted the dependence of channel activation to more positive voltages. Moreover, the inhibition was voltage-dependent, and strong depolarizing prepulses attenuated Hm-3 activity. The toxin is therefore concluded to represent the first sodium channel gating modifier from an araneomorph spider and features a membrane access mechanism of action. Its amino acid sequence and position of the hydrophobic cluster are notably different from other known gating modifiers from spider venom, all of which are described from mygalomorph species. We hypothesize parallel evolution of inhibitor cystine knot toxins from Araneomorphae and Mygalomorphae suborders.	[Berkut, Antonina A.; Myshkin, Mikhail Yu.; Paramonov, Alexander S.; Lyukmanova, Ekaterina N.; Arseniev, Alexander S.; Grishin, Eugene V.; Shenkarev, Zakhar O.; Vassilevski, Alexander A.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia; [Berkut, Antonina A.; Myshkin, Mikhail Yu.; Arseniev, Alexander S.] State Univ, Moscow Inst Phys & Technol, Moscow 117303, Russia; [Peigneur, Steve; Tytgat, Jan] Univ Leuven, B-3000 Leuven, Belgium	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow Institute of Physics & Technology; KU Leuven	Vassilevski, AA (corresponding author), Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia.	avas@ibch.ru	Vassilevski, Alexander/S-3824-2016; Shenkarev, Zakhar O./P-1808-2015; Berkut, Antonina/AAE-4247-2019; Lyukmanova, Ekaterina/F-2340-2014	Vassilevski, Alexander/0000-0002-1359-0076; Shenkarev, Zakhar O./0000-0003-1383-3522; Lyukmanova, Ekaterina/0000-0002-9728-9407; Tytgat, Jan/0000-0003-1778-6022; Peigneur, Steve/0000-0003-0504-5702	Russian Foundation for Basic Research [12-04-01712]; Molecular and Cell Biology Program of the Russian Academy of Sciences; Russian Federation [1924.2014.4]; Russian Science Foundation [14-14-01180]; Fonds Wetenschappelijk Onderzoek Vlaanderen [G.0433.12, G.A071.10N, G.0257.08]; Inter-University Attraction Poles Program from Belgian State, Belgian Science Policy [IUAP 7/10]; KU Leuven Grant [OT/12/081]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Molecular and Cell Biology Program of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Federation(Russian Federation); Russian Science Foundation(Russian Science Foundation (RSF)); Fonds Wetenschappelijk Onderzoek Vlaanderen(FWO); Inter-University Attraction Poles Program from Belgian State, Belgian Science Policy; KU Leuven Grant	This work was supported in part by Russian Foundation for Basic Research Grant 12-04-01712, the Molecular and Cell Biology Program of the Russian Academy of Sciences, and Grant 1924.2014.4 from the President of Russian Federation.; Supported by Russian Science Foundation Grant 14-14-01180 to perform large scale production of Hm-3 and physiological studies.; Supported by Fonds Wetenschappelijk Onderzoek Vlaanderen Grants G.0433.12, G.A071.10N, and G.0257.08; Inter-University Attraction Poles Program Grant IUAP 7/10 from Belgian State, Belgian Science Policy; and KU Leuven Grant OT/12/081.	Andreev YA, 2010, ANAL BIOCHEM, V407, P144, DOI 10.1016/j.ab.2010.07.023; Billen B, 2008, TOXICON, V52, P309, DOI 10.1016/j.toxicon.2008.05.018; Billen B, 2010, J BIOL CHEM, V285, P18545, DOI 10.1074/jbc.M110.125211; Bladen C, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-36; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Bosmans F, 2007, TOXICON, V49, P142, DOI 10.1016/j.toxicon.2006.09.023; CATTERALL WA, 1977, J BIOL CHEM, V252, P8660; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Corzo G, 2005, BIOCHEMISTRY-US, V44, P1542, DOI 10.1021/bi048434k; Corzo G, 2003, FEBS LETT, V547, P43, DOI 10.1016/S0014-5793(03)00666-5; da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012; de Lima ME, 2002, J INSECT PHYSIOL, V48, P53, DOI 10.1016/S0022-1910(01)00143-3; Delaglio F, 2001, J MAGN RESON, V149, P276, DOI 10.1006/jmre.2001.2297; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2006, MOL DIVERS, V10, P545, DOI 10.1007/s11030-006-9050-4; Estrada G, 2007, NAT PROD REP, V24, P145, DOI 10.1039/b603083c; French RJ, 2010, MAR DRUGS, V8, P2153, DOI 10.3390/md8072153; GRISHIN EV, 1986, BIOORG KHIM+, V12, P1121; Grishin EV, 1998, TOXICON, V36, P1693, DOI 10.1016/S0041-0101(98)00162-7; Gui JH, 2014, CURR BIOL, V24, P473, DOI 10.1016/j.cub.2014.01.013; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Kuhn-Nentwig L, 2003, CELL MOL LIFE SCI, V60, P2651, DOI 10.1007/s00018-003-3106-8; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Liao Z, 2007, TOXICON, V50, P135, DOI 10.1016/j.toxicon.2007.03.006; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Little MJ, 1998, FEBS LETT, V439, P246, DOI 10.1016/S0014-5793(98)01378-7; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Moran Y, 2009, TOXICON, V54, P1089, DOI 10.1016/j.toxicon.2009.02.028; Nikolsky AS, 2009, BIOCHEM MOSC SUPPL S, V3, P245, DOI 10.1134/S1990747809030027; Escalona MP, 2013, FRONT BIOSCI-LANDMRK, V18, P572, DOI 10.2741/4121; Peigneur S, 2011, BIOCHEM PHARMACOL, V82, P81, DOI 10.1016/j.bcp.2011.03.023; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Redaelli E, 2010, J BIOL CHEM, V285, P4130, DOI 10.1074/jbc.M109.054718; Rong MQ, 2011, FASEB J, V25, P3177, DOI 10.1096/fj.10-178848; Schroeder FC, 2008, P NATL ACAD SCI USA, V105, P14283, DOI 10.1073/pnas.0806840105; Shlyapnikov YM, 2008, PROTEIN EXPRES PURIF, V60, P89, DOI 10.1016/j.pep.2008.03.011; Silva AO, 2012, BIOCHIMIE, V94, P2756, DOI 10.1016/j.biochi.2012.08.016; SKINNER WS, 1989, J BIOL CHEM, V264, P2150; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Smith JJ, 2005, J BIOL CHEM, V280, P11127, DOI 10.1074/jbc.M412552200; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; Tao H, 2013, BIOCHEMISTRY-US, V52, P7439, DOI 10.1021/bi4006418; Trachsel C, 2012, FEBS J, V279, P2683, DOI 10.1111/j.1742-4658.2012.08650.x; Vassilevski AA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1505, DOI 10.1134/S0006297909130069; Xiao YC, 2004, J BIOL CHEM, V279, P26220, DOI 10.1074/jbc.M401387200; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Xiao YC, 2010, MOL PHARMACOL, V78, P1124, DOI 10.1124/mol.110.066332	57	10	11	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					492	504		10.1074/jbc.M114.595678	http://dx.doi.org/10.1074/jbc.M114.595678			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25352595	hybrid, Green Published			2022-12-28	WOS:000347231200043
J	Gupta, SD; Gable, K; Alexaki, A; Chandris, P; Proia, RL; Dunn, TM; Harmon, JM				Gupta, Sita D.; Gable, Kenneth; Alexaki, Aikaterini; Chandris, Panagiotis; Proia, Richard L.; Dunn, Teresa M.; Harmon, Jeffrey M.			Expression of the ORMDLS, Modulators of Serine Palmitoyltransferase, Is Regulated by Sphingolipids in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme; Lipid Metabolism; Metabolic Regulation; Serine Palmitoyltransferase; Sphingolipid	PROTEINS MEDIATE; GENE; ORM2; BIOSYNTHESIS; ACCUMULATION; HOMEOSTASIS; INHIBITION; SUBUNITS; ASTHMA	Background: In contrast to their yeast orthologues, the mechanism by which mammalian ORMDLs regulate serine palmitoyltransferase is not understood. Results: Overexpression of serine palmitoyltransferase in HEK293 cells results in increased long-chain base synthesis and an activity-dependent increase in ORMDL expression. Conclusion: A product of ceramide synthase mediates regulation of ORMDL expression and inhibition of serine palmitoyltransferase. Significance: Serine palmitoyltransferase activity indirectly regulates ORMDL expression. The relationship between serine palmitoyltransferase (SPT) activity and ORMDL regulation of sphingolipid biosynthesis was investigated in mammalian HEK293 cells. Each of the three human ORMDLs reduced the increase in long-chain base synthesis seen after overexpression of wild-type SPT or SPT containing the C133W mutation in hLCB1, which produces the non-catabolizable sphingoid base, 1-deoxySa. ORMDL-dependent repression of sphingoid base synthesis occurred whether SPT was expressed as individual subunits or as a heterotrimeric single-chain SPT fusion protein. Overexpression of the single-chain SPT fusion protein under the control of a tetracycline-inducible promoter in stably transfected cells resulted in increased endogenous ORMDL expression. This increase was not transcriptional; there was no significant increase in any of the ORMDL mRNAs. Increased ORMDL protein expression required SPT activity since overexpression of a catalytically inactive SPT with a mutation in hLCB2a had little effect. Significantly, increased ORMDL expression was also blocked by myriocin inhibition of SPT as well as fumonisin inhibition of the ceramide synthases, suggesting that increased expression is a response to a metabolic signal. Moreover, blocking ORMDL induction with fumonisin treatment resulted in significantly greater increases in in vivo SPT activity than was seen when ORMDLs were allowed to increase, demonstrating the physiological significance of this response.	[Gupta, Sita D.; Gable, Kenneth; Dunn, Teresa M.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA; [Harmon, Jeffrey M.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [Alexaki, Aikaterini; Chandris, Panagiotis; Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Harmon, JM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	jeffrey.harmon@usuhs.edu	Proia, Richard L/A-7908-2012	Harmon, Jeffrey/0000-0001-7833-931X; Alexaki, Aikaterini/0000-0003-2511-8569; Proia, Richard/0000-0003-0456-1270; CHANDRIS, PANAGIOTIS/0000-0002-6484-462X	Uniformed Services University [R071KD, CO75PI]; National Institutes of Health [R01NS072446, R21HD080181]; Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056018, ZIADK056016, ZIADK056014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072446] Funding Source: NIH RePORTER	Uniformed Services University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Uniformed Services University Grants R071KD and CO75PI, by National Institutes of Health Grants R01NS072446 and R21HD080181, and by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.	Akhabir L, 2011, RESPIROLOGY, V16, P396, DOI 10.1111/j.1440-1843.2011.01939.x; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Gable K, 2010, J BIOL CHEM, V285, P22844, DOI 10.1074/jbc.M110.122259; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Gururaj C, 2013, J BIOL CHEM, V288, P20453, DOI 10.1074/jbc.M113.472860; Halapi E, 2010, EUR J HUM GENET, V18, P902, DOI 10.1038/ejhg.2010.38; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Harmon JM, 2013, J BIOL CHEM, V288, P10144, DOI 10.1074/jbc.M113.451526; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Jin R, 2012, INT J BIOCHEM CELL B, V44, P1174, DOI 10.1016/j.biocel.2012.04.007; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Qiu RF, 2013, FEBS J, V280, P2014, DOI 10.1111/febs.12225; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Taouji S, 2013, J BIOL CHEM, V288, P17190, DOI 10.1074/jbc.M112.409185; Tsegaye Y, 2007, J BIOL CHEM, V282, P28195, DOI 10.1074/jbc.M705074200; WANG E, 1991, J BIOL CHEM, V266, P14486; Worgall TS, 2013, SCI TRANSL MED, V5; Zhuang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060630; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200; [No title captured]	29	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					90	98		10.1074/jbc.M114.588236	http://dx.doi.org/10.1074/jbc.M114.588236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25395622	Green Published, hybrid			2022-12-28	WOS:000347231200009
J	Bellanca, S; Summers, RL; Meyrath, M; Dave, A; Nash, MN; Dittmer, M; Sanchez, CP; Stein, WD; Martin, RE; Lanzer, M				Bellanca, Sebastiano; Summers, Robert L.; Meyrath, Max; Dave, Anurag; Nash, Megan N.; Dittmer, Martin; Sanchez, Cecilia P.; Stein, Wilfred D.; Martin, Rowena E.; Lanzer, Michael			Multiple Drugs Compete for Transport via the Plasmodium falciparum Chloroquine Resistance Transporter at Distinct but Interdependent Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN PFCRT; MALARIA PARASITES; DIGESTIVE VACUOLE; ARTEMETHER-LUMEFANTRINE; SIMULTANEOUS BINDING; ANTIMALARIAL-DRUG; SUBSTRATE-BINDING; EFFLUX SYSTEM; H+ LEAK; MUTATIONS	Mutations in the "chloroquine resistance transporter" (PfCRT) are a major determinant of drug resistance in the malaria parasite Plasmodium falciparum. We have previously shown that mutant PfCRT transports the antimalarial drug chloroquine away from its target, whereas the wild-type form of PfCRT does not. However, little is understood about the transport of other drugs via PfCRT or the mechanism by which PfCRT recognizes different substrates. Here we show that mutant PfCRT also transports quinine, quinidine, and verapamil, indicating that the protein behaves as a multidrug resistance carrier. Detailed kinetic analyses revealed that chloroquine and quinine compete for transport via PfCRT in a manner that is consistent with mixed-type inhibition. Moreover, our analyses suggest that PfCRT accepts chloroquine and quinine at distinct but antagonistically interacting sites. We also found verapamil to be a partial mixed-type inhibitor of chloroquine transport via PfCRT, further supporting the idea that PfCRT possesses multiple substrate-binding sites. Our findings provide new mechanistic insights into the workings of PfCRT, which could be exploited to design potent inhibitors of this key mediator of drug resistance.	[Bellanca, Sebastiano; Meyrath, Max; Dave, Anurag; Dittmer, Martin; Sanchez, Cecilia P.; Lanzer, Michael] Heidelberg Univ, Dept Infect Dis, D-69120 Heidelberg, Germany; [Summers, Robert L.; Nash, Megan N.; Martin, Rowena E.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Stein, Wilfred D.] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Ruprecht Karls University Heidelberg; Australian National University; Hebrew University of Jerusalem	Martin, RE (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	rowena.martin@anu.edu.au; michael_lanzer@med.uni-heidelberg.de	Martin, Rowena E/C-9992-2009; Lanzer, Michael/E-9752-2013; Summers, Robert L/E-8982-2012	Martin, Rowena E/0000-0001-7408-5295; Lanzer, Michael/0000-0002-0220-6526; Summers, Robert L/0000-0003-0840-1784; Meyrath, Max/0000-0001-8585-0474	Australian National Health and Medical Research Council (NHMRC) [1007035]; European Community [242095]; Konanz-Stiftung fellowship; NHMRC [520320, 1053082]; L'Oreal Australia For Women in Science fellowship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); European Community(European Commission); Konanz-Stiftung fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); L'Oreal Australia For Women in Science fellowship(L'Oreal Group)	This work was supported by the Australian National Health and Medical Research Council (NHMRC; Grant 1007035 to R. E. M.) and the European Community's Seventh Framework Programme (FP7/2007-2013; Grant 242095 to M. L.).; Supported by a Konanz-Stiftung fellowship.; Supported by NHMRC Fellowships 520320 and 1053082 as well as a L'Oreal Australia For Women in Science fellowship. To whom correspondence may be addressed. Tel.: 61-2-6197-0051; Fax: 61-2-6125-0313; E-mail: rowena.martin@anu.edu.au.	Achan J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-144; Alibert S, 2002, J MED CHEM, V45, P3195, DOI 10.1021/jm011046l; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Breslow R, 2000, PURE APPL CHEM, V72, P333, DOI 10.1351/pac200072030333; Brittain H, 2007, PROFILES DRUG SUBSTA, P33; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; CHEVILLARD C, 1993, BIOCHEM J, V289, P599, DOI 10.1042/bj2890599; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; Cooper RA, 2007, MOL MICROBIOL, V63, P270, DOI 10.1111/j.1365-2958.2006.05511.x; Cornish-Bowden A, 2001, METHODS, V24, P181, DOI 10.1006/meth.2001.1179; Cornish-Bowden A., 2012, FUNDAMENTALS ENZYME; Cornish-Bowden A, 2014, FEBS J, V281, P621, DOI 10.1111/febs.12469; Eastman RT, 2011, ANTIMICROB AGENTS CH, V55, P3908, DOI 10.1128/AAC.01793-10; Ecker A, 2012, TRENDS PARASITOL, V28, P504, DOI 10.1016/j.pt.2012.08.002; Ewers D, 2013, P NATL ACAD SCI USA, V110, P12486, DOI 10.1073/pnas.1300772110; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Folarin OA, 2011, ACTA TROP, V120, P224, DOI 10.1016/j.actatropica.2011.08.013; Harper JN, 2013, AM J PHYSIOL-RENAL, V304, pF56, DOI 10.1152/ajprenal.00486.2012; HASEGAWA J, 1984, J PHARM SCI, V73, P442, DOI 10.1002/jps.2600730405; Hrycyna CA, 2014, ACS CHEM BIOL, V9, P722, DOI 10.1021/cb4008953; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Kuzmic P, 2006, FEBS J, V273, P3054, DOI 10.1111/j.1742-4658.2006.05316.x; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; Lehane AM, 2008, ANTIMICROB AGENTS CH, V52, P4374, DOI 10.1128/AAC.00666-08; Lehane AM, 2008, J CELL SCI, V121, P1624, DOI 10.1242/jcs.016758; Lehane AM, 2010, MOL MICROBIOL, V77, P1039, DOI 10.1111/j.1365-2958.2010.07272.x; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; Martinez L, 2014, FEBS J, V281, P673, DOI 10.1111/febs.12613; Naude B, 2005, J BIOL CHEM, V280, P25596, DOI 10.1074/jbc.M503227200; Ohashi R, 2002, J PHARMACOL EXP THER, V302, P1286, DOI 10.1124/jpet.102.036004; Papakrivos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039569; R Development Core Team, 2009, R LANG ENV STAT COMP; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; Sanchez CP, 2007, MOL MICROBIOL, V64, P407, DOI 10.1111/j.1365-2958.2007.05664.x; Sanchez CP, 2011, MOL MICROBIOL, V82, P865, DOI 10.1111/j.1365-2958.2011.07855.x; Sanchez CP, 2010, INT J PARASITOL, V40, P1109, DOI 10.1016/j.ijpara.2010.04.001; Sanchez CP, 2005, BIOCHEMISTRY-US, V44, P9862, DOI 10.1021/bi050061f; Sanchez CP, 2004, BIOCHEMISTRY-US, V43, P16365, DOI 10.1021/bi048241x; Sanchez CP, 2003, BIOCHEMISTRY-US, V42, P9383, DOI 10.1021/bi034269h; Schumacher MA, 2004, EMBO J, V23, P2923, DOI 10.1038/sj.emboj.7600288; Segel IH., 1993, ENZYME KINETICS BEHA; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; Summers RL, 2014, P NATL ACAD SCI USA, V111, pE1759, DOI 10.1073/pnas.1322965111; Summers RL, 2012, CELL MOL LIFE SCI, V69, P1967, DOI 10.1007/s00018-011-0906-0; Ursing J, 2011, J INFECT DIS, V203, P109, DOI 10.1093/infdis/jiq001; van Schalkwyk DA, 2006, DRUG RESIST UPDATE, V9, P211, DOI 10.1016/j.drup.2006.09.002; Warhurst DC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-31; Yuan J, 2011, SCIENCE, V333, P724, DOI 10.1126/science.1205216	52	26	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36336	36351		10.1074/jbc.M114.614206	http://dx.doi.org/10.1074/jbc.M114.614206			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378409	Green Published, hybrid			2022-12-28	WOS:000346897900056
J	Velarde, JJ; Ashbaugh, M; Wessels, MR				Velarde, Jorge J.; Ashbaugh, Melissa; Wessels, Michael R.			The Human Antimicrobial Peptide LL-37 Binds Directly to CsrS, a Sensor Histidine Kinase of Group A Streptococcus, to Activate Expression of Virulence Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYALURONIC-ACID CAPSULE; CATHELICIDIN LL-37; REGULATORY SYSTEM; SKIN; FRAGMENTS; PYOGENES; IDENTIFICATION; KERATINOCYTES; INFECTIONS; MUTATIONS	Group A Streptococcus (GAS) responds to subinhibitory concentrations of LL-37 by up-regulation of virulence factors through the CsrRS (CovRS) two-component system. The signaling mechanism, however, is unclear. To determine whether LL-37 signaling reflects specific binding to CsrS or rather a nonspecific response to LL-37-mediated membrane damage, we tested LL-37 fragments for CsrRS signaling and for GAS antimicrobial activity. We identified a 10-residue fragment (RI-10) of LL-37 as the minimal peptide that retains the ability to signal increased expression of GAS virulence factors, yet it has no detectable antimicrobial activity against GAS. Substitution of individual key amino acids in RI-10 reduced or abrogated signaling. These data do not support the hypothesis that CsrS detects LL-37-induced damage to the bacterial cell membrane but rather suggest that LL-37 signaling is mediated by a direct interaction with CsrS. To test whether LL-37 binds to CsrS, we used the purified CsrS extracellular domain to pull down LL-37 in vitro, a result that provides further evidence that LL-37 binds to CsrS. The dissociation of CsrS-mediated signaling from membrane damage by LL-37 fragments together with in vitro evidence for a direct LL-37-CsrS binding interaction constitute compelling evidence that signal transduction by LL-37 through CsrS reflects a direct ligand/receptor interaction.	[Wessels, Michael R.] Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Wessels, MR (corresponding author), Boston Childrens Hosp, Div Infect Dis, 300 Longwood Ave, Boston, MA 02115 USA.	Michael.Wessels@childrens.harvard.edu			NICHD, National Institutes of Health [K12-HD000850]; Public Health Service from the National Institutes of Health [AI29952]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029952] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Public Health Service from the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NICHD, National Institutes of Health Grant K12-HD000850 (to J. J. V.) and Public Health Service Grant AI29952 from the National Institutes of Health.	Alam FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061655; Benson MA, 2012, J BACTERIOL, V194, P4355, DOI 10.1128/JB.00706-12; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Burton MF, 2009, NAT PROD REP, V26, P1572, DOI 10.1039/b912533g; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Engleberg NC, 2004, INFECT IMMUN, V72, P623, DOI 10.1128/IAI.72.2.623-628.2004; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Epand RF, 2009, ANTIMICROB AGENTS CH, V53, P3705, DOI 10.1128/AAC.00321-09; Feng XR, 2013, PEPTIDES, V49, P131, DOI 10.1016/j.peptides.2013.09.007; Frick IM, 2003, J BIOL CHEM, V278, P16561, DOI 10.1074/jbc.M301995200; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; Gryllos I, 2007, MOL MICROBIOL, V65, P671, DOI 10.1111/j.1365-2958.2007.05818.x; Hayashi K, 2010, J BIOMOL NMR, V48, P147, DOI 10.1007/s10858-010-9445-5; Hollands A, 2012, J BIOL CHEM, V287, P40891, DOI 10.1074/jbc.M112.404582; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Johansson L, 2008, INFECT IMMUN, V76, P3399, DOI 10.1128/IAI.01392-07; Kim JE, 2005, J KOREAN MED SCI, V20, P649, DOI 10.3346/jkms.2005.20.4.649; Lauth X, 2009, J INNATE IMMUN, V1, P202, DOI 10.1159/000203645; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Li X, 2006, J AM CHEM SOC, V128, P5776, DOI 10.1021/ja0584875; Love JF, 2012, MBIO, V3, DOI 10.1128/mBio.00394-12; Mumcu G, 2012, ARCH ORAL BIOL, V57, P642, DOI 10.1016/j.archoralbio.2011.11.003; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; O'Seaghdha M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003394; Porcelli F, 2008, BIOCHEMISTRY-US, V47, P5565, DOI 10.1021/bi702036s; Que YA, 2000, INFECT IMMUN, V68, P3516, DOI 10.1128/IAI.68.6.3516-3522.2000; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Sawai MV, 2002, PROTEIN ENG, V15, P225, DOI 10.1093/protein/15.3.225; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Tao RC, 2005, ANTIMICROB AGENTS CH, V49, P3883, DOI 10.1128/AAC.49.9.3883-3888.2005; Tran-Winkler HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002361; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; Wang GS, 2008, J BIOL CHEM, V283, P32637, DOI 10.1074/jbc.M805533200	40	38	38	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36315	36324		10.1074/jbc.M114.605394	http://dx.doi.org/10.1074/jbc.M114.605394			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378408	Green Published, hybrid			2022-12-28	WOS:000346897900054
J	Wu, HL; Yu, YB; David, L; Ho, YS; Lou, MF				Wu, Hongli; Yu, Yibo; David, Larry; Ho, Ye-Shih; Lou, Marjorie F.			Glutaredoxin 2 (Grx2) Gene Deletion Induces Early Onset of Age-dependent Cataracts in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LENS EPITHELIAL-CELLS; GLUTATHIONE MIXED DISULFIDE; PROTEIN S-GLUTATHIONYLATION; OXIDATIVE STRESS; REDOX REGULATION; THIOL-DISULFIDE; THIOLTRANSFERASE; MITOCHONDRIAL; THIOREDOXIN; CRYSTALLINS	Glutaredoxin 2 (Grx2) is an isozyme of glutaredoxin1 (thioltransferase) present in the mitochondria and nucleus with disulfide reductase and peroxidase activities, and it controls thiol/disulfide balance in cells. In this study, we investigated whether Grx2 gene deletion could induce faster age-related cataract formation and elucidated the biochemical changes effected by Grx2 gene deletion that may contribute to lens opacity. Slit lamp was used to examine the lenses in Grx2 knock-out (KO) mice and age-matched wild-type (WT) mice ages 1 to 16 months. In the Grx2 null mice, the lens nuclear opacity began at 5 months, 3 months sooner than that of the control mice, and the progression of cataracts was also much faster than the age-matched controls. Lenses of KO mice contained lower levels of protein thiols and GSH with a significant accumulation of S-glutathionylated proteins. Actin, alpha A-crystallin, and beta B2-crystallin were identified by Western blot and mass spectroscopy as the major S-glutathionylated proteins in the lenses of 16-month-old Grx2 KO mice. Compared with the WT control, the lens of Grx2 KO mice had only 50% of the activity in complex I and complex IV and less than 10% of the ATP pool. It was concluded that Grx2 gene deletion altered the function of lens structural proteins through S-glutathionylation and also caused severe disturbance in mitochondrial function. These combined alterations affected lens transparency.	[Wu, Hongli; Yu, Yibo; Lou, Marjorie F.] Univ Nebraska Lincoln, Sch Vet Med & Biomed Sci, Redox Biol Ctr, Lincoln, NE 68583 USA; [Wu, Hongli] Univ N Texas, Dept Pharmaceut Sci, Coll Pharm, Hlth Sci Ctr, Ft Worth, TX 76107 USA; [Yu, Yibo] Zhejiang Univ, Ctr Eye, Affiliated Hosp 2, Dept Ophthalmol,Med Coll, Hangzhou 310009, Zhejiang, Peoples R China; [David, Larry] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ho, Ye-Shih] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48201 USA; [Lou, Marjorie F.] Univ Nebraska Med Ctr, Dept Ophthalmol, Omaha, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of North Texas System; University of North Texas Health Science Center; Zhejiang University; Oregon Health & Science University; Wayne State University; University of Nebraska System; University of Nebraska Medical Center		mlou1@unl.edu			National Institutes of Health [RO1 EY10595]; NIEHS Pilot Grant [P30 ES06639]; American Heart Association Greater Midwest Affiliate Grants [0455876Z, 0655631Z]; NATIONAL EYE INSTITUTE [P30EY010572, R01EY010595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS Pilot Grant; American Heart Association Greater Midwest Affiliate Grants(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 EY10595 (to M. F. L.) and NIEHS Pilot Grant P30 ES06639 (to Y. S. H.). This work was also supported by American Heart Association Greater Midwest Affiliate Grants 0455876Z and 0655631Z.	[Anonymous], P NATL ACAD SCI US, V100, P3913; Augusteyn R., 1981, MECH CATARACT FORMAT, P72; AXELSSON K, 1983, FEBS LETT, V152, P114, DOI 10.1016/0014-5793(83)80494-3; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Bhat HK, 2003, P NATL ACAD SCI USA, V100, P3913, DOI 10.1073/pnas.0437929100; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; Cherian M, 1997, J BIOL CHEM, V272, P29099, DOI 10.1074/jbc.272.46.29099; CHYLACK LT, 1989, ARCH OPHTHALMOL-CHIC, V107, P991, DOI 10.1001/archopht.1989.01070020053028; Enoksson M, 2005, BIOCHEM BIOPH RES CO, V327, P774, DOI 10.1016/j.bbrc.2004.12.067; FECONDO JV, 1983, EXP EYE RES, V36, P15, DOI 10.1016/0014-4835(83)90085-4; Fernando MR, 2006, FASEB J, V20, P2645, DOI 10.1096/fj.06-5919fje; Fernando MR, 2004, INVEST OPHTH VIS SCI, V45, P230, DOI 10.1167/iovs.03-0545; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; Hanson SRA, 1999, J BIOL CHEM, V274, P4735, DOI 10.1074/jbc.274.8.4735; Harding J. J., 1984, LENS DEV PROTEINS ME, V1, p207 ; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; KONO M, 1990, BIOCHEMISTRY-US, V29, P464, DOI 10.1021/bi00454a022; LIANG JN, 1988, EXP EYE RES, V47, P17, DOI 10.1016/0014-4835(88)90020-6; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Loefgren S, 2008, INVEST OPHTH VIS SCI, V49, P4497, DOI 10.1167/iovs.07-1404; Lou M., 2004, REDOX GENOME INTERAC, P325; LOU MF, 1989, CURR EYE RES, V8, P883; LOU MF, 1986, EXP EYE RES, V42, P607, DOI 10.1016/0014-4835(86)90050-3; LOU MF, 1992, EXP EYE RES, V55, P889, DOI 10.1016/0014-4835(92)90015-K; Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8; LOU MF, 1988, EXP EYE RES, V46, P517, DOI 10.1016/S0014-4835(88)80009-5; Lou MF, 1999, EXP EYE RES, V68, P547, DOI 10.1006/exer.1998.0638; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Mailloux RJ, 2013, J BIOL CHEM, V288, P8365, DOI 10.1074/jbc.M112.442905; MANNERVIK B, 1980, BIOCHEM J, V190, P125, DOI 10.1042/bj1900125; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Moon S, 2005, INVEST OPHTH VIS SCI, V46, P3783, DOI 10.1167/iovs.05-0237; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Pai HV, 2007, ANTIOXID REDOX SIGN, V9, P2027, DOI 10.1089/ars.2007.1642; Qiao FY, 2000, EXP EYE RES, V70, P745, DOI 10.1006/exer.2000.0836; Raghavachari N, 1996, EXP EYE RES, V63, P433, DOI 10.1006/exer.1996.0133; REHNCRONA S, 1979, STROKE, V10, P437, DOI 10.1161/01.STR.10.4.437; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; SPECTOR A, 1995, FASEB J, V9, P1173, DOI 10.1096/fasebj.9.12.7672510; SPECTOR A, 1978, P NATL ACAD SCI USA, V75, P3244, DOI 10.1073/pnas.75.7.3244; Taylor HR, 2001, BRIT J OPHTHALMOL, V85, P261, DOI 10.1136/bjo.85.3.261; Tian X. L., 2013, INVEST OPHTHALMOL VI, V54; TRUSCOTT RJW, 1977, EXP EYE RES, V25, P139, DOI 10.1016/0014-4835(77)90126-9; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wolf N, 2005, EXP EYE RES, V81, P276, DOI 10.1016/j.exer.2005.01.024; Wu H. L., 2009, ARVO M; Wu HL, 2011, FREE RADICAL BIO MED, V51, P2108, DOI 10.1016/j.freeradbiomed.2011.09.011; Wu HL, 2010, BBA-BIOENERGETICS, V1797, P1705, DOI 10.1016/j.bbabio.2010.06.003; Xing KY, 2002, EXP EYE RES, V74, P113, DOI 10.1006/exer.2001.1103; Yan FF, 2010, MOL BIOL CELL, V21, P1945, DOI 10.1091/mbc.E10-02-0116; Yegorova S, 2003, INVEST OPHTH VIS SCI, V44, P3263, DOI 10.1167/iovs.02-1322	58	41	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36125	36139		10.1074/jbc.M114.620047	http://dx.doi.org/10.1074/jbc.M114.620047			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25362663	Green Published, hybrid			2022-12-28	WOS:000346897900039
J	Ainscough, JS; Gerberick, GF; Zahedi-Nejad, M; Lopez-Castejon, G; Brough, D; Kimber, I; Dearman, RJ				Ainscough, Joseph S.; Gerberick, G. Frank; Zahedi-Nejad, Maryam; Lopez-Castejon, Gloria; Brough, David; Kimber, Ian; Dearman, Rebecca J.			Dendritic Cell IL-1 alpha and IL-1 beta Are Polyubiquitinated and Degraded by the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dendritic Cell; Inflammation; Interleukin 1 (IL-1); Proteasome; Ubiquitylation (Ubiquitination); IL-1 IL-1	NF-KAPPA-B; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; NLRP3 INFLAMMASOME; IMMUNE-RESPONSES; ACTIVATION; INTERLEUKIN-1; UBIQUITIN; PATHWAY; SECRETION	IL-1 alpha and are key players in the innate immune system. The secretion of these cytokines by dendritic cells (DC) is integral to the development of proinflammatory responses. These cytokines are not secreted via the classical secretory pathway. Instead, 2 independent processes are required; an initial signal to induce up-regulation of the precursor pro-IL-1 and -, and a second signal to drive cleavage and consequent secretion. Pro-IL-1 and - are both cytosolic and thus, are potentially subject to post-translational modifications. These modifications may, in turn, have a functional outcome in the context of IL-1 and - secretion and hence inflammation. We report here that IL-1 and - were degraded intracellularly in murine bone marrow-derived DC and that this degradation was dependent on active cellular processes. In addition, we demonstrate that degradation was ablated when the proteasome was inhibited, whereas autophagy did not appear to play a major role. Furthermore, inhibition of the proteasome led to an accumulation of polyubiquitinated IL-1 and -, indicating that IL-1 and - were polyubiquitinated prior to proteasomal degradation. Finally, our investigations suggest that polyubiquitination and proteasomal degradation are not continuous processes but instead are up-regulated following DC activation. Overall, these data highlight that IL-1 and - polyubiquitination and proteasomal degradation are central mechanisms in the regulation of intracellular IL-1 levels in DC.	[Ainscough, Joseph S.; Zahedi-Nejad, Maryam; Lopez-Castejon, Gloria; Brough, David; Kimber, Ian; Dearman, Rebecca J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Gerberick, G. Frank] Procter & Gamble Co Co, Cincinnati, OH 45253 USA	University of Manchester; Procter & Gamble	Ainscough, JS (corresponding author), Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Joseph.ainscough@postgrad.manchester.ac.uk	Lopez-Castejon, Gloria/F-6985-2015	Lopez-Castejon, Gloria/0000-0002-8585-3381; Brough, David/0000-0002-2250-2381; Ainscough, Joseph/0000-0002-8823-3508	Medical Research Council (MRC); Procter Gamble Company; Medical Research Council [1067566] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Procter Gamble Company(Procter & Gamble); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Medical Research Council (MRC) and The Procter & Gamble Company (to J. S. A.).	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brough D, 2011, TRENDS PHARMACOL SCI, V32, P617, DOI 10.1016/j.tips.2011.06.002; BUCHAN G, 1988, CLIN EXP IMMUNOL, V73, P449; CACABELOS R, 1994, METHOD FIND EXP CLIN, V16, P141; CACABELOS R, 1991, METHOD FIND EXP CLIN, V13, P703; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Chen FT, 2012, INVEST OPHTH VIS SCI, V53, P3682, DOI 10.1167/iovs.12-9505; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Cumberbatch M, 2002, TOXICOL APPL PHARM, V182, P126, DOI 10.1006/taap.2002.9442; Dearman RJ, 1996, IMMUNOL LETT, V50, P29, DOI 10.1016/0165-2478(96)02512-6; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Ferrari D, 1997, J IMMUNOL, V159, P1451; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; GOLDSTEIN G, 1975, P NATL ACAD SCI USA, V72, P11, DOI 10.1073/pnas.72.1.11; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; KUPPER TS, 1990, J CLIN INVEST, V86, P1783, DOI 10.1172/JCI114907; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lim KL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S13; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Mee JB, 2005, J INVEST DERMATOL, V124, P1267, DOI 10.1111/j.0022-202X.2005.23684.x; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; Moors MA, 2000, J LEUKOCYTE BIOL, V68, P131; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Riederer BM, 2011, EXP BIOL MED, V236, P268, DOI 10.1258/ebm.2010.010327; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Steinman RM, 2003, PATHOL BIOL, V51, P59, DOI 10.1016/S0369-8114(03)00096-8; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; WATANABE N, 1994, CYTOKINE, V6, P597, DOI 10.1016/1043-4666(94)90046-9; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796	58	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35582	35592		10.1074/jbc.M114.595686	http://dx.doi.org/10.1074/jbc.M114.595686			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25371210	Green Published, hybrid			2022-12-28	WOS:000346660200045
J	Myeong, J; Kwak, M; Hong, C; Jeon, JH; So, I				Myeong, Jongyun; Kwak, Misun; Hong, Chansik; Jeon, Ju-Hong; So, Insuk			Identification of a Membrane-targeting Domain of the Transient Receptor Potential Canonical (TRPC)4 Channel Unrelated to Its Formation of a Tetrameric Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence Resonance Energy Transfer (FRET); Ion Channel; Membrane Trafficking; Phosphatidylinositol; Transient Receptor Potential Channels (TRP Channels)	SURFACE EXPRESSION; PLASMA-MEMBRANE; ACIDIC SEQUENCE; ENERGY-TRANSFER; PROTEIN; ACTIVATION; TRPC4; SUBUNIT; CALMODULIN; LOCALIZATION	Background: Functional TRPC4/5 channels make tetrameric structures in the plasma membrane. Results: The 21-30 motif of TRPC4/5 regulates the membrane expression of the channels by interacting with PI(4,5)P-2. Conclusion: The 21-30 motif of TRPC4/5 has an essential role in the membrane expression that does not involve the tetrameric structure. Significance: Our findings indicate the membrane expression regulating domain of TRP channels. Canonical transient receptor potential (TRPC) channels are Ca2+-permeable nonselective cation channels that are activated by a wide variety of stimuli, including G protein-coupled receptors (GPCRs). The TRPC4 channel is expressed in a punctate distribution in the membrane. To identify the regulating region of the channel trafficking to the membrane, we generated deletion mutants of the TRPC4 channel. We determined that when either region that was downstream of the 20 amino acids of the N terminus or the 700-730 amino acids was deleted, the mutants were retained in the endoplasmic reticulum. By coexpression of the wild-type TRPC4 with deletion mutants, we found that the 23-29 amino acids of the N terminus regulate a membrane trafficking. Additionally, by the fluorescence resonance energy transfer (FRET) method, we found that the regions downstream of the 99 amino acid region of the N terminus and upstream of the 730 amino acid region in the C terminus produce assembly of the TRPC4 tetramers. We inferred the candidate proteins that regulate or interact with the 23-29 domain of TRPC4.	[Myeong, Jongyun; Kwak, Misun; Hong, Chansik; Jeon, Ju-Hong; So, Insuk] Seoul Natl Univ, Dept Physiol, Coll Med, Seoul 110799, South Korea	Seoul National University (SNU)	So, I (corresponding author), Seoul Natl Univ, Grad Sch, Coll Med, Dept Physiol, Biomed Sci Bldg 101,103 Daehakro, Seoul 110799, South Korea.	insuk@snu.ac.kr		Hong, Chansik/0000-0001-9684-4651; Jeon, Ju-Hong/0000-0002-5603-2955	National Research Foundation of Korea - Ministry of Science, ICT (Information & Communication Technology) and Future Planning (MSIP) of the Korean government [2010-0019472, 2012R1A2A1A01003073]; graduate program of BK21; MSIP	National Research Foundation of Korea - Ministry of Science, ICT (Information & Communication Technology) and Future Planning (MSIP) of the Korean government; graduate program of BK21; MSIP	This study was supported by grants obtained from the National Research Foundation of Korea, which is funded by the Ministry of Science, ICT (Information & Communication Technology) and Future Planning (MSIP) of the Korean government (2010-0019472 and 2012R1A2A1A01003073) (to I. S.).; Supported by the graduate program of BK21 and by grants from the MSIP.	Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Brazer SCW, 2003, J BIOL CHEM, V278, P27208, DOI 10.1074/jbc.M301118200; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; Cayouette S, 2007, CELL CALCIUM, V42, P225, DOI 10.1016/j.ceca.2007.01.014; Cioffi DL, 2005, CIRC RES, V97, P1164, DOI 10.1161/01.RES.0000193597.65217.00; de Groot T, 2011, J BIOL CHEM, V286, P32132, DOI 10.1074/jbc.M111.226878; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; EPE B, 1983, P NATL ACAD SCI-BIOL, V80, P2579, DOI 10.1073/pnas.80.9.2579; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Errasti-Murugarren E, 2010, MOL PHARMACOL, V78, P795, DOI 10.1124/mol.110.065920; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hong C., 2014, PFLUGERS ARCH; Jeon JP, 2012, J BIOL CHEM, V287, P17029, DOI 10.1074/jbc.M111.326553; Jikim M, 2008, BIOCHEM BIOPH RES CO, V365, P239, DOI 10.1016/j.bbrc.2007.10.154; Kim H, 2013, PFLUG ARCH EUR J PHY, V465, P1011, DOI 10.1007/s00424-013-1236-x; Kim H, 2012, CHANNELS, V6, P333, DOI 10.4161/chan.21198; Kim MT, 2006, AM J PHYSIOL-CELL PH, V290, pC1031, DOI 10.1152/ajpcell.00602.2004; Lemmon MA, 2005, CELL, V120, P574, DOI 10.1016/j.cell.2005.02.023; Lepage PK, 2006, J BIOL CHEM, V281, P30356, DOI 10.1074/jbc.M603930200; Lepage PK, 2009, CELL CALCIUM, V45, P251, DOI 10.1016/j.ceca.2008.11.002; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Mery L, 2002, J CELL SCI, V115, P3497; Miehe S, 2010, J BIOL CHEM, V285, P12426, DOI 10.1074/jbc.M109.068304; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Murakami M, 2005, J BIOL CHEM, V280, P5626, DOI 10.1074/jbc.M411496200; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 2002, P NATL ACAD SCI USA, V99, P6755, DOI 10.1073/pnas.092150699; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Odell AF, 2008, J BIOL CHEM, V283, P4395, DOI 10.1074/jbc.M709729200; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Ordaz B, 2005, J BIOL CHEM, V280, P30788, DOI 10.1074/jbc.M504745200; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Patterson G, 2001, J CELL SCI, V114, P837; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V453, P753, DOI 10.1007/s00424-006-0153-7; Schindl R, 2008, CELL CALCIUM, V43, P260, DOI 10.1016/j.ceca.2007.05.015; So Insuk, 2003, Journal of Smooth Muscle Research, V39, P231, DOI 10.1540/jsmr.39.231; Song XY, 2005, GLIA, V49, P418, DOI 10.1002/glia.20128; Tourkina Elena, 2012, Open Rheumatol J, V6, P116, DOI 10.2174/1874312901206010116; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Wedel BJ, 2003, J BIOL CHEM, V278, P25758, DOI 10.1074/jbc.M303890200; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; Yan HD, 2003, BRIT J PHARMACOL, V139, P605, DOI 10.1038/sj.bjp.0705289; Zhang S, 2004, AM J PHYSIOL-CELL PH, V287, pC1192, DOI 10.1152/ajpcell.00158.2004; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x	55	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34990	35002		10.1074/jbc.M114.584649	http://dx.doi.org/10.1074/jbc.M114.584649			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25349210	Green Published, hybrid			2022-12-28	WOS:000346260800047
J	Wu, D; Jiao, M; Zu, SC; Sollecito, CC; Jimenez-Cowell, K; Mold, AJ; Kennedy, RM; Wei, QZ				Wu, Di; Jiao, Meng; Zu, Shicheng; Sollecito, Christopher C.; Jimenez-Cowell, Kevin; Mold, Alexander J.; Kennedy, Ryan M.; Wei, Qize			Intramolecular Interactions between the Dbl Homology (DH) Domain and the Carboxyl-terminal region of Myosin II-interacting Guanine Nucleotide Exchange Factor (MyoGEF) Act as an Autoinhibitory Mechanism for the Regulation of MyoGEF Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Cytokinesis; Guanine Nucleotide Exchange Factor (GEF); Myosin; Rho (Rho GTPase); MyoGEF	LOCALIZED RHOA ACTIVATION; CELL-MIGRATION; CENTRAL SPINDLE; AURORA-B; IN-VIVO; PLECKSTRIN HOMOLOGY; EPITHELIAL-CELLS; MEMBRANE RUFFLES; FAMILY PROTEINS; LIVING CELLS	Background: MyoGEF is implicated in regulating cytokinesis and breast cancer cell invasion. Results: Binding of the MyoGEF carboxyl-terminal region to its DH domain suppresses breast cancer cell invasion and interferes with cytokinesis. Conclusion: Intramolecular interactions of MyoGEF act as an autoinhibitory mechanism to regulate MyoGEF functions. Significance: Autoinhibitory intramolecular interactions of MyoGEF serve as a control point to regulate cytokinesis and breast cancer cell invasion. We have reported previously that nonmuscle myosin II-interacting guanine nucleotide exchange factor (MyoGEF) plays an important role in the regulation of cell migration and cytokinesis. Like many other guanine nucleotide exchange factors (GEFs), MyoGEF contains a Dbl homology (DH) domain and a pleckstrin homology domain. In this study, we provide evidence demonstrating that intramolecular interactions between the DH domain (residues 162-351) and the carboxyl-terminal region (501-790) of MyoGEF can inhibit MyoGEF functions. In vitro and in vivo pulldown assays showed that the carboxyl-terminal region (residues 501-790) of MyoGEF could interact with the DH domain but not with the pleckstrin homology domain. Expression of a MyoGEF carboxyl-terminal fragment (residues 501-790) decreased RhoA activation and suppressed actin filament formation in MDA-MB-231 breast cancer cells. Additionally, Matrigel invasion assays showed that exogenous expression of the MyoGEF carboxyl-terminal region decreased the invasion activity of MDA-MB-231 cells. Moreover, coimmunoprecipitation assays showed that phosphorylation of the MyoGEF carboxyl-terminal region by aurora B kinase interfered with the intramolecular interactions of MyoGEF. Furthermore, expression of the MyoGEF carboxyl-terminal region interfered with RhoA localization during cytokinesis and led to an increase in multinucleation. Together, our findings suggest that binding of the carboxyl-terminal region of MyoGEF to its DH domain acts as an autoinhibitory mechanism for the regulation of MyoGEF activation.	[Wu, Di; Jiao, Meng; Zu, Shicheng; Sollecito, Christopher C.; Jimenez-Cowell, Kevin; Mold, Alexander J.; Kennedy, Ryan M.; Wei, Qize] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA	Fordham University	Wei, QZ (corresponding author), Fordham Univ, Dept Biol Sci, 441 E Fordham Rd,Larkin Hall,Rm 160, Bronx, NY 10458 USA.	qwei3@fordham.edu		Jiao, Meng/0000-0001-6698-3482	National Institutes of Health [R15GM097702]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM097702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R15GM097702 (to Q. W.).	Ahmad K. F., 2010, PLOS ONE, V5; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Aittaleb M, 2009, CELL SIGNAL, V21, P1569, DOI 10.1016/j.cellsig.2009.06.003; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Asiedu M, 2008, J BIOL CHEM, V283, P28392, DOI 10.1074/jbc.M801801200; Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bi F, 2001, MOL CELL BIOL, V21, P1463, DOI 10.1128/MCB.21.5.1463-1474.2001; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Borm B, 2005, EXP CELL RES, V302, P83, DOI 10.1016/j.yexcr.2004.08.034; Bravo-Cordero JJ, 2013, J CELL SCI, V126, P3356, DOI 10.1242/jcs.123547; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chen M, 2013, ONCOGENE, V32, P3754, DOI 10.1038/onc.2012.383; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Chhatriwala MK, 2007, J MOL BIOL, V368, P1307, DOI 10.1016/j.jmb.2007.02.060; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Cook Danielle R, 2011, Genes Cancer, V2, P932, DOI 10.1177/1947601912437035; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Wu D, 2006, CELL CYCLE, V5, P1234, DOI 10.4161/cc.5.11.2815; Eisenhaure TM, 2003, J BIOL CHEM, V278, P30975, DOI 10.1074/jbc.M303277200; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Floyd S, 2013, J CELL SCI, V126, P2845, DOI 10.1242/jcs.123232; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hong TT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000312; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Martz MK, 2013, MOL BIOL CELL, V24, P2785, DOI 10.1091/mbc.E12-07-0533; Menager C, 1999, EXP CELL RES, V249, P221, DOI 10.1006/excr.1999.4481; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Pal D, 2010, CELL CYCLE, V9, P4117, DOI 10.4161/cc.9.20.13387; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Price LS, 2001, SEMIN CANCER BIOL, V11, P167, DOI 10.1006/scbi.2000.0367; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; van Golen KL, 2000, CANCER RES, V60, P5832; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Worzfeld T, 2012, J CLIN INVEST, V122, P1296, DOI 10.1172/JCI60568; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Wu D, 2014, J BIOL CHEM, V289, P7142, DOI 10.1074/jbc.M113.510388; Wu D, 2010, J BIOL CHEM, V285, P28643, DOI 10.1074/jbc.M110.107649; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yohe ME, 2008, BIOCHEMISTRY-US, V47, P6827, DOI 10.1021/bi702543p; Yonemura S, 2004, EXP CELL RES, V295, P300, DOI 10.1016/j.yexcr.2004.01.005; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zhu KJ, 2001, MOL CELL BIOL, V21, P425, DOI 10.1128/MCB.21.2.425-437.2001; Zhu XP, 2014, EXP THER MED, V7, P560, DOI 10.3892/etm.2014.1491	77	2	2	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34033	34048		10.1074/jbc.M114.607267	http://dx.doi.org/10.1074/jbc.M114.607267			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25336641	Green Published, hybrid			2022-12-28	WOS:000346077600030
J	Yi, JJ; Huang, XY; Yang, YX; Zhu, WG; Gu, W; Luo, JY				Yi, Jingjie; Huang, Xiangyang; Yang, Yuxia; Zhu, Wei-Guo; Gu, Wei; Luo, Jianyuan			Regulation of Histone Acetyltransferase TIP60 Function by Histone Deacetylase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; DNA Damage; Histone Acetylase; Histone Deacetylase 3 (HDAC3); Ubiquitylation (Ubiquitination)	DNA-DAMAGE RESPONSE; TIP60-DEPENDENT ACETYLATION; AUTOACETYLATION; PROTEIN; APOPTOSIS; INTERACTS; RECEPTOR; COMPLEX; REPAIR; DOMAIN	Background: TIP60 can be regulated by autoacetylation and deacetylated by SIRT1. Results: Novel lysine residues of TIP60 autoacetylation were identified, and TIP60 can be functionally regulated by HDAC3 through deacetylation. Conclusion: HDAC3 promotes TIP60 ubiquitination and cytoplasmic localization and protects cells from apoptosis after DNA damage. Significance: Our findings provide a better understanding of TIP60 regulatory mechanisms and its cellular functions. The key member of the MOZ (monocyticleukaemia zinc finger protein), Ybf2/Sas3, Sas2, and TIP60 acetyltransferases family, Tat-interactive protein, 60 kD (TIP60), tightly modulates a wide array of cellular processes, including chromatin remodeling, gene transcription, apoptosis, DNA repair, and cell cycle arrest. The function of TIP60 can be regulated by SIRT1 through deacetylation. Here we found that TIP60 can also be functionally regulated by HDAC3. We identified six lysine residues as its autoacetylation sites. Mutagenesis of these lysines to arginines completely abolishes the autoacetylation of TIP60. Overexpression of HDAC3 increases TIP60 ubiquitination levels. However, unlike SIRT1, HDAC3 increased the half-life of TIP60. Further study found that HDAC3 colocalized with TIP60 both in the nucleus and the cytoplasm, which could be the reason why HDAC3 can stabilize TIP60. The deacetylation of TIP60 by both SIRT1 and HDAC3 reduces apoptosis induced by DNA damage. Knockdown of HDAC3 in cells increased TIP60 acetylation levels and increased apoptosis after DNA damage. Together, our findings provide a better understanding of TIP60 regulation mechanisms, which is a significant basis for further studies of its cellular functions.	[Yi, Jingjie] Xiamen Univ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Yi, Jingjie; Huang, Xiangyang; Luo, Jianyuan] Univ Maryland, Sch Med, Dept Med & Res Technol, Program Oncol,Marlene & Stewart Greenebaum Canc C, Baltimore, MD 21201 USA; [Yi, Jingjie; Huang, Xiangyang; Luo, Jianyuan] Univ Maryland, Sch Med, Dept Pathol, Program Oncol,Marlene & Stewart Greenebaum Canc C, Baltimore, MD 21201 USA; [Yang, Yuxia; Zhu, Wei-Guo; Luo, Jianyuan] Peking Univ, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Huang, Xiangyang] Sichuan Univ, West China Sch Med, West China Hosp, Dept Rheumatol, Chengdu 610041, Sichuan, Peoples R China; [Gu, Wei] Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Gu, Wei] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Xiamen University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Peking University; Sichuan University; Columbia University; Columbia University	Luo, JY (corresponding author), Univ Maryland, Sch Med, Dept Med & Res Technol, AHB 405A,100 Penn St, Baltimore, MD 21201 USA.	JLuo@som.umaryland.edu	yang, yx/GZM-0464-2022; Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; Zhu, Wei-Guo/0000-0001-8385-6581	China Scholarship Council; National Basic Research Program of China [81072477]; Scientific and Technical Supporting Program of Sichuan Province [2011SZ0124]; NSFC [81321003]; NCI National Institutes of Health [5RO1CA172023, 5RO1 CA166294, 2P01CA080058]; NATIONAL CANCER INSTITUTE [R01CA172023, R01CA166294, P01CA080058] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Basic Research Program of China(National Basic Research Program of China); Scientific and Technical Supporting Program of Sichuan Province; NSFC(National Natural Science Foundation of China (NSFC)); NCI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Partially sponsored by the China Scholarship Council.; Partially supported by National Basic Research Program of China Grant 81072477 and Scientific and Technical Supporting Program of Sichuan Province Grant 2011SZ0124.; Partially supported by NSFC Grant 81321003.; Partially supported by NCI National Institutes of Health Grants 5RO1CA172023, 5RO1 CA166294, and 2P01CA080058.	Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Arif M, 2007, J PHYS CHEM B, V111, P11877, DOI 10.1021/jp0762931; Bararia D, 2008, LEUKEMIA, V22, P800, DOI 10.1038/sj.leu.2405101; Blanco-Garcia N, 2009, J BIOL CHEM, V284, P1343, DOI 10.1074/jbc.M806075200; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Fischle W, 2009, NAT CELL BIOL, V11, P1279, DOI 10.1038/ncb1109-1279; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Lee HJ, 2001, J BIOL CHEM, V276, P16597, DOI 10.1074/jbc.C000909200; Lee MS, 2013, CELL DEATH DIFFER, V20, P620, DOI 10.1038/cdd.2012.159; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Peng LR, 2012, MOL CELL BIOL, V32, P2823, DOI 10.1128/MCB.00496-12; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sheridan AM, 2001, MOL CELL BIOL, V21, P4470, DOI 10.1128/MCB.21.14.4470-4481.2001; Sliva D, 1999, BIOCHEM BIOPH RES CO, V263, P149, DOI 10.1006/bbrc.1999.1083; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Stiehl DP, 2007, CANCER RES, V67, P2256, DOI 10.1158/0008-5472.CAN-06-3985; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yamagata K, 2009, BIOCHEM BIOPH RES CO, V390, P1355, DOI 10.1016/j.bbrc.2009.10.156; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yang C, 2012, J BIOL CHEM, V287, P34917, DOI 10.1074/jbc.M112.359356; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382	32	22	22	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33878	33886		10.1074/jbc.M114.575266	http://dx.doi.org/10.1074/jbc.M114.575266			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25301942	Green Published, hybrid			2022-12-28	WOS:000346077600018
J	Hsieh, SC; Wu, YC; Zou, G; Nerurkar, VR; Shi, PY; Wang, WK				Hsieh, Szu-Chia; Wu, Yi-Chieh; Zou, Gang; Nerurkar, Vivek R.; Shi, Pei-Yong; Wang, Wei-Kung			Highly Conserved Residues in the Helical Domain of Dengue Virus Type 1 Precursor Membrane Protein Are Involved in Assembly, Precursor Membrane (prM) Protein Cleavage, and Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT SUBVIRAL PARTICLES; BORNE ENCEPHALITIS-VIRUS; ENVELOPE GLYCOPROTEIN; INFECTIOUS PROPERTIES; PREMEMBRANE PROTEIN; IN-VITRO; MATURATION; SECRETION; IMMATURE; ANTIBODY	The envelope and precursor membrane (prM) proteins of dengue virus (DENV) are present on the surface of immature virions. During maturation, prM protein is cleaved by furin protease into pr peptide and membrane (M) protein. Although previous studies mainly focusing on the pr region have identified several residues important for DENV replication, the functional role of Mprotein, particularly the alpha-helical domain (MH), which is predicted to undergo a large conformational change during maturation, remains largely unknown. In this study, we investigated the role of nine highly conserved MH domain residues in the replication cycle of DENV by site-directed mutagenesis in a DENV1 prME expression construct and found that alanine substitutions introduced to four highly conserved residues at the C terminus and one at the N terminus of the MH domain greatly affect the production of both virus-like particles and replicon particles. Eight of the nine alanine mutants affected the entry of replicon particles, which correlated with the impairment in prM cleavage. Moreover, seven mutants were found to have reduced prM-E interaction at low pH, which may inhibit the formation of smooth immature particles and exposure of prM cleavage site during maturation, thus contributing to inefficient prM cleavage. Taken together, these results are the first report showing that highly conserved MH domain residues, located at 20-38 amino acids downstream from the prM cleavage site, can modulate the prM cleavage, maturation of particles, and virus entry. The highly conserved nature of these residues suggests potential targets of antiviral strategy.	[Hsieh, Szu-Chia; Wu, Yi-Chieh; Nerurkar, Vivek R.; Wang, Wei-Kung] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96813 USA; [Zou, Gang; Shi, Pei-Yong] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA	University of Hawaii System; University of Hawaii Manoa; State University of New York (SUNY) System; Wadsworth Center	Wang, WK (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, 651 Ilalo St,BSB 325E, Honolulu, HI 96813 USA.	wangwk@hawaii.edu	Nerurkar, Vivek R/F-5533-2011; Zou, Gang/J-1833-2014	Zou, Gang/0000-0001-9607-7827	National Institutes of Health NIGMS Award [P20GM103516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	National Institutes of Health NIGMS Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS Award P20GM103516.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Calvert AE, 2012, VIROLOGY, V433, P35, DOI 10.1016/j.virol.2012.07.011; Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Gehrke R, 2003, J VIROL, V77, P8924, DOI 10.1128/JVI.77.16.8924-8933.2003; GUIRAKHOO F, 1993, VIROLOGY, V194, P219, DOI 10.1006/viro.1993.1252; GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4; Hsieh SC, 2011, VIROLOGY, V410, P170, DOI 10.1016/j.virol.2010.11.006; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034; Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08; Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10; Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004; Khromykh AA, 1998, J VIROL, V72, P5967, DOI 10.1128/JVI.72.7.5967-5977.1998; Kim JM, 2008, J VIROL, V82, P7846, DOI 10.1128/JVI.00789-08; KONISHI E, 1993, J VIROL, V67, P1672, DOI 10.1128/JVI.67.3.1672-1675.1993; Konishi E, 2002, VACCINE, V20, P1058, DOI 10.1016/S0264-410X(01)00446-7; Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13; Kroeger MA, 2002, ARCH VIROL, V147, P1155, DOI 10.1007/s00705-002-0809-3; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447; Lin YJ, 2005, J VIROL, V79, P8535, DOI 10.1128/JVI.79.13.8535-8544.2005; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003; Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; MURRAY JM, 1993, J GEN VIROL, V74, P175, DOI 10.1099/0022-1317-74-2-175; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030; Pryor MJ, 2004, J GEN VIROL, V85, P3627, DOI 10.1099/vir.0.80283-0; Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005; Qing M, 2010, ANTIVIR RES, V86, P163, DOI 10.1016/j.antiviral.2010.02.313; RANDOLPH VB, 1990, J GEN VIROL, V71, P1845, DOI 10.1099/0022-1317-71-8-1845; Scholle F, 2004, J VIROL, V78, P11605, DOI 10.1128/JVI.78.21.11605-11614.2004; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996; Tan TTT, 2009, J GEN VIROL, V90, P1081, DOI 10.1099/vir.0.007872-0; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tsai WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052600; Wang PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008325; Wang SL, 1999, J VIROL, V73, P2547, DOI 10.1128/JVI.73.3.2547-2551.1999; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; WHO, 2009, DENG HEM FEV DIAGN T; Yoshii K, 2012, J GEN VIROL, V93, P27, DOI 10.1099/vir.0.035964-0; Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang Q, 2012, J BIOL CHEM, V287, P40525, DOI 10.1074/jbc.M112.384446; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270; Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0	66	31	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33149	33160		10.1074/jbc.M114.610428	http://dx.doi.org/10.1074/jbc.M114.610428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25326389	hybrid, Green Published			2022-12-28	WOS:000345636600010
J	Miyata, Y; Shibata, T; Aoshima, M; Tsubata, T; Nishida, E				Miyata, Yoshihiko; Shibata, Takeshi; Aoshima, Masato; Tsubata, Takuichi; Nishida, Eisuke			The Molecular Chaperone TRiC/CCT Binds to the Trp-Asp 40 (WD40) Repeat Protein WDR68 and Promotes Its Folding, Protein Kinase DYRK1A Binding, and Nuclear Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-DIMER; DOWN-SYNDROME; EUKARYOTIC CHAPERONIN; CRYSTAL-STRUCTURE; POSTTRANSLATIONAL MODIFICATIONS; DUAL-SPECIFICITY; COMPLEX; FAMILY; HSP90; PHOSPHORYLATION	Trp-Asp (WD) repeat protein 68 (WDR68) is an evolutionarily conserved WD40 repeat protein that binds to several proteins, including dual specificity tyrosine phosphorylation-regulated protein kinase (DYRK1A), MAPK/ERK kinase kinase 1 (MEKK1), and Cullin4-damage-specific DNA-binding protein 1 (CUL4-DDB1). WDR68 affects multiple and diverse physiological functions, such as controlling anthocyanin synthesis in plants, tissue growth in insects, and craniofacial development in vertebrates. However, the biochemical basis and the regulatory mechanism of WDR68 activity remain largely unknown. To better understand the cellular function of WDR68, here we have isolated and identified cellular WDR68 binding partners using a phosphoproteomic approach. More than 200 cellular proteins with wide varieties of biochemical functions were identified as WDR68-binding protein candidates. Eight T-complex protein 1 (TCP1) subunits comprising the molecular chaperone TCP1 ring complex/chaperonin-containing TCP1 (TRiC/CCT) were identified as major WDR68-binding proteins, and phosphorylation sites in both WDR68 and TRiC/CCT were identified. Co-immunoprecipitation experiments confirmed the binding between TRiC/CCT and WDR68. Computer-aided structural analysis suggested that WDR68 forms a seven-bladed beta-propeller ring. Experiments with a series of deletion mutants in combination with the structural modeling showed that three of the seven beta-propeller blades of WDR68 are essential and sufficient for TRiC/CCT binding. Knockdown of cellular TRiC/CCT by siRNA caused an abnormal WDR68 structure and led to reduction of its DYRK1A-binding activity. Concomitantly, nuclear accumulation of WDR68 was suppressed by the knockdown of TRiC/CCT, and WDR68 formed cellular aggregates when overexpressed in the TRiC/CCT-deficient cells. Altogether, our results demonstrate that the molecular chaperone TRiC/CCT is essential for correct protein folding, DYRK1A binding, and nuclear accumulation of WDR68.	[Miyata, Yoshihiko; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; [Shibata, Takeshi; Aoshima, Masato; Tsubata, Takuichi] KK AB Sciex Japan, Tokyo 1400001, Japan	Kyoto University	Miyata, Y (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	ymiyata@lif.kyoto-u.ac.jp	Miyata, Y/X-7111-2019		Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [25440046] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Cloutier P, 2013, BBA-GENE REGUL MECH, V1829, P443, DOI 10.1016/j.bbagrm.2013.02.010; de Lagran MM, 2004, NEUROBIOL DIS, V15, P132, DOI 10.1016/j.nbd.2003.10.002; Degoutin JL, 2013, NAT CELL BIOL, V15, P1176, DOI 10.1038/ncb2829; deVetten N, 1997, GENE DEV, V11, P1422, DOI 10.1101/gad.11.11.1422; Dunn AY, 2001, J STRUCT BIOL, V135, P176, DOI 10.1006/jsbi.2001.4380; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hammerle B, 2003, J NEURAL TRANSM-SUPP, P129; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KIM S, 1994, TRENDS BIOCHEM SCI, V19, P543, DOI 10.1016/0968-0004(94)90058-2; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; KOYASU S, 1986, P NATL ACAD SCI USA, V83, P8054, DOI 10.1073/pnas.83.21.8054; Kubota S, 2006, P NATL ACAD SCI USA, V103, P8360, DOI 10.1073/pnas.0600195103; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Mazmanian G, 2010, GENESIS, V48, P20, DOI 10.1002/dvg.20578; Miyata Y, 2005, MOL CELL BIOCHEM, V274, P171, DOI 10.1007/s11010-005-2949-8; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; Miyata Y, 1997, P NATL ACAD SCI USA, V94, P14500, DOI 10.1073/pnas.94.26.14500; Miyata Y, 2000, ONCOGENE, V19, P1477, DOI 10.1038/sj.onc.1203475; Miyata Y, 1999, GENES CELLS, V4, P299, DOI 10.1046/j.1365-2443.1999.00261.x; Miyata Y, 2001, J BIOL CHEM, V276, P21841, DOI 10.1074/jbc.M010944200; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Miyata Y, 2011, BBA-MOL CELL RES, V1813, P1728, DOI 10.1016/j.bbamcr.2011.06.023; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Morita K, 2006, J DERMATOL SCI, V44, P11, DOI 10.1016/j.jdermsci.2006.06.001; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nissen RM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-28; Pan DQ, 2013, NAT STRUCT MOL BIOL, V20, P987, DOI 10.1038/nsmb.2618; Park J, 2007, MOL CELL NEUROSCI, V36, P270, DOI 10.1016/j.mcn.2007.07.007; Park KI, 2012, J PLANT PHYSIOL, V169, P523, DOI 10.1016/j.jplph.2011.12.001; Ritterhoff S, 2010, EMBO J, V29, P3750, DOI 10.1038/emboj.2010.251; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Skurat AV, 2004, J BIOL CHEM, V279, P2490, DOI 10.1074/jbc.M301769200; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054363; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Wu JF, 2008, PLANT PHYSIOL, V148, P948, DOI 10.1104/pp.108.124917; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Yi CL, 2006, INT J BIOCHEM CELL B, V38, P1076, DOI 10.1016/j.biocel.2005.12.019; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009	65	27	27	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33320	33332		10.1074/jbc.M114.586115	http://dx.doi.org/10.1074/jbc.M114.586115			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25342745	Green Published, hybrid			2022-12-28	WOS:000345636600023
J	Solaimani, P; Wang, F; Hankinson, O				Solaimani, Parrisa; Wang, Feng; Hankinson, Oliver			SIN3A, Generally Regarded as a Transcriptional Repressor, Is Required for Induction of Gene Transcription by the Aryl Hydrocarbon Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; AH RECEPTOR; TARGET GENES; CYP1A1; EXPRESSION; COMPLEX; DIOXIN; ACTIVATION; COREPRESSOR; RECRUITMENT	CYP1A1 bioactivates several procarcinogens and detoxifies several xenobiotic compounds. Transcription of CYP1A1 is highly induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) via the aryl hydrocarbon receptor. We recently described an RNAi high throughput screening performed in the Hepa-1 mouse hepatoma cell line, which revealed that SIN3A is necessary for the induction of CYP1A1-dependent ethoxyresorufin-o-deethylase (EROD) enzymatic activity by TCDD. In the current studies, we sought to provide insight into the role of SIN3A in this process, particularly because studies on SIN3A have usually focused on its repressive activity on transcription. We report that ectopic expression of human SIN3A in Hepa-1 cells enhanced EROD induction by TCDD and efficiently rescued TCDD induction of EROD activity in cells treated with an siRNA to mouse SIN3A, thus validating a role for SIN3A in CYP1A1 induction. We demonstrate that SIN3A is required for TCDD induction of the CYP1A1 protein in Hepa-1 cells but not for expression of the aryl hydrocarbon receptor protein. In addition, siRNAs for SIN3A decreased TCDD-mediated induction of CYP1A1 mRNA and EROD activity in human hepatoma cell line Hep3B. We establish that TCDD treatment of Hepa-1 cells rapidly increases the degree of SIN3A binding to both the proximal promoter and enhancer of the Cyp1a1 gene and demonstrate that increased binding to the promoter also occurs in human Hep3B, HepG2, and MCF-7 cells. These studies establish that SIN3A physically interacts with the CYP1A1 gene and extends the transcriptional role of SIN3A to a gene that is very rapidly and dramatically induced.	[Solaimani, Parrisa; Hankinson, Oliver] Univ Calif Los Angeles, Mol Toxicol Interdept Program, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Solaimani, Parrisa; Hankinson, Oliver] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Wang, Feng] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Hankinson, O (corresponding author), Univ Calif Los Angeles, Ctr Hlth Sci, Dept Pathol & Lab Med, Box 951732, Los Angeles, CA 90095 USA.	ohank@mednet.ucla.edu			National Institutes of Health [R01CA28868, R01ES015384]; National Institutes of Health, NIEHS [T32ES015457]; NATIONAL CANCER INSTITUTE [R01CA028868, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015384, T32ES015457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA28868 and R01ES015384 (to O. H.).; Supported in part by a fellowship from National Institutes of Health, NIEHS, Grant T32ES015457.	Androutsopoulos VP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-187; Baltus GA, 2009, J BIOL CHEM, V284, P6998, DOI 10.1074/jbc.M807670200; Beedanagari SR, 2010, TOXICOL LETT, V194, P26, DOI 10.1016/j.toxlet.2010.01.019; Beedanagari SR, 2009, TOXICOL SCI, V110, P61, DOI 10.1093/toxsci/kfp079; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Das TK, 2013, ONCOGENE, V32, P3184, DOI 10.1038/onc.2012.326; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Ellison-Zelski SJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-263; Farhana L, 2009, MOL CANCER THER, V8, P1625, DOI 10.1158/1535-7163.MCT-08-0964; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Fujii-Kuriyama Y, 2010, P JPN ACAD B-PHYS, V86, P40, DOI 10.2183/pjab.86.40; Giannone JV, 1998, BIOCHEM PHARMACOL, V55, P489, DOI 10.1016/S0006-2952(97)00493-0; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hankinson O., 2012, AH RECEPTOR BIOL TOX, P93; Hestermann EV, 2003, MOL CELL BIOL, V23, P7920, DOI 10.1128/MCB.23.21.7920-7925.2003; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Lee DM, 2012, ENVIRON TOXICOL PHAR, V34, P858, DOI 10.1016/j.etap.2012.08.014; Ma Q, 2000, J BIOL CHEM, V275, P12676, DOI 10.1074/jbc.275.17.12676; Ma Q, 2007, DRUG METAB DISPOS, V35, P1009, DOI 10.1124/dmd.107.015826; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; Matthews J, 2007, BIOCHEM J, V406, P343, DOI 10.1042/BJ20070585; Moehren U, 2004, NUCLEIC ACIDS RES, V32, P2995, DOI 10.1093/nar/gkh621; Monostory K, 2009, DRUG METAB REV, V41, P547, DOI 10.1080/03602530903112284; Nukaya M, 2009, BIOCHEM PHARMACOL, V77, P654, DOI 10.1016/j.bcp.2008.10.026; Schnekenburger M, 2007, BBA-GENE STRUCT EXPR, V1769, P569, DOI 10.1016/j.bbaexp.2007.07.002; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Solaimani P, 2013, TOXICOL SCI, V136, P107, DOI 10.1093/toxsci/kft191; Suzuki T, 2007, J BIOCHEM, V142, P443, DOI 10.1093/jb/mvm152; Taylor RT, 2009, TOXICOL SCI, V107, P1, DOI 10.1093/toxsci/kfn217; van Oevelen C, 2010, MOL CELL BIOL, V30, P5686, DOI 10.1128/MCB.00975-10; Wang F, 2006, BIOL CHEM, V387, P1215, DOI 10.1515/BC.2006.150; Wang F, 2007, GENE REGUL SYST BIO, V1, P49; Wang S, 2004, J BIOL CHEM, V279, P13593, DOI 10.1074/jbc.M312274200; Wang S, 2002, J BIOL CHEM, V277, P11821, DOI 10.1074/jbc.M110122200; Wihlen B, 2009, MOL CANCER RES, V7, P977, DOI 10.1158/1541-7786.MCR-08-0396; YOSHIMOTO H, 1992, MOL GEN GENET, V233, P327, DOI 10.1007/BF00587597; Ythier D, 2010, ONCOGENE, V29, P5946, DOI 10.1038/onc.2010.325	45	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33655	33662		10.1074/jbc.M114.611236	http://dx.doi.org/10.1074/jbc.M114.611236			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25305016	Green Published, hybrid			2022-12-28	WOS:000345636600050
J	Gabbai, CB; Yeeles, JTP; Marians, KJ				Gabbai, Carolina B.; Yeeles, Joseph T. P.; Marians, Kenneth J.			Replisome-mediated Translesion Synthesis and Leading Strand Template Lesion Skipping Are Competing Bypass Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-II; IRRADIATED ESCHERICHIA-COLI; STALLED REPLICATION FORKS; OKAZAKI FRAGMENT SIZE; POL-IV; LAGGING-STRAND; INDUCED-MUTAGENESIS; SLIDING-CLAMP; ERROR-PRONE; BETA-CLAMP	A number of different enzymatic pathways have evolved to ensure that DNA replication can proceed past template base damage. These pathways include lesion skipping by the replisome, replication fork regression followed by either correction of the damage and origin-independent replication restart or homologous recombination-mediated restart of replication downstream of the lesion, and bypass of the damage by a translesion synthesis DNA polymerase. We report here that of two translesion synthesis polymerases tested, only DNA polymerase IV, not DNA polymerase II, could engage productively with the Escherichia coli replisome to bypass leading strand template damage, despite the fact that both enzymes are shown to be interacting with the replicase. Inactivation of the 3' -> 5' proofreading exonuclease of DNA polymerase II did not enable bypass. Bypass by DNA polymerase IV required its ability to interact with the beta clamp and act as a translesion polymerase but did not require its "little finger" domain, a secondary region of interaction with the beta clamp. Bypass by DNA polymerase IV came at the expense of the inherent leading strand lesion skipping activity of the replisome, indicating that they are competing reactions.	[Gabbai, Carolina B.; Yeeles, Joseph T. P.; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu		Yeeles, Joseph/0000-0002-2255-2119	National Institutes of Health [GM34557]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034557, R01GM034557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34557 (to K. J. M.).	Banach-Orlowska M, 2005, MOL MICROBIOL, V58, P61, DOI 10.1111/j.1365-2958.2005.04805.x; Becherel OJ, 2001, P NATL ACAD SCI USA, V98, P8566, DOI 10.1073/pnas.141113398; BONNER CA, 1992, J BIOL CHEM, V267, P11431; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; CAI H, 1995, J BIOL CHEM, V270, P15327, DOI 10.1074/jbc.270.25.15327; Fijalkowska IJ, 2012, FEMS MICROBIOL REV, V36, P1105, DOI 10.1111/j.1574-6976.2012.00338.x; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Fuchs RP, 2004, ADV PROTEIN CHEM, V69, P229; Gawel D, 2008, J BACTERIOL, V190, P1730, DOI 10.1128/JB.01463-07; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Gon S, 2011, P NATL ACAD SCI USA, V108, P19311, DOI 10.1073/pnas.1113664108; Gupta S, 2014, J BIOL CHEM, V289, P28376, DOI 10.1074/jbc.M114.587881; Gupta S, 2014, J BIOL CHEM, V289, P28388, DOI 10.1074/jbc.M114.587907; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Heltzel JMH, 2012, J BACTERIOL, V194, P3589, DOI 10.1128/JB.00520-12; Heltzel JMH, 2009, P NATL ACAD SCI USA, V106, P12664, DOI 10.1073/pnas.0903460106; HIASA H, 1994, J BIOL CHEM, V269, P6058; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Ikeda M, 2014, NUCLEIC ACIDS RES, V42, P8461, DOI 10.1093/nar/gku547; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Indiani C, 2009, P NATL ACAD SCI USA, V106, P6031, DOI 10.1073/pnas.0901403106; Ippoliti Paul J, 2012, Cells, V1, P799, DOI 10.3390/cells1040799; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Kath JE, 2014, P NATL ACAD SCI USA, V111, P7647, DOI 10.1073/pnas.1321076111; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kim SR, 2001, MOL GENET GENOMICS, V266, P207; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kuban W, 2005, J BACTERIOL, V187, P6862, DOI 10.1128/JB.187.19.6862-6866.2005; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; MCHENRY C, 1977, J BIOL CHEM, V252, P6478; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; PazElizur T, 1996, J BIOL CHEM, V271, P24662, DOI 10.1074/jbc.271.40.24662; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; Rupp W.D., 1996, ESCHERICHIA COLI SAL, P2277; RUPP WD, 1971, J MOL BIOL, V61, P25, DOI 10.1016/0022-2836(71)90204-X; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Uchida K, 2008, MOL MICROBIOL, V70, P608, DOI 10.1111/j.1365-2958.2008.06423.x; Wagner J, 2000, J BACTERIOL, V182, P4587, DOI 10.1128/JB.182.16.4587-4595.2000; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Wagner J, 2000, EMBO REP, V1, P484; Wagner J, 2009, MOL MICROBIOL, V74, P1143, DOI 10.1111/j.1365-2958.2009.06920.x; Wang F, 2009, CELL, V139, P1279, DOI 10.1016/j.cell.2009.11.043; WICKNER W, 1973, P NATL ACAD SCI USA, V70, P1764, DOI 10.1073/pnas.70.6.1764; WU CA, 1992, J BIOL CHEM, V267, P4030; Yeeles JTP, 2013, MOL CELL, V52, P855, DOI 10.1016/j.molcel.2013.10.020; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111; ZECHNER EL, 1992, J BIOL CHEM, V267, P4045	51	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.613257	http://dx.doi.org/10.1074/jbc.M114.613257			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25301949	hybrid, Green Published			2022-12-28	WOS:000345335000035
J	Bagriantsev, SN; Gracheva, EO; Gallagher, PG				Bagriantsev, Sviatoslav N.; Gracheva, Elena O.; Gallagher, Patrick G.			Piezo Proteins: Regulators of Mechanosensation and Other Cellular Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Genetic Disease; Ion Channel; Mechanotransduction; Membrane Protein; Neuron; Gordon Syndrome; Arthrogryposis; Hereditary Xerocytosis; Somatosensation; Piezo1; Piezo2	MECHANICALLY ACTIVATED CURRENTS; OF-FUNCTION MUTATIONS; ION CHANNELS; SENSORY NEURONS; MERKEL CELLS; MEMBRANE; MECHANOSENSITIVITY; K+; MECHANOTRANSDUCTION; TRANSDUCTION	Piezo proteins have recently been identified as ion channels mediating mechanosensory transduction in mammalian cells. Characterization of these channels has yielded important insights into mechanisms of somatosensation, as well as other mechano-associated biologic processes such as sensing of shear stress, particularly in the vasculature, and regulation of urine flow and bladder distention. Other roles for Piezo proteins have emerged, some unexpected, including participation in cellular development, volume regulation, cellular migration, proliferation, and elongation. Mutations in human Piezo proteins have been associated with a variety of disorders including hereditary xerocytosis and several syndromes with muscular contracture as a prominent feature.	[Bagriantsev, Sviatoslav N.; Gracheva, Elena O.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Gracheva, Elena O.] Yale Univ, Sch Med, Yale Program Cellular Neurosci Neurodegenerat & R, New Haven, CT 06520 USA; [Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Gallagher, PG (corresponding author), Yale Univ, Sch Med, 333 Cedar St,POB 208064, New Haven, CT 06520 USA.	patrick.gallagher@yale.edu		Gracheva, Elena O/0000-0002-0846-3427; Bagriantsev, Sviatoslav/0000-0002-6661-3403	National Institutes of Health [RO1DK104046]; American Heart Association [14SDG17880015]; Alfred P. Sloan Foundation; Doris Duke Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104046] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK104046 (to P. G. G.). This work was also supported by American Heart Association Scientist Development Grant 14SDG17880015 (to S. N. B.), the Alfred P. Sloan Foundation (to E. O. G.), and the Doris Duke Foundation (to P. G. G.).	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Albuisson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2899; Andolfo I, 2013, BLOOD, V121, P3925, DOI 10.1182/blood-2013-02-482489; Bae C, 2013, BIOPHYS J, V105, P880, DOI 10.1016/j.bpj.2013.07.019; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Berrier C, 2013, J BIOL CHEM, V288, P27307, DOI 10.1074/jbc.M113.478321; Brain MC, 2004, BLOOD CELL MOL DIS, V32, P349, DOI 10.1016/j.bcmd.2004.01.005; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Bron R, 2014, J COMP NEUROL, V522, P2967, DOI 10.1002/cne.23560; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; Delmas P, 2013, CELL, V155, P278, DOI 10.1016/j.cell.2013.09.026; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Drew LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000515; Drew LJ, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-1; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Dyrda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009447; Eijkelkamp N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2673; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Faucherre A, 2014, HAEMATOLOGICA, V99, P70, DOI 10.3324/haematol.2013.086090; Gallagher PG, 2013, CURR OPIN HEMATOL, V20, P201, DOI 10.1097/MOH.0b013e32835f6870; Gottlieb PA, 2012, CHANNELS, V6, P282, DOI 10.4161/chan.21064; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Hua SZ, 2010, AM J PHYSIOL-CELL PH, V298, pC1424, DOI 10.1152/ajpcell.00503.2009; Ikeda R, 2014, NEUROSCI LETT, V583, P210, DOI 10.1016/j.neulet.2014.05.055; Ikeda R, 2014, CELL, V157, P664, DOI 10.1016/j.cell.2014.02.026; Inoue R, 2009, PHARMACOL THERAPEUT, V123, P371, DOI 10.1016/j.pharmthera.2009.05.009; Jia ZF, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-57; Jin Y, 2015, ANGLE ORTHOD, V85, P87, DOI 10.2319/123113-955.1; JOHNSON RM, 1994, BIOPHYS J, V67, P1876, DOI 10.1016/S0006-3495(94)80669-1; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; LARSEN FL, 1981, NATURE, V294, P667, DOI 10.1038/294667a0; Laurent AC, 2012, BIOCHEM SOC T, V40, P51, DOI 10.1042/BST20110642; Lew VL, 2007, TRENDS PARASITOL, V23, P481, DOI 10.1016/j.pt.2007.08.001; Lew VL, 2003, BLOOD, V102, P4206, DOI 10.1182/blood-2003-06-1787; Li GR, 2001, AM J PHYSIOL-HEART C, V280, pH272, DOI 10.1152/ajpheart.2001.280.1.H272; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Lolignier S, 2015, PFLUG ARCH EUR J PHY, V467, P133, DOI 10.1007/s00424-014-1532-0; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; Ma YL, 2012, J PHYSIOL-LONDON, V590, P2095, DOI 10.1113/jphysiol.2012.229609; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Maricich SM, 2012, J NEUROSCI, V32, P3296, DOI 10.1523/JNEUROSCI.5307-11.2012; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; McCarter GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-28; McHugh BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040346; McMillin MJ, 2014, AM J HUM GENET, V94, P734, DOI 10.1016/j.ajhg.2014.03.015; Miyamoto T, 2014, J BIOL CHEM, V289, P16565, DOI 10.1074/jbc.M113.528638; Mohandas N, 2013, BLOOD, V121, P3783, DOI 10.1182/blood-2013-04-491753; Nilius B, 2010, EMBO REP, V11, P902, DOI 10.1038/embor.2010.181; Owens DM, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013656; Pedersen SF, 2011, J AM SOC NEPHROL, V22, P1587, DOI 10.1681/ASN.2010121284; Peyronnet R, 2013, EMBO REP, V14, P1143, DOI 10.1038/embor.2013.170; Poole K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4520; Prole DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066068; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Redaelli E, 2010, J BIOL CHEM, V285, P4130, DOI 10.1074/jbc.M109.054718; Romero PJ, 1997, CELL CALCIUM, V21, P353, DOI 10.1016/S0143-4160(97)90028-2; Schneider ER, 2014, P NATL ACAD SCI USA, V111, P14941, DOI 10.1073/pnas.1413656111; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Sukharev S, 2012, J CELL SCI, V125, P3075, DOI 10.1242/jcs.092353; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Vandorpe DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008732; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Yang XN, 2014, DIGEST DIS SCI, V59, P1428, DOI 10.1007/s10620-014-3044-3; Zakrzewska JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g474; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253	74	133	142	9	97	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31673	31681		10.1074/jbc.R114.612697	http://dx.doi.org/10.1074/jbc.R114.612697			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25305018	Green Published, hybrid			2022-12-28	WOS:000345314700002
J	Lu, LY; Kuang, H; Korakavi, G; Yu, XC				Lu, Lin-Yu; Kuang, Henry; Korakavi, Gautam; Yu, Xiaochun			Topoisomerase II Regulates the Maintenance of DNA Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMIMETHYLATED CPG SITES; HISTONE H3 TAIL; SRA DOMAIN; METHYLTRANSFERASE DNMT1; EPIGENETIC INHERITANCE; LYSINE-9 METHYLATION; STRUCTURAL BASIS; PROTEIN UHRF1; TANDEM TUDOR; RECOGNITION	The maintenance of DNA methylation in nascent DNA is a critical event for numerous biological processes. Following DNA replication, DNMT1 is the key enzyme that strictly copies the methylation pattern from the parental strand to the nascent DNA. However, the mechanism underlying this highly specific event is not thoroughly understood. In this study, we identified topoisomerase II alpha (TopoII alpha) as a novel regulator of the maintenance DNA methylation. UHRF1, a protein important for global DNA methylation, interacts with TopoII alpha and regulates its localization to hemimethylated DNA. TopoII alpha decatenates the hemimethylated DNA following replication, which might facilitate the methylation of the nascent strand by DNMT1. Inhibiting this activity impairs DNA methylation at multiple genomic loci. We have uncovered a novel mechanism during the maintenance of DNA methylation.	[Lu, Lin-Yu] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou 310006, Zhejiang, Peoples R China; [Lu, Lin-Yu] Zhejiang Univ, Inst Translat Med, Hangzhou 310006, Zhejiang, Peoples R China; [Kuang, Henry; Korakavi, Gautam; Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA	Zhejiang University; Zhejiang University; University of Michigan System; University of Michigan	Lu, LY (corresponding author), Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou 310006, Zhejiang, Peoples R China.	lulinyu@zju.edu.cn; xiayu@umich.edu			National Institutes of Health [CA132755, CA130899]; National Natural Science Foundation of China [81471494]; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA130899, R01CA132755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132755 and CA130899 (to X. Y.). This work was also supported by National Natural Science Foundation of China Project 81471494 (to L.-Y. L.).; Recipient of an Era of Hope Scholar Award from the Department of Defense. To whom correspondence may be addressed. Tel.: 734-615-4945; Fax: 734-936-6684; E-mail: xiayu@umich.edu.	Akimitsu N, 2003, GENES CELLS, V8, P393, DOI 10.1046/j.1365-2443.2003.00643.x; Almouzni G, 2011, NUCLEUS-PHILA, V2, P332, DOI 10.4161/nucl.2.5.17707; Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bashtrykov P, 2014, J BIOL CHEM, V289, P4106, DOI 10.1074/jbc.M113.528893; Bashtrykov P, 2012, CHEM BIOL, V19, P572, DOI 10.1016/j.chembiol.2012.03.010; Berkyurek AC, 2014, J BIOL CHEM, V289, P379, DOI 10.1074/jbc.M113.523209; Boos G, 2001, INT J BIOL MACROMOL, V28, P103, DOI 10.1016/S0141-8130(00)00157-4; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bulut-Karslioglu A, 2014, MOL CELL, V55, P277, DOI 10.1016/j.molcel.2014.05.029; Cheng JD, 2013, J BIOL CHEM, V288, P1329, DOI 10.1074/jbc.M112.415398; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hiratani L, 2009, CURR OPIN GENET DEV, V19, P142, DOI 10.1016/j.gde.2009.02.002; Hu LL, 2011, CELL RES, V21, P1374, DOI 10.1038/cr.2011.124; Lane AB, 2013, J CELL BIOL, V203, P471, DOI 10.1083/jcb.201303045; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rothbart SB, 2013, GENE DEV, V27, P1288, DOI 10.1101/gad.220467.113; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang CK, 2011, CELL RES, V21, P1379, DOI 10.1038/cr.2011.123; Xie S, 2012, J MOL BIOL, V415, P318, DOI 10.1016/j.jmb.2011.11.012	35	11	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					851	860		10.1074/jbc.M114.611509	http://dx.doi.org/10.1074/jbc.M114.611509			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451918	hybrid, Green Published			2022-12-28	WOS:000347778200015
J	Sanz-Moreno, A; Fuhrmann, D; Zankel, A; Reingruber, H; Kern, L; Meijer, D; Niemann, A; Elsasser, HP				Sanz-Moreno, Adrian; Fuhrmann, David; Zankel, Armin; Reingruber, Herbert; Kern, Lara; Meijer, Dies; Niemann, Axel; Elsaesser, Hans-Peter			Late Onset Neuropathy with Spontaneous Clinical Remission in Mice Lacking the POZ Domain of the Transcription Factor Myc-interacting Zinc Finger Protein 1 (Miz1) in Schwann Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL ALLERGIC NEURITIS; MARIE-TOOTH-DISEASE; WALLERIAN DEGENERATION; INDUCED SENESCENCE; SIGNALING PATHWAY; PERIPHERAL-NERVES; NEURAL CREST; IN-VIVO; C-JUN; MYELIN	The transcription factor Miz1 (Myc-interacting zinc finger 1) is a known regulator of the cell cycle but also has cell cycle-independent functions. Here we analyzed the role of Miz1 in the peripheral nervous system, using an early embryonic conditional knock-out model in which the Miz1 POZ domain is ablated in Schwann cells. Although the development of myelinated nerve fibers was not impaired, Miz1 Delta POZ mice acquired behavioral signs of a peripheral neuropathy at the age of 3 months. At this time, ultrastructural analysis of the sciatic nerve showed de-and dysmyelination of fibers, with massive outfoldings and a focal infiltration of macrophages. Although the expression of genes encoding structural myelin proteins, such as periaxin, myelin basic protein, and myelin protein zero, was decreased, genes associated with a negative regulation of myelination, including c-Jun, Sox2, and Id2, were up-regulated in Miz1 Delta POZ mice compared with controls. In animals older than 4 months, the motor disabilities vanished, and the ultrastructure of the sciatic nerve exhibited numerous tomacula and remyelinated fibers, as indicated by thinner myelin. No second acute attack was observed up to the age of 1 year. Thus, the deletion of the Miz1 POZ domain in Schwann cells induces an acute neuropathy with a subsequent regeneration in which there is ongoing balancing between de-and remyelination. Miz1 Delta POZ mice are impaired in the maintenance of myelinated fibers and are a promising model for studying remyelination in adult peripheral nerves.	[Sanz-Moreno, Adrian; Fuhrmann, David; Kern, Lara; Elsaesser, Hans-Peter] Univ Marburg, Dept Cytobiol & Cytopathobiol, D-35033 Marburg, Germany; [Zankel, Armin; Reingruber, Herbert] Graz Univ Technol, A-8010 Graz, Austria; [Meijer, Dies] Erasmus MC, NL-3015 GE Rotterdam, Netherlands; [Niemann, Axel] ETH, CH-8093 Zurich, Switzerland	Philipps University Marburg; Graz University of Technology; Erasmus University Rotterdam; Erasmus MC; Swiss Federal Institutes of Technology Domain; ETH Zurich	Elsasser, HP (corresponding author), Univ Marburg, Dept Cytobiol & Cytopathobiol, Robert Koch Str 6, D-35033 Marburg, Germany.	elsaesse@mailer.uni-marburg.de	Meijer, Dies/C-7786-2012	Meijer, Dies/0000-0002-8461-6341; Fuhrmann, David/0000-0002-6208-9050; Sanz-Moreno, Adrian/0000-0001-9478-5432	Deutsche Forschungsgemeinschaft [EL-125/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant EL-125/6-1.	Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Atanasoski S, 2006, GLIA, V53, P147, DOI 10.1002/glia.20263; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; Bolis A, 2009, J NEUROSCI, V29, P8858, DOI 10.1523/JNEUROSCI.1423-09.2009; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cotter L, 2010, SCIENCE, V328, P1415, DOI 10.1126/science.1187735; Cray C, 2009, COMPARATIVE MED, V59, P517; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Gebhardt A, 2007, J CELL SCI, V120, P2586, DOI 10.1242/jcs.007104; Goebbels S, 2012, EMBO MOL MED, V4, P486, DOI 10.1002/emmm.201200227; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; HARTUNG HP, 1988, BRAIN, V111, P1039, DOI 10.1093/brain/111.5.1039; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; Honnemann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034885; HOLTZMAN E, 1965, J CELL BIOL, V27, P651, DOI 10.1083/jcb.27.3.651; Horn M, 2012, BRAIN, V135, P3567, DOI 10.1093/brain/aws275; Huxley C, 1998, HUM MOL GENET, V7, P449, DOI 10.1093/hmg/7.3.449; Ito S., 1968, J CELL BIOL, V39, p168a; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kerosuo L, 2008, J CELL SCI, V121, P3941, DOI 10.1242/jcs.024802; Khazen W, 2005, FEBS LETT, V579, P5631, DOI 10.1016/j.febslet.2005.09.032; KING RHM, 1983, ACTA NEUROPATHOL, V59, P262, DOI 10.1007/BF00691491; Kosan C, 2010, IMMUNITY, V33, P917, DOI 10.1016/j.immuni.2010.11.028; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lindeboom F, 2003, NUCLEIC ACIDS RES, V31, P5405, DOI 10.1093/nar/gkg723; Liu J, 2009, P NATL ACAD SCI USA, V106, P18279, DOI 10.1073/pnas.0906328106; Martini R, 2013, AM J PATHOL, V183, P655, DOI 10.1016/j.ajpath.2013.06.002; MELLER D, 1994, BRAIN RES, V648, P162, DOI 10.1016/0006-8993(94)91917-8; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Moroy T, 2011, SEMIN IMMUNOL, V23, P379, DOI 10.1016/j.smim.2011.09.001; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Pereira JA, 2012, TRENDS NEUROSCI, V35, P123, DOI 10.1016/j.tins.2011.11.006; PERRY VH, 1995, EUR J NEUROSCI, V7, P271, DOI 10.1111/j.1460-9568.1995.tb01063.x; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Roussarie JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001331; Sanz-Moreno A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089187; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stassart RM, 2013, NAT NEUROSCI, V16, P48, DOI 10.1038/nn.3281; Stead M. A., 2014, NACL INTERACTS POZ D, DOI [10.1042/BSR20140049, DOI 10.1042/BSR20140049]; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Takeuchi S, 2010, CANCER RES, V70, P9381, DOI 10.1158/0008-5472.CAN-10-0801; Tersar K, 2007, HUM MOL GENET, V16, P2991, DOI 10.1093/hmg/ddm257; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; Wolf E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3535; Woodhoo A, 2008, GLIA, V56, P1481, DOI 10.1002/glia.20723; Yang M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-5; Young P, 2005, HEREDITARY PERIPHERAL NEUROPATHIES, P227, DOI 10.1007/3-7985-1586-7_15; Zankel A, 2009, J MICROSC-OXFORD, V233, P140, DOI 10.1111/j.1365-2818.2008.03104.x; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	65	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					727	743		10.1074/jbc.M114.605931	http://dx.doi.org/10.1074/jbc.M114.605931			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25416780	Green Published, hybrid			2022-12-28	WOS:000347778200004
J	Li, CC; Feng, M; Shi, ZB; Hao, Q; Song, XM; Wang, WJ; Zhao, Y; Jiao, S; Zhou, ZC				Li, Chuanchuan; Feng, Miao; Shi, Zhubing; Hao, Qian; Song, Xiaomin; Wang, Wenjia; Zhao, Yun; Jiao, Shi; Zhou, Zhaocai			Structural and Biochemical Insights into the Activation Mechanisms of Germinal Center Kinase OSR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-RICH KINASE; CRYSTAL-STRUCTURE; STE20-RELATED KINASES; PROTEIN-KINASES; SPAK; WNK1; COTRANSPORTERS; HYPERTENSION; PATHWAY; COMPLEX	The oxidative stress-responsive 1 (OSR1) kinase belongs to the mammalian STE20-like kinase family. OSR1 is activated by with no lysine [K] (WNKs) kinases, and then it phosphorylates cation-coupled Cl-cotransporters, regulating ion homeostasis and cell volume in mammalian cells. However, the specific mechanisms of OSR1 activation remains poorly defined, largely due to its extremely low basal activity. Here, we dissect in detail the regulatory mechanisms of OSR1 activation from the aspects of autoinhibition, upstream kinase WNK, and the newly identified master regulator mouse protein-25 (MO25). Based on our structural and biochemical studies, we propose a "double lock" model, accounting for the tight autoinhibition of OSR1, an effect that has to be removed by WNK before MO25 further activates OSR1. Particularly, the conserved C-terminal (CCT) domain and alpha AL helix act together to strongly suppress OSR1 basal activity. WNKs bind to the CCT and trigger its conformational rearrangement to release the kinase domain of OSR1, allowing for MO25 binding and full activation. Finally, the regulatory mechanisms of OSR1 activation were further corroborated by cellular studies of OSR1-regulated cell volume control through WNK-OSR1 signaling pathway. Collectively, these results provide insights into the OSR1 kinase activation to facilitate further functional study.	[Li, Chuanchuan; Feng, Miao; Shi, Zhubing; Hao, Qian; Song, Xiaomin; Wang, Wenjia; Zhao, Yun; Jiao, Shi; Zhou, Zhaocai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai,State Key Lab Cell Bio, Shanghai 200031, Peoples R China; [Shi, Zhubing] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University	Jiao, S (corresponding author), Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	jiaoshi@sibcb.ac.cn; zczhou@sibcb.ac.cn	Shi, Zhubing/F-9490-2010	Shi, Zhubing/0000-0002-9624-4960	973 program of the Ministry of Science and Technology of China [2012CB910204]; National Natural Science Foundation of China [31270808, 31300734, 31470736, 31470868]; Science and Technology Commission of Shanghai Municipality [11JC14140000, 13ZR1446400]; "Cross and Cooperation in Science and Technology Innovation Team" Project of the Chinese Academy of Sciences	973 program of the Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); "Cross and Cooperation in Science and Technology Innovation Team" Project of the Chinese Academy of Sciences	This work was supported by the 973 program of the Ministry of Science and Technology of China (2012CB910204), the National Natural Science Foundation of China (31270808, 31300734, 31470736, 31470868), the Science and Technology Commission of Shanghai Municipality (11JC14140000, 13ZR1446400), and the "Cross and Cooperation in Science and Technology Innovation Team" Project of the Chinese Academy of Sciences.	Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cusick JK, 2006, BIOCHEM BIOPH RES CO, V340, P535, DOI 10.1016/j.bbrc.2005.12.033; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Delpire E, 2006, ACTA PHYSIOL, V187, P103, DOI 10.1111/j.1748-1716.2006.01565.x; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KB, 2012, PHYSIOL REV, V92, P1577, DOI 10.1152/physrev.00009.2012; Gagnon KB, 2011, CELL PHYSIOL BIOCHEM, V28, P1219, DOI 10.1159/000335854; Grimm PR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.402800; Hao Q, 2014, J STRUCT BIOL, V186, P224, DOI 10.1016/j.jsb.2014.04.005; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Latchoumycandane C, 2005, J PHARMACOL EXP THER, V313, P46, DOI 10.1124/jpet.104.078469; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Leiserson WM, 2000, NEURON, V28, P793, DOI 10.1016/S0896-6273(00)00154-9; Li YQ, 2004, EMBO J, V23, P1112, DOI 10.1038/sj.emboj.7600125; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; Mehellou Y, 2013, BIOCHEM BIOPH RES CO, V431, P604, DOI 10.1016/j.bbrc.2012.12.113; Milburn CC, 2004, NAT STRUCT MOL BIOL, V11, P193, DOI 10.1038/nsmb716; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Nishida H, 2012, HYPERTENSION, V60, P981, DOI 10.1161/HYPERTENSIONAHA.112.201509; Nugent BM, 2012, J NEUROSCI, V32, P593, DOI 10.1523/JNEUROSCI.5415-11.2012; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Ponce-Coria J, 2014, J BIOL CHEM, V289, P17680, DOI 10.1074/jbc.M113.540518; Ponce-Coria J, 2012, AM J PHYSIOL-CELL PH, V303, pC1198, DOI 10.1152/ajpcell.00284.2012; Record CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011905; Richardson C, 2011, J CELL SCI, V124, P789, DOI 10.1242/jcs.077230; Sengupta S, 2013, P NATL ACAD SCI USA, V110, P18826, DOI 10.1073/pnas.1318676110; Shi ZB, 2013, STRUCTURE, V21, P449, DOI 10.1016/j.str.2013.01.007; Villa F, 2007, EMBO REP, V8, P839, DOI 10.1038/sj.embor.7401048; Villa F, 2008, PROTEINS, V73, P1082, DOI 10.1002/prot.22238; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Yin HL, 2012, CELL MOL IMMUNOL, V9, P439, DOI 10.1038/cmi.2012.30; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126	43	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35969	35978		10.1074/jbc.M114.592097	http://dx.doi.org/10.1074/jbc.M114.592097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25389294	Green Published, hybrid			2022-12-28	WOS:000346897900027
J	Guo, JT; Zhang, JH; Zhang, XJ; Zhang, ZM; Wei, XD; Zhou, XY				Guo, Jitao; Zhang, Jianhua; Zhang, Xuejie; Zhang, Zhongmei; Wei, Xundong; Zhou, Xuyu			Constitutive Activation of MEK1 Promotes Treg Cell Instability in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmunity; Cell Signaling; Immunology; Inflammation; T Cell; Treg Cell; Instability; Foxp3; COT; MEK; ERK	REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; CIS-ELEMENT; CORD BLOOD; EXPRESSION; DIFFERENTIATION; GENERATION; INHIBITION; DISRUPTION; MECHANISMS	The instability of regulatory T (Treg) cells is involved in the pathogenesis of autoimmune diseases and also highlights safety concerns with regard to clinical Treg cell therapy. Cell-intrinsic molecular events linked to this Treg cell instability in vivo cells, which leads to safety concerns regardingare still obscure. Here we developed a novel luciferase-based reporter system and performed an unbiased screening for kinases that potentially modulate Foxp3 function. We found that the active form of COT/Tpl2 specifically inhibits the DNA binding activity of Foxp3 through a MEK-ERK-dependent pathway. Moreover, Treg cell-specific expression of activated MEK1 led to dysregulation of Treg function and instability of Foxp3 expression in vivo. Our results support the hypothesis that outside inflammatory signals act through the COT/Tpl2-MEK-ERK signaling pathway to destabilize the Treg lineage.	[Guo, Jitao; Zhang, Jianhua; Zhang, Xuejie; Zhang, Zhongmei; Wei, Xundong; Zhou, Xuyu] Chinese Acad Sci CASPMI, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Zhou, XY (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	zhouxy@im.ac.cn	Guo, Jitao/AAP-4971-2020; Zhou, Xuyu/L-7422-2019	Zhou, Xuyu/0000-0002-6626-0898; zhang, zhongmei/0000-0001-7450-8040; Guo, Jitao/0000-0002-0927-4249	National Key Basic Research and Development 973 Program of China [2012CB917102]; National Natural Science Foundation of China [31070804]; China Postdoctoral Science Foundation [2011M500422]	National Key Basic Research and Development 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Key Basic Research and Development 973 Program of China Grant 2012CB917102, by National Natural Science Foundation of China Grant 31070804, and by China Postdoctoral Science Foundation Grant 2011M500422.	Bagnyukova TV, 2013, BRIT J CANCER, V109, P1063, DOI 10.1038/bjc.2013.353; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Birzele F, 2011, NUCLEIC ACIDS RES, V39, P7946, DOI 10.1093/nar/gkr444; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Chang CF, 2012, J IMMUNOL, V189, P721, DOI 10.4049/jimmunol.1103015; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; d'Hennezel E, 2012, J MED GENET, V49, P291, DOI 10.1136/jmedgenet-2012-100759; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Koh KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008109; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Li LQ, 2005, BLOOD, V106, P3068, DOI 10.1182/blood-2005-04-1531; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Lin J, 2001, J CELL SCI, V114, P243; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Mocci S, 2000, CURR OPIN IMMUNOL, V12, P725, DOI 10.1016/S0952-7915(00)00169-2; Mor A, 2008, EUR J IMMUNOL, V38, P1493, DOI 10.1002/eji.200838292; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tang QZ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015552; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	43	10	11	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35139	35148		10.1074/jbc.M114.589192	http://dx.doi.org/10.1074/jbc.M114.589192			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25361764	Green Published, hybrid			2022-12-28	WOS:000346660200008
J	Li, J; Ballim, D; Rodriguez, M; Cui, RT; Goding, CR; Teng, HJ; Prince, S				Li, Jarod; Ballim, Deeya; Rodriguez, Mercedes; Cui, Rutao; Goding, Colin R.; Teng, Huajian; Prince, Sharon			The Anti-proliferative Function of the TGF-beta 1 Signaling Pathway Involves the Repression of the Oncogenic TBX2 by Its Homologue TBX3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Cell Proliferation; Gene Expression; Transcription Factor; Transforming Growth Factor (TGF-); TBX2; TBX3; p21	MAMMARY-GLAND DEVELOPMENT; CELL-CYCLE ARREST; TGF-BETA; BREAST-CANCER; C-MYC; EXPRESSION; GENE; SENESCENCE; PROLIFERATION; TRANSCRIPTION	A growing body of work has shown that the highly homologous T-box transcription factors TBX2 and TBX3 play critical but distinct roles in embryonic development and cancer progression. For example, TBX2 and TBX3 are up-regulated in several cancers and recent evidence suggests that whereas TBX2 functions as a pro-proliferative factor, TBX3 inhibits cell proliferation but promotes cancer cell migration and invasion. While the molecular mechanisms regulating these functions of TBX2 and TBX3 are poorly understood we recently reported that the TGF-1 signaling pathway up-regulates TBX3 expression to mediate, in part, its well described anti-proliferative and pro-migratory roles. The TBX3 targets responsible for these functions were however not identified. Here we reveal for the first time that the TGF-1 signaling pathway represses TBX2 transcriptionally and we provide a detailed mechanism to show that this is mediated by TBX3. Furthermore, we implicate the down-regulation of TBX2 in the anti-proliferative function of the TGF-1-TBX3 axis. These findings have important implications for our understanding of the regulation of TBX2 and TBX3 and shed light on the mechanisms involved in the anti-proliferative and pro-migratory roles of TGF-beta 1.	[Li, Jarod; Ballim, Deeya; Teng, Huajian; Prince, Sharon] Univ Cape Town, Dept Human Biol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Rodriguez, Mercedes; Goding, Colin R.] Univ Oxford, Ludwig Inst Canc Res, Oxford OX3 7DQ, England; [Cui, Rutao] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	University of Cape Town; Ludwig Institute for Cancer Research; University of Oxford; Boston University	Prince, S (corresponding author), Univ Cape Town, Dept Human Biol, Fac Hlth Sci, ZA-7925 Observatory, South Africa.	sharon.prince@uct.ac.za	Prince, Sharon/AFU-4911-2022	Prince, Sharon/0000-0002-6975-5255; Goding, Colin/0000-0002-1614-3909; Rodriguez-Teja, Mercedes/0000-0002-7258-301X	SA Medical Research Council; National Research Foundation (NRF); Cancer Association of South Africa (CANSA); Cancer Research Initiative of South Africa (CARISA); University of Cape Town	SA Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation (NRF); Cancer Association of South Africa (CANSA); Cancer Research Initiative of South Africa (CARISA); University of Cape Town	This work was supported by grants from the SA Medical Research Council, the National Research Foundation (NRF), Cancer Association of South Africa (CANSA), Cancer Research Initiative of South Africa (CARISA), and the University of Cape Town.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; ALEXANDROW MG, 1995, P NATL ACAD SCI USA, V92, P3239, DOI 10.1073/pnas.92.8.3239; Baldwin RL, 2003, CANCER RES, V63, P1413; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Davis E, 2008, ONCOGENE, V27, P976, DOI 10.1038/sj.onc.1210701; Douglas NC, 2013, J MAMMARY GLAND BIOL, V18, P143, DOI 10.1007/s10911-013-9282-8; Fan WW, 2004, CANCER RES, V64, P5132, DOI 10.1158/0008-5472.CAN-04-0615; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jahn Stephan Christopher, 2012, Front Biosci (Schol Ed), V4, P749; Jerome-Majewska LA, 2005, DEV DYNAM, V234, P922, DOI 10.1002/dvdy.20575; Jonsson G, 2007, ONCOGENE, V26, P4738, DOI 10.1038/sj.onc.1210252; Li J, 2013, MOL BIOL CELL, V24, P3569, DOI 10.1091/mbc.E13-05-0273; Lomnytska M, 2006, INT J CANCER, V118, P412, DOI 10.1002/ijc.21332; Lyng H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-268; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Mowla S, 2011, BIOCHEM J, V433, P145, DOI 10.1042/BJ20100886; Peres Jade, 2010, Genes Cancer, V1, P272, DOI 10.1177/1947601910365160; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Prince S, 2003, PIGM CELL RES, V16, P26, DOI 10.1034/j.1600-0749.2003.00008.x; Redmond KL, 2010, ONCOGENE, V29, P3252, DOI 10.1038/onc.2010.84; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Rodriguez M, 2008, CANCER RES, V68, P7872, DOI 10.1158/0008-5472.CAN-08-0301; Rowley M, 2004, J MAMMARY GLAND BIOL, V9, P109, DOI 10.1023/B:JOMG.0000037156.64331.3f; Sinclair CS, 2002, CANCER RES, V62, P3587; Teng HJ, 2008, GENE, V423, P8, DOI 10.1016/j.gene.2008.06.017; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yoo YD, 1999, INT J CANCER, V83, P512, DOI 10.1002/(SICI)1097-0215(19991112)83:4<512::AID-IJC13>3.0.CO;2-Z	36	25	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35633	35643		10.1074/jbc.M114.596411	http://dx.doi.org/10.1074/jbc.M114.596411			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25371204	hybrid, Green Published			2022-12-28	WOS:000346660200049
J	Singh, SK; Bharati, AP; Singh, N; Pandey, P; Joshi, P; Singh, K; Mitra, K; Gayen, JR; Sarkar, J; Akhtar, MS				Singh, Sudhir Kumar; Bharati, Akhilendra Pratap; Singh, Neha; Pandey, Praveen; Joshi, Pankaj; Singh, Kavita; Mitra, Kalyan; Gayen, Jiaur R.; Sarkar, Jayanta; Akhtar, Md. Sohail			The Prophage-encoded Hyaluronate Lyase Has Broad Substrate Specificity and Is Regulated by the N-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; Enzyme Catalysis; Glycosaminoglycan; Hyaluronate; Streptococcus; Domain; Hyaluronic Acid	STREPTOCOCCUS-EQUI INFECTION; HUMAN PHARYNGEAL CELLS; GROUP-A; BACTERIOPHAGE HYALURONIDASE; ESCHERICHIA-COLI; MOLECULAR-BASIS; PYOGENES; PHAGE; VIRULENCE; ACID	Streptococcus equi is the causative agent of the highly contagious disease strangles in equines and zoonotic meningitis in human. Spreading of infection in host tissues is thought to be facilitated by the bacterial gene encoded extracellular hyaluronate lyase (HL), which degrades hyaluronan (HA), chondroitin 6-sulfate, and dermatan sulfate of the extracellular matrix). The clinical strain S. equi 4047 however, lacks a functional extracellular HL. The prophages of S. equi and other streptococci encode intracellular HLs which are reported to partially degrade HA and do not cleave any other glycosaminoglycans. The phage HLs are thus thought to play a role limited to the penetration of streptococcal HA capsules, facilitating bacterial lysogenization and not in the bacterial pathogenesis. Here we systematically looked into the structure-function relationship of S. equi 4047 phage HL. Although HA is the preferred substrate, this HL has weak activity toward chondroitin 6-sulfate and dermatan sulfate and can completely degrade all of them. Even though the catalytic triple-stranded -helix domain of phage HL is functionally independent, its catalytic efficiency and specificity is influenced by the N-terminal domain. The phage HL also interacts with human transmembrane glycoprotein CD44. The above results suggest that the streptococci can use phage HLs to degrade glycosaminoglycans of the extracellular matrix for spreading virulence factors and toxins while utilizing the disaccharides as a nutrient source for proliferation at the site of infection.	[Singh, Sudhir Kumar; Bharati, Akhilendra Pratap; Singh, Neha; Akhtar, Md. Sohail] Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Lucknow 226031, Uttar Pradesh, India; [Pandey, Praveen; Sarkar, Jayanta] Cent Drug Res Inst, CSIR, Div Biochem, Lucknow 226031, Uttar Pradesh, India; [Joshi, Pankaj; Gayen, Jiaur R.] Cent Drug Res Inst, CSIR, Pharmacokinet & Metab Div, Lucknow 226031, Uttar Pradesh, India; [Singh, Kavita; Mitra, Kalyan] Cent Drug Res Inst, CSIR, Sophisticated Analyt Instrument Facil, Lucknow 226031, Uttar Pradesh, India; [Mitra, Kalyan; Gayen, Jiaur R.; Sarkar, Jayanta; Akhtar, Md. Sohail] Acad Sci & Innovat Res, Madras 600113, Tamil Nadu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Academy of Scientific & Innovative Research (AcSIR)	Akhtar, MS (corresponding author), Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10, Lucknow 226031, Uttar Pradesh, India.	sohail@cdri.res.in	Sarkar, Jayanta/C-3250-2009; Bharati, Akhiendra Pratap/GWR-1433-2022	Bharati, Akhiendra Pratap/0000-0001-8711-610X; Sarkar, Jayanta/0000-0002-9905-7722	Council of Scientific and Industrial Research (India) [YSA001]; Department of Biotechnology (India), New Delhi; Council of Scientific and Industrial Research (India), New Delhi	Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (India), New Delhi; Council of Scientific and Industrial Research (India), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Council of Scientific and Industrial Research (India) Grant YSA001 (to M. S. A.). This is Central Drug Research Institute communication number 8839.; Supported in part by Department of Biotechnology (India), New Delhi.; Supported in part by Council of Scientific and Industrial Research (India), New Delhi.	Akhtar MS, 2006, J BIOL CHEM, V281, P28336, DOI 10.1074/jbc.M601165200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Baker JR, 2002, BIOCHEM J, V365, P317, DOI 10.1042/BJ20020149; Banerji S, 1998, PROTEIN EXPRES PURIF, V14, P371, DOI 10.1006/prep.1998.0971; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Broudy TB, 2003, INFECT IMMUN, V71, P3782, DOI 10.1128/IAI.71.7.3782-3786.2003; Broudy TB, 2002, INFECT IMMUN, V70, P2805, DOI 10.1128/IAI.70.6.2805-2811.2002; Broudy TB, 2001, INFECT IMMUN, V69, P1440, DOI 10.1128/IAI.69.3.1440-1443.2001; Canchaya C, 2002, VIROLOGY, V302, P245, DOI 10.1006/viro.2002.1570; Elsayed S, 2003, CLIN MICROBIOL INFEC, V9, P869, DOI 10.1046/j.1469-0691.2003.00663.x; Frobisher M, 1927, B JOHNS HOPKINS HOSP, V41, P167; HALPERIN SA, 1987, J INFECT DIS, V155, P253, DOI 10.1093/infdis/155.2.253; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Harrington DJ, 2002, MICROBES INFECT, V4, P501, DOI 10.1016/S1286-4579(02)01565-4; Hynes WL, 2000, FEMS MICROBIOL LETT, V183, P201, DOI 10.1111/j.1574-6968.2000.tb08958.x; HYNES WL, 1995, INFECT IMMUN, V63, P3015, DOI 10.1128/IAI.63.8.3015-3020.1995; Kemparaju K, 2006, CELL BIOCHEM FUNCT, V24, P7, DOI 10.1002/cbf.1261; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar R, 2008, PROTEINS, V72, P892, DOI 10.1002/prot.21984; Lindsay AM, 2009, MICROBIOL-SGM, V155, P443, DOI 10.1099/mic.0.020826-0; Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5; Mishra P, 2009, FEBS J, V276, P3392, DOI 10.1111/j.1742-4658.2009.07065.x; PRITCHARD DG, 1994, ARCH BIOCHEM BIOPHYS, V315, P431, DOI 10.1006/abbi.1994.1521; Proft T, 2003, INFECT IMMUN, V71, P1361, DOI 10.1128/IAI.71.3.1361-1369.2003; Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977; Singh SK, 2014, BIOCHIMIE, V102, P203, DOI 10.1016/j.biochi.2014.03.012; Smith NL, 2005, P NATL ACAD SCI USA, V102, P17652, DOI 10.1073/pnas.0504782102; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; STING R, 1990, ZBL BAKT-INT J MED M, V272, P276; SWEENEY CR, 1987, J AM VET MED ASSOC, V191, P1446; Wagner PL, 2002, MOL MICROBIOL, V44, P957, DOI 10.1046/j.1365-2958.2002.02950.x; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Waller AS, 2007, VET J, V173, P492, DOI 10.1016/j.tvjl.2006.05.011	34	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35225	35236		10.1074/jbc.M113.507673	http://dx.doi.org/10.1074/jbc.M113.507673			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25378402	Green Published, hybrid			2022-12-28	WOS:000346660200016
J	Kim, HJ; Karki, S; Kwon, SY; Park, SH; Nahm, BH; Kim, YK; Kwon, HJ				Kim, Hyun-Ju; Karki, Suman; Kwon, So-Yeon; Park, Si-Hyung; Nahm, Baek-Hie; Kim, Yeon-Ki; Kwon, Hyung-Jin			A Single Module Type I Polyketide Synthase Directs de Novo Macrolactone Biogenesis during Galbonolide Biosynthesis in Streptomyces galbus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actinobacteria; Bacterial Genetics; Gene Knockout; Natural Product Biosynthesis; Polyketide; Streptomyces galbus; Galbonolide; Highly Reducing Type I Polyketide Synthase	STEM RUST FUNGUS; ESCHERICHIA-COLI; GENE-CLUSTER; CONJUGAL TRANSFER; RUSTMICIN; CLONING; DOMAIN; DNA	Background: Galbonolide (GAL) was proposed to be synthesized by a modular type I polyketide synthase (PKS) with GalA-E serving a supporting role. Results: GalA-C constitute a sole type I PKS that is involved in GAL biosynthesis in S. galbus. Conclusion: GalA-C catalyze the de novo formation of GAL macrolactone. Significance: GalA-C constitute a novel iterative PKS that incorporates methylmalonate units with highly programmed -keto group modifications. Galbonolide (GAL) A and B are antifungal macrolactone polyketides produced by Streptomyces galbus. During their polyketide chain assembly, GAL-A and -B incorporate methoxymalonate and methylmalonate, respectively, in the fourth chain extension step. The methoxymalonyl-acyl carrier protein biosynthesis locus (galG to K) is specifically involved in GAL-A biosynthesis, and this locus is neighbored by a gene cluster composed of galA-E. GalA-C constitute a single module, highly reducing type I polyketide synthase (PKS). GalD and GalE are cytochrome P450 and Rieske domain protein, respectively. Gene knock-out experiments verified that galB, -C, and -D are essential for GAL biosynthesis. A galD mutant accumulated a GAL-C that lacked two hydroxyl groups and a double bond when compared with GAL-B. A [U-C-13]propionate feeding experiment indicated that no rare precursor other than methoxymalonate was incorporated during GAL biogenesis. A search of the S. galbus genome for a modular type I PKS system, the type that was expected to direct GAL biosynthesis, resulted in the identification of only one modular type I PKS gene cluster. Homology analysis indicated that this PKS gene cluster is the locus for vicenistatin biosynthesis. This cluster was previously reported in Streptomyces halstedii. A gene deletion of the vinP2 ortholog clearly demonstrated that this modular type I PKS system is not involved in GAL biosynthesis. Therefore, we propose that GalA-C direct macrolactone polyketide formation for GAL. Our studies provide a glimpse into a novel biochemical strategy used for polyketide synthesis; that is, the iterative assembly of propionates with highly programmed -keto group modifications.	[Park, Si-Hyung] Mokpo Natl Univ, Dept Oriental Med Resources, Muan 534 729, Mokpo Si, South Korea; [Nahm, Baek-Hie; Kim, Yeon-Ki] GreenGene BioTech Inc, Yongin 449728, South Korea; [Kim, Hyun-Ju; Karki, Suman; Kwon, So-Yeon; Nahm, Baek-Hie; Kwon, Hyung-Jin] Myongji Univ, Dept Biol Sci, Yongin 449728, South Korea; [Park, Si-Hyung] Mokpo Natl Univ, Dept Oriental Med Resources, Muan 534729, South Korea; [Nahm, Baek-Hie; Kim, Yeon-Ki] GreenGene BioTech Inc, Yongin 449728, South Korea	Mokpo National University; Myongji University; Mokpo National University	Kwon, HJ (corresponding author), Myongji Univ, Dept Biol Sci, Myongji Ro 116, Yongin 449728, Gyeonggi Do, South Korea.	hjink@mju.ac.kr			National Research Foundation of Korea (NRF) by the Ministry of Education [2011-0021169, 2013R1A1A2059458]; Rural Development Administration, Republic of Korea [PJ009643]	National Research Foundation of Korea (NRF) by the Ministry of Education; Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) supported by the Ministry of Education (2011-0021169; 2013R1A1A2059458) and by a grant from the Next-Generation BioGreen 21 Program (PJ009643), Rural Development Administration, Republic of Korea.	ABE Y, 1985, J ANTIBIOT, V38, P1810, DOI 10.7164/antibiotics.38.1810; Achenbach H, 1988, Ann N Y Acad Sci, V544, P128, DOI 10.1111/j.1749-6632.1988.tb40396.x; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Cane DE, 2010, J BIOL CHEM, V285, P27517, DOI 10.1074/jbc.R110.144618; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; FAUTH U, 1986, J ANTIBIOT, V39, P1760, DOI 10.7164/antibiotics.39.1760; Fernandes ND, 1998, J BIOL CHEM, V273, P2823, DOI 10.1074/jbc.273.5.2823; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Gao ZZ, 2013, J AM CHEM SOC, V135, P1735, DOI 10.1021/ja4001823; Gokhale RS, 2007, NAT PROD REP, V24, P267, DOI 10.1039/b616817p; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hyun Chang-Gu, 1999, Agricultural Chemistry and Biotechnology, V42, P119; Karki S, 2010, FEMS MICROBIOL LETT, V310, P69, DOI 10.1111/j.1574-6968.2010.02048.x; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Mandala SM, 1998, J BIOL CHEM, V273, P14942, DOI 10.1074/jbc.273.24.14942; Mo S, 2011, J AM CHEM SOC, V133, P976, DOI 10.1021/ja108399b; Murli S, 2003, J IND MICROBIOL BIOT, V30, P500, DOI 10.1007/s10295-003-0073-x; Ogasawara Y, 2004, CHEM BIOL, V11, P79, DOI 10.1016/j.chembiol.2003.12.010; Rajkarnikar A, 2007, BIOCHEM BIOPH RES CO, V363, P322, DOI 10.1016/j.bbrc.2007.08.169; Shen B, 2002, CHEM REC, V2, P389, DOI 10.1002/tcr.10042; TAKATSU T, 1985, J ANTIBIOT, V38, P1806, DOI 10.7164/antibiotics.38.1806; Zhao QF, 2008, CHEM BIOL, V15, P693, DOI 10.1016/j.chembiol.2008.05.021	24	6	6	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34557	34568		10.1074/jbc.M114.602334	http://dx.doi.org/10.1074/jbc.M114.602334			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25336658	Green Published, hybrid			2022-12-28	WOS:000346260800015
J	Lu, ZY; Wang, Y; Chen, F; Tong, HM; Reddy, MVVVS; Luo, L; Seshadrinathan, S; Zhang, L; Holthauzen, LMF; Craig, AM; Ren, G; Rudenko, G				Lu, Zhuoyang; Wang, Yun; Chen, Fang; Tong, Huimin; Reddy, M. V. V. V. Sekhar; Luo, Lin; Seshadrinathan, Suchithra; Zhang, Lei; Holthauzen, Luis Marcelo F.; Craig, Ann Marie; Ren, Gang; Rudenko, Gabby			Calsyntenin-3 Molecular Architecture and Interaction with Neurexin 1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Cell Surface Receptor; Protein-Protein Interaction; Single-particle Analysis; Synapse; Calsyntenins; Neurexins; Neuropsychiatric Disorders; Synaptic Organizers	ELECTRON-MICROSCOPY; SYNAPTIC ADHESION; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; LIGAND-BINDING; BETA; VISUALIZATION; NEUROLIGIN; DIMERIZATION; PROMOTES	Background: Calsyntenin-3 (Cstn3) promotes synapse development, controversially interacting with neurexin 1 (n1). Results: Cstn3 binds n1 directly, and its structure adopts multiple forms. Conclusion: Cstn3 interacts with n1 via a novel mechanism and can produce distinct trans-synaptic bridges with n1. Significance: A complex portfolio of molecular interactions between proteins implicated in autism spectrum disorder and schizophrenia guide synapse development. Calsyntenin 3 (Cstn3 or Clstn3), a recently identified synaptic organizer, promotes the development of synapses. Cstn3 localizes to the postsynaptic membrane and triggers presynaptic differentiation. Calsyntenin members play an evolutionarily conserved role in memory and learning. Cstn3 was recently shown in cell-based assays to interact with neurexin 1 (n1), a synaptic organizer that is implicated in neuropsychiatric disease. Interaction would permit Cstn3 and n1 to form a trans-synaptic complex and promote synaptic differentiation. However, it is contentious whether Cstn3 binds n1 directly. To understand the structure and function of Cstn3, we determined its architecture by electron microscopy and delineated the interaction between Cstn3 and n1 biochemically and biophysically. We show that Cstn3 ectodomains form monomers as well as tetramers that are stabilized by disulfide bonds and Ca2+, and both are probably flexible in solution. We show further that the extracellular domains of Cstn3 and n1 interact directly and that both Cstn3 monomers and tetramers bind n1 with nanomolar affinity. The interaction is promoted by Ca2+ and requires minimally the LNS domain of Cstn3. Furthermore, Cstn3 uses a fundamentally different mechanism to bind n1 compared with other neurexin partners, such as the synaptic organizer neuroligin 2, because Cstn3 does not strictly require the sixth LNS domain of n1. Our structural data suggest how Cstn3 as a synaptic organizer on the postsynaptic membrane, particularly in tetrameric form, may assemble radially symmetric trans-synaptic bridges with the presynaptic synaptic organizer n1 to recruit and spatially organize proteins into networks essential for synaptic function.	[Reddy, M. V. V. V. Sekhar; Seshadrinathan, Suchithra; Rudenko, Gabby] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Holthauzen, Luis Marcelo F.; Rudenko, Gabby] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Lu, Zhuoyang; Tong, Huimin; Zhang, Lei; Ren, Gang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Lu, Zhuoyang] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Peoples R China; [Lu, Zhuoyang] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China; [Luo, Lin; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; [Wang, Yun; Chen, Fang] Univ Michigan, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Xi'an Jiaotong University; Xi'an Jiaotong University; University of British Columbia; University of Michigan System; University of Michigan	Ren, G (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry Rm 2220,1 Cyclotron Rd,MS 67R2206, Berkeley, CA 94720 USA.	gren@lbl.gov	Rudenko, Gabrielle (Gabby)/O-7938-2018; M, Sekharreddy/C-9428-2014; Craig, Ann Marie/M-2054-2014; Ren, Gang/B-1567-2012; Reddy, M. V. V. V. Sekhar/I-1093-2019; Zhang, Lei/G-6427-2012	Rudenko, Gabrielle (Gabby)/0000-0002-7372-0530; Ren, Gang/0000-0002-8036-2321; Zhang, Lei/0000-0002-4880-824X; manukonda, veera/0000-0002-9917-8778	National Institutes of Health, NIMH [R01MH077303, R01MH070860]; Sealy Center for Structural Biology and Molecular Biophysics (UTMB); Brain and Behavior Research Foundation; United States Department of Energy [DE-AC02-05CH11231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070860, R01MH077303] Funding Source: NIH RePORTER	National Institutes of Health, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sealy Center for Structural Biology and Molecular Biophysics (UTMB); Brain and Behavior Research Foundation; United States Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health, NIMH, Grants R01MH077303 and R01MH070860. This work was also supported by the Sealy Center for Structural Biology and Molecular Biophysics (UTMB) and the Brain and Behavior Research Foundation. Work at the Molecular Foundry was supported by the United States Department of Energy under Contract DE-AC02-05CH11231.	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Bena F, 2013, AM J MED GENET B, V162B, P388, DOI 10.1002/ajmg.b.32148; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Boucard AA, 2012, J BIOL CHEM, V287, P9399, DOI 10.1074/jbc.M111.318659; Chen F, 2011, STRUCTURE, V19, P779, DOI 10.1016/j.str.2011.03.012; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Fernandez JJ, 2006, ULTRAMICROSCOPY, V106, P587, DOI 10.1016/j.ultramic.2006.02.004; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Grimm S, 2011, FREE RADICAL RES, V45, P73, DOI 10.3109/10715762.2010.512040; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Hoerndli FJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004880; Ikeda DD, 2008, P NATL ACAD SCI USA, V105, P5260, DOI 10.1073/pnas.0711894105; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lee SJ, 2012, J NEUROSCI, V32, P4688, DOI 10.1523/JNEUROSCI.5584-11.2012; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Makagiansar IT, 2002, J BIOL CHEM, V277, P16002, DOI 10.1074/jbc.M200916200; Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011; Missler M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005694; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Pettem KL, 2013, NEURON, V80, P113, DOI 10.1016/j.neuron.2013.07.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poulopoulos A, 2012, BIOCHEM J, V446, P321, DOI 10.1042/BJ20120808; Rames M, 2014, JOVE-J VIS EXP, DOI 10.3791/51087; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sheckler LR, 2006, J BIOL CHEM, V281, P22896, DOI 10.1074/jbc.M603464200; Shen KC, 2008, STRUCTURE, V16, P422, DOI 10.1016/j.str.2008.01.005; Shipman SL, 2012, P NATL ACAD SCI USA, V109, P19432, DOI 10.1073/pnas.1217633109; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Steuble M, 2012, BIOL OPEN, V1, P761, DOI 10.1242/bio.20121578; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Treutlein B, 2014, P NATL ACAD SCI USA, V111, pE1291, DOI 10.1073/pnas.1403244111; Um JW, 2014, CELL REP, V6, P1096, DOI 10.1016/j.celrep.2014.02.010; Vagnoni A, 2012, HUM MOL GENET, V21, P2845, DOI 10.1093/hmg/dds109; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030249, 10.1371/journal.pone.0030592]; Zhang L, 2010, J LIPID RES, V51, P1228, DOI 10.1194/jlr.D002493	48	36	38	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34530	34542		10.1074/jbc.M114.606806	http://dx.doi.org/10.1074/jbc.M114.606806			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25352602	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000346260800013
J	Zhang, B; Wang, E; Dai, H; Shen, JF; Hsieh, HJ; Lu, XB; Peng, G				Zhang, Bo; Wang, Edward; Dai, Hui; Shen, Jianfeng; Hsieh, Hui-Ju; Lu, Xiongbin; Peng, Guang			Phosphorylation of the BRCA1C Terminus (BRCT) Repeat Inhibitor of hTERT (BRIT1) Protein Coordinates TopBP1 Protein Recruitment and Amplifies Ataxia Telangiectasia-mutated and Rad3-related (ATR) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cell Cycle; Cell Signaling; DNA Damage; DNA Repair; ATR; BRIT1; MCPH1; TopBP1; Replication Stress	DNA-DAMAGE RESPONSE; ONCOGENE-INDUCED SENESCENCE; GENOMIC INSTABILITY; HISTONE H2AX; MITOTIC ENTRY; CHECKPOINT; REPLICATION; ACTIVATION; MICROCEPHALIN; CHROMATIN	Background: ATR signaling depends on TopBP1 recruitment to replication stress sites. Results: Interaction between BRIT1 and TopBP1 is required for sustained TopBP1 recruitment to sites of replication stress, which maintains ATR substrate activation. Conclusion: ATR-mediated phosphorylation of BRIT1 and BRIT1 interaction with TopBP1 provide mechanisms of TopBP1 recruitment to promote ATR signaling. Significance: We further the understanding of how ATR signaling is maintained through TopBP1. The ataxia telangiectasia-mutated and Rad3-related (ATR) kinase functions as a central node in the DNA damage response signaling network. The mechanisms by which ATR activity is amplified and/or maintained are not understood. Here we demonstrate that BRIT1/microcephalin (MCPH1), a human disease-related protein, is dispensable for the initiation but essential for the amplification of ATR signaling. BRIT1 interacts with and recruits topoisomerase-binding protein 1 (TopBP1), a key activator of ATR signaling, to the sites of DNA damage. Notably, replication stress-induced ataxia telangiectasia-mutated or ATR-dependent BRIT1 phosphorylation at Ser-322 facilitates efficient TopBP1 recruitment. These results reveal a mechanism that ensures the continuation of ATR-initiated DNA damage signaling. Our study uncovers a previously unknown regulatory axis of ATR signaling in maintaining genomic integrity, which may provide mechanistic insights into the perturbation of ATR signaling in human diseases such as neurodevelopmental defects and cancer.	[Zhang, Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430022, Hubei Province, Peoples R China; [Wang, Edward; Dai, Hui] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77054 USA; [Lu, Xiongbin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Zhang, Bo; Shen, Jianfeng; Hsieh, Hui-Ju; Peng, Guang] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA	Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Peng, G (corresponding author), Dept Clin Canc Prevent, 1515 Holcombe,Unit 1013, Houston, TX 77030 USA.	gpeng@mdanderson.org	Hsieh, Hui-Ju/Q-1237-2015; Hsieh, Hui-Ju/S-3082-2018	Hsieh, Hui-Ju/0000-0002-2583-7670	National Institutes of Health [R00CA149186]; National Institutes of Health Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, R00CA149186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R00CA149186 (to G. P.) and National Institutes of Health Cancer Center Support Grant CA016672 (to The University of Texas MD Anderson Cancer Center).	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bhattacharya N, 2013, ANN SURG ONCOL, V20, pS424, DOI 10.1245/s10434-012-2715-6; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Brown EJ, 2000, GENE DEV, V14, P397; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Mordes DA, 2008, CELL CYCLE, V7, P2809, DOI 10.4161/cc.7.18.6689; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Peng G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4361; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Richardson J, 2011, BREAST CANCER RES TR, V127, P639, DOI 10.1007/s10549-010-1019-4; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	42	5	6	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34284	34295		10.1074/jbc.M114.587113	http://dx.doi.org/10.1074/jbc.M114.587113			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25301947	Green Published, hybrid			2022-12-28	WOS:000346077600050
J	Fahrner, M; Muik, M; Schindl, R; Butorac, C; Stathopulos, P; Zheng, L; Jardin, I; Ikura, M; Romanin, C				Fahrner, Marc; Muik, Martin; Schindl, Rainer; Butorac, Carmen; Stathopulos, Peter; Zheng, Le; Jardin, Isaac; Ikura, Mitsuhiko; Romanin, Christoph			A Coiled-coil Clamp Controls Both Conformation and Clustering of Stromal Interaction Molecule 1 (STIM1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CALCIUM-ENTRY; ACTIVATES CRAC CHANNELS; PLASMA-MEMBRANE; CA2+ SENSOR; MECHANISTIC INSIGHTS; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; ORAI CHANNELS; SAM DOMAIN; STORE	Store-operated Ca2+ entry, essential for the adaptive immunity, is initiated by the endoplasmic reticulum (ER) Ca2+ sensor STIM1. Ca2+ entry occurs through the plasma membrane resident Ca2+ channel Orai1 that directly interacts with the C-terminal STIM1 domain, named SOAR/CAD. Depletion of the ER Ca2+ store controls this STIM1/Orai1 interaction via transition to an extended STIM1 C-terminal conformation, exposure of the SOAR/CAD domain, and STIM1/Orai1 co-clustering. Here we developed a novel approach termed FRET-derived Interaction in a Restricted Environment (FIRE) in an attempt to dissect the interplay of coiled-coil (CC) interactions in controlling STIM1 quiescent as well as active conformation and cluster formation. We present evidence of a sequential activation mechanism in the STIM1 cytosolic domains where the interaction between CC1 and CC3 segment regulates both SOAR/CAD exposure and CC3-mediated higher-order oligomerization as well as cluster formation. These dual levels of STIM1 auto-inhibition provide efficient control over the coupling to and activation of Orai1 channels.	[Fahrner, Marc; Muik, Martin; Schindl, Rainer; Butorac, Carmen; Jardin, Isaac; Romanin, Christoph] Johannes Kepler Univ Linz, Inst Biophys, Life Sci Ctr JKU, A-4020 Linz, Austria; [Stathopulos, Peter] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Zheng, Le; Ikura, Mitsuhiko] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Zheng, Le; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	Johannes Kepler University Linz; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Romanin, C (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Life Sci Ctr JKU, Gruberstr 40, A-4020 Linz, Austria.	christoph.romanin@jku.at	Schindl, Rainer/V-4205-2019; Fahrner, Marc/AAI-7927-2021; Hoeglinger, Carmen/AAF-9364-2021; Romanin, Christoph/D-5399-2009; Jardin, Isaac/E-8310-2016; Schindl, Rainer/E-3959-2013	Romanin, Christoph/0000-0003-3756-4136; Jardin, Isaac/0000-0003-4575-8264; Schindl, Rainer/0000-0003-0896-8887; Ikura, Mitsuhiko/0000-0002-9524-1303; Fahrner, Marc/0000-0002-2689-0158; Hoglinger, Carmen/0000-0002-2754-592X; Stathopulos, Peter B./0000-0002-0536-6656	Austrian Science Fund (FWF) [P26067, M01506000, P25172, P27263]; Canadian Institutes for Health Research; Heart and Stroke Foundation of Canada; Austrian Science Fund (FWF) [M 1506, P 25172, P 27263] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF Project P26067, to R. S.; FWF Project M01506000, to I. J.; and FWF Project P25172 and P27263, to C. R.) and grant support by the Canadian Institutes for Health Research and Heart and Stroke Foundation of Canada (to M. I.).	Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Berridge MJ, 2000, SCIENCE, V287, P1604, DOI 10.1126/science.287.5458.1604; Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Engh A, 2012, FRONT BIOSCI-LANDMRK, V17, P1613, DOI 10.2741/4007; Fahrner M, 2013, CHANNELS, V7, P330, DOI 10.4161/chan.26742; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Furukawa Y, 2014, J MOL BIOL, V426, P2082, DOI 10.1016/j.jmb.2014.03.006; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Misceo D, 2014, HUM MUTAT, V35, P556, DOI 10.1002/humu.22544; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2012, CELL MOL LIFE SCI, V69, P4163, DOI 10.1007/s00018-012-1072-8; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Nesin V, 2014, P NATL ACAD SCI USA, V111, P4197, DOI 10.1073/pnas.1312520111; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rothberg BS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003971; Schindl R, 2009, CELL CALCIUM, V46, P227, DOI 10.1016/j.ceca.2009.08.003; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4183; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yu F, 2013, J CELL SCI, V126, P2401, DOI 10.1242/jcs.117200; Yu JW, 2013, BIOCHEM J, V454, P401, DOI 10.1042/BJ20130292; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhang W, 2011, CIRC RES, V109, P534, DOI 10.1161/CIRCRESAHA.111.246777; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129; Zheng L, 2011, P NATL ACAD SCI USA, V108, P1337, DOI 10.1073/pnas.1015125108; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	48	88	89	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33231	33244		10.1074/jbc.M114.610022	http://dx.doi.org/10.1074/jbc.M114.610022			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25342749	hybrid, Green Published			2022-12-28	WOS:000345636600016
J	Wang, W; Guo, HJ; Geng, JL; Zheng, XD; Wei, HM; Sun, R; Tian, ZG				Wang, Wei; Guo, Huaijian; Geng, Jianlin; Zheng, Xiaodong; Wei, Haiming; Sun, Rui; Tian, Zhigang			Tumor-released Galectin-3, a Soluble Inhibitory Ligand of Human NKp30, Plays an Important Role in Tumor Escape from NK Cell Attack	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; NATURAL-KILLER-CELLS; BINDING PROTEIN; IMMUNOGLOBULIN SUPERFAMILY; O-GLYCANS; EXPRESSION; APOPTOSIS; RECEPTOR; CANCER; METASTASIS	Human Galectin-3 (Gal-3), a beta-galactoside-binding protein expressed by tumor cells, has been reported to act as an immune regulator in antitumor T cells. However, its effect on natural killer (NK) cells is elusive. Using a recombinant human NK cell-activating receptor, NKp30 fusion protein (NKp30-Fc), we found that soluble NKp30-Fc could immunoprecipitate Galectin-3. The direct interaction between NKp30 and Galectin-3 was further confirmed using surface plasmon resonance experiments. Because Galectin-3 was mainly released from tumor cells in a soluble form in our study, the binding assay was performed to show that soluble Galectin-3 specifically bound to NK cells and NKp30 on the surface of the NK cells. Functionally, when soluble Galectin-3 was added to the NK-tumor cell coculture system, the NKp30-mediated, but not NKG2D-mediated, cytolysis and CD107a expression in the NK cells were inhibited, and these phenotypes could be restored by preincubation of soluble Galectin-3 with NKp30-Fc fusion protein or the addition of anti-Gal-3 antibody alone. Moreover, genetic down-regulation of Galectin-3 (shGal-3) resulted in tumor cells being more sensitive to NK cell lysis, and, reversely, Galectin-3-overexpressing HeLa cells (exGal-3) became less sensitive to NK cell killing. The results of these in vitro experiments were supported by studies in shGal-3-HeLa or exGal-3-HeLa xenograft non-obese diabetic/severe combined immunodeficiency mice after NK cell adoptive immunotherapy, indicating that Galectin-3 strongly antagonizes human NK cell attack against tumors in vivo. These findings indicate that Galectin-3 may function as an immune regulator to inhibit NK cell function against tumors, therefore providing a new therapeutic target for tumor treatment.	[Wang, Wei; Guo, Huaijian; Geng, Jianlin; Zheng, Xiaodong; Wei, Haiming; Sun, Rui; Tian, Zhigang] Univ Sci & Technol China, Sch Life Sci, China Acad Sci CAS Innate Immun & Chron Dis, Inst Immunol, Hefei 230027, Anhui, Peoples R China; [Wang, Wei; Guo, Huaijian; Geng, Jianlin; Zheng, Xiaodong; Wei, Haiming; Sun, Rui; Tian, Zhigang] Univ Sci & Technol China, Sch Life Sci, China Acad Sci CAS Innate Immun & Chron Dis, Key Lab, Hefei 230027, Anhui, Peoples R China; [Wang, Wei; Guo, Huaijian; Geng, Jianlin; Zheng, Xiaodong; Wei, Haiming; Sun, Rui; Tian, Zhigang] Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China; [Wei, Haiming; Sun, Rui; Tian, Zhigang] Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Sun, R (corresponding author), Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei 230027, Anhui, Peoples R China.	sunr@ustc.edu.cn; tzg@ustc.edu.cn	Zheng, Xiaodong/N-2830-2013; Geng, Jianlin/C-7981-2018; Tian, Zhigang/J-3512-2013	Geng, Jianlin/0000-0001-5642-9330; 	Ministry of Science and Technology of China (973 Basic Science Project) [2013CB530506, 2010CB911901]; Natural Science Foundation of China [91029303, 81361120388]; National Science and Technology Major Projects [2012ZX10002014, 2012ZX10002006]	Ministry of Science and Technology of China (973 Basic Science Project)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects	Supported by the Ministry of Science and Technology of China (973 Basic Science Project Grants 2013CB530506 and 2010CB911901), Natural Science Foundation of China Grants 91029303 and 81361120388, and National Science and Technology Major Projects 2012ZX10002014 and 2012ZX10002006.	Bottino C, 2005, TRENDS IMMUNOL, V26, P221, DOI 10.1016/j.it.2005.02.007; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Cheng M, 2013, CELL MOL IMMUNOL, V10, P230, DOI 10.1038/cmi.2013.10; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Friese MA, 2003, CANCER RES, V63, P8996; Fukumori T, 2003, CANCER RES, V63, P8302; Guha P, 2013, P NATL ACAD SCI USA, V110, P5052, DOI 10.1073/pnas.1202653110; Honjo Y, 2001, CLIN CANCER RES, V7, P661; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; Lahm H, 2001, J CANCER RES CLIN, V127, P375, DOI 10.1007/s004320000207; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LeMarer N, 1996, J CELL PHYSIOL, V168, P51, DOI 10.1002/(SICI)1097-4652(199607)168:1<51::AID-JCP7>3.0.CO;2-7; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; LOTAN R, 1991, CARBOHYD RES, V213, P47, DOI 10.1016/S0008-6215(00)90597-4; Miyazaki J, 2002, ONCOL REP, V9, P1307; Moon BK, 2001, AM J PATHOL, V159, P1055, DOI 10.1016/S0002-9440(10)61780-4; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; MOUTSATSOS IK, 1987, P NATL ACAD SCI USA, V84, P6452, DOI 10.1073/pnas.84.18.6452; Muller S, 2006, INFLAMM BOWEL DIS, V12, P588; Nalabolu SR, 1996, GENOMICS, V31, P215, DOI 10.1006/geno.1996.0034; Ochieng J, 1999, J CELL BIOCHEM, V75, P505, DOI 10.1002/(SICI)1097-4644(19991201)75:3<505::AID-JCB14>3.0.CO;2-I; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Peng W, 2008, CANCER RES, V68, P7228, DOI 10.1158/0008-5472.CAN-08-1245; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Radosavljevic G, 2011, CLIN EXP METASTAS, V28, P451, DOI 10.1007/s10585-011-9383-y; Ruebel KH, 2005, CANCER RES, V65, P1136, DOI 10.1158/0008-5472.CAN-04-3578; SATO S, 1994, J BIOL CHEM, V269, P4424; Spits H, 1998, IMMUNOL REV, V165, P75, DOI 10.1111/j.1600-065X.1998.tb01231.x; Sturm A, 2004, J IMMUNOL, V173, P3825, DOI 10.4049/jimmunol.173.6.3825; Sun HY, 2013, CELL MOL IMMUNOL, V10, P202, DOI 10.1038/cmi.2013.9; Suzuki Y, 2012, INT J ONCOL, V40, P1831, DOI 10.3892/ijo.2012.1411; Thijssen VLJL, 2007, BLOOD, V110, P2819, DOI 10.1182/blood-2007-03-077792; Tsuboi S, 2011, EMBO J, V30, P3173, DOI 10.1038/emboj.2011.215; Vereecken P, 2006, CLIN EXP DERMATOL, V31, P105, DOI 10.1111/j.1365-2230.2005.01992.x; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Zheng XD, 2009, J BIOL CHEM, V284, P21280, DOI 10.1074/jbc.M807053200; Zubieta MR, 2006, AM J PATHOL, V168, P1666, DOI 10.2353/ajpath.2006.050971	41	78	86	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33311	33319		10.1074/jbc.M114.603464	http://dx.doi.org/10.1074/jbc.M114.603464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25315772	hybrid, Green Published			2022-12-28	WOS:000345636600022
J	Bielecka, E; Scavenius, C; Kantyka, T; Jusko, M; Mizgalska, D; Szmigielski, B; Potempa, B; Enghild, JJ; Prossnitz, ER; Blom, AM; Potempa, J				Bielecka, Ewa; Scavenius, Carsten; Kantyka, Tomasz; Jusko, Monika; Mizgalska, Danuta; Szmigielski, Borys; Potempa, Barbara; Enghild, Jan J.; Prossnitz, Eric R.; Blom, Anna M.; Potempa, Jan			Peptidyl Arginine Deiminase from Porphyromonas gingivalis Abolishes Anaphylatoxin C5a Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT-SYSTEM; RECEPTOR; MECHANISMS; VIRULENCE; INACTIVATION; ACTIVATION; MATURATION; PATHWAYS; PROTEASE; ASSAY	Evasion of killing by the complement system, a crucial part of innate immunity, is a key evolutionary strategy of many human pathogens. A major etiological agent of chronic periodontitis, the Gram-negative bacterium Porphyromonas gingivalis, produces a vast arsenal of virulence factors that compromise human defense mechanisms. One of these is peptidylarginine deiminase (PPAD), an enzyme unique to P. gingivalis among bacteria, which converts Arg residues in polypeptide chains into citrulline. Here, we report that PPAD citrullination of a critical C-terminal arginine of the anaphylatoxin C5a disabled the protein function. Treatment of C5a with PPAD in vitro resulted in decreased chemotaxis of human neutrophils and diminished calcium signaling in monocytic cell line U937 transfected with the C5a receptor (C5aR) and loaded with a fluorescent intracellular calcium probe: Fura-2 AM. Moreover, a low degree of citrullination of internal arginine residues by PPAD was also detected using mass spectrometry. Further, after treatment of C5 with outer membrane vesicles naturally shed by P. gingivalis, we observed generation of C5a totally citrullinated at the C-terminal Arg-74 residue (Arg74Cit). In stark contrast, only native C5a was detected after treatment with PPAD-null outer membrane vesicles. Our study suggests reduced antibacterial and proinflammatory capacity of citrullinated C5a, achieved via lower level of chemotactic potential of the modified molecule, and weaker cell activation. In the context of previous studies, which showed crosstalk between C5aR and Toll-like receptors, as well as enhanced arthritis development in mice infected with PPAD-expressing P. gingivalis, our findings support a crucial role of PPAD in the virulence of P. gingivalis.	[Bielecka, Ewa; Jusko, Monika; Blom, Anna M.] Lund Univ, Dept Lab Med, SE-20502 Malmo, Sweden; [Bielecka, Ewa; Kantyka, Tomasz; Mizgalska, Danuta; Szmigielski, Borys; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland; [Scavenius, Carsten; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Scavenius, Carsten; Enghild, Jan J.] Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark; [Potempa, Barbara] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA; [Prossnitz, Eric R.] Univ New Mexico, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA	Lund University; Jagiellonian University; Aarhus University; Aarhus University; University of Louisville; University of New Mexico	Blom, AM (corresponding author), Lund Univ, Dept Lab Med, Wallenberg Lab, Fl 4,Inga Marie Nilsson St 53, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Prossnitz, Eric R./B-4543-2008; Prossnitz, Eric/I-4599-2019; Bielecka, Ewa/Q-4850-2018; Blom, Anna/AFS-7369-2022; Potempa, Jan/AAA-6850-2021; Blom, Anna/B-9607-2009; Scavenius, Carsten/Q-5941-2017	Prossnitz, Eric/0000-0001-9190-8302; Bielecka, Ewa/0000-0002-2631-6711; Blom, Anna/0000-0002-1348-1734; Potempa, Jan/0000-0002-3600-7461; Scavenius, Carsten/0000-0002-4304-0681; Kantyka, Tomasz/0000-0003-3023-2382; Enghild, Jan Johannes/0000-0001-9292-9172	Swedish Research Council [K2012-66X-14928-09-5]; Swedish Government Funds for Clinical Research (ALF); Torsten Soderberg Foundation; Osterlund Foundation; Greta and Johan Kock Foundation; King Gustav V's 80-year Anniversary Fund; Knut and Alice Wallenberg Foundation; Inga-Britt and Arne Lundberg Foundation; Polish National Science Center [OPUS 2012/05/B/NZ6/00581]; Polish Ministry of Science and Higher Education Grant IUVEN-TUS Plus [0221/IP1/2011/71]; European Commission [FP7-HEALTH-2010-261460, FP7-HEALTH-F3-2012-306029, FP7-PEOPLE-2011-ITN-290246]; National Institutes of Health/NIDCR [DE 09761]; National Science Center, Poland [UMO-2011/01/B/NZ6/00268, 2012/04/A/NZ1/00051]; Foundation for Polish Science (TEAM) [DPS/424-329/10]; Polish Ministry of Science and Higher Education [137/7.PR-EU/2011/2]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761, R01DE022597] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Government Funds for Clinical Research (ALF); Torsten Soderberg Foundation; Osterlund Foundation; Greta and Johan Kock Foundation; King Gustav V's 80-year Anniversary Fund; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Inga-Britt and Arne Lundberg Foundation; Polish National Science Center; Polish Ministry of Science and Higher Education Grant IUVEN-TUS Plus; European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Science Center, Poland(National Science Centre, Poland); Foundation for Polish Science (TEAM)(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Swedish Research Council (Grant K2012-66X-14928-09-5), the Swedish Government Funds for Clinical Research (ALF), the Torsten Soderberg Foundation, and the Osterlund Foundation, Greta and Johan Kock Foundation, King Gustav V's 80-year Anniversary Fund, Knut and Alice Wallenberg Foundation, and Inga-Britt and Arne Lundberg Foundation.; Supported by Polish National Science Center Grant OPUS 2012/05/B/NZ6/00581 and Polish Ministry of Science and Higher Education Grant IUVEN-TUS Plus 0221/IP1/2011/71.; Supported by grants from the European Commission (Grants FP7-HEALTH-2010-261460 "Gums & Joints", FP7-HEALTH-F3-2012-306029 "TRIGGER", and FP7-PEOPLE-2011-ITN-290246 "RAPID"), the National Institutes of Health/NIDCR (Grant DE 09761), the National Science Center, Poland (Grants UMO-2011/01/B/NZ6/00268 and 2012/04/A/NZ1/00051), the Foundation for Polish Science (TEAM project DPS/424-329/10), and the Polish Ministry of Science and Higher Education (Grant 137/7.PR-EU/2011/2).	Abe T, 2012, J IMMUNOL, V189, P5442, DOI 10.4049/jimmunol.1202339; Brown L J, 1993, Periodontol 2000, V2, P57; CLEARY PP, 1992, INFECT IMMUN, V60, P5219, DOI 10.1128/IAI.60.12.5219-5223.1992; Curtis MA, 2005, J CLIN PERIODONTOL, V32, P28, DOI 10.1111/j.1600-051X.2005.00817.x; Jagels MA, 1996, INFECT IMMUN, V64, P1984, DOI 10.1128/IAI.64.6.1984-1991.1996; Jusko M, 2012, J IMMUNOL, V188, P2338, DOI 10.4049/jimmunol.1101240; Kew RR, 1997, J LEUKOCYTE BIOL, V61, P329, DOI 10.1002/jlb.61.3.329; Kilsgard O, 2012, AM J RESP CELL MOL, V46, P240, DOI 10.1165/rcmb.2010-0500OC; Krause SW, 1998, IMMUNOL REV, V161, P119, DOI 10.1111/j.1600-065X.1998.tb01576.x; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Liao YF, 2005, ANAL BIOCHEM, V347, P176, DOI 10.1016/j.ab.2005.09.027; Loos T, 2008, BLOOD, V112, P2648, DOI 10.1182/blood-2008-04-149039; Maresz KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003627; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Nakao R, 2014, MICROBES INFECT, V16, P6, DOI 10.1016/j.micinf.2013.10.005; Popadiak K, 2007, J IMMUNOL, V178, P7242, DOI 10.4049/jimmunol.178.11.7242; POTEMPA J, 1995, INFECT IMMUN, V63, P1176, DOI 10.1128/IAI.63.4.1176-1182.1995; Potempa M, 2008, J IMMUNOL, V181, P5537, DOI 10.4049/jimmunol.181.8.5537; Potempa M, 2012, BIOL CHEM, V393, P873, DOI 10.1515/hsz-2012-0174; Pyrc K, 2013, INFECT IMMUN, V81, P55, DOI 10.1128/IAI.00830-12; Reis ES, 2012, J IMMUNOL, V189, P4797, DOI 10.4049/jimmunol.1200834; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Wang M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000697; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Willemze A, 2012, NAT REV RHEUMATOL, V8, P144, DOI 10.1038/nrrheum.2011.204; WINGROVE JA, 1992, J BIOL CHEM, V267, P18902; Zhou XY, 2013, MOL MICROBIOL, V89, P903, DOI 10.1111/mmi.12319	28	62	63	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.C114.617142	http://dx.doi.org/10.1074/jbc.C114.617142			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25324545	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000345335000008
J	Wang, YQ; Kim, SM; Trnka, MJ; Liu, Y; Burlingame, AL; Correia, MA				Wang, YongQiang; Kim, Sung-Mi; Trnka, Michael J.; Liu, Yi; Burlingame, A. L.; Correia, Maria Almira			Human Liver Cytochrome P450 3A4 Ubiquitination MOLECULAR RECOGNITION BY UBC7-gp78 AUTOCRINE MOTILITY FACTOR RECEPTOR AND UbcH5a-CHIP-Hsc70-Hsp40 E2-E3 UBIQUITIN LIGASE COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; MECHANISM-BASED INACTIVATION; HMG-COA REDUCTASE; IN-VIVO; PHOSPHORYLATED TAU; CONJUGATING ENZYME; MASS-SPECTROMETRY; RAT HEPATOCYTES; QUALITY-CONTROL; RING FINGER	CYP3A4 is an abundant and catalytically dominant human liver endoplasmic reticulum-anchored cytochrome P450 enzyme engaged in the biotransformation of endo- and xenobiotics, including >50% of clinically relevant drugs. Alterations of CYP3A4 protein turnover can influence clinically relevant drug metabolism and bioavailability and drug-drug interactions. This CYP3A4 turnover involves endoplasmic reticulum-associated degradation via the ubiquitin (Ub)-dependent 26 S proteasomal system that relies on two highly complementary E2 Ub-conjugating-E3 Ub-ligase (UBC7-gp78 and UbcH5a-C terminus of Hsc70-interacting protein (CHIP)-Hsc70-Hsp40) complexes, as well as protein kinases (PK) A and C. We have documented that CYP3A4 Ser/Thr phosphorylation (Ser(P)/Thr(P)) by PKA and/or PKC accelerates/enhances its Lys ubiquitination by either of these E2-E3 systems. Intriguingly, CYP3A4 Ser(P)/Thr(P) and ubiquitinated Lys residues reside within the cytosol-accessible surface loop and/or conformationally assembled acidic Asp/Glu clusters, leading us to propose that such post-translational Ser/Thr protein phosphorylation primes CYP3A4 for ubiquitination. Herein, this possibility was examined through various complementary approaches, including site-directed mutagenesis, chemical cross-linking, peptide mapping, and LC-MS/MS analyses. Our findings reveal that such CYP3A4 Asp/Glu/Ser(P)/Thr(P) surface clusters are indeed important for its intermolecular electrostatic interactions with each of these E2-E3 subcomponents. By imparting additional negative charge to these Asp/Glu clusters, such Ser/Thr phosphorylation would generate P450 phosphodegrons for molecular recognition by the E2-E3 complexes, thereby controlling the timing of CYP3A4 ubiquitination and endoplasmic reticulum-associated degradation. Although the importance of phosphodegrons in the CHIP targeting of its substrates is known, to our knowledge this is the first example of phosphodegron involvement in gp78-substrate recruitment, an important step in CYP3A4 proteasomal degradation.	[Wang, YongQiang; Kim, Sung-Mi; Liu, Yi; Correia, Maria Almira] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Trnka, Michael J.; Burlingame, A. L.; Correia, Maria Almira] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Correia, Maria Almira] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Correia, Maria Almira] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Correia, MA (corresponding author), Univ Calif San Francisco, Mission Bay Campus,Genentech Hall,600 16th St, San Francisco, CA 94158 USA.	almira.correia@ucsf.edu		Trnka, Michael/0000-0002-8808-5146	Biomedical Technology Research Centers Program of the NIGMS, National Institutes of Health [8P41GM103481]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK026506, R56DK026506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481, R01GM044037] Funding Source: NIH RePORTER	Biomedical Technology Research Centers Program of the NIGMS, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We sincerely thank Dr. A. M. Weissman (NCI, National Institutes of Health) for the UBC7 and gp78C expression plasmids; Dr. R. DeBose-Boyd (University of Texas SouthWestern) for the mammalian gp78 plasmid; Dr. C. Patterson (University of North Carolina) for the CHIP expression plasmid; Dr. L. Waskell (University of Michigan) for the cytochrome b<INF>5</INF> expression plasmid; and Dr. C. B. Kasper (University of Wisconsin) for the CPR expression plasmid. We thank Prof. P. Ortiz de Montellano (University of California at San Francisco) for helpful comments in the course of this project. We acknowledge the mass spectrometric analyses provided by the Bio-Organic Biomedical Mass Spectrometry Resource at University of California at San Francisco (A. L. Burlingame, Director) supported by the Biomedical Technology Research Centers Program of the NIGMS, National Institutes of Health Grant 8P41GM103481.	Acharya P, 2011, J BIOL CHEM, V286, P3815, DOI 10.1074/jbc.M110.186981; Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Baker PR, 2014, MOL CELL PROTEOMICS, V13, P1392, DOI 10.1074/mcp.O113.037200; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bardag-Gorce F, 2006, EXP MOL PATHOL, V81, P191, DOI 10.1016/j.yexmp.2006.07.007; BLACK SD, 1992, FASEB J, V6, P680, DOI 10.1096/fasebj.6.2.1537456; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Cederbaum AI, 2006, MT SINAI J MED, V73, P657; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chen JY, 1997, DRUG METAB DISPOS, V25, P1165; Chen ZL, 2012, CURR PROTEIN PEPT SC, V13, P414, DOI 10.2174/138920312802430590; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; CORREIA MA, 1992, ARCH BIOCHEM BIOPHYS, V297, P228, DOI 10.1016/0003-9861(92)90666-K; Correia MA, 2012, BASIC CLIN PHARM, P53; Correia MA, 2014, IUBMB LIFE, V66, P78, DOI 10.1002/iub.1247; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; EDWARDS RJ, 1991, BIOCHEMISTRY-US, V30, P71, DOI 10.1021/bi00215a011; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; ELIASSON E, 1994, J BIOL CHEM, V269, P18378; Faouzi S, 2007, BIOCHEMISTRY-US, V46, P7793, DOI 10.1021/bi700340n; FREY AB, 1985, J BIOL CHEM, V260, P5253; Gao QX, 2006, J BIOL CHEM, V281, P20404, DOI 10.1074/jbc.M601785200; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hatakeyama S, 2004, J NEUROCHEM, V91, P299, DOI 10.1111/j.1471-4159.2004.02713.x; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Jo Y, 2011, J BIOL CHEM, V286, P15022, DOI 10.1074/jbc.M110.211326; Kalgutkar AS, 2007, CURR DRUG METAB, V8, P407; Kim SM, 2010, J BIOL CHEM, V285, P35866, DOI 10.1074/jbc.M110.167189; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Korsmeyer KK, 1999, ARCH BIOCHEM BIOPHYS, V365, P31, DOI 10.1006/abbi.1999.1138; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Liao M, 2010, ENZYME INHIBITION DR, P363; Liao M, 2006, MOL PHARMACOL, V69, P1897, DOI 10.1124/mol.105.021816; Lin HL, 2012, CHEM RES TOXICOL, V25, P2642, DOI 10.1021/tx3002753; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Miao HH, 2010, ACTA BIOCH BIOPH SIN, V42, P303, DOI 10.1093/abbs/gmq022; Morishima Y, 2005, BIOCHEMISTRY-US, V44, P16333, DOI 10.1021/bi0515570; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murray BP, 2001, ARCH BIOCHEM BIOPHYS, V393, P106, DOI 10.1006/abbi.2001.2482; OMURA T, 1964, J BIOL CHEM, V239, P2370; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Rees I, 2006, BBA-PROTEINS PROTEOM, V1764, P1073, DOI 10.1016/j.bbapap.2006.03.013; Reisinger V, 2006, PROTEOMICS, P6, DOI 10.1002/pmic.200600553; ROBERTS BJ, 1995, J BIOL CHEM, V270, P29632; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; SchmiedlinRen P, 1997, DRUG METAB DISPOS, V25, P1228; Sevrioukova IF, 2012, J BIOL CHEM, V287, P3510, DOI 10.1074/jbc.M111.317081; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; SOHN DH, 1991, BIOCHEM BIOPH RES CO, V179, P449, DOI 10.1016/0006-291X(91)91391-O; SONG BJ, 1989, J BIOL CHEM, V264, P3568; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; TIERNEY DJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P9, DOI 10.1016/0003-9861(92)90358-4; Trnka MJ, 2014, MOL CELL PROTEOMICS, V13, P420, DOI 10.1074/mcp.M113.034009; Trnka MJ, 2010, MOL CELL PROTEOMICS, V9, P2306, DOI 10.1074/mcp.M110.003764; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Wang HF, 1999, ARCH BIOCHEM BIOPHYS, V365, P45, DOI 10.1006/abbi.1999.1139; Wang XY, 2001, BIOCHEMISTRY-US, V40, P11318, DOI 10.1021/bi010690z; Wang Y, 2014, ONCOTARGET, V5, P2044, DOI 10.18632/oncotarget.1478; Wang YQ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010132; Wang YQ, 2011, J BIOL CHEM, V286, P9443, DOI 10.1074/jbc.M110.176685; Wang YQ, 2009, J BIOL CHEM, V284, P5671, DOI 10.1074/jbc.M806104200; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu L, 2009, DRUG METAB DISPOS, V37, P2330, DOI 10.1124/dmd.108.025494; Yang JS, 2008, CURR DRUG METAB, V9, P384, DOI 10.2174/138920008784746382; Yang MX, 1997, ARCH BIOCHEM BIOPHYS, V341, P25, DOI 10.1006/abbi.1997.9907; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Ying Z, 2011, J BIOL CHEM, V286, P20835, DOI 10.1074/jbc.M110.200808; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	95	17	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3308	3332		10.1074/jbc.M114.611525	http://dx.doi.org/10.1074/jbc.M114.611525			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25451919	Green Published, hybrid			2022-12-28	WOS:000349456000011
J	Li, S; Fossati, G; Marchetti, C; Modena, D; Pozzi, P; Reznikov, LL; Moras, ML; Azam, T; Abbate, A; Mascagni, P; Dinarello, CA				Li, Suzhao; Fossati, Gianluca; Marchetti, Carlo; Modena, Daniela; Pozzi, Pietro; Reznikov, Leonid L.; Moras, Maria Luisa; Azam, Tania; Abbate, Antonio; Mascagni, Paolo; Dinarello, Charles A.			Specific Inhibition of Histone Deacetylase 8 Reduces Gene Expression and Production of Proinflammatory Cytokines in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERSUS-HOST-DISEASE; CD4(+) T-CELLS; CANDIDA-ALBICANS; HIV-1 EXPRESSION; RENAL-DISEASE; BETA-CELLS; IL-1-BETA; ACID; INFLAMMASOME; VORINOSTAT	ITF2357 (generic givinostat) is an orally active, hydroxamic-containing histone deacetylase (HDAC) inhibitor with broad anti-inflammatory properties, which has been used to treat children with systemic juvenile idiopathic arthritis. ITF2357 inhibits both Class I and II HDACs and reduces caspase-1 activity in human peripheral blood mononuclear cells and the secretion of IL-1 beta and other cytokines at 25-100 nM; at concentrations >200 nM, ITF2357 is toxic in vitro. ITF3056, an analog of ITF2357, inhibits only HDAC8 (IC50 of 285 nM). Here we compared the production of IL-1 beta, IL-1 alpha, TNF alpha, and IL-6 by ITF2357 with that of ITF3056 in peripheral blood mononuclear cells stimulated with lipopolysaccharide (LPS), heat-killed Candida albicans, or anti-CD3/anti-CD28 antibodies. ITF3056 reduced LPS-induced cytokines from 100 to 1000 nM; at 1000 nM, the secretion of IL-1 beta was reduced by 76%, secretion of TNF alpha was reduced by 88%, and secretion of IL-6 was reduced by 61%. The intracellular levels of IL-1 alpha were 30% lower. There was no evidence of cell toxicity at ITF3056 concentrations of 100-1000 nM. Gene expression of TNF alpha was markedly reduced (80%), whereas IL-6 gene expression was 40% lower. Although anti-CD3/28 and Candida stimulation of IL-1 beta and TNF alpha was modestly reduced, IFN gamma production was 75% lower. Mechanistically, ITF3056 reduced the secretion of processed IL-1 beta independent of inhibition of caspase-1 activity; however, synthesis of the IL-1 beta precursor was reduced by 40% without significant decrease in IL-1 beta mRNA levels. In mice, ITF3056 reduced LPS-induced serum TNF alpha by 85% and reduced IL-1 beta by 88%. These data suggest that specific inhibition of HDAC8 results in reduced inflammation without cell toxicity.	[Li, Suzhao; Reznikov, Leonid L.; Azam, Tania; Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Fossati, Gianluca; Modena, Daniela; Pozzi, Pietro; Moras, Maria Luisa; Mascagni, Paolo] Italfarmaco SpA, I-20092 Cinisello Balsamo, Italy; [Marchetti, Carlo; Abbate, Antonio] Virginia Commonwealth Univ, Dept Med, Richmond, VA 23298 USA; [Dinarello, Charles A.] Radboud Univ Nijmegen Med Ctr, Dept Med, NL-6525 HP Nijmegen, Netherlands	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Italfarmaco; Virginia Commonwealth University; Radboud University Nijmegen	Dinarello, CA (corresponding author), Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA.	cdinare333@aol.com	Abbate, Antonio/G-8805-2016; Dinarello, Charles/C-8524-2013	Abbate, Antonio/0000-0002-1930-785X; 	National Institutes of Health [AI-15614, AR-45584]; American Heart Association [12POST12030134]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI015614, R01AI015614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-15614 and AR-45584 (to C. A. D.). This work was also supported by American Heart Association Postdoctoral Fellowship Grant 12POST12030134 (to S. L.).	Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Archin NM, 2014, J INFECT DIS, V210, P728, DOI 10.1093/infdis/jiu155; Barton KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102684; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; CHEDID L, 1977, P NATL ACAD SCI USA, V74, P2089, DOI 10.1073/pnas.74.5.2089; Cheng SC, 2012, INFECT IMMUN, V80, P1304, DOI 10.1128/IAI.06146-11; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Choi SW, 2014, LANCET ONCOL, V15, P87, DOI 10.1016/S1470-2045(13)70512-6; Christensen DP, 2014, P NATL ACAD SCI USA, V111, P1055, DOI 10.1073/pnas.1320850111; Dinarello CA, 2011, MOL MED, V17, P333, DOI 10.2119/molmed.2011.00116; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Furlan A, 2011, MOL MED, V17, P353, DOI 10.2119/molmed.2011.00020; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Icardi L, 2012, CYTOKINE GROWTH F R, V23, P283, DOI 10.1016/j.cytogfr.2012.08.002; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kolle D, 1998, METHODS, V15, P323, DOI 10.1006/meth.1998.0636; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Levandowski CB, 2013, P NATL ACAD SCI USA, V110, P2952, DOI 10.1073/pnas.1222808110; Lewis EC, 2011, MOL MED, V17, P369, DOI 10.2119/molmed.2010.00152; Lundh M, 2010, DIABETOLOGIA, V53, P2569, DOI 10.1007/s00125-010-1892-8; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Matalon S, 2010, JAIDS-J ACQ IMM DEF, V54, P1, DOI 10.1097/QAI.0b013e3181d3dca3; McManamy Mary E. Manson, 2014, Antiviral Chemistry & Chemotherapy, V23, P145, DOI 10.3851/IMP2551; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Netea MG, 2002, J INFECT DIS, V185, P963, DOI 10.1086/339410; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Qiu ZJ, 2010, J IMMUNOL METHODS, V362, P101, DOI 10.1016/j.jim.2010.09.013; Rasmussen TA, 2013, HUM VACC IMMUNOTHER, V9, P993, DOI 10.4161/hv.23800; Reddy P, 2004, P NATL ACAD SCI USA, V101, P3921, DOI 10.1073/pnas.0400380101; Reilly CM, 2004, J IMMUNOL, V173, P4171, DOI 10.4049/jimmunol.173.6.4171; Rivera VR, 2006, ANAL BIOCHEM, V353, P248, DOI 10.1016/j.ab.2006.02.030; Skov S, 2003, BLOOD, V101, P1430, DOI 10.1182/blood-2002-07-2073; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; Vojinovic J, 2011, MOL MED, V17, P397, DOI 10.2119/molmed.2011.00030; Vojinovic J, 2011, ARTHRITIS RHEUM-US, V63, P1452, DOI 10.1002/art.30238; Wang H, 2004, WORLD J GASTROENTERO, V10, P2690, DOI 10.3748/wjg.v10.i18.2690	42	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2368	2378		10.1074/jbc.M114.618454	http://dx.doi.org/10.1074/jbc.M114.618454			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25451941	Green Published, hybrid			2022-12-28	WOS:000348588000040
J	Frederick, DW; Davis, JG; Davila, A; Agarwal, B; Michan, S; Puchowicz, MA; Nakamaru-Ogiso, E; Baur, JA				Frederick, David W.; Davis, James G.; Davila, Antonio, Jr.; Agarwal, Beamon; Michan, Shaday; Puchowicz, Michelle A.; Nakamaru-Ogiso, Eiko; Baur, Joseph A.			Increasing NAD Synthesis in Muscle via Nicotinamide Phosphoribosyltransferase Is Not Sufficient to Promote Oxidative Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN EXTENSION; SKELETAL-MUSCLE; CALORIE RESTRICTION; MITOCHONDRIAL BIOGENESIS; ENERGY-EXPENDITURE; SIRT1 DEACETYLASE; PATHWAY; INHIBITION; PROTECTS; EXERCISE	The NAD biosynthetic precursors nicotinamide mononucleotide and nicotinamide riboside are reported to confer resistance to metabolic defects induced by high fat feeding in part by promoting oxidative metabolism in skeletal muscle. Similar effects are obtained by germ line deletion of major NAD-consuming enzymes, suggesting that the bioavailability of NAD is limiting for maximal oxidative capacity. However, because of their systemic nature, the degree to which these interventions exert cell-or tissue-autonomous effects is unclear. Here, we report a tissue-specific approach to increase NAD biosynthesis only in muscle by overexpressing nicotinamide phosphoribosyltransferase, the rate-limiting enzyme in the salvage pathway that converts nicotinamide to NAD (mNAMPT mice). These mice display a similar to 50% increase in skeletal muscle NAD levels, comparable with the effects of dietary NAD precursors, exercise regimens, or loss of poly( ADP-ribose) polymerases yet surprisingly do not exhibit changes in muscle mitochondrial biogenesis or mitochondrial function and are equally susceptible to the metabolic consequences of high fat feeding. We further report that chronic elevation of muscle NAD in vivo does not perturb the NAD/NADH redox ratio. These studies reveal for the first time the metabolic effects of tissue-specific increases in NAD synthesis and suggest that critical sites of action for supplemental NAD precursors reside outside of the heart and skeletal muscle.	[Frederick, David W.; Davis, James G.; Davila, Antonio, Jr.; Agarwal, Beamon; Baur, Joseph A.] Univ Penn, Inst Diabet Obes & Metab, Dept Physiol, Philadelphia, PA 19066 USA; [Nakamaru-Ogiso, Eiko] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19066 USA; [Michan, Shaday] Inst Nacl Geriatria, Mexico City 10200, DF, Mexico; [Puchowicz, Michelle A.] Case Western Reserve Univ, Mouse Metab Phenotyping Ctr, Dept Nutr, Cleveland, OH 44106 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Case Western Reserve University	Baur, JA (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Dept Physiol, 3400 Civ Ctr Blvd,SCTR 12-114, Philadelphia, PA 19066 USA.	baur@mail.med.upenn.edu			National Institutes of Health [P30-DK19525, U24-DK76174]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076174, P30DK019525, R01DK098656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are indebted to D. Sinclair for valuable reagents and advice as well as D. Cromley and D. Rader for the analysis of plasma lipids. We also thank R. Ahima and R. Dhir of the Mouse Phenotyping, Physiology, and Metabolism Core and H. Collins of the Radioimmunoassay and Biomarkers Core, both provided by the University of Pennsylvania Diabetes Research Center (National Institutes of Health Grant P30-DK19525), as well as the Case Western Reserve Mouse Metabolic Phenotyping Center (National Institutes of Health Grant U24-DK76174). We thank R. Dellinger of ChromaDex for constructive discussions and the provision of NR and all members of the Baur laboratory for support and constructive feedback.	Akpan I, 2009, INT J OBESITY, V33, P1265, DOI 10.1038/ijo.2009.162; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Burgos ES, 2008, BIOCHEMISTRY-US, V47, P11086, DOI 10.1021/bi801198m; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Costford SR, 2010, AM J PHYSIOL-ENDOC M, V298, pE117, DOI 10.1152/ajpendo.00318.2009; de Figueiredo LF, 2011, BIOCHEM J, V439, P341, DOI 10.1042/BJ20110320; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; DIETRICH LS, 1968, J VITAMINOL, VS 14, P123, DOI 10.5925/jnsv1954.14.Supplement_123; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Garten A, 2010, BIOCHEM BIOPH RES CO, V391, P376, DOI 10.1016/j.bbrc.2009.11.066; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Koltai E, 2010, MECH AGEING DEV, V131, P21, DOI 10.1016/j.mad.2009.11.002; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; LITT MR, 1989, ANAL BIOCHEM, V179, P34, DOI 10.1016/0003-2697(89)90196-6; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2013, TRENDS BIOCHEM SCI, V38, P160, DOI 10.1016/j.tibs.2012.12.004; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Romacho T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/946427; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Schmidt MT, 2004, J BIOL CHEM, V279, P40122, DOI 10.1074/jbc.M407484200; Song J, 2014, J GERONTOL A-BIOL, V69, P44, DOI 10.1093/gerona/glt122; Tomcik K, 2011, ANAL BIOCHEM, V410, P110, DOI 10.1016/j.ab.2010.11.030; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; White AT, 2013, DIABETOLOGIA, V56, P1629, DOI 10.1007/s00125-013-2912-2; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104	57	60	62	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1546	1558		10.1074/jbc.M114.579565	http://dx.doi.org/10.1074/jbc.M114.579565			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25411251	hybrid, Green Published			2022-12-28	WOS:000348056400024
J	Trasino, SE; Benoit, YD; Gudas, LJ				Trasino, Steven E.; Benoit, Yannick D.; Gudas, Lorraine J.			Vitamin A Deficiency Causes Hyperglycemia and Loss of Pancreatic beta-Cell Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-I; RETINOIC ACID; INSULIN-RESISTANCE; STELLATE CELLS; ALPHA-CELL; ALL-TRANS; ENDOCRINE; DIFFERENTIATION; EXPRESSION; PROLIFERATION	We show that vitamin A (all-trans-retinol) (VA) is required both for the maintenance of pancreatic beta-cell and alpha-cell mass and for glucose-stimulated insulin secretion in adult mice. Dietary VA deprivation (VAD) causes greatly decreased pancreatic VA levels, hyperglycemia, and reduced insulin secretion. Adult mice fed VAD diets display remodeling of the endocrine pancreas, marked beta-cell apoptosis, shifts to smaller islet size distributions, decreased beta-cell mass, increased alpha-cell mass, and hyperglucagonemia. Importantly, although we induced VAD in the entire animal, the pancreatic beta-cells are exquisitely sensitive to VAD-associated apoptosis compared with other cell types in other organs. VAD causes major reductions in levels of the VA intracellular binding protein Crbp1 and the retinoic acid-metabolizing enzyme Cyp26a1 specifically in larger islets, suggesting the use of these proteins as biomarkers for early endocrine mass abnormalities. In the VAD mice, the reductions in pancreatic islet sizes and the associated aberrant endocrine functions, which show similarities to the phenotype in advanced type 2 diabetes, result from reductions in pancreatic VA signaling. Reintroduction of dietary VA to VAD mice restores pancreatic VA levels, glycemic control, normal islet size distributions, beta-cell to alpha-cell ratios, endocrine hormone profiles, and RAR beta 2 and RAR gamma 2 transcript levels. Restoration of beta-cell mass by reintroducing VA to VAD mice does not involve increased beta-cell proliferation or neogenesis. Pharmacologic modulation of pancreatic VA signaling should be explored for the preservation and/or restoration of pancreatic beta-cell mass and function in individuals with diabetes mellitus.	[Trasino, Steven E.; Benoit, Yannick D.; Gudas, Lorraine J.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA	Cornell University	Gudas, LJ (corresponding author), Cornell Univ, Dept Pharmacol, 1300 York Ave, New York, NY 10065 USA.	ljgudas@med.cornell.edu		Benoit, Yannick/0000-0002-6677-4020	National Institutes of Health [R01CA043796, RO1 DE010389, CA062948]; Weill Cornell funds; NATIONAL CANCER INSTITUTE [R01CA043796, T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA043796 and RO1 DE010389 (to L. J. G.) and CA062948 (to S. E. T.). This work was also supported by Weill Cornell funds.	Al-Hasani K, 2013, DEV CELL, V26, P86, DOI 10.1016/j.devcel.2013.05.018; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Brissova M, 2005, AM J PHYSIOL-ENDOC M, V288, pE707, DOI 10.1152/ajpendo.00252.2004; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; CHERTOW BS, 1987, J CLIN INVEST, V79, P163, DOI 10.1172/JCI112778; CHERTOW BS, 1994, PANCREAS, V9, P475, DOI 10.1097/00006676-199407000-00010; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gudas LJ, 2013, SEMIN CELL DEV BIOL, V24, P701, DOI 10.1016/j.semcdb.2013.08.002; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Guo LL, 2013, DIABETES, V62, P3459, DOI 10.2337/db12-1833; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Jo J, 2012, ISLETS, V4, DOI 10.4161/isl.18660; Kane MA, 2010, P NATL ACAD SCI USA, V107, P21884, DOI 10.1073/pnas.1008859107; Kilimnik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027445; Kilimnik G, 2009, AM J PHYSIOL-ENDOC M, V297, pE1331, DOI 10.1152/ajpendo.00479.2009; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Kim SC, 2014, HEPATOLOGY, V59, P1750, DOI 10.1002/hep.26699; Krakowski ML, 1999, J ENDOCRINOL, V162, P167, DOI 10.1677/joe.0.1620167; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Lotan R, 2005, JNCI-J NATL CANCER I, V97, P3, DOI 10.1093/jnci/dji031; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Masaki T, 2008, METABOLISM, V57, P1340, DOI 10.1016/j.metabol.2008.03.013; Matthews KA, 2004, J NUTR, V134, P1958, DOI 10.1093/jn/134.8.1958; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Nagy NE, 1997, J LIPID RES, V38, P645; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Offield MF, 1996, DEVELOPMENT, V122, P983; Ostrom M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002841; Perez RJ, 2013, EXP CELL RES, V319, P2196, DOI 10.1016/j.yexcr.2013.05.032; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puff R, 2011, HORM METAB RES, V43, P306, DOI 10.1055/s-0031-1271817; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Talchai C, 2012, NAT GENET, V44, P406, DOI 10.1038/ng.2215; TannousKhuri L, 1997, EXP CELL RES, V230, P38, DOI 10.1006/excr.1996.3399; Tattikota SG, 2014, CELL METAB, V19, P122, DOI 10.1016/j.cmet.2013.11.015; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; University of California San Diego, 2000, RAND DOUBL BLIND STU; Van de Casteele M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.52; Wang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067454; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036675	61	57	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1456	1473		10.1074/jbc.M114.616763	http://dx.doi.org/10.1074/jbc.M114.616763			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451926	Green Published, hybrid			2022-12-28	WOS:000348056400017
J	DePaoli-Roach, AA; Contreras, CJ; Segvich, DM; Heiss, C; Ishihara, M; Azadi, P; Roach, PJ				DePaoli-Roach, Anna A.; Contreras, Christopher J.; Segvich, Dyann M.; Heiss, Christian; Ishihara, Mayumi; Azadi, Parastoo; Roach, Peter J.			Glycogen Phosphomonoester Distribution in Mouse Models of the Progressive Myoclonic Epilepsy, Lafora Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KNOCKOUT MICE; PHOSPHATASE; METABOLISM; GLUCOSE; PHOSPHORYLATION; BODIES; STARCH; GENE; NEURODEGENERATION; ACCUMULATION	Glycogen is a branched polymer of glucose that acts as an energy reserve in many cell types. Glycogen contains trace amounts of covalent phosphate, in the range of 1 phosphate per 500-2000 glucose residues depending on the source. The function, if any, is unknown, but in at least one genetic disease, the progressive myoclonic epilepsy Lafora disease, excessive phosphorylation of glycogen has been implicated in the pathology by disturbing glycogen structure. Some 90% of Lafora cases are attributed to mutations of the EPM2A or EPM2B genes, and mice with either gene disrupted accumulate hyperphosphory-lated glycogen. It is, therefore, of importance to understand the chemistry of glycogen phosphorylation. Rabbit skeletal muscle glycogen contained covalent phosphate as monoesters of C2, C3, and C6 carbons of glucose residues based on analyses of phospho-oligosaccharides by NMR. Furthermore, using a sensitive assay for glucose 6-P in hydrolysates of glycogen coupled with measurement of total phosphate, we determined the proportion of C6 phosphorylation in rabbit muscle glycogen to be similar to 20%. C6 phosphorylation also accounted for similar to 20% of the covalent phosphate in wild type mouse muscle glycogen. Glycogen phosphorylation in Epm2a(-/-) and Epm2b(-/-) mice was increased 8- and 4-fold compared with wild type mice, but the proportion of C6 phosphorylation remained unchanged at similar to 20%. Therefore, our results suggest that C2, C3, and/or C6 phosphate could all contribute to abnormal glycogen structure or to Lafora disease.	[DePaoli-Roach, Anna A.; Contreras, Christopher J.; Segvich, Dyann M.; Roach, Peter J.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Heiss, Christian; Ishihara, Mayumi; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Indiana University System; Indiana University Bloomington; University System of Georgia; University of Georgia	Roach, PJ (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	proach@iu.edu	Heiss, Christian/GPX-7678-2022	Heiss, Christian/0000-0003-1118-8953; Aoki, Mayumi/0000-0002-8368-8546	National Institutes of Health [DK27221, NS56454, 1 P41 RR018502-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK027221, R01DK027221, R37DK027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK27221 (to P. J. R.), NS56454 (to P. J. R.), and the 1 P41 RR018502-01 (Integrated Technology Resource for Biomedical Glycomics; to the Complex Carbohydrate Research Center).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andrade D M, 2007, Acta Myol, V26, P83; Bergmeyer H. V., 1974, METHOD ENZYMAT AN, V2, P1196; Blennow A, 2002, TRENDS PLANT SCI, V7, P445, DOI 10.1016/S1360-1385(02)02332-4; Blennow A, 2010, TRENDS PLANT SCI, V15, P236, DOI 10.1016/j.tplants.2010.01.009; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Chikwana VM, 2013, P NATL ACAD SCI USA, V110, P20976, DOI 10.1073/pnas.1310106111; Criado O, 2012, HUM MOL GENET, V21, P1521, DOI 10.1093/hmg/ddr590; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; DePaoli-Roach AA, 2012, HUM MOL GENET, V21, P1604, DOI 10.1093/hmg/ddr598; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Fettke J, 2009, J EXP BOT, V60, P2907, DOI 10.1093/jxb/erp054; FONTANA JD, 1980, FEBS LETT, V109, P85, DOI 10.1016/0014-5793(80)81317-2; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Gessler K, 1999, P NATL ACAD SCI USA, V96, P4246, DOI 10.1073/pnas.96.8.4246; GUNJASMITH Z, 1970, FEBS LETT, V12, P101, DOI 10.1016/0014-5793(70)80573-7; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; LOMAKO J, 1994, BIOFACTORS, V4, P167; LOMAKO J, 1993, FEBS LETT, V329, P263, DOI 10.1016/0014-5793(93)80234-L; MacDonald D.L., 1972, CARBOHYDRATES CHEM B, P253; Melendez R, 1997, J MOL EVOL, V45, P446, DOI 10.1007/PL00006249; MELENDEZHEVIA E, 1993, BIOCHEM J, V295, P477, DOI 10.1042/bj2950477; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Nitschke F, 2013, CELL METAB, V17, P756, DOI 10.1016/j.cmet.2013.04.006; PALADINI AC, 1952, BIOCHEM J, V51, P426, DOI 10.1042/bj0510426; Patel MK, 2013, ORG LETT, V15, P346, DOI 10.1021/ol303271z; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Roach P. J., 2013, PROTEIN TYROSINE PHO, P239; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Teranishi K, 2003, TETRAHEDRON LETT, V44, P4843, DOI 10.1016/S0040-4039(03)01149-3; Tiberia E, 2012, J BIOL CHEM, V287, P25650, DOI 10.1074/jbc.M111.331611; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Valles-Ortega J, 2011, EMBO MOL MED, V3, P667, DOI 10.1002/emmm.201100174; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; Zhu AP, 2009, ANAL BIOCHEM, V388, P97, DOI 10.1016/j.ab.2009.02.009	43	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					841	850		10.1074/jbc.M114.607796	http://dx.doi.org/10.1074/jbc.M114.607796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25416783	hybrid, Green Published			2022-12-28	WOS:000347778200014
J	Khanna, MR; Mattie, FJ; Browder, KC; Radyk, MD; Crilly, SE; Bakerink, KJ; Harper, SL; Speicher, DW; Thomas, GH				Khanna, Mansi R.; Mattie, Floyd J.; Browder, Kristen C.; Radyk, Megan D.; Crilly, Stephanie E.; Bakerink, Katelyn J.; Harper, Sandra L.; Speicher, David W.; Thomas, Graham H.			Spectrin Tetramer Formation Is Not Required for Viable Development in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SPECTRIN; BETA-SPECTRIN; HEREDITARY ELLIPTOCYTOSIS; EPITHELIAL-CELLS; ERYTHROCYTE SPECTRIN; MEMBRANE SKELETON; HEMOLYTIC-ANEMIA; BRUSH-BORDER; ANKYRIN-G; MUTATIONS	The dominant paradigm for spectrin function is that (alpha beta)(2)-spectrin tetramers or higher order oligomers form membrane-associated two-dimensional networks in association with F-actin to reinforce the plasma membrane. Tetramerization is an essential event in such structures. We characterize the tetramerization interaction between alpha-spectrin and beta-spectrins in Drosophila. Wild-type alpha-spectrin binds to both beta- and beta(H)-chains with high affinity, resembling other non-erythroid spectrins. However, alpha-spec(R22S), a tetramerization site mutant homologous to the pathological alpha-spec(R28S) allele in humans, eliminates detectable binding to alpha-spectrin and reduces binding to beta(H)-spectrin similar to 1000-fold. Even though spectrins are essential proteins, alpha-spectrin(R22S) rescues alpha-spectrin mutants to adulthood with only minor phenotypes indicating that tetramerization, and thus conventional network formation, is not the essential function of non-erythroid spectrin. Our data provide the first rigorous test for the general requirement for tetramer-based non-erythroid spectrin networks throughout an organism and find that they have very limited roles, in direct contrast to the current paradigm.	[Khanna, Mansi R.; Mattie, Floyd J.; Browder, Kristen C.; Radyk, Megan D.; Crilly, Stephanie E.; Bakerink, Katelyn J.; Thomas, Graham H.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Khanna, Mansi R.; Mattie, Floyd J.; Browder, Kristen C.; Radyk, Megan D.; Crilly, Stephanie E.; Bakerink, Katelyn J.; Thomas, Graham H.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Harper, Sandra L.; Speicher, David W.] Wistar Inst Anat & Biol, Syst Biol Div, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; The Wistar Institute	Thomas, GH (corresponding author), Penn State Univ, Mueller Lab 208, University Pk, PA 16802 USA.	gxt5@psu.edu		Mattie, Floyd/0000-0001-7121-0206; Radyk, Megan/0000-0002-3660-2906	National Institutes of Health [HL038794]; National Science Foundation [MCB-1122013]; Div Of Molecular and Cellular Bioscience [1122013] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL038794 (to D. W. S.) and National Science Foundation Grant MCB-1122013 (to G. H. T.).	An XL, 2006, BIOCHEMISTRY-US, V45, P13670, DOI 10.1021/bi061368x; An XL, 2011, BBA-PROTEINS PROTEOM, V1814, P420, DOI 10.1016/j.bbapap.2010.12.010; An XL, 2002, J BIOL CHEM, V277, P31796, DOI 10.1074/jbc.M204567200; Ayalon G, 2011, J BIOL CHEM, V286, P7370, DOI 10.1074/jbc.M110.187831; Bignone PA, 2003, BIOCHEM J, V374, P613, DOI 10.1042/BJ20030507; BRAND AH, 1993, DEVELOPMENT, V118, P401; Clyne PJ, 2003, GENETICS, V165, P1433; COETZER TL, 1991, J CLIN INVEST, V88, P743, DOI 10.1172/JCI115371; Das A, 2006, J CELL BIOL, V175, P325, DOI 10.1083/jcb.200602095; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; deCuevas M, 1996, DEVELOPMENT, V122, P3959; Deng H, 1995, BIOCH FUNCTIONAL CHA; DENG HY, 1995, J CELL BIOL, V128, P71, DOI 10.1083/jcb.128.1.71; DESILVA TM, 1992, BIOCHEMISTRY-US, V31, P10872, DOI 10.1021/bi00159a030; Dubreuil RR, 2000, J CELL BIOL, V149, P647, DOI 10.1083/jcb.149.3.647; DUBREUIL RR, 1990, J CELL BIOL, V111, P1849, DOI 10.1083/jcb.111.5.1849; ELGSAETER A, 1986, SCIENCE, V234, P1217, DOI 10.1126/science.3775380; Gaetani M, 2008, BLOOD, V111, P5712, DOI 10.1182/blood-2007-11-122457; Gallagher PG, 1996, BLOOD CELL MOL DIS, V22, P254, DOI 10.1006/bcmd.1996.0105; GALLAGHER PG, 1995, J CLIN INVEST, V95, P1174, DOI 10.1172/JCI117766; Gallagher PG, 1997, J CLIN INVEST, V99, P267, DOI 10.1172/JCI119155; GARBARZ M, 1991, J CLIN INVEST, V88, P76, DOI 10.1172/JCI115307; Garbe DS, 2007, DEVELOPMENT, V134, P273, DOI 10.1242/dev.02653; Harper SL, 2001, BIOCHEMISTRY-US, V40, P9935, DOI 10.1021/bi0107795; HARTWIG JH, 1988, CELL MOTIL CYTOSKEL, V10, P117, DOI 10.1002/cm.970100116; HIROKAWA N, 1983, CELL, V32, P953, DOI 10.1016/0092-8674(83)90080-6; Hulsmeier J, 2007, DEVELOPMENT, V134, P713, DOI 10.1242/dev.02758; Ipsaro JJ, 2010, BLOOD, V115, P4843, DOI 10.1182/blood-2010-01-261396; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; KOTULA L, 1993, J BIOL CHEM, V268, P14788; Lee JK, 1997, DEVELOPMENT, V124, P353; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; Li DH, 2007, BIOCHEMISTRY-US, V46, P10585, DOI 10.1021/bi7007905; Lighthouse DV, 2008, DEV BIOL, V317, P59, DOI 10.1016/j.ydbio.2008.02.009; Lorenzo DN, 2010, J CELL BIOL, V189, P143, DOI 10.1083/jcb.200905158; LUX SE, 1979, SEMIN HEMATOL, V16, P21; Mazock GH, 2010, MOL BIOL CELL, V21, P2860, DOI 10.1091/mbc.E10-03-0180; McKeown C, 1998, DEVELOPMENT, V125, P2087; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; MORROW JS, 1980, P NATL ACAD SCI-BIOL, V77, P6592, DOI 10.1073/pnas.77.11.6592; MORROW JS, 1981, J CELL BIOL, V88, P463, DOI 10.1083/jcb.88.2.463; Nans A, 2011, BIOPHYS J, V101, P2341, DOI 10.1016/j.bpj.2011.09.050; Papal S, 2013, HUM MOL GENET, V22, P3773, DOI 10.1093/hmg/ddt228; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Porter GA, 1997, CELL MOTIL CYTOSKEL, V37, P7, DOI 10.1002/(SICI)1097-0169(1997)37:1<7::AID-CM2>3.0.CO;2-7; SLITER TJ, 1989, GENETICS, V123, P327; Soller M, 1999, DEV BIOL, V208, P337, DOI 10.1006/dbio.1999.9210; Thomas GH, 1998, DEVELOPMENT, V125, P2125; Thomas GH, 1997, MOL BIOL EVOL, V14, P1285, DOI 10.1093/oxfordjournals.molbev.a025738; Tjota M, 2011, J CELL SCI, V124, P2914, DOI 10.1242/jcs.078667; Wada H, 2004, HEARING RES, V187, P51, DOI 10.1016/S0378-5955(03)00334-4; Weed SA, 1996, LAB INVEST, V74, P1117; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Zarnescu DC, 1999, J CELL BIOL, V146, P1075, DOI 10.1083/jcb.146.5.1075	58	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					706	715		10.1074/jbc.M114.615427	http://dx.doi.org/10.1074/jbc.M114.615427			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25381248	Green Published, hybrid			2022-12-28	WOS:000347778200002
J	Prewitt, AR; Ghose, S; Frump, AL; Datta, A; Austin, ED; Kenworthy, AK; de Caestecker, MP				Prewitt, Allison R.; Ghose, Sampa; Frump, Andrea L.; Datta, Arumima; Austin, Eric D.; Kenworthy, Anne K.; de Caestecker, Mark P.			Heterozygous Null Bone Morphogenetic Protein Receptor Type 2 Mutations Promote SRC Kinase-dependent Caveolar Trafficking Defects and Endothelial Dysfunction in Pulmonary Arterial Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II RECEPTOR; MEDIATED INTERNALIZATION; GENETIC ABLATION; BARRIER FUNCTION; IN-VITRO; CELLS; ENDOCYTOSIS; MICE; INHIBITOR; BMPR2	Hereditary pulmonary arterial hypertension (HPAH) is a rare, fatal disease of the pulmonary vasculature. The majority of HPAH patients inherit mutations in the bone morphogenetic protein type 2 receptor gene (BMPR2), but how these promote pulmonary vascular disease is unclear. HPAH patients have features of pulmonary endothelial cell (PEC) dysfunction including increased vascular permeability and perivascular inflammation associated with decreased PEC barrier function. Recently, frameshift mutations in the caveolar structural protein gene Caveolin-1 (CAV-1) were identified in two patients with non-BMPR2- associated HPAH. Because caveolae regulate endothelial function and vascular permeability, we hypothesized that defects in caveolar function might be a common mechanism by which BMPR2 mutations promote pulmonary vascular disease. To explore this, we isolated PECs from mice carrying heterozygous null Bmpr2 mutations (Bmpr2(-/-)) similar to those found in the majority of HPAH patients. We show that Bmpr2(-/-) PECs have increased numbers and intracellular localization of caveolae and caveolar structural proteins CAV-1 and Cavin-1 and that these defects are reversed after blocking endocytosis with dynasore. SRC kinase is also constitutively activated in Bmpr2(-/-) PECs, and localization of CAV-1 to the plasma membrane is restored after treating Bmpr2(-/-) PECs with the SRC kinase inhibitor 3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1Hpyrazolo[3,4-d] pyrimidin-4-amine (PP2). Late outgrowth endothelial progenitor cells isolated from HPAH patients show similar increased activation of SRC kinase. Moreover, Bmpr2(-/-) PECs have impaired endothelial barrier function, and barrier function is restored after treatment with PP2. These data suggest that heterozygous null BMPR2 mutations promote SRC-dependent caveolar trafficking defects in PECs and that this may contribute to pulmonary endothelial barrier dysfunction in HPAH patients.	[Prewitt, Allison R.; Frump, Andrea L.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Ghose, Sampa; Datta, Arumima; de Caestecker, Mark P.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Austin, Eric D.] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; [Kenworthy, Anne K.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	de Caestecker, MP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol,Med Ctr North S3223, 1161 21st Ave S, Nashville, TN 37232 USA.	mark.de.caestecker@vanderbilt.edu	Frump, Andrea/W-5043-2019	Kenworthy, Anne/0000-0001-6567-9059; Frump, Andrea/0000-0002-5972-5079	National Institutes of Health [R01HL093057, R01HL111259, R03HL115112]; American Heart Association [12PRE11900020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111259, R01HL093057, R03HL115112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL093057 (to M. P. d. C.), R01HL111259 (to A. K. K.), and R03HL115112 (to M. P. d. C.).; Supported by American Heart Association Predoctoral Fellowship 12PRE11900020.	Anderson L, 2010, AM J PHYSIOL-REG I, V298, pR833, DOI 10.1152/ajpregu.00534.2009; Asosingh K, 2012, BLOOD, V120, P1218, DOI 10.1182/blood-2012-03-419275; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Beppu H, 2005, GENESIS, V41, P133, DOI 10.1002/gene.20099; BRICKMAN MJ, 1995, J CELL SCI, V108, P3611; Burton VJ, 2011, BLOOD, V118, P4750, DOI 10.1182/blood-2011-05-347393; Burton VJ, 2011, BLOOD, V117, P333, DOI 10.1182/blood-2010-05-285973; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Frank DB, 2008, AM J PHYSIOL-LUNG C, V294, pL98, DOI 10.1152/ajplung.00034.2007; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hanson CA, 2013, TRAFFIC, V14, P663, DOI 10.1111/tra.12066; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hong KH, 2008, CIRCULATION, V118, P722, DOI 10.1161/CIRCULATIONAHA.107.736801; Hu GC, 2009, MICROVASC RES, V77, P21, DOI 10.1016/j.mvr.2008.10.002; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Loyd J. E., 2012, GENEREVIEWS; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maniatis NA, 2008, AM J PHYSIOL-LUNG C, V294, pL865, DOI 10.1152/ajplung.00079.2007; Mathew R, 2004, CIRCULATION, V110, P1499, DOI 10.1161/01.CIR.0000141576.39579.23; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Minshall RD, 2002, HISTOCHEM CELL BIOL, V117, P105, DOI 10.1007/s00418-001-0367-x; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Parat MO, 2009, INT REV CEL MOL BIO, V273, P117, DOI 10.1016/S1937-6448(08)01804-2; Patel HH, 2007, FASEB J, V21, P2970, DOI 10.1096/fj.07-8424com; Paulin R, 2011, AM J PHYSIOL-HEART C, V301, pH1798, DOI 10.1152/ajpheart.00654.2011; Ramos M, 2006, VASC PHARMACOL, V44, P50, DOI 10.1016/j.vph.2005.09.007; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Richter A, 2004, AM J RESP CRIT CARE, V170, P1340, DOI 10.1164/rccm.200311-1602OC; Rode M, 1997, COMP BIOCHEM PHYS A, V117, P531, DOI 10.1016/S0300-9629(96)00414-8; Savai R, 2012, AM J RESP CRIT CARE, V186, P897, DOI 10.1164/rccm.201202-0335OC; Sbaa E, 2005, TRENDS CARDIOVAS MED, V15, P157, DOI 10.1016/j.tcm.2005.05.006; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P669, DOI 10.1146/annurev.bi.46.070177.003321; Sowa G, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00120; Spiekerkoetter E, 2013, J CLIN INVEST, V123, P3600, DOI 10.1172/JCI65592; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; Sun Y, 2011, METHODS MOL BIOL, V763, P303, DOI 10.1007/978-1-61779-191-8_21; Van Driessche W, 2007, AM J PHYSIOL-LUNG C, V293, pL520, DOI 10.1152/ajplung.00218.2007; Vultur A, 2008, MOL CANCER THER, V7, P1185, DOI 10.1158/1535-7163.MCT-08-0126; Wong WKP, 2005, AM J RESP CELL MOL, V33, P438, DOI 10.1165/rcmb.2005-0103OC; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338	53	34	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					960	971		10.1074/jbc.M114.591057	http://dx.doi.org/10.1074/jbc.M114.591057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25411245	Green Published, hybrid			2022-12-28	WOS:000347778200030
J	Hu, JM; Chuenchor, W; Rokita, SE				Hu, Jimin; Chuenchor, Watchalee; Rokita, Steven E.			A Switch between One- and Two-electron Chemistry of the Human Flavoprotein Iodotyrosine Deiodinase Is Controlled by Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Enzyme Structure; Flavin Mononucleotide (FMN); Oxidation-Reduction (Redox); Thyroid; Dehalogenase; Flavoprotein; Iodotyrosine	ACYL-COA DEHYDROGENASE; ELECTRON-TRANSFER FLAVOPROTEIN; REDOX PROPERTIES; FLAVIN; REDUCTION; SITE; MECHANISM; PROTEIN; IDENTIFICATION; FLAVOENZYMES	Background: Iodotyrosine deiodinase utilizes FMN to maintain iodide homeostasis by reductive deiodination of iodotyrosine. Results: Crystallographic, pH, and redox studies demonstrate the role of substrate in organizing the active site for effective catalysis. Conclusion: Stepwise single electron transfer is promoted only after coordination of a halotyrosine within iodotyrosine deiodinase. Significance: A synergy between substrate selectivity and catalytic activity is created by the enzyme. Reductive dehalogenation is not typical of aerobic organisms but plays a significant role in iodide homeostasis and thyroid activity. The flavoprotein iodotyrosine deiodinase (IYD) is responsible for iodide salvage by reductive deiodination of the iodotyrosine derivatives formed as byproducts of thyroid hormone biosynthesis. Heterologous expression of the human enzyme lacking its N-terminal membrane anchor has allowed for physical and biochemical studies to identify the role of substrate in controlling the active site geometry and flavin chemistry. Crystal structures of human IYD and its complex with 3-iodo-l-tyrosine illustrate the ability of the substrate to provide multiple interactions with the isoalloxazine system of FMN that are usually provided by protein side chains. Ligand binding acts to template the active site geometry and significantly stabilize the one-electron-reduced semiquinone form of FMN. The neutral form of this semiquinone is observed during reductive titration of IYD in the presence of the substrate analog 3-fluoro-l-tyrosine. In the absence of an active site ligand, only the oxidized and two-electron-reduced forms of FMN are detected. The pH dependence of IYD binding and turnover also supports the importance of direct coordination between substrate and FMN for productive catalysis.	[Hu, Jimin; Chuenchor, Watchalee; Rokita, Steven E.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Rokita, Steven E.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland College Park; Johns Hopkins University	Rokita, SE (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	rokita@jhu.edu	Rokita, Steven E/C-4793-2009	Chuenchor, Watchalee/0000-0002-4366-9914	National Institutes of Health [RO1 DK084186]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant RO1 DK084186 (to S. E. R.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afink G, 2008, J CLIN ENDOCR METAB, V93, P4894, DOI 10.1210/jc.2008-0865; ANDERSON RF, 1983, BIOCHIM BIOPHYS ACTA, V722, P158, DOI 10.1016/0005-2728(83)90169-X; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; BECKER DF, 1994, BIOCHEMISTRY-US, V33, P7082, DOI 10.1021/bi00189a010; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bowsher CG, 2011, BIOCHEMISTRY-US, V50, P1778, DOI 10.1021/bi1014562; Buss JM, 2012, PROTEIN SCI, V21, P351, DOI 10.1002/pro.2020; BYRON CM, 1989, BIOCHEMISTRY-US, V28, P8582, DOI 10.1021/bi00447a047; Clark W. M., 1960, OXIDATION REDUCTION; Cook G., 2007, FUNDAMENTALS PROTEIN, P325; Roldan M, 2008, FEMS MICROBIOL REV, V32, P474, DOI 10.1111/j.1574-6976.2008.00107.x; DRAPER RD, 1968, ARCH BIOCHEM BIOPHYS, V125, P802, DOI 10.1016/0003-9861(68)90517-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engst S, 1999, BIOCHEMISTRY-US, V38, P257, DOI 10.1021/bi9815041; Fagan RL, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P37; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Friedman JE, 2006, J BIOL CHEM, V281, P2812, DOI 10.1074/jbc.M510365200; GEMMILL CL, 1955, ARCH BIOCHEM BIOPHYS, V54, P359, DOI 10.1016/0003-9861(55)90048-5; Gnidehou S, 2004, FASEB J, V18, P1574, DOI 10.1096/fj.04-2023fje; Gnidehou S, 2006, THYROID, V16, P715, DOI 10.1089/thy.2006.16.715; GORELICK RJ, 1985, BIOCHEMISTRY-US, V24, P6830, DOI 10.1021/bi00345a015; GOSWAMI A, 1977, ENDOCRINOLOGY, V101, P331, DOI 10.1210/endo-101-2-331; GREEN WL, 1968, ENDOCRINOLOGY, V83, P336, DOI 10.1210/endo-83-2-336; GREENSTEIN JP, 1961, CHEMISTRY AMINO ACID, V1, P486; Hamill MJ, 2012, INT J MOL SCI, V13, P16899, DOI 10.3390/ijms131216899; Heroux A, 2009, BIOCHEMISTRY-US, V48, P3407, DOI 10.1021/bi8023042; Koziol J, 1971, METHOD ENZYMOL, V18, P235; Kunishima M, 1999, J AM CHEM SOC, V121, P4722, DOI 10.1021/ja990693n; Mansoorabadi SO, 2007, J ORG CHEM, V72, P6329, DOI 10.1021/jo0703092; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Massey V., 1991, P 10 INT S COM IT JU, P59; McDonald CA, 2011, J AM CHEM SOC, V133, P16809, DOI 10.1021/ja2081873; McTamney PM, 2009, J AM CHEM SOC, V131, P14212, DOI 10.1021/ja906642n; Metrangolo P, 2008, ANGEW CHEM INT EDIT, V47, P6114, DOI 10.1002/anie.200800128; Moreno JC, 2008, NEW ENGL J MED, V358, P1811, DOI 10.1056/NEJMoa0706819; Nicola JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4948; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Panda SP, 2006, J BIOL CHEM, V281, P34246, DOI 10.1074/jbc.M601041200; Phatarphekar A, 2014, MOL BIOSYST, V10, P86, DOI 10.1039/c3mb70398c; Pitsawong W, 2010, J BIOL CHEM, V285, P9697, DOI 10.1074/jbc.M109.073247; Rokita SE, 2013, HANDBOOK OF FLAVOPROTEINS, VOL 1: OXIDASES, DEHYDROGENASES AND RELATED SYSTEMS, P337; Rokita SE, 2010, BIOCHIMIE, V92, P1227, DOI 10.1016/j.biochi.2010.02.013; ROSENBERG IN, 1984, METHOD ENZYMOL, V107, P488; STRADINS J, 1993, J ELECTROANAL CHEM, V353, P57, DOI 10.1016/0022-0728(93)80286-Q; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Thomas SR, 2009, J BIOL CHEM, V284, P19659, DOI 10.1074/jbc.M109.013458; THORPE C, 1995, FASEB J, V9, P718, DOI 10.1096/fasebj.9.9.7601336; van den Heuvel RHH, 2000, J BIOL CHEM, V275, P14799, DOI 10.1074/jbc.275.20.14799; van den Heuvel RHH, 2002, METHOD ENZYMOL, V353, P177; Velazquez F, 2011, CHEM BIOL, V18, P1252, DOI 10.1016/j.chembiol.2011.08.003; Warner JR, 2007, BIOCHEMISTRY-US, V46, P13211, DOI 10.1021/bi701069n; Watson JA, 2008, CHEMBIOCHEM, V9, P504, DOI 10.1002/cbic.200700562; Yang KY, 2007, BIOCHEMISTRY-US, V46, P2289, DOI 10.1021/bi0616293; Zhou ZM, 1996, BIOCHEMISTRY-US, V35, P15980, DOI 10.1021/bi962124n	56	31	32	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					590	600		10.1074/jbc.M114.605964	http://dx.doi.org/10.1074/jbc.M114.605964			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25395621	Green Published, hybrid			2022-12-28	WOS:000347231200051
J	Chen, Q; Zou, JH; Shen, ZL; Zhang, WP; Yang, J				Chen, Qian; Zou, Junhuang; Shen, Zuolian; Zhang, Weiping; Yang, Jun			Whirlin and PDZ Domain-containing 7 (PDZD7) Proteins Are Both Required to Form the Quaternary Protein Complex Associated with Usher Syndrome Type 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COCHLEAR HAIR-CELLS; ANKLE-LINK COMPLEX; RETINITIS-PIGMENTOSA; CRYSTAL-STRUCTURE; HEARING-LOSS; MYOSIN-XVA; GENE; VLGR1; MUTATION; REVEALS	Usher syndrome (USH) is the leading genetic cause of combined hearing and vision loss. Among the three USH clinical types, type 2 (USH2) occurs most commonly. USH2A, GPR98, and WHRN are three known causative genes of USH2, whereas PDZD7 is a modifier gene found in USH2 patients. The proteins encoded by these four USH genes have been proposed to form a multiprotein complex, the USH2 complex, due to interactions found among some of these proteins in vitro, their colocalization in vivo, and mutual dependence of some of these proteins for their normal in vivo localizations. However, evidence showing the formation of the USH2 complex is missing, and details on how this complex is formed remain elusive. Here, we systematically investigated interactions among the intracellular regions of the four USH proteins using colocalization, yeast two-hybrid, and pull-down assays. We show that multiple domains of the four USH proteins interact among one another. Importantly, both WHRN and PDZD7 are required for the complex formation with USH2A and GPR98. In this USH2 quaternary complex, WHRN prefers to bind to USH2A, whereas PDZD7 prefers to bind to GPR98. Interaction between WHRN and PDZD7 is the bridge between USH2A and GPR98. Additionally, the USH2 quaternary complex has a variable stoichiometry. These findings suggest that a non-obligate, short term, and dynamic USH2 quaternary protein complex may exist in vivo. Our work provides valuable insight into the physiological role of the USH2 complex in vivo and informs possible reconstruction of the USH2 complex for future therapy.	[Chen, Qian; Zou, Junhuang; Shen, Zuolian; Zhang, Weiping; Yang, Jun] Univ Utah, Dept Opthalmol & Visual Sci, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Yang, Jun] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Yang, Jun] Univ Utah, Dept Otolaryngol Head & Neck Surg, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Yang, J (corresponding author), Univ Utah, Dept Opthalmol & Visual Sci, John A Moran Eye Ctr, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	jun.yang@hsc.utah.edu			National Institutes of Health [EY020853, EY014800]; Foundation Fighting Blindness; E. Matilda Ziegler Foundation for the Blind, Inc.; Research to Prevent Blindness, Inc.; Knights Templar Eye Foundation; Hearing Health Foundation; National Organization for Hearing Research Foundation; Moran Eye Center, University of Utah; NATIONAL EYE INSTITUTE [P30EY014800, R01EY020853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); E. Matilda Ziegler Foundation for the Blind, Inc.; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Knights Templar Eye Foundation; Hearing Health Foundation; National Organization for Hearing Research Foundation; Moran Eye Center, University of Utah; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY020853 (to J. Y.) and EY014800 (to the Department of Ophthalmology and Visual Sciences, University of Utah). This work was also supported by grants from the Foundation Fighting Blindness (to J. Y.), the E. Matilda Ziegler Foundation for the Blind, Inc. (to J. Y.), Research to Prevent Blindness, Inc. (to J. Y. and the Department of Ophthalmology and Visual Sciences, University of Utah), the Knights Templar Eye Foundation (to Q. C.), the Hearing Health Foundation (to J. Z.), and the National Organization for Hearing Research Foundation (to J. Z.) and a startup package from the Moran Eye Center, University of Utah (to J. Y.).	Adato A, 2005, HUM MOL GENET, V14, P3921, DOI 10.1093/hmg/ddi416; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; Ebermann I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Fanning AS, 2007, J BIOL CHEM, V282, P37710, DOI 10.1074/jbc.M707255200; Gee SH, 2000, BIOCHEMISTRY-US, V39, P14638, DOI 10.1021/bi001633t; Grati M, 2012, J NEUROSCI, V32, P14288, DOI 10.1523/JNEUROSCI.3071-12.2012; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; Johnson KR, 2005, GENOMICS, V85, P582, DOI 10.1016/j.ygeno.2005.02.006; Kikkawa Y, 2005, HUM MOL GENET, V14, P391, DOI 10.1093/hmg/ddi035; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Liebscher I, 2013, BIOL CHEM, V394, P937, DOI 10.1515/hsz-2013-0109; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; McMillan DR, 2004, MOL CELL NEUROSCI, V26, P322, DOI 10.1016/j.mcn.2004.02.005; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; Millan JM, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/417217; Nakayama J, 2002, ANN NEUROL, V52, P654, DOI 10.1002/ana.10347; Paavola K. J., MOL PHARM, V82, P777; Reiners J, 2005, HUM MOL GENET, V14, P3933, DOI 10.1093/hmg/ddi417; Rivolta C, 2002, ARCH OPHTHALMOL-CHIC, V120, P1566, DOI 10.1001/archopht.120.11.1566; Schneider E, 2009, HUM MOL GENET, V18, P655, DOI 10.1093/hmg/ddn395; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Sugi T, 2007, EMBO J, V26, P2192, DOI 10.1038/sj.emboj.7601651; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Wang L, 2012, HUM MOL GENET, V21, P692, DOI 10.1093/hmg/ddr503; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Wu L, 2012, J BIOL CHEM, V287, P33460, DOI 10.1074/jbc.M112.378505; Yagi H, 2005, J NEUROCHEM, V92, P191, DOI 10.1111/j.1471-4159.2004.02875.x; Yagi H, 2007, GENES CELLS, V12, P235, DOI 10.1111/j.1365-2443.2007.01046.x; Yang J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000955; Zallocchi M, 2012, J NEUROSCI, V32, P13841, DOI 10.1523/JNEUROSCI.1242-12.2012; Zallocchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030573; Zou JH, 2014, HUM MOL GENET, V23, P2374, DOI 10.1093/hmg/ddt629; Zou JH, 2011, INVEST OPHTH VIS SCI, V52, P2343, DOI 10.1167/iovs.10-6141	46	46	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36070	36088		10.1074/jbc.M114.610535	http://dx.doi.org/10.1074/jbc.M114.610535			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25406310	hybrid, Green Published			2022-12-28	WOS:000346897900035
J	Lim, JG; Bang, YJ; Choi, SH				Lim, Jong Gyu; Bang, Ye-Ji; Choi, Sang Ho			Characterization of the Vibrio vulnificus 1-Cys Peroxiredoxin Prx3 and Regulation of Its Expression by the Fe-S Cluster Regulator IscR in Response to Oxidative Stress and Iron Starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DISTINCT CHARACTERISTICS; 2-CYS PEROXIREDOXINS; ANTIOXIDANT PROTEIN; REACTIVE OXYGEN; GENE; GLUTAREDOXIN; ENZYME; IDENTIFICATION; PURIFICATION	Peroxiredoxins (Prxs) are ubiquitous antioxidant enzymes that reduce toxic peroxides. A new Vibrio vulnificus Prx, named Prx3, was identified and characterized in this study. Biochemical and mutational analyses revealed that Prx3 reduces H2O2, utilizing glutaredoxin 3 (Grx3) and glutathione (GSH) as reductants, and requires only N-terminal peroxidatic cysteine for its catalysis. These results, combined with the monomeric size of Prx3 observed under non-reducing conditions, suggested that Prx3 is a Grx3/GSH-dependent 1-Cys Prx and oxidized without forming intermolecular disulfide bonds. The prx3 mutation impaired growth in the medium containing peroxides and reduced virulence in mice, indicating that Prx3 is essential for survival under oxidative stress and pathogenesis of V. vulnificus. The Fe-S cluster regulator IscR activates prx3 by direct binding to a specific binding sequence centered at -44 from the transcription start site. The binding sequence was homologous to the Type 2 IscR-binding sequence, most likely recognized by the Fe-S clusterless apo-IscR in Escherichia coli. The iscR(3CA) mutant, chromosomally encoding the apo-locked IscR, exhibited 3-fold higher levels of activation of prx3 than the wild type and accumulated more IscR(3CA) protein in cells. The IscR-dependent activation of prx3 by aerobic growth and iron starvation was also associated with the increase in cellular levels of IscR protein. Taken together, the results suggested that IscR senses iron starvation as well as reactive oxygen species and shifts to the apo-form, which leads to the increase of cellular IscR and in turn prx3 expression, contributing to the survival and virulence of V. vulnificus during pathogenesis.	[Lim, Jong Gyu; Bang, Ye-Ji; Choi, Sang Ho] Seoul Natl Univ, Dept Agr Biotechnol, Ctr Food Safety & Toxicol, Natl Res Lab Mol Microbiol & Toxicol, Seoul 151921, South Korea	Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	choish@snu.ac.kr		Choi, Sang Ho/0000-0003-3865-1039; Bang, Ye-Ji/0000-0003-4009-0824	National Research Foundation - Ministry of Science, ICT, and Future Planning [2012R1A2A1A03009679]; R&D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs; Ministry of Food and Drug Safety, Republic of Korea [14162MFDS972]	National Research Foundation - Ministry of Science, ICT, and Future Planning; R&D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs; Ministry of Food and Drug Safety, Republic of Korea(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This work was supported by Mid-career Researcher Program Grant 2012R1A2A1A03009679 through the National Research Foundation funded by the Ministry of Science, ICT, and Future Planning; the R&D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs; and Ministry of Food and Drug Safety, Republic of Korea, Grant 14162MFDS972 (to S. H. C).	Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Baek WK, 2009, J MICROBIOL, V47, P624, DOI 10.1007/s12275-009-0130-x; Bang YJ, 2012, J BIOL CHEM, V287, P42516, DOI 10.1074/jbc.M112.421214; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; Chung KJ, 2010, J INFECT DIS, V201, P97, DOI 10.1086/648612; Clarke DJ, 2010, BIOCHEMISTRY-US, V49, P1319, DOI 10.1021/bi901703m; Cubadda F, 2005, MICROCHEM J, V79, P91, DOI 10.1016/j.microc.2004.10.007; Djuika CF, 2013, BBA-GEN SUBJECTS, V1830, P4073, DOI 10.1016/j.bbagen.2013.04.020; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Dubbs James M., 2007, V44, P143; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Giel JL, 2013, MOL MICROBIOL, V87, P478, DOI 10.1111/mmi.12052; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hugo M, 2009, BIOCHEMISTRY-US, V48, P9416, DOI 10.1021/bi901221s; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jeong W, 2000, J BIOL CHEM, V275, P2924, DOI 10.1074/jbc.275.4.2924; Kim SM, 2012, MICROBIOL-SGM, V158, P2017, DOI 10.1099/mic.0.059071-0; Kim S, 2014, MOL MICROBIOL, V93, P992, DOI 10.1111/mmi.12712; Knoops B, 1999, J BIOL CHEM, V274, P30451, DOI 10.1074/jbc.274.43.30451; Knoops Bernard, 2007, V44, P27; Lim JG, 2014, J MICROBIOL, V52, P413, DOI 10.1007/s12275-014-3592-4; Lim JG, 2014, INFECT IMMUN, V82, P569, DOI 10.1128/IAI.01141-13; Miller HK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004194; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nesbit AD, 2009, J MOL BIOL, V387, P28, DOI 10.1016/j.jmb.2009.01.055; Noguera-Mazon V, 2006, J BIOL CHEM, V281, P31736, DOI 10.1074/jbc.M602188200; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Pauwels F, 2003, J BIOL CHEM, V278, P16658, DOI 10.1074/jbc.M300157200; Poole Leslie B., 2007, V44, P61; Poole Leslie B, 2011, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0709s49; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Pedrajas JR, 2010, ANTIOXID REDOX SIGN, V13, P249, DOI 10.1089/ars.2009.2950; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.010586; Sarma GN, 2005, J MOL BIOL, V346, P1021, DOI 10.1016/j.jmb.2004.12.022; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Wu Y, 2009, J BACTERIOL, V191, P1248, DOI 10.1128/JB.01086-08; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	53	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36263	36274		10.1074/jbc.M114.611020	http://dx.doi.org/10.1074/jbc.M114.611020			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25398878	Green Published, hybrid			2022-12-28	WOS:000346897900050
J	Shivange, G; Kodipelli, N; Monisha, M; Anindya, R				Shivange, Gururaj; Kodipelli, Naveena; Monisha, Mohan; Anindya, Roy			A Role for Saccharomyces cerevisiae Tpa1 Protein in Direct Alkylation Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DNA-REPAIR; TRANSLATION TERMINATION; OXIDATIVE DEMETHYLATION; METHYLATION DAMAGE; MESSENGER-RNA; ALKB; YEAST; COMPLEX; REPLICATION	Alkylating agents induce cytotoxic DNA base adducts. In this work, we provide evidence to suggest, for the first time, that Saccharomyces cerevisiae Tpa1 protein is involved in DNA alkylation repair. Little is known about Tpa1 as a repair protein beyond the initial observation from a high-throughput analysis indicating that deletion of TPA1 causes methyl methane sulfonate sensitivity in S. cerevisiae. Using purified Tpa1, we demonstrate that Tpa1 repairs both single-and double-stranded methylated DNA. Tpa1 is a member of the Fe(II) and 2-oxoglutarate-dependent dioxygenase family, and we show that mutation of the amino acid residues involved in cofactor binding abolishes the Tpa1 DNA repair activity. Deletion of TPA1 along with the base excision repair pathway DNA glycosylase MAG1 renders the tpa1 Delta mag1 Delta double mutant highly susceptible to methylation-induced toxicity. We further demonstrate that the trans-lesion synthesis DNA polymerase Pol zeta (REV3) plays a key role in tolerating DNA methyl-base lesions and that tpa1 Delta mag1rev Delta 3 triple mutant is extremely susceptible to methylation-induced toxicity. Our results indicate a synergism between the base excision repair pathway and direct alkylation repair by Tpa1 in S. cerevisiae. We conclude that Tpa1 is a hitherto unidentified DNA repair protein in yeast and that it plays a crucial role in reverting alkylated DNA base lesions and cytotoxicity.	[Shivange, Gururaj; Kodipelli, Naveena; Monisha, Mohan; Anindya, Roy] Indian Inst Technol Hyderabad, Dept Biotechnol, Hyderabad 502205, Andhra Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Hyderabad	Anindya, R (corresponding author), Indian Inst Technol Hyderabad, Dept Biotechnol, Hyderabad 502205, Andhra Pradesh, India.	anindya@iith.ac.in	Anindya, Roy/F-8241-2012; Anindya, Roy/ABD-1326-2020	Anindya, Roy/0000-0001-8561-907X; Anindya, Roy/0000-0001-8561-907X	Innovative Young Biotechnologist Award Fellowship from the Department of Biotechnology, Government of India	Innovative Young Biotechnologist Award Fellowship from the Department of Biotechnology, Government of India	This work was supported by Innovative Young Biotechnologist Award Fellowship (2008) from the Department of Biotechnology, Government of India (to A. R.).	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Bjornstad LG, 2011, BIOCHEM J, V434, P391, DOI 10.1042/BJ20101667; Calvo JA, 2012, J CLIN INVEST, V122, P2680, DOI 10.1172/JCI63338; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Chen H, 2009, BIOMETALS, V22, P191, DOI 10.1007/s10534-008-9190-3; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046688, 10.1371/journal.pone.0039927]; Choudhary V, 2012, P NATL ACAD SCI USA, V109, P16882, DOI 10.1073/pnas.1209086109; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Dinglay S, 2000, GENE DEV, V14, P2097; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Eichhorn E, 1997, J BIOL CHEM, V272, P23031, DOI 10.1074/jbc.272.37.23031; Falnes PO, 2007, NEUROSCIENCE, V145, P1222, DOI 10.1016/j.neuroscience.2006.11.018; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P3456, DOI 10.1093/nar/gkh655; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hanway D, 2002, P NATL ACAD SCI USA, V99, P10605, DOI 10.1073/pnas.152264899; Hendricks CA, 2002, DNA REPAIR, V1, P645, DOI 10.1016/S1568-7864(02)00072-1; Henri J, 2010, J BIOL CHEM, V285, P30767, DOI 10.1074/jbc.M110.106864; Henshaw TF, 2004, J INORG BIOCHEM, V98, P856, DOI 10.1016/j.jinorgbio.2003.10.021; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer LM, 2001, GENOME BIOL, V2; John S, 2000, GENE DEV, V14, P1196; Johnson RE, 2007, MOL CELL BIOL, V27, P7198, DOI 10.1128/MCB.01079-07; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; Keeling KM, 2006, MOL CELL BIOL, V26, P5237, DOI 10.1128/MCB.02448-05; Kim HS, 2010, NUCLEIC ACIDS RES, V38, P2099, DOI 10.1093/nar/gkp1151; Korvald H, 2012, DNA REPAIR, V11, P453, DOI 10.1016/j.dnarep.2012.01.014; Kunz BA, 2000, MUTAT RES-FUND MOL M, V451, P169, DOI 10.1016/S0027-5107(00)00048-8; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Li Q, 2007, ANAL SCI, V23, P413, DOI 10.2116/analsci.23.413; Loenarz C, 2014, P NATL ACAD SCI USA, V111, P4019, DOI 10.1073/pnas.1311750111; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Ma WJ, 2008, NUCLEIC ACIDS RES, V36, P1836, DOI 10.1093/nar/gkm1148; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Petrov AN, 2008, NUCLEIC ACIDS RES, V36, P6187, DOI 10.1093/nar/gkn643; Rajski SR, 1998, CHEM REV, V98, P2723, DOI 10.1021/cr9800199; Rother S, 2007, GENE DEV, V21, P1409, DOI 10.1101/gad.428407; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shivange G, 2014, ANAL BIOCHEM, V465, P35, DOI 10.1016/j.ab.2014.07.003; SIKORSKI RS, 1989, GENETICS, V122, P19; Simmons JM, 2012, EXP PARASITOL, V131, P92, DOI 10.1016/j.exppara.2012.03.011; Singer B., 1983, MOL BIOL MUTAGENS CA; Spence EL, 1996, J BACTERIOL, V178, P5249, DOI 10.1128/jb.178.17.5249-5256.1996; Svilar D, 2012, MOL CANCER RES, V10, P1580, DOI 10.1158/1541-7786.MCR-12-0168; Taschner M, 2010, MOL CELL BIOL, V30, P436, DOI 10.1128/MCB.00822-09; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Van Sloun PPH, 2002, MOL CELL BIOL, V22, P2159, DOI 10.1128/MCB.22.7.2159-2169.2002; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; VOLKERT MR, 1991, MOL GEN GENET, V229, P319, DOI 10.1007/BF00272173; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; WEI YF, 1995, J BACTERIOL, V177, P5009, DOI 10.1128/jb.177.17.5009-5015.1995; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xiao W, 1996, CURR GENET, V30, P461, DOI 10.1007/s002940050157	70	19	19	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35939	35952		10.1074/jbc.M114.590216	http://dx.doi.org/10.1074/jbc.M114.590216			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25381260	Green Published, hybrid			2022-12-28	WOS:000346897900025
J	Yang, T; Gao, LP; Hu, H; Stoopen, G; Wang, CY; Jongsma, MA				Yang, Ting; Gao, Liping; Hu, Hao; Stoopen, Geert; Wang, Caiyun; Jongsma, Maarten A.			Chrysanthemyl Diphosphate Synthase Operates in Planta as a Bifunctional Enzyme with Chrysanthemol Synthase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMETHYLALLYL DIPHOSPHATE; SQUALENE SYNTHASE; MONOTERPENE SYNTHASE; TERPENE SYNTHASES; BIOSYNTHESIS; EXPRESSION; ARABIDOPSIS; METABOLISM; CLONING; LEAVES	Chrysanthemyl diphosphate synthase (CDS) is the first pathway-specific enzyme in the biosynthesis of pyrethrins, the most widely used plant-derived pesticide. CDS catalyzes c1'-2-3 cyclopropanation reactions of two molecules of dimethylallyl diphosphate (DMAPP) to yield chrysanthemyl diphosphate (CPP). Three proteins are known to catalyze this cyclopropanation reaction of terpene precursors. Two of them, phytoene and squalene synthase, are bifunctional enzymes with both prenyltransferase and terpene synthase activity. CDS, the other member, has been reported to perform only the prenyltransferase step. Here we show that the NDXXD catalytic motif of CDS, under the lower substrate conditions prevalent in plants, also catalyzes the next step, converting CPP into chrysanthemol by hydrolyzing the diphosphate moiety. The enzymatic hydrolysis reaction followed conventional Michaelis-Menten kinetics, with a Km value for CPP of 196 mu M. For the chrysanthemol synthase activity, DMAPP competed with CPP as substrate. The DMAPP concentration required for half-maximal activity to produce chrysanthemol was similar to 100 mu M, and significant substrate inhibition was observed at elevated DMAPP concentrations. The N-terminal peptide of CDS was identified as a plastid-targeting peptide. Transgenic tobacco plants overexpressing CDS emitted chrysanthemol at a rate of 0.12-0.16 mu g h(-1) g(-1) fresh weight. We propose that CDS should be renamed a chrysanthemol synthase utilizing DMAPP as substrate.	[Yang, Ting; Gao, Liping; Stoopen, Geert; Jongsma, Maarten A.] Wageningen UR, Business Unit PRI Biosci, NL-6700 AA Wageningen, Netherlands; [Yang, Ting] Wageningen UR, Entomol Lab, NL-6700 EH Wageningen, Netherlands; [Yang, Ting] Wageningen UR, Lab Plant Physiol, NL-6700 AR Wageningen, Netherlands; [Hu, Hao; Wang, Caiyun] Huazhong Agr Univ, Coll Hort & Forestry Sci, Minist Educ, Key Lab Biol Hort Plants, Wuhan 430070, Peoples R China	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Huazhong Agricultural University	Jongsma, MA (corresponding author), Wageningen UR, Plant Res Int, POB 619, NL-6700 AP Wageningen, Netherlands.	maarten.jongsma@wur.nl	Jongsma, Maarten A/A-2118-2010; Yang, Ting/J-1881-2015	Jongsma, Maarten A/0000-0001-5799-2301; Yang, Ting/0000-0001-8872-8749; HU, HAO/0000-0002-0614-3921	Technological Top Institute Green Genetics (Stichting TTI Groene Genetica) of The Netherlands [1C001RP]; National Natural Science Foundation of China [31372103]	Technological Top Institute Green Genetics (Stichting TTI Groene Genetica) of The Netherlands; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Technological Top Institute Green Genetics (Stichting TTI Groene Genetica) of The Netherlands Grant 1C001RP and by National Natural Science Foundation of China Project 31372103.	Aharoni A, 2004, PLANT CELL, V16, P3110, DOI 10.1105/tpc.104.023895; Bouwmeester HJ, 2002, PLANT PHYSIOL, V129, P134, DOI 10.1104/pp.001024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREWER J G, 1973, Pyrethrum Post, V12, P17; Bruggemann N, 2002, PHYSIOL PLANTARUM, V115, P190, DOI 10.1034/j.1399-3054.2002.1150203.x; Burke CC, 1999, P NATL ACAD SCI USA, V96, P13062, DOI 10.1073/pnas.96.23.13062; Casida J.E., 1995, PYRETHRUM FLOWERS PR; Chang TH, 2010, PLANT CELL, V22, P454, DOI 10.1105/tpc.109.071738; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; CROWLEY MP, 1961, NATURE, V191, P281, DOI 10.1038/191281a0; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; DOGBO O, 1988, P NATL ACAD SCI USA, V85, P7054, DOI 10.1073/pnas.85.19.7054; ELLIS JR, 1985, PLANTA, V165, P120, DOI 10.1007/BF00392220; EPSTEIN WW, 1973, PHYTOCHEMISTRY, V12, P737, DOI 10.1016/0031-9422(73)80670-3; Fisher AJ, 2001, ANAL BIOCHEM, V292, P272, DOI 10.1006/abio.2001.5079; Gao Y, 2012, NAT PROD REP, V29, P1153, DOI 10.1039/c2np20059g; Gilg AB, 2005, P NATL ACAD SCI USA, V102, P9760, DOI 10.1073/pnas.0503277102; Gilg AB, 2009, NATURWISSENSCHAFTEN, V96, P731, DOI 10.1007/s00114-009-0521-1; Green S, 2007, PHYTOCHEMISTRY, V68, P176, DOI 10.1016/j.phytochem.2006.10.017; Hemmerlin A, 2003, J BIOL CHEM, V278, P32132, DOI 10.1074/jbc.M213045200; HUXLEY PA, 1971, J APPL ECOL, V8, P147, DOI 10.2307/2402133; Iwata-Reuyl D, 2003, BIOCHEMISTRY-US, V42, P3359, DOI 10.1021/bi0206614; JONGSMA MA, 1995, P NATL ACAD SCI USA, V92, P8041, DOI 10.1073/pnas.92.17.8041; Kikuta Y, 2012, PLANT J, V71, P183, DOI 10.1111/j.1365-313X.2012.04980.x; Liu PL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-214; Loivamaki M, 2007, PLANT PHYSIOL, V144, P1066, DOI 10.1104/pp.107.098509; Lucker J, 2004, PLANT PHYSIOL, V134, P510, DOI 10.1104/pp.103.030189; Matsuda K, 2005, PHYTOCHEMISTRY, V66, P1529, DOI 10.1016/j.phytochem.2005.05.005; Mrack EM, 1973, PYRETHRUM NATURAL IN, P307; NAKASHIMA T, 1995, P NATL ACAD SCI USA, V92, P2328, DOI 10.1073/pnas.92.6.2328; Ogura K, 1998, CHEM REV, V98, P1263, DOI 10.1021/cr9600464; Orlova I, 2009, PLANT CELL, V21, P4002, DOI 10.1105/tpc.109.071282; Radisky ES, 2000, BIOCHEMISTRY-US, V39, P1748, DOI 10.1021/bi9915014; Ramirez AM, 2012, PLANT CELL, V24, P4252, DOI 10.1105/tpc.112.105031; Rivera SB, 2001, P NATL ACAD SCI USA, V98, P4373, DOI 10.1073/pnas.071543598; Rosenstiel TN, 2002, PLANT PHYSIOL, V129, P1276, DOI 10.1104/pp.002717; SEIICHI F, 1995, BREEDING SCI, V45, P179; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Szkopinska A, 2005, ACTA BIOCHIM POL, V52, P45; Tholl D, 2004, PLANT CELL, V16, P977, DOI 10.1105/tpc.020156; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Tholl Dorothea, 2011, Arabidopsis Book, V9, pe0143, DOI 10.1199/tab.0143; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786; Vickers CE, 2011, PLANT CELL ENVIRON, V34, P1043, DOI 10.1111/j.1365-3040.2011.02303.x; Wang GD, 2009, P NATL ACAD SCI USA, V106, P9914, DOI 10.1073/pnas.0904069106; Wu SQ, 2006, NAT BIOTECHNOL, V24, P1441, DOI 10.1038/nbt1251; Yang T, 2011, METAB ENG, V13, P414, DOI 10.1016/j.ymben.2011.01.011; ZHANG DL, 1993, ARCH BIOCHEM BIOPHYS, V304, P133, DOI 10.1006/abbi.1993.1331	49	28	29	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36325	36335		10.1074/jbc.M114.623348	http://dx.doi.org/10.1074/jbc.M114.623348			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378387	hybrid, Green Published			2022-12-28	WOS:000346897900055
J	Rout, AK; Strub, MP; Piszczek, G; Tjandra, N				Rout, Ashok K.; Strub, Marie-Paule; Piszczek, Grzegorz; Tjandra, Nico			Structure of Transmembrane Domain of Lysosome-associated Membrane Protein Type 2a (LAMP-2A) Reveals Key Features for Substrate Specificity in Chaperone-mediated Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Chaperone; Nuclear Magnetic Resonance (NMR); Protein Structure; Transport; CMA; DPC; LAMP-2; Micelles	TRIPLE-RESONANCE NMR; CYTOSOLIC PROTEINS; ALPHA-SYNUCLEIN; RAT-LIVER; BACKBONE DYNAMICS; RIBONUCLEASE-A; MUTANT UCH-L1; DISEASE; DEGRADATION; MACROAUTOPHAGY	Chaperone-mediated autophagy (CMA) is a highly regulated cellular process that mediates the degradation of a selective subset of cytosolic proteins in lysosomes. Increasing CMA activity is one way for a cell to respond to stress, and it leads to enhanced turnover of non-critical cytosolic proteins into sources of energy or clearance of unwanted or damaged proteins from the cytosol. The lysosome-associated membrane protein type 2a (LAMP-2A) together with a complex of chaperones and co-chaperones are key regulators of CMA. LAMP-2A is a transmembrane protein component for protein translocation to the lysosome. Here we present a study of the structure and dynamics of the transmembrane domain of human LAMP-2A in n-dodecylphosphocholine micelles by nuclear magnetic resonance (NMR). We showed that LAMP-2A exists as a homotrimer in which the membrane-spanning helices wrap around each other to form a parallel coiled coil conformation, whereas its cytosolic tail is flexible and exposed to the cytosol. This cytosolic tail of LAMP-2A interacts with chaperone Hsc70 and a CMA substrate RNase A with comparable affinity but not with Hsp40 and RNase S peptide. Because the substrates and the chaperone complex can bind at the same time, thus creating a bimodal interaction, we propose that substrate recognition by chaperones and targeting to the lysosomal membrane by LAMP-2A are coupled. This can increase substrate affinity and specificity as well as prevent substrate aggregation, assist in the unfolding of the substrate, and promote the formation of the higher order complex of LAMP-2A required for translocation.	[Rout, Ashok K.; Strub, Marie-Paule; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Piszczek, Grzegorz] NHLBI, Biophys Core, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tjandra, N (corresponding author), NHLBI, Lab Mol Biophys, NIH, Bldg 10, Bethesda, MD 20892 USA.	tjandran@nhlbi.nih.gov	Piszczek, Grzegorz/GYU-2029-2022	Rout, Ashok Kumar/0000-0003-1448-300X	Intramural Research Program of the National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001048, ZICHL000338] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the National Institutes of Health, NHLBI.	Agarraberes FA, 2001, J CELL SCI, V114, P2491; Agarraberes FA, 2001, BBA-BIOMEMBRANES, V1513, P1, DOI 10.1016/S0304-4157(01)00005-3; Akasaki K, 1998, BIOCHEM MOL BIOL INT, V46, P197; BACKER JM, 1983, P NATL ACAD SCI-BIOL, V80, P2166, DOI 10.1073/pnas.80.8.2166; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P12, DOI 10.1021/bi00215a002; Cuervo AM, 1998, J MOL MED-JMM, V76, P6, DOI 10.1007/s109-1998-8099-y; CUERVO AM, 1994, J BIOL CHEM, V269, P26374; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2000, J CELL SCI, V113, P4441; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dice J. F., 2000, LYSOSOMAL PATHWAYS P; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Dice JF, 2010, AUTOPHAGY, V6, P320, DOI 10.4161/auto.6.3.11263; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; DICE JF, 1990, CRIT REV THER DRUG, V7, P211; Ellis RJ, 2003, NATURE, V421, P801, DOI 10.1038/421801a; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FLEMING KG, 2008, CURR PROTOC PROTEIN, pCH7; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOUGH NR, 1995, DNA CELL BIOL, V14, P863, DOI 10.1089/dna.1995.14.863; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; HATEM CL, 1995, J CELL SCI, V108, P2093; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Kaushik S, 2012, PHARMACOL RES, V66, P484, DOI 10.1016/j.phrs.2012.10.002; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Kaushik S, 2011, J CELL SCI, V124, P495, DOI 10.1242/jcs.073874; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Keller RLJ, 2004, COMPUTER AIDED NMR R; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2009, AUTOPHAGY, V5, P1079, DOI 10.4161/auto.5.8.9476; Kluger R, 2004, BIOORG CHEM, V32, P451, DOI 10.1016/j.bioorg.2004.08.002; Koga H, 2011, NEUROBIOL DIS, V43, P29, DOI 10.1016/j.nbd.2010.07.006; KONECKI DS, 1995, BIOCHEM BIOPH RES CO, V215, P757, DOI 10.1006/bbrc.1995.2528; KONECKI DS, 1994, BIOCHEM BIOPH RES CO, V205, P1, DOI 10.1006/bbrc.1994.2620; Lustig A, 2000, BBA-BIOMEMBRANES, V1464, P199, DOI 10.1016/S0005-2736(99)00254-0; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Massey A, 2004, INT J BIOCHEM CELL B, V36, P2420, DOI 10.1016/j.biocel.2004.04.010; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Proenca CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068357; Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f; Roche J, 2014, P NATL ACAD SCI USA, V111, P3425, DOI 10.1073/pnas.1401397111; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; TERLECKY SR, 1993, J BIOL CHEM, V268, P23490; TERLECKY SR, 1992, J BIOL CHEM, V267, P9202; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xilouri M, 2008, AUTOPHAGY, V4, P917, DOI 10.4161/auto.6685; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	81	50	52	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35111	35123		10.1074/jbc.M114.609446	http://dx.doi.org/10.1074/jbc.M114.609446			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25342746	Green Published, hybrid			2022-12-28	WOS:000346660200006
J	Yu, SF; Zhang, YN; Yang, BY; Wu, CY				Yu, Si-fei; Zhang, Yan-nan; Yang, Bin-yan; Wu, Chang-you			Human Memory, but Not Naive, CD4(+) T Cells Expressing Transcription Factor T-bet Might Drive Rapid Cytokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cytokine; Immunology; T Helper Cells; Transcription Factor; Memory CD4+T Cells; T-bet; Cytokines	ROR-GAMMA-T; INTERFERON-GAMMA; HELPER-CELLS; TH2 CELLS; EFFECTOR; DIFFERENTIATION; RESPONSES; GENERATION; DIRECTS; RECALL	We found that after stimulation for a few hours, memory but not naive CD4(+) T cells produced a large amount of IFN-; however, the mechanism of rapid response of memory CD4(+) T cells remains undefined. We compared the expression of transcription factors in resting or activated naive and memory CD4(+) T cells and found that T-bet, but not pSTAT-1 or pSTAT-4, was highly expressed in resting memory CD4(+) T cells and that phenotypic characteristics of T-bet(+)CD4(+) T cells were CD45RA(low)CD62L(low) CCR7(low). After short-term stimulation, purified memory CD4(+) T cells rapidly produced effector cytokines that were closely associated with the pre-existence of T-bet. By contrast, resting naive CD4(+) T cells did not express T-bet, and they produced cytokines only after sustained stimulation. Our further studies indicated that T-bet was expressed in the nuclei of resting memory CD4(+) T cells, which might have important implications for rapid IFN- production. Our results indicate that the pre-existence and nuclear mobilization of T-bet in resting memory CD4(+) T cells might be a possible transcriptional mechanism for rapid production of cytokines by human memory CD4(+) T cells.	[Yu, Si-fei; Zhang, Yan-nan; Yang, Bin-yan; Wu, Chang-you] Sun Yat Sen Univ, Inst Immunol, Zhongshan Sch Med, Key Lab Trop Dis Control Res,Minist Educ, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University	Wu, CY (corresponding author), Sun Yat Sen Univ, Inst Immunol, Zhongshan Sch Med, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	changyou_wu@yahoo.com			Guangdong Recruitment Program of Creative Research Groups [2009010058]; National Basic Research Program of China (973) [2013CB531500]	Guangdong Recruitment Program of Creative Research Groups; National Basic Research Program of China (973)(National Basic Research Program of China)	This study was supported by grants from Guangdong Recruitment Program of Creative Research Groups (2009010058) and National Basic Research Program of China Grant 2013CB531500 (973).	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Chandok MR, 2007, J IMMUNOL, V179, P3689, DOI 10.4049/jimmunol.179.6.3689; Dooms H, 2002, NAT IMMUNOL, V3, P797, DOI 10.1038/ni0902-797; Frucht DM, 2000, J IMMUNOL, V164, P4659, DOI 10.4049/jimmunol.164.9.4659; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Joshi NS, 2011, J IMMUNOL, V187, P4068, DOI 10.4049/jimmunol.1002145; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Lai W, 2011, J IMMUNOL, V187, P133, DOI 10.4049/jimmunol.1002742; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Matsuda JL, 2007, J IMMUNOL, V178, P3457, DOI 10.4049/jimmunol.178.6.3457; McGeachy MJ, 2013, J LEUKOCYTE BIOL, V94, P921, DOI 10.1189/jlb.0313113; Mollo SB, 2014, J LEUKOCYTE BIOL, V95, P705, DOI 10.1189/jlb.0813429; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oestreich KJ, 2011, J EXP MED, V208, P1001, DOI 10.1084/jem.20102144; Patke DS, 2005, J IMMUNOL, V174, P5433, DOI 10.4049/jimmunol.174.9.5433; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Wu CY, 2002, NAT IMMUNOL, V3, P852, DOI 10.1038/ni832; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	30	13	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35561	35569		10.1074/jbc.M114.608745	http://dx.doi.org/10.1074/jbc.M114.608745			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25378399	hybrid, Green Published			2022-12-28	WOS:000346660200043
J	Vaidyanathan, K; Wells, L				Vaidyanathan, Krithika; Wells, Lance			Multiple Tissue-specific Roles for the O-GlcNAc Post-translational Modification in the Induction of and Complications Arising from Type II Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Diabetes; Insulin Resistance; O-GlcNAcylation; O-linked N-Acetylglucosamine (O-GlcNAc); Type 2 Diabetes; OGA; OGT; Hexosamine Biosynthetic Pathway	BETA-N-ACETYLGLUCOSAMINIDASE; INSULIN-RESISTANCE; CAENORHABDITIS-ELEGANS; CYTOSOLIC PROTEINS; 3T3-L1 ADIPOCYTES; LINKED GLCNAC; TETRATRICOPEPTIDE REPEATS; HEXOSAMINE BIOSYNTHESIS; MOLECULAR-MECHANISM; ENZYME REGULATION	In this minireview, we will highlight work in the last 30 years that has clearly demonstrated that the O-GlcNAc modification is nutrient-responsive and plays multiple roles in metabolic regulation of signaling and gene expression. Further, we will examine recent studies that have investigated the impact of O-GlcNAc in a variety of glucose- and insulin-responsive tissues and the roles attributed to O-GlcNAc in the induction of insulin resistance and glucose toxicity, the hallmarks of type II diabetes mellitus. We will also summarize potential causal roles for the O-GlcNAc modification in complications associated with diabetes.	Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Wells, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	lwells@ccrc.uga.edu	Vaidyanathan, Krithika/AAN-4574-2020	Wells, Lance/0000-0003-4956-5363	National Institutes of Health through the NIGMS [P41GM103490, P01GM107012]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM107012, P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41GM103490 and P01GM107012 (to L. W.) through the NIGMS. This is the sixth article in the Minireview Series on the Thirtieth Anniversary of Research on O-GlcNAcylation of Nuclear and Cytoplasmic Proteins: Nutrient Regulation of Cellular Metabolism and Physiology by O-GlcNAcylation.	Abdul-Ghani MA, 2013, AM J MANAG CARE, V19, pS43; Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Anthonisen EH, 2010, J BIOL CHEM, V285, P1607, DOI 10.1074/jbc.M109.082685; Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; Beleznai T, 2012, VASC PHARMACOL, V56, P115, DOI 10.1016/j.vph.2011.11.003; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bugger H, 2014, DIABETOLOGIA, V57, P660, DOI 10.1007/s00125-014-3171-6; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP; Dassanayaka S, 2014, PHARMACOL THERAPEUT, V142, P62, DOI 10.1016/j.pharmthera.2013.11.005; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Durgan DJ, 2011, J BIOL CHEM, V286, P44606, DOI 10.1074/jbc.M111.278903; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hanover John A, 2013, Worm, V2, pe27043, DOI 10.4161/worm.27043; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HART GW, 1989, CIBA F SYMP, V145, P102; Hazel M, 2004, ENDOCRINOLOGY, V145, P2118, DOI 10.1210/en.2003-0812; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Kang ES, 2008, EXP CELL RES, V314, P2238, DOI 10.1016/j.yexcr.2008.04.014; KORNFELD R, 1967, J BIOL CHEM, V242, P3135; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lee J, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.022665; Lewis BA, 2013, BBA-GENE REGUL MECH, V1829, P1202, DOI 10.1016/j.bbagrm.2013.09.003; Lim JM, 2008, J PROTEOME RES, V7, P1251, DOI 10.1021/pr7006945; Lim JM, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-20; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Ma JF, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-8; Macauley MS, 2010, CHEM BIOL, V17, P937, DOI 10.1016/j.chembiol.2010.07.006; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; MARSHALL S, 1991, FASEB J, V5, P3031, DOI 10.1096/fasebj.5.15.1743436; McClain DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE973, DOI 10.1152/ajpendo.00549.2004; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; McClain DA, 2002, J DIABETES COMPLICAT, V16, P72, DOI 10.1016/S1056-8727(01)00188-X; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; Nakamura M, 2001, J BIOL CHEM, V276, P43748, DOI 10.1074/jbc.M108594200; Ola MS, 2012, J DIABETES COMPLICAT, V26, P56, DOI 10.1016/j.jdiacomp.2011.11.004; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Park K, 2010, DIABETES, V59, P1845, DOI 10.2337/db09-1086; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Robinson KA, 2007, AM J PHYSIOL-ENDOC M, V292, pE884, DOI 10.1152/ajpendo.00569.2006; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Sun YM, 2013, BIOCHEM BIOPH RES CO, V433, P359, DOI 10.1016/j.bbrc.2013.02.120; Teo CF, 2010, MOL CELL ENDOCRINOL, V318, P44, DOI 10.1016/j.mce.2009.09.022; TORRES CR, 1984, J BIOL CHEM, V259, P3308; TRAXINGER RR, 1991, J BIOL CHEM, V266, P10148; Vaidyanathan K, 2014, CRIT REV BIOCHEM MOL, V49, P140, DOI 10.3109/10409238.2014.884535; Vasudevan KM, 2011, CURR TOP MICROBIOL, V347, P105, DOI 10.1007/82_2010_66; Vocadlo DJ, 2012, CURR OPIN CHEM BIOL, V16, P488, DOI 10.1016/j.cbpa.2012.10.021; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037427; Wang Z, 2009, DIABETES, V58, P309, DOI 10.2337/db08-0994; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zachara NE, 2012, AM J PHYSIOL-HEART C, V302, pH1905, DOI 10.1152/ajpheart.00445.2011	71	67	69	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34466	34471		10.1074/jbc.R114.591560	http://dx.doi.org/10.1074/jbc.R114.591560			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25336652	hybrid, Green Published			2022-12-28	WOS:000346260800007
J	Zhang, XL; Hoey, R; Koide, A; Dolios, G; Paduch, M; Nguyen, P; Wu, XZ; Li, YM; Wagner, SL; Wang, R; Koide, S; Sisodia, SS				Zhang, Xulun; Hoey, Robert; Koide, Akiko; Dolios, Georgia; Paduch, Marcin; Phuong Nguyen; Wu, Xianzhong; Li, Yueming; Wagner, Steven L.; Wang, Rong; Koide, Shohei; Sisodia, Sangram S.			A Synthetic Antibody Fragment Targeting Nicastrin Affects Assembly and Trafficking of gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid Precursor Protein (APP); Cancer; -Secretase; Notch Receptor; Synthetic Antibody	CARBOXYL-TERMINAL FRAGMENT; AMYLOID BETA-PROTEIN; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; INTRACELLULAR DOMAIN; PRESENILIN/GAMMA-SECRETASE; TRANSMEMBRANE ASPARTATES; NOTCH; COMPLEX; ENDOPROTEOLYSIS	Background: -Secretase is critical in Notch signaling and Alzheimer disease. Results: Coexpression of a nicastrin antibody affects maturation and trafficking of -secretase and alters Notch and APP processing. Conclusion: Nicastrin is a feasible target for modulating the targeting and substrate specificity of -secretase. Significance: Modulation of -secretase through nicastrin may be of therapeutic value in cancer and Alzheimer disease. The -secretase complex, composed of presenilin, nicastrin (NCT), anterior pharynx-defective 1 (APH-1), and presenilin enhancer 2 (PEN-2), is assembled in a highly regulated manner and catalyzes the intramembranous proteolysis of many type I membrane proteins, including Notch and amyloid precursor protein. The Notch family of receptors plays important roles in cell fate specification during development and in adult tissues, and aberrant hyperactive Notch signaling causes some forms of cancer. -Secretase-mediated processing of Notch at the cell surface results in the generation of the Notch intracellular domain, which associates with several transcriptional coactivators involved in nuclear signaling events. On the other hand, -secretase-mediated processing of amyloid precursor protein leads to the production of amyloid (A) peptides that play an important role in the pathogenesis of Alzheimer disease. We used a phage display approach to identify synthetic antibodies that specifically target NCT and expressed them in the single-chain variable fragment (scFv) format in mammalian cells. We show that expression of a NCT-specific scFv clone, G9, in HEK293 cells decreased the production of the Notch intracellular domain but not the production of amyloid peptides that occurs in endosomal and recycling compartments. Biochemical studies revealed that scFvG9 impairs the maturation of NCT by associating with immature forms of NCT and, consequently, prevents its association with the other components of the -secretase complex, leading to degradation of these molecules. The reduced cell surface levels of mature -secretase complexes, in turn, compromise the intramembranous processing of Notch.	[Zhang, Xulun; Sisodia, Sangram S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Hoey, Robert; Koide, Akiko; Paduch, Marcin; Koide, Shohei] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Dolios, Georgia; Wang, Rong] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Phuong Nguyen; Wagner, Steven L.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Wu, Xianzhong; Li, Yueming] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA	University of Chicago; University of Chicago; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Diego; Memorial Sloan Kettering Cancer Center	Sisodia, SS (corresponding author), Univ Chicago, Dept Neurobiol, 947 E 58th St,MC0928, Chicago, IL 60637 USA.	ssisodia@bsd.uchicago.edu	LI, Yue/GRS-8071-2022	Koide, Shohei/0000-0001-5473-4358	National Institutes of Health [P30 NS061777, S10 RR022415, U01 NS074501, R01AG026660, U54-GM087519, R01-GM072688]; Adler Foundation; Edward H. Levy Fund; Alzheimer's Association; American Health Assistance Foundation; Cure Alzheimer's Fund; University of Chicago Comprehensive Cancer Center; Eisai Research Labs Inc.; AZ Therapies Inc.; Jannsen Pharmaceutica NV; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072688, U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061777, U01NS074501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Adler Foundation; Edward H. Levy Fund; Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation(BrightFocus Foundation); Cure Alzheimer's Fund; University of Chicago Comprehensive Cancer Center; Eisai Research Labs Inc.; AZ Therapies Inc.; Jannsen Pharmaceutica NV; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 NS061777 and S10 RR022415 (to R. W.), U01 NS074501 (to S. L. W.), R01AG026660 (to Y. L.), and U54-GM087519 and R01-GM072688 (to S. K.). This work was also supported by the Adler Foundation, by the Edward H. Levy Fund, by the Alzheimer's Association, by the American Health Assistance Foundation, and by the Cure Alzheimer's Fund (to S. S. S.), and by the University of Chicago Comprehensive Cancer Center (to S. K.). S. S. S. is a paid consultant of Eisai Research Labs Inc., AZ Therapies Inc., and Jannsen Pharmaceutica NV but is not a shareholder in any company that is a maker or owner of an FDA-regulated drug or device.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Capaccione KM, 2013, CARCINOGENESIS, V34, P1420, DOI 10.1093/carcin/bgt127; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; Crump CJ, 2013, BIOCHEMISTRY-US, V52, P3197, DOI 10.1021/bi400377p; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Filipovic A, 2011, BREAST CANCER RES TR, V125, P43, DOI 10.1007/s10549-010-0823-1; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Gersbacher MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069363; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hayashi I, 2012, ONCOGENE, V31, P787, DOI 10.1038/onc.2011.265; Hayashi I, 2009, J BIOL CHEM, V284, P27838, DOI 10.1074/jbc.M109.055061; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Hecimovic S, 2004, NEUROBIOL DIS, V17, P205, DOI 10.1016/j.nbd.2004.04.018; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hu Y, 2003, J CELL BIOL, V161, P685, DOI 10.1083/jcb.200304014; Hust M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-14; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kim SH, 2005, J BIOL CHEM, V280, P1992, DOI 10.1074/jbc.M412404200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kulic L, 2000, P NATL ACAD SCI USA, V97, P5913, DOI 10.1073/pnas.100049897; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Martys-Zage JL, 2000, J MOL NEUROSCI, V15, P189, DOI 10.1385/JMN:15:3:189; Miller KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043746; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Renzi F, 2011, J BIOL CHEM, V286, P21440, DOI 10.1074/jbc.M110.193326; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Uljon SN, 2000, METH MOL B, V146, P439, DOI 10.1385/1-59259-045-4:439; Wolfe MS, 2013, BBA-BIOMEMBRANES, V1828, P2886, DOI 10.1016/j.bbamem.2013.04.015; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xie T, 2014, P NATL ACAD SCI USA, V111, P13349, DOI 10.1073/pnas.1414837111; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P8534, DOI 10.1073/pnas.1202691109	50	4	5	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34851	34861		10.1074/jbc.M114.609636	http://dx.doi.org/10.1074/jbc.M114.609636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25352592	hybrid, Green Published			2022-12-28	WOS:000346260800036
J	Peng, HM; Liu, JY; Forsberg, SE; Tran, HT; Anderson, SM; Auchus, RJ				Peng, Hwei-Ming; Liu, Jiayan; Forsberg, Sarah E.; Tran, Hong T.; Anderson, Sean M.; Auchus, Richard J.			Catalytically Relevant Electrostatic Interactions of Cytochrome P450c17 (CYP17A1) and Cytochrome b(5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Androgen; Cytochrome P450; Mass Spectrometry (MS); Protein Cross-linking; Steroidogenesis; CYP17A1; Cytochrome b5	ISOLATED 17,20-LYASE DEFICIENCY; PROTEIN-PROTEIN DOCKING; PROSTATE-CANCER; ABIRATERONE ACETATE; MASS-SPECTROMETRY; REDOX PARTNERS; WEB SERVER; MUTATION; OXIDOREDUCTASE; HADDOCK	Background: Cytochrome b(5) (b(5)) stimulates the 17,20-lyase activity of cytochrome P450c17 (CYP17A1). Results: A carboxylate group in b(5) residues Glu-48/Glu-49 is required for 17,20-lyase activity, and cross-linked peptides Lys-88(CYP17A1)-Glu-61(b(5)) and Lys-347(CYP17A1R347K)Glu-42(b(5)) involve adjacent residues. Conclusion: These data support a molecular model of a CYP17A1-b(5) complex. Significance: The CYP17A1-b(5) interaction site might be a drug target to inhibit androgen synthesis. Two acidic residues, Glu-48 and Glu-49, of cytochrome b(5) (b(5)) are essential for stimulating the 17,20-lyase activity of cytochrome P450c17 (CYP17A1). Substitution of Ala, Gly, Cys, or Gln for these two glutamic acid residues abrogated all capacity to stimulate 17,20-lyase activity. Mutations E49D and E48D/E49D retained 23 and 38% of wild-type activity, respectively. Using the zero-length cross-linker ethyl-3-(3-dimethylaminopropyl)carbodiimide, we obtained cross-linked heterodimers of b(5) and CYP17A1, wild-type, or mutations R347K and R358K. In sharp contrast, the b(5) double mutation E48G/E49G did not form cross-linked complexes with wild-type CYP17A1. Mass spectrometric analysis of the CYP17A1-b(5) complexes identified two cross-linked peptide pairs as follows: CYP17A1-WT: (EVLIKK89)-E-84-b(5): (53)EQAGGDATENFEDVGHSTDAR(73) and CYP17A1-R347K: (TPTISDKNR349)-T-341-b(5): (40)FLEEHPGGEEVLR(52). Using these two sites of interaction and Glu-48/Glu-49 in b(5) as constraints, protein docking calculations based on the crystal structures of the two proteins yielded a structural model of the CYP17A1-b(5) complex. The appositional surfaces include Lys-88, Arg-347, and Arg-358/Arg-449 of CYP17A1, which interact with Glu-61, Glu-42, and Glu-48/Glu-49 of b(5), respectively. Our data reveal the structural basis of the electrostatic interactions between these two proteins, which is critical for 17,20-lyase activity and androgen biosynthesis.	[Peng, Hwei-Ming; Liu, Jiayan; Forsberg, Sarah E.; Anderson, Sean M.; Auchus, Richard J.] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Tran, Hong T.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Auchus, Richard J.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Auchus, RJ (corresponding author), Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	rauchus@med.umich.edu			National Institutes of Health [R01-GM086596-04]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM086596-04.	Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Attard G, 2012, J CLIN ENDOCR METAB, V97, P507, DOI 10.1210/jc.2011-2189; Auchus ML, 2012, J INVEST MED, V60, P495, DOI 10.2310/JIM.0b013e3182408567; Auchus RJ, 2014, J CLIN ENDOCR METAB, V99, P2763, DOI 10.1210/jc.2014-1258; Auchus RJ, 1999, MOL ENDOCRINOL, V13, P1169, DOI 10.1210/me.13.7.1169; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dehouck Y, 2013, NUCLEIC ACIDS RES, V41, pW333, DOI 10.1093/nar/gkt450; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Friberg A, 2013, J MED CHEM, V56, P15, DOI 10.1021/jm301448p; Gao QX, 2006, J BIOL CHEM, V281, P20404, DOI 10.1074/jbc.M601785200; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Handratta VD, 2005, J MED CHEM, V48, P2972, DOI 10.1021/jm040202w; Hershkovitz E, 2008, J CLIN ENDOCR METAB, V93, P3584, DOI 10.1210/jc.2008-0051; Hlavica P, 2003, J INORG BIOCHEM, V96, P279, DOI 10.1016/S0162-0134(03)00152-1; Idkowiak J, 2012, J CLIN ENDOCR METAB, V97, pE465, DOI 10.1210/jc.2011-2413; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; KATER CE, 1994, ENDOCRIN METAB CLIN, V23, P341, DOI 10.1016/S0889-8529(18)30101-4; Kok RC, 2010, J CLIN ENDOCR METAB, V95, P994, DOI 10.1210/jc.2008-1745; Lee-Robichaud P, 2004, J STEROID BIOCHEM, V92, P119, DOI 10.1016/j.jsbmb.2004.07.005; LeeRobichaud P, 1997, BIOCHEM J, V321, P857, DOI 10.1042/bj3210857; Lewis DFV, 1998, J STEROID BIOCHEM, V66, P217, DOI 10.1016/S0960-0760(98)00032-6; Li WZ, 2012, BIOINFORMATICS, V28, P2548, DOI 10.1093/bioinformatics/bts442; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Miller WL, 1997, STEROIDS, V62, P133, DOI 10.1016/S0039-128X(96)00172-9; Mostaghel EA, 2008, BEST PRACT RES CL EN, V22, P243, DOI 10.1016/j.beem.2008.01.003; Mulrooney SB, 2000, PROTEIN EXPRES PURIF, V19, P173, DOI 10.1006/prep.2000.1228; Naffin-Olivos JL, 2006, BIOCHEMISTRY-US, V45, P755, DOI 10.1021/bi051623y; Pandey MK, 2013, J PHYS CHEM B, V117, P13851, DOI 10.1021/jp4086206; Peng HM, 2014, ARCH BIOCHEM BIOPHYS, V541, P53, DOI 10.1016/j.abb.2013.11.001; Peng HM, 2013, BIOCHEMISTRY-US, V52, P210, DOI 10.1021/bi301384n; Sandee D, 2011, ENDOCRINOLOGY, V152, P2904, DOI 10.1210/en.2011-0230; Schweizer MT, 2012, THER ADV UROL, V4, P167, DOI 10.1177/1756287212452196; Sherbet DP, 2003, J BIOL CHEM, V278, P48563, DOI 10.1074/jbc.M307586200; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Yoshimoto FK, 2012, BIOCHEMISTRY-US, V51, P7064, DOI 10.1021/bi300895w; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r	42	25	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33838	33849		10.1074/jbc.M114.608919	http://dx.doi.org/10.1074/jbc.M114.608919			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25315771	Green Published, hybrid			2022-12-28	WOS:000346077600011
J	Queval, R; Papin, C; Dalvai, M; Bystricky, K; Humbert, O				Queval, Richard; Papin, Christophe; Dalvai, Mathieu; Bystricky, Kerstin; Humbert, Odile			Reptin and Pontin Oligomerization and Activity Are Modulated through Histone H3 N-terminal Tail Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; Chromatin Remodeling; Histone Modification; Protein Conformation; Protein; DNA Interaction; Pontin; RUVBL1; Reptin; RUVBL2	CHROMATIN-REMODELING COMPLEX; NUCLEOSOME CORE PARTICLE; DNA-BINDING DOMAIN; CRYSTAL-STRUCTURE; PROTEIN RUVBL1; TRANSCRIPTION; EXCHANGE; TIP60; ARCHITECTURE; RESOLUTION	Background: Pontin and Reptin are main components of remodeling complexes responsible for chromatin dynamics. Results: These ATPases interact with the chromatin basic unit, the nucleosome, which regulates Pontin/Reptin enzymatic activities and oligomerization assemblies. Conclusion: By means of this interaction, pontin/reptin generate a loading platform that coordinates assembly of cofactors onto chromatin. Significance: Pontin/Reptin monomeric and multimeric forms control DNA metabolism. Pontin/RUVBL1 and Reptin/RUVBL2 are DNA-dependent ATPases involved in numerous cellular processes and are essential components of chromatin remodeling complexes and transcription factor assemblies. However, their existence as monomeric and oligomeric forms with differential activity in vivo reflects their versatility. Using a biochemical approach, we have studied the role of the nucleosome core particle and histone N-terminal tail modifications in the assembly and enzymatic activities of Reptin/Pontin. We demonstrate that purified Reptin and Pontin form stable complexes with nucleosomes. The ATPase activity of Reptin/Pontin is modulated by acetylation and methylation of the histone H3 N terminus. In vivo, association of Reptin with the progesterone receptor gene promoter is concomitant with changes in H3 marks of the surrounding nucleosomes. Furthermore, the presence of H3 tail peptides regulates the monomer-oligomer transition of Reptin/Pontin. Proteins that are pulled down by monomeric Reptin/Pontin differ from those that can bind to hexamers. We propose that changes in the oligomeric status of Reptin/Pontin create a platform that brings specific cofactors close to gene promoters and loads regulatory factors to establish an active state of chromatin.	[Queval, Richard; Dalvai, Mathieu; Bystricky, Kerstin; Humbert, Odile] CNRS, UMR 5099, Lab Biol Mol Eucaryote, F-31062 Toulouse, France; [Queval, Richard; Dalvai, Mathieu; Bystricky, Kerstin; Humbert, Odile] Univ Toulouse, UPS, F-31062 Toulouse, France; [Papin, Christophe] Univ Strasbourg, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Humbert, O (corresponding author), CNRS, UMR 5099, Lab Biol Mol Eucaryote, 118 Route Narbonne, F-31062 Toulouse, France.	odile.humbert@ibcg.biotoul.fr	Bystricky, Kerstin/AAA-3003-2020; BYSTRICKY, Kerstin/B-8670-2009	Bystricky, Kerstin/0000-0001-6717-3721; BYSTRICKY, Kerstin/0000-0001-6717-3721; Papin, Christophe/0000-0001-8124-5883	Centre National de la Recherche Scientifique; French Ministry for Research; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French Ministry for Research(Ministry of Research, France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported in part by the Centre National de la Recherche Scientifique.; Recipient of Ph.D. fellowships from the French Ministry for Research.; Recipient of a fellowship from the Fondation pour la Recherche Medicale.	Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Cheung KLY, 2010, J MOL BIOL, V404, P478, DOI 10.1016/j.jmb.2010.10.003; Cheung KLY, 2010, BIOCHEM CELL BIOL, V88, P77, DOI [10.1139/O09-159, 10.1139/o09-159]; Choi J, 2009, NUCLEIC ACIDS RES, V37, P5993, DOI 10.1093/nar/gkp660; Clark NJ, 2012, J BIOL CHEM, V287, P32430, DOI 10.1074/jbc.M112.397067; Dalvai M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003387; Diop SB, 2008, EMBO REP, V9, P260, DOI 10.1038/embor.2008.8; Elkaim J, 2012, BIOCHEM J, V443, P549, DOI 10.1042/BJ20111779; Ettig R, 2011, BIOPHYS J, V101, P1999, DOI 10.1016/j.bpj.2011.07.057; Fleury L, 2008, ONCOGENE, V27, P4075, DOI 10.1038/onc.2008.41; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Gribun A, 2008, J MOL BIOL, V376, P1320, DOI 10.1016/j.jmb.2007.12.049; Grigoletto A, 2011, BBA-REV CANCER, V1815, P147, DOI 10.1016/j.bbcan.2010.11.002; Grigoriev M, 1997, MOL CELL BIOL, V17, P7139, DOI 10.1128/MCB.17.12.7139; Hamiche A, 2004, METHOD ENZYMOL, V377, P353; Haurie V, 2009, HEPATOLOGY, V50, P1871, DOI 10.1002/hep.23215; Huen J, 2010, BIOCHEM CELL BIOL, V88, P29, DOI [10.1139/o09-122, 10.1139/O09-122]; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Jha S, 2013, MOL CELL BIOL, V33, P1164, DOI 10.1128/MCB.01567-12; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; Kanemaki M, 1997, BIOCHEM BIOPH RES CO, V235, P64, DOI 10.1006/bbrc.1997.6729; Lopez-Perrote A, 2012, NUCLEIC ACIDS RES, V40, P11086, DOI 10.1093/nar/gks871; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Nguyen VQ, 2013, CELL, V154, P1220, DOI 10.1016/j.cell.2013.08.018; Niewiarowski A, 2010, BIOCHEM J, V429, P113, DOI 10.1042/BJ20100489; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Papin C, 2010, FEBS J, V277, P2705, DOI [10.1111/j.1742-4658.2010.07687.x, 10.1111/j.1742-464X.2010.07687.x]; Petukhov M, 2012, STRUCTURE, V20, P1321, DOI 10.1016/j.str.2012.05.012; Pinnola A, 2007, J BIOL CHEM, V282, P32511, DOI 10.1074/jbc.M705989200; Puri T, 2007, J MOL BIOL, V366, P179, DOI 10.1016/j.jmb.2006.11.030; Qiu XB, 1998, J BIOL CHEM, V273, P27786, DOI 10.1074/jbc.273.43.27786; Rosenbaum J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003906; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Torreira E, 2008, STRUCTURE, V16, P1511, DOI 10.1016/j.str.2008.08.009; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; Udugama M, 2011, MOL CELL BIOL, V31, P662, DOI 10.1128/MCB.01035-10; Weiske J, 2005, J CELL SCI, V118, P3117, DOI 10.1242/jcs.02437; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yen KY, 2013, CELL, V154, P1246, DOI 10.1016/j.cell.2013.08.043; Zheng CY, 2003, BIOPOLYMERS, V68, P539, DOI 10.1002/bip.10303	49	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33999	34012		10.1074/jbc.M114.576785	http://dx.doi.org/10.1074/jbc.M114.576785			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25336637	hybrid, Green Published			2022-12-28	WOS:000346077600027
J	Hinz, A; Jedamzick, J; Herbring, V; Fischbach, H; Hartmann, J; Parcej, D; Koch, J; Tampe, R				Hinz, Andreas; Jedamzick, Johanna; Herbring, Valentina; Fischbach, Hanna; Hartmann, Jessica; Parcej, David; Koch, Joachim; Tampe, Robert			Assembly and Function of the Major Histocompatibility Complex (MHC) I Peptide-loading Complex Are Conserved Across Higher Vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN-PROCESSING TAP; ALLELIC VARIATION; ABC TRANSPORTER; MOLECULE; BINDING; TAPASIN; GENES; IDENTIFICATION; COEVOLUTION; INHIBITION	Antigen presentation to cytotoxic T lymphocytes via major histocompatibility complex class I (MHC I) molecules depends on the heterodimeric transporter associated with antigen processing (TAP). For efficient antigen supply to MHCI molecules in the ER, TAP assembles a macromolecular peptide-loading complex (PLC) by recruiting tapasin. In evolution, TAP appeared together with effector cells of adaptive immunity at the transition from jawless to jawed vertebrates and diversified further within the jawed vertebrates. Here, we compared TAP function and interaction with tapasin of a range of species within two classes of jawed vertebrates. We found that avian and mammalian TAP1 and TAP2 form heterodimeric complexes across taxa. Moreover, the extra N-terminal domain TMD0 of mammalian TAP1 and TAP2 as well as avian TAP2 recruits tapasin. Strikingly, however, only TAP1 and TAP2 from the same taxon can form a functional heterodimeric translocation complex. These data demonstrate that the dimerization interface between TAP1 and TAP2 and the tapasin docking sites for PLC assembly are conserved in evolution, whereas elements of antigen translocation diverged later in evolution and are thus taxon specific.	[Hinz, Andreas; Jedamzick, Johanna; Herbring, Valentina; Fischbach, Hanna; Parcej, David; Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany; [Tampe, Robert] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60438 Frankfurt, Germany; [Hartmann, Jessica; Koch, Joachim] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, D-60596 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Octapharma	Tampe, R (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Bioctr, Max von Laue Str 9, D-60438 Frankfurt, Germany.	tampe@em.uni-frankfurt.de	Hartmann, Jessica/AAL-8849-2021; Parcej, David/AAW-7306-2020; Tampé, Robert/H-2953-2015	Hartmann, Jessica/0000-0001-9372-8954; Tampé, Robert/0000-0002-0403-2160	The German Research Foundation [SFB 807]; European Drug Initiative on Channels and Transporters (EDICT) - European Commission Seventh Framework Program	The German Research Foundation(German Research Foundation (DFG)); European Drug Initiative on Channels and Transporters (EDICT) - European Commission Seventh Framework Program	This work was supported by The German Research Foundation (SFB 807-Transport and Communication across Biological Membranes, to R. T.) and the European Drug Initiative on Channels and Transporters (EDICT, to R. T.) funded by the European Commission Seventh Framework Program.	Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Dalmas O, 2005, J BIOL CHEM, V280, P36857, DOI 10.1074/jbc.M503266200; de la Salle H, 1999, J CLIN INVEST, V103, pR9, DOI 10.1172/JCI5687; DELASALLE H, 1994, SCIENCE, V265, P237, DOI 10.1126/science.7517574; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Gojanovich GS, 2013, DEV COMP IMMUNOL, V41, P578, DOI 10.1016/j.dci.2013.07.011; Grossmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6419; HEEMELS MT, 1994, IMMUNITY, V1, P775, DOI 10.1016/S1074-7613(94)80019-7; Heintke S, 2003, FEBS LETT, V533, P42, DOI 10.1016/S0014-5793(02)03746-8; Hewitt EW, 2001, EMBO J, V20, P387, DOI 10.1093/emboj/20.3.387; Hulpke S, 2013, TRENDS BIOCHEM SCI, V38, P412, DOI 10.1016/j.tibs.2013.06.003; Hulpke S, 2012, FASEB J, V26, P5071, DOI 10.1096/fj.12-217489; Hulpke S, 2012, CELL MOL LIFE SCI, V69, P3317, DOI 10.1007/s00018-012-1005-6; Kaufman J, 2013, MOL IMMUNOL, V55, P159, DOI 10.1016/j.molimm.2012.10.030; Koch J, 2005, FEBS LETT, V579, P4413, DOI 10.1016/j.febslet.2005.07.006; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Kyritsis C, 2001, J BIOL CHEM, V276, P48031, DOI 10.1074/jbc.M108528200; Laud PR, 1996, HUM IMMUNOL, V50, P91, DOI 10.1016/0198-8859(96)00137-1; LIVINGSTONE AM, 1991, IMMUNOGENETICS, V34, P157, DOI 10.1007/BF00205818; Loflin PT, 1996, IMMUNOGENETICS, V44, P161; Marusina K, 1997, J IMMUNOL, V158, P5251; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Panter MS, 2012, J BIOL CHEM, V287, P31172, DOI 10.1074/jbc.M112.387704; Parcej D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067112; Parcej D, 2010, NAT CHEM BIOL, V6, P572, DOI [10.1038/NCHEMBIO.410, 10.1038/nchembio.410]; Pinto RD, 2011, DEV COMP IMMUNOL, V35, P1173, DOI 10.1016/j.dci.2011.03.024; Procko E, 2005, IMMUNOL CELL BIOL, V83, P475, DOI 10.1111/j.1440-1711.2005.01354.x; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; van Hateren A, 2013, J BIOL CHEM, V288, P32797, DOI 10.1074/jbc.M113.474031; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; Walker BA, 2011, P NATL ACAD SCI USA, V108, P8396, DOI 10.1073/pnas.1019496108; Wycisk AI, 2011, J BIOL CHEM, V286, P41402, DOI 10.1074/jbc.M111.237784	36	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33109	33117		10.1074/jbc.M114.609263	http://dx.doi.org/10.1074/jbc.M114.609263			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25320083	hybrid, Green Published			2022-12-28	WOS:000345636600005
J	Horbelt, D; Boergermann, JH; Chaikuad, A; Alfano, I; Williams, E; Lukonin, I; Timmel, T; Bullock, AN; Knaus, P				Horbelt, Daniel; Boergermann, Jan H.; Chaikuad, Apirat; Alfano, Ivan; Williams, Eleanor; Lukonin, Ilya; Timmel, Tobias; Bullock, Alex N.; Knaus, Petra			Small Molecules Dorsomorphin and LDN-193189 Inhibit Myostatin/GDF8 Signaling and Promote Functional Myoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; GROSS MUSCLE HYPERTROPHY; TGF-BETA; SKELETAL-MUSCLE; SMAD1/5 PHOSPHORYLATION; CRYSTAL-STRUCTURE; RECEPTOR; MUTATION; DOMAIN; MASS	GDF8, or myostatin, is a member of the TGF-beta superfamily of secreted polypeptide growth factors. GDF8 is a potent negative regulator of myogenesis both in vivo and in vitro. We found that GDF8 signaling was inhibited by the small molecule ATP competitive inhibitors dorsomorphin and LDN-193189. These compounds were previously shown to be potent inhibitors of BMP signaling by binding to the BMP type I receptors ALK1/2/3/6. We present the crystal structure of the type II receptor ActRIIA with dorsomorphin and demonstrate that dorsomorphin or LDN-193189 target GDF8 induced Smad2/3 signaling and repression of myogenic transcription factors. As a result, both inhibitors rescued myogenesis in myoblasts treated with GDF8. As revealed by quantitative live cell microscopy, treatment with dorsomorphin or LDN-193189 promoted the contractile activity of myotubular networks in vitro. We therefore suggest these inhibitors as suitable tools to promote functional myogenesis.	[Horbelt, Daniel; Boergermann, Jan H.; Lukonin, Ilya; Knaus, Petra] Free Univ Berlin, Inst Chem Biochem, D-14195 Berlin, Germany; [Chaikuad, Apirat; Alfano, Ivan; Williams, Eleanor; Bullock, Alex N.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Timmel, Tobias] Expt & Clin Res Ctr, Muscle Res Unit, D-13125 Berlin, Germany	Free University of Berlin; University of Oxford	Knaus, P (corresponding author), Free Univ Berlin, Inst Chem Biochem, D-14195 Berlin, Germany.	knaus@chemie.fu-berlin.de	Williams, Eleanor/AAL-9937-2021	Chaikuad, Apirat/0000-0003-1120-2209	Freie Universitat Berlin; Myograd Program Grant [GK1631]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]	Freie Universitat Berlin; Myograd Program Grant; AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by an FK grant from the Freie Universitat Berlin (to P. K.) and Myograd Program Grant GK1631 (to P. K. and T. T.). The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust (Grant 092809/Z/10/Z).	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Amthor H, 2002, DEV BIOL, V251, P241, DOI 10.1006/dbio.2002.0812; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Artaza JN, 2002, J CELL PHYSIOL, V190, P170, DOI 10.1002/JCP.10044; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berardi E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00119; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P3822, DOI 10.1073/pnas.88.9.3822; Cash JN, 2009, EMBO J, V28, P2662, DOI 10.1038/emboj.2009.205; Chaikuad A, 2012, J BIOL CHEM, V287, P36990, DOI 10.1074/jbc.M112.365932; Chinga G, 2007, NORD PULP PAP RES J, V22, P441, DOI 10.3183/npprj-2007-22-04-p441-446; Cooper ST, 2004, CELL MOTIL CYTOSKEL, V58, P200, DOI 10.1002/cm.20010; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Durieux AC, 2007, ENDOCRINOLOGY, V148, P3140, DOI 10.1210/en.2006-1500; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engers DW, 2013, BIOORG MED CHEM LETT, V23, P3248, DOI 10.1016/j.bmcl.2013.03.113; Furutani Y, 2011, J CELL BIOCHEM, V112, P614, DOI 10.1002/jcb.22953; Greenwald J, 1999, NAT STRUCT BIOL, V6, P18; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Han S, 2007, PROTEIN SCI, V16, P2272, DOI 10.1110/ps.073068407; Hennebry A, 2009, AM J PHYSIOL-CELL PH, V296, pC525, DOI 10.1152/ajpcell.00259.2007; Hong CC, 2009, CYTOKINE GROWTH F R, V20, P409, DOI 10.1016/j.cytogfr.2009.10.021; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Johnson PL, 2005, J ANIM SCI, V83, P1988; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McFarlane C, 2011, AM J PHYSIOL-CELL PH, V301, pC195, DOI 10.1152/ajpcell.00012.2011; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mohedas AH, 2013, ACS CHEM BIOL, V8, P1291, DOI 10.1021/cb300655w; Mouisel E, 2014, AM J PHYSIOL-REG I, V307, pR444, DOI 10.1152/ajpregu.00377.2013; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Philippi Susanne, 2012, PLoS Curr, V4, pRRN1298, DOI 10.1371/currents.RRN1298; Qaisar R, 2012, FASEB J, V26, P1077, DOI 10.1096/fj.11-192195; Relizani K, 2014, MOL THER, V22, P1423, DOI 10.1038/mt.2014.90; Rodgers BD, 2014, ENDOCRINOLOGY, V155, P670, DOI 10.1210/en.2013-2107; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Sanvitale CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062721; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Schwaerzer GK, 2012, J BONE MINER RES, V27, P429, DOI 10.1002/jbmr.532; Shelton GD, 2007, NEUROMUSCULAR DISORD, V17, P721, DOI 10.1016/j.nmd.2007.06.008; Shi S, 2011, NEUROBIOL DIS, V41, P353, DOI 10.1016/j.nbd.2010.10.003; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; VAIDYA TB, 1989, MOL CELL BIOL, V9, P3576, DOI 10.1128/MCB.9.8.3576; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Wang Y, 2014, ENDOCRINOLOGY, V155, P1970, DOI 10.1210/en.2013-1741; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zuccotto F, 2010, J MED CHEM, V53, P2681, DOI 10.1021/jm901443h	74	39	42	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3390	3404		10.1074/jbc.M114.604397	http://dx.doi.org/10.1074/jbc.M114.604397			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25368322	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000349456000016
J	Colussi, F; Sorensen, TH; Alasepp, K; Kari, J; Cruys-Bagger, N; Windahl, MS; Olsen, JP; Borch, K; Westh, P				Colussi, Francieli; Sorensen, Trine H.; Alasepp, Kadri; Kari, Jeppe; Cruys-Bagger, Nicolaj; Windahl, Michael S.; Olsen, Johan P.; Borch, Kim; Westh, Peter			Probing Substrate Interactions in the Active Tunnel of a Catalytically Deficient Cellobiohydrolase (Cel7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULOSE-BINDING DOMAIN; TRICHODERMA-REESEI CELLOBIOHYDROLASES; HEAT-CAPACITY CHANGES; CRYSTAL-STRUCTURES; FREE-ENERGY; MICROCRYSTALLINE CELLULOSE; ENZYMATIC-HYDROLYSIS; GLYCOSIDE HYDROLASES; CELLULASES; PROTEIN	Cellobiohydrolases break down cellulose sequentially by sliding along the crystal surface with a single cellulose strand threaded through the catalytic tunnel of the enzyme. This so-called processive mechanism relies on a complex pattern of enzyme-substrate interactions, which need to be addressed in molecular descriptions of processivity and its driving forces. Here, we have used titration calorimetry to study interactions of cellooligosaccharides (COS) and a catalytically deficient variant (E212Q) of the enzyme Cel7A from Trichoderma reesei. This enzyme has similar to 10 glucopyranose subsites in the catalytic tunnel, and using COS ligands with a degree of polymerization (DP) from 2 to 8, different regions of the tunnel could be probed. For COS ligands with a DP of 2-3 the binding constants were around 10(5) M-1, and for longer ligands (DP 5-8) this value was similar to 10(7) M-1. Within each of these groups we did not find increased affinity as the ligands got longer and potentially filled more subsites. On the contrary, we found a small but consistent affinity loss as DP rose from 6 to 8, particularly at the higher investigated temperatures. Other thermodynamic functions (Delta H, Delta S, and Delta C-p) decreased monotonously with both temperature and DP. Combined interpretation of these thermodynamic results and previously published structural data allowed assessment of an affinity profile along the length axis of the active tunnel.	[Colussi, Francieli; Sorensen, Trine H.; Alasepp, Kadri; Kari, Jeppe; Cruys-Bagger, Nicolaj; Windahl, Michael S.; Olsen, Johan P.; Westh, Peter] Roskilde Univ, NSM, Res Unit Funct Biomat, DK-4000 Roskilde, Denmark; [Windahl, Michael S.; Borch, Kim] Novozymes AS, DK-2880 Bagsvaerd, Denmark	Roskilde University; Novozymes	Westh, P (corresponding author), Roskilde Univ, NSM, Res Unit Funct Biomat, 1 Univ Vej,Bldg 28, DK-4000 Roskilde, Denmark.	pwesth@ruc.dk	Olsen, Johan/A-5599-2016; Kari, Jeppe/AAP-6649-2021; Westh, Peter/AAR-9731-2021; Colussi, Francieli/J-9166-2016	Olsen, Johan/0000-0002-1383-8318; Kari, Jeppe/0000-0003-3792-3856; Westh, Peter/0000-0002-6185-0637; Windahl, Michael Skovbo/0000-0002-0572-3115; Colussi, Francieli/0000-0002-4392-767X; Sorensen, Trine Holst/0000-0002-2045-7580	Danish Council for Strategic Research; Program Commission on Sustainable Energy and Environment Grant [21 04-07-0028, 11-116772]; Carlsberg Foundation [2013-01-0208]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Program Commission on Sustainable Energy and Environment Grant; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by the Danish Council for Strategic Research, Program Commission on Sustainable Energy and Environment Grant 21 04-07-0028 and 11-116772 (to P. W.) and by Carlsberg Foundation Grant 2013-01-0208 (to P. W.).	Alasepp K, 2014, LANGMUIR, V30, P7134, DOI 10.1021/la500161e; Baranauskiene L, 2009, INT J MOL SCI, V10, P2752, DOI 10.3390/ijms10062752; Barnett CB, 2010, J AM CHEM SOC, V132, P12800, DOI 10.1021/ja103766w; Baumann MJ, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-45; Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Bommarius AS, 2014, CURR OPIN BIOTECH, V29, P139, DOI 10.1016/j.copbio.2014.04.007; Borch K., 2014, WIPO patent, Patent No. 2014138672; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; CABANI S, 1981, J SOLUTION CHEM, V10, P563, DOI 10.1007/BF00646936; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; CLAEYSSENS M, 1989, BIOCHEM J, V261, P819, DOI 10.1042/bj2610819; CLARKE ECW, 1966, T FARADAY SOC, V62, P539, DOI 10.1039/tf9666200539; CONNELLY PR, 1992, P NATL ACAD SCI USA, V89, P4781, DOI 10.1073/pnas.89.11.4781; COSTAS M, 1994, J CHEM SOC FARADAY T, V90, P1513, DOI 10.1039/ft9949001513; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Ducros VMA, 2003, CHEM BIOL, V10, P619, DOI 10.1016/S1074-5521(03)00143-1; Gallicchio E, 2000, J PHYS CHEM B, V104, P6271, DOI 10.1021/jp0006274; Gao DH, 2013, P NATL ACAD SCI USA, V110, P10922, DOI 10.1073/pnas.1213426110; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guo J, 2013, BIOMACROMOLECULES, V14, P1268, DOI 10.1021/bm300810t; Heerklotz H, 2001, BIOPHYS J, V80, P271, DOI 10.1016/S0006-3495(01)76012-2; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kern M, 2013, P NATL ACAD SCI USA, V110, P10189, DOI 10.1073/pnas.1301502110; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Koga Y, 2013, PHYS CHEM CHEM PHYS, V15, P14548, DOI 10.1039/c3cp51650d; LIN LN, 1991, BIOCHEMISTRY-US, V30, P11660, DOI 10.1021/bi00114a008; Linder M, 1997, J BIOTECHNOL, V57, P15, DOI 10.1016/S0168-1656(97)00087-4; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Mattinen ML, 1997, FEBS LETT, V407, P291, DOI 10.1016/S0014-5793(97)00356-6; Mayes HB, 2014, J AM CHEM SOC, V136, P1008, DOI 10.1021/ja410264d; Momeni M. H., 2014, THESIS SWEDISH U AGR; NIDETZKY B, 1994, ENZYME MICROB TECH, V16, P43, DOI 10.1016/0141-0229(94)90108-2; Nielsen AD, 2000, BBA-PROTEIN STRUCT M, V1479, P321, DOI 10.1016/S0167-4838(00)00012-1; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Palonen H, 1999, APPL ENVIRON MICROB, V65, P5229; Parkkinen T, 2008, PROTEIN SCI, V17, P1383, DOI 10.1110/ps.034488.108; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Pellegrini VOA, 2014, LANGMUIR, V30, P12602, DOI 10.1021/la5024423; Schonbeck C, 2014, J INCL PHENOM MACRO, V78, P351, DOI 10.1007/s10847-013-0305-2; Schonbeck C, 2012, ANAL CHEM, V84, P2305, DOI 10.1021/ac202842s; Srisodsuk M, 1997, J BIOTECHNOL, V57, P49, DOI 10.1016/S0168-1656(97)00088-6; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Taylor CB, 2013, J PHYS CHEM B, V117, P4924, DOI 10.1021/jp401410h; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011; Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	56	33	33	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2444	2454		10.1074/jbc.M114.624163	http://dx.doi.org/10.1074/jbc.M114.624163			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25477511	Green Published, hybrid			2022-12-28	WOS:000348588000046
J	Hori, Y; Takeda, S; Cho, H; Wegmann, S; Shoup, TM; Takahashi, K; Irimia, D; Elmaleh, DR; Hyman, BT; Hudry, E				Hori, Yukiko; Takeda, Shuko; Cho, Hansang; Wegmann, Susanne; Shoup, Timothy M.; Takahashi, Kazue; Irimia, Daniel; Elmaleh, David R.; Hyman, Bradley T.; Hudry, Eloise			A Food and Drug Administration-approved Asthma Therapeutic Agent Impacts Amyloid beta in the Brain in a Transgenic Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; PRECURSOR PROTEIN; FIBRIL FORMATION; MUTANT PRESENILIN-1; SYNAPTIC PLASTICITY; SECRETED OLIGOMERS; FLAVONOID FISETIN; OXIDATIVE STRESS; CROMOLYN SODIUM; MOUSE MODEL	Interfering with the assembly of Amyloid beta (A beta) peptides from monomer to oligomeric species and fibrils or promoting their clearance from the brain are targets of anti-A beta-directed therapies in Alzheimer disease. Here we demonstrate that cromolyn sodium (disodium cromoglycate), a Food and Drug Administration-approved drug already in use for the treatment of asthma, efficiently inhibits the aggregation of A beta monomers into higher-order oligomers and fibrils in vitro without affecting A beta production. In vivo, the levels of soluble A beta are decreased by over 50% after only 1 week of daily intraperitoneally administered cromolyn sodium. Additional in vivo microdialysis studies also show that this compound decreases the half-life of soluble A beta in the brain. These data suggest a clear effect of a peripherally administered, Food and Drug Administration-approved medication on A beta economy, supporting further investigation of the potential long-term efficacy of cromolyn sodium in Alzheimer disease.	[Hori, Yukiko; Takeda, Shuko; Wegmann, Susanne; Hyman, Bradley T.; Hudry, Eloise] Massachusetts Gen Hosp, Alzheimers Dis Res Lab, Dept Neurol, MassGen Inst Neurodegenerat Dis, Boston, MA 02129 USA; [Cho, Hansang; Irimia, Daniel] Massachusetts Gen Hosp, BioMEMS Resource Ctr, Boston, MA 02129 USA; [Shoup, Timothy M.; Elmaleh, David R.] Harvard Univ, Med Sch Charlestown, Div Nucl Med & Mol Imaging, Dept Radiol, Boston, MA 02129 USA; [Takahashi, Kazue] Harvard Univ, Med Sch Charlestown, Serv Pediat, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Hudry, E (corresponding author), MA Gen Hosp, MassGen Inst Neurodegenerat Dis, Dept Neurol, Alzheimers Dis Res Lab, Bldg 114,16th St, Charlestown, MA 02129 USA.	ehudry@partners.org	Irimia, Daniel/A-4095-2008; Cho, Hansang/AAF-6294-2020; Irimia, Daniel/S-5404-2019	Irimia, Daniel/0000-0001-7347-2082; Irimia, Daniel/0000-0001-7347-2082; Cho, Hansang/0000-0003-1829-2462	AZ Therapies Inc.; Uehara Memorial Foundation; Japan Society for the Promotion of Science; Dreyfoos Fund Against Alzheimer's Disease; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	AZ Therapies Inc.; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Dreyfoos Fund Against Alzheimer's Disease; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by AZ Therapies Inc., by a postdoctoral fellowship from the Uehara Memorial Foundation (to Y. H.), by the Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science (to S. T.), and by the Dreyfoos Fund Against Alzheimer's Disease.	Abraham JN, 2014, BIOMACROMOLECULES, V15, P3253, DOI 10.1021/bm501004q; Akaishi T, 2008, NEUROSCI LETT, V444, P280, DOI 10.1016/j.neulet.2008.08.052; Anand P, 2013, ARCH PHARM RES, V36, P375, DOI 10.1007/s12272-013-0036-3; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Cho HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01823; Cirrito JR, 2003, J NEUROSCI, V23, P8844; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cockcroft DW, 1999, J CLIN PHARMACOL, V39, P216; Cummings Jeffrey L, 2004, Rev Neurol Dis, V1, P60; Currais A, 2014, AGING CELL, V13, P379, DOI 10.1111/acel.12185; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Doody RS, 2009, NEUROLOGY, V72, P1555, DOI 10.1212/01.wnl.0000344650.95823.03; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Gotz J, 2004, INT J DEV NEUROSCI, V22, P453, DOI 10.1016/j.ijdevneu.2004.07.013; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto T, 2002, EMBO J, V21, P1524, DOI 10.1093/emboj/21.7.1524; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hashimoto T, 2011, J BIOL CHEM, V286, P27081, DOI 10.1074/jbc.M111.257378; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Ishige K, 2001, FREE RADICAL BIO MED, V30, P433, DOI 10.1016/S0891-5849(00)00498-6; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kim Darrick S H L, 2012, Recent Pat CNS Drug Discov, V7, P184; Kim H, 2005, J AGR FOOD CHEM, V53, P8537, DOI 10.1021/jf051985c; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kurt MA, 2003, NEUROBIOL DIS, V14, P89, DOI 10.1016/S0969-9961(03)00084-6; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEZA JC, 1995, EUR J PHARMACOL, V285, P95, DOI 10.1016/0014-2999(95)00474-Y; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Quitschke WW, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt170; Ratner PH, 2002, MAYO CLIN PROC, V77, P350, DOI 10.4065/77.4.350; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; SANMARTINCLARK O, 1995, PSYCHOPHARMACOLOGY, V118, P347, DOI 10.1007/BF02245965; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Storms W, 2005, J ASTHMA, V42, P79, DOI 10.1081/JAS-52017; Takeda S, 2011, NEUROSCIENCE, V186, P110, DOI 10.1016/j.neuroscience.2011.04.035; Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Ushikubo H, 2012, NEUROSCI LETT, V513, P51, DOI 10.1016/j.neulet.2012.02.006; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wegmann S, 2013, P NATL ACAD SCI USA, V110, pE313, DOI 10.1073/pnas.1212100110; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010	50	48	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1966	1978		10.1074/jbc.M114.586602	http://dx.doi.org/10.1074/jbc.M114.586602			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25468905	Green Published, hybrid			2022-12-28	WOS:000348588000006
J	Uppal, S; Salhotra, S; Mukhi, N; Zaidi, FK; Seal, M; Dey, SG; Bhat, R; Kundu, S				Uppal, Sheetal; Salhotra, Shikha; Mukhi, Nitika; Zaidi, Fatima Kamal; Seal, Manas; Dey, Somdatta Ghosh; Bhat, Rajiv; Kundu, Suman			Significantly Enhanced Heme Retention Ability of Myoglobin Engineered to Mimic the Third Covalent Linkage by Nonaxial Histidine to Heme (Vinyl) in Synechocystis Hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCOCCUS SP PCC-7002; LIGAND-BINDING; HEXACOORDINATE HEMOGLOBIN; BLOOD SUBSTITUTES; DISTAL HISTIDINE; POSTTRANSLATIONAL MODIFICATION; CYANOBACTERIAL HEMOGLOBINS; TRUNCATED HEMOGLOBIN; CRYSTAL-STRUCTURES; NITRIC-OXIDE	Heme proteins, which reversibly bind oxygen and display a particular fold originally identified in myoglobin (Mb), characterize the "(h)emoglobin (Hb) superfamily." The long known and widely investigated Hb superfamily, however, has been enriched by the discovery and investigation of new classes and members. Truncated Hbs typify such novel classes and exhibit a distinct two-on-two alpha-helical fold. The truncated Hb from the freshwater cyanobacterium Synechocystis exhibits hexacoordinate heme chemistry and bears an unusual covalent bond between the nonaxial His(117) and a heme porphyrin 2-vinyl atom, which remains tightly associated with the globin unlike any other. It seems to be the most stable Hb known to date, and His(117) is the dominant force holding the heme. Mutations of amino acid residues in the vicinity did not influence this covalent linkage. Introduction of a nonaxial His into sperm whaleMbat the topologically equivalent position and in close proximity to vinyl group significantly increased the heme stability of this prototype globin. Reversed phase chromatography, electrospray ionization-MS, and MALDI-TOF analyses confirmed the presence of covalent linkage in Mb I107H. The Mb mutant with the engineered covalent linkage was stable to denaturants and exhibited ligand binding and auto-oxidation rates similar to the wild type protein. This indeed is a novel finding and provides a new perspective to the evolution of Hbs. The successful attempt at engineering heme stability holds promise for the production of stable Hb-based blood substitute.	[Uppal, Sheetal; Salhotra, Shikha; Mukhi, Nitika; Kundu, Suman] Univ Delhi, Dept Biochem, New Delhi 110021, India; [Zaidi, Fatima Kamal; Bhat, Rajiv] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Seal, Manas; Dey, Somdatta Ghosh] Indian Assoc Cultivat Sci, Dept Inorgan Chem, Kolkata 700032, India	University of Delhi; Jawaharlal Nehru University, New Delhi; Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Kundu, S (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi 110021, India.	surnan.kundu@south.du.ac.in	Uppal, Sheetal/J-8665-2019	Uppal, Sheetal/0000-0002-3685-8602; MUKHI, NITIKA/0000-0001-5717-7948; Ghosh Dey, Somdatta/0000-0002-6142-2202	Indo-US Science and Technology Forum, University of Delhi (research and development grant) Department of Science and Technology (PURSE-Promotion of university research and scientific excellence), Government of India; CSIR, Government of India; UGC, Government of India	Indo-US Science and Technology Forum, University of Delhi (research and development grant) Department of Science and Technology (PURSE-Promotion of university research and scientific excellence), Government of India; CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India); UGC, Government of India(University Grants Commission, India)	This work was supported by Indo-US Science and Technology Forum, University of Delhi (research and development grant) Department of Science and Technology (PURSE-Promotion of university research and scientific excellence), Government of India and in the form of research fellowship as a visiting scientist in the laboratory of Prof. Mark Hargrove of Iowa State University (to S. K.); by a research fellowship from CSIR, Government of India (to S. U.); by a research fellowship from UGC, Government of India (to N. M.).	Aicart-Ramos C, 2012, BIOCHEMISTRY-US, V51, P7403, DOI 10.1021/bi300848x; AKIYAMA K, 1994, BBA-PROTEIN STRUCT M, V1208, P306, DOI 10.1016/0167-4838(94)90117-1; Banerjee M, 2011, J BIOSCIENCES, V36, P809, DOI 10.1007/s12038-011-9163-5; Batey S, 2005, J MOL BIOL, V349, P1045, DOI 10.1016/j.jmb.2005.04.028; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Cavalier-Smith T, 2006, PHILOS T R SOC B, V361, P969, DOI 10.1098/rstb.2006.1842; Codutti L, 2009, FEBS J, V276, P5177, DOI 10.1111/j.1742-4658.2009.07214.x; Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942; Dou Y, 2002, BIOPHYS CHEM, V98, P127, DOI 10.1016/S0301-4622(02)00090-X; Draghi F, 2002, J BIOL CHEM, V277, P7509, DOI 10.1074/jbc.M109206200; Falcon LI, 2010, ISME J, V4, P777, DOI 10.1038/ismej.2010.2; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hardison R, 1999, AM SCI, V87, P126, DOI 10.1511/1999.20.809; Hargrove MS, 2000, BIOPHYS J, V79, P2733, DOI 10.1016/S0006-3495(00)76512-X; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11310, DOI 10.1021/bi9603736; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11300, DOI 10.1021/bi960372d; HARGROVE MS, 1994, BIOCHEMISTRY-US, V33, P11767, DOI 10.1021/bi00205a012; Hoy JA, 2004, J BIOL CHEM, V279, P16535, DOI 10.1074/jbc.M313707200; Hoy JA, 2007, J MOL BIOL, V371, P168, DOI 10.1016/j.jmb.2007.05.029; Hoy JA, 2007, PROTEIN SCI, V16, P250, DOI 10.1110/ps.062572607; Hvitved AN, 2001, J BIOL CHEM, V276, P34714, DOI 10.1074/jbc.M105175200; Kakar S, 2011, BIOCHEMISTRY-US, V50, P4273, DOI 10.1021/bi2002423; Kumar A., 2008, RED GOLDMINE PROMISE; Kundu S, 2003, PROTEINS, V50, P239, DOI 10.1002/prot.10277; Kundu S, 2002, PROTEINS, V46, P268, DOI 10.1002/prot.10048; Lecomte JTJ, 2001, BIOCHEMISTRY-US, V40, P6541, DOI 10.1021/bi010226u; LEMON DD, 1987, J APPL PHYSIOL, V62, P798, DOI 10.1152/jappl.1987.62.2.798; Liong EC, 2001, J BIOL CHEM, V276, P9093, DOI 10.1074/jbc.M008593200; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Metcalfe CL, 2004, J AM CHEM SOC, V126, P16242, DOI 10.1021/ja048242c; Nothnagel HJ, 2009, J INORG BIOCHEM, V103, P107, DOI 10.1016/j.jinorgbio.2008.09.009; Olson J S, 1981, Methods Enzymol, V76, P631; Olson JM, 2004, PHOTOSYNTH RES, V80, P373, DOI 10.1023/B:PRES.0000030457.06495.83; OLSON JS, 1988, NATURE, V336, P265, DOI 10.1038/336265a0; Olson JS, 1997, ARTIF CELL BLOOD SUB, V25, P227, DOI 10.3109/10731199709118912; PEISACH J, 1969, P NATL ACAD SCI USA, V63, P934, DOI 10.1073/pnas.63.3.934; Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424; Pietra F, 2013, CHEM BIODIVERS, V10, P963, DOI 10.1002/cbdv.201300060; Preimesberger MR, 2013, BIOCHEMISTRY-US, V52, P3478, DOI 10.1021/bi400289e; Ptitsyn OB, 1999, J MOL BIOL, V291, P671, DOI 10.1006/jmbi.1999.2920; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; Roach MP, 2000, J INORG BIOCHEM, V81, P173, DOI 10.1016/S0162-0134(00)00101-X; Scott EE, 2000, J BIOL CHEM, V275, P27129; Scott MG, 1997, CLIN CHEM, V43, P1724; Scott NL, 2002, BIOCHEMISTRY-US, V41, P6902, DOI 10.1021/bi025609m; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smagghe BJ, 2006, BIOCHEMISTRY-US, V45, P561, DOI 10.1021/bi051902l; SMERDON SJ, 1993, BIOCHEMISTRY-US, V32, P5132, DOI 10.1021/bi00070a023; Sturms R, 2011, BIOCHEMISTRY-US, V50, P10829, DOI 10.1021/bi201425f; Sturms R, 2011, BIOCHEMISTRY-US, V50, P3873, DOI 10.1021/bi2004312; Tang Q, 1998, BIOCHEMISTRY-US, V37, P7047, DOI 10.1021/bi9729413; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Trent JT, 2004, J MOL BIOL, V341, P1097, DOI 10.1016/j.jmb.2004.05.070; Varnado CL, 2013, ANTIOXID REDOX SIGN, V18, P2314, DOI 10.1089/ars.2012.4917; Vinogradov SN, 2013, ADV MICROB PHYSIOL, V63, P391, DOI 10.1016/B978-0-12-407693-8.00009-1; Vinogradov SN, 2013, BBA-PROTEINS PROTEOM, V1834, P1789, DOI 10.1016/j.bbapap.2013.03.021; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Vu BC, 2004, J BIOL INORG CHEM, V9, P183, DOI 10.1007/s00775-003-0512-1; Vu BC, 2002, J AM CHEM SOC, V124, P8544, DOI 10.1021/ja026569c; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200	63	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1979	1993		10.1074/jbc.M114.603225	http://dx.doi.org/10.1074/jbc.M114.603225			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25451928	hybrid, Green Published			2022-12-28	WOS:000348588000007
J	Cai, PL; Wang, B; Ji, JX; Jiang, YS; Wan, L; Tian, CG; Ma, YH				Cai, Pengli; Wang, Bang; Ji, Jingxiao; Jiang, Yongsheng; Wan, Li; Tian, Chaoguang; Ma, Yanhe			The Putative Cellodextrin Transporter-like Protein CLP1 Is Involved in Cellulase Induction in Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIALLY EXPRESSED GENES; SACCHAROMYCES-CEREVISIAE; SYSTEMS-ANALYSIS; GLUCOSE; DEGRADATION; MECHANISMS; XYLOSE; SIGNAL; ROLES	Neurospora crassa recently has become a novel system to investigate cellulase induction. Here, we discovered a novel membrane protein, cellodextrin transporter-like protein 1 (CLP1; NCU05853), a putative cellodextrin transporter-like protein that is a critical component of the cellulase induction pathway in N. crassa. Although CLP1 protein cannot transport cellodextrin, the suppression of cellulase induction by this protein was discovered on both cellobiose and Avicel. The co-disruption of the cellodextrin transporters cdt2 and clp1 in strain Delta 3 beta G formed strain CPL7. With induction by cellobiose, cellulase production was enhanced 6.9-fold in CPL7 compared with Delta 3 beta G. We also showed that the suppression of cellulase expression by CLP1 occurred by repressing the expression of cellodextrin transporters, particularly cdt1 expression. Transcriptome analysis of the hypercellulase-producing strain CPL7 showed that the cellulase expression machinery was dramatically stimulated, as were the cellulase enzyme genes including the inducer transporters and the major transcriptional regulators.	[Cai, Pengli; Wang, Bang; Ji, Jingxiao; Jiang, Yongsheng; Wan, Li; Tian, Chaoguang; Ma, Yanhe] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Tian, CG (corresponding author), Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.	tian_cg@tib.cas.cn	MA, YAN/HHN-2912-2022; wan, li/GRY-7634-2022	Wang, Bang/0000-0003-4223-3040	Natural Science Foundation of China [31171207]; 973 Program of China [2011CB707400]; 863 Program of China [2012AA022203, SS2014AA021300]; Tianjin Zhuanxiang Grant [13ZCDZSY05000]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA022203] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); 863 Program of China(National High Technology Research and Development Program of China); Tianjin Zhuanxiang Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Natural Science Foundation of China Grant 31171207, 973 Program of China Grant 2011CB707400, 863 Program of China Grants 2012AA022203 and SS2014AA021300, and Tianjin Zhuanxiang Grant 13ZCDZSY05000.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Benz JP, 2014, MOL MICROBIOL, V91, P275, DOI 10.1111/mmi.12459; Cai PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089330; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109; Davis R.H., 1970, METHODS ENZYMOL, V17, P79, DOI [10.1016/0076-6879(71)17168-6, DOI 10.1016/0076-6879(71)17168-6]; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; Ivanova C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062631; Li J, 2013, APPL MICROBIOL BIOT, V97, P10479, DOI 10.1007/s00253-013-5301-3; Li JG, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-31; Liang H, 1996, MOL BIOL CELL, V7, P1953, DOI 10.1091/mbc.7.12.1953; Madi L, 1997, GENETICS, V146, P499; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sun JP, 2012, EUKARYOT CELL, V11, P482, DOI 10.1128/EC.05327-11; Suto M, 2001, J BIOSCI BIOENG, V92, P305, DOI 10.1263/jbb.92.305; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thevelein JM, 2009, MOL BIOL EVOL, V26, P2407, DOI 10.1093/molbev/msp168; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Xiong Y, 2014, FUNGAL GENET BIOL, V72, P21, DOI 10.1016/j.fgb.2014.05.005; Zhang WX, 2013, J BIOL CHEM, V288, P32861, DOI 10.1074/jbc.M113.505826; Zhou QX, 2012, EUKARYOT CELL, V11, P1371, DOI 10.1128/EC.00170-12; Znameroski EA, 2014, J BIOL CHEM, V289, P2610, DOI 10.1074/jbc.M113.533273; Znameroski EA, 2012, P NATL ACAD SCI USA, V109, P6012, DOI 10.1073/pnas.1118440109	32	23	26	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					788	796		10.1074/jbc.M114.609875	http://dx.doi.org/10.1074/jbc.M114.609875			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25398875	Green Published, hybrid			2022-12-28	WOS:000347778200009
J	Estrella, NL; Desjardins, CA; Nocco, SE; Clark, AL; Maksimenko, Y; Naya, FJ				Estrella, Nelsa L.; Desjardins, Cody A.; Nocco, Sarah E.; Clark, Amanda L.; Maksimenko, Yevgeniy; Naya, Francisco J.			MEF2 Transcription Factors Regulate Distinct Gene Programs in Mammalian Skeletal Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; PROTEIN; IDENTIFICATION; BINDING; MYOD; MECHANISMS; COSTAMERE; SARCOMERE; MIGRATION; NETWORKS	Skeletal muscle differentiation requires precisely coordinated transcriptional regulation of diverse gene programs that ultimately give rise to the specialized properties of this cell type. In Drosophila, this process is controlled, in part, by MEF2, the sole member of an evolutionarily conserved transcription factor family. By contrast, vertebrate MEF2 is encoded by four distinct genes, Mef2a, -b, -c, and -d, making it far more challenging to link this transcription factor to the regulation of specific muscle gene programs. Here, we have taken the first step in molecularly dissecting vertebrate MEF2 transcriptional function in skeletal muscle differentiation by depleting individual MEF2 proteins in myoblasts. Whereas MEF2A is absolutely required for proper myoblast differentiation, MEF2B, -C, and -D were found to be dispensable for this process. Furthermore, despite the extensive redundancy, we show that mammalian MEF2 proteins regulate a significant subset of nonoverlapping gene programs. These results suggest that individual MEF2 family members are able to recognize specific targets among the entire cohort of MEF2-regulated genes in the muscle genome. These findings provide opportunities to modulate the activity of MEF2 isoforms and their respective gene programs in skeletal muscle homeostasis and disease.	[Estrella, Nelsa L.; Desjardins, Cody A.; Nocco, Sarah E.; Clark, Amanda L.; Maksimenko, Yevgeniy; Naya, Francisco J.] Boston Univ, Dept Biol, Program Cell & Mol Biol, Boston, MA 02215 USA	Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, 24 Cummington Mall, Boston, MA 02215 USA.	fnaya@bu.edu			National Institutes of Health [HL73304, HL73304-S1]; Beckman Scholars Program; Boston University Undergraduate Research Opportunities Program (UROP); Boston University Bioinformatics Clinical and Translational Science Institute [U54-TR001012]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001012] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Scholars Program; Boston University Undergraduate Research Opportunities Program (UROP); Boston University Bioinformatics Clinical and Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL73304 (to F. J. N.) and diversity supplement HL73304-S1 (to N. L. E.). This work was also supported by funds from the Beckman Scholars Program (to S. E. N.), a Boston University Undergraduate Research Opportunities Program (UROP) fellowship (to Y. M.), and Boston University Bioinformatics Clinical and Translational Science Institute Grant U54-TR001012.	Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Buettner FFR, 2013, MOL CELL, V50, P295, DOI 10.1016/j.molcel.2013.03.003; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Grade CVC, 2009, DEV GENES EVOL, V219, P497, DOI 10.1007/s00427-009-0312-x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Estrella N, 2014, CELL MOL LIFE SCI, V71, P1641, DOI 10.1007/s00018-013-1512-0; Ewen EP, 2011, J BIOL CHEM, V286, P29644, DOI 10.1074/jbc.M111.268094; George B, 2014, BBA-MOL CELL RES, V1843, P1930, DOI 10.1016/j.bbamcr.2014.05.008; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Heidt AB, 2007, MOL CELL BIOL, V27, P5910, DOI 10.1128/MCB.01700-06; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imoto I, 2001, BIOCHEM BIOPH RES CO, V287, P270, DOI 10.1006/bbrc.2001.5578; Knoepfler PS, 1999, NUCLEIC ACIDS RES, V27, P3752, DOI 10.1093/nar/27.18.3752; Liu JJ, 2008, BIOINFORMATICS, V24, P1850, DOI 10.1093/bioinformatics/btn331; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Nguyen NUN, 2014, BIOCHEM BIOPH RES CO, V452, P728, DOI 10.1016/j.bbrc.2014.08.143; O'Mahoney JV, 1998, MOL CELL BIOL, V18, P6641, DOI 10.1128/MCB.18.11.6641; Ornatsky OI, 1997, J BIOL CHEM, V272, P33271, DOI 10.1074/jbc.272.52.33271; Paris J, 2004, PHYSIOL GENOMICS, V20, P143, DOI 10.1152/physiolgenomics.00149.2004; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ramachandran B, 2008, J BIOL CHEM, V283, P10318, DOI 10.1074/jbc.M707623200; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Sebastian S, 2013, GENE DEV, V27, P1247, DOI 10.1101/gad.215400.113; Seok HY, 2011, J BIOL CHEM, V286, P35339, DOI 10.1074/jbc.M111.273276; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Sorimachi H, 2012, CARDIOVASC RES, V96, P11, DOI 10.1093/cvr/cvs157; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Tassabehji M, 1999, EUR J HUM GENET, V7, P737, DOI 10.1038/sj.ejhg.5200396; Wales S, 2014, NUCLEIC ACIDS RES, V42, P11349, DOI 10.1093/nar/gku813; Watanabe K, 2011, DEVELOPMENT, V138, P4979, DOI 10.1242/dev.068155; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Zhu BM, 2005, J BIOL CHEM, V280, P28749, DOI 10.1074/jbc.M502491200	48	60	64	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1256	1268		10.1074/jbc.M114.589838	http://dx.doi.org/10.1074/jbc.M114.589838			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25416778	Green Published, hybrid			2022-12-28	WOS:000347778200054
J	Leon-Paravic, CG; Figueroa, VA; Guzman, DJ; Valderrama, CF; Vallejos, AA; Fiori, MC; Altenberg, GA; Reuss, L; Retamal, MA				Leon-Paravic, Carmen G.; Figueroa, Vania A.; Guzman, Diego J.; Valderrama, Carlos F.; Vallejos, Antonio A.; Fiori, Mariana C.; Altenberg, Guillermo A.; Reuss, Luis; Retamal, Mauricio A.			Carbon Monoxide (CO) Is a Novel Inhibitor of Connexin Hemichannels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ENDOTHELIAL-CELLS; PROTEIN CARBONYLATION; ION CHANNELS; CX46 HEMICHANNELS; STRESS; DECARBONYLATION; PERMEATION; MOLECULES; MECHANISM; RELEASE	Hemichannels (HCs) are hexamers of connexins that can form gap-junction channels at points of cell contacts or "free HCs" at non-contacting regions. HCs are involved in paracrine and autocrine cell signaling, and under pathological conditions may induce and/or accelerate cell death. Therefore, studies of HC regulation are of great significance. Nitric oxide affects the activity of Cx43 and Cx46 HCs, whereas carbon monoxide (CO), another gaseous transmitter, modulates the activity of several ion channels, but its effect on HCs has not been explored. We studied the effect of CO donors (CORMs) on Cx46 HCs expressed in Xenopus laevis oocytes using two-electrode voltage clamp and on Cx43 and Cx46 expressed in HeLa cells using a dye-uptake technique. CORM-2 inhibited Cx46 HC currents in a concentration-dependent manner. The C-terminal domain and intracellular Cys were not necessary for the inhibition. The effect of CORM-2 was not prevented by guanylyl-cyclase, protein kinase G, or thioredoxin inhibitors, and was not due to endocytosis of HCs. However, the effect of CORM-2 was reversed by reducing agents that act extracellularly. Additionally, CO inhibited dye uptake of HeLa cells expressing Cx43 or Cx46, and MCF-7 cells, which endogenously express Cx43 and Cx46. Because CORM-2 carbonylates Cx46 in vitro and induces conformational changes, a direct effect of that CO on Cx46 is possible. The inhibition of HCs could help to understand some of the biological actions of CO in physiological and pathological conditions.	[Leon-Paravic, Carmen G.; Figueroa, Vania A.; Guzman, Diego J.; Valderrama, Carlos F.; Vallejos, Antonio A.; Retamal, Mauricio A.] Clin Alemana Univ Desarrollo, Fac Med, Ctr Fisiol Celular & Integrat, Santiago 7690000, Chile; [Fiori, Mariana C.; Altenberg, Guillermo A.; Reuss, Luis; Retamal, Mauricio A.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Fiori, Mariana C.; Altenberg, Guillermo A.; Reuss, Luis; Retamal, Mauricio A.] Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Universidad del Desarrollo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Retamal, MA (corresponding author), Clin Alemana Univ Desarrollo, Fac Med, Ctr Fisiol Celular & Integrat, Ave Las Condes 12438, Santiago 7690000, Chile.	mretamal@udd.cl		Figueroa Ipinza, Vania A./0000-0002-2953-9507; Altenberg, Guillermo/0000-0002-8932-740X; Retamal, Mauricio A./0000-0003-2562-6686	National Institutes of Health [R01GM79629, 3R01GM079629-03S1]; American Heart Association; Texas Affiliate Inc. [14GRNT18750014]; Fondecyt Grant [1120214]; Anillo Grant [ACT1104]; Centro de costo Grant [23400077]; Fondecyt [3130577]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Texas Affiliate Inc.; Fondecyt Grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Anillo Grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Centro de costo Grant; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM79629 and 3R01GM079629-03S1 and American Heart Association, Texas Affiliate Inc. Grant 14GRNT18750014 (to G. A. A.), Fondecyt Grant 1120214 and Anillo Grant ACT1104 (to M. A. R.), Centro de costo Grant 23400077 (to C. G. L.), and Fondecyt Grant 3130577 (to V. F.).	ADACHI K, 1982, J BIOL CHEM, V257, P5738; Althaus M, 2009, AM J RESP CELL MOL, V41, P639, DOI 10.1165/rcmb.2008-0458OC; Banerjee D, 2010, INT J CANCER, V127, P839, DOI 10.1002/ijc.25107; Burr DB, 2011, EXP EYE RES, V92, P251, DOI 10.1016/j.exer.2011.02.003; Cattaruzza M, 2008, CIRC RES, V102, P273, DOI 10.1161/CIRCRESAHA.108.172148; Chi JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032531; Dahl G, 2013, NEUROPHARMACOLOGY, V75, P583, DOI 10.1016/j.neuropharm.2013.02.019; Desmard M, 2012, ANTIOXID REDOX SIGN, V16, P153, DOI 10.1089/ars.2011.3959; Dong DL, 2008, EUR J PHARMACOL, V590, P99, DOI 10.1016/j.ejphar.2008.05.042; Dong DL, 2007, HYPERTENSION, V50, P643, DOI 10.1161/HYPERTENSIONAHA.107.096057; Fiori MC, 2012, J BIOL CHEM, V287, P40826, DOI 10.1074/jbc.M112.383281; Griffiths HR, 2014, REDOX BIOL, V2, P430, DOI 10.1016/j.redox.2014.01.010; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Gullotta F, 2012, IUBMB LIFE, V64, P378, DOI 10.1002/iub.1015; Johnstone SR, 2012, J MEMBRANE BIOL, V245, P319, DOI 10.1007/s00232-012-9453-3; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; Kar R, 2012, ARCH BIOCHEM BIOPHYS, V524, P2, DOI 10.1016/j.abb.2012.03.008; Klaassen LJ, 2012, BRAIN RES, V1487, P25, DOI 10.1016/j.brainres.2012.04.059; Kronengold J, 2012, J MEMBRANE BIOL, V245, P453, DOI 10.1007/s00232-012-9457-z; Liang GSL, 2005, ANN NEUROL, V57, P749, DOI 10.1002/ana.20459; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Orellana JA, 2012, ADV EXP MED BIOL, V740, P777, DOI 10.1007/978-94-007-2888-2_34; Padgaonkar VA, 1997, EXP EYE RES, V65, P435, DOI 10.1006/exer.1997.0356; Peers C, 2011, EXP PHYSIOL, V96, P836, DOI 10.1113/expphysiol.2011.059063; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Retamal MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00080; Retamal MA, 2010, AM J PHYSIOL-CELL PH, V298, pC132, DOI 10.1152/ajpcell.00258.2009; Retamal MA, 2009, AM J PHYSIOL-CELL PH, V296, pC1356, DOI 10.1152/ajpcell.00054.2009; Saez JC, 2010, EXP CELL RES, V316, P2377, DOI 10.1016/j.yexcr.2010.05.026; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Schalper KA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00237; Stehberg J, 2012, FASEB J, V26, P3649, DOI 10.1096/fj.11-198416; Telezhkin V, 2011, PFLUG ARCH EUR J PHY, V461, P665, DOI 10.1007/s00424-011-0924-7; Wang K, 2012, J BIOL CHEM, V287, P15786, DOI 10.1074/jbc.M111.313171; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Wilkinson WJ, 2009, BRIT J PHARMACOL, V158, P862, DOI 10.1111/j.1476-5381.2009.00354.x; Wilkinson WJ, 2011, J PHYSIOL-LONDON, V589, P3055, DOI 10.1113/jphysiol.2011.206706; Wong CM, 2008, CIRC RES, V102, P310, DOI 10.1161/CIRCRESAHA.107.159814; Wong CM, 2010, ANTIOXID REDOX SIGN, V12, P393, DOI 10.1089/ars.2009.2805; Wong CM, 2013, FREE RADICAL BIO MED, V65, P1126, DOI 10.1016/j.freeradbiomed.2013.09.005	41	25	26	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36150	36157		10.1074/jbc.M114.602243	http://dx.doi.org/10.1074/jbc.M114.602243			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25384983	Green Published, hybrid			2022-12-28	WOS:000346897900041
J	Moreno, KX; Satapati, S; DeBerardinis, RJ; Burgess, SC; Malloy, CR; Merritt, ME				Moreno, Karlos X.; Satapati, Santhosh; DeBerardinis, Ralph J.; Burgess, Shawn C.; Malloy, Craig R.; Merritt, Matthew E.			Real-time Detection of Hepatic Gluconeogenic and Glycogenolytic States Using Hyperpolarized [2-C-13]Dihydroxyacetone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; GLUCOSE-PRODUCTION; C-13 NMR; PYRUVATE-CARBOXYLASE; INTEGRATED H-2; FUTILE CYCLES; IN-VIVO; METABOLISM; FLUX; PATHWAYS	Glycogenolysis and gluconeogenesis are sensitive to nutritional state, and the net direction of flux is controlled by multiple enzymatic steps. This delicate balance in the liver is disrupted by a variety of pathological states including cancer and diabetes mellitus. Hyperpolarized carbon-13 magnetic resonance is a new metabolic imaging technique that can probe intermediary metabolism nondestructively. There are currently no methods to rapidly distinguish livers in a gluconeogenic from glycogenolytic state. Here we use the gluconeogenic precursor dihydroxyacetone (DHA) to deliver hyperpolarized carbon-13 to the perfused mouse liver. DHA enters gluconeogenesis at the level of the trioses. Perfusion conditions were designed to establish either a gluconeogenic or a glycogenolytic state. Unexpectedly, we found that [2-C-13]DHA was metabolized within a few seconds to the common intermediates and end products of both glycolysis and gluconeogenesis under both conditions, including [2,5-C-13]glucose, [2-C-13]glycerol 3-phosphate, [2-C-13]phosphoenolpyruvate (PEP), [2-C-13]pyruvate, [2-C-13]alanine, and [2-C-13]lactate. [2-C-13]Phosphoenolpyruvate, a key branch point in gluconeogenesis and glycolysis, was monitored in functioning tissue for the first time. Observation of [2-C-13]PEP was not anticipated as the free energy difference between PEP and pyruvate is large. Pyruvate kinase is the only regulatory step of the common glycolytic-gluconeogenic pathway that appears to exert significant control over the kinetics of any metabolites of DHA. A ratio of glycolytic to gluconeogenic products distinguished the gluconeogenic from glycogenolytic state in these functioning livers.	[Moreno, Karlos X.; Satapati, Santhosh; Burgess, Shawn C.; Malloy, Craig R.; Merritt, Matthew E.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA; [Burgess, Shawn C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Malloy, Craig R.; Merritt, Matthew E.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Malloy, Craig R.] Vet Affairs North Texas Healthcare Syst, Lancaster, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Merritt, ME (corresponding author), Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	matthew.merritt@utsouthwestern.edu		Malloy, Craig/0000-0001-5077-0642; Merritt, Matthew/0000-0003-4617-9651	National Institutes of Health [P41 EB015908, R01 DK058398, R01 CA157996, R21 EB016197, R37 HL34557]; Robert A. Welch Foundation [I-1733, I-1804-01]; Damon Runyon Cancer Research Foundation; Cancer Prevention Research Institute of Texas (CPRIT) Grant [RP-101243]; NATIONAL CANCER INSTITUTE [R01CA157996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034557, R37HL034557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908, R21EB016197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398, R01DK078184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Damon Runyon Cancer Research Foundation; Cancer Prevention Research Institute of Texas (CPRIT) Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P41 EB015908 (to K. X. M., C. R. M., and M. E. M.), R01 DK058398 (to S. S. and S. C. B.), R01 CA157996 (to R. J. D.), and R21 EB016197 and R37 HL34557 (to M. E. M.). This work was also supported by Robert A. Welch Foundation Grants I-1733 (to R. J. D.) and I-1804-01 (to S. C. B.) and the Damon Runyon Cancer Research Foundation (to R. J. D.), and Cancer Prevention Research Institute of Texas (CPRIT) Grant RP-101243 (to M. E. M.).	Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Bergmeyer H. U., 1984, METHOD ENZYMAT AN, V6, P1198; Burgess SC, 2005, AM J PHYSIOL-ENDOC M, V289, pE53, DOI 10.1152/ajpendo.00601.2004; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Burgess SC, 2003, ANAL BIOCHEM, V318, P321, DOI 10.1016/S0003-2697(03)00158-1; Burgess SC, 2003, ANAL BIOCHEM, V312, P228, DOI 10.1016/S0003-2697(02)00465-7; Harris T, 2013, NMR BIOMED, V26, P1831, DOI 10.1002/nbm.3024; Hausler N, 2006, BIOCHEM J, V394, P465, DOI 10.1042/BJ20051174; HEMS R, 1966, BIOCHEM J, V101, P284, DOI 10.1042/bj1010284; Hue L, 1981, Adv Enzymol Relat Areas Mol Biol, V52, P247; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; Jones JG, 2001, AM J PHYSIOL-ENDOC M, V281, pE848, DOI 10.1152/ajpendo.2001.281.4.E848; Jones JG, 1997, FEBS LETT, V412, P131, DOI 10.1016/S0014-5793(97)00764-3; LANDAU BR, 1995, J CLIN INVEST, V95, P172, DOI 10.1172/JCI117635; Larson PEZ, 2011, MAGN RESON MED, V65, P610, DOI 10.1002/mrm.22650; Lau AZ, 2010, MAGN RESON MED, V64, P1323, DOI 10.1002/mrm.22525; Lee P, 2013, HEPATOLOGY, V57, P515, DOI 10.1002/hep.26028; Merritt ME, 2011, P NATL ACAD SCI USA, V108, P19084, DOI 10.1073/pnas.1111247108; NEESE RA, 1995, J BIOL CHEM, V270, P14452, DOI 10.1074/jbc.270.24.14452; Patyal BR, 1997, J MAGN RESON, V126, P58, DOI 10.1006/jmre.1997.1159; Petersen KF, 1996, AM J PHYSIOL-ENDOC M, V270, pE186, DOI 10.1152/ajpendo.1996.270.1.E186; Phillips JW, 2002, EUR J BIOCHEM, V269, P792, DOI 10.1046/j.0014-2956.2001.02687.x; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Qian H, 2006, IEE P SYST BIOL, V153, P192, DOI 10.1049/ip-syb:20050086; Rodrigues TB, 2014, NAT MED, V20, P93, DOI 10.1038/nm.3416; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Tayek JA, 1996, AM J PHYSIOL-ENDOC M, V270, pE709, DOI 10.1152/ajpendo.1996.270.4.E709; Yang CD, 2014, J BIOL CHEM, V289, P6212, DOI 10.1074/jbc.M113.543637	29	45	45	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35859	35867		10.1074/jbc.M114.613265	http://dx.doi.org/10.1074/jbc.M114.613265			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25352600	Green Published, hybrid			2022-12-28	WOS:000346897900018
J	Boesler, B; Meier, D; Forstner, KU; Friedrich, M; Hammann, C; Sharma, CM; Nellen, W				Boesler, Benjamin; Meier, Doreen; Foerstner, Konrad U.; Friedrich, Michael; Hammann, Christian; Sharma, Cynthia M.; Nellen, Wolfgang			Argonaute Proteins Affect siRNA Levels and Accumulation of a Novel Extrachromosomal DNA from the Dictyostelium Retrotransposon DIRS-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Argonaute; Gene Silencing; RNA Interference (RNAi); Small Interfering RNA (siRNA); Transposable Element (TE)	SELECTABLE MARKER; RNA INTERFERENCE; GENE-EXPRESSION; HEAT-SHOCK; C-ELEGANS; DISCOIDEUM; METHYLATION; AMPLIFICATION; ARABIDOPSIS; SEQUENCE	The retrotransposon DIRS-1 is the most abundant retroelement in Dictyostelium discoideum and constitutes the pericentromeric heterochromatin of the six chromosomes in D. discoideum. The vast majority of cellular siRNAs is derived from DIRS-1, suggesting that the element is controlled by RNAi-related mechanisms. We investigated the role of two of the five Argonaute proteins of D. discoideum, AgnA and AgnB, in DIRS-1 silencing. Deletion of agnA resulted in the accumulation of DIRS-1 transcripts, the expression of DIRS-1-encoded proteins, and the loss of most DIRS-1-derived secondary siRNAs. Simultaneously, extrachromosomal single-stranded DIRS-1 DNA accumulated in the cytoplasm of agnA- strains. These DNA molecules appear to be products of reverse transcription and thus could represent intermediate structures before transposition. We further show that transitivity of endogenous siRNAs is impaired in agnA- strains. The deletion of agnB alone had no strong effect on DIRS-1 transposon regulation. However, in agnA-/agnB- double mutant strains strongly reduced accumulation of extrachromosomal DNA compared with the single agnA- strains was observed.	[Boesler, Benjamin; Meier, Doreen; Friedrich, Michael; Nellen, Wolfgang] Univ Kassel, FB10, Dept Genet, D-34132 Kassel, Germany; [Foerstner, Konrad U.; Sharma, Cynthia M.] Univ Wurzburg, Res Ctr Infect Dis ZINF, D-97080 Wurzburg, Germany; [Hammann, Christian] Jacobs Univ Bremen, Mol Life Sci Res Ctr, Sch Sci & Engn, Ribogenet Biochem Lab, DE-28759 Bremen, Germany	Universitat Kassel; University of Wurzburg; Jacobs University	Nellen, W (corresponding author), Univ Kassel, FB10, Dept Genet, Heinrich Plett Str 40, D-34132 Kassel, Germany.	nellen@uni-kassel.de	Sharma, Cynthia/D-2869-2013; Förstner, Konrad U./B-1531-2010; Hammann, Christian/AAE-7325-2020	Förstner, Konrad U./0000-0002-1481-2996; Sharma, Cynthia Mira/0000-0002-2321-9705	Deutsche Forschungsgemeinschaft [NE285/10-1, HA3459/7]; Land Hessen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Land Hessen	This work was supported by Deutsche Forschungsgemeinschaft Grants NE285/10-1 (to W. N.) and HA3459/7 (to C. H.).; Supported by a stipend from the Land Hessen. Both are joint first authors.	Bouttier M, 2012, NUCLEIC ACIDS RES, V40, P775, DOI 10.1093/nar/gkr762; CAPPELLO J, 1985, CELL, V43, P105, DOI 10.1016/0092-8674(85)90016-9; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; CHUNG S, 1983, NUCLEIC ACIDS RES, V11, P4835, DOI 10.1093/nar/11.14.4835; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COHEN SM, 1984, MOL CELL BIOL, V4, P2332, DOI 10.1128/MCB.4.11.2332; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; Dubin M, 2010, NUCLEIC ACIDS RES, V38, P7526, DOI 10.1093/nar/gkq664; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Gaudet P, 2007, NAT PROTOC, V2, P1317, DOI 10.1038/nprot.2007.179; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Glockner G, 2001, GENOME RES, V11, P585, DOI 10.1101/gr.GR-1622RR; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Hinas A, 2007, NUCLEIC ACIDS RES, V35, P6714, DOI 10.1093/nar/gkm707; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Kuhlmann M, 2005, NUCLEIC ACIDS RES, V33, P6405, DOI 10.1093/nar/gki952; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Maida Y, 2011, BIOL CHEM, V392, P299, DOI 10.1515/BC.2011.035; Martens H, 2002, MOL BIOL CELL, V13, P445, DOI 10.1091/mbc.01-04-0211; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Muller S, 2013, NUCLEIC ACIDS RES, V41, P8615, DOI 10.1093/nar/gkt634; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pak J, 2012, CELL, V151, P885, DOI 10.1016/j.cell.2012.10.022; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Parrish S, 2001, RNA, V7, P1397; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piednoel M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-621; Poulter RTM, 2005, CYTOGENET GENOME RES, V110, P575, DOI 10.1159/000084991; ROSEN E, 1983, CELL, V35, P243, DOI 10.1016/0092-8674(83)90227-1; Rot G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-265; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; SUTOH K, 1993, PLASMID, V30, P150, DOI 10.1006/plas.1993.1042; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; WALLRAFF E, 1986, EMBO J, V5, P61, DOI 10.1002/j.1460-2075.1986.tb04178.x; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wiegand S, 2014, NUCLEIC ACIDS RES, V42, P3330, DOI 10.1093/nar/gkt1337; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; ZUKER C, 1983, CELL, V34, P997, DOI 10.1016/0092-8674(83)90557-3	51	8	9	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35124	35138		10.1074/jbc.M114.612663	http://dx.doi.org/10.1074/jbc.M114.612663			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25352599	Green Published, hybrid			2022-12-28	WOS:000346660200007
J	Brennan-Laun, SE; Li, XL; Ezelle, HJ; Venkataraman, T; Blackshear, PJ; Wilson, GM; Hassel, BA				Brennan-Laun, Sarah E.; Li, Xiao-Ling; Ezelle, Heather J.; Venkataraman, Thiagarajan; Blackshear, Perry J.; Wilson, Gerald M.; Hassel, Bret A.			RNase L Attenuates Mitogen-stimulated Gene Expression via Transcriptional and Post-transcriptional Mechanisms to Limit the Proliferative Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENTS; MESSENGER-RNA; 2-5A-DEPENDENT RNASE; GROWTH-FACTOR; TNF-ALPHA; TRISTETRAPROLIN EXPRESSION; 3'-UNTRANSLATED REGION; BINDING-PROTEINS; CELL; CANCER	The cellular response to mitogens is tightly regulated via transcriptional and post-transcriptional mechanisms to rapidly induce genes that promote proliferation and efficiently attenuate their expression to prevent malignant growth. RNase L is an endoribonuclease that mediates diverse antiproliferative activities, and tristetraprolin (TTP) is a mitogen-induced RNA-binding protein that directs the decay of proliferation-stimulatory mRNAs. In light of their roles as endogenous proliferative constraints, we examined the mechanisms and functional interactions of RNase Land TTP to attenuate a mitogenic response. Mitogen stimulation of RNase L-deficient cells significantly increased TTP transcription and the induction of other mitogen-induced mRNAs. This regulation corresponded with elevated expression of serum-response factor (SRF), a master regulator of mitogen-induced transcription. RNase L destabilized the SRF transcript and formed a complex with SRF mRNA in cells providing a mechanism by which RNase L down-regulates SRF-induced genes. TTP and RNase L proteins interacted in cells suggesting that RNase L is directed to cleave TTP bound RNAs as a mechanism of substrate specificity. Consistent with their concerted function in RNA turnover, the absence of either RNase Lor TTP stabilized SRF mRNA, and a subset of established TTP targets was also regulated by RNase L. RNase L deficiency enhanced mitogen-induced proliferation demonstrating its functional role in limiting the mitogenic response. Our findings support a model of feedback regulation in which RNase L and TTP target SRF mRNA and SRF-induced transcripts. Accordingly, meta-analysis revealed an enrichment of RNase L and TTP targets among SRF-regulated genes suggesting that the RNase L/TTP axis represents a viable target to inhibit SRF-driven proliferation in neoplastic diseases.	[Brennan-Laun, Sarah E.; Ezelle, Heather J.; Wilson, Gerald M.; Hassel, Bret A.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Brennan-Laun, Sarah E.; Ezelle, Heather J.; Venkataraman, Thiagarajan; Hassel, Bret A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Wilson, Gerald M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Li, Xiao-Ling] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Ezelle, Heather J.; Hassel, Bret A.] Baltimore Vet Affairs Med Ctr, Res Serv, Baltimore, MD 21201 USA; [Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hassel, BA (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 W Baltimore St,HSF I 380, Baltimore, MD 21201 USA.	bhassel@som.umaryland.edu	Wilson, Gerald/AAF-3874-2019; Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529; Venkataraman, Thiagarajan/0000-0003-0921-6345; Wilson, Gerald/0000-0002-1273-7507	National Institutes of Health [AI077556]; NCI [T32CA154274]; Veterans Affairs Merit Award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI077556 (to B. A. H.) and NCI T32 Cancer Biology Training Grant T32CA154274 from NCI (to S. E. B.-L.). This work was also supported by a Veterans Affairs Merit Award (to B. A. H.).	Al-Haj L, 2012, NUCLEIC ACIDS RES, V40, P7739, DOI 10.1093/nar/gks545; Andersen JB, 2007, ONCOGENE, V26, P3081, DOI 10.1038/sj.onc.1210111; Andersen JB, 2009, RNA BIOL, V6, P305, DOI 10.4161/rna.6.3.8526; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Benson CC, 2011, PHYSIOL GENOMICS, V43, P1038, DOI 10.1152/physiolgenomics.00098.2011; Bisbal C, 2000, MOL CELL BIOL, V20, P4959, DOI 10.1128/MCB.20.14.4959-4969.2000; BOURGEADE MF, 1984, CANCER RES, V44, P5355; Boutaud O, 2003, ADV EXP MED BIOL, V525, P157; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Brennan-Laun SE, 2014, J INTERF CYTOK RES, V34, P275, DOI 10.1089/jir.2013.0147; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Bros M, 2010, MOL IMMUNOL, V47, P1161, DOI 10.1016/j.molimm.2009.11.002; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; Castelli JC, 1997, J EXP MED, V186, P967, DOI 10.1084/jem.186.6.967; Cha HJ, 2011, HEPATO-GASTROENTEROL, V58, P790; Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Clark KA, 2014, GENE DEV, V28, P926, DOI 10.1101/gad.242420.114; CLEMENS MJ, 1978, CELL, V13, P565, DOI 10.1016/0092-8674(78)90329-X; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; Domingo-Gil E, 2010, J INTERF CYTOK RES, V30, P171, DOI 10.1089/jir.2009.0037; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; Dong BH, 1997, J BIOL CHEM, V272, P22236, DOI 10.1074/jbc.272.35.22236; DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Ezelle Heather J, 2012, Front Biosci (Schol Ed), V4, P767; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fabre O, 2012, CELL DEATH DIFFER, V19, P1470, DOI 10.1038/cdd.2012.23; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Han YC, 2014, SCIENCE, V343, P1244, DOI 10.1126/science.1249845; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HASSEL BA, 1993, EMBO J, V12, P3297, DOI 10.1002/j.1460-2075.1993.tb05999.x; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; Hausburg M. A., 2010, THESIS U COLORADO BO; Healy S, 2013, PHARMACOL THERAPEUT, V137, P64, DOI 10.1016/j.pharmthera.2012.09.001; Hovanessian AG, 2007, CYTOKINE GROWTH F R, V18, P351, DOI 10.1016/j.cytogfr.2007.06.003; Huang H, 2014, MOL CELL, V53, P221, DOI 10.1016/j.molcel.2013.12.025; JACOBSEN H, 1983, P NATL ACAD SCI-BIOL, V80, P4954, DOI 10.1073/pnas.80.16.4954; Jha BK, 2011, J BIOL CHEM, V286, P26319, DOI 10.1074/jbc.M111.253443; Johnson BA, 2000, ONCOGENE, V19, P1657, DOI 10.1038/sj.onc.1203474; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Kedar VP, 2012, J BIOL CHEM, V287, P5459, DOI 10.1074/jbc.M111.312652; Kim HK, 2012, J BIOL CHEM, V287, P28770, DOI 10.1074/jbc.M112.376483; Kim TW, 2010, BIOCHEM BIOPH RES CO, V391, P963, DOI 10.1016/j.bbrc.2009.11.174; Kimura Y, 2010, CANCER RES, V70, P501, DOI 10.1158/0008-5472.CAN-09-1469; KLEIN G, 1993, FASEB J, V7, P821, DOI 10.1096/fasebj.7.10.8344481; Kratochvill F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.93; KRISHNAN I, 1980, P NATL ACAD SCI-BIOL, V77, P6506, DOI 10.1073/pnas.77.11.6506; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1998, J BIOL CHEM, V273, P506, DOI 10.1074/jbc.273.1.506; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; Lee HH, 2010, J BIOL CHEM, V285, P17329, DOI 10.1074/jbc.M109.094235; Lee HH, 2010, INT J CANCER, V126, P1817, DOI 10.1002/ijc.24847; Li XL, 2007, J BIOL CHEM, V282, P7950, DOI 10.1074/jbc.M607939200; Li XL, 2008, P NATL ACAD SCI USA, V105, P20816, DOI 10.1073/pnas.0807265105; Liu W, 2007, EUR J CANCER, V43, P202, DOI 10.1016/j.ejca.2006.08.024; Long TM, 2013, INFLAMM BOWEL DIS, V19, P1295, DOI 10.1097/MIB.0b013e318281f2fd; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Madsen BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002492; Mahat DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033194; Malathi K, 2005, P NATL ACAD SCI USA, V102, P14533, DOI 10.1073/pnas.0507551102; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; Masuda K, 2009, AGING-US, V1, P681, DOI 10.18632/aging.100073; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Meyer MS, 2010, CARCINOGENESIS, V31, P1597, DOI 10.1093/carcin/bgq132; NAKAJIMA K, 1991, MOL CELL BIOL, V11, P1409, DOI 10.1128/MCB.11.3.1409; Raghavan A, 2001, J BIOL CHEM, V276, P47958, DOI 10.1074/jbc.M109511200; Ross CR, 2012, AGEING RES REV, V11, P473, DOI 10.1016/j.arr.2012.02.005; Rounbehler RJ, 2012, CELL, V150, P563, DOI 10.1016/j.cell.2012.06.033; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Sanduja S, 2012, FRONT BIOSCI-LANDMRK, V17, P174, DOI 10.2741/3920; Sanduja S, 2009, AGING-US, V1, P803, DOI 10.18632/aging.100086; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Shi ZD, 2010, J BIOL CHEM, V285, P32415, DOI 10.1074/jbc.M110.164863; SILVERMAN RH, 1988, J BIOL CHEM, V263, P7336; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Silverman RH, 2007, CYTOKINE GROWTH F R, V18, P381, DOI 10.1016/j.cytogfr.2007.06.012; Spencer JA, 1999, ONCOGENE, V18, P7319, DOI 10.1038/sj.onc.1203121; Stoecklin G, 2003, ONCOGENE, V22, P3554, DOI 10.1038/sj.onc.1206418; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Stritt C, 2009, NAT NEUROSCI, V12, P418, DOI 10.1038/nn.2280; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Suswam EA, 2013, J NEURO-ONCOL, V113, P195, DOI 10.1007/s11060-013-1112-8; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Suzuki K, 2003, J EXP MED, V198, P1717, DOI 10.1084/jem.20031701; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; VARNUM BC, 1989, ONCOGENE, V4, P119; Volinsky N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009043; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xie L, 2013, J INTERF CYTOK RES, V33, P588, DOI 10.1089/jir.2012.0065; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081269; Zhang SX, 2005, J BIOL CHEM, V280, P19115, DOI 10.1074/jbc.M413793200; Zhou AM, 2005, J INTERF CYTOK RES, V25, P595, DOI 10.1089/jir.2005.25.595; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355; ZULLO JN, 1985, CELL, V43, P793, DOI 10.1016/0092-8674(85)90252-1	117	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33629	33643		10.1074/jbc.M114.589556	http://dx.doi.org/10.1074/jbc.M114.589556			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25301952	hybrid, Green Published			2022-12-28	WOS:000345636600048
J	Sippel, KH; Vyas, NK; Zhang, W; Sankaran, B; Quiocho, FA				Sippel, Katherine H.; Vyas, Nand K.; Zhang, Wei; Sankaran, Banumathi; Quiocho, Florante A.			Crystal Structure of the Human Fatty Acid Synthase Enoyl-Acyl Carrier Protein-Reductase Domain Complexed with Triclosan Reveals Allosteric Protein-Protein Interface Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELL-DEATH; BREAST-CANCER CELLS; IN-VITRO; THIOESTERASE DOMAIN; OVEREXPRESSION; CHEMOPREVENTION; CYTOTOXICITY; MECHANISM; ONCOGENE; ANALOGS	Human fatty acid synthase (FAS) is a large, multidomain protein that synthesizes long chain fatty acids. Because these fatty acids are primarily provided by diet, FAS is normally expressed at low levels; however, it is highly up-regulated in many cancers. Human enoyl-acyl carrier protein-reductase (hER) is one of the FAS catalytic domains, and its inhibition by drugs like triclosan (TCL) can increase cytotoxicity and decrease drug resistance in cancer cells. We have determined the structure of hER in the presence and absence of TCL. TCL was not bound in the active site, as predicted, but rather at the protein-protein interface (PPI). TCL binding induces a dimer orientation change that causes downstream structural rearrangement in critical active site residues. Kinetics studies indicate that TCL is capable of inhibiting the isolated hER domain with an IC50 of similar to 55 mu M. Given the hER-TCL structure and the inhibition observed in the hER domain, it seems likely that TCL is observed in the physiologically relevant binding site and that it acts as an allosteric PPI inhibitor. TCL may be a viable scaffold for the development of anti-cancer PPI FAS inhibitors.	[Sippel, Katherine H.; Vyas, Nand K.; Zhang, Wei; Quiocho, Florante A.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Sankaran, Banumathi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Quiocho, FA (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	faq@bcm.edu			NIGMS, National Institutes of Health; Welch Foundation [Q-0581]; Howard Hughes Medical Institute; U.S. Department of Energy [DE-AC02-05CH11231]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported, in whole or in part, by a NIGMS, National Institutes of Health grant. This work was also supported by Welch Foundation Grant Q-0581, by the Howard Hughes Medical Institute, and by the U.S. Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adolfsson-Erici M, 2002, CHEMOSPHERE, V46, P1485, DOI 10.1016/S0045-6535(01)00255-7; Afonine P. V., 2013, COMPUT CRYSTALLOGR N, V4, P28; Ahn KC, 2008, ENVIRON HEALTH PERSP, V116, P1203, DOI 10.1289/ehp.11200; Allmyr M, 2008, SCI TOTAL ENVIRON, V393, P162, DOI 10.1016/j.scitotenv.2007.12.006; Allmyr M, 2006, SCI TOTAL ENVIRON, V372, P87, DOI 10.1016/j.scitotenv.2006.08.007; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bourgeas R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009598; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P303, DOI 10.1289/ehp.10768; Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; DAUB GW, 1977, J AM CHEM SOC, V99, P3526, DOI 10.1021/ja00452a069; Dayan AD, 2007, FOOD CHEM TOXICOL, V45, P125, DOI 10.1016/j.fct.2006.08.009; De Schrijver E, 2003, CANCER RES, V63, P3799; Deepa P R, 2010, J Ocul Biol Dis Infor, V3, P117, DOI 10.1007/s12177-011-9065-7; Deepa PR, 2012, BASIC CLIN PHARMACOL, V110, P494, DOI 10.1111/j.1742-7843.2011.00844.x; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dinwiddie MT, 2014, INT J ENV RES PUB HE, V11, P2209, DOI 10.3390/ijerph110202209; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Freundlich JS, 2009, CHEMMEDCHEM, V4, P241, DOI 10.1002/cmdc.200800261; Gao Y, 2006, CANCER BIOL THER, V5, P978, DOI 10.4161/cbt.5.8.2883; Gee RH, 2008, J APPL TOXICOL, V28, P78, DOI 10.1002/jat.1316; Henry ND, 2013, J APPL TOXICOL, V33, P265, DOI 10.1002/jat.1736; Higueruelo AP, 2009, CHEM BIOL DRUG DES, V74, P457, DOI 10.1111/j.1747-0285.2009.00889.x; Huang YY, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-171; JAYAKUMAR A, 1995, P NATL ACAD SCI USA, V92, P8695, DOI 10.1073/pnas.92.19.8695; Kapoor N, 2009, IUBMB LIFE, V61, P1083, DOI 10.1002/iub.258; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Knowles LM, 2004, J BIOL CHEM, V279, P30540, DOI 10.1074/jbc.M405061200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lenhard JM, 2011, CURR PHARM DESIGN, V17, P325, DOI 10.2174/138161211795164185; Leslie A.G.W., 2007, PROCESSING DIFFRACTI; Li JN, 2001, CANCER RES, V61, P1493; Liu BQ, 2002, CANCER CHEMOTH PHARM, V49, P187, DOI 10.1007/s00280-001-0399-x; Liu HL, 2008, MOL CANCER THER, V7, P263, DOI 10.1158/1535-7163.MCT-07-0445; Liu Hailan, 2010, Int J Biochem Mol Biol, V1, P69; Liu XS, 2006, MOL CANCER THER, V5, P494, DOI 10.1158/1535-7163.MCT-05-0049; Lu H, 2009, ACS CHEM BIOL, V4, P221, DOI 10.1021/cb800306y; Lu SY, 2005, CARCINOGENESIS, V26, P153, DOI 10.1093/carcin/bgh278; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A, 1982, PREPARATION ANAL PRO; Menendez JA, 2006, INT J GYNECOL CANCER, V16, P219, DOI 10.1111/j.1525-1438.2006.00297.x; Menendez JA, 2004, ONCOL REP, V12, P411; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Moss T, 2000, FOOD CHEM TOXICOL, V38, P361, DOI 10.1016/S0278-6915(99)00164-7; Orita H, 2008, CLIN CANCER RES, V14, P2458, DOI 10.1158/1078-0432.CCR-07-4177; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pappenberger G, 2010, J MOL BIOL, V397, P508, DOI 10.1016/j.jmb.2010.01.066; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Pizer ES, 1996, CANCER RES, V56, P1189; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Sandborgh-Englund G, 2006, J TOXICOL ENV HEAL A, V69, P1861, DOI 10.1080/15287390600631706; Stewart MJ, 1999, J MOL BIOL, V290, P859, DOI 10.1006/jmbi.1999.2907; Stivala A, 2011, BIOINFORMATICS, V27, P3315, DOI 10.1093/bioinformatics/btr575; STOOPS JK, 1979, J BIOL CHEM, V254, P7418; STOOPS JK, 1981, J BIOL CHEM, V256, P5128; Tipparaju SK, 2010, J MED CHEM, V53, P6287, DOI 10.1021/jm9017724; Turrado C, 2012, J MED CHEM, V55, P5013, DOI 10.1021/jm2016045; Vandhana S, 2013, BBA-MOL CELL BIOL L, V1831, P1458, DOI 10.1016/j.bbalip.2013.06.005; Vazquez-Martin A, 2008, CELL PROLIFERAT, V41, P59, DOI 10.1111/j.1365-2184.2007.00498.x; Vazquez-Martin A, 2007, ONCOL REP, V18, P973; Wang DZ, 2012, JNCI-J NATL CANCER I, V104, P343, DOI 10.1093/jnci/djs010; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Zhang W, 2011, P NATL ACAD SCI USA, V108, P15757, DOI 10.1073/pnas.1112334108; Zhang YM, 2004, LIPIDS, V39, P1055, DOI 10.1007/s11745-004-1330-3; Zhou WB, 2003, CANCER RES, V63, P7330	68	20	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33287	33295		10.1074/jbc.M114.608547	http://dx.doi.org/10.1074/jbc.M114.608547			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25301948	Green Published, hybrid			2022-12-28	WOS:000345636600020
J	Fu, YL; Liu, H; Ng, L; Kim, JW; Hao, H; Swaroop, A; Forrest, D				Fu, Yulong; Liu, Hong; Ng, Lily; Kim, Jung-Woong; Hao, Hong; Swaroop, Anand; Forrest, Douglas			Feedback Induction of a Photoreceptor-specific Isoform of Retinoid-related Orphan Nuclear Receptor beta by the Rod Transcription Factor NRL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FATE; CONE PHOTORECEPTORS; MOUSE RETINA; DIFFERENTIATION FACTOR; GENES; NR2E3; CRX; DEGENERATION; EXPRESSION; AMACRINE	Vision requires the generation of cone and rod photoreceptors that function in daylight and dim light, respectively. The neural retina leucine zipper factor (NRL) transcription factor critically controls photoreceptor fates as it stimulates rod differentiation and suppresses cone differentiation. However, the controls over NRL induction that balance rod and cone fates remain unclear. We have reported previously that the retinoid-related orphan receptor beta gene (Rorb) is required for Nrl expression and other retinal functions. We show that Rorb differentially expresses two isoforms: ROR beta 2 in photoreceptors and ROR beta 1 in photoreceptors, progenitor cells, and other cell types. Deletion of ROR beta 2 or ROR beta 1 increased the cone: rod ratio similar to 2-fold, whereas deletion of both isoforms in Rorb(-/-) mice produced almost exclusively cone-like cells at the expense of rods, suggesting that both isoforms induce Nrl. Electroporation of either ROR beta isoform into retinal explants from Rorb(-/-) neonates reactivated Nrl and rod genes but, in Nrl(-/-) explants, failed to reactivate rod genes, indicating that NRL is the effector for both ROR beta isoforms in rod differentiation. Unexpectedly, ROR beta 2 expression was lost in Nrl(-/-) mice. Moreover, NRL-activated the ROR beta 2-specific promoter of Rorb, indicating that NRL activates Rorb, its own inducer gene. We suggest that feedback activation between Nrl and Rorb genes reinforces the commitment to rod differentiation.	[Fu, Yulong; Liu, Hong; Ng, Lily; Forrest, Douglas] NIDDK, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Kim, Jung-Woong; Hao, Hong; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Forrest, D (corresponding author), NIDDK, Lab Endocrinol & Receptor Biol, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.	forrestd@niddk.nih.gov		Swaroop, Anand/0000-0002-1975-1141	NIDDK; NEI at the National Institutes of Health; KaroBio Foundation; NATIONAL EYE INSTITUTE [ZIAEY000450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047035] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); KaroBio Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the intramural research programs of the NIDDK (to D. F.) and NEI (to A. S.) at the National Institutes of Health. This work was also supported by the KaroBio Foundation (to D. F.).	Adler R, 2008, BRAIN RES, V1192, P134, DOI 10.1016/j.brainres.2007.03.044; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Andre E, 1998, GENE, V216, P277, DOI 10.1016/S0378-1119(98)00348-5; Baglietto MG, 2014, EUR J MED GENET, V57, P44, DOI 10.1016/j.ejmg.2013.12.001; Boudry-Labis E, 2013, EUR J MED GENET, V56, P163, DOI 10.1016/j.ejmg.2012.12.006; Brooks Matthew J, 2012, Methods Mol Biol, V884, P319, DOI 10.1007/978-1-61779-848-1_23; Brzezinski J., 2010, ENCY EYE, P73, DOI DOI 10.1016/B978-0-12-374203-2.00251-7; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cheng H, 2011, HUM MOL GENET, V20, P4102, DOI 10.1093/hmg/ddr334; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Forrest D, 2012, MOL ENDOCRINOL, V26, P905, DOI 10.1210/me.2012-1010; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Jukam D, 2010, CURR OPIN NEUROBIOL, V20, P6, DOI 10.1016/j.conb.2009.11.002; Kautzmann MAI, 2011, J BIOL CHEM, V286, P28247, DOI 10.1074/jbc.M111.257246; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Kobayashi M, 2000, MOL CELL BIOL, V20, P8731, DOI 10.1128/MCB.20.23.8731-8739.2000; Li SG, 2004, NEURON, V43, P795, DOI 10.1016/j.neuron.2004.08.041; Liu H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2793; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Matsuda Takahiko, 2008, V423, P259, DOI 10.1007/978-1-59745-194-9_19; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Montana CL, 2013, P NATL ACAD SCI USA, V110, P1732, DOI 10.1073/pnas.1214387110; Montana CL, 2011, J BIOL CHEM, V286, P36921, DOI 10.1074/jbc.M111.279026; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2011, J NEUROSCI, V31, P11118, DOI 10.1523/JNEUROSCI.1709-11.2011; Oeno S., 2005, EXP EYE RES, V81, P751; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Roger JE, 2014, J CLIN INVEST, V124, P631, DOI 10.1172/JCI72722; Roger JE, 2010, J BIOL CHEM, V285, P25637, DOI 10.1074/jbc.M110.142810; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Vetter ML, 2001, SEMIN CELL DEV BIOL, V12, P491, DOI 10.1006/scdb.2001.0273; Xiang MQ, 2013, CELL MOL LIFE SCI, V70, P2519, DOI 10.1007/s00018-012-1183-2; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	54	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.605774	http://dx.doi.org/10.1074/jbc.M114.605774			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25296752	hybrid, Green Published			2022-12-28	WOS:000345335000007
J	Ma, TC; Barco, A; Ratan, RR; Willis, DE				Ma, Thong C.; Barco, Angel; Ratan, Rajiv R.; Willis, Dianna E.			cAMP-responsive Element-binding Protein (CREB) and cAMP Co-regulate Activator Protein 1 (AP1)-dependent Regeneration-associated Gene Expression and Neurite Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; PROMOTES AXONAL REGENERATION; PERIPHERAL-NERVE INJURY; DORSAL-ROOT GANGLION; C-JUN; CYCLIC-AMP; FUNCTIONAL RECOVERY; SENSORY AXONS; SCHWANN-CELLS; TRANSCRIPTION FACTORS	To regenerate damaged axons, neurons must express a cassette of regeneration-associated genes (RAGs) that increases intrinsic growth capacity and confers resistance to extrinsic inhibitory cues. Here we show that dibutyrl-cAMP or forskolin combined with constitutive-active CREB are superior to either agent alone in driving neurite growth on permissive and inhibitory substrates. Of the RAGs examined, only arginase 1 (Arg1) expression correlated with the increased neurite growth induced by the cAMP/CREB combination, both of which were AP1-dependent. This suggests that cAMP-induced AP1 activity is necessary and interacts with CREB to drive expression of RAGs relevant for regeneration and demonstrates that combining a small molecule (cAMP) with an activated transcription factor (CREB) stimulates the gene expression necessary to enhance axonal regeneration.	[Ma, Thong C.; Ratan, Rajiv R.; Willis, Dianna E.] Burke Cornell Med Res Inst, White Plains, NY 10605 USA; [Barco, Angel] Univ Miguel Hernandez Elche, CSIC, Inst Neurociencias Alicante, Alicante 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Willis, DE (corresponding author), Burke Cornell Med Res Inst, 785 Mamaroneck Ave, White Plains, NY 10605 USA.	diw2004@med.cornell.edu	Barco, Angel/ABF-1864-2021; Barco, Angel/C-3062-2008	Barco, Angel/0000-0002-0653-3751; Barco, Angel/0000-0002-0653-3751; Ma, Thong/0000-0002-9395-0448	National Institutes of Health [NR010797]; Dr. Miriam and Sheldon G. Adelson Foundation; Center for Research Excellence in Spinal Cord Injury [DOHC019772]; Burke Medical Research Institute Foundation; Spanish Ministry of Science and Innovation [SAF2011-22855]; Generalitat Valenciana [Prometeo/2012/005]; NATIONAL INSTITUTE OF NURSING RESEARCH [K99NR010797, R00NR010797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Foundation; Center for Research Excellence in Spinal Cord Injury; Burke Medical Research Institute Foundation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant NR010797 (to D. W.). This work was also supported by grants from the Dr. Miriam and Sheldon G. Adelson Foundation (to R. R.), The Center for Research Excellence in Spinal Cord Injury (Grant DOHC019772; to R. R.), and the Burke Medical Research Institute Foundation (to D. W.). The Barco laboratory is supported by Grants SAF2011-22855 from the Spanish Ministry of Science and Innovation and Prometeo/2012/005 from the Generalitat Valenciana.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Andersen PL, 2000, EXP NEUROL, V166, P153, DOI 10.1006/exnr.2000.7485; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Anouar Y, 1999, MOL PHARMACOL, V56, P162, DOI 10.1124/mol.56.1.162; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Benito E, 2011, J NEUROSCI, V31, P18237, DOI 10.1523/JNEUROSCI.4554-11.2011; Blesch A, 2012, EXP NEUROL, V235, P162, DOI 10.1016/j.expneurol.2011.12.037; Boeshore KL, 2004, J NEUROBIOL, V59, P216, DOI 10.1002/neu.10308; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Cao ZX, 2006, J NEUROSCI, V26, P5565, DOI 10.1523/JNEUROSCI.0815-06.2006; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Costa LM, 2013, BEHAV BRAIN RES, V243, P66, DOI 10.1016/j.bbr.2012.12.056; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Eid AH, 2008, AM J PHYSIOL-HEART C, V295, pH266, DOI 10.1152/ajpheart.00084.2008; Fontana X, 2012, J CELL BIOL, V198, P127, DOI 10.1083/jcb.201205025; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hernandez JM, 2008, ONCOGENE, V27, P4757, DOI 10.1038/onc.2008.120; Jessen BA, 2000, GENE, V254, P77, DOI 10.1016/S0378-1119(00)00291-2; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kwon MJ, 2013, J NEUROSCI, V33, P15095, DOI 10.1523/JNEUROSCI.0278-13.2013; Lesiak A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064658; Li YM, 2003, J NEUROSCI, V23, P7830; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Ma CHE, 2011, J CLIN INVEST, V121, P4332, DOI 10.1172/JCI58675; Ma TC, 2010, J NEUROSCI, V30, P739, DOI 10.1523/JNEUROSCI.5266-09.2010; Michaelevski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000952; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Niemi JP, 2013, J NEUROSCI, V33, P16236, DOI 10.1523/JNEUROSCI.3319-12.2013; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Schwede F, 2000, PHARMACOL THERAPEUT, V87, P199, DOI 10.1016/S0163-7258(00)00051-6; Seijffers R, 2006, MOL CELL NEUROSCI, V32, P143, DOI 10.1016/j.mcn.2006.03.005; Sharda DR, 2011, J IMMUNOL, V187, P2181, DOI 10.4049/jimmunol.1003460; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Smith DS, 1997, J NEUROSCI, V17, P646; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Udina E, 2008, EXP NEUROL, V210, P238, DOI 10.1016/j.expneurol.2007.11.007; Yin YQ, 2009, P NATL ACAD SCI USA, V106, P19587, DOI 10.1073/pnas.0907085106; Ylera B, 2009, CURR BIOL, V19, P930, DOI 10.1016/j.cub.2009.04.017; Zhu WF, 2010, AM J PHYSIOL-CELL PH, V298, pC952, DOI 10.1152/ajpcell.00466.2009	54	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.582460	http://dx.doi.org/10.1074/jbc.M114.582460			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25296755	Green Published, hybrid			2022-12-28	WOS:000345335000043
J	Anekal, PV; Yong, J; Manser, E				Anekal, Praju Vikas; Yong, Jeffery; Manser, Ed			Arg Kinase-binding Protein 2 (ArgBP2) Interaction with alpha-Actinin and Actin Stress Fibers Inhibits Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONMUSCLE MYOSIN-II; CYTOSKELETAL ORGANIZATION; EPITHELIAL-CELLS; ADAPTER PROTEIN; Z-DISC; LOCALIZATION; EXPRESSION; ADHESION; FAMILY; PHOSPHORYLATION	Cell migration requires dynamic remodeling of the actomyosin network. We report here that an adapter protein, ArgBP2, is a component of alpha-actinin containing stress fibers and inhibits migration. ArgBP2 is undetectable in many commonly studied cancer-derived cell lines. COS-7 and HeLa cells express ArgBP2 (by Western analysis), but expression was detectable only in approximately half the cells by immunofluorescence. Short term clonal analysis demonstrated 0.2-0.3% of cells switch ArgBP2 expression (on or off) per cell division. ArgBP2 can have a fundamental impact on the actomyosin network: ArgBP2 positive COS-7 cells, for example, are clearly distinguishable by their denser actomyosin (stress fiber) network. ArgBP2 gamma binding to alpha-actinin appears to underlie its ability to localize to stress fibers and decrease cell migration. We map a small alpha-actinin binding region in ArgBP2 (residues 192-228) that is essential for these effects. Protein kinase A phosphorylation of ArgBP2 gamma at neighboring Ser-259 and consequent 14-3-3 binding blocks its interaction with alpha-actinin. ArgBP2 is known to be down-regulated in some aggressively metastatic cancers. Our work provides a biochemical explanation for the anti-migratory effect of ArgBP2.	[Anekal, Praju Vikas; Yong, Jeffery; Manser, Ed] sGSK Grp Inst Mol & Cell Biol IMCB, Singapore 138673, Singapore; [Manser, Ed] IMB, Singapore 138648, Singapore; [Manser, Ed] Natl Univ Singapore, Dept Pharmacol, Singapore 119077, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	Manser, E (corresponding author), sGSK Grp Inst Mol & Cell Biol IMCB, Proteos Bldg,61 Biopolis Dr, Singapore 138673, Singapore.	ed.manser@imb.a-star.edu.sg	Manser, Edward/ABD-2301-2020		GSK-Institute of Molecular and Cell Biology research fund	GSK-Institute of Molecular and Cell Biology research fund	This work was supported in part by the GSK-Institute of Molecular and Cell Biology research fund.	Backsch C, 2011, CARCINOGENESIS, V32, P1100, DOI 10.1093/carcin/bgr093; Barth AS, 2006, J AM COLL CARDIOL, V48, P1610, DOI 10.1016/j.jacc.2006.07.026; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Burnette DT, 2014, J CELL BIOL, V205, P83, DOI 10.1083/jcb.201311104; Cestra G, 2005, P NATL ACAD SCI USA, V102, P1731, DOI 10.1073/pnas.0409376102; Chan PM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005157; Faul C, 2007, MOL CELL BIOL, V27, P8215, DOI 10.1128/MCB.00950-07; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Gao CZ, 2010, BBA-MOL CELL RES, V1803, P1186, DOI 10.1016/j.bbamcr.2010.06.008; GEIGER B, 1981, J CELL BIOL, V91, P614, DOI 10.1083/jcb.91.3.614; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Hampton CM, 2007, J MOL BIOL, V368, P92, DOI 10.1016/j.jmb.2007.01.071; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Kawabe H, 1999, J BIOL CHEM, V274, P30914, DOI 10.1074/jbc.274.43.30914; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; Koga Y, 2008, MOL BIOL CELL, V19, P1062, DOI 10.1091/mbc.E07-07-0668; LAZARIDES E, 1975, CELL, V6, P289, DOI 10.1016/0092-8674(75)90180-4; Leung T, 1996, MOL CELL BIOL, V16, P5313; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Martin M, 2013, EMBO J, V32, P2491, DOI 10.1038/emboj.2013.187; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Murase K, 2012, MED MOL MORPHOL, V45, P22, DOI 10.1007/s00795-010-0537-9; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Robens JM, 2010, MOL CELL BIOL, V30, P829, DOI 10.1128/MCB.01574-08; Roignot J, 2010, CANCER LETT, V288, P116, DOI 10.1016/j.canlet.2009.06.030; Roignot J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087130; Roignot J, 2009, CELL ADHES MIGR, V3, P167, DOI 10.4161/cam.3.2.7576; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; SANGER JW, 1983, J CELL BIOL, V96, P961, DOI 10.1083/jcb.96.4.961; Scaife RM, 2000, J CELL SCI, V113, P215; Scaife RM, 2003, J CELL SCI, V116, P463, DOI 10.1242/jcs.00244; Taieb D, 2008, CANCER RES, V68, P4588, DOI 10.1158/0008-5472.CAN-08-0958; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang BL, 1997, J BIOL CHEM, V272, P17542, DOI 10.1074/jbc.272.28.17542; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yuan ZQ, 2005, J BIOL CHEM, V280, P21483, DOI 10.1074/jbc.M500097200	51	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2112	2125		10.1074/jbc.M114.610725	http://dx.doi.org/10.1074/jbc.M114.610725			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25429109	hybrid, Green Published			2022-12-28	WOS:000348588000017
J	Desai, R; Geeves, MA; Kad, NM				Desai, Rama; Geeves, Michael A.; Kad, Neil M.			Using Fluorescent Myosin to Directly Visualize Cooperative Activation of Thin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPONIN-TROPOMYOSIN; MOLECULE MECHANICS; HEAVY-MEROMYOSIN; ACTIN-FILAMENTS; MUSCLE; SUBFRAGMENT-1; PROTEINS; DYNAMICS; CALCIUM; FORCE	Contraction of striated muscle is tightly regulated by the release and sequestration of calcium within myocytes. At the molecular level, calcium modulates myosin's access to the thin filament. Once bound, myosin is hypothesized to potentiate the binding of further myosins. Here, we directly image single molecules of myosin binding to and activating thin filaments. Using this approach, the cooperative binding of myosin along thin filaments has been quantified. We have found that two myosin heads are required to laterally activate a regulatory unit of thin filament. The regulatory unit is found to be capable of accommodating 11 additional myosins. Three thin filament activation states possessing differential myosin binding capacities are also visible. To describe this system, we have formulated a simple chemical kinetic model of cooperative activation that holds across a wide range of solution conditions. The stochastic nature of activation is strongly highlighted by data obtained in suboptimal activation conditions where the generation of activation waves and their catastrophic collapse can be observed. This suggests that the thin filament has the potential to be turned fully on or off in a binary fashion.	[Desai, Rama; Geeves, Michael A.; Kad, Neil M.] Univ Kent, Sch Biosci, Canterbury C12 7NH, Kent, England	University of Kent	Kad, NM (corresponding author), Univ Kent, Sch Biosci, Canterbury C12 7NH, Kent, England.	n.kad@kent.ac.uk	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; Kad, Neil/0000-0002-3491-8595	Biotechnology and Biological Sciences Research Council [BB/I003460/1]; Wellcome Trust [085309]; BBSRC [BB/I003460/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/I003460/1 (to N. M. K.), and the Wellcome Trust Programme Grant 085309 (to M. A. G.).	COOKE R, 1978, J MOL BIOL, V120, P361, DOI 10.1016/0022-2836(78)90424-2; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FRASER IDC, 1995, J BIOL CHEM, V270, P7836, DOI 10.1074/jbc.270.14.7836; Fusi L, 2014, P NATL ACAD SCI USA, V111, P4626, DOI 10.1073/pnas.1321868111; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Geeves MA, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P251, DOI 10.1016/B978-0-12-374920-8.00416-1; GEEVES MA, 1994, BIOPHYS J, V67, P273, DOI 10.1016/S0006-3495(94)80478-3; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gorga JA, 2003, BIOPHYS J, V85, P2484, DOI 10.1016/S0006-3495(03)74671-2; GREENE LE, 1980, P NATL ACAD SCI-BIOL, V77, P2616, DOI 10.1073/pnas.77.5.2616; Guilford WH, 1997, BIOPHYS J, V72, P1006, DOI 10.1016/S0006-3495(97)78753-8; HACKNEY DD, 1984, P NATL ACAD SCI-BIOL, V81, P5345, DOI 10.1073/pnas.81.17.5345; Homsher E, 1996, BIOPHYS J, V70, P1881, DOI 10.1016/S0006-3495(96)79753-9; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Kad NM, 2010, MOL CELL, V37, P702, DOI 10.1016/j.molcel.2010.02.003; Kad NM, 2005, P NATL ACAD SCI USA, V102, P16990, DOI 10.1073/pnas.0506326102; Kad NM, 2003, J CELL BIOL, V162, P481, DOI 10.1083/jcb.200304023; Kalyva A, 2012, BIOCHEMISTRY-US, V51, P6388, DOI 10.1021/bi300340r; Konopka CA, 2008, PLANT J, V53, P186, DOI 10.1111/j.1365-313X.2007.03306.x; LEHRER SS, 1982, J BIOL CHEM, V257, P8073; Loong CKP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039676; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Mijailovich SM, 2012, EUR BIOPHYS J BIOPHY, V41, P1015, DOI 10.1007/s00249-012-0859-8; MOLLOY JE, 1995, BIOPHYS J, V68, pS298; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Phillips GN, 1996, BIOPOLYMERS, V38, P89, DOI 10.1002/(SICI)1097-0282(199601)38:1<89::AID-BIP7>3.3.CO;2-X; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; SILVERMAN BW, 1984, ANN STAT, V12, P898, DOI 10.1214/aos/1176346710; Smith DA, 2003, BIOPHYS J, V84, P3168, DOI 10.1016/S0006-3495(03)70041-1; Tanaka H, 1998, BIOPHYS J, V75, P1886, DOI 10.1016/S0006-3495(98)77629-5; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800	42	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1915	1925		10.1074/jbc.M114.609743	http://dx.doi.org/10.1074/jbc.M114.609743			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25429108	Green Published, hybrid			2022-12-28	WOS:000348588000002
J	Farmer, LK; Schmid, R; Evans, RJ				Farmer, Louise K.; Schmid, Ralf; Evans, Richard J.			Use of Chimeras, Point Mutants, and Molecular Modeling to Map the Antagonist-binding Site of 4,4 ',4 '',4 '''-(Carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic Acid (NF449) at P2X1 Receptors for ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P2X(1) RECEPTORS; ION-CHANNEL; IONOTROPIC RECEPTOR; POTENCY ANTAGONIST; P-2X RECEPTOR; AMINO-ACIDS; GATED P2X; DESENSITIZATION; SELECTIVITY; THROMBOSIS	P2X receptor subtype-selective antagonists are promising candidates for treatment of a range of pathophysiological conditions. However, in contrast to high resolution structural understanding of agonist action in the receptors, comparatively little is known about the molecular basis of antagonist binding. We have generated chimeras and point mutations in the extracellular ligand-binding loop of the human P2X1 receptor, which is inhibited by NF449, suramin, and pyridoxal-phosphate-6-azophenyl-2,4-disulfonate, with residues from the rat P2X4 receptor, which is insensitive to these antagonists. There was little or no effect on sensitivity to suramin and pyridoxal-phosphate-6-azophenyl-2,4-disulfonate in chimeric P2X1/4 receptors, indicating that a significant number of residues required for binding of these antagonists are present in the P2X4 receptor. Sensitivity to the P2X1 receptor-selective antagonist NF449 was reduced by similar to 60- and similar to 135-fold in chimeras replacing the cysteine-rich head, and the dorsal fin region below it in the adjacent subunit, respectively. Point mutants identified the importance of four positively charged residues at the base of the cysteine-rich head and two variant residues in the dorsal fin for high affinity NF449 binding. These six residues were used as the starting area for molecular docking. The four best potential NF449-binding poses were then discriminated by correspondence with the mutagenesis data and an additional mutant to validate the binding of one lobe of NF449 within the core conserved ATP-binding pocket and the other lobes coordinated by positive charge on the cysteine-rich head region and residues in the adjacent dorsal fin.	[Farmer, Louise K.; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Schmid, Ralf] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk	Schmid, Ralf/ABE-1065-2020; Schmid, Ralf/E-6722-2011	Schmid, Ralf/0000-0002-0203-4023; Schmid, Ralf/0000-0002-0203-4023; Farmer, Louise/0000-0002-9462-2606	British Heart Foundation	British Heart Foundation(British Heart Foundation)	The work was supported by a Ph.D. studentship from the British Heart Foundation (to L. K. F.).	Allsopp RC, 2011, J BIOL CHEM, V286, P44691, DOI 10.1074/jbc.M111.303917; BO XN, 1995, FEBS LETT, V375, P129, DOI 10.1016/0014-5793(95)01203-Q; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Braun K, 2001, N-S ARCH PHARMACOL, V364, P285, DOI 10.1007/s002100100463; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burnstock G, 2012, BIOESSAYS, V34, P218, DOI 10.1002/bies.201100130; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chataigneau T, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00273; El-Ajouz S, 2012, BRIT J PHARMACOL, V165, P390, DOI 10.1111/j.1476-5381.2011.01534.x; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Evans RJ, 2010, BRIT J PHARMACOL, V161, P961, DOI 10.1111/j.1476-5381.2010.00728.x; EVANS RJ, 1995, MOL PHARMACOL, V48, P178; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; GarciaGuzman M, 1997, MOL PHARMACOL, V51, P109, DOI 10.1124/mol.51.1.109; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hausmann R, 2006, MOL PHARMACOL, V69, P2058, DOI 10.1124/mol.106.022665; Hechler B, 2005, J PHARMACOL EXP THER, V314, P232, DOI 10.1124/jpet.105.084673; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Hulsmann M, 2003, EUR J PHARMACOL, V470, P1, DOI 10.1016/S0014-2999(03)01761-8; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Oury C, 2003, BLOOD, V101, P3969, DOI 10.1182/blood-2002-10-3215; Rettinger J, 2005, NEUROPHARMACOLOGY, V48, P461, DOI 10.1016/j.neuropharm.2004.11.003; Roberts JA, 2012, P NATL ACAD SCI USA, V109, P4663, DOI 10.1073/pnas.1201872109; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Sim JA, 2008, J BIOL CHEM, V283, P29841, DOI 10.1074/jbc.M802523200; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Xiong KM, 2004, NEUROSCI LETT, V367, P197, DOI 10.1016/j.neulet.2004.06.008; Young MT, 2010, TRENDS BIOCHEM SCI, V35, P83, DOI 10.1016/j.tibs.2009.09.006	34	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1559	1569		10.1074/jbc.M114.592246	http://dx.doi.org/10.1074/jbc.M114.592246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25425641	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000348056400025
J	Wei, Y; Stec, B; Redfield, AG; Weerapana, E; Roberts, MF				Wei, Yang; Stec, Boguslaw; Redfield, Alfred G.; Weerapana, Eranthie; Roberts, Mary F.			Phospholipid-binding Sites of Phosphatase and Tensin Homolog (PTEN) EXPLORING THE MECHANISM OF PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIELD-CYCLING NMR; TUMOR-SUPPRESSOR FUNCTION; MEMBRANE ASSOCIATION; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ANIONIC PHOSPHOLIPIDS; RELAXATION; ACTIVATION; DYNAMICS; PHOSPHOINOSITIDES; MECHANISM	The lipid phosphatase activity of the tumor suppressor phosphatase and tensin homolog (PTEN) is enhanced by the presence of its biological product, phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2). This enhancement is suggested to occur via the product binding to the N-terminal region of the protein. PTEN effects on short-chain phosphoinositide P-31 linewidths and on the full field dependence of the spin-lattice relaxation rate (measured by high resolution field cycling P-31 NMR using spin-labeled protein) are combined with enzyme kinetics with the same short-chain phospholipids to characterize where PI(4,5)P-2 binds on the protein. The results are used to model a discrete site for a PI(4,5)P-2 molecule close to, but distinct from, the active site of PTEN. This PI(4,5)P-2 site uses Arg-47 and Lys-13 as phosphate ligands, explaining why PTEN R47G and K13E can no longer be activated by that phosphoinositide. Placing a PI(4,5)P-2 near the substrate site allows for proper orientation of the enzyme on interfaces and should facilitate processive catalysis.	[Wei, Yang; Stec, Boguslaw; Weerapana, Eranthie; Roberts, Mary F.] Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA; [Redfield, Alfred G.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Boston College; Brandeis University	Roberts, MF (corresponding author), Boston Coll, Dept Chem, 2609 Beacon St, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu		Stec, Boguslaw/0000-0002-8696-0349	National Science Foundation [MCB-0950331]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0950331.	Cai JF, 2013, J BIOL CHEM, V288, P37277, DOI 10.1074/jbc.M113.512186; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Chang N, 2007, TRENDS NEUROSCI, V30, P581, DOI 10.1016/j.tins.2007.08.006; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gradziel CS, 2014, BIOCHEMISTRY-US, V53, P462, DOI 10.1021/bi401720v; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Kalli AC, 2014, BIOCHEMISTRY-US, V53, P1724, DOI 10.1021/bi5000299; Klauda JB, 2008, BIOPHYS J, V94, P3074, DOI 10.1529/biophysj.107.121806; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; LEWIS KA, 1993, BIOCHEMISTRY-US, V32, P8836, DOI 10.1021/bi00085a014; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Maler L, 2018, NUCL SPIN RELAXATION, V2nd; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Pu MM, 2010, J BIOL CHEM, V285, P26916, DOI 10.1074/jbc.M110.123083; Pu MM, 2009, BIOCHEMISTRY-US, V48, P8282, DOI 10.1021/bi901190j; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Redfern RE, 2008, BIOCHEMISTRY-US, V47, P2162, DOI 10.1021/bi702114w; Redfield AG, 2012, J BIOMOL NMR, V52, P159, DOI 10.1007/s10858-011-9594-1; Roberts MF, 2004, P NATL ACAD SCI USA, V101, P17066, DOI 10.1073/pnas.0407565101; Roberts MF, 2004, J AM CHEM SOC, V126, P13765, DOI 10.1021/ja046658k; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shenoy SS, 2012, J STRUCT BIOL, V180, P394, DOI 10.1016/j.jsb.2012.10.003; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839; Wang Q, 2010, J MOL GRAPH MODEL, V29, P102, DOI 10.1016/j.jmgm.2010.05.004; Wang YLK, 2008, J AM CHEM SOC, V130, P7746, DOI 10.1021/ja710348r; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	37	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1592	1606		10.1074/jbc.M114.588590	http://dx.doi.org/10.1074/jbc.M114.588590			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25429968	Green Published, hybrid			2022-12-28	WOS:000348056400028
J	Wang, WZ; Zhang, F; Li, L; Tang, FQ; Siedlak, SL; Fujioka, H; Liu, YC; Su, B; Pi, Y; Wang, XL				Wang, Wenzhang; Zhang, Fan; Li, Li; Tang, Fangqiang; Siedlak, Sandra L.; Fujioka, Hisashi; Liu, Yingchao; Su, Bo; Pi, Yan; Wang, Xinglong			MFN2 Couples Glutamate Excitotoxicity and Mitochondrial Dysfunction in Motor Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calpain; Excitotoxicity; Glutamate; Mitochondria; Neurodegeneration; MFN2; Glutamate Excitotoxicity; Mitochondrial Dynamics; Motor Neuron	AMYOTROPHIC-LATERAL-SCLEROSIS; CEREBRAL-ISCHEMIA; ENDOPLASMIC-RETICULUM; MONOSODIUM GLUTAMATE; HIPPOCAMPAL-NEURONS; MAMMALIAN-CELLS; BRAIN LESIONS; FISSION; DEATH; DYNAMICS	Background: Mitochondrial function is dependent on mitochondrial fission and fusion dynamics. Results: Calpain-mediated degradation of MFN2 is responsible for glutamate-induced mitochondrial dysfunction and neuronal death in spinal cord motor neurons. Conclusion: Calpain-mediated MFN2 degradation is a novel mechanism regulating mitochondrial fusion during glutamate excitotoxicity. Significance: MFN2 might be a novel therapeutic target against glutamate excitotoxicity in motor neurons. Mitochondrial dysfunction plays a central role in glutamate-evoked neuronal excitotoxicity, and mitochondrial fission/fusion dynamics are essential for mitochondrial morphology and function. Here, we establish a novel mechanistic linker among glutamate excitotoxicity, mitochondrial dynamics, and mitochondrial dysfunction in spinal cord motor neurons. Ca2+-dependent activation of the cysteine protease calpain in response to glutamate results in the degradation of a key mitochondrial outer membrane fusion regulator, mitofusin 2 (MFN2), and leads to MFN2-mediated mitochondrial fragmentation preceding glutamate-induced neuronal death. MFN2 deficiency impairs mitochondrial function, induces motor neuronal death, and renders motor neurons vulnerable to glutamate excitotoxicity. Conversely, MFN2 overexpression blocks glutamate-induced mitochondrial fragmentation, mitochondrial dysfunction, and/or neuronal death in spinal cord motor neurons both in vitro and in mice. The inhibition of calpain activation also alleviates glutamate-induced excitotoxicity of mitochondria and neurons. Overall, these results suggest that glutamate excitotoxicity causes mitochondrial dysfunction by impairing mitochondrial dynamics via calpain-mediated MFN2 degradation in motor neurons and thus present a molecular mechanism coupling glutamate excitotoxicity and mitochondrial dysfunction.	[Wang, Wenzhang; Zhang, Fan; Li, Li; Tang, Fangqiang; Siedlak, Sandra L.; Wang, Xinglong] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Fujioka, Hisashi] Case Western Reserve Univ, Electron Microscopy Core Facil, Cleveland, OH 44106 USA; [Zhang, Fan; Liu, Yingchao] Shandong Univ, Dept Neurosurg, Jinan 250012, Peoples R China; [Su, Bo] Shandong Univ, Dept Neurobiol, Jinan 250012, Peoples R China; [Pi, Yan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Case Western Reserve University; Case Western Reserve University; Shandong University; Shandong University; Fudan University	Wang, XL (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	xinglong.wang@case.edu	Wang, Wenzhang/H-8581-2015	Wang, Wenzhang/0000-0003-4426-019X	National Institutes of Health [R03AG044680, R21NS085747, R01NS089604]; Alzheimer's Association Grant [NIRG-11-204281]; China Scholarship Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS085747, R01NS089604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG044680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association Grant(Alzheimer's Association); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R03AG044680, R21NS085747, and R01NS089604. This work was also supported by Alzheimer's Association Grant NIRG-11-204281 and China Scholarship Council (to F. Z.).	Ackerley S, 2000, J CELL BIOL, V150, P165, DOI 10.1083/jcb.150.1.165; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Doshi Shachee, 2009, Front Biosci (Schol Ed), V1, P466, DOI 10.2741/e38; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fujisawa H, 1996, J NEUROTRAUM, V13, P245, DOI 10.1089/neu.1996.13.245; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; HAWKINS RA, 1995, CELL TISSUE RES, V281, P207, DOI 10.1007/s004410050417; Hirata A, 1997, BRAIN RES, V771, P37, DOI 10.1016/S0006-8993(97)00709-9; Hossain MI, 2013, J BIOL CHEM, V288, P9696, DOI 10.1074/jbc.M112.419713; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; Hou ST, 2002, INT REV CYTOL, V221, P93; Jaiswal MK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00199; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Li HM, 2013, NAT CELL BIOL, V15, P773, DOI 10.1038/ncb2791; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; MANEV H, 1989, MOL PHARMACOL, V36, P106; Martorell-Riera A, 2014, EMBO J, V33, P2388, DOI 10.15252/embj.201488327; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Namura S, 1998, J NEUROSCI, V18, P3659; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; OLNEY JW, 1969, SCIENCE, V166, P386, DOI 10.1126/science.166.3903.386; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; RANDALL RD, 1992, J NEUROSCI, V12, P1882; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; ROTHSTEIN JD, 1995, ADV NEUROL, V68, P7; Sargsyan SA, 2005, GLIA, V51, P241, DOI 10.1002/glia.20210; Schinder AF, 1996, J NEUROSCI, V16, P6125; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P45, DOI 10.1016/j.bbadis.2009.08.012; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Vincent AM, 2004, NEUROBIOL DIS, V16, P407, DOI 10.1016/j.nbd.2004.03.001; Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319; Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhao WH, 2004, J NEUROPATH EXP NEUR, V63, P964, DOI 10.1093/jnen/63.9.964	66	71	71	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					168	182		10.1074/jbc.M114.617167	http://dx.doi.org/10.1074/jbc.M114.617167			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25416777	Green Published, hybrid			2022-12-28	WOS:000347231200015
J	Zhao, X; Hsu, KS; Lim, JH; Bruggeman, LA; Kao, HY				Zhao, Xuan; Hsu, Kuo-Sheng; Lim, Jun Hee; Bruggeman, Leslie A.; Kao, Hung-Ying			alpha-Actinin 4 Potentiates Nuclear Factor kappa-Light-chain-enhancer of Activated B-cell (NF-kappa B) Activity in Podocytes Independent of Its Cytoplasmic Actin Binding Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glucocorticoid Receptor; NF-kappa B (NF-KB); Podocyte; Transcription Regulation; Transcriptional Coactivator; Alpha-Actinin 4; Focal Segmental Glomerulosclerosis; FSGS; ACTN4; Glomerulopathies	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; HIV-ASSOCIATED NEPHROPATHY; ALPHA-ACTININ-4; PROTEIN; ACTN4; TRANSCRIPTION; INFLAMMATION; EXPRESSION; MUTATIONS; APOPTOSIS	Background: ACTN4 is an actin-binding protein and is associated with kidney diseases. Results: Nuclear ACTN4 interacts with NF-B and is recruited to NF-B-targeted promoters to potentiate its transcription activity. Conclusion: ACTN4 coactivates NF-B activity independently of its cytoplasmic activity in cultured human podocytes. Significance: Nuclear ACTN4 may play an important role in glomerular function. Glomerular podocytes are highly specialized terminally differentiated cells that act as a filtration barrier in the kidney. Mutations in the actin-binding protein, -actinin 4 (ACTN4), are linked to focal segmental glomerulosclerosis (FSGS), a chronic kidney disease characterized by proteinuria. Aberrant activation of NF-B pathway in podocytes is implicated in glomerular diseases including proteinuria. We demonstrate here that stable knockdown of ACTN4 in podocytes significantly reduces TNF-mediated induction of NF-B target genes, including IL-1 and NPHS1, and activation of an NF-B-driven reporter without interfering with p65 nuclear translocation. Overexpression of ACTN4 and an actin binding-defective variant increases the reporter activity. In contrast, an FSGS-linked ACTN4 mutant, K255E, which has increased actin binding activity and is predominantly cytoplasmic, fails to potentiate NF-B activity. Mechanistically, IB blocks the association of ACTN4 and p65 in the cytosol. In response to TNF, both NF-B subunits p65 and p50 translocate to the nucleus, where they bind and recruit ACTN4 to their targeted promoters, IL-1 and IL-8. Taken together, our data identify ACTN4 as a novel coactivator for NF-B transcription factors in podocytes. Importantly, this nuclear function of ACTN4 is independent of its actin binding activity in the cytoplasm.	[Zhao, Xuan; Hsu, Kuo-Sheng; Lim, Jun Hee; Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Case Western Reserve Univ, Case Comprehens Canc Ctr, Sch Med, Cleveland, OH 44106 USA; [Bruggeman, Leslie A.] Case Western Reserve Univ, Rammelkamp Ctr Educ & Res, Sch Med, Cleveland, OH 44106 USA; [Bruggeman, Leslie A.] Case Western Reserve Univ, MetroHealth Med Ctr, Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System	Kao, HY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	hxk43@cwru.edu		Hsu, Kuo-Sheng/0000-0002-5700-6943	National Institutes of Health [HL093269, DK078965]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093269, DK078965 (to H. Y. K.).	Aksenova V, 2013, ONCOTARGET, V4, P362, DOI 10.18632/oncotarget.901; An HT, 2014, J BIOL CHEM, V289, P4969, DOI 10.1074/jbc.M113.515395; Babakov VN, 2008, EXP CELL RES, V314, P1030, DOI 10.1016/j.yexcr.2007.12.001; Brahler S, 2012, AM J PHYSIOL-RENAL, V303, pF1473, DOI 10.1152/ajprenal.00031.2012; Bruggeman LA, 2011, LAB INVEST, V91, P413, DOI 10.1038/labinvest.2010.199; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Choi HJ, 2008, AM J KIDNEY DIS, V51, P834, DOI 10.1053/j.ajkd.2008.01.018; Dai SC, 2010, NEPHROL DIAL TRANSPL, V25, P824, DOI 10.1093/ndt/gfp394; Dai SC, 2009, NEPHRON CLIN PRACT, V111, pC87, DOI 10.1159/000191198; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Guan D, 2013, ONCOGENE, V32, P3819, DOI 10.1038/onc.2012.406; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Hsu KS, 2013, J BIOL CHEM, V288, P25375, DOI 10.1074/jbc.M113.473124; Hussain S, 2009, J AM SOC NEPHROL, V20, P1733, DOI 10.1681/ASN.2008111219; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Khurana S, 2012, J BIOL CHEM, V287, P35418, DOI 10.1074/jbc.M112.401364; Khurana S, 2012, J BIOL CHEM, V287, P12027, DOI 10.1074/jbc.M112.345421; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kimura J, 2013, AM J NEPHROL, V38, P27, DOI 10.1159/000353093; Kimura M, 2008, INTERNAL MED, V47, P1099, DOI 10.2169/internalmedicine.47.0352; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Liu RJ, 2014, DIABETES, V63, P2440, DOI 10.2337/db13-1810; Liu ZM, 2011, J BIOL CHEM, V286, P30795, DOI 10.1074/jbc.M111.255984; Martinka S, 2006, AM J PHYSIOL-RENAL, V290, pF657, DOI 10.1152/ajprenal.00208.2005; Mudge SJ, 2001, KIDNEY INT, V59, P923; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Ory V, 2012, AM J PATHOL, V180, P2284, DOI 10.1016/j.ajpath.2012.02.008; Ransom RF, 2005, KIDNEY INT, V68, P2473, DOI 10.1111/j.1523-1755.2005.00723.x; Ristola M, 2012, NEPHROL DIAL TRANSPL, V27, P1737, DOI 10.1093/ndt/gfr576; Rood IM, 2012, NEPHROL DIAL TRANSPL, V27, P882, DOI 10.1093/ndt/gfr771; Ross MJ, 2005, J AM SOC NEPHROL, V16, P2403, DOI 10.1681/ASN.2004121101; Schell C, 2012, NEPHROL DIAL TRANSPL, V27, P3406, DOI 10.1093/ndt/gfs273; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; SCHLONDORFF D, 1990, METHOD ENZYMOL, V191, P130; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; Weins A, 2005, J AM SOC NEPHROL, V16, P3694, DOI 10.1681/ASN.2005070706; Xing CY, 2006, KIDNEY INT, V70, P1038, DOI 10.1038/sj.ki.5001655; Yamashita M, 2013, J INNATE IMMUN, V5, P231, DOI 10.1159/000345255; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167; Yasuno K, 2013, J COMP PATHOL, V149, P280, DOI 10.1016/j.jcpa.2013.01.012	43	31	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					338	349		10.1074/jbc.M114.597260	http://dx.doi.org/10.1074/jbc.M114.597260			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25411248	hybrid, Green Published			2022-12-28	WOS:000347231200030
J	Fahrenkrug, J; Falktoft, B; Georg, B; Hannibal, J; Kristiansen, SB; Klausen, TK				Fahrenkrug, Jan; Falktoft, Birgitte; Georg, Birgitte; Hannibal, Jens; Kristiansen, Sarah B.; Klausen, Thomas K.			Phosphorylation of Rat Melanopsin at Ser-381 and Ser-398 by Light/Dark and Its Importance for Intrinsically Photosensitive Ganglion Cells (ipRGCs) Cellular Ca2+ Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Imaging; G Protein-coupled Receptor (GPCR); Mutant; Phosphorylation; Photoreceptor; Retinal Ganglion Cells	DEPENDENT PHOSPHORYLATION; CARBOXY TAIL; PREDICTION; EXPRESSION; INDUCTION; SITES; FOS	The G protein-coupled light-sensitive receptor melanopsin is involved in non-image-forming light responses including circadian timing. The predicted secondary structure of melanopsin indicates a long cytoplasmic tail with many potential phosphorylation sites. Using bioinformatics, we identified a number of amino acids with a high probability of being phosphorylated. We generated antibodies against melanopsin phosphorylated at Ser-381 and Ser-398, respectively. The antibody specificity was verified by immunoblotting and immunohistochemical staining of HEK-293 cells expressing rat melanopsin mutated in Ser-381 or Ser-398. Using the antibody recognizing phospho-Ser-381 melanopsin, we demonstrated by immunoblotting and immunohistochemical staining in HEK-293 cells expressing rat melanopsin that the receptor is phosphorylated in this position during the dark and dephosphorylated when light is turned on. On the contrary, we found that melanopsin at Ser-398 was unphosphorylated in the dark and became phosphorylated after light stimulation. The light-induced changes in phosphorylation at both Ser-381 and Ser-398 were rapid and lasted throughout the 4-h experimental period. Furthermore, phosphorylation at Ser-381 and Ser-398 was independent of each other. The changes in phosphorylation were confirmed in vivo by immunohistochemical staining of rat retinas during light and dark. We further demonstrated that mutation of Ser-381 and Ser-398 in melanopsin-expressing HEK-293 cells affected the light-induced Ca2+ response, which was significantly reduced as compared with wild type. Examining the light-evoked Ca2+ response in a melanopsin Ser-381 plus Ser-398 double mutant provided evidence that the phosphorylation events were independent.	[Fahrenkrug, Jan; Falktoft, Birgitte; Georg, Birgitte; Hannibal, Jens; Kristiansen, Sarah B.] Bispebjerg Hosp, Dept Clin Biochem, Fac Hlth Sci, DK-2400 Copenhagen NV, Denmark; [Klausen, Thomas K.] Univ Copenhagen, Fac Sci, Dept Biol, DK-2200 Copenhagen N, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Fahrenkrug, J (corresponding author), Bispebjerg Hosp, Dept Clin Biochem, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.	jan.fahrenkrug@regionh.dk	Hannibal, Jens/H-5482-2019	Hannibal, Jens/0000-0001-9416-0125	Danish Biotechnology Center for Cellular Communication; Danish Natural Sciences Research Foundation [DFF 09-073391]; Novo Nordisk Foundation	Danish Biotechnology Center for Cellular Communication; Danish Natural Sciences Research Foundation(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by the Danish Biotechnology Center for Cellular Communication, the Danish Natural Sciences Research Foundation (DFF 09-073391), and The Novo Nordisk Foundation.	Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Blasic JR, 2014, BIOCHEMISTRY-US, V53, P2644, DOI 10.1021/bi401724r; Blasic JR, 2012, CELL MOL LIFE SCI, V69, P1551, DOI 10.1007/s00018-011-0891-3; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Fahrenkrug J, 2009, BIOCHEMISTRY-US, V48, P5142, DOI 10.1021/bi900249n; Falktoft B, 2009, NEUROPEPTIDES, V43, P387, DOI 10.1016/j.npep.2009.08.002; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hannibal J, 2001, J BIOL RHYTHM, V16, P457, DOI 10.1177/074873001129002132; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hatori M, 2010, TRENDS MOL MED, V16, P435, DOI 10.1016/j.molmed.2010.07.005; Hundahl CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034462; Kumbalasiri T, 2007, PHOTOCHEM PHOTOBIOL, V83, P273, DOI 10.1562/2006-07-11-RA-964; Lucas RJ, 2013, CURR BIOL, V23, pR125, DOI 10.1016/j.cub.2012.12.029; Moldrup ML, 2010, J NEUROCHEM, V112, P797, DOI 10.1111/j.1471-4159.2009.06504.x; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Rasband WS, 2014, IMAGEJ; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Sekaran S, 2007, J NEUROSCI, V27, P3981, DOI 10.1523/JNEUROSCI.4716-06.2007; Semo M, 2003, EUR J NEUROSCI, V18, P3007, DOI 10.1111/j.1460-9568.2003.03061.x; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; van Koppen CJ, 2004, MOL PHARMACOL, V66, P365, DOI 10.1124/mol.104.003822; Voolstra O, 2010, J BIOL CHEM, V285, P14275, DOI 10.1074/jbc.M110.102053; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094	27	13	13	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35482	35493		10.1074/jbc.M114.586529	http://dx.doi.org/10.1074/jbc.M114.586529			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25378407	Green Published, hybrid			2022-12-28	WOS:000346660200037
J	Rosado-Lugo, JD; Hampsey, M				Rosado-Lugo, Jesus D.; Hampsey, Michael			The Ssu72 Phosphatase Mediates the RNA Polymerase II Initiation-Elongation Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Phosphatase; RNA Polymerase II; Transcription; Transcription Initiation Factor; Transcription Regulation; Transcription Termination	C-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE GENOME; MESSENGER-RNA; TRANSCRIPTION TERMINATION; CTD PHOSPHATASE; ACTIVE-SITE; KINASE; PHOSPHORYLATION; YEAST; COMPLEX	Background: Ssu72 is a RNAPII CTD phosphatase; its function in the transcription cycle has not been established. Results: Ssu72 dephosphorylates Ser(P)(5) at the initiation-elongation transition and regulates Ser(2) phosphorylation status. Conclusion: Ssu72 functions at multiple stages of the RNAPII transcription cycle. Significance: Our results correct two previous misconceptions: (i) that Rtr1 is a Ser(P)(5) phosphatase and (ii) that Ssu72 dephosphorylates Ser(P)(5) only during transcription termination. Transitions between the different stages of the RNAPII transcription cycle involve the recruitment and exchange of factors, including mRNA capping enzymes, elongation factors, splicing factors, 3-end-processing complexes, and termination factors. These transitions are coordinated by the dynamic phosphorylation of the C-terminal domain (CTD) of the largest subunit of RNAPII (Rpb1). The CTD is composed of reiterated heptapeptide repeats ((YSPTSPS7)-S-1-P-2-T-3-S-4-P-5-S-6) that undergo phosphorylation and dephosphorylation as RNAPII transitions through the transcription cycle. An essential phosphatase in this process is Ssu72, which exhibits catalytic specificity for Ser(P)(5) and Ser(P)(7). Ssu72 is unique in that it is specific for Ser(P)(5) in one orientation of the CTD and for Ser(P)(7) when bound in the opposite orientation. Moreover, Ssu72 interacts with components of the initiation machinery and affects start site selection yet is an integral component of the CPF 3-end-processing complex. Here we provide a comprehensive view of the effects of Ssu72 with respect to its Ser(P)(5) phosphatase activity. We demonstrate that Ssu72 dephosphorylates Ser(P)(5) at the initiation-elongation transition. Furthermore, Ssu72 indirectly affects the levels of Ser(P)(2) during the elongation stage of transcription but does so independent of its catalytic activity.	[Rosado-Lugo, Jesus D.; Hampsey, Michael] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Hampsey, M (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 683 Hoes Lane W, Piscataway, NJ 08854 USA.	michael.hampsey@rutgers.edu			National Institutes of Health [R01 GM39484, R01 GM068887]; National Institutes of Health Bridge to Doctoral Degree Program [GM58389]; National Institutes of Health IMSD Award-UMDNJ/Rutgers University Pipeline Program [GM55145]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068887, R01GM039484, R25GM058389, R25GM055145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Bridge to Doctoral Degree Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health IMSD Award-UMDNJ/Rutgers University Pipeline Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM39484 (to M. H.) and R01 GM068887 (to Claire Moore and M. H.).; Supported by the National Institutes of Health Bridge to Doctoral Degree Program (Grant GM58389), by the National Institutes of Health IMSD Award-UMDNJ/Rutgers University Pipeline Program (Grant GM55145), and by a National Institutes of Health Grant R01 GM39484 supplement.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cho EJ, 1998, GENE DEV, V12, P3482, DOI 10.1101/gad.12.22.3482; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Costanzo M., SCIENCE, V327, P425; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Ganem C, 2006, MOL GENET GENOMICS, V275, P136, DOI 10.1007/s00438-005-0071-y; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Hanes SD, 2014, BBA-GENE REGUL MECH, V1839, P316, DOI 10.1016/j.bbagrm.2014.02.001; Hausmann S, 2005, J BIOL CHEM, V280, P37681, DOI 10.1074/jbc.M505292200; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Hintermair C, 2012, EMBO J, V31, P2784, DOI 10.1038/emboj.2012.123; Hong SW, 2009, P NATL ACAD SCI USA, V106, P14276, DOI 10.1073/pnas.0903642106; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Hsin JP, 2011, SCIENCE, V334, P683, DOI 10.1126/science.1206034; Hsu PL, 2014, J MOL BIOL, V426, P2970, DOI 10.1016/j.jmb.2014.06.010; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Meinhart A, 2003, J BIOL CHEM, V278, P15917, DOI 10.1074/jbc.M301643200; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Pappas DL, 2000, MOL CELL BIOL, V20, P8343, DOI 10.1128/MCB.20.22.8343-8351.2000; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Prelich G, 2002, EUKARYOT CELL, V1, P153, DOI 10.1128/EC.1.2.153-162.2002; Reyes-Reyes M, 2007, MOL CELL BIOL, V27, P926, DOI 10.1128/MCB.01361-06; Rino J, 2009, TRENDS CELL BIOL, V19, P375, DOI 10.1016/j.tcb.2009.05.004; Schwer B, 2014, P NATL ACAD SCI USA, V111, P4185, DOI 10.1073/pnas.1321842111; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Suh MH, 2005, P NATL ACAD SCI USA, V102, P17314, DOI 10.1073/pnas.0507987102; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xiang KH, 2012, GENE DEV, V26, P2265, DOI 10.1101/gad.198853.112; Xiang KH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1947; Zhang DW, 2012, J BIOL CHEM, V287, P8541, DOI 10.1074/jbc.M111.335687; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	52	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33916	33926		10.1074/jbc.M114.608695	http://dx.doi.org/10.1074/jbc.M114.608695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25339178	hybrid, Green Published			2022-12-28	WOS:000346077600021
J	Babbarwal, V; Fu, JH; Reese, JC				Babbarwal, Vinod; Fu, Jianhua; Reese, Joseph C.			The Rpb4/7 Module of RNA Polymerase II Is Required for Carbon Catabolite Repressor Protein 4-Negative on TATA (Ccr4-Not) Complex to Promote Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE; MESSENGER; TRANSCRIPTION; SUBUNIT; DEGRADATION; DECAY	Gene expression relies on the balance between mRNA synthesis in the nucleus and decay in the cytoplasm, processes once thought to be separate. We now know that transcription and decay rates are coordinated, but the factors or molecular mechanisms are unclear. The Ccr4-Not complex regulates multiple stages of gene expression, from mRNA synthesis to protein destruction. One of its functions is to promote RNA polymerase II elongation by reactivating arrested elongation complexes. Here we explored the features of polymerase required for Ccr4-Not to promote elongation and found that the Rpb4/7 module is important for Ccr4-Not to associate with elongation complexes and stimulate elongation. Rpb4/7 has also been implicated in coordinating mRNA synthesis and decay, but its role in this process is controversial. The interplay between Ccr4-Not and Rpb4/7 described here suggests a mechanism for how the cell coordinates mRNA synthesis and decay.	[Babbarwal, Vinod; Reese, Joseph C.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA; [Fu, Jianhua] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Medical College of Wisconsin	Reese, JC (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, 463A North Frear, University Pk, PA 16802 USA.	Jcr8@psu.edu			National Institutes of Health [GM58672, GM100997]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058672, R01GM100997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM58672 (to J. C. R.) and GM100997 (to J. F.).	Choder M, 2004, TRENDS BIOCHEM SCI, V29, P674, DOI 10.1016/j.tibs.2004.10.007; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Dori-Bachash M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001106; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Gaillard H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000364; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Haimovich G, 2013, BBA-GENE REGUL MECH, V1829, P643, DOI 10.1016/j.bbagrm.2013.01.004; Jensen GJ, 1998, EMBO J, V17, P2353, DOI 10.1017/S1431927600024983; Kruk JA, 2011, GENE DEV, V25, P581, DOI 10.1101/gad.2020911; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Lotan R, 2007, J CELL BIOL, V178, P1133, DOI 10.1083/jcb.200701165; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Perez-Ortin JE, 2012, BBA-GENE REGUL MECH, V1819, P604, DOI 10.1016/j.bbagrm.2011.12.002; Reese JC, 2013, BBA-GENE REGUL MECH, V1829, P127, DOI 10.1016/j.bbagrm.2012.09.001; Runner VM, 2008, MOL CELL BIOL, V28, P1883, DOI 10.1128/MCB.01714-07; Schulz D, 2014, J BIOL CHEM, V289, P17446, DOI 10.1074/jbc.M114.568014; Schwalb B, 2012, BIOINFORMATICS, V28, P884, DOI 10.1093/bioinformatics/bts052; Selleck William, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0521s52; Shalem O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002273; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Suh MH, 2005, P NATL ACAD SCI USA, V102, P17314, DOI 10.1073/pnas.0507987102; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Zhang ZQ, 2004, J BIOL CHEM, V279, P23223, DOI 10.1074/jbc.M402956200	26	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33125	33130		10.1074/jbc.C114.601088	http://dx.doi.org/10.1074/jbc.C114.601088			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25315781	Green Published, hybrid			2022-12-28	WOS:000345636600007
J	Gutierrez, E; Richardson, DR; Jansson, PJ				Gutierrez, Elaine; Richardson, Des R.; Jansson, Patric J.			The Anticancer Agent Di-2-pyridylketone 4,4-Dimethyl-3-thiosemicarbazone ( Dp44mT) Overcomes Prosurvival Autophagy by Two Mechanisms PERSISTENT INDUCTION OF AUTOPHAGOSOME SYNTHESIS AND IMPAIRMENT OF LYSOSOMAL INTEGRITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDOXAL ISONICOTINOYL HYDRAZONE; EFFECTIVE ANTIPROLIFERATIVE AGENTS; SELECTIVE ANTITUMOR-ACTIVITY; BREAST-CANCER CELLS; IRON CHELATORS; OXIDATIVE-STRESS; METASTASIS SUPPRESSOR; INTRALYSOSOMAL IRON; MEDIATED CLEAVAGE; HYDROGEN-PEROXIDE	Autophagy functions as a survival mechanism during cellular stress and contributes to resistance against anticancer agents. The selective antitumor and antimetastatic chelator di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) causes lysosomal membrane permeabilization and cell death. Considering the integral role of lysosomes in autophagy and cell death, it was important to assess the effect of Dp44mT on autophagy to further understand its mechanism of action. Notably, Dp44mT affected autophagy by two mechanisms. First, concurrent with its antiproliferative activity, Dp44mT increased the expression of the classical autophagic marker LC3-II as a result of induced autophagosome synthesis. Second, this effect was supplemented by a reduction in autophagosome degradation as shown by the accumulation of the autophagic substrate and receptor p62. Conversely, the classical iron chelator desferrioxamine induced autophagosome accumulation only by inhibiting autophagosome degradation. The formation of redox-active iron or copper Dp44mT complexes was critical for its dual effect on autophagy. The cytoprotective antioxidant N-acetylcysteine inhibited Dp44mT-induced autophagosome synthesis and p62 accumulation. Importantly, Dp44mT inhibited autophagosome degradation via lysosomal disruption. This effect prevented the fusion of lysosomes with autophagosomes to form autolysosomes, which is crucial for the completion of the autophagic process. The antiproliferative activity of Dp44mT was suppressed by Beclin1 and ATG5 silencing, indicating the role of persistent autophagosome synthesis in Dp44mT-induced cell death. These studies demonstrate that Dp44mT can overcome the prosurvival activity of autophagy in cancer cells by utilizing this process to potentiate cell death.	[Richardson, Des R.] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Blackburn Bldg D06, Sydney, NSW 2006, Australia.	d.richardson@sydney.edu.au; patric.jansson@sydney.edu.au		Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274	University of Sydney; National Health and Medical Research Council of Australia; Cancer Institute of New South Wales Early Career Research Fellowship	University of Sydney(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute of New South Wales Early Career Research Fellowship	Supported by an Australian Postgraduate Award from the University of Sydney.; Supported by a National Health and Medical Research Council of Australia Senior Principal Research Fellowship and Project Grant funding. To whom correspondence may be addressed. Tel.: 61-2-9036-6548; Fax: 61-2-9036-6549; E-mail: d.richardson@sydney.edu.au.; Supported by a Cancer Institute of New South Wales Early Career Research Fellowship. To whom correspondence may be addressed. Tel.: 61-2-9036-7120; Fax: 61-2-9351-3429; E-mail: patric.jansson@sydney.edu.au.	Altan N, 1999, P NATL ACAD SCI USA, V96, P4432, DOI 10.1073/pnas.96.8.4432; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Betin VMS, 2009, J CELL SCI, V122, P2554, DOI 10.1242/jcs.046250; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BLATT J, 1987, CANCER RES, V47, P1749; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Brunk UT, 1997, FREE RADICAL BIO MED, V23, P616, DOI 10.1016/S0891-5849(97)00007-5; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Buss JL, 2004, CURR TOP MED CHEM, V4, P1623, DOI 10.2174/1568026043387269; Buss JL, 2003, CURR MED CHEM, V10, P1021, DOI 10.2174/0929867033457638; Chaston TB, 2003, CLIN CANCER RES, V9, P402; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Chen Y, 1999, J BIOL CHEM, V274, P18364, DOI 10.1074/jbc.274.26.18364; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Cooper G. M., 1997, CELL, P379; De Domenico I, 2009, BLOOD, V114, P4546, DOI 10.1182/blood-2009-05-224188; DONFRANCESCO A, 1990, CANCER RES, V50, P4929; DONFRANCESCO A, 1992, AM J CLIN ONCOL-CANC, V15, P319, DOI 10.1097/00000421-199208000-00009; DORER FE, 1978, J BIOL CHEM, V253, P3140; Doulias PT, 2003, FREE RADICAL BIO MED, V35, P719, DOI 10.1016/S0891-5849(03)00396-4; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Esteve Juan M, 2011, World J Biol Chem, V2, P232, DOI 10.4331/wjbc.v2.i10.232; ESTROV Z, 1987, BLOOD, V69, P757; Farkas E, 1997, J INORG BIOCHEM, V65, P281, DOI 10.1016/S0162-0134(96)00144-4; Ford CHJ, 2011, ANTICANCER RES, V31, P521; Gaal A, 2014, J INORG BIOCHEM, V130, P52, DOI 10.1016/j.jinorgbio.2013.09.016; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; Hwang JJ, 2010, BIOMETALS, V23, P997, DOI 10.1007/s10534-010-9346-9; Jansson PJ, 2010, J MED CHEM, V53, P5759, DOI 10.1021/jm100561b; Jeong J, 2006, FASEB J, V20, pA49; Kalinowski DS, 2007, J MED CHEM, V50, P6212, DOI 10.1021/jm070839q; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kenific CM, 2010, CURR OPIN CELL BIOL, V22, P241, DOI 10.1016/j.ceb.2009.10.008; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kurz T, 2004, BIOCHEM J, V378, P1039, DOI 10.1042/BJ20031029; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Kurz T, 2006, FEBS J, V273, P3106, DOI 10.1111/j.1742-4658.2006.05321.x; Lamparska-Przybysz M, 2005, J Physiol Pharmacol, V56 Suppl 3, P159; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Predmore BL, 2012, ANTIOXID REDOX SIGN, V17, P119, DOI 10.1089/ars.2012.4612; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; LLOYD JB, 1991, BIOCHEM PHARMACOL, V41, P1361, DOI 10.1016/0006-2952(91)90109-I; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Luo S, 2007, CELL DEATH DIFFER, V14, P1247, DOI 10.1038/sj.cdd.4402149; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Noulsri E, 2009, AM J HEMATOL, V84, P170, DOI 10.1002/ajh.21350; Paglin S, 2001, CANCER RES, V61, P439; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Persson HL, 2005, EXPERT OPIN INV DRUG, V14, P997, DOI 10.1517/13543784.14.8.997; Persson HL, 2003, FREE RADICAL BIO MED, V34, P1295, DOI 10.1016/S0891-5849(03)00106-0; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Quach P, 2012, MOL PHARMACOL, V82, P105, DOI 10.1124/mol.112.078964; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Rao VA, 2011, CANCER CHEMOTH PHARM, V68, P1125, DOI 10.1007/s00280-011-1587-y; Rao VA, 2009, CANCER RES, V69, P948, DOI 10.1158/0008-5472.CAN-08-1437; RICHARDSON D, 1994, CANCER RES, V54, P685; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; Richardson DR, 1997, BLOOD, V89, P3025, DOI 10.1182/blood.V89.8.3025; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Robert G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007889; Sahni S, 2014, J BIOL CHEM, V289, P9692, DOI 10.1074/jbc.M113.529511; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; SAWICKI SG, 1971, J CELL BIOL, V50, P746, DOI 10.1083/jcb.50.3.746; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; SELIG RA, 1993, ANTICANCER RES, V13, P721; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Voss V, 2010, MOL CANCER RES, V8, P1002, DOI 10.1158/1541-7786.MCR-09-0562; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Wong VKW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.217; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yelamanchili SV, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-52; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu HJ, 2009, BIOCHEM J, V417, P133, DOI 10.1042/BJ20081421; Yu ZQ, 2003, FREE RADICAL BIO MED, V34, P1243, DOI 10.1016/S0891-5849(03)00109-6; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhang Y, 2013, MOL CELL BIOL, V33, P1104, DOI 10.1128/MCB.01215-12	99	51	53	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33568	33589		10.1074/jbc.M114.599480	http://dx.doi.org/10.1074/jbc.M114.599480			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25301941	Green Published, hybrid			2022-12-28	WOS:000345636600043
J	Laubli, H; Alisson-Silva, F; Stanczak, MA; Siddiqui, SS; Deng, LW; Verhagen, A; Varki, N; Varki, A				Laeubli, Heinz; Alisson-Silva, Frederico; Stanczak, Michal A.; Siddiqui, Shoib S.; Deng, Liwen; Verhagen, Andrea; Varki, Nissi; Varki, Ajit			Lectin Galactoside-binding Soluble 3 Binding Protein (LGALS3BP) Is a Tumor-associated Immunomodulatory Ligand for CD33-related Siglecs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSE; SIALIC-ACID DIVERSITY; GROUP-B STREPTOCOCCUS; C-ASSOCIATED PROTEIN; MAC-2-BINDING PROTEIN; BREAST-CANCER; ANTIGEN 90K; LUNG-CARCINOMA; CYCLOPHILIN-C; NK CELLS	Lectin galactoside-binding soluble 3 binding protein (LGALS3BP, also called Mac-2 binding protein) is a heavily glycosylated secreted molecule that has been shown previously to be up-regulated in many cancers and has been implicated in tumor metastatic processes, as well as in other cell adhesion and immune functions. The CD33-related subset of sialic acid-binding immunoglobulin-like lectins (Siglecs) consists of immunomodulatory molecules that have recently been associated with the modulation of immune responses to cancer. Because up-regulation of Siglec ligands in cancer tissue has been observed, the characterization of these cancer-associated ligands that bind to inhibitory CD33-related Siglecs could provide novel targets for cancer immunomodulatory therapy. Here we used affinity chromatography of tumor cell extracts to identify LGALS3BP as a novel sialic acid-dependent ligand for human Siglec-9 and for other immunomodulatory Siglecs, such as Siglec-5 and Siglec-10. In contrast, the mouse homolog Siglec-E binds to murine LGALS3BP with lower affinity. LGALS3BP has been observed to be up-regulated in human colorectal and prostate cancer specimens, particularly in the extracellular matrix. Finally, LGALS3BP was able to inhibit neutrophil activation in a sialic acid-and Siglec-dependent manner. These findings suggest a novel immunoinhibitory function for LGALS3BP that might be important for immune evasion of tumor cells during cancer progression.	Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Glycobiol Res & Training Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Laubli, H (corresponding author), Univ Basel Hosp, Dept Med Oncol, Petersgraben 4, CH-4031 Basel, Switzerland.	heinz.laeubli@unibas.ch; a1varki@ucsd.edu	Siddiqui, Shoib/M-7713-2017; da Silva, Frederico/AAY-4758-2021; da Silva, Frederico/X-7822-2018	da Silva, Frederico/0000-0001-6717-2518; da Silva, Frederico/0000-0001-6717-2518; Deng, Liwen/0000-0002-7984-8471; Stanczak, Michal/0000-0003-2563-7254; Siddiqui, Shoib/0000-0002-7028-290X	National Institutes of Health [R01CA38701]; Swiss National Science Foundation; Programa Ciencias S.E. Fronteiras Brazil; NATIONAL CANCER INSTITUTE [R01CA038701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Programa Ciencias S.E. Fronteiras Brazil; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA38701 (to A. V.). This work was also supported by the Swiss National Science Foundation (to H. L.) and by the Programa Ciencias S.E. Fronteiras Brazil (to F. A. S.).	Aalto K, 2011, BLOOD, V118, P3725, DOI 10.1182/blood-2010-09-311076; Ali SR, 2014, J EXP MED, V211, P1231, DOI 10.1084/jem.20131853; Altindag ZZ, 1996, CANCER LETT, V107, P143, DOI 10.1016/0304-3835(96)04364-9; Bandala-Sanchez E, 2013, NAT IMMUNOL, V14, P741, DOI 10.1038/ni.2610; Belisle JA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-118; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; CARLIN CR, 1983, EXP CELL RES, V147, P359, DOI 10.1016/0014-4827(83)90218-5; Cesinaro AM, 2002, J INVEST DERMATOL, V119, P187, DOI 10.1046/j.1523-1747.2002.17642.x; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Cheong KA, 2011, INT ARCH ALLERGY IMM, V154, P111, DOI 10.1159/000320225; Cladman WM, 1996, BIOCHEM BIOPH RES CO, V220, P141, DOI 10.1006/bbrc.1996.0371; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 2012, ANN NY ACAD SCI, V1253, P102, DOI 10.1111/j.1749-6632.2011.06449.x; FRIEDMAN J, 1993, P NATL ACAD SCI USA, V90, P6815, DOI 10.1073/pnas.90.14.6815; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Gunnarsson P, 2007, FASEB J, V21, P4059, DOI 10.1096/fj.07-8534com; Hudak JE, 2014, NAT CHEM BIOL, V10, P69, DOI [10.1038/NCHEMBIO.1388, 10.1038/nchembio.1388]; IACOBELLI S, 1994, BRIT J CANCER, V69, P172, DOI 10.1038/bjc.1994.29; IACOBELLI S, 1986, CANCER RES, V46, P3005; IACOBELLI S, 1993, FEBS LETT, V319, P59, DOI 10.1016/0014-5793(93)80037-U; Ikehara Y, 2004, J BIOL CHEM, V279, P43117, DOI 10.1074/jbc.M403538200; Inohara H, 1996, CANCER RES, V56, P4530; Jandus C, 2014, J CLIN INVEST, V124, P1810, DOI 10.1172/JCI65899; Kashyap MK, 2010, CANCER BIOL THER, V10, P796, DOI 10.4161/cbt.10.8.12914; Koopmann J, 2004, CANCER-AM CANCER SOC, V101, P1609, DOI 10.1002/cncr.20469; KOTHS K, 1993, J BIOL CHEM, V268, P14245; Lacovazzi PA, 2001, CLIN CHEM LAB MED, V39, P961; Laubli H, 2009, BLOOD, V114, P4583, DOI 10.1182/blood-2008-10-186585; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Laubli H, 2014, P NATL ACAD SCI USA, V111, P14211, DOI 10.1073/pnas.1409580111; LINSLEY PS, 1986, BIOCHEMISTRY-US, V25, P2978, DOI 10.1021/bi00358a037; McMillan SJ, 2013, BLOOD, V121, P2084, DOI 10.1182/blood-2012-08-449983; Mitic N, 2012, DIS MARKERS, V32, P187, DOI [10.1155/2012/309203, 10.3233/DMA-2011-0872]; Ohta M, 2010, BIOCHEM BIOPH RES CO, V402, P663, DOI 10.1016/j.bbrc.2010.10.079; Ozaki Y, 2002, CANCER, V95, P1954, DOI 10.1002/cncr.10899; Padler-Karavani V, 2014, FASEB J, V28, P1280, DOI 10.1096/fj.13-241497; Padler-Karavani V, 2012, J BIOL CHEM, V287, P22593, DOI 10.1074/jbc.M112.359323; Parham P, 2008, SEMIN IMMUNOL, V20, P311, DOI 10.1016/j.smim.2008.10.002; Park YP, 2007, INT J CANCER, V120, P813, DOI 10.1002/ijc.22369; Pegon JN, 2012, HAEMATOL-HEMATOL J, V97, P1855, DOI 10.3324/haematol.2012.063297; Piccolo E, 2013, J MOL MED, V91, P83, DOI 10.1007/s00109-012-0936-6; Pillai S, 2011, CURR OPIN IMMUNOL, V23, P721, DOI 10.1016/j.coi.2011.10.007; Polgar J, 2005, J THROMB HAEMOST, V3, P1590, DOI 10.1111/j.1538-7836.2005.01373.x; Sackstein R, 2012, ANN NY ACAD SCI, V1253, P193, DOI 10.1111/j.1749-6632.2011.06421.x; Sardana G, 2007, CLIN CHEM, V53, P429, DOI 10.1373/clinchem.2006.077370; SCAMBIA G, 1988, ANTICANCER RES, V8, P761; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Silverman AM, 2012, CANCER RES, V72, P2228, DOI 10.1158/0008-5472.CAN-11-2165; Srirajaskanthan R, 2010, MOL CELL PROTEOMICS, V9, P656, DOI 10.1074/mcp.M900401-MCP200; Stampolidis P, 2015, ONCOGENE, V34, P39, DOI 10.1038/onc.2013.548; Tanida S, 2013, J BIOL CHEM, V288, P31842, DOI 10.1074/jbc.M113.471318; Trahey M, 1999, P NATL ACAD SCI USA, V96, P3006, DOI 10.1073/pnas.96.6.3006; Traini S, 2014, MOL CANCER THER, V13, P916, DOI 10.1158/1535-7163.MCT-12-1117; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tyler C, 2012, AM J REPROD IMMUNOL, V68, P28, DOI 10.1111/j.1600-0897.2012.01113.x; ULLRICH A, 1994, J BIOL CHEM, V269, P18401; Ulmer TA, 2006, J CELL BIOCHEM, V98, P1351, DOI 10.1002/jcb.20784; Varki A., 2009, ESSENTIALS GLYCOBIOL, P459; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Varki A, 2011, GLYCOBIOLOGY, V21, P1121, DOI 10.1093/glycob/cwr087; von Gunten S, 2008, ANN NY ACAD SCI, V1143, P61, DOI 10.1196/annals.1443.011; Wang XX, 2011, GLYCOBIOLOGY, V21, P1038, DOI 10.1093/glycob/cwr039; Xue H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-52; Yurugi H, 2013, BIOCHEM BIOPH RES CO, V434, P376, DOI 10.1016/j.bbrc.2013.03.085	65	69	71	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33481	33491		10.1074/jbc.M114.593129	http://dx.doi.org/10.1074/jbc.M114.593129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25320078	hybrid, Green Published			2022-12-28	WOS:000345636600036
J	Zhelkovsky, AM; McReynolds, LA				Zhelkovsky, Alexander M.; McReynolds, Larry A.			Polynucleotide 3 '-terminal Phosphate Modifications by RNA and DNA Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HELA-CELLS; LIGATION; CYCLASE; INTERMEDIATE; SPECIFICITY; MECHANISM; BACTERIA; DISEASE; ARCHAEA	RNA and DNA ligases catalyze the formation of a phosphodiester bond between the 5'-phosphate and 3'-hydroxyl ends of nucleic acids. In this work, we describe the ability of the thermophilic RNA ligase MthRnl from Methanobacterium thermoautotrophicum to recognize and modify the 3'-terminal phosphate of RNA and single-stranded DNA (ssDNA). This ligase can use an RNA 3'p substrate to generate an RNA 2',3'-cyclic phosphate or convertDNA 3'p to ssDNA(3') pp(5') A. An RNA ligase from the Thermus scotoductus bacteriophage TS2126 and a predicted T4 Rnl1-like protein from Thermovibrio ammonificans, TVa, were also able to adenylate ssDNA 3'p. These modifications of RNA and DNA 3'-phosphates are similar to the activities of RtcA, an RNA 3'-phosphate cyclase. The initial step involves adenylation of the enzyme by ATP, which is then transferred to either RNA 3'p or DNA 3'p to generate the adenylated intermediate. ForRNA(3') pp(5')A, the third step involves attack of the adjacent 2'hydroxyl to generate the RNA 2',3'-cyclic phosphate. These steps are analogous to those in classical 5' phosphate ligation. MthRnl and TS2126 RNA ligases were not able to modify a 3'p in nicked double-stranded DNA. However, T4 DNA ligase and RtcA can use 3'-phosphorylated nicks in double-stranded DNA to produce a 3'-adenylated product. These 3'-terminal phosphate-adenylated intermediates are substrates for deadenylation by yeast 5'Deadenylase. Our findings that classic ligases can duplicate the adenylation and phosphate cyclization activity of RtcA suggests that they have an essential role in metabolism of nucleic acids with 3'-terminal phosphates.	[Zhelkovsky, Alexander M.; McReynolds, Larry A.] New England Biolabs Inc, Div RNA Biol, Ipswich, MA 01938 USA	New England Biolabs	McReynolds, LA (corresponding author), New England Biolabs Inc, Div RNA Biol, 240 Cty Rd, Ipswich, MA 01938 USA.	mcreynolds@neb.com			New England Biolabs	New England Biolabs	We thank Jingmin Jin, Greg Lohman, Ira Schildkraut, and Bill Jack for support and useful discussions in manuscript preparation. We also thank Don Comb and New England Biolabs for supporting this research.	Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; AMITSUR M, 1987, EMBO J, V6, P2499, DOI 10.1002/j.1460-2075.1987.tb02532.x; Billy E, 1999, J BIOL CHEM, V274, P34955, DOI 10.1074/jbc.274.49.34955; Blondal T, 2005, NUCLEIC ACIDS RES, V33, P135, DOI 10.1093/nar/gki149; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Chakravarty AK, 2012, NUCLEIC ACIDS RES, V40, P8558, DOI 10.1093/nar/gks558; Chakravarty AK, 2011, J BIOL CHEM, V286, P4117, DOI 10.1074/jbc.M110.196766; Das U, 2014, P NATL ACAD SCI USA, V111, P11317, DOI 10.1073/pnas.1409203111; Das U, 2013, P NATL ACAD SCI USA, V110, P20437, DOI 10.1073/pnas.1314289110; Das U, 2013, NUCLEIC ACIDS RES, V41, P355, DOI 10.1093/nar/gks977; Englert M, 2011, P NATL ACAD SCI USA, V108, P1290, DOI 10.1073/pnas.1018307108; Filipowicz W, 1998, ACTA BIOCHIM POL, V45, P895, DOI 10.18388/abp.1998_4348; FILIPOWICZ W, 1985, P NATL ACAD SCI USA, V82, P1316, DOI 10.1073/pnas.82.5.1316; FILIPOWICZ W, 1983, NUCLEIC ACIDS RES, V11, P1405, DOI 10.1093/nar/11.5.1405; Genschik P, 1998, J BIOL CHEM, V273, P25516, DOI 10.1074/jbc.273.39.25516; Genschik P, 1997, EMBO J, V16, P2955, DOI 10.1093/emboj/16.10.2955; HINTON DM, 1982, NUCLEIC ACIDS RES, V10, P1877, DOI 10.1093/nar/10.6.1877; Huang SYN, 2013, P NATL ACAD SCI USA, V110, P20354, DOI 10.1073/pnas.1320033110; Lohman GJS, 2014, NUCLEIC ACIDS RES, V42, P1831, DOI 10.1093/nar/gkt1032; Molina-Serrano D, 2012, RNA BIOL, V9, P326, DOI 10.4161/rna.19218; Nandakumar J, 2004, J BIOL CHEM, V279, P31337, DOI 10.1074/jbc.M402394200; PERKINS KK, 1985, P NATL ACAD SCI USA, V82, P684, DOI 10.1073/pnas.82.3.684; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Povirk Lawrence F, 2012, ISRN Mol Biol, V2012, DOI 10.5402/2012/345805; Remus BS, 2014, RNA, V20, P462, DOI 10.1261/rna.043752.113; Tanaka N, 2011, J BIOL CHEM, V286, P7727, DOI 10.1074/jbc.C111.219022; Tanaka N, 2010, STRUCTURE, V18, P449, DOI 10.1016/j.str.2010.01.016; Torchia C, 2008, NUCLEIC ACIDS RES, V36, P6218, DOI 10.1093/nar/gkn602; Vetriani C, 2004, INT J SYST EVOL MICR, V54, P175, DOI 10.1099/ijs.0.02781-0; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zhelkovsky AM, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-24; Zhelkovsky AM, 2011, NUCLEIC ACIDS RES, V39, pE117, DOI 10.1093/nar/gkr544	33	9	9	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33608	33616		10.1074/jbc.M114.612929	http://dx.doi.org/10.1074/jbc.M114.612929			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25324547	Green Published, hybrid			2022-12-28	WOS:000345636600046
J	Petrunak, EM; DeVore, NM; Porubsky, PR; Scott, EE				Petrunak, Elyse M.; DeVore, Natasha M.; Porubsky, Patrick R.; Scott, Emily E.			Structures of Human Steroidogenic Cytochrome P450 17A1 with Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							17,20-LYASE ACTIVITY; MICROSOMAL CYTOCHROME-P-450; HUMAN P450C17; ACTIVE-SITE; LYASE ACTIVITY; B(5); ABIRATERONE; CANCER; BIOSYNTHESIS; TARGET	The human cytochrome P450 17A1 (CYP17A1) enzyme operates at a key juncture of human steroidogenesis, controlling the levels of mineralocorticoids influencing blood pressure, glucocorticoids involved in immune and stress responses, and androgens and estrogens involved in development and homeostasis of reproductive tissues. Understanding CYP17A1 multifunctional biochemistry is thus integral to treating prostate and breast cancer, subfertility, blood pressure, and other diseases. CYP17A1 structures with all four physiologically relevant steroid substrates suggest answers to four fundamental aspects of CYP17A1 function. First, all substrates bind in a similar overall orientation, rising similar to 60 degrees with respect to the heme. Second, both hydroxylase substrates pregnenolone and progesterone hydrogen bond to Asn(202) in orientations consistent with production of 17 alpha-hydroxy major metabolites, but functional and structural evidence for an A105L mutation suggests that a minor conformation may yield the minor 16 alpha-hydroxyprogesterone metabolite. Third, substrate specificity of the subsequent 17,20-lyase reaction may be explained by variation in substrate height above the heme. Although 17 alpha-hydroxyprogesterone is only observed farther from the catalytic iron, 17 alpha-hydroxypregnenolone is also observed closer to the heme. In conjunction with spectroscopic evidence, this suggests that only 17 alpha-hydroxypregnenolone approaches and interacts with the proximal oxygen of the catalytic iron-peroxy intermediate, yielding efficient production of dehydroepiandrosterone as the key intermediate in human testosterone and estrogen synthesis. Fourth, differential positioning of 17 alpha-hydroxypregnenolone offers a mechanism whereby allosteric binding of cytochrome b(5) might selectively enhance the lyase reaction. In aggregate, these structures provide a structural basis for understanding multiple key reactions at the heart of human steroidogenesis.	[Petrunak, Elyse M.; DeVore, Natasha M.; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Porubsky, Patrick R.] Univ Kansas, Specialized Chem Ctr, Lawrence, KS 66047 USA	University of Kansas; University of Kansas	Scott, EE (corresponding author), Univ Kansas, Dept Med Chem, 1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	eescott@ku.edu		DeVore, Natasha/0000-0003-0772-8929	National Institutes of Health [RR01778, GM103420, RR00129, GM103393]; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR000129, P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM076343, R01GM102505, P20GM103420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The University of Kansas Protein Structure Laboratory was supported by National Institutes of Health Grants RR01778 and GM103420, and the Stanford Synchrotron Radiation Lightsource was supported by National Institutes of Health Grants RR00129 and GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKHTAR M, 1994, BIOCHEMISTRY-US, V33, P4410, DOI 10.1021/bi00180a039; Akhtar MK, 2005, J ENDOCRINOL, V187, P267, DOI 10.1677/joe.1.06375; Arlt W, 2002, ENDOCRINOLOGY, V143, P4665, DOI 10.1210/en.2002-220456; Attard G, 2012, J CLIN ENDOCR METAB, V97, P507, DOI 10.1210/jc.2011-2189; Auchus ML, 2012, J INVEST MED, V60, P495, DOI 10.2310/JIM.0b013e3182408567; Auchus RJ, 1999, MOL ENDOCRINOL, V13, P1169, DOI 10.1210/me.13.7.1169; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DeVore NM, 2009, DRUG METAB DISPOS, V37, P1319, DOI 10.1124/dmd.109.026765; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Ferraldeschi R, 2013, CANCER J, V19, P34, DOI 10.1097/PPO.0b013e31827e0b6f; Fluck CE, 2003, J CLIN ENDOCR METAB, V88, P3762, DOI 10.1210/jc.2003-030143; Gilep AA, 2011, BBA-PROTEINS PROTEOM, V1814, P200, DOI 10.1016/j.bbapap.2010.06.021; Gregory M, 2013, ANGEW CHEM INT EDIT, V52, P5342, DOI 10.1002/anie.201300760; Gregory MC, 2013, J AM CHEM SOC, V135, P16245, DOI 10.1021/ja4086403; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; Guengerich FP, 2007, J BIOCHEM MOL TOXIC, V21, P163, DOI 10.1002/jbt.20174; Haider SM, 2010, J MOL BIOL, V400, P1078, DOI 10.1016/j.jmb.2010.05.069; Idkowiak J, 2012, J CLIN ENDOCR METAB, V97, pE465, DOI 10.1210/jc.2011-2413; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Khatri Y, 2014, BIOCHEM BIOPH RES CO, V443, P179, DOI 10.1016/j.bbrc.2013.11.094; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kok RC, 2010, J CLIN ENDOCR METAB, V95, P994, DOI 10.1210/jc.2008-1745; LAUGHTON CA, 1990, BIOCHEM BIOPH RES CO, V171, P1160, DOI 10.1016/0006-291X(90)90806-X; LEEROBICHAUD P, 1995, BIOCHEM J, V308, P901, DOI 10.1042/bj3080901; LIN D, 1994, MOL ENDOCRINOL, V8, P392, DOI 10.1210/me.8.3.392; Loriot Y, 2013, ANN ONCOL, V24, P1807, DOI 10.1093/annonc/mdt136; Maitra Anurupa, 2003, Indian Journal of Experimental Biology, V41, P701; Mak PJ, 2014, BIOCHEMISTRY-US, V53, P90, DOI 10.1021/bi4014424; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Moon JY, 2013, THER DRUG MONIT, V35, P473, DOI 10.1097/FTD.0b013e318286ee02; Naffin-Olivos JL, 2006, BIOCHEMISTRY-US, V45, P755, DOI 10.1021/bi051623y; NAKAJIN S, 1981, J BIOL CHEM, V256, P3871; OGO A, 1991, MOL CELL ENDOCRINOL, V80, P83, DOI 10.1016/0303-7207(91)90145-I; ONODA M, 1982, BIOCHEM BIOPH RES CO, V108, P454, DOI 10.1016/0006-291X(82)90850-6; Pia A, 2013, CANCER TREAT REV, V39, P966, DOI 10.1016/j.ctrv.2013.03.003; Qin KN, 1998, MOL CELL ENDOCRINOL, V145, P111, DOI 10.1016/S0303-7207(98)00177-4; Sandee D, 2011, ENDOCRINOLOGY, V152, P2904, DOI 10.1210/en.2011-0230; Schappach A, 2001, PHARMAZIE, V56, P435; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; Strauss JF, 2003, ANN NY ACAD SCI, V997, P42, DOI 10.1196/annals.1290.005; Swart AC, 2010, J STEROID BIOCHEM, V119, P112, DOI 10.1016/j.jsbmb.2009.12.014; SWART P, 1993, J CLIN ENDOCR METAB, V77, P98, DOI 10.1210/jc.77.1.98; Tee MK, 2013, J BIOL CHEM, V288, P23903, DOI 10.1074/jbc.M113.460048; Yoshimoto FK, 2012, BIOCHEMISTRY-US, V51, P7064, DOI 10.1021/bi300895w; ZHANG LH, 1995, P NATL ACAD SCI USA, V92, P10619, DOI 10.1073/pnas.92.23.10619	55	76	77	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.610998	http://dx.doi.org/10.1074/jbc.M114.610998			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25301938	Green Published, hybrid			2022-12-28	WOS:000345335000046
J	Bermek, O; Willcox, S; Griffith, JD				Bermek, Oya; Willcox, Smaranda; Griffith, Jack D.			DNA Replication Catalyzed by Herpes Simplex Virus Type 1 Proteins Reveals Trombone Loops at the Fork	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Replication; Electron Microscopy (EM); Gel Electrophoresis; Herpesvirus; Structural Biology; Virology	LAGGING-STRAND SYNTHESIS; BACTERIOPHAGE-T4 PROTEINS; HELICASE-PRIMASE; IN-VITRO; COMPLEX; ARCHITECTURE; TEMPLATE	Background: DNA is replicated in vitro by proteins encoded by herpes simplex virus type 1. Results: Electron microscopic examination of the replication forks reveals looping of the lagging strand. Conclusion: The trombone model has been demonstrated. Significance: This provides the first evidence of the trombone mechanism in a eukaryotic viral system. Using purified replication factors encoded by herpes simplex virus type 1 and a 70-base minicircle template, we obtained robust DNA synthesis with leading strand products of >20,000 nucleotides and lagging strand fragments from 600 to 9,000 nucleotides as seen by alkaline gel electrophoresis. ICP8 was crucial for the synthesis on both strands. Visualization of the deproteinized products using electron microscopy revealed long, linear dsDNAs, and in 87%, one end, presumably the end with the 70-base circle, was single-stranded. The remaining 13% had multiple single-stranded segments separated by dsDNA segments 500 to 1,000 nucleotides in length located at one end. These features are diagnostic of the trombone mechanism of replication. Indeed, when the products were examined with the replication proteins bound, a dsDNA loop was frequently associated with the replication complex located at one end of the replicated DNA. Furthermore, the frequency of loops correlated with the fraction of DNA undergoing Okazaki fragment synthesis.	[Bermek, Oya; Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Griffith, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27599 USA.	jdg@med.unc.edu			National Institutes of Health [GM31819, CA19014]; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31819 and CA19014.	ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; BOEHMER PE, 1993, J VIROL, V67, P711, DOI 10.1128/JVI.67.2.711-715.1993; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Chen Y, 2011, J VIROL, V85, P968, DOI 10.1128/JVI.01690-10; DEBYSER Z, 1994, CELL, V77, P157, DOI 10.1016/0092-8674(94)90243-7; Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; HERNANDEZ TR, 1990, J BIOL CHEM, V265, P11227; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Muylaert I, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609453; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; OKAZAKI T, 1969, P NATL ACAD SCI USA, V64, P1242, DOI 10.1073/pnas.64.4.1242; Park K, 1998, J BIOL CHEM, V273, P5260, DOI 10.1074/jbc.273.9.5260; Ramirez-Aguilar KA, 2002, BIOCHEMISTRY-US, V41, P14569, DOI 10.1021/bi026680v; Skaliter R, 1996, J VIROL, V70, P1132, DOI 10.1128/JVI.70.2.1132-1136.1996; SKALITER R, 1994, P NATL ACAD SCI USA, V91, P10665, DOI 10.1073/pnas.91.22.10665; Stengel G, 2011, J VIROL, V85, P957, DOI 10.1128/JVI.01688-10; Weller SK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013011	22	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2539	2545		10.1074/jbc.M114.623009	http://dx.doi.org/10.1074/jbc.M114.623009			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25471368	Green Published, hybrid			2022-12-28	WOS:000349310700002
J	Sasaki, S; Futagi, Y; Kobayashi, M; Ogura, J; Iseki, K				Sasaki, Shotaro; Futagi, Yuya; Kobayashi, Masaki; Ogura, Jiro; Iseki, Ken			Functional Characterization of 5-Oxoproline Transport via SLC16A1/MCT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYROGLUTAMIC ACID; HORMONE; IDENTIFICATION; BRAIN; GENE; MCT8; POLYMORPHISM; CELLS; LIGHT	Thyrotropin-releasing hormone is a tripeptide that consists of 5-oxoproline, histidine, and proline. The peptide is rapidly metabolized by various enzymes. 5-Oxoproline is produced by enzymatic hydrolysis in a variety of peptides. Previous studies showed that 5-oxoproline could become a possible biomarker for autism spectrum disorders. Here we demonstrate the involvement of SLC16A1 in the transport of 5-oxoproline. An SLC16A1 polymorphism (rs1049434) was recently identified. However, there is no information about the effect of the polymorphism on SLC16A1 function. In this study, the polymorphism caused an observable change in 5-oxoproline and lactate transport via SLC16A1. The Michaelis constant (K-m) was increased in an SLC16A1 mutant compared with that in the wild type. In addition, the proton concentration required to produce half-maximal activation of transport activity (K-0.5, H(+)) was increased in the SLC16A1 mutant compared with that in the wild type. Furthermore, we examined the transport of 5-oxoproline in T98G cells as an astrocyte cell model. Despite the fact that 5-oxoproline is an amino acid derivative, Na+-dependent and amino acid transport systems scarcely contributed to 5-oxoproline transport. Based on our findings, we conclude that H+-coupled 5-oxoproline transport is mediated solely by SLC16A1 in the cells.	[Sasaki, Shotaro; Futagi, Yuya; Kobayashi, Masaki; Ogura, Jiro; Iseki, Ken] Hokkaido Univ, Lab Clin Pharmaceut & Therapeut, Div Pharmasci, Fac Pharmaceut Sci,Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Iseki, Ken] Hokkaido Univ Hosp, Dept Pharm, Sapporo, Hokkaido 0608648, Japan	Hokkaido University; Hokkaido University	Iseki, K (corresponding author), Hokkaido Univ, Lab Clin Pharmaceut & Therapeut, Div Pharmasci, Fac Pharmaceut Sci,Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	ken-i@pharm.hokudai.ac.jp	kobayashi, masaki/B-1638-2015	Futagi, Yuya/0000-0003-2829-2845	Northern Advancement Center for Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan	Northern Advancement Center for Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Northern Advancement Center for Science and Technology and Grant-in-aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arjona FJ, 2011, ENDOCRINOLOGY, V152, P5065, DOI 10.1210/en.2011-1166; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; BASSIRI RM, 1973, J CLIN INVEST, V52, P1616, DOI 10.1172/JCI107339; Ben-Zaken S, 2015, SCAND J MED SCI SPOR, V25, P365, DOI 10.1111/sms.12226; Cupeiro R, 2010, J SCI MED SPORT, V13, P526, DOI 10.1016/j.jsams.2009.07.004; de Souza ECL, 2013, ENDOCRINOLOGY, V154, P1948, DOI 10.1210/en.2012-2101; de Vrieze E, 2014, ENDOCRINOLOGY, V155, P2320, DOI 10.1210/en.2013-1962; Emmett M, 2014, CLIN J AM SOC NEPHRO, V9, P191, DOI 10.2215/CJN.07730713; Fedotovskaya ON, 2014, INT J SPORT PHYSIOL, V9, P173, DOI [10.1123/ijspp.2013-0026, 10.1123/IJSPP.2013-0026]; Foltz M, 2004, FASEB J, V18, P1758, DOI 10.1096/fj.03-1387fje; Fujisawa Y, 2006, ARCH BIOCHEM BIOPHYS, V445, P166, DOI 10.1016/j.abb.2005.10.020; Fujita T, 2004, BRAIN RES, V997, P52, DOI 10.1016/j.brainres.2003.10.049; Ganapathy V, 2008, AAPS J, V10, P193, DOI 10.1208/s12248-008-9022-y; Gasque P, 1996, J IMMUNOL, V156, P2247; GRIOLI S, 1990, FUNDAM CLIN PHARM, V4, P169, DOI 10.1111/j.1472-8206.1990.tb00485.x; Groeneweg S, 2014, ENDOCRINOLOGY, V155, P618, DOI 10.1210/en.2013-1521; Groeneweg S, 2013, ENDOCRINOLOGY, V154, P2525, DOI 10.1210/en.2012-2225; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; Hildebrand MS, 2014, EPILEPSIA, V55, pE18, DOI 10.1111/epi.12519; Kumar A, 2012, CURR SCI INDIA, V102, P288; Kuwabara H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073814; Lean CB, 2009, DRUG METAB PHARMACOK, V24, P469, DOI 10.2133/dmpk.24.469; Lee WJ, 1996, J BIOL CHEM, V271, P19129, DOI 10.1074/jbc.271.32.19129; Lengacher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082505; Mao XR, 2006, J BIOL CHEM, V281, P35863, DOI 10.1074/jbc.M604166200; Merezhinskaya N, 2000, MUSCLE NERVE, V23, P90, DOI 10.1002/(SICI)1097-4598(200001)23:1<90::AID-MUS12>3.0.CO;2-M; Miyauchi S, 2010, BBA-BIOMEMBRANES, V1798, P1164, DOI 10.1016/j.bbamem.2010.03.002; PHAROAH POD, 1991, EARLY HUM DEV, V25, P43, DOI 10.1016/0378-3782(91)90205-H; Pillai SM, 2011, J BIOL CHEM, V286, P2455, DOI 10.1074/jbc.M110.172403; Sasaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067690; Sawczuk M., 2014, J SCI MED SPORT; Schindler AE, 2003, GYNECOL ENDOCRINOL, V17, P79, DOI 10.1080/713603177; Seki A, 2007, BIOPHYS J, V92, P2559, DOI 10.1529/biophysj.106.093153; Selmi-Ruby S, 2014, ENDOCRINOLOGY, V155, P635, DOI 10.1210/en.2013-1435; STWERTKA SA, 1992, PHARMACOL BIOCHEM BE, V41, P145, DOI 10.1016/0091-3057(92)90074-P; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Takekuma Y, 2007, J PHARM PHARM SCI, V10, P71; Viljoen J, 2012, METAB BRAIN DIS, V27, P327, DOI 10.1007/s11011-012-9285-y; Weng LX, 2003, MICROBIOL-SGM, V149, P451, DOI 10.1099/mic.0.25942-0	39	36	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2303	2311		10.1074/jbc.M114.581892	http://dx.doi.org/10.1074/jbc.M114.581892			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25371203	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000348588000035
J	Pollak, NM; Jaeger, D; Kolleritsch, S; Zimmermann, R; Zechner, R; Lass, A; Haemmerle, G				Pollak, Nina M.; Jaeger, Doris; Kolleritsch, Stephanie; Zimmermann, Robert; Zechner, Rudolf; Lass, Achim; Haemmerle, Guenter			The Interplay of Protein Kinase A and Perilipin 5 Regulates Cardiac Lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; CHANARIN-DORFMAN-SYNDROME; LIPID DROPLET PROTEINS; FATTY-ACID; PPAR-ALPHA; MUSCLE; MICE; ADIPOCYTES; METABOLISM; OXIDATION	Defective lipolysis in mice lacking adipose triglyceride lipase provokes severe cardiac steatosis and heart dysfunction, markedly shortening life span. Similarly, cardiac muscle (CM)-specific Plin5 overexpression (CM-Plin5) leads to severe triglyceride (TG) accumulation in cardiomyocytes via impairing TG breakdown. Interestingly, cardiac steatosis due to overexpression of Plin5 is compatible with normal heart function and life span indicating a more moderate impact of Plin5 overexpression on cardiac lipolysis and energy metabolism. We hypothesized that cardiac Plin5 overexpression does not constantly impair cardiac lipolysis. In line with this assumption, TG levels decreased in CM of fasted compared with nonfasted CM-Plin5 mice indicating that fasting may lead to a diminished barrier function of Plin5. Recent studies demonstrated that Plin5 is phosphorylated, and activation of adenylyl cyclase leads to phosphorylation of Plin5, suggesting that Plin5 is a substrate for PKA. Furthermore, any significance of Plin5 phosphorylation by PKA in the regulation of TG mobilization from lipid droplets (LDs) is unknown. Here, we show that the lipolytic barrier of Plin5-enriched LDs, either prepared from cardiac tissue of CM-Plin5 mice or Plin5-transfected cells, is abrogated by incubation with PKA. Notably, PKA-induced lipolysis of LDs enriched with Plin5 carrying a single mutation at serine 155 (PlinS155A) of the putative PKA phosphorylation site was substantially impaired revealing a critical role for PKA in Plin5-regulated lipolysis. The strong increase in protein levels of phosphorylated PKA in CM of Plin5 transgenic mice may partially restore fatty acid release from Plin5-enriched LDs, rendering these hearts compatible with normal heart function despite massive steatosis.	[Pollak, Nina M.; Jaeger, Doris; Kolleritsch, Stephanie; Zimmermann, Robert; Zechner, Rudolf; Lass, Achim; Haemmerle, Guenter] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	University of Graz	Haemmerle, G (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.	guenter.haemmerle@uni-graz.at	Pollak, Nina M./L-3308-2018; Lass, Achim/C-3332-2008	Pollak, Nina M./0000-0001-8437-3303; Lass, Achim/0000-0002-8190-7151; Zimmermann, Robert/0000-0002-7354-870X; Zechner, Rudolf/0000-0001-5483-1182; Haemmerle, Guenter/0000-0001-9900-5896	Austrian Ministry for Science and Research grants; Fonds zur Forderung der Wissenschaftlichen Forschung Project [DK-MCD W1226, P20602-B05]; Austrian Science Fund (Fonds zur Forderung der Wissenschaftlichen Forschung); Special Research Program Lipotox [F30-B05]; Austrian Science Fund (FWF) [Z 136, W 901, F 3002] Funding Source: researchfish	Austrian Ministry for Science and Research grants; Fonds zur Forderung der Wissenschaftlichen Forschung Project(Austrian Science Fund (FWF)); Austrian Science Fund (Fonds zur Forderung der Wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Special Research Program Lipotox; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Ministry for Science and Research grants, Fonds zur Forderung der Wissenschaftlichen Forschung Project DK-MCD W1226 and P20602-B05, Austrian Science Fund (Fonds zur Forderung der Wissenschaftlichen Forschung), and Special Research Program Lipotox F30-B05.	Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Banke NH, 2010, CIRC RES, V107, P233, DOI 10.1161/CIRCRESAHA.110.221713; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bosma M, 2012, DIABETES, V61, P2679, DOI 10.2337/db11-1402; Bosma M, 2012, HISTOCHEM CELL BIOL, V137, P205, DOI 10.1007/s00418-011-0888-x; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Kimmel AR, 2014, CURR OPIN LIPIDOL, V25, P110, DOI 10.1097/MOL.0000000000000057; Konige M, 2014, BBA-MOL BASIS DIS, V1842, P393, DOI 10.1016/j.bbadis.2013.05.007; Kuhnlein RP, 2012, J LIPID RES, V53, P1430, DOI 10.1194/jlr.R024299; Kuramoto K, 2012, J BIOL CHEM, V287, P23852, DOI 10.1074/jbc.M111.328708; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; MacPherson REK, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.84; Mason RR, 2014, MOL METAB, V3, P652, DOI 10.1016/j.molmet.2014.06.002; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Pollak NM, 2013, J LIPID RES, V54, P1092, DOI 10.1194/jlr.M034710; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Wang C, 2015, HEPATOLOGY, V61, P870, DOI 10.1002/hep.27409; Wang H, 2013, J LIPID RES, V54, P953, DOI 10.1194/jlr.M032466; Wang H, 2011, J LIPID RES, V52, P2159, DOI 10.1194/jlr.M017939; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zierler KA, 2013, J BIOL CHEM, V288, P9892, DOI 10.1074/jbc.M112.420620; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	39	54	54	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1295	1306		10.1074/jbc.M114.604744	http://dx.doi.org/10.1074/jbc.M114.604744			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25418045	Green Published, hybrid			2022-12-28	WOS:000348056400001
J	Liang, HW; Liu, MH; Yan, X; Zhou, Y; Wang, WG; Wang, XL; Fu, Z; Wang, N; Zhang, SY; Wang, YB; Zen, K; Zhang, CY; Hou, DX; Li, J; Chen, X				Liang, Hongwei; Liu, Minghui; Yan, Xin; Zhou, Yong; Wang, Wengong; Wang, Xueliang; Fu, Zheng; Wang, Nan; Zhang, Suyang; Wang, Yanbo; Zen, Ke; Zhang, Chen-Yu; Hou, Dongxia; Li, Jing; Chen, Xi			miR-193a-3p Functions as a Tumor Suppressor in Lung Cancer by Down-regulating ERBB4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; SIGNALING NETWORK; DNA METHYLATION; EXPRESSION; MICRORNAS; PROLIFERATION; APOPTOSIS; TARGET; CELLS; MIR-9-3	ERBB4, one of four ErbB receptor tyrosine kinase family members, plays an important role in the etiology and progression of lung cancer. In this study, we found that the ERBB4 protein levels were consistently up-regulated in lung cancer tissues, whereas the mRNA levels varied randomly, suggesting that a post-transcriptional mechanism was involved in regulating ERBB4 expression. Because microRNAs are powerful post-transcriptional regulators of gene expression, we used bioinformatic analyses to search for microRNAs that can potentially target ERBB4. Weidentified specific targeting sites for miR-193a-3p in the 3'-UTR of ERBB4. We further identified an inverse correlation between miR-193a-3p levels and ERBB4 protein levels, but not mRNA levels, in lung cancer tissue samples. By overexpressing or knocking down miR-193a-3p in lung cancer cells, we experimentally confirmed that miR-193a-3p directly recognizes the 3'-UTR of the ERBB4 transcript and regulates ERBB4 expression. Furthermore, the biological consequences of the targeting of ERBB4 by miR-193a-3p were examined in vitro via cell proliferation, invasion, and apoptosis assays and in vivo using a mouse xenograft tumor model. We demonstrated that the repression of ERBB4 by miR-193a-3p suppressed proliferation and invasion and promoted apoptosis in lung cancer cells and that miR-193a-3p exerted an anti-tumor effect by negatively regulating ERBB4 in xenograft mice. Taken together, our findings provide the first clues regarding the role of miR-193a-3p as a tumor suppressor in lung cancer through the inhibition of ERBB4 translation.	[Liang, Hongwei; Liu, Minghui; Wang, Xueliang; Fu, Zheng; Wang, Nan; Zhang, Suyang; Wang, Yanbo; Zen, Ke; Zhang, Chen-Yu; Hou, Dongxia; Li, Jing; Chen, Xi] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Yan, Xin] Nanjing Univ, Sch Med, Ctr Comprehens Canc, Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Yan, Xin] Nanjing Univ, Clin Canc Inst, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Yong; Wang, Wengong] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Thorac & Cardiovasc Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University	Hou, DX (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	dxhou128@nju.edu.cn; jingli220@nju.edu.cn; xichen@nju.edu.cn			National Basic Research Program of China (973 Program) [2014CB542300]; National Natural Science Foundation of China [81101330, 31271378, 81250044]; Natural Science Foundation of Jiangsu Province [BK2012014]; Research Special Fund for Public Welfare Industry of Health [201302018]; program for New Century Excellent Talents in University from the Ministry of Education, China [NCET-12-0261]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Research Special Fund for Public Welfare Industry of Health; program for New Century Excellent Talents in University from the Ministry of Education, China	This work was supported by National Basic Research Program of China (973 Program) Grant 2014CB542300; National Natural Science Foundation of China Grants 81101330, 31271378, and 81250044; Natural Science Foundation of Jiangsu Province Grant BK2012014; and Research Special Fund for Public Welfare Industry of Health Grant 201302018. This work was also supported by the program for New Century Excellent Talents in University from the Ministry of Education, China, Grant NCET-12-0261.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aurisicchio L, 2012, J CELL PHYSIOL, V227, P3381, DOI 10.1002/jcp.24037; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen Dan, 2013, J Oral Maxillofac Res, V4, pe2, DOI 10.5037/jomr.2013.4102; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Du LQ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-75; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Furger C, 1998, CANCER RES, V58, P1773; Gao XN, 2011, ONCOGENE, V30, P3416, DOI 10.1038/onc.2011.62; Gilbertson R, 2001, GENE CHROMOSOME CANC, V31, P288, DOI 10.1002/gcc.1146; Gilbertson RJ, 1998, CANCER RES, V58, P3932; Gilbertson RJ, 1997, CANCER RES, V57, P3272; Gilbertson RJ, 2002, CLIN CANCER RES, V8, P3054; Gilmour LMR, 2001, CANCER RES, V61, P2169; Graber HU, 1999, INT J CANCER, V84, P24, DOI 10.1002/(SICI)1097-0215(19990219)84:1<24::AID-IJC5>3.0.CO;2-2; Guz M, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/218169; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harpole DH, 1995, CLIN CANCER RES, V1, P659; Haugen DRF, 1996, CANCER RES, V56, P1184; HE L, 2004, NAT REV GENET, V5, P522; Heist RS, 2012, CANCER CELL, V21; Heller G, 2012, CLIN CANCER RES, V18, P1619, DOI 10.1158/1078-0432.CCR-11-2450; Iliopoulos D, 2011, CANCER RES, V71, P5144, DOI 10.1158/0008-5472.CAN-11-0425; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kang SM, 2014, EXP BIOL MED, V239, P1505, DOI 10.1177/1535370214533887; Klapper LN, 2000, ADV CANCER RES, V77, P25; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kwon JE, 2013, APOPTOSIS, V18, P896, DOI 10.1007/s10495-013-0841-7; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li B, 2014, AM J CANCER RES, V4, P161; Lyne JC, 1997, CANCER J SCI AM, V3, P21; Ma KL, 2012, J BIOL CHEM, V287, P5639, DOI 10.1074/jbc.M111.291229; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Merimsky O, 2002, EUR J CANCER, V38, P1335, DOI 10.1016/S0959-8049(02)00075-8; Merimsky O, 2001, ANN ONCOL, V12, P1127, DOI 10.1023/A:1011665216616; Nakano H, 2013, INT J ONCOL, V42, P1875, DOI 10.3892/ijo.2013.1896; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Noh Hyangsoon, 2011, Genes Cancer, V2, P140, DOI 10.1177/1947601911408888; Paatero Ilkka, 2008, Recent Pat DNA Gene Seq, V2, P27; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Salvi A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-162; Schneider PM, 2000, BRIT J CANCER, V83, P473, DOI 10.1054/bjoc.2000.1287; Srinivasan R, 1999, CLIN CANCER RES, V5, P2877; Starr A, 2006, INT J CANCER, V119, P269, DOI 10.1002/ijc.21818; Tahiri A, 2014, CARCINOGENESIS, V35, P76, DOI 10.1093/carcin/bgt333; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Walter BA, 2013, J CANCER, V4, P350, DOI 10.7150/jca.6394; Wang JL, 2013, CELL PHYSIOL BIOCHEM, V32, P1707, DOI 10.1159/000356605; Wang XC, 2010, AM J MED SCI, V340, P385, DOI 10.1097/MAJ.0b013e3181e892a0; Watson JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053417; Yong FL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-280; Yu T., 2014, ONCOGENE IN PRESS; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	56	78	82	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					926	940		10.1074/jbc.M114.621409	http://dx.doi.org/10.1074/jbc.M114.621409			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25391651	hybrid, Green Published			2022-12-28	WOS:000347778200027
J	Bancroft, T; Bouaouina, M; Roberts, S; Lee, M; Calderwood, DA; Schwartz, M; Simons, M; Sessa, WC; Kyriakides, TR				Bancroft, Tara; Bouaouina, Mohamed; Roberts, Sophia; Lee, Monica; Calderwood, David A.; Schwartz, Martin; Simons, Michael; Sessa, William C.; Kyriakides, Themis R.			Up-regulation of Thrombospondin-2 in Akt1-null Mice Contributes to Compromised Tissue Repair Due to Abnormalities in Fibroblast Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; Angiogenesis; Fibroblast; Thrombospondin; Wound Healing; TSP	NITRIC-OXIDE SYNTHASE; ENDOTHELIAL-CELLS; IN-VIVO; ANGIOGENESIS INHIBITOR; VASCULAR MATURATION; BLOOD-FLOW; ACTIVATION; EXPRESSION; AKT1; MIGRATION	Background: TSP2 and Akt1 exert opposite effects on tissue repair. Results: Akt1 KO mice display defects in fibroblast morphology and adhesion due to diminished Rac activation, which is a result of increased TSP2 expression. Loss of TSP2 rescues these defects. Conclusion: TSP2 contributes to compromised tissue repair in Akt1 KO mice. Significance: These data support a novel, NO-independent TSP2 regulatory mechanism in fibroblasts. Vascular remodeling is essential for tissue repair and is regulated by multiple factors, including thrombospondin-2 (TSP2) and hypoxia/VEGF-induced activation of Akt. In contrast to TSP2 knock-out (KO) mice, Akt1 KO mice have elevated TSP2 expression and delayed tissue repair. To investigate the contribution of increased TSP2 to Akt1 KO mice phenotypes, we generated Akt1/TSP2 double KO (DKO) mice. Full-thickness excisional wounds in DKO mice healed at an accelerated rate when compared with Akt1 KO mice. Isolated dermal Akt1 KO fibroblasts expressed increased TSP2 and displayed altered morphology and defects in migration and adhesion. These defects were rescued in DKO fibroblasts or after TSP2 knockdown. Conversely, the addition of exogenous TSP2 to WT cells induced cell morphology and migration rates that were similar to those of Akt1 KO cells. Akt1 KO fibroblasts displayed reduced adhesion to fibronectin with manganese stimulation when compared with WT and DKO cells, revealing an Akt1-dependent role for TSP2 in regulating integrin-mediated adhesions; however, this effect was not due to changes in 1 integrin surface expression or activation. Consistent with these results, Akt1 KO fibroblasts displayed reduced Rac1 activation that was dependent upon expression of TSP2 and could be rescued by a constitutively active Rac mutant. Our observations show that repression of TSP2 expression is a critical aspect of Akt1 function in tissue repair.	[Bancroft, Tara; Kyriakides, Themis R.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Bouaouina, Mohamed; Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Lee, Monica; Calderwood, David A.; Sessa, William C.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Schwartz, Martin] Yale Univ, Sch Med, Dept Cardiol, New Haven, CT 06520 USA; [Kyriakides, Themis R.] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT 06520 USA; [Bancroft, Tara; Roberts, Sophia; Lee, Monica; Calderwood, David A.; Schwartz, Martin; Simons, Michael; Sessa, William C.; Kyriakides, Themis R.] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Kyriakides, TR (corresponding author), Vasc Biol & Therapeut Program, 10 Amistad St, New Haven, CT 06520 USA.	themis.kyriakides@yale.edu	Sessa, William C/B-6844-2011; Simons, Michael/G-8553-2014; Calderwood, David A/AAC-6954-2019	Sessa, William C/0000-0001-5759-1938; Simons, Michael/0000-0003-0348-7734; Calderwood, David A/0000-0002-0791-4142; Roberts, Sophia/0000-0003-1062-9913	National Institutes of Health [HL 107205]; American Cancer Society [RSG-12-053-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107205, R01HL075092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 107205 (to T. R. K., W. C. S., M. S., and M. A. S.). This work was also supported by American Cancer Society Grant RSG-12-053-01 (to D. A. C.).	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Adya R, 2012, J VASC RES, V49, P534, DOI 10.1159/000338279; Agah A, 2005, AM J PATHOL, V167, P81, DOI 10.1016/S0002-9440(10)62955-0; Agah A, 2004, MATRIX BIOL, V22, P539, DOI 10.1016/j.matbio.2003.09.004; Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Bialkowska K, 2003, J BIOL CHEM, V278, P33342, DOI 10.1074/jbc.M301217200; Bornstein P, 2004, INT J BIOCHEM CELL B, V36, P1115, DOI 10.1016/j.biocel.2004.01.012; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Bouaouina M, 2011, METHODS MOL BIOL, V757, P325, DOI 10.1007/978-1-61779-166-6_20; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Diez H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032715; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Fernandez-Hernando C, 2009, ARTERIOSCL THROM VAS, V29, P2033, DOI 10.1161/ATVBAHA.109.196394; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hynes RO, 2004, MATRIX BIOL, V23, P333, DOI 10.1016/j.matbio.2004.08.001; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Kimura K, 2006, INVEST OPHTH VIS SCI, V47, P4323, DOI 10.1167/iovs.05-1508; Krady MM, 2008, AM J PATHOL, V173, P879, DOI 10.2353/ajpath.2008.080128; Kyriakides TR, 1999, J INVEST DERMATOL, V113, P782, DOI 10.1046/j.1523-1747.1999.00755.x; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Kyriakides TR, 2001, AM J PATHOL, V159, P1255, DOI 10.1016/S0002-9440(10)62512-6; Kyriakides TR, 1998, J HISTOCHEM CYTOCHEM, V46, P1007, DOI 10.1177/002215549804600904; Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449; Lanahan AA, 2006, PHYSIOL GENOMICS, V27, P380, DOI 10.1152/physiolgenomics.00145.2006; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; Linnerth-Petrik NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094595; Liu SX, 2007, MOL BIOL CELL, V18, P2169, DOI 10.1091/mbc.E06-12-1121; Liu SX, 2010, J CELL SCI, V123, P3674, DOI 10.1242/jcs.070672; MacLauchlan S, 2011, P NATL ACAD SCI USA, V108, pE1137, DOI 10.1073/pnas.1104357108; MacLauchlan S, 2009, J HISTOCHEM CYTOCHEM, V57, P301, DOI 10.1369/jhc.2008.952689; Marnmoto A, 2008, CURR OPIN HEMATOL, V15, P228, DOI 10.1097/MOH.0b013e3282fa7445; Oganesian A, 2008, MOL BIOL CELL, V19, P563, DOI 10.1091/mbc.E07-07-0649; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Ridley AJ, 2004, CELL, V116, P357, DOI 10.1016/S0092-8674(04)00123-0; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Schaffer MR, 1996, J SURG RES, V63, P237, DOI 10.1006/jsre.1996.0254; Schleicher M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000343; Sessa WC, 2009, J THROMB HAEMOST, V7, P35, DOI 10.1111/j.1538-7836.2009.03424.x; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Simantov R, 2005, MATRIX BIOL, V24, P27, DOI 10.1016/j.matbio.2004.11.005; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Skaletz-Rorowski Adriane, 2004, Semin Vasc Med, V4, P395, DOI 10.1055/s-2004-869596; Somanath PR, 2008, ANGIOGENESIS, V11, P277, DOI 10.1007/s10456-008-9111-7; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Somanath PR, 2009, J CELL PHYSIOL, V218, P394, DOI 10.1002/jcp.21612; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; TZENG E, 1995, P NATL ACAD SCI USA, V92, P11771, DOI 10.1073/pnas.92.25.11771; Wennerberg K, 2002, J BIOL CHEM, V277, P47810, DOI 10.1074/jbc.M203816200; WERNERFELMAYER G, 1990, J EXP MED, V172, P1599, DOI 10.1084/jem.172.6.1599; Wheeler AP, 2006, J CELL SCI, V119, P2749, DOI 10.1242/jcs.03024; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	71	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					409	422		10.1074/jbc.M114.618421	http://dx.doi.org/10.1074/jbc.M114.618421			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25389299	Green Published, hybrid			2022-12-28	WOS:000347231200036
J	Wang, T; Chen, Z; Zhu, YF; Pan, QX; Liu, YJ; Qi, XW; Jin, LF; Jin, J; Ma, X; Hua, D				Wang, Teng; Chen, Zhen; Zhu, Yifei; Pan, Qiongxi; Liu, Yanjun; Qi, Xiaowei; Jin, Linfang; Jin, Jian; Ma, Xin; Hua, Dong			Inhibition of Transient Receptor Potential Channel 5 Reverses 5-Fluorouracil Resistance in Human Colorectal Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Beta-Catenin (B-catenin); Chemoresistance; Colorectal Cancer; Transient Receptor Potential Channels (TRP Channels)	MULTIDRUG-RESISTANCE; PROSTATE-CANCER; P-GLYCOPROTEIN; TRP CHANNELS; BETA-CATENIN; TUMOR PROGRESSION; GENE-EXPRESSION; BREAST-CANCER; ION CHANNELS; PROLIFERATION	Background: Resistance to 5-fluorouracil leads to the failure of chemotherapy for colorectal cancer. Results: Suppressing TrpC5 expression decreased nuclear -catenin accumulation, reduced the induction of ABCB1, and reversed 5-fluorouracil resistance. Conclusion: TrpC5 is essential in ABCB1 induction and drug resistance in human colorectal cancer cells. Significance: These findings may help develop a novel target for overcoming resistance to chemotherapy in colorectal cancer. 5-Fluorouracil (5-Fu) is commonly used in the chemotherapy of colorectal cancer (CRC), but resistance to 5-Fu occurs in most cases, allowing cancer progression. Suppressing ABCB1 (ATP-binding cassette, subfamily B, member 1), which is a pump overproduced in cancer cells to export cytotoxic drugs, is an attractive strategy to overcome drug resistance. In the present study, transient receptor potential channel TrpC5 was found to be overproduced at the mRNA and protein levels together with ABCB1 in 5-Fu-resistant human CRC HCT-8 (HCT-8/5-Fu) and LoVo (LoVo/5-Fu) cells. More nuclear-stabilized -catenin accumulation was found in HCT-8/5-Fu and LoVo/5-Fu cells than in HCT-8 and LoVo cells. Suppressing TrpC5 expression with TrpC5-specific siRNA inhibited the canonical Wnt/-catenin signal pathway, reduced the induction of ABCB1, weakened the ABCB1 efflux pump, and caused a remarkable reversal of 5-Fu resistance in HCT-8/5-Fu and LoVo/5-Fu cells. On the contrary, enforcing TrpC5 expression resulted in an activated Wnt/-catenin signal pathway and up-regulation of ABCB1. Taken together, we demonstrated an essential role of TrpC5 in ABCB1 induction and drug resistance in human CRC cells via promoting nuclear -catenin accumulation.	[Wang, Teng; Hua, Dong] Jiangnan Univ, Affiliated Hosp, Dept Med Oncol, Wuxi 214062, Jiangsu, Peoples R China; [Qi, Xiaowei; Jin, Linfang] Jiangnan Univ, Affiliated Hosp, Dept Pathol, Wuxi 214062, Jiangsu, Peoples R China; Fourth Peoples Hosp Wuxi, Wuxi 214062, Jiangsu, Peoples R China; [Chen, Zhen; Zhu, Yifei; Pan, Qiongxi; Liu, Yanjun; Jin, Jian; Ma, Xin] Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University; Jiangnan University	Ma, X (corresponding author), Jiangnan Univ, Sch Pharmaceut Sci, 1800 Lihu Rd, Wuxi 214122, Jiangsu, Peoples R China.	maxin@jiangnan.edu.cn; huadong@csco.org.cn	Ma, Xin/G-1297-2013; liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022; 刘, 严君/GZL-5764-2022		Natural Science Foundation for Distinguished Young Scholars of Jiangsu Province [BK20140004]; National High Technology Research and Development Program of China [SQ2015AA0201349]; Program for New Century Excellent Talents in University of The Ministry of Education of China [NCET-12-0880]; National Natural Science Foundation of China [81100185, 91439131, 81273437]; Fundamental Research Funds for the Central Universities [JUSRP51311A]; Jiangsu Province National Natural Science Foundation [BK2010161]; Jiangsu Province Clinical Medical Science and Technology Specialized Research Fund Grant [BL2014019]; scientific and technological development funds from Wuxi science and technology bureau [CSE31N1419]; Strategic Priority Research Program from the Chinese Academy of Sciences [XDA01040000]	Natural Science Foundation for Distinguished Young Scholars of Jiangsu Province; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Program for New Century Excellent Talents in University of The Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Jiangsu Province National Natural Science Foundation; Jiangsu Province Clinical Medical Science and Technology Specialized Research Fund Grant; scientific and technological development funds from Wuxi science and technology bureau; Strategic Priority Research Program from the Chinese Academy of Sciences	This work was supported by the Natural Science Foundation for Distinguished Young Scholars of Jiangsu Province BK20140004 (to X. M.); the National High Technology Research and Development Program of China SQ2015AA0201349 (863 Program; to X. M.); the Program for New Century Excellent Talents in University of The Ministry of Education of China NCET-12-0880 (to X. M.); National Natural Science Foundation of China Grants 81100185, 91439131 (to X. M.) and 81273437 (to J. J.); Fundamental Research Funds for the Central Universities Grant JUSRP51311A (to X. M. and J. J.), Jiangsu Province National Natural Science Foundation Grant BK2010161 (to D. H.), Jiangsu Province Clinical Medical Science and Technology Specialized Research Fund Grant BL2014019 (to D. H.), scientific and technological development funds from Wuxi science and technology bureau CSE31N1419 (to T. W.), and Strategic Priority Research Program Grant XDA01040000 from the Chinese Academy of Sciences (to J. J.).	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Aydar E, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-23; Bomben VC, 2008, CELL PROLIFERAT, V41, P98, DOI 10.1111/j.1365-2184.2007.00504.x; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Chikazawa N, 2010, ANTICANCER RES, V30, P2041; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Fixemer T, 2003, ONCOGENE, V22, P7858, DOI 10.1038/sj.onc.1206895; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Goda K, 2009, CURR CANCER DRUG TAR, V9, P281, DOI 10.2174/156800909788166493; Gomez-Sintes R, 2010, J CLIN INVEST, V120, P2432, DOI 10.1172/JCI37873; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Han Ying, 2005, Chin J Dig Dis, V6, P82, DOI 10.1111/j.1443-9573.2005.00197.x; Hiani YEL, 2009, CELL PHYSIOL BIOCHEM, V23, P335, DOI 10.1159/000218179; Hiendlmeyer E, 2004, CANCER RES, V64, P1209, DOI 10.1158/0008-5472.CAN-3627-2; Janikova M, 2012, NEOPLASMA, V59, P6, DOI 10.4149/neo_2012_002; Jiang HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067637; Komoto C, 2007, KOBE J MED SCI, V53, P355; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Lehen'kyi V, 2011, ADV EXP MED BIOL, V704, P929, DOI 10.1007/978-94-007-0265-3_48; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Ma X, 2014, P NATL ACAD SCI USA, V111, P6389, DOI 10.1073/pnas.1400272111; Ma X, 2012, P NATL ACAD SCI USA, V109, P16282, DOI 10.1073/pnas.1202989109; McEwen DG, 2000, CURR BIOL, V10, pR562, DOI 10.1016/S0960-9822(00)00611-4; Molnar J, 2010, CURR TOP MED CHEM, V10, P1757; Pansters NAM, 2011, CELL MOL LIFE SCI, V68, P523, DOI 10.1007/s00018-010-0467-7; Pla AF, 2012, AM J PHYSIOL-CELL PH, V302, pC9, DOI 10.1152/ajpcell.00280.2011; Riganti C, 2009, TOXICOL APPL PHARM, V240, P385, DOI 10.1016/j.taap.2009.07.026; Shapiro AB, 1998, ACTA PHYSIOL SCAND, V163, P227; Shen DY, 2013, CANCER SCI, V104, P1303, DOI 10.1111/cas.12223; Shtil AA, 2005, INT REV CYTOL, V246, P1, DOI 10.1016/S0074-7696(05)46001-5; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Song MY, 2010, ADV EXP MED BIOL, V661, P99, DOI 10.1007/978-1-60761-500-2_6; Thebault S, 2006, CANCER RES, V66, P2038, DOI 10.1158/0008-5472.CAN-05-0376; Thrasivoulou C, 2013, J BIOL CHEM, V288, P35651, DOI 10.1074/jbc.M112.437913; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Vennekens R, 2012, REV PHYSIOL BIOCH P, V163, P27, DOI 10.1007/112_2012_8; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yamada T, 2000, CANCER RES, V60, P4761; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; Yu ZW, 2004, WORLD J GASTROENTERO, V10, P1979; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107	44	61	66	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					448	456		10.1074/jbc.M114.590364	http://dx.doi.org/10.1074/jbc.M114.590364			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25404731	hybrid, Green Published			2022-12-28	WOS:000347231200039
J	Pollitt, AY; Poulter, NS; Gitz, E; Navarro-Nunez, L; Wang, YJ; Hughes, CE; Thomas, SG; Nieswandt, B; Douglas, MR; Owen, DM; Jackson, DG; Dustin, ML; Watson, SP				Pollitt, Alice Y.; Poulter, Natalie S.; Gitz, Eelo; Navarro-Nunez, Leyre; Wang, Ying-Jie; Hughes, Craig E.; Thomas, Steven G.; Nieswandt, Bernhard; Douglas, Michael R.; Owen, Dylan M.; Jackson, David G.; Dustin, Michael L.; Watson, Steve P.			Syk and Src Family Kinases Regulate C-type Lectin Receptor 2 (CLEC-2)-mediated Clustering of Podoplanin and Platelet Adhesion to Lymphatic Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SYNAPSE FORMATION; LIPID RAFTS; CLEC-2; ACTIVATION; MICROCLUSTERS; AGGREGATION; SEPARATION; ANTIGEN; ACTIN	The interaction of C-type lectin receptor 2 (CLEC-2) on platelets with Podoplanin on lymphatic endothelial cells initiates platelet signaling events that are necessary for prevention of blood-lymph mixing during development. In the present study, we show that CLEC-2 signaling via Src family and Syk tyrosine kinases promotes platelet adhesion to primary mouse lymphatic endothelial cells at low shear. Using supported lipid bilayers containing mobile Podoplanin, we further show that activation of Src and Syk in platelets promotes clustering of CLEC-2 and Podoplanin. Clusters of CLEC-2-bound Podoplanin migrate rapidly to the center of the platelet to form a single structure. Fluorescence lifetime imaging demonstrates that molecules within these clusters are within 10 nm of one another and that the clusters are disrupted by inhibition of Src and Syk family kinases. CLEC-2 clusters are also seen in platelets adhered to immobilized Podoplanin using direct stochastic optical reconstruction microscopy. These findings provide mechanistic insight by which CLEC-2 signaling promotes adhesion to Podoplanin and regulation of Podoplanin signaling, thereby contributing to lymphatic vasculature development.	[Pollitt, Alice Y.; Poulter, Natalie S.; Gitz, Eelo; Navarro-Nunez, Leyre; Hughes, Craig E.; Thomas, Steven G.; Watson, Steve P.] Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Gitz, Eelo] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, NL-3584 CX Utrecht, Netherlands; [Wang, Ying-Jie; Jackson, David G.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Human Immunol Unit, Oxford OX3 9DS, England; [Nieswandt, Bernhard] Univ Wurzburg, Univ Hosp, Dept Expt Biomed, D-97080 Wurzburg, Germany; [Douglas, Michael R.] Univ Birmingham, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Douglas, Michael R.] Dudley Grp Natl Hlth Serv Fdn Trust, Dept Neurol, Dudley DY1 2HQ, W Midlands, England; [Owen, Dylan M.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Dustin, Michael L.] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Headington OX3 7FY, England; [Dustin, Michael L.] NYU, Dept Mol Pathogenesis, Skirball Inst Biomol Med, Sch Med,New York Univ Langone Med Ctr, New York, NY 10016 USA	University of Birmingham; Utrecht University; Utrecht University Medical Center; University of Oxford; University of Wurzburg; University of Birmingham; University of London; King's College London; University of Oxford; New York University	Pollitt, AY (corresponding author), Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England.	a.y.pollitt@bham.ac.uk; s.p.watson@bham.ac.uk	Dustin, Michael/AAM-4611-2020; engelmann, florent/A-9058-2011; Watson, Stephen P/Q-6292-2016	Watson, Stephen P/0000-0002-7846-7423; Hughes, Craig/0000-0002-9790-5820; Thomas, Steven/0000-0001-8733-7842; Poulter, Natalie/0000-0002-3187-2130; Dustin, Michael/0000-0003-4983-6389; Pollitt, Alice/0000-0001-8706-5154; , david/0000-0002-4133-9364	Wellcome Trust [088410/Z/09/Z, 100262/Z/12/Z]; NIH [R37AI43542]; MRC; Medical Research Council; Advantage West Midlands; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043542] Funding Source: NIH RePORTER; Medical Research Council [G1100134, MC_U137884182, MC_UU_12010/2] Funding Source: researchfish; MRC [MC_U137884182, MC_UU_12010/2, G1100134] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Advantage West Midlands(General Electric); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Wellcome Trust; programme numbers 088410/Z/09/Z (S. P. W.) and 100262/Z/12/Z. This work was also supported by NIH research grant R37AI43542 (to M. L. D.), and by funds from the MRC (D. G. J.) and by funds from the Medical Research Council (to D. G. J.) and Advantage West Midlands (to the Birmingham Advanced Light Microscopy Unit).	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Au-Yeung BB, 2010, NAT IMMUNOL, V11, P1085, DOI 10.1038/ni.1955; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Bohmer R, 2010, DEV CELL, V18, P437, DOI 10.1016/j.devcel.2010.01.009; Borgognone A, 2014, J THROMB HAEMOST, V12, P550, DOI 10.1111/jth.12514; Boulaftali Y, 2013, J CLIN INVEST, V123, P908, DOI 10.1172/JCI65154; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; Colonna M, 2000, EUR J IMMUNOL, V30, P697; Cueni LN, 2010, AM J PATHOL, V177, P1004, DOI 10.2353/ajpath.2010.090703; Davis SJ, 2011, TRENDS IMMUNOL, V32, P1, DOI 10.1016/j.it.2010.11.003; Depoil D, 2008, NAT IMMUNOL, V9, P63, DOI 10.1038/ni1547; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Fleire Sebastian J., 2009, V462, P145, DOI 10.1007/978-1-60327-115-8_9; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Gitz E, 2012, HAEMATOL-HEMATOL J, V97, P1873, DOI 10.3324/haematol.2012.066290; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hess PR, 2014, J CLIN INVEST, V124, P273, DOI 10.1172/JCI70422; Hou TZ, 2010, FEBS LETT, V584, P3955, DOI 10.1016/j.febslet.2010.07.053; Hughes CE, 2010, J THROMB HAEMOST, V8, P2328, DOI 10.1111/j.1538-7836.2010.04006.x; Hughes CE, 2015, BLOOD, V125, P144, DOI 10.1182/blood-2014-05-579375; Hughes CE, 2013, J BIOL CHEM, V288, P5127, DOI 10.1074/jbc.M112.411462; Ichise H, 2009, DEVELOPMENT, V136, P191, DOI 10.1242/dev.025353; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kerrigan AM, 2012, J THROMB HAEMOST, V10, P484, DOI 10.1111/j.1538-7836.2011.04614.x; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Kunita A, 2011, AM J PATHOL, V179, P1041, DOI 10.1016/j.ajpath.2011.04.027; Martin-Villar E, 2005, INT J CANCER, V113, P899, DOI 10.1002/ijc.20656; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; Metcalf DJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50579; Mourao-Sa D, 2011, EUR J IMMUNOL, V41, P3040, DOI 10.1002/eji.201141641; Navarro A, 2008, AM J PHYSIOL-LUNG C, V295, pL543, DOI 10.1152/ajplung.90262.2008; Navarro A, 2011, AM J PHYSIOL-LUNG C, V300, pL32, DOI 10.1152/ajplung.00171.2010; Osada M, 2012, J BIOL CHEM, V287, P22241, DOI 10.1074/jbc.M111.329987; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; Perry GLW, 2004, ENVIRON MODELL SOFTW, V19, P559, DOI 10.1016/j.envsoft.2003.07.004; Pollitt AY, 2010, BLOOD, V115, P2938, DOI 10.1182/blood-2009-12-257212; Reilly MP, 2011, BLOOD, V117, P2241, DOI 10.1182/blood-2010-03-274969; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Severin S, 2011, J BIOL CHEM, V286, P4107, DOI 10.1074/jbc.M110.167502; Spalton JC, 2009, J THROMB HAEMOST, V7, P1192, DOI 10.1111/j.1538-7836.2009.03451.x; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2003, BLOOD, V102, P1367, DOI 10.1182/blood-2003-01-0029; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Watson AA, 2009, BIOCHEMISTRY-US, V48, P10988, DOI 10.1021/bi901427d; Watson SP, 2014, ADV ANAT EMBRYOL CEL, V214, P93, DOI 10.1007/978-3-7091-1646-3_8; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011	63	49	51	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35695	35710		10.1074/jbc.M114.584284	http://dx.doi.org/10.1074/jbc.M114.584284			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25368330	hybrid, Green Published			2022-12-28	WOS:000346897900003
J	Wang, Y; Yang, Y; Wu, SF; Pan, S; Zhou, CD; Ma, YJ; Ru, YX; Dong, SX; He, B; Zhang, CZ; Cao, YJ				Wang, Yu; Yang, Yin; Wu, Songfang; Pan, Shuang; Zhou, Chaodong; Ma, Yijie; Ru, Yongxin; Dong, Shuxu; He, Bin; Zhang, Cuizhu; Cao, Youjia			p32 Is a Novel Target for Viral Protein ICP34.5 of Herpes Simplex Virus Type 1 and Facilitates Viral Nuclear Egress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMIN-B-RECEPTOR; GAMMA(1)34.5 PROTEIN; INFECTED-CELLS; IN-VITRO; PRODUCTIVE INFECTION; CELLULAR-PROTEIN; SPLICING FACTOR; KINASE-C; CYTOMEGALOVIRAL PROTEINS; MITOCHONDRIAL PROTEIN	As a large double-stranded DNA virus, herpes simplex virus type 1 (HSV-1) assembles capsids in the nucleus where the viral particles exit by budding through the inner nuclear membrane. Although a number of viral and host proteins are involved, the machinery of viral egress is not well understood. In a search for host interacting proteins of ICP34.5, which is a virulence factor of HSV-1, we identified a cellular protein, p32 (gC1qR/HABP1), by mass spectrophotometer analysis. When expressed, ICP34.5 associated with p32 in mammalian cells. Upon HSV-1 infection, p32 was recruited to the inner nuclear membrane by ICP34.5, which paralleled the phosphorylation and rearrangement of nuclear lamina. Knockdown of p32 in HSV-1-infected cells significantly reduced the production of cell-free viruses, suggesting that p32 is a mediator of HSV-1 nuclear egress. These observations suggest that the interaction between HSV-1 ICP34.5 and p32 leads to the disintegration of nuclear lamina and facilitates the nuclear egress of HSV-1 particles.	[Wang, Yu; Yang, Yin; Wu, Songfang; Pan, Shuang; Zhang, Cuizhu; Cao, Youjia] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China; [Zhou, Chaodong] Inst Drug Control, Dept Biochem, Tianjin 300070, Peoples R China; [Ma, Yijie; He, Bin] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Ru, Yongxin; Dong, Shuxu] Peking Union Coll, Inst Hematol & Blood Dis Hosp, Dept Electron Microscopy, Tianjin 300020, Peoples R China	Nankai University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS	He, B (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol MC 790, 835 S Wolcott Ave, Chicago, IL 60612 USA.	tshuo@uic.edu; czz912@aliyun.com; caoyj@nankai.edu.cn			National Institutes of Health from the NIAID [AI092230]; National Natural Science Foundation of China Grants [81171556, 31370862]; Ministry of Science and Technology of China Grant [BE091561]; Program of Introducing Talents of Discipline to Universities [B08011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092230] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China Grant; Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI092230 from the NIAID (to B. H.). This work was also supported by National Natural Science Foundation of China Grants 81171556 and 31370862 (to Y. C.), Ministry of Science and Technology of China Grant BE091561 (to Y. C.), and Program of Introducing Talents of Discipline to Universities Grant B08011.	Bjerke SL, 2006, VIROLOGY, V347, P261, DOI 10.1016/j.virol.2005.11.053; BROWN SM, 1994, J GEN VIROL, V75, P3679, DOI 10.1099/0022-1317-75-12-3679; Bruni R, 1996, P NATL ACAD SCI USA, V93, P10423, DOI 10.1073/pnas.93.19.10423; Calistri A, 2007, J VIROL, V81, P11468, DOI 10.1128/JVI.01364-07; Cheng GF, 2002, J VIROL, V76, P9434, DOI 10.1128/JVI.76.18.9434-9445.2002; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; Chouljenko DV, 2012, J VIROL, V86, P4262, DOI 10.1128/JVI.06766-11; Chouljenko VN, 2009, J VIROL, V83, P12301, DOI 10.1128/JVI.01329-09; Dedio J, 1998, J IMMUNOL, V160, P3534; Ghebrehiwet B, 2004, MOL IMMUNOL, V41, P173, DOI 10.1016/j.molimm.2004.03.014; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; HUTCHINSON L, 1995, J VIROL, V69, P5401, DOI 10.1128/JVI.69.9.5401-5413.1995; Jin HL, 2009, J VIROL, V83, P4984, DOI 10.1128/JVI.02535-08; Jing XH, 2004, J VIROL, V78, P7653, DOI 10.1128/JVI.78.14.7653-7666.2004; JOHNSON DC, 1982, J VIROL, V43, P1102, DOI 10.1128/JVI.43.3.1102-1112.1982; Kato A, 2006, J VIROL, V80, P1476, DOI 10.1128/JVI.80.3.1476-1486.2006; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Leach N, 2007, J VIROL, V81, P10792, DOI 10.1128/JVI.00196-07; Li YP, 2011, J BIOL CHEM, V286, P24785, DOI 10.1074/jbc.M111.232439; Liu ZM, 2014, J VIROL, V88, P4657, DOI 10.1128/JVI.00137-14; MACLEAN AR, 1991, J GEN VIROL, V72, P631, DOI 10.1099/0022-1317-72-3-631; Marschall M, 2005, J BIOL CHEM, V280, P33357, DOI 10.1074/jbc.M502672200; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Milbradt J, 2007, J GEN VIROL, V88, P2642, DOI 10.1099/vir.0.82924-0; Milbradt J, 2009, J GEN VIROL, V90, P579, DOI 10.1099/vir.0.005231-0; Morris JB, 2007, J VIROL, V81, P4429, DOI 10.1128/JVI.02354-06; Mou F, 2007, J VIROL, V81, P6459, DOI 10.1128/JVI.00380-07; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PETER M, 1991, EMBO J, V10, P1535, DOI 10.1002/j.1460-2075.1991.tb07673.x; Petersen-Mahrt SK, 1999, EMBO J, V18, P1014, DOI 10.1093/emboj/18.4.1014; Reynolds AE, 2004, J VIROL, V78, P5564, DOI 10.1128/JVI.78.11.5564-5575.2004; Reynolds AE, 2002, J VIROL, V76, P8939, DOI 10.1128/JVI.76.17.8939-8952.2002; Reynolds AE, 2001, J VIROL, V75, P8803, DOI 10.1128/JVI.75.18.8803-8817.2001; Robles-Flores M, 2002, J BIOL CHEM, V277, P5247, DOI 10.1074/jbc.M109333200; Ryckman BJ, 2004, J VIROL, V78, P399, DOI 10.1128/JVI.78.1.399-412.2004; Sagou K, 2010, J VIROL, V84, P2110, DOI 10.1128/JVI.02007-09; Scott ES, 2001, J VIROL, V75, P8818, DOI 10.1128/JVI.75.18.8818-8830.2001; SENIOR A, 1988, J CELL BIOL, V107, P2029, DOI 10.1083/jcb.107.6.2029; SIMOS G, 1994, FEBS LETT, V346, P225, DOI 10.1016/0014-5793(94)00479-X; Simpson-Holley M, 2004, J VIROL, V78, P5591, DOI 10.1128/JVI.78.11.5591-5600.2004; STACKPOLE CW, 1969, J VIROL, V4, P75, DOI 10.1128/JVI.4.1.75-93.1969; Sunayama J, 2004, CELL DEATH DIFFER, V11, P771, DOI 10.1038/sj.cdd.4401418; Tange TO, 1996, J BIOL CHEM, V271, P10066, DOI 10.1074/jbc.271.17.10066; van Leeuwen HC, 2001, J CELL SCI, V114, P2115; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; Wang YL, 1997, VIROLOGY, V236, P18, DOI 10.1006/viro.1997.8739; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; WHITLEY RJ, 1993, J CLIN INVEST, V91, P2837, DOI 10.1172/JCI116527; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; Wild P, 2005, J VIROL, V79, P1071, DOI 10.1128/JVI.79.2.1071-1083.2005; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774; YU L, 1995, J VIROL, V69, P3007, DOI 10.1128/JVI.69.5.3007-3016.1995	58	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35795	35805		10.1074/jbc.M114.603845	http://dx.doi.org/10.1074/jbc.M114.603845			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25355318	hybrid, Green Published			2022-12-28	WOS:000346897900011
J	Chen, YY; Soman, R; Shanmugam, K; Kuhn, A; Dalbey, RE				Chen, Yuanyuan; Soman, Raunak; Shanmugam, Karthika; Kuhn, Andreas; Dalbey, Ross E.			The Role of the Strictly Conserved Positively Charged Residue Differs among the Gram-positive, Gram-negative, and Chloroplast YidC Homologs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Membrane Biogenesis; Membrane Enzyme; Membrane Function; Membrane Protein; Membrane Structure; Alb3; YidC; YidC Mechanism; Membrane Insertion; Structure-Function	ESCHERICHIA-COLI YIDC; M13 PROCOAT PROTEIN; MEMBRANE INSERTION; PERIPLASMIC DOMAIN; CRYSTAL-STRUCTURE; BACTERIAL YIDC; TRANSLOCATION; BIOGENESIS; EVOLUTION; SUBSTRATE	Recently, the structure of YidC2 from Bacillus halodurans revealed that the conserved positively charged residue within transmembrane segment one (at position 72) is located in a hydrophilic groove that is embedded in the inner leaflet of the lipid bilayer. The arginine residue was essential for the Bacillus subtilis SpoIIIJ (YidC1) to insert MifM and to complement a SpoIIIJ mutant strain. Here, we investigated the importance of the conserved positively charged residue for the function of the Escherichia coli YidC, Streptococcus mutans YidC2, and the chloroplast Arabidopsis thaliana Alb3. Like the Gram-positive B. subtilis SpoIIIJ, the conserved arginine was required for functioning of the Gram-positive S. mutans YidC2 and was necessary to complement the E. coli YidC depletion strain and to promote insertion of a YidC-dependent membrane protein synthesized with one but not two hydrophobic segments. In contrast, the conserved positively charged residue was not required for the E. coli YidC or the A. thaliana Alb3 to functionally complement the E. coli YidC depletion strain or to promote insertion of YidC-dependent membrane proteins. Our results also show that the C-terminal half of the helical hairpin structure in cytoplasmic loop C1 is important for the activity of YidC because various deletions in the region either eliminate or impair YidC function. The results here underscore the importance of the cytoplasmic hairpin region for YidC and show that the arginine is critical for the tested Gram-positive YidC homolog but is not essential for the tested Gram-negative and chloroplast YidC homologs.	[Chen, Yuanyuan; Soman, Raunak; Shanmugam, Karthika; Dalbey, Ross E.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Kuhn, Andreas] Univ Hohenheim, Inst Microbiol & Mol Biol, D-70599 Stuttgart, Germany	University System of Ohio; Ohio State University; University Hohenheim	Dalbey, RE (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.	dalbey@chemistry.ohio-state.edu	Chen, Yuanyuan/GXG-2130-2022		National Science Foundation Grant [MCB-1052033]; Deutsche Forschungsgemeinschaft [Ku749/6]	National Science Foundation Grant(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by National Science Foundation Grant MCB-1052033 (to R. E. D.) and Deutsche Forschungsgemeinschaft Ku749/6 (to A. K.).	CAO GQ, 1994, EMBO J, V13, P4662, DOI 10.1002/j.1460-2075.1994.tb06789.x; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Dalbey RE, 2014, BBA-MOL CELL RES, V1843, P1489, DOI 10.1016/j.bbamcr.2013.12.022; Dong Y, 2008, J BACTERIOL, V190, P2458, DOI 10.1128/JB.01366-07; Eisenhawer M, 2001, BIOCHEMISTRY-US, V40, P12321, DOI 10.1021/bi0107694; Funes S, 2011, BIOL CHEM, V392, P13, DOI 10.1515/BC.2011.013; Hasona A, 2005, P NATL ACAD SCI USA, V102, P17466, DOI 10.1073/pnas.0508778102; Hennon SW, 2014, BIOCHEMISTRY-US, V53, P3278, DOI 10.1021/bi500257u; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Jiang FL, 2002, J BIOL CHEM, V277, P19281, DOI 10.1074/jbc.M110857200; Kedrov A, 2013, J MOL BIOL, V425, P4112, DOI 10.1016/j.jmb.2013.07.042; Kiefer D, 2007, INT REV CYTOL, V259, P113, DOI 10.1016/S0074-7969(06)59003-5; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; KUHN A, 1990, EMBO J, V9, P2385, DOI 10.1002/j.1460-2075.1990.tb07413.x; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Lemaire C, 2004, J BIOL CHEM, V279, P47464, DOI 10.1074/jbc.M404861200; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Preuss M, 2005, J BIOL CHEM, V280, P13004, DOI 10.1074/jbc.M414093200; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Saaf A, 1998, J BIOL CHEM, V273, P30415, DOI 10.1074/jbc.273.46.30415; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Seitl I, 2014, MOL MICROBIOL, V91, P408, DOI 10.1111/mmi.12465; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; van Bloois E, 2005, J BIOL CHEM, V280, P12996, DOI 10.1074/jbc.M414094200; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; Yen MR, 2001, FEMS MICROBIOL LETT, V204, P223, DOI 10.1111/j.1574-6968.2001.tb10889.x	30	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35656	35667		10.1074/jbc.M114.595082	http://dx.doi.org/10.1074/jbc.M114.595082			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25359772	hybrid, Green Published			2022-12-28	WOS:000346660200051
J	Eisenach, PA; Schikora, F; Posern, G				Eisenach, Patricia A.; Schikora, Franziska; Posern, Guido			Inhibition of Arginyltransferase 1 Induces Transcriptional Activity of Myocardin-related Transcription Factor A (MRTF-A) and Promotes Directional Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Adherens Junction; Breast Cancer; Cell Adhesion; Cell Signaling; Myocardin; Rho (Rho GTPase); Transcriptional Co-activator	SRF-MEDIATED TRANSCRIPTION; SERUM RESPONSE FACTOR; END RULE PATHWAY; MEGAKARYOBLASTIC LEUKEMIA; ACTIN DYNAMICS; CELL MOTILITY; ARGINYLATION; PROTEIN; MKL1; PHOSPHORYLATION	Myocardin-related transcription factor A (MRTF-A/MAL/MKL1/BSAC) regulates the expression of serum-response factor (SRF)-dependent target genes in response to the Rho-actin signaling pathway. Overexpression or activation of MRTF-A affects shape, migration, and invasion of cells and contributes to human malignancies, including cancer. In this study, we report that inhibition of arginyltransferase 1 (ATE1), an enzyme mediating post-transcriptional protein arginylation, is sufficient to increase MRTF-A activity in MCF-7 human breast carcinoma cells independently of external growth factor stimuli. In addition, silencing or inhibiting ATE1 disrupted E-cadherin-mediated cell-cell contacts, enhanced formation of actin-rich protrusions, and increased the number of focal adhesions, subsequently leading to elevated chemotactic migration. Although arginylated actin did not differentially affect MRTF-A, a rapid loss of E-cadherin and F-actin reorganization preceded MRTF-A activation upon ATE1 inhibition. Conversely, ectopic ATE1 expression was sufficient to render MRTF-A inactive, both in resting cells and in cells with exogenously activated RhoA-actin pathways. In this study, we provide a critical link between protein arginylation and MRTF-A activity and place ATE1 upstream of myocardin-related transcription factor.	[Eisenach, Patricia A.; Schikora, Franziska; Posern, Guido] Univ Halle Wittenberg, Inst Physiol Chem, D-06114 Halle, Saale, Germany; [Eisenach, Patricia A.] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Martin Luther University Halle Wittenberg; Max Planck Society	Posern, G (corresponding author), Univ Halle Wittenberg, Inst Physiol Chem, D-06114 Halle, Saale, Germany.	guido.posern@medizin.uni-halle.de			Department of Reinhard Fassler at the Max Planck Institute of Biochemistry; Department of Axel Ullrich at the Max Planck Institute of Biochemistry	Department of Reinhard Fassler at the Max Planck Institute of Biochemistry; Department of Axel Ullrich at the Max Planck Institute of Biochemistry	We thank Anna Kashina (University of Pennsylvania) for kindly providing the ubiquitin fusion and the ATE1-GFP constructs. Generous support was provided by the Departments of Reinhard Fassler and Axel Ullrich at the Max Planck Institute of Biochemistry.	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Becam IE, 2005, NAT CELL BIOL, V7, P510, DOI 10.1038/ncb1253; Busche S, 2008, J CELL SCI, V121, P1025, DOI 10.1242/jcs.014456; Busche S, 2010, J CELL SCI, V123, P2803, DOI 10.1242/jcs.061887; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; Eisenach PA, 2012, J BIOL CHEM, V287, P11533, DOI 10.1074/jbc.M111.306340; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Leitner L, 2011, J CELL SCI, V124, P4318, DOI 10.1242/jcs.092791; Lian LR, 2014, HAEMATOLOGICA, V99, P554, DOI 10.3324/haematol.2013.093047; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Miano JM, 2010, LAB INVEST, V90, P1274, DOI 10.1038/labinvest.2010.104; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; Rai R, 2005, P NATL ACAD SCI USA, V102, P10123, DOI 10.1073/pnas.0504500102; Saha S, 2012, BIOCHEM PHARMACOL, V83, P866, DOI 10.1016/j.bcp.2012.01.012; Scharenberg MA, 2010, INT J BIOCHEM CELL B, V42, P1911, DOI 10.1016/j.biocel.2010.08.014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sebe A, 2008, FEBS LETT, V582, P291, DOI 10.1016/j.febslet.2007.12.021; Shaposhnikov D, 2012, CELL CYCLE, V11, P141, DOI 10.4161/cc.11.1.18499; Speight P, 2013, MOL BIOL CELL, V24, P3326, DOI 10.1091/mbc.E13-04-0220; Terman JR, 2013, CURR OPIN CELL BIOL, V25, P30, DOI 10.1016/j.ceb.2012.10.009; Yang F, 2010, J BIOL CHEM, V285, P39437, DOI 10.1074/jbc.M110.159913; Zhang FL, 2012, J CELL BIOL, V197, P819, DOI 10.1083/jcb.201112129	30	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35376	35387		10.1074/jbc.M114.578674	http://dx.doi.org/10.1074/jbc.M114.578674			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25381249	Green Published, hybrid			2022-12-28	WOS:000346660200028
J	Hanoun, N; Fritsch, S; Gayet, O; Gigoux, V; Cordelier, P; Dusetti, N; Torrisani, J; Dufresne, M				Hanoun, Naima; Fritsch, Samuel; Gayet, Odile; Gigoux, Veronique; Cordelier, Pierre; Dusetti, Nelson; Torrisani, Jerome; Dufresne, Marlene			The E3 Ubiquitin Ligase Thyroid Hormone Receptor-interacting Protein 12 Targets Pancreas Transcription Factor 1a for Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Basic Helix-Loop-Helix Transcription Factor (bHLH); E3 Ubiquitin Ligase; Pancreas; Pancreatic Cancer; Proteasome; Protein Degradation; Protein-Protein Interaction; Transcription Factor; Ubiquitylation (Ubiquitination); Yeast Two-Hybrid	CELL-PROLIFERATION; PTF1A MUTATION; EXPRESSION; COMPLEX; EXOCRINE; CANCER; FATES; P53; DIFFERENTIATION; AUTOREGULATION	Pancreas transcription factor 1a (PTF1a) plays a crucial role in the early development of the pancreas and in the maintenance of the acinar cell phenotype. Several transcriptional mechanisms regulating expression of PTF1a have been identified. However, regulation of PTF1a protein stability and degradation is still unexplored. Here, we report that inhibition of proteasome leads to elevated levels of PTF1a and to the existence of polyubiquitinated forms of PTF1a. We used the Sos recruitment system, an alternative two-hybrid system method to detect protein-protein interactions in the cytoplasm and to map the interactome of PTF1a. We identified TRIP12 (thyroid hormone receptor-interacting protein 12), an E3 ubiquitin-protein ligase as a new partner of PTF1a. We confirmed PTF1a/TRIP12 interaction in acinar cell lines and in co-transfected HEK-293T cells. The protein stability of PTF1a is significantly increased upon decreased expression of TRIP12. It is reduced upon overexpression of TRIP12 but not a catalytically inactive TRIP12-C1959A mutant. We identified a region of TRIP12 required for interaction and identified lysine 312 of PTF1a as essential for proteasomal degradation. We also demonstrate that TRIP12 down-regulates PTF1a transcriptional and antiproliferative activities. Our data suggest that an increase in TRIP12 expression can play a part in PTF1a down-regulation and indicate that PTF1a/TRIP12 functional interaction may regulate pancreatic epithelial cell homeostasis.	[Hanoun, Naima; Fritsch, Samuel; Cordelier, Pierre; Torrisani, Jerome; Dufresne, Marlene] Univ Toulouse 3, INSERM UMR1037, CRCT, F-31037 Toulouse, France; [Gigoux, Veronique] Univ Toulouse 3, EA 4552, F-31432 Toulouse, France; [Gayet, Odile; Dusetti, Nelson] Univ Aix Marseille, Canc Res Ctr Marseille, INSERM UMR1068, Inst J Paoli I Calmettes,CNRS UMR7258, F-13273 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Dufresne, M (corresponding author), UMR1037 INSERM, CRCT, 2 Ave Hubert Curien,Oncopole Entree C,CS 53717, F-31037 Toulouse 1, France.	marlene.dufresne@inserm.fr	Dufresne, Marlène/M-6332-2014; Cordelier, Pierre/D-1150-2014; Gigoux, Véronique/AAE-6090-2020; Dusetti, Nelson/O-7919-2017; Torrisani, Jérôme/M-6203-2014	Cordelier, Pierre/0000-0003-2096-7967; Gigoux, Véronique/0000-0003-1408-5335; Dusetti, Nelson/0000-0002-6161-8483; Torrisani, Jérôme/0000-0001-6880-9357	INSERM; Agence Nationale pour la Recherche; Association pour la Recherche contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by INSERM, Agence Nationale pour la Recherche, and Association pour la Recherche contre le Cancer.	Adell T, 2000, CELL GROWTH DIFFER, V11, P137; Al-Shammari M, 2011, CLIN GENET, V80, P196, DOI 10.1111/j.1399-0004.2010.01613.x; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Dong PDS, 2008, GENE DEV, V22, P1445, DOI 10.1101/gad.1663208; Dullin JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-110; Ghosh B, 2006, BIOCHEM J, V393, P679, DOI 10.1042/BJ20051063; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1998, GENE DEV, V12, P901, DOI 10.1101/gad.12.7.901; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Kajiro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025871; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Keppler BR, 2010, J BIOL CHEM, V285, P35665, DOI 10.1074/jbc.M110.173997; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Lelievre EC, 2011, DEV BIOL, V358, P296, DOI 10.1016/j.ydbio.2011.07.033; Lu CK, 2012, DNA CELL BIOL, V31, P1245, DOI 10.1089/dna.2012.1619; Masui T, 2008, MOL CELL BIOL, V28, P5458, DOI 10.1128/MCB.00549-08; Masui T, 2010, GASTROENTEROLOGY, V139, P270, DOI 10.1053/j.gastro.2010.04.003; Meredith DM, 2009, J NEUROSCI, V29, P11139, DOI 10.1523/JNEUROSCI.2303-09.2009; Molero X, 2007, EUR J CLIN INVEST, V37, P791, DOI 10.1111/j.1365-2362.2007.01856.x; Nakajima D, 2005, DNA RES, V12, P257, DOI 10.1093/dnares/dsi010; Park Y, 2008, BIOCHEM BIOPH RES CO, V374, P294, DOI 10.1016/j.bbrc.2008.07.019; Park Y, 2009, J BIOL CHEM, V284, P1540, DOI 10.1074/jbc.M807554200; Pascual M, 2007, P NATL ACAD SCI USA, V104, P5193, DOI 10.1073/pnas.0605699104; Rodolosse A, 2004, GASTROENTEROLOGY, V127, P937, DOI 10.1053/j.gastro.2004.06.058; Rodolosse A, 2009, BIOCHEM J, V418, P463, DOI 10.1042/BJ20080293; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Thalappilly S, 2008, PROTEOMICS, V8, P3071, DOI 10.1002/pmic.200701157; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Tutak E, 2009, GENET COUNSEL, V20, P147; Yang YK, 2012, FEBS LETT, V586, P422, DOI 10.1016/j.febslet.2012.01.015	39	13	13	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35593	35604		10.1074/jbc.M114.620104	http://dx.doi.org/10.1074/jbc.M114.620104			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25355311	hybrid, Green Published			2022-12-28	WOS:000346660200046
J	Andreotti, G; de Vaca, IC; Poziello, A; Monti, MC; Guallar, V; Cubellis, MV				Andreotti, Giuseppina; Cabeza de Vaca, Israel; Poziello, Angelita; Monti, Maria Chiara; Guallar, Victor; Cubellis, Maria Vittoria			Conformational Response to Ligand Binding in Phosphomannomutase2 INSIGHTS INTO INBORN GLYCOSYLATION DISORDER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Drug Discovery; Glycosylation; Glycosylation Inhibitor; Ligand-binding Protein; 1; 6-Bisphosphate; PELE; Phosphomannomutase	CONGENITAL DISORDER; PMM2 GENE; CDG-IA; IDENTIFICATION; FIBROBLASTS; MUTATIONS; PROTEINS; SURFACES; MODEL	Background: Mutations in phosphomannomutase2 cause glycosylation disorder, a disease without a cure that will largely benefit from accurate ligand-bound models. Results: We obtained two models of phospomannomutase2 bound to glucose 1,6-bisphosphate and validated them with limited proteolysis. Conclusion: Ligand binding induces a large conformational transition in PMM2. Significance: We produce and validate closed-form models of PMM2 that represent a starting point for rational drug discovery. The most common glycosylation disorder is caused by mutations in the gene encoding phosphomannomutase2, producing a disease still without a cure. Phosphomannomutase2, a homodimer in which each chain is composed of two domains, requires a bisphosphate sugar (either mannose or glucose) as activator, opening a possible drug design path for therapeutic purposes. The crystal structure of human phosphomannomutase2, however, lacks bound substrate and a key active site loop. To speed up drug discovery, we present here the first structural model of a bisphosphate substrate bound to human phosphomannomutase2. Taking advantage of recent developments in all-atom simulation techniques in combination with limited and site-directed proteolysis, we demonstrated that -glucose 1,6-bisphosphate can adopt two low energy orientations as required for catalysis. Upon ligand binding, the two domains come close, making the protein more compact, in analogy to the enzyme in the crystals from Leishmania mexicana. Moreover, proteolysis was also carried out on two common mutants, R141H and F119L. It was an unexpected finding that the mutant most frequently found in patients, R141H, although inactive, does bind -glucose 1,6-bisphosphate and changes conformation.	[Andreotti, Giuseppina; Poziello, Angelita] CNR, Ist Chim Biomol, I-80078 Pozzuoli, Italy; [Cabeza de Vaca, Israel; Guallar, Victor] Barcelona Supercomp Ctr, Inst Res Biomed Res Program Computat Biol, Ctr Genom Regulat, Joint Barcelona Supercomp Ctr, Barcelona 08034, Spain; [Monti, Maria Chiara] Univ Salerno, Dipartimento Farm, I-84084 Fisciano, Italy; [Guallar, Victor] Passeig Lluis Co 23, Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain; [Poziello, Angelita; Cubellis, Maria Vittoria] Univ Naples Federico II, Dipartimento Biol, I-80126 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); University of Salerno; ICREA; University of Naples Federico II	Guallar, V (corresponding author), Barcelona Supercomp Ctr, LifeSci Dept, C Jordi Girona 29, Barcelona 08034, Spain.	victor.guallar@bsc.es; cubellis@unina.it	ANDREOTTI, GIUSEPPINA/AAX-8952-2020; Guallar, Victor/B-1579-2013	ANDREOTTI, GIUSEPPINA/0000-0002-1594-0156; Guallar, Victor/0000-0002-4580-1114; cubellis, maria vittoria/0000-0001-6147-6553	Telethon-Italy [GGP12108]; European Research Council [ERC-2009-Adg 25027-PELE]; ICREA Funding Source: Custom	Telethon-Italy(Fondazione Telethon); European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	This work was supported by Telethon-Italy Grant GGP12108 and European Research Council Grant ERC-2009-Adg 25027-PELE.	Andreotti G, 2013, MOL GENET GENOM MED, V1, P32, DOI 10.1002/mgg3.3; Andreotti G, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-36; Bjursell C, 1998, EUR J HUM GENET, V6, P603, DOI 10.1038/sj.ejhg.5200234; Borrelli KW, 2005, J CHEM THEORY COMPUT, V1, P1304, DOI 10.1021/ct0501811; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briones P, 2002, J INHERIT METAB DIS, V25, P635; Cammisa M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S9; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Cromphout K, 2006, MOL CELL BIOL, V26, P5621, DOI 10.1128/MCB.02357-05; Cubellis MV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S8; Cubellis MV, 2005, PROTEINS, V58, P880, DOI 10.1002/prot.20327; Eklund EA, 2005, GLYCOBIOLOGY, V15, P1084, DOI 10.1093/glycob/cwj006; Grunewald S, 2009, BBA-MOL BASIS DIS, V1792, P827, DOI 10.1016/j.bbadis.2009.01.003; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kedzierski L, 2006, J MOL BIOL, V363, P215, DOI 10.1016/j.jmb.2006.08.023; Kjaergaard S, 1998, EUR J HUM GENET, V6, P331, DOI 10.1038/sj.ejhg.5200194; Le Bizec Christiane, 2005, Hum Mutat, V25, P504, DOI 10.1002/humu.9336; Leidenheimer NJ, 2014, PHARMACOL RES, V83, P10, DOI 10.1016/j.phrs.2014.01.005; Matthijs G, 1999, MOL GENET METAB, V68, P220, DOI 10.1006/mgme.1999.2914; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Nogly P, 2013, ACTA CRYSTALLOGR D, V69, P2008, DOI 10.1107/S0907444913017046; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; PATTHY L, 1975, J BIOL CHEM, V250, P565; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirard M, 1999, BIOCHEM J, V339, P201, DOI 10.1042/0264-6021:3390201; Schneider A, 2012, NAT MED, V18, P71, DOI 10.1038/nm.2548; Schollen E, 2000, EUR J HUM GENET, V8, P367, DOI 10.1038/sj.ejhg.5200470; Schrodinger LLC, 2011, PROT PREP WIZ EPIK V; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Sharma V, 2011, J BIOL CHEM, V286, P39431, DOI 10.1074/jbc.M111.285502; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Takahashi R, 2014, J CHEM THEORY COMPUT, V10, P282, DOI 10.1021/ct400678g; Vega AI, 2009, HUM MUTAT, V30, P795, DOI 10.1002/humu.20960; Vermeer S, 2007, J NEUROL, V254, P1356, DOI 10.1007/s00415-007-0546-3	35	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34900	34910		10.1074/jbc.M114.586362	http://dx.doi.org/10.1074/jbc.M114.586362			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25324542	Green Published, hybrid			2022-12-28	WOS:000346260800040
J	Sand, KMK; Bern, M; Nilsen, J; Dalhus, B; Gunnarsen, KS; Cameron, J; Grevys, A; Bunting, K; Sandlie, I; Andersen, JT				Sand, Kine Marita Knudsen; Bern, Malin; Nilsen, Jeannette; Dalhus, Bjorn; Gunnarsen, Kristin Stoen; Cameron, Jason; Grevys, Algirdas; Bunting, Karen; Sandlie, Inger; Andersen, Jan Terje			Interaction with Both Domain I and III of Albumin Is Required for Optimal pH-dependent Binding to the Neonatal Fc Receptor (FcRn)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Albumin; Biodegradation; Bioengineering; Fc Receptor; pH Regulation; Pharmacokinetics	HUMAN SERUM-ALBUMIN; HALF-LIFE; CRYSTAL-STRUCTURE; HUMAN IGG1; MUTAGENESIS; REVEALS; SITE; EXPRESSION; ANTIBODIES; CONSEQUENCES	Background: FcRn regulates the long serum half-life of albumin. Results: The C-terminal DIII of HSA is the principal domain for FcRn binding, whereas two loops in DI at the N terminus modulate the interaction. Conclusion: DI of albumin contributes to optimal FcRn binding. Significance: We highlight the importance of DI for pH-dependent binding to FcRn. Albumin is an abundant blood protein that acts as a transporter of a plethora of small molecules like fatty acids, hormones, toxins, and drugs. In addition, it has an unusual long serum half-life in humans of nearly 3 weeks, which is attributed to its interaction with the neonatal Fc receptor (FcRn). FcRn protects albumin from intracellular degradation via a pH-dependent cellular recycling mechanism. To understand how FcRn impacts the role of albumin as a distributor, it is of importance to unravel the structural mechanism that determines pH-dependent binding. Here, we show that although the C-terminal domain III (DIII) of human serum albumin (HSA) contains the principal binding site, the N-terminal domain I (DI) is important for optimal FcRn binding. Specifically, structural inspection of human FcRn (hFcRn) in complex with HSA revealed that two exposed loops of DI were in proximity with the receptor. To investigate to what extent these contacts affected hFcRn binding, we targeted selected amino acid residues of the loops by mutagenesis. Screening by in vitro interaction assays revealed that several of the engineered HSA variants showed decreased binding to hFcRn, which was also the case for two missense variants with mutations within these loops. In addition, four of the variants showed improved binding. Our findings demonstrate that both DI and DIII are required for optimal binding to FcRn, which has implications for our understanding of the FcRn-albumin relationship and how albumin acts as a distributor. Such knowledge may inspire development of novel HSA-based diagnostics and therapeutics.	[Sand, Kine Marita Knudsen; Bern, Malin; Grevys, Algirdas; Sandlie, Inger] Univ Oslo, CIR, N-0316 Oslo, Norway; [Sand, Kine Marita Knudsen; Bern, Malin; Grevys, Algirdas; Sandlie, Inger] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Sand, Kine Marita Knudsen; Bern, Malin; Nilsen, Jeannette; Gunnarsen, Kristin Stoen; Grevys, Algirdas; Sandlie, Inger; Andersen, Jan Terje] Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Immune Regulat, N-0424 Oslo, Norway; [Sand, Kine Marita Knudsen; Bern, Malin; Nilsen, Jeannette; Gunnarsen, Kristin Stoen; Grevys, Algirdas; Sandlie, Inger; Andersen, Jan Terje] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Immunol, N-0424 Oslo, Norway; [Sand, Kine Marita Knudsen; Bern, Malin; Nilsen, Jeannette; Dalhus, Bjorn; Gunnarsen, Kristin Stoen; Grevys, Algirdas; Sandlie, Inger; Andersen, Jan Terje] Univ Oslo, N-0424 Oslo, Norway; [Nilsen, Jeannette; Bunting, Karen] Univ Oslo, Inst Clin Med, N-0424 Oslo, Norway; [Dalhus, Bjorn] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Microbiol, N-0424 Oslo, Norway; [Dalhus, Bjorn] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Med Biochem, N-0424 Oslo, Norway; [Dalhus, Bjorn; Cameron, Jason] Novozymes Biopharma UK Ltd, Nottingham NG7 1FD, England	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Novozymes	Andersen, JT (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Immune Regulat, POB 4956, N-0424 Oslo, Norway.	j.t.andersen@medisin.uio.no	Andersen, Jan Terje/AAB-6209-2020; Dalhus, Bjørn/AAK-2895-2020	Andersen, Jan Terje/0000-0003-1710-1628; Grevys, Algirdas/0000-0001-7350-5841	Research Council of Norway through its Centres of Excellence funding scheme [179573]; University of Oslo; Research Council of Norway [143822, 230526/F20, 179573/V40]; South-Eastern Norway Regional Health Authority [2009100, 2011040, 2012085, 39457]	Research Council of Norway through its Centres of Excellence funding scheme; University of Oslo; Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	This work was supported in part by the Research Council of Norway through its Centres of Excellence funding scheme (Project 179573). I. S., J. T. A., B. D., K. B., and J. C. are co-inventors of pending patent applications related to the data described in this paper.; Supported by the University of Oslo.; Supported by the Research Council of Norway through its programme for Global Health and Vaccination Research (GLOBVAC) (Grant 143822).; Supported by the Research Council of Norway (Grant 230526/F20).; Supported by the South-Eastern Norway Regional Health Authority to establish the Regional Technology Platform for Structural Biology and Bioinformatics (Grants 2009100, 2011040, and 2012085).; Supported by the South-Eastern Norway Regional Health Authority (Grant 39457).; Supported by the Research Council of Norway (Grants 230526/F20 and 179573/V40).	Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Andersen JT, 2008, FEBS J, V275, P4097, DOI 10.1111/j.1742-4658.2008.06551.x; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2014, J BIOL CHEM, V289, P13492, DOI 10.1074/jbc.M114.549832; Andersen JT, 2013, J BIOL CHEM, V288, P24277, DOI 10.1074/jbc.M113.463000; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Andersen JT, 2011, J BIOL CHEM, V286, P5234, DOI 10.1074/jbc.M110.164848; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Andersen JT, 2010, CLIN BIOCHEM, V43, P367, DOI 10.1016/j.clinbiochem.2009.12.001; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; Anderson CL, 2006, TRENDS IMMUNOL, V27, P343, DOI 10.1016/j.it.2006.05.004; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Cardoso RMF, 2003, PROTEINS, V51, P137, DOI 10.1002/prot.10345; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Elsadek B, 2012, J CONTROL RELEASE, V157, P4, DOI 10.1016/j.jconrel.2011.09.069; Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993; Flora K, 1998, BIOPHYS J, V75, P1084, DOI 10.1016/S0006-3495(98)77598-8; GALLIANO M, 1990, P NATL ACAD SCI USA, V87, P8721, DOI 10.1073/pnas.87.22.8721; Ghetie V, 1997, NAT BIOTECHNOL, V15, P637, DOI 10.1038/nbt0797-637; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Kim JH, 2006, AM J PHYSIOL-GASTR L, V290, pG352, DOI 10.1152/ajpgi.00286.2005; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; Kim J, 2007, CLIN IMMUNOL, V122, P146, DOI 10.1016/j.clim.2006.09.001; Kobayashi K, 2009, GASTROENTEROLOGY, V137, P1746, DOI 10.1053/j.gastro.2009.07.059; Kragh-Hansen U, 2013, BBA-GEN SUBJECTS, V1830, P5405, DOI 10.1016/j.bbagen.2013.03.026; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Sand KMK, 2014, J BIOL CHEM, V289, P17228, DOI 10.1074/jbc.M113.522565; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; SIMISTER NE, 1989, COLD SPRING HARB SYM, V54, P571, DOI 10.1101/SQB.1989.054.01.068; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; STORY CM, 1994, J EXP MED, V180, P2377, DOI 10.1084/jem.180.6.2377; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; TAKAHASHI N, 1987, P NATL ACAD SCI USA, V84, P8001, DOI 10.1073/pnas.84.22.8001; Vaughn DE, 1997, BIOCHEMISTRY-US, V36, P9374, DOI 10.1021/bi970841r; Wani MA, 2006, P NATL ACAD SCI USA, V103, P5084, DOI 10.1073/pnas.0600548103; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zhou JC, 2005, J MOL BIOL, V345, P1071, DOI 10.1016/j.jmb.2004.11.014	47	32	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34583	34594		10.1074/jbc.M114.587675	http://dx.doi.org/10.1074/jbc.M114.587675			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25344603	Green Published, hybrid			2022-12-28	WOS:000346260800017
J	Lucana, DOD; Fedosov, SN; Wedderhoff, I; Che, EN; Torda, AE				Lucana, Dario Ortiz de Orue; Fedosov, Sergey N.; Wedderhoff, Ina; Che, Edith N.; Torda, Andrew E.			The Extracellular Heme-binding Protein HbpS from the Soil Bacterium Streptomyces reticuli Is an Aquo-cobalamin Binder	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Ligand-binding Protein; Metalloprotein; Microbiology; Spectroscopy	X-RAY-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA; CONFORMATIONAL-CHANGES; ARABIDOPSIS-THALIANA; INTRINSIC-FACTOR; SENSING PROTEIN; VITAMIN-B-12; TRANSCOBALAMIN; BIOSYNTHESIS	Background: Sequence and structure comparisons suggested that the heme-binding protein HbpS from Streptomyces reticuli might bind cobalamin. Results: HbpS binds aquo-cobalamin and the responsible histidine was identified. Conclusion: The calculated K-d of 34 m suggests that HbpS might bind cobalamin in both bacterial cultures and in the Streptomyces natural environment the soil. Significance: The results suggest an evolutionary path between tetrapyrrole binding roles in the HbpS-like protein family. The extracellular protein HbpS from Streptomyces reticuli interacts with iron ions and heme. It also acts in concert with the two-component sensing system SenS-SenR in response to oxidative stress. Sequence comparisons suggested that the protein may bind a cobalamin. UV-visible spectroscopy confirmed binding (K-d = 34 m) to aquo-cobalamin (H(2)OCbl(+)) but not to other cobalamins. Competition experiments with the H(2)OCbl(+)-coordinating ligand CN- and comparison of mutants identified a histidine residue (His-156) that coordinates the cobalt ion of H(2)OCbl(+) and substitutes for water. HbpSCobalamin lacks the Asp-X-His-X-X-Gly motif seen in some cobalamin binding enzymes. Preliminary tests showed that a related HbpS protein from a different species also binds H(2)OCbl(+). Furthermore, analyses of HbpS-heme binding kinetics are consistent with the role of HbpS as a heme-sensor and suggested a role in heme transport. Given the high occurrence of HbpS-like sequences among Gram-positive and Gram-negative bacteria, our findings suggest a great functional versatility among these proteins.	[Lucana, Dario Ortiz de Orue; Wedderhoff, Ina; Che, Edith N.] Univ Osnabruck, Dept Biol Chem, D-49067 Osnabruck, Germany; [Fedosov, Sergey N.] Aarhus Univ, Dept Engn, DK-8000 Aarhus, Denmark; [Torda, Andrew E.] Univ Hamburg, Ctr Bioinformat, D-20146 Hamburg, Germany	University Osnabruck; Aarhus University; University of Hamburg	Lucana, DOD (corresponding author), Univ Osnabruck, Dept Biol Chem, Barbarastr 13, D-49067 Osnabruck, Germany.	ortiz@biologie.uni-osnabrueck.de	Fedosov, Sergey N./J-2340-2019	Fedosov, Sergey N./0000-0002-7016-2959	Deutsche Forschungsgemeinschaft [OR 224/2-1, OR 224/4-1]; Heisenberg Programme from the Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heisenberg Programme from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants OR 224/2-1 and OR 224/4-1.; Supported by the Heisenberg Programme from the Deutsche Forschungsgemeinschaft. To whom correspondence should be addressed: Applied Genetics of Microorganisms, Dept. of Biology/Chemistry, University of Osnabrueck, Barbarastr. 13, 49067 Osnabrueck, Germany. Tel.: 495419693439; Fax: 495419692804; E-mail: ortiz@biologie.uni-osnabrueck.de.	Allen KD, 2014, ARCH BIOCHEM BIOPHYS, V543, P67, DOI 10.1016/j.abb.2013.12.004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asher C, 2009, INORG CHEM, V48, P7994, DOI 10.1021/ic900647y; Bhakta MN, 2006, BIOCHEMISTRY-US, V45, P11642, DOI 10.1021/bi060980l; Bogel G, 2009, AMINO ACIDS, V37, P681, DOI 10.1007/s00726-008-0188-5; Book AJ, 2014, APPL ENVIRON MICROB, V80, P4692, DOI 10.1128/AEM.01133-14; Borovok I, 2006, J BACTERIOL, V188, P2512, DOI 10.1128/JB.188.7.2512-2520.2006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; DAWSON JH, 1983, J BIOL CHEM, V258, P3637; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Deniau C, 2003, BIOCHEMISTRY-US, V42, P10627, DOI 10.1021/bi030015k; Fedosov SN, 2007, BIOCHEMISTRY-US, V46, P6446, DOI 10.1021/bi062063l; Fedosov SN, 2005, BIOCHEMISTRY-US, V44, P3604, DOI 10.1021/bi047936v; Fedosov SN, 1999, J BIOL CHEM, V274, P26015, DOI 10.1074/jbc.274.37.26015; Fedosov SN, 2000, J BIOL CHEM, V275, P11791, DOI 10.1074/jbc.275.16.11791; Fedosov SN, 2003, EUR J BIOCHEM, V270, P3362, DOI 10.1046/j.1432-1033.2003.03716.x; Flinspach K, 2010, BIOPOLYMERS, V93, P823, DOI 10.1002/bip.21493; FRIEDMANN HC, 1970, ANNU REV MICROBIOL, V24, P159, DOI 10.1146/annurev.mi.24.100170.001111; Gruber K, 2011, CHEM SOC REV, V40, P4346, DOI 10.1039/c1cs15118e; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hoffmann B, 1999, EUR J BIOCHEM, V263, P178, DOI 10.1046/j.1432-1327.1999.00482.x; Hopwood D.A., 1985, GENETIC MANIPULATION; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Johnson CLV, 2001, J BACTERIOL, V183, P1577, DOI 10.1128/JB.183.5.1577-1584.2001; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Krautler B, 2005, BIOCHEM SOC T, V33, P806; KRAUTLER B, 2006, ENCY INORGANIC CHEM, P1272; Kuznets G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004407; LOCHHEAD AG, 1956, NATURE, V178, P144, DOI 10.1038/178144a0; LOCHHEAD AG, 1951, NATURE, V167, P1034, DOI 10.1038/1671034a0; Lucana DOD, 2010, J BIOL CHEM, V285, P28086, DOI 10.1074/jbc.M110.127506; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; Lucana DODO, 2009, J MOL BIOL, V386, P1108, DOI 10.1016/j.jmb.2009.01.017; Lucana DOD, 2004, MICROBIOL-SGM, V150, P2575, DOI 10.1099/mic.0.27091-0; Margraf T, 2009, NUCLEIC ACIDS RES, V37, pW480, DOI 10.1093/nar/gkp431; Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7; Meschke H, 2010, MICROB BIOTECHNOL, V3, P428, DOI 10.1111/j.1751-7915.2010.00165.x; MOZAFAR A, 1992, PLANT SOIL, V139, P23, DOI 10.1007/BF00012838; MOZAFAR A, 1994, PLANT SOIL, V167, P305, DOI 10.1007/BF00007957; NEXO E, 1975, BIOCHIM BIOPHYS ACTA, V379, P189, DOI 10.1016/0005-2795(75)90021-5; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Parsons JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014009; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Pratt J. M., 1972, INORGANIC CHEM VITAM; Romero D, 2011, CHEM REV, V111, P5492, DOI 10.1021/cr2000509; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Sambrook J., 2002, MOL CLONING LAB MANU; Shibata N, 1999, STRUCTURE, V7, P997, DOI 10.1016/S0969-2126(99)80126-9; Siedenburg G, 2012, ANTIOXID REDOX SIGN, V16, P668, DOI 10.1089/ars.2011.4290; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sjuts H, 2013, ACTA CRYSTALLOGR D, V69, P1609, DOI 10.1107/S0907444913011323; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun JB, 2003, BIOTECHNOL PROGR, V19, P263, DOI 10.1021/bp025739m; Torda AE, 2013, FEMS MICROBIOL LETT, V342, P106, DOI 10.1111/1574-6968.12093; Walsh CT, 2006, NAT PROD REP, V23, P517, DOI 10.1039/b605245m; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Wedderhoff I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071579; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103; Wuerges J, 2007, IUBMB LIFE, V59, P722, DOI 10.1080/15216540701673413; Yin L, 2013, MBIO, V4, DOI 10.1128/mBio.00563-13; Yin L, 2012, J BIOL CHEM, V287, P13850, DOI 10.1074/jbc.M112.346494; Yukl ET, 2010, BIOCHEMISTRY-US, V49, P6646, DOI 10.1021/bi100692f; Zou P, 2008, ACTA CRYSTALLOGR F, V64, P386, DOI 10.1107/S1744309108008348	69	7	7	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34214	34228		10.1074/jbc.M114.585489	http://dx.doi.org/10.1074/jbc.M114.585489			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25342754	Green Published, hybrid			2022-12-28	WOS:000346077600044
J	Seth-Vollenweider, T; Joshi, S; Dhawan, P; Sif, S; Christakos, S				Seth-Vollenweider, Tanya; Joshi, Sneha; Dhawan, Puneet; Sif, Said; Christakos, Sylvia			Novel Mechanism of Negative Regulation of 1,25-Dihydroxyvitamin D-3-induced 25-Hydroxyvitamin D-3 24-Hydroxylase (Cyp24a1) Transcription EPIGENETIC MODIFICATION INVOLVING CROSS-TALK BETWEEN PROTEIN-ARGININE METHYLTRANSFERASE 5 AND THE SWI/SNF COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; CCAAT-Enhancer-binding Protein (C; EBP); Protein-arginine N-Methyltransferase 5 (PRMT5); Transcription; Transcription Corepressor; Vitamin D; CYP24A1; SWI; SNF; Vitamin D Receptor	VITAMIN-D-RECEPTOR; CHROMATIN REMODELING COMPLEXES; ESTROGEN-RECEPTOR; C/EBP-BETA; GENE-EXPRESSION; BRG1 COMPLEX; IN-VIVO; METHYLATION; REPRESSION; HISTONE	Background: CYP24A1 is the principal enzyme involved in the catabolism of 1,25(OH)(2)D-3. Results: The SWI/SNF complex and PRMT5 converge at the transcriptional level to control 1,25(OH)(2)D-3-induced Cyp24a1 gene expression. Conclusion: PRMT5-mediated repression represents a novel mechanism of negative regulation of Cyp24a1. Significance: Our study reveals key factors involved in the regulation of 1,25(OH)(2)D-3 catabolism and therefore in the control of calcium homeostasis. The SWI/SNF chromatin remodeling complex facilitates gene transcription by remodeling chromatin using the energy of ATP hydrolysis. Recent studies have indicated an interplay between the SWI/SNF complex and protein-arginine methyltransferases (PRMTs). Little is known, however, about the role of SWI/SNF and PRMTs in vitamin D receptor (VDR)-mediated transcription. Using SWI/SNF-defective cells, we demonstrated that Brahma-related gene 1 (BRG1), an ATPase that is a component of the SWI/SNF complex, plays a fundamental role in induction by 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) of the transcription of Cyp24a1 encoding the enzyme 25-hydroxyvitamin D-3 24-hydroxylase involved in the catabolism of 1,25(OH)(2)D-3. BRG1 was found to associate with CCAAT-enhancer-binding protein (C/EBP) and cooperate with VDR and C/EBP in regulating Cyp24a1 transcription. PRMT5, a type II PRMT that interacts with BRG1, repressed Cyp24a1 transcription and mRNA expression. Our findings indicate the requirement of the C/EBP site for the inhibitory effect of PRMT5 via its methylation of H3R8 and H4R3. These findings indicate that the SWI/SNF complex and PRMT5 may be key factors involved in regulation of 1,25(OH)(2)D-3 catabolism and therefore in the maintenance of calcium homeostasis by vitamin D. These studies also define epigenetic events linked to a novel mechanism of negative regulation of VDR-mediated transcription.	[Seth-Vollenweider, Tanya; Joshi, Sneha; Dhawan, Puneet; Christakos, Sylvia] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Sif, Said] Ohio State Univ, Dept Mol & Cellular Biochem, Coll Med & Publ Hlth, Columbus, OH 43210 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University System of Ohio; Ohio State University	Christakos, S (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, 185 South Orange Ave, Newark, NJ 07103 USA.	christak@njms.rutgers.edu	Sif, Said/AAE-5554-2019	Sif, Said/0000-0001-6268-1145	National Institutes of Health [DK-38961-22, AI-100379, AG-044552, CA-116093]; Merck, Sharp and Dohme Corp. [CMO0052]; NATIONAL CANCER INSTITUTE [R01CA116093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI100379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG044552] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck, Sharp and Dohme Corp.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-38961-22, AI-100379, and AG-044552 (to S. C.) and CA-116093 (to S. S.). This work was also supported by Merck, Sharp and Dohme Corp. Fellowship Grant CMO0052 (to the laboratory of S. C.).	Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Barletta F, 2004, AM J PHYSIOL-ENDOC M, V286, pE598, DOI 10.1152/ajpendo.00214.2003; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bikle D., 2013, PRIMER METABOLIC BON, P235; Bilodeau S, 2006, GENE DEV, V20, P2871, DOI 10.1101/gad.1444606; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cesaro E, 2009, J BIOL CHEM, V284, P32321, DOI 10.1074/jbc.M109.043349; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; Christakos S, 2012, ARCH BIOCHEM BIOPHYS, V523, P73, DOI 10.1016/j.abb.2011.12.020; Christakos S, 2010, ENDOCRIN METAB CLIN, V39, P243, DOI 10.1016/j.ecl.2010.02.002; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; DeLuca HF, 2008, NUTR REV, V66, pS73, DOI 10.1111/j.1753-4887.2008.00105.x; Dhawan P, 2005, MOL CELL BIOL, V25, P472, DOI 10.1128/MCB.25.1.472-487.2005; Dhawan P, 2010, J CELL BIOCHEM, V110, P1314, DOI 10.1002/jcb.22645; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; Esteban L, 2004, J STEROID BIOCHEM, V89-90, P131, DOI 10.1016/j.jsbmb.2004.03.092; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Flowers S, 2009, J BIOL CHEM, V284, P10067, DOI 10.1074/jbc.M808782200; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hong E, 2012, BIOGERONTOLOGY, V13, P329, DOI 10.1007/s10522-012-9379-2; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Hou ZY, 2010, P NATL ACAD SCI USA, V107, P2938, DOI 10.1073/pnas.0908656107; Huang ZQ, 2003, EMBO J, V22, P2146, DOI 10.1093/emboj/cdg219; Huening M, 2002, MOL ENDOCRINOL, V16, P2052, DOI 10.1210/me.2001-0260; Inayoshi Y, 2005, J BIOCHEM, V138, P457, DOI 10.1093/jb/mvi147; Johnson JA, 1995, EXP GERONTOL, V30, P631, DOI 10.1016/0531-5565(95)00014-3; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; King HA, 2012, BBA-GENE REGUL MECH, V1819, P716, DOI 10.1016/j.bbagrm.2012.02.019; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kurahashi I, 2002, ENDOCRINE, V17, P109, DOI 10.1385/ENDO:17:2:109; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Marshall TW, 2003, J BIOL CHEM, V278, P30605, DOI 10.1074/jbc.M304582200; MATKOVITS T, 1995, ENDOCRINOLOGY, V136, P3971, DOI 10.1210/en.136.9.3971; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Pike JW, 2010, ENDOCRIN METAB CLIN, V39, P255, DOI 10.1016/j.ecl.2010.02.007; Rachez C, 2000, GENE, V246, P9, DOI 10.1016/S0378-1119(00)00052-4; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; St-Arnaud R., 2011, VITAMIN D, P43; Stoffels K, 2006, J BONE MINER RES, V21, P37, DOI 10.1359/JBMR.050908; Trotter K., 2008, NUCL RECEPT SIGNAL, V6, P1, DOI DOI 10.1621/NRS.06004; Trotter KW, 2004, MOL CELL BIOL, V24, P3347, DOI 10.1128/MCB.24.8.3347-3358.2004; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Xu W, 2004, GENE DEV, V18, P144, DOI 10.1101/gad.1141704; Zhang B, 2007, ONCOGENE, V26, P7153, DOI 10.1038/sj.onc.1210509; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhong Y, 2009, J BIOL CHEM, V284, P11059, DOI 10.1074/jbc.M806561200	60	27	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33958	33970		10.1074/jbc.M114.583302	http://dx.doi.org/10.1074/jbc.M114.583302			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25324546	Green Published, hybrid			2022-12-28	WOS:000346077600024
J	Yue, MM; Lv, K; Meredith, SC; Martindale, JL; Gorospe, M; Schuger, L				Yue, Michael M.; Lv, Kaosheng; Meredith, Stephen C.; Martindale, Jennifer L.; Gorospe, Myriam; Schuger, Lucia			Novel RNA-binding Protein P311 Binds Eukaryotic Translation Initiation Factor 3 Subunit b (eIF3b) to Promote Translation of Transforming Growth Factor beta 1-3 (TGF-beta 1-3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; Protein-Protein Interaction; RNA-binding Protein; Transforming Growth Factor (TGF-); Translation Initiation Factor	MESSENGER-RNA; INHIBITS PROLIFERATION; PCI DOMAIN; WD-REPEAT; TGF-BETA; COMPLEX; IDENTIFICATION; ARCHITECTURE; EXPRESSION; INTERACTS	Background: P311 is a stimulator of TGF-1-3 translation, but its mechanism of action is unknown. Results: P311 binds eIF3b and the 5UTRs of TGF-1-3 mRNAs. Thereby, P311 recruits TGF-1-3 mRNAs to the translation machinery. Conclusion: P311 is an RNA-binding protein that binds to eIF3b to stimulate TGF-1-3 translation. Significance: Our studies add a new level of complexity to TGF- signaling regulation. P311, a conserved 8-kDa intracellular protein expressed in brain, smooth muscle, regenerating tissues, and malignant glioblastomas, represents the first documented stimulator of TGF-1-3 translation in vitro and in vivo. Here we initiated efforts to define the mechanism underlying P311 function. PONDR (R) (Predictor Of Naturally Disordered Regions) analysis suggested and CD confirmed that P311 is an intrinsically disordered protein, therefore requiring an interacting partner to acquire tertiary structure and function. Immunoprecipitation coupled with mass spectroscopy identified eIF3 subunit b (eIF3b) as a novel P311 binding partner. Immunohistochemical colocalization, GST pulldown, and surface plasmon resonance studies revealed that P311-eIF3b interaction is direct and has a K-d of 1.26 m. Binding sites were mapped to the non-canonical RNA recognition motif of eIF3b and a central 11-amino acid-long region of P311, here referred to as eIF3b binding motif. Disruption of P311-eIF3b binding inhibited translation of TGF-1, 2, and 3, as indicated by luciferase reporter assays, polysome fractionation studies, and Western blot analysis. RNA precipitation assays after UV cross-linking and RNA-protein EMSA demonstrated that P311 binds directly to TGF- 5UTRs mRNAs through a previously unidentified RNA recognition motif-like motif. Our results demonstrate that P311 is a novel RNA-binding protein that, by interacting with TGF-s 5UTRs and eIF3b, stimulates the translation of TGF-1, 2, and 3.	[Yue, Michael M.; Lv, Kaosheng; Meredith, Stephen C.; Schuger, Lucia] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Meredith, Stephen C.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Martindale, Jennifer L.; Gorospe, Myriam] NIA, Genet Lab, NIH, Baltimore, MD 21224 USA	University of Chicago; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Schuger, L (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	lschuger@bsd.uchicago.edu	Martindale, Jennifer Luethy/AAD-1963-2022	Martindale, Jennifer Luethy/0000-0002-3234-6861	National Institutes of Health [R01GM111116]; American Heart Association; NIA, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM111116 (to L. S.). This work was also supported by an award from the American Heart Association (to M. M. Y.).; Supported by the Intramural Research Program of the NIA, National Institutes of Health.	Alekhina OM, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1465, DOI 10.1134/S0006297912130056; Alvarez M, 2007, MOL BIOL CELL, V18, P1167, DOI 10.1091/mbc.E06-08-0668; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Badri KR, 2013, J CLIN INVEST, V123, P4502, DOI 10.1172/JCI69884; Bendak K, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks285; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; Dong ZZ, 2013, J BIOL CHEM, V288, P27951, DOI 10.1074/jbc.M113.483164; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; ElAntak L, 2007, J BIOL CHEM, V282, P8165, DOI 10.1074/jbc.M610860200; ElAntak L, 2010, J MOL BIOL, V396, P1097, DOI 10.1016/j.jmb.2009.12.047; Eliscovich C, 2013, J BIOL CHEM, V288, P20361, DOI 10.1074/jbc.R113.452094; Fathinajafabadi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087898; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; Fraser CS, 2004, J BIOL CHEM, V279, P8946, DOI 10.1074/jbc.M312745200; Fraser D, 2008, KIDNEY INT, V73, P724, DOI 10.1038/sj.ki.5002719; Fujitani M, 2004, J NEUROCHEM, V91, P737, DOI 10.1111/j.1471-4159.2004.02738.x; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Harvey RA, 2011, BIOCHEMISTRY-US, V5th; Herrmannova A, 2012, NUCLEIC ACIDS RES, V40, P2294, DOI 10.1093/nar/gkr765; Hershey JWB, 2010, BRAZ J MED BIOL RES, V43, P920, DOI 10.1590/S0100-879X2010001000002; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Jenkins RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012283; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Khoshnevis S, 2014, NUCLEIC ACIDS RES, V42, P4123, DOI 10.1093/nar/gkt1369; Khoshnevis S, 2012, RNA, V18, P2306, DOI 10.1261/rna.032532.112; Khoshnevis S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012784; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; Lee KH, 2014, NUCLEIC ACIDS RES, V42, P3590, DOI 10.1093/nar/gkt1379; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liang H, 2012, NEUROL SCI, V33, P1057, DOI 10.1007/s10072-011-0894-8; Lindqvist L, 2008, RNA, V14, P960, DOI 10.1261/rna.971208; Liu Y, 2014, STRUCTURE, V22, P923, DOI 10.1016/j.str.2014.03.010; Lomakin IB, 2013, NATURE, V500, P307, DOI 10.1038/nature12355; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Mariani L, 2001, CANCER RES, V61, P4190; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Martin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025044; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; McDonough WS, 2005, NEOPLASIA, V7, P862, DOI 10.1593/neo.05190; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; Morino S, 1996, EUR J BIOCHEM, V239, P597, DOI 10.1111/j.1432-1033.1996.0597u.x; Nielsen KH, 2004, EMBO J, V23, P1166, DOI 10.1038/sj.emboj.7600116; Paliwal S, 2004, BIOCHEM BIOPH RES CO, V315, P1104, DOI 10.1016/j.bbrc.2004.01.171; Pan DS, 2002, J CLIN INVEST, V110, P1349, DOI 10.1172/JCI200215614; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Romanelli MG, 2013, INT J MOL SCI, V14, P22906, DOI 10.3390/ijms141122906; Roobol A, 2014, BIOCHEM J, V458, P213, DOI 10.1042/BJ20130979; Shalev A, 2001, J BIOL CHEM, V276, P34948, DOI 10.1074/jbc.M102161200; Shi JH, 2006, EXP CELL RES, V312, P3432, DOI 10.1016/j.yexcr.2006.07.016; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sokabe M, 2014, J BIOL CHEM, V289, P31827, DOI 10.1074/jbc.M114.602870; STUDLER JM, 1993, EUR J NEUROSCI, V5, P614, DOI 10.1111/j.1460-9568.1993.tb00527.x; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Sun YG, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-23; Tan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009995; Taylor GA, 2008, GENES BRAIN BEHAV, V7, P786, DOI 10.1111/j.1601-183X.2008.00420.x; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang H, 2013, CLIN CANCER RES, V19, P2850, DOI 10.1158/1078-0432.CCR-12-3084; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang Z, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-119; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wrzesinski SH, 2007, CLIN CANCER RES, V13, P5262, DOI 10.1158/1078-0432.CCR-07-1157; Wu CY, 2012, TRENDS GENET, V28, P454, DOI 10.1016/j.tig.2012.05.005; Yin JY, 2013, CARCINOGENESIS, V34, P1224, DOI 10.1093/carcin/bgt052; Zhao LQ, 2006, AM J RESP CELL MOL, V35, P48, DOI 10.1165/rcmb.2005-0475OC	72	26	27	1	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33971	33983		10.1074/jbc.M114.609495	http://dx.doi.org/10.1074/jbc.M114.609495			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25336651	Green Published, hybrid			2022-12-28	WOS:000346077600025
J	Yang, ND; Tan, SH; Ng, S; Shi, Y; Zhou, J; Tan, KSW; Wong, WSF; Shen, HM				Yang, Nai-Di; Tan, Shi-Hao; Ng, Shukie; Shi, Yin; Zhou, Jing; Tan, Kevin Shyong Wei; Wong, Wai-Shiu Fred; Shen, Han-Ming			Artesunate Induces Cell Death in Human Cancer Cells via Enhancing Lysosomal Function and Lysosomal Degradation of Ferritin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IN-VIVO; CYCLE ARREST; ENDOPEROXIDE ANTIMALARIAL; CARCINOMA-CELLS; LUNG-CANCER; IRON; ARTEMISININ; AUTOPHAGY; GROWTH	Artesunate (ART) is an anti-malaria drug that has been shown to exhibit anti-tumor activity, and functional lysosomes are reported to be required for ART-induced cancer cell death, whereas the underlying molecular mechanisms remain largely elusive. In this study, we aimed to elucidate the molecular mechanisms underlying ART-induced cell death. We first confirmed that ART induces apoptotic cell death in cancer cells. Interestingly, we found that ART preferably accumulates in the lysosomes and is able to activate lysosomal function via promotion of lysosomal V-ATPase assembly. Furthermore, we found that lysosomes function upstream of mitochondria in reactive oxygen species production. Importantly, we provided evidence showing that lysosomal iron is required for the lysosomal activation and mitochondrial reactive oxygen species production induced by ART. Finally, we showed that ART-induced cell death is mediated by the release of iron in the lysosomes, which results from the lysosomal degradation of ferritin, an iron storage protein. Meanwhile, overexpression of ferritin heavy chain significantly protected cells from ART-induced cell death. In addition, knockdown of nuclear receptor coactivator 4, the adaptor protein for ferritin degradation, was able to block ART-mediated ferritin degradation and rescue the ART-induced cell death. In summary, our study demonstrates that ART treatment activates lysosomal function and then promotes ferritin degradation, subsequently leading to the increase of lysosomal iron that is utilized by ART for its cytotoxic effect on cancer cells. Thus, our data reveal a new mechanistic action underlying ART-induced cell death in cancer cells.	[Yang, Nai-Di; Tan, Shi-Hao; Ng, Shukie; Shi, Yin; Zhou, Jing; Shen, Han-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore; [Tan, Shi-Hao; Shen, Han-Ming] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore; [Tan, Kevin Shyong Wei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore; [Wong, Wai-Shiu Fred] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Shen, Han-Ming] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Shen, HM (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore.	han-ming_shen@nuhs.edu.sg	SHEN, Han-Ming/B-5942-2011	SHEN, Han-Ming/0000-0001-7369-5227; Wong, Wai Shiu Fred/0000-0001-7010-3759; Shi, Yin/0000-0003-3858-8500; ZHOU, JING/0000-0002-2475-7783	Singapore National Medical Research Council [NMRC/1260/2010]; Singapore Biomedical Research Council [BMRC/08/1/21/19/554]; National University of Singapore	Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore)	This work was supported in part by research grants from Singapore National Medical Research Council (NMRC/1260/2010) and the Singapore Biomedical Research Council (BMRC/08/1/21/19/554) (to H. M. S.). K. S. W. T. is founding director of BioLynx Technologies (Singapore), which provided the LynxTag-ART<SUP>TM</SUP>AS<INF>Blue</INF> used in this study.; Supported by a research scholarship from the National University of Singapore.	Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Cable H, 1999, J PHARM PHARMACOL, V51, P131, DOI 10.1211/0022357991772231; Chen HH, 2003, PHARMACOL RES, V48, P231, DOI 10.1016/S1043-6618(03)00107-5; Chen K, 2014, ANTI-CANCER DRUG, V25, P652, DOI 10.1097/CAD.0000000000000089; Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020932; Cheng R, 2013, INVEST OPHTH VIS SCI, V54, P3400, DOI 10.1167/iovs.12-11068; China Cooperative Research Group on Qinghaosu and Its Derivatives as Antimalarials, 1982, J TRADIT CHIN MED, V2, P3; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; De Domenico I, 2009, BLOOD, V114, P4546, DOI 10.1182/blood-2009-05-224188; Dell'Eva R, 2004, BIOCHEM PHARMACOL, V68, P2359, DOI 10.1016/j.bcp.2004.08.021; Du JH, 2010, CANCER CHEMOTH PHARM, V65, P895, DOI 10.1007/s00280-009-1095-5; Du XX, 2013, BIOMED PHARMACOTHER, V67, P417, DOI 10.1016/j.biopha.2013.01.013; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Efferth T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000693; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; FORD GC, 1984, PHILOS T R SOC B, V304, P551, DOI 10.1098/rstb.1984.0046; Hamacher-Brady A, 2011, J BIOL CHEM, V286, P6587, DOI 10.1074/jbc.M110.210047; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Ho WE, 2014, PHARMACOL THERAPEUT, V142, P126, DOI 10.1016/j.pharmthera.2013.12.001; Ho WE, 2012, FREE RADICAL BIO MED, V53, P498, DOI 10.1016/j.freeradbiomed.2012.05.021; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Hu W, 2014, CANCER LETT, V343, P239, DOI 10.1016/j.canlet.2013.09.035; Hung HI, 2013, J BIOL CHEM, V288, P677, DOI 10.1074/jbc.M112.422667; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kurz T, 2004, BIOCHEM J, V378, P1039, DOI 10.1042/BJ20031029; Lai HC, 2013, INVEST NEW DRUG, V31, P230, DOI 10.1007/s10637-012-9873-z; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; LLOYD JB, 1991, BIOCHEM PHARMACOL, V41, P1361, DOI 10.1016/0006-2952(91)90109-I; Luo JD, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-84; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Mercer AE, 2007, J BIOL CHEM, V282, P9372, DOI 10.1074/jbc.M610375200; Mercer AE, 2011, J BIOL CHEM, V286, P987, DOI 10.1074/jbc.M110.144188; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Pandey AV, 1999, J BIOL CHEM, V274, P19383, DOI 10.1074/jbc.274.27.19383; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; PUNNONEN EL, 1990, EXP MOL PATHOL, V52, P87, DOI 10.1016/0014-4800(90)90061-H; Rasheed SAK, 2010, INT J CANCER, V127, P1475, DOI 10.1002/ijc.25315; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Saggu S, 2012, PHOTOCHEM PHOTOBIOL, V88, P461, DOI 10.1111/j.1751-1097.2012.01081.x; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Shen HM, 2014, TRENDS BIOCHEM SCI, V39, P61, DOI 10.1016/j.tibs.2013.12.001; Stocks PA, 2007, ANGEW CHEM INT EDIT, V46, P6278, DOI 10.1002/anie.200604697; Terman A, 2013, ANTIOXID REDOX SIGN, V18, P888, DOI 10.1089/ars.2012.4885; Thanaketpaisarn O, 2011, INT J ONCOL, V39, P279, DOI 10.3892/ijo.2011.1017; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Uchiyama A, 2008, HEPATOLOGY, V48, P1644, DOI 10.1002/hep.22498; Wang Z, 2012, FEBS OPEN BIO, V2, P103, DOI 10.1016/j.fob.2012.05.002; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; WOERDENBAG HJ, 1993, J NAT PROD, V56, P849, DOI 10.1021/np50096a007; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007472; Zhao YY, 2011, INT IMMUNOPHARMACOL, V11, P2039, DOI 10.1016/j.intimp.2011.08.017; Zhou CJ, 2012, J CELL PHYSIOL, V227, P3778, DOI 10.1002/jcp.24086; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	69	95	102	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33425	33441		10.1074/jbc.M114.564567	http://dx.doi.org/10.1074/jbc.M114.564567			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25305013	hybrid, Green Published			2022-12-28	WOS:000345636600032
J	Pendlebury, D; Wang, RY; Henin, RD; Hockla, A; Soares, AS; Madden, BJ; Kazanov, MD; Radisky, ES				Pendlebury, Devon; Wang, Ruiying; Henin, Rachel D.; Hockla, Alexandra; Soares, Alexei S.; Madden, Benjamin J.; Kazanov, Marat D.; Radisky, Evette S.			Sequence and Conformational Specificity in Substrate Recognition SEVERAL HUMAN KUNITZ PROTEASE INHIBITOR DOMAINS ARE SPECIFIC SUBSTRATES OF MESOTRYPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; TRYPSIN-INHIBITOR; CRYSTAL-STRUCTURE; PROSTATE-CANCER; HUMAN BRAIN; PROTEINASE-INHIBITORS; TUMOR-GROWTH; MESOTRYPSIN; METASTASIS; EXPRESSION	Mesotrypsin is an isoform of trypsin that is uniquely resistant to polypeptide trypsin inhibitors and can cleave some inhibitors rapidly. Previous studies have shown that the amyloid precursor protein Kunitz protease inhibitor domain (APPI) is a specific substrate of mesotrypsin and that stabilization of the APPI cleavage site in a canonical conformation contributes to recognition by mesotrypsin. We hypothesized that other proteins possessing potential cleavage sites stabilized in a similar conformation might also be mesotrypsin substrates. Here we evaluated a series of candidate substrates, including human Kunitz protease inhibitor domains from amyloid precursor-like protein 2 (APLP2), bikunin, hepatocyte growth factor activator inhibitor type 2 (HAI2), tissue factor pathway inhibitor-1 (TFPI1), and tissue factor pathway inhibitor-2 (TFPI2), as well as E-selectin, an unrelated protein possessing a potential cleavage site displaying canonical conformation. We find that Kunitz domains within APLP2, bikunin, and HAI2 are cleaved by mesotrypsin with kinetic profiles of specific substrates. TFPI1 and TFPI2 Kunitz domains are cleaved less efficiently by mesotrypsin, and E-selectin is not cleaved at the anticipated site. Cocrystal structures of mesotrypsin with HAI2 and bikunin Kunitz domains reveal the mode of mesotrypsin interaction with its canonical substrates. Our data suggest that major determinants of mesotrypsin substrate specificity include sequence preferences at the P-1 and P-2' positions along with conformational stabilization of the cleavage site in the canonical conformation. Mesotrypsin up-regulation has been implicated previously in cancer progression, and proteolytic clearance of Kunitz protease inhibitors offers potential mechanisms by which mesotrypsin may mediate pathological effects in cancer.	[Pendlebury, Devon; Wang, Ruiying; Henin, Rachel D.; Hockla, Alexandra; Radisky, Evette S.] Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA; [Soares, Alexei S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Madden, Benjamin J.] Mayo Clin, Med Genome Facil, Prote Core, Rochester, MN 55905 USA; [Kazanov, Marat D.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow 127994, Russia	Mayo Clinic; United States Department of Energy (DOE); Brookhaven National Laboratory; Mayo Clinic; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences	Radisky, ES (corresponding author), Mayo Clin, Dept Canc Biol, 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Radisky, Evette S/C-8526-2012; Kazanov, Marat D/D-6381-2013	Radisky, Evette S/0000-0003-3121-109X; Kazanov, Marat D/0000-0002-2314-5507	National Institutes of Health [R01CA154387]; Mayo Clinic Cancer Center [P30 CA15083]; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; Russian Science Foundation [14-24-00155]; NATIONAL CANCER INSTITUTE [P30CA015083, R01CA154387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Cancer Center; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA154387 (to E. S. R.). Proteomics analysis was conducted at the Medical Genome Facility Proteomics Core, which is supported in part by Mayo Clinic Cancer Center Support Grant P30 CA15083. Diffraction data were measured at beamlines X25 and X29 of the National Synchrotron Light Source, which is supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and the National Center for Research Resources of the National Institutes of Health.; Supported by Russian Science Foundation Grant 14-24-00155.	Agard NJ, 2012, P NATL ACAD SCI USA, V109, P1913, DOI 10.1073/pnas.1117158109; Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; Barkan DT, 2010, BIOINFORMATICS, V26, P1714, DOI 10.1093/bioinformatics/btq267; Belushkin AA, 2014, PROTEOMICS, V14, P42, DOI 10.1002/pmic.201300416; Bergum C, 2010, PROSTATE, V70, P1422, DOI 10.1002/pros.21177; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Chand HS, 2004, J BIOL CHEM, V279, P17500, DOI 10.1074/jbc.M400802200; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Cohen M, 2008, PROTEINS, V72, P741, DOI 10.1002/prot.21960; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME, P105; Delaria KA, 1997, J BIOL CHEM, V272, P12209, DOI 10.1074/jbc.272.18.12209; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fries E, 2000, INT J BIOCHEM CELL B, V32, P125, DOI 10.1016/S1357-2725(99)00125-9; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gil-Bernabe AM, 2013, BRIT J HAEMATOL, V162, P433, DOI 10.1111/bjh.12381; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; Han S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076667; Hanson WM, 2007, J MOL BIOL, V366, P230, DOI 10.1016/j.jmb.2006.11.003; Hockla A, 2012, MOL CANCER RES, V10, P1555, DOI 10.1158/1541-7786.MCR-12-0314; Hockla A, 2010, BREAST CANCER RES TR, V124, P27, DOI 10.1007/s10549-009-0699-0; Hubbard SJ, 1998, PROTEIN ENG, V11, P349, DOI 10.1093/protein/11.5.349; Jackson RM, 2000, J MOL BIOL, V296, P325, DOI 10.1006/jmbi.1999.3389; Jiang GZ, 2010, GUT, V59, P1535, DOI 10.1136/gut.2009.200105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Kobayashi H, 2003, BIOL CHEM, V384, P749, DOI 10.1515/BC.2003.083; KOBAYASHI H, 1994, CANCER RES, V54, P844; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Miyai M, 2014, J INVEST DERMATOL, V134, P1665, DOI 10.1038/jid.2014.3; Morris MR, 2005, CANCER RES, V65, P4598, DOI 10.1158/0008-5472.CAN-04-3371; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy A, 2003, EUR J BIOCHEM, V270, P2101, DOI 10.1046/j.1432-1033.2003.03593.x; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; Navaneetham D, 2005, J BIOL CHEM, V280, P36165, DOI 10.1074/jbc.M504990200; Navaneetham D, 2010, J BIOCHEM, V148, P467, DOI 10.1093/jb/mvq080; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parr C, 2004, CLIN CANCER RES, V10, P202, DOI 10.1158/1078-0432.CCR-0553-3; Parr C, 2006, INT J CANCER, V119, P1176, DOI 10.1002/ijc.21881; Petersen LC, 1996, EUR J BIOCHEM, V235, P310, DOI 10.1111/j.1432-1033.1996.0310f.x; POTEMPA J, 1989, J BIOL CHEM, V264, P15109; Qin L, 1998, FEBS LETT, V436, P111, DOI 10.1016/S0014-5793(98)01105-3; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Radisky ES, 2013, ASIAN J ANDROL, V15, P439, DOI 10.1038/aja.2013.14; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh Moh'd A, 2013, Int J Biochem Mol Biol, V4, P129; Salameh MA, 2012, PROTEIN SCI, V21, P1103, DOI 10.1002/pro.2097; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Toth J, 2007, NEUROCHEM RES, V32, P1423, DOI 10.1007/s11064-007-9327-8; Tsai CH, 2014, ONCOGENE, V33, P4643, DOI 10.1038/onc.2013.412; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANNOSTRAND WE, 1994, BBA-PROTEIN STRUCT M, V1209, P165, DOI 10.1016/0167-4838(94)90180-5; VANNOSTRAND WE, 1990, J BIOL CHEM, V265, P9591; WAGNER SL, 1992, BIOCHEM BIOPH RES CO, V186, P1138, DOI 10.1016/0006-291X(92)90865-I; WIEGAND U, 1993, GENE, V136, P167, DOI 10.1016/0378-1119(93)90460-K; WRIGHT HT, 1977, EUR J BIOCHEM, V73, P567, DOI 10.1111/j.1432-1033.1977.tb11352.x; Xu F, 2009, J NEUROSCI, V29, P5666, DOI 10.1523/JNEUROSCI.0095-09.2009; Xu YB, 1998, J MOL BIOL, V276, P955, DOI 10.1006/jmbi.1997.1582; Yagyu T, 2006, INT J CANCER, V118, P2322, DOI 10.1002/ijc.21293; Yamamoto-Tanaka M, 2014, J BIOL CHEM, V289, P20026, DOI 10.1074/jbc.M113.543421; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106	85	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.609560	http://dx.doi.org/10.1074/jbc.M114.609560			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25301953	hybrid, Green Published			2022-12-28	WOS:000345335000033
J	Gundlach, J; Dickmanns, A; Schroder-Tittmann, K; Neumann, P; Kaesler, J; Kampf, J; Herzberg, C; Hammer, E; Schwede, F; Kaever, V; Tittmann, K; Stulke, J; Ficner, R				Gundlach, Jan; Dickmanns, Achim; Schroeder-Tittmann, Kathrin; Neumann, Piotr; Kaesler, Jan; Kampf, Jan; Herzberg, Christina; Hammer, Elke; Schwede, Frank; Kaever, Volkhard; Tittmann, Kai; Stuelke, Joerg; Ficner, Ralf			Identification, Characterization, and Structure Analysis of the Cyclic di-AMP-binding P-II-like Signal Transduction Protein DarA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Signal Transduction; Crystal Structure; Cyclic Di-GMP (c-di-GMP); Cyclic Diadenosine Monophosphate (c-di-AMP); Isothermal Titration Calorimetry (ITC)	BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; DNA INTEGRITY; CHECKPOINT PROTEIN; ESCHERICHIA-COLI; REVEALS; REGULATOR; COMPLEX; GENE; SPORULATION	Background: Cyclic di-AMP is an essential second messenger in eubacteria. Results: The c-di-AMP receptor DarA was identified in B. subtilis. The crystal structure and ITC data revealed the nucleotide specificity of DarA. Conclusion: DarA is a P-II-like protein that undergoes conformational changes upon c-di-AMP binding. Significance: A novel P-II-like protein is involved in c-di-AMP signaling. The cyclic dimeric AMP nucleotide c-di-AMP is an essential second messenger in Bacillus subtilis. We have identified the protein DarA as one of the prominent c-di-AMP receptors in B. subtilis. Crystal structure analysis shows that DarA is highly homologous to P-II signal transducer proteins. In contrast to P-II proteins, the functionally important B- and T-loops are swapped with respect to their size. DarA is a homotrimer that binds three molecules of c-di-AMP, each in a pocket located between two subunits. We demonstrate that DarA is capable to bind c-di-AMP and with lower affinity cyclic GMP-AMP (33-cGAMP) but not c-di-GMP or 23-cGAMP. Consistently the crystal structure shows that within the ligand-binding pocket only one adenine is highly specifically recognized, whereas the pocket for the other adenine appears to be promiscuous. Comparison with a homologous ligand-free DarA structure reveals that c-di-AMP binding is accompanied by conformational changes of both the fold and the position of the B-loop in DarA.	[Gundlach, Jan; Kampf, Jan; Herzberg, Christina; Stuelke, Joerg] Univ Gottingen, Dept Gen Microbiol, D-37077 Gottingen, Germany; [Dickmanns, Achim; Neumann, Piotr; Kaesler, Jan; Ficner, Ralf] Univ Gottingen, Dept Mol Struct Biol, D-37077 Gottingen, Germany; [Schroeder-Tittmann, Kathrin; Tittmann, Kai] Univ Gottingen, Dept Mol Enzymol, D-37077 Gottingen, Germany; [Hammer, Elke] Univ Med Greifswald, Interfac Inst Genet & Funct Gen, Dept Funct Genom, D-17487 Greifswald, Germany; [Schwede, Frank] BIOLOG Life Sci Inst, D-28199 Bremen, Germany; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Metabol, D-30625 Hannover, Germany	University of Gottingen; University of Gottingen; University of Gottingen; Greifswald Medical School; Hannover Medical School	Stulke, J (corresponding author), Univ Gottingen, Dept Gen Microbiol, D-37077 Gottingen, Germany.	jstuelk@gwdg.de; rficner@uni-goettingen.de	Stülke, Jörg/AAD-1600-2021; Kaever, Volkhard/G-3280-2013	Hammer, Elke/0000-0002-1507-0402; Stulke, Jorg/0000-0001-5881-5390	Deutsche Forschungsgemeinschaft [HI 291/13-1, SFB860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants HI 291/13-1 and SFB860.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Block KF, 2010, J BACTERIOL, V192, P3983, DOI 10.1128/JB.00450-10; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Campos SS, 2014, J BACTERIOL, V196, P568, DOI 10.1128/JB.01259-13; Carr PD, 1996, ACTA CRYSTALLOGR D, V52, P93, DOI 10.1107/S0907444995007293; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Commichau FM, 2007, MOL MICROBIOL, V65, P642, DOI 10.1111/j.1365-2958.2007.05816.x; Commichau FM, 2013, MOL BIOSYST, V9, P1068, DOI 10.1039/c3mb25595f; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Diethmaier C, 2014, J BACTERIOL, V196, P265, DOI 10.1128/JB.00826-13; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; Gao XH, 2013, J BACTERIOL, V195, P4782, DOI 10.1128/JB.00373-13; Gentner M, 2012, J AM CHEM SOC, V134, P1019, DOI 10.1021/ja207742q; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Jones CP, 2014, EMBO J, V33, P2692, DOI 10.15252/embj.201489209; KABSCH W, 1976, J MOL BIOL, V100, P283, DOI 10.1016/S0022-2836(76)80064-2; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kriel A, 2012, MOL CELL, V48, P231, DOI 10.1016/j.molcel.2012.08.009; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Maier S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026327; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Mehne FMP, 2014, J BIOL CHEM, V289, P21098, DOI 10.1074/jbc.M114.562066; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Meyer FM, 2011, METAB ENG, V13, P18, DOI 10.1016/j.ymben.2010.10.001; Michna RH, 2014, NUCLEIC ACIDS RES, V42, pD692, DOI 10.1093/nar/gkt1002; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Sambrook J., 2001, MOL CLONING LAB MANU; Schirmer F, 1997, J BACTERIOL, V179, P1329, DOI 10.1128/jb.179.4.1329-1336.1997; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yildiz O, 2007, EMBO J, V26, P589, DOI 10.1038/sj.emboj.7601492; Zeth K, 2012, ACTA CRYSTALLOGR D, V68, P901, DOI 10.1107/S0907444912016447; Zhang L, 2013, J BIOL CHEM, V288, P22426, DOI 10.1074/jbc.M113.464883; Zhao MX, 2010, J MOL BIOL, V402, P552, DOI 10.1016/j.jmb.2010.08.006	55	57	58	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3069	3080		10.1074/jbc.M114.619619	http://dx.doi.org/10.1074/jbc.M114.619619			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25433025	hybrid, Green Published			2022-12-28	WOS:000349310700043
J	Poblete, H; Oyarzun, I; Olivero, P; Comer, J; Zuniga, M; Sepulveda, RV; Baez-Nieto, D; Leon, CG; Gonzalez-Nilo, F; Latorre, R				Poblete, Horacio; Oyarzun, Ingrid; Olivero, Pablo; Comer, Jeffrey; Zuniga, Matias; Sepulveda, Ronnina V.; Baez-Nieto, David; Gonzalez Leon, Carlos; Gonzalez-Nilo, Fernando; Latorre, Ramon			Molecular Determinants of Phosphatidylinositol 4,5-Bisphosphate (PI(4,5)P-2) Binding to Transient Receptor Potential V1 (TRPV1) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSAICIN RECEPTOR; ION-CHANNEL; VANILLOID RECEPTOR-1; STRUCTURAL BASIS; PLASMA-MEMBRANE; PIP2 ACTIVATION; VOLTAGE SENSOR; FORCE-FIELD; PHOSPHOINOSITIDES; DESENSITIZATION	Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) has been recognized as an important activator of certain transient receptor potential (TRP) channels. More specifically, TRPV1 is a pain receptor activated by a wide range of stimuli. However, whether or not PI(4,5)P-2 is a TRPV1 agonist remains open to debate. Utilizing a combined approach of mutagenesis and molecular modeling, we identified a PI(4,5)P-2 binding site located between the TRP box and the S4-S5 linker. At this site, PI(4,5)P-2 interacts with the amino acid residues Arg-575 and Arg-579 in the S4-S5 linker and with Lys-694 in the TRP box. We confirmed that PI(4,5)P-2 behaves as a channel agonist and found that Arg-575, Arg-579, and Lys-694 mutations to alanine reduce PI(4,5) P2 binding affinity. Additionally, in silico mutations R575A, R579A, and K694A showed that the reduction in binding affinity results from the delocalization of PI(4,5)P-2 in the binding pocket. Molecular dynamics simulations indicate that PI(4,5)P-2 binding induces conformational rearrangements of the structure formed by S6 and the TRP domain, which cause an opening of the lower TRPV1 channel gate.	[Poblete, Horacio] Univ Talca, Ctr Bioinformat & Mol Simulat, Talca, Chile; [Oyarzun, Ingrid; Baez-Nieto, David; Gonzalez Leon, Carlos; Gonzalez-Nilo, Fernando; Latorre, Ramon] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso 2366103, Chile; [Olivero, Pablo] Univ Valparaiso, Escuela Med, Valparaiso 2366103, Chile; [Comer, Jeffrey] Kansas State Univ, Dept Anat & Physiol, Inst Computat Comparat Med, Manhattan, KS 66506 USA; [Zuniga, Matias; Sepulveda, Ronnina V.] Univ Andres Bello, Santiago, Chile; [Sepulveda, Ronnina V.; Gonzalez-Nilo, Fernando] Univ Andres Bello, Ctr Bioinformat & Integrat Biol, Fac Ciencias Biol, Santiago, Chile	Universidad de Talca; Universidad de Valparaiso; Universidad de Valparaiso; Kansas State University; Universidad Andres Bello; Universidad Andres Bello	Gonzalez-Nilo, F (corresponding author), Univ Andres Bello, Ctr Bioinformat & Integrat Biol, Fac Ciencias Biol, Ave Republ 239, Santiago, Chile.	fernando.gonzalez@unab.cl; ramon.latorre@uv.cl	González-Nilo, Fernando/M-5671-2016; Olivero, Pablo/AAS-5076-2021; González Nilo, Fernando Danilo/M-5368-2017; Poblete, Horacio/J-9781-2012; Poblete, Horacio N/E-4974-2012; Gonzalez, Carlos/V-7628-2019	González-Nilo, Fernando/0000-0001-6857-3575; Olivero, Pablo/0000-0001-8886-7706; González Nilo, Fernando Danilo/0000-0001-6857-3575; Poblete, Horacio N/0000-0003-2650-3565; Zuniga-Bustos, Matias/0000-0003-2448-9376	Centro Interdisciplinario de Neurociencia de Valparaiso (CINV); Millennium Institute by Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo; Applied Sciences at Talca University; CONICYT-Chile; Project FONDECYT [3140288, 1110430, 1131003, 11100047]; Anillo Cientifico [ACT-1107, ACT-1104, RI-130006]	Centro Interdisciplinario de Neurociencia de Valparaiso (CINV); Millennium Institute by Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo; Applied Sciences at Talca University; CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Project FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Anillo Cientifico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS)	This work was supported by the Centro Interdisciplinario de Neurociencia de Valparaiso (CINV), a Millennium Institute supported by the Millennium Scientific Initiative of the Ministerio de Economia, Fomento y Turismo. This work was also supported by the Doctoral Program of Applied Sciences at Talca University, as well as CONICYT-Chile for a doctoral fellowship and Project FONDECYT 3140288 (to H. P.), the Project FONDECYT 1110430 (to R. L) and 1131003 (to F. G. N.), and Anillo Cientifico ACT-1107 (to F. G. N.) and Anillo ACT-1104 (to C. G. L.), Grant RI-130006 (to R. L. and C. G.) and Project FONDECYT 11100047 (to P. O.).	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Baez-Nieto D, 2011, ADV EXP MED BIOL, V704, P469, DOI 10.1007/978-94-007-0265-3_26; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Dahl ACE, 2012, BIOINFORMATICS, V28, P2193, DOI 10.1093/bioinformatics/bts357; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gamper Nikita, 2012, Subcell Biochem, V59, P289, DOI 10.1007/978-94-007-3015-1_10; Garcia-Elias A, 2013, P NATL ACAD SCI USA, V110, P9553, DOI 10.1073/pnas.1220231110; Gaudet R, 2008, J PHYSIOL-LONDON, V586, P3565, DOI 10.1113/jphysiol.2008.155812; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; Henin J, 2008, J PHYS CHEM B, V112, P7008, DOI 10.1021/jp800687p; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2006, SCIENCE, V314, P1402, DOI 10.1126/science.1136314; Moriyama T, 2003, J NEUROSCI, V23, P6058, DOI 10.1523/JNEUROSCI.23-14-06058.2003; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Senning EN, 2014, J BIOL CHEM, V289, P10999, DOI 10.1074/jbc.M114.553180; Simon F, 2010, J BIOL CHEM, V285, P37150, DOI 10.1074/jbc.M110.155390; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Zaydman MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00195; Zhang QS, 2013, P NATL ACAD SCI USA, V110, P20093, DOI 10.1073/pnas.1312483110; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200	47	44	45	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2086	2098		10.1074/jbc.M114.613620	http://dx.doi.org/10.1074/jbc.M114.613620			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25425643	Green Published, hybrid			2022-12-28	WOS:000348588000015
J	Tagami, T; Yamashita, K; Okuyama, M; Mori, H; Yao, M; Kimura, A				Tagami, Takayoshi; Yamashita, Keitaro; Okuyama, Masayuki; Mori, Haruhide; Yao, Min; Kimura, Atsuo			Structural Advantage of Sugar Beet alpha-Glucosidase to Stabilize the Michaelis Complex with Long-chain Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTASE-GLUCOAMYLASE; RECOGNITION; SPECIFICITY; BINDING; DEGRADATION; REFINEMENT; RESOLUTION; RESIDUES; AMYLASE; FORMS	The alpha-glucosidase from sugar beet (SBG) is an exo-type glycosidase. The enzyme has a pocket-shaped active site, but efficiently hydrolyzes longer maltooligosaccharides and soluble starch due to lower K-m and higher k(cat)/K-m for such substrates. To obtain structural insights into the mechanism governing its unique substrate specificity, a series of acarviosyl-maltooligo-saccharides was employed for steady-state kinetic and structural analyses. The acarviosyl-maltooligosaccharides have a longer maltooligosaccharide moiety compared with the maltose moiety of acarbose, which is known to be the transition state analog of alpha-glycosidases. The clear correlation obtained between log K-i of the acarviosyl-maltooligosaccharides and log(K-m/k(cat)) for hydrolysis of maltooligosaccharides suggests that the acarviosyl-maltooligosaccharides are transition state mimics. The crystal structure of the enzyme bound with acarviosyl-maltohexaose reveals that substrate binding at a distance from the active site is maintained largely by van der Waals interactions, with the four glucose residues at the reducing terminus of acarviosyl-maltohexaose retaining a left-handed single-helical conformation, as also observed in cycloamyloses and single helical V-amyloses. The kinetic behavior and structural features suggest that the subsite structure suitable for the stable conformation of amylose lowers the K-m for long-chain substrates, which in turn is responsible for higher specificity of the longer substrates.	[Tagami, Takayoshi; Okuyama, Masayuki; Mori, Haruhide; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Yamashita, Keitaro; Yao, Min] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0608589, Japan; [Yao, Min] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Okuyama, M (corresponding author), Hokkaido Univ, Res Fac Agr, Kita Ku, Kita 9 Nishi 9, Sapporo, Hokkaido, Japan.	okuyama@abs.agr.hokudai.ac.jp; kimura@abs.agr.hokudai.ac.jp	Mori, Haruhide/AAV-6374-2021; Okuyama, Masayuki/D-8739-2012; Tagami, Takayoshi/Q-3953-2019; yao, min/F-5287-2011	Mori, Haruhide/0000-0001-7346-9131; Okuyama, Masayuki/0000-0001-7013-6032; yao, min/0000-0003-1687-5904; Tagami, Takayoshi/0000-0002-4004-1558; Yamashita, Keitaro/0000-0002-5442-7582				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; CHIBA S, 1979, AGR BIOL CHEM TOKYO, V43, P237, DOI 10.1080/00021369.1979.10863439; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Gessler K, 1999, P NATL ACAD SCI USA, V96, P4246, DOI 10.1073/pnas.96.8.4246; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; HIZUKURI S, 1978, CARBOHYD RES, V63, P261, DOI 10.1016/S0008-6215(00)80950-7; Jacob J, 1999, CARBOHYD RES, V322, P228, DOI 10.1016/S0008-6215(99)00216-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koropatkin NM, 2010, STRUCTURE, V18, P200, DOI 10.1016/j.str.2009.12.010; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mader MM, 1997, CHEM REV, V97, P1281, DOI 10.1021/cr960435y; MATSUI H, 1978, AGR BIOL CHEM TOKYO, V42, P1855, DOI 10.1080/00021369.1978.10863265; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIKAMI B, 1993, BIOCHEMISTRY-US, V32, P6836, DOI 10.1021/bi00078a006; Mosi R, 1998, BIOCHEMISTRY-US, V37, P17192, DOI 10.1021/bi981109a; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakai H, 2007, BIOCHIMIE, V89, P49, DOI 10.1016/j.biochi.2006.09.014; Prates ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059069; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Ren LM, 2011, PROTEIN CELL, V2, P827, DOI 10.1007/s13238-011-1105-3; Robert X, 2005, J BIOL CHEM, V280, P32968, DOI 10.1074/jbc.M505515200; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Sauer J, 2000, BBA-PROTEIN STRUCT M, V1543, P275, DOI 10.1016/S0167-4838(00)00232-6; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; SUGIMOTO M, 1995, BIOSCI BIOTECH BIOCH, V59, P673, DOI 10.1271/bbb.59.673; Suzuki N, 2012, J BIOL CHEM, V287, P19916, DOI 10.1074/jbc.M112.342444; Tagami T, 2013, J BIOL CHEM, V288, P19296, DOI 10.1074/jbc.M113.465211; Tagami T, 2013, BIOSCI BIOTECH BIOCH, V77, P312, DOI 10.1271/bbb.120732; Tagami T, 2013, BBA-PROTEINS PROTEOM, V1834, P329, DOI 10.1016/j.bbapap.2012.08.007; Tamura M, 2012, FEBS J, V279, P1871, DOI 10.1111/j.1742-4658.2012.08568.x; Tan KM, 2010, FASEB J, V24, P3939, DOI 10.1096/fj.10-156257	36	11	11	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1796	1803		10.1074/jbc.M114.606939	http://dx.doi.org/10.1074/jbc.M114.606939			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451917	Green Published, hybrid			2022-12-28	WOS:000348056400044
J	Wang, Y; Chen, JM; Ling, MH; Lopez, JA; Chung, DW; Fu, XY				Wang, Yi; Chen, Junmei; Ling, Minhua; Lopez, Jose A.; Chung, Dominic W.; Fu, Xiaoyun			Hypochlorous Acid Generated by Neutrophils Inactivates ADAMTS13 AN OXIDATIVE MECHANISM FOR REGULATING ADAMTS13 PROTEOLYTIC ACTIVITY DURING INFLAMMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; INFLAMMATORY CYTOKINES; OXIDATION; CLEAVAGE; DOMAINS; METALLOPROTEASE; MYELOPEROXIDASE; DEFICIENCY; METHIONINE	ADAMTS13 is a plasma metalloproteinase that cleaves large multimeric forms of von Willebrand factor (VWF) to smaller, less adhesive forms. ADAMTS13 activity is reduced in systemic inflammatory syndromes, but the cause is unknown. Here, we examined whether neutrophil-derived oxidants can regulate ADAMTS13 activity. We exposed ADAMTS13 to hypochlorous acid (HOCl), produced by a myeloperoxidase-H2O2-Cl- system, and determined its residual proteolytic activity using both a VWF A2 peptide substrate and multimeric plasma VWF. Treatment with 25 nM myeloperoxidase plus 50 mu M H2O2 reduced ADAMTS13 activity by >85%. Using mass spectrometry, we demonstrated that Met(249), Met(331), and Met(496) in important functional domains of ADAMTS13 were oxidized to methionine sulfoxide in an HOCl concentration-dependent manner. The loss of enzyme activity correlated with the extent of oxidation of these residues. These Met residues were also oxidized in ADAMTS13 exposed to activated human neutrophils, accompanied by reduced enzyme activity. ADAMTS13 treated with either neutrophil elastase or plasmin was inhibited to a lesser extent, especially in the presence of plasma. These observations suggest that oxidation could be an important mechanism for ADAMTS13 inactivation during inflammation and contribute to the prothrombotic tendency associated with inflammation.	[Wang, Yi; Chen, Junmei; Ling, Minhua; Lopez, Jose A.; Chung, Dominic W.; Fu, Xiaoyun] Puget Sound Blood Ctr, Res Inst, Seattle, WA 98104 USA; [Lopez, Jose A.; Chung, Dominic W.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Lopez, Jose A.; Fu, Xiaoyun] Univ Washington, Dept Med, Seattle, WA 98195 USA	Puget Sound Blood Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fu, XY (corresponding author), Puget Sound Blood Ctr, Res Inst, 921 Terry Ave, Seattle, WA 98104 USA.	xiaoyunf@psbc.org	Sessum, Rachel/F-7312-2015	Sessum, Rachel/0000-0002-2444-7056; Chung, Dominic/0000-0002-2645-5703	National Institutes of Health [R21 HL098672, R01 HL091153, R01 HL112633, R01 HL075381]; Puget Sound Blood Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075381, R01HL091153, R01HL112633, R21HL098672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Puget Sound Blood Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 HL098672 (to D. W. C.), R01 HL091153 and R01 HL112633 (to J. A. L.), and R01 HL075381 (to X. F.). This work was also supported by institutional funds from the Puget Sound Blood Center (to X. F.).	Ai JH, 2005, J BIOL CHEM, V280, P29428, DOI 10.1074/jbc.M505513200; Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; Bockmeyer CL, 2007, HAEMATOLOGICA, V93, P137, DOI 10.3324/haematol.11677; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Cao WJ, 2008, J THROMB HAEMOST, V6, P1233, DOI 10.1111/j.1538-7836.2008.02989.x; Chen JM, 2010, BLOOD, V115, P706, DOI 10.1182/blood-2009-03-213967; Claus RA, 2010, CURR MOL MED, V10, P236, DOI 10.2174/156652410790963367; Crawley JTB, 2005, BLOOD, V105, P1085, DOI 10.1182/blood-2004-03-1101; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Feys HB, 2010, J THROMB HAEMOST, V8, P2053, DOI 10.1111/j.1538-7836.2010.03942.x; Fu XY, 2011, BLOOD, V118, P5283, DOI 10.1182/blood-2011-01-331074; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Gao WQ, 2008, BLOOD, V112, P1713, DOI 10.1182/blood-2008-04-148759; GLASER CB, 1992, J CLIN INVEST, V90, P2565, DOI 10.1172/JCI116151; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Hovinga JAK, 2007, J THROMB HAEMOST, V5, P2284; KALYANARAMAN B, 1985, J CLIN INVEST, V75, P1618, DOI 10.1172/JCI111868; Larkin D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000349; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Levy GG, 2005, BLOOD, V106, P11, DOI 10.1182/blood-2004-10-4097; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; Lowenberg EC, 2010, THROMB HAEMOSTASIS, V103, P181, DOI 10.1160/TH09-04-0223; Manea M, 2009, PEDIATR NEPHROL, V24, P447, DOI 10.1007/s00467-008-0986-8; Martin K, 2007, CRIT CARE MED, V35, P2375, DOI 10.1097/01.CCM.0000284508.05247.B3; Morioka C, 2008, SCAND J GASTROENTERO, V43, P1387, DOI 10.1080/00365520802179933; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nguyen TC, 2007, HAEMATOL-HEMATOL J, V92, P121, DOI 10.3324/haematol.10262; Ono T, 2006, BLOOD, V107, P528, DOI 10.1182/blood-2005-03-1087; Parker H, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00424; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Perez L, 2007, BIOCHEM CELL BIOL, V85, P141, DOI 10.1139/O06-179; Reiter RA, 2005, THROMB HAEMOSTASIS, V93, P554, DOI 10.1160/TH04-08-0467; Soejima K, 2003, BLOOD, V102, P3232, DOI 10.1182/blood-2003-03-0908; STIEF TW, 1988, THROMB RES, V49, P581, DOI 10.1016/0049-3848(88)90255-1; Taggart C, 2000, J BIOL CHEM, V275, P27258; Turner NA, 2009, BLOOD, V114, P5102, DOI 10.1182/blood-2009-07-231597; Wang Y, 2007, J BIOL CHEM, V282, P31826, DOI 10.1074/jbc.M704894200; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Wu JJ, 2006, P NATL ACAD SCI USA, V103, P18470, DOI 10.1073/pnas.0609190103; Wu JJ, 2006, J THROMB HAEMOST, V4, P129, DOI 10.1111/j.1538-7836.2005.01677.x; Yeh HC, 2010, J THROMB HAEMOST, V8, P2778, DOI 10.1111/j.1538-7836.2010.04094.x; Zhang P, 2007, BLOOD, V110, P1887, DOI 10.1182/blood-2007-04-083329; Zheng XL, 2008, ANNU REV PATHOL-MECH, V3, P249, DOI 10.1146/annurev.pathmechdis.3.121806.154311; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200; Zheng XL, 2003, J BIOL CHEM, V278, P30136, DOI 10.1074/jbc.M305331200; Zheng XL, 2002, CURR OPIN HEMATOL, V9, P389, DOI 10.1097/00062752-200209000-00001	50	42	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1422	1431		10.1074/jbc.M114.599084	http://dx.doi.org/10.1074/jbc.M114.599084			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25422322	hybrid, Green Published			2022-12-28	WOS:000348056400012
J	Lopez-Cotarelo, P; Escribano-Diaz, C; Gonzalez-Bethencourt, IL; Gomez-Moreira, C; Deguiz, ML; Torres-Bacete, J; Gomez-Cabanas, L; Fernandez-Barrera, J; Delgado-Martin, C; Mellado, M; Regueiro, JR; Miranda-Carus, ME; Rodriguez-Fernandez, JL				Lopez-Cotarelo, Pilar; Escribano-Diaz, Cristina; Luis Gonzalez-Bethencourt, Ivan; Gomez-Moreira, Carolina; Laura Deguiz, Maria; Torres-Bacete, Jesus; Gomez-Cabanas, Laura; Fernandez-Barrera, Jaime; Delgado-Martin, Cristina; Mellado, Mario; Ramon Regueiro, Jose; Eugenia Miranda-Carus, Maria; Luis Rodriguez-Fernandez, Jose			A Novel MEK-ERK-AMPK Signaling Axis Controls Chemokine Receptor CCR7-dependent Survival in Human Mature Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MAMMALIAN TARGET; ENERGY SENSOR; PROXIMITY LIGATION; FLOW-CYTOMETRY; RAPAMYCIN MTOR; LYMPH-NODES; LIFE-SPAN; APOPTOSIS; PHOSPHORYLATION	Chemokine receptor CCR7 directs mature dendritic cells (mDCs) to secondary lymph nodes where these cells regulate the activation of T cells. CCR7 also promotes survival in mDCs, which is believed to take place largely through Akt-dependent signaling mechanisms. We have analyzed the involvement of the AMP-dependent kinase (AMPK) in the control of CCR7-dependent survival. Apro-apoptotic role for AMPK is suggested by the finding that pharmacological activators induce apoptosis, whereas knocking down of AMPK with siRNA extends mDC survival. Pharmacological activation of AMPK also induces apoptosis of mDCs in the lymph nodes. Stimulation of CCR7 leads to inhibition of AMPK, through phosphorylation of Ser-485, which was mediated by G(i)/G beta gamma, but not by Akt or S6K, two kinases that control the phosphorylation of AMPK on Ser-485 in other settings. Using selective pharmacological inhibitors, we show that CCR7-induced phosphorylation of AMPK on Ser-485 is mediated by MEK and ERK. Coimmunoprecipitation analysis and proximity ligation assays indicate that AMPK associates with ERK, but not with MEK. These results suggest that in addition to Akt-dependent signaling mechanisms, CCR7 can also promote survival of mDCs through a novel MEK1/2-ERK1/2-AMPK signaling axis. The data also suggest that AMPK may be a potential target to modulate mDC lifespan and the immune response.	[Lopez-Cotarelo, Pilar; Escribano-Diaz, Cristina; Luis Gonzalez-Bethencourt, Ivan; Gomez-Moreira, Carolina; Laura Deguiz, Maria; Torres-Bacete, Jesus; Gomez-Cabanas, Laura; Fernandez-Barrera, Jaime; Delgado-Martin, Cristina; Luis Rodriguez-Fernandez, Jose] CSIC, Ctr Invest Biol, C Ramiro de Maeztu 9, Madrid 28040, Spain; [Mellado, Mario] CSIC, CNB, E-28049 Madrid, Spain; [Ramon Regueiro, Jose] Univ Complutense, Sch Med, E-28040 Madrid, Spain; [Eugenia Miranda-Carus, Maria] Hosp La Paz, Dept Rheumatol, Madrid 28046, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Complutense University of Madrid; Hospital Universitario La Paz	Rodriguez-Fernandez, JL (corresponding author), CSIC, Ctr Invest Biol, C Ramiro de Maeztu 9, Madrid 28040, Spain.	rodrifer@cib.csic.es	López-Cotarelo García de Diego, Pilar/Y-1777-2018; Regueiro, José R./B-5499-2014; Rodriguez-Fernandez, Jose Luis/Q-5021-2019; Mellado, Mario/M-9893-2014; Gomez Cabañas, Laura/I-3112-2015; Miranda-Carus, Maria-Eugenia/S-7403-2019	López-Cotarelo García de Diego, Pilar/0000-0003-1578-0110; Regueiro, José R./0000-0001-8442-7762; Rodriguez-Fernandez, Jose Luis/0000-0001-8874-1425; Mellado, Mario/0000-0001-6325-1630; Gomez Cabañas, Laura/0000-0003-3759-4116; Fernandez Barrera, Jaime/0000-0002-4186-9533; Gomez-Moreira, Carolina/0000-0002-5700-1130; Torres, Jesus/0000-0003-3410-6930	Ministerio de Educacion y Ciencia [SAF2005-00801]; Ministerio de Ciencia e Innovacion [SAF2008-01468]; Ministerio de Economia y Competitividad [SAF2011-23890]; RIER (RETICS Program/Instituto de Salud Carlos III) [RD08/0075]; Consejeria de Educacion y Empleo from Comunidad de Madrid (Raphyme) [S2010/BMD-2350]; FPI scholarship (Ministerio de Economia y competitividad); I3P contract (Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo); Consejeria de Educacion y Empleo, Comunidad de Madrid [Raphyme S2010/BMD-2350]; JAEdoc contract (Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo); FPU scholarship (Ministerio de Educacion y Ciencia); scholarship I3P intro (Ministerio de Educacion y Ciencia); FPI fellowship;  [RD08/0075 (RIER)]	Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government); RIER (RETICS Program/Instituto de Salud Carlos III)(Instituto de Salud Carlos III); Consejeria de Educacion y Empleo from Comunidad de Madrid (Raphyme); FPI scholarship (Ministerio de Economia y competitividad); I3P contract (Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo); Consejeria de Educacion y Empleo, Comunidad de Madrid(Comunidad de Madrid); JAEdoc contract (Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo); FPU scholarship (Ministerio de Educacion y Ciencia)(German Research Foundation (DFG)); scholarship I3P intro (Ministerio de Educacion y Ciencia); FPI fellowship(Spanish Government); 	This work was supported by grants awarded by the Ministerio de Educacion y Ciencia (SAF2005-00801), Ministerio de Ciencia e Innovacion (SAF2008-01468), Ministerio de Economia y Competitividad (SAF2011-23890), Ministerio de Economia y Competitividad (SAF2011-23890), RIER (RETICS Program/Instituto de Salud Carlos III) (RD08/0075), and Consejeria de Educacion y Empleo from Comunidad de Madrid (Raphyme, S2010/BMD-2350).r Supported by an FPI scholarship (Ministerio de Economia y competitividad).r Recipient of an I3P contract (Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo).r Supported by a contract associated with Grant Raphyme S2010/BMD-2350 (Consejeria de Educacion y Empleo, Comunidad de Madrid).r Recipient of a JAEdoc contract (Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo).r Supported by an FPU scholarship (Ministerio de Educacion y Ciencia).r Supported by scholarship I3P intro (Ministerio de Educacion y Ciencia).r Partially supported by an FPI fellowship, conferred by the Ministerio de Educacion y Ciencia (Spain), and by a contract associated with grant RD08/0075 (RIER).	Aronov AM, 2007, J MED CHEM, V50, P1280, DOI 10.1021/jm061381f; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beauloye C, 2001, FEBS LETT, V505, P348, DOI 10.1016/S0014-5793(01)02788-0; Campas C, 2003, BLOOD, V101, P3674, DOI 10.1182/blood-2002-07-2339; Chen M, 2007, BLOOD, V109, P4360, DOI 10.1182/blood-2006-11-056424; Comerford I, 2013, CYTOKINE GROWTH F R, V24, P269, DOI 10.1016/j.cytogfr.2013.03.001; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; Du JH, 2008, BIOCHEM BIOPH RES CO, V368, P402, DOI 10.1016/j.bbrc.2008.01.099; Escribano C, 2009, J IMMUNOL, V183, P6282, DOI 10.4049/jimmunol.0804093; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gomez-Cabanas L, 2014, NAT PROTOC, V9, P1102, DOI 10.1038/nprot.2014.078; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hatzivassiliou G, 2012, MOL CANCER THER, V11, P1143, DOI 10.1158/1535-7163.MCT-11-1010; Hildeman D, 2007, CURR OPIN IMMUNOL, V19, P516, DOI 10.1016/j.coi.2007.05.005; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hou WS, 2004, NAT IMMUNOL, V5, P583, DOI 10.1038/ni1071; Hung CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008771; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Hwang SL, 2013, BRIT J PHARMACOL, V169, P69, DOI 10.1111/bph.12124; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Iijima N, 2005, INT IMMUNOL, V17, P1201, DOI 10.1093/intimm/dxh297; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kayampilly PP, 2009, ENDOCRINOLOGY, V150, P929, DOI 10.1210/en.2008-1032; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Kushwah R, 2010, J IMMUNOL, V185, P795, DOI 10.4049/jimmunol.1000325; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nopora A, 2002, J IMMUNOL, V169, P3006, DOI 10.4049/jimmunol.169.6.3006; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Pulinilkunnil T, 2011, J BIOL CHEM, V286, P8798, DOI 10.1074/jbc.M111.218719; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Riol-Blanco L, 2009, NAT IMMUNOL, V10, P753, DOI 10.1038/ni.1750; Sanchez-Sanchez N, 2004, BLOOD, V104, P619, DOI 10.1182/blood-2003-11-3943; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Shen CH, 2013, MOL CELL, V52, P161, DOI 10.1016/j.molcel.2013.08.044; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhu BL, 2012, J VIROL, V86, P12003, DOI 10.1128/JVI.01434-12	57	33	36	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					827	840		10.1074/jbc.M114.596551	http://dx.doi.org/10.1074/jbc.M114.596551			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25425646	Green Published, hybrid			2022-12-28	WOS:000347778200013
J	Roed, SN; Nohr, AC; Wismann, P; Iversen, H; Brauner-Osborne, H; Knudsen, SM; Waldhoer, M				Roed, Sarah Noerklit; Nohr, Anne Cathrine; Wismann, Pernille; Iversen, Helle; Brauner-Osborne, Hans; Knudsen, Sanne Moeller; Waldhoer, Maria			Functional Consequences of Glucagon-like Peptide-1 Receptor Cross-talk and Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; MEMBRANE TRAFFICKING; INSULIN-SECRETION; TERMINAL DOMAIN; INTERNALIZATION; POLYPEPTIDE; ENDOCYTOSIS; ACTIVATION; FAMILY; ALPHA	The signaling capacity of seven-transmembrane/G-protein-coupled receptors (7TM/GPCRs) can be regulated through ligand-mediated receptor trafficking. Classically, the recycling of internalized receptors is associated with resensitization, whereas receptor degradation terminates signaling. We have shown previously that the incretin glucagon-like peptide-1 receptor (GLP-1R) internalizes fast and is primarily resensitized through recycling back to the cell surface. GLP-1R is expressed in pancreatic islets together with the closely related glucose-dependent insulinotropic polypeptide (GIPR) and glucagon (GCGR) receptors. The interaction and cross-talk between coexpressed receptors is a wide phenomenon of the 7TM/GPCR superfamily. Numerous reports show functional consequences for signaling and trafficking of the involved receptors. On the basis of the high structural similarity and tissue coexpression, we here investigated the potential cross-talk between GLP-1R and GIPR or GCGR in both trafficking and signaling pathways. Using a real-time time-resolved FRET-based internalization assay, we show that GLP-1R, GIPR, and GCGR internalize with differential properties. Remarkably, upon coexpression of the internalizing GLP-1R and the non-internalizing GIPR, GLP-1-mediated GLP-1R internalization was impaired in a GIPR concentration-dependent manner. As a functional consequence of such impaired internalization capability, GLP-1-mediated GLP-1R signaling was abrogated. A similar compromised signaling was found when GLP-1R internalization was abrogated by a dominant-negative version of dynamin (dynamin-1 K44E), which provides a mechanistic link between GLP-1R trafficking and signaling. This study highlights the importance of receptor internalization for full functionality of GLP-1R. Moreover, cross-talk between the two incretin receptors GLP-1R and GIPR is shown to alter receptor trafficking with functional consequences for GLP-1R signaling.	[Roed, Sarah Noerklit; Wismann, Pernille; Iversen, Helle; Knudsen, Sanne Moeller; Waldhoer, Maria] Novo Nordisk AS, Dept Incretin Biol, DK-2760 Malov, Denmark; [Nohr, Anne Cathrine; Brauner-Osborne, Hans] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-1165 Copenhagen, Denmark	Novo Nordisk; University of Copenhagen	Roed, SN (corresponding author), Novo Nordisk AS, Dept Incretin Biol, Novo Nordisk Pk, DK-2760 Malov, Denmark.	snro@novonordisk.com	Bräuner-Osborne, Hans/D-7260-2011; Iversen, Helle Klingenberg/P-5726-2019; Waldhoer, Maria/HDO-0619-2022	Bräuner-Osborne, Hans/0000-0001-9495-7388; Iversen, Helle Klingenberg/0000-0002-5880-6352; Waldhoer, Maria/0000-0003-3534-1959				Buggy JJ, 1997, DIABETES, V46, P1400, DOI 10.2337/diabetes.46.9.1400; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; GALLWITZ B, 1993, J MOL ENDOCRINOL, V10, P259, DOI 10.1677/jme.0.0100259; Gromada J, 1997, PFLUG ARCH EUR J PHY, V434, P515, DOI 10.1007/s004240050431; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harikumar KG, 2008, J MOL NEUROSCI, V36, P279, DOI 10.1007/s12031-008-9060-z; Harper CB, 2013, TRENDS CELL BIOL, V23, P90, DOI 10.1016/j.tcb.2012.10.007; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Holst Jens Juul, 2007, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V7, P49; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Jorgensen R, 2007, J PHARMACOL EXP THER, V322, P148, DOI 10.1124/jpet.107.120006; Jorgensen R, 2011, PHARMACOLOGY, V88, P174, DOI 10.1159/000330742; Kedees MH, 2009, MOL CELL ENDOCRINOL, V311, P69, DOI 10.1016/j.mce.2009.07.024; Kieffer TJ, 1996, ENDOCRINOLOGY, V137, P5119, DOI 10.1210/en.137.11.5119; Krilov L, 2011, EXP CELL RES, V317, P2981, DOI 10.1016/j.yexcr.2011.10.001; Kuna RS, 2013, AM J PHYSIOL-ENDOC M, V305, pE161, DOI 10.1152/ajpendo.00551.2012; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Merlen C, 2006, FEBS LETT, V580, P5697, DOI 10.1016/j.febslet.2006.09.021; Moens K, 1996, DIABETES, V45, P257, DOI 10.2337/diabetes.45.2.257; Moens K, 1998, DIABETES, V47, P66, DOI 10.2337/diabetes.47.1.66; Montrose-Rafizadeh C, 1999, ENDOCRINOLOGY, V140, P1132, DOI 10.1210/en.140.3.1132; Pamir N, 2003, AM J PHYSIOL-ENDOC M, V284, pE931, DOI 10.1152/ajpendo.00270.2002; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Roed SN, 2014, MOL CELL ENDOCRINOL, V382, P938, DOI 10.1016/j.mce.2013.11.010; Roed Sarah Norklit, 2012, Front Endocrinol (Lausanne), V3, P62, DOI 10.3389/fendo.2012.00062; Schelshorn D, 2012, MOL PHARMACOL, V81, P309, DOI 10.1124/mol.111.074757; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; van Rijn RM, 2010, CURR OPIN PHARMACOL, V10, P73, DOI 10.1016/j.coph.2009.09.007; Wheeler MB, 1999, J BIOL CHEM, V274, P24593, DOI 10.1074/jbc.274.35.24593; Whitaker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032675; WIDMANN C, 1995, BIOCHEM J, V310, P203, DOI 10.1042/bj3100203	40	51	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1233	1243		10.1074/jbc.M114.592436	http://dx.doi.org/10.1074/jbc.M114.592436			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451942	hybrid, Green Published			2022-12-28	WOS:000347778200052
J	Barnes, M; van Rensburg, G; Li, WM; Mehmood, K; Mackedenski, S; Chan, CM; King, DT; Miller, AL; Lee, CH				Barnes, Mark; van Rensburg, Gerrit; Li, Wai-Ming; Mehmood, Kashif; Mackedenski, Sebastian; Chan, Ching-Man; King, Dustin T.; Miller, Andrew L.; Lee, Chow H.			Molecular Insights into the Coding Region Determinant-binding Protein-RNA Interaction through Site-directed Mutagenesis in the Heterogeneous Nuclear Ribonucleoprotein-K-homology Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA; RNA-binding Protein; RNA Metabolism; RNA Processing; RNA Turnover; RNA-Protein Interaction	MYC MESSENGER-RNA; C-MYC; CRD-BP; CELL-MIGRATION; CANCER-CELLS; IN-VITRO; GROWTH; IMP1; ENDORIBONUCLEASE; IDENTIFICATION	Background: Coding region determinant-binding protein (CRD-BP) interacts physically with oncogenic mRNAs. Results: Point mutation in the K-homology (KH) domains of CRD-BP abolishes its RNA-binding ability. Conclusion: Two KH domains of CRD-BP are required for efficient binding to oncogenic mRNAs and for granule formation in zebrafish embryos. Significance: Learning how the KH domains interact with mRNAs is crucial for understanding oncogenic function of CRD-BP. The ability of its four heterogeneous nuclear RNP-K-homology (KH) domains to physically associate with oncogenic mRNAs is a major criterion for the function of the coding region determinant-binding protein (CRD-BP). However, the particular RNA-binding role of each of the KH domains remains largely unresolved. Here, we mutated the first glycine to an aspartate in the universally conserved GXXG motif of the KH domain as an approach to investigate their role. Our results show that mutation of a single GXXG motif generally had no effect on binding, but the mutation in any two KH domains, with the exception of the combination of KH3 and KH4 domains, completely abrogated RNA binding in vitro and significantly retarded granule formation in zebrafish embryos, suggesting that any combination of at least two KH domains cooperate in tandem to bind RNA efficiently. Interestingly, we found that any single point mutation in one of the four KH domains significantly impacted CRD-BP binding to mRNAs in HeLa cells, suggesting that the dynamics of the CRD-BP-mRNA interaction vary over time in vivo. Furthermore, our results suggest that different mRNAs bind preferentially to distinct CRD-BP KH domains. The novel insights revealed in this study have important implications on the understanding of the oncogenic mechanism of CRD-BP as well as in the future design of inhibitors against CRD-BP function.	[Barnes, Mark; van Rensburg, Gerrit; Li, Wai-Ming; Mehmood, Kashif; Mackedenski, Sebastian; King, Dustin T.; Lee, Chow H.] Univ No British Columbia, Chem Program, Prince George, BC V2N 4Z9, Canada; [Chan, Ching-Man; Miller, Andrew L.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Chan, Ching-Man; Miller, Andrew L.] Hong Kong Univ Sci & Technol, Key State Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Miller, Andrew L.] Marine Biol Lab, Woods Hole, MA 02543 USA	University of Northern British Columbia; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Marine Biological Laboratory - Woods Hole	Lee, CH (corresponding author), Univ No British Columbia, Chem Program, 3333 Univ Way, Prince George, BC V2N 4Z9, Canada.	chow.lee@unbc.ca		Miller, Andrew/0000-0003-0237-317X; King, Dustin/0000-0003-1775-2885	Natural Sciences and Engineering Research Council [227158]; University of Northern British Columbia; French National Research Agency/Hong Kong Research Grants Council Joint Research Scheme [A-HKUST601/13]; Natural Sciences and Engineering Research Council; British Columbia Cancer Agency	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Northern British Columbia; French National Research Agency/Hong Kong Research Grants Council Joint Research Scheme(French National Research Agency (ANR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); British Columbia Cancer Agency	This work was supported in part by Discovery Grant 227158 from Natural Sciences and Engineering Research Council (to C. H. L.), University of Northern British Columbia research project awards (to M. B., G. V. R., K. M., and S. M.), and the French National Research Agency/Hong Kong Research Grants Council Joint Research Scheme A-HKUST601/13 (to A. L. M.).; Recipient of Natural Sciences and Engineering Research Council undergraduate student research awards and a British Columbia Cancer Agency summer studentship.	Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Coulis CM, 2000, MOL PHARMACOL, V57, P485, DOI 10.1124/mol.57.3.485; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Git A, 2002, RNA, V8, P1319, DOI 10.1017/S135583820202705X; Gu W, 2008, MOL CELL BIOL, V28, P4963, DOI 10.1128/MCB.00266-08; Gutschner T, 2014, HEPATOLOGY, V59, P1900, DOI 10.1002/hep.26997; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hamilton KE, 2013, CARCINOGENESIS, V34, P2647, DOI 10.1093/carcin/bgt217; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Hollingworth D, 2012, NUCLEIC ACIDS RES, V40, P6873, DOI 10.1093/nar/gks368; Ioannidis P, 2005, J BIOL CHEM, V280, P20086, DOI 10.1074/jbc.M410036200; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kim Wan-Cheol, 2010, Int J Biochem Mol Biol, V1, P12; King DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091585; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Nielsen FC, 2002, J CELL SCI, V115, P2087; Nielsen J, 2004, NUCLEIC ACIDS RES, V32, P4368, DOI 10.1093/nar/gkh754; Nielsen J, 2003, BIOCHEM J, V376, P383, DOI 10.1042/BJ20030943; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Patel VL, 2012, GENE DEV, V26, P43, DOI 10.1101/gad.177428.111; Paziewska A, 2004, FEBS LETT, V577, P134, DOI 10.1016/j.febslet.2004.08.086; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sparanese D, 2007, NUCLEIC ACIDS RES, V35, P1209, DOI 10.1093/nar/gkl1148; Stohr N, 2012, GENE DEV, V26, P176, DOI 10.1101/gad.177642.111; Tafech A, 2007, BBA-GENE STRUCT EXPR, V1769, P49, DOI 10.1016/j.bbaexp.2006.11.009; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Wachter K, 2013, BIOL CHEM, V394, P1077, DOI 10.1515/hsz-2013-0111; Webb SE, 1997, DEV BIOL, V192, P78, DOI 10.1006/dbio.1997.8724; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Yaniv K, 2003, DEVELOPMENT, V130, P5649, DOI 10.1242/dev.00810; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zhou Y, 2002, J MOL BIOL, V318, P1175, DOI 10.1016/S0022-2836(02)00238-3	43	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					625	639		10.1074/jbc.M114.614735	http://dx.doi.org/10.1074/jbc.M114.614735			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25389298	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000347231200054
J	Bastian, AR; Nangarlia, A; Bailey, LD; Holmes, A; Sundaram, RVK; Ang, C; Moreira, DRM; Freedman, K; Duffy, C; Contarino, M; Abrams, C; Root, M; Chaiken, I				Bastian, Arangassery Rosemary; Nangarlia, Aakansha; Bailey, Lauren D.; Holmes, Andrew; Sundaram, R. Venkat Kalyana; Ang, Charles; Moreira, Diogo R. M.; Freedman, Kevin; Duffy, Caitlin; Contarino, Mark; Abrams, Cameron; Root, Michael; Chaiken, Irwin			Mechanism of Multivalent Nanoparticle Encounter with HIV-1 for Potency Enhancement of Peptide Triazole Virus Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Design; Human Immunodeficiency Virus (HIV); Nanotechnology; Peptides; Virology; Gold Nanoparticles; Microbicide; p24 Release; Virolysis	HUMAN-IMMUNODEFICIENCY-VIRUS; GP120 ENVELOPE GLYCOPROTEIN; ENTRY INHIBITORS; GOLD NANOPARTICLES; ENV GP120; CCR5 ANTAGONISTS; CD4-BOUND STATE; DRUG-DELIVERY; TYPE-1; BINDING	Background: HIV-1 envelope spike protein remains a compelling but elusive target for preventing infection. Results: Gold nanoparticle conjugates of peptide triazole Env inhibitors demonstrated impressive picomolar antiviral potencies. Conclusion: Nanoparticle conjugates enhanced antiviral functions by multivalent attachment to virus Env spikes. Significance: Findings reveal that multispike engagement can exploit the metastability of the virus envelope to irreversibly inactivate HIV-1. Entry of HIV-1 into host cells remains a compelling yet elusive target for developing agents to prevent infection. A peptide triazole (PT) class of entry inhibitor has previously been shown to bind to HIV-1 gp120, suppress interactions of the Env protein at host cell receptor binding sites, inhibit cell infection, and cause envelope spike protein breakdown, including gp120 shedding and, for some variants, virus membrane lysis. We found that gold nanoparticle-conjugated forms of peptide triazoles (AuNP-PT) exhibit substantially more potent antiviral effects against HIV-1 than corresponding peptide triazoles alone. Here, we sought to reveal the mechanism of potency enhancement underlying nanoparticle conjugate function. We found that altering the physical properties of the nanoparticle conjugate, by increasing the AuNP diameter and/or the density of PT conjugated on the AuNP surface, enhanced potency of infection inhibition to impressive picomolar levels. Further, compared with unconjugated PT, AuNP-PT was less susceptible to reduction of antiviral potency when the density of PT-competent Env spikes on the virus was reduced by incorporating a peptide-resistant mutant gp120. We conclude that potency enhancement of virolytic activity and corresponding irreversible HIV-1 inactivation of PTs upon AuNP conjugation derives from multivalent contact between the nanoconjugates and metastable Env spikes on the HIV-1 virus. The findings reveal that multispike engagement can exploit the metastability built into virus the envelope to irreversibly inactivate HIV-1 and provide a conceptual platform to design nanoparticle-based antiviral agents for HIV-1 specifically and putatively for metastable enveloped viruses generally.	[Bastian, Arangassery Rosemary; Nangarlia, Aakansha; Bailey, Lauren D.; Holmes, Andrew; Sundaram, R. Venkat Kalyana; Ang, Charles; Duffy, Caitlin; Contarino, Mark; Chaiken, Irwin] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Bastian, Arangassery Rosemary; Nangarlia, Aakansha; Sundaram, R. Venkat Kalyana; Ang, Charles] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Moreira, Diogo R. M.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil; [Freedman, Kevin; Abrams, Cameron] Drexel Univ, Dept Chem & Biol Engn, Philadelphia, PA 19104 USA; [Root, Michael] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Drexel University; Drexel University; Fundacao Oswaldo Cruz; Drexel University; Jefferson University	Chaiken, I (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,Mail Stop 497, Philadelphia, PA 19102 USA.	Irwin.chaiken@drexelmed.edu	Moreira, Diogo Rodrigo M./S-9071-2019; Kalyana Sundaram, Ramalingam Venkat/T-7840-2018	Moreira, Diogo Rodrigo M./0000-0003-3323-4404; Kalyana Sundaram, Ramalingam Venkat/0000-0002-0232-4186; Holmes, Andrew/0000-0001-5012-4026; Ang, Charles/0000-0002-2368-552X; Nangarlia, Aakansha/0000-0003-2796-9092; Freedman, Kevin/0000-0001-8801-4578	National Institutes of Health [RO1GM11029]; W. W. Smith Foundation Award; National Science Foundation [CBET 0853680]; Schlumberger Foundation Faculty of the Future Award; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111029, P01GM056550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. W. Smith Foundation Award; National Science Foundation(National Science Foundation (NSF)); Schlumberger Foundation Faculty of the Future Award(Schlumberger); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM11029. This work was also supported by a W. W. Smith Foundation Award, National Science Foundation Grant CBET 0853680, and a Schlumberger Foundation Faculty of the Future Award (to A. R. B.).	Bastian AR, 2011, CHEMMEDCHEM, V6, P1335, DOI 10.1002/cmdc.201100177; Bastian AR, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-153; Bennett A, 2007, J BIOL CHEM, V282, P27754, DOI 10.1074/jbc.M702025200; Biorn AC, 2004, BIOCHEMISTRY-US, V43, P1928, DOI 10.1021/bi035088i; Bowman MC, 2008, J AM CHEM SOC, V130, P6896, DOI 10.1021/ja710321g; Champagne K, 2009, J BIOL CHEM, V284, P3619, DOI 10.1074/jbc.M809269200; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; Cocklin S, 2007, J VIROL, V81, P3645, DOI 10.1128/JVI.01778-06; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Contarino M, 2013, ANTIMICROB AGENTS CH, V57, P4743, DOI 10.1128/AAC.00309-13; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Dimitrov AS, 2007, BIOCHEMISTRY-US, V46, P1398, DOI 10.1021/bi062245f; Doyle T, 2012, CURR OPIN INFECT DIS, V25, P17, DOI 10.1097/QCO.0b013e32834ef5d9; Emileh A, 2013, BIOCHEMISTRY-US, V52, P2245, DOI 10.1021/bi400166b; Emmelkamp JM, 2007, EUR J MED RES, V12, P409; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; Ferrer M, 1999, J VIROL, V73, P5795, DOI 10.1128/JVI.73.7.5795-5802.1999; Flint S. J., 2008, PRINCIPLES VIROLOGY, P83; Flores A, 2013, CURR MED CHEM, V20, P751; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Gopi H, 2009, J MOL RECOGNIT, V22, P169, DOI 10.1002/jmr.892; Gopi HN, 2006, CHEMMEDCHEM, V1, P54, DOI 10.1002/cmdc.200500037; Granich R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-1; Haiss W, 2007, ANAL CHEM, V79, P4215, DOI 10.1021/ac0702084; Hamidi M, 2013, CRIT REV THER DRUG, V30, P435, DOI 10.1615/CritRevTherDrugCarrierSyst.2013007419; Haqqani AA, 2013, ANTIVIR RES, V98, P158, DOI 10.1016/j.antiviral.2013.03.017; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Heidel JD, 2011, PHARM RES-DORDR, V28, P187, DOI 10.1007/s11095-010-0178-7; Henrich TJ, 2013, CURR OPIN VIROL, V3, P51, DOI 10.1016/j.coviro.2012.12.002; Hermann FG, 2009, J VIROL, V83, P4844, DOI 10.1128/JVI.00666-08; Hughes A, 2008, J INFECTION, V57, P1, DOI 10.1016/j.jinf.2008.05.006; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Joint United Nations Programme on HIV/AIDS, 2013, GLOB REP UNAIDS REP, P198; Kim T, 2005, LANGMUIR, V21, P9524, DOI 10.1021/la0504560; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Madani N, 2008, STRUCTURE, V16, P1689, DOI 10.1016/j.str.2008.09.005; Madani N, 2014, J VIROL, V88, P6542, DOI 10.1128/JVI.00540-14; Mahmoud KA, 2008, ANAL CHEM, V80, P7056, DOI 10.1021/ac801174r; Mamo T, 2010, NANOMEDICINE-UK, V5, P269, DOI [10.2217/nnm.10.1, 10.2217/NNM.10.1]; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; McFadden K, 2012, ANTIMICROB AGENTS CH, V56, P1073, DOI 10.1128/AAC.05555-11; Muranyi W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003198; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Nakamura M, 2000, HYBRIDOMA, V19, P427, DOI 10.1089/027245700750053913; Nettles RE, 2012, J INFECT DIS, V206, P1002, DOI 10.1093/infdis/jis432; Nichols WG, 2008, ANTIMICROB AGENTS CH, V52, P858, DOI 10.1128/AAC.00821-07; Nichols WK, 2003, TOXICOL SCI, V71, P229, DOI 10.1093/toxsci/71.2.229; Palmisano L, 2011, ANN I SUPER SANITA, V47, P44, DOI 10.4415/ANN_11_01_10; Pan CG, 2010, J FORMOS MED ASSOC, V109, P94, DOI 10.1016/S0929-6646(10)60029-0; Park EJ, 1998, J VIROL, V72, P7099, DOI 10.1128/JVI.72.9.7099-7107.1998; Perry CM, 2010, DRUGS, V70, P1189, DOI 10.2165/11203940-000000000-00000; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Qiu S, 2012, CURR HIV RES, V10, P182, DOI 10.2174/157016212799937191; SUMMERS MF, 1992, PROTEIN SCI, V1, P563, DOI 10.1002/pro.5560010502; Tuzer F, 2013, PROTEINS, V81, P271, DOI 10.1002/prot.24184; Umashankara M, 2010, CHEMMEDCHEM, V5, P1871, DOI 10.1002/cmdc.201000222; Vogt VM, 1999, J VIROL, V73, P7050, DOI 10.1128/JVI.73.8.7050-7055.1999; Wallace BJ, 2011, AUSTRALAS J DERMATOL, V52, P19, DOI 10.1111/j.1440-0960.2010.00717.x; Wallin M, 2005, J VIROL, V79, P1678, DOI 10.1128/JVI.79.3.1678-1685.2005; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Xie H, 2003, ANAL CHEM, V75, P5797, DOI 10.1021/ac034578d; Xu YY, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-123; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zhao Q, 2005, VIROLOGY, V339, P213, DOI 10.1016/j.virol.2005.06.008	74	29	30	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					529	543		10.1074/jbc.M114.608315	http://dx.doi.org/10.1074/jbc.M114.608315			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25371202	Green Published, hybrid			2022-12-28	WOS:000347231200046
J	Han, DY; Di, XJ; Fu, YL; Mu, TW				Han, Dong-Yun; Di, Xiao-Jing; Fu, Yan-Lin; Mu, Ting-Wei			Combining Valosin-containing Protein (VCP) Inhibition and Suberanilohydroxamic Acid (SAHA) Treatment Additively Enhances the Folding, Trafficking, and Function of Epilepsy-associated gamma-Aminobutyric Acid, Type A (GABA(A)) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epilepsy; ER Quality Control; ER-associated Degradation; GABA Receptor; Protein Misfolding; Proteostasis; SAHA; VCP	RETICULUM-ASSOCIATED DEGRADATION; ER-ASSOCIATED DEGRADATION; CYS-LOOP RECEPTORS; MUTATION A322D; AAA-ATPASE; SUBUNIT; ALPHA-1; PROTEOSTASIS; ENDOCYTOSIS; MECHANISMS	Background: The 1 subunit harboring the A322D mutation is subject to excessive ERAD. Results: VCP inhibition using Eeyarestatin I reduces the ERAD of 1(A322D) subunits, and coapplication of SAHA additively enhances their proteostasis. Conclusion: Combining ERAD inhibition and folding enhancement yields significant functional rescue. Significance: This combination represents a new, promising strategy to treat epilepsy resulting from GABA(A) receptor misfolding. GABA(A) receptors are the primary inhibitory ion channels in the mammalian central nervous system. The A322D mutation in the 1 subunit results in its excessive endoplasmic reticulum-associated degradation at the expense of plasma membrane trafficking, leading to autosomal dominant juvenile myoclonic epilepsy. Presumably, valosin-containing protein (VCP)/p97 extracts misfolded subunits from the endoplasmic reticulum membrane to the cytosolic proteasome for degradation. Here we showed that inhibiting VCP using Eeyarestatin I reduces the endoplasmic reticulum-associated degradation of the 1(A322D) subunit without an apparent effect on its dynamin-1 dependent endocytosis and that this treatment enhances its trafficking. Furthermore, coapplication of Eeyarestatin I and suberanilohydroxamic acid, a known small molecule that promotes chaperone-assisted folding, yields an additive restoration of surface expression of 1(A322D) subunits in HEK293 cells and neuronal SH-SY5Y cells. Consequently, this combination significantly increases GABA-induced chloride currents in whole-cell patch clamping experiments than either chemical compound alone in HEK293 cells. Our findings suggest that VCP inhibition without stress induction, together with folding enhancement, represents a new strategy to restore proteostasis of misfolding-prone GABA(A) receptors and, therefore, a potential remedy for idiopathic epilepsy.	[Han, Dong-Yun; Di, Xiao-Jing; Fu, Yan-Lin; Mu, Ting-Wei] Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Mu, TW (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	tingwei.mu@case.edu	Mu, Tingwei/AAU-8596-2020	Mu, Tingwei/0000-0002-6419-9296	Epilepsy Foundation of America [225243]	Epilepsy Foundation of America	This work was supported by the Epilepsy Foundation of America (225243).	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Arain FM, 2012, EPILEPSIA, V53, pE161, DOI 10.1111/j.1528-1167.2012.03596.x; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bradley CA, 2008, J BIOL CHEM, V283, P22043, DOI 10.1074/jbc.M801708200; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Di XJ, 2013, CHEM BIOL, V20, P1456, DOI 10.1016/j.chembiol.2013.09.020; Ding L, 2010, J BIOL CHEM, V285, P26390, DOI 10.1074/jbc.M110.142299; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; Franz A, 2014, BBA-MOL CELL RES, V1843, P205, DOI 10.1016/j.bbamcr.2013.03.031; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Herring D, 2003, J BIOL CHEM, V278, P24046, DOI 10.1074/jbc.M301420200; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kralic JE, 2002, J PHARMACOL EXP THER, V302, P1037, DOI 10.1124/jpet.102.036665; Krampfl K, 2005, EUR J NEUROSCI, V22, P10, DOI 10.1111/j.1460-9568.2005.04168.x; Lachance-Touchette P, 2011, EUR J NEUROSCI, V34, P237, DOI 10.1111/j.1460-9568.2011.07767.x; Leitman J, 2013, DNA CELL BIOL, V32, P2, DOI 10.1089/dna.2012.1889; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mowrey DD, 2015, BBA-BIOMEMBRANES, V1848, P307, DOI 10.1016/j.bbamem.2014.03.014; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Pavitt GD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012278; Rudolph U, 2004, ANNU REV PHARMACOL, V44, P475, DOI 10.1146/annurev.pharmtox.44.101802.121429; Steinlein OK, 2004, NAT REV NEUROSCI, V5, P400, DOI 10.1038/nrn1388; Steinlein OK, 2012, CHEM REV, V112, P6334, DOI 10.1021/cr300044d; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vicini S, 2001, J NEUROSCI, V21, P3009, DOI 10.1523/JNEUROSCI.21-09-03009.2001; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Vilchez D, 2014, TRENDS CELL BIOL, V24, P161, DOI 10.1016/j.tcb.2013.09.002; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang YJ, 2013, J PROTEOME RES, V12, P5570, DOI 10.1021/pr400535z; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	48	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					325	337		10.1074/jbc.M114.580324	http://dx.doi.org/10.1074/jbc.M114.580324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25406314	Green Published, hybrid			2022-12-28	WOS:000347231200029
J	Zomot, E; Gur, M; Bahar, I				Zomot, Elia; Gur, Mert; Bahar, Ivet			Microseconds Simulations Reveal a New Sodium-binding Site and the Mechanism of Sodium-coupled Substrate Uptake by LeuT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; Membrane Transport; Neurotransmitter Transport; Sodium Transport; Transport; LeuT; NSS; Mechanism of Binding; Sodium-coupled	DEPENDENT NEUROTRANSMITTER TRANSPORTERS; PROTEIN FORCE-FIELD; MOLECULAR-DYNAMICS; BACTERIAL HOMOLOG; DOPAMINE TRANSPORTER; CRYSTAL-STRUCTURE; ACID TRANSPORTER; PLASMA-MEMBRANE; OUTWARD-OPEN; SYMPORTER	Background: LeuT is a homologue of neurotransmitter transporters. Results: Microseconds simulations disclose multiple translocation sites for Na+, including a new site for initial binding. Conclusion: Coupled Na+- and substrate-binding events are accompanied by local and global (interhelical) rearrangements in the outward facing structure. Significance: New insights are gained into Na+ and substrate uptake/efflux mechanisms of LeuT. The bacterial sodium-coupled leucine/alanine transporter LeuT is broadly used as a model system for studying the transport mechanism of neurotransmitters because of its structural and functional homology to mammalian transporters such as serotonin, dopamine, or norepinephrine transporters, and because of the resolution of its structure in different states. Although the binding sites (S1 for substrate, and Na1 and Na2 for two co-transported sodium ions) have been resolved, we still lack a mechanistic understanding of coupled Na+- and substrate-binding events. We present here results from extensive (>20 s) unbiased molecular dynamics simulations generated using the latest computing technology. Simulations show that sodium binds initially the Na1 site, but not Na2, and, consistently, sodium unbinding/escape to the extracellular (EC) region first takes place at Na2, succeeded by Na1. Na2 diffusion back to the EC medium requires prior dissociation of substrate from S1. Significantly, Na+ binding (and unbinding) consistently involves a transient binding to a newly discovered site, Na1, near S1, as an intermediate state. A robust sequence of substrate uptake events coupled to sodium bindings and translocations between those sites assisted by hydration emerges from the simulations: (i) bindings of a first Na+ to Na1, translocation to Na1, a second Na+ to vacated Na1 and then to Na2, and substrate to S1; (ii) rotation of Phe(253) aromatic group to seclude the substrate from the EC region; and (iii) concerted tilting of TM1b and TM6a toward TM3 and TM8 to close the EC vestibule.	[Zomot, Elia; Gur, Mert; Bahar, Ivet] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zomot, E (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, 3064 BST3,3501 Fifth Ave, Pittsburgh, PA 15213 USA.	elia.zumot@gmail.com; bahar@pitt.edu	Gur, Mert/O-5304-2015; Bahar, Ivet/AAH-2921-2020	Gur, Mert/0000-0003-0983-4397; 	National Institutes of Health [P41GM103712, 5R01 GM086238, 1P30 DA035778 01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086238, P41GM103712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA035778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants P41GM103712, 5R01 GM086238, and 1P30 DA035778 01.	Amara S G, 1991, Curr Opin Neurobiol, V1, P84, DOI 10.1016/0959-4388(91)90014-X; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Cheng MH, 2013, BIOPHYS J, V105, P630, DOI 10.1016/j.bpj.2013.06.032; CLARK JA, 1994, MOL PHARMACOL, V46, P550; Clausen RP, 2006, ADV PHARMACOL, V54, P265, DOI 10.1016/S1054-3589(06)54011-6; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; FULLER RW, 1991, MED RES REV, V11, P17, DOI 10.1002/med.2610110103; Gur M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816375; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Henin J, 2008, J PHYS CHEM B, V112, P7008, DOI 10.1021/jp800687p; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Lester HA, 1996, NEURON, V17, P807, DOI 10.1016/S0896-6273(00)80213-5; Norgaard-Nielsen K, 2002, FEBS LETT, V524, P87, DOI 10.1016/S0014-5793(02)03008-9; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; RADIAN R, 1983, BIOCHEMISTRY-US, V22, P1236, DOI 10.1021/bi00274a038; Richerson GB, 2004, ADV EXP MED BIOL, V548, P76; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shaw DE, 2007, CONF PROC INT SYMP C, P1, DOI 10.1145/1273440.1250664; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Wang H, 2012, EMBO REP, V13, P861, DOI 10.1038/embor.2012.110; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Wei H, 2009, NEUROPHARMACOLOGY, V56, P399, DOI 10.1016/j.neuropharm.2008.09.008; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	50	37	37	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					544	555		10.1074/jbc.M114.617555	http://dx.doi.org/10.1074/jbc.M114.617555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25381247	Green Published, hybrid			2022-12-28	WOS:000347231200047
J	Tian, Y; Pan, Q; Shang, YY; Zhu, R; Ye, J; Liu, Y; Zhong, XL; Li, SS; He, YH; Chen, L; Zhao, JJ; Chen, WS; Peng, ZH; Wang, RQ				Tian, Yin; Pan, Qiong; Shang, Yangyang; Zhu, Rong; Ye, Jun; Liu, Yun; Zhong, Xiaoli; Li, Shanshan; He, Yonghong; Chen, Lei; Zhao, Jingjing; Chen, Wensheng; Peng, Zhihong; Wang, Rongquan			MicroRNA-200 (miR-200) Cluster Regulation by Achaete Scute-like 2 (Ascl2) IMPACT ON THE EPITHELIAL-MESENCHYMAL TRANSITION IN COLON CANCER CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; EXPRESSION; ZEB1; ESTABLISHMENT; MIGRATION; NETWORK	Ascl2, a basic helix-loop-helix transcription factor, is a downstream target of WNT signaling that controls the fate of intestinal cryptic stem cells and colon cancer progenitor cells. However, its involvement in colon cancer and downstream molecular events is largely undefined; in particular, the mechanism by which Ascl2 regulates the plasticity of epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) programs in colon cancer cells remains unknown. In this study, we systematically demonstrate that Ascl2 loss of function in colon cancer cells promotes MET by derepressing the expression of microRNA (miR)-200s (i.e. miR-200b, miR-200a, miR-429, miR-200c, and miR-141) and further activating their expression through a transcriptional mechanism that involves direct binding to the most proximal E-box (E-box2) in the miR-200b-a-429 promoter. Activation of miR-200s due to Ascl2 deficiency led to the inhibition of ZEB1/2 expression and the alteration of epithelial and mesenchymal features. Transfection of miR-200b, miR-200a, and miR-429 inhibitors into Ascl2-deficient colon cancer cells promoted the epithelial-mesenchymal transition in a reversible manner. Transfection of miR-200a or miR-429 inhibitors into Ascl2-deficient colon cancer cells increased cellular proliferation and migration. Ascl2 mRNA levels and the miR-200a, miR-200b, miR-200c, miR-141, or miR-429 levels in the colon cancerous samples were inversely correlated. These results provide the first evidence of a link between Ascl2 and miR-200s in the regulation of EMT-MET plasticity in colon cancer.	[He, Yonghong; Chen, Lei; Zhao, Jingjing; Chen, Wensheng; Peng, Zhihong; Wang, Rongquan] Third Mil Med Univ, Southwest Hosp, Inst Gastroenterol Peoples Liberat Army, Chongqing 400038, Peoples R China; [Zhu, Rong] Zunyi Med Univ, Dept Gastroenterol, Zunyi 563000, Guizhou, Peoples R China	Army Medical University; Zunyi Medical University	Peng, ZH (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing 400038, Peoples R China.	pengzhh@yahoo.com.cn; rongquanw@hotmail.com	Pan, Qiong/ENK-9675-2022	Pan, Qiong/0000-0003-1033-3098; ye, jun/0000-0002-0631-556X; Wang, Rongquan/0000-0001-5307-0086; shang, yangyang/0000-0003-0764-0572	National Natural Science Foundation of China [81201685, 81200268, 81170340, 81372557]; Program for Changjiang Scholars and Innovative Research Team at the Third Military Medical University [IRT 13050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team at the Third Military Medical University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by National Natural Science Foundation of China Grants 81201685 (to R. Z.), 81200268 (to J. Z.), and 81170340 and 81372557 (to R. W.) and the Program for Changjiang Scholars and Innovative Research Team at the Third Military Medical University (Grant IRT 13050).	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Edvardsson K, 2013, CARCINOGENESIS, V34, P1431, DOI 10.1093/carcin/bgt067; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Grassian AR, 2012, J BIOL CHEM, V287, P42180, DOI 10.1074/jbc.M112.417832; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Hill L, 2013, INT J CANCER, V132, P745, DOI 10.1002/ijc.27708; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; Jubb AM, 2011, GUT, V60, P1606, DOI 10.1136/gut.2010.231746; Jubb AM, 2006, ONCOGENE, V25, P3445, DOI 10.1038/sj.onc.1209382; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Pan Q, 2013, J BIOL CHEM, V288, P5407, DOI 10.1074/jbc.M112.408245; Reed KR, 2012, GUT, V61, P1435, DOI 10.1136/gutjnl-2011-300842; Roy SS, 2014, ONCOGENE, V33, P3707, DOI 10.1038/onc.2013.332; Stange DE, 2010, GUT, V59, P1236, DOI 10.1136/gut.2009.195701; Sureban SM, 2011, CANCER RES, V71, P2328, DOI 10.1158/0008-5472.CAN-10-2738; Teng Y, 2014, ONCOGENE, V33, P203, DOI 10.1038/onc.2012.565; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Xiang X, 2011, ONCOGENE, V30, P3440, DOI 10.1038/onc.2011.54; Zhu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032170; Ziskin JL, 2013, GUT, V62, P1012, DOI 10.1136/gutjnl-2011-301195	33	73	77	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36101	36115		10.1074/jbc.M114.598383	http://dx.doi.org/10.1074/jbc.M114.598383			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25371200	Green Published, hybrid			2022-12-28	WOS:000346897900037
J	Su, WM; Han, GS; Carman, GM				Su, Wen-Min; Han, Gil-Soo; Carman, George M.			Yeast Nem1-Spo7 Protein Phosphatase Activity on Pah1 Phosphatidate Phosphatase Is Specific for the Pho85-Pho80 Protein Kinase Phosphorylation Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diacylglycerol; Lipid; Phosphatidate; Phospholipid; Protein Phosphatase; Triacylglycerol; Yeast	NUCLEAR-MEMBRANE GROWTH; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; LIPID-METABOLISM; MEDIATED REGULATION; ORTHOLOGUE PAH1P; PHO85P-PHO80P; LIPODYSTROPHY; BIOSYNTHESIS; BIOGENESIS	Background: Pah1 phosphatidate phosphatase translocates to the membrane through its dephosphorylation by the membrane-associated Nem1-Spo7 phosphatase complex. Results: Nem1-Spo7 phosphatase was characterized for its enzymological, kinetic, and regulatory properties with phosphorylated forms of Pah1. Conclusion: Nem1-Spo7 phosphatase exhibits the highest specificity for Pah1 phosphorylated by the Pho85-Pho80 protein kinase complex. Significance: The Nem1-Spo7-mediated dephosphorylation regulates the function of Pah1 in lipid metabolism. Pah1 is the phosphatidate phosphatase in the yeast Saccharomyces cerevisiae that produces diacylglycerol for triacylglycerol synthesis and concurrently controls the levels of phosphatidate used for phospholipid synthesis. Phosphorylation and dephosphorylation of Pah1 regulate its subcellular location and phosphatidate phosphatase activity. Compared with its phosphorylation by multiple protein kinases, Pah1 is dephosphorylated by a protein phosphatase complex consisting of Nem1 (catalytic subunit) and Spo7 (regulatory subunit). In this work, we characterized the Nem1-Spo7 phosphatase complex for its enzymological, kinetic, and regulatory properties with phosphorylated Pah1. The dephosphorylation of Pah1 by Nem1-Spo7 phosphatase resulted in the stimulation (6-fold) of phosphatidate phosphatase activity. For Pah1 phosphorylated by the Pho85-Pho80 kinase complex, maximum Nem1-Spo7 phosphatase activity required Mg2+ ions (8 mm) and Triton X-100 (0.25 mm) at pH 5.0. The energy of activation for the reaction was 8.4 kcal/mol, and the enzyme was thermally labile at temperatures above 40 degrees C. The enzyme activity was inhibited by sodium vanadate, sodium fluoride, N-ethylmaleimide, and phenylglyoxal but was not significantly affected by lipids or nucleotides. Nem1-Spo7 phosphatase activity was dependent on the concentrations of Pah1 phosphorylated by Pho85-Pho80, Cdc28-cyclin B, PKA, and PKC with k(cat) and K-m values of 0.29 s(-1) and 81 nm, 0.11 s(-1) and 127 nm, 0.10 s(-1) and 46 nm, and 0.02 s(-1) and 38 nm, respectively. Its specificity constant (k(cat)/K-m) for Pah1 phosphorylated by Pho85-Pho80 was 1.6-, 4-, and 6-fold higher, respectively, than that phosphorylated by PKA, Cdc28-cyclin B, and PKC.	Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health from the United States Public Health Service [GM050679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM050679 from the United States Public Health Service.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROT FE, 1969, J AM CHEM SOC, V91, P7187, DOI 10.1021/ja01053a050; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Dubots E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104194; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Grkovich A, 2009, ADV ENZYME REGUL, V49, P114, DOI 10.1016/j.advenzreg.2009.01.005; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindegaard B, 2007, INT J OBESITY, V31, P449, DOI 10.1038/sj.ijo.0803434; Lussier M, 1997, GENETICS, V147, P435; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021; MORLOCK KR, 1991, J BIOL CHEM, V266, P3586; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Rose MD., 1990, METHODS YEAST GENETI; Ruiz C, 1999, YEAST, V15, P1001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Siniossoglou S, 2000, J BIOL CHEM, V275, P19352, DOI 10.1074/jbc.M001314200; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Valente V, 2010, FEBS J, V277, P4775, DOI 10.1111/j.1742-4658.2010.07883.x; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; Wu R, 2011, BIOCHEMISTRY-US, V50, P3045, DOI 10.1021/bi200336b; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003	76	32	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34699	34708		10.1074/jbc.M114.614883	http://dx.doi.org/10.1074/jbc.M114.614883			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25359770	Green Published, hybrid			2022-12-28	WOS:000346260800026
J	Tang, B; Wu, W; Wei, XW; Li, Y; Ren, G; Fan, WH				Tang, Bo; Wu, Wei; Wei, Xiaowei; Li, Yang; Ren, Gang; Fan, Wenhai			Activation of Glioma Cells Generates Immune Tolerant NKT Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellular Immune Response; Glioblastoma; Lymphocyte; RNA; Tolerance	MACROPHAGES	Background: Micro RNA plays a role in the pathogenesis of glioma. Results: Glioma-derived miR-92a induces IL-6(+) IL-10(+) NKT cells, which suppress CD8 cells. Conclusion: Glioma-derived miR-92a compromises the antitumor immunity. Significance: miR-92a may be a therapeutic target in the treatment of glioma. Therapeutic outcomes of glioma are currently not encouraging. Tumor tolerance plays an important role in the pathogenesis of glioma. It is reported that micro RNAs (miR) are associated with tumor development. This study aims to investigate the role of miR-92a in the development of tolerant natural killer T (NKT) cells. In this study, U87 cells (a human glioma cell line) and primary glioma cells were prepared. The assessment of miR-92a was performed by real time RT-PCR. The expression of interleukin (IL)-10 and IL-6 in NKT cells was evaluated by flow cytometry. Results showed that abundant IL-6(+) IL-10(+) NKT cells were detected in glioma tissue. Cultures of glioma cells and NKT cells induced the expression of IL-6 and IL-10 in NKT cells. Glioma cells expressed miR-92a; the latter played a critical role in the induction of IL-6 and IL-10 expression in NKT cells. The expression of the antitumor molecules, including perforin, Fas ligand, and interferon-, was significantly attenuated compared with control NKT cells. The IL-6(+) IL-10(+) NKT cells showed less capability in the induction of apoptosis in glioma cells, but showed the immune suppressor functions on CD8(+) T cell activities. We conclude that glioma-derived miR-92a induces IL-6(+) IL-10(+) NKT cells; this fraction of NKT cells can suppress cytotoxic CD8(+) T cells.	[Tang, Bo; Li, Yang] Guilin Med Univ, Affiliated Hosp, Dept Hepatobiliary Surg, Guilin 541001, Peoples R China; [Wu, Wei] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130021, Peoples R China; [Wei, Xiaowei; Ren, Gang; Fan, Wenhai] Dalian Univ, Affiliated Zhongshan Hosp, Dalian 116001, Peoples R China	Guilin Medical University; Jilin University; Dalian University	Fan, WH (corresponding author), Dalian Univ, Affiliated Zhongshan Hosp, 6 Jiefang St, Dalian 116001, Liaoning, Peoples R China.	wenhairfan@163.com			National Natural Science Foundation of China [81360367]; Guangxi Provincial University Science and Technology Research Projects [2013ZD046]; Health Department of Guangxi Traditional Chinese Medical Science and Technology Special Project [QT2013025]; Guangxi Provincial Key Laboratory of Molecular Medicine of Liver Injury and Repair [*SYS2013009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Provincial University Science and Technology Research Projects; Health Department of Guangxi Traditional Chinese Medical Science and Technology Special Project; Guangxi Provincial Key Laboratory of Molecular Medicine of Liver Injury and Repair	This work was supported by the National Natural Science Foundation of China (No. 81360367), The Guangxi Provincial University Science and Technology Research Projects (2013ZD046), the Health Department of Guangxi Traditional Chinese Medical Science and Technology Special Project (QT2013025), and the development project of Guangxi Provincial Key Laboratory of Molecular Medicine of Liver Injury and Repair (*SYS2013009).	Berzins SP, 2014, NAT REV IMMUNOL, V14, P640, DOI 10.1038/nri3725; Biragyn A., 2014, METHOD MOL BIOL, V1190, P89; Hanin G, 2014, HUM MOL GENET, V23, P4569, DOI 10.1093/hmg/ddu170; Hegde S, 2010, IMMUNOLOGY, V130, P471, DOI 10.1111/j.1365-2567.2010.03293.x; Janz C, 2014, CLIN NEUROL NEUROSUR, V125, P114, DOI 10.1016/j.clineuro.2014.07.013; Li ML, 2014, EXP CELL RES, V323, P1, DOI 10.1016/j.yexcr.2013.12.025; Li RH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101903; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pan YF, 2013, HEPATOLOGY, V58, P680, DOI 10.1002/hep.26391; Quezada SA, 2011, IMMUNOL REV, V241, P104, DOI 10.1111/j.1600-065X.2011.01007.x; Sag D, 2014, J CLIN INVEST, V124, P3725, DOI 10.1172/JCI72308; Skinner JPJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088997; Wang L, 2014, ONCOTARGET, V5, P5416, DOI 10.18632/oncotarget.2116; Xie N, 2014, J IMMUNOL, V193, P327, DOI 10.4049/jimmunol.1400203; Ye ZP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105350; Yin ZL, 2014, NEUROREPORT, V25, P199, DOI 10.1097/WNR.0000000000000045	16	23	24	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34595	34600		10.1074/jbc.M114.614503	http://dx.doi.org/10.1074/jbc.M114.614503			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25342742	hybrid, Green Published			2022-12-28	WOS:000346260800018
J	Zhu, YP; Shan, XY; Yuzwa, SA; Vocadlo, DJ				Zhu, Yanping; Shan, Xiaoyang; Yuzwa, Scott A.; Vocadlo, David J.			The Emerging Link between O-GlcNAc and Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Alzheimer Disease; Amyloid- (A); Brain Metabolism; Glucose Metabolism; Glycobiology; Glycoprotein; Glycosylation; O-GlcNAcylation; O-Linked N-Acetylglucosamine (O-GlcNAc); Tau Protein (Tau)	AMYLOID PRECURSOR PROTEIN; PAIRED HELICAL FILAMENTS; TAU TRANSGENIC MICE; BETA-N-ACETYLGLUCOSAMINIDASE; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; MASS-SPECTROMETRY; COGNITIVE DECLINE; MOUSE MODEL; NUCLEOCYTOPLASMIC PROTEINS	Regional glucose hypometabolism is a defining feature of Alzheimer disease (AD). One emerging link between glucose hypometabolism and progression of AD is the nutrient-responsive post-translational O-GlcNAcylation of nucleocytoplasmic proteins. O-GlcNAc is abundant in neurons and occurs on both tau and amyloid precursor protein. Increased brain O-GlcNAcylation protects against tau and amyloid- peptide toxicity. Decreased O-GlcNAcylation occurs in AD, suggesting that glucose hypometabolism may impair the protective roles of O-GlcNAc within neurons and enable neurodegeneration. Here, we review how O-GlcNAc may link cerebral glucose hypometabolism to progression of AD and summarize data regarding the protective role of O-GlcNAc in AD models.	[Zhu, Yanping; Shan, Xiaoyang; Yuzwa, Scott A.; Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Zhu, Yanping; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Vocadlo, DJ (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [MOP 275394]; Alzheimer Society of Canada; Canadian Institutes of Health Research; Canada Research Chairs Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs)	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research Grant MOP 275394, and the Alzheimer Society of Canada. S. A. Y., X. S., and D. J. V. may receive royalties from SFU for commercialization of technology relating to OGA inhibitors. D. J. V. is a cofounder, holds equity in, and serves as CSO of Alectos Therapeutics. This is the seventh article in the Minireview Series on the Thirtieth Anniversary of Research on O-GlcNAcylation of Nuclear and Cytoplasmic Proteins: Nutrient Regulation of Cellular Metabolism and Physiology by O-GlcNAcylation.; Recipient of a postdoctoral fellowship from the Canadian Institutes of Health Research.; Recipient of a Tier I Canada Research Chair in Chemical Glycobiology from the Canada Research Chairs Program.	Akimoto Y, 2003, BRAIN RES, V966, P194, DOI 10.1016/S0006-8993(02)04158-6; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Baker M, 1997, ANN NEUROL, V42, P794, DOI 10.1002/ana.410420516; Beckett LA, 2010, ALZHEIMERS DEMENT, V6, P257, DOI 10.1016/j.jalz.2010.03.002; Bitel CL, 2012, J ALZHEIMERS DIS, V32, P291, DOI 10.3233/JAD-2012-120571; Borghgraef P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084442; Burns CM, 2013, NEUROLOGY, V80, P1557, DOI 10.1212/WNL.0b013e31828f17de; Calvo-Ochoa E, 2015, DIABETES-METAB RES, V31, P1, DOI 10.1002/dmrr.2531; Cameron A, 2013, FEBS LETT, V587, P3722, DOI 10.1016/j.febslet.2013.09.042; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; CHOU CF, 1992, J BIOL CHEM, V267, P3901; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Cohen AD, 2009, J NEUROSCI, V29, P14770, DOI 10.1523/JNEUROSCI.3669-09.2009; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Correia SC, 2012, BRAIN RES, V1441, P64, DOI 10.1016/j.brainres.2011.12.063; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; de la Monte SM, 2014, BIOCHEM PHARMACOL, V88, P548, DOI 10.1016/j.bcp.2013.12.012; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; De Santi S, 2001, NEUROBIOL AGING, V22, P529, DOI 10.1016/S0197-4580(01)00230-5; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Dodart JC, 1999, NEUROSCI LETT, V277, P49, DOI 10.1016/S0304-3940(99)00847-2; Edison P, 2007, NEUROLOGY, V68, P501, DOI 10.1212/01.wnl.0000244749.20056.d4; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; Foerster S, 2014, BBA-MOL BASIS DIS, V1842, P1333, DOI 10.1016/j.bbadis.2014.05.014; Francisco H, 2009, DEV NEUROBIOL, V69, P162, DOI 10.1002/dneu.20695; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Graham DL, 2014, NEUROPHARMACOLOGY, V79, P307, DOI 10.1016/j.neuropharm.2013.11.025; GRIFFITH LS, 1995, J NEUROSCI RES, V41, P270, DOI 10.1002/jnr.490410214; GRIFFITH LS, 1995, BIOCHEM BIOPH RES CO, V213, P424, DOI 10.1006/bbrc.1995.2149; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Ibanez V, 1998, NEUROLOGY, V50, P1585, DOI 10.1212/WNL.50.6.1585; Jacobsen KT, 2011, BIOCHEM BIOPH RES CO, V404, P882, DOI 10.1016/j.bbrc.2010.12.080; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim C, 2013, NEUROBIOL AGING, V34, P275, DOI 10.1016/j.neurobiolaging.2012.03.001; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; Leboucher A, 2013, DIABETES, V62, P1681, DOI 10.2337/db12-0866; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Li X, 2006, EUR J NEUROSCI, V23, P2078, DOI 10.1111/j.1460-9568.2006.04735.x; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Liu K, 2004, J NEUROCHEM, V89, P1044, DOI 10.1111/j.1471-4159.2004.02389.x; Liu Y, 2008, FEBS LETT, V582, P359, DOI 10.1016/j.febslet.2007.12.035; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043724; Lo RY, 2011, ARCH NEUROL-CHICAGO, V68, P1257, DOI 10.1001/archneurol.2011.123; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Macauley MS, 2010, BBA-GEN SUBJECTS, V1800, P107, DOI 10.1016/j.bbagen.2009.07.028; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; Nicholson RM, 2010, BRAIN RES, V1347, P179, DOI 10.1016/j.brainres.2010.05.084; NUKINA N, 1987, P NATL ACAD SCI USA, V84, P3415, DOI 10.1073/pnas.84.10.3415; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Okuyama R, 2003, J NEUROCHEM, V86, P1271, DOI 10.1046/j.1471-4159.2003.01939.x; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; Pekkurnaz G, 2014, CELL, V158, P54, DOI 10.1016/j.cell.2014.06.007; Rex-Mathes M, 2001, BIOCHIMIE, V83, P583, DOI 10.1016/S0300-9084(01)01305-0; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; Sadowski M, 2004, J NEUROPATH EXP NEUR, V63, P418, DOI 10.1093/jnen/63.5.418; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Skorobogatko YV, 2011, AMINO ACIDS, V40, P765, DOI 10.1007/s00726-010-0645-9; Smet-Nocca C, 2011, MOL BIOSYST, V7, P1420, DOI 10.1039/c0mb00337a; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; Tarrant MK, 2012, NAT CHEM BIOL, V8, P262, DOI [10.1038/NCHEMBIO.771, 10.1038/nchembio.771]; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Uno Y, 2009, BRAIN RES, V1296, P148, DOI 10.1016/j.brainres.2009.08.034; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vocadlo DJ, 2012, CURR OPIN CHEM BIOL, V16, P488, DOI 10.1016/j.cbpa.2012.10.021; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035277; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-42; Yuzwa SA, 2014, J MOL BIOL, V426, P1736, DOI 10.1016/j.jmb.2014.01.004; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/nchembio.797, 10.1038/NCHEMBIO.797]; Yuzwa SA, 2011, AMINO ACIDS, V40, P857, DOI 10.1007/s00726-010-0705-1; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhang X, 1996, J BIOL CHEM, V271, P31391, DOI 10.1074/jbc.271.49.31391	100	156	163	6	73	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34472	34481		10.1074/jbc.R114.601351	http://dx.doi.org/10.1074/jbc.R114.601351			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25336656	Green Published, hybrid			2022-12-28	WOS:000346260800008
J	Xie, Q; Peng, SY; Tao, L; Ruan, HH; Yang, YL; Li, TM; Adams, U; Meng, SS; Bi, XL; Dong, MQ; Yuan, ZQ				Xie, Qi; Peng, Shengyi; Tao, Li; Ruan, Haihe; Yang, Yanglu; Li, Tie-Mei; Adams, Ursula; Meng, Songshu; Bi, Xiaolin; Dong, Meng-Qiu; Yuan, Zengqiang			E2F Transcription Factor 1 Regulates Cellular and Organismal Senescence by Inhibiting Forkhead Box O Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E2F Transcription Factor; FOXO; Oxidative Stress; Senescence; Transcription Regulation	LIFE-SPAN; PROMOTES TUMORIGENESIS; DNA-DAMAGE; FOXO; APOPTOSIS; DAF-16; CELLS; ROS; ACTIVATION; INDUCTION	Background: E2F1 and FOXO3 are two transcription factors participating in cellular senescence. Results: E2F1 represses FOXO3 transactivity through interaction. Conclusion: E2F1-FOXO3 regulatory mechanism is conserved and participates in regulating cellular senescence. Significance: Drugs and/or therapies that inhibit the physical interaction might be candidates for reducing cellular senescence and increasing longevity. E2F1 and FOXO3 are two transcription factors that have been shown to participate in cellular senescence. Previous report reveals that E2F1 enhanced cellular senescence in human fibroblast cells, while FOXO transcription factors play against senescence by regulation reactive oxygen species scavenging proteins. However, their functional interplay has been unclear. Here we use E2F1 knock-out murine Embryonic fibroblasts (MEFs), knockdown RNAi constructs, and ectopic expression of E2F1 to show that it functions by negatively regulating FOXO3. E2F1 attenuates FOXO3-mediated expression of MnSOD and Catalase without affecting FOXO3 protein stability, subcellular localization, or phosphorylation by Akt. We mapped the interaction between E2F1 and FOXO3 to a region including the DNA binding domain of E2F1 and the C-terminal transcription-activation domain of FOXO3. We propose that E2F1 inhibits FOXO3-dependent transcription by directly binding FOXO3 in the nucleus and preventing activation of its target genes. Moreover, knockdown of the Caenorhabditis elegans E2F1 ortholog efl-1 significantly extends lifespan in a manner that requires the activity of the C. elegans FOXO gene daf-16. We conclude that there is an evolutionarily conserved signaling connection between E2F1 and FOXO3, which regulates cellular senescence and aging by regulating the activity of FOXO3. We speculate that drugs and/or therapies that inhibit this physical interaction might be good candidates for reducing cellular senescence and increasing longevity.	[Xie, Qi; Peng, Shengyi; Ruan, Haihe; Yang, Yanglu; Yuan, Zengqiang] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Tao, Li; Li, Tie-Mei; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Meng, Songshu; Bi, Xiaolin] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian 116044, Peoples R China; [Adams, Ursula] Univ Chicago, Chicago, IL 60637 USA; [Peng, Shengyi; Yang, Yanglu] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; National Institute of Biological Sciences, Beijing; Dalian Medical University; University of Chicago; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yuan, ZQ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, 15 Datun Rd, Beijing 100101, Peoples R China.	zqyuan@sun5.ibp.ac.cn	Yuan, Zengqiang/G-5245-2017; TAO, Li/HIR-4254-2022; Bi, Xiaolin/E-7469-2010	Bi, Xiaolin/0000-0002-7172-7851; Yuan, Zengqiang/0000-0001-5739-2867; Xie, Qi/0000-0002-2370-2078	Ministry of Science and Technology of China [973-2012CB910701, 2013DFA31990, 973-2010CB835203]; National Science Foundation of China [81125010, 81030025]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China (973-2012CB910701 and 2013DFA31990) (to Z. Y.), (973-2010CB835203) (to M. D.), and the National Science Foundation of China (81125010 and 81030025) (to Z. Y.).	Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Ceol CJ, 2001, MOL CELL, V7, P461, DOI 10.1016/S1097-2765(01)00194-0; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Espada L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051544; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Han YH, 2006, FREE RADICAL RES, V40, P1182, DOI 10.1080/10715760600868552; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Kodama R, 2013, GENES CELLS, V18, P32, DOI 10.1111/gtc.12015; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Li J., 2008, PLOS BIOL; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pan HC, 1998, MOL CELL, V2, P283, DOI 10.1016/S1097-2765(00)80273-7; Perrot V, 2003, J BIOL CHEM, V278, P26111, DOI 10.1074/jbc.M212750200; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Rodicker F, 2001, CANCER RES, V61, P7052; Shats I, 2013, CANCER RES, V73, P6056, DOI 10.1158/0008-5472.CAN-13-0453; Song YS, 2005, MECH AGEING DEV, V126, P580, DOI 10.1016/j.mad.2004.11.008; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Wu ZL, 2009, INT J BIOCHEM CELL B, V41, P2389, DOI 10.1016/j.biocel.2009.06.004; Xie Q, 2012, ACTA BIOCH BIOPH SIN, V44, P897, DOI 10.1093/abbs/gms067; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; You H, 2005, CELL CYCLE, V4, P37, DOI 10.4161/cc.4.1.1401; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102	34	24	25	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34205	34213		10.1074/jbc.M114.587170	http://dx.doi.org/10.1074/jbc.M114.587170			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25344604	Green Published, hybrid			2022-12-28	WOS:000346077600043
J	Akpa, MM; Iglesias, DM; Chu, LL; Cybulsky, M; Bravi, C; Goodyer, PR				Akpa, Murielle M.; Iglesias, Diana M.; Chu, Lee Lee; Cybulsky, Marta; Bravi, Cristina; Goodyer, Paul R.			Wilms Tumor Suppressor, WT1, Suppresses Epigenetic Silencing of the beta-Catenin Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; DEVELOPMENTAL REGULATORS; KIDNEY DEVELOPMENT; EZH2; POLYCOMB; EXPRESSION; METHYLATION; HYPERMETHYLATION; DIFFERENTIATION; PROLIFERATION	The mammalian kidney is derived from progenitor cells in intermediate mesoderm. During embryogenesis, progenitor cells expressing the Wilms tumor suppressor gene, WT1, are induced to differentiate in response to WNT signals from the ureteric bud. In hereditary Wilms tumors, clonal loss of WT1 precludes the beta-catenin pathway response and leads to precancerous nephrogenic rests. We hypothesized that WT1 normally primes progenitor cells for differentiation by suppressing the enhancer of zeste2 gene (EZH2), involved in epigenetic silencing of differentiation genes. In human amniotic fluid-derived mesenchymal stem cells, we show that exogenous WT1B represses EZH2 transcription. This leads to a dramatic decrease in the repressive lysine 27 trimethylation mark on histone H3 that silences beta-catenin gene expression. As a result, amniotic fluid mesenchymal stem cells acquire responsiveness to WNT9b and increase expression of genes that mark the onset of nephron differentiation. Our observations suggest that biallelic loss of WT1 sustains the inhibitory histone methylation state that characterizes Wilms tumors.	[Akpa, Murielle M.; Goodyer, Paul R.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Iglesias, Diana M.; Chu, Lee Lee; Cybulsky, Marta; Bravi, Cristina; Goodyer, Paul R.] Montreal Childrens Hosp, Res Inst, Dept Paediat, Montreal, PQ H3Z 2Z3, Canada	McGill University; McGill University	Goodyer, PR (corresponding author), Montreal Childrens Hosp, Res Inst, Dept Human Genet, 4060 Rue St Catherine Quest,Ste 413-1, Montreal, PQ H2Z2Z3, Canada.	paul.goodyer@mcgill.ca			Canadian Institutes of Health Research (CIHR) [MOP-119571]; Fonds de la Recherche en Sante du Quebec (FRSQ)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by Operating Grant MOP-119571 from the Canadian Institutes of Health Research (CIHR) and an infrastructure support grant to the McGill University Health Center Research Institute from the Fonds de la Recherche en Sante du Quebec (FRSQ).	Aiden AP, 2010, CELL STEM CELL, V6, P591, DOI 10.1016/j.stem.2010.03.016; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572; Chen YH, 2012, AM J TRANSL RES, V4, P364; Chou RH, 2011, AM J TRANSL RES, V3, P243; Dziarmaga A, 2006, J AM SOC NEPHROL, V17, P1568, DOI 10.1681/ASN.2005101074; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Essafi A, 2011, DEV CELL, V21, P559, DOI 10.1016/j.devcel.2011.07.014; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fukuzawa R, 2007, J CLIN PATHOL, V60, P1013, DOI 10.1136/jcp.2006.043083; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Haruta M, 2008, MOL CARCINOGEN, V47, P660, DOI 10.1002/mc.20412; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Honda S, 2008, BRIT J CANCER, V99, P1891, DOI 10.1038/sj.bjc.6604754; Iglesias DM, 2014, PEDIATR NEPHROL, V29, P705, DOI 10.1007/s00467-013-2685-3; Iglesias DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042840; Kim MS, 2010, J BIOL CHEM, V285, P14585, DOI 10.1074/jbc.M109.094334; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; McLaughlin N, 2014, EPIGENETICS-US, V9, P222, DOI 10.4161/epi.26793; McLaughlin N, 2013, EPIGENETICS-US, V8, P970, DOI 10.4161/epi.25753; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Metsuyanim S, 2008, STEM CELLS, V26, P1808, DOI 10.1634/stemcells.2007-0322; Miller-Hodges E, 2012, J PATHOL, V226, P229, DOI 10.1002/path.2977; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; NAKAGAMA H, 1995, MOL CELL BIOL, V15, P1489; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Riccio A, 2009, ENDOCR DEV, V14, P1, DOI 10.1159/000207461; Royer-Pokora B, 2010, HUM MOL GENET, V19, P1651, DOI 10.1093/hmg/ddq042; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Szemes M, 2013, HUM MOL GENET, V22, P74, DOI 10.1093/hmg/dds403; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Zhang Z, 2011, HUM MOL GENET, V20, P4167, DOI 10.1093/hmg/ddr341; Zhu NX, 2011, ANAT REC, V294, P1150, DOI 10.1002/ar.21416; Zirn B, 2006, INT J CANCER, V118, P1954, DOI 10.1002/ijc.21564	42	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2279	2288		10.1074/jbc.M114.573576	http://dx.doi.org/10.1074/jbc.M114.573576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25331950	Green Published, hybrid			2022-12-28	WOS:000348588000031
J	Varkuti, BH; Yang, ZH; Malnasi-Csizmadia, A				Varkuti, Boglarka H.; Yang, Zhenhui; Malnasi-Csizmadia, Andras			Structural Model of Weak Binding Actomyosin in the Prepowerstroke State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; CROSS-LINKING; HEAVY-CHAIN; MYOSIN; MECHANISM; COMPLEX; AMBER; ATP; STABILIZATION; SIMULATIONS	We present the first in silico model of the weak binding actomyosin in the initial powerstroke state, representing the actin binding-induced major structural changes in myosin. First, we docked an actin trimer to prepowerstroke myosin then relaxed the complex by a 100-ns long unrestrained molecular dynamics. In the first few nanoseconds, actin binding induced an extra primed myosin state, i.e. the further priming of the myosin lever by 18 degrees coupled to a further closure of switch 2 loop. We demonstrated that actin induces the extra primed state of myosin specifically through the actin N terminus-activation loop interaction. The applied in silico methodology was validated by forming rigor structures that perfectly fitted into an experimentally determined EM map of the rigor actomyosin. Our results unveiled the role of actin in the powerstroke by presenting that actin moves the myosin lever to the extra primed state that leads to the effective lever swing.	[Varkuti, Boglarka H.; Yang, Zhenhui; Malnasi-Csizmadia, Andras] Eotvos Lorand Univ, Dept Biochem, Inst Biol, H-1117 Budapest, Hungary; [Malnasi-Csizmadia, Andras] Eotvos Lorand Univ, ELTE HAS Mol Biophys Res Grp, H-1117 Budapest, Hungary; [Malnasi-Csizmadia, Andras] Optopharma Ltd, H-1015 Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University	Malnasi-Csizmadia, A (corresponding author), Eotvos Lorand Univ, Dept Biochem, Inst Biol, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.	malnalab@yahoo.com	Csizmadia, András Málnási/K-7632-2018	Csizmadia, András Málnási/0000-0002-2430-8398	Hungarian Academy of Sciences (HAS-ELTE research group) [01055]; European Community's Seventh Framework Programme FP7/European Research Council [208319]; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4.A/1-11-1-2012-0001]	Hungarian Academy of Sciences (HAS-ELTE research group); European Community's Seventh Framework Programme FP7/European Research Council; European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF))	This work was supported in part by the Hungarian Academy of Sciences (HAS-ELTE research group ID: 01055) and European Community's Seventh Framework Programme FP7/2007-2013)/European Research Council Grant Agreement 208319 (to A. M.-C. and Z. Y.).; Supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/1-11-1-2012-0001 "National Excellence Program."	ANSON M, 1995, BIOPHYS J, V68, P1991, DOI 10.1016/S0006-3495(95)80376-0; Baker JL, 2013, BIOPHYS J, V105, P1624, DOI 10.1016/j.bpj.2013.08.023; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERTRAND R, 1994, FEBS LETT, V345, P113, DOI 10.1016/0014-5793(94)00398-X; Bertrand R, 1997, BIOCHEMISTRY-US, V36, P9703, DOI 10.1021/bi970615h; CHAUSSEPIED P, 1988, P NATL ACAD SCI USA, V85, P7471, DOI 10.1073/pnas.85.20.7471; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Frisch M.J., 2016, GAUSSIAN16 REV B01; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; GEEVES MA, 1995, BIOPHYS J, V68, pS196; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gyimesi M, 2008, J BIOL CHEM, V283, P8153, DOI 10.1074/jbc.M708863200; Gyimesi M, 2008, BIOCHEMISTRY-US, V47, P283, DOI 10.1021/bi701554a; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kiani FA, 2013, J BIOL CHEM, V288, P35569, DOI 10.1074/jbc.M113.500298; KOTTALAM J, 1990, BIOPOLYMERS, V29, P1409, DOI 10.1002/bip.360291008; Kuhner S, 2011, P NATL ACAD SCI USA, V108, P7793, DOI 10.1073/pnas.1018420108; Lorenz M, 2010, P NATL ACAD SCI USA, V107, P12529, DOI 10.1073/pnas.1003604107; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; Malnasi-Csizmadia A, 2010, TRENDS BIOCHEM SCI, V35, P684, DOI 10.1016/j.tibs.2010.07.012; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Menetrey J, 2007, CELL, V131, P300, DOI 10.1016/j.cell.2007.08.027; Milligan RA, 1996, P NATL ACAD SCI USA, V93, P21, DOI 10.1073/pnas.93.1.21; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Pollard TD, 2000, TRENDS BIOCHEM SCI, V25, P607, DOI 10.1016/S0968-0004(00)01719-9; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Takacs B, 2011, FASEB J, V25, P111, DOI 10.1096/fj.10-164871; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; YORK DM, 1993, J CHEM PHYS, V99, P8345, DOI 10.1063/1.465608	40	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1679	1688		10.1074/jbc.M114.606665	http://dx.doi.org/10.1074/jbc.M114.606665			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25416786	Green Published, hybrid			2022-12-28	WOS:000348056400034
J	Shi, WL; Xu, G; Wang, CD; Sperber, SM; Chen, YL; Zhou, Q; Deng, Y; Zhao, H				Shi, Weili; Xu, Gang; Wang, Chengdong; Sperber, Steven M.; Chen, Yonglong; Zhou, Qin; Deng, Yi; Zhao, Hui			Heat Shock 70-kDa Protein 5 (Hspa5) Is Essential for Pronephros Formation by Mediating Retinoic Acid Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Embryo; Endoplasmic Reticulum Stress (ER Stress); Kidney; Retinoic Acid; Xenopus	ENDOPLASMIC-RETICULUM STRESS; XENOPUS-LAEVIS; KIDNEY DEVELOPMENT; CELL-SURFACE; EMBRYONIC-DEVELOPMENT; ANIMAL CAPS; GENE; DIFFERENTIATION; EXPRESSION; INDUCTION	Background: The function of Hspa5 in early embryonic development is not well understood. Results: Hspa5 is involved in mediating retinoic acid signaling and is required for pronephros. Conclusion: Hspa5 is essential for pronephros formation by mediating retinoic acid signaling. Significance: This is the first report on the cross-talk between physiological ER stress and transduction of retinoic acid signaling. Heat shock 70-kDa protein 5 (Hspa5), also known as binding immunoglobulin protein (Bip) or glucose-regulated protein 78 (Grp78), belongs to the heat shock protein 70 kDa family. As a multifunctional protein, it participates in protein folding and calcium homeostasis and serves as an essential regulator of the endoplasmic reticulum (ER) stress response. It has also been implicated in signal transduction by acting as a receptor or co-receptor residing at the plasma membrane. Its function during embryonic development, however, remains largely elusive. In this study, we used morpholino antisense oligonucleotides (MOs) to knock down Hspa5 activity in Xenopus embryos. In Hspa5 morphants, pronephros formation was strongly inhibited with the reduction of pronephric marker genes Lim homeobox protein 1 (lhx1), pax2, and 1 subunit of Na/K-ATPase (atp1b1). Pronephros tissue was induced in vitro by treating animal caps with all-trans-retinoic acid and activin. Depletion of Hspa5 in animal caps, however, blocked the induction of pronephros as well as reduced the expression of retinoic acid (RA)-responsive genes, suggesting that knockdown of Hspa5 attenuated RA signaling. Knockdown of Hspa5 in animal caps resulted in decreased expression of lhx1, a transcription factor directly regulated by RA signaling and essential for pronephros specification. Co-injection of Hspa5MO with lhx1 mRNA partially rescued the phenotype induced by Hspa5MO. These results suggest that the RA-Lhx1 signaling cascade is involved in Hspa5MO-induced pronephros malformation. This study shows that Hspa5, a key regulator of the unfolded protein response, plays an essential role in pronephros formation, which is mediated in part through RA signaling during early embryonic development.	[Shi, Weili; Wang, Chengdong; Zhao, Hui] Chinese Univ Hong Kong, Sch Biomed Sci, Key Lab Regenerat Med, Minist Educ,Fac Med, Hong Kong, Hong Kong, Peoples R China; [Xu, Gang] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon Tong, Hong Kong, Peoples R China; [Deng, Yi] South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China; [Wang, Chengdong; Zhao, Hui] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518057, Peoples R China; [Sperber, Steven M.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Chen, Yonglong] Chinese Acad Sci, Guangzhou Inst Biomed, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Chen, Yonglong] Chinese Acad Sci, Guangzhou Inst Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Zhou, Qin] Chongqing Med Univ, Coll Lab Med, Minist Educ, Div Mol Nephrol,Key Lab Lab Med Diagnost, Chongqing 400016, Peoples R China; [Zhou, Qin] Chongqing Med Univ, Coll Lab Med, Minist Educ, Creat Training Ctr Undergrad,Key Lab Lab Med Diag, Chongqing 400016, Peoples R China	Chinese University of Hong Kong; Hong Kong Baptist University; Southern University of Science & Technology; Chinese University of Hong Kong, Shenzhen; Icahn School of Medicine at Mount Sinai; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Chongqing Medical University; Chongqing Medical University	Deng, Y (corresponding author), South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China.	deng.y@sustc.edu.cn; zhaohui@cuhk.edu.hk	Zhao, Hui/B-8429-2016	Zhao, Hui/0000-0001-8160-6415; Deng, Yi/0000-0003-1378-015X; Sperber PhD, MSc, FACMG, Steven M./0000-0002-1868-029X; Wang, Chengdong/0000-0001-9891-8765	Research Grants Council of Hong Kong [N_CUHK413/12]; National Basic Research Program of China [81270438, 81200566]; Chinese University of Hong Kong	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Basic Research Program of China(National Basic Research Program of China); Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported in part by Research Grants Council of Hong Kong Grant N_CUHK413/12 (to H. Z.) and National Basic Research Program of China Grants 81270438 (to G. X.) and 81200566 (to Y. D.).; Supported by a graduate studentship from The Chinese University of Hong Kong.	Agius E, 2000, DEVELOPMENT, V127, P1173; Al-Hashimi AA, 2010, J BIOL CHEM, V285, P28912, DOI 10.1074/jbc.M110.119107; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bellucci A, 2011, J NEUROCHEM, V116, P588, DOI 10.1111/j.1471-4159.2010.07143.x; Bracken CM, 2008, DEV DYNAM, V237, P132, DOI 10.1002/dvdy.21387; Brandli AW, 1999, INT J DEV BIOL, V43, P381; Cartry J, 2006, DEV BIOL, V299, P35, DOI 10.1016/j.ydbio.2006.06.047; Chan TC, 2000, DEV BIOL, V228, P256, DOI 10.1006/dbio.2000.9951; Chan T, 2006, NEPHRON EXP NEPHROL, V103, pE81, DOI 10.1159/000092192; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; Cho GS, 2011, DEVELOPMENT, V138, P465, DOI 10.1242/dev.061234; Cirio MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018858; Cybulsky AV, 2010, KIDNEY INT, V77, P187, DOI 10.1038/ki.2009.389; Diep CQ, 2011, NATURE, V470, P95, DOI 10.1038/nature09669; Dong DZ, 2011, CANCER RES, V71, P2848, DOI 10.1158/0008-5472.CAN-10-3151; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Drews C, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-5; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Gerth VE, 2005, DEV DYNAM, V233, P1131, DOI 10.1002/dvdy.20415; Ghiaur G, 2013, P NATL ACAD SCI USA, V110, P16121, DOI 10.1073/pnas.1305937110; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Gray PC, 2012, FEBS LETT, V586, P1836, DOI 10.1016/j.febslet.2012.01.051; Gu XM, 2010, LIFE SCI, V87, P724, DOI 10.1016/j.lfs.2010.10.012; Haldin CE, 2008, DEV BIOL, V322, P74, DOI 10.1016/j.ydbio.2008.07.012; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Heller N, 1997, MECH DEVELOP, V69, P83, DOI 10.1016/S0925-4773(97)00158-5; Hensey C, 2002, NEPHROL DIAL TRANSPL, V17, P73, DOI 10.1093/ndt/17.suppl_9.73; Hollemann T, 1996, MECH DEVELOP, V55, P19, DOI 10.1016/0925-4773(95)00485-8; Hou S, 2007, DEV CELL, V13, P226, DOI 10.1016/j.devcel.2007.07.001; Jones EA, 2005, J AM SOC NEPHROL, V16, P313, DOI 10.1681/ASN.2004070617; Kam RKT, 2013, J BIOL CHEM, V288, P31477, DOI 10.1074/jbc.M113.514984; Kam RKT, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-11; Kelber JA, 2008, J BIOL CHEM, V283, P4490, DOI 10.1074/jbc.M704960200; Kimura K, 2008, BIOCHEM BIOPH RES CO, V366, P1048, DOI 10.1016/j.bbrc.2007.12.098; King L, 2001, PROTEIN EXPRES PURIF, V22, P148, DOI 10.1006/prep.2001.1424; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kolm PJ, 1997, DEV BIOL, V192, P1, DOI 10.1006/dbio.1997.8754; Leclerc C, 2008, DEV BIOL, V321, P357, DOI 10.1016/j.ydbio.2008.06.029; Lee SJ, 2010, MECH DEVELOP, V127, P49, DOI 10.1016/j.mod.2009.11.001; Li JM, 2014, DIABETOLOGIA, V57, P754, DOI 10.1007/s00125-013-3147-y; Liu GG, 2008, BIOCHEM BIOPH RES CO, V370, P651, DOI 10.1016/j.bbrc.2008.04.031; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MORIYA N, 1993, DEV GROWTH DIFFER, V35, P123; Okabayashi K, 2003, CURR OPIN GENET DEV, V13, P502, DOI 10.1016/S0959-437X(03)00111-4; Pedersen A, 2005, DEV BIOL, V288, P571, DOI 10.1016/j.ydbio.2005.09.027; Poulain S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-423; Saw YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-329; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Strate I, 2009, DEVELOPMENT, V136, P461, DOI 10.1242/dev.024901; Strnad P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016454; Taelman V, 2006, DEVELOPMENT, V133, P2961, DOI 10.1242/dev.02458; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; TAIRA M, 1994, NATURE, V372, P677, DOI 10.1038/372677a0; Tanegashima K, 2009, DEVELOPMENT, V136, P3543, DOI 10.1242/dev.036715; Tetelin S, 2010, DEV DYNAM, V239, P148, DOI 10.1002/dvdy.22012; Tran U, 2007, DEV BIOL, V307, P152, DOI 10.1016/j.ydbio.2007.04.030; Urban AE, 2006, DEV BIOL, V297, P103, DOI 10.1016/j.ydbio.2006.04.469; Wang CD, 2011, DEV DYNAM, V240, P2028, DOI 10.1002/dvdy.22693; Wei JA, 2011, BRAIN RES, V1382, P77, DOI 10.1016/j.brainres.2011.01.027; Wessely O, 2011, PEDIATR NEPHROL, V26, P1545, DOI 10.1007/s00467-011-1881-2; Yao TT, 2011, MED SCI MONITOR, V17, pHY21, DOI 10.12659/MSM.881886; Yuan L, 2008, MECH DEVELOP, V125, P207, DOI 10.1016/j.mod.2007.11.010; Zhang B, 2013, DEV BIOL, V376, P31, DOI 10.1016/j.ydbio.2013.01.017; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhao H, 2003, DEV BIOL, V257, P278, DOI 10.1016/S0012-1606(03)00069-1; Zhao H, 2001, INT J DEV BIOL, V45, P817; Zhao H, 2008, DEVELOPMENT, V135, P1283, DOI 10.1242/dev.015073	73	23	25	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					577	589		10.1074/jbc.M114.591628	http://dx.doi.org/10.1074/jbc.M114.591628			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25398881	hybrid, Green Published			2022-12-28	WOS:000347231200050
J	Li, C; Mpollo, MSEM; Gonsalves, CS; Tahara, SM; Malik, P; Kalra, VK				Li, Chen; Mpollo, Marthe-Sandrine Eiymo Mwa; Gonsalves, Caryn S.; Tahara, Stanley M.; Malik, Punam; Kalra, Vijay K.			Peroxisome Proliferator-activated Receptor-alpha-mediated Transcription of miR-199a2 Attenuates Endothelin-1 Expression via Hypoxia-inducible Factor-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SICKLE-CELL-DISEASE; PLACENTA GROWTH-FACTOR; PULMONARY-HYPERTENSION; GENE-EXPRESSION; BLOOD-PRESSURE; KNOCKOUT MICE; CANCER-CELLS; FACTOR-I; RISK; CONTRIBUTES	Endothelin-1, a potent vasoconstrictor, plays an important role in pulmonary hypertension (PH) in sickle cell disease (SCD). Our previous studies show that higher levels of placenta growth factor (PlGF), secreted by erythroid precursor cells, correlate with increased plasma levels of endothelin-1 (ET-1) and other functional markers of PH in SCD. PlGF-mediated ET-1 expression occurs via activation of hypoxia-inducible factor-1 alpha (HIF-1 alpha). However, relatively less is understood regarding how PlGF-mediated expression of HIF-1 alpha and its downstream effector ET-1 are post-transcriptionally regulated. Herein, we show that PlGF treatment of endothelial cells resulted in reduced levels of miR-199a2, which targeted the 3'-UTR of HIF-1 alpha mRNA and concomitantly led to augmented ET-1 expression. Plasma levels of miR-199a2 in SCD subjects were significantly lower with reciprocally high levels of plasma ET-1, unlike unaffected controls. This observation provided a molecular link between miR-199a2 and high levels of ET-1 in SCD. Furthermore, we show that miR-199a2 located in the DNM3os transcription unit was co-transcriptionally regulated by peroxisome proliferator-activated receptor alpha (PPAR alpha). Binding of the latter to PPAR alpha cis-elements in the promoter of DNM3os was demonstrated by promoter mutational analysis and ChIP. Additionally, we show that fenofibrate, a PPAR alpha agonist, increased the expression of miR-199a2 and DNM3os; the former was responsible for reduced expression of HIF-1 alpha and ET-1. In vivo studies of fenofibrate-fed Berkeley sickle mice resulted in increased levels of miR-199a2 and reduced levels of ET-1 in lung tissues. Our studies provide a potential therapeutic approach whereby fenofibrate-induced miR-199a2 expression can ameliorate PH by reduction of ET-1 levels.	[Li, Chen; Gonsalves, Caryn S.; Kalra, Vijay K.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Tahara, Stanley M.] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA; [Mpollo, Marthe-Sandrine Eiymo Mwa; Malik, Punam] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	University of Southern California; University of Southern California; Cincinnati Children's Hospital Medical Center	Malik, P (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	Punam.Malik@cchmc.org; vkalra@usc.edu		Tahara, Stanley/0000-0001-5097-0927; Malik, Punam/0000-0002-8942-2108	National Institutes of Health [RO1-HL111372, P30-DK048522]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL111372 (to V. K. K. and P. M.) and P30-DK048522 (to the University of Southern California Research Center for Liver Disease).	Ataga KI, 2007, HAEMATOLOGICA, V93, P20, DOI 10.3324/haematol.11763; Bunn HF, 2010, BLOOD, V116, P687, DOI 10.1182/blood-2010-02-268193; Chen Y, 2013, DIABETES, V62, P261, DOI 10.2337/db11-0413; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Desvignes T, 2014, RNA BIOL, V11, P281, DOI 10.4161/rna.28141; Ding G, 2013, MOL CELL BIOCHEM, V384, P173, DOI 10.1007/s11010-013-1795-3; el Azzouzi H, 2013, CELL METAB, V18, P341, DOI 10.1016/j.cmet.2013.08.009; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Glineur C, 2013, ARTERIOSCL THROM VAS, V33, P621, DOI 10.1161/ATVBAHA.112.300665; Gonsalves C. S., 2014, MOL CELL BIOL, DOI [10.1128/MCB.01199-14, DOI 10.1128/MCB.01199-14]; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Hsu LL, 2007, BLOOD, V109, P3088, DOI 10.1182/blood-2006-08-039438; Hu J, 1998, BIOCHEM BIOPH RES CO, V245, P894, DOI 10.1006/bbrc.1998.8543; Kang J, 2009, ANAL BIOCHEM, V386, P251, DOI 10.1016/j.ab.2008.12.021; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; Kisanuki YY, 2010, HYPERTENSION, V56, P121, DOI 10.1161/HYPERTENSIONAHA.109.138701; Klings ES, 2008, AM J HEMATOL, V83, P4, DOI 10.1002/ajh.21083; Klings ES, 2014, AM J RESP CRIT CARE, V189, P727, DOI 10.1164/rccm.201401-0065ST; KOUREMBANAS S, 1991, J CLIN INVEST, V88, P1054, DOI 10.1172/JCI115367; Lalloyer F, 2010, ARTERIOSCL THROM VAS, V30, P894, DOI 10.1161/ATVBAHA.108.179689; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Loebel DAF, 2005, GENOMICS, V85, P782, DOI 10.1016/j.ygeno.2005.02.001; Miller AC, 2012, AM J RESP CRIT CARE, V185, P1154, DOI 10.1164/rccm.201111-2082CI; Minniti CP, 2009, BRIT J HAEMATOL, V147, P737, DOI 10.1111/j.1365-2141.2009.07906.x; Morris CR, 2008, BLOOD, V111, P402, DOI 10.1182/blood-2007-04-081703; Nallamshetty S, 2013, FREE RADICAL BIO MED, V64, P20, DOI 10.1016/j.freeradbiomed.2013.05.022; Nourale M, 2013, HAEMATOLOGICA, V98, P464, DOI 10.3324/haematol.2012.068965; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Patel N, 2008, BLOOD, V112, P856, DOI 10.1182/blood-2007-12-130567; Patel N, 2011, BIOCHEM J, V434, P473, DOI 10.1042/BJ20101585; Patel N, 2010, J BIOL CHEM, V285, P16713, DOI 10.1074/jbc.M110.101691; Patel N, 2009, BLOOD, V113, P1129, DOI 10.1182/blood-2008-07-169821; Pereira ER, 2014, J BIOL CHEM, V289, P3352, DOI 10.1074/jbc.M113.507194; Perelman N, 2003, BLOOD, V102, P1506, DOI 10.1182/blood-2002-11-3422; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Rybicki AC, 1998, BLOOD, V92, P2594, DOI 10.1182/blood.V92.7.2594.2594_2594_2596; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Sundaram N, 2010, BLOOD, V116, P109, DOI 10.1182/blood-2009-09-244830; Watanabe T, 2008, DEV DYNAM, V237, P3738, DOI 10.1002/dvdy.21787; Wood KC, 2013, ARTERIOSCL THROM VAS, V33, P1861, DOI 10.1161/ATVBAHA.112.301068; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Zhang X, 2014, CIRCULATION, V129, P1650, DOI 10.1161/CIRCULATIONAHA.113.005296; Zhou JD, 2012, J BIOL CHEM, V287, P35161, DOI 10.1074/jbc.M112.367367	46	25	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36031	36047		10.1074/jbc.M114.600775	http://dx.doi.org/10.1074/jbc.M114.600775			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25389292	Green Published, hybrid			2022-12-28	WOS:000346897900032
J	Little, DJ; Bamford, NC; Pokrovskaya, V; Robinson, H; Nitz, M; Howell, PL				Little, Dustin J.; Bamford, Natalie C.; Pokrovskaya, Varvara; Robinson, Howard; Nitz, Mark; Howell, P. Lynne			Structural Basis for the De-N-acetylation of Poly-beta-1,6-N-acetyl-D-glucosamine in Gram-positive Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI PGAB; STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION; CARBOHYDRATE ESTERASE; BPS POLYSACCHARIDE; PROTEIN-STRUCTURE; MOLECULAR-BASIS; EXOPOLYSACCHARIDE; DEACETYLASE; ELECTROSTATICS	Exopolysaccharides are required for the development and integrity of biofilms produced by a wide variety of bacteria. In staphylococci, partial de-N-acetylation of the exopolysaccharide poly-beta-1,6-N-acetyl-D-glucosamine (PNAG) by the extra-cellular protein IcaB is required for biofilm formation. To understand the molecular basis for PNAG de-N-acetylation, the structure of IcaB from Ammonifex degensii (IcaB(Ad)) has been determined to 1.7 angstrom resolution. The structure of IcaB(Ad) reveals a (beta/alpha)(7) barrel common to the family four carbohydrate esterases (CE4s) with the canonical motifs circularly permuted. The metal dependence of IcaB(Ad) is similar to most CE4s showing the maximum rates of de-N-acetylation with Ni2+, Co2+, and Zn2+. From docking studies with beta-1,6-GlcNAc oligomers and structural comparison to PgaB from Escherichia coli, the Gram-negative homologue of IcaB, we identify Arg-45, Tyr-67, and Trp180 as key residues for PNAG binding during catalysis. The absence of these residues in PgaB provides a rationale for the requirement of a C-terminal domain for efficient deacetylation of PNAG in Gram-negative species. Mutational analysis of conserved active site residues suggests that IcaB uses an altered catalytic mechanism in comparison to other characterized CE4 members. Furthermore, we identified a conserved surface-exposed hydrophobic loop found only in Gram-positive homologues of IcaB. Our data suggest that this loop is required for membrane association and likely anchors IcaB to the membrane during polysaccharide biosynthesis. The work presented herein will help guide the design of IcaB inhibitors to combat biofilm formation by staphylococci.	[Little, Dustin J.; Bamford, Natalie C.; Howell, P. Lynne] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Little, Dustin J.; Bamford, Natalie C.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Pokrovskaya, Varvara; Nitz, Mark] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Robinson, Howard] Brookhaven Natl Lab, Photon Sci Div, Upton, NY 11973 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; United States Department of Energy (DOE); Brookhaven National Laboratory	Nitz, M (corresponding author), Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada.	mnitz@chem.utoronto.ca; howell@sickkids.ca		Bamford, Natalie/0000-0003-1959-856X	United States Department of Energy Office of Biological and Environmental Research; National Institutes of Health National Centre for Research Resources; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	United States Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health National Centre for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Patrick Yip for technical assistance and the Trimble laboratory at The Hospital for Sick Children for the use of their micro-ultracentrifuge. The National Synchrotron Light Source beam line X29A is supported by the United States Department of Energy Office of Biological and Environmental Research and the National Institutes of Health National Centre for Research Resources.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andres E, 2014, ANGEW CHEM INT EDIT, V53, P6882, DOI 10.1002/anie.201400220; Atkin KE, 2014, FEBS LETT, V588, P1869, DOI 10.1016/j.febslet.2014.04.002; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Cerca N, 2007, INFECT IMMUN, V75, P3406, DOI 10.1128/IAI.00078-07; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; CHRISTIANSON DW, 1989, ACCOUNTS CHEM RES, V22, P62, DOI 10.1021/ar00158a003; CHRISTIANSON DW, 1987, P NATL ACAD SCI USA, V84, P1512, DOI 10.1073/pnas.84.6.1512; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; Cywes-Bentley C, 2013, P NATL ACAD SCI USA, V110, pE2209, DOI 10.1073/pnas.1303573110; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Hernick M, 2005, ARCH BIOCHEM BIOPHYS, V433, P71, DOI 10.1016/j.abb.2004.08.006; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Joyce JG, 2003, CARBOHYD RES, V338, P903, DOI 10.1016/S0008-6215(03)00045-4; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Leung C, 2009, CARBOHYD RES, V344, P570, DOI 10.1016/j.carres.2008.12.021; Little D. J., 2014, ENCY INORGANIC BIOIN, P1; Little DJ, 2014, P NATL ACAD SCI USA, V111, P11013, DOI 10.1073/pnas.1406388111; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Little DJ, 2012, ACTA CRYSTALLOGR F, V68, P842, DOI 10.1107/S1744309112022075; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Lovering AL, 2010, NAT STRUCT MOL BIOL, V17, P582, DOI 10.1038/nsmb.1819; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nishiyama T, 2013, ACTA CRYSTALLOGR D, V69, P44, DOI 10.1107/S0907444912042059; O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pokrovskaya V, 2013, BIOCHEMISTRY-US, V52, P5463, DOI 10.1021/bi400836g; Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005; Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Whittington DA, 2003, P NATL ACAD SCI USA, V100, P8146, DOI 10.1073/pnas.1432990100; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woods Group, 2005, GLYCAM WEB; Yakandawala N, 2011, APPL ENVIRON MICROB, V77, P8303, DOI 10.1128/AEM.05814-11; Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155	61	18	18	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35907	35917		10.1074/jbc.M114.611400	http://dx.doi.org/10.1074/jbc.M114.611400			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25359777	Green Published, hybrid			2022-12-28	WOS:000346897900022
J	Hwang, S; Li, Z; Bar-Peled, Y; Aronov, A; Ericson, J; Bar-Peled, M				Hwang, Soyoun; Li, Zi; Bar-Peled, Yael; Aronov, Avi; Ericson, Jaime; Bar-Peled, Maor			The Biosynthesis of UDP-D-FucNAc-4N-(2)-oxoglutarate (UDP-Yelosamine) in Bacillus cereus ATCC 14579 Pat AND Pyl, AN AMINOTRANSFERASE AND AN ATP-DEPENDENT Grasp PROTEIN THAT LIGATES 2-OXOGLUTARATE TO UDP-4-AMINO-SUGARS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Biofilm; Carbohydrate Biosynthesis; Enzyme Catalysis; Glycobiology	CELL-WALL POLYSACCHARIDE; D-ALANINE LIGASE; ESCHERICHIA-COLI; GLUTATHIONE SYNTHETASE; H-1-NMR SPECTRA; HUMAN PATHOGEN; SPECTROSCOPY; ATP; ENZYMES; 4-AMINO-4-DEOXY-L-ARABINOSE	Surface glycan switching is often observed when micro-organisms transition between different biotic and abiotic niches, including biofilms, although the advantages of this switching to the organism are not well understood. Bacillus cereus grown in a biofilm-inducing medium has been shown to synthesize an unusual cell wall polysaccharide composed of the repeating subunit 6)Gal(1-2)(2-R-hydroxyglutar-5-ylamido)Fuc2NAc4N(1-6)GlcNAc(1, where galactose is linked to the hydroxyglutarate moiety of FucNAc-4-amido-(2)-hydroxyglutarate. The molecular mechanism involved in attaching 2-hydroxyglutarate to 4-amino-FucNAc has not been determined. Here, we show two genes in B. cereus ATCC 14579 encoding enzymes involved in the synthesis of UDP-FucNAc-4-amido-(2)-oxoglutarate (UDP-Yelosamine), a modified UDP-sugar not previously reported to exist. Using mass spectrometry and real time NMR spectroscopy, we show that Bc5273 encodes a C4-aminotransferase (herein referred to as Pat) that, in the presence of pyridoxal phosphate, transfers the primary amino group of l-Glu to C-4 of UDP-4-keto-6-deoxy-d-GlcNAc to form UDP-4-amino-FucNAc and 2-oxoglutarate. Pat also converts 4-keto-xylose, 4-keto-glucose, and 4-keto-2-acetamido-altrose to their corresponding UDP-4-amino-sugars. Bc5272 encodes a carboxylate-amine ligase (herein referred as Pyl) that, in the presence of ATP and Mg(II), adds 2-oxoglutarate to the 4-amino moiety of UDP-4-amino-FucNAc to form UDP-Yelosamine and ADP. Pyl is also able to ligate 2-oxoglutarate to other 4-amino-sugar derivatives to form UDP-Yelose, UDP-Solosamine, and UDP-Aravonose. Characterizing the metabolic pathways involved in the formation of modified nucleotide sugars provides a basis for understanding some of the mechanisms used by bacteria to modify or alter their cell surface polysaccharides in response to changing growth and environmental challenges.	[Hwang, Soyoun; Li, Zi; Bar-Peled, Yael; Aronov, Avi; Ericson, Jaime; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Li, Zi; Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu		Aronov, Avi/0000-0003-1781-6068	NIH grant [S10 RR027097]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027097] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr. Malcolm O'Neill of the Complex Carbohydrate Research Center for constructive comments on the manuscript. We also thank Dr. John Glushka of the Complex Carbohydrate Research Center for NMR technical assistance. Our research benefitted from instrumentation provided by an NIH grant, S10 RR027097.	Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; BERNASSAU JM, 1994, J MAGN RESON SER B, V103, P77, DOI 10.1006/jmrb.1994.1011; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Bubb WA, 2003, CONCEPT MAGN RESON A, V19A, P1, DOI 10.1002/cmr.a.10080; Candela T, 2011, J BIOL CHEM, V286, P31250, DOI 10.1074/jbc.M111.249821; Chamot-Rooke J, 2007, P NATL ACAD SCI USA, V104, P14783, DOI 10.1073/pnas.0705335104; Cook PD, 2008, BIOCHEMISTRY-US, V47, P2833, DOI 10.1021/bi702430d; Esser L, 1998, EMBO J, V17, P977, DOI 10.1093/emboj/17.4.977; FAN C, 1995, P NATL ACAD SCI USA, V92, P1172, DOI 10.1073/pnas.92.4.1172; FAN C, 1994, SCIENCE, V266, P439, DOI 10.1126/science.7939684; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Gu XG, 2010, J BIOL CHEM, V285, P24825, DOI 10.1074/jbc.M110.125872; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Jitrapakdee S, 2003, CURR PROTEIN PEPT SC, V4, P217, DOI 10.2174/1389203033487199; Leoff C, 2008, J BIOL CHEM, V283, P29812, DOI 10.1074/jbc.M803234200; Ludlam A, 2009, J BIOL CHEM, V284, P17138, DOI 10.1074/jbc.M109.002568; Madej T, 2012, NUCLEIC ACIDS RES, V40, pD461, DOI 10.1093/nar/gkr1162; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Martinez V, 2012, J BIOL CHEM, V287, P879, DOI 10.1074/jbc.M111.287367; Mochalkin I, 2008, PROTEIN SCI, V17, P1706, DOI 10.1110/ps.035584.108; Nothaft H, 2013, J BIOL CHEM, V288, P6912, DOI 10.1074/jbc.R112.417857; Polekhina G, 1999, EMBO J, V18, P3204, DOI 10.1093/emboj/18.12.3204; Raetz CRH, 2002, BIOCHEMISTRY-US, V41, P8962; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Suzuki M, 2012, ACTA CRYSTALLOGR D, V68, P1535, DOI 10.1107/S0907444912038103; Vilain S, 2006, J PROTEOME RES, V5, P1924, DOI 10.1021/pr050402b; Vinogradov E, 2003, EUR J BIOCHEM, V270, P1810, DOI 10.1046/j.1432-1033.2003.03543.x	32	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35620	35632		10.1074/jbc.M114.614917	http://dx.doi.org/10.1074/jbc.M114.614917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25368324	Green Published, hybrid			2022-12-28	WOS:000346660200048
J	Kallemeijn, WW; Witte, MD; Voorn-Brouwer, TM; Walvoort, MTC; Li, KY; Codee, JDC; van der Marel, GA; Boot, RG; Overkleeft, HS; Aerts, JMFG				Kallemeijn, Wouter W.; Witte, Martin D.; Voorn-Brouwer, Tineke M.; Walvoort, Marthe T. C.; Li, Kah-Yee; Codee, Jeroen D. C.; van der Marel, Gijsbert A.; Boot, Rolf G.; Overkleeft, Herman S.; Aerts, Johannes M. F. G.			A Sensitive Gel-based Method Combining Distinct Cyclophellitol-based Probes for the Identification of Acid/Base Residues in Human Retaining beta-Glucosidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gaucher Disease; Glycobiology; Glycoconjugate; Glycolipid; Glycosidase; Acid; Base; Activity-based Probe; Labeling; Nucleophile	LACTASE-PHLORHIZIN HYDROLASE; 2 CATALYTIC SITES; GAUCHER-DISEASE; INTESTINAL LACTASE; ACTIVE-SITE; NONLYSOSOMAL GLUCOSYLCERAMIDASE; GLYCOSIDE-HYDROLASE; MOLECULAR-CLONING; TRPV5 CHANNEL; IN-VIVO	Retaining -exoglucosidases operate by a mechanism in which the key amino acids driving the glycosidic bond hydrolysis act as catalytic acid/base and nucleophile. Recently we designed two distinct classes of fluorescent cyclophellitol-type activity-based probes (ABPs) that exploit this mechanism to covalently modify the nucleophile of retaining -glucosidases. Whereas -epoxide ABPs require a protonated acid/base for irreversible inhibition of retaining -glucosidases, -aziridine ABPs do not. Here we describe a novel sensitive method to identify both catalytic residues of retaining -glucosidases by the combined use of cyclophellitol -epoxide- and -aziridine ABPs. In this approach putative catalytic residues are first substituted to noncarboxylic amino acids such as glycine or glutamine through site-directed mutagenesis. Next, the acid/base and nucleophile can be identified via classical sodium azide-mediated rescue of mutants thereof. Selective labeling with fluorescent -aziridine but not -epoxide ABPs identifies the acid/base residue in mutagenized enzyme, as only the -aziridine ABP can bind in its absence. The Absence of the nucleophile abolishes any ABP labeling. We validated the method by using the retaining -glucosidase GBA (CAZy glycosylhydrolase family GH30) and then applied it to non-homologous (putative) retaining -glucosidases categorized in GH1 and GH116: GBA2, GBA3, and LPH. The described method is highly sensitive, requiring only femtomoles (nanograms) of ABP-labeled enzymes.	[Kallemeijn, Wouter W.; Voorn-Brouwer, Tineke M.; Boot, Rolf G.; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Witte, Martin D.; Walvoort, Marthe T. C.; Li, Kah-Yee; Codee, Jeroen D. C.; van der Marel, Gijsbert A.; Overkleeft, Herman S.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC	Overkleeft, HS (corresponding author), Leiden Univ, Leiden Inst Chem, Einsteinweg 55, NL-2300 RA Leiden, Netherlands.	h.s.overkleeft@chem.leidenuniv.nl; j.m.aerts@amc.uva.nl	Aerts, Johannes/A-1028-2009; Kallemeijn, Wouter W./F-6801-2014; Walvoort, Marthe/AAE-4468-2019; Kallemeijn, W. W./P-2768-2019; Walvoort, Marthe/ABE-8335-2020	Aerts, Johannes/0000-0001-8168-2565; Kallemeijn, Wouter W./0000-0002-3660-2930; Walvoort, Marthe/0000-0003-1101-2659; Kallemeijn, W. W./0000-0002-3660-2930; Overkleeft, Herman/0000-0001-6976-7005; Boot, Rolf/0000-0002-7031-3390	Netherlands Organization for Scientific Research (NWO-CW); European Research Council (ERC AdG)	Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC AdG)(European Research Council (ERC))	This work was supported by The Netherlands Organization for Scientific Research (NWO-CW, Top Grant (to H. S. O. and J. M. F. G. A.) and the European Research Council (ERC AdG; to H. S. O.).	Andersson U, 2000, BIOCHEM PHARMACOL, V59, P821, DOI 10.1016/S0006-2952(99)00384-6; Arribas JCD, 2000, EUR J BIOCHEM, V267, P6996, DOI 10.1046/j.1432-1327.2000.01784.x; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; BRADY RO, 1966, J CLIN INVEST, V45, P1112, DOI 10.1172/JCI105417; Bravman T, 2003, J BIOL CHEM, V278, P26742, DOI 10.1074/jbc.M304144200; Bultron G, 2010, J INHERIT METAB DIS, V33, P167, DOI 10.1007/s10545-010-9055-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Cobucci-Ponzano B, 2010, J BIOL CHEM, V285, P20691, DOI 10.1074/jbc.M109.086470; Dekker N, 2011, BLOOD CELL MOL DIS, V46, P19, DOI 10.1016/j.bcmd.2010.07.009; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; GOPALAN V, 1992, J BIOL CHEM, V267, P14027; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Grabowski GA, 2012, HEMATOL-AM SOC HEMAT, P13, DOI 10.1182/asheducation-2012.1.13; Hammer MB, 2013, AM J HUM GENET, V92, P245, DOI 10.1016/j.ajhg.2012.12.012; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Ito S, 2002, BBA-GENE STRUCT EXPR, V1576, P341, DOI 10.1016/S0167-4781(02)00281-6; Kallemeijn WW, 2012, ANGEW CHEM INT EDIT, V51, P12529, DOI 10.1002/anie.201207771; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; LLOYD M, 1992, J CLIN INVEST, V89, P524, DOI 10.1172/JCI115616; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; MacLeod AM, 1996, BIOCHEMISTRY-US, V35, P13165, DOI 10.1021/bi9610616; Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021; Noguchi J, 2008, BIOCHEM BIOPH RES CO, V374, P549, DOI 10.1016/j.bbrc.2008.07.089; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Rempel BP, 2008, GLYCOBIOLOGY, V18, P570, DOI 10.1093/glycob/cwn041; SKOVBJERG H, 1981, EUR J BIOCHEM, V114, P653, DOI 10.1111/j.1432-1033.1981.tb05193.x; Sorli SC, 2013, FASEB J, V27, P489, DOI 10.1096/fj.12-215152; Tayebi N, 2001, MOL GENET METAB, V73, P313, DOI 10.1006/mgme.2001.3201; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; TULL D, 1991, J BIOL CHEM, V266, P15621; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; WACKER H, 1992, J BIOL CHEM, V267, P18744; Wennekes T, 2007, J ORG CHEM, V72, P1088, DOI 10.1021/jo061280p; Williams SJ, 2000, CARBOHYD RES, V327, P27, DOI 10.1016/S0008-6215(00)00041-0; WITHERS SG, 1988, J BIOL CHEM, V263, P7929; WITHERS SG, 1987, J AM CHEM SOC, V109, P7530, DOI 10.1021/ja00258a047; Witte MD, 2010, NAT CHEM BIOL, V6, P907, DOI 10.1038/NCHEMBIO.466; Yahata K, 2000, J MOL MED, V78, P389, DOI 10.1007/s001090000131; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Zecca L, 1998, FEBS LETT, V435, P225, DOI 10.1016/S0014-5793(98)01076-X	44	16	16	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35351	35362		10.1074/jbc.M114.593376	http://dx.doi.org/10.1074/jbc.M114.593376			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25344605	Green Published, hybrid			2022-12-28	WOS:000346660200026
J	Peigneur, S; Paolini-Bertrand, M; Gaertner, H; Biass, D; Violette, A; Stocklin, R; Favreau, P; Tytgat, J; Hartley, O				Peigneur, Steve; Paolini-Bertrand, Marianne; Gaertner, Hubert; Biass, Daniel; Violette, Aude; Stoecklin, Reto; Favreau, Philippe; Tytgat, Jan; Hartley, Oliver			delta-Conotoxins Synthesized Using an Acid-cleavable Solubility Tag Approach Reveal Key Structural Determinants for Na-V Subtype Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Molecular Pharmacology; Natural Product Biosynthesis; Neurotoxin; Peptide Chemical Synthesis; Sodium Channel; Conotoxin	GATED SODIUM-CHANNELS; HYDROPHOBIC PEPTIDES; NATURAL-PRODUCTS; BUILDING-BLOCKS; VENOM PEPTIDES; CONUS-ERMINEUS; INACTIVATION; CONOPEPTIDES; PHARMACOLOGY; PROTEINS	Conotoxins are venom peptides from cone snails with multiple disulfide bridges that provide a rigid structural scaffold. Typically acting on ion channels implicated in neurotransmission, conotoxins are of interest both as tools for pharmacological studies and as potential new medicines. -Conotoxins act by inhibiting inactivation of voltage-gated sodium channels (Na-v). Their pharmacology has not been extensively studied because their highly hydrophobic character makes them difficult targets for chemical synthesis. Here we adopted an acid-cleavable solubility tag strategy that facilitated synthesis, purification, and directed disulfide bridge formation. Using this approach we readily produced three native -conotoxins from Conus consors plus two rationally designed hybrid peptides. We observed striking differences in Na-v subtype selectivity across this group of compounds, which differ in primary structure at only three positions: 12, 23, and 25. Our results provide new insights into the structure-activity relationships underlying the Na-v subtype selectivity of -conotoxins. Use of the acid-cleavable solubility tag strategy should facilitate synthesis of other hydrophobic peptides with complex disulfide bridge patterns.	[Peigneur, Steve; Tytgat, Jan] Catholic Univ, Lab Toxicol & Pharmacol, Dept Pharmaceut Sci, B-3000 Leuven, Belgium; [Paolini-Bertrand, Marianne; Gaertner, Hubert; Hartley, Oliver] Univ Geneva, Fac Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Biass, Daniel; Violette, Aude; Stoecklin, Reto; Favreau, Philippe] Atheris Labs, CH-1233 Bernex, Switzerland; [Favreau, Philippe] Serv Toxicol Environm, Dept Environm Transport & Agr, CH-1211 Geneva, Switzerland	KU Leuven; University Hospital Leuven; University of Geneva	Tytgat, J (corresponding author), Univ Leuven KU Leuven, Campus Gasthuisberg,Herestr 49, B-3000 Leuven, Belgium.	jan.tytgat@pharm.kuleuven.be; oliver.hartley@unige.ch		Tytgat, Jan/0000-0003-1778-6022; Violette, Aude/0000-0002-6048-6992; Peigneur, Steve/0000-0003-0504-5702	LIFESCIHEALTH-6 Integrated Project Grant LSHB-CT; F.W.O. Vlaanderen [G.0433.12, G.A071.10N, G.0257.08]; KU Leuven [OT/12/081]; EU-FP7-MAREX; IUAP from Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy [7/10]	LIFESCIHEALTH-6 Integrated Project Grant LSHB-CT; F.W.O. Vlaanderen(FWO); KU Leuven(KU Leuven); EU-FP7-MAREX; IUAP from Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy	This work was supported in part by LIFESCIHEALTH-6 Integrated Project Grant LSHB-CT-2007 performed as part of the CONCO cone snail genome project for health within the 6th Framework Program.; Supported by Grants G.0433.12, G.A071.10N, and G.0257.08 from F.W.O. Vlaanderen, Grant OT/12/081 from KU Leuven, and Grants EU-FP7-MAREX and IUAP 7/10 from the Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy. To whom correspondence may be addressed: University of Leuven (KU Leuven), Campus Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium. Tel.: 32-16-323403; E-mail: jan.tytgat@pharm.kuleuven.be.	Barbier J, 2004, J BIOL CHEM, V279, P4680, DOI 10.1074/jbc.M309576200; Biass D, 2009, J PROTEOMICS, V72, P210, DOI 10.1016/j.jprot.2009.01.019; Bogdanowich-Knipp SJ, 1999, J PEPT RES, V54, P43, DOI 10.1034/j.1399-3011.1999.00091.x; Buczek O, 2004, BIOCHEMISTRY-US, V43, P1093, DOI 10.1021/bi0354233; Bulaj G, 2001, BIOCHEMISTRY-US, V40, P13201, DOI 10.1021/bi010683a; Choma CT, 1998, TETRAHEDRON LETT, V39, P2417, DOI 10.1016/S0040-4039(98)00214-7; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Englebretsen DR, 1999, TETRAHEDRON, V55, P6623, DOI 10.1016/S0040-4020(99)00309-9; Englebretsen DR, 1996, TETRAHEDRON LETT, V37, P8431, DOI 10.1016/0040-4039(96)01910-7; FAINZILBER M, 1995, J BIOL CHEM, V270, P1123, DOI 10.1074/jbc.270.3.1123; Favreau P., 1999, PHYSICOCHEMICAL PHAR; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Hossain MA, 2009, BIOCONJUGATE CHEM, V20, P1390, DOI 10.1021/bc900181a; Johnson ECB, 2007, TETRAHEDRON LETT, V48, P1795, DOI 10.1016/j.tetlet.2007.01.030; Leipold E, 2005, FEBS LETT, V579, P3881, DOI 10.1016/j.febslet.2005.05.077; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Park Y, 2011, NAT PROD COMMUN, V6, P1403; Peigneur S, 2012, FASEB J, V26, P5141, DOI 10.1096/fj.12-218479; Puillandre N, 2012, J MOL EVOL, V74, P297, DOI 10.1007/s00239-012-9507-2; Sampson WR, 1999, J PEPT SCI, V5, P403, DOI 10.1002/(SICI)1099-1387(199909)5:9<403::AID-PSC213>3.0.CO;2-S; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SHON KJ, 1995, BIOCHEMISTRY-US, V34, P4913, DOI 10.1021/bi00015a002; SHON KJ, 1994, BIOCHEMISTRY-US, V33, P11420, DOI 10.1021/bi00204a003; Smith JJ, 2013, CELL MOL LIFE SCI, V70, P3665, DOI 10.1007/s00018-013-1315-3; Teichert RW, 2010, FUTURE MED CHEM, V2, P731, DOI 10.4155/FMC.10.31; Theile JW, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00054; Tripet B, 2007, J CHROMATOGR A, V1141, P212, DOI 10.1016/j.chroma.2006.12.024; Vetter I, 2012, CURR TOP MED CHEM, V12, P1546, DOI 10.2174/156802612802652457; Volpon L, 2004, J BIOL CHEM, V279, P21356, DOI 10.1074/jbc.M309594200	30	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35341	35350		10.1074/jbc.M114.610436	http://dx.doi.org/10.1074/jbc.M114.610436			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25352593	Green Published, hybrid			2022-12-28	WOS:000346660200025
J	Liu, C; Yang, Y; Chen, L; Lin, YL; Li, F				Liu, Chang; Yang, Yang; Chen, Lang; Lin, Yi-Lun; Li, Fang			A Unified Mechanism for Aminopeptidase N-based Tumor Cell Motility and Tumor-homing Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cancer Therapy; Cell Motility; Crystallography; Extracellular Matrix Protein; Tumor Marker; Tumor Metastases	RECEPTOR-BINDING DOMAIN; ADVANCED SOLID TUMORS; CRYSTAL-STRUCTURE; INTEGRIN ALPHA-V-BETA-3; EXTRACELLULAR SEGMENT; CD13/AMINOPEPTIDASE N; SEMINAL PLASMA; DRUG-DELIVERY; CD13; CANCER	Background: Aminopeptidase N (APN) mediates tumor cell motility and is a receptor for tumor-homing peptides containing NGR motifs. Results: Using crystallographic and biochemical methods, we investigated how APN interacts with NGR motifs in tumor-homing peptides and extracellular matrix proteins. Conclusion: APN forms specific and stable interactions with these NGR motifs, accounting for APN's functions. Significance: This study facilitates development of APN-targeting cancer therapies. Tumor cell surface aminopeptidase N (APN or CD13) has two puzzling functions unrelated to its enzymatic activity: mediating tumor cell motility and serving as a receptor for tumor-homing peptides (peptides that bring anti-cancer drugs to tumor cells). To investigate APN-based tumor-homing therapy, we determined the crystal structure of APN complexed with a tumor-homing peptide containing a representative Asn-Gly-Arg (NGR) motif. The tumor-homing peptide binds to the APN enzymatic active site, but it resists APN degradation due to a distorted scissile peptide bond. To explore APN-based tumor cell motility, we examined the interactions between APN and extracellular matrix (ECM) proteins. APN binds to, but does not degrade, NGR motifs in ECM proteins that share similar conformations with the NGR motif in the APN-bound tumor-homing peptide. Therefore, APN-based tumor cell motility and tumor-homing therapy rely on a unified mechanism in which both functions are driven by the specific and stable interactions between APN and the NGR motifs in ECM proteins and tumor-homing peptides. This study further implicates APN as an integrin-like molecule that functions broadly in cell motility and adhesion by interacting with its signature NGR motifs in the extracellular environment.	[Liu, Chang; Yang, Yang; Chen, Lang; Lin, Yi-Lun; Li, Fang] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Li, F (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, 6-121 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	lifang@umn.edu	Yang, Yang/R-7215-2016	Yang, Yang/0000-0001-9061-3828				Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; Bauvois B, 2004, ONCOGENE, V23, P317, DOI 10.1038/sj.onc.1207124; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUITRAGO JMG, 1985, ANDROLOGIA, V17, P139; Carl-McGrath S, 2006, HISTOL HISTOPATHOL, V21, P1339, DOI 10.14670/HH-21.1339; Carlsson L, 2006, INT J ANDROL, V29, P331, DOI 10.1111/j.1365-2605.2005.00601.x; Chang YW, 2005, INT J CANCER, V116, P243, DOI 10.1002/ijc.21089; Chen L, 2012, P NATL ACAD SCI USA, V109, P17966, DOI 10.1073/pnas.1210123109; Chen YL, 2009, CANCER RES, V69, P3713, DOI 10.1158/0008-5472.CAN-08-2515; Curnis F, 2000, NAT BIOTECHNOL, V18, P1185, DOI 10.1038/81183; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Di Matteo P, 2006, MOL IMMUNOL, V43, P1509, DOI 10.1016/j.molimm.2005.10.009; Du LY, 2014, J VIROL, V88, P7045, DOI 10.1128/JVI.00433-14; Eskens FALM, 2003, EUR J CANCER, V39, P917, DOI 10.1016/S0959-8049(03)00057-1; FUJII H, 1995, CLIN EXP METASTAS, V13, P337; Fukasawa K, 2006, CANCER LETT, V243, P135, DOI 10.1016/j.canlet.2005.11.051; Gregorc V, 2009, BRIT J CANCER, V101, P219, DOI 10.1038/sj.bjc.6605162; Gregorc V, 2010, J CLIN ONCOL, V28, P2604, DOI 10.1200/JCO.2009.27.3649; Gregorc V, 2010, EUR J CANCER, V46, P198, DOI 10.1016/j.ejca.2009.10.005; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hashida H, 2002, GASTROENTEROLOGY, V122, P376, DOI 10.1053/gast.2002.31095; Irazusta J, 2004, J ANDROL, V25, P733; Kehlen A, 2003, CANCER RES, V63, P8500; MENRAD A, 1993, CANCER RES, V53, P1450; Mina-Osorio P, 2008, TRENDS MOL MED, V14, P361, DOI 10.1016/j.molmed.2008.06.003; Mina-Osorio P, 2008, J LEUKOCYTE BIOL, V84, P448, DOI 10.1189/jlb.1107802; Mina-Osorio P, 2006, J LEUKOCYTE BIOL, V79, P719, DOI 10.1189/jlb.0705425; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasqualini R, 2000, CANCER RES, V60, P722; Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108; Petrovic N, 2007, BLOOD, V110, P142, DOI 10.1182/blood-2006-02-002931; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; SAIKI I, 1993, INT J CANCER, V54, P137, DOI 10.1002/ijc.2910540122; Shimizu T, 2002, ARTHRITIS RHEUM-US, V46, P2330, DOI 10.1002/art.10517; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Svensen N, 2012, TRENDS PHARMACOL SCI, V33, P186, DOI 10.1016/j.tips.2012.02.002; Tani K, 2000, AM J RESP CRIT CARE, V161, P1636, DOI 10.1164/ajrccm.161.5.9902008; Wickstrom M, 2011, CANCER SCI, V102, P501, DOI 10.1111/j.1349-7006.2010.01826.x; WILLIAMS MJ, 1994, J MOL BIOL, V235, P1302, DOI 10.1006/jmbi.1994.1083; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang Y, 2013, J BIOL CHEM, V288, P25638, DOI 10.1074/jbc.M113.494955	45	32	33	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34520	34529		10.1074/jbc.M114.566802	http://dx.doi.org/10.1074/jbc.M114.566802			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25359769	Green Published, hybrid			2022-12-28	WOS:000346260800012
J	Weber, S; Stirnimann, CU; Wieser, M; Frey, D; Meier, R; Engelhardt, S; Li, XD; Capitani, G; Kammerer, RA; Hilbi, H				Weber, Stephen; Stirnimann, Christian U.; Wieser, Mara; Frey, Daniel; Meier, Roger; Engelhardt, Sabrina; Li, Xiaodan; Capitani, Guido; Kammerer, Richard A.; Hilbi, Hubert			A Type IV Translocated Legionella Cysteine Phytase Counteracts Intracellular Growth Restriction by Phytate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Dictyostelium; Host-Pathogen Interaction; Phosphatidylinositol Phosphatase; Phosphoinositide; Legionella; Bacterial Effector Protein; myo-Inositol Hexakisphosphate; Pathogen Vacuole; Phytate	PHOSPHATIDYLINOSITOL 4-PHOSPHATE; MYOINOSITOL HEXAKISPHOSPHATE; PHYTIC ACID; PNEUMOPHILA; PROTEIN; IDENTIFICATION; VIRULENCE; RESISTANCE; TRAFFICKING; VALIDATION	Background:Legionella governs pathogen-host interactions by translocating approximate to 300 effector proteins through a type IV secretion system. Results: The hitherto unrecognized effector LppA is a phytase that counteracts intracellular bacterial growth restriction by phytate. Conclusion: The chelator phytate is a bacteriostatic component of cell-autonomous immunity, which is degraded by a bacterial effector. Significance:Legionella LppA represents the first translocated phytase and a potential therapeutic target. The causative agent of Legionnaires' pneumonia, Legionella pneumophila, colonizes diverse environmental niches, including biofilms, plant material, and protozoa. In these habitats, myo-inositol hexakisphosphate (phytate) is prevalent and used as a phosphate storage compound or as a siderophore. L. pneumophila replicates in protozoa and mammalian phagocytes within a unique Legionella-containing vacuole. The bacteria govern host cell interactions through the Icm/Dot type IV secretion system (T4SS) and approximate to 300 different effector proteins. Here we characterize a hitherto unrecognized Icm/Dot substrate, LppA, as a phytate phosphatase (phytase). Phytase activity of recombinant LppA required catalytically essential cysteine (Cys(231)) and arginine (Arg(237)) residues. The structure of LppA at 1.4 resolution revealed a mainly -helical globular protein stabilized by four antiparallel -sheets that binds two phosphate moieties. The phosphates localize to a P-loop active site characteristic of dual specificity phosphatases or to a non-catalytic site, respectively. Phytate reversibly abolished growth of L. pneumophila in broth, and growth inhibition was relieved by overproduction of LppA or by metal ion titration. L. pneumophila lacking lppA replicated less efficiently in phytate-loaded Acanthamoeba castellanii or Dictyostelium discoideum, and the intracellular growth defect was complemented by the phytase gene. These findings identify the chelator phytate as an intracellular bacteriostatic component of cell-autonomous host immunity and reveal a T4SS-translocated L. pneumophila phytase that counteracts intracellular bacterial growth restriction by phytate. Thus, bacterial phytases might represent therapeutic targets to combat intracellular pathogens.	[Weber, Stephen; Hilbi, Hubert] Univ Munich, Dept Med, Max von Pettenkofer Inst, D-80336 Munich, Germany; [Stirnimann, Christian U.; Wieser, Mara; Frey, Daniel; Li, Xiaodan; Capitani, Guido; Kammerer, Richard A.] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Meier, Roger] ETH, Sci Ctr Opt & Electron Microscopy, CH-8093 Zurich, Switzerland; [Engelhardt, Sabrina] Univ Zurich, Inst Vet Physiol, CH-8057 Zurich, Switzerland; [Engelhardt, Sabrina] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Vetsuisse Fac, CH-8057 Zurich, Switzerland; [Hilbi, Hubert] Univ Zurich, Inst Med Microbiol, Dept Med, CH-8006 Zurich, Switzerland	University of Munich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich	Hilbi, H (corresponding author), Univ Zurich, Inst Med Microbiol, Dept Med, CH-8006 Zurich, Switzerland.	hilbi@imm.uzh.ch	Hilbi, Hubert/AAU-5815-2020	Hilbi, Hubert/0000-0002-5462-9301; Fischer, Sabrina/0000-0002-7262-8652; Stirnimann, Christian/0000-0002-1030-8864; Kammerer, Richard/0000-0003-4570-5197; li, xiaodan/0000-0001-8647-7317	Paul Scherrer Institute; Swiss National Science Foundation (SNF); Max von Pettenkofer Institute, Ludwig-Maximilians University Munich; German Research Foundation (Deutsche Forschungsgemeinschaft) [HI 1511/1-1, SPP 1316, SPP 1580]; German Ministry of Education and Research (BMBF) in the context of the Infect-ERA initiative (project EUGENPATH)	Paul Scherrer Institute; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Max von Pettenkofer Institute, Ludwig-Maximilians University Munich; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF) in the context of the Infect-ERA initiative (project EUGENPATH)(Federal Ministry of Education & Research (BMBF))	Supported by the Paul Scherrer Institute and grants from the Swiss National Science Foundation (SNF).; Work in this author's group was supported by the Max von Pettenkofer Institute, Ludwig-Maximilians University Munich, the German Research Foundation (Deutsche Forschungsgemeinschaft Grants HI 1511/1-1, SPP 1316, and SPP 1580), and the German Ministry of Education and Research (BMBF) in the context of the Infect-ERA initiative (project EUGENPATH). To whom correspondence should be addressed: Institute of Medical Microbiology, Dept. of Medicine, University of Zurich, 8006 Zurich, Switzerland. Tel.: 41-44-634-2650; Fax: 41-44-634-4906; E-mail: hilbi@imm.uzh.ch.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beresford N, 2007, BIOCHEM J, V406, P13, DOI 10.1042/BJ20070670; Bozzaro S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00050; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Chatterjee S, 2003, MOL PLANT MICROBE IN, V16, P973, DOI 10.1094/MPMI.2003.16.11.973; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Chu HM, 2004, STRUCTURE, V12, P2015, DOI 10.1016/j.str.2004.08.010; Cianciotto NP, 2007, BIOMETALS, V20, P323, DOI 10.1007/s10534-006-9057-4; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dolinsky S, 2014, INFECT IMMUN, V82, P4021, DOI 10.1128/IAI.01685-14; Duarte JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-334; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finsel I, 2013, CELL HOST MICROBE, V14, P38, DOI 10.1016/j.chom.2013.06.001; Grundner C, 2005, STRUCTURE, V13, P1625, DOI 10.1016/j.str.2005.07.017; Ham H, 2011, NAT REV MICROBIOL, V9, P635, DOI 10.1038/nrmicro2602; Haneburger I, 2014, CURR TOP MICROBIOL, V376, P155, DOI 10.1007/82_2013_341; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; Hilbi H., 2014, SMALL GTPAS IN PRESS; Hilbi H, 2012, TRAFFIC, V13, P1187, DOI 10.1111/j.1600-0854.2012.01344.x; Hilbi H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00091; Hilbi H, 2011, ENV MICROBIOL REP, V3, P286, DOI 10.1111/j.1758-2229.2011.00247.x; Hirst PH, 1999, J APPL MICROBIOL, V86, P537, DOI 10.1046/j.1365-2672.1999.00697.x; Hoffmann C, 2014, CELL MICROBIOL, V16, P1034, DOI 10.1111/cmi.12256; Hoffmann C, 2014, CELL MICROBIOL, V16, P15, DOI 10.1111/cmi.12235; Hsu FS, 2012, P NATL ACAD SCI USA, V109, P13567, DOI 10.1073/pnas.1207903109; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Itzen A, 2011, CELL HOST MICROBE, V10, P89, DOI 10.1016/j.chom.2011.08.002; Jank T, 2012, CELL MICROBIOL, V14, P852, DOI 10.1111/j.1462-5822.2012.01761.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kessler A, 2013, ENVIRON MICROBIOL, V15, P646, DOI 10.1111/j.1462-2920.2012.02889.x; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Lim BL, 2007, ISME J, V1, P321, DOI 10.1038/ismej.2007.40; Mampel J, 2006, APPL ENVIRON MICROB, V72, P2885, DOI 10.1128/AEM.72.4.2885-2895.2006; MARTIN JB, 1987, BIOCHIM BIOPHYS ACTA, V931, P16, DOI 10.1016/0167-4889(87)90045-0; Mullaney EJ, 2003, BIOCHEM BIOPH RES CO, V312, P179, DOI 10.1016/j.bbrc.2003.09.176; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Peracino B, 2013, J CELL SCI, V126, P301, DOI 10.1242/jcs.116210; Peracino B, 2010, J CELL SCI, V123, P4039, DOI 10.1242/jcs.072124; Pisani F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085533; Puhl AA, 2007, PROTEIN SCI, V16, P1368, DOI 10.1110/ps.062738307; Ragaz C, 2008, CELL MICROBIOL, V10, P2416, DOI 10.1111/j.1462-5822.2008.01219.x; Rao DECS, 2009, CRIT REV BIOTECHNOL, V29, P182, DOI 10.1080/07388550902919571; REEVES MW, 1981, J CLIN MICROBIOL, V13, P688, DOI 10.1128/JCM.13.4.688-695.1981; Rothmeier E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003598; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361, DOI 10.1128/IAI.61.12.5361-5373.1993; Schoebel S, 2010, EMBO REP, V11, P598, DOI 10.1038/embor.2010.97; Segal G, 1998, MOL MICROBIOL, V30, P197, DOI 10.1046/j.1365-2958.1998.01054.x; Sherwood RK, 2013, CELL HOST MICROBE, V14, P256, DOI 10.1016/j.chom.2013.08.010; Simon S, 2014, CELL MICROBIOL, V16, P977, DOI 10.1111/cmi.12258; SMITH AW, 1994, J BACTERIOL, V176, P3455, DOI 10.1128/JB.176.12.3455-3459.1994; STEPHENS LR, 1990, NATURE, V346, P580, DOI 10.1038/346580a0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tiaden A, 2007, CELL MICROBIOL, V9, P2903, DOI 10.1111/j.1462-5822.2007.01005.x; Toulabi L, 2013, J BIOL CHEM, V288, P24518, DOI 10.1074/jbc.M113.474239; Turner BL, 2002, PHILOS T ROY SOC B, V357, P449, DOI 10.1098/rstb.2001.0837; Urbano G, 2000, J PHYSIOL BIOCHEM, V56, P283, DOI 10.1007/BF03179796; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Weber SS, 2009, CELL MICROBIOL, V11, P442, DOI 10.1111/j.1462-5822.2008.01266.x; Weber S, 2014, MBIO, V5, DOI 10.1128/mBio.00839-13; Whiley H, 2011, EMERG INFECT DIS, V17, P579, DOI 10.3201/eid1704.100446; WIATER LA, 1994, MOL MICROBIOL, V11, P641; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	66	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34175	34188		10.1074/jbc.M114.592568	http://dx.doi.org/10.1074/jbc.M114.592568			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25339170	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000346077600041
J	Madeo, M; Kovacs, AD; Pearce, DA				Madeo, Marianna; Kovacs, Attila D.; Pearce, David A.			The Human Synaptic Vesicle Protein, SV2A, Functions as a Galactose Transporter in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; LEVETIRACETAM; FUCOSE; SYNAPTOTAGMIN; RAT; GLYCOSYLATION; SUPPRESSES; CHICKS	SV2A is a synaptic vesicle membrane protein expressed in neurons and endocrine cells and involved in the regulation of neurotransmitter release. Although the exact function of SV2A still remains elusive, it was identified as the specific binding site for levetiracetam, a second generation antiepileptic drug. Our sequence analysis demonstrates that SV2A has significant homology with several yeast transport proteins belonging to the major facilitator superfamily (MFS). Many of these transporters are involved in sugar transport into yeast cells. Here we present evidence showing, for the first time, that SV2A is a galactose transporter. We expressed human SV2A in hexose transport-deficient EBY. VW4000 yeast cells and demonstrated that these cells are able to grow on galactose-containing medium but not on other fermentable carbon sources. Furthermore, the addition of the SV2A-binding antiepileptic drug levetiracetam to the medium inhibited the galactose-dependent growth of hexose transport-deficient EBY. VW4000 yeast cells expressing human SV2A. Most importantly, direct measurement of galactose uptake in the same strain verified that SV2A is able to transport extracellular galactose inside the cells. The newly identified galactose transport capability of SV2A may have an important role in regulating/modulating synaptic function.	[Madeo, Marianna; Kovacs, Attila D.; Pearce, David A.] Sanford Res, Sanford Childrens Hlth Res Ctr, Sioux Falls, SD 57014 USA; [Pearce, David A.] Univ S Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57104 USA	Sanford Health; University of South Dakota	Pearce, DA (corresponding author), Sanford Childrens Hlth Res Ctr, 2301 E 60th St N, Sioux Falls, SD 57014 USA.	David.Pearce@sanfordhealth.org			National Institutes of Health [P20 GM103620, NS36610]; Sanford Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanford Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 GM103620 and NS36610 (to D. A. P.). This work was also supported by Sanford Health.	Badawy RAB, 2009, J CLIN NEUROSCI, V16, P355, DOI 10.1016/j.jocn.2008.08.026; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; Bordji K, 2011, REV NEUROSCIENCE, V22, P285, DOI 10.1515/RNS.2011.029; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Chattopadhyay S, 2002, EUKARYOT CELL, V1, P606, DOI 10.1128/EC.1.4.606-612.2002; Crevecoeur J, 2014, NEUROPATH APPL NEURO, V40, P191, DOI 10.1111/nan.12054; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Kochubey O, 2011, TRENDS NEUROSCI, V34, P237, DOI 10.1016/j.tins.2011.02.006; KRUG M, 1994, BRAIN RES, V643, P130, DOI 10.1016/0006-8993(94)90018-3; KRUG M, 1991, BRAIN RES, V540, P237, DOI 10.1016/0006-8993(91)90513-U; Kwon SE, 2012, J BIOL CHEM, V287, P35658, DOI 10.1074/jbc.M112.398883; Lorenzini CGA, 1997, NEUROBIOL LEARN MEM, V68, P317, DOI 10.1006/nlme.1997.3798; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Matthies H, 1996, BRAIN RES, V725, P276, DOI 10.1016/0006-8993(96)00406-4; Meehan AL, 2011, J NEUROPHYSIOL, V106, P1227, DOI 10.1152/jn.00279.2011; Murrey HE, 2006, P NATL ACAD SCI USA, V103, P21, DOI 10.1073/pnas.0503381102; Palacios G, 2002, J CLIN MICROBIOL, V40, P182, DOI 10.1128/JCM.40.1.182-192.2002; POHLE W, 1987, BRAIN RES, V410, P245, DOI 10.1016/0006-8993(87)90321-0; ROSE SPR, 1987, BEHAV NEURAL BIOL, V48, P246, DOI 10.1016/S0163-1047(87)90808-9; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Tiunova AA, 1998, LEARN MEMORY, V4, P401, DOI 10.1101/lm.4.5.401; Torre ER, 1996, J NEUROSCI, V16, P5967; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Yang XF, 2007, EPILEPSIA, V48, P1861, DOI 10.1111/j.1528-1167.2006.01132.x; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010	27	28	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33066	33071		10.1074/jbc.C114.584516	http://dx.doi.org/10.1074/jbc.C114.584516			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25326386	Green Published, hybrid			2022-12-28	WOS:000345636600001
J	Rigat, KL; Lu, H; Wang, YK; Argyrou, A; Fanslau, C; Beno, B; Wang, Y; Marcinkeviciene, J; Ding, M; Gentles, RG; Gao, M; Abell, LM; Roberts, SB				Rigat, Karen L.; Lu, Hao; Wang, Ying-Kai; Argyrou, Argyrides; Fanslau, Caroline; Beno, Brett; Wang, Yi; Marcinkeviciene, Jovita; Ding, Min; Gentles, Robert G.; Gao, Min; Abell, Lynn M.; Roberts, Susan B.			Mechanism of Inhibition for BMS-791325, a Novel Non-nucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; GENOTYPE 1 INFECTION; TARGET RESIDENCE TIME; DE-NOVO INITIATION; CRYSTAL-STRUCTURE; UNITED-STATES; PRECLINICAL CHARACTERIZATION; ALLOSTERIC INHIBITOR; ANTIVIRAL ACTIVITY; BI 207127	HCV infection is an urgent global health problem that has triggered a drive to discover therapies that specifically target the virus. BMS-791325 is a novel direct antiviral agent specifically targeting HCV NS5B, an RNA-dependent RNA polymerase. Robust viral clearance of HCV was observed in infected patients treated with BMS-791325 in combination with other anti-HCV agents in Phase 2 clinical studies. Biochemical and biophysical studies revealed that BMS-791325 is a time-dependent, noncompetitive inhibitor of the polymerase. Binding studies with NS5B genetic variants (WT, L30S, and P495L) exposed a two-step, slow binding mechanism, but details of the binding mechanism differed for each of the polymerase variants. For the clinically relevant resistance variant (P495L), the rate of initial complex formation and dissociation is similar to WT, but the kinetics of the second step is significantly faster, showing that this variant impacts the final tight complex. The resulting shortened residence time translates into the observed decrease in inhibitor potency. The L30S variant has a significantly different profile. The rate of initial complex formation and dissociation is 7-10 times faster for the L30S variant compared with WT; however, the forward and reverse rates to form the final complex are not significantly different. The impact of the L30S variant on the inhibition profile and binding kinetics of BMS-791325 provides experimental evidence for the dynamic interaction of fingers and thumb domains in an environment that supports the formation of active replication complexes and the initiation of RNA synthesis.	[Rigat, Karen L.; Wang, Ying-Kai; Wang, Yi; Gao, Min; Roberts, Susan B.] Bristol Myers Squibb Co, Dept Virol, Wallingford, CT 06492 USA; [Beno, Brett] Bristol Myers Squibb Co, Dept Comp Assisted Drug Design, Wallingford, CT 06492 USA; [Ding, Min; Gentles, Robert G.] Bristol Myers Squibb Co, Dept Early Discovery Chem, Res & Dev, Wallingford, CT 06492 USA; [Lu, Hao; Argyrou, Argyrides; Fanslau, Caroline; Marcinkeviciene, Jovita; Abell, Lynn M.] Bristol Myers Squibb Co, Dept Mechanist Biochem, Res & Dev, Pennington, NJ 08534 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Roberts, SB (corresponding author), Bristol Myers Squibb Co, Dept Virol, 5 Res Pkwy, Wallingford, CT 06492 USA.	susan.roberts@bms.com	Argyrou, Argyrides/AAC-4156-2020	Argyrou, Argyrides/0000-0003-3141-9122				Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Averhoff FM, 2012, CLIN INFECT DIS, V55, pS10, DOI 10.1093/cid/cis361; Bambara RA, 1995, METHOD ENZYMOL, V262, P270; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Brainard DM, 2009, HEPATOLOGY, V50, p1026A; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Chinnaswamy S, 2010, VIRUS ADAPT TREAT, V2, P21; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Copeland RA, 2010, EXPERT OPIN DRUG DIS, V5, P305, DOI 10.1517/17460441003677725; Dahl G, 2013, DRUG DISCOV TODAY, V18, P697, DOI 10.1016/j.drudis.2013.02.010; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Devogelaere B, 2012, ANTIMICROB AGENTS CH, V56, P4676, DOI 10.1128/AAC.00245-12; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Ditah I, 2014, J HEPATOL, V60, P691, DOI 10.1016/j.jhep.2013.11.014; El-Serag HB, 2007, HEPATOL RES, V37, pS88, DOI 10.1111/j.1872-034X.2007.00168.x; Erhardt A, 2009, ANTIVIR THER, V14, P23; Everson GT, 2014, GASTROENTEROLOGY, V146, P420, DOI 10.1053/j.gastro.2013.10.057; Gentles RG, 2014, J MED CHEM, V57, P1855, DOI 10.1021/jm4016894; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Karam P, 2014, J BIOL CHEM, V289, P14399, DOI 10.1074/jbc.M113.529743; Labonte P, 2002, J BIOL CHEM, V277, P38838, DOI 10.1074/jbc.M204657200; LaPlante SR, 2010, J AM CHEM SOC, V132, P15204, DOI 10.1021/ja101358s; Larrey D, 2013, ANTIMICROB AGENTS CH, V57, P4727, DOI 10.1128/AAC.00565-13; Larrey D, 2012, J HEPATOL, V57, P39, DOI 10.1016/j.jhep.2012.02.015; Lemm JA, 2014, ANTIMICROB AGENTS CH, V58, P3485, DOI 10.1128/AAC.02495-13; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; McKercher G, 2004, NUCLEIC ACIDS RES, V32, P422, DOI 10.1093/nar/gkh160; Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200; Miyata Y, 2013, ACS CHEM NEUROSCI, V4, P930, DOI 10.1021/cn300210g; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Narjes F, 2011, J MED CHEM, V54, P289, DOI 10.1021/jm1013105; National Institutes of Health, 2012, PHAS 3 STUD BI 20712; National Institutes of Health, 2012, STUD EV SAF TOL EFF; Ranjith-Kumar CT, 2006, RNA, V12, P303, DOI 10.1261/rna.2163106; Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002; Rigat K, 2010, ANTIVIR RES, V88, P197, DOI 10.1016/j.antiviral.2010.08.014; Rothwell PJ, 2007, J BIOL CHEM, V282, P28884, DOI 10.1074/jbc.M704824200; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Schmitt HM, 1997, BIOSENS BIOELECTRON, V12, P809, DOI 10.1016/S0956-5663(97)00046-8; Sims KD, 2014, ANTIMICROB AGENTS CH, V58, P3496, DOI 10.1128/AAC.02579-13; Sofia MJ, 2012, J MED CHEM, V55, P2481, DOI 10.1021/jm201384j; Tatum H., 2013, J HEPATOL S1, V58, pS182; Tomei L, 2003, J VIROL, V77, P13225, DOI 10.1128/JVI.77.24.13225-13231.2003; Vendeville S, 2012, BIOORG MED CHEM LETT, V22, P4437, DOI 10.1016/j.bmcl.2012.04.113; Wang YK, 2008, ARCH BIOCHEM BIOPHYS, V470, P146, DOI 10.1016/j.abb.2007.11.012; Wang YK, 2006, ANAL BIOCHEM, V359, P106, DOI 10.1016/j.ab.2006.09.013; Ward JW, 2012, GASTROENTEROLOGY, V143, P887, DOI 10.1053/j.gastro.2012.08.027; World Health Organization, 2012, PREV CONTR VIR HEP I; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557; Zheng XF, 2011, BIOORG MED CHEM LETT, V21, P2925, DOI 10.1016/j.bmcl.2011.03.067; Zhong WD, 2000, J VIROL, V74, P9134, DOI 10.1128/JVI.74.19.9134-9143.2000	54	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33456	33468		10.1074/jbc.M114.613653	http://dx.doi.org/10.1074/jbc.M114.613653			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25301950	hybrid, Green Published			2022-12-28	WOS:000345636600034
J	Stewart, MD; Ramani, VC; Sanderson, RD				Stewart, Mark D.; Ramani, Vishnu C.; Sanderson, Ralph D.			Shed Syndecan-1 Translocates to the Nucleus of Cells Delivering Growth Factors and Inhibiting Histone Acetylation A NOVEL MECHANISM OF TUMOR-HOST CROSS-TALK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; MULTIPLE-MYELOMA; I COLLAGEN; SOLUBLE SYNDECAN-1; BONE-MARROW; EXPRESSION; ACETYLTRANSFERASE; ADHESION; GLYCOSAMINOGLYCANS; TRANSCRIPTION	The heparan sulfate proteoglycan syndecan-1 is proteolytically shed from the surface of multiple myeloma cells and is abundant in the bone marrow microenvironment where it promotes tumor growth, angiogenesis, and metastasis. In this study, we demonstrate for the first time that shed syndecan-1 present in the medium conditioned by tumor cells is taken up by bone marrow-derived stromal cells and transported to the nucleus. Translocation of shed syndecan-1 (sSDC1) to the nucleus was blocked by addition of exogenous heparin or heparan sulfate, pretreatment of conditioned medium with heparinase III, or growth of cells in sodium chlorate, indicating that sulfated heparan sulfate chains are required for nuclear translocation. Interestingly, cargo bound to sSDC1 heparan sulfate chains (i.e. hepatocyte growth factor) was transported to the nucleus along with sSDC1, and removal of heparan sulfate-bound cargo from sSDC1 abolished its translocation to the nucleus. Once in the nucleus, sSDC1 binds to the histone acetyltransferase enzyme p300, and histone acetyltransferase activity and histone acetylation are diminished. These findings reveal a novel function for shed syndecan-1 in mediating tumor-host cross-talk by shuttling growth factors to the nucleus and by altering histone acetylation in host cells. In addition, this work has broad implications beyond myeloma because shed syndecan-1 is present in high levels in many tumor types as well as in other disease states.	[Stewart, Mark D.; Ramani, Vishnu C.; Sanderson, Ralph D.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Sanderson, Ralph D.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sanderson, RD (corresponding author), Univ Alabama Birmingham, Dept Pathol, WTI 602B,1720 2nd Ave S, Birmingham, AL 35294 USA.	sanderson@uab.edu			UAB Comprehensive Cancer Center Core Support Grant from the National Institutes of Health [CA13148]; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA138340, F31CA176955, R01CA135075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	UAB Comprehensive Cancer Center Core Support Grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the UAB High Resolution Imaging Shared Facility supported by the UAB Comprehensive Cancer Center Core Support Grant CA13148 from the National Institutes of Health.	AMALRIC F, 1994, BIOCHEM PHARMACOL, V47, P111, DOI 10.1016/0006-2952(94)90443-X; Bailly K, 2000, FASEB J, V14, P333, DOI 10.1096/fasebj.14.2.333; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Borset M, 2000, BLOOD, V96, P2528; Borset M, 1996, BLOOD, V88, P3998, DOI 10.1182/blood.V88.10.3998.bloodjournal88103998; Buczek-Thomas JA, 2008, J CELL BIOCHEM, V105, P108, DOI 10.1002/jcb.21803; BUSCH SJ, 1992, J CELL BIOL, V116, P31, DOI 10.1083/jcb.116.1.31; Chen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004947; Dhodapkar MV, 1997, BRIT J HAEMATOL, V99, P368, DOI 10.1046/j.1365-2141.1997.3893203.x; Dudas J, 2000, BIOCHEM J, V350, P245, DOI 10.1042/0264-6021:3500245; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; FEDARKO NS, 1989, J CELL PHYSIOL, V139, P287, DOI 10.1002/jcp.1041390210; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Hsia E, 2003, J CELL BIOCHEM, V88, P1214, DOI 10.1002/jcb.10470; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; Li WL, 2000, J CELL SCI, V113, P1525; LIEBERSBACH BF, 1994, J BIOL CHEM, V269, P20013; LOIDL P, 1994, CHROMOSOMA, V103, P441; Nakamura T, 2002, BIOL PHARM BULL, V25, P356, DOI 10.1248/bpb.25.356; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Purushothaman A, 2011, J BIOL CHEM, V286, P30377, DOI 10.1074/jbc.M111.254789; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Raman K, 2013, MOL PHARMACEUT, V10, P1442, DOI 10.1021/mp300679a; Ramani VC, 2014, MATRIX BIOL, V35, P215, DOI 10.1016/j.matbio.2013.10.005; Ramani VC, 2012, J BIOL CHEM, V287, P9952, DOI 10.1074/jbc.M111.330803; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Reiland J, 2004, J BIOL CHEM, V279, P8047, DOI 10.1074/jbc.M304872200; Richardson PG, 2013, LEUKEMIA RES, V37, P829, DOI 10.1016/j.leukres.2013.03.006; RIDLEY RC, 1993, BLOOD, V81, P767; SANDERSON RD, 1992, J IMMUNOL, V148, P3902; Seidel C, 2000, BLOOD, V96, P3139, DOI 10.1182/blood.V96.9.3139.h8003139_3139_3146; Stewart MD, 2014, MATRIX BIOL, V35, P56, DOI 10.1016/j.matbio.2013.10.009; Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001; TURNER BM, 1995, SEMIN CELL BIOL, V6, P229, DOI 10.1006/scel.1995.0031; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745; Zhang HG, 2014, AM J PATHOL, V184, P28, DOI 10.1016/j.ajpath.2013.09.027; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	42	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					941	949		10.1074/jbc.M114.608455	http://dx.doi.org/10.1074/jbc.M114.608455			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25404732	hybrid, Green Published			2022-12-28	WOS:000347778200028
J	Takei, N; Sobu, Y; Kimura, A; Urano, S; Piao, Y; Araki, Y; Taru, H; Yamamoto, T; Hata, S; Nakaya, T; Suzuki, T				Takei, Norio; Sobu, Yuriko; Kimura, Ayano; Urano, Satomi; Piao, Yi; Araki, Yoichi; Taru, Hidenori; Yamamoto, Tohru; Hata, Saori; Nakaya, Tadashi; Suzuki, Toshiharu			Cytoplasmic Fragment of Alcadein alpha Generated by Regulated Intramembrane Proteolysis Enhances Amyloid beta-Protein Precursor (APP) Transport into the Late Secretory Pathway and Facilitates APP Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE65-DEPENDENT GENE TRANSACTIVATION; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; MEMBRANE-PROTEINS; ENDOCYTIC PATHWAY; TRANSGENIC MICE; PDZ DOMAINS; MOUSE-BRAIN; PHOSPHORYLATION; X11-ALPHA	The neural type I membrane protein Alcadein alpha (Alc alpha), is primarily cleaved by amyloid beta-protein precursor (APP) alpha-secretase to generate a membrane-associated carboxyl-terminal fragment (Alc alpha CTF), which is further cleaved by gamma-secretase to secrete p3-Alc alpha peptides and generate an intracellular cytoplasmic domain fragment (Alc alpha ICD) in the late secretory pathway. By association with the neural adaptor protein X11L (X11-like), Alc alpha and APP form a ternary complex that suppresses the cleavage of both Alc alpha and APP by regulating the transport of these membrane proteins into the late secretory pathway where secretases are active. However, it has not been revealed how Alc alpha and APP are directed from the ternary complex formed largely in the Golgi into the late secretory pathway to reach a nerve terminus. Using a novel transgenic mouse line expressing excess amounts of human Alc alpha CTF (hAlc alpha CTF) in neurons, we found that expression of hAlc alpha CTF induced excess production of hAlc alpha ICD, which facilitated APP transport into the nerve terminus and enhanced APP metabolism, including A beta generation. In vitro cell studies also demonstrated that excess expression of Alc alpha ICD released both APP and Alc alpha from the ternary complex. These results indicate that regulated intramembrane proteolysis of Alc alpha by gamma-secretase regulates APP trafficking and the production of A beta in vivo.	[Takei, Norio; Sobu, Yuriko; Kimura, Ayano; Urano, Satomi; Piao, Yi; Araki, Yoichi; Taru, Hidenori; Hata, Saori; Nakaya, Tadashi; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Yamamoto, Tohru] Kagawa Univ, Fac Med, Dept Mol Neurobiol, Miki, Kagawa 7610793, Japan	Hokkaido University; Kagawa University	Suzuki, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tsuzuki@pharm.hokudai.ac.jp	Suzuki, Toshiharu/B-5342-2013; Hata, Saori/AAP-9634-2020; Yamamoto, Tohru/A-3801-2012	Yamamoto, Tohru/0000-0002-1652-0233; Hata, Saori/0000-0003-4723-5993; Sobu, Yuriko/0000-0003-1178-005X	Ministry of Education, Culture, Sports, Science, and Technology in Japan [26293010, 24790062]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [26293010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 26293010 (to T. S.) and 24790062 (to S. H.) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan and by Bilateral Joint Research Projects (to S. H.) and an Asian Core Program (to T. S.) of the Japan Society for the Promotion of Science.	Almenar-Queralt A, 2014, J NEUROSCI, V34, P3320, DOI 10.1523/JNEUROSCI.1503-13.2014; Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chaufty J, 2012, J NEUROSCI, V32, P9613, DOI 10.1523/JNEUROSCI.0602-12.2012; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Hata S, 2011, ANN NEUROL, V69, P1026, DOI 10.1002/ana.22343; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Ho A, 2008, J NEUROSCI, V28, P14392, DOI 10.1523/JNEUROSCI.2481-08.2008; HOGAN B, 1986, MANIPULATING MOUSE E; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kondo M, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-35; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Konno T, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-76; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Lee JH, 2004, J BIOL CHEM, V279, P49099, DOI 10.1074/jbc.M405602200; Ludwig A, 2009, TRAFFIC, V10, P572, DOI 10.1111/j.1600-0854.2009.00886.x; Matsushima T, 2012, J BIOL CHEM, V287, P19715, DOI 10.1074/jbc.M111.334847; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; Mitchell JC, 2009, HUM MOL GENET, V18, P4492, DOI 10.1093/hmg/ddp408; Morohashi Y, 2013, BBA-BIOMEMBRANES, V1828, P2855, DOI 10.1016/j.bbamem.2013.06.001; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; Piao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062431; Saito Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022108; Saito Y, 2008, J BIOL CHEM, V283, P35763, DOI 10.1074/jbc.M801353200; Saluja I, 2009, NEUROBIOL DIS, V36, P162, DOI 10.1016/j.nbd.2009.07.006; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Tam JHK, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0054-1; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Vogt L, 2001, MOL CELL NEUROSCI, V17, P151, DOI 10.1006/mcne.2000.0937; Xie ZC, 2005, J BIOL CHEM, V280, P15413, DOI 10.1074/jbc.M414353200	41	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					987	995		10.1074/jbc.M114.599852	http://dx.doi.org/10.1074/jbc.M114.599852			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25406318	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000347778200032
J	Wickramaratne, S; Boldry, EJ; Buehler, C; Wang, YC; Distefano, MD; Tretyakova, NY				Wickramaratne, Susith; Boldry, Emily J.; Buehler, Charles; Wang, Yen-Chih; Distefano, Mark D.; Tretyakova, Natalia Y.			Error-prone Translesion Synthesis Past DNA-Peptide Cross-links Conjugated to the Major Groove of DNA via C5 of Thymidine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; POLYMERASE-ETA; REPLICATION BYPASS; MAMMALIAN-CELLS; ALZHEIMERS-DISEASE; UVRABC NUCLEASE; LESION BYPASS; LOW FIDELITY; Y-FAMILY; IN-VITRO	DNA-protein cross-links (DPCs) are exceptionally bulky, structurally diverse DNA adducts formed in cells upon exposure to endogenous and exogenous bis-electrophiles, reactive oxygen species, and ionizing radiation. If not repaired, DPCs can induce toxicity and mutations. It has been proposed that the protein component of a DPC is proteolytically degraded, giving rise to smaller DNA-peptide conjugates, which can be subject to nucleotide excision repair and replication bypass. In this study, polymerase bypass of model DNA-peptide conjugates structurally analogous to the lesions induced by reactive oxygen species and DNA methyltransferase inhibitors was examined. DNA oligomers containing site-specific DNA-peptide conjugates were generated by copper-catalyzed [3 + 2] Huisgen cyclo-addition between an alkyne-functionalized C5-thymidine in DNA and an azide-containing 10-mer peptide. The resulting DNA-peptide conjugates were subjected to steady-state kinetic experiments in the presence of recombinant human lesion bypass polymerases kappa and eta, followed by PAGE-based assays to determine the catalytic efficiency and the misinsertion frequency opposite the lesion. We found that human polymerase kappa and eta can incorporate A, G, C, or T opposite the C5-dT-conjugated DNA-peptide conjugates, whereas human polymerase eta preferentially inserts G opposite the lesion. Furthermore, HPLC-ESI--MS/MS sequencing of the extension products has revealed that post-lesion synthesis was highly error-prone, resulting in mutations opposite the adducted site or at the + 1 position from the adduct and multiple deletions. Collectively, our results indicate that replication bypass of peptides conjugated to the C5 position of thymine by human translesion synthesis polymerases leads to large numbers of base substitution and frame-shift mutations.	[Wickramaratne, Susith; Boldry, Emily J.; Distefano, Mark D.; Tretyakova, Natalia Y.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Wickramaratne, Susith; Boldry, Emily J.; Distefano, Mark D.; Tretyakova, Natalia Y.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Wickramaratne, Susith; Buehler, Charles; Wang, Yen-Chih; Distefano, Mark D.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Tretyakova, NY (corresponding author), Univ Minnesota, Mason Canc Ctr, 2231 6th St SE,2-147 CCRB, Minneapolis, MN 55455 USA.	trety001@umn.edu			National Institutes of Health [CA100670, ES023350]; University of Minnesota Masonic Cancer Center; NATIONAL CANCER INSTITUTE [R01CA100670, P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Masonic Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100670 and ES023350. This work was also supported by a Brainstorm Award from the University of Minnesota Masonic Cancer Center.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Barker S, 2005, ANAL BIOCHEM, V344, P204, DOI 10.1016/j.ab.2005.06.039; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Bau DT, 2002, ENVIRON HEALTH PERSP, V110, P753, DOI 10.1289/ehp.02110s5753; Becherel OJ, 2001, P NATL ACAD SCI USA, V98, P8566, DOI 10.1073/pnas.141113398; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; Charlton TS, 1999, FREE RADICAL BIO MED, V27, P254, DOI 10.1016/S0891-5849(99)00030-1; Cho SH, 2013, CHEM RES TOXICOL, V26, P1005, DOI 10.1021/tx400145e; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Christov PP, 2009, CHEM RES TOXICOL, V22, P1086, DOI 10.1021/tx900047c; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; CordeiroStone M, 1997, J BIOL CHEM, V272, P13945, DOI 10.1074/jbc.272.21.13945; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DeFlora S, 1996, MUTAT RES-REV GENET, V366, P197, DOI 10.1016/S0165-1110(96)00043-7; DIZDAROGLU M, 1989, CANCER RES, V49, P3463; Dizdaroglu M, 2012, FREE RADICAL RES, V46, P382, DOI 10.3109/10715762.2011.653969; Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024; Efrati E, 1997, J BIOL CHEM, V272, P2559; Fersht A., 1999, STRUCTURE MECH PROTE, P103; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Geacintov N. E., 2010, CHEM BIOL DNA DAMAGE, P299; Gherezghiher TB, 2013, J PROTEOME RES, V12, P2151, DOI 10.1021/pr3011974; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hang B, 2003, MUTAT RES-FUND MOL M, V531, P191, DOI 10.1016/j.mrfmmm.2003.07.006; Huang H, 2010, BIOCHEMISTRY-US, V49, P6155, DOI 10.1021/bi100364f; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Klug AR, 2012, CHEM RES TOXICOL, V25, P755, DOI 10.1021/tx300011w; Kotapati S, 2012, J BIOL CHEM, V287, P38800, DOI 10.1074/jbc.M112.396788; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Kurtz AJ, 2003, J BIOL CHEM, V278, P5970, DOI 10.1074/jbc.M212012200; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; Loeber RL, 2009, CHEM RES TOXICOL, V22, P1151, DOI 10.1021/tx900078y; Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Marini F, 2003, J BIOL CHEM, V278, P32014, DOI 10.1074/jbc.M305646200; Martin LJ, 2008, J NEUROPATH EXP NEUR, V67, P377, DOI 10.1097/NEN.0b013e31816ff780; Matsuda T, 2001, J MOL BIOL, V312, P335, DOI 10.1006/jmbi.2001.4937; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Michaelson-Richie ED, 2010, J PROTEOME RES, V9, P4356, DOI 10.1021/pr1000835; Minko IG, 2005, BIOCHEMISTRY-US, V44, P3000, DOI 10.1021/bi0478805; Minko IG, 2002, P NATL ACAD SCI USA, V99, P1905, DOI 10.1073/pnas.042700399; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Morimoto S, 1998, BIOORG MED CHEM LETT, V8, P865, DOI 10.1016/S0960-894X(98)00124-3; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Novakova O, 2003, NUCLEIC ACIDS RES, V31, P6450, DOI 10.1093/nar/gkg863; Ohashi E, 2000, GENE DEV, V14, P1589; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; PERMANA PA, 1994, CARCINOGENESIS, V15, P1031, DOI 10.1093/carcin/15.5.1031; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892; Reardon JT, 2006, P NATL ACAD SCI USA, V103, P4056, DOI 10.1073/pnas.0600538103; Reddy VP, 2009, J ALZHEIMERS DIS, V16, P763, DOI 10.3233/JAD-2009-1013; Sabo A, 2014, COLD SPRING HARB PER, V4; SMITH SS, 1992, P NATL ACAD SCI USA, V89, P4744, DOI 10.1073/pnas.89.10.4744; Stover JS, 2006, CHEM RES TOXICOL, V19, P1506, DOI 10.1021/tx0601455; Tretyakova NY, 2013, BIOCHEMISTRY-US, V52, P3171, DOI 10.1021/bi400273m; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Yamanaka K, 2011, J BACTERIOL, V193, P3815, DOI 10.1128/JB.01550-10; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Yeo JE, 2014, ACS CHEM BIOL, V9, P1860, DOI 10.1021/cb5001795; Zahn RK, 1999, MECH AGEING DEV, V108, P99, DOI 10.1016/S0047-6374(98)00151-1; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4717, DOI 10.1093/nar/28.23.4717; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4147, DOI 10.1093/nar/28.21.4147; Zhao LL, 2012, J BIOL CHEM, V287, P35516, DOI 10.1074/jbc.M112.403253; Zhao LL, 2012, ANGEW CHEM INT EDIT, V51, P5466, DOI 10.1002/anie.201109004	74	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					775	787		10.1074/jbc.M114.613638	http://dx.doi.org/10.1074/jbc.M114.613638			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25391658	hybrid, Green Published			2022-12-28	WOS:000347778200008
J	Marx, A; Alian, A				Marx, Ailie; Alian, Akram			The First Crystal Structure of a dTTP-bound Deoxycytidylate Deaminase Validates and Details the Allosteric-Inhibitor Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Cytidine Deaminase; Protein Structure; X-ray Crystallography; Zinc; Deoxycytidylate Deaminase; S-TIM5; dCMP Deaminase; dTTP	DCTP DEAMINASE; SUBSTRATE; FAMILY; MUTANT; ANALOG	Background: Deoxycytidylate deaminases are the only allosterically regulated members of the zinc-dependent cytidine deaminase family. Results: dTTP binding is confirmed and described in the previously defined dCTP allosteric binding site. Conclusion: Higher affinity of dTTP than dCTP to the allosteric site may confer its inhibitory effect. Significance: This is the first dTTP-bound crystal structure of deoxycytidylate deaminase. Deoxycytidylate deaminase is unique within the zinc-dependent cytidine deaminase family as being allosterically regulated, activated by dCTP, and inhibited by dTTP. Here we present the first crystal structure of a dTTP-bound deoxycytidylate deaminase from the bacteriophage S-TIM5, confirming that this inhibitor binds to the same site as the dCTP activator. The molecular details of this structure, complemented by structures apo- and dCMP-bound, provide insights into the allosteric mechanism. Although the positioning of the nucleoside moiety of dTTP is almost identical to that previously described for dCTP, protonation of N3 in deoxythymidine and not deoxycytidine would facilitate hydrogen bonding of dTTP but not dCTP and may result in a higher affinity of dTTP to the allosteric site conferring its inhibitory activity. Further the functional group on C4 (O in dTTP and NH2 in dCTP) makes interactions with nonconserved protein residues preceding the allosteric motif, and the relative strength of binding to these residues appears to correspond to the potency of dTTP inhibition. The active sites of these structures are also uniquely occupied by dTMP and dCMP resolving aspects of substrate specificity. The methyl group of dTMP apparently clashes with a highly conserved tyrosine residue, preventing the formation of a correct base stacking shown to be imperative for deamination activity. The relevance of these findings to the wider zinc-dependent cytidine deaminase family is also discussed.	[Marx, Ailie; Alian, Akram] Technion Israel Inst Technol, Fac Biol, IL-320003 Haifa, Israel	Technion Israel Institute of Technology	Alian, A (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-320003 Haifa, Israel.	alian@tx.technion.ac.il	Alian, Akram/D-3033-2018; Alian, Akram/O-9740-2019	Alian, Akram/0000-0003-1901-3832; Alian, Akram/0000-0003-1901-3832	Israel Science Foundation [1354/14]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 1354/14.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Almog R, 2004, BIOCHEMISTRY-US, V43, P13715, DOI 10.1021/bi048928h; Bransteitter R, 2009, CELL MOL LIFE SCI, V66, P3137, DOI 10.1007/s00018-009-0070-y; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Demorest ZL, 2011, J BIOL CHEM, V286, P26568, DOI 10.1074/jbc.M111.235721; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hou HF, 2008, J MOL BIOL, V377, P220, DOI 10.1016/j.jmb.2007.12.064; Jansen RS, 2011, FUND CLIN PHARMACOL, V25, P172, DOI 10.1111/j.1472-8206.2010.00823.x; Johansson E, 2005, J BIOL CHEM, V280, P3051, DOI 10.1074/jbc.M409534200; Keefe RG, 2000, J BIOL CHEM, V275, P12598, DOI 10.1074/jbc.275.17.12598; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liou JY, 2003, MOL PHARMACOL, V63, P105, DOI 10.1124/mol.63.1.105; Maley F, 1990, Prog Nucleic Acid Res Mol Biol, V39, P49, DOI 10.1016/S0079-6603(08)60623-6; MALEY F, 1982, J BIOL CHEM, V257, P1876; MALEY GF, 1968, J BIOL CHEM, V243, P4506; MALEY GF, 1982, BIOCHEMISTRY-US, V21, P3780, DOI 10.1021/bi00259a009; MALEY GF, 1993, BIOCHIM BIOPHYS ACTA, V1162, P161, DOI 10.1016/0167-4838(93)90143-F; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGaughey KM, 1996, J BIOL CHEM, V271, P23037, DOI 10.1074/jbc.271.38.23037; MOORE JT, 1993, J BIOL CHEM, V268, P2288; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Sabehi G, 2012, P NATL ACAD SCI USA, V109, P2037, DOI 10.1073/pnas.1115467109; Vincenzetti S, 2000, PROTEIN ENG, V13, P791, DOI 10.1093/protein/13.11.791; Zhang YZ, 2007, J VIROL, V81, P7662, DOI 10.1128/JVI.00186-07	25	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					682	690		10.1074/jbc.M114.617720	http://dx.doi.org/10.1074/jbc.M114.617720			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25404739	hybrid, Green Published			2022-12-28	WOS:000347231200058
J	Caohuy, H; Yang, QF; Eudy, Y; Ha, TA; Xu, AE; Glover, M; Frizzell, RA; Jozwik, C; Pollard, HB				Caohuy, Hung; Yang, Qingfeng; Eudy, Yvonne; Ha, Thien-An; Xu, Andrew E.; Glover, Matthew; Frizzell, Raymond A.; Jozwik, Catherine; Pollard, Harvey B.			Activation of 3-Phosphoinositide-dependent Kinase 1 (PDK1) and Serum-and Glucocorticoid-induced Protein Kinase 1 (SGK1) by Short-chain Sphingolipid C4-ceramide Rescues the Trafficking Defect of Delta F508-Cystic Fibrosis Transmembrane Conductance Regulator (Delta F508-CFTR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTIC-FIBROSIS; NATURAL CERAMIDE; ENDOCYTIC TRAFFICKING; POTENT INHIBITOR; CELL-DEATH; CFTR; PHOSPHORYLATION; 1-PHOSPHATE; CHANNELS; 3-KINASE	Cystic fibrosis (CF) is due to a folding defect in the CF transmembrane conductance regulator (CFTR) protein. The most common mutation, Delta F508, prevents CFTR from trafficking to the apical plasma membrane. Here we show that activation of the PDK1/SGK1 signaling pathway with C4-ceramide (C4-CER), a non-toxic small molecule, functionally corrects the trafficking defect in both cultured CF cells and primary epithelial cell explants from CF patients. The mechanism of C4-CER action involves a series of mutual autophosphorylation and phosphorylation events between PDK1 and SGK1. Detailed mechanistic studies indicate that C4-CER initially induces autophosphorylation of SGK1 at Ser(422). SGK1[Ser(P)(422)] and C4-CER coincidently bind PDK1 and permit PDK1 to autophosphorylate at Ser(241). Then PDK1[Ser(P)(241)] phosphorylates SGK1[Ser(P)(422)] at Thr(256) to generate fully activated SGK1[Ser(422), Thr(P)(256)]. SGK1[Ser(P)(422), Thr(P)(256)] phosphorylates and inactivates the E3 ubiquitin ligase Nedd4-2. Delta F508-CFTR is thus free to traffic to the plasma membrane. Importantly, C4-CER-mediated activation of both PDK1 and SGK1 is independent of the PI3K/Akt/mammalian target of rapamycin signaling pathway. Physiologically, C4-CER significantly increases maturation and stability of Delta F508-CFTR (t1/2 similar to 10 h), enhances cAMP-activated chloride secretion, and suppresses hypersecretion of interleukin-8 (IL-8). We suggest that candidate drugs for CF directed against the PDK1/SGK1 signaling pathway, such as C4-CER, provide a novel therapeutic strategy for a life-limiting disorder that affects one child, on average, each day.	[Caohuy, Hung; Yang, Qingfeng; Eudy, Yvonne; Ha, Thien-An; Xu, Andrew E.; Jozwik, Catherine; Pollard, Harvey B.] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Glover, Matthew; Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15224 USA	Uniformed Services University of the Health Sciences - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Caohuy, H (corresponding author), Uniformed Serv Univ Hlth Sci, Sch Med, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	hung.caohuy@usuhs.edu; harvey.pollard@usuhs.edu	Yang, Heroine/GRY-2630-2022		National Institutes of Health [RO1-DK-35051, NO1-HV-28187]; Cystic Fibrosis Foundation Grant [CAOHUY11G0]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Grant; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK-35051 and NO1-HV-28187 (to H. P.). This work was also supported by Cystic Fibrosis Foundation Grant CAOHUY11G0 (to H. C.).	ANDERSON MP, 1992, AM J PHYSIOL, V263, pL1, DOI 10.1152/ajplung.1992.263.1.L1; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Ardail D, 2002, BBA-MOL CELL BIOL L, V1583, P305, DOI 10.1016/S1388-1981(02)00252-4; Babenko N., 2010, WEBMEDCENTRAL APOPTO, V1; Bhattacharyya S, 2011, J BIOL CHEM, V286, P11604, DOI 10.1074/jbc.M110.198390; Bielawska A, 1996, J BIOL CHEM, V271, P12646, DOI 10.1074/jbc.271.21.12646; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Chen H, 2001, BIOCHEMISTRY-US, V40, P11851, DOI 10.1021/bi010743c; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Conese Massimo, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P8; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; Dechecchi MC, 2007, AM J RESP CELL MOL, V36, P615, DOI 10.1165/rcmb.2006-0200OC; EIDELMAN O, 1992, P NATL ACAD SCI USA, V89, P5562, DOI 10.1073/pnas.89.12.5562; Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; GomezMunoz A, 1997, BIOCHEM J, V325, P435, DOI 10.1042/bj3250435; Graf C, 2009, ANAL BIOCHEM, V384, P166, DOI 10.1016/j.ab.2008.09.008; Guilbault C, 2008, AM J RESP CELL MOL, V38, P47, DOI 10.1165/rcmb.2007-0036OC; Guilbault C, 2009, AM J RESP CELL MOL, V41, P100, DOI 10.1165/rcmb.2008-0279OC; Holleran JP, 2012, MOL MED, V18, P685, DOI 10.2119/molmed.2012.00001; JI L, 1995, FEBS LETT, V358, P211, DOI 10.1016/0014-5793(94)01428-4; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060118; Loo TW, 2010, BIOCHEMISTRY-US, V49, P6352, DOI 10.1021/bi100807h; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Pakladok T, 2013, CELL PHYSIOL BIOCHEM, V31, P785, DOI 10.1159/000350096; Paris F, 2001, J BIOL CHEM, V276, P8297, DOI 10.1074/jbc.M008732200; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pedemonte N, 2011, METHODS MOL BIOL, V741, P13, DOI 10.1007/978-1-61779-117-8_2; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Riordan JR, 1999, AM J HUM GENET, V64, P1499, DOI 10.1086/302429; Rottner M, 2007, FASEB J, V21, P2939, DOI 10.1096/fj.06-7614com; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sato JD, 2007, CELL PHYSIOL BIOCHEM, V20, P91, DOI 10.1159/000104157; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Sheppard Karen E., 2012, Critical Reviews in Oncogenesis, V17, P69; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Srivastava M, 2004, P NATL ACAD SCI USA, V101, P7693, DOI 10.1073/pnas.0402030101; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wijesinghe DS, 2009, J LIPID RES, V50, P1986, DOI 10.1194/jlr.M800367-JLR200; Yatomi Y, 1996, BIOCHEMISTRY-US, V35, P626, DOI 10.1021/bi9515533	58	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35953	35968		10.1074/jbc.M114.598649	http://dx.doi.org/10.1074/jbc.M114.598649			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25384981	Green Published, hybrid			2022-12-28	WOS:000346897900026
J	Thompson, D; McArthur, S; Hislop, JN; Flower, RJ; Perretti, M				Thompson, Dawn; McArthur, Simon; Hislop, James N.; Flower, Roderick J.; Perretti, Mauro			Identification of a Novel Recycling Sequence in the C-tail of FPR2/ALX Receptor ASSOCIATION WITH CELL PROTECTION FROM APOPTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMYL PEPTIDE RECEPTOR; PROTEIN-COUPLED-RECEPTORS; BETA-ARRESTINS; MEMBRANE TRAFFICKING; DOPAMINE-RECEPTOR; AGONIST AFFINITY; PHOSPHORYLATION; RESENSITIZATION; INTERNALIZATION; INFLAMMATION	Formyl-peptide receptor type 2 (FPR2; also called ALX because it is the receptor for lipoxin A(4)) sustains a variety of biological responses relevant to the development and control of inflammation, yet the cellular regulation of this G-protein-coupled receptor remains unexplored. Here we report that, in response to peptide agonist activation, FPR2/ALX undergoes beta-arrestin-mediated endocytosis followed by rapid recycling to the plasma membrane. We identify a transplantable recycling sequence that is both necessary and sufficient for efficient receptor recycling. Furthermore, removal of this C-terminal recycling sequence alters the endocytic fate of FPR2/ALX and evokes pro-apoptotic effects in response to agonist activation. This study demonstrates the importance of endocytic recycling in the anti-apoptotic properties of FPR2/ALX and identifies the molecular determinant required for modulation of this process fundamental for the control of inflammation.	[Thompson, Dawn; McArthur, Simon; Flower, Roderick J.; Perretti, Mauro] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Thompson, Dawn; Hislop, James N.] Univ Aberdeen, Inst Med Sci, Coll Life Sci & Med, Sch Med Sci, Aberdeen AB25 2ZD, Scotland	University of London; Queen Mary University London; University of Aberdeen	Thompson, D (corresponding author), Univ Aberdeen, Inst Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland.	dthompson@abdn.ac.uk; m.perretti@qmul.ac.uk	McArthur, Simon/V-6839-2019	McArthur, Simon/0000-0001-8521-1808; McArthur, Simon/0000-0002-9603-4381	Wellcome Trust [08667/Z/08/Z]; Friends of Anchor Trust [BM114 RGB4561]; University of Aberdeen	Wellcome Trust(Wellcome TrustEuropean Commission); Friends of Anchor Trust; University of Aberdeen	This work was funded by the Wellcome Trust (Program Grant 08667/Z/08/Z), The Friends of Anchor Trust (Grant BM114 RGB4561) and, in part by the University of Aberdeen.	Babbin BA, 2008, J IMMUNOL, V181, P5035, DOI 10.4049/jimmunol.181.7.5035; Bennett TA, 2001, J BIOL CHEM, V276, P49195, DOI 10.1074/jbc.M106414200; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Dufton N, 2010, PHARMACOL THERAPEUT, V127, P175, DOI 10.1016/j.pharmthera.2010.04.010; Ernst S, 2004, CELL MOL LIFE SCI, V61, P1684, DOI 10.1007/s00018-004-4116-x; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gilbert TL, 2001, BIOCHEMISTRY-US, V40, P3467, DOI 10.1021/bi001320y; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Huet E, 2007, CELL SIGNAL, V19, P1939, DOI 10.1016/j.cellsig.2007.05.006; Kam AYF, 2007, CELL SIGNAL, V19, P2106, DOI 10.1016/j.cellsig.2007.06.005; Key TA, 2005, TRAFFIC, V6, P87, DOI 10.1111/j.1600-0854.2004.00248.x; Key TA, 2003, J BIOL CHEM, V278, P4041, DOI 10.1074/jbc.M204687200; Key TA, 2001, J BIOL CHEM, V276, P49204, DOI 10.1074/jbc.M109475200; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Le YY, 1999, J IMMUNOL, V163, P6777; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Levy BD, 2012, CLIN CHEST MED, V33, P559, DOI 10.1016/j.ccm.2012.06.006; Maestes DC, 1999, J BIOL CHEM, V274, P29791, DOI 10.1074/jbc.274.42.29791; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Potter RM, 2006, J IMMUNOL, V176, P5418, DOI 10.4049/jimmunol.176.9.5418; Rabiet MJ, 2011, J BIOL CHEM, V286, P26718, DOI 10.1074/jbc.M111.244590; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Revankar CM, 2004, J BIOL CHEM, V279, P24578, DOI 10.1074/jbc.M402121200; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Thompson D, 2007, J BIOL CHEM, V282, P29178, DOI 10.1074/jbc.M704014200; Thompson D, 2011, TRAFFIC, V12, P644, DOI 10.1111/j.1600-0854.2011.01179.x; Thompson D, 2011, J BIOL CHEM, V286, P1598, DOI 10.1074/jbc.M110.158345; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; Wagener BM, 2009, TRAFFIC, V10, P1286, DOI 10.1111/j.1600-0854.2009.00957.x; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	42	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36166	36178		10.1074/jbc.M114.612630	http://dx.doi.org/10.1074/jbc.M114.612630			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25326384	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000346897900043
J	Amado, NG; Predes, D; Fonseca, BF; Cerqueira, DM; Reis, AH; Dudenhoeffer, AC; Borges, HL; Mendes, FA; Abreu, JG				Amado, Nathalia G.; Predes, Danilo; Fonseca, Barbara F.; Cerqueira, Debora M.; Reis, Alice H.; Dudenhoeffer, Ana C.; Borges, Helena L.; Mendes, Fabio A.; Abreu, Jose G.			Isoquercitrin Suppresses Colon Cancer Cell Growth in Vitro by Targeting the Wnt/beta-Catenin Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Catenin (B-Catenin); Colon Cancer; Flavonoid; Wnt Signaling; Xenopus; Quercetin	BETA-CATENIN; XENOPUS EMBRYOS; QUERCETIN; WNT; EXPRESSION; FLAVONOIDS; AXIS; POLYPHENOLS; DISEASE; BMP	Flavonoids are plant-derived polyphenolic molecules that have potential biological effects including anti-oxidative, anti-inflammatory, anti-viral, and anti-tumoral effects. These effects are related to the ability of flavonoids to modulate signaling pathways, such as the canonical Wnt signaling pathway. This pathway controls many aspects of embryonic development and tissue maintenance and has been found to be deregulated in a range of human cancers. We performed several in vivo assays in Xenopus embryos, a functional model of canonical Wnt signaling studies, and also used in vitro models, to investigate whether isoquercitrin affects Wnt/-catenin signaling. Our data provide strong support for an inhibitory effect of isoquercitrin on Wnt/-catenin, where the flavonoid acts downstream of -catenin translocation to the nuclei. Isoquercitrin affects Xenopus axis establishment, reverses double axes and the LiCl hyperdorsalization phenotype, and reduces Xnr3 expression. In addition, this flavonoid shows anti-tumoral effects on colon cancer cells (SW480, DLD-1, and HCT116), whereas exerting no significant effect on non-tumor colon cell (IEC-18), suggesting a specific effect in tumor cells in vitro. Taken together, our data indicate that isoquercitrin is an inhibitor of Wnt/-catenin and should be further investigated as a potential novel anti-tumoral agent.	[Amado, Nathalia G.; Predes, Danilo; Fonseca, Barbara F.; Cerqueira, Debora M.; Reis, Alice H.; Dudenhoeffer, Ana C.; Borges, Helena L.; Mendes, Fabio A.; Abreu, Jose G.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Program Cell & Dev Biol, BR-21949590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Abreu, JG (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Program Cell & Dev Biol, Ave Carlos Chagas Filho,373,Bloco F2 Sala 15, BR-21949590 Rio De Janeiro, Brazil.	garciajr@icb.ufrj.br	Borges, Helena/W-7533-2019; Abreu, Jose G/ABB-1199-2021; Borges, Helena L/E-5044-2013; Predes, Danilo/J-7558-2015; Borges, Helena/AAG-3701-2020; Abreu, Jose G/G-6159-2010; Cerqueira, Debora Malta/AAB-6204-2020; Cerqueira, Debora Malta/CAF-4323-2022; Mendes, Fabio/J-6911-2015	Borges, Helena/0000-0003-2866-4223; Abreu, Jose G/0000-0002-1363-1755; Borges, Helena L/0000-0003-2866-4223; Predes, Danilo/0000-0003-1864-0324; Abreu, Jose G/0000-0002-9875-7786; Fonseca, Barbara/0000-0001-6403-4099; Malta Cerqueira Sant'Anna Santos, Debora/0000-0001-9773-4606; Reis, Alice/0000-0002-7431-5502	CNPq (National Council of Technological and Scientific Development); FAPERJ (Rio de Janeiro State Foundation for Research and Development); CAPES (Federal Agency for Higher Education)	CNPq (National Council of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Rio de Janeiro State Foundation for Research and Development)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES (Federal Agency for Higher Education)	This work was supported by CNPq (National Council of Technological and Scientific Development), FAPERJ (Rio de Janeiro State Foundation for Research and Development), and CAPES (Federal Agency for Higher Education).	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Amado NG, 2012, CURR TOP MED CHEM, V12, P2103; Amado NG, 2011, LIFE SCI, V89, P545, DOI 10.1016/j.lfs.2011.05.003; Amado NG, 2009, ANTI-CANCER DRUG, V20, P543, DOI 10.1097/CAD.0b013e32832d1149; Aoki M, 1999, P NATL ACAD SCI USA, V96, P139, DOI 10.1073/pnas.96.1.139; Boots AW, 2007, TOXICOL APPL PHARM, V222, P89, DOI 10.1016/j.taap.2007.04.004; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Cialdella-Kam L, 2013, BRIT J NUTR, V109, P1923, DOI 10.1017/S0007114512003972; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dajas F, 2012, J ETHNOPHARMACOL, V143, P383, DOI 10.1016/j.jep.2012.07.005; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Ferry DR, 1996, CLIN CANCER RES, V2, P659; GARCIAABREU J, 1995, J NEUROSCI RES, V40, P471, DOI 10.1002/jnr.490400406; Hallett RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033976; Haramoto Y, 2007, DEV GENES EVOL, V217, P29, DOI 10.1007/s00427-006-0115-2; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; KAO KR, 1986, NATURE, V322, P371, DOI 10.1038/322371a0; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Lee J, 2010, LIFE SCI, V86, P416, DOI 10.1016/j.lfs.2010.01.012; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Niehrs C, 2010, DEVELOPMENT, V137, P845, DOI 10.1242/dev.039651; Nieuwkoop PD, 1956, NORMAL TABLE XENOPUS, V22; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Okamoto T, 2005, INT J MOL MED, V16, P275; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Reis AH, 2012, DEV BIOL, V365, P350, DOI 10.1016/j.ydbio.2012.03.003; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Russo GL, 2007, BIOCHEM PHARMACOL, V74, P533, DOI 10.1016/j.bcp.2007.02.014; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Sies H, 2010, ARCH BIOCHEM BIOPHYS, V501, P2, DOI 10.1016/j.abb.2010.04.006; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P200, DOI 10.1016/S0753-3322(02)00178-6; Tarapore RS, 2012, CARCINOGENESIS, V33, P483, DOI 10.1093/carcin/bgr305; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039	40	66	68	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35456	35467		10.1074/jbc.M114.621599	http://dx.doi.org/10.1074/jbc.M114.621599			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25359775	hybrid, Green Published			2022-12-28	WOS:000346660200035
J	Malik, MQ; Bertke, MM; Huber, PW				Malik, Mariam Q.; Bertke, Michelle M.; Huber, Paul W.			Small Ubiquitin-like Modifier (SUMO)-mediated Repression of the Xenopus Oocyte 5 S rRNA Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Histone Methylation; RNA Polymerase III; SUMOylation; Transcription Repressor; Xenopus; 5 S rRNA Genes; PIAS2b; TFIIIA; XCtBP	TRANSCRIPTION FACTOR IIIA; VG1 MESSENGER-RNA; AT-RICH FLANKS; HISTONE H1; IN-VITRO; MULTIPROTEIN COMPLEX; CHROMATIN-STRUCTURE; POLYMERASE-III; LAEVIS OOCYTE; ZINC FINGERS	The 5 S rRNA gene-specific transcription factor IIIA (TFIIIA) interacts with the small ubiquitin-like modifier (SUMO) E3 ligase PIAS2b and with one of its targets, the transcriptional corepressor, XCtBP. PIAS2b is restricted to the cytoplasm of Xenopus oocytes but relocates to the nucleus immediately after fertilization. Following the midblastula transition, PIAS2b and XCtBP are present on oocyte-type, but not somatic-type, 5 S rRNA genes up through the neurula stage, as is a limiting amount of TFIIIA. Histone H3 methylation, coincident with the binding of XCtBP, also occurs exclusively on the oocyte-type genes. Immunohistochemical staining of embryos confirms the occupancy of a subset of the oocyte-type genes by TFIIIA that become positioned at the nuclear periphery shortly after the midblastula transition. Inhibition of SUMOylation activity relieves repression of oocyte-type 5 S rRNA genes and is correlated with a decrease in methylation of H3K9 and H3K27 and disruption of subnuclear localization. These results reveal a novel function for TFIIIA as a negative regulator that recruits histone modification activity through the CtBP repressor complex exclusively to the oocyte-type 5 S rRNA genes, leading to their terminal repression.	[Malik, Mariam Q.; Bertke, Michelle M.; Huber, Paul W.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Huber, PW (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	huber.1@nd.edu			National Institutes of Health [GM38200]; Office of Research (University of Notre Dame); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research (University of Notre Dame); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM38200. This work was also supported by the Office of Research (University of Notre Dame).	ALMOUZNI G, 1994, DEV BIOL, V165, P654, DOI 10.1006/dbio.1994.1283; ANDREWS MT, 1991, DEV BIOL, V146, P250, DOI 10.1016/0012-1606(91)90466-G; ANDREWS MT, 1987, CELL, V51, P445, DOI 10.1016/0092-8674(87)90640-4; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; Boddy MN, 1996, ONCOGENE, V13, P971; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Boggio R, 2007, J BIOL CHEM, V282, P15376, DOI 10.1074/jbc.M700889200; BOUVET P, 1994, GENE DEV, V8, P1147, DOI 10.1101/gad.8.10.1147; Brannon M, 1999, DEVELOPMENT, V126, P3159; BROWN DD, 1968, SCIENCE, V160, P272, DOI 10.1126/science.160.3825.272; Burn B, 2011, DEV DYNAM, V240, P2120, DOI 10.1002/dvdy.22701; BUSBY SJ, 1982, DEV BIOL, V91, P458, DOI 10.1016/0012-1606(82)90052-5; CAMIER S, 1995, P NATL ACAD SCI USA, V92, P9338, DOI 10.1073/pnas.92.20.9338; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G., 2006, CTBP FAMILY PROTEINS, P1; CHIPEV CC, 1992, MOL CELL BIOL, V12, P45, DOI 10.1128/MCB.12.1.45; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Damjanovski Sashko, 2002, Methods Mol Biol, V202, P153; DIMITROV S, 1993, DEV BIOL, V160, P214, DOI 10.1006/dbio.1993.1299; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; Duval D, 2003, FEBS LETT, V554, P111, DOI 10.1016/S0014-5793(03)01116-5; DWORKINRASTL E, 1994, DEV BIOL, V161, P425, DOI 10.1006/dbio.1994.1042; Ferreira HC, 2011, NAT CELL BIOL, V13, P867, DOI 10.1038/ncb2263; FLYNN JM, 1980, DEV BIOL, V75, P222, DOI 10.1016/0012-1606(80)90157-8; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Ghose R, 2004, MOL CELL BIOL, V24, P2467, DOI 10.1128/MCB.24.6.2467-2477.2004; GOTTESFELD JM, 1980, CELL, V21, P751, DOI 10.1016/0092-8674(80)90438-9; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; HARPER ME, 1983, NUCLEIC ACIDS RES, V11, P2313, DOI 10.1093/nar/11.8.2313; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Howe L, 1998, J BIOL CHEM, V273, P20693, DOI 10.1074/jbc.273.33.20693; Howe L, 1998, BIOCHEMISTRY-US, V37, P7077, DOI 10.1021/bi980410o; Howe LW, 1998, MOL CELL BIOL, V18, P1156, DOI 10.1128/MCB.18.3.1156; Iniguez-Lluhi JA, 2009, SUMO REGULATION OF CELLULAR PROCESSES, P13, DOI 10.1007/978-90-481-2649-1_2; JERZMANOWSKI A, 1990, J BIOL CHEM, V265, P10726; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; KANDOLF H, 1994, P NATL ACAD SCI USA, V91, P7257, DOI 10.1073/pnas.91.15.7257; Kay B. K., 1991, XENOPUS LAEVIS PRACT; KLOCKE B, 1995, MOL CELL BIOCHEM, V142, P49, DOI 10.1007/BF00928913; Kolev NG, 2003, MOL CELL, V11, P745, DOI 10.1016/S1097-2765(03)00071-6; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kroll TT, 2002, DEVELOPMENT, V129, P5609, DOI 10.1242/dev.00160; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; MAO XZ, 1993, MOL CELL BIOL, V13, P7496, DOI 10.1128/MCB.13.12.7496; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; MCCONKEY GA, 1988, GENE DEV, V2, P205, DOI 10.1101/gad.2.2.205; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Nieuwkoop P. D., 1956, NORMAL TABLES XENOPU; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; PARDUE ML, 1973, CHROMOSOMA, V42, P191, DOI 10.1007/BF00320940; PECK LJ, 1987, MOL CELL BIOL, V7, P3503, DOI 10.1128/MCB.7.10.3503; PELHAM HRB, 1981, P NATL ACAD SCI-BIOL, V78, P1760, DOI 10.1073/pnas.78.3.1760; PERKOWSKA E, 1968, NATURE, V217, P649, DOI 10.1038/217649a0; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Pozzebon Mariaelena, 2009, V497, P285, DOI 10.1007/978-1-59745-566-4_19; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; SCHLISSEL MS, 1984, CELL, V37, P903, DOI 10.1016/0092-8674(84)90425-2; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Sera T, 1998, MOL CELL BIOL, V18, P3668, DOI 10.1128/MCB.18.7.3668; SHASTRY BS, 1984, J BIOL CHEM, V259, P1373; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Stielow B, 2008, EMBO REP, V9, P899, DOI 10.1038/embor.2008.127; Sun LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04365; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Tomaszewski R, 1998, NUCLEIC ACIDS RES, V26, P5596, DOI 10.1093/nar/26.24.5596; Tomaszewski R, 1997, NUCLEIC ACIDS RES, V25, P458, DOI 10.1093/nar/25.3.458; Towbin BD, 2013, TRENDS BIOCHEM SCI, V38, P356, DOI 10.1016/j.tibs.2013.04.004; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Westmark CJ, 2002, BIOCHEM J, V362, P375, DOI 10.1042/0264-6021:3620375; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; WOLFFE AP, 1989, EMBO J, V8, P527, DOI 10.1002/j.1460-2075.1989.tb03407.x; WOLFFE AP, 1988, SCIENCE, V241, P1626, DOI 10.1126/science.3420414; WORMINGTON WM, 1983, DEV BIOL, V99, P248, DOI 10.1016/0012-1606(83)90273-7; Wuttke DS, 1997, J MOL BIOL, V273, P183, DOI 10.1006/jmbi.1997.1291; YOUNG D, 1983, MOL CELL BIOL, V3, P720, DOI 10.1128/MCB.3.4.720; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4; Zhao WM, 2001, EMBO J, V20, P2315, DOI 10.1093/emboj/20.9.2315; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	86	4	4	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35468	35481		10.1074/jbc.M114.609123	http://dx.doi.org/10.1074/jbc.M114.609123			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25368327	hybrid, Green Published			2022-12-28	WOS:000346660200036
J	Parnell, EJ; Yu, YX; Lucena, R; Yoon, Y; Bai, L; Kellogg, DR; Stillman, DJ				Parnell, Emily J.; Yu, Yaxin; Lucena, Rafael; Yoon, Youngdae; Bai, Lu; Kellogg, Douglas R.; Stillman, David J.			The Rts1 Regulatory Subunit of PP2A Phosphatase Controls Expression of the HO Endonuclease via Localization of the Ace2 Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Gene Regulation; Nuclear Translocation; Phosphatase; Yeast Transcription	SACCHAROMYCES-CEREVISIAE; MITOTIC EXIT; CELL-CYCLE; FACTOR-BINDING; KINASE; GENE; PHOSPHORYLATION; IDENTIFICATION; CHITINASE; PATHWAYS	The RTS1 gene encodes a subunit of the PP2A phosphatase that regulates cell cycle progression. Ace2 and Swi5 are cell cycle-regulated transcription factors, and we recently showed that phosphorylation of Ace2 and Swi5 is altered in an rts1 mutant. Here we examine expression of Ace2 and Swi5 target genes and find that an rts1 mutation markedly reduces expression of the HO gene. The decreased HO expression in an rts1 mutant is significantly restored by an additional ace2 mutation, a surprising result because HO is normally activated by Swi5 but not by Ace2. Ace2 normally accumulates only in daughter cells, and only activates transcription in daughters. However, in an rts1 mutant, Ace2 is present in both mother and daughter cells. One of the genes activated by Ace2 is ASH1, a protein that normally accumulates mostly in daughter cells; Ash1 is a transcriptional repressor, and it blocks HO expression in daughters. We show that in the rts1 mutant, Ace2 accumulation in mother cells results in Ash1 expression in mothers, and the Ash1 can now repress HO expression in mothers.	[Parnell, Emily J.; Yu, Yaxin; Stillman, David J.] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84112 USA; [Lucena, Rafael; Kellogg, Douglas R.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Yoon, Youngdae; Bai, Lu] Penn State Univ, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA; [Yoon, Youngdae; Bai, Lu] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bai, Lu] Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Utah System of Higher Education; University of Utah; University of California System; University of California Santa Cruz; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Stillman, DJ (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Pathol, 15 N Med Dr East, Salt Lake City, UT 84112 USA.	david.stillman@path.utah.edu	Lucena, Rafael/D-2239-2016	Stillman, David/0000-0002-5268-2416; Lucena, Rafael/0000-0003-2050-0611; Mooring, Meghan/0000-0002-8513-7430	National Institutes of Health [GM053959, GM39067]; Penn State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053959, R01GM039067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM053959 (to D. R. K.) and GM39067 (to D. J. S.). This work was also supported by startup funds from Penn State University (to L. B.).	Artiles K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000727; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Jensen TH, 2000, MOL CELL BIOL, V20, P8047, DOI 10.1128/MCB.20.21.8047-8058.2000; Lombardi IM, 2013, CURR BIOL, V23, P1736, DOI 10.1016/j.cub.2013.07.032; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Mazanka E, 2010, MOL BIOL CELL, V21, P2809, DOI 10.1091/mbc.E10-02-0174; Mazanka E, 2008, PLOS BIOL, V6, P1778, DOI 10.1371/journal.pbio.0060203; O'Conallain C, 1999, MOL GEN GENET, V262, P275, DOI 10.1007/s004380051084; Racki WJ, 2000, EMBO J, V19, P4524, DOI 10.1093/emboj/19.17.4524; Sbia M, 2008, J BIOL CHEM, V283, P11135, DOI 10.1074/jbc.M800196200; Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1; Stillman DJ, 2013, TRENDS BIOCHEM SCI, V38, P467, DOI 10.1016/j.tibs.2013.06.009; Takahata S, 2011, J BIOL CHEM, V286, P34809, DOI 10.1074/jbc.M111.281626; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Voth WP, 2007, EMBO J, V26, P4324, DOI 10.1038/sj.emboj.7601859; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Weiss EL, 2012, GENETICS, V192, P1165, DOI 10.1534/genetics.112.145516; Zapata J, 2014, J CELL BIOL, V204, P359, DOI 10.1083/jcb.201309119; Zhang Q, 2013, P NATL ACAD SCI USA, V110, P14012, DOI 10.1073/pnas.1306113110; Zhao Y, 1997, J BIOL CHEM, V272, P8256, DOI 10.1074/jbc.272.13.8256	22	6	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35431	35437		10.1074/jbc.M114.611715	http://dx.doi.org/10.1074/jbc.M114.611715			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25352596	Green Published, hybrid			2022-12-28	WOS:000346660200033
J	van Bel, N; Das, AT; Cornelissen, M; Abbink, TEM; Berkhout, B				van Bel, Nikki; Das, Atze T.; Cornelissen, Marion; Abbink, Truus E. M.; Berkhout, Ben			A Short Sequence Motif in the 5 ' Leader of the HIV-1 Genome Modulates Extended RNA Dimer Formation and Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV-1 Protease; Molecular Evolution; Reverse Transcription; RNA Structure; Virology; HIV-1 RNA; HIV-1 RNA Packaging; RNA Dimerization; Virus Evolution	DIMERIZATION INITIATION SITE; INFECTIOUS MOLECULAR CLONES; 1ST STRAND TRANSFER; REVERSE TRANSCRIPTION; TYPE-1 RNA; IN-VITRO; SECONDARY STRUCTURE; KISSING COMPLEX; TAR HAIRPIN; VIRAL INFECTIVITY	The 5 leader of the HIV-1 RNA genome encodes signals that control various steps in the replication cycle, including the dimerization initiation signal (DIS) that triggers RNA dimerization. The DIS folds a hairpin structure with a palindromic sequence in the loop that allows RNA dimerization via intermolecular kissing loop (KL) base pairing. The KL dimer can be stabilized by including the DIS stem nucleotides in the intermolecular base pairing, forming an extended dimer (ED). The role of the ED RNA dimer in HIV-1 replication has hardly been addressed because of technical challenges. We analyzed a set of leader mutants with a stabilized DIS hairpin for in vitro RNA dimerization and virus replication in T cells. In agreement with previous observations, DIS hairpin stability modulated KL and ED dimerization. An unexpected previous finding was that mutation of three nucleotides immediately upstream of the DIS hairpin significantly reduced in vitro ED formation. In this study, we tested such mutants in vivo for the importance of the ED in HIV-1 biology. Mutants with a stabilized DIS hairpin replicated less efficiently than WT HIV-1. This defect was most severe when the upstream sequence motif was altered. Virus evolution experiments with the defective mutants yielded fast replicating HIV-1 variants with second site mutations that (partially) restored the WT hairpin stability. Characterization of the mutant and revertant RNA molecules and the corresponding viruses confirmed the correlation between in vitro ED RNA dimer formation and efficient virus replication, thus indicating that the ED structure is important for HIV-1 replication.	[van Bel, Nikki; Das, Atze T.; Cornelissen, Marion; Abbink, Truus E. M.; Berkhout, Ben] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Abbink, Truus E. M.] Addenbrookes Hosp, Dept Med, Cambridge CB2 0SP, England	University of Amsterdam; Academic Medical Center Amsterdam; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Abbink, TEM (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pediat Child Neurol, NL-1081 HZ Amsterdam, Netherlands.	G.Abbink@vumc.nl; Berkhout@amc.uva.nl	Abbink, Truus/N-4990-2018	van Bel, Nikki/0000-0003-0070-4043	Netherlands Organization for Scientific Research, Chemical Sciences Division [700.59.301]; Intra-European Marie Curie Fellowship [220092]	Netherlands Organization for Scientific Research, Chemical Sciences Division; Intra-European Marie Curie Fellowship(European Commission)	This work was supported by Netherlands Organization for Scientific Research, Chemical Sciences Division Grant 700.59.301.; Supported by Intra-European Marie Curie Fellowship 220092. To whom correspondence may be addressed: Dept. of Pediatrics/Child Neurology, VU Medical Centre, 1081 HZ Amsterdam, The Netherlands. E-mail: G.Abbink@vumc.nl.	Abbink TEM, 2005, BIOCHEMISTRY-US, V44, P9058, DOI 10.1021/bi0502588; Abbink TEM, 2003, J BIOL CHEM, V278, P11601, DOI 10.1074/jbc.M210291200; Abd El-Wahab EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5304; Andersen ES, 2004, J BIOL CHEM, V279, P22243, DOI 10.1074/jbc.M314326200; Baig TT, 2009, J VIROL, V83, P802, DOI 10.1128/JVI.01521-08; Baig TT, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-65; BENDER W, 1976, CELL, V7, P595, DOI 10.1016/0092-8674(76)90210-5; BERKHOUT B, 1995, J MOL BIOL, V252, P59, DOI 10.1006/jmbi.1994.0475; Berkhout B, 1998, VIROLOGY, V249, P211, DOI 10.1006/viro.1998.9321; Berkhout B, 1996, J VIROL, V70, P6723, DOI 10.1128/JVI.70.10.6723-6732.1996; Berkhout Ben, 2009, V485, P435, DOI 10.1007/978-1-59745-170-3_30; Chen JB, 2009, P NATL ACAD SCI USA, V106, P13535, DOI 10.1073/pnas.0906822106; Chin MPS, 2005, P NATL ACAD SCI USA, V102, P9002, DOI 10.1073/pnas.0502522102; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; DARLIX JL, 1990, J MOL BIOL, V216, P689, DOI 10.1016/0022-2836(90)90392-Y; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; DAS AT, 1995, J VIROL, V69, P3090, DOI 10.1128/JVI.69.5.3090-3097.1995; Das AT, 1997, J VIROL, V71, P2346, DOI 10.1128/JVI.71.3.2346-2356.1997; Das AT, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-59; Das AT, 2010, PHILOS T R SOC B, V365, P1965, DOI 10.1098/rstb.2010.0072; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; DESTEFANO JJ, 1994, J MOL BIOL, V243, P558, DOI 10.1016/0022-2836(94)90030-2; Ennifar E, 2001, NAT STRUCT BIOL, V8, P1064, DOI 10.1038/nsb727; Feng YX, 1996, P NATL ACAD SCI USA, V93, P7577, DOI 10.1073/pnas.93.15.7577; FU W, 1994, J VIROL, V68, P5013, DOI 10.1128/JVI.68.8.5013-5018.1994; FU W, 1993, J VIROL, V67, P5443, DOI 10.1128/JVI.67.9.5443-5449.1993; Greatorex J, 1998, J GEN VIROL, V79, P2877, DOI 10.1099/0022-1317-79-12-2877; Haddrick M, 1996, J MOL BIOL, V259, P58, DOI 10.1006/jmbi.1996.0301; Heng X, 2012, J MOL BIOL, V417, P224, DOI 10.1016/j.jmb.2012.01.033; Hill MK, 2003, J VIROL, V77, P8329, DOI 10.1128/JVI.77.15.8329-8335.2003; Hoglund S, 1997, VIROLOGY, V233, P271, DOI 10.1006/viro.1997.8585; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; HU WS, 1990, P NATL ACAD SCI USA, V87, P1556, DOI 10.1073/pnas.87.4.1556; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; Huthoff H, 2002, BIOCHEMISTRY-US, V41, P10439, DOI 10.1021/bi025993n; Huthoff H, 2001, NUCLEIC ACIDS RES, V29, P2594, DOI 10.1093/nar/29.12.2594; Jalalirad M, 2010, VIROLOGY, V407, P225, DOI 10.1016/j.virol.2010.08.013; Jeeninga RE, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-64; Jones KL, 2008, NUCLEIC ACIDS RES, V36, P1578, DOI 10.1093/nar/gkm1149; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; King SR, 2008, J VIROL, V82, P2376, DOI 10.1128/JVI.02100-07; KLAVER B, 1994, EMBO J, V13, P2650, DOI 10.1002/j.1460-2075.1994.tb06555.x; Kuiken C., 2013, 1326007 LAUR LOS AL; Kutluay SB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001200; L'Hernault A, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-90; L'Hernault A, 2012, J VIROL, V86, P5867, DOI 10.1128/JVI.00124-12; LAUGHREA M, 1994, BIOCHEMISTRY-US, V33, P13464, DOI 10.1021/bi00249a035; Laughrea M, 1996, BIOCHEMISTRY-US, V35, P1589, DOI 10.1021/bi951838f; Laughrea M, 1997, J VIROL, V71, P3397, DOI 10.1128/JVI.71.5.3397-3406.1997; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; MARQUET R, 1991, NUCLEIC ACIDS RES, V19, P2349, DOI 10.1093/nar/19.9.2349; Moore MD, 2007, J VIROL, V81, P4002, DOI 10.1128/JVI.02589-06; Moore MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000627; Moore MD, 2009, AIDS REV, V11, P91; Muriaux D, 1996, BIOCHEMISTRY-US, V35, P5075, DOI 10.1021/bi952822s; Nikolaitchik OA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003249; Nikolaitchik OA, 2011, J MOL BIOL, V407, P521, DOI 10.1016/j.jmb.2011.01.052; Ohishi M, 2011, NUCLEIC ACIDS RES, V39, P3404, DOI 10.1093/nar/gkq1314; PAILLART JC, 1994, J BIOL CHEM, V269, P27486; Paillart JC, 1996, P NATL ACAD SCI USA, V93, P5572, DOI 10.1073/pnas.93.11.5572; Pasternak AO, 2008, J CLIN MICROBIOL, V46, P2206, DOI 10.1128/JCM.00055-08; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Russell Rodney S, 2004, Retrovirology, V1, P23, DOI 10.1186/1742-4690-1-23; Sakuragi J, 2003, J VIROL, V77, P4060, DOI 10.1128/JVI.77.7.4060-4069.2003; Sakuragi J, 2012, NUCLEIC ACIDS RES, V40, P5012, DOI 10.1093/nar/gks156; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Song R, 2008, BIOCHEMISTRY-US, V47, P3283, DOI 10.1021/bi7023173; Song R, 2007, J MOL BIOL, V371, P1084, DOI 10.1016/j.jmb.2007.06.010; St Louis DC, 1998, J VIROL, V72, P3991; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Theilleux-Delalande V, 2000, EUR J BIOCHEM, V267, P2711, DOI 10.1046/j.1432-1327.2000.01292.x; van Bel N, 2014, J VIROL, V88, P1870, DOI 10.1128/JVI.02942-13; van Wamel JLB, 1998, VIROLOGY, V244, P245, DOI 10.1006/viro.1998.9096; Vrolijk MM, 2008, NUCLEIC ACIDS RES, V36, P4352, DOI 10.1093/nar/gkn364; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096	80	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35061	35074		10.1074/jbc.M114.621425	http://dx.doi.org/10.1074/jbc.M114.621425			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25368321	hybrid, Green Published			2022-12-28	WOS:000346660200002
J	Lu, JS; Isaji, T; Im, S; Fukuda, T; Hashii, N; Takakura, D; Kawasaki, N; Gu, JG				Lu, Jishun; Isaji, Tomoya; Im, Sanghun; Fukuda, Tomohiko; Hashii, Noritaka; Takakura, Daisuke; Kawasaki, Nana; Gu, Jianguo			beta-Galactoside alpha 2,6-Sialyltranferase 1 Promotes Transforming Growth Factor-beta-mediated Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cadherin; Cell Migration; Epithelial-Mesenchymal Transition (EMT); N-Linked Glycosylation; Sialyltransferase	SPONTANEOUS METASTASIS; CELL-MIGRATION; BREAST-CANCER; E-CADHERIN; TGF-BETA; SIALYLATION; EXPRESSION; ST6GAL-I; INVASION; RECEPTOR	Background: Molecular mechanisms underlying the effect of sialylation on tumor progression remain unclear. Results: ST6GAL1 promoted the TGF--induced EMT through down-regulation of E-cadherin-mediated cell adhesion and up-regulation of integrin-mediated cell migration. Conclusion: Expression of ST6GAL1 is critical for sufficient induction of EMT. Significance: 2,6-Sialylation of N-glycans may play a role in EMT. -Galactoside 2,6-sialyltranferase 1 (ST6GAL1) catalyzes the addition of terminal 2,6-sialylation to N-glycans. Increased expression of ST6GAL1 has been reported in diverse carcinomas and highly correlates with tumor progression. Here, we report that St6gal1 transcription and 2,6-sialylated N-glycans are up-regulated during TGF--induced epithelial-mesenchymal transition (EMT) in GE11 cells, requiring the Sp1 element within the St6gal1 promoter. Knockdown of St6gal1 strongly suppressed TGF--induced EMT with a concomitant increase in E-cadherin expression, a major determinant of epithelial cell adherens junctions. Conversely, overexpression of ST6GAL1 increased the turnover of cell surface E-cadherin and promoted TGF--induced EMT. Overexpressing -galactoside 2,3-sialyltranferase 4 had little influence on EMT, indicating specificity for 2,6-sialylation. The basal mesenchymal phenotype of MDA-MB-231 human breast cancer cells was partially reversed by ST6GAL1 silencing. Moreover, ST6GAL1 knockdown inhibited the phosphorylation of Akt, but not Smad2, suggesting that ST6GAL1 contributes to EMT through a non-Smad signaling pathway. Taken together, our data indicate that ST6GAL1 promotes TGF--dependent EMT as well as maintenance of the mesenchymal state by growth signaling, providing a plausible mechanism whereby up-regulated ST6GAL1 may promote malignant progression.	[Lu, Jishun; Isaji, Tomoya; Im, Sanghun; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Hashii, Noritaka; Takakura, Daisuke; Kawasaki, Nana] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan	Tohoku Medical & Pharmaceutical University; National Institute of Health Sciences - Japan	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021		Japan Society for the Promotion of Science [21370059, 24570169, 23651196]; Scientific Research on Innovative Areas Grants [23110002, 23110001]; Strategic Research Foundation from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [24570169] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Scientific Research on Innovative Areas Grants; Strategic Research Foundation from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research 21370059 (to J. G.) and 24570169 (to T. I.) and Grant-in-Aid for Challenging Exploratory Research 23651196 (to J. G.) from the Japan Society for the Promotion of Science, by Scientific Research on Innovative Areas Grants 23110002 (to J. G.) and 23110001 (to N. K.); and the Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Bae GY, 2013, ONCOTARGET, V4, P2512, DOI 10.18632/oncotarget.1463; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bull C, 2013, MOL CANCER THER, V12, P1935, DOI 10.1158/1535-7163.MCT-13-0279; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chen QM, 2008, CLIN EXP METASTAS, V25, P139, DOI 10.1007/s10585-007-9132-4; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Crespo HJ, 2009, IMMUNOLOGY, V128, pe621, DOI 10.1111/j.1365-2567.2009.03047.x; de Oliveira JT, 2011, INT J DEV BIOL, V55, P823, DOI 10.1387/ijdb.113359jt; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Granovsky M, 2000, NAT MED, V6, P306; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Hay ED, 1995, ACTA ANAT, V154, P8; Hinek A, 2008, AM J PATHOL, V173, P1042, DOI 10.2353/ajpath.2008.071081; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Jungert K, 2007, CANCER RES, V67, P1563, DOI 10.1158/0008-5472.CAN-06-1670; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Lee M, 2008, MOL CANCER RES, V6, P1316, DOI 10.1158/1541-7786.MCR-07-2209; Li SG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070282, 10.1371/journal.pone.0070461]; Lillehoj EP, 2012, J BIOL CHEM, V287, P8214, DOI 10.1074/jbc.M111.292888; Lin SQ, 2002, EXP CELL RES, V276, P101, DOI 10.1006/excr.2002.5521; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Ma H, 2015, ONCOGENE, V34, P726, DOI 10.1038/onc.2014.7; Mamuya FA, 2012, J CELL MOL MED, V16, P445, DOI 10.1111/j.1582-4934.2011.01419.x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maupin KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013002; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pinho SS, 2009, BIOCHEM BIOPH RES CO, V379, P1091, DOI 10.1016/j.bbrc.2009.01.024; Ranjan A, 2013, J BIOSCIENCES, V38, P867, DOI 10.1007/s12038-013-9382-z; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Saldova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071159; SCHACHTER H, 1983, CAN J BIOCHEM CELL B, V61, P1049, DOI 10.1139/o83-134; Schachter H, 1986, Adv Exp Med Biol, V205, P53; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Shen L, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.48; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Tan ZQ, 2014, J PROTEOME RES, V13, P2783, DOI 10.1021/pr401185z; Taniguchi A, 2000, GLYCOBIOLOGY, V10, P623, DOI 10.1093/glycob/10.6.623; Taniguchi A, 1998, FEBS LETT, V441, P191, DOI 10.1016/S0014-5793(98)01548-8; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomas GJ, 2001, INT J CANCER, V92, P641, DOI 10.1002/1097-0215(20010601)92:5<641::AID-IJC1243>3.0.CO;2-P; Thomas GJ, 2001, J INVEST DERMATOL, V117, P67, DOI 10.1046/j.0022-202x.2001.01379.x; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065218; Zhao YF, 2014, MOL CELL PROTEOMICS, V13, P520, DOI 10.1074/mcp.M113.034025; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983; Zhu YT, 2001, BBA-MOL BASIS DIS, V1536, P148, DOI 10.1016/S0925-4439(01)00044-8; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	62	74	76	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34627	34641		10.1074/jbc.M114.593392	http://dx.doi.org/10.1074/jbc.M114.593392			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25344606	Green Published, hybrid			2022-12-28	WOS:000346260800021
J	Romanow, A; Keys, TG; Stummeyer, K; Freiberger, F; Henrissat, B; Gerardy-Schahn, R				Romanow, Angela; Keys, Timothy G.; Stummeyer, Katharina; Freiberger, Friedrich; Henrissat, Bernard; Gerardy-Schahn, Rita			Dissection of Hexosyl- and Sialyltransferase Domains in the Bifunctional Capsule Polymerases from Neisseria meningitidis Wand Y Defines a New Sialyltransferase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Enzyme Catalysis; Glycosyltransferase; Phylogenetics; Polysaccharide; Fluorescence-based Testing of Glycosyltransferases; Neisseria meningitidis Serogroup W and Y; Capsule Polymerases; Hexosyltransferases; Sialyltransferases	ULTRASENSITIVE CHEMICAL METHOD; POLYSIALIC ACID; PSI-BLAST; BIOSYNTHESIS; PROTEIN; POLYSACCHARIDES; PERFORMANCE; EXPRESSION; PREDICTION; ACCURACY	Background: Capsule polymerases of Neisseria meningitidis serogroups W and Y comprise hexosyl- and sialyltransferase activity. Results: Hexosyltransferase activity is encoded by the predicted N-terminal GT-B fold. Sialyltransferase activity requires 168 additional amino acids upstream of the predicted C-terminal GT-B fold. Conclusion: The sialyltransferase domains of NmW/Y define a new glycosyltransferase (CAZy) family. Significance: The new CAZy family comprises sequences from distantly related species. Crucial virulence determinants of disease causing Neisseria meningitidis species are their extracellular polysaccharide capsules. In the serogroups W and Y, these are heteropolymers of the repeating units (6)--d-Gal-(14)--Neu5Ac-(2)(n) in NmW and (6)--d-Glc-(14)--Neu5Ac-(2)(n) in NmY. The capsule polymerases, SiaD(W) and SiaD(Y), which synthesize these highly unusual polymers, are composed of two predicted GT-B fold domains separated by a large stretch of amino acids (aa 399-762). We recently showed that residues critical to the hexosyl- and sialyltransferase activity are found in the predicted N-terminal (aa 1-398) and C-terminal (aa 763-1037) GT-B fold domains, respectively. Here we use a mutational approach and synthetic fluorescent substrates to define the boundaries of the hexosyl- and sialyltransferase domains. Our results reveal that the active sialyltransferase domain extends well beyond the predicted C-terminal GT-B domain and defines a new glycosyltransferase family, GT97, in CAZy (Carbohydrate-Active enZYmes Database).	[Romanow, Angela; Keys, Timothy G.; Stummeyer, Katharina; Freiberger, Friedrich; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Henrissat, Bernard] Aix Marseille Univ, CNRS, UMR 7257, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21589, Saudi Arabia	Hannover Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University	Gerardy-Schahn, R (corresponding author), Hannover Med Sch, Inst Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gerardy-schahn.rita@mh-hannover.de	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Keys, Timothy Gerard/0000-0003-2921-0362	DFG [Ge801/10-1]	DFG(German Research Foundation (DFG))	This work arose as a new research aspect in the frame of Deutsche Forschungsgemeinschaft (DFG) Research Unit 548. This work was supported in part through DFG Grant Ge801/10-1 and in part through impact-derived resources of the Institute for Cellular Chemistry.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BHATTACHARJEE AK, 1976, CAN J BIOCHEM CELL B, V54, P1, DOI 10.1139/o76-001; Bravo IG, 2004, TRENDS MICROBIOL, V12, P120, DOI 10.1016/j.tim.2004.01.004; Claus H, 1997, MOL GEN GENET, V257, P28, DOI 10.1007/s004380050620; Claus H, 2009, MOL MICROBIOL, V71, P960, DOI 10.1111/j.1365-2958.2008.06580.x; Deole R, 2013, J BIOL CHEM, V288, P581, DOI 10.1074/jbc.M112.420505; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; Gilbert M, 1997, BIOTECHNOL LETT, V19, P417, DOI 10.1023/A:1018379607492; Gouveia-Oliveira R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-312; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hao JJ, 2005, BIOCHEM BIOPH RES CO, V338, P1507, DOI 10.1016/j.bbrc.2005.10.113; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Inoue S, 2001, BIOCHIMIE, V83, P605, DOI 10.1016/S0300-9084(01)01307-4; Inoue S, 2001, GLYCOBIOLOGY, V11, P759, DOI 10.1093/glycob/11.9.759; Kandiba L, 2013, FEMS MICROBIOL LETT, V345, P110, DOI 10.1111/1574-6968.12193; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Keys TG, 2012, ANAL BIOCHEM, V427, P107, DOI 10.1016/j.ab.2012.05.011; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Lewis AL, 2009, P NATL ACAD SCI USA, V106, P13552, DOI 10.1073/pnas.0902431106; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Romanow A, 2013, J BIOL CHEM, V288, P11718, DOI 10.1074/jbc.M113.452276; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schauer R, 1997, INDIAN J BIOCHEM BIO, V34, P131; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; WEISGERBER C, 1990, J BIOL CHEM, V265, P1578; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Willis LM, 2013, P NATL ACAD SCI USA, V110, P20753, DOI 10.1073/pnas.1312637110; Willis LM, 2013, CARBOHYD RES, V378, P35, DOI 10.1016/j.carres.2013.05.007; Yamamoto T, 2007, GLYCOBIOLOGY, V17, P1167, DOI 10.1093/glycob/cwm086	42	19	19	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33945	33957		10.1074/jbc.M114.597773	http://dx.doi.org/10.1074/jbc.M114.597773			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25342753	Green Published, hybrid			2022-12-28	WOS:000346077600023
J	Yaffe, D; Vergara-Jaque, A; Shuster, Y; Listov, D; Meena, S; Singh, SK; Forrest, LR; Schuldiner, S				Yaffe, Dana; Vergara-Jaque, Ariela; Shuster, Yonatan; Listov, Dina; Meena, Sitaram; Singh, Satinder K.; Forrest, Lucy R.; Schuldiner, Shimon			Functionally Important Carboxyls in a Bacterial Homologue of the Vesicular Monoamine Transporter (VMAT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotic Resistance; Membrane Transport; Multidrug Transporter; Neurotransmitter; Neurotransmitter Transport; Proton Transport	MAJOR FACILITATOR SUPERFAMILY; MULTIPLE SEQUENCE ALIGNMENT; PROTEIN SECONDARY STRUCTURE; MULTIDRUG TRANSPORTER; ESCHERICHIA-COLI; NEUROTRANSMITTER TRANSPORTERS; ALTERNATING ACCESS; RESERPINE BINDING; CRYSTAL-STRUCTURE; STRUCTURAL BASIS	Background: Bacterial homologues of neurotransporters served as structural paradigms for interpretation of the functional data available for their eukaryotic counterparts. Results: We identified and characterized a close bacterial homologue of the rat vesicular monoamine transporter rVMAT2. Conclusion: BbMAT is a multidrug antiporter. Conserved membrane-embedded carboxyls play a role in substrate and proton transport. Significance: Understanding of the bacterial homologue should provide insights into rVMAT2. Transporters essential for neurotransmission in mammalian organisms and bacterial multidrug transporters involved in antibiotic resistance are evolutionarily related. To understand in more detail the evolutionary aspects of the transformation of a bacterial multidrug transporter to a mammalian neurotransporter and to learn about mechanisms in a milieu amenable for structural and biochemical studies, we identified, cloned, and partially characterized bacterial homologues of the rat vesicular monoamine transporter (rVMAT2). We performed preliminary biochemical characterization of one of them, Brevibacillus brevis monoamine transporter (BbMAT), from the bacterium B. brevis. BbMAT shares substrates with rVMAT2 and transports them in exchange with >1H(+), like the mammalian transporter. Here we present a homology model of BbMAT that has the standard major facilitator superfamily fold; that is, with two domains of six transmembrane helices each, related by 2-fold pseudosymmetry whose axis runs normal to the membrane and between the two halves. The model predicts that four carboxyl residues, a histidine, and an arginine are located in the transmembrane segments. We show here that two of the carboxyls are conserved, equivalent to the corresponding ones in rVMAT2, and are essential for H+-coupled transport. We conclude that BbMAT provides an excellent experimental paradigm for the study of its mammalian counterparts and bacterial multidrug transporters.	[Yaffe, Dana; Shuster, Yonatan; Listov, Dina; Schuldiner, Shimon] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Vergara-Jaque, Ariela; Forrest, Lucy R.] NINDS, Computat Struct Biol Sect, NIH, Bethesda, MD 20852 USA; [Meena, Sitaram; Singh, Satinder K.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Yale University	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	shimon.schuldiner@huji.ac.il	Vergara-Jaque, Ariela/H-1275-2017; Vergara-Jaque, Ariela/AAJ-1645-2020; Schuldiner, Shimon/F-7628-2012; Vergara, Ariela/AAD-3594-2020; Forrest, Lucy/E-8113-2016	Vergara-Jaque, Ariela/0000-0002-1236-013X; Vergara-Jaque, Ariela/0000-0002-1236-013X; Schuldiner, Shimon/0000-0002-4874-6237; Forrest, Lucy/0000-0003-1855-7985	National Institutes of Health [NS16708, R21MH098180]; Division of Intramural Research of the NINDS, National Institutes of Health; Israel-USA Binational Science Foundation; L'Oreal Chile-UNESCO Women in Science fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH098180, R00MH083050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016708, ZIANS003139, R56NS016708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research of the NINDS, National Institutes of Health; Israel-USA Binational Science Foundation(US-Israel Binational Science Foundation); L'Oreal Chile-UNESCO Women in Science fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS16708 (to S. S.) and R21MH098180 (to S. K. S.) and by the Division of Intramural Research of the NINDS, National Institutes of Health (to L. R. F. and A. V. J.). This work was also supported by the Israel-USA Binational Science Foundation (to S. S. and S. K. S.).; Recipient of the L'Oreal Chile-UNESCO Women in Science fellowship.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Center for Disease Control, 2013, ANN REP CTR DIS CONT; Chaudhry FA, 2008, ANNU REV PHARMACOL, V48, P277, DOI 10.1146/annurev.pharmtox.46.120604.141146; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DARCHEN F, 1988, BIOCHEM PHARMACOL, V37, P4381, DOI 10.1016/0006-2952(88)90621-1; Doki S, 2013, P NATL ACAD SCI USA, V110, P11343, DOI 10.1073/pnas.1301079110; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards R H, 1992, Curr Opin Neurobiol, V2, P586, DOI 10.1016/0959-4388(92)90023-E; Eiden LE, 2000, FASEB J, V14, P2396, DOI 10.1096/fj.00-0817rev; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; Fluman N, 2012, MOL CELL, V47, P777, DOI 10.1016/j.molcel.2012.06.018; Fluman N, 2009, BBA-PROTEINS PROTEOM, V1794, P738, DOI 10.1016/j.bbapap.2008.11.020; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gouaux E, 2009, PHILOS T R SOC B, V364, P149, DOI 10.1098/rstb.2008.0181; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gros Y, 2010, J BIOL CHEM, V285, P5076, DOI 10.1074/jbc.M109.081216; Iancu CV, 2013, P NATL ACAD SCI USA, V110, P17862, DOI 10.1073/pnas.1311485110; Jiang DH, 2013, P NATL ACAD SCI USA, V110, P14664, DOI 10.1073/pnas.1308127110; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kumar H, 2014, P NATL ACAD SCI USA, V111, P1784, DOI 10.1073/pnas.1324141111; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBERT B, 1984, BIOCHEMISTRY-US, V23, P166, DOI 10.1021/bi00296a027; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; Masureel M, 2014, NAT CHEM BIOL, V10, P149, DOI 10.1038/nchembio.1408; Mazurkiewicz P, 2002, J BIOL CHEM, V277, P26081, DOI 10.1074/jbc.M203141200; MERICKEL A, 1995, J BIOL CHEM, V270, P25798, DOI 10.1074/jbc.270.43.25798; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mitchell BA, 1999, J BIOL CHEM, V274, P3541, DOI 10.1074/jbc.274.6.3541; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Ray A, 2010, BIOINFORMATICS, V26, P3067, DOI 10.1093/bioinformatics/btq581; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rotem D, 2004, J BIOL CHEM, V279, P48787, DOI 10.1074/jbc.M408187200; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RUDNICK G, 1990, BIOCHEMISTRY-US, V29, P603, DOI 10.1021/bi00455a002; Schaedler TA, 2010, FASEB J, V24, P3653, DOI 10.1096/fj.10-156927; SCHERMAN D, 1984, MOL PHARMACOL, V25, P113; SCHERMAN D, 1983, P NATL ACAD SCI-BIOL, V80, P584, DOI 10.1073/pnas.80.2.584; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; Schuldiner S, 2014, J MOL BIOL, V426, P2539, DOI 10.1016/j.jmb.2014.05.020; Sigal N, 2009, J BIOL CHEM, V284, P6966, DOI 10.1074/jbc.M808877200; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Singh SK, 2008, CHANNELS, V2, P380, DOI 10.4161/chan.2.5.6904; Smirnova I, 2012, P NATL ACAD SCI USA, V109, P16835, DOI 10.1073/pnas.1214890109; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Soskine M, 2004, J BIOL CHEM, V279, P9951, DOI 10.1074/jbc.M312853200; Stamm M, 2014, NUCLEIC ACIDS RES, V42, pW246, DOI 10.1093/nar/gku291; Steed PR, 2013, BIOCHEMISTRY-US, V52, P7964, DOI 10.1021/bi4012385; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Tal N, 2009, P NATL ACAD SCI USA, V106, P9051, DOI 10.1073/pnas.0902400106; Vardy E, 2005, J BACTERIOL, V187, P7518, DOI 10.1128/JB.187.21.7518-7525.2005; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xu ZQ, 2006, J BIOL CHEM, V281, P792, DOI 10.1074/jbc.M508676200; Yaffe D, 2013, P NATL ACAD SCI USA, V110, pE1332, DOI 10.1073/pnas.1220497110; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yelin R, 1995, FEBS LETT, V377, P201, DOI 10.1016/0014-5793(95)01346-6; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	68	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34229	34240		10.1074/jbc.M114.607366	http://dx.doi.org/10.1074/jbc.M114.607366			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25336661	Green Published, hybrid			2022-12-28	WOS:000346077600045
J	Bowers, PM; Verdino, P; Wang, ZY; Correia, JD; Chhoa, M; Macondray, G; Do, M; Neben, TY; Horlick, RA; Stanfield, RL; Wilson, IA; King, DJ				Bowers, Peter M.; Verdino, Petra; Wang, Zhengyuan; Correia, Jean da Silva; Chhoa, Mark; Macondray, Griffin; Do, Minjee; Neben, Tamlyn Y.; Horlick, Robert A.; Stanfield, Robyn L.; Wilson, Ian A.; King, David J.			Nucleotide Insertions and Deletions Complement Point Mutations to Massively Expand the Diversity Created by Somatic Hypermutation of Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRALIZING ANTIBODIES; SURFACE DISPLAY; HIV-1; INDELS; DIVERSIFICATION; DNA; POTENT; BROAD; CONFORMATIONS; RECOGNITION	During somatic hypermutation (SHM), deamination of cytidine by activation-induced cytidine deaminase and subsequent DNA repair generates mutations within immunoglobulin V-regions. Nucleotide insertions and deletions (indels) have recently been shown to be critical for the evolution of antibody binding. Affinity maturation of 53 antibodies using in vitro SHM in a non-B cell context was compared with mutation patterns observed for SHM in vivo. The origin and frequency of indels seen during in vitro maturation were similar to that in vivo. Indels are localized to CDRs, and secondary mutations within insertions further optimize antigen binding. Structural determination of an antibody matured in vitro and comparison with human-derived antibodies containing insertions reveal conserved patterns of antibody maturation. These findings indicate that activation-induced cytidine deaminase acting on V-region sequences is sufficient to initiate authentic formation of indels in vitro and in vivo and that point mutations, indel formation, and clonal selection form a robust tripartite system for antibody evolution.	[Bowers, Peter M.; Verdino, Petra; Wang, Zhengyuan; Correia, Jean da Silva; Chhoa, Mark; Macondray, Griffin; Do, Minjee; Neben, Tamlyn Y.; Horlick, Robert A.; King, David J.] Anaptysbio Inc, San Diego, CA 92121 USA; [Stanfield, Robyn L.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Mol Biol, La Jolla, CA 92037 USA; [Stanfield, Robyn L.; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Bowers, PM (corresponding author), AnaptysBio Inc, Prot Sci, 10421 Pacific Ctr Ct,Ste 200, San Diego, CA 92121 USA.	pbowers@anaptysbio.com	Stanfield, Robyn/AAH-3190-2019; wang, zhengyuan/HGA-0435-2022; Wang, Zhengyuan/GWV-6069-2022	wang, zhengyuan/0000-0002-8447-9674; 				Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Bowers PM, 2014, METHODS, V65, P44, DOI 10.1016/j.ymeth.2013.06.010; Bowers PM, 2011, P NATL ACAD SCI USA, V108, P20455, DOI 10.1073/pnas.1114010108; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Breden F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016857; Briney BS, 2012, GENES IMMUN, V13, P523, DOI 10.1038/gene.2012.28; Briney BS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00042; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; de Wildt RMT, 1999, J MOL BIOL, V294, P701, DOI 10.1006/jmbi.1999.3289; Dorner T, 1998, EUR J IMMUNOL, V28, P3384; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Horlick RA, 2013, J BIOL CHEM, V288, P19861, DOI 10.1074/jbc.M113.452482; Hsing M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-293; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-24; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Krause JC, 2011, MBIO, V2, DOI 10.1128/mBio.00345-10; Light S, 2013, MOL BIOL EVOL, V30, P2645, DOI 10.1093/molbev/mst157; Light S, 2013, BBA-PROTEINS PROTEOM, V1834, P890, DOI 10.1016/j.bbapap.2013.01.002; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miura Y, 2003, MOL MED, V9, P166, DOI 10.1007/BF03402181; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Reason DC, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-24; Rogozin IB, 2004, J IMMUNOL, V172, P3382, DOI 10.4049/jimmunol.172.6.3382; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stanfield RL, 1999, STRUCTURE, V7, P131, DOI 10.1016/S0969-2126(99)80020-3; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhang Z, 2012, NUCLEIC ACIDS RES, V40, pD512, DOI 10.1093/nar/gkr1107; Zhang Z, 2011, MOL BIOL EVOL, V28, P291, DOI 10.1093/molbev/msq196; Zhou C, 2010, MABS-AUSTIN, V2, P508, DOI 10.4161/mabs.2.5.12970; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	46	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33557	33567		10.1074/jbc.M114.607176	http://dx.doi.org/10.1074/jbc.M114.607176			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25320089	Green Published, hybrid			2022-12-28	WOS:000345636600042
J	Di Noia, MA; Todisco, S; Cirigliano, A; Rinaldi, T; Agrimi, G; Iacobazzi, V; Palmieri, F				Di Noia, Maria Antonietta; Todisco, Simona; Cirigliano, Angela; Rinaldi, Teresa; Agrimi, Gennaro; Iacobazzi, Vito; Palmieri, Ferdinando			The Human SLC25A33 and SLC25A36 Genes of Solute Carrier Family 25 Encode Two Mitochondrial Pyrimidine Nucleotide Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASIC-AMINO-ACIDS; FUNCTIONAL-CHARACTERIZATION; BACTERIAL EXPRESSION; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; TISSUE DISTRIBUTION; COENZYME-A; MOLECULAR-IDENTIFICATION; THYMIDINE MONOPHOSPHATE; OXOGLUTARATE CARRIER	The human genome encodes 53 members of the solute carrier family 25 (SLC25), also called the mitochondrial carrier family, many of which have been shown to transport inorganic anions, amino acids, carboxylates, nucleotides, and coenzymes across the inner mitochondrial membrane, thereby connecting cytosolic and matrix functions. Here two members of this family, SLC25A33 and SLC25A36, have been thoroughly characterized biochemically. These proteins were overexpressed in bacteria and reconstituted in phospholipid vesicles. Their transport properties and kinetic parameters demonstrate that SLC25A33 transports uracil, thymine, and cytosine (deoxy) nucleoside di- and triphosphates by an antiport mechanism and SLC25A36 cytosine and uracil (deoxy) nucleoside mono-, di-, and triphosphates by uniport and antiport. Both carriers also transported guanine but not adenine (deoxy) nucleotides. Transport catalyzed by both carriers was saturable and inhibited by mercurial compounds and other inhibitors of mitochondrial carriers to various degrees. In confirmation of their identity (i) SLC25A33 and SLC25A36 were found to be targeted to mitochondria and (ii) the phenotypes of Saccharomyces cerevisiae cells lacking RIM2, the gene encoding the well characterized yeast mitochondrial pyrimidine nucleotide carrier, were overcome by expressing SLC25A33 or SLC25A36 in these cells. The main physiological role of SLC25A33 and SLC25A36 is to import/export pyrimidine nucleotides into and from mitochondria, i.e. to accomplish transport steps essential for mitochondrial DNA and RNA synthesis and breakdown.	[Di Noia, Maria Antonietta; Todisco, Simona; Agrimi, Gennaro; Iacobazzi, Vito; Palmieri, Ferdinando] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70125 Bari, Italy; [Di Noia, Maria Antonietta] Univ Basilicata, Dept Sci, I-85100 Potenza, Italy; [Cirigliano, Angela; Rinaldi, Teresa] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Pasteur Inst Cenci Bolognetti Fdn, I-00185 Rome, Italy; [Cirigliano, Angela] ASM Azienda Sanit Locale Matera, Assoc Gian Franco Lupo Sorriso Vita, I-75100 Matera, Italy; [Iacobazzi, Vito] Univ Bari, Ctr Excellence Comparat Genom, I-70125 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Italfarmaco; University of Basilicata; Fondazione Cenci Bolognetti; Sapienza University Rome; Universita degli Studi di Bari Aldo Moro	Palmieri, F (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy.	ferdpalmieri@gmail.com	Rinaldi, Teresa/AAC-9710-2020; Agrimi, Gennaro/D-4001-2018; Todisco, Simona/AAU-2091-2021; Iacobazzi, Vito/A-6106-2016	Rinaldi, Teresa/0000-0001-6291-245X; Agrimi, Gennaro/0000-0002-5219-4412; Iacobazzi, Vito/0000-0002-0470-2056	Ministero dell'Universita e della Ricerca (MIUR); National Research Council (CNR); Centro di Eccellenza in Genomica Comparata (CEGBA); Apulia Region; Italian Human ProteomeNet [RBRN07BMCT_009]	Ministero dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); National Research Council (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Centro di Eccellenza in Genomica Comparata (CEGBA); Apulia Region; Italian Human ProteomeNet	This work was supported by grants from the Ministero dell'Universita e della Ricerca (MIUR), the National Research Council (CNR), Centro di Eccellenza in Genomica Comparata (CEGBA), Apulia Region, and the Italian Human ProteomeNet no. RBRN07BMCT_009 (MIUR).	Agrimi G, 2012, J BIOENERG BIOMEMBR, V44, P333, DOI 10.1007/s10863-012-9445-0; Agrimi G, 2012, BIOCHEM J, V443, P241, DOI 10.1042/BJ20111420; BEREITERHAHN J, 1976, BIOCHIM BIOPHYS ACTA, V423, P1, DOI 10.1016/0005-2728(76)90096-7; Bridges EG, 1999, J BIOL CHEM, V274, P4620, DOI 10.1074/jbc.274.8.4620; Capobianco L, 1996, BIOCHEMISTRY-US, V35, P8974, DOI 10.1021/bi960258v; Chen YL, 2008, GENES CELLS, V13, P679, DOI 10.1111/j.1365-2443.2008.01197.x; Da-Re C, 2014, J BIOL CHEM, V289, P7448, DOI 10.1074/jbc.M113.543926; Favre C, 2010, ONCOGENE, V29, P3964, DOI 10.1038/onc.2010.146; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Fiermonte G, 2001, J BIOL CHEM, V276, P8225, DOI 10.1074/jbc.M009607200; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Franzolin E, 2012, EXP CELL RES, V318, P2226, DOI 10.1016/j.yexcr.2012.05.028; Froschauer EM, 2013, BIOCHEM J, V455, P57, DOI 10.1042/BJ20130144; Gandhi VV, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002078; Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Gutierrez-Aguilar M, 2013, BIOCHEM J, V454, P371, DOI 10.1042/BJ20121753; Hoyos ME, 2003, PLANT J, V33, P1027, DOI 10.1046/j.1365-313X.2003.01685.x; Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200; Lasorsa FM, 2003, J BIOL CHEM, V278, P38686, DOI 10.1074/jbc.M304988200; Leadsham JE, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-92; Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284; Marobbio CMT, 2003, EMBO J, V22, P5975, DOI 10.1093/emboj/cdg574; McDonald BM, 2009, FEBS LETT, V583, P739, DOI 10.1016/j.febslet.2009.01.039; Monne M, 2014, CURR TOP MEMBR, V73, P289, DOI 10.1016/B978-0-12-800223-0.00008-6; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI [10.1042/BSE0470037, 10.1042/bse0470037]; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Palmieri L, 1999, FEBS LETT, V462, P472, DOI 10.1016/S0014-5793(99)01555-0; Palmieri L, 2001, J BIOL CHEM, V276, P1916, DOI 10.1074/jbc.M004332200; Palmieri L, 2008, BIOCHEM J, V410, P621, DOI 10.1042/BJ20070867; Palmieri L, 2006, PLANT PHYSIOL, V142, P855, DOI 10.1104/pp.106.086975; Palmisano A, 1998, BIOCHEM J, V333, P151, DOI 10.1042/bj3330151; Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Porcelli V, 2014, J BIOL CHEM, V289, P13374, DOI 10.1074/jbc.M114.547448; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VANDYCK E, 1995, MOL GEN GENET, V246, P426, DOI 10.1007/BF00290446; Volejnikova A, 2013, FEMS YEAST RES, V13, P7, DOI 10.1111/1567-1364.12001; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Xu YJ, 2008, J BIOL CHEM, V283, P1563, DOI 10.1074/jbc.M707997200; Yoon H, 2011, BIOCHEM J, V440, P137, DOI 10.1042/BJ20111036; ZARA V, 1992, J BIOL CHEM, V267, P12077	55	72	74	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33137	33148		10.1074/jbc.M114.610808	http://dx.doi.org/10.1074/jbc.M114.610808			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25320081	Green Published, hybrid			2022-12-28	WOS:000345636600009
J	Hong, JY; Lee, SH; Lee, SC; Kim, JW; Kim, KP; Kim, SM; Tapia, N; Lim, KT; Kim, J; Ahn, HS; Ko, K; Shin, CY; Lee, HT; Scholer, HR; Hyun, JK; Han, DW				Hong, Jin Young; Lee, Sung Ho; Lee, Seung Chan; Kim, Jong-Wan; Kim, Kee-Pyo; Kim, Sung Min; Tapia, Natalia; Lim, Kyung Tae; Kim, Jonghun; Ahn, Hong-Sun; Ko, Kinarm; Shin, Chan Young; Lee, Hoon Taek; Schoeler, Hans R.; Hyun, Jung Keun; Han, Dong Wook			Therapeutic Potential of Induced Neural Stem Cells for Spinal Cord Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL RECOVERY; DIRECT CONVERSION; AXONAL GROWTH; FIBROBLASTS; TRANSPLANTATION; CONNECTIVITY; CONTUSION; NEURONS; CYCLE; RATS	The spinal cord does not spontaneously regenerate, and treatment that ensures functional recovery after spinal cord injury (SCI) is still not available. Recently, fibroblasts have been directly converted into induced neural stem cells (iNSCs) by the forced expression defined transcription factors. Although directly converted iNSCs have been considered to be a cell source for clinical applications, their therapeutic potential has not yet been investigated. Here we show that iNSCs directly converted from mouse fibroblasts enhance the functional recovery of SCI animals. Engrafted iNSCs could differentiate into all neuronal lineages, including different subtypes of mature neurons. Furthermore, iNSC-derived neurons could form synapses with host neurons, thus enhancing the locomotor function recovery. A time course analysis of iNSC-treated SCI animals revealed that engrafted iNSCs effectively reduced the inflammatory response and apoptosis in the injured area. iNSC transplantation also promoted the active regeneration of the endogenous recipient environment in the absence of tumor formation. Therefore, our data suggest that directly converted iNSCs hold therapeutic potential for treatment of SCI and may thus represent a promising cell source for transplantation therapy in patients with SCI.	[Hong, Jin Young; Kim, Jong-Wan; Ahn, Hong-Sun; Hyun, Jung Keun] Dankook Univ, Grad Sch, Dept Nanobiomed Sci, Cheonan 330714, South Korea; [Hong, Jin Young; Kim, Jong-Wan; Ahn, Hong-Sun; Hyun, Jung Keun] Dankook Univ, Grad Sch, NBM Global Res Ctr BK21PLUS, Cheonan 330714, South Korea; [Hong, Jin Young; Kim, Jong-Wan; Ahn, Hong-Sun; Hyun, Jung Keun] Dankook Univ, Inst Tissue Regenerat Engn, Cheonan 330714, South Korea; [Lee, Sung Ho; Lee, Seung Chan; Kim, Sung Min; Lim, Kyung Tae; Kim, Jonghun; Ko, Kinarm; Lee, Hoon Taek; Han, Dong Wook] Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul 143701, South Korea; [Shin, Chan Young] Konkuk Univ, Sch Med, Dept Pharmacol, Seoul 143701, South Korea; [Shin, Chan Young; Han, Dong Wook] Konkuk Univ, Open Innovat Ctr, Inst Biomed Sci & Technol, Seoul 143701, South Korea; [Kim, Kee-Pyo; Tapia, Natalia; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Hyun, Jung Keun] Dankook Univ, Coll Med, Dept Rehabil Med, Cheonan 330714, South Korea	Dankook University; Dankook University; Dankook University; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; Max Planck Society; University of Munster; Dankook University	Hyun, JK (corresponding author), Dankook Univ, Grad Sch, Dept Nanobiomed Sci, Cheonan 330714, South Korea.	rhhyun@dankook.ac.kr; dwhan@konkuk.ac.kr	, HS/AAB-4434-2019; Hyun, Jung Keun/ABB-2173-2020; Lim, Kyungtae/GYU-3532-2022; Tapia, Natalia/H-5500-2012	, HS/0000-0003-2643-5136; Hyun, Jung Keun/0000-0001-9254-4424; Lim, Kyungtae/0000-0001-6044-2191; Kim, Jonghun/0000-0002-9154-5529; Tapia, Natalia/0000-0003-0226-1952; Kim, Sungmin/0000-0002-3249-9075	Korea Health Technology R&D Project, Ministry of Health Welfare [A120392]; Priority Research Center Program of the National Research Foundation of Korea (Ministry of Education, Science and Technology) [2009-0093829]	Korea Health Technology R&D Project, Ministry of Health Welfare; Priority Research Center Program of the National Research Foundation of Korea (Ministry of Education, Science and Technology)	This work was supported by Korea Health Technology R&D Project, Ministry of Health & Welfare Grant A120392 and Priority Research Center Program Grant 2009-0093829) of the National Research Foundation of Korea (Ministry of Education, Science and Technology).	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Ben-Hur T, 2004, STEM CELLS, V22, P1246, DOI 10.1634/stemcells.2004-0094; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Fouad K, 2004, EUR J NEUROSCI, V20, P2479, DOI 10.1111/j.1460-9568.2004.03716.x; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Han DW, 2009, STEM CELLS, V27, P1088, DOI 10.1002/stem.43; Hyun JK, 2009, J NEUROTRAUM, V26, P1773, DOI [10.1089/neu.2007.0485, 10.1089/neu.2007-0485]; Joo NY, 2012, ACTA BIOMATER, V8, P1802, DOI 10.1016/j.actbio.2012.01.026; Kim SM, 2014, NAT PROTOC, V9, P871, DOI 10.1038/nprot.2014.056; Kumamaru H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2132; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Lu P, 2014, CURR OPIN NEUROBIOL, V27, P103, DOI 10.1016/j.conb.2014.03.010; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Marthaler AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085138; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Park WB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-119; Siebert JR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-148; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Willyard C, 2013, NATURE, V503, pS4, DOI 10.1038/503S4a; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564	29	54	58	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.588871	http://dx.doi.org/10.1074/jbc.M114.588871			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25294882	hybrid, Green Published			2022-12-28	WOS:000345335000011
J	Bill, A; Popa, MO; van Diepen, MT; Gutierrez, A; Lilley, S; Velkova, M; Acheson, K; Choudhury, H; Renaud, NA; Auld, DS; Gosling, M; Groot-Kormelink, PJ; Gaither, LA				Bill, Anke; Popa, M. Oana; van Diepen, Michiel T.; Gutierrez, Abraham; Lilley, Sarah; Velkova, Maria; Acheson, Kathryn; Choudhury, Hedaythul; Renaud, Nicole A.; Auld, Douglas S.; Gosling, Martin; Groot-Kormelink, Paul J.; Gaither, L. Alex			Variomics Screen Identifies the Re-entrant Loop of the Calcium-activated Chloride Channel ANO1 That Facilitates Channel Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED CL-CHANNEL; MEMBRANE-PROTEIN; ESSENTIAL COMPONENT; INTERSTITIAL-CELLS; TMEM16A; CONTRIBUTES; EXPRESSION; MUTATIONS; LIPIDS; CAJAL	The calcium-activated chloride channel ANO1 regulates multiple physiological processes. However, little is known about the mechanism of channel gating and regulation of ANO1 activity. Using a high-throughput, random mutagenesis-based variomics screen, we generated and functionally characterized similar to 6000 ANO1 mutants and identified novel mutations that affected channel activity, intracellular trafficking, or localization of ANO1. Mutations such as S741T increased ANO1 calcium sensitivity and rendered ANO1 calcium gating voltage-independent, demonstrating a critical role of the re-entrant loop in coupling calcium and voltage sensitivity of ANO1 and hence in regulating ANO1 activation. Our data present the first unbiased and comprehensive study of the structure-function relationship of ANO1. The novel ANO1 mutants reported have diverse functional characteristics, providing new tools to study ANO1 function in biological systems, paving the path for a better understanding of the function of ANO1 and its role in health and diseases.	[Bill, Anke; Gutierrez, Abraham; Renaud, Nicole A.; Auld, Douglas S.; Gaither, L. Alex] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Popa, M. Oana; van Diepen, Michiel T.; Lilley, Sarah; Velkova, Maria; Acheson, Kathryn; Choudhury, Hedaythul; Gosling, Martin] Novartis Inst Biomed Res, Horsham RH12 5AB, W Sussex, England; [Groot-Kormelink, Paul J.] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	Novartis; Novartis; Novartis	Gaither, LA (corresponding author), Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	alex.gaither@novartis.com		van Diepen, Michiel/0000-0001-8156-4294; Popa, Mariana Oana/0000-0002-2766-6801; Bill, Anke/0000-0003-1244-7574; Choudhury, Hedaythul/0000-0003-3374-7939; Lilley, Sarah/0000-0002-0236-2027				Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; Bill A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097973; Bill A, 2014, J BIOL CHEM, V289, P11029, DOI 10.1074/jbc.M114.549188; Bolduc V, 2010, AM J HUM GENET, V86, P213, DOI 10.1016/j.ajhg.2009.12.013; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Charlesworth G, 2012, AM J HUM GENET, V91, P1041, DOI 10.1016/j.ajhg.2012.10.024; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Das S, 2008, CANCER RES, V68, P6306, DOI 10.1158/0008-5472.CAN-08-0870; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Duran C, 2010, ANNU REV PHYSIOL, V72, P95, DOI 10.1146/annurev-physiol-021909-135811; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Faria D, 2014, KIDNEY INT, V85, P1369, DOI 10.1038/ki.2013.535; Fischer MA, 2009, TRAFFIC, V10, P1084, DOI 10.1111/j.1600-0854.2009.00926.x; Forrest AS, 2012, AM J PHYSIOL-CELL PH, V303, pC1229, DOI 10.1152/ajpcell.00044.2012; Galindo BE, 2005, INT J MOL MED, V16, P919; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Huang F., P NATL ACAD SCI US, V106, P21413; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Jung J, 2013, P NATL ACAD SCI USA, V110, P360, DOI 10.1073/pnas.1211594110; Kumar S, 2012, BIOORGAN MED CHEM, V20, P4237, DOI 10.1016/j.bmc.2012.05.074; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Maass K, 2009, J CELL SCI, V122, P625, DOI 10.1242/jcs.036012; Manoury B, 2010, J PHYSIOL-LONDON, V588, P2305, DOI 10.1113/jphysiol.2010.189506; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; McPate M, 2014, ASSAY DRUG DEV TECHN, V12, P282, DOI 10.1089/adt.2014.574; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Ousingsawat J, 2011, PFLUG ARCH EUR J PHY, V461, P579, DOI 10.1007/s00424-011-0947-0; Paran Y, 2006, METHOD ENZYMOL, V414, P228, DOI 10.1016/S0076-6879(06)14013-6; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Sarkozy A, 2013, HUM MUTAT, V34, P1111, DOI 10.1002/humu.22342; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Scudieri P, 2013, BIOCHEM J, V452, P443, DOI 10.1042/BJ20130348; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Sondo E, 2014, INT J BIOCHEM CELL B, V52, P73, DOI 10.1016/j.biocel.2014.03.022; Sondo E, 2014, BBA-BIOMEMBRANES, V1838, P89, DOI 10.1016/j.bbamem.2013.08.010; Suzuki T, 2014, J BIOL CHEM, V289, P7438, DOI 10.1074/jbc.M113.542324; Tanaka T, 2014, KIDNEY INT, V85, P1007, DOI 10.1038/ki.2013.436; Terashima H, 2013, P NATL ACAD SCI USA, V110, P19354, DOI 10.1073/pnas.1312014110; Tian YM, 2011, FASEB J, V25, P1058, DOI 10.1096/fj.10-166884; Tien J, 2014, ELIFE, V3, DOI 10.7554/eLife.02772; Tien J, 2013, P NATL ACAD SCI USA, V110, P6352, DOI 10.1073/pnas.1303672110; Vermeer S, 2010, AM J HUM GENET, V87, P813, DOI 10.1016/j.ajhg.2010.10.015; Vocke K, 2013, J GEN PHYSIOL, V142, P381, DOI 10.1085/jgp.201311015; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2014, J GEN PHYSIOL, V143, P253, DOI 10.1085/jgp.201311047; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Zhang CH, 2013, AM J RESP CRIT CARE, V187, P374, DOI 10.1164/rccm.201207-1303OC	56	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					889	903		10.1074/jbc.M114.618140	http://dx.doi.org/10.1074/jbc.M114.618140			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25425649	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000347778200024
J	Dolino, DM; Cooper, D; Ramaswamy, S; Jaurich, H; Landes, CF; Jayaraman, V				Dolino, Drew M.; Cooper, David; Ramaswamy, Swarna; Jaurich, Henriette; Landes, Christy F.; Jayaraman, Vasanthi			Structural Dynamics of the Glycine-binding Domain of the N-Methyl-D-Aspartate Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; PARTIAL AGONIST ACTION; GLUR2 AMPA RECEPTOR; SINGLE-MOLECULE; CRYSTAL-STRUCTURES; NMDA RECEPTORS; CONFORMATIONAL-CHANGES; ION-CHANNEL; ACTIVATION; MECHANISM	N-Methyl-D-aspartate receptors mediate the slow component of excitatory neurotransmission in the central nervous system. These receptors are obligate heteromers containing glycine- and glutamate-binding subunits. The ligands bind to a bilobed agonist-binding domain of the receptor. Previous x-ray structures of the glycine-binding domain of NMDA receptors showed no significant changes between the partial and full agonist-bound structures. Here we have used single molecule fluorescence resonance energy transfer (smFRET) to investigate the cleft closure conformational states that the glycine-binding domain of the receptor adopts in the presence of the antagonist 5,7-dichlorokynurenic acid (DCKA), the partial agonists 1-amino-1-cyclobutanecarboxylic acid (ACBC) and L-alanine, and full agonists glycine and D-serine. For these studies, we have incorporated the unnatural amino acid p-acetyl-L-phenylalanine for specific labeling of the protein with hydrazide derivatives of fluorophores. The single molecule fluorescence resonance energy transfer data show that the agonist-binding domain can adopt a wide range of cleft closure states with significant overlap in the states occupied by ligands of varying efficacy. The difference lies in the fraction of the protein in a more closed-cleft form, with full agonists having a larger fraction in the closed-cleft form, suggesting that the ability of ligands to select for these states could dictate the extent of activation.	[Dolino, Drew M.; Ramaswamy, Swarna; Jayaraman, Vasanthi] Univ Texas Hlth Sci Ctr Houston, Ctr Membrane Biol, Dept Biochem & Mol Biol, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Cooper, David; Jaurich, Henriette; Landes, Christy F.] Rice Univ, Dept Chem, Houston, TX 77251 USA; [Landes, Christy F.] Rice Univ, Dept Elect & Comp Engn, Houston, TX 77251 USA	University of Texas System; University of Texas Health Science Center Houston; Rice University; Rice University	Landes, CF (corresponding author), Rice Univ, Dept Chem, MS 60, Houston, TX 77251 USA.	cflandes@rice.edu; vasanthi.jayaraman@uth.tmc.edu	Landes, Christy/I-5501-2014	Dolino, Drew/0000-0002-2690-7140	National Institutes of Health [GM094246]; Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia (NIGMS) [1 T32 GM089657-05]; Welch Foundation [C-1787]; National Science Foundation [CHE-1151647]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM089657, R01GM094246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia (NIGMS); Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM094246 (to V. J.) and by a training fellowship from the Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia (NIGMS Grant 1 T32 GM089657-05) (to D. M. D.). This work was also supported by the Welch Foundation Grant C-1787 and the National Science Foundation Grant CHE-1151647 (to C. F. L.).	Ahmed AH, 2013, J BIOL CHEM, V288, P27658, DOI 10.1074/jbc.M113.495564; Ahmed AH, 2009, BIOCHEMISTRY-US, V48, P3894, DOI 10.1021/bi900107m; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Chen PE, 2008, J PHYSIOL-LONDON, V586, P227, DOI 10.1113/jphysiol.2007.143172; Cooper D, 2013, CHEMBIOCHEM, V14, P1075, DOI 10.1002/cbic.201300030; Darugar Q, 2008, J VIROL, V82, P12164, DOI 10.1128/JVI.01158-08; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Hansen KB, 2013, MOL PHARMACOL, V84, P114, DOI 10.1124/mol.113.085803; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; JOHNSON KR, 2009, NATL GEOGR, V215, P8; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Mankiewicz KA, 2008, BIOCHEMISTRY-US, V47, P398, DOI 10.1021/bi702004b; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Ramaswamy S, 2012, J BIOL CHEM, V287, P43557, DOI 10.1074/jbc.M112.371815; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Taylor JN, 2008, BIOCHEM BIOPH RES CO, V373, P213, DOI 10.1016/j.bbrc.2008.05.191; Taylor JN, 2011, J PHYS CHEM B, V115, P1105, DOI 10.1021/jp1050707; Taylor JN, 2010, BIOPHYS J, V98, P164, DOI 10.1016/j.bpj.2009.09.047; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Yao YN, 2013, STRUCTURE, V21, P1788, DOI 10.1016/j.str.2013.07.011; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	31	31	31	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					797	804		10.1074/jbc.M114.605436	http://dx.doi.org/10.1074/jbc.M114.605436			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25404733	hybrid, Green Published			2022-12-28	WOS:000347778200010
J	Lin, CW; Wang, PH; Ismail, W; Tsai, YW; El Nayal, A; Yang, CY; Yang, FC; Wang, CH; Chiang, YR				Lin, Ching-Wen; Wang, Po-Hsiang; Ismail, Wael; Tsai, Yu-Wen; El Nayal, Ashraf; Yang, Chia-Ying; Yang, Fu-Chun; Wang, Chia-Hsiang; Chiang, Yin-Ru			Substrate Uptake and Subcellular Compartmentation of Anoxic Cholesterol Catabolism in Sterolibacterium denitrificans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; CELL-SURFACE HYDROPHOBICITY; OUTER-MEMBRANE TRANSPORT; MYCOBACTERIUM-TUBERCULOSIS; FATTY-ACIDS; PSEUDOMONAS-TESTOSTERONI; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; METABOLISM; STEROIDS	Cholesterol catabolism by actinobacteria has been extensively studied. In contrast, the uptake and catabolism of cholesterol by Gram-negative species are poorly understood. Here, we investigated microbial cholesterol catabolism at the subcellular level. C-13 metabolomic analysis revealed that anaerobically grown Sterolibacterium denitrificans, a beta-proteobacterium, adopts an oxygenase-independent pathway to degrade cholesterol. S. denitrificans cells did not produce biosurfactants upon growth on cholesterol and exhibited high cell surface hydrophobicity. Moreover, S. denitrificans did not produce extracellular catabolic enzymes to transform cholesterol. Accordingly, S. denitrificans accessed cholesterol by direction adhesion. Cholesterol is imported through the outer membrane via a putative FadL-like transport system, which is induced by neutral sterols. The outer membrane steroid transporter is able to selectively import various C-27 sterols into the periplasm. S. denitrificans spheroplasts exhibited a significantly higher efficiency in cholest-4-en-3-one-26-oic acid uptake than in cholesterol uptake. We separated S. denitrificans proteins into four fractions, namely the outer membrane, periplasm, inner membrane, and cytoplasm, and we observed the individual catabolic reactions within them. Our data indicated that, in the periplasm, various periplasmic and peripheral membrane enzymes transform cholesterol into cholest-4-en-3-one-26-oic acid. The C27 acidic steroid is then transported into the cytoplasm, in which side-chain degradation and the subsequent sterane cleavage occur. This study sheds light into microbial cholesterol metabolism under anoxic conditions.	[Lin, Ching-Wen; Wang, Po-Hsiang; Tsai, Yu-Wen; Yang, Chia-Ying; Yang, Fu-Chun; Wang, Chia-Hsiang; Chiang, Yin-Ru] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Ismail, Wael; El Nayal, Ashraf] Arabian Gulf Univ, Coll Grad Studies, Biotechnol Program, Dept Life Sci, Manama 329, Bahrain	Academia Sinica - Taiwan; Arabian Gulf University	Chiang, YR (corresponding author), Acad Sinica, Biodivers Res Ctr, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	yinru915@gate.sinica.edu.tw	Chiang, Yin-Ru/L-7727-2019; Ismail, Wael/X-5336-2019	Chiang, Yin-Ru/0000-0001-6899-3166; Ahmed Ismail El Moslimany, Wael/0000-0002-3027-928X	Ministry of Science and Technology of Taiwan [103-2311-B-001-013]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Science and Technology of Taiwan Grant 103-2311-B-001-013.	Abumrad N, 1998, J LIPID RES, V39, P2309; Adachi O., 2007, MODERN OXIDATION ENZ, P1, DOI [DOI 10.1002/9783527611522.CH1, 10.1002/9783527611522.ch1]; Al-Tahhan RA, 2000, APPL ENVIRON MICROB, V66, P3262, DOI 10.1128/AEM.66.8.3262-3268.2000; Birkenmaier A, 2007, J BACTERIOL, V189, P7165, DOI 10.1128/JB.00665-07; Casali N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-60; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chatfield CH, 2011, J BACTERIOL, V193, P1563, DOI 10.1128/JB.01111-10; Chiang YR, 2008, J BACTERIOL, V190, P905, DOI 10.1128/JB.01525-07; Chiang YR, 2008, APPL ENVIRON MICROB, V74, P107, DOI 10.1128/AEM.01968-07; Chiang YR, 2007, J BIOL CHEM, V282, P13240, DOI 10.1074/jbc.M610963200; Chitale S, 2001, CELL MICROBIOL, V3, P247, DOI 10.1046/j.1462-5822.2001.00110.x; DEMAAGD RA, 1986, J BACTERIOL, V167, P1083, DOI 10.1128/jb.167.3.1083-1085.1986; Dermer J, 2012, J BIOL CHEM, V287, P36905, DOI 10.1074/jbc.M112.407304; Donova MV, 2007, APPL BIOCHEM MICRO+, V43, P1, DOI 10.1134/S0003683807010012; Fernandes P, 2003, ENZYME MICROB TECH, V32, P688, DOI 10.1016/S0141-0229(03)00029-2; Garcia JL, 2012, MICROB BIOTECHNOL, V5, P679, DOI 10.1111/j.1751-7915.2012.00331.x; Hearn EM, 2008, P NATL ACAD SCI USA, V105, P8601, DOI 10.1073/pnas.0801264105; Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678; Hotze EM, 2013, INFECT IMMUN, V81, P216, DOI 10.1128/IAI.00927-12; Ismail W., 2011, J BIOREMED BIODEGR S, DOI [10.4172/2155-6199, DOI 10.4172/2155-6199]; Kaczorek E, 2013, NEW BIOTECHNOL, V30, P173, DOI 10.1016/j.nbt.2012.09.003; Keleti G., 1974, HDB MICROMETHODS BIO, P74; Kingston RL, 1996, STRUCTURE, V4, P1413, DOI 10.1016/S0969-2126(96)00149-9; Kniemeyer O, 2001, J BIOL CHEM, V276, P21381, DOI 10.1074/jbc.M101679200; Kreit J, 2009, FEBS J, V276, P6844, DOI 10.1111/j.1742-4658.2009.07378.x; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Lepore BW, 2011, P NATL ACAD SCI USA, V108, P10121, DOI 10.1073/pnas.1018532108; Leu YL, 2011, J BACTERIOL, V193, P4447, DOI 10.1128/JB.00331-11; MACKENZIE AS, 1982, SCIENCE, V217, P491, DOI 10.1126/science.217.4559.491; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Mnif S, 2011, J APPL MICROBIOL, V111, P525, DOI 10.1111/j.1365-2672.2011.05071.x; Mohn WW, 2008, J BIOL CHEM, V283, P35368, DOI 10.1074/jbc.M805496200; MORIKAWA M, 1993, J BACTERIOL, V175, P6459, DOI 10.1128/JB.175.20.6459-6466.1993; Myers JD, 2005, MICROBIOL-SGM, V151, P233, DOI 10.1099/mic.0.27573-0; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; O'Brien DK, 2004, INFECT IMMUN, V72, P5204, DOI 10.1128/IAI.72.9.5204-5215.2004; Obuekwe CO, 2009, INT BIODETER BIODEGR, V63, P273, DOI 10.1016/j.ibiod.2008.10.004; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Philipp B, 2011, APPL MICROBIOL BIOT, V89, P903, DOI 10.1007/s00253-010-2998-0; Plesiat P, 1997, J BACTERIOL, V179, P7004, DOI 10.1128/jb.179.22.7004-7010.1997; PLESIAT P, 1992, MOL MICROBIOL, V6, P1323, DOI 10.1111/j.1365-2958.1992.tb00853.x; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; RUDEL LL, 1973, J LIPID RES, V14, P364; STOCK JB, 1977, J BIOL CHEM, V252, P7850; Swain K, 2012, J BACTERIOL, V194, P6720, DOI 10.1128/JB.01167-12; TAMAOKA J, 1987, INT J SYST BACTERIOL, V37, P52, DOI 10.1099/00207713-37-1-52; Tarlera S, 2003, INT J SYST EVOL MICR, V53, P1085, DOI 10.1099/ijs.0.02039-0; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Villamon E, 2003, ANTON LEEUW INT J G, V84, P31, DOI 10.1023/A:1024435612550; Walter V, 2010, ADV EXP MED BIOL, V672, P1; Wang PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066675; WATANABE M, 1974, J STEROID BIOCHEM, V5, P439, DOI 10.1016/0022-4731(74)90041-7; Wiener MC, 2005, CURR OPIN STRUC BIOL, V15, P394, DOI 10.1016/j.sbi.2005.07.001; Wiener MC, 2011, P NATL ACAD SCI USA, V108, P10929, DOI 10.1073/pnas.1106927108; WULFING C, 1994, J MOL BIOL, V242, P655, DOI 10.1006/jmbi.1994.1615; Yi S, 2012, APPL ENVIRON MICROB, V78, P7745, DOI 10.1128/AEM.02150-12; Zoueki CW, 2010, J COLLOID INTERF SCI, V344, P492, DOI 10.1016/j.jcis.2009.12.043	60	23	24	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1155	1169		10.1074/jbc.M114.603779	http://dx.doi.org/10.1074/jbc.M114.603779			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25418128	Green Published, hybrid			2022-12-28	WOS:000347778200046
J	Liu, C; Wajih, N; Liu, XH; Basu, S; Janes, J; Marvel, M; Keggi, C; Helms, CC; Lee, AN; Belanger, AM; Diz, DI; Laurienti, PJ; Caudell, DL; Wang, J; Gladwin, MT; Kim-Shapiro, DB				Liu, Chen; Wajih, Nadeem; Liu, Xiaohua; Basu, Swati; Janes, John; Marvel, Madison; Keggi, Christian; Helms, Christine C.; Lee, Amber N.; Belanger, Andrea M.; Diz, Debra I.; Laurienti, Paul J.; Caudell, David L.; Wang, Jun; Gladwin, Mark T.; Kim-Shapiro, Daniel B.			Mechanisms of Human Erythrocytic Bioactivation of Nitrite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELL; DIETARY NITRATE; XANTHINE OXIDOREDUCTASE; DEPENDENT VASODILATION; PLATELET ACTIVATION; MET HEMOGLOBIN; OXIDE; NO; REDUCTION; MYOGLOBIN	Nitrite signaling likely occurs through its reduction to nitric oxide (NO). Several reports support a role of erythrocytes and hemoglobin in nitrite reduction, but this remains controversial, and alternative reductive pathways have been proposed. In this work we determined whether the primary human erythrocytic nitrite reductase is hemoglobin as opposed to other erythrocytic proteins that have been suggested to be the major source of nitrite reduction. We employed several different assays to determine NO production from nitrite in erythrocytes including electron paramagnetic resonance detection of nitrosyl hemoglobin, chemiluminescent detection of NO, and inhibition of platelet activation and aggregation. Our studies show that NO is formed by red blood cells and inhibits platelet activation. Nitric oxide formation and signaling can be recapitulated with isolated deoxyhemoglobin. Importantly, there is limited NO production from erythrocytic xanthine oxidoreductase and nitric-oxide synthase. Under certain conditions we find dorzolamide (an inhibitor of carbonic anhydrase) results in diminished nitrite bioactivation, but the role of carbonic anhydrase is abrogated when physiological concentrations of CO2 are present. Importantly, carbon monoxide, which inhibits hemoglobin function as a nitrite reductase, abolishes nitrite bioactivation. Overall our data suggest that deoxyhemoglobin is the primary erythrocytic nitrite reductase operating under physiological conditions and accounts for nitrite-mediated NO signaling in blood.	[Liu, Chen; Wajih, Nadeem; Liu, Xiaohua; Basu, Swati; Janes, John; Marvel, Madison; Keggi, Christian; Lee, Amber N.; Belanger, Andrea M.; Kim-Shapiro, Daniel B.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [Basu, Swati; Diz, Debra I.; Laurienti, Paul J.; Kim-Shapiro, Daniel B.] Wake Forest Univ, Translat Sci Ctr, Winston Salem, NC 27109 USA; [Helms, Christine C.] Univ Richmond, Dept Phys, Richmond, VA 23173 USA; [Diz, Debra I.; Kim-Shapiro, Daniel B.] Wake Forest Univ, Sch Med, Hypertens & Vasc Res Ctr, Winston Salem, NC 27157 USA; [Basu, Swati; Laurienti, Paul J.] Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27157 USA; [Laurienti, Paul J.; Kim-Shapiro, Daniel B.] Wake Forest Univ, Sch Med, Dept Biomed Engn, Winston Salem, NC 27157 USA; [Caudell, David L.] Wake Forest Univ, Sch Med, Dept Pathol Comparat Med, Winston Salem, NC 27157 USA; [Wang, Jun; Gladwin, Mark T.] Univ Pittsburgh, Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA 15213 USA; [Gladwin, Mark T.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA	Wake Forest University; Wake Forest University; University of Richmond; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim-Shapiro, DB (corresponding author), Wake Forest Univ, Dept Phys, Olin Phys Lab 208, Winston Salem, NC 27109 USA.	shapiro@wfu.edu	Wajih, Nadeem/GMW-6625-2022; Kim-Shapiro, Daniel/HGA-2682-2022	Keggi, Christian/0000-0002-6190-4893; Wang, Jun/0000-0001-7564-2364	NCI, National Institutes of Health [P30 CA121291-37]; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA121291] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058091, R01HL058091, R29HL058091, R01HL098032] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge services provided by the Flow Cytometry Core Laboratory of the Comprehensive Cancer Center, supported in part by NCI, National Institutes of Health Grant P30 CA121291-37.	Aamand R, 2009, AM J PHYSIOL-HEART C, V297, pH2068, DOI 10.1152/ajpheart.00525.2009; Akrawinthawong K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092435; Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; AZUMA H, 1986, BRIT J PHARMACOL, V88, P411, DOI 10.1111/j.1476-5381.1986.tb10218.x; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Brooks J, 1937, PROC R SOC SER B-BIO, V123, P368, DOI 10.1098/rspb.1937.0057; CASSOLY R, 1975, J MOL BIOL, V91, P301, DOI 10.1016/0022-2836(75)90382-4; CLASSEN HG, 1990, J AM COLL NUTR, V9, P500, DOI 10.1080/07315724.1990.10720407; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dalsgaard T, 2007, AM J PHYSIOL-HEART C, V292, pH3072, DOI 10.1152/ajpheart.01298.2006; Dautov RF, 2014, NITRIC OXIDE-BIOL CH, V40, P36, DOI 10.1016/j.niox.2014.05.005; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Ghosh SM, 2013, HYPERTENSION, V61, P1091, DOI 10.1161/HYPERTENSIONAHA.111.00933; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Herold S, 2001, BIOCHEMISTRY-US, V40, P3385, DOI 10.1021/bi002407m; Huang KT, 2007, NITRIC OXIDE-BIOL CH, V16, P209, DOI 10.1016/j.niox.2006.11.002; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Huang Z, 2001, BBA-GEN SUBJECTS, V1568, P252, DOI 10.1016/S0304-4165(01)00227-6; Isbell TS, 2007, AM J PHYSIOL-HEART C, V293, pH2565, DOI 10.1152/ajpheart.00759.2007; Jeffers A, 2005, COMP BIOCHEM PHYS A, V142, P130, DOI 10.1016/j.cbpb.2005.04.016; Kevil CG, 2011, FREE RADICAL BIO MED, V51, P576, DOI 10.1016/j.freeradbiomed.2011.04.042; Kim-Shapiro DB, 2004, FREE RADICAL BIO MED, V36, P402, DOI 10.1016/j.freeradbiomed.2003.10.030; Koppenol WH, 2012, INORG CHEM, V51, P5637, DOI 10.1021/ic202561f; Larsen FJ, 2006, NEW ENGL J MED, V355, P2792, DOI 10.1056/NEJMc062800; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; Li HT, 2008, J BIOL CHEM, V283, P17855, DOI 10.1074/jbc.M801785200; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Modin A, 2001, ACTA PHYSIOL SCAND, V171, P9, DOI 10.1046/j.1365-201x.2001.171001009.x; Nagababu E, 2006, NITRIC OXIDE-BIOL CH, V15, P20, DOI 10.1016/j.niox.2006.01.012; Navati MS, 2010, J PHYS CHEM B, V114, P2938, DOI 10.1021/jp909425z; Navati MS, 2009, J AM CHEM SOC, V131, P12273, DOI 10.1021/ja903364h; Ormerod JOM, 2011, CARDIOVASC RES, V89, P560, DOI 10.1093/cvr/cvq299; Patel RP, 2011, CARDIOVASC RES, V89, P507, DOI 10.1093/cvr/cvq323; Robinson JM, 2005, AM J RESP CELL MOL, V32, P257, DOI 10.1165/rcmb.F292; Salgado MT, 2009, J BIOL CHEM, V284, P12710, DOI 10.1074/jbc.M808647200; Schafer A, 2004, CIRCULATION, V109, P1819, DOI 10.1161/01.CIR.0000126837.88743.DD; Srihirun S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030380; Totzeck M, 2012, CIRCULATION, V126, P325, DOI 10.1161/CIRCULATIONAHA.111.087155; Tsai AL, 2012, BIOCHEMISTRY-US, V51, P172, DOI 10.1021/bi2015629; Tu C, 2009, FREE RADICAL BIO MED, V46, P14, DOI 10.1016/j.freeradbiomed.2008.09.016; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Wollny T, 1997, AM J PHYSIOL-HEART C, V272, pH2875, DOI 10.1152/ajpheart.1997.272.6.H2875	47	61	62	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1281	1294		10.1074/jbc.M114.609222	http://dx.doi.org/10.1074/jbc.M114.609222			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25471374	hybrid, Green Published			2022-12-28	WOS:000347778200056
J	Badarau, A; Rouha, H; Malafa, S; Logan, DT; Hakansson, M; Stulik, L; Dolezilkova, I; Teubenbacher, A; Gross, K; Maierhofer, B; Weber, S; Jagerhofer, M; Hoffman, D; Nagy, E				Badarau, Adriana; Rouha, Harald; Malafa, Stefan; Logan, Derek T.; Hakansson, Maria; Stulik, Lukas; Dolezilkova, Ivana; Teubenbacher, Astrid; Gross, Karin; Maierhofer, Barbara; Weber, Susanne; Jaegerhofer, Michaela; Hoffman, David; Nagy, Eszter			Structure-Function Analysis of Heterodimer Formation, Oligomerization, and Receptor Binding of the Staphylococcus aureus Bi-component Toxin LukGH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Toxin; Crystal Structure; Crystallography; Microbial Pathogenesis; Mutagenesis; Staphylococcus aureus (S; aureus)	PORE-FORMING TOXINS; GAMMA-HEMOLYSIN; SEQUENTIAL BINDING; MACROMOLECULAR CRYSTALLOGRAPHY; ERYTHROCYTE-MEMBRANES; 2 COMPONENTS; LEUKOCIDIN; NEUTROPHILS; TARGETS; INFECTION	Background:LukGH is a member of the family of two-component bacterial toxins of Staphylococcus aureus that lyse human phagocytic cells. Results:The crystal structure of LukGH and mutagenesis revealed the molecular basis for heterodimer formation in solution. Conclusion:LukGH differs from other two-component leukocidins that interact only upon cell contact. Significance:These data might assist with development of therapeutics that counteract Staphylococcus aureus pathogenesis. The bi-component leukocidins of Staphylococcus aureus are important virulence factors that lyse human phagocytic cells and contribute to immune evasion. The -hemolysins (HlgAB and HlgCB) and Panton-Valentine leukocidin (PVL or LukSF) were shown to assemble from soluble subunits into membrane-bound oligomers on the surface of target cells, creating barrel-like pore structures that lead to cell lysis. LukGH is the most distantly related member of this toxin family, sharing only 30-40% amino acid sequence identity with the others. We observed that, unlike other leukocidin subunits, recombinant LukH and LukG had low solubility and were unable to bind to target cells, unless both components were present. Using biolayer interferometry and intrinsic tryptophan fluorescence we detected binding of LukH to LukG in solution with an affinity in the low nanomolar range and dynamic light scattering measurements confirmed formation of a heterodimer. We elucidated the structure of LukGH by x-ray crystallography at 2.8- resolution. This revealed an octameric structure that strongly resembles that reported for HlgAB, but with important structural differences. Structure guided mutagenesis studies demonstrated that three salt bridges, not found in other bi-component leukocidins, are essential for dimer formation in solution and receptor binding. We detected weak binding of LukH, but not LukG, to the cellular receptor CD11b by biolayer interferometry, suggesting that in common with other members of this toxin family, the S-component has the primary contact role with the receptor. These new insights provide the basis for novel strategies to counteract this powerful toxin and Staphylococcus aureus pathogenesis.	[Badarau, Adriana; Rouha, Harald; Malafa, Stefan; Stulik, Lukas; Dolezilkova, Ivana; Teubenbacher, Astrid; Gross, Karin; Maierhofer, Barbara; Weber, Susanne; Jaegerhofer, Michaela; Hoffman, David; Nagy, Eszter] Arsanis Biosci, A-1030 Vienna, Austria; [Logan, Derek T.; Hakansson, Maria] SARom Biostruct AB, S-22381 Lund, Sweden		Nagy, E (corresponding author), Helmut Qualtinger Gasse 2, A-1030 Vienna, Austria.	eszter.nagy@arsanis.com	Logan, Derek/O-2497-2019; Logan, Derek T/A-1114-2011	Logan, Derek/0000-0002-0098-8560; Logan, Derek T/0000-0002-0098-8560; Malafa, Stefan/0000-0002-0222-9832; Stulik, Lukas/0000-0002-9055-3690	Forschungsforderungsgesellschaft (FFG) "Basisprogramm" from the Austrian Research Promotion Agency [832915, 837128, 841918, 845382]	Forschungsforderungsgesellschaft (FFG) "Basisprogramm" from the Austrian Research Promotion Agency	This work was supported by the Forschungsforderungsgesellschaft (FFG) "Basisprogramm" Grants 832915, 837128, 841918, and 845382 from the Austrian Research Promotion Agency (awarded to Arsanis Biosciences). This work was performed by employees of two biotech companies who own stock (A. B., H. R., L. S., D. T. L., I. D., A. T., K. G., B. M., S. W., M. J., and E. N.) and are inventors on patents (A. B., H. R., and E. N.).	Alonzo F, 2014, MICROBIOL MOL BIOL R, V78, P199, DOI 10.1128/MMBR.00055-13; Alonzo F, 2013, NATURE, V493, P51, DOI 10.1038/nature11724; Aman MJ, 2014, TOXINS, V6, P950, DOI 10.3390/toxins6030950; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COLIN DA, 1994, INFECT IMMUN, V62, P3184, DOI 10.1128/IAI.62.8.3184-3188.1994; DuMont AL, 2014, INFECT IMMUN, V82, P1268, DOI 10.1128/IAI.01444-13; DuMont AL, 2014, TRENDS MICROBIOL, V22, P21, DOI 10.1016/j.tim.2013.10.004; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Gouaux E, 1997, PROTEIN SCI, V6, P2631; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Jayasinghe L, 2005, PROTEIN SCI, V14, P2550, DOI 10.1110/ps.051648505; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneko J, 1997, BIOSCI BIOTECH BIOCH, V61, P846, DOI 10.1271/bbb.61.846; Kato F, 2011, J MICROBIOL METH, V87, P76, DOI 10.1016/j.mimet.2011.07.010; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menestrina G, 2003, FEBS LETT, V552, P54, DOI 10.1016/S0014-5793(03)00850-0; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Monma N, 2004, J BIOCHEM, V136, P427, DOI 10.1093/jb/mvh140; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nguyen VT, 2003, EMBO J, V22, P4968, DOI 10.1093/emboj/cdg498; Reyes-Robles T, 2013, CELL HOST MICROBE, V14, P453, DOI 10.1016/j.chom.2013.09.005; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Ursby T, 2013, J SYNCHROTRON RADIAT, V20, P648, DOI 10.1107/S0909049513011734; Vandenesch F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00012; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108; Yokota K, 2000, BIOSCI BIOTECH BIOCH, V64, P2744, DOI 10.1271/bbb.64.2744	36	39	42	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					142	156		10.1074/jbc.M114.598110	http://dx.doi.org/10.1074/jbc.M114.598110			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25371205	hybrid, Green Published			2022-12-28	WOS:000347231200013
J	Chakrabarti, M; Barlas, MN; McCormick, SP; Lindahl, LS; Lindahl, PA				Chakrabarti, Mrinmoy; Barlas, Mirza Nofil; McCormick, Sean P.; Lindahl, Lora S.; Lindahl, Paul A.			Kinetics of Iron Import into Developing Mouse Organs Determined by a Pup-swapping Method	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Iron Metabolism; Mathematical Modeling; Mossbauer Spectroscopy; Plasma; Transferrin	TRANSFERRIN-BOUND IRON; BRAIN IRON; LIVER; RAT; CELLS; FE-59; FERRITIN; RECEPTOR; MODEL; MICE	Background: Rates of iron import from blood to developing organs were measured. Results: Two distinct iron species in the blood are imported. Conclusion: Nontransferrin-bound iron dominates the iron import process in young mice. Significance: The role of transferrin-bound iron in import should be reevaluated. The kinetics of dietary iron import into various organs of mice were evaluated using a novel pup-swapping approach. Newborn pups whose bodies primarily contained Fe-56 or Fe-57 were swapped at birth such that each nursed on milk containing the opposite isotope. A pup from each litter was euthanized weekly over a 7-week period. Blood plasma was obtained, and organs were isolated typically after flushing with Ringer's buffer. Fe-56 and Fe-57 concentrations were determined for organs and plasma; organ volumes were also determined. Mossbauer spectra of equivalent Fe-57-enriched samples were used to quantify residual blood in organs; this fraction was excluded from later analysis. Rates of import into brain, spleen, heart, and kidneys were highest during the first 2 weeks of life. In contrast, half of iron in the newborn liver exited during that time, and influx peaked later. Two mathematical models were developed to analyze the import kinetics. The only model that simulated the data adequately assumed that an iron-containing species enters the plasma and converts into a second species and that both are independently imported into organs. Consistent with this, liquid chromatography with an on-line ICP-MS detector revealed numerous iron species in plasma besides transferrin. Model fitting required that the first species, assigned to non-transferrin-bound iron, imports faster into organs than the second, assigned to transferrin-bound-iron. Non-transferrin-bound iron rather than transferrin-bound-iron appears to play the dominant role in importing iron into organs during early development of healthy mice.	[Chakrabarti, Mrinmoy; McCormick, Sean P.; Lindahl, Lora S.; Lindahl, Paul A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Barlas, Mirza Nofil] Allegheny Univ Hlth Sci, Dept Math Phys & Stat, Philadelphia, PA 19104 USA; [Lindahl, Paul A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Drexel University; Texas A&M University System; Texas A&M University College Station	Lindahl, PA (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	lindahl@chem.tamu.edu	Lindahl, Paul/B-6137-2015	Lindahl, Paul/0000-0001-8307-9647	National Institutes of Health [GM084266, GM46441]; Robert A. Welch Foundation [A1170]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084266, R56GM046441, R01GM046441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM084266 and GM46441) and the Robert A. Welch Foundation (A1170).	BARISANI D, 1995, AM J PHYSIOL-GASTR L, V269, pG570, DOI 10.1152/ajpgi.1995.269.4.G570; Beard JL, 2005, J NEUROSCI RES, V79, P254, DOI 10.1002/jnr.20324; Brissot P, 2012, BBA-GEN SUBJECTS, V1820, P403, DOI 10.1016/j.bbagen.2011.07.014; CAVILL I, 1971, J CLIN PATHOL, V24, P472, DOI 10.1136/jcp.24.5.472; D'Anna MC, 2011, INT J MORPHOL, V29, P747, DOI 10.4067/S0717-95022011000300014; Chen JH, 2013, METALLOMICS, V5, P167, DOI 10.1039/c2mt20226c; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; DALLMAN PR, 1977, J NUTR, V107, P1075, DOI 10.1093/jn/107.6.1075; Erikson KM, 1997, J NUTR, V127, P2030, DOI 10.1093/jn/127.10.2030; Evans RW, 2008, J BIOL INORG CHEM, V13, P57, DOI 10.1007/s00775-007-0297-8; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Grebe M, 2011, METALLOMICS, V3, P176, DOI 10.1039/c0mt00076k; GROOTVELD M, 1989, J BIOL CHEM, V264, P4417; Gunji H, 2002, CYTOKINE, V20, P30, DOI 10.1006/cyto.2002.1977; Hider RC, 2002, EUR J CLIN INVEST, V32, P50, DOI 10.1046/j.1365-2362.2002.0320s1050.x; Holmes-Hampton GP, 2012, METALLOMICS, V4, P761, DOI 10.1039/c2mt20086d; Jacobs EMG, 2005, ANAL BIOCHEM, V341, P241, DOI 10.1016/j.ab.2005.03.008; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Liao YL, 2012, BIOCHEM CELL BIOL, V90, P476, DOI [10.1139/o11-075, 10.1139/O11-075]; LINK G, 1985, J LAB CLIN MED, V106, P147; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Fernandez-Sanchez ML, 2012, MICROCHEM J, V105, P108, DOI 10.1016/j.microc.2012.03.016; Malecki EA, 1999, J NEUROL SCI, V170, P112, DOI 10.1016/S0022-510X(99)00203-8; MAY PM, 1977, J CHEM SOC DALTON, P588, DOI 10.1039/dt9770000588; Meynard D, 2014, BLOOD, V123, P168, DOI 10.1182/blood-2013-06-427757; PARKES JG, 1995, BBA-GEN SUBJECTS, V1243, P373, DOI 10.1016/0304-4165(94)00162-Q; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Schumann K, 2007, TOXICOLOGY, V241, P19, DOI 10.1016/j.tox.2007.08.082; SIIMES MA, 1980, AM J CLIN NUTR, V33, P2601, DOI 10.1093/ajcn/33.12.2601; Simpson R. J., 1991, BIOCHEM SOC T, V19, p317S; Stankiewicz J, 2007, NEUROTHERAPEUTICS, V4, P371, DOI 10.1016/j.nurt.2007.05.006; TAYLOR EM, 1990, DEV BRAIN RES, V55, P35, DOI 10.1016/0165-3806(90)90103-6; UEDA F, 1993, J NEUROCHEM, V60, P106, DOI 10.1111/j.1471-4159.1993.tb05828.x; WRIGHT TL, 1986, J BIOL CHEM, V261, P909	36	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					520	528		10.1074/jbc.M114.606731	http://dx.doi.org/10.1074/jbc.M114.606731			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25371212	Green Published, hybrid			2022-12-28	WOS:000347231200045
J	Chandra, A; Lin, T; Zhu, J; Tong, W; Huo, YY; Jia, HR; Zhang, YJ; Liu, XS; Cengel, K; Xia, B; Qin, L				Chandra, Abhishek; Lin, Tiao; Zhu, Ji; Tong, Wei; Huo, Yanying; Jia, Haoruo; Zhang, Yejia; Liu, X. Sherry; Cengel, Keith; Xia, Bing; Qin, Ling			PTH1-34 Blocks Radiation-induced Osteoblast Apoptosis by Enhancing DNA Repair through Canonical Wnt Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; DNA Repair; Osteoblast; Parathyroid Hormone; Wnt Pathway; Ionizing Radiation	PELVIC INSUFFICIENCY FRACTURES; PARATHYROID-HORMONE; BONE-FORMATION; IONIZING-RADIATION; INTERMITTENT PTH; PROTEIN-KINASE; IN-VITRO; CELLS; IRRADIATION; EXPRESSION	Background: PTH1-34 alleviates radiation-induced osteoporosis in a preclinical radiotherapy model. Results: PTH1-34 attenuates radiation damage on osteoblasts by increasing Ku70 amount, accelerating DNA repair, and suppressing osteoblast apoptosis. Pathway analyses identify canonical Wnt pathway as an important mediator. Conclusion: PTH1-34 blocks radiation-induced osteoblast apoptosis through activation of -catenin. Significance: PTH1-34 or Wnt agonist could be possible therapy for radiation-induced osteoporosis. Focal radiotherapy for cancer patients has detrimental effects on bones within the radiation field and the primary clinical signs of bone damage include the loss of functional osteoblasts. We reported previously that daily injection of parathyroid hormone (PTH, 1-34) alleviates radiation-induced osteopenia in a preclinical radiotherapy model by improving osteoblast survival. To elucidate the molecular mechanisms, we irradiated osteoblastic UMR 106-01 cells and calvarial organ culture and demonstrated an anti-apoptosis effect of PTH1-34 on these cultures. Inhibitor assay indicated that PTH exerts its radioprotective action mainly through protein kinase A/-catenin pathway. -H2AX foci staining and comet assay revealed that PTH efficiently promotes the repair of DNA double strand breaks (DSBs) in irradiated osteoblasts via activating the -catenin pathway. Interestingly, Wnt3a alone also blocked cell death and accelerated DNA repair in primary osteoprogenitors, osteoblastic and osteocytic cells after radiation through the canonical signaling. Further investigations revealed that both Wnt3a and PTH increase the amount of Ku70, a core protein for initiating the assembly of DSB repair machinery, in osteoblasts after radiation. Moreover, down-regulation of Ku70 by siRNA abrogated the prosurvival effect of PTH and Wnt3a on irradiated osteoblasts. In summary, our results identify a novel role of PTH and canonical Wnt signaling in regulating DSB repair machinery and apoptosis in osteoblasts and shed light on using PTH1-34 or Wnt agonist as possible therapy for radiation-induced osteoporosis.	[Chandra, Abhishek; Lin, Tiao; Zhu, Ji; Tong, Wei; Jia, Haoruo; Liu, X. Sherry; Qin, Ling] Univ Penn, Dept Orthopaed Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zhang, Yejia] Univ Penn, Dept Phys Med & Rehabil, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zhang, Yejia] Univ Penn, Dept Orthoped Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cengel, Keith] Univ Penn, Dept Radiat Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lin, Tiao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthopaed Surg, Hangzhou 310009, Zhejiang, Peoples R China; [Tong, Wei] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed Surg, Wuhan 430022, Hubei, Peoples R China; [Xia, Bing] Rutgers State Univ, Dept Radiat Oncol, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Xia, Bing] Rutgers State Univ, Dept Radiat Oncol, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA; [Zhang, Yejia] Philadelphia Vet Affairs Med Ctr, Translat Musculoskeletal Res Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Zhejiang University; Huazhong University of Science & Technology; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Qin, L (corresponding author), Univ Penn, Dept Orthopaed Surg, Perelman Sch Med, 424 Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA.	qinling@mail.med.upenn.edu	Jia, Haoruo/AAI-1747-2019; Chandra, Abhishek/AAG-8781-2020; Liu, Xiaowei Sherry/H-1664-2017; Tong, Wei/AAJ-1093-2021	Liu, Xiaowei Sherry/0000-0001-7247-2232; Tong, Wei/0000-0001-8031-0380; HUO, YANYING/0000-0003-4747-4951; Chandra, Abhishek/0000-0001-9423-9669	National Institutes of Health [R01DK095803, R01CA138804]; Penn Center for Musculoskeletal Disorder [P30AR050950]; ASBMR Junior Faculty Osteoporosis Basic Research Award; McCabe Pilot Award; NATIONAL CANCER INSTITUTE [R01CA138804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Center for Musculoskeletal Disorder; ASBMR Junior Faculty Osteoporosis Basic Research Award; McCabe Pilot Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK095803 (to L. Q.) and R01CA138804 (to B. X.), Penn Center for Musculoskeletal Disorder Grant P30AR050950 (NIAMS, National Institutes of Health), the ASBMR Junior Faculty Osteoporosis Basic Research Award (to L. Q.), and the McCabe Pilot Award (to X. S. L.).	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; de Oliveira ECA, 2010, CALCIFIED TISSUE INT, V87, P424, DOI 10.1007/s00223-010-9396-6; Amsel AD, 2008, P NATL ACAD SCI USA, V105, P5117, DOI 10.1073/pnas.0706700105; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Baxter NN, 2005, JAMA-J AM MED ASSOC, V294, P2587, DOI 10.1001/jama.294.20.2587; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Chandra A, 2014, BONE, V67, P33, DOI 10.1016/j.bone.2014.06.030; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; Chandra A, 2013, BONE, V55, P449, DOI 10.1016/j.bone.2013.02.023; CIVITELLI R, 1988, AM J PHYSIOL, V255, pE660, DOI 10.1152/ajpendo.1988.255.5.E660; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Dudziak ME, 2000, PLAST RECONSTR SURG, V106, P1049, DOI 10.1097/00006534-200010000-00015; Fei YR, 2012, J CELL PHYSIOL, V227, P3539, DOI 10.1002/jcp.24075; Gal TJ, 2000, ARCH OTOLARYNGOL, V126, P1124, DOI 10.1001/archotol.126.9.1124; Gortazar AR, 2013, J BIOL CHEM, V288, P8168, DOI 10.1074/jbc.M112.437921; Gu YS, 2000, P NATL ACAD SCI USA, V97, P2668, DOI 10.1073/pnas.97.6.2668; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Jilka RL, 2009, BONE, V44, P275, DOI 10.1016/j.bone.2008.10.037; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Kanis JA, 2003, BONE, V32, P468, DOI 10.1016/S8756-3282(03)00061-9; Kitase Y, 2010, J BONE MINER RES, V25, P2381, DOI 10.1002/jbmr.168; Li GC, 1998, MOL CELL, V2, P1, DOI 10.1016/S1097-2765(00)80108-2; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Matsumura S, 1996, CALCIFIED TISSUE INT, V59, P307, DOI 10.1007/s002239900129; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; Mitchell MJ, 1998, RADIOGRAPHICS, V18, P1125, DOI 10.1148/radiographics.18.5.9747611; Moester MJC, 2010, CALCIFIED TISSUE INT, V87, P99, DOI 10.1007/s00223-010-9372-1; Mohammad Khalid S., 2008, V455, P37, DOI 10.1007/978-1-59745-104-8_3; Moreno A, 1999, INT J RADIAT ONCOL, V44, P61, DOI 10.1016/S0360-3016(98)00534-3; Motyl KJ, 2012, J CELL PHYSIOL, V227, P1326, DOI 10.1002/jcp.22844; Mumber MP, 1997, SKELETAL RADIOL, V26, P94, DOI 10.1007/s002560050200; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; PARTRIDGE NC, 1981, ENDOCRINOLOGY, V108, P220, DOI 10.1210/endo-108-1-220; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Qin L, 2012, TOPICS BONE BIOL, P1; Romero G, 2010, J BIOL CHEM, V285, P14756, DOI 10.1074/jbc.M110.102970; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Schnoke M, 2009, BONE, V45, P590, DOI 10.1016/j.bone.2009.05.006; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; SHALHOUB V, 1992, J CELL BIOCHEM, V50, P425, DOI 10.1002/jcb.240500411; Szymczyk KH, 2004, BONE, V34, P148, DOI 10.1016/j.bone.2003.09.003; Tobimatsu T, 2006, ENDOCRINOLOGY, V147, P2583, DOI 10.1210/en.2005-1627; Uezono H, 2013, J RADIAT RES, V54, P1102, DOI 10.1093/jrr/rrt055; Vahle JL, 2002, TOXICOL PATHOL, V30, P312, DOI 10.1080/01926230252929882; Vahle JL, 2004, TOXICOL PATHOL, V32, P426, DOI 10.1080/01926230490462138; Vignard J, 2013, RADIOTHER ONCOL, V108, P362, DOI 10.1016/j.radonc.2013.06.013; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Wang B, 2014, CELL DEATH DIFFER, V21, P1160, DOI 10.1038/cdd.2014.42; Weinstein RS, 2010, ENDOCRINOLOGY, V151, P2641, DOI 10.1210/en.2009-1488; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104	53	39	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					157	167		10.1074/jbc.M114.608158	http://dx.doi.org/10.1074/jbc.M114.608158			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25336648	Green Published, hybrid			2022-12-28	WOS:000347231200014
J	Greenblatt, MB; Kim, JM; Oh, H; Park, KH; Choo, MK; Sano, Y; Tye, CE; Skobe, Z; Davis, RJ; Park, JM; Bei, M; Glimcher, LH; Shim, JH				Greenblatt, Matthew B.; Kim, Jung-Min; Oh, Hwanhee; Park, Kwang Hwan; Choo, Min-Kyung; Sano, Yasuyo; Tye, Coralee E.; Skobe, Ziedonis; Davis, Roger J.; Park, Jin Mo; Bei, Marianna; Glimcher, Laurie H.; Shim, Jae-Hyuck			p38 alpha MAPK Is Required for Tooth Morphogenesis and Enamel Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone Morphogenetic Protein (BMP); Microtubule-associated Protein (MAP); p38 MAPK; SMAD Transcription Factor; Tooth Development; Ameloblast; Ectodermal Dysplasia	ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; IN-VIVO; MOUSE; BMP; APOPTOSIS; MICE; KNOT; FOLLISTATIN; DOWNSTREAM	Background: Little is known regarding the contribution of MAPKs to the development of ectodermal appendages. Results: Mice with a deletion of p38 in ectoderm display defective secretion of dental enamel and the absence of dental cusps. Conclusion: p38 mediates critical steps in tooth morphogenesis and enamel secretion. Significance: This is the first in vivo study demonstrating that the p38 MAPK pathway is critical for tooth morphogenesis and enamel secretion. An improved understanding of the molecular pathways that drive tooth morphogenesis and enamel secretion is needed to generate teeth from organ cultures for therapeutic implantation or to determine the pathogenesis of primary disorders of dentition (Abdollah, S., Macias-Silva, M., Tsukazaki, T., Hayashi, H., Attisano, L., and Wrana, J. L. (1997) J. Biol. Chem. 272, 27678-27685). Here we present a novel ectodermal dysplasia phenotype associated with conditional deletion of p38 MAPK in ectodermal appendages using K14-cre mice (p38(K14) mice). These mice display impaired patterning of dental cusps and a profound defect in the production and biomechanical strength of dental enamel because of defects in ameloblast differentiation and activity. In the absence of p38, expression of amelogenin and (4)-integrin in ameloblasts and p21 in the enamel knot was significantly reduced. Mice lacking the MAP2K MKK6, but not mice lacking MAP2K MKK3, also show the enamel defects, implying that MKK6 functions as an upstream kinase of p38 in ectodermal appendages. Lastly, stimulation with BMP2/7 in both explant culture and an ameloblast cell line confirm that p38 functions downstream of BMPs in this context. Thus, BMP-induced activation of the p38 MAPK pathway is critical for the morphogenesis of tooth cusps and the secretion of dental enamel.	[Greenblatt, Matthew B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kim, Jung-Min; Oh, Hwanhee; Park, Kwang Hwan; Shim, Jae-Hyuck] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Park, Kwang Hwan] Yonsei Univ, Coll Med, Dept Microbiol, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Park, Kwang Hwan] Yonsei Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea; [Choo, Min-Kyung; Sano, Yasuyo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Choo, Min-Kyung; Sano, Yasuyo] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Tye, Coralee E.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [Skobe, Ziedonis] Forsyth Inst, Cambridge, MA 02142 USA; [Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Davis, Roger J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Program Mol Med, Worcester, MA 01605 USA; [Bei, Marianna] Harvard Univ, Sch Med, Shriners Burns Hosp, Dept Surg,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Glimcher, Laurie H.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA	Harvard University; Brigham & Women's Hospital; Cornell University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Harvard University; Massachusetts General Hospital; Harvard University; University of Vermont; Harvard University; Forsyth Institute; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Massachusetts General Hospital; Cornell University	Greenblatt, MB (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	mag3003@med.cornell.edu; jas2060@med.cornell.edu	Kim, Jung Min/AAL-8604-2021	Kim, Jung Min/0000-0002-9072-4293; Davis, Roger/0000-0002-0130-1652; Shim, Jae-Hyuck/0000-0002-4947-3293; Park, Kwang Hwan/0000-0002-2110-0559; Tye, Coralee/0000-0002-3349-1833	National Institutes of Health [AI074957]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI074957 (to J. M. P.). L. H. G. is a member of the board of directors of and holds equity in Bristol-Myers Squibb.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Bartlett JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012703; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; GRUNEBERG H, 1971, J EMBRYOL EXP MORPH, V25, P1; Jernvall J, 1998, DEVELOPMENT, V125, P161; Jernvall J, 2012, DEVELOPMENT, V139, P3487, DOI 10.1242/dev.085084; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Koppinen P, 2001, EXP CELL RES, V269, P180, DOI 10.1006/excr.2001.5331; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Lavelle D, 2003, LEUKEMIA RES, V27, P999, DOI 10.1016/S0145-2126(03)00068-7; Li Y, 2011, CELLS TISSUES ORGANS, V194, P227, DOI 10.1159/000324559; Mikkola ML, 2008, CYTOKINE GROWTH F R, V19, P219, DOI 10.1016/j.cytogfr.2008.04.008; Nakata A, 2003, BIOCHEM BIOPH RES CO, V308, P834, DOI 10.1016/S0006-291X(03)01467-0; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Obara N, 2007, CELL TISSUE RES, V330, P461, DOI 10.1007/s00441-007-0502-7; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Shim JH, 2013, J CLIN INVEST, V123, P4010, DOI 10.1172/JCI69443; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Tanaka N, 2002, EMBO REP, V3, P785, DOI 10.1093/embo-reports/kvf153; Tucker AS, 2000, DEVELOPMENT, V127, P4691; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; Wang XP, 2004, DEV CELL, V7, P719, DOI 10.1016/j.devcel.2004.09.012; Wang XP, 2004, DEV DYNAM, V231, P98, DOI 10.1002/dvdy.20118; Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293; Wysk M, 1999, P NATL ACAD SCI USA, V96, P3763, DOI 10.1073/pnas.96.7.3763; Xu X, 2008, DEV CELL, V15, P322, DOI 10.1016/j.devcel.2008.06.004; Xue H, 2013, EUR J ORAL SCI, V121, P293, DOI 10.1111/eos.12059; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zou WG, 2011, J CLIN INVEST, V121, P4383, DOI 10.1172/JCI59041	36	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					284	295		10.1074/jbc.M114.599274	http://dx.doi.org/10.1074/jbc.M114.599274			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25406311	Green Published, hybrid			2022-12-28	WOS:000347231200026
J	Schroder, J; Moll, JM; Baran, P; Grotzinger, J; Scheller, J; Floss, DM				Schroeder, Jutta; Moll, Jens M.; Baran, Paul; Groetzinger, Joachim; Scheller, Juergen; Floss, Doreen M.			Non-Canonical Interleukin 23 Receptor Complex Assembly P40 PROTEIN RECRUITS INTERLEUKIN 12 RECEPTOR beta 1 VIA SITE II AND INDUCES P19/INTERLEUKIN 23 RECEPTOR INTERACTION VIA SITE III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Cytokine Action; Interleukin; Molecular Modeling; Mutagenesis; Interleukin 12 Receptor; Interleukin 23; Interleukin 23 Receptor; p19; p40	IL-12 P40 HOMODIMER; T-CELLS; BINDING DOMAIN; CYTOKINE; SUBUNIT; GP130; INFLAMMATION; ACTIVATION; DISTINCT; PROTEIN	Background: The heterodimeric cytokine IL-23 binds to a receptor complex consisting of IL-23R and IL-12R1. Results: Binding of IL-23 to IL-12R1 is mediated by domains 1 and 2 of p40. Conclusion: The IL-23<bold>IL</bold>-23R<bold>IL</bold>-12R1 complex formation does not follow the classical site I-II-III architectural paradigm. Significance: The p40 subunit is shared by IL-23 and IL-12 and interacts directly with IL-12R1. IL-23, composed of the cytokine subunit p19 and the soluble receptor subunit p40, binds to a receptor complex consisting of the IL-23 receptor (IL-23R) and the IL-12 receptor 1 (IL-12R1). Complex formation was hypothesized to follow the site I-II-III architectural paradigm, with site I of p19 being required for binding to p40, whereas sites II and III of p19 mediate binding to IL-12R1 and IL-23R, respectively. Here we show that the binding mode of p19 to p40 and of p19 to IL-23R follow the canonical site I and III paradigm but that interaction of IL-23 to IL-12R1 is independent of site II in p19. Instead, binding of IL-23 to the cytokine binding module of IL-12R1 is mediated by domains 1 and 2 of p40 via corresponding site II amino acids of IL-12R1. Moreover, domains 2 and 3 of p40 were sufficient for complex formation with p19 and to induce binding of p19 to IL-23R. The Fc-tagged fusion protein of p40_D2D3/p19 did, however, not act as a competitive IL-23 antagonist but, at higher concentrations, induced proliferation via IL-23R but independent of IL-12R1. On the basis of our experimental validation, we propose a non-canonical topology of the IL-23<bold>IL</bold>-23R<bold>IL</bold>-12R1 complex. Furthermore, our data help to explain why p40 is an antagonist of IL-23 and IL-12 signaling and show that site II of p19 is dispensable for IL-23 signaling.	[Schroeder, Jutta; Moll, Jens M.; Baran, Paul; Scheller, Juergen; Floss, Doreen M.] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Groetzinger, Joachim] Univ Kiel, Fac Med, Inst Biochem, D-24098 Kiel, Germany	Heinrich Heine University Dusseldorf; University of Kiel	Scheller, J (corresponding author), Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de; doreen.floss@uni-duesseldorf.de	Scheller, Jürgen/K-5290-2015		DFG [SCHE 907/2-1, SFB877, A6]; RCMF of the University of Dusseldorf	DFG(German Research Foundation (DFG)); RCMF of the University of Dusseldorf	This work was supported by DFG Grants (SCHE 907/2-1 (to J. Scheller) and SFB877 and A6 (to J. G.) and by the RCMF of the University of Dusseldorf (to D. M. F. and J. Scheller).	Althoff K, 2001, BIOCHEM J, V353, P663, DOI 10.1042/0264-6021:3530663; Bobby R, 2014, FEBS J, V281, P2471, DOI 10.1111/febs.12800; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; CHUA AO, 1995, J IMMUNOL, V155, P4286; Cosmi L, 2014, CYTOM PART A, V85A, P36, DOI 10.1002/cyto.a.22348; Dahmen H, 1998, BIOCHEM J, V331, P695, DOI 10.1042/bj3310695; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Floss DM, 2013, J BIOL CHEM, V288, P19386, DOI 10.1074/jbc.M112.432153; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Ha SJ, 1999, J IMMUNOL, V163, P2902; He W, 2005, FEBS LETT, V579, P4317, DOI 10.1016/j.febslet.2005.06.061; Jalah R, 2013, J BIOL CHEM, V288, P6763, DOI 10.1074/jbc.M112.436675; Jones DS, 2008, TRENDS BIOTECHNOL, V26, P498, DOI 10.1016/j.tibtech.2008.05.009; Jones LL, 2012, MOL IMMUNOL, V51, P234, DOI 10.1016/j.molimm.2012.03.025; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuchar M, 2014, PROTEINS, V82, P975, DOI 10.1002/prot.24472; Levin AA, 2014, J AM ACAD DERMATOL, V70, P555, DOI 10.1016/j.jaad.2013.10.043; LING P, 1995, J IMMUNOL, V154, P116; Lupardus PJ, 2008, J MOL BIOL, V382, P931, DOI 10.1016/j.jmb.2008.07.051; MATTNER F, 1993, EUR J IMMUNOL, V23, P2202, DOI 10.1002/eji.1830230923; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Shimozato O, 2006, IMMUNOLOGY, V117, P22, DOI 10.1111/j.1365-2567.2005.02257.x; Timmermann A, 2000, FEBS LETT, V468, P120, DOI 10.1016/S0014-5793(00)01205-9; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang X, 1999, EUR J IMMUNOL, V29, P2007, DOI 10.1002/(SICI)1521-4141(199906)29:06<2007::AID-IMMU2007>3.0.CO;2-0; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530; Zhao J, 2010, J MASS SPECTROM, V45, P1416, DOI 10.1002/jms.1858	38	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					359	370		10.1074/jbc.M114.617597	http://dx.doi.org/10.1074/jbc.M114.617597			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25371211	Green Published, hybrid			2022-12-28	WOS:000347231200032
J	Larson-Casey, JL; Murthy, S; Ryan, AJ; Carter, AB				Larson-Casey, Jennifer L.; Murthy, Shubha; Ryan, Alan J.; Carter, A. Brent			Modulation of the Mevalonate Pathway by Akt Regulates Macrophage Survival and Development of Pulmonary Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITOR-INDUCED APOPTOSIS; FARNESYLTRANSFERASE INHIBITORS; CELL-TRANSFORMATION; SIGNALING PATHWAY; OXIDATIVE STRESS; GENE-EXPRESSION; CANCER-CELLS; PHOSPHORYLATION; KINASE; GROWTH	Protein kinase B (Akt) is a key effector of multiple cellular processes, including cell survival. Akt, a serine/threonine kinase, is known to increase cell survival by regulation of the intrinsic pathway for apoptosis. In this study, we found that Akt modulated the mevalonate pathway, which is also linked to cell survival, by increasing Rho GTPase activation. Akt modulated the pathway by phosphorylating mevalonate diphosphate decarboxylase (MDD) at Ser(96). This phosphorylation in macrophages increased activation of Rac1, which enhanced macrophage survival because mutation of MDD (MDDS96A) induced apoptosis. Akt-mediated activation in macrophages was specific for Rac1 because Akt did not increase activity of other Rho GTP-binding proteins. The relationship between Akt and Rac1 was biologically relevant because Akt(+/-) mice had significantly less active Rac1 in alveolar macrophages, and macrophages from Akt(+/-) mice had an increase in active caspase-9 and -3. More importantly, Akt(+/-) mice were significantly protected from the development of pulmonary fibrosis, suggesting that macrophage survival is associated with the fibrotic phenotype. These observations for the first time suggest that Akt plays a critical role in the development and progression of pulmonary fibrosis by enhancing macrophage survival via modulation of the mevalonate pathway.	[Larson-Casey, Jennifer L.; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Larson-Casey, Jennifer L.; Carter, A. Brent] Univ Iowa, Carver Coll Med, Program Free Rad & Radiat Biol, Iowa City, IA 52242 USA; [Murthy, Shubha; Ryan, Alan J.; Carter, A. Brent] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Carter, A. Brent] Univ Iowa, Coll Publ Hlth, Dept Human Toxicol, Iowa City, IA 52242 USA; [Carter, A. Brent] Iowa City Vet Affairs Hlth Care Syst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Carter, AB (corresponding author), Univ Iowa, Carver Coll Med, Iowa City Vet Affairs Hlth Care Syst, 200 Hawkins Dr, Iowa City, IA 52242 USA.	brent-carter@uiowa.edu	Casey, Jennifer/N-8385-2019	Casey, Jennifer/0000-0001-7238-7986	National Institutes of Health [2R01ES015981-07, T32CA078586, P30CA086862]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biological Laboratory Research and Development Merit Review Grant [1BX001135-01]; NATIONAL CANCER INSTITUTE [T32CA078586, P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605, R01ES015981] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biological Laboratory Research and Development Merit Review Grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01ES015981-07 (to A. B. C.), T32CA078586 (to the Free Radical and Radiation Biology Program), and P30CA086862 (to the University of Iowa Comprehensive Cancer Center). This work was also supported by Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biological Laboratory Research and Development Merit Review Grant 1BX001135-01 (to A. B. C.).	Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Brodersen P, 2012, P NATL ACAD SCI USA, V109, P1778, DOI 10.1073/pnas.1112500109; CARANO A, 1990, J CLIN INVEST, V85, P456, DOI 10.1172/JCI114459; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; Chensue SW, 1997, J IMMUNOL, V159, P3565; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Dan HC, 2004, ONCOGENE, V23, P706, DOI 10.1038/sj.onc.1207171; Danesh FR, 2002, P NATL ACAD SCI USA, V99, P8301, DOI 10.1073/pnas.122228799; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dolado I, 2008, CANCER CELL, V14, P427, DOI 10.1016/j.ccr.2008.11.006; Du W, 1999, CANCER RES, V59, P5492; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Guo F, 2008, BLOOD, V112, P1767, DOI 10.1182/blood-2008-01-132068; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; He C, 2013, J BIOL CHEM, V288, P20745, DOI 10.1074/jbc.M112.410720; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Hollander MC, 2011, ONCOGENE, V30, P1812, DOI 10.1038/onc.2010.556; Huang JF, 2011, HEPATOL RES, V41, P430, DOI 10.1111/j.1872-034X.2011.00786.x; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Jiang K, 2000, MOL CELL BIOL, V20, P139, DOI 10.1128/MCB.20.1.139-148.2000; Kazi A, 2009, MOL CELL BIOL, V29, P2254, DOI 10.1128/MCB.01029-08; Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Le Cras TD, 2010, AM J PATHOL, V176, P679, DOI 10.2353/ajpath.2010.090123; Li LF, 2008, CRIT CARE, V12, DOI 10.1186/cc6983; Lin CH, 2011, J BIOL CHEM, V286, P10483, DOI 10.1074/jbc.M110.112433; Lu YJ, 2010, AM J RESP CELL MOL, V42, P432, DOI 10.1165/rcmb.2009-0002OC; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Miquel K, 1997, CANCER RES, V57, P1846; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Osborn-Heaford HL, 2012, J BIOL CHEM, V287, P3301, DOI 10.1074/jbc.M111.308387; Ozaki M, 2003, CELL DEATH DIFFER, V10, P508, DOI 10.1038/sj.cdd.4401172; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Rosenson RS, 1998, JAMA-J AM MED ASSOC, V279, P1643, DOI 10.1001/jama.279.20.1643; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shull LW, 2006, BIOORGAN MED CHEM, V14, P4130, DOI 10.1016/j.bmc.2006.02.010; Sun JZ, 2003, CANCER RES, V63, P8922; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; Vasudevan KM, 2011, CURR TOP MICROBIOL, V347, P105, DOI 10.1007/82_2010_66; Vittal R, 2005, AM J PATHOL, V166, P367, DOI 10.1016/S0002-9440(10)62260-2; Wasko BM, 2011, J PHARMACOL EXP THER, V337, P540, DOI 10.1124/jpet.110.175521; Weigert A, 2006, BLOOD, V108, P1635, DOI 10.1182/blood-2006-04-014852; Wong WB, 2013, PHARMACOEPIDEM DR S, V22, P345, DOI 10.1002/pds.3381; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Xue Y, 2011, AM J PHYSIOL-HEART C, V300, pH2169, DOI 10.1152/ajpheart.00970.2010; Zeng PY, 2003, ONCOGENE, V22, P1124, DOI 10.1038/sj.onc.1206181; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zins K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074924	75	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36204	36219		10.1074/jbc.M114.593285	http://dx.doi.org/10.1074/jbc.M114.593285			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378391	Green Published, hybrid			2022-12-28	WOS:000346897900046
J	Schaefer, L				Schaefer, Liliana			Complexity of Danger: The Diverse Nature of Damage-associated Molecular Patterns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						ATP; Autophagy; Biglycan; Decorin; Heat Shock Protein (HSP); Heparan Sulfate; Hyaluronan; Inflammasome; Necrosis (Necrotic Death); Small Leucine-rich Proteoglycan (SLRP); Toll-like Receptor (TLR)	TOLL-LIKE-RECEPTORS; LEUCINE-RICH PROTEOGLYCANS; HEAT-SHOCK PROTEINS; END-PRODUCTS RAGE; CELL-DEATH; URIC-ACID; HEPARAN-SULFATE; INFLAMMATORY RESPONSES; STERILE INFLAMMATION; NLRP3 INFLAMMASOME	In reply to internal or external danger stimuli, the body orchestrates an inflammatory response. The endogenous triggers of this process are the damage-associated molecular patterns (DAMPs). DAMPs represent a heterogeneous group of molecules that draw their origin either from inside the various compartments of the cell or from the extracellular space. Following interaction with pattern recognition receptors in cross-talk with various non-immune receptors, DAMPs determine the downstream signaling outcome of septic and aseptic inflammatory responses. In this review, the diverse nature, structural characteristics, and signaling pathways elicited by DAMPs will be critically evaluated.	[Schaefer, Liliana] Klinikum Goethe Univ Frankfurt Main, Inst Allgemeine Pharmakol & Toxikol, Pharmazentrum Frankfurt, Zentrum Arzneimittelforsch Entwicklung & Sicherhe, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Schaefer, L (corresponding author), Klinikum JW Goethe Univ Frankfurt Main, Inst Allgemeine Pharmakol & Toxikol, Pharmazentrum Frankfurt, Haus 74,Z3-108a,Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Schaefer@med.uni-frankfurt.de		Schaefer, Liliana/0000-0002-3318-3005	German Research Council [SFB 815, SFB 1039]	German Research Council(German Research Foundation (DFG))	This work was supported by the German Research Council (Grant SFB 815, Project A5, Grant SFB 1039, Project B2, Excellence Cluster ECCPS, and LOEWE Program Ub-Net).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allam R, 2013, EUR J IMMUNOL, V43, P3336, DOI 10.1002/eji.201243224; Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077; Anders HJ, 2014, J AM SOC NEPHROL, V25, P1387, DOI 10.1681/ASN.2014010117; Ayna G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040069; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Barbouri D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00004; Beyer C, 2012, INNATE IMMUN-LONDON, V18, P727, DOI 10.1177/1753425912437981; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Brennan TV, 2012, BLOOD, V120, P2899, DOI 10.1182/blood-2011-07-368720; Broggi A, 2015, MOL IMMUNOL, V63, P127, DOI 10.1016/j.molimm.2014.06.037; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Chaney MO, 2005, BBA-MOL BASIS DIS, V1741, P199, DOI 10.1016/j.bbadis.2005.03.014; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chun KH, 2010, INT IMMUNOPHARMACOL, V10, P98, DOI 10.1016/j.intimp.2009.10.002; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Eisenbacher JL, 2014, J IMMUNOL, V192, P6102, DOI 10.4049/jimmunol.1303144; Escamilla-Tilch M, 2013, IMMUNOL CELL BIOL, V91, P601, DOI 10.1038/icb.2013.58; Fernandez-Ruiz I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095073; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Goldberg R, 2013, MATRIX BIOL, V32, P234, DOI 10.1016/j.matbio.2013.02.008; Goode KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109596; Hodgkinson CR, 2008, THROMB HAEMOSTASIS, V100, P301, DOI 10.1160/TH08-03-0179; Hoffman HM, 2010, ARTHRITIS RHEUM-US, V62, P2170, DOI 10.1002/art.27456; Hou W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.493; Hsieh LTH, 2014, INT J BIOCHEM CELL B, V54, P223, DOI 10.1016/j.biocel.2014.07.020; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang N, 2003, BLOOD, V102, P2243, DOI 10.1182/blood-2002-10-3312; Johnson RJ, 2005, SEMIN NEPHROL, V25, P3, DOI 10.1016/j.semnephrol.2004.09.002; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Lee Eun Ji, 2013, Genomics & Informatics, V11, P224, DOI 10.5808/GI.2013.11.4.224; Lee YL, 2014, J SURG RES, V191, P286, DOI 10.1016/j.jss.2014.06.003; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Li W, 2011, BIOCHEM PHARMACOL, V81, P1152, DOI 10.1016/j.bcp.2011.02.015; Li XY, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-19; Little JP, 2014, MOL CELL NEUROSCI, V60, P88, DOI 10.1016/j.mcn.2014.04.003; Maeda A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.277; Mani K, 2006, GLYCOBIOLOGY, V16, P711, DOI 10.1093/glycob/cwj121; Fader CM, 2012, AUTOPHAGY, V8, P1741, DOI 10.4161/auto.21858; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moreth K, 2014, MATRIX BIOL, V35, P143, DOI 10.1016/j.matbio.2014.01.010; Moreth K, 2012, CELL CYCLE, V11, P2084, DOI 10.4161/cc.20316; Moreth K, 2010, J CLIN INVEST, V120, P4251, DOI 10.1172/JCI42213; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nastase MV, 2014, BBA-GEN SUBJECTS, V1840, P2460, DOI 10.1016/j.bbagen.2014.01.035; Nastase MV, 2012, J HISTOCHEM CYTOCHEM, V60, P963, DOI 10.1369/0022155412456380; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Patel VN, 2007, DEVELOPMENT, V134, P4177, DOI 10.1242/dev.011171; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Pisetsky DS, 2014, ANTIOXID REDOX SIGN, V20, P1117, DOI 10.1089/ars.2012.5143; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Rammes A, 1997, J BIOL CHEM, V272, P9496; Rani SG, 2014, BBA-PROTEINS PROTEOM, V1844, P1718, DOI 10.1016/j.bbapap.2014.06.017; Rosin DL, 2011, J AM SOC NEPHROL, V22, P416, DOI 10.1681/ASN.2010040430; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Ru LB, 2005, ARTHRITIS RHEUM-US, V52, P2936, DOI 10.1002/art.21238; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2012, CURR OPIN GENET DEV, V22, P56, DOI 10.1016/j.gde.2011.12.002; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Singleton PA, 2014, ADV CANCER RES, V123, P191, DOI 10.1016/B978-0-12-800092-2.00007-1; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Sorci G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001315; Spencer DM, 2014, SCAND J IMMUNOL, V80, P101, DOI 10.1111/sji.12191; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Tran TT, 2008, BIOMARKERS, V13, P184, DOI 10.1080/13547500701791719 ; Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848; Urbonaviciute V, 2011, J INTERN MED, V270, P309, DOI 10.1111/j.1365-2796.2011.02432.x; Vabulas RM, 2002, CURR TOP MICROBIOL, V270, P169; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wenceslau CF, 2014, EUR HEART J, V35, P1172, DOI 10.1093/eurheartj/ehu047; Wheeler DS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-31; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Xie JL, 2013, CELL SIGNAL, V25, P2185, DOI 10.1016/j.cellsig.2013.06.013; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang QH, 2013, AUTOPHAGY, V9, P451, DOI 10.4161/auto.23691; Zhang XR, 2012, CARTILAGE, V3, P267, DOI 10.1177/1947603511435273	100	376	381	2	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35237	35245		10.1074/jbc.R114.619304	http://dx.doi.org/10.1074/jbc.R114.619304			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25391648	hybrid, Green Published			2022-12-28	WOS:000346660200017
J	Song, HJ; Olsen, OH; Persson, E; Rand, KD				Song, Hongjian; Olsen, Ole H.; Persson, Egon; Rand, Kasper D.			Sites Involved in Intra- and Interdomain Allostery Associated with the Activation of Factor VIIa Pinpointed by Hydrogen-Deuterium Exchange and Electron Transfer Dissociation Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Blood; Coagulation Factor; Conformational Change; Hydrogen Exchange Mass Spectrometry; Serine Protease; Electron Transfer Dissociation	COAGULATION-FACTOR VIIA; SINGLE-RESIDUE RESOLUTION; CALCIUM-BINDING SITE; TISSUE FACTOR; BLOOD-COAGULATION; HYDROGEN/DEUTERIUM EXCHANGE; CAPTURE DISSOCIATION; CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURE; PROTEASE DOMAIN	Factor VIIa (FVIIa) is a trypsin-like protease that plays an important role in initiating blood coagulation. Very limited structural information is available for the free, inactive form of FVIIa that circulates in the blood prior to vascular injury and the molecular details of its activity enhancement remain elusive. Here we have applied hydrogen/deuterium exchange mass spectrometry coupled to electron transfer dissociation to pinpoint individual residues in the heavy chain of FVIIa whose conformation and/or local interaction pattern changes when the enzyme transitions to the active form, as induced either by its cofactor tissue factor or a covalent active site inhibitor. Identified regulatory residues are situated at key sites across one continuous surface of the protease domain spanning the TF-binding helix across the activation pocket to the calcium binding site and are embedded in elements of secondary structure and at the base of flexible loops. Thus these residues are optimally positioned to mediate crosstalk between functional sites in FVIIa, particularly the cofactor binding site and the active site. Our results unambiguously show that the conformational allosteric activation signal extends to the EGF1 domain in the light chain of FVIIa, underscoring a remarkable intra- and interdomain allosteric regulation of this trypsin-like protease.	[Song, Hongjian; Rand, Kasper D.] Univ Copenhagen, Dept Pharm, DK-2100 Copenhagen O, Denmark; [Olsen, Ole H.; Persson, Egon] Novo Nordisk AS, Haemostasis Biol, DK-2760 Malov, Denmark	University of Copenhagen; Novo Nordisk	Rand, KD (corresponding author), Univ Copenhagen, Dept Pharm, Univ Pk 2, DK-2100 Copenhagen O, Denmark.	kasper.rand@sund.ku.dk	Rand, Kasper/ABG-7446-2021	Rand, Kasper/0000-0002-6337-5489; Persson, Egon/0000-0003-3005-4926	Marie Curie Actions Programme of the E.U [PCIG09-GA-2011-294214]; Danish Council for Independent Research Natural Sciences [11-104058]	Marie Curie Actions Programme of the E.U; Danish Council for Independent Research Natural Sciences(Det Frie Forskningsrad (DFF))	This work was supported by the Marie Curie Actions Programme of the E.U Grant No. PCIG09-GA-2011-294214 (to K. D. R.) and the Danish Council for Independent Research Natural Sciences (Steno Grant No. 11-104058, to K. D. R.).	Abzalimov RR, 2009, J AM SOC MASS SPECTR, V20, P1514, DOI 10.1016/j.jasms.2009.04.006; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Bjelke JR, 2008, J BIOL CHEM, V283, P25863, DOI 10.1074/jbc.M800841200; BODE W, 1975, FEBS LETT, V56, P139, DOI 10.1016/0014-5793(75)80128-1; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Freskgard PO, 1996, PROTEIN SCI, V5, P1531, DOI 10.1002/pro.5560050809; HAGEN FS, 1986, P NATL ACAD SCI USA, V83, P2412, DOI 10.1073/pnas.83.8.2412; HIGASHI S, 1994, J BIOL CHEM, V269, P18891; Higashi S, 1996, J BIOL CHEM, V271, P26569, DOI 10.1074/jbc.271.43.26569; Hoofnagle AN, 2001, P NATL ACAD SCI USA, V98, P956, DOI 10.1073/pnas.98.3.956; Jin JP, 2001, J MOL BIOL, V307, P1503, DOI 10.1006/jmbi.2001.4556; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Mosbaek CR, 2010, BIOCHEMISTRY-US, V49, P9739, DOI 10.1021/bi1011207; Ohkubo YZ, 2010, J THROMB HAEMOST, V8, P1044, DOI 10.1111/j.1538-7836.2010.03826.x; Olsen OH, 2008, CELL MOL LIFE SCI, V65, P953, DOI 10.1007/s00018-007-7480-5; Olsen OH, 2007, PROTEIN SCI, V16, P671, DOI 10.1110/ps.062504907; Pan J, 2008, J AM CHEM SOC, V130, P11574, DOI 10.1021/ja802871c; Persson E, 2001, BIOCHEMISTRY-US, V40, P3251, DOI 10.1021/bi001612z; Persson E, 2011, FRONT BIOSCI-LANDMRK, V16, P3156, DOI 10.2741/3903; Pike ACW, 1999, P NATL ACAD SCI USA, V96, P8925, DOI 10.1073/pnas.96.16.8925; Rand KD, 2008, J BIOL CHEM, V283, P13378, DOI 10.1074/jbc.M709716200; Rand KD, 2008, J AM CHEM SOC, V130, P1341, DOI 10.1021/ja076448i; Rand KD, 2006, J BIOL CHEM, V281, P23018, DOI 10.1074/jbc.M602968200; Rand KD, 2014, ACCOUNTS CHEM RES, V47, P3018, DOI 10.1021/ar500194w; Rand KD, 2013, INT J MASS SPECTROM, V338, P2, DOI 10.1016/j.ijms.2012.08.010; Rand KD, 2012, ANAL CHEM, V84, P1931, DOI 10.1021/ac202918j; Rand KD, 2011, J AM SOC MASS SPECTR, V22, P1784, DOI 10.1007/s13361-011-0196-7; Rand KD, 2009, ANAL CHEM, V81, P5577, DOI 10.1021/ac9008447; REZAIE AR, 1994, J BIOL CHEM, V269, P21495; SABHARWAL AK, 1995, J BIOL CHEM, V270, P15523, DOI 10.1074/jbc.270.26.15523; Sichler K, 2002, J MOL BIOL, V322, P591, DOI 10.1016/S0022-2836(02)00747-7; Sorensen BB, 1997, J BIOL CHEM, V272, P11863, DOI 10.1074/jbc.272.18.11863; THIM L, 1988, BIOCHEMISTRY-US, V27, P7785, DOI 10.1021/bi00420a030; WILDGOOSE P, 1993, BIOCHEMISTRY-US, V32, P114, DOI 10.1021/bi00052a016; Zehl M, 2008, J AM CHEM SOC, V130, P17453, DOI 10.1021/ja805573h	36	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35388	35396		10.1074/jbc.M114.614297	http://dx.doi.org/10.1074/jbc.M114.614297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25344622	hybrid, Green Published			2022-12-28	WOS:000346660200029
J	Diepenhorst, NA; Petrie, EJ; Chen, CZ; Wang, A; Hossain, MA; Bathgate, RAD; Gooley, PR				Diepenhorst, Natalie A.; Petrie, Emma J.; Chen, Catherine Z.; Wang, Amy; Hossain, Mohammed Akhter; Bathgate, Ross A. D.; Gooley, Paul R.			Investigation of Interactions at the Extracellular Loops of the Relaxin Family Peptide Receptor 1 (RXFP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptor (GPCR); Nuclear Magnetic Resonance (NMR); Peptide Hormone; Protein Engineering; Receptor Structure-Function; RXFP1; Relaxin; Serelaxin	CLASS-A MODULE; PROTEIN-COUPLED RECEPTORS; SMALL-MOLECULE AGONISTS; BINDING-SITE; CHEMOKINE-RECEPTOR; CHEMICAL-SYNTHESIS; ACTIVATION; IDENTIFICATION; LGR7; HORMONE	Background: Extracellular loops of the transmembrane domain of the relaxin receptor RXFP1 are predicted to interact with relaxin. Results: RXFP1 extracellular loops displayed on a scaffold protein enabled investigation of ligand interactions. Conclusion: RXFP1 activation involves interactions between the extracellular loops with relaxin and the receptor LDLa module. Significance: Understanding the molecular mechanisms of RXFP1 activation will aid drug design at this receptor. Relaxin, an emerging pharmaceutical treatment for acute heart failure, activates the relaxin family peptide receptor (RXFP1), which is a class A G-protein-coupled receptor. In addition to the classic transmembrane (TM) domain, RXFP1 possesses a large extracellular domain consisting of 10 leucine-rich repeats and an N-terminal low density lipoprotein class A (LDLa) module. Relaxin-mediated activation of RXFP1 requires multiple coordinated interactions between the ligand and various receptor domains including a high affinity interaction involving the leucine-rich repeats and a predicted lower affinity interaction involving the extracellular loops (ELs). The LDLa is essential for signal activation; therefore the ELs/TM may additionally present an interaction site to facilitate this LDLa-mediated signaling. To overcome the many challenges of investigating relaxin and the LDLa module interactions with the ELs, we engineered the EL1 and EL2 loops onto a soluble protein scaffold, mapping specific ligand and loop interactions using nuclear magnetic resonance spectroscopy. Key EL residues were subsequently mutated in RXFP1, and changes in function and relaxin binding were assessed alongside the RXFP1 agonist ML290 to monitor the functional integrity of the TM domain of these mutant receptors. The outcomes of this work make an important contribution to understanding the mechanism of RXFP1 activation and will aid future development of small molecule RXFP1 agonists/antagonists.	[Diepenhorst, Natalie A.; Hossain, Mohammed Akhter; Bathgate, Ross A. D.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Diepenhorst, Natalie A.; Petrie, Emma J.; Bathgate, Ross A. D.; Gooley, Paul R.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Hossain, Mohammed Akhter] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia; [Chen, Catherine Z.; Wang, Amy] NIH, Natl Ctr Adv Translat Sci, Div Preclin Innovat, Rockville, MD 20850 USA	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Bathgate, RAD (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.	bathgate@florey.edu.au; prg@unimelb.edu.au	Bathgate, Ross/ABE-6471-2020; Diepenhorst, Natalie/HHS-2496-2022	Bathgate, Ross/0000-0001-6301-861X; Hossain, Mohammed/0000-0002-9961-0006; Gooley, Paul/0000-0002-0323-449X	National Health and Medical Research Council of Australia [628427, 1043750]; Victorian Government Operational Infrastructure Support Program; State of Victoria; Australian Research Council; Rowden White Foundation; Melbourne Research Fellowship (Career Interruptions); National Health and Medical Research Council Research Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Program; State of Victoria; Australian Research Council(Australian Research Council); Rowden White Foundation; Melbourne Research Fellowship (Career Interruptions); National Health and Medical Research Council Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia Project Grants 628427 and 1043750 (to R. A. D. B. and P. R. G.) by the Victorian Government Operational Infrastructure Support Program, and through instrument funding from the State of Victoria, Australian Research Council, and the Rowden White Foundation.; Recipient of a Melbourne Research Fellowship (Career Interruptions).; Recipient of a National Health and Medical Research Council Research Fellowship. To whom correspondence may be addressed: Florey Inst. of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria 3010, Australia. Tel.: 61-3-9035-6735; E-mail: bathgate@florey.edu.au.	Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Bruell Shoni, 2013, Front Endocrinol (Lausanne), V4, P171, DOI 10.3389/fendo.2013.00171; Bullesbach EE, 2000, J BIOL CHEM, V275, P35276, DOI 10.1074/jbc.M005728200; Bullesbach EE, 2005, J BIOL CHEM, V280, P14051, DOI 10.1074/jbc.M500030200; Chen CZ, 2013, J BIOMOL SCREEN, V18, P670, DOI 10.1177/1087057112469406; Dagil R, 2013, J BIOL CHEM, V288, P4424, DOI 10.1074/jbc.M112.434159; Datta A, 2003, PROTEIN SCI, V12, P2482, DOI 10.1110/ps.03254303; Datta-Mannan A, 2004, BIOCHEMISTRY-US, V43, P14602, DOI 10.1021/bi048990e; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demene H, 2003, BIOCHEMISTRY-US, V42, P8204, DOI 10.1021/bi027358n; Diepenhorst Natalie A, 2013, Ital J Anat Embryol, V118, P1; Dogo-Isonagie C, 2012, J BIOL CHEM, V287, P15076, DOI 10.1074/jbc.M111.332361; Feng S, 2011, INT J ONCOL, V39, P1559, DOI 10.3892/ijo.2011.1159; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Halls ML, 2005, J PHARMACOL EXP THER, V313, P677, DOI 10.1124/jpet.104.080655; Hartley BJ, 2009, ANN NY ACAD SCI, V1160, P67, DOI 10.1111/j.1749-6632.2009.03949.x; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hopkins EJ, 2005, ANN NY ACAD SCI, V1041, P27, DOI 10.1196/annals.1282.006; Hopkins EJ, 2007, J BIOL CHEM, V282, P4172, DOI 10.1074/jbc.M609526200; Hossain MA, 2008, CHEMBIOCHEM, V9, P1816, DOI 10.1002/cbic.200800113; Hossain MA, 2006, INT J PEPT RES THER, V12, P211, DOI 10.1007/s10989-006-9020-9; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kong RCK, 2014, BIOCHEMISTRY-US, V53, P4537, DOI 10.1021/bi500797d; Kong RCK, 2013, J BIOL CHEM, V288, P28138, DOI 10.1074/jbc.M113.499640; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Ott TR, 2002, MOL ENDOCRINOL, V16, P1079, DOI 10.1210/me.16.5.1079; Pritz S, 2008, ANGEW CHEM INT EDIT, V47, P3642, DOI 10.1002/anie.200705718; Scott DJ, 2007, MOL ENDOCRINOL, V21, P1699, DOI 10.1210/me.2007-0097; Scott DJ, 2009, ANN NY ACAD SCI, V1160, P74, DOI 10.1111/j.1749-6632.2009.03950.x; Scott DJ, 2006, J BIOL CHEM, V281, P34942, DOI 10.1074/jbc.M602728200; Shabanpoor F, 2012, BIOCHEM BIOPH RES CO, V420, P253, DOI 10.1016/j.bbrc.2012.02.141; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Walser R, 2012, BIOL CHEM, V393, P1341, DOI 10.1515/hsz-2012-0234; Walser R, 2011, CHEMBIOCHEM, V12, P1690, DOI 10.1002/cbic.201100244; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Wurch T, 1998, MOL PHARMACOL, V54, P1088, DOI 10.1124/mol.54.6.1088; Xiao JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2953; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	49	24	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34938	34952		10.1074/jbc.M114.600882	http://dx.doi.org/10.1074/jbc.M114.600882			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25352603	Green Published, hybrid			2022-12-28	WOS:000346260800043
J	Ke, HJ; Sigala, PA; Miura, K; Morrisey, JM; Mather, MW; Crowley, JR; Henderson, JP; Goldberg, DE; Long, CA; Vaidya, AB				Ke, Hangjun; Sigala, Paul A.; Miura, Kazutoyo; Morrisey, Joanne M.; Mather, Michael W.; Crowley, Jan R.; Henderson, Jeffrey P.; Goldberg, Daniel E.; Long, Carole A.; Vaidya, Akhil B.			The Heme Biosynthesis Pathway Is Essential for Plasmodium falciparum Development in Mosquito Stage but Not in Blood Stages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heme; Insect; Malaria; Mitochondria; Mitochondrial Metabolism	MASS-SPECTROMETRY; MALARIAL PARASITE; METABOLISM; MECHANISM; ACID; DRUG; IRON; IDENTIFICATION; FERROCHELATASE; DECARBOXYLASE	Background: Malaria parasites require heme for growth. Results: Genetic disruption of the P. falciparum heme biosynthesis pathway ablated growth in mosquitoes but had no effect on blood-stage growth. Conclusion: The heme biosynthesis pathway is only essential for exoerythrocytic parasite growth and transmission to mosquitoes. Significance: Pathway inhibition is unlikely to be an effective antimalarial drug strategy. Heme salvage mechanisms likely exist in blood stages. Heme is an essential cofactor for aerobic organisms. Its redox chemistry is central to a variety of biological functions mediated by hemoproteins. In blood stages, malaria parasites consume most of the hemoglobin inside the infected erythrocytes, forming nontoxic hemozoin crystals from large quantities of heme released during digestion. At the same time, the parasites possess a heme de novo biosynthetic pathway. This pathway in the human malaria parasite Plasmodium falciparum has been considered essential and is proposed as a potential drug target. However, we successfully disrupted the first and last genes of the pathway, individually and in combination. These knock-out parasite lines, lacking 5-aminolevulinic acid synthase and/or ferrochelatase (FC), grew normally in blood-stage culture and exhibited no changes in sensitivity to heme-related antimalarial drugs. We developed a sensitive LC-MS/MS assay to monitor stable isotope incorporation into heme from its precursor 5-[C-13(4)]aminolevulinic acid, and this assay confirmed that de novo heme synthesis was ablated in FC knock-out parasites. Disrupting the FC gene also caused no defects in gametocyte generation or maturation but resulted in a greater than 70% reduction in male gamete formation and completely prevented oocyst formation in female Anopheles stephensi mosquitoes. Our data demonstrate that the heme biosynthesis pathway is not essential for asexual blood-stage growth of P. falciparum parasites but is required for mosquito transmission. Drug inhibition of pathway activity is therefore unlikely to provide successful antimalarial therapy. These data also suggest the existence of a parasite mechanism for scavenging host heme to meet metabolic needs.	[Ke, Hangjun; Morrisey, Joanne M.; Mather, Michael W.; Vaidya, Akhil B.] Drexel Univ, Dept Microbiol & Immunol, Ctr Mol Parasitol, Coll Med, Philadelphia, PA 19129 USA; [Sigala, Paul A.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Sigala, Paul A.; Goldberg, Daniel E.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Miura, Kazutoyo; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Crowley, Jan R.; Henderson, Jeffrey P.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Henderson, Jeffrey P.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Drexel University; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington University (WUSTL); Washington University (WUSTL)	Vaidya, AB (corresponding author), Drexel Univ, Dept Microbiol & Immunol, Ctr Mol Parasitol, Coll Med, 2900 Queen Lane, Philadelphia, PA 19129 USA.	avaidya@drexelmed.edu	Miura, Kazutoyo/AAY-9751-2020; Henderson, Jeffrey P/D-3337-2015	Miura, Kazutoyo/0000-0003-4455-2432; Sigala, Paul/0000-0002-3464-3042; Mather, Michael/0000-0002-1062-0137	National Institutes of Health [R01 AI028398, R01 DK099534]; Burroughs Wellcome Fund Career Award at the Scientific Interface; Burroughs Wellcome Fund Career Award for Medical Scientists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020, R01AI028398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI028398 (to A. B. V.) and R01 DK099534 (to J. P. H.).; Recipient of a Burroughs Wellcome Fund Career Award at the Scientific Interface.; Recipient of a Burroughs Wellcome Fund Career Award for Medical Scientists.	ATAMNA H, 1995, J BIOL CHEM, V270, P24876, DOI 10.1074/jbc.270.42.24876; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Bonday ZQ, 1997, J BIOL CHEM, V272, P21839, DOI 10.1074/jbc.272.35.21839; Bonday ZQ, 2000, NAT MED, V6, P898, DOI 10.1038/78659; Boysen KE, 2011, J BIOL CHEM, V286, P32661, DOI 10.1074/jbc.M111.269399; Celli JP, 2010, CHEM REV, V110, P2795, DOI 10.1021/cr900300p; CHAN RYY, 1993, BIOCHEM J, V292, P343, DOI 10.1042/bj2920343; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Chiabrando D, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00061; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Dhanasekaran S, 2004, J BIOL CHEM, V279, P6934, DOI 10.1074/jbc.M311409200; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fitch C D, 1998, Trans Am Clin Climatol Assoc, V109, P97; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; Ginsburg H, 1999, PARASITOL TODAY, V15, P357, DOI 10.1016/S0169-4758(99)01502-1; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Hino A, 2012, J BIOCHEM, V152, P259, DOI 10.1093/jb/mvs058; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Koreny L, 2010, INT J PARASITOL, V40, P149, DOI 10.1016/j.ijpara.2009.11.007; Kresge N, 2006, J BIOL CHEM, V281; Lau AOT, 2009, MOL BIOCHEM PARASIT, V164, P1, DOI 10.1016/j.molbiopara.2008.11.013; LIU SC, 1988, BLOOD, V71, P1755; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Mather MW, 2010, MOL BIOCHEM PARASIT, V174, P150, DOI 10.1016/j.molbiopara.2010.07.006; Meunier B, 2010, ACCOUNTS CHEM RES, V43, P1444, DOI 10.1021/ar100070k; Miura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057909; Nagaraj VA, 2008, J BIOL CHEM, V283, P437, DOI 10.1074/jbc.M706861200; Nagaraj VA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003522; Nagaraj VA, 2010, MOL BIOCHEM PARASIT, V174, P44, DOI 10.1016/j.molbiopara.2010.06.012; Nagaraj VA, 2010, PARASITOL INT, V59, P121, DOI 10.1016/j.parint.2009.12.001; Nagaraj VA, 2009, MOL BIOCHEM PARASIT, V168, P109, DOI 10.1016/j.molbiopara.2009.05.008; Nagaraja VA, 2009, INT J PARASITOL, V39, P559, DOI 10.1016/j.ijpara.2008.10.011; Padmanaban G, 2000, BIOCHEM BIOPH RES CO, V268, P665, DOI 10.1006/bbrc.1999.1892; Padmanaban Govinarajan, 2001, Expert Opin Ther Targets, V5, P423, DOI 10.1517/14728222.5.4.423; Padmanaban G, 2007, TRENDS BIOCHEM SCI, V32, P443, DOI 10.1016/j.tibs.2007.09.005; Pashynska VA, 2004, J AM SOC MASS SPECTR, V15, P1181, DOI 10.1016/j.jasms.2004.04.030; Ponka P, 1997, BLOOD, V89, P1; PORRA RJ, 1983, EUR J BIOCHEM, V130, P509, DOI 10.1111/j.1432-1033.1983.tb07179.x; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Ramya TNC, 2007, ANTIMICROB AGENTS CH, V51, P307, DOI 10.1128/AAC.00808-06; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Rivera M, 2004, ANAL BIOANAL CHEM, V378, P1464, DOI 10.1007/s00216-003-2340-0; Robert A, 2013, ANTIMICROB AGENTS CH, V57, P3998, DOI 10.1128/AAC.01064-13; RUTHERFORD T, 1979, P NATL ACAD SCI USA, V76, P833, DOI 10.1073/pnas.76.2.833; SHEMIN D, 1955, J BIOL CHEM, V215, P613; Sigala PA, 2014, ANNU REV MICROBIOL, V68, P259, DOI 10.1146/annurev-micro-091313-103537; Sigala PA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414078; SLATER AFG, 1992, NATURE, V355, P167, DOI 10.1038/355167a0; Srivastava IK, 1997, J BIOL CHEM, V272, P3961, DOI 10.1074/jbc.272.7.3961; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; SUROLIA N, 1992, BIOCHEM BIOPH RES CO, V187, P744, DOI 10.1016/0006-291X(92)91258-R; van Dooren GG, 2012, ANTIOXID REDOX SIGN, V17, P634, DOI 10.1089/ars.2012.4539; Varadharajan S, 2002, BIOCHEM J, V367, P321, DOI 10.1042/BJ20020834; Wang Y, 2008, ANAL CHEM, V80, P2599, DOI 10.1021/ac702130n; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WRISTON JC, 1955, J BIOL CHEM, V215, P603; Yuan XJ, 2012, J BIOL CHEM, V287, P4914, DOI 10.1074/jbc.M111.326785	61	83	84	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34827	34837		10.1074/jbc.M114.615831	http://dx.doi.org/10.1074/jbc.M114.615831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25352601	Green Published, hybrid			2022-12-28	WOS:000346260800034
J	Pandyarajan, V; Smith, BJ; Phillips, NB; Whittaker, L; Cox, GP; Wickramasinghe, N; Menting, JG; Wan, ZL; Whittaker, J; Ismail-Beigi, F; Lawrence, MC; Weiss, MA				Pandyarajan, Vijay; Smith, Brian J.; Phillips, Nelson B.; Whittaker, Linda; Cox, Gabriella P.; Wickramasinghe, Nalinda; Menting, John G.; Wan, Zhu-li; Whittaker, Jonathan; Ismail-Beigi, Faramarz; Lawrence, Michael C.; Weiss, Michael A.			Aromatic Anchor at an Invariant Hormone-Receptor Interface FUNCTION OF INSULIN RESIDUE B24 WITH APPLICATION TO PROTEIN DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Mutagenesis; Protein Design; Protein Structure; Receptor Tyrosine Kinase; Hormone; nonstandard mutagenesis	GROWTH-FACTOR-I; AMINO-ACID-SEQUENCE; HUMAN INSULIN; PROTEIN-STRUCTURE; BIOLOGICAL-ACTIVITY; STRUCTURAL SWITCH; SIDE-CHAIN; BINDING; DYNAMICS; SEMISYNTHESIS	Background: Invariant insulin residue Phe(B24) (a site of diabetes-associated mutation) contacts the insulin receptor. Results: Hormonal function requires hydrophobicity rather than aromaticity at this site. Conclusion: The B24 side chain provides a nonpolar anchor at the receptor interface. Significance: Nonstandard aliphatic modification of residue B24 may enhance therapeutic properties of insulin analogs. Crystallographic studies of insulin bound to fragments of the insulin receptor have recently defined the topography of the primary hormone-receptor interface. Here, we have investigated the role of Phe(B24), an invariant aromatic anchor at this interface and site of a human mutation causing diabetes mellitus. An extensive set of B24 substitutions has been constructed and tested for effects on receptor binding. Although aromaticity has long been considered a key requirement at this position, Met(B24) was found to confer essentially native affinity and bioactivity. Molecular modeling suggests that this linear side chain can serve as an alternative hydrophobic anchor at the hormone-receptor interface. These findings motivated further substitution of Phe(B24) by cyclohexanylalanine (Cha), which contains a nonplanar aliphatic ring. Contrary to expectations, [Cha(B24)]insulin likewise exhibited high activity. Furthermore, its resistance to fibrillation and the rapid rate of hexamer disassembly, properties of potential therapeutic advantage, were enhanced. The crystal structure of the Cha(B24) analog, determined as an R-6 zinc-stabilized hexamer at a resolution of 1.5 angstrom, closely resembles that of wild-type insulin. The nonplanar aliphatic ring exhibits two chair conformations with partial occupancies, each recapitulating the role of Phe(B24) at the dimer interface. Together, these studies have defined structural requirements of an anchor residue within the B24-binding pocket of the insulin receptor; similar molecular principles are likely to pertain to insulin-related growth factors. Our results highlight in particular the utility of nonaromatic side chains as probes of the B24 pocket and suggest that the nonstandard Cha side chain may have therapeutic utility.	[Pandyarajan, Vijay; Phillips, Nelson B.; Whittaker, Linda; Wickramasinghe, Nalinda; Wan, Zhu-li; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Cox, Gabriella P.; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Physiol, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Menting, John G.; Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; La Trobe University; Walter & Eliza Hall Institute; University of Melbourne	Lawrence, MC (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	lawrence@wehi.edu.au; michael.weiss@case.edu	Lawrence, Michael C/A-5357-2009; Wickramasinghe, Nalinda P/F-9465-2010; Smith, Brian J/F-8282-2011	Smith, Brian J/0000-0003-0498-1910; Menting, John/0000-0003-3638-3544; Lawrence, Michael/0000-0003-1999-0801; Wickramasinghe, Nalinda P./0000-0002-8700-2775; Pandyarajan, Vijay/0000-0002-8835-5601	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079233, R01DK040949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q.-X. Hua, W. Jia, and S. H. Nakagawa for advice regarding experimental procedures and P. Arvan, T. L. Blundell, P. De Meyts, P. G. Katsoyannis, M. Liu, D. F. Steiner, and C. Ward for discussion. The crystallographic results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by the UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bakaysa DL, 1996, PROTEIN SCI, V5, P2521, DOI 10.1002/pro.5560051215; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Barany G., 1980, PEPTIDES, P273; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Birnbaum DT, 1997, PHARMACEUT RES, V14, P25, DOI 10.1023/A:1012095115151; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Brange I., 1987, GALENICS INSULIN PHY; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1993, Pharm Biotechnol, V5, P315; Brange J, 1997, Pharm Biotechnol, V10, P343; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen JM, 2001, BIOCHEMISTRY-US, V40, P15280, DOI 10.1021/bi011776v; Conlon JM, 2001, PEPTIDES, V22, P1183, DOI 10.1016/S0196-9781(01)00423-5; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DeFelippis MR, 2001, CRIT REV THER DRUG, V18, P201; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Elleman TC, 2000, BIOCHEM J, V347, P771, DOI 10.1042/0264-6021:3470771; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; GELLMAN SH, 1991, BIOCHEMISTRY-US, V30, P6633, DOI 10.1021/bi00241a001; Gore SP, 2005, BIOINFORMATICS, V21, P3316, DOI 10.1093/bioinformatics/bti523; GREIDER MH, 1969, J CELL BIOL, V41, P162, DOI 10.1083/jcb.41.1.162; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; HANEDA M, 1985, DIABETES, V34, P568, DOI 10.2337/diabetes.34.6.568; HELLMAN U, 1990, BIOCHEM BIOPH RES CO, V169, P571, DOI 10.1016/0006-291X(90)90369-X; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Hovorka R, 2006, DIABETIC MED, V23, P1, DOI 10.1111/j.1464-5491.2005.01672.x; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; INOUYE K, 1981, BIOPOLYMERS, V20, P1845, DOI 10.1002/bip.1981.360200909; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KATSOYANNIS PG, 1973, J AM CHEM SOC, V95, P6427, DOI 10.1021/ja00800a045; KOBAYASHI M, 1984, BIOMED RES-TOKYO, V5, P267, DOI 10.2220/biomedres.5.267; KUBIAK T, 1986, INT J PEPT PROT RES, V27, P514; KUROSE T, 1994, J BIOL CHEM, V269, P29190; Lachenmann MJ, 2004, PROTEIN SCI, V13, P3115, DOI 10.1110/ps.04866404; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MICHAEL J, 1987, J BIOL CHEM, V262, P16531; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; MIRMIRA RG, 1991, BIOCHEMISTRY-US, V30, P8222, DOI 10.1021/bi00247a019; NAKAGAWA SH, 1993, BIOCHEMISTRY-US, V32, P7237, DOI 10.1021/bi00079a021; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; NISHI M, 1990, MOL ENDOCRINOL, V4, P1192, DOI 10.1210/mend-4-8-1192; Olechnovic K, 2011, BIOINFORMATICS, V27, P723, DOI 10.1093/bioinformatics/btq720; Pandyarajan V, 2012, CURR DIABETES REP, V12, P697, DOI 10.1007/s11892-012-0318-z; Pandyarajan V, 2014, J BIOL CHEM, V289, P23367, DOI 10.1074/jbc.M114.588277; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P5043, DOI 10.1021/bi00563a017; RINDERKNECHT E, 1978, FEBS LETT, V89, P283, DOI 10.1016/0014-5793(78)80237-3; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; ROY M, 1989, J BIOL CHEM, V264, P19081; SATO A, 1993, INT J PEPT PROT RES, V41, P433; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; SHOELSON S, 1983, P NATL ACAD SCI-BIOL, V80, P7390, DOI 10.1073/pnas.80.24.7390; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; SHOELSON SE, 1984, J CLIN INVEST, V73, P1351, DOI 10.1172/JCI111338; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; Smith GD, 2000, ACTA CRYSTALLOGR D, V56, P1541, DOI 10.1107/S0907444900012749; STEINER DF, 1985, ANNU REV GENET, V19, P463, DOI 10.1146/annurev.ge.19.120185.002335; TAGER H, 1980, P NATL ACAD SCI-BIOL, V77, P3181, DOI 10.1073/pnas.77.6.3181; TORRES AM, 1995, J MOL BIOL, V248, P385, DOI 10.1006/jmbi.1995.0229; Vajdos FF, 2001, BIOCHEMISTRY-US, V40, P11022, DOI 10.1021/bi0109111; WAUGH DF, 1953, J AM CHEM SOC, V75, P2592, DOI 10.1021/ja01107a013; Weiss MA, 2013, FEBS LETT, V587, P1942, DOI 10.1016/j.febslet.2013.04.044; WEITZEL G, 1978, H-S Z PHYSIOL CHEM, V359, P945, DOI 10.1515/bchm2.1978.359.2.945; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850; Zakova L, 2013, J BIOL CHEM, V288, P10230, DOI 10.1074/jbc.M112.448050	89	18	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34709	34727		10.1074/jbc.M114.608562	http://dx.doi.org/10.1074/jbc.M114.608562			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25305014	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000346260800027
J	De Gieter, S; Konijnenberg, A; Talavera, A; Butterer, A; Haesaerts, S; De Greve, H; Sobott, F; Loris, R; Garcia-Pino, A				De Gieter, Steven; Konijnenberg, Albert; Talavera, Ariel; Butterer, Annika; Haesaerts, Sarah; De Greve, Henri; Sobott, Frank; Loris, Remy; Garcia-Pino, Abel			The Intrinsically Disordered Domain of the Antitoxin Phd Chaperones the Toxin Doc against Irreversible Inactivation and Misfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chaperone; Chemical Biology; Crystal Structure; Phosphorylation Enzyme; Translation Control; Doc; Fic; Phd; Small Angle X-ray Scattering; Toxin-Antitoxin	STRUCTURAL BASIS; ION-MOBILITY; CELL-DEATH; TRANSCRIPTION; COMPLEXES; PLASMID; MASS; PERSISTENCE; MECHANISMS; SCATTERING	Background: The doc/phd family is a paradigm for toxin-antitoxin modules in particular and protein-protein regulation in general. Results: Without Phd and because of its incomplete Fic fold, Doc is heterogeneous and aggregation-prone and could dimerize in solution at high concentration. Conclusion: Phd acts as an antiaggregation chaperone, protecting the toxin Doc from misfolding. Significance: The intrinsically disordered domain of antitoxins can expand protein functionality. The toxin Doc from the phd/doc toxin-antitoxin module targets the cellular translation machinery and is inhibited by its antitoxin partner Phd. Here we show that Phd also functions as a chaperone, keeping Doc in an active, correctly folded conformation. In the absence of Phd, Doc exists in a relatively expanded state that is prone to dimerization through domain swapping with its active site loop acting as hinge region. The domain-swapped dimer is not capable of arresting protein synthesis in vitro, whereas the Doc monomer is. Upon binding to Phd, Doc becomes more compact and is secured in its monomeric state with a neutralized active site.	[De Gieter, Steven; Talavera, Ariel; Haesaerts, Sarah; De Greve, Henri; Loris, Remy; Garcia-Pino, Abel] Vrije Univ Brussel, Struct Biol Brussels, Dept Biotechnol DBIT, B-1050 Brussels, Belgium; [De Gieter, Steven; Talavera, Ariel; Haesaerts, Sarah; Loris, Remy; Garcia-Pino, Abel] VIB, Mol Recognit Unit MoRe, B-1050 Brussels, Belgium; [De Greve, Henri] VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Konijnenberg, Albert; Butterer, Annika; Sobott, Frank] Univ Antwerp, Biomol & Analyt Mass Spectrometry Grp, Dept Chem, B-2020 Antwerp, Belgium; [Sobott, Frank] Univ Antwerp, Ctr Prote CFP CeProMa, B-2020 Antwerp, Belgium	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp	Garcia-Pino, A (corresponding author), Vrije Univ Brussel, Struct Biol Brussels, Dept Biotechnol DBIT, Pl Laan 2, B-1050 Brussels, Belgium.	agarciap@vub.ac.be	Loris, Remy/GPG-0894-2022; Talavera, Ariel/AAG-9932-2019	DE GIETER, STEVEN/0000-0002-2776-3791; Haesaerts, Sarah/0000-0003-3913-9125; Garcia-Pino, Abel/0000-0002-0634-0300; Sobott, Frank/0000-0001-9029-1865; Loris, Remy/0000-0002-8862-3338	Onderzoeksraad-Vrije Universiteit Brussel; Vlaams Instituut voor Biotechnologie; Fonds Wetenschappelijk Onderzoek (FWO)-Vlaanderen; Hercules Foundation; Biostruct-X Projects [20110864, 1673, 6131]; FWO-Vlaanderen; Francqui research professorship	Onderzoeksraad-Vrije Universiteit Brussel; Vlaams Instituut voor Biotechnologie; Fonds Wetenschappelijk Onderzoek (FWO)-Vlaanderen(FWO); Hercules Foundation; Biostruct-X Projects; FWO-Vlaanderen(FWO); Francqui research professorship	This work was supported in part by research grants from Onderzoeksraad-Vrije Universiteit Brussel, Vlaams Instituut voor Biotechnologie, Fonds Wetenschappelijk Onderzoek (FWO)-Vlaanderen, the Hercules Foundation, and Biostruct-X Projects 20110864, 1673, and 6131.; Supported by an individual predoctoral fellowship from FWO-Vlaanderen.; Supported by a Francqui research professorship.	Afonine P. V., 2005, CCP4 NEWSLETT, V42; Atmanene C, 2012, ANAL CHEM, V84, P4703, DOI 10.1021/ac203223h; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boggild A, 2012, STRUCTURE, V20, P1641, DOI 10.1016/j.str.2012.08.017; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; David G, 2009, J APPL CRYSTALLOGR, V42, P892, DOI 10.1107/S0021889809029288; De Gieter S, 2014, BIOMOL NMR ASSIGN, V8, P145, DOI 10.1007/s12104-013-9471-9; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Garcia-Pino A, 2008, ACTA CRYSTALLOGR F, V64, P1034, DOI 10.1107/S1744309108031722; Garcia-Pino A, 2014, TRENDS BIOCHEM SCI, V39, P121, DOI 10.1016/j.tibs.2014.01.001; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936; Hall Z, 2012, J AM CHEM SOC, V134, P3429, DOI 10.1021/ja2096859; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Jurneczko E, 2013, ANGEW CHEM INT EDIT, V52, P4370, DOI 10.1002/anie.201210015; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loris R, 2014, CHEM REV, V114, P6933, DOI 10.1021/cr400656f; Magnuson R, 1998, J BACTERIOL, V180, P6342; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Pagel K, 2013, ANGEW CHEM INT EDIT, V52, P361, DOI 10.1002/anie.201203047; Pauwels K, 2006, NAT STRUCT MOL BIOL, V13, P374, DOI 10.1038/nsmb1065; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Smith JA, 2004, J BACTERIOL, V186, P2692, DOI 10.1128/JB.186.9.2692-2698.2004; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tripathi A, 2012, P NATL ACAD SCI USA, V109, P12497, DOI 10.1073/pnas.1121217109; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412	47	7	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34013	34023		10.1074/jbc.M114.572396	http://dx.doi.org/10.1074/jbc.M114.572396			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25326388	Green Published, hybrid			2022-12-28	WOS:000346077600028
J	Mohan, CD; Bharathkumar, H; Bulusu, KC; Pandey, V; Rangappa, S; Fuchs, JE; Shanmugam, MK; Dai, XY; Li, F; Deivasigamani, A; Hui, KM; Kumar, AP; Lobie, PE; Bender, A; Basappa; Sethi, G; Rangappa, KS				Mohan, Chakrabhavi Dhananjaya; Bharathkumar, Hanumantharayappa; Bulusu, Krishna C.; Pandey, Vijay; Rangappa, Shobith; Fuchs, Julian E.; Shanmugam, Muthu K.; Dai, Xiaoyun; Li, Feng; Deivasigamani, Amudha; Hui, Kam M.; Kumar, Alan Prem; Lobie, Peter E.; Bender, Andreas; Basappa; Sethi, Gautam; Rangappa, Kanchugarakoppal S.			Development of a Novel Azaspirane That Targets the Janus Kinase-Signal Transducer and Activator of Transcription (STAT) Pathway in Hepatocellular Carcinoma in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Cell Migration; Hepatocellular Carcinoma; Janus Kinase (JAK); STAT3	SERINE PHOSPHORYLATION; DNA-BINDING; APOPTOSIS; GROWTH; INHIBITORS; JAK3; PROTEIN; CELLS	Background: Constitutive activation of STAT3 is associated with the progression of hepatocellular carcinoma (HCC), and abrogation of STAT3 signaling is a potential target for HCC treatment. Results: A novel azaspirane modulates the JAK-STAT pathway in HCC. Conclusion: The lead compound induces apoptosis by down-regulating STAT3 signaling. Significance: This investigation reports a novel inhibitor of the JAK-STAT pathway with the potential to target various cancers. Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that regulates genes involved in cell growth, proliferation, and survival, and given its association with many types of cancers, it has recently emerged as a promising target for therapy. In this work, we present the synthesis of N-substituted azaspirane derivatives and their biological evaluation against hepatocellular carcinoma (HCC) cells (IC50 = 7.3 m), thereby identifying 2-(1-(4-(2-cyanophenyl)1-benzyl-1H-indol-3-yl)-5-(4-methoxy-phenyl)-1-oxa-3-azaspiro(5,5) undecane (CIMO) as a potent inhibitor of the JAK-STAT pathway with selectivity over normal LO2 cells (IC50 > 100 m). The lead compound, CIMO, suppresses proliferation of HCC cells and achieves this effect by reducing both constitutive and inducible phosphorylation of JAK1, JAK2, and STAT3. Interestingly, CIMO displayed inhibition of Tyr-705 phosphorylation, which is required for nuclear translocation of STAT3, but it has no effect on Ser-727 phosphorylation. CIMO accumulates cancer cells in the sub-G(1) phase and decreases STAT3 in the nucleus and thereby causes down-regulation of genes regulated via STAT3. Suppression of STAT3 phosphorylation by CIMO and knockdown of STAT3 mRNA using siRNA transfection displayed a similar effect on the viability of HCC cells. Furthermore, CIMO significantly decreased the tumor development in an orthotopic HCC mouse model through the modulation of phospho-STAT3, Ki-67, and cleaved caspase-3 in tumor tissues. Thus, CIMO represents a chemically novel and biologically in vitro and in vivo validated compound, which targets the JAK-STAT pathway as a potential cancer treatment.	[Mohan, Chakrabhavi Dhananjaya; Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India; [Bharathkumar, Hanumantharayappa; Basappa] Bangalore Univ, Biol Chem Lab, Dept Chem, Bangalore 560001, Karnataka, India; [Bulusu, Krishna C.; Fuchs, Julian E.; Bender, Andreas] Univ Cambridge, Dept Chem, Ctr Mol Sci Informat, Cambridge CB2 1EW, England; [Pandey, Vijay; Kumar, Alan Prem; Lobie, Peter E.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Rangappa, Shobith] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido 060, Japan; [Shanmugam, Muthu K.; Dai, Xiaoyun; Li, Feng; Kumar, Alan Prem; Lobie, Peter E.; Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Deivasigamani, Amudha; Hui, Kam M.] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore 169610, Singapore	University of Mysore; Bangalore University; University of Cambridge; National University of Singapore; Hokkaido University; National University of Singapore; National Cancer Centre Singapore (NCCS)	Basappa (corresponding author), Bangalore Univ, Biol Chem Lab, Dept Chem, Palace Rd, Bangalore 560001, Karnataka, India.	salundibasappa@gmail.com; phcgs@nus.edu.sg; rangappaks@yahoo.com	Kumar, Alan Prem/ABE-7492-2020; Pandey, Vijay/P-2767-2016; Rangappa, Shobith/AAI-2169-2020; Mohan, Chakrabhavi Dhananjaya/AGO-1276-2022; Sethi, Gautam/F-2372-2011; Bender, Andreas/C-6942-2009	Kumar, Alan Prem/0000-0002-3754-5712; Rangappa, Shobith/0000-0002-9800-7192; Sethi, Gautam/0000-0002-8677-8475; Bender, Andreas/0000-0002-6683-7546; Hui, Kam/0000-0003-1820-1399; Bulusu, Krishna/0000-0002-5092-6640; Mohan, Chakrabhavi Dhananjaya/0000-0002-6810-9219; Basappa, Basappa/0000-0002-8844-468X	University Grants Commission [41-257-2012-SR]; Vision Group Science and Technology, Department of Science and Technology [SR/FT/LS-142/2012]; National Medical Research Council of Singapore; Academic Research Fund Tier 1; National University Health System Bench-to-Bedside and Bench-to-Bedside-to-Product Grant; Department of Science and Technology (DST)-INSPIRE fellowship; University Grants Commission-Basic Scientific Research fellowship; European Research Commission; DST-Japan Society for the Promotion of Science [DST/INT/JAP/P-79/09]; DST-Korea [INT/Indo-Korea/122/2011-12]; Institution of Excellence (IOE) grants from the University of Mysore	University Grants Commission(University Grants Commission, India); Vision Group Science and Technology, Department of Science and Technology; National Medical Research Council of Singapore(National Medical Research Council, Singapore); Academic Research Fund Tier 1; National University Health System Bench-to-Bedside and Bench-to-Bedside-to-Product Grant; Department of Science and Technology (DST)-INSPIRE fellowship(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); University Grants Commission-Basic Scientific Research fellowship; European Research Commission(European CommissionEuropean Commission Joint Research Centre); DST-Japan Society for the Promotion of Science; DST-Korea; Institution of Excellence (IOE) grants from the University of Mysore	This work was supported by University Grants Commission Grant 41-257-2012-SR and Vision Group Science and Technology, Department of Science and Technology, Grant SR/FT/LS-142/2012 (to B.). This work was also supported by a grant from the National Medical Research Council of Singapore, Academic Research Fund Tier 1, and National University Health System Bench-to-Bedside and Bench-to-Bedside-to-Product Grant (to G. S.).; Supported by a Department of Science and Technology (DST)-INSPIRE fellowship.; Supported by a University Grants Commission-Basic Scientific Research fellowship.; Supported by the European Research Commission.; Supported by DST-Japan Society for the Promotion of Science (DST/INT/JAP/P-79/09), DST-Korea (INT/Indo-Korea/122/2011-12), and Institution of Excellence (IOE) grants from the University of Mysore. To whom correspondence may be addressed: DOS in Chemistry, Manasagangotri, Mysore 570006, India. Tel.: 91-821-2419666; Fax: 91-821-2419363; E-mail: rangappaks@yahoo.com.	Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Amit-Vazina M, 2005, BRIT J CANCER, V93, P70, DOI 10.1038/sj.bjc.6602637; Basappa, 2010, CANCER LETT, V297, P231, DOI 10.1016/j.canlet.2010.05.016; Bharathkumar H, 2014, RSC ADV, V4, P45143, DOI 10.1039/c4ra08713e; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Furqan M, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-5; Gish RG, 2006, CLIN GASTROENTEROL H, V4, P252, DOI 10.1016/j.cgh.2006.01.001; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Hamasaki M, 2005, BLOOD, V105, P4470, DOI 10.1182/blood-2004-09-3794; Han YJ, 2006, BLOOD, V108, P2796, DOI 10.1182/blood-2006-04-017434; Hazan-Halevy I, 2010, BLOOD, V115, P2852, DOI 10.1182/blood-2009-10-230060; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Kavitha BCV, 2004, BIOORG MED CHEM LETT, V14, P3279, DOI 10.1016/j.bmcl.2004.03.098; Keerthy HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107118; Keerthy HK, 2014, J BIOL CHEM, V289, P31879, DOI 10.1074/jbc.M114.593855; Koutsoukas A, 2013, J CHEM INF MODEL, V53, P1957, DOI 10.1021/ci300435j; Koutsoukas A, 2011, J PROTEOMICS, V74, P2554, DOI 10.1016/j.jprot.2011.05.011; Li F, 2013, CANCER PREV RES, V6, P843, DOI 10.1158/1940-6207.CAPR-13-0070; Manu KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057015; McMurray JS, 2006, CHEM BIOL, V13, P1123, DOI 10.1016/j.chembiol.2006.11.001; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Moran DM, 2008, J SURG RES, V147, P23, DOI 10.1016/j.jss.2007.04.022; Murase S, 2014, EUR J NEUROSCI, V39, P557, DOI 10.1111/ejn.12412; Nakagawa Hayato, 2012, Patholog Res Int, V2012, P172894, DOI 10.1155/2012/172894; Nam S, 2013, MOL ONCOL, V7, P369, DOI 10.1016/j.molonc.2012.10.013; Pandey V, 2010, TRANSL ONCOL, V3, P218, DOI 10.1593/tlo.09325; Quintas-Cardama A, 2011, INVEST NEW DRUG, V29, P818, DOI 10.1007/s10637-010-9429-z; Rajendran P, 2012, CANCER PREV RES, V5, P631, DOI 10.1158/1940-6207.CAPR-11-0420; Rajendran P, 2011, BRIT J PHARMACOL, V163, P283, DOI 10.1111/j.1476-5381.2010.01187.x; Rajendran P, 2011, CLIN CANCER RES, V17, P1425, DOI 10.1158/1078-0432.CCR-10-1123; Rosmorduc O, 2011, J HEPATOL, V55, P957, DOI 10.1016/j.jhep.2011.06.005; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Su QB, 2014, J MED CHEM, V57, P144, DOI 10.1021/jm401546n; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Tam CS, 2013, EXPERT OPIN INV DRUG, V22, P687, DOI 10.1517/13543784.2013.774373; TEMPLE C, 1983, J MED CHEM, V26, P1614, DOI 10.1021/jm00365a012; Turkson J, 2004, MOL CANCER THER, V3, P261; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062; Whang-Peng J., 2010, J EXP CLIN MED, V2, P93; Wilson LJ, 2009, BIOORG MED CHEM LETT, V19, P3333, DOI 10.1016/j.bmcl.2009.04.039; Worns MA, 2010, DIGEST LIVER DIS, V42, pS302, DOI 10.1016/S1590-8658(10)60521-X; Yang SM, 2007, BIOORG MED CHEM LETT, V17, P326, DOI 10.1016/j.bmcl.2006.10.062; Yellaturu CR, 2003, J BIOL CHEM, V278, P9986, DOI 10.1074/jbc.M211276200; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zauberman A, 1999, ONCOGENE, V18, P3886, DOI 10.1038/sj.onc.1202738	49	123	127	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34296	34307		10.1074/jbc.M114.601104	http://dx.doi.org/10.1074/jbc.M114.601104			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25320076	Green Published, hybrid			2022-12-28	WOS:000346077600051
J	Yang, XC; Sabath, I; Kunduru, L; van Wijnen, AJ; Marzluff, WF; Dominski, Z				Yang, Xiao-cui; Sabath, Ivan; Kunduru, Lalitha; van Wijnen, Andre J.; Marzluff, William F.; Dominski, Zbigniew			A Conserved Interaction That Is Essential for the Biogenesis of Histone Locus Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Expression; Histone; Nuclear Organization; Protein-Protein Interaction; RNA Processing; Histone Locus Bodies; 3' End Processing; NPAT; FLASH; YARP; mute	PRE-MESSENGER-RNA; LOOP BINDING-PROTEIN; XENOPUS GERMINAL VESICLE; TRANSCRIPTION FACTOR YY1; EMBRYONIC STEM-CELLS; SM CORE STRUCTURE; GENE-EXPRESSION; CAJAL BODIES; NUCLEAR-BODIES; U7 SNRNP	Background: Proteins involved in expression of histone genes co-localize to discrete nuclear structures called histone locus bodies (HLBs). Results: Two main components of HLBs directly interact with each other through their C-terminal regions. Conclusion: Formation of HLBs depends on a subset of critical protein-protein interactions. Significance: Our work may help to understand the mechanisms that integrate transcription of histone genes with maturation of the nascent histone transcripts. Nuclear protein, ataxia-telangiectasia locus (NPAT) and FLICE-associated huge protein (FLASH) are two major components of discrete nuclear structures called histone locus bodies (HLBs). NPAT is a key co-activator of histone gene transcription, whereas FLASH through its N-terminal region functions in 3 end processing of histone primary transcripts. The C-terminal region of FLASH contains a highly conserved domain that is also present at the end of Yin Yang 1-associated protein-related protein (YARP) and its Drosophila homologue, Mute, previously shown to localize to HLBs in Drosophila cells. Here, we show that the C-terminal domain of human FLASH and YARP interacts with the C-terminal region of NPAT and that this interaction is essential and sufficient to drive FLASH and YARP to HLBs in HeLa cells. Strikingly, only the last 16 amino acids of NPAT are sufficient for the interaction. We also show that the C-terminal domain of Mute interacts with a short region at the end of the Drosophila NPAT orthologue, multi sex combs (Mxc). Altogether, our data indicate that the conserved C-terminal domain shared by FLASH, YARP, and Mute recognizes the C-terminal sequence of NPAT orthologues, thus acting as a signal targeting proteins to HLBs. Finally, we demonstrate that the C-terminal domain of human FLASH can be directly joined with its N-terminal region through alternative splicing. The resulting 190-amino acid MiniFLASH, despite lacking 90% of full-length FLASH, contains all regions necessary for 3 end processing of histone pre-mRNA in vitro and accumulates in HLBs.	[Yang, Xiao-cui; Sabath, Ivan; Kunduru, Lalitha; Marzluff, William F.; Dominski, Zbigniew] Univ N Carolina, Dept Biochem & Biophys, Integrat Program Biol & Genome Sci, Chapel Hill, NC 27599 USA; [van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic	Dominski, Z (corresponding author), Univ N Carolina, Integrat Program Biol & Genome Sci, CB 3280, Chapel Hill, NC 27599 USA.	dominski@med.unc.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946	National Institutes of Health [GM29832]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM29832.	Abbott J, 1999, MOL BIOL CELL, V10, P487, DOI 10.1091/mbc.10.2.487; Alm-Kristiansen AH, 2008, ONCOGENE, V27, P4644, DOI 10.1038/onc.2008.105; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14802, DOI 10.1073/pnas.0604225103; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14808, DOI 10.1073/pnas.0604227103; Bolisetty MT, 2012, NUCLEIC ACIDS RES, V40, P9244, DOI 10.1093/nar/gks652; Bongiorno-Borbone L, 2008, CELL CYCLE, V7, P2357, DOI 10.4161/cc.6344; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Bulchand S, 2010, J CELL SCI, V123, P2697, DOI 10.1242/jcs.063172; Burch BD, 2011, RNA, V17, P1132, DOI 10.1261/rna.2566811; Deran M, 2008, MOL CELL BIOL, V28, P435, DOI 10.1128/MCB.00607-07; Dominski Z, 1999, GENE, V239, P1, DOI 10.1016/S0378-1119(99)00367-4; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Dominski Z, 2007, GENE, V396, P373, DOI 10.1016/j.gene.2007.04.021; Dominski Z, 2013, BBA-GENE REGUL MECH, V1829, P532, DOI 10.1016/j.bbagrm.2013.01.010; Dundr M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000711; Eliassen KA, 1998, MOL CELL BIOL, V18, P7106, DOI 10.1128/MCB.18.12.7106; Erkmann JA, 2005, MOL BIOL CELL, V16, P2960, DOI 10.1091/mbc.E04-11-1023; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GALLINARI P, 1989, MOL CELL BIOL, V9, P1566, DOI 10.1128/MCB.9.4.1566; Ghule PN, 2008, P NATL ACAD SCI USA, V105, P16964, DOI 10.1073/pnas.0809273105; Ghule PN, 2009, J CELL PHYSIOL, V220, P129, DOI 10.1002/jcp.21740; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; HEINTZ N, 1991, BIOCHIM BIOPHYS ACTA, V1088, P327, DOI 10.1016/0167-4781(91)90122-3; Horton JR, 2007, PROTEINS, V67, P1198, DOI 10.1002/prot.21352; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Kiriyama M, 2009, MOL CELL BIOL, V29, P4729, DOI 10.1128/MCB.00289-09; Kuryshev VY, 2006, GENOMICS, V88, P143, DOI 10.1016/j.ygeno.2006.02.002; Last TJ, 1999, J CELL BIOCHEM, V72, P507, DOI 10.1002/(SICI)1097-4644(19990315)72:4<507::AID-JCB6>3.0.CO;2-5; Liu JL, 2006, CHROMOSOME RES, V14, P465, DOI 10.1007/s10577-006-1062-5; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; Liu YM, 2007, BLOOD, V110, P99, DOI 10.1182/blood-2006-11-059204; Lu P, 2011, J BIOL CHEM, V286, P18311, DOI 10.1074/jbc.M110.133603; Lu P, 2010, J EXP MED, V207, P1359, DOI 10.1084/jem.20100147; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Machyna M, 2013, WIRES RNA, V4, P17, DOI 10.1002/wrna.1139; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Miele A, 2005, MOL CELL BIOL, V25, P6140, DOI 10.1128/MCB.25.14.6140-6153.2005; Mitra P, 2003, MOL CELL BIOL, V23, P8110, DOI 10.1128/MCB.23.22.8110-8123.2003; Nizami ZF, 2010, COLD SH Q B, V75, P313, DOI 10.1101/sqb.2010.75.005; Nizami Z, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000653; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Ohtomo T, 2007, AMINO ACIDS, V33, P645, DOI 10.1007/s00726-006-0482-z; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; Pillai RS, 2003, GENE DEV, V17, P2321, DOI 10.1101/gad.274403; Pillai RS, 2001, EMBO J, V20, P5470, DOI 10.1093/emboj/20.19.5470; Rajendra TK, 2010, COLD SH Q B, V75, P365, DOI 10.1101/sqb.2010.75.043; Sabath I, 2013, RNA, V19, P1726, DOI 10.1261/rna.040360.113; Salzler HR, 2013, DEV CELL, V24, P623, DOI 10.1016/j.devcel.2013.02.014; Schumperli D, 2004, CELL MOL LIFE SCI, V61, P2560, DOI 10.1007/s00018-004-4190-0; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; STEIN GS, 1994, J CELL BIOCHEM, V54, P393, DOI 10.1002/jcb.240540406; Strzelecka M, 2010, NUCLEUS-PHILA, V1, P96, DOI 10.4161/nucl.1.1.10680; Tan DZ, 2013, SCIENCE, V339, P318, DOI 10.1126/science.1228705; Wagner EJ, 2007, MOL CELL, V28, P692, DOI 10.1016/j.molcel.2007.10.009; Walther TN, 1998, RNA, V4, P1034, DOI 10.1017/S1355838298971771; Wang CY, 2004, J BIOL CHEM, V279, P17750, DOI 10.1074/jbc.M310532200; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; White AE, 2011, J CELL BIOL, V193, P677, DOI 10.1083/jcb.201012077; WU CHH, 1993, P NATL ACAD SCI USA, V90, P6257, DOI 10.1073/pnas.90.13.6257; Yang XC, 2013, MOL CELL BIOL, V33, P28, DOI 10.1128/MCB.00653-12; Yang XC, 2011, MOL CELL BIOL, V31, P1492, DOI 10.1128/MCB.00979-10; Yang XC, 2009, MOL CELL, V36, P267, DOI 10.1016/j.molcel.2009.08.016; Yang XC, 2009, MOL CELL BIOL, V29, P31, DOI 10.1128/MCB.00776-08; Ye X, 2003, MOL CELL BIOL, V23, P8586, DOI 10.1128/MCB.23.23.8586-8600.2003; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zheng LX, 2003, MOL CELL BIOL, V23, P1590, DOI 10.1128/MCB.23.5.1590-1601.2003	71	23	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33767	33782		10.1074/jbc.M114.616466	http://dx.doi.org/10.1074/jbc.M114.616466			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25339177	Green Published, hybrid			2022-12-28	WOS:000346077600005
J	Eggensperger, S; Fisette, O; Parcej, D; Schafer, LV; Tampe, R				Eggensperger, Sabine; Fisette, Olivier; Parcej, David; Schaefer, Lars V.; Tampe, Robert			An Annular Lipid Belt Is Essential for Allosteric Coupling and Viral Inhibition of the Antigen Translocation Complex TAP (Transporter Associated with Antigen Processing)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS PROTEIN ICP47; PHOSPHOLIPID-BILAYER NANODISCS; PEPTIDE-BINDING-SITE; FORCE-FIELD; MICROSCALE THERMOPHORESIS; TAPASIN BINDING; ABC TRANSPORTER; ACTIVE DOMAIN; CONFORMATION; VALIDATION	The transporter associated with antigen processing (TAP) constitutes a focal element in the adaptive immune response against infected or malignantly transformed cells. TAP shuttles proteasomal degradation products into the lumen of the endoplasmic reticulum for loading of major histocompatibility complex (MHC) class I molecules. Here, the heterodimeric TAP complex was purified and reconstituted in nanodiscs in defined stoichiometry. We demonstrate that a single heterodimeric core-TAP complex is active in peptide binding, which is tightly coupled to ATP hydrolysis. Notably, with increasing peptide length, the ATP turnover was gradually decreased, revealing that ATP hydrolysis is coupled to the movement of peptide through the ATP-binding cassette transporter. In addition, all-atom molecular dynamics simulations show that the observed 22 lipids are sufficient to form an annular belt surrounding the TAP complex. This lipid belt is essential for high affinity inhibition by the herpesvirus immune evasin ICP47. In conclusion, nanodiscs are a powerful approach to study the important role of lipids as well as the function, interaction, and modulation of the antigen translocation machinery.	[Eggensperger, Sabine; Parcej, David; Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany; [Fisette, Olivier; Schaefer, Lars V.] Ruhr Univ Bochum, Lehrstuhl Theoret Chem, D-44780 Bochum, Germany; [Tampe, Robert] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Ruhr University Bochum; Goethe University Frankfurt	Tampe, R (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Bioctr, Max von Laue Str 9, D-60438 Frankfurt, Germany.	tampe@em.uni-frankfurt.de	Parcej, David/AAW-7306-2020; Tampé, Robert/H-2953-2015; Fisette, Olivier/C-8360-2015	Tampé, Robert/0000-0002-0403-2160; Fisette, Olivier/0000-0002-8043-4655; Schafer, Lars/0000-0002-8498-3061	German Research Foundation [SFB 807]; German Research Foundation (Cluster of Excellence RESOLV) [EXC 1069]; European Drug Initiative on Channels and Transporters EDICT - European Commission Seventh Framework Program	German Research Foundation(German Research Foundation (DFG)); German Research Foundation (Cluster of Excellence RESOLV)(German Research Foundation (DFG)); European Drug Initiative on Channels and Transporters EDICT - European Commission Seventh Framework Program	This work was supported by German Research Foundation Grant SFB 807 (Transport and Communication across Biological Membranes (to R. T. and L. V. S.), Emmy Noether grant (to L. V. S.), Cluster of Excellence RESOLV EXC 1069 (to L. V. S.), and the European Drug Initiative on Channels and Transporters EDICT (to R. T.) funded by the European Commission Seventh Framework Program.	Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; Aisenbrey C, 2006, J BIOL CHEM, V281, P30365, DOI 10.1074/jbc.M603000200; ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; Bao H, 2014, J BIOL CHEM, V289, P9844, DOI 10.1074/jbc.M113.545525; Bao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034836; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Beinert D, 1997, BIOCHEMISTRY-US, V36, P4694, DOI 10.1021/bi962940v; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Hagn F, 2013, J AM CHEM SOC, V135, P1919, DOI 10.1021/ja310901f; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; Herget M, 2011, P NATL ACAD SCI USA, V108, P1349, DOI 10.1073/pnas.1012355108; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; Hulpke S, 2013, TRENDS BIOCHEM SCI, V38, P412, DOI 10.1016/j.tibs.2013.06.003; Jambeck JPM, 2012, J CHEM THEORY COMPUT, V8, P2938, DOI 10.1021/ct300342n; Jambeck JPM, 2012, J PHYS CHEM B, V116, P3164, DOI 10.1021/jp212503e; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karasawa A, 2013, J BIOL CHEM, V288, P29862, DOI 10.1074/jbc.M113.499327; Kawai T, 2011, FEBS LETT, V585, P3533, DOI 10.1016/j.febslet.2011.10.015; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Koch J, 2006, FEBS LETT, V580, P4091, DOI 10.1016/j.febslet.2006.06.053; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mishra S, 2014, ELIFE, V3, DOI 10.7554/eLife.02740; Mors K, 2013, BBA-BIOMEMBRANES, V1828, P1222, DOI 10.1016/j.bbamem.2012.12.011; Nasr ML, 2014, BIOCHEMISTRY-US, V53, P4, DOI 10.1021/bi401412e; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Neumann L, 1997, J MOL BIOL, V272, P484, DOI 10.1006/jmbi.1997.1282; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Parcej D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067112; Pfander R, 1999, BIOCHEMISTRY-US, V38, P13692, DOI 10.1021/bi9909647; Procko E, 2005, IMMUNOL CELL BIOL, V83, P475, DOI 10.1111/j.1440-1711.2005.01354.x; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ritchie TK, 2011, J BIOL CHEM, V286, P39489, DOI 10.1074/jbc.M111.284554; Roos C, 2012, BBA-BIOMEMBRANES, V1818, P3098, DOI 10.1016/j.bbamem.2012.08.007; Scholz C, 2011, J BIOL CHEM, V286, P13346, DOI 10.1074/jbc.M110.216416; Seyffer F, 2015, BBA-GEN SUBJECTS, V1850, P449, DOI 10.1016/j.bbagen.2014.05.022; Smith EL, 1940, P NATL ACAD SCI USA, V26, P272, DOI 10.1073/pnas.26.4.272; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Tomazin R, 1996, EMBO J, V15, P3256, DOI 10.1002/j.1460-2075.1996.tb00690.x; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093	49	24	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33098	33108		10.1074/jbc.M114.592832	http://dx.doi.org/10.1074/jbc.M114.592832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25305015	Green Published, hybrid			2022-12-28	WOS:000345636600004
J	Kanamarlapudi, V				Kanamarlapudi, Venkateswarlu			Exchange Factor EFA6R Requires C-terminal Targeting to the Plasma Membrane to Promote Cytoskeletal Rearrangement through the Activation of ADP-ribosylation Factor 6 (ARF6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE; PH DOMAIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; G-PROTEINS; FAMILY; ACTIN; ROLES; CENTAURIN-ALPHA(1); GENES; ARNO	ADP-ribosylation factor 6 (ARF6) small GTPase regulates membrane trafficking and cytoskeleton rearrangements at the plasma membrane (PM) by cycling between the GTP-bound active and GDP-bound inactive conformations. Guanine nucleotide exchange factors (GEFs) activate ARF6. The exchange factor for ARF6 (EFA6) R has been identified as a biomarker for ovarian cancer. EFA6R shares the catalytic Sec7, pleckstrin homology (PH), and coiled coil (CC) domains of the other EFA6 family GEFs. Here we report the functional characterization of EFA6R. Endogenous EFA6R was present in the plasma membrane fraction. The exogenously expressed FLAG-and GFP-tagged EFA6R were targeted to the PM. In vitro, GFP-EFA6R associated weakly but preferentially with phosphatidylinositol 4,5-bisphosphate (PIP2) through the PH domain. EFA6R required both its PH and CC domains localized at the C terminus to target the PM. Consistent with this, EFA6R lacking the CC domain (EFA6R Delta CC) was released from the PM into the cytosol upon PIP2 depletion, whereas EFA6R release from the PM required both PIP2 depletion and actin destabilization. These results suggest that the dual targeting via the PH and CC domains is important for the PM localization of EFA6R. EFA6R specifically catalyzed the GTP loading of ARF6 in mammalian cells. Moreover, EFA6R regulated ARF6 localization and thereby actin stress fiber loss. The GEF activity of EFA6R was dependent on the presence of the Sec7 domain. The PH and CC domains were also required for the in vivo GEF activity of EFA6R but could be functionally replaced by the CAAX motif of K-Ras, suggesting a role for these domains in the membrane targeting of EFA6R.	Swansea Univ, Coll Med, Inst Life Sci 1, Swansea SA2 8PP, W Glam, Wales	Swansea University	Kanamarlapudi, V (corresponding author), Swansea Univ, Coll Med, Inst Life Sci 1, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	k.venkateswarlu@swansea.ac.uk	Kanamarlapudi, Venkateswarlu/A-9864-2011	Kanamarlapudi, Venkateswarlu/0000-0002-8739-1483	Biotechnology and Biological Sciences Research Council UK [BB/C515455/2]; Medical Research Council UK [G0401232]; Royal Society UK; MRC [G0401232] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C515455/2] Funding Source: researchfish; Medical Research Council [G0401232] Funding Source: researchfish; Health and Care Research Wales [HS-14-64] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society UK(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Health and Care Research Wales	This work was supported by Biotechnology and Biological Sciences Research Council UK Grant BB/C515455/2, Medical Research Council UK Grant G0401232, and the Royal Society UK.	Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Davies JCB, 2014, BIOCHEM PHARMACOL, V90, P406, DOI 10.1016/j.bcp.2014.06.012; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Derrien V, 2002, J CELL SCI, V115, P2867; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Eva R, 2012, J NEUROSCI, V32, P10352, DOI 10.1523/JNEUROSCI.1409-12.2012; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Freed EO, 2006, P NATL ACAD SCI USA, V103, P11101, DOI 10.1073/pnas.0604715103; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hiroyama M, 2005, J CELL PHYSIOL, V202, P608, DOI 10.1002/jcp.20156; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Kanamarlapudi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043532; Kanamarlapudi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037954; Kanamarlapudi V, 2012, J BIOL CHEM, V287, P20443, DOI 10.1074/jbc.M112.362087; Klein S, 2008, J BIOL CHEM, V283, P30129, DOI 10.1074/jbc.M803375200; Lawrence J, 2005, MOL PHARMACOL, V67, P1822, DOI 10.1124/mol.105.011338; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Macia E, 2008, J BIOL CHEM, V283, P19836, DOI 10.1074/jbc.M800781200; Nagel WG, 1998, MOL BIOL CELL, V9, P1981, DOI 10.1091/mbc.9.8.1981; Pils D, 2005, CANCER-AM CANCER SOC, V104, P2417, DOI 10.1002/cncr.21538; Radhakrishna H, 1999, J CELL SCI, V112, P855; Sakagami H, 2008, TOHOKU J EXP MED, V214, P191, DOI 10.1620/tjem.214.191; Sakagami H, 2007, EUR J NEUROSCI, V25, P618, DOI 10.1111/j.1460-9568.2007.05345.x; Sakagami H, 2006, BRAIN RES, V1093, P1, DOI 10.1016/j.brainres.2006.02.058; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 1999, CURR BIOL, V9, P1173, DOI 10.1016/S0960-9822(00)80019-6; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; Thomassen M, 2009, BREAST CANCER RES TR, V113, P239, DOI 10.1007/s10549-008-9927-2; Thyagarajan B, 2008, J BIOL CHEM, V283, P14980, DOI 10.1074/jbc.M704224200; Turner CE, 2001, CURR BIOL, V11, pR875, DOI 10.1016/S0960-9822(01)00521-8; van den Boom J, 2006, INT J CANCER, V119, P2330, DOI 10.1002/ijc.22108; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Venkateswarlu K, 2005, METHOD ENZYMOL, V404, P252, DOI 10.1016/S0076-6879(05)04024-3; Venkateswarlu K, 2005, J CELL SCI, V118, P2471, DOI 10.1242/jcs.02369; Venkateswarlu K, 2004, J BIOL CHEM, V279, P6205, DOI 10.1074/jbc.C300482200; Venkateswarlu K, 2000, BIOCHEM J, V345, P719, DOI 10.1042/0264-6021:3450719; Venkateswarlu K, 2007, J CELL SCI, V120, P792, DOI 10.1242/jcs.03373; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037	45	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33378	33390		10.1074/jbc.M113.534156	http://dx.doi.org/10.1074/jbc.M113.534156			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25296758	hybrid, Green Published			2022-12-28	WOS:000345636600028
J	Shiba-Fukushima, K; Inoshita, T; Hattori, N; Imai, Y				Shiba-Fukushima, Kahori; Inoshita, Tsuyoshi; Hattori, Nobutaka; Imai, Yuzuru			Lysine 63-linked Polyubiquitination Is Dispensable for Parkin-mediated Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; MITOCHONDRIAL TRANSLOCATION; DEPOLARIZED MITOCHONDRIA; RECESSIVE PARKINSONISM; DAMAGED MITOCHONDRIA; DEPENDENT MITOPHAGY; ACTIVATE PARKIN; LIGASE ACTIVITY; PROTEIN LIGASE; CELL-DEATH	PINK1/Parkin-mediated mitophagy is thought to ensure mitochondrial quality control in neurons as well as other cells. Upon the loss of mitochondrial membrane potential (Delta Psi m), Lys-63-linked polyubiquitin chains accumulate on the mitochondrial outer membrane in a Parkin-dependent manner. However, the physiological significance of Lys-63-linked polyubiquitination during mitophagy is not fully understood. Here, we report that the suppression of Lys-63-linked polyubiquitination through the removal of Ubc13 activity essentially affects neither PINK1 activation nor the degradation of depolarized mitochondria. Moreover, the inactivation of Ubc13 did not modulate the mitochondrial phenotypes of PINK1 knockdown Drosophila. Our data indicate that the formation of Lys-63-linked polyubiquitin chains on depolarized mitochondria is not a key factor for the PINK1-Parkin pathway as was once thought.	[Shiba-Fukushima, Kahori] Juntendo Univ, Grad Sch Med, Dept Neurol, Tokyo 1138421, Japan; [Inoshita, Tsuyoshi; Hattori, Nobutaka; Imai, Yuzuru] Juntendo Univ, Grad Sch Med, Dept Res Parkinsons Dis, Tokyo 1138421, Japan	Juntendo University; Juntendo University	Hattori, N (corresponding author), Juntendo Univ, Grad Sch Med, Dept Neurol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	nhattori@juntendo.ac.jp; yzimai@juntendo.ac.jp	Imai, Yuzuru/AAA-6472-2019; Hattori, Nobutaka/ACR-0069-2022	Imai, Yuzuru/0000-0003-2924-5231; 	Takeda Science Foundation; Life Science Foundation of Japan; Daiichi-Sankyo Foundation for Life Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Otsuka Pharmaceutical; Grants-in-Aid for Scientific Research [26293070] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Life Science Foundation of Japan(Life Science Foundation of Japan); Daiichi-Sankyo Foundation for Life Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Otsuka Pharmaceutical(Otsuka Pharmaceutical); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Takeda Science Foundation, (to Y. I.), the Life Science Foundation of Japan (to Y. I.), the Daiichi-Sankyo Foundation for Life Science (to Y. I.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to Y. I.), and Otsuka Pharmaceutical (to N. H. and Y. I.).	Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Fiesel FC, 2014, J CELL SCI, V127, P3488, DOI 10.1242/jcs.147520; Fujita N, 2013, J CELL BIOL, V203, P115, DOI 10.1083/jcb.201304188; Geisler S, 2014, J CELL SCI, V127, P3280, DOI 10.1242/jcs.146035; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Haddad DM, 2013, MOL CELL, V50, P831, DOI 10.1016/j.molcel.2013.04.012; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lim GGY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073235; Ma XJ, 2012, CELL RES, V22, P425, DOI 10.1038/cr.2011.135; Manzanillo PS, 2013, NATURE, V501, P512, DOI 10.1038/nature12566; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Murata H, 2013, MOL BIOL CELL, V24, P2772, DOI 10.1091/mbc.E13-01-0016; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Shiba K, 2009, BIOCHEM BIOPH RES CO, V383, P331, DOI 10.1016/j.bbrc.2009.04.006; Shiba-Fukushima K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004391; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van Wijk SJL, 2012, MOL CELL, V47, P797, DOI 10.1016/j.molcel.2012.06.017; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zheng XD, 2013, CELL RES, V23, P886, DOI 10.1038/cr.2013.66	40	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33131	33136		10.1074/jbc.C114.580944	http://dx.doi.org/10.1074/jbc.C114.580944			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25336644	Green Published, hybrid			2022-12-28	WOS:000345636600008
J	Chen, Q; Courtennanche, N; Pollard, TD				Chen, Qian; Courtennanche, Naomi; Pollard, Thomas D.			Aip1 Promotes Actin Filament Severing by Cofilin and Regulates Constriction of the Cytokinetic Contractile Ring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING PROTEIN-1 UNC-78; CAENORHABDITIS-ELEGANS; FISSION YEAST; IN-VIVO; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE STATE; CAPPING PROTEIN; TURNOVER; BINDING; ADF/COFILIN	Aip1 (actin interacting protein 1) is ubiquitous in eukaryotic organisms, where it cooperates with cofilin to disassemble actin filaments, but neither its mechanism of action nor its biological functions have been clear. We purified both fission yeast and human Aip1 and investigated their biochemical activities with or without cofilin. Both types of Aip1 bind actin filaments with micromolar affinities and weakly nucleate actin polymerization. Aip1 increases up to 12-fold the rate that high concentrations of yeast or human cofilin sever actin filaments, most likely by competing with cofilin for binding to the side of actin filaments, reducing the occupancy of the filaments by cofilin to a range favorable for severing. Aip1 does not cap the barbed ends of filaments severed by cofilin. Fission yeast lacking Aip1 are viable and assemble cytokinetic contractile rings normally, but rings in these Delta aip1 cells accumulate 30% less myosin II. Further, these mutant cells initiate the ingression of cleavage furrows earlier than normal, shortening the stage of cytokinetic ring maturation by 50%. The Delta aip1 mutation has negative genetic interactions with deletion mutations of both capping protein subunits and cofilin mutations with severing defects, but no genetic interaction with deletion of coronin.	[Chen, Qian; Courtennanche, Naomi; Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	thomas.pollard@yale.edu	Chen, Qian/AAV-1871-2020	Chen, Qian/0000-0002-2768-6570	National Institutes of Health [R01GM026338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM026338.	Aggeli D, 2014, CYTOSKELETON, V71, P361, DOI 10.1002/cm.21178; Aizawa H, 1999, GENES CELLS, V4, P311, DOI 10.1046/j.1365-2443.1999.00262.x; AMBERG DC, 1995, NAT STRUCT BIOL, V2, P28, DOI 10.1038/nsb0195-28; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Berro J, 2014, MOL BIOL CELL, V25, P3515, DOI 10.1091/mbc.E13-01-0005; Blanchoin L, 2000, J MOL BIOL, V295, P203, DOI 10.1006/jmbi.1999.3336; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Chen Q, 2013, CURR BIOL, V23, P1154, DOI 10.1016/j.cub.2013.05.005; Chen Q, 2011, J CELL BIOL, V195, P485, DOI 10.1083/jcb.201103067; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Clark MG, 2006, MOL BIOL CELL, V17, P1971, DOI 10.1091/mbc.E05-10-0956; COOPER JA, 1984, J CELL BIOL, V99, P217, DOI 10.1083/jcb.99.1.217; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; Elam WA, 2013, BIOCHEM BIOPH RES CO, V438, P728, DOI 10.1016/j.bbrc.2013.07.109; Fujibuchi T, 2005, BIOCHEM BIOPH RES CO, V327, P268, DOI 10.1016/j.bbrc.2004.11.156; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Iida K, 1999, GENES CELLS, V4, P21, DOI 10.1046/j.1365-2443.1999.00235.x; Ishikawa-Ankerhold HC, 2010, CYTOSKELETON, V67, P442, DOI 10.1002/cm.20456; Kato A, 2008, BIOCHEM J, V414, P261, DOI 10.1042/BJ20071655; Ketelaar T, 2004, CURR BIOL, V14, P145, DOI 10.1016/j.cub.2004.01.004; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Konzok A, 1999, J CELL BIOL, V146, P453, DOI 10.1083/jcb.146.2.453; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lin MC, 2010, J CELL SCI, V123, P1329, DOI 10.1242/jcs.065698; MACLEANFLETCHER SD, 1980, J CELL BIOL, V85, P414, DOI 10.1083/jcb.85.2.414; Michelot A, 2013, DEV CELL, V24, P182, DOI 10.1016/j.devcel.2012.12.008; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; Mohri K, 2003, J CELL SCI, V116, P4107, DOI 10.1242/jcs.00717; Nakano K, 2006, MOL BIOL CELL, V17, P1933, DOI 10.1091/mbc.E05-09-0900; OHTA Y, 1989, J BIOL CHEM, V264, P16143; Okada K, 1999, J CELL SCI, V112, P1553; Okada K, 2002, J BIOL CHEM, V277, P43011, DOI 10.1074/jbc.M203111200; Okada K, 2006, MOL BIOL CELL, V17, P2855, DOI 10.1091/mbc.e06-02-0135; Okreglak V, 2010, J CELL BIOL, V188, P769, DOI 10.1083/jcb.200909176; Ono K, 2014, CYTOSKELETON, V71, P36, DOI 10.1002/cm.21152; Ono S, 2004, J BIOL CHEM, V279, P14207, DOI 10.1074/jbc.M313418200; Ono S, 2001, J CELL BIOL, V152, P1313, DOI 10.1083/jcb.152.6.1313; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Ren N, 2007, GENETICS, V176, P2223, DOI 10.1534/genetics.107.072959; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Shi M, 2013, PLANT J, V73, P747, DOI 10.1111/tpj.12065; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; Voegtli WC, 2003, J BIOL CHEM, V278, P34373, DOI 10.1074/jbc.M302773200; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Yu R, 2006, CELL MOTIL CYTOSKEL, V63, P659, DOI 10.1002/cm.20152	54	41	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2289	2300		10.1074/jbc.M114.612978	http://dx.doi.org/10.1074/jbc.M114.612978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25451933	hybrid, Green Published			2022-12-28	WOS:000348588000032
J	Bartkowiak, B; Greenleaf, AL				Bartkowiak, Bartlomiej; Greenleaf, Arno L.			Expression, Purification, and Identification of Associated Proteins of the Full-length hCDK12/CyclinK Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II CTD; TERMINAL REPEAT DOMAIN; P-TEFB; RNA; KINASE; PHOSPHORYLATION; TRANSCRIPTION; FLAVOPIRIDOL; SPECIFICITY; SUBUNIT	The coupling of transcription and associated processes has been shown to be dependent on the RNA polymerase II (RNA-PII) C-terminal repeat domain (CTD) and the phosphorylation of the heptad repeats of which it is composed (consensus sequence Y1S2P3T4S5P6S7). Two primary S-2 position CTD kinases have been identified in higher eukaryotes: P-TEFb and CDK12/CyclinK. The more recently discovered CDK12 appears to act at the 3'-end of the transcription unit and has been identified as a tumor suppressor for ovarian cancer; however much is still unknown about the in vivo roles of CDK12/CyclinK. In an effort to further characterize these roles we have purified to near homogeneity and characterized, full-length, active, human CDK12/CyclinK, and identified hCDK12-associated proteins via mass spectrometry. We find that employing a "2A" peptide-linked multicistronic construct containing CDK12 and CyclinK results in the efficient production of active, recombinant enzyme in the baculovirus/Sf9 expression system. Using GST-CTD fusion protein substrates we find that CDK12/CyclinK prefers a substrate with unmodified repeats or one that mimics prephosphorylation at the S-7 position of the CTD; also the enzyme is sensitive to the inhibitor flavopiridol at higher concentrations. Identification of CDK12-associating proteins reveals a strong enrichment for RNA-processing factors suggesting that CDK12 affects RNA processing events in two distinct ways: Indirectly through generating factor-binding phos-pho-epitopes on the CTD of elongating RNAPII and directly through binding to specific factors.	[Bartkowiak, Bartlomiej; Greenleaf, Arno L.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Greenleaf, AL (corresponding author), Duke Univ, Med Ctr, 0034 CARL Bldg, Durham, NC 27710 USA.	arno@duke.edu			National Institutes of Health [GM040505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in whole or in part, by Grant GM040505 from the National Institutes of Health (to A. L. G.).	Bartkowiak B, 2011, GENET RES INT, V2011, DOI 10.4061/2011/623718; Bartkowiak B, 2011, TRANSCR-AUSTIN, V2, P115, DOI 10.4161/trns.2.3.15004; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Blethrow Justin, 2004, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1811s66; Bosken CA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4505; Carey Michael F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5330; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Cheng SWG, 2012, MOL CELL BIOL, V32, P4691, DOI 10.1128/MCB.06267-11; Corden JL, 2013, CHEM REV, V113, P8423, DOI 10.1021/cr400158h; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Davidson L, 2014, GENE DEV, V28, P342, DOI 10.1101/gad.231274.113; Edwards MC, 1998, MOL CELL BIOL, V18, P4291, DOI 10.1128/MCB.18.7.4291; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Eifler T.T., 2014, MOL CELL BIOL, DOI [10.1128/MCB.01157-14, DOI 10.1128/MCB.01157-14]; Garriga J, 1996, BIOCHEM J, V319, P293, DOI 10.1042/bj3190293; Garriga J, 2010, J CELL PHYSIOL, V222, P200, DOI 10.1002/jcp.21938; Harlow E., 1999, USING ANTIBODIES LAB; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Joshi PM, 2014, J BIOL CHEM, V289, P9247, DOI 10.1074/jbc.M114.551143; Ko TK, 2001, J CELL SCI, V114, P2591; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; LEE JM, 1989, P NATL ACAD SCI USA, V86, P3624, DOI 10.1073/pnas.86.10.3624; Leroy D, 1996, FEBS LETT, V379, P217, DOI 10.1016/0014-5793(95)01514-0; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; Morris DP, 1997, METHODS, V12, P264, DOI 10.1006/meth.1997.0478; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Schmerwitz UK, 2011, ARTERIOSCL THROM VAS, V31, P280, DOI 10.1161/ATVBAHA.110.213934; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Singh G, 2012, CELL, V151, P750, DOI 10.1016/j.cell.2012.10.007; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Werner-Allen JW, 2011, J BIOL CHEM, V286, P5717, DOI 10.1074/jbc.M110.197129; Zhang Y, 2011, BIOCHEM J, V434, P435, DOI 10.1042/BJ20101471; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016	40	35	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1786	1795		10.1074/jbc.M114.612226	http://dx.doi.org/10.1074/jbc.M114.612226			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25429106	Green Published, hybrid			2022-12-28	WOS:000348056400043
J	Kim, KW; Smith, CA; Daily, MD; Cort, JR; Davin, LB; Lewis, NG				Kim, Kye-Won; Smith, Clyde A.; Daily, Michael D.; Cort, John R.; Davin, Laurence B.; Lewis, Norman G.			Trimeric Structure of (+)-Pinoresinol-forming Dirigent Protein at 1.95 angstrom Resolution with Three Isolated Active Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-RESISTANCE RESPONSE; ALLENE OXIDE CYCLASE; SECONDARY; MODEL; ARABIDOPSIS; EXPRESSION; INSIGHTS; PEA	Control over phenoxy radical-radical coupling reactions in vivo in vascular plants was enigmatic until our discovery of dirigent proteins (DPs, from the Latin dirigere, to guide or align). The first three-dimensional structure of a DP ((+)-pinoresinol-forming DP, 1.95 angstrom resolution, rhombohedral space group H32)) is reported herein. It has a tightly packed trimeric structure with an eight-stranded beta-barrel topology for each DP monomer. Each putative substrate binding and orientation coupling site is located on the trimer surface but too far apart for intermolecular coupling between sites. It is proposed that each site enables stereoselective coupling (using either two coniferyl alcohol radicals or a radical and a monolignol). Interestingly, there are six differentially conserved residues in DPs affording either the (+)- or (-)-antipodes in the vicinity of the putative binding site and region known to control stereoselectivity. DPs are involved in lignan biosynthesis, whereas dirigent domains/sites have been implicated in lignin deposition.	[Kim, Kye-Won; Davin, Laurence B.; Lewis, Norman G.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Smith, Clyde A.] Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Daily, Michael D.; Cort, John R.] Pacific NW Natl Lab, Fundamental & Computat Sci Directorate, Richland, WA 99354 USA	Washington State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Lewis, NG (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lewisn@wsu.edu		Lewis, Norman/0000-0001-5742-032X; Davin, Laurence/0000-0002-3248-6485; Hwang, Julianne/0000-0002-9222-1729	U.S. Dept. of Energy, Office of Science, Basic Energy Sciences (BES) [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research (BER); National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; Dept. of Energy's BER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER; Direct For Biological Sciences [1052557] Funding Source: National Science Foundation	U.S. Dept. of Energy, Office of Science, Basic Energy Sciences (BES)(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research (BER)(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Dept. of Energy's BER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Marlisa Burton, Terri Lincoln, Mia Ryckman, and Paul Ziegler for assistance in DP purification. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Dept. of Energy, Office of Science, Basic Energy Sciences (BES), under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research (BER), and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). A portion of the work was performed in the Environmental Molecular Sciences Laboratory (EMSL), a national scientific user facility sponsored by the Dept. of Energy's BER and located at Pacific Northwest National Laboratory (PNNL), Richland, WA.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CULLEY DE, 1995, PLANT PHYSIOL, V107, P301, DOI 10.1104/pp.107.1.301; Davin LB, 2008, NAT PROD REP, V25, P1015, DOI 10.1039/b510386j; Davin LB, 2005, CURR OPIN BIOTECH, V16, P407, DOI 10.1016/j.copbio.2005.06.011; Davin LB, 2005, CURR OPIN BIOTECH, V16, P398, DOI 10.1016/j.copbio.2005.06.010; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; DeLano WL, 2002, THE PYMOL MOLECULAR; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FETROW JS, 1995, FASEB J, V9, P708, DOI 10.1096/fasebj.9.9.7601335; FRISTENSKY B, 1988, PLANT MOL BIOL, V11, P713, DOI 10.1007/BF00017470; FRISTENSKY B, 1985, PHYSIOL PLANT PATHOL, V27, P15, DOI 10.1016/0048-4059(85)90053-0; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Halls SC, 2002, BIOCHEMISTRY-US, V41, P9455, DOI 10.1021/bi0259709; Halls SC, 2004, BIOCHEMISTRY-US, V43, P2587, DOI 10.1021/bi035959o; Hofmann E, 2006, PLANT CELL, V18, P3201, DOI 10.1105/tpc.106.043984; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hosmani PS, 2013, P NATL ACAD SCI USA, V110, P14498, DOI 10.1073/pnas.1308412110; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim KW, 2012, J BIOL CHEM, V287, P33957, DOI 10.1074/jbc.M112.387423; Kim MK, 2002, PLANT MOL BIOL, V49, P199, DOI 10.1023/A:1014940930703; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Neumann P, 2012, PLANT PHYSIOL, V160, P1251, DOI 10.1104/pp.112.205138; Pickel B, 2012, FEBS J, V279, P1980, DOI 10.1111/j.1742-4658.2012.08580.x; Pickel B, 2010, ANGEW CHEM INT EDIT, V49, P202, DOI 10.1002/anie.200904622; RIGGLEMAN RC, 1985, PLANT MOL BIOL, V4, P81, DOI 10.1007/BF02418753; Schaller F, 2004, J PLANT GROWTH REGUL, V23, P179, DOI 10.1007/s00344-004-0047-x; Seneviratne HK, 2015, PHYTOCHEMISTRY, V113, P140, DOI 10.1016/j.phytochem.2014.10.013; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vassao DG, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P815; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	40	38	40	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1308	1318		10.1074/jbc.M114.611780	http://dx.doi.org/10.1074/jbc.M114.611780			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25411250	hybrid, Green Published			2022-12-28	WOS:000348056400002
J	Bruck, I; Kaplan, DL				Bruck, Irina; Kaplan, Daniel L.			The Dbf4-Cdc7 Kinase Promotes Mcm2-7 Ring Opening to Allow for Single-stranded DNA Extrusion and Helicase Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE; REPLICATION ORIGINS; ACTIVE-SITES; COMPLEX; CDC45; GINS; INITIATION; PROTEINS; SLD2; ASSOCIATION	The replication fork helicase in eukaryotes is composed of Cdc45, Mcm2-7, and GINS (CMG). The Dbf4-Cdc7 kinase phosphorylates Mcm2 in vitro, but the in vivo role for Dbf4-Cdc7 phosphorylation of Mcm2 is unclear. We find that budding yeast Dbf4-Cdc7 phosphorylates Mcm2 in vivo under normal conditions during S phase. Inhibiting Dbf4-Cdc7 phosphorylation of Mcm2 confers a dominant-negative phenotype with a severe growth defect. Inhibiting Dbf4-Cdc7 phosphorylation of Mcm2 under wild-type expression conditions also results in impaired DNA replication, substantially decreased single-stranded formation at an origin, and markedly disrupted interaction between GINS and Mcm2-7 during S phase. In vitro, Dbf4-Cdc7 kinase (DDK) phosphorylation of Mcm2 substantially weakens the interaction between Mcm2 and Mcm5, and Dbf4-Cdc7 phosphorylation of Mcm2 promotes Mcm2-7 ring opening. The extrusion of ssDNA from the central channel of Mcm2-7 triggers GINS attachment to Mcm2-7. Thus, Dbf4-Cdc7 phosphorylation of Mcm2 may open the Mcm2-7 ring at the Mcm2-Mcm5 interface, allowing for single-stranded DNA extrusion and subsequent GINS assembly with Mcm2-7.	[Bruck, Irina; Kaplan, Daniel L.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Kaplan, DL (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, 1115 W Call St, Tallahassee, FL 32306 USA.	Daniel.Kaplan@med.fsu.edu			National Science Foundation [1265431]	National Science Foundation(National Science Foundation (NSF))	This work was funded by National Science Foundation Award 1265431 (to D. L. K.).	Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2007, J BIOL CHEM, V282, P33795, DOI 10.1074/jbc.M703824200; Bochman ML, 2010, NUCLEIC ACIDS RES, V38, P6078, DOI 10.1093/nar/gkq422; Bruck I, 2014, J BIOL CHEM, V289, P1948, DOI 10.1074/jbc.M113.532085; Bruck I, 2013, J BIOL CHEM, V288, P7550, DOI 10.1074/jbc.M112.440941; Bruck I, 2011, J BIOL CHEM, V286, P36414, DOI 10.1074/jbc.M111.282822; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Froelich CA, 2014, ELIFE, V3, DOI 10.7554/eLife.01993; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Geraghty DS, 2000, J BIOL CHEM, V275, P18011, DOI 10.1074/jbc.M909787199; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Itou H, 2014, STRUCTURE, V22, P1341, DOI 10.1016/j.str.2014.07.001; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanter DM, 2011, NUCLEIC ACIDS RES, V39, P2580, DOI 10.1093/nar/gkq1222; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Ramer MD, 2013, J BIOL CHEM, V288, P14926, DOI 10.1074/jbc.M112.392910; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Samel SA, 2014, GENE DEV, V28, P1653, DOI 10.1101/gad.242404.114; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Stead BE, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-36; Stead BE, 2011, NUCLEIC ACIDS RES, V39, P6998, DOI 10.1093/nar/gkr371; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka S, 2011, CURR BIOL, V21, P2055, DOI 10.1016/j.cub.2011.11.038; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	45	24	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1210	1221		10.1074/jbc.M114.608232	http://dx.doi.org/10.1074/jbc.M114.608232			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25471369	Green Published, hybrid			2022-12-28	WOS:000347778200050
J	Ksiazek, M; Mizgalska, D; Enghild, JJ; Scavenius, C; Thogersen, IB; Potempa, J				Ksiazek, Miroslaw; Mizgalska, Danuta; Enghild, Jan J.; Scavenius, Carsten; Thogersen, Ida B.; Potempa, Jan			Miropin, a Novel Bacterial Serpin from the Periodontopathogen Tannerella forsythia, Inhibits a Broad Range of Proteases by Using Different Peptide Bonds within the Reactive Center Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Infectious Disease; Periodontal Disease; Protease Inhibitor; Serine Protease; Serpin; Tannerella forsythia	NEUTROPHIL ELASTASE; SERINE PROTEASES; MECHANISM; TRYPSIN; ALPHA-1-ANTITRYPSIN; CHYMOTRYPSIN; SUPERFAMILY; INFECTIONS; PROTEINS; DISEASE	Background: Serpins are uncommon in bacteria; little is known about their function. Results: Serpin from T. forsythia (miropin) inhibits a broad array of proteases with divergent specificities. Conclusion: Miropin may allow T. forsythia to dwell in a highly proteolytic environment. Significance: Miropin is the first pathogen-derived serpin with the unusual ability to efficiently inhibit different proteases at several active sites. All prokaryotic genes encoding putative serpins identified to date are found in environmental and commensal microorganisms, and only very few prokaryotic serpins have been investigated from a mechanistic standpoint. Herein, we characterized a novel serpin (miropin) from the human pathogen Tannerella forsythia, a bacterium implicated in initiation and progression of human periodontitis. In contrast to other serpins, miropin efficiently inhibited a broad range of proteases (neutrophil and pancreatic elastases, cathepsin G, subtilisin, and trypsin) with a stoichiometry of inhibition of around 3 and second-order association rate constants that ranged from 2.7 x 10(4) (cathepsin G) to 7.1 x 10(5) m(-1)s(-1) (subtilisin). Inhibition was associated with the formation of complexes that were stable during SDS-PAGE. The unusually broad specificity of miropin for target proteases is achieved through different active sites within the reactive center loop upstream of the P1-P1 site, which was predicted from an alignment of the primary structure of miropin with those of well studied human and prokaryotic serpins. Thus, miropin is unique among inhibitory serpins, and it has apparently evolved the ability to inhibit a multitude of proteases at the expense of a high stoichiometry of inhibition and a low association rate constant. These characteristics suggest that miropin arose as an adaptation to the highly proteolytic environment of subgingival plaque, which is exposed continually to an array of host proteases in the inflammatory exudate. In such an environment, miropin may function as an important virulence factor by protecting bacterium from the destructive activity of neutrophil serine proteases. Alternatively, it may act as a housekeeping protein that regulates the activity of endogenous T. forsythia serine proteases.	[Ksiazek, Miroslaw; Mizgalska, Danuta; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland; [Enghild, Jan J.; Scavenius, Carsten; Thogersen, Ida B.] Aarhus Univ, Dept Mol Biol & Genet, Ctr Insoluble Prot Struct InSPIN, DK-8000 Aarhus, Denmark; [Enghild, Jan J.; Scavenius, Carsten; Thogersen, Ida B.] Aarhus Univ, Dept Mol Biol & Genet, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Potempa, Jan] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA	Jagiellonian University; Aarhus University; Aarhus University; University of Louisville	Ksiazek, M (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Ul Gronostajowa 7, PL-30387 Krakow, Poland.	ksiazek.miroslaw@gmail.com	Potempa, Jan/AAA-6850-2021; Scavenius, Carsten/Q-5941-2017	Enghild, Jan Johannes/0000-0001-9292-9172; Potempa, Jan/0000-0002-3600-7461; Scavenius, Carsten/0000-0002-4304-0681	National Institutes of Health [DE 09761, DE 022597]; National Science Center (NCN, Krakow, Poland) [2013/08/T/NZ1/00315, 2011/03/N/NZ1/00586]; NCN [2012/04/A/NZ1/00051]; European Commission [FP7-HEALTH-2010-261460, FP7-PEOPLE-2011-ITN-290246, FP7-HEALTH-F3-2012-306029]; Polish Ministry of Science and Higher Education [137/7.PR-EU/2011/2]; European Union [POIG.02.01.00-12-064/08]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761, R01DE022597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Center (NCN, Krakow, Poland); NCN; European Commission(European CommissionEuropean Commission Joint Research Centre); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union(European Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE 09761 and DE 022597). This work was also supported by Grants 2013/08/T/NZ1/00315 (a doctoral scholarship) and 2011/03/N/NZ1/00586 from the National Science Center (NCN, Krakow, Poland; to M. K.) and by grants from the NCN (2012/04/A/NZ1/00051), European Commission (FP7-HEALTH-2010-261460 "Gums and Joints," FP7-PEOPLE-2011-ITN-290246 "RAPID," and FP7-HEALTH-F3-2012-306029 "TRIGGER"), and Polish Ministry of Science and Higher Education (project 137/7.PR-EU/2011/2; to J. P.). The Faculty of Biochemistry, Biophysics, and Biotechnology of the Jagiellonian University is a beneficiary of structural funds from the European Union (POIG.02.01.00-12-064/08).	Behle JH, 2006, INT DENT J, V56, P256; Belaaouaj A, 2002, MICROBES INFECT, V4, P1259, DOI 10.1016/S1286-4579(02)01654-4; Cabrita LD, 2007, J BIOL CHEM, V282, P26802, DOI 10.1074/jbc.M705020200; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Dahl SW, 1996, J BIOL CHEM, V271, P25083, DOI 10.1074/jbc.271.41.25083; Dahlen JR, 1998, J BIOL CHEM, V273, P1851, DOI 10.1074/jbc.273.4.1851; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Djie MZ, 1996, BIOCHEMISTRY-US, V35, P11461, DOI 10.1021/bi952717i; Eggers CT, 2004, BIOCHEM J, V379, P107, DOI 10.1042/BJ20031790; Flemmig T F, 1999, Ann Periodontol, V4, P32, DOI 10.1902/annals.1999.4.1.32; Fox C H, 1992, Curr Opin Dent, V2, P5; Garcia R I, 2001, Ann Periodontol, V6, P71, DOI 10.1902/annals.2001.6.1.71; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington James A., 2001, Science Progress, V84, P125, DOI 10.3184/003685001783239032; Irving JA, 2003, STRUCTURE, V11, P387, DOI 10.1016/S0969-2126(03)00057-1; Irving JA, 2002, MOL BIOL EVOL, V19, P1881, DOI 10.1093/oxfordjournals.molbev.a004012; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Ivanov D, 2006, J BIOL CHEM, V281, P17246, DOI 10.1074/jbc.M601678200; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169; Kang SH, 2006, MOL MICROBIOL, V60, P1344, DOI 10.1111/j.1365-2958.2006.05182.x; Kantyka T, 2011, BIOL CHEM, V392, P483, DOI 10.1515/BC.2011.044; Kantyka T, 2010, BIOCHIMIE, V92, P1644, DOI 10.1016/j.biochi.2010.06.004; Mailhot JM, 1998, J CLIN PERIODONTOL, V25, P578, DOI 10.1111/j.1600-051X.1998.tb02491.x; Mast AE, 1999, BLOOD, V94, P3922, DOI 10.1182/blood.V94.11.3922.423k33_3922_3927; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Offenbacher S, 1996, J PERIODONTOL, V67, P1103, DOI 10.1902/jop.1996.67.10s.1103; Ostergaard H, 2000, J BIOL CHEM, V275, P33272, DOI 10.1074/jbc.M004633200; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; Peter J, 2000, CLIN CHEM, V46, P474; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; POTEMPA J, 1991, J BIOL CHEM, V266, P21482; POTEMPA J, 1988, SCIENCE, V241, P699, DOI 10.1126/science.2456616; Riewald M, 1996, J BIOL CHEM, V271, P14526, DOI 10.1074/jbc.271.24.14526; Roberts TH, 2004, J MOL EVOL, V59, P437, DOI 10.1007/s00239-004-2635-6; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stanley P, 2006, BIOCHEM J, V400, P169, DOI 10.1042/BJ20060444; Tanaka S, 2011, BBA-PROTEINS PROTEOM, V1814, P299, DOI 10.1016/j.bbapap.2010.11.003; Wang CY, 2010, J MICROBIOL IMMUNOL, V43, P491, DOI 10.1016/S1684-1182(10)60076-X; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Zhang Q, 2007, EMBO REP, V8, P658, DOI 10.1038/sj.embor.7400986	47	38	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					658	670		10.1074/jbc.M114.601716	http://dx.doi.org/10.1074/jbc.M114.601716			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25389290	hybrid, Green Published			2022-12-28	WOS:000347231200056
J	Malecki, J; Ho, AYY; Moen, A; Dahl, HA; Falnes, PO				Malecki, Jedrzej; Ho, Angela Y. Y.; Moen, Anders; Dahl, Helge-Andre; Falnes, Pal O.			Human METTL20 Is a Mitochondrial Lysine Methyltransferase That Targets the beta Subunit of Electron Transfer Flavoprotein (ETF beta) and Modulates Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Mitochondrial Metabolism; Post-translational Modification (PTM); Protein Methylation; Protein Targeting; Electron Transfer Flavoprotein	RAT-LIVER MITOCHONDRIA; COA DEHYDROGENASE; MEDIUM-CHAIN; SET DOMAIN; METHYLATION; IDENTIFICATION; PROTEINS; PURIFICATION; RESOLUTION; SUBSTRATE	Background: Many proteins are modified by lysine methylation. Results: It is shown that the previously uncharacterized enzyme METTL20 methylates electron transfer flavoprotein (ETF), thereby inhibiting its ability to mediate electron transfer from acyl-CoA dehydrogenases. Conclusion: METTL20-mediated methylation modulates the function of ETF. Significance: The first mitochondrial lysine-specific protein methyltransferase in animals is reported, and the resulting methylation is shown to have functional consequences. Proteins are frequently modified by post-translational methylation of lysine residues, catalyzed by S-adenosylmethionine-dependent lysine methyltransferases (KMTs). Lysine methylation of histone proteins has been extensively studied, but it has recently become evident that methylation of non-histone proteins is also abundant and important. The human methyltransferase METTL20 belongs to a group of 10 established and putative human KMTs. We here found METTL20 to be associated with mitochondria and determined that recombinant METTL20 methylated a single protein in extracts from human cells. Using an methyltransferase activity-based purification scheme, we identified the -subunit of the mitochondrially localized electron transfer flavoprotein (ETF) as the substrate of METTL20. Furthermore, METTL20 was found to specifically methylate two adjacent lysine residues, Lys(200) and Lys(203), in ETF both in vitro and in cells. Interestingly, the residues methylated by METTL20 partially overlap with the so-called recognition loop in ETF, which has been shown to mediate its interaction with various dehydrogenases. Accordingly, we found that METTL20-mediated methylation of ETF in vitro reduced its ability to receive electrons from the medium chain acyl-CoA dehydrogenase and the glutaryl-CoA dehydrogenase. In conclusion, the present study establishes METTL20 as the first human KMT localized to mitochondria and suggests that it may regulate cellular metabolism through modulating the interaction between its substrate ETF and dehydrogenases. Based on the previous naming of similar enzymes, we suggest the renaming of human METTL20 to ETF-KMT.	[Malecki, Jedrzej; Ho, Angela Y. Y.; Moen, Anders; Dahl, Helge-Andre; Falnes, Pal O.] Univ Oslo, Dept Biosci, Fac Math & Nat Sci, N-0316 Oslo, Norway	University of Oslo	Falnes, PO (corresponding author), Univ Oslo, Dept Biosci, Fac Math & Nat Sci, N-0316 Oslo, Norway.	pal.falnes@ibv.uio.no	Falnes, Pål Ø./AAA-4581-2020	Malecki, Jedrzej/0000-0003-0825-7962	University of Oslo; Norwegian Cancer Society; Research Council of Norway	University of Oslo; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway)	This work was supported by the University of Oslo and grants from the Norwegian Cancer Society and the Research Council of Norway.	Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Cho HS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2074; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Davydova E, 2014, J BIOL CHEM, V289, P30499, DOI 10.1074/jbc.M114.601658; Del Rizzo PA, 2011, EPIGENETICS-US, V6, P1059, DOI 10.4161/epi.6.9.16069; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; GOODMAN SI, 1995, HUM MOL GENET, V4, P1493; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; HUSAIN M, 1983, BIOCHEM J, V209, P541, DOI 10.1042/bj2090541; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; MCKEAN MC, 1983, J BIOL CHEM, V258, P1866; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; RAMSAY RR, 1987, BIOCHEM J, V241, P883, DOI 10.1042/bj2410883; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Shimazu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105394; STEENKAMP DJ, 1982, BIOCHEM J, V203, P707, DOI 10.1042/bj2030707; Tiffany KA, 1997, BIOCHEMISTRY-US, V36, P8455, DOI 10.1021/bi970422u; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WITTWER AJ, 1981, J BIOL CHEM, V256, P4109	33	42	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					423	434		10.1074/jbc.M114.614115	http://dx.doi.org/10.1074/jbc.M114.614115			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25416781	Green Published, hybrid			2022-12-28	WOS:000347231200037
J	Yin, Y; Zhang, SY; Luo, HH; Zhang, X; Geng, GN; Li, J; Guo, XM; Cai, WP; Li, LH; Liu, C; Zhang, H				Yin, Yue; Zhang, Shaoying; Luo, Haihua; Zhang, Xu; Geng, Guannan; Li, Jun; Guo, Xuemin; Cai, Weiping; Li, Linghua; Liu, Chao; Zhang, Hui			Interleukin 7 Up-regulates CD95 Protein on CD4(+) T Cells by Affecting mRNA Alternative Splicing PRIMING FOR A SYNERGISTIC EFFECT ON HIV-1 RESERVOIR MAINTENANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Human Immunodeficiency Virus (HIV); Interleukin; MicroRNA (miRNA); Post-transcriptional Regulation; CD95; PTB	IMMUNODEFICIENCY-VIRUS TYPE-1; FAS-MEDIATED APOPTOSIS; CD95-MEDIATED APOPTOSIS; IMMUNE ACTIVATION; MEMORY CELLS; STEM-CELLS; IL-7; EXPRESSION; DEATH; PROMOTES	Background: IL-7 can up-regulate CD95 expression on memory CD4(+) T cells, but the mechanism remains unclear. Results: IL-7 elevates miR-124 to decrease the expression of splicing regulator PTB and represses CD95 mRNA splicing. Conclusion: IL-7 elevates CD95 expression by regulating its alternative splicing. Significance: Our data demonstrate that the co-stimulation of IL-7 and CD95 ligand benefits HIV-1 reservoir maintenance. Interleukin-7 (IL-7) has been used as an immunoregulatory and latency-reversing agent in human immunodeficiency virus type 1 (HIV-1) infection. Although IL-7 can restore circulating CD4(+) T cell counts in HIV-1-infected patients, the anti-apoptotic and proliferative effects of IL-7 appear to benefit survival and expansion of HIV-1-latently infected memory CD4(+) T lymphocytes. IL-7 has been shown to elevate CD95 on CD4(+) T cells in HIV-1-infected individuals and prime CD4(+) T lymphocytes to CD95-mediated proliferative or apoptotic signals. Here we observed that through increasing microRNA-124, IL-7 down-regulates the splicing regulator polypyrimidine tract binding protein (PTB), leading to inclusion of the transmembrane domain-encoding exon 6 of CD95 mRNA and, subsequently, elevation of CD95 on memory CD4(+) T cells. Moreover, IL-7 up-regulates cellular FLICE-like inhibitory protein (c-FLIP) and stimulates c-Jun N-terminal kinase (JNK) phosphorylation, which switches CD95 signaling to survival mode in memory CD4(+) T lymphocytes. As a result, co-stimulation through IL-7/IL-7R and FasL/CD95 signal pathways augments IL-7-mediated survival and expansion of HIV-1-latently infected memory CD4(+) T lymphocytes. Collectively, we have demonstrated a novel mechanism for IL-7-mediated maintenance of HIV-1 reservoir.	[Liu, Chao; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China; [Yin, Yue; Zhang, Shaoying; Luo, Haihua; Zhang, Xu; Geng, Guannan; Li, Jun; Guo, Xuemin; Liu, Chao; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China; [Cai, Weiping; Li, Linghua] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Dept Infect Dis, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Liu, C (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China.	liuchao9@mail.sysu.edu.cn; zhangh92@mail.sysu.edu.cn		Li, Jun/0000-0002-2611-8918; Yin, Yue/0000-0002-4502-3682	National Special Research Program for Important Infectious Diseases [2013ZX10001004]; Guangdong Innovative Research Team Program [2009010058]; National Basic Research Program of China (973 Program) [2010CB912202]; National Natural Science Foundation of China [30972620, 81101255, 81471935]; Natural Science Foundation of Guangdong [9251008901000022]	National Special Research Program for Important Infectious Diseases; Guangdong Innovative Research Team Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Special Research Program for Important Infectious Diseases (2013ZX10001004), Guangdong Innovative Research Team Program (2009010058), National Basic Research Program of China (973 Program) (2010CB912202), National Natural Science Foundation of China (30972620, 81101255, and 81471935), and Natural Science Foundation of Guangdong (9251008901000022).	ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; Bosque A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002288; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; CASCINO I, 1995, J IMMUNOL, V154, P2706; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; Corsini NS, 2009, CELL STEM CELL, V5, P178, DOI 10.1016/j.stem.2009.05.004; Curtin JF, 2004, J BIOL CHEM, V279, P17090, DOI 10.1074/jbc.M307629200; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Desbarats J, 1999, P NATL ACAD SCI USA, V96, P8104, DOI 10.1073/pnas.96.14.8104; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Fas SC, 2006, EUR J IMMUNOL, V36, P2894, DOI 10.1002/eji.200635925; Ferenbach DA, 1997, J PATHOL, V183, P299; Fluur C, 2007, J IMMUNOL, V178, P5340, DOI 10.4049/jimmunol.178.8.5340; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Grigoryev YA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007906; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Inaba M, 1999, J IMMUNOL, V163, P1315; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Katlama C, 2013, 20 C RETR OPP INF CR; Koesters SA, 2006, EUR J IMMUNOL, V36, P336, DOI 10.1002/eji.200535111; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Legembre P, 2004, EMBO REP, V5, P1084, DOI 10.1038/sj.embor.7400280; Lelievre JD, 2005, J VIROL, V79, P3195, DOI 10.1128/JVI.79.5.3195-3199.2005; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Liszewski MK, 2009, METHODS, V47, P254, DOI 10.1016/j.ymeth.2009.01.002; Liu C, 2012, J BIOL CHEM, V287, P29373, DOI 10.1074/jbc.M112.354001; Llano A, 2001, J VIROL, V75, P10319, DOI 10.1128/JVI.75.21.10319-10325.2001; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; O'Neill RM, 2003, J IMMUNOL, V170, P4524, DOI 10.4049/jimmunol.170.9.4524; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Rethi B, 2008, BLOOD, V112, P1195, DOI 10.1182/blood-2007-12-126698; Rethia B, 2009, AIDS, V23, P745, DOI 10.1097/QAD.0b013e3283298572; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmitz I, 2004, J IMMUNOL, V172, P2194, DOI 10.4049/jimmunol.172.4.2194; Scripture-Adams DD, 2002, J VIROL, V76, P13077, DOI 10.1128/JVI.76.24.13077-13082.2002; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Swainson L, 2006, J IMMUNOL, V176, P6702, DOI 10.4049/jimmunol.176.11.6702; Tabler CO, 2014, J VIROL, V88, P4976, DOI 10.1128/JVI.00324-14; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Vandergeeten C, 2013, BLOOD, V121, P4321, DOI 10.1182/blood-2012-11-465625; Vranjkovic A, 2007, INT IMMUNOL, V19, P1329, DOI 10.1093/intimm/dxm102; Wagner TA, 2013, J VIROL, V87, P1770, DOI 10.1128/JVI.01985-12; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; ZHANG H, 1994, J VIROL, V68, P7591, DOI 10.1128/JVI.68.11.7591-7597.1994	59	20	20	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					35	45		10.1074/jbc.M114.598631	http://dx.doi.org/10.1074/jbc.M114.598631			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25411246	Green Published, hybrid			2022-12-28	WOS:000347231200004
J	Camus, G; Schweiger, M; Herker, E; Harris, C; Kondratowicz, AS; Tsou, CL; Farese, RV; Herath, K; Previs, SF; Roddy, TP; Pinto, S; Zechner, R; Ott, M				Camus, Gregory; Schweiger, Martina; Herker, Eva; Harris, Charles; Kondratowicz, Andrew S.; Tsou, Chia-Lin; Farese, Robert V., Jr.; Herath, Kithsiri; Previs, Stephen F.; Roddy, Thomas P.; Pinto, Shirly; Zechner, Rudolf; Ott, Melanie			The Hepatitis C Virus Core Protein Inhibits Adipose Triglyceride Lipase (ATGL)-mediated Lipid Mobilization and Enhances the ATGL Interaction with Comparative Gene Identification 58 (CGI-58) and Lipid Droplets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE-1; LIPOLYSIS; ADIPOCYTES; STEATOSIS; METABOLISM; PERILIPIN; STORAGE; RECEPTOR; TURNOVER; ALPHA	Liver steatosis is a common health problem associated with hepatitis C virus (HCV) and an important risk factor for the development of liver fibrosis and cancer. Steatosis is caused by triglycerides (TG) accumulating in lipid droplets (LDs), cellular organelles composed of neutral lipids surrounded by a monolayer of phospholipids. The HCV nucleocapsid core localizes to the surface of LDs and induces steatosis in cultured cells and mouse livers by decreasing intracellular TG degradation (lipolysis). Here we report that core at the surface of LDs interferes with the activity of adipose triglyceride lipase (ATGL), the key lipolytic enzyme in the first step of TG breakdown. Expressing core in livers or mouse embryonic fibroblasts of ATGL(-/-) mice no longer decreases TG degradation as observed in LDs from wild-type mice, supporting the model that core reduces lipolysis by engaging ATGL. Core must localize at LDs to inhibit lipolysis, as ex vivo TG hydrolysis is impaired in purified LDs coated with core but not when free core is added to LDs. Coimmunoprecipitation experiments revealed that core does not directly interact with the ATGL complex but, unexpectedly, increased the interaction between ATGL and its activator CGI-58 as well as the recruitment of both proteins to LDs. These data link the antilipolytic activity of the HCV core protein with altered ATGL binding to CGI-58 and the enhanced association of both proteins with LDs.	[Camus, Gregory; Schweiger, Martina; Herker, Eva; Kondratowicz, Andrew S.; Tsou, Chia-Lin; Ott, Melanie] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Schweiger, Martina; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Herker, Eva; Harris, Charles; Farese, Robert V., Jr.; Ott, Melanie] Univ Calif San Francisco, UCSF Liver Ctr, San Francisco, CA 94158 USA; [Herker, Eva] Heinrich Pette Inst, Leibniz Inst Expt Virol, D-20251 Hamburg, Germany; [Harris, Charles; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Harris, Charles; Farese, Robert V., Jr.; Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Harris, Charles] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Herath, Kithsiri; Previs, Stephen F.; Roddy, Thomas P.; Pinto, Shirly] Merck & Co Inc, Merck Res Labs, Kenilworth, NJ 07065 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Graz; University of California System; University of California San Francisco; Heinrich Pette Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Washington University (WUSTL); University of California System; University of California San Francisco; Merck & Company	Ott, M (corresponding author), Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	mott@gladstone.ucsf.edu	Herker, Eva/AAQ-1944-2021; Herker, Eva/B-9699-2014	Herker, Eva/0000-0001-9644-2484; Schweiger, Martina/0000-0002-3419-1007; Zechner, Rudolf/0000-0001-5483-1182; Ott, Melanie/0000-0002-5697-1274	National Institutes of Health Grants [AI069090, AI097552, P30 DK026743]; Gladstone Institutes; American Liver Foundation; European Molecular Biology Organization; Austrian Science Fund (FWF) [F 3002, Z 136] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI069090, R01AI097552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gladstone Institutes(University of California System); American Liver Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI069090, AI097552 (to M. O.), and P30 DK026743 (University of California-San Francisco Liver Center). This work was also supported by the Gladstone Institutes.; Supported in part of by fellowship from the American Liver Foundation.; Supported in part of by fellowship from the European Molecular Biology Organization.	Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Camus G, 2013, J BIOL CHEM, V288, P9915, DOI 10.1074/jbc.M112.434910; Cheng FKF, 2014, J VIRAL HEPATITIS, V21, P1, DOI 10.1111/jvh.12172; Clement S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340; Depla M, 2010, CELL MOL LIFE SCI, V67, P3151, DOI 10.1007/s00018-010-0373-z; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Han S, 2013, J LIPID RES, V54, P2615, DOI 10.1194/jlr.M035592; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Lyn RK, 2010, BIOCHEM BIOPH RES CO, V399, P518, DOI 10.1016/j.bbrc.2010.07.101; MacPherson REK, 2013, AM J PHYSIOL-REG I, V304, pR644, DOI 10.1152/ajpregu.00418.2012; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Murugesan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064950; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Olzmann JA, 2013, P NATL ACAD SCI USA, V110, P1345, DOI 10.1073/pnas.1213738110; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Pollak NM, 2013, J LIPID RES, V54, P1092, DOI 10.1194/jlr.M034710; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Schweiger M, 2014, METHOD ENZYMOL, V538, P171, DOI 10.1016/B978-0-12-800280-3.00010-4; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Shah V, 2010, ANAL BIOCHEM, V404, P235, DOI 10.1016/j.ab.2010.05.010; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Tsutsumi T, 2002, HEPATOLOGY, V35, P937, DOI 10.1053/jhep.2002.32470; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Yamaguchi A, 2005, DIGEST DIS SCI, V50, P1361, DOI 10.1007/s10620-005-2788-1; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003	54	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35770	35780		10.1074/jbc.M114.587816	http://dx.doi.org/10.1074/jbc.M114.587816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25381252	Green Published, hybrid			2022-12-28	WOS:000346897900009
J	Chen, SJ; Hoffman, NE; Shanmughapriya, S; Bao, L; Keefer, K; Conrad, K; Merali, S; Takahashi, Y; Abraham, T; Hirschler-Laszkiewicz, I; Wang, JF; Zhang, XQ; Song, JL; Barrero, C; Shi, YG; Kawasawa, YI; Bayerl, M; Sun, TY; Barbour, M; Wang, HG; Madesh, M; Cheung, JY; Miller, BA				Chen, Shu-jen; Hoffman, Nicholas E.; Shanmughapriya, Santhanam; Bao, Lei; Keefer, Kerry; Conrad, Kathleen; Merali, Salim; Takahashi, Yoshinori; Abraham, Thomas; Hirschler-Laszkiewicz, Iwona; Wang, JuFang; Zhang, Xue-Qian; Song, Jianliang; Barrero, Carlos; Shi, Yuguang; Kawasawa, Yuka Imamura; Bayerl, Michael; Sun, Tianyu; Barbour, Mustafa; Wang, Hong-Gang; Madesh, Muniswamy; Cheung, Joseph Y.; Miller, Barbara A.			A Splice Variant of the Human Ion Channel TRPM2 Modulates Neuroblastoma Tumor Growth through Hypoxia-inducible Factor (HIF)-1/2 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; MITOCHONDRIAL CA2+ UPTAKE; OXIDATIVE STRESS; ADP-RIBOSE; CATION CHANNEL; HYDROGEN-PEROXIDE; INTRACELLULAR CALCIUM; CELL-PROLIFERATION; DOWN-REGULATION; CANCER-CELLS	The calcium-permeable ion channel TRPM2 is highly expressed in a number of cancers. In neuroblastoma, full-length TRPM2 (TRPM2-L) protected cells from moderate oxidative stress through increased levels of forkhead box transcription factor 3a (FOXO3a) and superoxide dismutase 2. Cells expressing the dominant negative short isoform (TRPM2-S) had reduced FOXO3a and superoxide dismutase 2 levels, reduced calcium influx in response to oxidative stress, and enhanced reactive oxygen species, leading to decreased cell viability. Here, in xenografts generated with SH-SY5Y neuroblastoma cells stably expressing TRPM2 isoforms, growth of tumors expressing TRPM2-S was significantly reduced compared with tumors expressing TRPM2-L. Expression of hypoxia-inducible factor (HIF)-1/2 alpha was significantly reduced in TRPM2-S-expressing tumor cells as was expression of target proteins regulated by HIF-1/2 alpha including those involved in glycolysis (lactate dehydrogenase A and enolase 2), oxidant stress (FOXO3a), angiogenesis (VEGF), mitophagy and mitochondrial function (BNIP3 and NDUFA4L2), and mitochondrial electron transport chain activity (cytochrome oxidase 4.1/4.2 in complex IV). The reduction in HIF-1/2 alpha was mediated through both significantly reduced HIF-1/2 alpha mRNA levels and increased levels of von Hippel-Lindau E3 ligase in TRPM2-S-expressing cells. Inhibition of TRPM2-L by pretreatment with clotrimazole or expression of TRPM2-S significantly increased sensitivity of cells to doxorubicin. Reduced survival of TRPM2-S-expressing cells after doxorubicin treatment was rescued by gain of HIF-1 or -2 alpha function. These data suggest that TRPM2 activity is important for tumor growth and for cell viability and survival following doxorubicin treatment and that interference with TRPM2-L function may be a novel approach to reduce tumor growth through modulation of HIF-1/2 alpha, mitochondrial function, and mitophagy.	[Chen, Shu-jen; Bao, Lei; Keefer, Kerry; Conrad, Kathleen; Takahashi, Yoshinori; Hirschler-Laszkiewicz, Iwona; Sun, Tianyu; Barbour, Mustafa; Wang, Hong-Gang; Miller, Barbara A.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura; Miller, Barbara A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Takahashi, Yoshinori; Kawasawa, Yuka Imamura; Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Shi, Yuguang] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Bayerl, Michael] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura] Penn State Univ, Coll Med, Inst Personalized Med, Hershey, PA 17033 USA; [Abraham, Thomas] Penn State Univ, Coll Med, Hershey, PA 17033 USA; [Hoffman, Nicholas E.; Shanmughapriya, Santhanam; Wang, JuFang; Zhang, Xue-Qian; Song, Jianliang; Madesh, Muniswamy; Cheung, Joseph Y.] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA; [Hoffman, Nicholas E.; Shanmughapriya, Santhanam; Merali, Salim; Barrero, Carlos; Madesh, Muniswamy] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Cheung, Joseph Y.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Miller, BA (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, POB 850, Hershey, PA 17033 USA.	bmiller3@psu.edu	Abraham, Thomas/J-7080-2014; Wang, Hong-Gang/A-3018-2015; Abraham, Thomas/AAJ-7950-2020; Shanmughapriya, Santhanam/P-2828-2017	Abraham, Thomas/0000-0003-0750-8774; Wang, Hong-Gang/0000-0003-0551-0571; Takahashi, Yoshinori/0000-0002-8004-4817; Barrero, Carlos/0000-0001-5779-6642; Shanmughapriya, Santhanam/0000-0003-1041-8198	National Institutes of Health [RO1-DK46778, RO1-HL86699, RO1-HL58672, RO1-HL74854]; Hyundai Hope-on-Wheels Foundation; Pennsylvania State University College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058672, R01HL074854, R01HL086699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046778] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hyundai Hope-on-Wheels Foundation; Pennsylvania State University College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK46778 (to B. A. M.), RO1-HL86699 (to M. M.), and RO1-HL58672 and RO1-HL74854 (to J. Y. C.). This work was also supported by grants from the Hyundai Hope-on-Wheels Foundation (to B. A. M.) and by the Four Diamonds Fund of the Pennsylvania State University College of Medicine.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Bai JZ, 2010, NEUROTOXICOLOGY, V31, P204, DOI 10.1016/j.neuro.2010.01.001; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Barrero CA, 2013, AM J RESP CRIT CARE, V188, P673, DOI 10.1164/rccm.201302-0342OC; Barrero CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068376; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chen SJ, 2013, AM J PHYSIOL-CELL PH, V304, pC548, DOI 10.1152/ajpcell.00069.2012; Cheung JY, 1997, BLOOD, V89, P92, DOI 10.1182/blood.V89.1.92.92_92_100; Csanady L, 2010, J PHYSIOL-LONDON, V588, P1661, DOI 10.1113/jphysiol.2010.190223; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171; Du JY, 2009, J GEN PHYSIOL, V134, P471, DOI 10.1085/jgp.200910254; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Duncan LM, 1998, CANCER RES, V58, P1515; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; Ewer MS, 2010, NAT REV CARDIOL, V7, P564, DOI 10.1038/nrcardio.2010.121; Faouzi M, 2014, HANDB EXP PHARMACOL, V222, P403, DOI 10.1007/978-3-642-54215-2_16; Feng SJ, 2013, P NATL ACAD SCI USA, V110, P11011, DOI 10.1073/pnas.1309531110; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Fredlund E, 2008, BIOCHEM BIOPH RES CO, V366, P1054, DOI 10.1016/j.bbrc.2007.12.074; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Gilliam LAA, 2012, AM J PHYSIOL-CELL PH, V302, pC195, DOI 10.1152/ajpcell.00217.2011; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Gustafsson AB, 2011, PEDIATR CARDIOL, V32, P267, DOI 10.1007/s00246-010-9876-5; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Hermosura MC, 2008, P NATL ACAD SCI USA, V105, P18029, DOI 10.1073/pnas.0808218105; Hill K, 2004, N-S ARCH PHARMACOL, V370, P227, DOI 10.1007/s00210-004-0981-y; Hill K, 2004, NEUROPHARMACOLOGY, V47, P450, DOI 10.1016/j.neuropharm.2004.04.014; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hui AS, 2006, FASEB J, V20, P466, DOI 10.1096/fj.05-5086com; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kornmann B, 2013, CURR OPIN CELL BIOL, V25, P443, DOI 10.1016/j.ceb.2013.02.010; Lackner LL, 2013, P NATL ACAD SCI USA, V110, pE458, DOI 10.1073/pnas.1215232110; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li MY, 2006, J BIOL CHEM, V281, P40429, DOI 10.1074/jbc.M606596200; Liu Q, 2004, BLOOD, V104, P3993, DOI 10.1182/blood-2004-03-1017; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Maynard MA, 2007, CELL MOL LIFE SCI, V64, P2170, DOI 10.1007/s00018-007-7082-2; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Miller BA, 1999, J BIOL CHEM, V274, P20465, DOI 10.1074/jbc.274.29.20465; Miller BA, 2014, J BIOL CHEM, V289, P7615, DOI 10.1074/jbc.M113.533851; Miller BA, 2013, AM J PHYSIOL-HEART C, V304, pH1010, DOI 10.1152/ajpheart.00906.2012; Miller BA, 2011, ADV EXP MED BIOL, V704, P531, DOI 10.1007/978-94-007-0265-3_29; Mohlin S, 2013, NEOPLASIA, V15, P328, DOI 10.1593/neo.121706; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Noguera R, 2009, CLIN CANCER RES, V15, P7130, DOI 10.1158/1078-0432.CCR-09-0223; Orfanelli U, 2008, CELL RES, V18, P1128, DOI 10.1038/cr.2008.296; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Prawitt D, 2000, HUM MOL GENET, V9, P203, DOI 10.1093/hmg/9.2.203; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Starkus JG, 2010, J PHYSIOL-LONDON, V588, P1227, DOI 10.1113/jphysiol.2010.187476; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Toth B, 2010, J BIOL CHEM, V285, P30091, DOI 10.1074/jbc.M109.066464; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsavaler L, 2001, CANCER RES, V61, P3760; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1232, DOI 10.1016/j.bbrc.2005.01.086; Vadrot N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040879; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang JF, 2011, AM J PHYSIOL-HEART C, V300, pH859, DOI 10.1152/ajpheart.00894.2010; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Young MM, 2012, J BIOL CHEM, V287, P12455, DOI 10.1074/jbc.M111.309104; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	85	64	66	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36284	36302		10.1074/jbc.M114.620922	http://dx.doi.org/10.1074/jbc.M114.620922			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25391657	hybrid, Green Published			2022-12-28	WOS:000346897900052
J	Tripathi, V; Darnauer, S; Hartwig, NR; Obermann, WMJ				Tripathi, Vishwadeepak; Darnauer, Stefanie; Hartwig, Nadine R.; Obermann, Wolfgang M. J.			Aha1 Can Act as an Autonomous Chaperone to Prevent Aggregation of Stressed Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; COCHAPERONE AHA1; ATPASE ACTIVITY; MIDDLE DOMAIN; IN-VIVO; ACTIVATION; BINDING; CYCLE; CONTRIBUTES; HYDROLYSIS	Aha1 (activator of Hsp90 ATPase) stimulates the ATPase activity of the molecular chaperone Hsp90 to accelerate the conformational cycle during which client proteins attain their final shape. Thereby, Aha1 promotes effective folding of Hsp90-dependent clients such as steroid receptors and many kinases involved in cellular signaling. In our current study, we find that Aha1 plays a novel, additional role beyond regulating the Hsp90 ATP hydrolysis rate. We propose a new concept suggesting that Aha1 acts as an autonomous chaperone and associates with stress-denatured proteins to prevent them from aggregation similar to the chaperonin GroEL. Our study reveals that an N-terminal sequence of 22 amino acids, present in human but absent from yeast Aha1, is critical for this capability. However, in lieu of fostering their refolding, Aha1 allows ubiquitination of bound clients by the E3 ubiquitin ligase CHIP. Accordingly, Aha1 may promote disposal of folding defective proteins by the cellular protein quality control.	[Tripathi, Vishwadeepak; Darnauer, Stefanie; Hartwig, Nadine R.; Obermann, Wolfgang M. J.] Ruhr Univ Bochum, Dept Cardiovasc Physiol, D-44801 Bochum, Germany	Ruhr University Bochum	Obermann, WMJ (corresponding author), Ruhr Univ Bochum, Dept Cardiovasc Physiol, Univ Str 150, D-44801 Bochum, Germany.	Wolfgang.Obermann@rub.de	Obermann, Wolfgang/AAN-3896-2020		German Science Association (DFG) [OB 163/1-1]; Ruhr-University Bochum FoRUM [F698]	German Science Association (DFG)(German Research Foundation (DFG)); Ruhr-University Bochum FoRUM	This work was supported by the German Science Association (DFG Grant OB 163/1-1, to W. O.) and by Ruhr-University Bochum FoRUM Grant F698 (to W. O.).	ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Berg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089436; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Buchberger A, 1996, J MOL BIOL, V261, P328, DOI 10.1006/jmbi.1996.0465; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li J, 2013, NAT STRUCT MOL BIOL, V20, P326, DOI 10.1038/nsmb.2502; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Mollapour M, 2014, MOL CELL, V53, P317, DOI 10.1016/j.molcel.2013.12.007; NIMMESGERN E, 1993, FEBS LETT, V331, P25, DOI 10.1016/0014-5793(93)80290-B; Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tripathi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071856; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Xu WP, 2012, MOL CELL, V47, P434, DOI 10.1016/j.molcel.2012.05.015	32	16	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36220	36228		10.1074/jbc.M114.590141	http://dx.doi.org/10.1074/jbc.M114.590141			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378400	Green Published, hybrid			2022-12-28	WOS:000346897900047
J	Janetzko, J; Walker, S				Janetzko, John; Walker, Suzanne			The Making of a Sweet Modification: Structure and Function of O-GlcNAc Transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Crystal Structure; Glycosylation; Glycosyltransferase; Ligand-binding Protein; O-GlcNAcylation; Host Cell Factor 1; Enzymology	BETA-N-ACETYLGLUCOSAMINE; METASTABLE BINDING-SITES; COACTIVATOR C1 HCF; CRYSTAL-STRUCTURE; TETRATRICOPEPTIDE REPEAT; SUBSTRATE-SPECIFICITY; CELLULAR FACTOR; PROTEIN; TRANSCRIPTION; COMPLEX	O-GlcNAc transferase is an essential mammalian enzyme responsible for transferring a single GlcNAc moiety from UDP-GlcNAc to specific serine/threonine residues of hundreds of nuclear and cytoplasmic proteins. This modification is dynamic and has been implicated in numerous signaling pathways. An unexpected second function for O-GlcNAc transferase as a protease involved in cleaving the epigenetic regulator HCF-1 has also been reported. Recent structural and biochemical studies that provide insight into the mechanism of glycosylation and HCF-1 cleavage will be described, with outstanding questions highlighted.	[Walker, Suzanne] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Janetzko, John] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Walker, S (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	suzanne_walker@hms.harvard.edu	Janetzko, John/AAQ-2602-2021	Janetzko, John/0000-0003-1604-2515	National Institutes of Health [R01GM094263]; National Science and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01GM094263 (to S. W.). This is the first article in the Minireview Series on the Thirtieth Anniversary of Research on O-GlcNAcylation of Nuclear and Cytoplasmic Proteins: Nutrient Regulation of Cellular Metabolism and Physiology by O-GlcNAcylation.; Supported by National Science and Engineering Research Council of Canada PGS-M and PGS-D3 fellowships.	Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; APRHYS CMJ, 1989, J VIROL, V63, P2798, DOI 10.1128/JVI.63.6.2798-2812.1989; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Borodkin VS, 2014, BIOCHEM J, V457, P497, DOI 10.1042/BJ20131272; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Brown K, 2013, PROTEIN PEPTIDE LETT, V20, P1002; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cukierman S, 2006, BBA-BIOENERGETICS, V1757, P876, DOI 10.1016/j.bbabio.2005.12.001; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; de Grotthuss C, 1806, ANN CHIM, V58, P54; Deng RP, 2014, PROTEOMICS, V14, P1020, DOI 10.1002/pmic.201300144; Dias WB, 2012, BIOCHEM BIOPH RES CO, V422, P224, DOI 10.1016/j.bbrc.2012.04.124; Dorfmueller HC, 2011, AMINO ACIDS, V40, P781, DOI 10.1007/s00726-010-0688-y; ERICKSON BW, 1983, ANN NY ACAD SCI, V421, P167, DOI 10.1111/j.1749-6632.1983.tb18107.x; Fletcher BS, 2002, LEUKEMIA, V16, P1507, DOI 10.1038/sj.leu.2402557; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; GERSTER T, 1988, P NATL ACAD SCI USA, V85, P6347, DOI 10.1073/pnas.85.17.6347; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Gloster TM, 2010, CURR SIGNAL TRANSD T, V5, P74, DOI 10.2174/157436210790226537; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Harwood KR, 2014, J CELL SCI, V127, P1857, DOI 10.1242/jcs.113233; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Hurtado-Guerrero R, 2008, CURR OPIN STRUC BIOL, V18, P551, DOI 10.1016/j.sbi.2008.09.005; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Jiang JY, 2012, NAT CHEM BIOL, V8, P72, DOI 10.1038/nchembio.711; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; KATAN M, 1990, NUCLEIC ACIDS RES, V18, P6871, DOI 10.1093/nar/18.23.6871; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Kebede M, 2012, P NATL ACAD SCI USA, V109, P2376, DOI 10.1073/pnas.1114350109; KHAN SA, 1986, BIOCHEMISTRY-US, V25, P5165, DOI 10.1021/bi00366a027; KHAN SA, 1982, J BIOL CHEM, V257, P1864; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; KRISTIE TM, 1993, J BIOL CHEM, V268, P6525; KRISTIE TM, 1990, GENE DEV, V4, P2383, DOI 10.1101/gad.4.12b.2383; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Lazarus BD, 2005, J BIOL CHEM, V280, P35537, DOI 10.1074/jbc.M504948200; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Luciano RL, 2003, J BIOL CHEM, V278, P51116, DOI 10.1074/jbc.M303470200; Marz P, 2006, J BIOL CHEM, V281, P20263, DOI 10.1074/jbc.M601563200; Mangone M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009020; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Martinez-Fleites C, 2010, BBA-GEN SUBJECTS, V1800, P122, DOI 10.1016/j.bbagen.2009.07.019; Mazars R, 2010, J BIOL CHEM, V285, P13364, DOI 10.1074/jbc.M109.072579; Michaud J, 2013, GENOME RES, V23, P907, DOI 10.1101/gr.150078.112; Nolte D, 2002, MAMM GENOME, V13, P62, DOI 10.1007/s00335-001-2108-9; Ortiz-Meoz RF, 2014, J AM CHEM SOC, V136, P4845, DOI 10.1021/ja500451w; Park J, 2012, P NATL ACAD SCI USA, V109, P17430, DOI 10.1073/pnas.1208378109; Riu IH, 2008, BIOCHEM BIOPH RES CO, V372, P203, DOI 10.1016/j.bbrc.2008.05.034; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; Shin SH, 2011, AMINO ACIDS, V40, P885, DOI 10.1007/s00726-010-0719-8; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN S, 1991, GENE DEV, V5, P2555, DOI 10.1101/gad.5.12b.2555; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Tvaroska I, 2012, J AM CHEM SOC, V134, P15563, DOI 10.1021/ja307040m; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Vocadlo DJ, 2012, CURR OPIN CHEM BIOL, V16, P488, DOI 10.1016/j.cbpa.2012.10.021; Vogel JL, 2000, P NATL ACAD SCI USA, V97, P9425, DOI 10.1073/pnas.160266697; Vogel JL, 2000, EMBO J, V19, P683, DOI 10.1093/emboj/19.4.683; Wilson AC, 2000, MOL CELL BIOL, V20, P6721, DOI 10.1128/MCB.20.18.6721-6730.2000; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; XIAO P, 1990, MOL CELL BIOL, V10, P4974, DOI 10.1128/MCB.10.9.4974; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Zhang Q, 2014, J BIOL CHEM, V289, P5986, DOI 10.1074/jbc.M113.524140; Zhou PP, 2013, J BIOL CHEM, V288, P17532, DOI 10.1074/jbc.M112.439729	95	45	46	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34424	34432		10.1074/jbc.R114.604405	http://dx.doi.org/10.1074/jbc.R114.604405			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25336649	Green Published, hybrid			2022-12-28	WOS:000346260800002
J	Malmirchegini, GR; Sjodt, M; Shnitkind, S; Sawaya, MR; Rosinski, J; Newton, SM; Klebba, PE; Clubb, RT				Malmirchegini, G. Reza; Sjodt, Megan; Shnitkind, Sergey; Sawaya, Michael R.; Rosinski, Justin; Newton, Salete M.; Klebba, Phillip E.; Clubb, Robert T.			Novel Mechanism of Hemin Capture by Hbp2, the Hemoglobin-binding Hemophore from Listeria monocytogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Heme; Hemoglobin; Iron; X-ray Crystallography	STAPHYLOCOCCUS-AUREUS USES; NEAT DOMAIN; SURFACE PROTEIN; MACROMOLECULAR STRUCTURES; TRANSPORTER DOMAINS; MAXIMUM-LIKELIHOOD; ANTHRAX HEMOPHORE; STRUCTURAL BASIS; EXTRACT HEME; SORTASE-B	Background:Listeria monocytogenes scavenges iron from heme and human hemoglobin using the Hbp1 and Hbp2 proteins. Results: Crystal structures and heme transfer studies of Hbp2 reveal an unusual binding mechanism. Conclusion: Hbp2 is a novel hemoglobin-binding hemophore that rapidly delivers hemin to Hbp1 and other Hbp2 proteins. Significance: These studies provides insight into how L. monocytogenes captures heme iron. Iron is an essential nutrient that is required for the growth of the bacterial pathogen Listeria monocytogenes. In cell cultures, this microbe secretes hemin/hemoglobin-binding protein 2 (Hbp2; Lmo2185) protein, which has been proposed to function as a hemophore that scavenges heme from the environment. Based on its primary sequence, Hbp2 contains three NEAr transporter (NEAT) domains of unknown function. Here we show that each of these domains mediates high affinity binding to ferric heme (hemin) and that its N- and C-terminal domains interact with hemoglobin (Hb). The results of hemin transfer experiments are consistent with Hbp2 functioning as an Hb-binding hemophore that delivers hemin to other Hbp2 proteins that are attached to the cell wall. Surprisingly, our work reveals that the central NEAT domain in Hbp2 binds hemin even though its primary sequence lacks a highly conserved YXXXY motif that is used by all other previously characterized NEAT domains to coordinate iron in the hemin molecule. To elucidate the mechanism of hemin binding by Hbp2, we determined crystal structures of its central NEAT domain (Hbp2(N2); residues 183-303) in its free and hemin-bound states. The structures reveal an unprecedented mechanism of hemin binding in which Hbp2(N2) undergoes a major conformational rearrangement that facilitates metal coordination by a non-canonical tyrosine residue. These studies highlight previously unrecognized plasticity in the hemin binding mechanism of NEAT domains and provide insight into how L. monocytogenes captures heme iron.	[Malmirchegini, G. Reza; Sjodt, Megan; Shnitkind, Sergey; Sawaya, Michael R.; Rosinski, Justin; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Malmirchegini, G. Reza; Sjodt, Megan; Shnitkind, Sergey; Sawaya, Michael R.; Rosinski, Justin; Clubb, Robert T.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Sawaya, Michael R.] Kansas State Univ, Howard Hughes Med Inst, Manhattan, KS 66502 USA; [Newton, Salete M.; Klebba, Phillip E.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66502 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; Kansas State University; Kansas State University	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 602 Boyer Hall, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu		Sjodt, Megan/0000-0003-0234-4336; Sawaya, Michael/0000-0003-0874-9043; Shnitkind, Sergey/0000-0003-1858-4908	National Institutes of Health R01 [AI52217, GM53836, F31GM101931]; National Science Foundation [MCB0952299]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053836, F31GM101931, T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health R01 Grants AI52217 (to R. T. C.) and GM53836 (to P. E. K. and S. M. N.) and Grant F31GM101931 (to M. S.). This work was also supported by National Science Foundation Grant MCB0952299 (to P. E. K. and S. M. N.).	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; Ascoli F, 1981, Methods Enzymol, V76, P72; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Borezee E, 2001, MICROBIOL-SGM, V147, P2913, DOI 10.1099/00221287-147-11-2913; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; Calvo E, 2005, PROTEOMICS, V5, P433, DOI 10.1002/pmic.200400936; Camejo A, 2011, VIRULENCE, V2, P379, DOI 10.4161/viru.2.5.17703; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Dickson CF, 2014, J BIOL CHEM, V289, P6728, DOI 10.1074/jbc.M113.545566; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Ekworomadu MT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002559; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Honsa ES, 2013, J BIOL CHEM, V288, P8479, DOI 10.1074/jbc.M112.430009; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Jin B, 2006, MOL MICROBIOL, V59, P1185, DOI 10.1111/j.1365-2958.2005.05015.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Klebba PE, 2012, MOL MEMBR BIOL, V29, P69, DOI 10.3109/09687688.2012.694485; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mariscotti JF, 2009, J BIOL CHEM, V284, P6140, DOI 10.1074/jbc.M807989200; McLaughlin HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030928; Moriwaki Y, 2013, BIOCHEMISTRY-US, V52, P8866, DOI 10.1021/bi4008325; Mujahid S, 2007, ELECTROPHORESIS, V28, P3998, DOI 10.1002/elps.200600858; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nobles CL, 2011, METALLOMICS, V3, P788, DOI 10.1039/c1mt00047k; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Ran YC, 2013, BIOCHEMISTRY-US, V52, P6537, DOI 10.1021/bi400965u; Senturia R, 2010, PROTEIN SCI, V19, P1354, DOI 10.1002/pro.414; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Spirig T, 2013, J BIOL CHEM, V288, P1065, DOI 10.1074/jbc.M112.419119; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Vu NT, 2013, PROTEIN SCI, V22, P942, DOI 10.1002/pro.2276; Wandersman C, 2012, MOL MICROBIOL, V85, P618, DOI 10.1111/j.1365-2958.2012.08136.x; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wojtowicz H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000419; Xiao QB, 2011, MOL MICROBIOL, V80, P1581, DOI 10.1111/j.1365-2958.2011.07667.x	57	21	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34886	34899		10.1074/jbc.M114.583013	http://dx.doi.org/10.1074/jbc.M114.583013			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25315777	Green Published, hybrid			2022-12-28	WOS:000346260800039
J	Pedersen, AV; Andreassen, TF; Loland, CJ				Pedersen, Anders V.; Andreassen, Thorvald F.; Loland, Claus J.			A Conserved Salt Bridge between Transmembrane Segments 1 and 10 Constitutes an Extracellular Gate in the Dopamine Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Molecular Pharmacology; Monoamine Transporter; Neuroscience; Neurotransmitter Transport; Protein Structure; Structure-Function Relationship; Zinc Site Engineering	ACID GABA TRANSPORTER-1; SEROTONIN TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; BACTERIAL HOMOLOG; BINDING-SITES; CONFORMATIONAL DYNAMICS; ALTERNATING ACCESS; COCAINE BINDING; LEUT; PERMEATION	Background: The presence of an extracellular gate in the dopamine transporter has been proposed. Results: We use rescue mutations, zinc site engineering, and cysteine-reactive chemistry to establish the presence of the gate. Conclusion: Arg-85 and Asp-476 constitute a functional thin gate in the dopamine transporter. Significance: This gains further insight into the molecular mechanisms behind substrate transport by mammalian neurotransmitter transporters. Neurotransmitter transporters play an important role in termination of synaptic transmission by mediating reuptake of neurotransmitter, but the molecular processes behind translocation are still unclear. The crystal structures of the bacterial homologue, LeuT, provided valuable insight into the structural and dynamic requirements for substrate transport. These structures support the existence of gating domains controlling access to a central binding site. On the extracellular side, access is controlled by the thin gate formed by an interaction between Arg-30 and Asp-404. In the human dopamine transporter (DAT), the corresponding residues are Arg-85 and Asp-476. Here, we present results supporting the existence of a similar interaction in DAT. The DAT R85D mutant has a complete loss of function, but the additional insertion of an arginine in opposite position (R85D/D476R), causing a charge reversal, results in a rescue of binding sites for the cocaine analogue [H-3]CFT. Also, the coordination of Zn2+ between introduced histidines (R85H/D476H) caused a approximate to 2.5-fold increase in [H-3]CFT binding (B-max). Importantly, Zn2+ also inhibited [H-3]dopamine transport in R85H/D476H, suggesting that a dynamic interaction is required for the transport process. Furthermore, cysteine-reactive chemistry shows that mutation of the gating residues causes a higher proportion of transporters to reside in the outward facing conformation. Finally, we show that charge reversal of the corresponding residues (R104E/E493R) in the serotonin transporter also rescues [H-3](S)-citalopram binding, suggesting a conserved feature. Taken together, these data suggest that the extracellular thin gate is present in monoamine transporters and that a dynamic interaction is required for substrate transport.	[Pedersen, Anders V.; Andreassen, Thorvald F.; Loland, Claus J.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Neuropharmacol Lab, DK-2200 Copenhagen N, Denmark	University of Copenhagen	Loland, CJ (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark.	cllo@sund.ku.dk	Loland, Claus/E-5975-2014	Loland, Claus/0000-0002-1773-1446	Danish Independent Research Council, Sapere Aude; Lundbeck Foundation; UNIK Center for Synthetic Biology	Danish Independent Research Council, Sapere Aude; Lundbeck Foundation(Lundbeckfonden); UNIK Center for Synthetic Biology	This work was supported in part by funds from the Danish Independent Research Council, Sapere Aude (to C. J. L.), the Lundbeck Foundation (to C. J. L.), and the UNIK Center for Synthetic Biology (to C. J. L.).	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Ben-Yona A, 2013, J BIOL CHEM, V288, P4549, DOI 10.1074/jbc.M112.430215; Ben-Yona A, 2012, J BIOL CHEM, V287, P7159, DOI 10.1074/jbc.M111.323634; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Borre L, 2014, J BIOL CHEM, V289, P25764, DOI 10.1074/jbc.M114.574269; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen NH, 2004, J NEUROCHEM, V89, P853, DOI 10.1111/j.1471-4159.2004.02386.x; Chen NH, 2004, J BIOL CHEM, V279, P5508, DOI 10.1074/jbc.M306294200; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Kniazeff J, 2005, NEUROPHARMACOLOGY, V49, P715, DOI 10.1016/j.neuropharm.2005.07.003; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Loland CJ, 2008, MOL PHARMACOL, V73, P813, DOI 10.1124/mol.107.039800; Loland CJ, 2012, BIOL PSYCHIAT, V72, P405, DOI 10.1016/j.biopsych.2012.03.022; MacAulay N, 2002, J PHYSIOL-LONDON, V544, P447, DOI 10.1113/jphysiol.2002.022897; MacAulay N, 2001, J BIOL CHEM, V276, P40476, DOI 10.1074/jbc.M105578200; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Norregaard L, 2000, BIOCHEMISTRY-US, V39, P15836, DOI 10.1021/bi0018335; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; SCHWABE JWR, 1994, NAT STRUCT BIOL, V1, P345, DOI 10.1038/nsb0694-345; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sonders MS, 1997, J NEUROSCI, V17, P960; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Stockner T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002909; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057	43	15	16	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					35003	35014		10.1074/jbc.M114.586982	http://dx.doi.org/10.1074/jbc.M114.586982			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25339174	Green Published, hybrid			2022-12-28	WOS:000346260800048
J	Paris, D; Ait-Ghezala, G; Bachmeier, C; Laco, G; Beaulieu-Abdelahad, D; Lin, Y; Jin, C; Crawford, F; Mullan, M				Paris, Daniel; Ait-Ghezala, Ghania; Bachmeier, Corbin; Laco, Gary; Beaulieu-Abdelahad, David; Lin, Yong; Jin, Chao; Crawford, Fiona; Mullan, Michael			The Spleen Tyrosine Kinase (Syk) Regulates Alzheimer Amyloid-beta Production and Tau Hyperphosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid (AB); Glycogen Synthase Kinase 3 (GSK-3); Neuroinflammation; Protein Kinase A (PKA); Tau Protein (Tau); Hyperphosphorylation; Mechanism of Action; Nilvadipine; Therapeutic Target	GLYCOGEN-SYNTHASE KINASE-3; CEREBRAL-BLOOD-FLOW; PROTEIN-KINASE; SYSTOLIC HYPERTENSION; COGNITIVE DECLINE; COX-2 EXPRESSION; MOUSE MODEL; IN-VITRO; ACTIVATION; DISEASE	Background: Spleen tyrosine kinase (Syk) mediates microglial activation and neurotoxicity elicited by Alzheimer A peptides. Results: Syk regulates A production via NFB-dependent mechanisms and Tau phosphorylation by controlling the activation of glycogen synthase 3. Conclusion: Inhibition of Syk can interrupt the neuroinflammation, pathological A accumulation, and Tau hyperphosphorylation in AD. Significance: Syk represents a therapeutic target for the key pathological lesions that define AD. We have previously shown that the L-type calcium channel (LCC) antagonist nilvadipine reduces brain amyloid- (A) accumulation by affecting both A production and A clearance across the blood-brain barrier (BBB). Nilvadipine consists of a mixture of two enantiomers, (+)-nilvadipine and (-)-nilvadipine, in equal proportion. (+)-Nilvadipine is the active enantiomer responsible for the inhibition of LCC, whereas (-)-nilvadipine is considered inactive. Both nilvadipine enantiomers inhibit A production and improve the clearance of A across the BBB showing that these effects are not related to LCC inhibition. In addition, treatment of P301S mutant human Tau transgenic mice (transgenic Tau P301S) with (-)-nilvadipine reduces Tau hyperphosphorylation at several Alzheimer disease (AD) pertinent epitopes. A search for the mechanism of action of (-)-nilvadipine revealed that this compound inhibits the spleen tyrosine kinase (Syk). We further validated Syk as a target-regulating A by showing that pharmacological inhibition of Syk or down-regulation of Syk expression reduces A production and increases the clearance of A across the BBB mimicking (-)-nilvadipine effects. Moreover, treatment of transgenic mice overexpressing A and transgenic Tau P301S mice with a selective Syk inhibitor respectively decreased brain A accumulation and Tau hyperphosphorylation at multiple AD relevant epitopes. We show that Syk inhibition induces an increased phosphorylation of the inhibitory Ser-9 residue of glycogen synthase kinase-3, a primary Tau kinase involved in Tau phosphorylation, by activating protein kinase A, providing a mechanism explaining the reduction of Tau phosphorylation at GSK3-dependent epitopes following Syk inhibition. Altogether our data highlight Syk as a promising target for preventing both A accumulation and Tau hyperphosphorylation in AD.	[Paris, Daniel; Ait-Ghezala, Ghania; Bachmeier, Corbin; Laco, Gary; Beaulieu-Abdelahad, David; Lin, Yong; Jin, Chao; Crawford, Fiona; Mullan, Michael] Roskamp Inst, Sarasota, FL 34243 USA		Paris, D (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	dparis@rfdn.org	Lin, Yong/I-4505-2016; , Yong/T-4079-2019	Lin, Yong/0000-0002-2839-5740; Paris, Daniel/0000-0002-9622-0846; Ait-Ghezala, Ghania/0000-0002-9836-8617	Roskamp Foundation	Roskamp Foundation	This work was supported by the Roskamp Foundation.	Acker CM, 2013, NEUROBIOL AGING, V34, P338, DOI 10.1016/j.neurobiolaging.2012.05.010; Bachmeier C, 2013, MOL CELL NEUROSCI, V56, P255, DOI 10.1016/j.mcn.2013.06.004; Bachmeier C, 2013, J MOL NEUROSCI, V49, P270, DOI 10.1007/s12031-012-9866-6; Bachmeier C, 2011, EUR J PHARMACOL, V659, P124, DOI 10.1016/j.ejphar.2011.03.048; Bachmeier C, 2010, CYTOTECHNOLOGY, V62, P519, DOI 10.1007/s10616-010-9313-x; Bachmeier CJ, 2011, MICROCIRCULATION, V18, P373, DOI 10.1111/j.1549-8719.2011.00096.x; Baxter PS, 2011, J NEUROCHEM, V118, P365, DOI 10.1111/j.1471-4159.2011.07330.x; Bhaskar K, 2010, NEUROPATH APPL NEURO, V36, P462, DOI 10.1111/j.1365-2990.2010.01103.x; Buggia-Prevot V, 2008, J BIOL CHEM, V283, P10037, DOI 10.1074/jbc.M706579200; Carnevale J, 2013, LEUKEMIA, V27, P2118, DOI 10.1038/leu.2013.89; Chami L, 2012, J BIOL CHEM, V287, P24573, DOI 10.1074/jbc.M111.333054; Cheng X, 2014, DRUG DISCOV TODAY, V19, P1822, DOI 10.1016/j.drudis.2014.06.029; Combs CK, 2001, J NEUROSCI, V21, P1179; Combs CK, 1999, J NEUROSCI, V19, P928; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doraiswamy PM, 2012, NEUROLOGY, V79, P1636, DOI 10.1212/WNL.0b013e3182661f74; Duffy S, 1998, ANAL BIOCHEM, V262, P122, DOI 10.1006/abio.1998.2770; El-Agnaf OMA, 2000, BIOCHEM BIOPH RES CO, V273, P1003, DOI 10.1006/bbrc.2000.3051; Fang F, 2012, BBA-MOL BASIS DIS, V1822, P286, DOI 10.1016/j.bbadis.2011.10.004; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gottesman RF, 2014, JAMA NEUROL, V71, P1218, DOI 10.1001/jamaneurol.2014.1646; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hanyu H, 2007, NUCL MED COMMUN, V28, P281, DOI 10.1097/MNM.0b013e32804c58aa; Hefti F, 2013, TRENDS PHARMACOL SCI, V34, P261, DOI 10.1016/j.tips.2013.03.002; Hernandez F, 2013, J ALZHEIMERS DIS, V33, pS141, DOI 10.3233/JAD-2012-129025; Hitomi T, 2001, GENES CELLS, V6, P475, DOI 10.1046/j.1365-2443.2001.00434.x; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kawauchi K, 1996, MOL IMMUNOL, V33, P287, DOI 10.1016/0161-5890(95)00134-4; Kennelly SP, 2011, INT J GERIATR PSYCH, V26, P1038, DOI 10.1002/gps.2638; Kennelly S, 2012, INT J GERIATR PSYCH, V27, P415, DOI 10.1002/gps.2735; Kero M, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.09.017; Kim HN, 2014, CANCER LETT, V351, P41, DOI 10.1016/j.canlet.2014.03.037; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Launay P, 1998, J LEUKOCYTE BIOL, V63, P636, DOI 10.1002/jlb.63.5.636; Lebouvier T, 2008, BBA-MOL CELL RES, V1783, P188, DOI 10.1016/j.bbamcr.2007.11.005; Lee HR, 2014, J NEUROSCI RES, V92, P206, DOI 10.1002/jnr.23310; Li HL, 1999, P NATL ACAD SCI USA, V96, P6890, DOI 10.1073/pnas.96.12.6890; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Linnartz Bettina, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/587463; Liu D, 2009, NUTR CANCER, V61, P855, DOI 10.1080/01635580903285080; Llorens-Martin M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00046; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Matoba K, 2014, AM J PHYSIOL-RENAL, V307, pF571, DOI 10.1152/ajprenal.00113.2014; Matsuzaki K, 2006, NEUROSCI LETT, V400, P230, DOI 10.1016/j.neulet.2006.02.077; McDonald DR, 1997, J NEUROSCI, V17, P2284; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; O'Driscoll C, 2007, J NEUROCHEM, V103, P860, DOI 10.1111/j.1471-4159.2007.04827.x; Paris D, 2004, BRAIN RES, V999, P53, DOI 10.1016/j.brainres.2003.11.061; Paris D., 2014, BRAIN DISORD THER, V3, P126; Paris D, 2007, NEUROSCI LETT, V415, P11, DOI 10.1016/j.neulet.2006.12.029; Paris D, 2011, EUR J PHARMACOL, V670, P384, DOI 10.1016/j.ejphar.2011.09.019; Paris D, 2011, MOL MED, V17, P149, DOI 10.2119/molmed.2010.00180; Paris D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-17; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; Piaceri Irene, 2013, Front Biosci (Elite Ed), V5, P167; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Raeder EMB, 1999, J IMMUNOL, V163, P6785; ROVNYAK GC, 1995, J MED CHEM, V38, P119, DOI 10.1021/jm00001a017; Santos AN, 2012, J ALZHEIMERS DIS, V29, P171, DOI 10.3233/JAD-2012-111361; SATOH Y, 1994, CHEM PHARM BULL, V42, P950; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Seux ML, 1999, ARCH MAL COEUR VAISS, V92, P1083; Sierksma ASR, 2014, NEUROPHARMACOLOGY, V77, P120, DOI 10.1016/j.neuropharm.2013.09.015; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; TOKUMA Y, 1995, J CHROMATOGR A, V694, P181, DOI 10.1016/0021-9673(94)00832-T; TOKUMA Y, 1987, J PHARM SCI, V76, P310, DOI 10.1002/jps.2600760410; TOKUMA Y, 1989, RES COMMUN CHEM PATH, V63, P249; Valera E, 2008, NEUROCHEM INT, V53, P148, DOI 10.1016/j.neuint.2008.07.007; Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200; Xanthos DN, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-42; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yu S, 2013, J BIOL CHEM, V288, P10870, DOI 10.1074/jbc.M112.426130; Zhou Q, 2009, ONCOGENE, V28, P1348, DOI 10.1038/onc.2008.493	80	46	46	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33927	33944		10.1074/jbc.M114.608091	http://dx.doi.org/10.1074/jbc.M114.608091			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25331948	Green Published, hybrid			2022-12-28	WOS:000346077600022
J	Bhattacharya, D; Dwivedi, VP; Kumar, S; Reddy, MC; Van Kaer, L; Moodley, P; Das, G				Bhattacharya, Debapriya; Dwivedi, Ved Prakash; Kumar, Santosh; Reddy, Madhava C.; Van Kaer, Luc; Moodley, Prashini; Das, Gobardhan			Simultaneous Inhibition of T Helper 2 and T Regulatory Cell Differentiation by Small Molecules Enhances Bacillus Calmette-Guerin Vaccine Efficacy against Tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; BCG; INFECTION; MICE; RESPONSES; IMMUNITY; CD4(+); MEMORY; INTERLEUKIN-4	Tuberculosis affects nine million individuals and kills almost two million people every year. The only vaccine available, Bacillus Calmette-Guerin (BCG), has been used since its inception in 1921. Although BCG induces host-protective T helper 1 (Th1) cell immune responses, which play a central role in host protection, its efficacy is unsatisfactory, suggesting that additional methods to enhance protective immune responses are needed. Recently we have shown that simultaneous inhibition of Th2 cells and Tregs by using the pharmacological inhibitors suplatast tosylate and D4476, respectively, dramatically enhances Mycobacterium tuberculosis clearance and induces superior Th1 responses. Here we show that treatment with these two drugs during BCG vaccination dramatically improves vaccine efficacy. Furthermore, we demonstrate that these drugs induce a shift in the development of T cell memory, favoring central memory T (Tcm) cell responses over effector memory T (Tem) cell responses. Collectively, our findings provide evidence that simultaneous inhibition of Th2 cells and Tregs during BCG vaccination promotes vaccine efficacy.	[Bhattacharya, Debapriya; Dwivedi, Ved Prakash; Kumar, Santosh; Moodley, Prashini; Das, Gobardhan] Univ Kwazulu Natal, Coll Hlth Sci, Lab Med & Med Sci, ZA-4001 Durban, South Africa; [Reddy, Madhava C.] Yogi Vemana Univ, Kadapa 516003, India; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Das, Gobardhan] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	University of Kwazulu Natal; Yogi Vemana University; Vanderbilt University; Jawaharlal Nehru University, New Delhi	Das, G (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	gobardhan.das07@gmail.com	Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309; Dwivedi, Ved Prakash/0000-0003-4321-2567; Reddy, Madhava/0000-0003-4885-0437	The Wellcome Trust/DBT India Alliance; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research-Open Source Drug Discovery program, Government of India; University of KwaZulu-Natal, South Africa; Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation; University of KwaZulu-Natal	The Wellcome Trust/DBT India Alliance; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research-Open Source Drug Discovery program, Government of India; University of KwaZulu-Natal, South Africa; Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation; University of KwaZulu-Natal	This work was supported by grants from The Wellcome Trust/DBT India Alliance, Department of Biotechnology, Government of India and Council of Scientific and Industrial Research-Open Source Drug Discovery program, Government of India and University of KwaZulu-Natal, South Africa. Publication of this article has been made possible through support from the Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation and the University of KwaZulu-Natal.	Andersen P, 2014, TRENDS IMMUNOL, V35, P387, DOI 10.1016/j.it.2014.04.006; Beamer GL, 2012, EUR J IMMUNOL, V42, P870, DOI 10.1002/eji.201142054; Bhattacharya D, 2014, J BIOL CHEM, V289, P16508, DOI 10.1074/jbc.M114.558098; Bhattacharyya S, 1999, INFECT IMMUN, V67, P5597, DOI 10.1128/IAI.67.11.5597-5603.1999; Boom WH, 2007, J CLIN INVEST, V117, P2092, DOI 10.1172/JCI32933; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Checkley AM, 2011, TRENDS PHARMACOL SCI, V32, P601, DOI 10.1016/j.tips.2011.06.003; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; da Costa AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00152; da Fonseca DM, 2009, INFECT IMMUN, V77, P5311, DOI 10.1128/IAI.00580-09; Dlugovitzky D, 1999, RESP MED, V93, P557, DOI 10.1016/S0954-6111(99)90155-5; Erb KJ, 1998, IMMUNOL CELL BIOL, V76, P41, DOI 10.1046/j.1440-1711.1998.00719.x; Fenhalls G, 2000, INFECT IMMUN, V68, P2827, DOI 10.1128/IAI.68.5.2827-2836.2000; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001; Henao-Tamayo MI, 2010, CLIN VACCINE IMMUNOL, V17, P618, DOI 10.1128/CVI.00368-09; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Nagata T, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/764542; North RJ, 1998, CLIN EXP IMMUNOL, V113, P55, DOI 10.1046/j.1365-2249.1998.00636.x; Cavalcanti YVN, 2012, PULM MED, V2012, DOI 10.1155/2012/745483; Ottenhoff THM, 1998, IMMUNOL TODAY, V19, P491, DOI 10.1016/S0167-5699(98)01321-8; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Rahman MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086886; Raviglione MC, 2002, LANCET, V359, P775, DOI 10.1016/S0140-6736(02)07880-7; Rook GAW, 2007, CURR MOL MED, V7, P327; Russo DM, 2000, INFECT IMMUN, V68, P6826, DOI 10.1128/IAI.68.12.6826-6832.2000; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shafiani S, 2013, IMMUNITY, V38, P1261, DOI 10.1016/j.immuni.2013.06.003; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Wareham AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088149; WHO, 2006, STAT ART NEW VACC DE, P29; WHO Global Tuberculosis Control Report, 2010, CENT EUR J PUBL HEAL, V18, P237	38	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33404	33411		10.1074/jbc.M114.600452	http://dx.doi.org/10.1074/jbc.M114.600452			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25315774	Green Published, hybrid			2022-12-28	WOS:000345636600030
J	Han, GA; Park, S; Bin, NR; Jung, CH; Kim, B; Chandrasegaram, P; Matsuda, M; Riadi, I; Han, LP; Sugita, S				Han, Gayoung Anna; Park, Seungmee; Bin, Na-Ryum; Jung, Chang Hun; Kim, Byungjin; Chandrasegaram, Prashanth; Matsuda, Maiko; Riadi, Indira; Han, Liping; Sugita, Shuzo			A Pivotal Role for Pro-335 in Balancing the Dual Functions of Munc18-1 Domain-3a in Regulated Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-PEPTIDE; VESICLE DOCKING; SYNTAXIN 1A; SNARE; COMPLEX; BINDING; FUSION; 3A; PROMOTES; ACTIVATION	Munc18-1 plays essential dual roles in exocytosis: (i) stabilizing and trafficking the central SNARE protein, syntaxin-1 (i.e. chaperoning function), by its domain-1; and (ii) priming/stimulating exocytosis by its domain-3a. Here, we examine whether or not domain-3a also plays a significant role in the chaperoning of syntaxin-1 and, if so, how these dual functions of domain-3a are regulated. We demonstrate that introduction of quintuple mutations (K332E/K333E/P335A/Q336A/Y337L) in domain-3a of Munc18-1 abolishes its ability to bind syntaxin-1 and fails to rescue the level and trafficking of syntaxin-1 as well as to restore exocytosis in Munc18-1/2 double knockdown cells. By contrast, a quadruple mutant (K332E/K333E/Q336A/Y337L) sparing the Pro-335 residue retains all of these capabilities. A single point mutant of P335A reduces the ability to bind syntaxin-1 and rescue syntaxin-1 levels. Nonetheless, it surprisingly outperforms the wild type in the rescue of exocytosis. However, when additional mutations in the neighboring residues are combined with P335A mutation (K332E/K333E/P335A, P335A/Q336A/Y337L), the ability of the Munc18-1 variants to chaperone syntaxin-1 and to rescue exocytosis is strongly impaired. Our results indicate that residues from Lys-332 to Tyr-337 of domain-3a are intimately tied to the chaperoning function of Munc18-1. We also propose that Pro-335 plays a pivotal role in regulating the balance between the dual functions of domain-3a. The hinged conformation of the alpha-helix containing Pro-335 promotes the syntaxin-1 chaperoning function, whereas the P335A mutation promotes its priming function by facilitating the alpha-helix to adopt an extended conformation.	[Han, Gayoung Anna; Park, Seungmee; Bin, Na-Ryum; Jung, Chang Hun; Kim, Byungjin; Chandrasegaram, Prashanth; Matsuda, Maiko; Riadi, Indira; Han, Liping; Sugita, Shuzo] Univ Hlth Network, Toronto Western Res Inst, Div Fundamental Neurobiol, Toronto, ON M5T 2S8, Canada; [Han, Gayoung Anna; Park, Seungmee; Bin, Na-Ryum; Jung, Chang Hun; Han, Liping; Sugita, Shuzo] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Sugita, S (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Krembil Discovery Tower,7KD 419,60 Leonard Ave, Toronto, ON M5T 2S8, Canada.	ssugita@uhnres.utoronto.ca		Sugita, Shuzo/0000-0002-9182-873X	Natural Sciences and Engineering Research Council of Canada [298461-09]; Heart and Stroke Foundation [NA6217, T6700]; Canadian Institute of Health Research [MOP-93665, 130573]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by the Natural Sciences and Engineering Research Council of Canada (Grant 298461-09), the Heart and Stroke Foundation (Grants NA6217 and T6700), and the Canadian Institute of Health Research (Grants MOP-93665 and 130573).	Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Han GYA, 2011, MOL BIOL CELL, V22, P4134, DOI 10.1091/mbc.E11-02-0135; Han GA, 2010, J NEUROCHEM, V115, P1, DOI 10.1111/j.1471-4159.2010.06900.x; Han GA, 2013, J CELL SCI, V126, P2361, DOI 10.1242/jcs.126862; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HOSONO R, 1992, J NEUROCHEM, V58, P1517, DOI 10.1111/j.1471-4159.1992.tb11373.x; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Malintan NT, 2009, J BIOL CHEM, V284, P21637, DOI 10.1074/jbc.M109.013508; Martin S, 2013, J CELL SCI, V126, P2353, DOI 10.1242/jcs.126813; McEwen JM, 2008, MOL BIOL CELL, V19, P3836, DOI 10.1091/mbc.E08-02-0160; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Meijer M, 2012, EMBO J, V31, P2156, DOI 10.1038/emboj.2012.72; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Parisotto D, 2014, J BIOL CHEM, V289, P9639, DOI 10.1074/jbc.M113.514273; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rodkey TL, 2008, MOL BIOL CELL, V19, P5422, DOI 10.1091/mbc.E08-05-0538; Rowe J, 2001, J CELL SCI, V114, P3323; Rowe J, 1999, J CELL SCI, V112, P1865; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878	35	19	19	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33617	33628		10.1074/jbc.M114.584805	http://dx.doi.org/10.1074/jbc.M114.584805			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25326390	hybrid, Green Published			2022-12-28	WOS:000345636600047
J	Pijuan-Galito, S; Tamm, C; Anneren, C				Pijuan-Galito, Sara; Tamm, Christoffer; Anneren, Cecilia			Serum Inter-alpha-inhibitor Activates the Yes Tyrosine Kinase and YAP/TEAD Transcriptional Complex in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GENE-6 TSG-6; HUMAN AMNIOTIC MEMBRANE; SELF-RENEWAL; TRYPSIN-INHIBITOR; HEAVY-CHAINS; EXTRACELLULAR-MATRIX; HUMAN-PLASMA; LUNG INJURY; HYALURONAN; PROTEINS	We have previously demonstrated that the Src family kinase Yes, the Yes-associated protein (YAP) and TEA domain TEAD2 transcription factor pathway are activated by leukemia inhibitory factor (LIF) and contribute to mouse embryonic stem (mES) cell maintenance of pluripotency and self-renewal. In addition, we have shown that fetal bovine serum (FBS) induces Yes autophosphorylation and activation. In the present study we confirm that serum also activates TEAD-dependent transcription in a time-and dose-dependent manner and we identify Inter-alpha-inhibitor (I alpha I) as a component in serum capable of activating the Yes/YAP/TEAD pathway by inducing Yes auto-phosphorylation, YAP nuclear localization and TEAD-dependent transcription. The cleaved heavy chain 2 (HC2) sub-component of I alpha I, is demonstrated to be responsible for this effect. Moreover, I alpha I is also shown to efficiently increase expression of TEAD-downstream target genes including well-known stem cell factors Nanog and Oct 3/4. I alpha I is not produced by the ES cells per se but is added to the cells via the cell culture medium containing serum or serum-derived components such as bovine serum albumin (BSA). In conclusion, we describe a novel function of I alpha I in activating key pluripotency pathways associated with ES cell maintenance and self-renewal.	[Pijuan-Galito, Sara; Tamm, Christoffer; Anneren, Cecilia] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Anneren, Cecilia] GE Healthcare Biosci AB, SE-75184 Uppsala, Sweden	Uppsala University; General Electric	Anneren, C (corresponding author), Dept Med Biochem & Microbiol, Husargatan 3 Box 582, SE-75123 Uppsala, Sweden.	cecilia.anneren@imbim.uu.se		Anneren, Cecilia/0000-0003-3600-6650; Pijuan Galito, Sara/0000-0002-7398-9441	Swedish Research Council; Jaenssons' Foundations; Faculty of Medicine, Uppsala University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Jaenssons' Foundations; Faculty of Medicine, Uppsala University	This work was supported by the Swedish Research Council, the Jaenssons' Foundations, and the Faculty of Medicine, Uppsala University.	Adair JE, 2009, J BIOL CHEM, V284, P16922, DOI 10.1074/jbc.M808560200; Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Anneren C, 2008, CLIN SCI, V115, P43, DOI 10.1042/CS20070388; Arakawa T, 2007, J BIOCHEM BIOPH METH, V70, P493, DOI 10.1016/j.jbbm.2006.12.001; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Blom AM, 1999, J BIOL CHEM, V274, P298, DOI 10.1074/jbc.274.1.298; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Garantziotis S, 2008, AM J RESP CRIT CARE, V178, P939, DOI 10.1164/rccm.200803-386OC; Garantziotis S, 2007, J IMMUNOL, V179, P4187, DOI 10.4049/jimmunol.179.6.4187; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Hess KA, 1999, BIOL REPROD, V61, P436, DOI 10.1095/biolreprod61.2.436; Ilic D, 2006, REGEN MED, V1, P95, DOI 10.2217/17460751.1.1.95; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; JIANG SW, 1995, J BIOL CHEM, V270, P13906, DOI 10.1074/jbc.270.23.13906; Jin YJ, 2011, CELL SIGNAL, V23, P125, DOI 10.1016/j.cellsig.2010.08.012; Josic D, 2006, PROTEOMICS, V6, P2874, DOI 10.1002/pmic.200500563; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lei T, 2008, CLIN CHIM ACTA, V388, P173, DOI 10.1016/j.cca.2007.10.034; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Musah S, 2012, ACS NANO, V6, P10168, DOI 10.1021/nn3039148; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Shay E, 2011, INVEST OPHTH VIS SCI, V52, P2669, DOI 10.1167/iovs.10-5888; Shimabukuro Y, 2011, J CELL PHYSIOL, V226, P809, DOI 10.1002/jcp.22406; SMITH A, 1991, METHODS CELL SCI, V13, P89; Stojkovic P, 2005, STEM CELLS, V23, P895, DOI 10.1634/stemcells.2004-0326; Tamm C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081156; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tan KT, 2011, AESTHET SURG J, V31, P47, DOI 10.1177/1090820X10391778; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Werbowetski-Ogilvie TE, 2006, CANCER RES, V66, P1464, DOI 10.1158/0008-5472.CAN-05-1913; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873; Zhang X, 2014, ACS CHEM BIOL, V9, P139, DOI 10.1021/cb400249b; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657	51	10	10	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33492	33502		10.1074/jbc.M114.580076	http://dx.doi.org/10.1074/jbc.M114.580076			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25301940	Green Published, hybrid			2022-12-28	WOS:000345636600037
J	Schafer, CT; Farrens, DL				Schafer, Christopher T.; Farrens, David L.			Conformational Selection and Equilibrium Governs the Ability of Retinals to Bind Opsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2) ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; LIGAND-FREE; ROD OPSIN; FLUORESCENCE SPECTROSCOPY; CONSTITUTIVE ACTIVATION; METARHODOPSIN-II; BOVINE RHODOPSIN; VISUAL PIGMENTS	Despite extensive study, how retinal enters and exits the visual G protein-coupled receptor rhodopsin remains unclear. One clue may lie in two openings between transmembrane helix 1 (TM1) and TM7 and between TM5 and TM6 in the active receptor structure. Recently, retinal has been proposed to enter the inactive apoprotein opsin (ops) through these holes when the receptor transiently adopts the active opsin conformation (ops*). Here, we directly test this "transient activation" hypothesis using a fluorescence-based approach to measure rates of retinal binding to samples containing differing relative fractions of ops and ops*. In contrast to what the transient activation hypothesis model would predict, we found that binding for the inverse agonist, 11-cis-retinal (11CR), slowed when the sample contained more ops* (produced using M257Y, a constitutively activating mutation). Interestingly, the increased presence of ops* allowed for binding of the agonist, all-trans-retinal (ATR), whereas WT opsin showed no binding. Shifting the conformational equilibrium toward even more ops* using a G protein peptide mimic (either free in solution or fused to the receptor) accelerated the rate of ATR binding and slowed 11CR binding. An arrestin peptide mimic showed little effect on 11CR binding; however, it stabilized opsin.ATR complexes. The TM5/TM6 hole is apparently not involved in this conformational selection. Increasing its size by mutagenesis did not enable ATR binding but instead slowed 11CR binding, suggesting that it may play a role in trapping 11CR. In summary, our results indicate that conformational selection dictates stable retinal binding, which we propose involves ATR and 11CR binding to different states, the latter a previously unidentified, open-but-inactive conformation.	[Schafer, Christopher T.; Farrens, David L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Farrens, DL (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	farrensd@ohsu.edu		Schafer, Christopher/0000-0001-9907-295X	National Institutes of Health [R01 EY015436, T32 EY023211, T32 GM071338]; Medical Research Foundation of Oregon; Achievement Rewards for College Scientists Foundation of Portland; Oregon Health and Science University Tartar Trust; NATIONAL EYE INSTITUTE [T32EY023211, R01EY015436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Foundation of Oregon; Achievement Rewards for College Scientists Foundation of Portland; Oregon Health and Science University Tartar Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY015436 (to D. L. F.) and Training Grants T32 EY023211 and T32 GM071338 (to C. T. S.). This work was also supported by the Medical Research Foundation of Oregon (to D. L. F.).; Supported by the Achievement Rewards for College Scientists Foundation of Portland and Oregon Health and Science University Tartar Trust.	Blakeley LR, 2011, INVEST OPHTH VIS SCI, V52, P3483, DOI 10.1167/iovs.10-6694; Brown MF, 2010, BBA-BIOMEMBRANES, V1798, P177, DOI 10.1016/j.bbamem.2009.08.013; Brueggemann LI, 2001, BIOCHEMISTRY-US, V40, P4446, DOI 10.1021/bi002267g; Buczylko J, 1996, J BIOL CHEM, V271, P20621, DOI 10.1074/jbc.271.34.20621; Chen CH, 2012, J BIOL CHEM, V287, P24662, DOI 10.1074/jbc.M112.354514; Chen MH, 2012, BIOCHEMISTRY-US, V51, P4117, DOI 10.1021/bi201522h; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; DRATZ EA, 1993, NATURE, V363, P276, DOI 10.1038/363276a0; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fay JF, 2012, J BIOL CHEM, V287, P33873, DOI 10.1074/jbc.M112.352328; FERRETTI L, 1986, P NATL ACAD SCI USA, V83, P599, DOI 10.1073/pnas.83.3.599; Feuerstein SE, 2009, BIOCHEMISTRY-US, V48, P10733, DOI 10.1021/bi900544p; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Heck M, 2003, VISION RES, V43, P3003, DOI 10.1016/j.visres.2003.08.011; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Hunyady L, 2003, TRENDS PHARMACOL SCI, V24, P81, DOI 10.1016/S0165-6147(02)00050-0; Imamoto Y, 2013, BIOCHEMISTRY-US, V52, P3010, DOI 10.1021/bi3015967; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Jastrzebska B, 2011, J BIOL CHEM, V286, P18930, DOI 10.1074/jbc.M111.234583; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kono M, 2008, BIOCHEMISTRY-US, V47, P7567, DOI 10.1021/bi800357b; Lee KA, 2010, BIOCHEMISTRY-US, V49, P2454, DOI 10.1021/bi1001085; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu J, 2011, J BIOL CHEM, V286, P27622, DOI 10.1074/jbc.M111.233312; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2010, P NATL ACAD SCI USA, V107, P8428, DOI 10.1073/pnas.1000640107; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Matsumoto H, 2008, PHOTOCHEM PHOTOBIOL, V84, P985, DOI 10.1111/j.1751-1097.2008.00338.x; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Mustafi D, 2009, MOL PHARMACOL, V75, P1, DOI 10.1124/mol.108.051938; Ostermaier MK, 2014, P NATL ACAD SCI USA, V111, P1825, DOI 10.1073/pnas.1319402111; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Park JH, 2013, ANGEW CHEM INT EDIT, V52, P11021, DOI 10.1002/anie.201302374; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piechnick R, 2012, P NATL ACAD SCI USA, V109, P5247, DOI 10.1073/pnas.1117268109; Piechnick R, 2011, BIOCHEMISTRY-US, V50, P7168, DOI 10.1021/bi200675y; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; RESEK JF, 1993, BIOCHEMISTRY-US, V32, P12025, DOI 10.1021/bi00096a012; Saari JC, 1998, VISION RES, V38, P1325, DOI 10.1016/S0042-6989(97)00198-3; Sachs K, 2000, J BIOL CHEM, V275, P6189, DOI 10.1074/jbc.275.9.6189; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Sinha A, 2014, BIOCHEMISTRY-US, V53, P3294, DOI 10.1021/bi401534y; Sommer ME, 2006, VISION RES, V46, P4532, DOI 10.1016/j.visres.2006.08.031; Sommer ME, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2000; Sommer ME, 2006, J BIOL CHEM, V281, P9407, DOI 10.1074/jbc.M510037200; Srinivasan S, 2014, CHEM BIOL, V21, P369, DOI 10.1016/j.chembiol.2014.01.006; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Sugihara M, 2014, J STRUCT BIOL, V188, P79, DOI 10.1016/j.jsb.2014.08.001; Surya A, 1998, EXP EYE RES, V66, P599, DOI 10.1006/exer.1997.0453; SURYA A, 1995, J BIOL CHEM, V270, P5024, DOI 10.1074/jbc.270.10.5024; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Tian H, 2014, CHEMBIOCHEM, V15, P1820, DOI 10.1002/cbic.201402193; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; Tsukamoto H, 2011, BIOCHEMISTRY-US, V50, P5086, DOI 10.1021/bi200391a; Tsukamoto H, 2010, J BIOL CHEM, V285, P7351, DOI 10.1074/jbc.M109.078709; Van Eps N, 2010, BIOCHEMISTRY-US, V49, P6877, DOI 10.1021/bi100846c; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Wang T, 2011, J MOL RECOGNIT, V24, P350, DOI 10.1002/jmr.1087; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	85	18	18	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4304	4318		10.1074/jbc.M114.603134	http://dx.doi.org/10.1074/jbc.M114.603134			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25451936	Green Published, hybrid			2022-12-28	WOS:000349458400040
J	Banigan, JR; Gayen, A; Cho, MK; Traaseth, NJ				Banigan, James R.; Gayen, Anindita; Cho, Min-Kyu; Traaseth, Nathaniel J.			A Structured Loop Modulates Coupling between the Substrate-binding and Dimerization Domains in the Multidrug Resistance Transporter EmrE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-TETRACYCLINE/H+ ANTIPORTER; INDUCED CONFORMATIONAL-CHANGES; PROTEIN SECONDARY STRUCTURE; NUCLEAR-MAGNETIC-RESONANCE; STATE NMR-SPECTROSCOPY; ANGLE-SPINNING NMR; ESCHERICHIA-COLI; CROSS-POLARIZATION; CHEMICAL-SHIFTS; CYTOPLASMIC LOOP	Secondary active transporters undergo large conformational changes to facilitate the efflux of substrates across the lipid bilayer. Among the smallest known transport proteins are members of the small multidrug resistance (SMR) family that are composed of four transmembrane (TM) domains and assemble into dimers. An unanswered question in the SMR field is how the dimerization domain (TM4) is coupled with the substrate-binding chamber (TM1-3). To provide insight for this essential aspect of ion-coupled transport, we carried out a structure-function study on the SMR protein EmrE using solid-state-NMR spectroscopy in lipid bilayers and resistance assays in Escherichia coli. The chemical shifts for EmrE were consistent with beta-strand secondary structure for the loop connecting TM3 and TM4. Based on these structural results, EmrE mutants were created to ascertain whether a specific loop length and composition were necessary for function. A linker encompassing six extra Gly residues relative to wild-type EmrE failed to give resistance; however, the number of residues in the loop was not the only criterion for a functional efflux pump. Replacement of the central hydrophobic residue with Gly (L83G) also conferred no ethidium resistance phenotype, which supported the conclusion that the structure and length of the loop were both essential for ion-coupled transport. Taken together with a bioinformatics analysis, a structured linker is likely conserved across the SMR family to play an active role in mediating the conformational switch between inward-open and outward-open states necessary for drug efflux. These findings underscore the important role loops can play in mediating efflux.	[Banigan, James R.; Gayen, Anindita; Cho, Min-Kyu; Traaseth, Nathaniel J.] NYU, Dept Chem, New York, NY 10003 USA	New York University	Traaseth, NJ (corresponding author), NYU, Dept Chem, 100 Washington Sq East, New York, NY 10003 USA.	traaseth@nyu.edu	Cho, Min-Kyu/H-1303-2011	Cho, Min-Kyu/0000-0003-0537-2340; Banigan, James/0000-0002-1807-1769; Traaseth, Nathaniel/0000-0002-1185-6088	NYSTAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI083745, R01AI108889] Funding Source: NIH RePORTER	NYSTAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The collection of NMR data at the New York Structural Biology Center was made possible by a grant from NYSTAR. We thank Matthew Devany for assistance in using the NMR spectrometer at Hunter College. We thank Prof. Raymond J. Turner at the University of Calgary for providing wild-type EmrE in the pMS119EH vector.	Amadi ST, 2010, J BIOL CHEM, V285, P26710, DOI 10.1074/jbc.M110.132621; AMMANN C, 1982, J MAGN RESON, V46, P319, DOI 10.1016/0022-2364(82)90147-0; Baldus M, 1996, J MAGN RESON SER A, V118, P140, DOI 10.1006/jmra.1996.0022; Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Banigan JR, 2015, BBA-BIOMEMBRANES, V1848, P334, DOI 10.1016/j.bbamem.2014.05.003; Banigan JR, 2013, J BIOMOL NMR, V55, P391, DOI 10.1007/s10858-013-9724-z; Banigan JR, 2012, J PHYS CHEM B, V116, P7138, DOI 10.1021/jp303269m; Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015; Bay DC, 2012, BBA-BIOMEMBRANES, V1818, P1318, DOI 10.1016/j.bbamem.2012.01.022; Bay DC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-140; Berjanskii MV, 2008, J BIOMOL NMR, V40, P31, DOI 10.1007/s10858-007-9208-0; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Cho MK, 2014, J AM CHEM SOC, V136, P8072, DOI 10.1021/ja503145x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuff AL, 2006, BIOINFORMATICS, V22, P1464, DOI 10.1093/bioinformatics/btl120; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ditty JL, 1999, J BACTERIOL, V181, P5068, DOI 10.1128/JB.181.16.5068-5074.1999; Dutta S, 2014, BIOPHYS J, V107, P613, DOI 10.1016/j.bpj.2014.06.030; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; Eletsky A, 2001, J BIOMOL NMR, V20, P177, DOI 10.1023/A:1011265430149; Franks WT, 2007, J BIOMOL NMR, V39, P107, DOI 10.1007/s10858-007-9179-1; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P14284, DOI 10.1021/bi972314d; Gayen A, 2013, ANGEW CHEM INT EDIT, V52, P10321, DOI 10.1002/anie.201303091; Goddard T. D., 2006, SPARKY 3; Gopinath T, 2012, J MAGN RESON, V220, P79, DOI 10.1016/j.jmr.2012.04.006; Hohwy M, 1999, J CHEM PHYS, V110, P7983, DOI 10.1063/1.478702; Jack DL, 2000, J BACTERIOL, V182, P2311, DOI 10.1128/JB.182.8.2311-2313.2000; Koebnik R, 1999, J BACTERIOL, V181, P3688, DOI 10.1128/JB.181.12.3688-3694.1999; Kolbusz MA, 2012, BIOCHEMISTRY-US, V51, P8867, DOI 10.1021/bi300854c; Lehner I, 2008, J BIOL CHEM, V283, P3281, DOI 10.1074/jbc.M707899200; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Lloris-Garcera P, 2013, J MOL BIOL, V425, P4642, DOI 10.1016/j.jmb.2013.07.039; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Morrison EA, 2014, J BIOL CHEM, V289, P6825, DOI 10.1074/jbc.M113.535328; Parry-Smith DJ, 1998, GENE, V221, pGC57, DOI 10.1016/S0378-1119(97)00650-1; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poget SF, 2010, BIOMOL NMR ASSIGN, V4, P139, DOI 10.1007/s12104-010-9228-7; Poulsen BE, 2012, ANTIMICROB AGENTS CH, V56, P3911, DOI 10.1128/AAC.00158-12; Poulsen BE, 2011, J BACTERIOL, V193, P5929, DOI 10.1128/JB.05846-11; Poulsen BE, 2009, J BIOL CHEM, V284, P9870, DOI 10.1074/jbc.M900182200; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Schulte-Herbruggen T, 2000, J MAGN RESON, V144, P123, DOI 10.1006/jmre.2000.2020; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi LC, 2009, J MOL BIOL, V386, P1078, DOI 10.1016/j.jmb.2009.01.011; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stringer JA, 2005, J MAGN RESON, V173, P40, DOI 10.1016/j.jmr.2004.11.015; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Takegoshi K, 2003, J CHEM PHYS, V118, P2325, DOI 10.1063/1.1534105; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tate CG, 2003, J MOL BIOL, V332, P229, DOI 10.1016/S0022-2836(03)00895-7; Traaseth NJ, 2011, J MAGN RESON, V211, P18, DOI 10.1016/j.jmr.2011.03.013; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Weinglass AB, 2000, P NATL ACAD SCI USA, V97, P8938, DOI 10.1073/pnas.140224497; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; YAMAGUCHI A, 1993, J BIOL CHEM, V268, P6496; YAMAGUCHI A, 1990, J BIOL CHEM, V265, P15525; YAMAGUCHI A, 1992, J BIOL CHEM, V267, P19155; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	71	18	18	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					805	814		10.1074/jbc.M114.601963	http://dx.doi.org/10.1074/jbc.M114.601963			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25406320	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000347778200011
J	Kitai, Y; Takeuchi, O; Kawasaki, T; Ori, D; Sueyoshi, T; Murase, M; Akira, S; Kawai, T				Kitai, Yuichi; Takeuchi, Osamu; Kawasaki, Takumi; Ori, Daisuke; Sueyoshi, Takuya; Murase, Motoya; Akira, Shizuo; Kawai, Taro			Negative Regulation of Melanoma Differentiation-associated Gene 5 (MDA5)-dependent Antiviral Innate Immune Responses by Arf-like Protein 5B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-LIKE RECEPTORS; E3 UBIQUITIN LIGASE; SENSORS RIG-I; MULTIPLE-SCLEROSIS; DSRNA RECOGNITION; MDA5; VIRUS; MITOCHONDRIA; ACTIVATION; INFECTION	RIG-I-like receptors (RLRs), including retinoic acid-inducible gene-I (RIG-I) and MDA5, constitute a family of cytoplasmic RNA helicases that senses viral RNA and mounts antiviral innate immunity by producing type I interferons and inflammatory cytokines. Despite their essential roles in antiviral host defense, RLR signaling is negatively regulated to protect the host from excessive inflammation and autoimmunity. Here, we identified ADP-ribosylation factor-like protein 5B (Arl5B), an Arl family small GTPase, as a regulator of RLR signaling through MDA5 but not RIG-I. Overexpression of Arl5B repressed interferon beta promoter activation by MDA5 but not RIG-I, and its knockdown enhanced MDA5-mediated responses. Furthermore, Arl5B-deficient mouse embryonic fibroblast cells exhibited increased type I interferon expression in response to MDA5 agonists such as poly(I:C) and encephalomyocarditis virus. Arl5B-mediated negative regulation of MDA5 signaling does not require its GTP binding ability but requires Arl5B binding to the C-terminal domain of MDA5, which prevents interaction between MDA5 and poly(I: C). Our results, therefore, suggest that Arl5B is a negative regulator for MDA5.	[Kitai, Yuichi; Kawasaki, Takumi; Sueyoshi, Takuya; Murase, Motoya; Kawai, Taro] Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Lab Mol Immunobiol, Nara 6300192, Japan; [Kitai, Yuichi; Akira, Shizuo] Osaka Univ, Immunol Frontier Res Ctr IFReC, Host Def Lab, Suita, Osaka 5650871, Japan; [Kitai, Yuichi; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Takeuchi, Osamu; Ori, Daisuke] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Sakyo Ku, Kyoto 6068507, Japan	Nara Institute of Science & Technology; Osaka University; Osaka University; Kyoto University	Kawai, T (corresponding author), Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Lab Mol Immunobiol, 8916-5 Takayama Cho, Nara 6300192, Japan.	tarokawai@bs.naist.jp	Takeuchi, Osamu/AAG-9359-2019; Akira, Shizuo/C-3134-2009	Takeuchi, Osamu/0000-0002-1260-6232; Kawai, Taro/0000-0001-7510-4662	KAKENHI [26293107]; Japan Society for the Promotion of Science through the Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Cell Science Research Foundation; Naito Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science through the Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Naito Foundation(Naito Memorial Foundation)	This work was supported by a KAKENHI Grant-in-aid for Scientific Research (B) 26293107 and by the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), The Cell Science Research Foundation, and The Naito Foundation.	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Berke IC, 2012, P NATL ACAD SCI USA, V109, P18437, DOI 10.1073/pnas.1212186109; Boppana S, 2013, J NEUROIMMUNOL, V265, P68, DOI 10.1016/j.jneuroim.2013.10.007; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Clark K, 2013, NAT REV MOL CELL BIO, V14, P673, DOI 10.1038/nrm3644; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948; Enevold C, 2009, J NEUROIMMUNOL, V212, P125, DOI 10.1016/j.jneuroim.2009.04.008; Fan YH, 2014, J EXP MED, V211, P313, DOI 10.1084/jem.20122844; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Houghton FJ, 2012, EXP CELL RES, V318, P464, DOI 10.1016/j.yexcr.2011.12.023; Jacobs JL, 2013, J MOL BIOL, V425, P5009, DOI 10.1016/j.jmb.2013.10.007; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kuniyoshi K, 2014, P NATL ACAD SCI USA, V111, P5646, DOI 10.1073/pnas.1401674111; Lee H, 2013, P NATL ACAD SCI USA, V110, P12379, DOI 10.1073/pnas.1310604110; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Pfender N, 2014, EXP NEUROL, V262, P44, DOI 10.1016/j.expneurol.2014.04.015; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Torres IL, 2014, J CELL SCI, V127, P2151, DOI 10.1242/jcs.122028; Tuli A, 2013, MOL BIOL CELL, V24, P3721, DOI 10.1091/mbc.E13-05-0259; Walkiewicz MP, 2011, J GEN VIROL, V92, P60, DOI 10.1099/vir.0.025015-0; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yang YK, 2011, J BIOL CHEM, V286, P10568, DOI 10.1074/jbc.M110.206896; Yoo JS, 2014, CURR OPIN MICROBIOL, V20, P131, DOI 10.1016/j.mib.2014.05.011; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	41	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1269	1280		10.1074/jbc.M114.611053	http://dx.doi.org/10.1074/jbc.M114.611053			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451939	Green Published, hybrid			2022-12-28	WOS:000347778200055
J	Ogunbayo, OA; Zhu, YM; Shen, B; Agbani, E; Li, J; Ma, JJ; Zhu, MX; Evans, AM				Ogunbayo, Oluseye A.; Zhu, Yingmin; Shen, Bing; Agbani, Ejaife; Li, Jie; Ma, Jianjie; Zhu, Michael X.; Evans, A. Mark			Organelle-specific Subunit Interactions of the Vertebrate Two-pore Channel Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM; NAADP; CA2+; REQUIREMENT; RECEPTORS; RELEASE; SODIUM	The organellar targeting of two-pore channels (TPCs) and their capacity to associate as homo-and heterodimers may be critical to endolysosomal signaling. A more detailed understanding of the functional association of vertebrate TPC1-3 is therefore necessary. We report here that when stably expressed in HEK293 cells, human (h) TPC1 and chicken (c) TPC3 were specifically targeted to different subpopulations of endosomes, hTPC2 was specifically targeted to lysosomes, and rabbit (r) TPC3 was specifically targeted to both endosomes and lysosomes. Intracellular dialysis of NAADP evoked a Ca2+ transient in HEK293 cells that stably overexpressed hTPC1, hTPC2, and rTPC3, but not in cells that stably expressed cTPC3. The Ca2+ transients induced in cells that overexpressed endosome-targeted hTPC1 were abolished upon depletion of acidic Ca2+ stores by bafilomycin A(1), but remained unaffected following depletion of endoplasmic reticulum stores by thapsigargin. In contrast, Ca2+ transients induced via lysosome-targeted hTPC2 and endolysosome-targeted rTPC3 were abolished by bafilomycin A(1) and markedly attenuated by thapsigargin. NAADP induced marked Ca2+ transients in HEK293 cells that stably coexpressed hTPC2 with hTPC1 or cTPC3, but failed to evoke any such response in cells that coexpressed interacting hTPC2 and rTPC3 subunits. We therefore conclude that 1) all three TPC subtypes may support Ca2+ signaling from their designate acidic stores, and 2) lysosome-targeted (but not endosome-targeted) TPCs support coupling to the endoplasmic reticulum.	[Ogunbayo, Oluseye A.; Agbani, Ejaife; Evans, A. Mark] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Zhu, Yingmin; Shen, Bing; Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Shen, Bing; Li, Jie] Anhui Med Univ, Dept Physiol, Hefei 230032, Anhui, Peoples R China; [Ma, Jianjie] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA	University of Edinburgh; University of Texas System; University of Texas Health Science Center Houston; Anhui Medical University; University System of Ohio; Ohio State University	Zhu, MX (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	michael.x.zhu@uth.tmc.edu; mark.evans@ed.ac.uk	Agbani, Ejaife O./AAC-9418-2020		National Institutes of Health [R01 GM092759]; British Heart Foundation [PG/10/95/28657, RG/12/14/29885]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM092759 (to M. X. Z.) and by British Heart Foundation Project and Programme Grants PG/10/95/28657 and RG/12/14/29885 (to A. M. E.).	Aoyama M, 2004, J CELL SCI, V117, P2813, DOI 10.1242/jcs.01136; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Cai XJ, 2010, MOL BIOL EVOL, V27, P2352, DOI 10.1093/molbev/msq122; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6015; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Miller WR, 2011, MOL CELL ENDOCRINOL, V340, P127, DOI 10.1016/j.mce.2011.04.020; Morgan AJ, 2014, BIOESSAYS, V36, P173, DOI 10.1002/bies.201300118; Ogunbayo OA, 2011, J BIOL CHEM, V286, P9136, DOI 10.1074/jbc.M110.202002; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	19	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1086	1095		10.1074/jbc.M114.610493	http://dx.doi.org/10.1074/jbc.M114.610493			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451935	Green Published, hybrid			2022-12-28	WOS:000347778200040
J	Kashlan, OB; Blobner, BM; Zuzek, Z; Tolino, M; Kleyman, TR				Kashlan, Ossama B.; Blobner, Brandon M.; Zuzek, Zachary; Tolino, Michael; Kleyman, Thomas R.			Na+ Inhibits the Epithelial Na+ Channel by Binding to a Site in an Extracellular Acidic Cleft	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acid-sensing Ion Channel (ASIC); Allosteric Regulation; Epithelial Sodium Channel (ENaC); Hypertension; Ion Channel; Membrane Transport; Protein Cross-linking; Effector Specificity; pH-dependent Activation	CONSERVED CHARGED RESIDUES; SODIUM SELF-INHIBITION; OPEN PROBABILITY; ALPHA-SUBUNITS; GAMMA-SUBUNITS; BETA-SUBUNITS; THUMB DOMAINS; ENAC; EXPRESSION; RAT	Background: External Na+ inhibits ENaC. Results: Mutations centered about a key aspartate in an acidic cleft weakened Na+ inhibition and altered inhibitor selectivity. Conclusion: The acidic cleft hosts an inhibitory Na+ binding site. Significance: The acidic cleft harbors a key Na+ binding site for ENaC and perhaps sites for ligands that regulate other members of the ENaC/degenerin family. The epithelial Na+ channel (ENaC) has a key role in the regulation of extracellular fluid volume and blood pressure. ENaC belongs to a family of ion channels that sense the external environment. These channels have large extracellular regions that are thought to interact with environmental cues, such as Na+, Cl-, protons, proteases, and shear stress, which modulate gating behavior. We sought to determine the molecular mechanism by which ENaC senses high external Na+ concentrations, resulting in an inhibition of channel activity. Both our structural model of an ENaC subunit and the resolved structure of an acid-sensing ion channel (ASIC1) have conserved acidic pockets in the periphery of the extracellular region of the channel. We hypothesized that these acidic pockets host inhibitory allosteric Na+ binding sites. Through site-directed mutagenesis targeting the acidic pocket, we modified the inhibitory response to external Na+. Mutations at selected sites altered the cation inhibitory preference to favor Li+ or K+ rather than Na+. Channel activity was reduced in response to restraining movement within this region by cross-linking structures across the acidic pocket. Our results suggest that residues within the acidic pocket form an allosteric effector binding site for Na+. Our study supports the hypothesis that an acidic cleft is a key ligand binding locus for ENaC and perhaps other members of the ENaC/degenerin family.	[Kashlan, Ossama B.; Blobner, Brandon M.; Zuzek, Zachary; Tolino, Michael; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kashlan, OB (corresponding author), Univ Pittsburgh, Dept Med, 3550 Terrace St, Pittsburgh, PA 15261 USA.	obk2@pitt.edu			National Institutes of Health [R01 DK051391, R01 DK098204, K01 DK078734, P30 DK079307, T32 DK061296]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK061296, R37DK051391, R01DK051391, P30DK079307, R01DK098204, K01DK078734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part by National Institutes of Health Grants R01 DK051391 (to T. R. K.), R01 DK098204 and K01 DK078734 (to O. B. K.), P30 DK079307, and T32 DK061296.	Anantharam A, 2006, J PHYSIOL-LONDON, V574, P333, DOI 10.1113/jphysiol.2006.109173; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Chen JX, 2013, AM J PHYSIOL-RENAL, V304, pF207, DOI 10.1152/ajprenal.00563.2012; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2012, J BIOL CHEM, V287, P40907, DOI 10.1074/jbc.M112.417519; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Condliffe SB, 2004, J BIOL CHEM, V279, P10085, DOI 10.1074/jbc.M313592200; Drummond HA, 2004, HYPERTENSION, V44, P643, DOI 10.1161/01.HYP.0000144465.56360.ad; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Edelheit O, 2014, FEBS J, V281, P2097, DOI 10.1111/febs.12765; Edelheit O, 2011, AM J PHYSIOL-RENAL, V300, pF887, DOI 10.1152/ajprenal.00648.2010; FUCHS W, 1977, J PHYSIOL-LONDON, V267, P137, DOI 10.1113/jphysiol.1977.sp011805; Grunder S, 2001, EUR J NEUROSCI, V13, P641, DOI 10.1046/j.1460-9568.2001.01426.x; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Horisberger JD., 2004, NEPHRON PHYSIOL, V96, P37, DOI [10.1159/000076406, DOI 10.1159/000076406]; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Ishikawa T, 1998, J GEN PHYSIOL, V111, P825, DOI 10.1085/jgp.111.6.825; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Kashlan OB, 2012, J BIOL CHEM, V287, P20720, DOI 10.1074/jbc.M112.358218; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; Kretz O, 1999, J HISTOCHEM CYTOCHEM, V47, P51, DOI 10.1177/002215549904700106; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pearce D., 2014, CLIN J AM S IN PRESS; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963	47	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					568	576		10.1074/jbc.M114.606152	http://dx.doi.org/10.1074/jbc.M114.606152			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25389295	Green Published, hybrid			2022-12-28	WOS:000347231200049
J	Liu, TF; Vachharajani, V; Millet, P; Bharadwaj, MS; Molina, AJ; McCall, CE				Liu, Tie Fu; Vachharajani, Vidula; Millet, Patrick; Bharadwaj, Manish S.; Molina, Anthony J.; McCall, Charles E.			Sequential Actions of SIRT1-RELB-SIRT3 Coordinate Nuclear-Mitochondrial Communication during Immunometabolic Adaptation to Acute Inflammation and Sepsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondrial Respiratory Chain Complex; Monocyte; Reactive Oxygen Species (ROS); Sepsis; Sirtuin 1 (SIRT1); Acute Inflammation; Mitochondrial Bioenergetics; RELB; SIRT3; Nuclear-mitochondrial Communication	METABOLISM; HISTONE; DAMAGE; IMMUNOSUPPRESSION; DYSFUNCTION; BIOGENESIS; GLUCOSE; STRESS; ALPHA	Background: Nuclear SIRT1 and SIRT6 switch monocyte energy sources from glycolysis to fatty acid oxidation during sepsis adaptation. Results: Sequential actions of nuclear SIRT1 and RELB differentially induce SIRT3 expression and increase mitochondrial biogenesis during sepsis adaptation. Conclusion: SIRT1 and RELB link nuclear and mitochondrial alterations in bioenergetics during sepsis. Significance: Communication between nuclear and mitochondrial functions may influence sepsis outcomes. We reported that NAD(+)-dependent SIRT1, RELB, and SIRT6 nuclear proteins in monocytes regulate a switch from the glycolysis-dependent acute inflammatory response to fatty acid oxidation-dependent sepsis adaptation. We also found that disrupting SIRT1 activity during adaptation restores immunometabolic homeostasis and rescues septic mice from death. Here, we show that nuclear SIRT1 guides RELB to differentially induce SIRT3 expression and also increases mitochondrial biogenesis, which alters bioenergetics during sepsis adaptation. We constructed this concept using TLR4-stimulated THP1 human promonocytes, a model that mimics the initiation and adaptation stages of sepsis. Following increased expression, mitochondrial SIRT3 deacetylase activates the rate-limiting tricarboxylic acid cycle (TCA) isocitrate dehydrogenase 2 and superoxide dismutase 2, concomitant with increases in citrate synthase activity. Mitochondrial oxygen consumption rate increases early and decreases during adaptation, parallel with modifications to membrane depolarization, ATP generation, and production of mitochondrial superoxide and whole cell hydrogen peroxide. Evidence of SIRT1-RELB induction of mitochondrial biogenesis included increases in mitochondrial mass, mitochondrial-to-nuclear DNA ratios, and both nuclear and mitochondrial encoded proteins. We confirmed the SIRT-RELB-SIRT3 adaptation link to mitochondrial bioenergetics in both TLR4-stimulated normal and sepsis-adapted human blood monocytes and mouse splenocytes. We also found that SIRT1 inhibition ex vivo reversed the sepsis-induced changes in bioenergetics.	[Liu, Tie Fu; Vachharajani, Vidula; Millet, Patrick; McCall, Charles E.] Wake Forest Univ, Bowman Gray Sch Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Bharadwaj, Manish S.; Molina, Anthony J.] Wake Forest Univ, Bowman Gray Sch Med, Sect Gerontol & Geriatr Med, Dept Internal Med, Winston Salem, NC 27157 USA; [Vachharajani, Vidula] Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Liu, TF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Sect Mol Med, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	tliu@wakehealth.edu; chmccall@wakehealth.edu	Vachharajani, Vidula/AAX-3640-2021	Millet, Patrick/0000-0002-7917-7428; Vachharajani, Vidula/0000-0002-0892-7084; Molina, Anthony/0000-0002-5786-4622	National Institutes of Health [R01AI079144, R01-AI065791, R01GM102497, R01GM099807]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079144, R01AI065791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102497, R01GM099807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI079144, R01-AI065791, and R01GM102497 (to C. E. M.), and R01GM099807 (to V. V.).	Andersson AK, 2011, LEUKEMIA, V25, P1570, DOI 10.1038/leu.2011.133; Belikoff BG, 2011, J IMMUNOL, V186, P2444, DOI 10.4049/jimmunol.1001567; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Carre JE, 2008, BBA-BIOENERGETICS, V1777, P763, DOI 10.1016/j.bbabio.2008.04.024; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gil R, 2013, NUCLEIC ACIDS RES, V41, P8537, DOI 10.1093/nar/gkt642; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Liu TF, 2012, J LEUKOCYTE BIOL, V92, P499, DOI 10.1189/jlb.0212078; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; McCall CE, 2011, J LEUKOCYTE BIOL, V90, P439, DOI 10.1189/jlb.0211075; McCall CE, 2010, J INNATE IMMUN, V2, P395, DOI 10.1159/000314077; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Piantadosi CA, 2012, BBA-GEN SUBJECTS, V1820, P532, DOI 10.1016/j.bbagen.2012.01.003; Singer M, 2014, VIRULENCE, V5, P66, DOI 10.4161/viru.26907; Singer M, 2008, CLIN CHEST MED, V29, P655, DOI 10.1016/j.ccm.2008.06.003; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Suliman HB, 2005, FASEB J, V19, P1531, DOI 10.1096/fj.04-3500fje; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Vachharajani VT, 2014, J LEUKOCYTE BIOL, V96, P785, DOI 10.1189/jlb.3MA0114-034RR; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Williams SCP, 2012, NAT MED, V18, P1001, DOI 10.1038/nm0712-1001; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	39	97	104	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					396	408		10.1074/jbc.M114.566349	http://dx.doi.org/10.1074/jbc.M114.566349			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25404738	hybrid, Green Published			2022-12-28	WOS:000347231200035
J	Tristan, CA; Ramos, A; Shahani, N; Emiliani, FE; Nakajima, H; Noeh, CC; Kato, Y; Takeuchi, T; Noguchi, T; Kadowaki, H; Sedlak, TW; Ishizuka, K; Ichijo, H; Sawa, A				Tristan, Carlos A.; Ramos, Adriana; Shahani, Neelam; Emiliani, Francesco E.; Nakajima, Hidemitsu; Noeh, Christopher C.; Kato, Yoshinori; Takeuchi, Tadayoshi; Noguchi, Takuya; Kadowaki, Hisae; Sedlak, Thomas W.; Ishizuka, Koko; Ichijo, Hidenori; Sawa, Akira			Role of Apoptosis Signal-regulating Kinase 1 (ASK1) as an Activator of the GAPDH-Siah1 Stress-Signaling Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Nuclear Translocation; Oxidative Stress; Protein Phosphorylation; Protein Translocation; Protein-Protein Interaction; Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH); Seven in absentia homolog 1 (Siah1); Apoptosis Signal-regulating Kinase 1 (ASK1)	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CARDIAC-HYPERTROPHY; CELL-DEATH; GAPDH; PROTEIN; TRANSLOCATION; MECHANISMS	Background: Apoptosis signal-regulating kinase 1 (ASK1), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and seven in absentia homolog 1 (Siah1) are molecules associated with stress-signaling cascades. Results: Identification of Siah1 as a substrate of ASK1 for activation of the GAPDH-Siah1 signaling cascade. Conclusion: ASK1 triggers the GAPDH-Siah1 stress-signaling cascade. Significance: This study provides insight into crosstalk among cell stress-signaling cascades. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) plays roles in both energy maintenance, and stress signaling by forming a protein complex with seven in absentia homolog 1 (Siah1). Mechanisms to coordinate its glycolytic and stress cascades are likely to be very important for survival and homeostatic control of any living organism. Here we report that apoptosis signal-regulating kinase 1 (ASK1), a representative stress kinase, interacts with both GAPDH and Siah1 and is likely able to phosphorylate Siah1 at specific amino acid residues (Thr-70/Thr-74 and Thr-235/Thr-239). Phosphorylation of Siah1 by ASK1 triggers GAPDH-Siah1 stress signaling and activates a key downstream target, p300 acetyltransferase in the nucleus. This novel mechanism, together with the established S-nitrosylation/oxidation of GAPDH at Cys-150, provides evidence of how the stress signaling involving GAPDH is finely regulated. In addition, the present results imply crosstalk between the ASK1 and GAPDH-Siah1 stress cascades.	[Tristan, Carlos A.; Ramos, Adriana; Shahani, Neelam; Emiliani, Francesco E.; Sedlak, Thomas W.; Ishizuka, Koko; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; [Noeh, Christopher C.; Kato, Yoshinori] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA; [Kato, Yoshinori] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Nakajima, Hidemitsu; Takeuchi, Tadayoshi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka 5998531, Japan; [Noguchi, Takuya; Kadowaki, Hisae; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1138654, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Osaka Metropolitan University; University of Tokyo	Sawa, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA.	asawa1@jhmi.edu	Noguchi, Takuya/T-6767-2019; Ishizuka, Koko/L-2071-2014; Kadowaki, Hisae/ABD-3954-2020	Noguchi, Takuya/0000-0001-6187-6645; Nakajima, Hidemitsu/0000-0002-0441-1929; Ichijo, Hidenori/0000-0002-5005-6438; Kato, Yoshinori/0000-0002-6218-8710	United States Public Health Service [H-084018, MH-094268, MH-069853, MH-085226, MH-088753, MH-092443]; National Institutes of Health NRSA F31 Grant [1F31NS070459-01A1]; Stanley; RUSK; S-R foundations; NARSAD; Maryland Stem Cell Research Fund; Japan Society for the promotion of Science [22580339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085226, P50MH094268, RC1MH088753, R01MH069853, P20MH084018, R01MH092443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS070459, K08NS057824] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health NRSA F31 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley; RUSK; S-R foundations; NARSAD(NARSAD); Maryland Stem Cell Research Fund; Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by United States Public Health Service Grants MH-084018 (to A. S.), MH-094268 Silvo O. Conte Center (to A. S.), MH-069853 (to A. S.), MH-085226 (to A. S.), MH-088753 (to A. S.), MH-092443 (to A. S.), National Institutes of Health NRSA F31 Grant 1F31NS070459-01A1 (to C. T.), Stanley (to A. S.), RUSK (to A. S.), S-R foundations (to A. S.), NARSAD (to A. S. and N. S.), and Maryland Stem Cell Research Fund (A. S.). This work was also supported in part by Grant-in-aid 22580339 for Scientific Research from the Japan Society for the promotion of Science (to H. N).	Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chiras D. D., 2010, HUMAN BIOL; Cho KJ, 2009, NEUROSCIENCE, V163, P1128, DOI 10.1016/j.neuroscience.2009.07.048; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Chuang DM, 1996, NAT MED, V2, P609, DOI 10.1038/nm0696-609; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hattori K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-9; Hayakawa Y, 2011, P NATL ACAD SCI USA, V108, P780, DOI 10.1073/pnas.1011418108; He XG, 2003, AM J PATHOL, V163, P243, DOI 10.1016/S0002-9440(10)63647-4; Homma K, 2009, EXPERT OPIN THER TAR, V13, P653, DOI 10.1517/14728220902980249; Hsu MJ, 2007, J NEUROSCI, V27, P5719, DOI 10.1523/JNEUROSCI.1874-06.2007; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Imoto K, 2006, DIABETES, V55, P1197, DOI 10.2337/db05-1187; Iriyama T, 2009, EMBO J, V28, P843, DOI 10.1038/emboj.2009.32; Ishitani R, 1996, J PHARMACOL EXP THER, V278, P447; Ishitani R, 1996, P NATL ACAD SCI USA, V93, P9937, DOI 10.1073/pnas.93.18.9937; Izumiya Y, 2003, CIRC RES, V93, P874, DOI 10.1161/01.RES.0000100665.67510.F5; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Langley L. L., 1973, HOMEOSTASIS ORIGINS; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Oliveira AMM, 2007, LEARN MEMORY, V14, P564, DOI 10.1101/lm.656907; Ou XM, 2010, BIOL PSYCHIAT, V67, P855, DOI 10.1016/j.biopsych.2009.10.032; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Saunders PA, 1997, J NEUROCHEM, V69, P1820; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Schulkin J, 2003, RETHINKING HOMEOSTAS; Schulkin J., 2004, ALLOSTASIS HOMEOSTAS; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sen N, 2009, NEURON, V63, P81, DOI 10.1016/j.neuron.2009.05.024; Seong HA, 2011, J BIOL CHEM, V286, P31123, DOI 10.1074/jbc.M111.248674; Shahani N, 2012, BBA-GEN SUBJECTS, V1820, P736, DOI 10.1016/j.bbagen.2011.07.010; Shahani N, 2011, ANTIOXID REDOX SIGN, V14, P1493, DOI 10.1089/ars.2010.3580; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Takeda K, 2011, ANTIOXID REDOX SIGN, V15, P719, DOI 10.1089/ars.2010.3392; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Tatton WG, 2003, ANN NEUROL, V53, pS61, DOI 10.1002/ana.10489; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Voet D., 2011, BIOCHEMISTRY-US, V4th edn.; Wei JQ, 2008, CIRCULATION, V118, P934, DOI 10.1161/CIRCULATIONAHA.107.760488; Yu Y, 2011, J BIOL CHEM, V286, P15413, DOI 10.1074/jbc.M111.225946	49	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					56	64		10.1074/jbc.M114.596205	http://dx.doi.org/10.1074/jbc.M114.596205			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25391652	Green Published, hybrid			2022-12-28	WOS:000347231200006
J	Jakhria, T; Hellewell, AL; Porter, MY; Jackson, MP; Tipping, KW; Xue, WF; Radford, SE; Hewitt, EW				Jakhria, Toral; Hellewell, Andrew L.; Porter, Morwenna Y.; Jackson, Matthew P.; Tipping, Kevin W.; Xue, Wei-Feng; Radford, Sheena E.; Hewitt, Eric W.			beta(2)-Microglobulin Amyloid Fibrils Are Nanoparticles That Disrupt Lysosomal Membrane Protein Trafficking and Inhibit Protein Degradation by Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PEPTIDE ALTERS; IN-VIVO; ALPHA-SYNUCLEIN; MEDIATED ENDOCYTOSIS; COMMON MECHANISM; GAUCHER-DISEASE; MTT REDUCTION; CELL-DEATH; OLIGOMERS; TOXICITY	Fragmentation of amyloid fibrils produces fibrils that are reduced in length but have an otherwise unchanged molecular architecture. The resultant nanoscale fibril particles inhibit the cellular reduction of the tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), a substrate commonly used to measure cell viability, to a greater extent than unfragmented fibrils. Here we show that the internalization of beta(2)-microglobulin (beta(2)m) amyloid fibrils is dependent on fibril length, with fragmented fibrils being more efficiently internalized by cells. Correspondingly, inhibiting the internalization of fragmented beta(2)m fibrils rescued cellular MTT reduction. Incubation of cells with fragmented beta(2)m fibrils did not, however, cause cell death. Instead, fragmented beta(2)m fibrils accumulate in lysosomes, alter the trafficking of lysosomal membrane proteins, and inhibit the degradation of a model protein substrate by lysosomes. These findings suggest that nanoscale fibrils formed early during amyloid assembly reactions or by the fragmentation of longer fibrils could play a role in amyloid disease by disrupting protein degradation by lysosomes and trafficking in the endolysosomal pathway.	[Hewitt, Eric W.] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Hewitt, Eric W.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds	Hewitt, EW (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	e.w.hewitt@leeds.ac.uk		Radford, Sheena/0000-0002-3079-8039; Hewitt, Eric/0000-0002-6238-6303; Xue, Wei-Feng/0000-0002-6504-0404	Wellcome Trust Grants [075675, 092896/Z/10/Z, 093794/Z/10/Z]; BBSRC [BB/526502/1, BB/F01614X/1]; Yorkshire Kidney Research Fund; European Research Council under the European Union [322408]; Biotechnology and Biological Sciences Research Council [961800] Funding Source: researchfish	Wellcome Trust Grants(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Yorkshire Kidney Research Fund; European Research Council under the European Union(European Research Council (ERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grants 075675, 092896/Z/10/Z, and 093794/Z/10/Z); by BBSRC Grants BB/526502/1 and BB/F01614X/1; and by the Yorkshire Kidney Research Fund. This work was also supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement 322408 (to E. W. H., M. P. J., and S. E. R.).	Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Argiles A, 2002, NEPHROL DIAL TRANSPL, V17, P1136, DOI 10.1093/ndt/17.6.1136; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; BEATTIE GM, 1994, J CLIN ENDOCR METAB, V78, P1232, DOI 10.1210/jc.78.5.1232; BEAUFAY H, 1974, J CELL BIOL, V61, P188, DOI 10.1083/jcb.61.1.188; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Berthelot K, 2011, J MOL BIOL, V412, P137, DOI 10.1016/j.jmb.2011.07.009; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Casey TM, 2007, MOL CELL PROTEOMICS, V6, P767, DOI 10.1074/mcp.M600365-MCP200; Chafekar SM, 2008, BBA-MOL BASIS DIS, V1782, P523, DOI 10.1016/j.bbadis.2008.06.003; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Follett J, 2014, TRAFFIC, V15, P230, DOI 10.1111/tra.12136; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Garcia-Garcia M, 1999, KIDNEY INT, V55, P899, DOI 10.1046/j.1523-1755.1999.055003899.x; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Giraldo AMV, 2014, BIOCHEM SOC T, V42, P1460, DOI 10.1042/BST20140145; Goodchild SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104492; Grudzielanek S, 2007, J MOL BIOL, V370, P372, DOI 10.1016/j.jmb.2007.04.053; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Heegaard NHH, 2009, AMYLOID, V16, P151, DOI 10.1080/13506120903151775; Isobe I, 1999, NEUROSCI LETT, V266, P129, DOI 10.1016/S0304-3940(99)00282-7; Jahn TR, 2008, J BIOL CHEM, V283, P17279, DOI 10.1074/jbc.M710351200; Jiang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00857; Julien O, 2014, NAT CHEM BIOL, V10, P969, DOI [10.1038/nchembio.1639, 10.1038/NCHEMBIO.1639]; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kerokoski P, 2001, NEUROCHEM INT, V38, P127, DOI 10.1016/S0197-0186(00)00071-1; Khurana V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001026; Kubo T, 2002, MOL BRAIN RES, V106, P94, DOI 10.1016/S0169-328X(02)00416-3; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020244; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liu YB, 1998, P NATL ACAD SCI USA, V95, P13266, DOI 10.1073/pnas.95.22.13266; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Liu YB, 1997, J NEUROCHEM, V69, P2285; Lorincz M, 1997, BLOOD, V89, P3412, DOI 10.1182/blood.V89.9.3412; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109; Monti M, 2002, PROTEIN SCI, V11, P2362, DOI 10.1110/ps.0206902; Morten IJ, 2007, J BIOL CHEM, V282, P29691, DOI 10.1074/jbc.M705004200; Mossuto ME, 2011, ANGEW CHEM INT EDIT, V50, P7048, DOI 10.1002/anie.201100986; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nesterov EE, 2005, ANGEW CHEM INT EDIT, V44, P5452, DOI 10.1002/anie.200500845; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Porter MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027353; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheynis T, 2013, BIOPHYS J, V105, P745, DOI 10.1016/j.bpj.2013.06.015; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Sims NA, 2008, SEMIN CELL DEV BIOL, V19, P444, DOI 10.1016/j.semcdb.2008.07.016; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Soura V, 2012, BIOCHEM J, V441, P579, DOI 10.1042/BJ20110749; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Torres Manuel, 2012, Mol Neurodegener, V7, P59, DOI 10.1186/1750-1326-7-59; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Xue WF, 2009, PROTEIN ENG DES SEL, V22, P489, DOI 10.1093/protein/gzp026; Zhang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012529; Zhang T, 2000, IMMUNOLOGY, V100, P13, DOI 10.1046/j.1365-2567.2000.00000.x; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	87	29	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35781	35794		10.1074/jbc.M114.586222	http://dx.doi.org/10.1074/jbc.M114.586222			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378395	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000346897900010
J	Wang, L; Li, XL; Xiang, B; Zhou, M; Li, XY; Xiong, W; Niu, M; Wei, PP; Wang, ZY; Wang, HR; Chen, P; Shen, SR; Peng, SP; Li, GY				Wang, Li; Li, Xiaoling; Xiang, Bo; Zhou, Ming; Li, Xiayu; Xiong, Wei; Niu, Man; Wei, Pingpin; Wang, Zeyou; Wang, Heran; Chen, Pan; Shen, Shourong; Peng, Shuping; Li, Guiyuan			NGX6a Is Degraded through a Proteasome-dependent Pathway without Ubiquitination Mediated by Ezrin, a Cytoskeleton-Membrane Linker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NASOPHARYNGEAL CARCINOMA-CELLS; HUMAN COLORECTAL-CANCER; BREAST-CANCER; COLON-CANCER; EXPRESSION; PROTEIN; PROLIFERATION; METASTASIS; MIGRATION; ADHESION	Our previous study demonstrated that the NGX6b gene acts as a suppressor in the invasion and migration of nasopharyngeal carcinoma (NPC). Recently, we identified the novel isoform NGX6a, which is longer than NGX6b. In this study, we first found that NGX6a was degraded in NPC cells and that this degradation was mediated by ezrin, a linker between membrane proteins and the cytoskeleton. Specific siRNAs against ezrin increase the protein level of NGX6a in these cells. During degradation, NGX6a is not ubiquitinated but is degraded through a proteasome-dependent pathway. The distribution pattern of ezrin was negatively associated with NGX6a in an immunochemistry analysis of a nasopharyngeal carcinoma tissue microarray and fetus multiple organ tissues and Western blot analysis in nasopharyngeal and NPC cell lines, suggesting that ezrin and NGX6a are associated and are involved in the progression and invasion of NPC. By mapping the interacting binding sites, the seven-transmembrane domain of NGX6a was found to be the critical region for the degradation of NGX6a, and the amino terminus of ezrin is required for the induction of NGX6a degradation. The knockdown of ezrin or transfection of the NGX6a mutant CO, which has an EGF-like domain and a transmembrane 1 domain, resulted in no degradation, significantly reducing the ability of invasion and migration of NPC cells. This study provides a novel molecular mechanism for the low expression of NGX6a in NPC cells and an important molecular event in the process of invasion and metastasis of nasopharyngeal carcinoma cells.	[Li, Xiaoling; Xiang, Bo; Zhou, Ming; Xiong, Wei; Chen, Pan; Peng, Shuping; Li, Guiyuan] Cent S Univ, Hunan Prov Tumor Hosp, Changsha 410013, Hunan, Peoples R China; [Li, Xiaoling; Xiang, Bo; Zhou, Ming; Xiong, Wei; Chen, Pan; Peng, Shuping; Li, Guiyuan] Cent S Univ, Xiangya Sch Med, Affiliated Tumor Hosp, Changsha 410013, Hunan, Peoples R China; [Wang, Li; Li, Xiaoling; Xiang, Bo; Zhou, Ming; Xiong, Wei; Niu, Man; Wei, Pingpin; Wang, Zeyou; Wang, Heran; Peng, Shuping; Li, Guiyuan] Cent S Univ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Wang, Li] Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha 410012, Hunan, Peoples R China; [Li, Xiayu; Shen, Shourong] Cent S Univ, Xiang Ya Hosp 3, Changsha 410013, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University	Peng, SP (corresponding author), Cent S Univ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China.	shuping@csu.edu.cn; lgy@csu.edu.cn	li, xia/HHZ-7468-2022		National Natural Science Foundation of China [30971147, 81101767, 81372366, 81372907, 81171934]; New Century Excellent Talents in University of Ministry of Education of China [NCET-12-0544]; Overseas, Hong Kong, and Macao Scholars Collaborative Researching Fund of the National Natural Science Foundation of China [81428018]; Central South University Faculty Research Grant [2013JSJJ046]; 111 Project [111-2-12]; 863 Plan Grant [2012AA02A206]; Hunan Province key laboratory program of non-resolving inflammation and cancer; Specialized Research Fund for the Doctoral Program of Higher Education Grant [20110162120018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Overseas, Hong Kong, and Macao Scholars Collaborative Researching Fund of the National Natural Science Foundation of China; Central South University Faculty Research Grant; 111 Project(Ministry of Education, China - 111 Project); 863 Plan Grant; Hunan Province key laboratory program of non-resolving inflammation and cancer; Specialized Research Fund for the Doctoral Program of Higher Education Grant	This work was supported by National Natural Science Foundation of China Grants 30971147, 81101767, 81372366,81372907, and 81171934; New Century Excellent Talents in University of Ministry of Education of China Grant NCET-12-0544; the Overseas, Hong Kong, and Macao Scholars Collaborative Researching Fund of the National Natural Science Foundation of China Grant 81428018; Central South University Faculty Research Grant 2013JSJJ046; 111 Project Grant 111-2-12; 863 Plan Grant 2012AA02A206; the Hunan Province key laboratory program of non-resolving inflammation and cancer; and Specialized Research Fund for the Doctoral Program of Higher Education Grant 20110162120018.	Bellail AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5234; BRETSCHER A, 1986, METHOD ENZYMOL, V134, P24; Bretscher A, 1997, J CELL SCI, V110, P3011; Brown L, 2014, ONCOGENE, V33, P2363, DOI 10.1038/onc.2013.186; Cannon JL, 2011, MOL BIOL CELL, V22, P954, DOI 10.1091/mbc.E10-07-0586; Donatello S, 2012, AM J PATHOL, V181, P2172, DOI 10.1016/j.ajpath.2012.08.025; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Guo Q, 2010, ACTA BIOCH BIOPH SIN, V42, P450, DOI 10.1093/abbs/gmq049; Guo Q, 2009, MOL CELL BIOCHEM, V330, P71, DOI 10.1007/s11010-009-0102-9; Hoover KB, 2000, CURR OPIN CELL BIOL, V12, P229, DOI 10.1016/S0955-0674(99)00080-0; Huang YF, 2014, CELL CYCLE, V13, P2200, DOI 10.4161/cc.29209; JARIELENCONTRE I, 1995, J BIOL CHEM, V270, P11623, DOI 10.1074/jbc.270.19.11623; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kong JN, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-520; Li J, 2001, J PROTEIN CHEM, V20, P265, DOI 10.1023/A:1010912311564; Liu Fen, 2005, Ai Zheng, V24, P1064; Ma J, 2005, CARCINOGENESIS, V26, P281, DOI 10.1093/carcin/bgh312; Ma J, 2002, J CANCER RES CLIN, V128, P683, DOI 10.1007/s00432-002-0387-5; Ma LF, 2013, ONCOL REP, V30, P1899, DOI 10.3892/or.2013.2641; Mao J, 2013, CELL BIOCHEM BIOPHYS, V67, P1507, DOI 10.1007/s12013-013-9653-1; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Ohtani K, 2002, CANCER LETT, V179, P79, DOI 10.1016/S0304-3835(01)00857-6; Peng SP, 2006, ONCOLOGY-BASEL, V71, P273, DOI 10.1159/000106073; Peng SP, 2007, CANCER SCI, V98, P341, DOI 10.1111/j.1349-7006.2007.00410.x; Peng Y, 2009, ACTA BIOCH BIOPH SIN, V41, P504, DOI 10.1093/abbs/gmp039; Romero IA, 2002, MOL BRAIN RES, V105, P47, DOI 10.1016/S0169-328X(02)00392-3; Shanmugaratnam K, 1991, INT HISTOLOGICAL TYP, P32; Wang L, 2010, J HISTOCHEM CYTOCHEM, V58, P41, DOI 10.1369/jhc.2009.954412; Wang LL, 2005, J CELL BIOCHEM, V95, P64, DOI 10.1002/jcb.20393; Wang XY, 2010, MOL CELL BIOCHEM, V345, P283, DOI 10.1007/s11010-010-0582-7; Wang Y, 2014, BRIT J CANCER, V110, P695, DOI 10.1038/bjc.2013.770; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhang XM, 2003, WORLD J GASTROENTERO, V9, P1729, DOI 10.3748/wjg.v9.i8.1729	35	4	5	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35731	35742		10.1074/jbc.M114.584771	http://dx.doi.org/10.1074/jbc.M114.584771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378401	hybrid, Green Published			2022-12-28	WOS:000346897900006
J	Hines, CS; Ray, K; Schmidt, JJ; Xiong, F; Feenstra, RW; Pras-Raves, M; de Moes, JP; Lange, JHM; Melikishvili, M; Fried, MG; Mortenson, P; Charlton, M; Patel, Y; Courtney, SM; Kruse, CG; Rodgers, DW				Hines, Christina S.; Ray, Kallol; Schmidt, Jack J.; Xiong, Fei; Feenstra, Rolf W.; Pras-Raves, Mia; de Moes, Jan Peter; Lange, Jos H. M.; Melikishvili, Manana; Fried, Michael G.; Mortenson, Paul; Charlton, Michael; Patel, Yogendra; Courtney, Stephen M.; Kruse, Chris G.; Rodgers, David W.			Allosteric Inhibition of the Neuropeptidase Neurolysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Hydrolase; Metalloprotease; Neurochemistry; Neuropeptide; Peptidase; X-ray Crystallography	MAST-CELL DEGRANULATION; HINGE-BENDING MOTION; CRYSTAL-STRUCTURE; THIMET OLIGOPEPTIDASE; ENDOPEPTIDASE 3.4.24.16; SELECTIVE INHIBITOR; NEUROTENSIN; POTENT; THROMBIN; BINDING	Neuropeptidases specialize in the hydrolysis of the small bioactive peptides that play a variety of signaling roles in the nervous and endocrine systems. One neuropeptidase, neurolysin, helps control the levels of the dopaminergic circuit modulator neurotensin and is a member of a fold group that includes the antihypertensive target angiotensin converting enzyme. We report the discovery of a potent inhibitor that, unexpectedly, binds away from the enzyme catalytic site. The location of the bound inhibitor suggests it disrupts activity by preventing a hinge-like motion associated with substrate binding and catalysis. In support of this model, the inhibition kinetics are mixed, with both noncompetitive and competitive components, and fluorescence polarization shows directly that the inhibitor reverses a substrate-associated conformational change. This new type of inhibition may have widespread utility in targeting neuropeptidases.	[Melikishvili, Manana; Fried, Michael G.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Melikishvili, Manana; Fried, Michael G.] Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA; [Feenstra, Rolf W.; Pras-Raves, Mia; de Moes, Jan Peter; Lange, Jos H. M.; Kruse, Chris G.] Abbott Healthcare Prod BV, NL-1381 CP Weesp, Netherlands; [Mortenson, Paul; Charlton, Michael; Patel, Yogendra; Courtney, Stephen M.] Evotec UK Ltd, Abingdon OX14 4SA, Oxon, England	University of Kentucky; University of Kentucky; Evotec	Rodgers, DW (corresponding author), 741 South Limestone, Lexington, KY 40536 USA.	david.rodgers@uky.edu	Mortenson, Paul N/E-2520-2011	Mortenson, Paul/0000-0002-3583-3163	National Institute of General Medical Sciences [P20 GM103486]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038041, R56NS038041] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the staffs of Advanced Photon Source beamline 19-ID (SBC) and beamline 22-ID (SER-CAT) for their help with data collection. Use of the Advanced Photon Source is supported by the United States Department of Energy. We thank Dr. Louis B. Hersh for comments on the manuscript. Use of the Protein Core of the Center for Molecular Medicine was supported by Grant P20 GM103486 from the National Institute of General Medical Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexacos N, 1999, UROLOGY, V53, P1035, DOI 10.1016/S0090-4295(98)00627-X; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Arndt JW, 2002, STRUCTURE, V10, P215, DOI 10.1016/S0969-2126(02)00698-6; BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529; BROOKS I, 1994, METHOD ENZYMOL, V240, P459; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; Brown S, 2004, CURR TOP MED CHEM, V4, P1227, DOI 10.2174/1568026043387854; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Chen JM, 2000, J AM CHEM SOC, V122, P9648, DOI 10.1021/ja001547g; Cohn E. J., 1943, PROTEINS AMINO ACIDS; Comellas-Bigier M, 2005, J MOL BIOL, V349, P99, DOI 10.1016/j.jmb.2005.03.016; Croy CH, 2004, BIOCHEMISTRY-US, V43, P5246, DOI 10.1021/bi0499718; Cuniasse P, 2005, BIOCHIMIE, V87, P393, DOI 10.1016/j.biochi.2004.09.025; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERTL G, 1993, AM J PHYSIOL, V264, pH1062, DOI 10.1152/ajpheart.1993.264.4.H1062; Feenstra R. W., 2004, U. S. Patent, Patent No. [2004/0242493, 20040242493]; Fredrickson P, 2005, PSYCHIAT CLIN N AM, V28, P737, DOI 10.1016/j.psc.2005.05.001; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; HOLLAND DR, 1992, BIOCHEMISTRY-US, V31, P11310, DOI 10.1021/bi00161a008; JIRACEK J, 1995, J BIOL CHEM, V270, P21701, DOI 10.1074/jbc.270.37.21701; Jiracek J, 1996, J BIOL CHEM, V271, P19606, DOI 10.1074/jbc.271.32.19606; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kelder J, 1999, PHARMACEUT RES, V16, P1514, DOI 10.1023/A:1015040217741; Ketelhuth DFJ, 2011, CURR ATHEROSCLER REP, V13, P162, DOI 10.1007/s11883-010-0159-7; Kinkead B, 2004, INT REV NEUROBIOL, V59, P327; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Konkoy CS, 1996, TRENDS PHARMACOL SCI, V17, P288, DOI 10.1016/0165-6147(96)10036-5; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Lamm O., 1929, ARK MAT ASTR FYS, V21B, P1; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lian W, 2000, ACTA CRYSTALLOGR D, V56, P1644, DOI 10.1107/S0907444900012683; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; LUTTINGER D, 1982, BRAIN RES, V237, P183, DOI 10.1016/0006-8993(82)90566-2; Malone JF, 1997, J CHEM SOC FARADAY T, V93, P3429, DOI 10.1039/a700669a; MargetaMitrovic M, 1997, J NEUROPHYSIOL, V78, P1341, DOI 10.1152/jn.1997.78.3.1341; MATTHEWS BW, 1974, J BIOL CHEM, V249, P8030; Meier Pascal, 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P15, DOI 10.2174/1568006053004994; Morales R, 2004, J MOL BIOL, V341, P1063, DOI 10.1016/j.jmb.2004.06.039; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oliveira V, 2001, ANAL BIOCHEM, V292, P257, DOI 10.1006/abio.2001.5083; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang XZ, 1998, J PHARMACOL EXP THER, V287, P307; Pytliak M, 2012, ONKOLOGIE, V35, P49, DOI 10.1159/000336304; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Ray K, 2004, J BIOL CHEM, V279, P20480, DOI 10.1074/jbc.M400795200; Reich J. G., 1992, CURVE FITTING MODELL; Rioli V, 1998, BIOCHEM BIOPH RES CO, V250, P5, DOI 10.1006/bbrc.1998.8941; ROSTENE W, 1992, ANN NY ACAD SCI, V668, P217, DOI 10.1111/j.1749-6632.1992.tb27352.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Segel IH., 1993, ENZYME KINETICS BEHA; Sharma RP, 1997, AM J PSYCHIAT, V154, P1019; Skiles JW, 2004, CURR MED CHEM, V11, P2911, DOI 10.2174/0929867043364018; Steiner T, 2001, J MOL BIOL, V305, P535, DOI 10.1006/jmbi.2000.4301; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; VINCENT B, 1995, BRIT J PHARMACOL, V115, P1053, DOI 10.1111/j.1476-5381.1995.tb15918.x; Vincent B, 1997, BRIT J PHARMACOL, V121, P705, DOI 10.1038/sj.bjp.0701182; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wasserman ZR, 2005, CHEM BIOL, V12, P143, DOI 10.1016/j.chembiol.2005.01.008	71	16	16	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35605	35619		10.1074/jbc.M114.620930	http://dx.doi.org/10.1074/jbc.M114.620930			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25378390	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000346660200047
J	Bajaj, R; Munari, F; Becker, S; Zweckstetter, M				Bajaj, Rakhi; Munari, Francesca; Becker, Stefan; Zweckstetter, Markus			Interaction of the Intermembrane Space Domain of Tim23 Protein with Mitochondrial Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lipid; Membrane; Mitochondria; Nuclear Magnetic Resonance (NMR); Protein Translocation; Protein Import	PRESEQUENCE TRANSLOCASE; YEAST MITOCHONDRIA; CHEMICAL-SHIFTS; CONTACT SITES; INNER; BINDING; IMPORT; OUTER; SUPERCOMPLEX; CARDIOLIPIN	Background: Tim23 mediates protein translocation into mitochondria. Results: Tim23 binds to mitochondria-like membranes through a hydrophobic anchor at its N terminus, with cardiolipin enhancing the interaction. Conclusion: The intermembrane space domain of Tim23 can interact with both inner and outer mitochondria-like membranes. Significance: Tim23 provides the central element for formation of the translocation contact. Tim23 mediates protein translocation into mitochondria. Although inserted into the inner membrane, the dynamic association of its intermembrane space (IMS) domain with the outer membrane promotes protein import. However, little is known about the molecular basis of this interaction. Here, we demonstrate that the IMS domain of Tim23 tightly associates with both inner and outer mitochondrial membrane-like membranes through a hydrophobic anchor at its N terminus. The structure of membrane-bound Tim23(IMS) is highly dynamic, allowing recognition of both the incoming presequence and other translocase components at the translocation contact. Cardiolipin enhances Tim23 membrane attachment, suggesting that cardiolipin can influence preprotein import.	[Bajaj, Rakhi; Munari, Francesca; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Munari, Francesca; Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Univ Med Gottingen, Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, D-37073 Gottingen, Germany	Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen	Zweckstetter, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany.	markus.zweckstetter@dzne.de		Zweckstetter, Markus/0000-0002-2536-6581; Munari, Francesca/0000-0002-8217-1481	Deutsche Forschungsgemeinschaft Collaborative Research Center [860]	Deutsche Forschungsgemeinschaft Collaborative Research Center(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Collaborative Research Center 860 Project B2 (to M. Z.).	ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Bajaj R, 2014, STRUCTURE, V22, P1501, DOI 10.1016/j.str.2014.07.015; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Bauer MF, 2000, TRENDS CELL BIOL, V10, P25, DOI 10.1016/S0962-8924(99)01684-0; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; de la Cruz L, 2010, PROTEIN SCI, V19, P2045, DOI 10.1002/pro.482; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Fernandez C, 2003, FEBS LETT, V555, P144, DOI 10.1016/S0014-5793(03)01155-4; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Haiens TH, 2002, FEBS LETT, V528, P35, DOI 10.1016/S0014-5793(02)03292-1; Hammen PK, 1996, BIOCHEMISTRY-US, V35, P3772, DOI 10.1021/bi951848g; HORST M, 1995, EMBO J, V14, P2293, DOI 10.1002/j.1460-2075.1995.tb07223.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6; Schatz G, 1996, J BIOL CHEM, V271, P31763, DOI 10.1074/jbc.271.50.31763; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schulke N, 1999, J BIOL CHEM, V274, P22847, DOI 10.1074/jbc.274.32.22847; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; SWANSON ST, 1992, BIOCHEMISTRY-US, V31, P5746, DOI 10.1021/bi00140a009; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P15297, DOI 10.1021/bi001774v; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	33	13	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34620	34626		10.1074/jbc.M114.595702	http://dx.doi.org/10.1074/jbc.M114.595702			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25349212	hybrid, Green Published			2022-12-28	WOS:000346260800020
J	Manna, JD; Wepy, JA; Hsu, KL; Chang, JW; Cravatt, BF; Marnett, LJ				Manna, Joseph D.; Wepy, James A.; Hsu, Ku-Lung; Chang, Jae Won; Cravatt, Benjamin F.; Marnett, Lawrence J.			Identification of the Major Prostaglandin Glycerol Ester Hydrolase in Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Chemical Biology; Enzyme Kinetics; Lipid Metabolism; Prostaglandin; Activity-based Protein Profiling; Endocannabinoids; Prostaglandin Glycerol Esters; Serine Hydrolase	COX-2 OXIDATIVE METABOLITE; ACID AMIDE HYDROLASE; MONOACYLGLYCEROL LIPASE; IN-VIVO; ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL; CANNABINOID RECEPTORS; SYNAPTIC-TRANSMISSION; PROTEIN THIOESTERASE; SERINE HYDROLASES; HYDROLYSIS	Background: Prostaglandin glycerol esters are rapidly hydrolyzed in biological systems. Results: Complementary approaches demonstrated that lysophospholipase A2 hydrolyzes prostaglandin glycerol esters. Conclusion: Lysophospholipase A2 is a major prostaglandin glycerol ester-specific hydrolase in human cancer cells. Significance: Perturbation of lysophospholipase A2 provides a means to understand prostaglandin glycerol ester function in vivo. Prostaglandin glycerol esters (PG-Gs) are produced as a result of the oxygenation of the endocannabinoid, 2-arachidonoylglycerol, by cyclooxygenase 2. Understanding the role that PG-Gs play in a biological setting has been difficult because of their sensitivity to enzymatic hydrolysis. By comparing PG-G hydrolysis across human cancer cell lines to serine hydrolase activities determined by activity-based protein profiling, we identified lysophospholipase A2 (LYPLA2) as a major enzyme responsible for PG-G hydrolysis. The principal role played by LYPLA2 in PGE(2)-G hydrolysis was confirmed by siRNA knockdown. Purified recombinant LYPLA2 hydrolyzed PG-Gs in the following order of activity: PGE(2)-G > PGF(2)-G > PGD(2)-G; LYPLA2 hydrolyzed 1- but not 2-arachidonoylglycerol or arachidonoylethanolamide. Chemical inhibition of LYPLA2 in the mouse macrophage-like cell line, RAW264.7, elicited an increase in PG-G production. Our data indicate that LYPLA2 serves as a major PG-G hydrolase in human cells. Perturbation of this enzyme should enable selective modulation of PG-Gs without alterations in endocannabinoids, thereby providing a means to decipher the unique functions of PG-Gs in biology and disease.	[Manna, Joseph D.; Wepy, James A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Bi, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Nashville, TN 37232 USA; [Manna, Joseph D.; Wepy, James A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Ch, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Nashville, TN 37232 USA; [Manna, Joseph D.; Wepy, James A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Ph, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Nashville, TN 37232 USA; [Hsu, Ku-Lung; Chang, Jae Won; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Hsu, Ku-Lung; Chang, Jae Won; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Scripps Research Institute; Scripps Research Institute	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Bi, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu	Chang, Jae Won/AAN-4139-2020; Hsu, Ku-Lung/L-6256-2019; Hsu, Ku-Lung/J-2885-2014	Hsu, Ku-Lung/0000-0001-5620-3972; Hsu, Ku-Lung/0000-0001-5620-3972	National Institutes of Health [GM15431, DK033760, GM65086]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431, T32GM065086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA035864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM15431 (to L. J. M.) and DK033760 (to B. F. C.) and Training Grant GM65086 (to J. D. M.).	Adibekian A, 2012, J AM CHEM SOC, V134, P10345, DOI 10.1021/ja303400u; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Crow JA, 2012, TOXICOL APPL PHARM, V258, P145, DOI 10.1016/j.taap.2011.10.017; Di Marzo V, 2005, HANDB EXP PHARMACOL, V168, P147; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; Di Marzo V, 2007, CHEM BIOL, V14, P741, DOI 10.1016/j.chembiol.2007.05.014; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Ghosh S, 2000, PHYSIOL GENOMICS, V2, P1, DOI 10.1152/physiolgenomics.2000.2.1.1; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; Kogan N M, 2006, J Endocrinol Invest, V29, P3; Kozak KR, 2001, J BIOL CHEM, V276, P36993, DOI 10.1074/jbc.M105854200; Laitinen T, 2014, MOL PHARMACOL, V85, P510, DOI 10.1124/mol.113.090795; Lichtman AH, 2002, J PHARMACOL EXP THER, V302, P73, DOI 10.1124/jpet.302.1.73; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lu JY, 2006, J LIPID RES, V47, P1352, DOI 10.1194/jlr.R600010-JLR200; Lu JY, 2006, J INHERIT METAB DIS, V29, P119, DOI 10.1007/s10545-006-0225-z; Maccarrone M, 1998, J BIOL CHEM, V273, P32332, DOI 10.1074/jbc.273.48.32332; NATARAJAN V, 1984, J NEUROCHEM, V42, P1613, DOI 10.1111/j.1471-4159.1984.tb12750.x; Navia-Paldanius D, 2012, J LIPID RES, V53, P2413, DOI 10.1194/jlr.M030411; Nirodi CS, 2004, P NATL ACAD SCI USA, V101, P1840, DOI 10.1073/pnas.0303950101; Nomura DK, 2011, CHEM BIOL, V18, P846, DOI 10.1016/j.chembiol.2011.05.009; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Pertwee RG, 2001, PROG NEUROBIOL, V63, P569, DOI 10.1016/S0301-0082(00)00031-9; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Quiroga AD, 2011, TRENDS ENDOCRIN MET, V22, P218, DOI 10.1016/j.tem.2011.03.003; Richie-Jannetta R, 2010, PROSTAG OTH LIPID M, V92, P19, DOI 10.1016/j.prostaglandins.2010.01.003; Ross MK, 2012, ARCH BIOCHEM BIOPHYS, V522, P44, DOI 10.1016/j.abb.2012.04.010; Rouzer CA, 2002, CHEM PHYS LIPIDS, V119, P69, DOI 10.1016/S0009-3084(02)00068-3; Sang N, 2007, J NEUROCHEM, V102, P1966, DOI 10.1111/j.1471-4159.2007.04668.x; Sang N, 2006, J PHYSIOL-LONDON, V572, P735, DOI 10.1113/jphysiol.2006.105569; Savinainen JR, 2014, MOL PHARMACOL, V86, P522, DOI 10.1124/mol.114.094284; SCHMID PC, 1985, J BIOL CHEM, V260, P4145; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Valdeolivas S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.387; Valenzano KJ, 2005, NEUROPHARMACOLOGY, V48, P658, DOI 10.1016/j.neuropharm.2004.12.008; Vila A, 2007, BIOCHEMISTRY-US, V46, P9578, DOI 10.1021/bi7005898; Walker JM, 2002, PHARMACOL THERAPEUT, V95, P127, DOI 10.1016/S0163-7258(02)00252-8; Wang AJ, 1999, BBA-MOL CELL BIOL L, V1437, P157, DOI 10.1016/S1388-1981(99)00012-8; Wang AJ, 1999, BBA-MOL CELL BIOL L, V1439, P1, DOI 10.1016/S1388-1981(99)00063-3; Wang R, 2013, BIOCHEMISTRY-US, V52, P7559, DOI 10.1021/bi401138s; Whiteside GT, 2005, EUR J PHARMACOL, V528, P65, DOI 10.1016/j.ejphar.2005.10.043; Xie SQ, 2010, CHEM RES TOXICOL, V23, P1890, DOI 10.1021/tx1002194	47	21	22	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33741	33753		10.1074/jbc.M114.582353	http://dx.doi.org/10.1074/jbc.M114.582353			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25301951	hybrid, Green Published			2022-12-28	WOS:000346077600003
J	Soncini, D; Caffa, I; Zoppoli, G; Cea, M; Cagnetta, A; Passalacqua, M; Mastracci, L; Boero, S; Montecucco, F; Sociali, G; Lasiglie, D; Damonte, P; Grozio, A; Mannino, E; Poggi, A; D'Agostino, VG; Monacelli, F; Provenzani, A; Odetti, P; Ballestrero, A; Bruzzone, S; Nencioni, A				Soncini, Debora; Caffa, Irene; Zoppoli, Gabriele; Cea, Michele; Cagnetta, Antonia; Passalacqua, Mario; Mastracci, Luca; Boero, Silvia; Montecucco, Fabrizio; Sociali, Giovanna; Lasiglie, Denise; Damonte, Patrizia; Grozio, Alessia; Mannino, Elena; Poggi, Alessandro; D'Agostino, Vito G.; Monacelli, Fiammetta; Provenzani, Alessandro; Odetti, Patrizio; Ballestrero, Alberto; Bruzzone, Santina; Nencioni, Alessio			Nicotinamide Phosphoribosyltransferase Promotes Epithelial-to-Mesenchymal Transition as a Soluble Factor Independent of Its Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Epithelial-Mesenchymal Transition (EMT); Nicotinamide Adenine Dinucleotide (NAD); Secretion; Signaling	COLONY-ENHANCING FACTOR; BREAST-CANCER; METABOLIC SYNDROME; VISFATIN LEVELS; SERUM VISFATIN; NAD(+); INFLAMMATION; SIRTUINS; CELLS; NAMPT/PBEF/VISFATIN	Background: Nicotinamide phosphoribosyltransferase (NAMPT) acts both as an enzyme in the production of the coenzyme NAD(+) and as a secreted cytokine. Results: In breast cancer cells, NAMPT induces the epithelial-to-mesenchymal transition, a process that underlies metastasis, as a secreted protein independent of its enzymatic activity. Conclusion: Secreted NAMPT promotes epithelial-to-mesenchymal transition. Significance: Extracellular NAMPT neutralization may be of therapeutic value. Boosting NAD(+) biosynthesis with NAD(+) intermediates has been proposed as a strategy for preventing and treating age-associated diseases, including cancer. However, concerns in this area were raised by observations that nicotinamide phosphoribosyltransferase (NAMPT), a key enzyme in mammalian NAD(+) biosynthesis, is frequently up-regulated in human malignancies, including breast cancer, suggesting possible protumorigenic effects for this protein. We addressed this issue by studying NAMPT expression and function in human breast cancer in vivo and in vitro. Our data indicate that high NAMPT levels are associated with aggressive pathological and molecular features, such as estrogen receptor negativity as well as HER2-enriched and basal-like PAM50 phenotypes. Consistent with these findings, we found that NAMPT overexpression in mammary epithelial cells induced epithelial-to-mesenchymal transition, a morphological and functional switch that confers cancer cells an increased metastatic potential. However, importantly, NAMPT-induced epithelial-to-mesenchymal transition was found to be independent of NAMPT enzymatic activity and of the NAMPT product nicotinamide mononucleotide. Instead, it was mediated by secreted NAMPT through its ability to activate the TGF signaling pathway via increased TGF1 production. These findings have implications for the design of therapeutic strategies exploiting NAD(+) biosynthesis via NAMPT in aging and cancer and also suggest the potential of anticancer agents designed to specifically neutralize extracellular NAMPT. Notably, because high levels of circulating NAMPT are found in obese and diabetic patients, our data could also explain the increased predisposition to cancer of these subjects.	[Soncini, Debora; Caffa, Irene; Cea, Michele; Montecucco, Fabrizio; Lasiglie, Denise; Damonte, Patrizia; Monacelli, Fiammetta; Odetti, Patrizio; Ballestrero, Alberto; Nencioni, Alessio] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy; [Passalacqua, Mario; Sociali, Giovanna; Grozio, Alessia; Mannino, Elena; Bruzzone, Santina] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Sociali, Giovanna; Grozio, Alessia; Mannino, Elena; Bruzzone, Santina] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Mastracci, Luca] Univ Genoa, Pathol Unit, Dept Integrated Surg & Diagnost Sci, I-16132 Genoa, Italy; [Zoppoli, Gabriele] Univ Libre Bruxelles, Inst Jules Bordet, B-1000 Brussels, Belgium; [Zoppoli, Gabriele] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Cea, Michele; Cagnetta, Antonia] Harvard Univ, Sch Med, Boston Novartis Inst BioMed Res, Jerome Lipper Multiple Myeloma Ctr,Dana Farber Ca, Cambridge, MA 02139 USA; [Mastracci, Luca; Boero, Silvia; Poggi, Alessandro; Odetti, Patrizio; Ballestrero, Alberto; Nencioni, Alessio] Azienda Osped Univ San Martino, Ist Ricovero & Cura Carattere Sci, Ist Nazl Ric Cancro, Ist Sci Tumori, I-16132 Genoa, Italy; [Montecucco, Fabrizio] Univ Geneva, Div Cardiol, Fdn Med Res, Dept Med Specialties, CH-1211 Geneva, Switzerland; [D'Agostino, Vito G.; Provenzani, Alessandro] Univ Trent, Ctr Integrat Biol, Lab Genom Screening, I-38123 Trento, Italy; [Passalacqua, Mario] Univ Genoa, Italian Inst Biostruct & Biosyst, I-16132 Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa; Institut Jules Bordet; Universite Libre de Bruxelles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; University of Genoa; IRCCS AOU San Martino IST; University of Geneva; University of Trento; University of Genoa	Nencioni, A (corresponding author), Univ Genoa, Dept Internal Med, Vle Benedetto 15 6, I-16132 Genoa, Italy.	alessio.nencioni@unige.it	Caffa, Irene/J-9835-2016; D'Agostino, Vito/AAS-4260-2020; Provenzani, Alessandro/I-9211-2012; Ballestrero, Alberto/K-7546-2016; Passalacqua, Mario/W-1973-2019; cea, Michele/K-3863-2018; Poggi, Alessandro/K-6664-2016; Nencioni, Alessio/K-3692-2018; Mastracci, Luca/AAA-6411-2020; Montecucco, Fabrizio/K-8543-2016; Monacelli, F/K-4198-2016; Zoppoli, Gabriele/B-6935-2016; Bruzzone, Santina/A-4264-2015; Soncini, Debora/AAB-2230-2019; Zoppoli, Gabriele/B-6935-2016	Caffa, Irene/0000-0003-1111-9915; D'Agostino, Vito/0000-0003-3379-2254; Provenzani, Alessandro/0000-0003-1652-3415; Ballestrero, Alberto/0000-0002-2601-7711; Passalacqua, Mario/0000-0003-2779-6259; cea, Michele/0000-0002-1530-6729; Poggi, Alessandro/0000-0002-1860-430X; Mastracci, Luca/0000-0003-0193-5281; Montecucco, Fabrizio/0000-0003-0823-8729; Zoppoli, Gabriele/0000-0003-3890-5588; Bruzzone, Santina/0000-0003-2034-3716; Soncini, Debora/0000-0001-5156-498X; MONACELLI, FIAMMETTA/0000-0003-4303-7252; ODETTI, PATRIZIO/0000-0001-9559-7273; CAGNETTA, ANTONIA/0000-0003-1973-3768; Zoppoli, Gabriele/0000-0002-1619-1708; NENCIONI, ALESSIO/0000-0001-5068-8884	Associazione Italiana per la Ricerca sul Cancro [6108]; Seventh Framework Project PANACREAS [256986]; Italian Ministry of Health [GR-2008-1135635]; Compagnia di San Paolo; Fondazione Umberto Veronesi; University of Genoa; PO CRO Fondo Sociale Europeo Regione Liguria Asse IV "Capitale Umano"; Swiss National Science Foundation [310030_152639/1]	Associazione Italiana per la Ricerca sul Cancro; Seventh Framework Project PANACREAS; Italian Ministry of Health; Compagnia di San Paolo(Compagnia di San Paolo); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); University of Genoa; PO CRO Fondo Sociale Europeo Regione Liguria Asse IV "Capitale Umano"; Swiss National Science Foundation	This work was supported in part by Associazione Italiana per la Ricerca sul Cancro Grant 6108 (to A. N.), by Seventh Framework Project PANACREAS Grant 256986 (to A. N.), by Italian Ministry of Health Project Grant GR-2008-1135635 (to A. N.), by the Compagnia di San Paolo (to A. N.), by the Fondazione Umberto Veronesi (to A. N.), by the University of Genoa, by the PO CRO Fondo Sociale Europeo Regione Liguria 2007-2013 Asse IV "Capitale Umano" (to S. Boero), and by Swiss National Science Foundation Grant 310030_152639/1 (to F. M.).	Adya R, 2008, CARDIOVASC RES, V78, P356, DOI 10.1093/cvr/cvm111; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Biganzoli L, 2012, LANCET ONCOL, V13, pE148, DOI 10.1016/S1470-2045(11)70383-7; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bruzzone S, 2013, CURR PHARM DESIGN, V19, P614, DOI 10.2174/138161213804581954; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Cea M, 2012, BLOOD, V120, P3519, DOI 10.1182/blood-2012-03-416776; Cerna D, 2012, J BIOL CHEM, V287, P22408, DOI 10.1074/jbc.M112.357301; Chang YH, 2011, DIABETES-METAB RES, V27, P515, DOI 10.1002/dmrr.1201; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dalamaga M, 2012, MATURITAS, V71, P301, DOI 10.1016/j.maturitas.2011.12.013; de Luis DA, 2013, DIABETES-METAB RES, V29, P576, DOI 10.1002/dmrr.2430; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Fazeli MS, 2013, CYTOKINE, V62, P81, DOI 10.1016/j.cyto.2013.02.012; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grozio A, 2013, J BIOL CHEM, V288, P25938, DOI 10.1074/jbc.M113.470435; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasmann M, 2003, CANCER RES, V63, P7436; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Imai SI, 2010, PHARMACOL RES, V62, P42, DOI 10.1016/j.phrs.2010.01.006; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lee YC, 2011, CANCER EPIDEM BIOMAR, V20, P1892, DOI 10.1158/1055-9965.EPI-11-0399; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li YK, 2008, J BIOL CHEM, V283, P34833, DOI 10.1074/jbc.M805866200; Liu P, 2009, J BIOL CHEM, V284, P27344, DOI 10.1074/jbc.M109.002519; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Magnone M, 2012, J BIOL CHEM, V287, P21067, DOI 10.1074/jbc.M111.324269; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mantovani A, 2007, BREAST, V16, pS27, DOI 10.1016/j.breast.2007.07.013; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Montecucco F, 2013, CURR TOP MED CHEM, V13, P2930, DOI 10.2174/15680266113136660208; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Noto H, 2013, J DIABETES INVEST, V4, P225, DOI 10.1111/jdi.12068; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Reddy PS, 2008, CANCER BIOL THER, V7, P663, DOI 10.4161/cbt.7.5.5663; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Roxanis I, 2013, J CLIN PATHOL, V66, P517, DOI 10.1136/jclinpath-2012-201348; Santidrian A. F., 2014, DNA REPAIR S; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Shackelford Rodney E, 2013, Genes Cancer, V4, P447, DOI 10.1177/1947601913507576; Tsouma I, 2014, GYNECOL ENDOCRINOL, V30, P516, DOI 10.3109/09513590.2014.896896; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114	52	55	55	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34189	34204		10.1074/jbc.M114.594721	http://dx.doi.org/10.1074/jbc.M114.594721			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25331943	Green Published, hybrid			2022-12-28	WOS:000346077600042
J	Tepper, K; Biernat, J; Kumar, S; Wegmann, S; Timm, T; Hubschmann, S; Redecke, L; Mandelkow, EM; Muller, DJ; Mandelkow, E				Tepper, Katharina; Biernat, Jacek; Kumar, Satish; Wegmann, Susanne; Timm, Thomas; Huebschmann, Sabrina; Redecke, Lars; Mandelkow, Eva-Maria; Mueller, Daniel J.; Mandelkow, Eckhard			Oligomer Formation of Tau Protein Hyperphosphorylated in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence Anisotropy; Neuron; Phosphorylation; Synapse; Tau Protein (Tau); Oligomers; Time-correlated Single Photon Counting; Toxicity	MICROTUBULE-ASSOCIATED PROTEIN; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; ABNORMAL PHOSPHORYLATION; REPEAT DOMAIN; IN-VITRO; AGGREGATION; BRAIN; EXPRESSION; KINASES	Background: The causal relationship between Tau hyperphosphorylation and aggregation in neuropathology is still under debate. Results: Tau highly phosphorylated in cells increases oligomerization without pronounced aggregation. Oligomers cause reduction of dendritic spines but not cell death. Conclusion: Hyperphosphorylation does not drive Tau fibrillization but contributes to synaptotoxicity. Significance: Pathways and effects of Tau hyperphosphorylation are distinct from those of aggregation. Abnormal phosphorylation (hyperphosphorylation) and aggregation of Tau protein are hallmarks of Alzheimer disease and other tauopathies, but their causative connection is still a matter of debate. Tau with Alzheimer-like phosphorylation is also present in hibernating animals, mitosis, or during embryonic development, without leading to pathophysiology or neurodegeneration. Thus, the role of phosphorylation and the distinction between physiological and pathological phosphorylation needs to be further refined. So far, the systematic investigation of highly phosphorylated Tau was difficult because a reliable method of preparing reproducible quantities was not available. Here, we generated full-length Tau (2N4R) in Sf9 cells in a well defined phosphorylation state containing up to approximate to 20 phosphates as judged by mass spectrometry and Western blotting with phospho-specific antibodies. Despite the high concentration in living Sf9 cells (estimated approximate to 230 m) and high phosphorylation, the protein was not aggregated. However, after purification, the highly phosphorylated protein readily formed oligomers, whereas fibrils were observed only rarely. Exposure of mature primary neuronal cultures to oligomeric phospho-Tau caused reduction of spine density on dendrites but did not change the overall cell viability.	[Tepper, Katharina; Biernat, Jacek; Kumar, Satish; Huebschmann, Sabrina; Mandelkow, Eva-Maria; Mandelkow, Eckhard] German Ctr Neurodegenerat Dis, DZNE, D-53175 Bonn, Germany; [Tepper, Katharina; Biernat, Jacek; Kumar, Satish; Huebschmann, Sabrina; Mandelkow, Eva-Maria; Mandelkow, Eckhard] CAESAR Res Ctr, D-53175 Bonn, Germany; [Wegmann, Susanne; Mueller, Daniel J.] ETHZ, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Timm, Thomas] Univ Giessen, Fac Med, Inst Biochem, D-35390 Giessen, Germany; [Redecke, Lars] Univ Hamburg, Joint Lab Struct Biol Infect & Inflammat, D-22603 Hamburg, Germany; [Redecke, Lars] Med Univ Lubeck, DESY, D-22603 Hamburg, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR); Swiss Federal Institutes of Technology Domain; ETH Zurich; Justus Liebig University Giessen; University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Lubeck	Mandelkow, E (corresponding author), German Ctr Neurodegenerat Dis, DZNE, D-53175 Bonn, Germany.	Eckhard.Mandelkow@dzne.de	Müller, Daniel J./A-5967-2010; Mueller, Daniel Josef/GVT-7899-2022	Müller, Daniel J./0000-0003-3075-0665; Mueller, Daniel Josef/0000-0003-4978-4400	German Center for Neurodegenerative Diseases; Max-Planck-Gesellschaft; Wellcome Trust/Medical Research Center; Tau Consortium	German Center for Neurodegenerative Diseases; Max-Planck-Gesellschaft(Max Planck Society); Wellcome Trust/Medical Research Center; Tau Consortium	This work was supported by the German Center for Neurodegenerative Diseases, Max-Planck-Gesellschaft, Wellcome Trust/Medical Research Center, and Tau Consortium.	Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Arendt T, 2003, J NEUROSCI, V23, P6972, DOI 10.1523/JNEUROSCI.23-18-06972.2003; Ausubel F. M., 2002, SHORT PROTOCOLS MOL, P625; BAAS PW, 1991, J CELL BIOL, V115, P1333, DOI 10.1083/jcb.115.5.1333; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Berberan-Santos MN, 2001, SPR S FLUOR, V1, P7; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; BIRCH DJS, 1991, REV SCI INSTRUM, V62, P2405, DOI 10.1063/1.1142255; Braak H, 1991, BRAIN PATHOL, V1, P213, DOI 10.1111/j.1750-3639.1991.tb00661.x; CHELEY S, 1992, J CELL SCI, V102, P739; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Coppola G, 2012, HUM MOL GENET, V21, P3500, DOI 10.1093/hmg/dds161; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; DRUBIN DG, 1984, J CELL BIOL, V98, P1090, DOI 10.1083/jcb.98.3.1090; Eidenmuller J, 2001, BIOCHEM J, V357, P759, DOI 10.1042/0264-6021:3570759; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Giurleo JT, 2008, J MOL BIOL, V381, P1332, DOI 10.1016/j.jmb.2008.06.043; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Hundelt M, 2011, NEUROBIOL AGING, V32, P991, DOI 10.1016/j.neurobiolaging.2009.06.007; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; Konzack S, 2007, J NEUROSCI, V27, P9916, DOI 10.1523/JNEUROSCI.0927-07.2007; Kopeikina KJ, 2012, TRANSL NEUROSCI, V3, P223, DOI 10.2478/s13380-012-0032-y; KOPKE E, 1993, J BIOL CHEM, V268, P24374; KOSIK KS, 1994, CELL MOTIL CYTOSKEL, V28, P195, DOI 10.1002/cm.970280302; Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; KUBITSCHEK HE, 1990, J BACTERIOL, V172, P94, DOI 10.1128/JB.172.1.94-101.1990; Kumar S, 2014, J BIOL CHEM, V289, P20318, DOI 10.1074/jbc.M114.554725; Landrieu I, 2010, BIOCHEM SOC T, V38, P1006, DOI 10.1042/BST0381006; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee HG, 2005, TRENDS MOL MED, V11, P164, DOI 10.1016/j.molmed.2005.02.008; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lippens G, 2007, PRION, V1, P21, DOI 10.4161/pri.1.1.4055; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Preuss U, 1998, EUR J CELL BIOL, V76, P176, DOI 10.1016/S0171-9335(98)80032-0; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sahara N, 2008, CURR ALZHEIMER RES, V5, P591, DOI 10.2174/156720508786898442; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SERRANO L, 1984, P NATL ACAD SCI-BIOL, V81, P5989, DOI 10.1073/pnas.81.19.5989; Singh SA, 2012, NAT METHODS, V9, P504, DOI [10.1038/NMETH.1970, 10.1038/nmeth.1970]; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Steiner R. F., 1999, TOPICS FLUORESCENCE, P1; Stieler JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014530; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Strauss A, 2005, J BIOMOL NMR, V31, P343, DOI 10.1007/s10858-005-2451-3; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; Tai HC, 2012, AM J PATHOL, V181, P1426, DOI 10.1016/j.ajpath.2012.06.033; Takashima A, 2010, CURR ALZHEIMER RES, V7, P665, DOI 10.2174/156720510793611600; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Wilson DM, 1997, AM J PATHOL, V150, P2181; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Yu Y, 2009, J NEUROCHEM, V108, P1480, DOI 10.1111/j.1471-4159.2009.05882.x; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	87	93	95	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34389	34407		10.1074/jbc.M114.611368	http://dx.doi.org/10.1074/jbc.M114.611368			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25339173	Green Published, hybrid			2022-12-28	WOS:000346077600058
J	Grell, TAJ; Goldman, PJ; Drennan, CL				Grell, Tsehai A. J.; Goldman, Peter J.; Drennan, Catherine L.			SPASM and Twitch Domains in S-Adenosylmethionine (SAM) Radical Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SULFATASE-MATURATING ENZYMES; COLI BIOTIN SYNTHASE; FORMYLGLYCINE-GENERATING ENZYME; LYASE ACTIVATING ENZYME; ESCHERICHIA-COLI; 4FE-4S CLUSTERS; IN-VITRO; POSTTRANSLATIONAL MODIFICATION; LIPOYL SYNTHASE; PYRROLOQUINOLINE QUINONE	S-Adenosylmethionine (SAM, also known as AdoMet) radical enzymes use SAM and a [4Fe-4S] cluster to catalyze a diverse array of reactions. They adopt a partial triose-phosphate isomerase (TIM) barrel fold with N- and C-terminal extensions that tailor the structure of the enzyme to its specific function. One extension, termed a SPASM domain, binds two auxiliary [4Fe-4S] clusters and is present within peptide-modifying enzymes. The first structure of a SPASM-containing enzyme, anaerobic sulfatase-maturating enzyme (anSME), revealed unexpected similarities to two non-SPASM proteins, butirosin biosynthetic enzyme 2-deoxy-scyllo-inosamine dehydrogenase (BtrN) and molybdenum cofactor biosynthetic enzyme (MoaA). The latter two enzymes bind one auxiliary cluster and exhibit a partial SPASM motif, coined a Twitch domain. Here we review the structure and function of auxiliary cluster domains within the SAM radical enzyme superfamily.	[Grell, Tsehai A. J.; Goldman, Peter J.; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 01239 USA; [Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 01239 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 01239 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 01239 USA.	cdrennan@mit.edu			MIT Office of the Dean of Graduate Education Fellowship; National Science Foundation [MCB-0543833]	MIT Office of the Dean of Graduate Education Fellowship; National Science Foundation(National Science Foundation (NSF))	This work was supported by an MIT Office of the Dean of Graduate Education Fellowship (to T. A. J. G.) and National Science Foundation Grant MCB-0543833 (to C. L. D.). This is the first article in the Thematic Minireview series Radical SAM Enzymes.	Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Benjdia A, 2008, J BIOL CHEM, V283, P17815, DOI 10.1074/jbc.M710074200; Benjdia A, 2007, J AM CHEM SOC, V129, P3462, DOI 10.1021/ja067175e; Benjdia A, 2011, J BIOL CHEM, V286, P25973, DOI 10.1074/jbc.M111.228841; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Berteau O, 2006, J BIOL CHEM, V281, P22464, DOI 10.1074/jbc.M602504200; Bojarova P, 2008, CURR OPIN CHEM BIOL, V12, P573, DOI 10.1016/j.cbpa.2008.06.018; Bui BTS, 2003, BIOCHEMISTRY-US, V42, P8791, DOI 10.1021/bi034426c; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P11770, DOI 10.1021/bi0488505; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Dowling DP, 2014, NAT CHEM BIOL, V10, P106, DOI 10.1038/nchembio.1426; Dowling DP, 2012, BBA-PROTEINS PROTEOM, V1824, P1178, DOI 10.1016/j.bbapap.2012.04.006; Engelberg-Kulka H, 2003, SCIENCE, V301, P467, DOI 10.1126/science.1088051; Fang QH, 2004, J BIOL CHEM, V279, P14570, DOI 10.1074/jbc.M313855200; Farrar CE, 2009, BIOCHEMISTRY-US, V48, P2448, DOI 10.1021/bi8022569; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fluhe L, 2013, J AM CHEM SOC, V135, P959, DOI 10.1021/ja310542g; Forouhar F, 2013, NAT CHEM BIOL, V9, P333, DOI [10.1038/NCHEMBIO.1229, 10.1038/nchembio.1229]; Fugate CJ, 2012, J AM CHEM SOC, V134, P9042, DOI 10.1021/ja3012963; Ghosh D, 2007, CELL MOL LIFE SCI, V64, P2013, DOI 10.1007/s00018-007-7175-y; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P15949, DOI 10.1073/pnas.1312228110; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P8519, DOI 10.1073/pnas.1302417110; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Grove TL, 2008, BIOCHEMISTRY-US, V47, P7523, DOI 10.1021/bi8004297; Grove TL, 2013, BIOCHEMISTRY-US, V52, P2874, DOI 10.1021/bi400136u; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Haft DH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-21; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; HOUCK DR, 1991, J AM CHEM SOC, V113, P3162, DOI 10.1021/ja00008a053; Hover BM, 2013, J AM CHEM SOC, V135, P7019, DOI 10.1021/ja401781t; Jameson GNL, 2004, BIOCHEMISTRY-US, V43, P2022, DOI 10.1021/bi035666v; JOHNSON JL, 1993, ADV EXP MED BIOL, V338, P373; Kuchenreuther JM, 2014, SCIENCE, V343, P424, DOI 10.1126/science.1246572; Landgraf BJ, 2013, J AM CHEM SOC, V135, P15404, DOI 10.1021/ja4048448; Lanz ND, 2012, BBA-PROTEINS PROTEOM, V1824, P1196, DOI 10.1016/j.bbapap.2012.07.009; Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w; Lees NS, 2009, J AM CHEM SOC, V131, P9184, DOI 10.1021/ja903978u; Liu WT, 2010, P NATL ACAD SCI USA, V107, P16286, DOI 10.1073/pnas.1008368107; Mehta AP, 2013, BIOCHEMISTRY-US, V52, P1134, DOI 10.1021/bi3016026; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; Nicolet Y, 2009, P NATL ACAD SCI USA, V106, P14867, DOI 10.1073/pnas.0904385106; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Shelburne CE, 2007, J ANTIMICROB CHEMOTH, V59, P297, DOI 10.1093/jac/dkl495; Shisler KA, 2012, CURR OPIN STRUC BIOL, V22, P701, DOI 10.1016/j.sbi.2012.10.005; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Ugulava NB, 2001, BIOCHEMISTRY-US, V40, P8352, DOI 10.1021/bi010463x; VELTEROP JS, 1995, J BACTERIOL, V177, P5088, DOI 10.1128/jb.177.17.5088-5098.1995; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Walsby CJ, 2002, J AM CHEM SOC, V124, P11270, DOI 10.1021/ja027078v; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s; Wecksler SR, 2010, CHEM COMMUN, V46, P7031, DOI 10.1039/c0cc00968g; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; Yokoyama K, 2008, BIOCHEMISTRY-US, V47, P8950, DOI 10.1021/bi800509x; Yokoyama K, 2007, J AM CHEM SOC, V129, P15147, DOI 10.1021/ja072481t; Zheng GL, 2000, J BACTERIOL, V182, P3266, DOI 10.1128/JB.182.11.3266-3273.2000	61	95	95	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					3964	3971		10.1074/jbc.R114.581249	http://dx.doi.org/10.1074/jbc.R114.581249			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25477505	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000349458400008
J	Delcourt, N; Quevedo, C; Nonne, C; Fons, P; O'Brien, D; Loyaux, D; Diez, M; Autelitano, F; Guillemot, JC; Ferrara, P; Muriana, A; Callol, C; Herault, JP; Herbert, JM; Favre, G; Bono, F				Delcourt, Nicolas; Quevedo, Celia; Nonne, Christelle; Fons, Pierre; O'Brien, Donogh; Loyaux, Denis; Diez, Maria; Autelitano, Franois; Guillemot, Jean-Claude; Ferrara, Pascual; Muriana, Arantza; Callol, Carlos; Herault, Jean-Pascal; Herbert, Jean-Marc; Favre, Gilles; Bono, Francoise			Targeted Identification of Sialoglycoproteins in Hypoxic Endothelial Cells and Validation in Zebrafish Reveal Roles for Proteins in Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROPILIN-1; APOPTOSIS; GLYCANS	The formation of new vessels in the tumor, termed angiogenesis, is essential for primary tumor growth and facilitates tumor invasion and metastasis. Hypoxia has been described as one trigger of angiogenesis. Indeed, hypoxia, which is characterized by areas of low oxygen levels, is a hallmark of solid tumors arising from an imbalance between oxygen delivery and consumption. Hypoxic conditions have profound effects on the different components of the tumoral environment. For example, hypoxia is able to activate endothelial cells, leading to angiogenesis but also thereby initiating a cascade of reactions involving neutrophils, smooth muscle cells, and fibroblasts. In addition, hypoxia directly regulates the expression of many genes for which the role and the importance in the tumoral environment remain to be completely elucidated. In this study, we used a method to selectively label sialoglycoproteins to identify new membrane and secreted proteins involved in the adaptative process of endothelial cells by mass spectrometry-based proteomics. We used an in vitro assay under hypoxic condition to observe an increase of protein expression or modifications of glycosylation. Then the function of the identified proteins was assessed in a vasculogenesis assay in vivo by using a morpholino strategy in zebrafish. First, our approach was validated by the identification of sialoglycoproteins such as CD105, neuropilin-1, and CLEC14A, which have already been described as playing key roles in angiogenesis. Second, we identified several new proteins regulated by hypoxia and demonstrated for the first time the pivotal role of GLUT-1, TMEM16F, and SDF4 in angiogenesis.	[Delcourt, Nicolas; Nonne, Christelle; Fons, Pierre; Loyaux, Denis; Autelitano, Franois; Guillemot, Jean-Claude; Ferrara, Pascual; Herault, Jean-Pascal; Herbert, Jean-Marc; Bono, Francoise] Sanofi Res & Dev, F-31000 Toulouse, France; [O'Brien, Donogh] Donogh OBrien BioConsulting, F-18310 Les Poirioux, St Outrille, France; [Delcourt, Nicolas; Favre, Gilles] Univ Toulouse, INSERM UMR1037, Ctr Rech Cancerol Toulouse, F-31057 Toulouse, France; [Quevedo, Celia; Diez, Maria; Callol, Carlos] Biobide SL, San Sebastian 20009, Spain; [Quevedo, Celia; Muriana, Arantza] BBD BioPhenix SL Bionaturis Grp, San Sebastian 20009, Spain	Sanofi-Aventis; Sanofi France; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Bono, F (corresponding author), Sanofi R&D, E2C, 195 Route Espagne, F-31000 Toulouse, France.	francoise.bono@sanofi.com	Diez, Maria Suarez/AAI-1354-2020; nonne, christelle/AAI-8775-2020; DELCOURT, Nicolas/H-2877-2016; FAVRE, Gilles/K-9189-2014	DELCOURT, Nicolas/0000-0001-8136-9392; FAVRE, Gilles/0000-0002-2344-1883; Autelitano, Francois/0000-0001-6269-2629				Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cassavaugh J, 2011, J CELL BIOCHEM, V112, P735, DOI 10.1002/jcb.22956; Chiche J, 2013, ANN ENDOCRINOL-PARIS, V74, P111, DOI 10.1016/j.ando.2013.02.004; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Hanson SR, 2007, J AM CHEM SOC, V129, P7266, DOI 10.1021/ja0724083; Jensen PJ, 2006, J BIOL CHEM, V281, P13382, DOI 10.1074/jbc.M601881200; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kwapiszewska G, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-109; Laughlin ST, 2006, METHOD ENZYMOL, V415, P230, DOI 10.1016/S0076-6879(06)15015-6; Lee KY, 2002, NAT BIOTECHNOL, V20, P795, DOI 10.1038/nbt721; Lee P, 2002, P NATL ACAD SCI USA, V99, P10470, DOI 10.1073/pnas.162366299; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Martyn U, 2004, DEV DYNAM, V231, P33, DOI 10.1002/dvdy.20048; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Mura M, 2012, ONCOGENE, V31, P293, DOI 10.1038/onc.2011.233; Nagao K, 2011, BIOCHEM BIOPH RES CO, V407, P260, DOI 10.1016/j.bbrc.2011.03.017; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pan S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003251; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Rabuka D, 2006, J AM CHEM SOC, V128, P12078, DOI 10.1021/ja064619y; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Saxon E, 2001, ANNU REV CELL DEV BI, V17, P1, DOI 10.1146/annurev.cellbio.17.1.1; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Traiffort E, 2013, MOL ASPECTS MED, V34, P646, DOI 10.1016/j.mam.2012.10.011; Wang L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001161; Wykoff CC, 2000, ONCOGENE, V19, P6297, DOI 10.1038/sj.onc.1204012	41	18	18	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3405	3417		10.1074/jbc.M114.618611	http://dx.doi.org/10.1074/jbc.M114.618611			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25384978	Green Published, hybrid			2022-12-28	WOS:000349456000017
J	Oh, J; Kim, JY; Kim, HS; Oh, JC; Cheon, YH; Park, J; Yoon, KH; Lee, MS; Youn, BS				Oh, Jaemin; Kim, Ju-Young; Kim, Han-Soo; Oh, Justin Cheesung; Cheon, Yoon-Hee; Park, Jongtae; Yoon, Kwon-Ha; Lee, Myeung Su; Youn, Byung-Soo			Progranulin and a Five Transmembrane Domain-Containing Receptor-like Gene Are the Key Components in Receptor Activator of Nuclear Factor kappa B (RANK)-dependent Formation of Multinucleated Osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; GROWTH-FACTOR; EPITHELIN PRECURSOR; BONE HOMEOSTASIS; TNF RECEPTORS; LIGAND; RANKL; DIFFERENTIATION; OSTEOPROTEGERIN; OSTEOPOROSIS	Homeostatic bone remodeling is vital to maintain healthy bone tissue. Although the receptor activator of nuclear factor kappa B ligand (RANKL)/RANK axis is considered the master regulator of osteoclastogenesis, the underlying mechanisms including cell fusion remain incompletely defined. Here, we introduce a new axis in the formation of multinucleated cells via RANK signaling: the progranulin (PGRN)/PIRO (PGRN-induced receptor-like gene during osteoclastogenesis) axis. When mouse bone marrow-derived macrophages were stimulated with PGRN in the presence of RANKL, explosive OC formation was observed. PGRN knockdown experiments suggested that endogenous PGRN is an essential component of the RANKL/RANK axis. Our efforts for identifying genes that are induced by PGRN unveiled a remarkably induced (20-fold) gene named PIRO. Substantial PGRN and PIRO expression was detected after 2 and 3 days, respectively, suggesting that their sequential induction. PIRO was predicted to be a five transmembrane domain-containing receptor-like molecule. The tissue distribution of PGRN and PIRO mRNA expression suggested that bone marrow cells are the most suitable niche. Mouse and human PIRO are part of a multigene family. Knockdown experiments suggested that PIRO is a direct target for the formation of multinucleated cells by PGRN. PGRN levels were also substantially higher in ovariectomized mice than in sham control mice. These observations suggest that PGRN and PIRO form a new regulatory axis in osteoclastogenesis that is included in RANK signaling in cell fusion and OC resorption of osteoclastogenesis, which may offer a novel therapeutic modality for osteoporosis and other bone-associated diseases.	[Oh, Jaemin; Kim, Ju-Young; Yoon, Kwon-Ha; Lee, Myeung Su] Wonkwang Univ, Imaging Sci Based Lung & Bone Dis Res Ctr, Sch Med, Iksan 570749, Jeonbuk, South Korea; [Oh, Justin Cheesung; Cheon, Yoon-Hee; Youn, Byung-Soo] Wonkwang Univ, Dept Anat, Sch Med, Iksan 570749, Jeonbuk, South Korea; [Yoon, Kwon-Ha] Wonkwang Univ, Dept Radiol, Sch Med, Iksan 570749, Jeonbuk, South Korea; [Oh, Jaemin; Cheon, Yoon-Hee] Wonkwang Univ, Grad Sch, Program BK21plus, Iksan 570749, Jeonbuk, South Korea; [Park, Jongtae] Wonkwang Univ, Dept Neurosurg, Iksan 570749, Jeonbuk, South Korea; [Lee, Myeung Su] Wonkwang Univ, Div Rheumatol, Dept Internal Med, Iksan 570749, Jeonbuk, South Korea; [Kim, Han-Soo] Catholic Kwandong Univ, Inst Biomed Convergence, Inchon 404834, South Korea; [Kim, Han-Soo] Int St Marys Hosp, Innovat Cell & Gene Therapy Ctr, Inchon 404834, South Korea; [Youn, Byung-Soo] OsteoNeuroGen, Bundang 461871, Kyunggi Do, South Korea	Wonkwang University; Wonkwang University; Wonkwang University; Wonkwang University; Wonkwang University; Wonkwang University; Catholic Kwandong University	Lee, MS (corresponding author), Wonkwang Univ, Div Rheumatol, Dept Internal Med, Iksan 570749, Jeonbuk, South Korea.	ckhlms@wku.ac.kr; byung4jc@gmail.com			OsteoNeuroGen; Korean Health Technology R&D Project of the Ministry of Health & Welfare, Republic of Korea [HI12C0110]	OsteoNeuroGen; Korean Health Technology R&D Project of the Ministry of Health & Welfare, Republic of Korea	This work was supported by intramural funding from OsteoNeuroGen and Grant HI12C0110 from the Korean Health Technology R&D Project of the Ministry of Health & Welfare, Republic of Korea. B.-S.Y. has ownership in OsteoNeuroGen.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; BHANDARI V, 1992, BIOCHEM BIOPH RES CO, V188, P57, DOI 10.1016/0006-291X(92)92349-3; Brouwers N, 2007, ARCH NEUROL-CHICAGO, V64, P1436, DOI 10.1001/archneur.64.10.1436; Capozzi A, 2014, GYNECOL ENDOCRINOL, V30, P403, DOI 10.3109/09513590.2014.892067; Chen X, 2013, J NEUROSCI, V33, P9202, DOI 10.1523/JNEUROSCI.5336-12.2013; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Etemadi N, 2013, IMMUNOL CELL BIOL, V91, P661, DOI 10.1038/icb.2013.53; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Gao X, 2010, PROTEIN CELL, V1, P552, DOI 10.1007/s13238-010-0067-1; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lems WF, 2014, CURR OPIN RHEUMATOL, V26, P245, DOI 10.1097/BOR.0000000000000057; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Morony S, 2001, CANCER RES, V61, P4432; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Nguyen AD, 2013, TRENDS ENDOCRIN MET, V24, P597, DOI 10.1016/j.tem.2013.08.003; Romanello M, 2014, BONE, V58, P81, DOI 10.1016/j.bone.2013.10.003; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sleegers K, 2010, BIOMARK MED, V4, P37, DOI 10.2217/BMM.09.82; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tokuyama Naoto, 2014, Clin Calcium, V24, P85, DOI CliCa14018591; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yao Q, 2014, CELL BIOCHEM BIOPHYS, V69, P229, DOI 10.1007/s12013-013-9787-1; ZHOU J, 1993, J BIOL CHEM, V268, P10863	30	13	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2042	2052		10.1074/jbc.M114.608786	http://dx.doi.org/10.1074/jbc.M114.608786			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25406312	hybrid, Green Published			2022-12-28	WOS:000348588000012
J	Nakashima, H; Nguyen, T; Goins, WF; Chiocca, EA				Nakashima, Hiroshi; Tran Nguyen; Goins, William F.; Chiocca, Ennio Antonio			Interferon-stimulated Gene 15 (ISG15) and ISG15-linked Proteins Can Associate with Members of the Selective Autophagic Process, Histone Deacetylase 6 (HDAC6) and SQSTM1/p62	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINDBIS VIRUS-INFECTION; UBIQUITIN-LIKE PROTEIN; SEQUESTOSOME 1/P62; BINDING; DOMAIN; P62; AGGRESOME; RECOGNITION; CONJUGATION; ACTIVATION	The ubiquitin-like interferon (IFN)-stimulated gene 15 (ISG15) and its specific E1, E2, and E3 enzymes are transcriptionally induced by type I IFNs. ISG15 conjugates newly synthesized proteins. ISG15 linkage to proteins appears to be an important downstream IFN signaling event that discriminates cellular and pathogenic proteins synthesized during IFN stimulation from existing proteins. This eliminates potentially pathogenic proteins as the cell attempts to return to normal homeostasis after IFN "stressed" conditions. However, the molecular events that occur in this process are not well known. Here, we show that the C-terminal LRLRGG of ISG15 interacts with the binder of ubiquitin zinc finger (BUZ) domain of histone deacetylase 6 (HDAC6). Because HDAC6 is involved in the autophagic clearance of ubiquitinated aggregates during which SQSTM1/p62 plays a major role as a cargo adapter, we also were able to confirm that p62 binds to ISG15 protein and its conjugated proteins upon forced expression. Both HDAC6 and p62 co-localized with ISG15 in an insoluble fraction of the cytosol, and this co-localization was magnified by the proteasome inhibitor MG132. In addition, ISG15 was degraded via the lysosome. Overexpression of ISG15, which leads to an increased conjugation level of the cellular proteome, enhanced autophagic degradation independently of IFN signaling transduction. These results thus indicate that ISG15 conjugation marks proteins for interaction with HDAC6 and p62 upon forced stressful conditions likely as a step toward autophagic clearance.	[Nakashima, Hiroshi; Tran Nguyen; Chiocca, Ennio Antonio] Brigham & Womens Hosp, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Harvard Inst Med, Boston, MA 02115 USA; [Nakashima, Hiroshi; Tran Nguyen; Chiocca, Ennio Antonio] Brigham & Womens Hosp, Inst Neurosci, Boston, MA 02115 USA; [Goins, William F.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15219 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chiocca, EA (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	EAChiocca@partners.org	Goins, William/GLT-6681-2022	Goins, William/0000-0001-7744-9891	National Institutes of Health from the NCI [P01 CA069246, P01 CA163205]; Brigham and Women's Hospital; NATIONAL CANCER INSTITUTE [P01CA069246, P01CA163205] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brigham and Women's Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 CA069246 and P01 CA163205 from the NCI. This work was also supported by a sundry fund from the Brigham and Women's Hospital (to E. A. C.).	Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Boyle KB, 2013, CURR OPIN MICROBIOL, V16, P339, DOI 10.1016/j.mib.2013.03.010; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Geeraert C, 2010, J BIOL CHEM, V285, P24184, DOI 10.1074/jbc.M109.091553; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Judith D, 2013, EMBO REP, V14, P534, DOI 10.1038/embor.2013.51; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Liu MJ, 2003, J BIOL CHEM, V278, P1594, DOI 10.1074/jbc.M208123200; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Ouyang H, 2012, J BIOL CHEM, V287, P2317, DOI 10.1074/jbc.M111.273730; Pai MT, 2007, J MOL BIOL, V370, P290, DOI 10.1016/j.jmb.2007.04.015; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Potter JL, 1999, J BIOL CHEM, V274, P25061, DOI 10.1074/jbc.274.35.25061; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Romijn RA, 2003, J BIOL CHEM, V278, P15035, DOI 10.1074/jbc.M208977200; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Schmeisser H, 2014, J INTERF CYTOK RES, V34, P71, DOI 10.1089/jir.2013.0128; Searle MS, 2012, BIOCHEM SOC T, V40, P404, DOI 10.1042/BST20110729; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Trempe JF, 2010, ACTA CRYSTALLOGR F, V66, P994, DOI 10.1107/S1744309110027600; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zuin A, 2010, EMBO J, V29, P981, DOI 10.1038/emboj.2009.407	42	64	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1485	1495		10.1074/jbc.M114.593871	http://dx.doi.org/10.1074/jbc.M114.593871			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25429107	Green Published, hybrid			2022-12-28	WOS:000348056400019
J	Xu, WW; Ge, Y; Liu, ZH; Gong, RJ				Xu, Weiwei; Ge, Yan; Liu, Zhihong; Gong, Rujun			Glycogen Synthase Kinase 3 beta Orchestrates Microtubule Remodeling in Compensatory Glomerular Adaptation to Podocyte Depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PARIETAL EPITHELIAL-CELLS; ACUTE KIDNEY INJURY; ADRIAMYCIN NEPHROPATHY; PHOSPHORYLATION; LITHIUM; TAU; MICE; INHIBITORS; DISEASES	Reminiscent of neural repair, following podocyte depletion, remnant-surviving podocytes exhibit a considerable adaptive capacity to expand and cover the denuded renal glomerular basement membrane. Microtubules, one of the principal cytoskeletal components of podocyte major processes, play a crucial role in podocyte morphogenesis and podocyte process outgrowth, branching, and elongation. Here, we demonstrated that the microtubule-associated proteins Tau and collapsin response mediator protein (CRMP) 2, key regulators of microtubule dynamics, were abundantly expressed by glomerular podocytes in vivo and in vitro, interacted with glycogen synthase kinase (GSK)3 beta, and served as its putative substrates. GSK3 beta overactivity induced by adriamycin injury or by a constitutively active mutant of GSK3 beta augmented phosphorylation of Tau and CRMP2, concomitant with microtubule depolymerization, cell body shrinkage, and shortening of podocyte processes. Conversely, inhibition of GSK3 beta by a dominant negative mutant or by lithium, a Food and Drug Administration-approved neuroprotective mood stabilizer, diminished Tau and CRMP2 phosphorylation, resulting in microtubule polymerization, podocyte expansion, and lengthening of podocyte processes. In a mouse model of adriamycin-induced podocyte depletion and nephropathy, delayed administration of a single low dose of lithium attenuated proteinuria and ameliorated progressive glomerulosclerosis despite no correction of podocytopenia. Mechanistically, lithium therapy obliterated GSK3 beta overactivity, mitigated phosphorylation of Tau and CRMP2, and enhanced microtubule polymerization and stabilization in glomeruli in adriamycin-injured kidneys, associated with elongation of podocyte major processes. Collectively, our findings suggest that the GSK3 beta-dictated podocyte microtubule dynamics might serve as a novel therapeutic target to reinforce the compensatory glomerular adaptation to podocyte loss.	[Xu, Weiwei; Liu, Zhihong] Nanjing Univ, Sch Med, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Nanjing 210002, Jiangsu, Peoples R China; [Xu, Weiwei; Ge, Yan; Gong, Rujun] Brown Univ, Rhode Isl Hosp, Div Kidney Dis & Hypertens, Dept Med,Sch Med, Providence, RI 02903 USA	Nanjing University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Gong, RJ (corresponding author), Brown Univ, Rhode Isl Hosp, Div Kidney Dis & Hypertens, Dept Med,Sch Med, 593 Eddy St, Providence, RI 02903 USA.	rujun_gong@Brown.edu	xu, wei/HHD-2891-2022	Liu, Zhi-Hong/0000-0001-6093-0726	National Institutes of Health [R01DK092485]; China 973 Program [2012CB517600]; International Society of Nephrology Sister Renal Center Trio Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China 973 Program(National Basic Research Program of China); International Society of Nephrology Sister Renal Center Trio Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK092485. This work was also supported by China 973 Program 2012CB517600 and the International Society of Nephrology Sister Renal Center Trio Program.	Al-Bassam J, 2010, DEV CELL, V19, P245, DOI 10.1016/j.devcel.2010.07.016; Bai XY, 2011, AM J NEPHROL, V33, P91, DOI 10.1159/000322701; Barisoni L, 2007, CLIN J AM SOC NEPHRO, V2, P529, DOI 10.2215/CJN.04121206; Bendz H, 2010, KIDNEY INT, V77, P219, DOI 10.1038/ki.2009.433; Boini KM, 2009, AM J PHYSIOL-RENAL, V296, pF153, DOI 10.1152/ajprenal.90398.2008; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; Caberlotto L, 2013, N-S ARCH PHARMACOL, V386, P893, DOI 10.1007/s00210-013-0893-9; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Cullen-McEwen Luise A, 2012, Methods Mol Biol, V886, P333, DOI 10.1007/978-1-61779-851-1_30; D'Agati VD, 2012, CURR OPIN NEPHROL HY, V21, P243, DOI 10.1097/MNH.0b013e32835200df; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; DRENCKHAHN D, 1988, LAB INVEST, V59, P673; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Forlenza OV, 2012, DRUG AGING, V29, P335, DOI 10.2165/11599180-000000000-00000; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Fukuda A, 2012, J AM SOC NEPHROL, V23, P1351, DOI 10.1681/ASN.2012030271; Gong R, 2008, AM J TRANSPLANT, V8, P1852, DOI 10.1111/j.1600-6143.2008.02319.x; Gong R, 2003, J AM SOC NEPHROL, V14, P3047, DOI 10.1097/01.ASN.0000098686.72971.DB; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Goold RG, 2001, J CELL SCI, V114, P4273; Gu YJ, 1996, J NEUROCHEM, V67, P1235; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Guzman J, 2014, DIABETES, V63, P701, DOI 10.2337/db13-0752; Hevia D, 2011, PROTOCOL EXCHANGE, DOI [10.1038/protex.2011.272, DOI 10.1038/PROTEX.2011.272]; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Kett MM, 2001, J HYPERTENS, V19, P1505, DOI 10.1097/00004872-200108000-00020; Khanfar MA, 2009, BIOORGAN MED CHEM, V17, P6032, DOI 10.1016/j.bmc.2009.06.054; Kobayashi N, 1998, CELL TISSUE RES, V291, P163, DOI 10.1007/s004410050988; Kobayashi N, 2002, MICROSC RES TECHNIQ, V57, P217, DOI 10.1002/jemt.10077; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Kretzler M, 2005, J AM SOC NEPHROL, V16, P2830, DOI 10.1681/ASN.2005080841; Kriz W, 2012, NAT REV NEPHROL, V8, P618, DOI 10.1038/nrneph.2012.198; Lasagni L, 2013, CURR MOL MED, V13, P13, DOI 10.2174/156652413804486250; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Li B, 2007, ACTA NEUROPATHOL, V113, P501, DOI 10.1007/s00401-007-0207-8; Liapis H, 2013, AM J PATHOL, V183, P1364, DOI 10.1016/j.ajpath.2013.06.033; Lin CL, 2006, J AM SOC NEPHROL, V17, P2812, DOI 10.1681/ASN.2005121355; Luippold G, 2004, NEPHROL DIAL TRANSPL, V19, P342, DOI 10.1093/ndt/gfg584; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Macconi D, 2009, AM J PATHOL, V174, P797, DOI 10.2353/ajpath.2009.080227; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; Marmol F, 2008, PROG NEURO-PSYCHOPH, V32, P1761, DOI 10.1016/j.pnpbp.2008.08.012; Matsui I, 2007, LAB INVEST, V87, P273, DOI 10.1038/labinvest.3700518; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Munoz-Montano Juan Ramon, 1999, J Alzheimers Dis, V1, P361; Namekata K, 2012, J NEUROSCI, V32, P264, DOI 10.1523/JNEUROSCI.4884-11.2012; NYENGAARD JR, 1993, MICROVASC RES, V45, P243, DOI 10.1006/mvre.1993.1022; Obligado S, 2008, KIDNEY INT, V73, P684, DOI 10.1038/sj.ki.5002731; Pippin JW, 2013, AM J PATHOL, V183, P542, DOI 10.1016/j.ajpath.2013.04.024; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Sanchez C, 2000, EUR J CELL BIOL, V79, P252, DOI 10.1078/S0171-9335(04)70028-X; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shankland SJ, 2013, CURR OPIN NEPHROL HY, V22, P302, DOI 10.1097/MNH.0b013e32835fefd4; Si J, 2013, KIDNEY INT, V83, P635, DOI 10.1038/ki.2012.447; Sun L, 2011, J PATHOL, V225, P364, DOI 10.1002/path.2961; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tan MH, 2013, J NEUROCHEM, V125, P685, DOI 10.1111/jnc.12230; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Wang Z, 2013, FREE RADICAL BIO MED, V65, P849, DOI 10.1016/j.freeradbiomed.2013.08.169; Wang ZY, 2010, J AM SOC NEPHROL, V21, P284, DOI 10.1681/ASN.2009080828; Waters A, 2009, J AM SOC NEPHROL, V20, P1864, DOI 10.1681/ASN.2009070762; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488; Xu W., 2014, J AM SOC NEPHROL, V25, p92A; Yang ES, 2009, J CLIN INVEST, V119, P1124, DOI 10.1172/JCI34051; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zoja C, 2002, J AM SOC NEPHROL, V13, P2898, DOI 10.1097/01.ASN.0000034912.55186.EC	72	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1348	1363		10.1074/jbc.M114.593830	http://dx.doi.org/10.1074/jbc.M114.593830			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25468908	hybrid, Green Published			2022-12-28	WOS:000348056400005
J	Falcon, B; Cavallini, A; Angers, R; Glover, S; Murray, TK; Barnham, L; Jackson, S; O'Neill, MJ; Isaacs, AM; Hutton, ML; Szekeres, PG; Goedert, M; Bose, S				Falcon, Benjamin; Cavallini, Annalisa; Angers, Rachel; Glover, Sarah; Murray, Tracey K.; Barnham, Luanda; Jackson, Samuel; O'Neill, Michael J.; Isaacs, Adrian M.; Hutton, Michael L.; Szekeres, Philip G.; Goedert, Michel; Bose, Suchira			Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; PATHOLOGICAL ALPHA-SYNUCLEIN; DEPENDENT PROTEIN-KINASE; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; CORTICOBASAL DEGENERATION; NEUROFIBRILLARY TANGLES; PTDP-43 PATHOLOGY; MAMMALIAN PRIONS; BETA-STRUCTURE	Intracellular Tau inclusions are a pathological hallmark of several neurodegenerative diseases, collectively known as the tauopathies. They include Alzheimer disease, tangle-only dementia, Pick disease, argyrophilic grain disease, chronic traumatic encephalopathy, progressive supranuclear palsy, and cortico-basal degeneration. Tau pathology appears to spread through intercellular propagation, requiring the formation of assembled "prion-like" species. Several cell and animal models have been described that recapitulate aspects of this phenomenon. However, the molecular characteristics of seed-competent Tau remain unclear. Here, we have used a cell model to understand the relationships between Tau structure/phosphorylation and seeding by aggregated Tau species from the brains of mice transgenic for human mutant P301S Tau and full-length aggregated recombinant P301S Tau. Deletion of motifs (275)VQIINK(280) and (306)VQIVYK(311) abolished the seeding activity of recombinant full-length Tau, suggesting that its aggregation was necessary for seeding. We describe conformational differences between native and synthetic Tau aggregates that may account for the higher seeding activity of native assembled Tau. When added to aggregated Tau seeds from the brains of mice transgenic for P301S Tau, soluble recombinant Tau aggregated and acquired the molecular properties of aggregated Tau from transgenic mouse brain. We show that seeding is conferred by aggregated Tau that enters cells through macropinocytosis and seeds the assembly of endogenous Tau into filaments.	[Falcon, Benjamin; Angers, Rachel; Goedert, Michel] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Cavallini, Annalisa; Angers, Rachel; Glover, Sarah; Murray, Tracey K.; Barnham, Luanda; Jackson, Samuel; O'Neill, Michael J.; Hutton, Michael L.; Szekeres, Philip G.; Bose, Suchira] Eli Lilly & Co, Windlesham GU20 6PH, Surrey, England; [Isaacs, Adrian M.] UCL Inst Neurol, London WC1N 3BG, England	MRC Laboratory Molecular Biology; Eli Lilly; University of London; University College London	Goedert, M (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	mg@mrc-lmb.cam.ac.uk; bose_suchira@lilly.com		Ryskeldi-Falcon, Benjamin/0000-0002-8176-2618	Medical Research Council [1359123] Funding Source: researchfish; MRC [MR/J004022/1, MC_U105184291] Funding Source: UKRI; Medical Research Council [MC_U105184291, MR/J004022/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Allen B, 2002, J NEUROSCI, V22, P9340; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, ACTA NEUROPATHOL, V121, P589, DOI 10.1007/s00401-011-0825-z; Brettschneider J, 2014, ACTA NEUROPATHOL, V127, P423, DOI 10.1007/s00401-013-1238-y; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; Cavallini A, 2013, J BIOL CHEM, V288, P23331, DOI 10.1074/jbc.M113.463984; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2013, BRAIN PATHOL, V23, P342, DOI 10.1111/bpa.12044; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Delacourte A, 1996, J NEUROPATH EXP NEUR, V55, P159, DOI 10.1097/00005072-199602000-00004; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; FLAMENT S, 1991, ACTA NEUROPATHOL, V81, P591, DOI 10.1007/BF00296367; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Ghaemmaghami S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000673; Goedert M, 1997, FEBS LETT, V409, P57, DOI 10.1016/S0014-5793(97)00483-3; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Jicha GA, 1999, J NEUROCHEM, V72, P214, DOI 10.1046/j.1471-4159.1999.0720214.x; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; KSIEZAKREDING H, 1994, AM J PATHOL, V145, P1496; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morozova OA, 2013, BIOCHEMISTRY-US, V52, P6960, DOI 10.1021/bi400866w; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Noda K, 2006, NEUROPATHOLOGY, V26, P508, DOI 10.1111/j.1440-1789.2006.00722.x; Perez M, 1996, J NEUROCHEM, V67, P1183; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Puoti G, 1999, NEUROLOGY, V53, P2173, DOI 10.1212/WNL.53.9.2173; Ramachandran G, 2011, J BIOL CHEM, V286, P38948, DOI 10.1074/jbc.M111.271874; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911, DOI 10.1093/jnen/63.9.911; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Santa-Maria I, 2012, J BIOL CHEM, V287, P20522, DOI 10.1074/jbc.M111.323279; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Togo T, 2002, J NEUROPATH EXP NEUR, V61, P547, DOI 10.1093/jnen/61.6.547; Tremblay MA, 2010, J ALZHEIMERS DIS, V19, P721, DOI 10.3233/JAD-2010-1271; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wegmann S, 2013, P NATL ACAD SCI USA, V110, pE313, DOI 10.1073/pnas.1212100110; Wilson DM, 1997, AM J PATHOL, V150, P2181; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yoshida H, 2006, J NEUROCHEM, V99, P154, DOI 10.1111/j.1471-4159.2006.04052.x; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	75	168	174	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1049	1065		10.1074/jbc.M114.589309	http://dx.doi.org/10.1074/jbc.M114.589309			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25406315	Green Published, hybrid			2022-12-28	WOS:000347778200037
J	Denhez, B; Lizotte, F; Guimond, MO; Jones, N; Takano, T; Geraldes, P				Denhez, Benoit; Lizotte, Farah; Guimond, Marie-Odile; Jones, Nina; Takano, Tomoko; Geraldes, Pedro			Increased SHP-1 Protein Expression by High Glucose Levels Reduces Nephrin Phosphorylation in Podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Nephrology; Phosphotyrosine; Podocyte; Src Homology 2 domain (SH2 domain); Protein-Tyrosine Phosphatase (Tyrosine Phosphatase); Nephrin	DIABETIC-NEPHROPATHY; KIDNEY-DISEASE; GROWTH-FACTOR; NCK; ACTIVATION; KINASE; MICE; MUTATIONS; APOPTOSIS; MAINTAIN	Background: Elevated expression of SHP-1 in diabetic podocytes may potentially interact with nephrin phosphorylation. Results: Rat nephrin Tyr(1127) and Tyr(1152) are essential for SHP-1 induced nephrin dephosphorylation under high-glucose conditions. Conclusion: SHP-1 contributes to nephrin deactivation in podocytes exposed to high glucose levels. Significance: Reduction of SHP-1 may serve as potential therapeutic target to prevent glomerular pathology in diabetes. Nephrin, a critical podocyte membrane component that is reduced in diabetic nephropathy, has been shown to activate phosphotyrosine signaling pathways in human podocytes. Nephrin signaling is important to reduce cell death induced by apoptotic stimuli. We have shown previously that high glucose level exposure and diabetes increased the expression of SHP-1, causing podocyte apoptosis. SHP-1 possesses two Src homology 2 domains that serve as docking elements to dephosphorylate tyrosine residues of target proteins. However, it remains unknown whether SHP-1 interacts with nephrin and whether its elevated expression affects the nephrin phosphorylation state in diabetes. Here we show that human podocytes exposed to high glucose levels exhibited elevated expression of SHP-1, which was associated with nephrin. Coexpression of nephrin-CD16 and SHP-1 reduced nephrin tyrosine phosphorylation in transfected human embryonic kidney 293 cells. A single tyrosine-to-phenylalanine mutation revealed that rat nephrin Tyr(1127) and Tyr(1152) are required to allow SHP-1 interaction with nephrin. Overexpression of dominant negative SHP-1 in human podocytes prevented high glucose-induced reduction of nephrin phosphorylation. In vivo, immunoblot analysis demonstrated that nephrin expression and phosphorylation were decreased in glomeruli of type 1 diabetic Akita mice (Ins2(+/C96Y)) compared with control littermate mice (Ins2(+/+)), and this was associated with elevated SHP-1 and cleaved caspase-3 expression. Furthermore, immunofluorescence analysis indicated increased colocalization of SHP-1 with nephrin in diabetic mice compared with control littermates. In conclusion, our results demonstrate that high glucose exposure increases SHP-1 interaction with nephrin, causing decreased nephrin phosphorylation, which may, in turn, contribute to diabetic nephropathy.	[Denhez, Benoit; Lizotte, Farah; Guimond, Marie-Odile; Geraldes, Pedro] Univ Sherbrooke, Res Ctr, Ctr Hosp, Quebec City, PQ J1H 5N4, Canada; [Denhez, Benoit; Lizotte, Farah; Guimond, Marie-Odile; Geraldes, Pedro] Univ Sherbrooke, Dept Med, Div Endocrinol, Quebec City, PQ J1H 5N4, Canada; [Jones, Nina] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Takano, Tomoko] McGill Univ, Ctr Hlth, Montreal, PQ H3H 2R9, Canada	Laval University; University of Sherbrooke; University of Sherbrooke; University of Guelph; McGill University	Geraldes, P (corresponding author), Univ Sherbrooke, Dept Med, Div Endocrinol, Quebec City, PQ J1H 5N4, Canada.	Pedro.Geraldes@USherbrooke.ca			Canadian Institute of Health Research [201209PNI]; Juvenile Diabetes Research Foundation [27-2012-531]; Fonds de Recherche du Quebec-Sante; Canadian Diabetes Association	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Canadian Diabetes Association	This work was supported by Canadian Institute of Health Research Grant 201209PNI (to P. G.) and Juvenile Diabetes Research Foundation Grant 27-2012-531 (to P. G.). This work was performed at the Centre Hospitalier Universitaire de Sherbrooke Research Center funded by the Fonds de Recherche du Quebec-Sante.; Holder of the Canadian Research Chair in Vascular Complications of Diabetes and recipient of a scholarship award from the Canadian Diabetes Association. To whom correspondence should be addressed: Div. of Endocrinology, Depts. of Medicine, Universite de Sherbrooke, Quebec, Canada. Tel.: 819-820-6868 ext. 12442; Fax: 819-564-5292; E-mail: Pedro.Geraldes@USherbrooke.ca.	Aoudjit L, 2011, J SIGNAL TRANSDUCT, V2011, DOI [10.1155/2011/376543, DOI 10.1155/2011/376543]; Baelde HJ, 2007, KIDNEY INT, V71, P637, DOI 10.1038/sj.ki.5002101; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Collins A. J., 2006, AM J KIDNEY DIS, V49, pS1; Coward RJM, 2005, DIABETES, V54, P3095, DOI 10.2337/diabetes.54.11.3095; Drapeau N, 2013, AM J PHYSIOL-ENDOC M, V304, pE1188, DOI 10.1152/ajpendo.00560.2012; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Foster RR, 2005, AM J PHYSIOL-RENAL, V288, pF48, DOI 10.1152/ajprenal.00146.2004; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Hohenstein B, 2006, KIDNEY INT, V69, P1654, DOI 10.1038/sj.ki.5000294; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jones N, 2009, J AM SOC NEPHROL, V20, P1533, DOI 10.1681/ASN.2009010056; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JJ, 2007, J AM SOC NEPHROL, V18, P2303, DOI 10.1681/ASN.2006101145; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Mima A, 2012, FASEB J, V26, P2963, DOI 10.1096/fj.11-202994; New LA, 2013, J BIOL CHEM, V288, P1500, DOI 10.1074/jbc.M112.439463; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Reiser J, 2000, KIDNEY INT, V57, P2035, DOI 10.1046/j.1523-1755.2000.00070.x; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Roy S, 2010, ENDOCRINOLOGY, V151, P660, DOI 10.1210/en.2009-0826; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Welsh GI, 2010, J PATHOL, V220, P328, DOI 10.1002/path.2661; Wharram BL, 2000, J CLIN INVEST, V106, P1281, DOI 10.1172/JCI7236; White KE, 2002, DIABETES, V51, P3083, DOI 10.2337/diabetes.51.10.3083; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	39	34	37	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					350	358		10.1074/jbc.M114.612721	http://dx.doi.org/10.1074/jbc.M114.612721			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25404734	hybrid, Green Published			2022-12-28	WOS:000347231200031
J	Ito, S; Horikawa, S; Suzuki, T; Kawauchi, H; Tanaka, Y; Suzuki, T; Suzuki, T				Ito, Satoshi; Horikawa, Sayuri; Suzuki, Tateki; Kawauchi, Hiroki; Tanaka, Yoshikazu; Suzuki, Takeo; Suzuki, Tsutomu			Human NAT10 Is an ATP-dependent RNA Acetyltransferase Responsible for N-4-Acetylcytidine Formation in 18 S Ribosomal RNA (rRNA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-SUBUNIT; PROTEIN; ACETYLATION; ANTICODON; DATABASE; CANCER	Human N-acetyltransferase 10 (NAT10) is known to be a lysine acetyltransferase that targets microtubules and histones and plays an important role in cell division. NAT10 is highly expressed in malignant tumors, and is also a promising target for therapies against laminopathies and premature aging. Here we report that NAT10 is an ATP-dependent RNA acetyltransferase responsible for formation of N-4-acetylcytidine (ac(4)C) at position 1842 in the terminal helix of mammalian 18 S rRNA. RNAi-mediated knockdown of NAT10 resulted in growth retardation of human cells, and this was accompanied by high-level accumulation of the 30 S precursor of 18 S rRNA, suggesting that ac(4)C1842 formation catalyzed by NAT10 is involved in rRNA processing and ribosome biogenesis.	[Ito, Satoshi; Horikawa, Sayuri; Suzuki, Takeo; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Suzuki, Tateki; Kawauchi, Hiroki; Tanaka, Yoshikazu] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Tanaka, Yoshikazu] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan	University of Tokyo; Hokkaido University; Hokkaido University	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ts@chembio.t.u-tokyo.ac.jp	Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731; Tanaka, Yoshikazu/0000-0002-7893-3236	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research on priority areas from the Ministry of Education, Science, Sports, and Culture of Japan (to Tsutomu Suzuki).	Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; Chimnaronk S, 2009, EMBO J, V28, P1362, DOI 10.1038/emboj.2009.69; He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482; Ikeuchi Y, 2008, EMBO J, V27, P2194, DOI 10.1038/emboj.2008.154; Ito S, 2014, J BIOL CHEM, V289, P26201, DOI 10.1074/jbc.M114.593996; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Kong RR, 2011, J BIOL CHEM, V286, P7139, DOI 10.1074/jbc.M110.173393; Larrieu D, 2014, SCIENCE, V344, P527, DOI 10.1126/science.1252651; Lv JJ, 2003, BIOCHEM BIOPH RES CO, V311, P506, DOI 10.1016/j.bbrc.2003.09.235; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; McCann KL, 2013, SCIENCE, V341, P849, DOI 10.1126/science.1244156; MCCARROLL R, 1983, BIOCHEMISTRY-US, V22, P5858, DOI 10.1021/bi00294a027; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P60, DOI 10.1016/1044-0305(92)85019-G; Miyauchi K, 2013, NAT CHEM BIOL, V9, P105, DOI [10.1038/NCHEMBIO.1137, 10.1038/nchembio.1137]; Mullineux ST, 2012, BIOCHIMIE, V94, P1521, DOI 10.1016/j.biochi.2012.02.001; Piekna-Przybylska D, 2008, NUCLEIC ACIDS RES, V36, pD178, DOI 10.1093/nar/gkm855; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Sondalle SB, 2014, BBA-MOL BASIS DIS, V1842, P758, DOI 10.1016/j.bbadis.2013.11.004; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Tan TZ, 2013, EMBO MOL MED, V5, P1051, DOI 10.1002/emmm.201201823; THOMAS G, 1978, J BIOL CHEM, V253, P1101; Zhang H, 2014, CLIN CANCER RES, V20, P4717, DOI 10.1158/1078-0432.CCR-13-3477	24	82	85	7	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35724	35730		10.1074/jbc.C114.602698	http://dx.doi.org/10.1074/jbc.C114.602698			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25411247	hybrid, Green Published			2022-12-28	WOS:000346897900005
J	Mori, Y; Akita, K; Tanida, S; Ishida, A; Toda, M; Inoue, M; Yashiro, M; Sawada, T; Hirakawa, K; Nakada, H				Mori, Yugo; Akita, Kaoru; Tanida, Shuhei; Ishida, Akiko; Toda, Munetoyo; Inoue, Mizue; Yashiro, Masakazu; Sawada, Tetsuji; Hirakawa, Kosei; Nakada, Hiroshi			MUC1 Protein Induces Urokinase-type Plasminogen Activator (uPA) by Forming a Complex with NF-kappa B p65 Transcription Factor and Binding to the uPA Promoter, Leading to Enhanced Invasiveness of Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cell Invasion; Mucin 1; Cell Surface Associated (MUC1); NF-B Transcription Factor; Transcription Regulation; uPA	INTERCELLULAR-ADHESION MOLECULE-1; CARCINOMA-ASSOCIATED ANTIGEN; BETA-CATENIN; ONCOPROTEIN FUNCTIONS; PROTEOLYTIC CLEAVAGE; BREAST CARCINOMAS; REGULATORY LOOP; DOWN-REGULATION; TARGET GENES; E-CADHERIN	Mucin 1 (MUC1) is overexpressed in various human malignant tumors and its expression is correlated with a poor prognosis. MUC1 engages in signal transduction by interacting with receptors for growth and differentiation factors, which contributes to the growth and survival of cancer cells. However, the mechanism by which MUC1 promotes cancer cell invasion remains unclear. Microarray analysis revealed that expression of urokinase-type plasminogen activator (uPA) was elevated in MUC1-overexpressing cells. Furthermore, up- and down-modulation of MUC1 expression was clearly correlated with the change of uPA expression. An immunochemical study showed that the distribution of uPA coincided with that of MUC1 in various human cancer tissues. The MUC1 C-terminal domain (MUC1-CD) was associated with nuclear factor-B (NF-B) p65 in MUC1-expressing cells. Chromatin immunoprecipitation (ChIP) assays demonstrated that MUC1-CD existed with NF-B p65 on the uPA promoter. Luciferase assays indicated that the uPA transcriptional activity was correlated with the level of MUC1 expression and that this MUC1-enhancing effect on the uPA transcription was abolished by introduction of mutations into the NF-B binding sites on the uPA promoter. These results indicate that formation of the MUC1-CD and NF-B p65 complex enhanced nuclear translocation of NF-B p65 and subsequent occupancy of NF-B binding region on the uPA promoter, leading to elevated transcription of uPA. We also demonstrated that uPA induced by MUC1 enhanced the matrix metalloproteinase (MMP)-2 and -9 activities, and consequently promoted cancer cell invasion. Thus, a MUC1 co-operating NF-B signaling pathway plays a critical role in cancer cell invasion in MUC1-expressing cells.	[Mori, Yugo; Akita, Kaoru; Tanida, Shuhei; Ishida, Akiko; Toda, Munetoyo; Inoue, Mizue; Nakada, Hiroshi] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kyoto 6038555, Japan; [Yashiro, Masakazu; Sawada, Tetsuji; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 5458585, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Oncol Inst Geriatr & Med Sci, Osaka 5458585, Japan	Kyoto Sangyo University; Osaka Metropolitan University; Osaka Metropolitan University	Nakada, H (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan.	hnakada@cc.kyoto-su.ac.jp			Private University Strategic Research Foundation Support Program	Private University Strategic Research Foundation Support Program	This work was supported by the Private University Strategic Research Foundation Support Program.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Cantero D, 1997, BRIT J CANCER, V75, P388, DOI 10.1038/bjc.1997.63; Cicek M, 2009, CLIN EXP METASTAS, V26, P229, DOI 10.1007/s10585-009-9235-1; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Farina AR, 1999, CELL GROWTH DIFFER, V10, P353; GENDLER S, 1988, J BIOL CHEM, V263, P12820; Ghiso JAA, 2002, ONCOGENE, V21, P2513, DOI 10.1038/sj/onc/1205342; Gond CS, 2007, INT J ONCOL, V31, P19; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He Y, 2007, CLIN CANCER RES, V13, P3115, DOI 10.1158/1078-0432.CCR-06-2088; Hemsen A, 2003, INT J CANCER, V107, P903, DOI 10.1002/ijc.11488; Hiendlmeyer E, 2004, CANCER RES, V64, P1209, DOI 10.1158/0008-5472.CAN-3627-2; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Irigoyen JP, 1999, CELL MOL LIFE SCI, V56, P104, DOI 10.1007/PL00000615; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Memarzedeh S, 2002, P NATL ACAD SCI USA, V99, P10647, DOI 10.1073/pnas.152127499; MERLO GR, 1989, CANCER RES, V49, P6966; NAKAMORI S, 1994, GASTROENTEROLOGY, V106, P353, DOI 10.1016/0016-5085(94)90592-4; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; NIELSEN LS, 1986, FEBS LETT, V196, P269, DOI 10.1016/0014-5793(86)80261-7; NOVAK U, 1991, NUCLEIC ACIDS RES, V19, P3389, DOI 10.1093/nar/19.12.3389; Parry S, 2001, BIOCHEM BIOPH RES CO, V283, P715, DOI 10.1006/bbrc.2001.4775; Qu CF, 2004, BRIT J CANCER, V91, P2086, DOI 10.1038/sj.bjc.6602232; Rahn JJ, 2004, J BIOL CHEM, V279, P29386, DOI 10.1074/jbc.C400010200; Raina D, 2012, INT J ONCOL, V40, P1644, DOI 10.3892/ijo.2011.1308; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Rajabi H, 2014, ONCOGENE, V33, P1680, DOI 10.1038/onc.2013.114; Ren J, 2006, MOL CANCER RES, V4, P873, DOI 10.1158/1541-7786.MCR-06-0204; Sahraei M, 2012, ONCOGENE, V31, P4935, DOI 10.1038/onc.2011.651; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shen Q, 2008, MOL CANCER RES, V6, P555, DOI 10.1158/1541-7786.MCR-07-2033; SIDDIQUI J, 1988, P NATL ACAD SCI USA, V85, P2320, DOI 10.1073/pnas.85.7.2320; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Tanida S, 2014, BBA-GEN SUBJECTS, V1840, P1790, DOI 10.1016/j.bbagen.2014.02.008; Tanida S, 2013, J BIOL CHEM, V288, P31842, DOI 10.1074/jbc.M113.471318; Toupance S, 2012, CLIN EXP METASTAS, V29, P511, DOI 10.1007/s10585-012-9467-3; Ustach CV, 2005, MOL CELL BIOL, V25, P6279, DOI 10.1128/MCB.25.14.6279-6288.2005; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; Wang Q, 2010, ONCOGENE, V29, P128, DOI 10.1038/onc.2009.302; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wesseling J, 1996, MOL BIOL CELL, V7, P565, DOI 10.1091/mbc.7.4.565; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492	54	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35193	35204		10.1074/jbc.M114.586461	http://dx.doi.org/10.1074/jbc.M114.586461			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25371209	Green Published, hybrid			2022-12-28	WOS:000346660200013
J	Ma, ZY; Vosseller, K				Ma, Zhiyuan; Vosseller, Keith			Cancer Metabolism and Elevated O-GlcNAc in Oncogenic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Cancer; Glycosylation; Metabolism; O-GlcNAcylation; Signal Transduction; Warburg Effect; O-GlcNAc; OGT	BETA-N-ACETYLGLUCOSAMINE; SHOCK-PROTEIN EXPRESSION; C-MYC; KAPPA-B; OXIDATIVE STRESS; NUCLEOCYTOPLASMIC PROTEINS; TRANSCRIPTIONAL ACTIVITY; LINKED GLYCOSYLATION; ANGIOGENIC SWITCH; CELL-GROWTH	O-Linked -N-acetylglucosamine (O-GlcNAc) is a carbohydrate post-translational modification on hydroxyl groups of serine and/or threonine residues of cytosolic and nuclear proteins. Analogous to phosphorylation, O-GlcNAcylation plays crucial regulatory roles in cellular signaling. Recent work indicates that increased O-GlcNAcylation is a general feature of cancer and contributes to transformed phenotypes. In this minireview, we discuss how hyper-O-GlcNAcylation may be linked to various hallmarks of cancer, including cancer cell proliferation, survival, invasion, and metastasis; energy metabolism; and epigenetics. We also discuss potential therapeutic modulation of O-GlcNAc levels in cancer treatment.	[Ma, Zhiyuan; Vosseller, Keith] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA	Drexel University	Vosseller, K (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA.	keith.vosseller@drexelmed.edu	Ma, Zhiyuan/I-6678-2015	Ma, Zhiyuan/0000-0002-0381-7804				Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; CHOU TY, 1995, P NATL ACAD SCI USA, V92, P4417, DOI 10.1073/pnas.92.10.4417; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Dai CK, 2012, J CELL PHYSIOL, V227, P2982, DOI 10.1002/jcp.24017; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Frank LA, 2014, HUM REPROD, V29, P1292, DOI 10.1093/humrep/deu066; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Gong J, 2011, MINERVA ANESTESIOL, V77, P488; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Guinez C, 2004, BIOCHEM BIOPH RES CO, V319, P21, DOI 10.1016/j.bbrc.2004.04.144; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Huang X, 2013, J BIOL CHEM, V288, P36418, DOI 10.1074/jbc.M113.495713; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Kamigaito T, 2014, PROSTATE CANCER P D, V17, P18, DOI 10.1038/pcan.2013.56; Kanwal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069150; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Kwei KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046518; Lewis BA, 2014, J BIOL CHEM, V289, P34440, DOI 10.1074/jbc.R114.595439; Liu J, 2007, J MOL CELL CARDIOL, V42, P177, DOI 10.1016/j.yjmcc.2006.09.015; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Manzari B, 2007, INT J IMMUNOPATH PH, V20, P47, DOI 10.1177/039463200702000106; Marotta NP, 2012, CHEMBIOCHEM, V13, P2665, DOI 10.1002/cbic.201200478; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nandi A, 2006, ANAL CHEM, V78, P452, DOI 10.1021/ac051207j; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Olivier-Van Stichelen S, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.36; Onodera Y, 2014, J CLIN INVEST, V124, P367, DOI 10.1172/JCI63146; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Park SY, 2010, EMBO J, V29, P3787, DOI 10.1038/emboj.2010.254; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Penque BA, 2013, MOL ENDOCRINOL, V27, P536, DOI 10.1210/me.2012-1213; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rozanski W, 2012, CLIN LAB, V58, P579; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sakiyama H, 2010, BIOCHEM BIOPH RES CO, V402, P784, DOI 10.1016/j.bbrc.2010.10.113; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Singleton KD, 2008, JPEN-PARENTER ENTER, V32, P371, DOI 10.1177/0148607108320661; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tomic J, 2013, EXP HEMATOL, V41, P675, DOI 10.1016/j.exphem.2013.04.004; Tong XM, 2009, P NATL ACAD SCI USA, V106, P21660, DOI 10.1073/pnas.0911316106; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yehezkel G, 2012, J BIOL CHEM, V287, P28755, DOI 10.1074/jbc.M112.345546; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/nchembio.797, 10.1038/NCHEMBIO.797]; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zhang FX, 2012, AM J PHYSIOL-CELL PH, V302, pC1786, DOI 10.1152/ajpcell.00004.2012; Zhang Q, 2014, J BIOL CHEM, V289, P5986, DOI 10.1074/jbc.M113.524140; Zhu QQ, 2012, MED ONCOL, V29, P985, DOI 10.1007/s12032-011-9912-1; Zhu WJ, 2001, EMBO J, V20, P5999, DOI 10.1093/emboj/20.21.5999	98	124	129	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34457	34465		10.1074/jbc.R114.577718	http://dx.doi.org/10.1074/jbc.R114.577718			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25336642	Green Published, hybrid			2022-12-28	WOS:000346260800006
J	Iablokov, V; Hirota, CL; Peplowski, MA; Ramachandran, R; Mihara, K; Hollenberg, MD; MacNaughton, WK				Iablokov, Vadim; Hirota, Christina L.; Peplowski, Michael A.; Ramachandran, Rithwik; Mihara, Koichiro; Hollenberg, Morley D.; MacNaughton, Wallace K.			Proteinase-activated Receptor 2 (PAR2) Decreases Apoptosis in Colonic Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; G Protein-coupled Receptor (GPCR); Intestinal Epithelium; Mitogen-activated Protein Kinase (MAPK); Protease	EPIDERMAL-GROWTH-FACTOR; ARRESTIN-DEPENDENT ENDOCYTOSIS; INFLAMMATORY BOWEL DISEASES; SIGNALING PATHWAY; ULCERATIVE-COLITIS; BAD PHOSPHORYLATION; CROHNS-DISEASE; HUMAN-TISSUES; FACTOR VIIA; EXPRESSION	Background: Inflammatory bowel disease management lacks therapies that heal the epithelial barrier. Results: PAR2 activation increases activities of MEK1/2 and PI3K in intestinal epithelial cells, which blocks apoptosis. Conclusion: Cytokine-induced apoptosis in colonic epithelial cells is inhibited by PAR2 signaling. Significance: PAR2 is important in maintaining intestinal epithelial homeostasis. Mucosal biopsies from inflamed colon of inflammatory bowel disease patients exhibit elevated epithelial apoptosis compared with those from healthy individuals, disrupting mucosal homeostasis and perpetuating disease. Therapies that decrease intestinal epithelial apoptosis may, therefore, ameliorate inflammatory bowel disease, but treatments that specifically target apoptotic pathways are lacking. Proteinase-activated receptor-2 (PAR2), a G protein-coupled receptor activated by trypsin-like serine proteinases, is expressed on intestinal epithelial cells and stimulates mitogenic pathways upon activation. We sought to determine whether PAR2 activation and signaling could rescue colonic epithelial (HT-29) cells from apoptosis induced by proapoptotic cytokines that are increased during inflammatory bowel disease. The PAR2 agonists 2-furoyl-LIGRLO (2f-LI), SLIGKV and trypsin all significantly reduced cleavage of caspase-3, -8, and -9, poly(ADP-ribose) polymerase, and the externalization of phosphatidylserine after treatment of cells with IFN- and TNF-. Knockdown of PAR2 with siRNA eliminated the anti-apoptotic effect of 2f-LI and increased the sensitivity of HT-29 cells to cytokine-induced apoptosis. Concurrent inhibition of both MEK1/2 and PI3K was necessary to inhibit PAR2-induced survival. 2f-LI was found to increase phosphorylation and inactivation of pro-apoptotic BAD at Ser(112) and Ser(136) by MEK1/2 and PI3K-dependent signaling, respectively. PAR2 activation also increased the expression of anti-apoptotic MCL-1. Simultaneous knockdown of both BAD and MCL-1 had minimal effects on PAR2-induced survival, whereas single knockdown had no effect. We conclude that PAR2 activation reduces cytokine-induced epithelial apoptosis via concurrent stimulation of MEK1/2 and PI3K but little involvement of MCL-1 and BAD. Our findings represent a novel mechanism whereby serine proteinases facilitate epithelial cell survival and may be important in the context of colonic healing.	Univ Calgary, Dept Physiol & Pharmacol, Inflammat Res Network, Calgary, AB T2N 4N1, Canada; Univ Calgary, Snyder Inst Chron Dis, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	MacNaughton, WK (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	wmacnaug@ucalgary.ca	Ramachandran, Rithwik/N-7815-2015; Hollenberg, Morley/AFV-6966-2022; Hirota, Christina/AAS-8585-2020	Ramachandran, Rithwik/0000-0001-9557-9905; Hirota, Christina/0000-0003-0799-2041	Crohn's and Colitis Canada	Crohn's and Colitis Canada	This work was supported by a grant-in-aid from Crohn's and Colitis Canada (to W. K. M.).	Adams MN, 2012, N-S ARCH PHARMACOL, V385, P861, DOI 10.1007/s00210-012-0783-6; Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Baert F, 2010, GASTROENTEROLOGY, V138, P463, DOI 10.1053/j.gastro.2009.09.056; Booy EP, 2011, ONCOGENE, V30, P2367, DOI 10.1038/onc.2010.616; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; D'Andrea MR, 1998, J HISTOCHEM CYTOCHEM, V46, P157; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Darragh MR, 2010, CANCER RES, V70, P1505, DOI 10.1158/0008-5472.CAN-09-1640; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Degasperi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087293; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dirisina R, 2011, GASTROENTEROLOGY, V141, P1036, DOI 10.1053/j.gastro.2011.05.032; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Gilmore AP, 2002, J BIOL CHEM, V277, P27643, DOI 10.1074/jbc.M108863200; Gitter AH, 2001, GASTROENTEROLOGY, V121, P1320, DOI 10.1053/gast.2001.29694; Gratio V, 2011, AM J PATHOL, V179, P2625, DOI 10.1016/j.ajpath.2011.07.016; Grossmann J, 2002, AM J GASTROENTEROL, V97, P1421, DOI 10.1016/S0002-9270(02)04143-6; Hirota CL, 2012, AM J PHYSIOL-GASTR L, V303, pG111, DOI 10.1152/ajpgi.00358.2011; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; Iwamoto M, 1996, J PATHOL, V180, P152; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kiesslich R, 2012, GUT, V61, P1146, DOI 10.1136/gutjnl-2011-300695; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kobayashi S, 2005, GASTROENTEROLOGY, V128, P2054, DOI 10.1053/j.gastro.2005.03.010; Kong WY, 1997, P NATL ACAD SCI USA, V94, P8884, DOI 10.1073/pnas.94.16.8884; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Ma YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072383; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Neurath MF, 2012, GUT, V61, P1619, DOI 10.1136/gutjnl-2012-302830; O'Connell J, 2000, J CELL PHYSIOL, V185, P331, DOI 10.1002/1097-4652(200012)185:3<331::AID-JCP3>3.0.CO;2-V; Ossina NK, 1997, J BIOL CHEM, V272, P16351, DOI 10.1074/jbc.272.26.16351; PROCACCINO F, 1994, GASTROENTEROLOGY, V107, P12, DOI 10.1016/0016-5085(94)90055-8; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; Sawamukai N, 2010, ARTHRITIS RHEUM-US, V62, P952, DOI 10.1002/art.27331; Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sinha A, 2003, NEW ENGL J MED, V349, P350, DOI 10.1056/NEJMoa013136; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sorensen BB, 2003, BLOOD, V102, P1708, DOI 10.1182/blood-2003-01-0157; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Townsend KJ, 1999, J BIOL CHEM, V274, P1801, DOI 10.1074/jbc.274.3.1801; Tsuruta F, 2002, J BIOL CHEM, V277, P14040, DOI 10.1074/jbc.M108975200; Versteeg HH, 2004, ONCOGENE, V23, P410, DOI 10.1038/sj.onc.1207066; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Wang P, 2007, BIOCHEM J, V408, P221, DOI 10.1042/BJ20070483; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	63	40	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34366	34377		10.1074/jbc.M114.610485	http://dx.doi.org/10.1074/jbc.M114.610485			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25331954	Green Published, hybrid			2022-12-28	WOS:000346077600056
J	Xiao, N; Li, H; Mei, WH; Cheng, JK				Xiao, Ning; Li, Hui; Mei, Wenhan; Cheng, Jinke			SUMOylation Attenuates Human beta-Arrestin 2 Inhibition of IL-1R/TRAF6 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; UBIQUITINATION; ACTIVATION; REQUIRES; KINASE; SUMO; BETA-ARRESTIN2; DEGRADATION; PROTEINS; HISTORY	beta-Arrestin 2 as an adaptor plays a role in the regulation of receptor desensitization, trafficking, and signaling. Bovine beta-arrestin 2 has been shown to be SUMOylated on the lysine 400 residue, which links it to the endocytosis of the beta(2)-adrenergic receptor. Here we identify a major SUMOylation site, lysine 295, on human beta-arrestin 2. SUMOylation on this site attenuates beta-arrestin 2 binding to TRAF6, then enhances TRAF6 oligomerization and autoubiquitination, and consequently leads to the increase of TRAF6-mediated NF-kappa B/AP-1 activation. We further determine SENP1 as a specific de-SUMOylation protease that can reverse the SUMOylation of beta-arrestin 2-mediated processes. Our study reveals SUMOylation as a novel mechanism in the regulation of beta-arrestin 2-mediated IL-1R/TRAF6 signaling.	[Xiao, Ning; Mei, Wenhan; Cheng, Jinke] Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200025, Peoples R China; [Xiao, Ning; Cheng, Jinke] Shanghai Jiao Tong Univ, Shanghai Canc Inst, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai 200025, Peoples R China; [Li, Hui] Shanghai Jiao Tong Univ, Sch Med, Pediat Translat Med Inst, Key Lab Pediat Hematol & Oncol,Minist Hlth, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Mei, WH (corresponding author), Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Sch Med, 280 Chongqing S Rd, Shanghai 200025, Peoples R China.	jymeiwh@shsmu.edu.cn; jkcheng@shsmu.edu.cn			National Basic Research Program of China (973 Program) [2013CB910902]; National Natural Science Foundation of China [91019021, 81302296]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program) Grant 2013CB910902 (to J. C.) and National Natural Science Foundation of China Grants 91019021 to J. C.) and 81302296 (to W. M.).	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Bonnans C, 2012, P NATL ACAD SCI USA, V109, P3047, DOI 10.1073/pnas.1109457109; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chung JY, 2002, J CELL SCI, V115, P679; Creton S, 2010, CELL, V143, P848, DOI 10.1016/j.cell.2010.11.026; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dickey BF, 2010, CURR OPIN PHARMACOL, V10, P254, DOI 10.1016/j.coph.2010.03.002; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; Kawai T, 2005, ARTHRITIS RES THER, V7, P12, DOI 10.1186/ar1469; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Lin FT, 2002, BIOCHEMISTRY-US, V41, P10692, DOI 10.1021/bi025705n; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Smith WC, 2000, INVEST OPHTH VIS SCI, V41, P2445; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wyatt D, 2011, J BIOL CHEM, V286, P3884, DOI 10.1074/jbc.M110.152116; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	30	14	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1927	1935		10.1074/jbc.M114.608703	http://dx.doi.org/10.1074/jbc.M114.608703			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25425640	Green Published, hybrid			2022-12-28	WOS:000348588000003
J	Bourne, Y; Renault, L; Marchot, P				Bourne, Yves; Renault, Ludovic; Marchot, Pascale			Crystal Structure of Snake Venom Acetylcholinesterase in Complex with Inhibitory Antibody Fragment Fab410 Bound at the Peripheral Site EVIDENCE FOR OPEN AND CLOSED STATES OF A BACK DOOR CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUNGARUS-FASCIATUS VENOM; DROSOPHILA-MELANOGASTER ACETYLCHOLINESTERASE; TORPEDO-CALIFORNICA; MOLECULAR-DYNAMICS; MOUSE ACETYLCHOLINESTERASE; MONOCLONAL-ANTIBODIES; SUBSTRATE; FASCICULIN; BINDING; GORGE	The acetylcholinesterase found in the venom of Bungarus fasciatus (BfAChE) is produced as a soluble, non-amphiphilic monomer with a canonical catalytic domain but a distinct C terminus compared with the other vertebrate enzymes. Moreover, the peripheral anionic site of BfAChE, a surface site located at the active site gorge entrance, bears two substitutions altering sensitivity to cationic inhibitors. Antibody Elec410, generated against Electrophorus electricus acetylcholinesterase (EeAChE), inhibits EeAChE and BfAChE by binding to their peripheral sites. However, both complexes retain significant residual catalytic activity, suggesting incomplete gorge occlusion by bound antibody and/or high frequency back door opening. To explore a novel acetylcholinesterase species, ascertain the molecular bases of inhibition by Elec410, and document the determinants and mechanisms for back door opening, we solved a 2.7-angstrom resolution crystal structure of natural BfAChE in complex with antibody fragment Fab410. Crystalline BfAChE forms the canonical dimer found in all acetylcholinesterase structures. Equally represented open and closed states of a back door channel, associated with alternate positions of a tyrosine phenol ring at the active site base, coexist in each subunit. At the BfAChE molecular surface, Fab410 is seated on the long Omega-loop between two N-glycan chains and partially occludes the gorge entrance, a position that fully reflects the available mutagenesis and biochemical data. Experimentally based flexible molecular docking supports a similar Fab410 binding mode onto the EeAChE antigen. These data document the molecular and dynamic peculiarities of BfAChE with high frequency back door opening, and the mode of action of Elec410 as one of the largest peptidic inhibitors targeting the acetylcholinesterase peripheral site.	[Bourne, Yves; Marchot, Pascale] Aix Marseille Univ, F-13228 Marseille 09, France; [Bourne, Yves; Marchot, Pascale] CNRS, F-13228 Marseille 09, France; [Renault, Ludovic; Marchot, Pascale] Aix Marseille Univ, CNRS, Fac Med, Sect Nord, F-13344 Marseille 15, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Marchot, P (corresponding author), AFMB CNRS AMU UMR 7257, Campus Luminy Case 932,163 Av Luminy, F-13288 Marseille 09, France.	pascale.marchot@univ-amu.fr	MARCHOT, Pascale/AAC-4752-2022; Bourne, Yves/AAC-4635-2022	MARCHOT, Pascale/0000-0003-0630-0541; Bourne, Yves/0000-0003-3850-0548; Renault, Ludovic/0000-0001-6464-8808	Association Francaise contre les Myopathies	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by the Association Francaise contre les Myopathies (a Ph.D. grant to L. R.) and (research fees to P. M.).	Ahmed M, 2012, J VENOM ANIM TOXINS, V18, P236, DOI 10.1590/S1678-91992012000200014; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blanc E., 2011, BUSTER VERSION 2 11; Bourne Y, 1999, J BIOL CHEM, V274, P2963, DOI 10.1074/jbc.274.5.2963; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; Bourne Y, 2004, P NATL ACAD SCI USA, V101, P1449, DOI 10.1073/pnas.0308206100; Bourne Y, 2006, J BIOL CHEM, V281, P29256, DOI 10.1074/jbc.M603018200; Bourne Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077226; Carletti E, 2010, J MED CHEM, V53, P4002, DOI 10.1021/jm901853b; Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Colletier JP, 2006, EMBO J, V25, P2746, DOI 10.1038/sj.emboj.7601175; Colletier JP, 2006, J AM CHEM SOC, V128, P4526, DOI 10.1021/ja058683b; Cousin X, 1996, J BIOL CHEM, V271, P15099, DOI 10.1074/jbc.271.25.15099; Cousin X, 1996, FEBS LETT, V387, P196, DOI 10.1016/0014-5793(96)00447-4; Cousin X, 1999, J NAT TOXINS, V8, P285; Cousin Xavier, 1997, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V191, P381; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Duhaiman AS, 1996, BIOCHIMIE, V78, P46, DOI 10.1016/0300-9084(96)81328-9; EASTMAN J, 1995, J BIOL CHEM, V270, P19694, DOI 10.1074/jbc.270.34.19694; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felder CE, 2002, ACTA CRYSTALLOGR D, V58, P1765, DOI 10.1107/S0907444902011642; Frobert Y, 1997, BBA-PROTEIN STRUCT M, V1339, P253, DOI 10.1016/S0167-4838(97)00009-5; GILSON MK, 1994, SCIENCE, V263, P1276, DOI 10.1126/science.8122110; Harel M, 1995, STRUCTURE, V3, P1355, DOI 10.1016/S0969-2126(01)00273-8; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; Ito S, 2002, BBA-GENE STRUCT EXPR, V1576, P341, DOI 10.1016/S0167-4781(02)00281-6; Johnson JL, 2003, J BIOL CHEM, V278, P38948, DOI 10.1074/jbc.M304797200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KRONMAN C, 1994, J BIOL CHEM, V269, P27819; Kryger G, 2000, ACTA CRYSTALLOGR D, V56, P1385, DOI 10.1107/S0907444900010659; KUMAR V, 1973, EUR J BIOCHEM, V34, P586, DOI 10.1111/j.1432-1033.1973.tb02799.x; KUMAR V, 1975, COMP BIOCHEM PHYS C, V51, P249, DOI 10.1016/0306-4492(75)90069-6; KUMAR V, 1975, COMP BIOCHEM PHYS C, V51, P255, DOI 10.1016/0306-4492(75)90070-2; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mallender WD, 2000, BIOCHEMISTRY-US, V39, P7753, DOI 10.1021/bi000210o; MARCHOT P, 1993, J BIOL CHEM, V268, P12458; Marchot P., 2002, TOXINES RECHERCHES B, P287; Masson P, 2002, BBA-PROTEIN STRUCT M, V1594, P313, DOI 10.1016/S0167-4838(01)00323-5; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MASSOULIE J, 1976, EUR J BIOCHEM, V68, P531, DOI 10.1111/j.1432-1033.1976.tb10841.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nachon F, 2008, FEBS J, V275, P2659, DOI 10.1111/j.1742-4658.2008.06413.x; Nachon F, 2013, BIOCHEM J, V453, P393, DOI 10.1042/BJ20130013; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICKERSON PA, 1974, TOXICON, V12, P83, DOI 10.1016/0041-0101(74)90103-2; Porschke D, 1996, BIOPHYS J, V70, P1603, DOI 10.1016/S0006-3495(96)79759-X; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; RABA R, 1979, EUR J BIOCHEM, V96, P151, DOI 10.1111/j.1432-1033.1979.tb13024.x; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; RADIC Z, 1994, J BIOL CHEM, V269, P11233; RADIC Z, 1995, J BIOL CHEM, V270, P20391, DOI 10.1074/jbc.270.35.20391; RADIC Z, 1991, MOL PHARMACOL, V39, P98; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; REMY MH, 1995, EUR J BIOCHEM, V231, P651, DOI 10.1111/j.1432-1033.1995.tb20744.x; Renault L, 2005, CHEM-BIOL INTERACT, V157, P397, DOI 10.1016/j.cbi.2005.10.074; RIPOLL DR, 1993, P NATL ACAD SCI USA, V90, P5128, DOI 10.1073/pnas.90.11.5128; Sanson B, 2011, PROTEIN SCI, V20, P1114, DOI 10.1002/pro.661; SIKORAV JL, 1987, EMBO J, V6, P1865, DOI 10.1002/j.1460-2075.1987.tb02445.x; Silman I, 2008, CHEM-BIOL INTERACT, V175, P3, DOI 10.1016/j.cbi.2008.05.035; Simon S, 1997, J BIOL CHEM, V272, P33045, DOI 10.1074/jbc.272.52.33045; Simon S, 1999, J BIOL CHEM, V274, P27740, DOI 10.1074/jbc.274.39.27740; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Szegletes T, 1999, BIOCHEMISTRY-US, V38, P122, DOI 10.1021/bi9813577; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; TAYLOR P, 1975, BIOCHEMISTRY-US, V14, P1989, DOI 10.1021/bi00680a029; Vonk FJ, 2013, P NATL ACAD SCI USA, V110, P20651, DOI 10.1073/pnas.1314702110; Xu YC, 2010, BIOPHYS J, V99, P4003, DOI 10.1016/j.bpj.2010.10.047; Zhou HX, 2010, TRENDS BIOCHEM SCI, V35, P179, DOI 10.1016/j.tibs.2009.10.007	78	16	16	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1522	1535		10.1074/jbc.M114.603902	http://dx.doi.org/10.1074/jbc.M114.603902			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25411244	Green Published, hybrid			2022-12-28	WOS:000348056400022
J	Lee, DJ; Bahn, YS; Kim, HJ; Chung, SY; Kang, HA				Lee, Dong-Jik; Bahn, Yong-Sun; Kim, Hong-Jin; Chung, Seung-Yeon; Kang, Hyun Ah			Unraveling the Novel Structure and Biosynthetic Pathway of O-Linked Glycans in the Golgi Apparatus of the Human Pathogenic Yeast Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; SCHIZOSACCHAROMYCES-POMBE; PICHIA-PASTORIS; FUNCTIONAL-CHARACTERIZATION; MANNOSYL GLYCANS; GENE FAMILY; GLYCOSYLATION; MANNOSYLTRANSFERASE	Cryptococcus neoformans is an encapsulated basidiomycete causing cryptococcosis in immunocompromised humans. The cell surface mannoproteins of C. neoformans were reported to stimulate the host T-cell response and to be involved in fungal pathogenicity; however, their O-glycan structure is uncharacterized. In this study, we performed a detailed structural analysis of the O-glycans attached to cryptococcal mannoproteins using HPLC combined with exoglycosidase treatment and showed that the major C. neoformans O-glycans were short manno-oligosaccharides that were connected mostly by alpha 1,2-linkages but connected by an alpha 1,6-linkage at the third mannose residue. Comparison of the O-glycan profiles from wild-type and uxs1 Delta mutant strains strongly supports the presence of minor O-glycans carrying a xylose residue. Further analyses of C. neoformans mutant strains identified three mannosyltransferase genes involved in O-glycan extensions in the Golgi. C. neoformans KTR3, the only homolog of the Saccharomyces cerevisiae KRE2/MNT1 family genes, was shown to encode an alpha 1,2-mannosyltransferase responsible for the addition of the second mannose residue via an alpha 1,2-linkage to the major O-glycans. C. neoformans HOC1 and HOC3, homologs of the Saccharomyces cerevisiae OCH1 family genes, were shown to encode alpha 1,6-mannosyltransferases that can transfer the third mannose residue, via an alpha 1,6-linkage, to minor O-glycans containing xylose and to major O-glycans without xylose, respectively. Moreover, the C. neoformans ktr3 Delta mutant strain, which displayed increased sensitivity to SDS, high salt, and high temperature, showed attenuated virulence in a mouse model of cryptococcosis, suggesting that the extended structure of O-glycans is required for cell integrity and full pathogenicity of C. neoformans.	[Lee, Dong-Jik; Chung, Seung-Yeon; Kang, Hyun Ah] Chung Ang Univ, Dept Life Sci, Ctr Fungal Pathogenesis, Seoul 156756, South Korea; [Kim, Hong-Jin] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Bahn, Yong-Sun] Yonsei Univ, Dept Biotechnol, Ctr Fungal Pathogenesis, Seoul 120749, South Korea	Chung Ang University; Chung Ang University; Yonsei University	Kang, HA (corresponding author), Chung Ang Univ, Dept Life Sci, Ctr Fungal Pathogenesis, Seoul 156756, South Korea.	hyunkang@cau.ac.kr	Bahn, Yong-Sun/C-1211-2012	Bahn, Yong-Sun/0000-0001-9573-5752	National Research Foundation of Korea from the Korea Ministry of Education and Science Technology [NRF-2012-0001150, NRF-2013R1A1A2A10063473]	National Research Foundation of Korea from the Korea Ministry of Education and Science Technology(Ministry of Education (MOE), Republic of Korea)	This work is supported by National Research Foundation of Korea Grants NRF-2012-0001150 and NRF-2013R1A1A2A10063473 from the Korea Ministry of Education and Science Technology.	Bahn YS, 2004, EUKARYOT CELL, V3, P1476, DOI 10.1128/EC.3.6.1476-1491.2004; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Baker LG, 2011, EUKARYOT CELL, V10, P1264, DOI 10.1128/EC.05138-11; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; Biondo C, 2006, FEMS YEAST RES, V6, P645, DOI 10.1111/j.1567-1364.2006.00043.x; Cheon SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002177; Diaz-Jimenez DF, 2012, BIOCHEM BIOPH RES CO, V419, P77, DOI 10.1016/j.bbrc.2012.01.131; Duman JG, 1998, BIOTECHNOL APPL BIOC, V28, P39; Endo T, 1999, BBA-GEN SUBJECTS, V1473, P237, DOI 10.1016/S0304-4165(99)00182-8; Fernandez-Alvarez A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002563; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gentzsch M, 1997, GLYCOBIOLOGY, V7, P481, DOI 10.1093/glycob/7.4.481; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; GRAHAM TR, 1994, J CELL BIOL, V127, P667, DOI 10.1083/jcb.127.3.667; Hall RA, 2013, MOL MICROBIOL, V90, P1147, DOI 10.1111/mmi.12426; HAUSLER A, 1992, P NATL ACAD SCI USA, V89, P6846, DOI 10.1073/pnas.89.15.6846; Ikeda Y, 2009, FEMS YEAST RES, V9, P115, DOI 10.1111/j.1567-1364.2008.00458.x; Kim MS, 2009, BIOCHEM BIOPH RES CO, V390, P983, DOI 10.1016/j.bbrc.2009.10.089; Kim MW, 2006, J BIOL CHEM, V281, P6261, DOI 10.1074/jbc.M508507200; Leitao EA, 2003, GLYCOBIOLOGY, V13, P681, DOI 10.1093/glycob/cwg089; Levitz SM, 2006, FEMS YEAST RES, V6, P513, DOI 10.1111/j.1567-1364.2006.00071.x; Loibl M, 2013, BBA-MOL CELL RES, V1833, P2438, DOI 10.1016/j.bbamcr.2013.02.008; Lommel M, 2004, MOL CELL BIOL, V24, P46, DOI 10.1128/MCB.24.1.46-57.2004; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Lussier M, 1997, J BIOL CHEM, V272, P15527, DOI 10.1074/jbc.272.24.15527; Lussier M, 1996, J BIOL CHEM, V271, P11001, DOI 10.1074/jbc.271.18.11001; Mansour MK, 2006, J IMMUNOL, V176, P3053, DOI 10.4049/jimmunol.176.5.3053; Mansour MK, 2004, INFECT IMMUN, V72, P1746, DOI 10.1128/IAI.72.3.1746-1754.2004; Mansour MK, 2002, J IMMUNOL, V168, P2872, DOI 10.4049/jimmunol.168.6.2872; Mille C, 2008, J BIOL CHEM, V283, P9724, DOI 10.1074/jbc.M708825200; MOORE TDE, 1993, MOL CELL BIOL, V13, P1962, DOI 10.1128/MCB.13.3.1962; Munro CA, 2005, J BIOL CHEM, V280, P1051, DOI 10.1074/jbc.M411413200; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Neiman AM, 1997, GENETICS, V145, P637; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Park JN, 2012, J BIOL CHEM, V287, P19501, DOI 10.1074/jbc.M112.354209; Park JN, 2011, APPL ENVIRON MICROB, V77, P1187, DOI 10.1128/AEM.02323-10; Perfect JR, 2002, INFECT DIS CLIN N AM, V16, P837, DOI 10.1016/S0891-5520(02)00064-8; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Reilly MC, 2011, J BIOL CHEM, V286, P26888, DOI 10.1074/jbc.M111.262162; Romero PA, 1999, GLYCOBIOLOGY, V9, P1045, DOI 10.1093/glycob/9.10.1045; Schutzbach J, 2007, CARBOHYD RES, V342, P881, DOI 10.1016/j.carres.2007.01.002; Specht CA, 2007, J INFECT DIS, V196, P796, DOI 10.1086/520536; Steen BR, 2003, EUKARYOT CELL, V2, P1336, DOI 10.1128/EC.2.6.1336-1349.2003; Trimble RB, 2004, GLYCOBIOLOGY, V14, P265, DOI 10.1093/glycob/cwh036; Willer T, 2003, CURR OPIN STRUC BIOL, V13, P621, DOI 10.1016/j.sbi.2003.09.003; Willger SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006321; Wozniak Karen L., 2009, V470, P71, DOI 10.1007/978-1-59745-204-5_7; YIP CL, 1994, P NATL ACAD SCI USA, V91, P2723, DOI 10.1073/pnas.91.7.2723; Yoko-O T, 1998, EUR J BIOCHEM, V257, P630, DOI 10.1046/j.1432-1327.1998.2570630.x; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Zhou H, 2007, EUKARYOT CELL, V6, P2260, DOI 10.1128/EC.00261-07; Ziegler FD, 1999, GLYCOBIOLOGY, V9, P497, DOI 10.1093/glycob/9.5.497	54	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1861	1873		10.1074/jbc.M114.607705	http://dx.doi.org/10.1074/jbc.M114.607705			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25477510	Green Published, hybrid			2022-12-28	WOS:000348056400050
J	Bhaskar, A; Munshi, M; Khan, SZ; Fatima, S; Arya, R; Jameel, S; Singh, A				Bhaskar, Ashima; Munshi, MohamedHusen; Khan, Sohrab Zafar; Fatima, Sadaf; Arya, Rahul; Jameel, Shahid; Singh, Amit			Measuring Glutathione Redox Potential of HIV-1-infected Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; REACTIVE OXYGEN; OXIDATIVE STRESS; T-CELLS; HYDROGEN-PEROXIDE; HIV-INFECTION; IN-VIVO; INTRACELLULAR GLUTATHIONE; OXIDIZED GLUTATHIONE	Redox signaling plays a crucial role in the pathogenesis of human immunodeficiency virus type-1 (HIV-1). The majority of HIV redox research relies on measuring redox stress using invasive technologies, which are unreliable and do not provide information about the contributions of subcellular compartments. A major technological leap emerges from the development of genetically encoded redox-sensitive green fluorescent proteins (roGFPs), which provide sensitive and compartment-specific insights into redox homeostasis. Here, we exploited a roGFP-based specific bioprobe of glutathione redox potential (E-GSH; Grx1-roGFP2) and measured subcellular changes in E-GSH during various phases of HIV-1 infection using U1 monocytic cells (latently infected U937 cells with HIV-1). We show that although U937 and U1 cells demonstrate significantly reduced cytosolic and mitochondrial E-GSH (approximately -310 mV), active viral replication induces substantial oxidative stress (E-GSH more than -240 mV). Furthermore, exposure to a physiologically relevant oxidant, hydrogen peroxide (H2O2), induces significant deviations in subcellular E-GSH between U937 and U1, which distinctly modulates susceptibility to apoptosis. Using Grx1-roGFP2, we demonstrate that a marginal increase of about similar to 25 mV in E-GSH is sufficient to switch HIV-1 from latency to reactivation, raising the possibility of purging HIV-1 by redox modulators without triggering detrimental changes in cellular physiology. Importantly, we show that bioactive lipids synthesized by clinical drug-resistant isolates of Mycobacterium tuberculosis reactivate HIV-1 through modulation of intracellular E-GSH. Finally, the expression analysis of U1 and patient peripheral blood mononuclear cells demonstrated a major recalibration of cellular redox homeostatic pathways during persistence and active replication of HIV.	[Bhaskar, Ashima; Munshi, MohamedHusen; Singh, Amit] Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis & Res, Bangalore 560012, Karnataka, India; [Khan, Sohrab Zafar; Arya, Rahul; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, New Delhi 11067, India; [Munshi, MohamedHusen; Fatima, Sadaf] Jamia Millia Islamia, Dept Biotechnol, New Delhi 25, India	Indian Institute of Science (IISC) - Bangalore; Jamia Millia Islamia	Singh, A (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis & Res, Bangalore 560012, Karnataka, India.	asingh@mcbl.iisc.ernet.in	Munshi, MohamedHusen/AFY-6972-2022; Khan, Sohrab/H-4074-2019	Munshi, MohamedHusen/0000-0002-2764-5322; Khan, Sohrab/0000-0002-9564-5092; BHASKAR, ASHIMA/0000-0002-7367-874X; Arya, Rahul/0000-0003-0867-6585; Singh, Amit/0000-0001-6761-1664	National Institutes of Health from Office of AIDS Research [P30AI027767]; Wellcome-Department of Biotechnology India Alliance Grant [500034-Z-09-Z]; Indian Council of Medical Research [ICM/13/037]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER	National Institutes of Health from Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome-Department of Biotechnology India Alliance Grant; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant P30AI027767 from Office of AIDS Research (to A. S.). This work was also supported by Wellcome-Department of Biotechnology India Alliance Grant, 500034-Z-09-Z (to A. S.) and Indian Council of Medical Research Grant ICM/13/037.	Abdelwahab SF, 2003, P NATL ACAD SCI USA, V100, P15006, DOI 10.1073/pnas.2035075100; Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; Amarnath S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-57; Ambruso DR, 2013, METHOD ENZYMOL, V527, P145, DOI 10.1016/B978-0-12-405882-8.00008-8; Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; AUKRUST P, 1995, BLOOD, V86, P258, DOI 10.1182/blood.V86.1.258.bloodjournal861258; Awodele O, 2012, J INFECT DEV COUNTR, V6, P79, DOI 10.3855/jidc.1906; Baine Michael J, 2013, Methods Mol Biol, V980, P157, DOI 10.1007/978-1-62703-287-2_8; Balestra E, 2001, J BIOL REG HOMEOS AG, V15, P272; Bhaskar A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003902; Budhiraja S, 2013, J VIROL, V87, P1211, DOI 10.1128/JVI.02413-12; Chaudhry A, 2007, CELL HOST MICROBE, V1, P37, DOI 10.1016/j.chom.2007.01.001; Choi H, 2014, J DERMATOL SCI, V74, P56, DOI 10.1016/j.jdermsci.2013.11.011; Cohen I, 2004, APOPTOSIS, V9, P181, DOI 10.1023/B:APPT.0000018800.87358.ba; Cota-Gomez A, 2011, FREE RADICAL BIO MED, V51, P1697, DOI 10.1016/j.freeradbiomed.2011.07.023; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; De Rosa SC, 2000, EUR J CLIN INVEST, V30, P915, DOI 10.1046/j.1365-2362.2000.00736.x; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Dumont A, 1999, ONCOGENE, V18, P747, DOI 10.1038/sj.onc.1202325; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; FLORES SC, 1993, P NATL ACAD SCI USA, V90, P7632, DOI 10.1073/pnas.90.16.7632; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Fukuhara A, 2012, BIOCHEM J, V443, P75, DOI 10.1042/BJ20111889; Garaci E, 1997, J LEUKOCYTE BIOL, V62, P54, DOI 10.1002/jlb.62.1.54; Geiben-Lynn R, 2003, J BIOL CHEM, V278, P1569, DOI 10.1074/jbc.M209964200; Guerra C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028378; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; HANSEN SH, 1990, EXP CELL RES, V187, P255, DOI 10.1016/0014-4827(90)90089-S; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Herzenberg LA, 1997, P NATL ACAD SCI USA, V94, P1967, DOI 10.1073/pnas.94.5.1967; Hirrlinger J, 2001, J NEUROCHEM, V76, P627, DOI 10.1046/j.1471-4159.2001.00101.x; Hogarth LA, 1999, METH MOLEC MED, V28, P91, DOI 10.1385/1-59259-687-8:91; Ibeh BO, 2012, IMMUNOPHARM IMMUNOT, V34, P1060, DOI 10.3109/08923973.2012.681327; Israel N, 1997, CELL MOL LIFE SCI, V53, P864, DOI 10.1007/s000180050106; Kalantari P, 2008, J BIOL CHEM, V283, P33183, DOI 10.1074/jbc.M807403200; Kim CH, 1996, AIDS RES HUM RETROV, V12, P1361, DOI 10.1089/aid.1996.12.1361; Kim C, 2008, BMB REP, V41, P555, DOI 10.5483/BMBRep.2008.41.8.555; Kishimoto N, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-107; Kraft-Terry S, 2010, PROTEOM CLIN APPL, V4, P706, DOI 10.1002/prca.201000010; Krishnan V, 2004, J VIROL, V78, P9458, DOI 10.1128/JVI.78.17.9458-9473.2004; Kristiansen KA, 2009, PHYSIOL PLANTARUM, V136, P369, DOI 10.1111/j.1399-3054.2009.01243.x; Kundu TK, 2012, BIOCHEMISTRY-US, V51, P2930, DOI 10.1021/bi3000879; Lake-Bakaar G, 2001, DIGEST DIS SCI, V46, P1072, DOI 10.1023/A:1010770230422; Lang CA, 2001, EXP BIOL MED, V226, P866, DOI 10.1177/153537020122600910; Larrosa PNF, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-19; Lichtenfels R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041345; Liddell JR, 2006, GLIA, V54, P873, DOI 10.1002/glia.20433; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Melendez LM, 2011, J NEUROIMMUNE PHARM, V6, P89, DOI 10.1007/s11481-010-9253-4; Mesfin YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082235; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Morgan B, 2013, NAT CHEM BIOL, V9, P119, DOI [10.1038/nchembio.1142, 10.1038/NCHEMBIO.1142]; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; Mougiakakos D, 2009, BLOOD, V113, P3542, DOI 10.1182/blood-2008-09-181040; MULLER F, 1992, FREE RADICAL BIO MED, V13, P651, DOI 10.1016/0891-5849(92)90039-J; Palanisamy GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026254; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; PEREZ VL, 1991, J IMMUNOL, V147, P3145; Perl A, 2000, ANTIOXID REDOX SIGN, V2, P551, DOI 10.1089/15230860050192323; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Pinti M, 2003, EXP BIOL MED, V228, P1346, DOI 10.1177/153537020322801113; Pirmohamed M, 1996, AIDS, V10, P501, DOI 10.1097/00002030-199605000-00008; POLI G, 1990, P NATL ACAD SCI USA, V87, P782, DOI 10.1073/pnas.87.2.782; Pyo CW, 2008, BIOCHEM BIOPH RES CO, V376, P180, DOI 10.1016/j.bbrc.2008.08.114; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Ranjbar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006116; Reyskens KMSE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073347; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; Savarino A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-52; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schmidt WN, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00129; Siddappa NB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-53; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; Tarpey MM, 2004, AM J PHYSIOL-REG I, V286, pR431, DOI 10.1152/ajpregu.00361.2003; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Torre D, 2002, LANCET INFECT DIS, V2, P273, DOI 10.1016/S1473-3099(02)00262-1; Venketaraman V, 2003, INFECT IMMUN, V71, P1864, DOI 10.1128/IAI.71.4.1864-1871.2003; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; WITSCHI A, 1995, AIDS RES HUM RETROV, V11, P141, DOI 10.1089/aid.1995.11.141; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zuo L, 2002, METHOD ENZYMOL, V352, P307	84	37	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1020	1038		10.1074/jbc.M114.588913	http://dx.doi.org/10.1074/jbc.M114.588913			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25406321	Green Published, hybrid			2022-12-28	WOS:000347778200035
J	Huang, G; Towe, CW; Choi, L; Yonekawa, Y; Bommelje, CC; Bains, S; Rechler, W; Hao, B; Ramanathan, Y; Singh, B				Huang, Guochang; Towe, Christopher W.; Choi, Lydia; Yonekawa, Yoshihiro; Bommelje, Claire C.; Bains, Sarina; Rechler, Willi; Hao, Bing; Ramanathan, Yegnanarayana; Singh, Bhuvanesh			The Ubiquitin-associated (UBA) Domain of SCCRO/DCUN1D1 Protein Serves as a Feedback Regulator of Biochemical and Oncogenic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma (HNSCC); Oncogene; Ubiquitin; Ubiquitination; DCUN1D1; SCCRO; Neddylation; Ubiquitin Binding Domain; Ubiquitin-associated Domain	PAGETS-DISEASE; STRUCTURAL BASIS; LIGASE; POLYUBIQUITIN; RECOGNITION; MECHANISM; INSIGHTS; COMPLEX; MOTIF	Background: SCCRO/DCUN1D1 is commonly amplified in squamous cell carcinomas. Although the SCCRO PONY domain is required for its function, the contribution of its UBA domain is undefined. Results: Binding of polyubiquitin chains to UBA domain inhibits SCCRO-promoted neddylation and oncogenic activity. Conclusion: UBA domain serves as a sensor and regulator of SCCRO. Significance: Targeting the UBA domain may inhibit SCCRO function in human cancers. Amplification of squamous cell carcinoma-related oncogene (SCCRO) activates its function as an oncogene in a wide range of human cancers. The oncogenic activity of SCCRO requires its potentiating neddylation domain, which regulates its E3 activity for neddylation. The contribution of the N-terminal ubiquitin-associated (UBA) domain to SCCRO function remains to be defined. We found that the UBA domain of SCCRO preferentially binds to polyubiquitin chains in a linkage-independent manner. Binding of polyubiquitin chains to the UBA domain inhibits the neddylation activity of SCCRO in vivo by inhibiting SCCRO-promoted nuclear translocation of neddylation components and results in a corresponding decrease in cullin-RING-ligase-promoted ubiquitination. The results of colony formation and xenograft assays showed a mutation in the UBA domain of SCCRO that reduces binding to polyubiquitin chains, significantly enhancing its oncogenic activity. Analysis of 47 lung and head and neck squamous cell carcinomas identified a case with a frameshift mutation in SCCRO that putatively codes for a protein that lacks a UBA domain. Analysis of data from The Cancer Genome Atlas showed that recurrent mutations cluster in the UBA domains of SCCRO, lose the ability to bind to polyubiquitinated proteins, and have increased neddylation and transformation activities. Combined, these data suggest that the UBA domain functions as a negative regulator of SCCRO function. Mutations in the UBA domain lead to loss of inhibitory control, which results in increased biochemical and oncogenic activity. The clustering of mutations in the UBA domain of SCCRO suggests that mutations may be a mechanism of oncogene activation in human cancers.	[Huang, Guochang; Towe, Christopher W.; Choi, Lydia; Yonekawa, Yoshihiro; Bommelje, Claire C.; Bains, Sarina; Rechler, Willi; Ramanathan, Yegnanarayana; Singh, Bhuvanesh] Mem Sloan Kettering Canc Ctr, Dept Surg, Lab Epithelial Canc Biol, New York, NY 10065 USA; [Hao, Bing] Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA	Memorial Sloan Kettering Cancer Center; University of Connecticut	Singh, B (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Lab Epithelial Canc Biol, New York, NY 10065 USA.	singhb@mskcc.org		Towe, Christopher/0000-0002-3850-8040	 [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank David B. Sewell for constructive editing and Dr. Zhen-Qiang Pan for generously providing SCCRO<SUP>3KR</SUP> construct. We also thank Molecular Cytology Core Facility (sponsored by Core Grant P30 CA008748) for great help.	Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098293; Daroszewska A, 2005, CLIN SCI, V109, P257, DOI 10.1042/CS20050053; Heir P, 2013, MOL CELL BIOL, V33, P1621, DOI 10.1128/MCB.01342-12; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Huang GC, 2013, CLIN CANCER RES, V19, P5549, DOI 10.1158/1078-0432.CCR-13-2117; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Layfield R, 2004, BIOCHEM SOC T, V32, P728, DOI 10.1042/BST0320728; Layfield R, 2008, BIOCHEM SOC T, V36, P469, DOI 10.1042/BST0360469; Lee JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040361; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Lucas GJA, 2006, J BONE MINER RES, V21, pP31, DOI 10.1359/JBMR.06S206; Madura K, 2002, CELL CYCLE, V1, P233, DOI 10.4161/cc.1.4.130; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Searle MS, 2012, BIOCHEM SOC T, V40, P404, DOI 10.1042/BST20110729; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Trempe JF, 2011, CURR OPIN STRUC BIOL, V21, P792, DOI 10.1016/j.sbi.2011.09.009; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Wang J, 2013, CLIN CANCER RES, V19, P5580, DOI 10.1158/1078-0432.CCR-13-0594; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wu K, 2011, J BIOL CHEM, V286, P34060, DOI 10.1074/jbc.M111.273045; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Yang XY, 2007, J BIOL CHEM, V282, P24490, DOI 10.1074/jbc.C700038200; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	43	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					296	309		10.1074/jbc.M114.560169	http://dx.doi.org/10.1074/jbc.M114.560169			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25411243	Green Published, hybrid			2022-12-28	WOS:000347231200027
J	Lee, H; Morales, LD; Slaga, TJ; Kim, DJ				Lee, Hyunseung; Morales, Liza D.; Slaga, Thomas J.; Kim, Dae Joon			Activation of T-cell Protein-tyrosine Phosphatase Suppresses Keratinocyte Survival and Proliferation following UVB Irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Keratinocyte; Skin; STAT3; Tyrosine-protein Phosphatase (Tyrosine Phosphatase); UVB	GROWTH-FACTOR RECEPTOR; EPITHELIAL CARCINOGENESIS; SIGNAL TRANSDUCER; SKIN CARCINOGENESIS; KINASE INHIBITORS; PROMOTION STAGES; TRANSCRIPTION 3; STAT PROTEINS; CANCER; DISRUPTION	Background: STAT3 promotes UVB-induced keratinocyte cell proliferation. Results: TC-PTP inhibits STAT3-mediated mouse keratinocyte skin cell proliferation and survival following UVB irradiation. Conclusion: TC-PTP plays an important role in the skin cell response to UVB radiation by regulating cell proliferation and survival. Significance: TC-PTP shows tumor-suppressive capabilities in skin. Chronic exposure to UV radiation can contribute to the development of skin cancer by promoting protein-tyrosine kinase (PTK) signaling. Studies show that exposure to UV radiation increases the ligand-independent activation of PTKs and induces protein-tyrosine phosphatase (PTP) inactivation. In the present work, we report that T-cell PTP (TC-PTP) activity is stimulated during the initial response to UVB irradiation, which leads to suppression of keratinocyte cell survival and proliferation via the down-regulation of STAT3 signaling. Our results show that TC-PTP-deficient keratinocyte cell lines expressed a significantly increased level of phosphorylated STAT3 after exposure to low dose UVB. This increase corresponded with increased cell proliferation in TC-PTP-deficient keratinocytes following UVB irradiation. Loss of TC-PTP also reduced UVB-induced apoptosis. Corroborating with these results, overexpression of TC-PTP in keratinocyte cell lines yielded a decrease in phosphorylated STAT3 levels, which corresponded with a significant decrease in cell proliferation in response to low dose UVB. We demonstrate that TC-PTP activity was increased upon UVB exposure, and overexpression of TC-PTP in keratinocyte cell lines further increased its activity in the presence of UVB. Treatment of TC-PTP-deficient keratinocytes with the STAT3 inhibitor STA21 significantly reduced cell viability following UVB exposure in comparison with untreated TC-PTP-deficient keratinocytes, confirming that the effect of TC-PTP on cell viability is mediated by STAT3 dephosphorylation. Combined, our results indicate that UVB-mediated activation of TC-PTP plays an important role in the STAT3-dependent regulation of keratinocyte cell proliferation and survival. Furthermore, these results suggest that TC-PTP may be a novel potential target for the prevention of UVB-induced skin cancer.	[Lee, Hyunseung; Morales, Liza D.; Kim, Dae Joon] Univ Texas Hlth Sci Ctr San Antonio, Div Med Res, Edinburg Reg Acad Hlth Ctr, Edinburg, TX 78541 USA; [Lee, Hyunseung; Slaga, Thomas J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Kim, DJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Med Res, Edinburg Reg Acad Hlth Ctr, 1214 W Schunior St, San Antonio, TX 78229 USA.	KimDJ@uthscsa.edu		KIM, DAE/0000-0002-7977-9955; Morales, Liza/0000-0003-1056-9121	National Institutes of Health; NIEHS [ES022250]; National Institutes of Health Cancer Center Support Grant [P30 CA054174]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, NIEHS, Grant ES022250 and National Institutes of Health Cancer Center Support Grant P30 CA054174.	Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chow LQM, 2007, J CLIN ONCOL, V25, P884, DOI 10.1200/JCO.2006.06.3602; COFFER PJ, 1995, ONCOGENE, V11, P561; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; Cooper SJ, 2003, MOL CANCER RES, V1, P848; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Denu JM, 2002, METHOD ENZYMOL, V348, P297, DOI 10.1016/S0076-6879(02)48648-X; Dube N, 2005, BBA-PROTEINS PROTEOM, V1754, P108, DOI 10.1016/j.bbapap.2005.07.030; Groen A, 2005, J BIOL CHEM, V280, P10298, DOI 10.1074/jbc.M412424200; Hendriks WJAJ, 2013, FEBS J, V280, P708, DOI 10.1111/febs.12000; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Kamatkar S, 1996, J BIOL CHEM, V271, P26755, DOI 10.1074/jbc.271.43.26755; Kataoka K, 2008, CARCINOGENESIS, V29, P1108, DOI 10.1093/carcin/bgn061; Kim AL, 2002, PHOTOCHEM PHOTOBIOL, V75, P58, DOI 10.1562/0031-8655(2002)075<0058:SSAOCE>2.0.CO;2; Kim DJ, 2009, ONCOGENE, V28, P950, DOI 10.1038/onc.2008.453; Kim DJ, 2007, MOL CARCINOGEN, V46, P725, DOI 10.1002/mc.20342; Kim DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010290; Kim DJ, 2009, CANCER RES, V69, P7587, DOI 10.1158/0008-5472.CAN-09-1180; KLANN RC, 1989, CANCER RES, V49, P699; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; Rho OK, 2011, MOL CARCINOGEN, V50, P264, DOI 10.1002/mc.20665; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Sano S, 2008, J DERMATOL SCI, V50, P1, DOI 10.1016/j.jdermsci.2007.05.016; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; TILLMANN U, 1994, MOL CELL BIOL, V14, P3030, DOI 10.1128/MCB.14.5.3030; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Xu YR, 2006, J BIOL CHEM, V281, P27389, DOI 10.1074/jbc.M602355200; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X	50	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					13	24		10.1074/jbc.M114.611681	http://dx.doi.org/10.1074/jbc.M114.611681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25406309	hybrid, Green Published			2022-12-28	WOS:000347231200002
J	Ou, Y; Wang, SJ; Jiang, L; Zheng, B; Gu, W				Ou, Yang; Wang, Shang-Jui; Jiang, Le; Zheng, Bin; Gu, Wei			p53 Protein-mediated Regulation of Phosphoglycerate Dehydrogenase (PHGDH) Is Crucial for the Apoptotic Response upon Serine Starvation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cancer Biology; Cell Death; Melanoma; Metabolism; p53; Tumor Suppressor Gene	TUMOR-SUPPRESSOR P53; P53-INDUCIBLE REGULATOR; MALIGNANT-MELANOMA; GLUCOSE-METABOLISM; TARGET GENE; WARBURG; CANCER; GROWTH; CELLS; INHIBITION	Background:PHGDH encodes a key metabolic enzyme in the serine biosynthesis pathway and is frequently amplified in melanomas. Results: p53 transcriptionally represses PHGDH expression. Serine starvation promotes p53-mediated apoptosis in melanomas through PHGDH suppression. Conclusion: p53-mediated repression of PHGDH enhances the apoptotic response upon serine starvation in melanoma cells. Significance: The combination of the drugs activating p53 and serine deprivation could be a better treatment for melanomas. Although p53 is frequently mutated in human cancers, about 80% of human melanomas retain wild-type p53. Here we report that PHGDH, the key metabolic enzyme that catalyzes the rate-limiting step of the serine biosynthesis pathway, is a target of p53 in human melanoma cells. p53 suppresses PHGDH expression and inhibits de novo serine biosynthesis. Notably, upon serine starvation, p53-mediated cell death is enhanced dramatically in response to Nutlin-3 treatment. Moreover, PHGDH has been found recently to be amplified frequently in human melanomas. We found that PHGDH overexpression significantly suppresses the apoptotic response, whereas RNAi-mediated knockdown of endogenous PHGDH promotes apoptosis under the same treatment. These results demonstrate an important role of p53 in regulating the serine biosynthesis pathway through suppressing PHGDH expression and reveal serine deprivation as a novel approach to sensitize p53-mediated apoptotic responses in human melanoma cells.	[Ou, Yang; Wang, Shang-Jui; Jiang, Le; Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Ou, Yang; Wang, Shang-Jui; Jiang, Le; Gu, Wei] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Zheng, Bin] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	Columbia University; Columbia University; Harvard University; Massachusetts General Hospital	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu		Zheng, Bin/0000-0002-0998-7177	NCI, National Institutes of Health [5RO1CA085533, 5RO1CA172023, 5RO1 CA166294, 2P01CA080058, R01 CA166717]; National Institutes of Health Cancer Biology Training Grant [T32-CA09503]; NATIONAL CANCER INSTITUTE [R01CA166717, R01CA172023, R01CA166294, R01CA085533, P01CA080058] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Cancer Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Awards 5RO1CA085533, 5RO1CA172023, 5RO1 CA166294, 5RO1CA085533, and 2P01CA080058 (to W. G.) and R01 CA166717 (to B. Z.).; Supported by National Institutes of Health Cancer Biology Training Grant T32-CA09503.	ALBINO AP, 1994, MELANOMA RES, V4, P35, DOI 10.1097/00008390-199402000-00006; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Chen JY, 2013, ONCOTARGET, V4, P2502, DOI 10.18632/oncotarget.1540; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; de Lange J, 2012, ONCOGENE, V31, P1105, DOI 10.1038/onc.2011.309; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Ji ZY, 2012, J INVEST DERMATOL, V132, P356, DOI 10.1038/jid.2011.313; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Jochemsen AG, 2014, CURR OPIN ONCOL, V26, P114, DOI 10.1097/CCO.0000000000000033; Kuge O, 2003, J BIOCHEM, V133, P397, DOI 10.1093/jb/mvg052; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liang YJ, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-9; Liu Y, 2014, P NATL ACAD SCI USA, V111, pE2414, DOI 10.1073/pnas.1315605111; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mandinova A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001366; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; Mullarky E, 2011, PIGM CELL MELANOMA R, V24, P1112, DOI 10.1111/j.1755-148X.2011.00919.x; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tseng HY, 2010, MOL CANCER THER, V9, P3363, DOI 10.1158/1535-7163.MCT-10-0646; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vu BT, 2011, CURR TOP MICROBIOL, V348, P151, DOI 10.1007/82_2010_110; Wang SJ, 2013, CELL CYCLE, V12, P753, DOI 10.4161/cc.23597; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhang C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3935; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108; Zhang J, 2013, INT J GYNECOL CANCER, V23, P1465, DOI 10.1097/IGC.0b013e3182a0c068	37	76	77	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					457	466		10.1074/jbc.M114.616359	http://dx.doi.org/10.1074/jbc.M114.616359			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25404730	hybrid, Green Published			2022-12-28	WOS:000347231200040
J	Bishop, P; Rubin, P; Thomson, AR; Rocca, D; Henley, JM				Bishop, Paul; Rubin, Philip; Thomson, Andrew R.; Rocca, Dan; Henley, Jeremy M.			The Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) C Terminus Plays a Key Role in Protein Stability, but Its Farnesylation Is Not Required for Membrane Association in Primary Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; AGGREGATION; EXPRESSION; PLASTICITY; PATHWAY; BODIES; RAS	Ubiquitin C-terminal hydrolase L1 (UCH-L1) is a deubiquitinating enzyme that is highly expressed in neurons. A possible role for UCH-L1 in neurodegeneration has been highlighted because of its presence in Lewy bodies associated with Parkinson disease and neurofibrillary tangles observed in Alzheimer disease. UCH-L1 exists in two forms in neurons, a soluble cytoplasmic form (UCH-L1(C)) and a membrane-associated form (UCH-L1(M)). Alzheimer brains show reduced levels of soluble UCH-L1(C) correlating with the formation of UCH-L1-immunoreactive tau tangles, whereas UCH-L1(M) has been implicated in alpha-synuclein dysfunction. Given these reports of divergent roles, we investigated the properties of UCH-L1 membrane association. Surprisingly, our results indicate that UCH-L1 does not partition to the membrane in the cultured cell lines we tested. Furthermore, in primary cultured neurons, a proportion of UCH-L1(M) does partition to the membrane, but, contrary to a previous report, this does not require farnesylation. Deletion of the four C-terminal residues caused the loss of protein solubility, abrogation of substrate binding, increased cell death, and an abnormal intracellular distribution, consistent with protein dysfunction and aggregation. These data indicate that UCH-L1 is differently processed in neurons compared with clonal cell lines and that farnesylation does not account for the membrane association in neurons.	[Bishop, Paul; Rubin, Philip; Thomson, Andrew R.; Rocca, Dan; Henley, Jeremy M.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	University of Bristol	Henley, JM (corresponding author), Univ Bristol, Sch Biochem, MRC Ctr Synapt Plast, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	J.M.Henley@bristol.ac.uk		Thomson, Andrew/0000-0002-1066-1369; Henley, Jeremy/0000-0003-3589-8335	Medical Research Council; Biotechnology and Biological Sciences Research Council; European Research Council; BBSRC [BB/K014358/1, BB/K014366/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K014366/1, BB/K014358/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Medical Research Council, the Biotechnology and Biological Sciences Research Council, and the European Research Council.	Andersson FI, 2011, J MOL BIOL, V407, P261, DOI 10.1016/j.jmb.2010.12.029; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Cartier AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034713; Chen JJ, 2013, ANAL CHEM, V85, P6011, DOI 10.1021/ac400831z; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; Evangelisti E, 2012, J CELL SCI, V125, P2416, DOI 10.1242/jcs.098434; Fang Y, 2010, BBA-REV CANCER, V1806, P1, DOI 10.1016/j.bbcan.2010.03.001; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Kantamneni S, 2007, J NEUROCHEM, V100, P1003, DOI 10.1111/j.1471-4159.2006.04271.x; Kaplan A, 2012, PROG NEUROBIOL, V99, P262, DOI 10.1016/j.pneurobio.2012.08.004; Koharudin LMI, 2010, P NATL ACAD SCI USA, V107, P6835, DOI 10.1073/pnas.1002295107; Kurihara LJ, 2000, MOL CELL BIOL, V20, P2498, DOI 10.1128/MCB.20.7.2498-2504.2000; Last NB, 2013, P NATL ACAD SCI USA, V110, P6382, DOI 10.1073/pnas.1219059110; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Liu ZH, 2009, P NATL ACAD SCI USA, V106, P4635, DOI 10.1073/pnas.0806474106; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Nagamine S, 2010, NEUROCHEM INT, V57, P102, DOI 10.1016/j.neuint.2010.04.015; Navarro-Lerida I, 2012, EMBO J, V31, P534, DOI 10.1038/emboj.2011.446; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Perestenko PV, 2003, J BIOL CHEM, V278, P43525, DOI 10.1074/jbc.M306206200; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sommer David B, 2008, Expert Rev Neurother, V8, P1829, DOI 10.1586/14737175.8.12.1829; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, pE1715, DOI 10.1073/pnas.1205918109; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	38	25	26	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36140	36149		10.1074/jbc.M114.557124	http://dx.doi.org/10.1074/jbc.M114.557124			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25326379	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000346897900040
J	Jones, KA; Eng, AG; Raval, P; Srivastava, DP; Penzes, P				Jones, Kelly A.; Eng, Andrew G.; Raval, Pooja; Srivastava, Deepak P.; Penzes, Peter			Scaffold Protein X11 alpha Interacts with Kalirin-7 in Dendrites and Recruits It to Golgi Outposts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dendritic Spine; Neurobiology; Neuron; Neuroscience; Small GTPase; Synapse	GDP/GTP EXCHANGE FACTOR; SECRETORY TRAFFICKING; RECEPTOR; DOMAINS; LOCALIZATION; EXPRESSION; PLASTICITY; PATHWAYS; MLIN-10; GROWTH	Pyramidal neurons in the mammalian forebrain receive their synaptic inputs through their dendritic trees, and dendritic spines are the sites of most excitatory synapses. Dendritic spine structure is important for brain development and plasticity. Kalirin-7 is a guanine nucleotide-exchange factor for the small GTPase Rac1 and is a critical regulator of dendritic spine remodeling. The subcellular localization of kalirin-7 is thought to be important for regulating its function in neurons. A yeast two-hybrid screen has identified the adaptor protein X11 as an interacting partner of kalirin-7. Here, we show that kalirin-7 and X11 form a complex in the brain, and this interaction is mediated by the C terminus of kalirin-7. Kalirin-7 and X11 co-localize at excitatory synapses in cultured cortical neurons. Using time-lapse imaging of fluorescence recovery after photobleaching, we show that X11 is present in a mobile fraction of the postsynaptic density. X11 also localizes to Golgi outposts in dendrites, and its overexpression induces the removal of kalirin-7 from spines and accumulation of kalirin-7 in Golgi outposts. In addition, neurons overexpressing X11 displayed thinner spines. These data support a novel mechanism of regulation of kalirin-7 localization and function in dendrites, providing insight into signaling pathways underlying neuronal plasticity. Dissecting the molecular mechanisms of synaptic structural plasticity will improve our understanding of neuropsychiatric and neurodegenerative disorders, as kalirin-7 has been associated with schizophrenia and Alzheimer disease.	[Jones, Kelly A.; Srivastava, Deepak P.; Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Eng, Andrew G.] Northwestern Univ, Interdept Neurosci Grad Program, Chicago, IL 60611 USA; [Raval, Pooja; Srivastava, Deepak P.] Kings Coll London, Dept Neurosci, London SE5 9NU, England; [Raval, Pooja; Srivastava, Deepak P.] Kings Coll London, Inst Psychiat, James Black Ctr, Ctr Cellular Basis Behav, London SE5 9NU, England	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; University of London; King's College London; University of London; King's College London	Srivastava, DP (corresponding author), 125 Coldharbour Lane, London SE5 9NU, England.	deepak.srivastava@kcl.ac.uk; p-penzes@northwestern.edu	Penzes, Peter/L-3987-2016	Penzes, Peter/0000-0001-5449-1640; Srivastava, Deepak Prakash/0000-0001-6512-9065; Raval, Pooja/0000-0002-5298-1950	National Institutes of Health from NIMH [MH071316, MH097216]; NRSA Ruth L. Kirschstein Award [F31MH085362]; Royal Society United Kingdom; Brain and Behavior Foundation; Psychiatric Research Trust; American Heart Association; National Alliance for Research on Schizophrenia and Depression; Brain Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH085362, R01MH071316, R01MH097216] Funding Source: NIH RePORTER	National Institutes of Health from NIMH; NRSA Ruth L. Kirschstein Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society United Kingdom(Royal Society of London); Brain and Behavior Foundation; Psychiatric Research Trust; American Heart Association(American Heart Association); National Alliance for Research on Schizophrenia and Depression(NARSAD); Brain Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH071316 and MH097216 from NIMH (to P. P.) and NRSA Ruth L. Kirschstein Award F31MH085362 (to K. A. J.). This work was also supported by grants from the Royal Society United Kingdom, Brain and Behavior Foundation (formally National Alliance for Research on Schizophrenia and Depression (NARSAD)), Psychiatric Research Trust, American Heart Association (to D. P. S.), and National Alliance for Research on Schizophrenia and Depression, Brain Research Foundation.	Alam MR, 1997, J BIOL CHEM, V272, P12667, DOI 10.1074/jbc.272.19.12667; Biederer T, 2002, J NEUROSCI, V22, P7340; Cahill ME, 2012, MOL PSYCHIATR, V17, P99, DOI 10.1038/mp.2011.35; Ehlers MD, 2007, NEURON, V55, P686, DOI 10.1016/j.neuron.2007.08.009; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Ho A, 2008, J NEUROSCI, V28, P14392, DOI 10.1523/JNEUROSCI.2481-08.2008; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Horton AC, 2003, J NEUROSCI, V23, P6188; Hsieh-Wilson LC, 2003, J BIOL CHEM, V278, P1186, DOI 10.1074/jbc.M205754200; Jaskolski F, 2009, J BIOL CHEM, V284, P12491, DOI 10.1074/jbc.M808401200; Jones KA, 2009, P NATL ACAD SCI USA, V106, P19575, DOI 10.1073/pnas.0905884106; King GD, 2004, J NEUROCHEM, V88, P971, DOI 10.1046/j.1471-4159.2003.02234.x; King GD, 2003, NEUROSCIENCE, V120, P143, DOI 10.1016/S0306-4522(03)00284-7; Maximov A, 2002, J NEUROSCI, V22, P6939; Minami SS, 2010, FASEB J, V24, P58, DOI 10.1096/fj.09-138123; Nakajima Y, 2001, MOL BRAIN RES, V92, P27, DOI 10.1016/S0169-328X(01)00126-7; Okamoto M, 2000, EUR J NEUROSCI, V12, P3067, DOI 10.1046/j.1460-9568.2000.00200.x; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2001, J NEUROSCI, V21, P8426, DOI 10.1523/JNEUROSCI.21-21-08426.2001; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Penzes P, 2008, TRENDS CELL BIOL, V18, P405, DOI 10.1016/j.tcb.2008.07.002; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Penzes P, 2012, CYTOSKELETON, V69, P426, DOI 10.1002/cm.21015; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pierce JP, 2001, CURR BIOL, V11, P351, DOI 10.1016/S0960-9822(01)00077-X; Remmers C, 2014, BRAIN RES BULL, V103, P29, DOI 10.1016/j.brainresbull.2013.12.006; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Srivastava DP, 2011, JOVE-J VIS EXP, DOI 10.3791/2794; Stricker NL, 2003, NEUROPHARMACOLOGY, V45, P837, DOI 10.1016/S0028-3908(03)00275-2; Teber I, 2005, BIOL CHEM, V386, P671, DOI 10.1515/BC.2005.078; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Zheng CY, 2010, J NEUROSCI, V30, P4757, DOI 10.1523/JNEUROSCI.6108-09.2010; Zhou W, 2014, CURR BIOL, V24, P1227, DOI 10.1016/j.cub.2014.04.008	42	11	11	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35517	35529		10.1074/jbc.M114.587709	http://dx.doi.org/10.1074/jbc.M114.587709			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25378388	hybrid, Green Published			2022-12-28	WOS:000346660200040
J	Mariappan, MM; Prasad, S; D'Silva, K; Cedillo, E; Sataranatarajan, K; Barnes, JL; Choudhury, GG; Kasinath, BS				Mariappan, Meenalakshmi M.; Prasad, Sanjay; D'Silva, Kristin; Cedillo, Esteban; Sataranatarajan, Kavithalakshmi; Barnes, Jeffrey L.; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.			Activation of Glycogen Synthase Kinase 3 beta Ameliorates Diabetes-induced Kidney Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Eukaryotic Translation Initiation; Extracellular Matrix Protein; Glycogen Synthase Kinase 3 (GSK-3); Kidney; Mammalian Target of Rapamycin (mTOR); Type 1 Diabetes; Diabetic Nephropathy; Sodium Nitroprusside; Kidney Hypertrophy	MESSENGER-RNA TRANSLATION; RENAL EPITHELIAL-CELLS; PROTEIN-SYNTHESIS; HIGH GLUCOSE; HIGH INSULIN; AKT KINASE; PHOSPHORYLATION; NEPHROPATHY; INITIATION; GROWTH	Increase in protein synthesis contributes to kidney hypertrophy and matrix protein accumulation in diabetes. We have previously shown that high glucose-induced matrix protein synthesis is associated with inactivation of glycogen synthase kinase 3 (GSK3) in renal cells and in the kidneys of diabetic mice. We tested whether activation of GSK3 by sodium nitroprusside (SNP) mitigates kidney injury in diabetes. Studies in kidney-proximal tubular epithelial cells showed that SNP abrogated high glucose-induced laminin increment by stimulating GSK3 and inhibiting Akt, mTORC1, and events in mRNA translation regulated by mTORC1 and ERK. NONOate, an NO donor, also activated GSK3, indicating that NO may mediate SNP stimulation of GSK3. SNP administered for 3 weeks to mice with streptozotocin-induced type 1 diabetes ameliorated kidney hypertrophy, accumulation of matrix proteins, and albuminuria without changing blood glucose levels. Signaling studies showed that diabetes caused inactivation of GSK3 by activation of Src, Pyk2, Akt, and ERK; GSK3 inhibition activated mTORC1 and downstream events in mRNA translation in the kidney cortex. These reactions were abrogated by SNP. We conclude that activation of GSK3 by SNP ameliorates kidney injury induced by diabetes.	[Mariappan, Meenalakshmi M.; Prasad, Sanjay; D'Silva, Kristin; Cedillo, Esteban; Sataranatarajan, Kavithalakshmi; Barnes, Jeffrey L.; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78245 USA; [Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78229 USA; [Mariappan, Meenalakshmi M.; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.] South Texas Vet Hlth Care Syst, Med Serv, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Kasinath, BS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med MC7882, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	kasinath@uthscsa.edu		D'Silva, Kristin/0000-0001-8370-4166	Veterans Affairs Merit Review Program; National Institutes of Health [DK077295, RC2AG036613, DK050190]; American Diabetes Association; Juvenile Diabetes Research Foundation; Veterans Affairs Merit Review Grant [5I01BX000926]; Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK050190, R01DK077295, R01DK050190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036613] Funding Source: NIH RePORTER	Veterans Affairs Merit Review Program(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the Veterans Affairs Merit Review Program (to B. S. K.), National Institutes of Health Grants DK077295 (to B. S. K.) and RC2AG036613 (to B. S. K.). This work was also supported by the American Diabetes Association (to B. S. K.) and the Juvenile Diabetes Research Foundation (to M. M. M.).; Supported by National Institutes of Health R01 Grant DK050190 and Veterans Affairs Merit Review Grant 5I01BX000926; recipient of a Veterans Affairs Senior Research Career Scientist Award.	Anderton BH, 2001, BIOCHEM SOC SYMP, V67, P73; Bandyopadhyay G, 2000, J BIOL CHEM, V275, P40817, DOI 10.1074/jbc.M007920200; Bao H, 2014, J AM SOC NEPHROL, V25, P488, DOI 10.1681/ASN.2013040350; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Boini KM, 2009, AM J PHYSIOL-RENAL, V296, pF153, DOI 10.1152/ajprenal.90398.2008; Brion JP, 2001, BIOCHEM SOC SYMP, V67, P81; Covington MD, 2012, KIDNEY INT, V81, P391, DOI 10.1038/ki.2011.356; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089835; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Day RT, 2013, AM J PHYSIOL-RENAL, V304, pF788, DOI 10.1152/ajprenal.00306.2012; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Ge Y, 2011, LAB INVEST, V91, P85, DOI 10.1038/labinvest.2010.142; Ghosh C, 2004, CELL SIGNAL, V16, P31, DOI DOI 10.1016/S0898-6568(03)00094-9; Goc A, 2014, ONCOTARGET, V5, P775, DOI 10.18632/oncotarget.1770; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Ha TS, 1999, J AM SOC NEPHROL, V10, P1931; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Lin L, 2010, AM J PATHOL, V177, P1687, DOI 10.2353/ajpath.2010.100213; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062844; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Mariappan MM, 2014, AM J PHYSIOL-CELL PH, V306, pC202, DOI 10.1152/ajpcell.00144.2013; Mariappan MM, 2005, J BIOL CHEM, V280, P28402, DOI 10.1074/jbc.M504861200; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Proud CG, 2006, BIOCHEM SOC T, V34, P213, DOI 10.1042/BST0340213; Sanchez AP, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001057; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Sataranatarajan K, 2012, AGING CELL, V11, P1065, DOI 10.1111/acel.12008; Senthil D, 2003, KIDNEY INT, V64, P468, DOI 10.1046/j.1523-1755.2003.00135.x; Sonomura K, 2012, KIDNEY INT, V81, P449, DOI 10.1038/ki.2011.403; Sorokin A, 2001, J BIOL CHEM, V276, P21521, DOI 10.1074/jbc.M008869200; Sun WX, 2014, FREE RADICAL BIO MED, V68, P22, DOI 10.1016/j.freeradbiomed.2013.11.015; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; Turenne GA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-12; Urbanska K, 2007, ONCOGENE, V26, P2308, DOI 10.1038/sj.onc.1210018; Wang XM, 2008, MOL CELL BIOL, V28, P1429, DOI 10.1128/MCB.01512-07; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Zdychova J, 2008, PHYSIOL RES, V57, P709, DOI 10.33549/physiolres.931337; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zhang YH, 2005, FEBS LETT, V579, P6230, DOI 10.1016/j.febslet.2005.09.095; Zhou JB, 2013, J CLIN INVEST, V123, P1821, DOI 10.1172/JCI64398	51	35	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35363	35375		10.1074/jbc.M114.587840	http://dx.doi.org/10.1074/jbc.M114.587840			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25339176	Green Published, hybrid			2022-12-28	WOS:000346660200027
J	Rao, MK; Matsumoto, Y; Richardson, ME; Panneerdoss, S; Bhardwaj, A; Ward, JM; Shanker, S; Bettegowda, A; Wilkinson, MF				Rao, Manjeet K.; Matsumoto, Yuiko; Richardson, Marcy E.; Panneerdoss, Subbarayalu; Bhardwaj, Anjana; Ward, Jacqueline M.; Shanker, Sreenath; Bettegowda, Anilkumar; Wilkinson, Miles F.			Hormone-induced and DNA Demethylation-induced Relief of a Tissue-specific and Developmentally Regulated Block in Transcriptional Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Androgen Receptor; DNA Methylation; Hormone; Testosterone; Transcriptional Regulation; Transcriptional Elongation	RNA-POLYMERASE-II; PEM HOMEOBOX GENE; P-TEFB COMPLEX; IN-VIVO; DROSOPHILA EMBRYO; CHROMATIN-STRUCTURE; PROSTATE-CANCER; ONCOFETAL GENE; SERTOLI-CELLS; GATA FACTORS	Genome-wide studies have revealed that genes commonly have a high density of RNA polymerase II just downstream of the transcription start site. This has raised the possibility that genes are commonly regulated by transcriptional elongation, but this remains largely untested in vivo, particularly in vertebrates. Here, we show that the proximal promoter from the Rhox5 homeobox gene recruits polymerase II and begins elongating in all tissues and cell lines that we tested, but it only completes elongation in a tissue-specific and developmentally regulated manner. Relief of the elongation block is associated with recruitment of the elongation factor P-TEFb, the co-activator GRIP1, the chromatin remodeling factor BRG1, and specific histone modifications. We provide evidence that two mechanisms relieve the elongation block at the proximal promoter: demethylation and recruitment of androgen receptor. Together, our findings support a model in which promoter proximal pausing helps confer tissue-specific and developmental gene expression through a mechanism regulated by DNA demethylation-dependent nuclear hormone receptor recruitment.	[Rao, Manjeet K.; Matsumoto, Yuiko; Bhardwaj, Anjana; Shanker, Sreenath; Bettegowda, Anilkumar; Wilkinson, Miles F.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Richardson, Marcy E.; Ward, Jacqueline M.; Wilkinson, Miles F.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92037 USA; [Richardson, Marcy E.; Ward, Jacqueline M.; Bettegowda, Anilkumar; Wilkinson, Miles F.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Rao, Manjeet K.; Panneerdoss, Subbarayalu] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA	University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Health San Antonio	Wilkinson, MF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	mfwilkinson@ucsd.edu		Bhardwaj, Anjana/0000-0003-4234-0241	National Institutes of Health [R01 HD045595, F32 GM096722]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD045595 (to M. F. W.) and F32 GM096722 (to M. E. R.).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Ahn SH, 2009, EMBO J, V28, P205, DOI 10.1038/emboj.2008.280; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Barbulescu K, 2001, MOL ENDOCRINOL, V15, P1803, DOI 10.1210/me.15.10.1803; Bhalla AD, 2009, J BIOL CHEM, V284, P4062, DOI 10.1074/jbc.M805193200; Bhardwaj A, 2008, MOL CELL BIOL, V28, P2138, DOI 10.1128/MCB.01170-07; Bhardwaj A, 2012, MOL ENDOCRINOL, V26, P538, DOI 10.1210/me.2011-1059; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Boettiger AN, 2013, CELL REP, V3, P8, DOI 10.1016/j.celrep.2012.12.015; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Chang YF, 2012, P NATL ACAD SCI USA, V109, P5750, DOI 10.1073/pnas.1117837109; Chen HL, 2010, ENDOCR-RELAT CANCER, V17, P857, DOI 10.1677/ERC-10-0081; Clement JQ, 2001, J BIOL CHEM, V276, P16919, DOI 10.1074/jbc.M005104200; Daggag H, 2008, BIOL REPROD, V79, P468, DOI 10.1095/biolreprod.107.067348; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; DEWINTER JAR, 1991, J HISTOCHEM CYTOCHEM, V39, P927, DOI 10.1177/39.7.1865110; EDEN S, 1994, CURR OPIN GENET DEV, V4, P255, DOI 10.1016/S0959-437X(05)80052-8; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Ehrensberger AH, 2013, CELL, V154, P713, DOI 10.1016/j.cell.2013.07.032; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Gaertner B, 2014, DEVELOPMENT, V141, P1179, DOI 10.1242/dev.088492; Gilchrist DA, 2012, GENE DEV, V26, P933, DOI 10.1101/gad.187781.112; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; GROUDINE M, 1981, NATURE, V292, P311, DOI 10.1038/292311a0; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hu Z, 2008, J BIOL CHEM, V283, P3866, DOI 10.1074/jbc.M706717200; Hu ZY, 2010, MOL ENDOCRINOL, V24, P60, DOI 10.1210/me.2009-0303; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Kapoor-Vazirani P, 2011, MOL CELL BIOL, V31, P1594, DOI 10.1128/MCB.00524-10; Kino T, 2002, J BIOL CHEM, V277, P2396, DOI 10.1074/jbc.M106312200; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Kulaeva OI, 2007, MUTAT RES-FUND MOL M, V618, P116, DOI 10.1016/j.mrfmmm.2006.05.040; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Lindsey JS, 1996, DEV BIOL, V179, P471, DOI 10.1006/dbio.1996.0276; Lindsey JS, 1996, BIOL REPROD, V55, P975, DOI 10.1095/biolreprod55.5.975; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; MacLean JA, 2005, CELL, V120, P369, DOI 10.1016/j.cell.2004.12.022; MacLean JA, 2013, J BIOL CHEM, V288, P34809, DOI 10.1074/jbc.M113.486340; MacLean JA, 2011, MOL CELL BIOL, V31, P1275, DOI 10.1128/MCB.00734-10; Maiti S, 1996, J BIOL CHEM, V271, P17536, DOI 10.1074/jbc.271.29.17536; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; O'Shaughnessy PJ, 2007, ENDOCRINOLOGY, V148, P2914, DOI 10.1210/en.2006-1412; Pelletier G, 2004, J ENDOCRINOL, V180, P77, DOI 10.1677/joe.0.1800077; Pitman JL, 1998, DEV BIOL, V202, P196, DOI 10.1006/dbio.1998.8978; Puustinen R, 2001, EUR J ENDOCRINOL, V145, P323, DOI 10.1530/eje.0.1450323; QianWu J, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-1-r3, 10.1186/gb-2008-9-5-220]; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rao MK, 2003, MOL ENDOCRINOL, V17, P223, DOI 10.1210/me.2002-0232; Rao MK, 2002, J BIOL CHEM, V277, P26036, DOI 10.1074/jbc.M203374200; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Richardson ME, 2014, HUM MOL GENET, V23, P12, DOI 10.1093/hmg/ddt392; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; SASAKI AW, 1991, MECH DEVELOP, V34, P155, DOI 10.1016/0925-4773(91)90052-8; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Subtil-Rodriguez A, 2010, EMBO REP, V11, P751, DOI 10.1038/embor.2010.131; Sutton KA, 1998, J ANDROL, V19, P21; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Trotter K., 2008, NUCL RECEPT SIGNAL, V6, P1, DOI DOI 10.1621/NRS.06004; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; WILKINSON MF, 1990, DEV BIOL, V141, P451, DOI 10.1016/0012-1606(90)90400-D; Wu DY, 2011, TRENDS ENDOCRIN MET, V22, P474, DOI 10.1016/j.tem.2011.07.006; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	78	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35087	35101		10.1074/jbc.M114.615435	http://dx.doi.org/10.1074/jbc.M114.615435			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25331959	hybrid, Green Published			2022-12-28	WOS:000346660200004
J	Bartolome, RA; Pelaez-Garcia, A; Gomez, I; Torres, S; Fernandez-Acenero, MJ; Escudero-Paniagua, B; Imbaud, JI; Casal, JI				Bartolome, Ruben A.; Pelaez-Garcia, Alberto; Gomez, Inmaculada; Torres, Sofia; Jesus Fernandez-Acenero, Maria; Escudero-Paniagua, Beatriz; Ignacio Imbaud, J.; Ignacio Casal, J.			An RGD Motif Present in Cadherin 17 Induces Integrin Activation and Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cadherin; Cell Signaling; Colon Cancer; Integrin; Tumor Metastasis; RGD Motif	LIVER-INTESTINE CADHERIN; COLORECTAL-CANCER; DIAGNOSTIC MARKER; CELL-ADHESION; METASTASIS; EXPRESSION; FIBRONECTIN; CARCINOMA; COLLAGEN; ADENOCARCINOMAS	Background: The interaction between cadherin 17 and 21 integrin promotes cell adhesion and proliferation. Results: Cadherin 17 contains an RGD motif that constitutes the critical switch for integrin binding and activation. Conclusion: The cadherin RGD motif is a critical ligand for tumor growth and metastasis. Significance: Cadherin 17 is the first known integrin-ligand RGD-cadherin. Other RGD-cadherins might play important roles in cancer metastasis. Little is known about the mechanism of integrin activation by cadherin 17 (CDH17). Here we observed the presence of a tri-peptide motif, RGD, in domain 6 of the human CDH17 sequence and other cadherins such as cadherin 5 and cadherin 6. The use of CDH17 RAD mutants demonstrated a considerable decrease of proliferation and adhesion in RKO and KM12SM colon cancer cells. Furthermore, RGD peptides inhibited the adhesion of both cell lines to recombinant CDH17 domain 6. The RGD motif added exogenously to the cells provoked a change in 1 integrin to an active, high-affinity conformation and an increase in focal adhesion kinase and ERK1/2 activation. In vivo experiments with Swiss nude mice demonstrated that cancer cells expressing the CDH17 RAD mutant showed a considerable delay in tumor growth and liver homing. CDH17 RGD effects were also active in pancreatic cancer cells. Our results suggest that 21 integrin interacts with two different ligands, collagen IV and CDH17, using two different binding sites. In summary, the RGD binding motif constitutes a switch for integrin pathway activation and shows a novel capacity of CDH17 as an integrin ligand. This motif could be targeted to avoid metastatic dissemination in tumors overexpressing CDH17 and other RGD-containing cadherins.	[Bartolome, Ruben A.; Pelaez-Garcia, Alberto; Torres, Sofia; Escudero-Paniagua, Beatriz; Ignacio Casal, J.] CSIC, CIB, Dept Cellular & Mol Med, E-28040 Madrid, Spain; [Gomez, Inmaculada; Ignacio Imbaud, J.] Prot Alternat SL, Madrid, Spain; [Jesus Fernandez-Acenero, Maria] Fdn Jimenez Diaz, Dept Pathol, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Casal, JI (corresponding author), CSIC, CIB, Dept Cellular & Mol Med, Ramiro de Maeztu 9, E-28040 Madrid, Spain.	icasal@cib.csic.es	Aceñero, M Jesús Fernández/ABC-5904-2020; Casal, Ignacio/M-2312-2014; Imbaud, Juan Ignacio/AAP-2121-2021; Bartolome, Ruben A/M-1873-2014	Aceñero, M Jesús Fernández/0000-0002-2439-3553; Casal, Ignacio/0000-0003-1085-2840; Imbaud, Juan Ignacio/0000-0002-6026-4265; Bartolome, Ruben A/0000-0002-3292-1491; Pelaez Garcia, Alberto/0000-0002-5401-3216; Torres, Sofia/0000-0002-9007-8105	Spanish Ministry of Economy and Competitiveness [BIO2012-31023]; Comunidad de Madrid [S2011/BMD-2344/ (Colomics2)]; ProteoRed-ISCIII; FPI; Juan de la Cierva program grant	Spanish Ministry of Economy and Competitiveness(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); ProteoRed-ISCIII; FPI(Spanish Government); Juan de la Cierva program grant	This research was supported by grant BIO2012-31023 from the Spanish Ministry of Economy and Competitiveness, by a grant to established research groups (AECC), and by grant S2011/BMD-2344/ (Colomics2) from Comunidad de Madrid and ProteoRed-ISCIII.; Recipient of an FPI fellowship.; Recipient of a Juan de la Cierva program grant.	Babel I, 2009, MOL CELL PROTEOMICS, V8, P2382, DOI 10.1074/mcp.M800596-MCP200; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Barderas R, 2013, MOL CELL PROTEOMICS, V12, P1602, DOI 10.1074/mcp.M112.022848; Barderas R, 2012, CANCER RES, V72, P2780, DOI 10.1158/0008-5472.CAN-11-4090; Bartolome RA, 2014, ONCOGENE, V33, P1658, DOI 10.1038/onc.2013.117; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; CARDARELLI PM, 1992, J BIOL CHEM, V267, P23159; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dunne E, 2012, ARTERIOSCL THROM VAS, V32, P1724, DOI 10.1161/ATVBAHA.112.250464; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Labelle M, 2008, CANCER RES, V68, P1388, DOI 10.1158/0008-5472.CAN-07-2706; Lee NP, 2010, BBA-REV CANCER, V1806, P138, DOI 10.1016/j.bbcan.2010.05.002; Li G, 2001, CANCER RES, V61, P3819; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; Luque-Garcia JL, 2010, PROTEOMICS, V10, P940, DOI 10.1002/pmic.200900441; Park JH, 2011, HISTOPATHOLOGY, V58, P316, DOI 10.1111/j.1365-2559.2011.03746.x; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Pfaff M., 1997, INTEGRIN LIGAND INTE, P101, DOI [10.1007/978-1-4757-4064-6_4, DOI 10.1007/978-1-4757-4064-6_4]; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; Su MC, 2008, MODERN PATHOL, V21, P1379, DOI 10.1038/modpathol.2008.107; Takamura M, 2004, CANCER LETT, V212, P253, DOI 10.1016/j.canlet.2004.03.016; YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29; Yoshimura K, 2009, CANCER RES, V69, P7320, DOI 10.1158/0008-5472.CAN-09-0315	29	29	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34801	34814		10.1074/jbc.M114.600502	http://dx.doi.org/10.1074/jbc.M114.600502			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25336636	Green Published, hybrid			2022-12-28	WOS:000346260800032
J	de Juan-Sanz, J; Nunez, E; Zafra, F; Berrocal, M; Corbacho, I; Ibanez, I; Arribas-Gonzalez, E; Marcos, D; Lopez-Corcuera, B; Mata, AM; Aragon, C				de Juan-Sanz, Jaime; Nunez, Enrique; Zafra, Francisco; Berrocal, Maria; Corbacho, Isaac; Ibanez, Ignacio; Arribas-Gonzalez, Esther; Marcos, Daniel; Lopez-Corcuera, Beatriz; Mata, Ana M.; Aragon, Carmen			Presynaptic Control of Glycine Transporter 2 (GlyT2) by Physical and Functional Association with Plasma Membrane Ca2+-ATPase (PMCA) and Na+-Ca2+ Exchanger (NCX)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium ATPase; Lipid Raft; Neurotransmitter Transport; Proteomics; Sodium-Calcium Exchange; GlyT2	NA+/CA2+ EXCHANGE; CA2+ ATPASE; CALCIUM-PUMP; LIPID RAFTS; SARCOPLASMIC-RETICULUM; SYNAPTIC-TRANSMISSION; NA/CA EXCHANGER; REVERSE MODE; NA+/K+-PUMP; LOCALIZATION	Background: GlyT2 is crucial for glycinergic neurotransmission, but only a few interacting partners for this protein are known. Results: PMCA2/3 and NCX1 interact with GlyT2 and modulate its activity in lipid raft subdomains. Conclusion: Functional interaction of GlyT2 with PMCA2/3 and NCX1 helps Na+ and Ca2+ local homeostasis in glycinergic terminals. Significance: Learning how GlyT2 is regulated might help with developing new therapies for hyperekplexia or neuropathic pain. Fast inhibitory glycinergic transmission occurs in spinal cord, brainstem, and retina to modulate the processing of motor and sensory information. After synaptic vesicle fusion, glycine is recovered back to the presynaptic terminal by the neuronal glycine transporter 2 (GlyT2) to maintain quantal glycine content in synaptic vesicles. The loss of presynaptic GlyT2 drastically impairs the refilling of glycinergic synaptic vesicles and severely disrupts neurotransmission. Indeed, mutations in the gene encoding GlyT2 are the main presynaptic cause of hyperekplexia in humans. Here, we show a novel endogenous regulatory mechanism that can modulate GlyT2 activity based on a compartmentalized interaction between GlyT2, neuronal plasma membrane Ca2+-ATPase (PMCA) isoforms 2 and 3, and Na+/Ca2+-exchanger 1 (NCX1). This GlyT2PMCA2,3NCX1 complex is found in lipid raft subdomains where GlyT2 has been previously found to be fully active. We show that endogenous PMCA and NCX activities are necessary for GlyT2 activity and that this modulation depends on lipid raft integrity. Besides, we propose a model in which GlyT2PMCA2-3NCX complex would help Na+/K+-ATPase in controlling local Na+ increases derived from GlyT2 activity after neurotransmitter release.	[de Juan-Sanz, Jaime] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Nunez, Enrique; Zafra, Francisco; Ibanez, Ignacio; Arribas-Gonzalez, Esther; Lopez-Corcuera, Beatriz; Aragon, Carmen] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, E-28049 Madrid, Spain; [Zafra, Francisco; Ibanez, Ignacio; Arribas-Gonzalez, Esther; Lopez-Corcuera, Beatriz; Aragon, Carmen] ISCIII, Ctr Invest Biomed Red Enfermedades Raras, Valencia 46009, Spain; [Nunez, Enrique; Zafra, Francisco; Ibanez, Ignacio; Arribas-Gonzalez, Esther; Lopez-Corcuera, Beatriz; Aragon, Carmen] Univ La Paz, IdiPAZ Hosp, Madrid 28046, Spain; [Berrocal, Maria; Corbacho, Isaac; Marcos, Daniel; Mata, Ana M.] Univ Extremadura, Fac Ciencias, Dept Bioquim & Biol Mol & Genet, Badajoz 06006, Spain	Cornell University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Universidad de Extremadura	Aragon, C (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	caragon@cbm.csic.es	Berrocal Carrillo, María/H-1527-2018; Corbacho, Isaac/J-8438-2014; Aragon, Carmen/K-9783-2014; Mata, Ana M./J-8460-2014; Corcuera, Beatriz López/D-5188-2009; de Juan-Sanz, Jaime/L-7990-2017; Marcos, Daniel/J-9730-2014	Berrocal Carrillo, María/0000-0003-0684-3853; Corbacho, Isaac/0000-0003-1768-8270; Aragon, Carmen/0000-0001-8287-9386; Mata, Ana M./0000-0002-2887-7854; Corcuera, Beatriz López/0000-0002-0383-4241; Arribas Gonzalez, Esther/0000-0001-6579-3396; de Juan-Sanz, Jaime/0000-0002-1212-5623; Marcos, Daniel/0000-0002-1007-1780	Spanish Direccion General de Investigacion Cientifica y Tecnica [SAF2008-05436, SAF2011-28674]; Fondo de Investigaciones Sanitarias (Centro de Investigacion Biomedica en Red de Enfermedades Raras); Fundacion Ramon Areces; Ministerio de Economia y Competitividad; Junta de Extremadura; Fondo Europeo de Desarrollo Regional Grants [BFU2011-23313]	Spanish Direccion General de Investigacion Cientifica y Tecnica(Spanish Government); Fondo de Investigaciones Sanitarias (Centro de Investigacion Biomedica en Red de Enfermedades Raras); Fundacion Ramon Areces; Ministerio de Economia y Competitividad(Spanish Government); Junta de Extremadura; Fondo Europeo de Desarrollo Regional Grants	This work was supported by Spanish Direccion General de Investigacion Cientifica y Tecnica Grants SAF2008-05436 and SAF2011-28674, Fondo de Investigaciones Sanitarias (Centro de Investigacion Biomedica en Red de Enfermedades Raras) and Fundacion Ramon Areces (to C. A. and B. L. C.), and Ministerio de Economia y Competitividad, Junta de Extremadura, and Fondo Europeo de Desarrollo Regional Grants BFU2011-23313 from (to A. M. M.).	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Apostolides PF, 2013, J NEUROSCI, V33, P4768, DOI 10.1523/JNEUROSCI.5555-12.2013; Aragon C, 2005, TRENDS PHARMACOL SCI, V26, P283, DOI 10.1016/j.tips.2005.04.007; Ariel P, 2012, PHYSIOLOGY, V27, P15, DOI 10.1152/physiol.00035.2011; Arribas-Gonzalez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063230; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berrocal M, 2012, BBA-MOL BASIS DIS, V1822, P961, DOI 10.1016/j.bbadis.2012.02.013; Blaustein MP, 2002, ANN NY ACAD SCI, V976, P356; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boczek T, 2012, CELL CALCIUM, V52, P433, DOI 10.1016/j.ceca.2012.08.002; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonzon-Kulichenko E, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003335; Brini M, 2011, COLD SPRING HARB PER, V3, P2, DOI DOI 10.1101/CSHPERSPECT.A004168; Bublitz M, 2013, J BIOL CHEM, V288, P10759, DOI 10.1074/jbc.R112.436550; Bublitz M, 2011, J CELL SCI, V124, P2515, DOI 10.1242/jcs.088716; Burette A, 2007, J COMP NEUROL, V500, P1127, DOI 10.1002/cne.21237; Burette AC, 2009, J COMP NEUROL, V512, P500, DOI 10.1002/cne.21909; Carta E, 2012, J BIOL CHEM, V287, P28975, DOI 10.1074/jbc.M112.372094; Chaudhary J, 2001, AM J PHYSIOL-CELL PH, V280, pC1027, DOI 10.1152/ajpcell.2001.280.4.C1027; Cubelos B, 2014, NEUROCHEM INT, V73, P204, DOI 10.1016/j.neuint.2013.09.002; de Juan-Sanz J, 2013, J NEUROSCI, V33, P14269, DOI 10.1523/JNEUROSCI.1532-13.2013; de Juan-Sanz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058863; de Juan-Sanz J, 2011, TRAFFIC, V12, P1850, DOI 10.1111/j.1600-0854.2011.01278.x; DeMarco SJ, 2001, J BIOL CHEM, V276, P21594, DOI 10.1074/jbc.M101448200; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Dohi T, 2009, PHARMACOL THERAPEUT, V123, P54, DOI 10.1016/j.pharmthera.2009.03.018; Dostanic I, 2004, J BIOL CHEM, V279, P54053, DOI 10.1074/jbc.M410737200; Duman JG, 2008, J GEN PHYSIOL, V131, P307, DOI 10.1085/jgp.200709915; Eckert G. P., 2010, OPEN BIOL J, V3, P32; Elias CL, 2001, AM J PHYSIOL-HEART C, V281, pH1334, DOI 10.1152/ajpheart.2001.281.3.H1334; Enyedi Agnes, 2011, Commun Integr Biol, V4, P340, DOI 10.4161/cib.4.3.15040; Ficarella R, 2007, P NATL ACAD SCI USA, V104, P1516, DOI 10.1073/pnas.0609775104; Fornes A, 2008, BIOCHEM J, V412, P495, DOI 10.1042/BJ20071018; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; Garside ML, 2009, NEUROSCIENCE, V162, P383, DOI 10.1016/j.neuroscience.2009.04.059; Geerlings A, 2001, J BIOL CHEM, V276, P17584, DOI 10.1074/jbc.M010602200; Gimenez C, 2012, J BIOL CHEM, V287, P28986, DOI 10.1074/jbc.M111.319244; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Gomez-Varela D, 2012, J NEUROSCI, V32, P6894, DOI 10.1523/JNEUROSCI.5972-11.2012; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Hilgemann DW, 1996, BIOPHYS J, V71, P759, DOI 10.1016/S0006-3495(96)79275-5; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; Iwamoto Takahiro, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P188, DOI 10.2174/187152907781745288; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Jensen TP, 2007, J PHYSIOL-LONDON, V579, P85, DOI 10.1113/jphysiol.2006.123901; Jiang L, 2007, J NEUROCHEM, V102, P378, DOI 10.1111/j.1471-4159.2007.04480.x; Jiang L, 2012, J NEUROCHEM, V123, P689, DOI 10.1111/j.1471-4159.2012.07918.x; Jimenez E, 2011, J BIOL CHEM, V286, P10712, DOI 10.1074/jbc.M110.167056; Kurnellas MP, 2010, CELL DEATH DIFFER, V17, P1501, DOI 10.1038/cdd.2010.54; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Mata AM, 2005, BRAIN RES REV, V49, P398, DOI 10.1016/j.brainresrev.2004.11.004; Mata AM, 2011, BIOCHEM SOC T, V39, P819, DOI 10.1042/BST0390819; Matchkov VV, 2007, CIRC RES, V100, P1026, DOI 10.1161/01.RES.0000262659.09293.56; MOORE EDW, 1993, NATURE, V365, P657, DOI 10.1038/365657a0; Nothdurfter C, 2010, NEUROPSYCHOPHARMACOL, V35, P1510, DOI 10.1038/npp.2010.20; Nunez E, 2008, J NEUROCHEM, V105, P2080, DOI 10.1111/j.1471-4159.2008.05292.x; Nunez E, 2009, TRAFFIC, V10, P829, DOI 10.1111/j.1600-0854.2009.00911.x; Pande Jyoti, 2011, World J Biol Chem, V2, P39, DOI 10.4331/wjbc.v2.i3.39; PHILIPSON KD, 1988, BIOCHIM BIOPHYS ACTA, V945, P298, DOI 10.1016/0005-2736(88)90492-0; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; REUTER H, 1995, NEURON, V15, P1077, DOI 10.1016/0896-6273(95)90096-9; Roh SE, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-9; Roome CJ, 2013, J NEUROPHYSIOL, V109, P1669, DOI 10.1152/jn.00854.2012; Roome CJ, 2013, ADV EXP MED BIOL, V961, P251, DOI 10.1007/978-1-4614-4756-6_21; Rousseau F, 2008, J NEUROSCI, V28, P9755, DOI 10.1523/JNEUROSCI.0509-08.2008; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Sepulveda MR, 2007, J NEUROCHEM, V103, P1009, DOI 10.1111/j.1471-4159.2007.04794.x; Sepulveda MR, 2006, J BIOL CHEM, V281, P447, DOI 10.1074/jbc.M506950200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; SKOU JC, 1990, FEBS LETT, V268, P314, DOI 10.1016/0014-5793(90)81278-V; Strehler EE, 2007, BIOCHEM SOC T, V35, P919, DOI 10.1042/BST0350919; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Szewczyk MM, 2008, PFLUG ARCH EUR J PHY, V456, P255, DOI 10.1007/s00424-007-0348-6; Tian J, 2008, PHYSIOLOGY, V23, P205, DOI 10.1152/physiol.00008.2008; Tidow H, 2012, NATURE, V491, P468, DOI 10.1038/nature11539; Tortelote GG, 2004, FEBS LETT, V576, P31, DOI 10.1016/j.febslet.2004.08.055; Vandecaetsbeek Ilse, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004184; Watano T, 1996, BRIT J PHARMACOL, V119, P555, DOI 10.1111/j.1476-5381.1996.tb15708.x; Yu L, 1997, MOL BRAIN RES, V50, P285, DOI 10.1016/S0169-328X(97)00202-7; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Zanni G, 2012, P NATL ACAD SCI USA, V109, P14514, DOI 10.1073/pnas.1207488109; Zhang J, 2009, CELL CALCIUM, V45, P177, DOI [10.1016/j.ceca.2008.09.002, 10.3778/j.issn.1002-8331.2009.04.050]; Zhong N, 2001, J NEUROSCI, V21, P9598, DOI 10.1523/JNEUROSCI.21-24-09598.2001; Zinchuk Vadim, 2011, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s52	96	24	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34308	34324		10.1074/jbc.M114.586966	http://dx.doi.org/10.1074/jbc.M114.586966			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25315779	Green Published, hybrid			2022-12-28	WOS:000346077600052
J	Wanichawan, P; Hafver, TL; Hodne, K; Aronsen, JM; Lunde, IG; Dalhus, B; Lunde, M; Kvaloy, H; Louch, WE; Tonnessen, T; Sjaastad, I; Sejersted, OM; Carlson, CR				Wanichawan, Pimthanya; Hafver, Tandekile Lubelwana; Hodne, Kjetil; Aronsen, Jan Magnus; Lunde, Ida Gjervold; Dalhus, Bjorn; Lunde, Marianne; Kvaloy, Heidi; Louch, William Edward; Tonnessen, Theis; Sjaastad, Ivar; Sejersted, Ole Mathias; Carlson, Cathrine Rein			Molecular Basis of Calpain Cleavage and Inactivation of the Sodium-Calcium Exchanger 1 in Heart Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Animal Model; Calpain; Computer Modeling; Electrophysiology; Heart Failure; Ion Channel; Peptide Array; Protein-Protein Interaction; Aortic Stenosis; Sodium-Calcium Exchanger	CARDIAC NA+/CA2+ EXCHANGER; ELECTROSTATIC SWITCH MECHANISM; PROTEIN-KINASE-C; DIASTOLIC DYSFUNCTION; CA2+ REGULATION; BINDING DOMAIN; ACTIVE-SITE; ACTIVATION; ACCUMULATION; ERYTHROCYTE	Background: Sodium-calcium exchanger 1 (NCX1) and calpain are up-regulated in heart failure (HF). Molecular mechanisms and functional consequences of NCX1 cleavage by calpain are not known. Results: Calpain anchors to two NCX1 regions and cleaves at methionine-369, leading to inactivation. Conclusion: NCX1 inhibition by calpain might improve cardiac function. Significance: Calpain might play a pivotal role in NCX1 regulation during HF. Cardiac sodium (Na+)-calcium (Ca2+) exchanger 1 (NCX1) is central to the maintenance of normal Ca2+ homeostasis and contraction. Studies indicate that the Ca2+-activated protease calpain cleaves NCX1. We hypothesized that calpain is an important regulator of NCX1 in response to pressure overload and aimed to identify molecular mechanisms and functional consequences of calpain binding and cleavage of NCX1 in the heart. NCX1 full-length protein and a 75-kDa NCX1 fragment along with calpain were up-regulated in aortic stenosis patients and rats with heart failure. Patients with coronary artery disease and sham-operated rats were used as controls. Calpain co-localized, co-fractionated, and co-immunoprecipitated with NCX1 in rat cardiomyocytes and left ventricle lysate. Immunoprecipitations, pull-down experiments, and extensive use of peptide arrays indicated that calpain domain III anchored to the first Ca2+ binding domain in NCX1, whereas the calpain catalytic region bound to the catenin-like domain in NCX1. The use of bioinformatics, mutational analyses, a substrate competitor peptide, and a specific NCX1-Met(369) antibody identified a novel calpain cleavage site at Met(369). Engineering NCX1-Met(369) into a tobacco etch virus protease cleavage site revealed that specific cleavage at Met(369) inhibited NCX1 activity (both forward and reverse mode). Finally, a short peptide fragment containing the NCX1-Met(369) cleavage site was modeled into the narrow active cleft of human calpain. Inhibition of NCX1 activity, such as we have observed here following calpain-induced NCX1 cleavage, might be beneficial in pathophysiological conditions where increased NCX1 activity contributes to cardiac dysfunction.	[Wanichawan, Pimthanya; Hafver, Tandekile Lubelwana; Hodne, Kjetil; Aronsen, Jan Magnus; Lunde, Ida Gjervold; Lunde, Marianne; Kvaloy, Heidi; Louch, William Edward; Tonnessen, Theis; Sjaastad, Ivar; Sejersted, Ole Mathias; Carlson, Cathrine Rein] Oslo Univ Hosp, Expt Med Res Inst, N-0407 Oslo, Norway; [Wanichawan, Pimthanya; Hafver, Tandekile Lubelwana; Hodne, Kjetil; Aronsen, Jan Magnus; Lunde, Ida Gjervold; Lunde, Marianne; Kvaloy, Heidi; Louch, William Edward; Tonnessen, Theis; Sjaastad, Ivar; Sejersted, Ole Mathias; Carlson, Cathrine Rein] Univ Oslo, N-0407 Oslo, Norway; [Wanichawan, Pimthanya; Hafver, Tandekile Lubelwana; Hodne, Kjetil; Lunde, Ida Gjervold; Lunde, Marianne; Kvaloy, Heidi; Louch, William Edward; Sjaastad, Ivar; Sejersted, Ole Mathias; Carlson, Cathrine Rein] Univ Oslo, KG Jebsen Cardiac Res Ctr, N-0318 Oslo, Norway; [Wanichawan, Pimthanya; Hafver, Tandekile Lubelwana; Hodne, Kjetil; Lunde, Ida Gjervold; Lunde, Marianne; Kvaloy, Heidi; Louch, William Edward; Sjaastad, Ivar; Sejersted, Ole Mathias; Carlson, Cathrine Rein] Univ Oslo, Ctr Heart Failure Res, N-0318 Oslo, Norway; [Tonnessen, Theis] Oslo Univ Hosp, Dept Cardiothorac Surg, N-0407 Oslo, Norway; [Aronsen, Jan Magnus] Bjorknes Coll, N-0456 Oslo, Norway; [Dalhus, Bjorn] Natl Hosp Norway, Oslo Univ Hosp, Dept Microbiol, N-0372 Oslo, Norway; [Dalhus, Bjorn] Natl Hosp Norway, Oslo Univ Hosp, Dept Med Biochem, N-0372 Oslo, Norway; [Lunde, Ida Gjervold] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Harvard University; Harvard Medical School	Carlson, CR (corresponding author), Oslo Univ Hosp, Expt Med Res Inst, Kirkeveien 166, N-0407 Oslo, Norway.	c.r.carlson@medisin.uio.no	Dalhus, Bjørn/AAK-2895-2020; Lunde, Ida Gjervold/ABN-5567-2022	Hodne, Kjetil/0000-0001-8528-9728; Lunde, Ida Gjervold/0000-0001-9502-6841	Research Council of Norway; Norwegian National Health Association; Stiftelsen Kristian Gerhard Jebsen; Anders Jahre's Fund for the promotion of Science; South-Eastern Norway Regional Health Authority; Simon Fougner Hartmanns Family Fund, Denmark; South-Eastern Regional Health Authorities' Technology Platform for Structural Biology and Bioinformatics [2012085]	Research Council of Norway(Research Council of Norway); Norwegian National Health Association; Stiftelsen Kristian Gerhard Jebsen; Anders Jahre's Fund for the promotion of Science; South-Eastern Norway Regional Health Authority; Simon Fougner Hartmanns Family Fund, Denmark; South-Eastern Regional Health Authorities' Technology Platform for Structural Biology and Bioinformatics	This work was supported by the Research Council of Norway, Norwegian National Health Association, Stiftelsen Kristian Gerhard Jebsen, Anders Jahre's Fund for the promotion of Science, the South-Eastern Norway Regional Health Authority, and the Simon Fougner Hartmanns Family Fund, Denmark.; Supported by South-Eastern Regional Health Authorities' Technology Platform for Structural Biology and Bioinformatics Grant 2012085.	Acsai K, 2011, J PHYSIOL-LONDON, V589, P2569, DOI 10.1113/jphysiol.2010.202663; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bers D. M., 2001, EXCITATION CONTRACTI, p[147, 152, 253]; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Brattelid T, 2007, J MOL CELL CARDIOL, V43, P767, DOI 10.1016/j.yjmcc.2007.08.019; Brown CS, 2007, PLATELETS, V18, P207, DOI 10.1080/09537100600954037; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; Despa S, 2013, J MOL CELL CARDIOL, V61, P2, DOI 10.1016/j.yjmcc.2013.04.011; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Frank R, 1996, Methods Mol Biol, V66, P149; French JP, 2006, AM J PHYSIOL-HEART C, V290, pH128, DOI 10.1152/ajpheart.00739.2005; Galvez AS, 2007, CIRC RES, V100, P1071, DOI 10.1161/01.RES.0000261938.28365.11; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; Hnatowich M, 2012, CELL CALCIUM, V51, P164, DOI 10.1016/j.ceca.2011.12.006; Inserte J, 2012, CARDIOVASC RES, V96, P23, DOI 10.1093/cvr/cvs232; Iwamoto T, 1996, J BIOL CHEM, V271, P13609, DOI 10.1074/jbc.271.23.13609; JAMES P, 1989, J BIOL CHEM, V264, P8289; Kang MY, 2010, CIRC RES, V107, P903, DOI 10.1161/CIRCRESAHA.110.220772; Kang TM, 2004, NATURE, V427, P544, DOI 10.1038/nature02271; Kar P, 2009, ARCH BIOCHEM BIOPHYS, V482, P66, DOI 10.1016/j.abb.2008.11.024; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Letavernier E, 2012, CARDIOVASC RES, V96, P38, DOI 10.1093/cvr/cvs099; Li LR, 2012, BIOPHYS J, V102, P2039, DOI 10.1016/j.bpj.2012.03.045; Li QS, 2006, BIOCHEMISTRY-US, V45, P701, DOI 10.1021/bi052077b; LI ZP, 1991, J BIOL CHEM, V266, P1014; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Louch WE, 2010, J PHYSIOL-LONDON, V588, P465, DOI 10.1113/jphysiol.2009.183517; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; Matsumura Y, 2001, J MOL CELL CARDIOL, V33, P1133, DOI 10.1006/jmcc.2001.1373; Moldoveanu T, 2004, J MOL BIOL, V343, P1313, DOI 10.1016/j.jmb.2004.09.016; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Ozdemir S, 2008, CIRC RES, V102, P1398, DOI 10.1161/CIRCRESAHA.108.173922; Panigrahi AK, 2011, MOL CELL BIOL, V31, P4335, DOI 10.1128/MCB.06075-11; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pedrozo Z, 2010, BBA-MOL BASIS DIS, V1802, P356, DOI 10.1016/j.bbadis.2009.12.005; SALAMINO F, 1994, CELL CALCIUM, V15, P28, DOI 10.1016/0143-4160(94)90101-5; Samanta K, 2010, J BIOCHEM, V147, P225, DOI 10.1093/jb/mvp176; Shaikh S, 2010, MOL CELL BIOCHEM, V341, P167, DOI 10.1007/s11010-010-0448-z; Singh RB, 2004, J MOL CELL CARDIOL, V37, P101, DOI 10.1016/j.yjmcc.2004.04.009; Sorimachi H, 2012, CARDIOVASC RES, V96, P11, DOI 10.1093/cvr/cvs157; Sossalla S, 2008, J MOL CELL CARDIOL, V45, P32, DOI 10.1016/j.yjmcc.2008.03.006; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Swift F, 2008, CARDIOVASC RES, V78, P71, DOI 10.1093/cvr/cvn013; Ter Keurs HEDJ, 2007, PHYSIOL REV, V87, P457, DOI 10.1152/physrev.00011.2006; Tompa P, 2001, BIOCHEM BIOPH RES CO, V280, P1333, DOI 10.1006/bbrc.2001.4279; Wanichawan P, 2011, AM J PHYSIOL-CELL PH, V300, pC989, DOI 10.1152/ajpcell.00196.2010; Wasserstrom JA, 2000, AM J PHYSIOL-HEART C, V279, pH798, DOI 10.1152/ajpheart.2000.279.2.H798	52	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33984	33998		10.1074/jbc.M114.602581	http://dx.doi.org/10.1074/jbc.M114.602581			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25336645	Green Published, hybrid			2022-12-28	WOS:000346077600026
J	Kojima, K; Amano, Y; Yoshino, K; Tanaka, N; Sugamura, K; Takeshita, T				Kojima, Katsuhiko; Amano, Yuji; Yoshino, Kazuhisa; Tanaka, Nobuyuki; Sugamura, Kazuo; Takeshita, Toshikazu			ESCRT-0 Protein Hepatocyte Growth Factor-regulated Tyrosine Kinase Substrate (Hrs) Is Targeted to Endosomes Independently of Signal-transducing Adaptor Molecule (STAM) and the Complex Formation with STAM Promotes Its Endosomal Dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIVESICULAR BODY FORMATION; RECEPTOR DOWN-REGULATION; E VPS PROTEINS; UBIQUITIN ISOPEPTIDASE; MASTER MOLECULE; CELL-GROWTH; FYVE DOMAIN; MEMBRANE; BINDING; CARGO	The ESCRT-0 complex, consisting of the hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) and the signal-transducing adaptor molecule (STAM) proteins, recognizes ubiquitylated cargo during the initial step of endosomal sorting. The endosomal accumulation of overexpressed Hrs has been reported previously to be associated with endosome enlargement. In this study, we have found that co-expressing exogenous STAM1 in Hrs-overexpressing cells leads to a diffuse localization for a large part of the Hrs accumulated on endosomes and a recovery of the impaired cargo protein degradation process, thus suggesting that exogenous STAM abrogates the abnormalities of the Hrs-positive endosomes. A fluorescently labeled Hrs, introduced into the cells by membrane permeabilization, exhibited endosomal localization in the absence of STAM1 and gradually dissociated from the endosomes upon the sequential addition of recombinant STAM1. Furthermore, when microinjected into cells, the fluorescently labeled Hrs also showed endosomal accumulation; however, ESCRT-0 complexes formed prior to the microinjection did not. Analysis of the state of the complex in HeLa cells using blue-native PAGE revealed that the membrane-associated Hrs exists partly as a monomer and not only in the STAM1-bound form. Thus, our data suggest that the membrane binding and dissociation cycle of the ESCRT-0 proteins on the endosomal membrane is a critical step during the cargo sorting process.	[Kojima, Katsuhiko; Amano, Yuji; Yoshino, Kazuhisa; Takeshita, Toshikazu] Shinshu Univ, Sch Med, Dept Microbiol & Immunol, Matsumoto, Nagano 3908621, Japan; [Tanaka, Nobuyuki] Miyagi Canc Ctr, Res Inst, Div Immunol, Natori, Miyagi 9811293, Japan; [Sugamura, Kazuo] Miyagi Canc Ctr, Res Inst, Div Mol & Cellular Oncol, Natori, Miyagi 9811293, Japan	Shinshu University; Miyagi Cancer Center; Miyagi Cancer Center	Takeshita, T (corresponding author), Shinshu Univ, Sch Med, Dept Microbiol & Immunol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	takesit@shinshu-u.ac.jp	Takeshita, Toshikazu/AAL-1382-2021		 [C_25461586]; Grants-in-Aid for Scientific Research [25461586] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research C_25461586 (to T. T.).	Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Fiala GJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2164; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kobayashi H, 2005, J BIOL CHEM, V280, P10468, DOI 10.1074/jbc.M409969200; Kyuuma M, 2006, CELL STRUCT FUNCT, V31, P159, DOI 10.1247/csf.06023; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Mayers JR, 2011, J BIOL CHEM, V286, P9636, DOI 10.1074/jbc.M110.185363; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Miedema H, 1996, J MEMBRANE BIOL, V152, P159, DOI 10.1007/s002329900094; Mitsui K, 2011, J BIOL CHEM, V286, P37625, DOI 10.1074/jbc.M111.260612; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Pullan L, 2006, STRUCTURE, V14, P661, DOI 10.1016/j.str.2006.01.012; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; Takeshita T, 1996, BIOCHEM BIOPH RES CO, V225, P1035, DOI 10.1006/bbrc.1996.1290; Tanaka N, 1999, J BIOL CHEM, V274, P19129, DOI 10.1074/jbc.274.27.19129; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	38	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33296	33310		10.1074/jbc.M114.578245	http://dx.doi.org/10.1074/jbc.M114.578245			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25296754	hybrid, Green Published			2022-12-28	WOS:000345636600021
J	Soni, SP; Stahelin, RV				Soni, Smita P.; Stahelin, Robert V.			The Ebola Virus Matrix Protein VP40 Selectively Induces Vesiculation from Phosphatidylserine-enriched Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMORRHAGIC-FEVER; STOMATITIS-VIRUS; PLASMA-MEMBRANE; ENTRY REQUIRES; BINDING; DOMAIN; OLIGOMERIZATION; GLYCOPROTEIN; ASSOCIATION; ANTIBODY	Ebola virus is from the Filoviridae family of viruses and is one of the most virulent pathogens known with similar to 60% clinical fatality. The Ebola virus negative sense RNA genome encodes seven proteins including viral matrix protein 40 (VP40), which is the most abundant protein found in the virions. Within infected cells VP40 localizes at the inner leaflet of the plasma membrane (PM), binds lipids, and regulates formation of new virus particles. Expression of VP40 in mammalian cells is sufficient to form virus-like particles that are nearly indistinguishable from the authentic virions. However, how VP40 interacts with the PM and forms virus-like particles is for the most part unknown. To investigate VP40 lipid specificity in a model of viral egress we employed giant unilamellar vesicles with different lipid compositions. The results demonstrate VP40 selectively induces vesiculation from membranes containing phosphatidylserine (PS) at concentrations of PS that are representative of the PM inner leaflet content. The formation of intraluminal vesicles was not significantly detected in the presence of other important PM lipids including cholesterol and polyvalent phosphoinositides, further demonstrating PS selectivity. Taken together, these studies suggest that PM phosphatidylserine may be an important component of Ebola virus budding and that VP40 may be able to mediate PM scission.	[Soni, Smita P.; Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Stahelin, Robert V.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	Indiana University System; Indiana University South Bend; University of Notre Dame; University of Notre Dame	Stahelin, RV (corresponding author), Indiana Univ Sch Med, 143 Raclin Carmichael Hall,1234 Notre Dame Ave, South Bend, IN 46617 USA.	rstaheli@iu.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863	National Institutes of Health [AI081077]; Center for Rare and Neglected Diseases at the University of Notre Dame; Indiana University School of Medicine-South Bend Imaging and Flow Cytometry Core Facility; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Rare and Neglected Diseases at the University of Notre Dame; Indiana University School of Medicine-South Bend Imaging and Flow Cytometry Core Facility; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI081077, the Center for Rare and Neglected Diseases at the University of Notre Dame, and grants from the Indiana University School of Medicine-South Bend Imaging and Flow Cytometry Core Facility (to R. V. S.).	Adu-Gyamfi E, 2013, J BIOL CHEM, V288, P5779, DOI 10.1074/jbc.M112.443960; Adu-Gyamfi E, 2012, BIOPHYS J, V102, P2517, DOI 10.1016/j.bpj.2012.04.022; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109; Blaney JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003389; Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Farrar J. J., 2014, NEW ENGL J MED, V371, P1481; Feldmann H, 2014, NEW ENGL J MED, V371, P1375, DOI 10.1056/NEJMp1405314; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; Harty RN, 2009, ANTIVIR RES, V81, P189, DOI 10.1016/j.antiviral.2008.12.003; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Jasenosky LD, 2001, J VIROL, V75, P5205, DOI 10.1128/JVI.75.11.5205-5214.2001; Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471; JOHNSON KM, 1977, LANCET, V1, P569; Kay JG, 2012, MOL BIOL CELL, V23, P2198, DOI 10.1091/mbc.E11-11-0936; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Licata JM, 2004, J VIROL, V78, P7344, DOI 10.1128/JVI.78.14.7344-7351.2004; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; McCarthy SE, 2007, J VIROL, V81, P11452, DOI 10.1128/JVI.00853-07; Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Neumann G, 2005, J VIROL, V79, P10300, DOI 10.1128/JVI.79.16.10300-10307.2005; Olejnik J, 2011, VIRUSES-BASEL, V3, P1501, DOI 10.3390/v3081501; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Scianimanico S, 2000, EMBO J, V19, P6732, DOI 10.1093/emboj/19.24.6732; Shnyrova AV, 2007, J CELL BIOL, V179, P627, DOI 10.1083/jcb.200705062; Solon J, 2005, J GEN VIROL, V86, P3357, DOI 10.1099/vir.0.81129-0; Soni SP, 2013, BIOPHYS J, V104, P1940, DOI [10.1016/j.bpj.2013.03.021, 10.1016/j.bPj.2013.03.021]; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Stahelin RV, 2014, CHEM PHYS LIPIDS, V182, P3, DOI 10.1016/j.chemphyslip.2014.02.002; Stahelin RV, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00300; Stahelin RV, 2014, EXPERT OPIN THER TAR, V18, P115, DOI 10.1517/14728222.2014.863877; Timmins J, 2003, J MOL BIOL, V326, P493, DOI 10.1016/S0022-2836(02)01406-7; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Ward KE, 2012, J LIPID RES, V53, P2656, DOI 10.1194/jlr.M030718; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; ZAKOWSKI JJ, 1981, BIOCHEMISTRY-US, V20, P3902, DOI 10.1021/bi00516a037	50	41	41	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33590	33597		10.1074/jbc.M114.586396	http://dx.doi.org/10.1074/jbc.M114.586396			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25315776	hybrid, Green Published			2022-12-28	WOS:000345636600044
J	Krishnan, S; Paredes, JA; Zhou, XS; Kuiper, RV; Hultenby, K; Curbo, S; Karlsson, A				Krishnan, Shuba; Paredes, Joao A.; Zhou, Xiaoshan; Kuiper, Raoul V.; Hultenby, Kjell; Curbo, Sophie; Karlsson, Anna			Long Term Expression of Drosophila melanogaster Nucleoside Kinase in Thymidine Kinase 2-deficient Mice with No Lethal Effects Caused by Nucleotide Pool Imbalances	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTISUBSTRATE DEOXYRIBONUCLEOSIDE KINASE; DNA DEPLETION MYOPATHY; MITOCHONDRIAL-DNA; DEOXYNUCLEOSIDE TRIPHOSPHATES; DNTP POOLS; PHOSPHORYLASE; REPLICATION; SAMHD1; CELLS; MNGIE	Mitochondrial DNA depletion caused by thymidine kinase 2 (TK2) deficiency can be compensated by a nucleoside kinase from Drosophila melanogaster (Dm-dNK) in mice. We show that transgene expression of Dm-dNK in Tk2 knock-out (Tk2(-/-)) mice extended the life span of Tk2(-/-) mice from 3 weeks to at least 20 months. The Dm-dNK(+/-)Tk2(-/-) mice maintained normal mitochondrial DNA levels throughout the observation time. A significant difference in total body weight due to the reduction of subcutaneous and visceral fat in the Dm-dNK(+/-)Tk2(-/-) mice was the only visible difference compared with control mice. This indicates an effect on fat metabolism mediated through residual Tk2 deficiency because Dm-dNK expression was low in both liver and fat tissues. Dm-dNK expression led to increased dNTP pools and an increase in the catabolism of purine and pyrimidine nucleotides but these alterations did not apparently affect the mice during the 20 months of observation. In conclusion, Dm-dNK expression in the cell nucleus expanded the total dNTP pools to levels required for efficient mitochondrial DNA synthesis, thereby compensated the Tk2 deficiency, during a normal life span of the mice. The Dm-dNK(+/-) mouse serves as a model for nucleoside gene or enzyme substitutions, nucleotide imbalances, and dNTP alterations in different tissues.	[Krishnan, Shuba; Paredes, Joao A.; Zhou, Xiaoshan; Curbo, Sophie; Karlsson, Anna] Karolinska Inst, Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, SE-14186 Huddinge, Sweden; [Kuiper, Raoul V.; Hultenby, Kjell] Karolinska Inst, Karolinska Univ Hosp, Div Clin Res Ctr, Dept Lab Med, SE-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Karlsson, A (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, F68, SE-14186 Huddinge, Sweden.	anna.karlsson@ki.se	Karlsson, Anna/E-7945-2018; curbo, sophie/AAA-8614-2020	curbo, sophie/0000-0002-0964-0712; Kuiper, Raoul/0000-0001-5645-2389; Karlsson, Anna/0000-0001-6843-6685; Paredes, Joao/0000-0002-7788-8939	Swedish Cancer Society [CAN 2011/1277]; Swedish Research Council [2010-2828]; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet)	This work was supported by Swedish Cancer Society Grant CAN 2011/1277, Swedish Research Council Grant 2010-2828, and the Karolinska Institutet.	Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Frangini M, 2013, J BIOL CHEM, V288, P5624, DOI 10.1074/jbc.M112.441147; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gonzalez-Vioque E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002035; Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002; Hirschhorn R, 1983, Birth Defects Orig Artic Ser, V19, P73; Johansson M, 1999, J BIOL CHEM, V274, P23814, DOI 10.1074/jbc.274.34.23814; Krishnan S, 2013, J BIOL CHEM, V288, P5072, DOI 10.1074/jbc.M112.437152; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lopez LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401; Marti R, 2012, METHODS MOL BIOL, V837, P135, DOI 10.1007/978-1-61779-504-6_9; Martinon Fabio, 2010, Curr Rheumatol Rep, V12, P135, DOI 10.1007/s11926-010-0092-3; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Munch-Petersen B, 1998, J BIOL CHEM, V273, P3926, DOI 10.1074/jbc.273.7.3926; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Paredes JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053698; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Saada A, 2008, MOL GENET METAB, V95, P169, DOI 10.1016/j.ymgme.2008.07.007; SCHMIDT EV, 1990, MOL CELL BIOL, V10, P4406, DOI 10.1128/MCB.10.8.4406; Sheikhi M, 2013, FERTIL STERIL, V100, P170, DOI 10.1016/j.fertnstert.2013.03.018; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Solaroli N, 2007, GENE THER, V14, P86, DOI 10.1038/sj.gt.3302835; Solaroli N, 2007, MOL PHARMACOL, V72, P1593, DOI 10.1124/mol.107.037051; Torres-Torronteras J, 2014, MOL THER, V22, P901, DOI 10.1038/mt.2014.6; Tyynismaa H, 2010, METHODS, V51, P405, DOI 10.1016/j.ymeth.2010.03.009; Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042; Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200; Zheng XY, 2001, MOL PHARMACOL, V60, P262, DOI 10.1124/mol.60.2.262; Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133; Zhou XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058843	37	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.588921	http://dx.doi.org/10.1074/jbc.M114.588921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25296759	Green Published, hybrid			2022-12-28	WOS:000345335000037
J	Eibinger, M; Ganner, T; Bubner, P; Rosker, S; Kracher, D; Haltrich, D; Ludwig, R; Plank, H; Nidetzky, B				Eibinger, Manuel; Ganner, Thomas; Bubner, Patricia; Rosker, Stephanie; Kracher, Daniel; Haltrich, Dietmar; Ludwig, Roland; Plank, Harald; Nidetzky, Bernd			Cellulose Surface Degradation by a Lytic Polysaccharide Monooxygenase and Its Effect on Cellulase Hydrolytic Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; IN-SITU-OBSERVATION; ENZYMATIC-HYDROLYSIS; CELLOBIOSE DEHYDROGENASE; LIGNOCELLULOSIC BIOMASS; STRUCTURAL-DYNAMICS; NEUROSPORA-CRASSA; NATIVE CELLULOSE; PICHIA-PASTORIS; ENZYMES	Lytic polysaccharide monooxygenase (LPMO) represents a unique principle of oxidative degradation of recalcitrant insoluble polysaccharides. Used in combination with hydrolytic enzymes, LPMO appears to constitute a significant factor of the efficiency of enzymatic biomass depolymerization. LPMO activity on different cellulose substrates has been shown from the slow release of oxidized oligosaccharides into solution, but an immediate and direct demonstration of the enzyme action on the cellulose surface is lacking. Specificity of LPMO for degrading ordered crystalline and unordered amorphous cellulose material of the substrate surface is also unknown. We show by fluorescence dye adsorption analyzed with confocal laser scanning microscopy that a LPMO (from Neurospora crassa) introduces carboxyl groups primarily in surface-exposed crystalline areas of the cellulosic substrate. Using time-resolved in situ atomic force microscopy we further demonstrate that cellulose nano-fibrils exposed on the surface are degraded into shorter and thinner insoluble fragments. Also using atomic force microscopy, we show that prior action of LPMO enables cellulases to attack otherwise highly resistant crystalline substrate areas and that it promotes an overall faster and more complete surface degradation. Overall, this study reveals key characteristics of LPMO action on the cellulose surface and suggests the effects of substrate morphology on the synergy between LPMO and hydrolytic enzymes in cellulose depolymerization.	[Eibinger, Manuel; Bubner, Patricia; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Ganner, Thomas; Rosker, Stephanie; Plank, Harald] Inst Electron Microscopy & Nanoanal, A-8010 Graz, Austria; [Plank, Harald] Graz Ctr Electron Microscopy, A-8010 Graz, Austria; [Kracher, Daniel; Haltrich, Dietmar; Ludwig, Roland] BOKU Univ Nat Resources & Life Sci, Dept Food Sci & Technol, A-1190 Vienna, Austria; [Nidetzky, Bernd] Austrian Ctr Ind Biotechnol, A-8010 Graz, Austria	Graz University of Technology; University of Natural Resources & Life Sciences, Vienna; Austrian Centre of Industrial Biotechnology	Plank, H (corresponding author), Inst Electron Microscopy & Nanoanal, Steyrergasse 17, A-8010 Graz, Austria.	harald.plank@felmi-zfe.at; bernd.nidetzky@tugraz.at	Kracher, Daniel/H-6667-2019; Haltrich, Dietmar/N-2624-2019	Kracher, Daniel/0000-0002-3856-3170; Haltrich, Dietmar/0000-0002-8722-8176; Nidetzky, Bernd/0000-0002-5030-2643; Ludwig, Roland/0000-0002-5058-5874	Austrian Science Fund FWF Grant [P 24156-B21]; Doctoral program BioToP-Molecular Technology of Proteins Grant [W1224]; Austrian Science Fund (FWF) [P 24156] Funding Source: researchfish	Austrian Science Fund FWF Grant(Austrian Science Fund (FWF)); Doctoral program BioToP-Molecular Technology of Proteins Grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund FWF Grant P 24156-B21 (to B. N.) and Doctoral program BioToP-Molecular Technology of Proteins Grant W1224 (to D. K.).	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Ahola S, 2008, LANGMUIR, V24, P11592, DOI 10.1021/la801550j; Alasepp K, 2014, LANGMUIR, V30, P7134, DOI 10.1021/la500161e; Araki J, 1998, COLLOID SURFACE A, V142, P75, DOI 10.1016/S0927-7757(98)00404-X; Beck-Candanedo S, 2005, BIOMACROMOLECULES, V6, P1048, DOI 10.1021/bm049300p; Bubner P, 2013, BIOTECHNOL BIOENG, V110, P1529, DOI 10.1002/bit.24884; Bubner P, 2012, J BIOL CHEM, V287, P2759, DOI 10.1074/jbc.M111.257717; Cannella D, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-26; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Dimarogona M, 2013, APPL MICROBIOL BIOT, V97, P8455, DOI 10.1007/s00253-013-5197-y; Eibinger M, 2014, FEBS J, V281, P275, DOI 10.1111/febs.12594; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Fox JM, 2013, NAT CHEM BIOL, V9, P356, DOI 10.1038/nchembio.1227; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Ganner T, 2014, CELLULOSE, V21, P3927, DOI 10.1007/s10570-014-0419-8; Ganner T, 2012, J BIOL CHEM, V287, P43215, DOI 10.1074/jbc.M112.419952; Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x; Harris PV, 2014, CURR OPIN CHEM BIOL, V19, P162, DOI 10.1016/j.cbpa.2014.02.015; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Hu JG, 2014, ENERG ENVIRON SCI, V7, P2308, DOI 10.1039/c4ee00891j; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Kim IJ, 2014, APPL MICROBIOL BIOT, V98, P8469, DOI 10.1007/s00253-014-6001-3; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kjaergaard CH, 2014, P NATL ACAD SCI USA, V111, P8797, DOI 10.1073/pnas.1408115111; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Levine SE, 2010, BIOTECHNOL BIOENG, V107, P37, DOI 10.1002/bit.22789; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; Lu P, 2010, CARBOHYD POLYM, V82, P329, DOI 10.1016/j.carbpol.2010.04.073; Medve J, 1998, J CHROMATOGR A, V808, P153, DOI 10.1016/S0021-9673(98)00132-0; Mellitzer A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-61; Novy V, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-49; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rodiger S, 2011, ANAL CHEM, V83, P3379, DOI 10.1021/ac103277s; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Wang JP, 2013, LANGMUIR, V29, P14997, DOI 10.1021/la403401c; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Wildberger P, 2011, FEBS LETT, V585, P499, DOI 10.1016/j.febslet.2010.12.041; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396	48	173	180	9	132	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35929	35938		10.1074/jbc.M114.602227	http://dx.doi.org/10.1074/jbc.M114.602227			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25361767	hybrid, Green Published			2022-12-28	WOS:000346897900024
J	Filios, SR; Xu, GL; Chen, JQ; Hong, K; Jing, G; Shalev, A				Filios, Stephen R.; Xu, Guanlan; Chen, Junqin; Hong, Kyunghee; Jing, Gu; Shalev, Anath			MicroRNA-200 Is Induced by Thioredoxin-interacting Protein and Regulates Zeb1 Protein Signaling and Beta Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MIR-200 FAMILY; REPRESSORS ZEB1; FEEDBACK LOOP; CANCER-CELLS; GLUCOSE; PROLIFERATION; INVASION; TARGETS; EMT	Small noncoding microRNAs have emerged as important regulators of cellular processes, but their role in pancreatic beta cells has only started to be elucidated. Loss of pancreatic beta cells is a key factor in the pathogenesis of diabetes, and we have demonstrated that beta cell expression of thioredoxin-interacting protein (TXNIP) is increased in diabetes and causes beta cell apoptosis, whereas TXNIP deficiency is protective against diabetes. Recently, we found that TXNIP also impairs beta cell function by inducing microRNA (miR)-204. Interestingly, using INS-1 beta cells and primary islets, we have now discovered that expression of another microRNA, miR-200, is induced by TXNIP and by diabetes. Furthermore, we found that miR-200 targeted and decreased Zeb1 (zinc finger E-box-binding homeobox 1) and promoted beta cell apoptosis as measured by cleaved caspase-3 levels, Bax/Bcl2 ratio, and TUNEL. In addition, Zeb1 knockdown mimicked the miR-200 effects on beta cell apoptosis, suggesting that Zeb1 plays an important role in mediating miR-200 effects. Moreover, miR-200 increased beta cell expression of the epithelial marker E-cadherin, consistent with inhibition of epithelial-mesenchymal transition, a process thought to be involved in beta cell expansion. Thus, we have identified a novel TXNIP/miR-200/Zeb1/E-cadherin signaling pathway that, for the first time, links miR-200 to beta cell apoptosis and diabetes and also beta cell TXNIP to epithelial-mesenchymal transition. In addition, our results shed new light on the regulation and function of miR-200 in beta cells and show that TXNIP-induced microRNAs control various processes of beta cell biology.	Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Shalev, A (corresponding author), Univ Alabama Birmingham, 1825 Univ Blvd,SHEL 1206, Birmingham, AL 35294 USA.	shalev@uab.edu			National Institutes of Health [R01 DK-078752]; American Diabetes Association [7-12-BS-167]; JDRF/JNJSI [40-2011-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); JDRF/JNJSI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK-078752. This work was also supported by American Diabetes Association Grant 7-12-BS-167 and JDRF/JNJSI Grant 40-2011-1.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Atouf F, 2007, DIABETES, V56, P699, DOI 10.2337/db06-1446; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hay ED, 1995, ACTA ANAT, V154, P8; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Joglekar MV, 2010, CELL CYCLE, V9, P4077, DOI 10.4161/cc.9.20.13590; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Lim YY, 2013, J CELL SCI, V126, P2256, DOI 10.1242/jcs.122275; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Schliekelman MJ, 2011, CANCER RES, V71, P7670, DOI 10.1158/0008-5472.CAN-11-0964; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Tang HL, 2013, CANCER LETT, V340, P72, DOI 10.1016/j.canlet.2013.06.027; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Wiklund ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027840; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Williams LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083991; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	39	72	75	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36275	36283		10.1074/jbc.M114.592360	http://dx.doi.org/10.1074/jbc.M114.592360			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25391656	hybrid, Green Published			2022-12-28	WOS:000346897900051
J	Mallick, S; D'Mello, SR				Mallick, Sathi; D'Mello, Santosh R.			JAZ (Znf346), a SIRT1-interacting Protein, Protects Neurons by Stimulating p21 (WAF/CIP1) Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Huntington Disease; Neurodegeneration; Neuroprotection; Sirtuin 1 (SIRT1)	TRAUMATIC BRAIN-INJURY; ZINC-FINGER PROTEIN; CELL-CYCLE ARREST; PROVIDES NEUROPROTECTION; DEACETYLASE ACTIVITY; OXIDATIVE STRESS; CORTICAL-NEURONS; SIRT1; P21(WAF1/CIP1); APOPTOSIS	SIRT1, a class III histone deacetylase, protects neurons in various models of neurodegenerative diseases. We previously described that neuroprotection by SIRT1 is independent of its catalytic activity. To elucidate how SIRT1 protects neurons, we performed a mass spectrometric screen to find SIRT1-interacting proteins. One of the proteins identified was JAZ (Znf346), a member of a new class of Cys-2-His-2 zinc finger proteins. To investigate the significance of JAZ in the regulation of neuronal survival, we overexpressed it in neurons. We found that JAZ protects cerebellar granule neurons against potassium deprivation-induced death and cortical neurons from death resulting from oxidative stress. JAZ also protects neurons against toxicity induced by mutant huntingtin and mutant ataxin-1 expression. Although expression of endogenous JAZ does not change in neurons primed to die, knockdown of its expression promotes death of otherwise healthy neurons. In contrast to its protective effect in neurons, overexpression of JAZ in different cell lines promotes death. We find that JAZ suppresses cell cycle progression, thereby explaining its contrasting effect in postmitotic neurons versus proliferating cell lines. Although not affecting the expression of several cyclins, overexpression of JAZ stimulates expression of p21 (WAF1/CIP1), a cell cycle inhibitor known to have neuroprotective effects. Results of chromatin immunoprecipitation and transcriptional assays indicate that the stimulatory effect of JAZ on p21 expression is mediated at the transcriptional level. Furthermore, knockdown of p21 expression inhibits the neuroprotective effect of JAZ. Together, our results suggest that JAZ protects neurons by inhibiting cell cycle re-entry through the transcriptional stimulation of p21 expression.	[Mallick, Sathi] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [Mallick, Sathi; D'Mello, Santosh R.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA	University of Texas System; University of Texas Dallas; Southern Methodist University	D'Mello, SR (corresponding author), So Methodist Univ, Dept Biol Sci, Dedman Life Sci Bldg,6501 Airline Rd, Dallas, TX 75275 USA.	sdmello@smu.edu	D'Mello, Santosh/AAM-3644-2020; D'Mello, Santosh/AAO-7192-2020	D'Mello, Santosh/0000-0002-7652-1334	National Institutes of Health [NS040408, NS066404]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040408, R21NS066404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS040408 and NS066404.	Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Burge RG, 2014, BIOCHEMISTRY-US, V53, P1495, DOI 10.1021/bi401675h; Chen T, 2004, MOL CELL BIOL, V24, P6608, DOI 10.1128/mcb.24.15.6608-6619.2004; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Cox LS, 1997, J PATHOL, V183, P134, DOI 10.1002/(SICI)1096-9896(199710)183:2<134::AID-PATH960>3.0.CO;2-D; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dastidar SG, 2011, J NEUROSCI, V31, P402, DOI 10.1523/JNEUROSCI.2897-10.2011; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Donmez G, 2013, EMBO MOL MED, V5, P344, DOI 10.1002/emmm.201302451; Donmez G, 2012, TRENDS PHARMACOL SCI, V33, P494, DOI 10.1016/j.tips.2012.05.007; Duan WZ, 2013, CNS DRUGS, V27, P345, DOI 10.1007/s40263-013-0055-0; Finerty PJ, 1997, J MOL BIOL, V271, P195, DOI 10.1006/jmbi.1997.1177; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Harms C, 2007, J NEUROSCI, V27, P4562, DOI 10.1523/JNEUROSCI.5110-06.2007; Haskew-Layton RE, 2010, P NATL ACAD SCI USA, V107, P17385, DOI 10.1073/pnas.1003996107; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kang H, 2011, MOL CELL, V44, P203, DOI 10.1016/j.molcel.2011.07.038; Langley B, 2008, J NEUROSCI, V28, P163, DOI 10.1523/JNEUROSCI.3200-07.2008; Ma TC, 2013, NEUROBIOL DIS, V49, P13, DOI 10.1016/j.nbd.2012.08.016; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Mergenthaler P, 2013, J CEREBR BLOOD F MET, V33, P351, DOI 10.1038/jcbfm.2012.213; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Poluha W, 1996, MOL CELL BIOL, V16, P1335; RATAN RR, 1994, J NEUROSCI, V14, P4385; Schaefer JS, 2010, J BIOL CHEM, V285, P11258, DOI 10.1074/jbc.M109.073932; Tang BL, 2008, MOL ASPECTS MED, V29, P187, DOI 10.1016/j.mam.2007.02.001; Tomita K, 2006, BRAIN RES, V1081, P44, DOI 10.1016/j.brainres.2006.01.120; Verma P, 2014, J NEUROSCI, V34, P1599, DOI 10.1523/JNEUROSCI.3039-13.2014; Yang ML, 2006, BLOOD, V108, P4136, DOI 10.1182/blood-2006-06-029645; Yang ML, 2011, CELL CYCLE, V10, P2390, DOI 10.4161/cc.10.14.16587; Yang ML, 1999, J BIOL CHEM, V274, P27399, DOI 10.1074/jbc.274.39.27399	35	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35409	35420		10.1074/jbc.M114.597575	http://dx.doi.org/10.1074/jbc.M114.597575			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25331946	hybrid, Green Published			2022-12-28	WOS:000346660200031
J	Solanki, AK; Rathore, YS; Badmalia, MD; Dhoke, RR; Nath, SK; Nihalani, D; Ashish,				Solanki, Ashish K.; Rathore, Yogendra S.; Badmalia, Maulik D.; Dhoke, Reema R.; Nath, Samir K.; Nihalani, Deepak; Ashish			Global Shape and Ligand Binding Efficiency of the HIV-1-neutralizing Antibodies Differ from Those of Antibodies That Cannot Neutralize HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV-1 Protease; Molecular Modeling; Protein Folding; Protein Structure; X-ray Scattering; Global Shape; Limited Proteolysis; Neutralizing Antibodies; Small Angle X-ray Scattering; Solution Scattering	SMALL-ANGLE SCATTERING; X-RAY; 3-DIMENSIONAL STRUCTURE; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; LOW PH; IGG; GLYCOPROTEIN; EPITOPE; COMPLEMENT	Background: It remains unaddressed whether varying neutralizing potency of mAbs is somehow correlated with differences in their global shapes. Results: Non-neutralizing mAbs have an open shape, whereas Fab-Fab and Fab-Fc interactions induce a closed shape in HIV-1-neutralizing mAbs. Conclusion: An unopen shape appears to be a hallmark of neutralizing potency, at least for HIV-1. Significance: This work provides new insight into the shape-function relationship of mAbs. Asymmetric disposition of Fab arms in the structures solved for the broadly neutralizing monoclonal antibody (nmAb) IgG1 b12 raised the question of whether the unusual shape observed for b12 is common for all IgG1 mAbs or if there is a difference in the overall shape of nmAbs versus non-nmAbs. We compared small angle x-ray scattering (SAXS) data-based models and limited proteolysis profiles of some IgG1 mAbs known to be having and lacking HIV-1 neutralizing potency. In non-nmAbs, the Fab arms were found to be symmetrically disposed in space relative to central Fc, but in most nmAbs, the Fab arms were asymmetrically disposed, as seen for IgG1 b12. The only exceptions were 2G12 and 4E10, where both Fab arms were closed above Fc, suggesting some Fab-Fc and/or Fab-Fab interaction in the nmAbs that constrained extension of the Fab-Fc linker. Interestingly, these observations were correlated with differential proteolysis profiles of the mAbs by papain. Under conditions when papain could cut both Fab arms of non-nmAbs, only one Fab arm could be removed from neutralizing ones (except for 2G12 and 4E10). Chromatography and small angle x-ray scattering results of papain-digested products revealed that 1) the Fab-Fc or Fab-Fab interactions in unliganded mAbs are retained in digested products, and 2) whereas anti-gp120 non-nmAbs could bind two gp120 molecules, nmAbs could bind only one gp120. Additional experiments showed that except for 2G12 and 4E10, unopen shapes of nmAbs remain uninfluenced by ionic strength but can be reversibly opened by low pH of buffer accompanied by loss of ligand binding ability.	[Solanki, Ashish K.; Rathore, Yogendra S.; Badmalia, Maulik D.; Dhoke, Reema R.; Nath, Samir K.; Ashish] CSIR, Inst Microbial Technol, Chandigarh 160036, India; [Nihalani, Deepak] Univ Penn, Renal Electrolyte Div, Philadelphia, PA 19104 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Pennsylvania	Ashish, (corresponding author), CSIR, Inst Microbial Technol, Sect 39-A, Chandigarh 160036, India.	ashgang@imtech.res.in	Solanki, Ashish K/F-5210-2017; nihalani, deepak/AAK-9453-2020	Solanki, Ashish K/0000-0002-5043-1699; 	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DEAC02-98CH10886]	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We appreciate consistent support from the faculty and staff of CSIR-IMTECH. We thank the National Institutes of Health AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, for providing the reagents. Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DEAC02-98CH10886.	Albericio F, 2000, SOLID-PHASE SYNTHESIS, P275; Ashish, 2010, BIOCHEM BIOPH RES CO, V391, P947, DOI 10.1016/j.bbrc.2009.11.170; Balla-Jhagjhoorsingh SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068863; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; El-Faham A, 2009, CHEM-EUR J, V15, P9404, DOI 10.1002/chem.200900615; FIELDS C G, 1991, Peptide Research, V4, P95; Fouts TR, 1998, AIDS RES HUM RETROV, V14, P591, DOI 10.1089/aid.1998.14.591; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Garg R, 2011, J BIOL CHEM, V286, P20387, DOI 10.1074/jbc.M111.236943; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; GUDDAT LW, 1993, P NATL ACAD SCI USA, V90, P4271, DOI 10.1073/pnas.90.9.4271; Harris AK, 2013, J VIROL, V87, P7191, DOI 10.1128/JVI.03284-12; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huarte N, 2008, FEBS LETT, V582, P3798, DOI 10.1016/j.febslet.2008.10.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Lau H, 2010, J CHROMATOGR B, V878, P868, DOI 10.1016/j.jchromb.2010.02.003; Lightle S, 2010, PROTEIN SCI, V19, P753, DOI 10.1002/pro.352; Lilyestrom WG, 2012, J PHYS CHEM B, V116, P9611, DOI 10.1021/jp303839t; Liu HG, 2012, J APPL CRYSTALLOGR, V45, P587, DOI 10.1107/S0021889812015786; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lu YL, 2007, BIOPHYS J, V93, P3733, DOI 10.1529/biophysj.107.108993; Miranda LR, 2007, J IMMUNOL, V178, P7132, DOI 10.4049/jimmunol.178.11.7132; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Pandey K, 2014, J PHYS CHEM B, V118, P5059, DOI 10.1021/jp501641r; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rathore YS, 2011, BIOCHEM BIOPH RES CO, V415, P680, DOI 10.1016/j.bbrc.2011.10.136; Rayner LE, 2013, J MOL BIOL, V425, P506, DOI 10.1016/j.jmb.2012.11.019; Roux KH, 2004, MOL IMMUNOL, V41, P1001, DOI 10.1016/j.molimm.2004.05.008; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; STELOS P, 1962, J BIOL CHEM, V237, P3679; STULTS NL, 1989, ANAL BIOCHEM, V180, P114, DOI 10.1016/0003-2697(89)90097-3; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tian XS, 2014, J PHARM SCI-US, V103, P1701, DOI 10.1002/jps.23964; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; TSUJI FI, 1962, J IMMUNOL, V88, P83; Veiga AS, 2009, CHEMBIOCHEM, V10, P1032, DOI 10.1002/cbic.200800609; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang WT, 2001, BIOCHEMISTRY-US, V40, P1662, DOI 10.1021/bi001397m; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	59	18	19	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34780	34800		10.1074/jbc.M114.563486	http://dx.doi.org/10.1074/jbc.M114.563486			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25331945	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000346260800031
J	Sorek, N; Sorek, H; Kijac, A; Szemenyei, HJ; Bauer, S; Hematy, K; Wemmer, DE; Somerville, CR				Sorek, Nadav; Sorek, Hagit; Kijac, Aleksandra; Szemenyei, Heidi J.; Bauer, Stefan; Hematy, Kian; Wemmer, David E.; Somerville, Chris R.			The Arabidopsis COBRA Protein Facilitates Cellulose Crystallization at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellulose; Isothermal Titration Calorimetry (ITC); Plant Biochemistry; Plant Cell Wall; Solid State NMR; Arabidopsis COBRA; Cellulose Biosynthesis	SECONDARY CELL-WALL; SOLID-STATE NMR; ANCHORED PROTEIN; KORRIGAN; EXPANSION; SEQUENCE; MUTANT; GENES; POLYSACCHARIDES; BIOSYNTHESIS	Background: The COBRA gene is highly coexpressed with cellulose synthase genes, but its function remains unclear. Results: COBRA localizes at the plasma membrane and binds glucan chains. NMR studies indicate structural defects in cellulose in the mutant despite normal polymerization rate. Conclusion: COBRA functions downstream of cellulose biosynthesis. Significance: This work suggests that alignment of glucan chains into cellulose fibrils is facilitated by one or more proteins. Mutations in the Arabidopsis COBRA gene lead to defects in cellulose synthesis but the function of COBRA is unknown. Here we present evidence that COBRA localizes to discrete particles in the plasma membrane and is sensitive to inhibitors of cellulose synthesis, suggesting that COBRA and the cellulose synthase complex reside in close proximity on the plasma membrane. Live-cell imaging of cellulose synthesis indicated that, once initiated, cellulose synthesis appeared to proceed normally in the cobra mutant. Using isothermal calorimetry, COBRA was found to bind individual 1-4-linked glucan chains with a K-D of 3.2 m. Competition assays suggests that COBRA binds individual 1-4-linked glucan chains with higher affinity than crystalline cellulose. Solid-state nuclear magnetic resonance studies of the cell wall of the cobra mutant also indicated that, in addition to decreases in cellulose amount, the properties of the cellulose fibrils and other cell wall polymers differed from wild type by being less crystalline and having an increased number of reducing ends. We interpret the available evidence as suggesting that COBRA facilitates cellulose crystallization from the emerging 1-4-glucan chains by acting as a polysaccharide chaperone.	[Sorek, Nadav; Sorek, Hagit; Szemenyei, Heidi J.; Bauer, Stefan; Wemmer, David E.; Somerville, Chris R.] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Sorek, Nadav; Szemenyei, Heidi J.; Somerville, Chris R.] Univ Calif Berkeley, Plant & Microbial Biol Dept, Berkeley, CA 94720 USA; [Kijac, Aleksandra; Wemmer, David E.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Hematy, Kian] INRA, Inst Jean Pierre Bourgin, UMR 1318, ERL CNRS3559,Saclay Plant Sci,RD10, F-78026 Versailles, France; [Hematy, Kian] AgroParisTech, Inst Jean Pierre Bourgin, UMR 1318, ERL CNRS3559,Saclay Plant Sci,RD10, F-78026 Versailles, France; [Somerville, Chris R.] King Abdulaziz Univ, Fac Meteorol Environm & Arid Land Agr, Dept Arid Land Agr, Jeddah 21589, Saudi Arabia	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; King Abdulaziz University	Sorek, N (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, 1521 Berkeley Way, Berkeley, CA 94704 USA.	nadavsorek@berkeley.edu	Hématy, Kian/AAD-8989-2021	Hematy, Kian/0000-0002-3933-3852	Energy Biosciences Institute; Binational Agricultural Research and Development Fund [FI-434-2010]	Energy Biosciences Institute; Binational Agricultural Research and Development Fund	This work was supported in part by grants from the Energy Biosciences Institute (to C. R. S. and D. E. W.).; Recipient of Postdoctoral Award FI-434-2010 from the Binational Agricultural Research and Development Fund. To whom correspondence should be addressed: Energy Biosciences Institute, University of California Berkeley, 1521 Berkeley Way, Berkeley, CA 94704. Tel.: 510-643-6265; E-mail: nadavsorek@berkeley.edu.	Bashline L, 2014, MOL PLANT, V7, P586, DOI 10.1093/mp/ssu018; Bauer S, 2014, BIOTECHNOL BIOENG, V111, P2355, DOI 10.1002/bit.25276; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brabham C, 2013, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00309; Brady SM, 2007, PLANT PHYSIOL, V143, P172, DOI 10.1104/pp.106.087262; Carroll A, 2012, PLANT PHYSIOL, V160, P726, DOI 10.1104/pp.112.199208; Dai XX, 2011, PLANT MOL BIOL, V75, P333, DOI 10.1007/s11103-011-9730-z; DeBolt S, 2007, PLANT PHYSIOL, V145, P334, DOI 10.1104/pp.107.104703; Dick-Perez M, 2012, MAGN RESON CHEM, V50, P539, DOI 10.1002/mrc.3836; Dick-Perez M, 2011, BIOCHEMISTRY-US, V50, P989, DOI 10.1021/bi101795q; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; Eisenhaber B, 2003, PLANT PHYSIOL, V133, P1691, DOI 10.1104/pp.103.023580; Estevez JM, 2006, BIOTECHNIQUES, V41, P569, DOI 10.2144/000112264; Foston M, 2014, CURR OPIN BIOTECH, V27, P176, DOI 10.1016/j.copbio.2014.02.002; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Harris DM, 2012, P NATL ACAD SCI USA, V109, P4098, DOI 10.1073/pnas.1200352109; His I, 2001, PLANTA, V212, P348, DOI 10.1007/s004250000437; Lei L, 2014, PLANT CELL, V26, P2601, DOI 10.1105/tpc.114.126193; Li SD, 2012, P NATL ACAD SCI USA, V109, P185, DOI 10.1073/pnas.1118560109; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Liu LF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003704; Mansfield SD, 2012, NAT PROTOC, V7, P1579, DOI 10.1038/nprot.2012.064; McFarlane HE, 2014, ANNU REV PLANT BIOL, V65, P69, DOI 10.1146/annurev-arplant-050213-040240; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Ruprecht C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00083; Sanchez-Rodriguez C, 2012, PLANT CELL, V24, P589, DOI 10.1105/tpc.111.094672; Sato K, 2010, PLANT SIGNAL BEHAV, V5, P1433, DOI [10.4161/psb.5.11.13342, 10.1007/s00425-010-1171-4]; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Vain T, 2014, PLANT PHYSIOL, V165, P1521, DOI 10.1104/pp.114.241216; Walter S, 2003, J BIOL CHEM, V278, P26639, DOI 10.1074/jbc.M212792200; Wang T, 2012, BIOCHEMISTRY-US, V51, P9846, DOI 10.1021/bi3015532; Zuo JR, 2000, PLANT CELL, V12, P1137, DOI 10.1105/tpc.12.7.1137	42	26	26	4	69	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34911	34920		10.1074/jbc.M114.607192	http://dx.doi.org/10.1074/jbc.M114.607192			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25331944	Green Published, hybrid			2022-12-28	WOS:000346260800041
J	Clayton, CC; Donthamsetti, P; Lambert, NA; Javitch, JA; Neve, KA				Clayton, Cecilea C.; Donthamsetti, Prashant; Lambert, Nevin A.; Javitch, Jonathan A.; Neve, Kim A.			Mutation of Three Residues in the Third Intracellular Loop of the Dopamine D-2 Receptor Creates an Internalization-defective Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; D2 RECEPTOR; CLATHRIN; ADAPTER; TRAFFICKING; SELECTIVITY; PROTEINS; RECRUITMENT; AGONISM	Arrestins mediate desensitization and internalization of G protein-coupled receptors and also direct receptor signaling toward heterotrimeric G protein-independent signaling pathways. We previously identified a four-residue segment (residues 212-215) of the dopamine D2 receptor that is necessary for arrestin binding in an in vitro heterologous expression system but that also impairs receptorexpression. We now describe the characterization of additional mutations at that arrestin binding site in the third intracellular loop. Mutating two (residues 214 and 215) or three (residues 213-215) of the four residues to alanine partially decreased agonist-induced recruitment of arrestin3 without altering activation of aGprotein. Arrestin-dependent receptor internalization, which requires arrestin binding to beta 2-adaptin (the beta 2 subunit of the clathrin-associated adaptor protein AP2) and clathrin, was disproportionately affected by the three-residue mutation, with no agonist-induced internalization observed even in the presence of over-expressed arrestin or G protein-coupled receptor kinase 2. The disjunction between arrestin recruitment and internalization could not be explained by alterations in the time course of the receptor-arrestin interaction, the recruitment of G protein-coupled receptor kinase 2, or the receptor-induced interaction between arrestin and beta 2-adaptin, suggesting that the mutation impairs a property of the internalization complex that has not yet been identified.	[Neve, Kim A.] Dept Vet Affairs Med Ctr, Res Serv, Portland, OR 97239 USA; [Clayton, Cecilea C.; Neve, Kim A.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; [Donthamsetti, Prashant; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Donthamsetti, Prashant; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Donthamsetti, Prashant; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Lambert, Nevin A.] Georgia Regents Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA 30912 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Columbia University; Columbia University; New York State Psychiatry Institute; University System of Georgia; Augusta University	Javitch, JA (corresponding author), Columbia Univ, 1051 Riverside Dr,Unit 19, New York, NY 10032 USA.	jaj2@columbia.edu; nevek@ohsu.edu		Javitch, Jonathan/0000-0001-7395-2967	National Institutes of Health [RO1 MH045372, T32 DA007262, K05 DA022413, R01 MH054137, R01 DA015170]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137, R01MH045372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015170, K05DA022413, T32DA007262] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000810] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 MH045372 (to K. A. N.); T32 DA007262 (to C. C. C.); and K05 DA022413, R01 MH054137, and R01 DA015170 (to J. A. J.). This work was also supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development.	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Baik JH, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00152; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Cho DI, 2013, BRIT J PHARMACOL, V168, P1355, DOI 10.1111/bph.12025; Coulon V, 2008, BIOPHYS J, V94, P1001, DOI 10.1529/biophysj.107.117275; Diviani D, 2003, J BIOL CHEM, V278, P19331, DOI 10.1074/jbc.M302110200; Grunberg R, 2013, NAT METHODS, V10, P1021, DOI [10.1038/nmeth.2625, 10.1038/NMETH.2625]; Guo NN, 2010, NEUROPSYCHOPHARMACOL, V35, P806, DOI 10.1038/npp.2009.189; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Itokawa M, 1996, MOL PHARMACOL, V49, P560; Iwata K, 1999, EUR J BIOCHEM, V263, P596, DOI 10.1046/j.1432-1327.1999.00549.x; Jenner P, 2003, CURR OPIN NEUROL, V16, pS3, DOI 10.1097/00019052-200312001-00002; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Klewe IV, 2008, NEUROPHARMACOLOGY, V54, P1215, DOI 10.1016/j.neuropharm.2008.03.015; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Lan HX, 2009, MOL PHARMACOL, V75, P113, DOI 10.1124/mol.108.050534; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Leck KJ, 2006, NEUROPHARMACOLOGY, V51, P597, DOI 10.1016/j.neuropharm.2006.05.002; Macey TA, 2004, MOL PHARMACOL, V66, P1635, DOI 10.1124/mol.104.001495; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Newman AH, 2012, J MED CHEM, V55, P6689, DOI 10.1021/jm300482h; Obadiah J, 1999, CELL MOL NEUROBIOL, V19, P653, DOI 10.1023/A:1006988603199; OHARA K, 1988, MOL PHARMACOL, V33, P290; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Skinbjerg M, 2009, SYNAPSE, V63, P621, DOI 10.1002/syn.20636; Strange PG, 2008, TRENDS PHARMACOL SCI, V29, P314, DOI 10.1016/j.tips.2008.03.009; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200	42	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33663	33675		10.1074/jbc.M114.605378	http://dx.doi.org/10.1074/jbc.M114.605378			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25336643	Green Published, hybrid			2022-12-28	WOS:000345636600051
J	Wei, J; Fu, ZY; Li, PS; Miao, HH; Li, BL; Ma, YT; Song, BL				Wei, Jian; Fu, Zhen-Yan; Li, Pei-Shan; Miao, Hong-Hua; Li, Bo-Liang; Ma, Yi-Tong; Song, Bao-Liang			The Clathrin Adaptor Proteins ARH, Dab2, and Numb Play Distinct Roles in Niemann-Pick C1-Like 1 Versus Low Density Lipoprotein Receptor-mediated Cholesterol Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA; LDL RECEPTOR; CELL-MIGRATION; RISK-FACTORS; PTB DOMAIN; INTERNALIZATION; ENDOCYTOSIS; DIFFERENTIATION; PROLIFERATION; ABSORPTION	The uptake of circulating low density lipoproteins (LDL) is mediated by LDL receptor (LDLR) through clathrin-dependent endocytosis. At the early stage of this process, adaptor proteins ARH and Dab2 specifically bind the endocytic signal motif in LDLR and recruit clathrin/AP2 to initiate internalization. On the other hand, intestinal cholesterol is absorbed by Niemann-Pick C1-Like 1 (NPC1L1) through clathrin-dependent endocytosis. Another adaptor protein, Numb recognizes the endocytic motif in NPC1L1 C terminus and couples NPC1L1 to endocytic machinery. The ARH, Dab2, and Numb proteins contain a homogeneous phosphotyrosine binding (PTB) domain that directly binds endocytic motifs. Because ARH, Dab2, and Numb are all PTB domain family members, the emerging mystery is whether these adaptors act complementally in LDLR and NPC1L1 endocytosis. Here, we found that ARH and Dab2 did not bind NPC1L1 and were not required for NPC1L1 internalization. Similarly, Numb lacked the ability to interact with the LDLR C terminus and was dispensable for LDL uptake. Only the Numb isoforms with shorter PTB domain could facilitate NPC1L1 endocytosis. Besides the reported function in intestinal cholesterol absorption, Numb also mediated cholesterol reabsorption from bile in liver. We further identified a Numb variant with G595D substitution in humans of low blood LDL-cholesterol. The G595D substitution impaired NPC1L1 internalization and cholesterol reabsorption, due to attenuating affinity of Numb to clathrin/AP2. These results demonstrate that Numb specifically regulates NPC1L1-mediated cholesterol absorption both in human intestine and liver, distinct from ARH and Dab2, which selectively participate in LDLR-mediated LDL uptake.	[Wei, Jian; Li, Pei-Shan; Miao, Hong-Hua; Li, Bo-Liang; Song, Bao-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Fu, Zhen-Yan; Ma, Yi-Tong] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Urumqi 830054, Peoples R China; [Song, Bao-Liang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Xinjiang Medical University; Wuhan University	Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Urumqi 830054, Peoples R China.	myt-xj@163.com; blsong@whu.edu.cn		Li, Peishan/0000-0002-6881-396X; Song, Bao-Liang/0000-0002-6397-5935; Wei, Jian/0000-0002-4368-9763	Ministry of Science and Technology of China [2011CB910900, 2012CB524900]; National Natural Science Foundation of China [30925012, 31230020, 81260041, 81270155, 91213306]; Xinjiang Science and Technology Department [2013911111]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xinjiang Science and Technology Department	This work was supported by Ministry of Science and Technology of China Grants 2011CB910900 and 2012CB524900, National Natural Science Foundation of China Grants 30925012, 31230020, 81260041, 81270155, and 91213306, and Xinjiang Science and Technology Department Grant 2013911111.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Bechara EG, 2013, MOL CELL, V52, P720, DOI 10.1016/j.molcel.2013.11.010; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; Fang L, 2009, J CLIN INVEST, V119, P3278, DOI 10.1172/JCI37950; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Jones C, 2003, J BIOL CHEM, V278, P29024, DOI 10.1074/jbc.M304855200; Kim KK, 2013, J CELL BIOL, V200, P443, DOI 10.1083/jcb.201206146; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Li NF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-499; Li PS, 2014, NAT MED, V20, P80, DOI 10.1038/nm.3417; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; Ranganathan S, 2004, J BIOL CHEM, V279, P40536, DOI 10.1074/jbc.M407592200; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Tao J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-185; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wang LJ, 2012, BBA-MOL CELL BIOL L, V1821, P964, DOI 10.1016/j.bbalip.2012.03.004; Wang LJ, 2011, J BIOL CHEM, V286, P7397, DOI 10.1074/jbc.M110.178368; Zong FY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004289; Zuliani G, 1999, ARTERIOSCL THROM VAS, V19, P802, DOI 10.1161/01.ATV.19.3.802; Zwahlen C, 2000, EMBO J, V19, P1505, DOI 10.1093/emboj/19.7.1505	41	22	25	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33689	33700		10.1074/jbc.M114.593764	http://dx.doi.org/10.1074/jbc.M114.593764			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25331956	Green Published, hybrid			2022-12-28	WOS:000345636600053
J	Shao, HS; Li, SY; Watkins, SC; Wells, A				Shao, Hanshuang; Li, Shaoyan; Watkins, Simon C.; Wells, Alan			alpha-Actinin-4 Is Required for Amoeboid-type Invasiveness of Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION MATURATION; ALPHA-ACTININ; GENE AMPLIFICATION; CANCER INVASION; MIGRATION; MOTILITY; TUMOR; PROTEOLYSIS; PHOSPHORYLATION; CHEMORESISTANCE	alpha-Actinin-4 (ACTN4), a key regulator of the actin cytoskeleton, is up-regulated in melanoma, though its role in melanoma remains speculative. We have discovered that in WM1158, a highly aggressive melanoma cell line, down-regulation of ACTN4 by shRNA induces a collagen I-dependent amoeboidal-to-mesenchymal transition. Re-expression of low levels of WT ACTN4 but not similar expression levels of ACTN1 successfully restores the amoeboidal morphology and limits collagen I gel compaction. A truncated ACTN4 mutant 1-890, which lacks the C-terminal tail, fails to rescue the amoeboidal morphology and to compact collagen I gel. Interestingly, in three-dimensional collagen I gels, ACTN4 KD cells are more polarized compared with cells in which scrambled shRNA is expressed. Surprisingly, ACTN4 KD cells migrate faster than the ones expressing the scrambled shRNA on a collagen I gel (two-dimensional) although these two cell lines migrate similarly on tissue culture. Most importantly, down-regulation of ACTN4 significantly reduced invasion of WM1158 cells into the three-dimensional collagen I gel, a representative of the dermis. Taken together, these findings suggest that ACTN4 plays an important role in maintaining the amoeboidal morphology of invasive melanoma and thus promoting dissemination through collagen-rich matrices.	[Shao, Hanshuang; Wells, Alan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Watkins, Simon C.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA; [Li, Shaoyan] Shady Side Acad, Pittsburgh, PA 15238 USA; [Wells, Alan] Pittsburgh Vet Affairs Hlth Syst, Lab & Pathol Serv, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wells, A (corresponding author), Univ Pittsburgh, Sch Med, 3550 Terrace St,S713 Scaife Hall, Pittsburgh, PA 15261 USA.	wellsa@upmc.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552; Wells, Alan/0000-0002-1637-8150	National Institutes of Health (NIGMS); VA Merit Award Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103529] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); VA Merit Award Program(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health (NIGMS) and the VA Merit Award Program.	Arozarena I, 2011, CANCER CELL, V19, P45, DOI 10.1016/j.ccr.2010.10.029; Babakov VN, 2008, EXP CELL RES, V314, P1030, DOI 10.1016/j.yexcr.2007.12.001; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Feng YF, 2013, EXP CELL RES, V319, P1124, DOI 10.1016/j.yexcr.2013.02.009; Foley KS, 2013, BIOCHEM J, V452, P477, DOI 10.1042/BJ20121824; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P253, DOI 10.1016/j.ceb.2011.03.001; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Grahovac J, 2014, LAB INVEST, V94, P31, DOI 10.1038/labinvest.2013.132; Grahovac J, 2013, J INVEST DERMATOL, V133, P210, DOI 10.1038/jid.2012.263; GRAZI E, 1994, BIOCHEM J, V298, P129, DOI 10.1042/bj2980129; Hamill KJ, 2013, FASEB J, V27, P546, DOI 10.1096/fj.12-217406; HAMILL KJ, 2012, J INVEST DERMATOL S1, V132, pS35; Ho H, 2012, CANCER RES, V72, P5516, DOI 10.1158/0008-5472.CAN-12-0775; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Hood BL, 2010, J PROTEOME RES, V9, P3656, DOI 10.1021/pr100164x; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Kedracka-Krok S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084621; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Menez J, 2004, ONCOGENE, V23, P2630, DOI 10.1038/sj.onc.1207347; Michaud JLR, 2009, CELL MOTIL CYTOSKEL, V66, P166, DOI 10.1002/cm.20339; Nakatsuji H, 2008, MOL CELL BIOL, V28, P3324, DOI 10.1128/MCB.00144-08; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Orgaz JL, 2013, PIGM CELL MELANOMA R, V26, P39, DOI 10.1111/pcmr.12041; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Shao HS, 2013, INT J BIOCHEM CELL B, V45, P1051, DOI 10.1016/j.biocel.2013.02.015; Shao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013921; Shao HS, 2010, J BIOL CHEM, V285, P2591, DOI 10.1074/jbc.M109.035790; Sprague CR, 2008, J BIOL CHEM, V283, P9217, DOI 10.1074/jbc.M707436200; Travers T, 2013, BIOPHYS J, V104, P705, DOI 10.1016/j.bpj.2012.12.003; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yamagata N, 2003, CLIN CANCER RES, V9, P4695; Yamaguchi U, 2008, J CLIN ONCOL, V26, P4100, DOI 10.1200/JCO.2007.14.2331; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	41	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.579185	http://dx.doi.org/10.1074/jbc.M114.579185			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25296750	hybrid, Green Published			2022-12-28	WOS:000345335000028
J	Jansen, KB; Baker, SL; Sousa, MC				Jansen, Katarina Bartos; Baker, Susan Lynn; Sousa, Marcelo Carlos			Crystal Structure of BamB Bound to a Periplasmic Domain Fragment of BamA, the Central Component of the beta-Barrel Assembly Machine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; BIOGENESIS; COMPLEX; FLEXIBILITY; DISULFIDE; PROTEINS	The beta-barrel assembly machinery (BAM) mediates folding and insertion of beta-barrel outer membrane proteins (OMPs) into the outer membrane of Gram-negative bacteria. BAM is a five-protein complex consisting of the beta-barrel OMP BamA and lipoproteins BamB, -C, -D, and -E. High resolution structures of all the individual BAM subunits and a BamD-BamC complex have been determined. However, the overall complex architecture remains elusive. BamA is the central component of BAM and consists of a membrane-embedded beta-barrel and a periplasmic domain with five polypeptide translocation-associated (POTRA) motifs thought to interact with the accessory lipoproteins. Here we report the crystal structure of a fusion between BamB and a POTRA3-5 fragment of BamA. Extended loops 13 and 17 protruding from one end of the BamB beta-propeller contact the face of the POTRA3 beta-sheet in BamA. The interface is stabilized by several hydrophobic contacts, a network of hydrogen bonds, and a cation-pi interaction between BamA Tyr-255 and BamB Arg-195. Disruption of BamA-BamB binding by BamA Y255A and probing of the interface by disulfide bond cross-linking validate the physiological relevance of the observed interface. Furthermore, the structure is consistent with previously published mutagenesis studies. The periplasmic five-POTRA domain of BamA is flexible in solution due to hinge motions in the POTRA2-3 linker. Modeling BamB in complex with full-length BamA shows BamB binding at the POTRA2-3 hinge, suggesting a role in modulation of BamA flexibility and the conformational changes associated with OMP folding and insertion.	[Jansen, Katarina Bartos; Baker, Susan Lynn; Sousa, Marcelo Carlos] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Sousa, MC (corresponding author), Univ Colorado, Dept Chem & Biochem, 596 UCB, Boulder, CO 80309 USA.	Marcelo.Sousa@colorado.edu			National Institutes of Health [R01 AI080709, T32 GM065103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI080709 (to M. C. S.) and Training Grant T32 GM065103 (to K. B. J.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht R, 2014, ACTA CRYSTALLOGR D, V70, P1779, DOI 10.1107/S1399004714007482; Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; Anwari K, 2012, MOL MICROBIOL, V84, P832, DOI 10.1111/j.1365-2958.2012.08059.x; Bass RB, 2007, METHOD ENZYMOL, V423, P25, DOI 10.1016/S0076-6879(07)23002-2; Bass RB, 2007, METHOD ENZYMOL, V423, P3, DOI 10.1016/S0076-6879(07)23001-0; Craig DB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-346; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Endo T, 2011, EMBO REP, V12, P94, DOI 10.1038/embor.2010.217; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Jansen KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049749; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim KH, 2011, J BIOL CHEM, V286, P39116, DOI 10.1074/jbc.M111.298166; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Vuong P, 2008, J BACTERIOL, V190, P1507, DOI 10.1128/JB.01477-07; Warner LR, 2011, J MOL BIOL, V411, P83, DOI 10.1016/j.jmb.2011.05.022; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	33	34	34	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2126	2136		10.1074/jbc.M114.584524	http://dx.doi.org/10.1074/jbc.M114.584524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25468906	hybrid, Green Published			2022-12-28	WOS:000348588000018
J	Okino, Y; Machida, Y; Frankland-Searby, S; Machida, YJ				Okino, Yuki; Machida, Yuka; Frankland-Searby, Sarah; Machida, Yuichi J.			BRCA1-associated Protein 1 (BAP1) Deubiquitinase Antagonizes the Ubiquitin-mediated Activation of FoxK2 Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXK2; HISTONE H2A; MUTATIONS PREDISPOSE; TUMOR-SUPPRESSOR; UVEAL MELANOMA; FHA DOMAIN; CELL; COMPLEX; EXPRESSION; HYDROLASE	BRCA1-associated protein 1 (BAP1), which is frequently mutated in cancer, functions as a deubiquitinase (DUB) for histone H2A. Although BAP1 interacts with a transcriptional regulator, HCF-1, and transcription factors FoxK1 and FoxK2, how BAP1 controls gene expression remains unclear. This study investigates the importance of BAP1 DUB activity and the interactions with FoxK2 and HCF-1 in the regulation of FoxK2 target genes. We show that FoxK2 recruits BAP1 to the target genes through the forkhead-associated domain, which interacts with Thr(P)-493 on BAP1. BAP1, in turn, recruits HCF-1, thereby forming a ternary complex in which BAP1 bridges FoxK2 and HCF-1. BAP1 represses FoxK2 target genes, and this effect requires BAP1 DUB activity but not interaction with HCF-1. Importantly, BAP1 depletion causes up-regulation of FoxK2 target genes only in the presence of the Ring1B-Bmi1 complex, an E3 ubiquitin ligase for histone H2A, indicating an antagonizing role of BAP1 against Ring1B-Bmi1. Our findings suggest that BAP1 deficiency causes increased expression of target genes in a Ring1B-Bmi1-dependent manner.	[Okino, Yuki; Machida, Yuka; Machida, Yuichi J.] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Frankland-Searby, Sarah; Machida, Yuichi J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Machida, YJ (corresponding author), Mayo Clin, Dept Oncol, 200 First St SW, Rochester, MN 55905 USA.	machida.yuichi@mayo.edu	Machida, Yuichi/AAO-3533-2021	Machida, Yuichi/0000-0003-1414-0568	Minnesota Partnership for Biotechnology and Medical Genomics; Eagles Funds for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA015083] Funding Source: NIH RePORTER	Minnesota Partnership for Biotechnology and Medical Genomics; Eagles Funds for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Minnesota Partnership for Biotechnology and Medical Genomics (to Y. J. M.) and Eagles Funds for Cancer Research (Y. J. M.).	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Farley MN, 2013, MOL CANCER RES, V11, P1061, DOI 10.1158/1541-7786.MCR-13-0111; Frangini A, 2013, MOL CELL, V51, P647, DOI 10.1016/j.molcel.2013.08.022; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Grant GD, 2012, MOL BIOL CELL, V23, P3079, DOI 10.1091/mbc.E11-02-0170; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Gutierrez L, 2012, DEVELOPMENT, V139, P117, DOI 10.1242/dev.074450; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hawke TJ, 2003, J BIOL CHEM, V278, P4015, DOI 10.1074/jbc.M209200200; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Ji ZL, 2014, NUCLEIC ACIDS RES, V42, P6232, DOI 10.1093/nar/gku274; Ji ZL, 2012, MOL CELL BIOL, V32, P385, DOI 10.1128/MCB.05504-11; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Komorek J, 2010, J VIROL, V84, P2719, DOI 10.1128/JVI.02119-09; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Marais A, 2010, J BIOL CHEM, V285, P35728, DOI 10.1074/jbc.M110.154005; Matatall KA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-371; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Popova T, 2013, AM J HUM GENET, V92, P974, DOI 10.1016/j.ajhg.2013.04.012; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Shi XZ, 2012, BIOCHEM J, V446, P349, DOI 10.1042/BJ20120563; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10	40	52	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1580	1591		10.1074/jbc.M114.609834	http://dx.doi.org/10.1074/jbc.M114.609834			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451922	hybrid, Green Published			2022-12-28	WOS:000348056400027
J	Ward, MD; Leahy, DJ				Ward, Matthew D.; Leahy, Daniel J.			Kinase Activator-Receiver Preference in ErbB Heterodimers Is Determined by Intracellular Regions and Is Not Coupled to Extracellular Asymmetry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; STRUCTURAL-ANALYSIS; MECHANISM; LIGAND; DOMAIN; DIFFERENTIATION; INHIBITION; PROTEINS; NETWORK; COMPLEX	The EGF receptor (EGFR) family comprises four homologs in humans collectively known as the ErbB or HER proteins. ErbB proteins are receptor tyrosine kinases that become activated when ligands bind to their extracellular regions and promote formation of specific homo- and heterodimers with enhanced tyrosine kinase activity. An essential feature of ErbB activation is formation of an asymmetric kinase dimer in which the C-terminal lobe of one kinase serves as the activator or donor kinase by binding the N-terminal lobe of a receiver or acceptor kinase and stabilizing its active conformation. ErbB extracellular regions are also thought to form active asymmetric dimers in which only one subunit binds ligand. The observation that the unliganded ErbB2 kinase preferentially serves as the activator kinase when paired with EGFR/ErbB1 implied that extracellular asymmetry in ErbB proteins might be coupled to intracellular asymmetry with unliganded partners favoring the activator kinase position. Using cell-based stimulation assays and chimeric ErbB proteins, we show that extracellular asymmetry is not coupled to intracellular asymmetry and that ErbB intracellular regions are sufficient to determine relative kinase activator-receiver orientation. We further show a hierarchy of activator-receiver preferences among ErbB proteins, with EGFR/ErbB1 being the strongest receiver, followed by ErbB2 and then ErbB4, and that cis-phosphorylation of EGFR and ErbB2 appears to be negligible. This hierarchy shapes the nature of signaling responses to different ligands in cells expressing multiple ErbB proteins.	[Ward, Matthew D.; Leahy, Daniel J.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 716 Hunterian Bldg,725 N Wolfe St, Baltimore, MD 21205 USA.	dleahy@jhmi.edu			National Institutes of Health [R01GM099321]; NATIONAL CANCER INSTITUTE [R01CA090466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445, R01GM099321, R01GM099092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM099321 (to D. J. L.).	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; ALIMANDI M, 1995, ONCOGENE, V10, P1813; Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Alvarado D, 2009, NATURE, V461, P287, DOI 10.1038/nature08297; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; CARPENTER G, 1992, FASEB J, V6, P3283, DOI 10.1096/fasebj.6.14.1385243; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Costantini DL, 2008, J NUCL MED, V49, P1498, DOI 10.2967/jnumed.108.051771; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Huynh CQ, 1999, J MOL BIOL, V288, P13, DOI 10.1006/jmbi.1999.2674; Inlow D., 1989, J TISSUE CULTURE MET, V12, P13; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; LAMMERS R, 1990, J BIOL CHEM, V265, P16886; Leahy DJ, 2004, ADV PROTEIN CHEM, V68, P1; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Macdonald-Obermann JL, 2012, P NATL ACAD SCI USA, V109, P137, DOI 10.1073/pnas.1111316109; Mendrola JM, 2013, BIOCHEM SOC T, V41, P1029, DOI 10.1042/BST20130104; Mill C. P., 2011, CANC GENES CANC, V2, P792, DOI DOI 10.1177/1947601911431080; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Panke C, 2013, PROTEIN ENG DES SEL, V26, P645, DOI 10.1093/protein/gzt035; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PinkasKramarski R, 1996, J BIOL CHEM, V271, P19029, DOI 10.1074/jbc.271.32.19029; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Red Brewer M, 2013, P NATL ACAD SCI USA, V110, pE3595, DOI 10.1073/pnas.1220050110; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Wang S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.79; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang Q, 2012, P NATL ACAD SCI USA, V109, P13237, DOI 10.1073/pnas.1200105109; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	52	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1570	1579		10.1074/jbc.M114.612085	http://dx.doi.org/10.1074/jbc.M114.612085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25468910	Green Published, hybrid			2022-12-28	WOS:000348056400026
J	Groveman, BR; Kraus, A; Raymond, LD; Dolan, MA; Anson, KJ; Dorward, DW; Caughey, B				Groveman, Bradley R.; Kraus, Allison; Raymond, Lynne D.; Dolan, Michael A.; Anson, Kelsie J.; Dorward, David W.; Caughey, Byron			Charge Neutralization of the Central Lysine Cluster in Prion Protein (PrP) Promotes PrPSc-like Folding of Recombinant PrP Amyloids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL TRUNCATION; SCRAPIE PRION; IN-VITRO; MAMMALIAN PRIONS; HYDROGEN/DEUTERIUM EXCHANGE; MOLECULAR-BASIS; NORMAL BRAIN; CONVERSION; FIBRILS; FORM	The structure of the infectious form of prion protein, PrPSc, remains unclear. Most pure recombinant prion protein (PrP) amyloids generated in vitro are not infectious and lack the extent of the protease-resistant core and solvent exclusion of infectious PrPSc, especially within residues similar to 90-160. Polyanionic cofactors can enhance infectivity and PrPSc-like characteristics of such fibrils, but the mechanism of this enhancement is unknown. In considering structural models of PrPSc multimers, we identified an obstacle to tight packing that might be overcome with polyanionic cofactors, namely, electrostatic repulsion between four closely spaced cationic lysines within a central lysine cluster of residues 101-110. For example, in our parallel in-register intermolecular beta-sheet model of PrPSc, not only would these lysines be clustered within the 101-110 region of the primary sequence, but they would have intermolecular spacings of only similar to 4.8 between stacke beta-strands. We have now performed molecular dynamics simulations predicting that neutralization of the charges on these lysine residues would allow more stable parallel in-register packing in this region. We also show empirically that substitution of these clustered lysine residues with alanines or asparagines results in recombinant PrP amyloid fibrils with extended proteinase-K resistant beta-sheet cores and infrared spectra that are more reminiscent of bona fide PrPSc. These findings indicate that charge neutralization at the central lysine cluster is critical for the folding and tight packing of N-proximal residues within PrP amyloid fibrils. This charge neutralization may be a key aspect of the mechanism by which anionic cofactors promote PrPSc formation.	[Groveman, Bradley R.; Kraus, Allison; Raymond, Lynne D.; Anson, Kelsie J.; Caughey, Byron] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Dorward, David W.] NIAID, Res Technol Branch, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Dolan, Michael A.] NIAID, Computat Biol Sect, Bioinformat & Computat Biosci Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Caughey, B (corresponding author), NIAID, Rocky Mt Labs, 903 S 4th St, Hamilton, MT 59840 USA.	bcaughey@nih.gov			Intramural Program of the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001052, ZIAAI000580] Funding Source: NIH RePORTER	Intramural Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Intramural Program of the National Institute of Allergy and Infectious Diseases.	Abalos GC, 2008, J BIOL CHEM, V283, P34021, DOI 10.1074/jbc.M804475200; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; CAUGHEY B, 1988, P NATL ACAD SCI USA, V85, P4657, DOI 10.1073/pnas.85.13.4657; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2008, J BIOL CHEM, V283, P34704, DOI 10.1074/jbc.M806701200; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; DIRINGER H, 1983, NATURE, V306, P476, DOI 10.1038/306476a0; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fox BG, 2009, CURR PROTOC PROTEIN, V56; GABIZON R, 1993, J CELL PHYSIOL, V157, P319, DOI 10.1002/jcp.1041570215; Gonzalez-Iglesias R, 2002, J MOL BIOL, V319, P527, DOI 10.1016/S0022-2836(02)00341-8; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Kocisko DA, 1996, BIOCHEMISTRY-US, V35, P13434, DOI 10.1021/bi9610562; Kraus A, 2013, ANNU REV MICROBIOL, V67, P543, DOI 10.1146/annurev-micro-092412-155735; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MERZ PA, 1981, ACTA NEUROPATHOL, V54, P63, DOI 10.1007/BF00691333; Miller MB, 2013, STRUCTURE, V21, P2061, DOI 10.1016/j.str.2013.08.025; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Qi X, 2012, BIOCHEMISTRY-US, V51, P4600, DOI 10.1021/bi300201e; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Vascellari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048969; Vieira TCRG, 2014, FASEB J, V28, P2667, DOI 10.1096/fj.13-246777; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377	57	32	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1119	1128		10.1074/jbc.M114.619627	http://dx.doi.org/10.1074/jbc.M114.619627			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25416779	hybrid, Green Published			2022-12-28	WOS:000347778200043
J	Ananthanarayanan, M; Banales, JM; Guerra, MT; Spirli, C; Munoz-Garrido, P; Mitchell-Richards, K; Tafur, D; Saez, E; Nathanson, MH				Ananthanarayanan, Meenakshisundaram; Banales, Jesus M.; Guerra, Mateus T.; Spirli, Carlo; Munoz-Garrido, Patricia; Mitchell-Richards, Kisha; Tafur, Denisse; Saez, Elena; Nathanson, Michael H.			Post-translational Regulation of the Type III Inositol 1,4,5-Trisphosphate Receptor by miRNA-506	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Epithelial Cell; Inositol 1; 4; 5-Trisphosphate (IP3); MicroRNA (miRNA); Secretion; Cholangiocytes; IP3 Receptor Type III; IP3 Receptor Type III H69 Cells; Cholangiocytes; miR-506	BILE-DUCT EPITHELIA; CALCIUM; CHOLANGIOCYTES; EXPRESSION; MICRORNAS; SECRETION; CA2+; STIMULATION; ACTIVATION; DYNAMICS	Background: Inositol 1,4,5-trisphosphate receptor (InsP(3)R3) is critical to secretion in a number of epithelia and its expression is lost in secretory disorders. Results: miR-506 down-regulates InsP(3)R3 expression and impairs Ca2+ signaling and secretion. Conclusion: Post-translational regulation of InsP(3)R3 expression by miR-506 might contribute to disease phenotype. Significance: Restoring InsP(3)R3 expression by use of anti-miR-506 therapy might be beneficial in a variety of secretory disorders. The type III isoform of the inositol 1,4,5-trisphosphate receptor (InsP(3)R3) is apically localized and triggers Ca2+ waves and secretion in a number of polarized epithelia. However, nothing is known about epigenetic regulation of this InsP3R isoform. We investigated miRNA regulation of InsP(3)R3 in primary bile duct epithelia (cholangiocytes) and in the H69 cholangiocyte cell line, because the role of InsP(3)R3 in cholangiocyte Ca2+ signaling and secretion is well established and because loss of InsP(3)R3 from cholangiocytes is responsible for the impairment in bile secretion that occurs in a number of liver diseases. Analysis of the 3-UTR of human InsP(3)R3 mRNA revealed two highly conserved binding sites for miR-506. Transfection of miR-506 mimics into cell lines expressing InsP(3)R3-3UTR-luciferase led to decreased reporter activity, whereas co-transfection with miR-506 inhibitors led to enhanced activity. Reporter activity was abrogated in isolated mutant proximal or distal miR-506 constructs in miR-506-transfected HEK293 cells. InsP(3)R3 protein levels were decreased by miR-506 mimics and increased by inhibitors, and InsP(3)R3 expression was markedly decreased in H69 cells stably transfected with miR-506 relative to control cells. miR-506-H69 cells exhibited a fibrotic signature. In situ hybridization revealed elevated miR-506 expression in vivo in human-diseased cholangiocytes. Histamine-induced, InsP(3)-mediated Ca2+ signals were decreased by 50% in stable miR-506 cells compared with controls. Finally, InsP(3)R3-mediated fluid secretion was significantly decreased in isolated bile duct units transfected with miR-506, relative to control IBDU. Together, these data identify miR-506 as a regulator of InsP(3)R3 expression and InsP(3)R3-mediated Ca2+ signaling and secretion.	[Ananthanarayanan, Meenakshisundaram; Guerra, Mateus T.; Spirli, Carlo; Tafur, Denisse; Nathanson, Michael H.] Yale Univ, Sch Med, Sect Digest Dis, Dept Med, New Haven, CT 06520 USA; [Mitchell-Richards, Kisha] Yale Univ, Sch Med, Sect Digest Dis, Dept Pathol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ctr Liver, New Haven, CT 06520 USA; [Banales, Jesus M.; Munoz-Garrido, Patricia] Univ Basque Country UPV EHU, Dept Liver & Gastrointestinal Dis, Biodonostia Res Inst, Donostia Univ Hosp,CIBERehd,IKERBASQUE,AECC, San Sebastian 20014, Spain; [Saez, Elena] Univ Navarra, CIMA, Div Gene Therapy & Hepatol, Pamplona 31009, Spain	Yale University; Yale University; Yale University; Basque Foundation for Science; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University Hospital Donostia; University of Basque Country; University of Navarra	Ananthanarayanan, M (corresponding author), Yale Univ, Sch Med, Sect Digest Dis, Dept Med, 333 Cedar St, New Haven, CT 06520 USA.	ananth.meena@yale.edu	Banales, Jesus M/R-9739-2019	Banales, Jesus/0000-0002-5224-2373; Saez De Blas, Elena/0000-0002-6494-9739	National Institutes of Health [DK045710, DK057751, DK61747, DK034989]; Spanish Ministries of Economy and Competitiveness [FIS PI12/00380]; "Instituto de Salud Carlos III" (Ciberehd), Spain; Department of Industry of the Basque Country Grant [SAIO12-PE12BN002]; Asociacion Espanola Contra el Cancer (AECC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045710, P30DK034989, R01DK045710, P01DK057751, R01DK061747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministries of Economy and Competitiveness(Spanish Government); "Instituto de Salud Carlos III" (Ciberehd), Spain(Instituto de Salud Carlos III); Department of Industry of the Basque Country Grant; Asociacion Espanola Contra el Cancer (AECC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK045710, DK057751, DK61747, and DK034989 (to M. H. N.), Spanish Ministries of Economy and Competitiveness Grant FIS PI12/00380, a grant from the "Instituto de Salud Carlos III" (Ciberehd), Spain (to J. M. B.), and Department of Industry of the Basque Country Grant SAIO12-PE12BN002 (to J. M. B.).; Supported by the "Asociacion Espanola Contra el Cancer (AECC)."	Allen RM, 2012, EMBO MOL MED, V4, P882, DOI 10.1002/emmm.201201228; Arora H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064273; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bessho K, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-104; Cazanave SC, 2011, J LIPID RES, V52, P1517, DOI 10.1194/jlr.M014654; Choe Chi-Un, 2006, Sci STKE, V2006, pre15; Cruz LN, 2010, HEPATOLOGY, V52, P327, DOI 10.1002/hep.23625; Drawnel FM, 2012, J CELL BIOL, V199, P783, DOI 10.1083/jcb.201111095; Francis H, 2008, AM J PHYSIOL-CELL PH, V295, pC499, DOI 10.1152/ajpcell.00369.2007; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Giovannucci DR, 2002, J PHYSIOL-LONDON, V540, P469, DOI 10.1113/jphysiol.2001.013453; Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030; Hanna JA, 2012, LAB INVEST, V92, P1390, DOI 10.1038/labinvest.2012.119; Hirata K, 2002, GASTROENTEROLOGY, V122, P1088, DOI 10.1053/gast.2002.32363; Hirata K, 2001, GASTROENTEROLOGY, V121, P396, DOI 10.1053/gast.2001.26280; Hirschfield GM, 2013, ANNU REV PATHOL-MECH, V8, P303, DOI 10.1146/annurev-pathol-020712-164014; Ito K, 1997, EMBO J, V16, P242, DOI 10.1093/emboj/16.2.242; Kruglov EA, 2011, HEPATOLOGY, V54, P1790, DOI 10.1002/hep.24548; Marin JJG, 2014, CURR OPIN GASTROEN, V30, P303, DOI 10.1097/MOG.0000000000000051; MENNONE A, 1995, P NATL ACAD SCI USA, V92, P6527, DOI 10.1073/pnas.92.14.6527; Minagawa N, 2007, GASTROENTEROLOGY, V133, P1592, DOI 10.1053/j.gastro.2007.08.020; Nathanson MH, 1998, J CLIN INVEST, V101, P2665, DOI 10.1172/JCI2835; Ozcan L, 2012, CELL METAB, V15, P739, DOI 10.1016/j.cmet.2012.03.002; Padgett KA, 2009, J AUTOIMMUN, V32, P246, DOI 10.1016/j.jaut.2009.02.022; Park KM, 2009, J BIOL CHEM, V284, P27557, DOI 10.1074/jbc.M109.034504; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200; Shibao K, 2003, GASTROENTEROLOGY, V125, P1175, DOI 10.1016/S0016-5085(03)01201-0; Shibao K, 2010, CELL CALCIUM, V48, P315, DOI 10.1016/j.ceca.2010.09.005; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Urribarri AD, 2014, GUT, V63, P1658, DOI 10.1136/gutjnl-2013-305281; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Yin M, 2015, ONCOGENE, V34, P691, DOI 10.1038/onc.2013.597	35	52	53	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					184	196		10.1074/jbc.M114.587030	http://dx.doi.org/10.1074/jbc.M114.587030			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25378392	Green Published, hybrid			2022-12-28	WOS:000347231200016
J	Kuriakose, T; Rada, B; Watford, WT				Kuriakose, Teneema; Rada, Balazs; Watford, Wendy T.			Tumor Progression Locus 2-dependent Oxidative Burst Drives Phosphorylation of Extracellular Signal-regulated Kinase during TLR3 and 9 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASES; TOLL-LIKE RECEPTORS; TPL2 ACTIVATION; LIPOPOLYSACCHARIDE ACTIVATION; REDOX REGULATION; TNF-ALPHA; CELL-TYPE; LPS; MACROPHAGES	Signal transduction via NF kappa B and MAP kinase cascades is a universal response initiated upon pathogen recognition by Toll-like receptors (TLRs). How activation of these divergent signaling pathways is integrated to dictate distinct immune responses to diverse pathogens is still incompletely understood. Herein, contrary to current perception, we demonstrate that a signaling pathway defined by the inhibitor of kappa B kinase beta (IKK beta), MAP3 kinase tumor progression locus 2 (Tpl2/MAP3K8), and MAP kinase ERK is differentially activated by TLRs. TLRs 2, 4, and 7 directly activate this inflammatory axis, inducing immediate ERK phosphorylation and early TNF alpha secretion. In addition to TLR adaptor proteins, IKK beta-Tpl2-ERK activation by TLR4 is regulated by the TLR4 co-receptor CD14 and the tyrosine kinase Syk. Signals from TLRs 3 and 9 do not initiate early activation of IKK beta-Tpl2-ERK pathway but instead induce delayed, NADPH-oxidase-dependent ERK phosphorylation and TNF alpha secretion via autocrine reactive oxygen species signaling. Unexpectedly, Tpl2 is an essential regulator of ROS production during TLR signaling. Overall, our study reveals distinct mechanisms activating a common inflammatory signaling cascade and delineates differences in MyD88-dependent signaling between endosomal TLRs 7 and 9. These findings further confirm the importance of Tpl2 in innate host defense mechanisms and also enhance our understanding of how the immune system tailors pathogen-specific gene expression patterns.	[Kuriakose, Teneema; Rada, Balazs; Watford, Wendy T.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Watford, WT (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, 501 DW Brooks Dr, Athens, GA 30602 USA.	watfordw@uga.edu		Kuriakose, Teneema/0000-0003-4032-1290; Watford, Wendy/0000-0003-4261-5399	startup funds by the Office of the Vice President for Research at the University of Georgia	startup funds by the Office of the Vice President for Research at the University of Georgia	This work was supported by startup funds (to W. T. W.) by the Office of the Vice President for Research at the University of Georgia.	AOKI M, 1993, J BIOL CHEM, V268, P22723; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Buxade M, 2012, J EXP MED, V209, P379, DOI 10.1084/jem.20111569; Cho J, 2005, J BIOL CHEM, V280, P20442, DOI 10.1074/jbc.M413554200; Cho JH, 2005, P NATL ACAD SCI USA, V102, P2350, DOI 10.1073/pnas.0409856102; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Corcoran A, 2013, FEBS J, V280, P1944, DOI 10.1111/febs.12224; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2006, J BIOL CHEM, V281, P1371, DOI 10.1074/jbc.M506790200; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Hacker H, 1999, EMBO J, V18, P6973, DOI 10.1093/emboj/18.24.6973; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kyrmizi I., 2013, J LEUKOCYTE BIOL; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; MAKRIS A, 1993, J VIROL, V67, P4283, DOI 10.1128/JVI.67.7.4283-4289.1993; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; McNab FW, 2013, J IMMUNOL, V191, P1732, DOI 10.4049/jimmunol.1300146; Melo MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001071; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pohar J, 2013, J BIOL CHEM, V288, P442, DOI 10.1074/jbc.M112.413922; Qi RS, 2010, J BIOL CHEM, V285, P36635, DOI 10.1074/jbc.M110.144402; RATAN RR, 1994, J NEUROSCI, V14, P4385; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Robinson MJ, 2007, MOL CELL BIOL, V27, P7355, DOI 10.1128/MCB.00301-07; Roget K, 2012, MOL CELL BIOL, V32, P4684, DOI 10.1128/MCB.01065-12; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Schmid S, 2014, J BIOL CHEM, V289, P299, DOI 10.1074/jbc.M113.519934; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang CS, 2013, J IMMUNOL, V190, P6368, DOI 10.4049/jimmunol.1202574; Yang HT, 2012, MOL CELL BIOL, V32, P3438, DOI 10.1128/MCB.00564-12; Yi AK, 1998, J IMMUNOL, V161, P4493; Yi AK, 1998, J IMMUNOL, V160, P4755; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	51	15	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36089	36100		10.1074/jbc.M114.587121	http://dx.doi.org/10.1074/jbc.M114.587121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25378393	Green Published, hybrid			2022-12-28	WOS:000346897900036
J	Borahay, MA; Kilic, GS; Yallampalli, C; Snyder, RR; Hankins, GDV; Al-Hendy, A; Boehning, D				Borahay, Mostafa A.; Kilic, Gokhan S.; Yallampalli, Chandrasekha; Snyder, Russell R.; Hankins, Gary D. V.; Al-Hendy, Ayman; Boehning, Darren			Simvastatin Potently Induces Calcium-dependent Apoptosis of Human Leiomyoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Calcium; Calcium Channel; Cell Proliferation; Inositol Trisphosphate Receptor (InsP3R); Tumor; Tumor Cell Biology; Statin; Leiomyoma	HMG-COA REDUCTASE; SMOOTH-MUSCLE-CELLS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; HUMAN UTERINE LEIOMYOMA; CANCER CELLS; ENDOPLASMIC-RETICULUM; GROWTH-FACTORS; STATINS; PROLIFERATION; EXPRESSION	Statins are drugs commonly used for the treatment of high plasma cholesterol levels. Beyond these well known lipid-lowering properties, they possess broad-reaching effects in vivo, including antitumor effects. Statins inhibit the growth of multiple tumors. However, the mechanisms remain incompletely understood. Here we show that simvastatin inhibits the proliferation of human leiomyoma cells. This was associated with decreased mitogen-activated protein kinase signaling and multiple changes in cell cycle progression. Simvastatin potently stimulated leiomyoma cell apoptosis in a manner mechanistically dependent upon apoptotic calcium release from voltage-gated calcium channels. Therefore, simvastatin possesses antitumor effects that are dependent upon the apoptotic calcium release machinery.	[Borahay, Mostafa A.; Kilic, Gokhan S.; Snyder, Russell R.; Hankins, Gary D. V.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Borahay, Mostafa A.; Boehning, Darren] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Yallampalli, Chandrasekha] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Al-Hendy, Ayman] Georgia Regents Univ, Dept Obstet & Gynecol, Augusta, GA 30912 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University System of Georgia; Augusta University	Borahay, MA (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, 301 Univ Blvd, Galveston, TX 77555 USA.	maboraha@utmb.edu; Darren.F.Boehning@uth.tmc.edu	Al-hendy, Ayman/J-9324-2019; Borahay, Mostafa/AAJ-6582-2020; Yallampalli, Chandra/B-7655-2014; Boehning, Darren/I-8539-2015	Borahay, Mostafa/0000-0002-0554-132X; Boehning, Darren/0000-0001-7920-6922	National Institutes of Health [5K12HD001269-12, 1R01GM081685-01, 3R01GM081685-03S1]; Institute for Translational Sciences at the University of Texas Medical Branch by NCATS, National Institutes of Health CTSA [UL1TR000071]; University of Texas Health Science Center at Houston; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001269] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Translational Sciences at the University of Texas Medical Branch by NCATS, National Institutes of Health CTSA; University of Texas Health Science Center at Houston; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the following grants to M. A. B.: National Institutes of Health K12 Career Development Award 5K12HD001269-12 and by an award from the Institute for Translational Sciences at the University of Texas Medical Branch supported in part by NCATS, National Institutes of Health Grant CTSA UL1TR000071. This work was also supported by the following grants to D. B.: National Institutes of Health Grants 1R01GM081685-01 and 3R01GM081685-03S1 and startup funds provided by the University of Texas Health Science Center at Houston.	Akimzhanov AM, 2013, CELL CALCIUM, V53, P152, DOI 10.1016/j.ceca.2012.10.002; Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C; BEZPROZVANNY L, 1995, MOL PHARMACOL, V48, P540; Blanks AM, 2007, J PHYSIOL-LONDON, V581, P915, DOI 10.1113/jphysiol.2007.132126; BLEASDALE JE, 1989, ADV PROSTAG THROMB L, V19, P590; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Bruner-Tran KL, 2009, J CLIN ENDOCR METAB, V94, P2489, DOI 10.1210/jc.2008-2802; BULUN SE, 1994, J CLIN ENDOCR METAB, V78, P736, DOI 10.1210/jc.78.3.736; Burroughs KD, 2002, J ENDOCRINOL, V172, P83, DOI 10.1677/joe.0.1720083; Cafforio P, 2005, CARCINOGENESIS, V26, P883, DOI 10.1093/carcin/bgi036; Cano-Abad MF, 2001, J BIOL CHEM, V276, P39695, DOI 10.1074/jbc.M102334200; Carney SA, 2002, LAB INVEST, V82, P719, DOI 10.1097/01.LAB.0000017499.51216.3E; Chapman-Shimshoni D, 2003, EXP HEMATOL, V31, P779, DOI 10.1016/S0301-472X(03)00192-9; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cho SJ, 2008, INT J CANCER, V123, P951, DOI 10.1002/ijc.23593; Clunn GF, 2010, INT J CARDIOL, V139, P2, DOI 10.1016/j.ijcard.2009.05.019; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; Dalrymple A, 2004, J CLIN ENDOCR METAB, V89, P1291, DOI 10.1210/jc.2003-031428; De Smet P, 1999, CELL CALCIUM, V26, P9; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Denoyelle C, 2001, CARCINOGENESIS, V22, P1139, DOI 10.1093/carcin/22.8.1139; Dziegielewska B, 2014, PFLUG ARCH EUR J PHY, V466, P801, DOI 10.1007/s00424-014-1444-z; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Hoque A, 2008, CANCER EPIDEM BIOMAR, V17, P88, DOI 10.1158/1055-9965.EPI-07-0531; Islam MS, 2013, FERTIL STERIL, V100, P178, DOI 10.1016/j.fertnstert.2013.03.007; Jeschke MG, 2009, J CELL MOL MED, V13, P1857, DOI 10.1111/j.1582-4934.2009.00644.x; Kato S, 2010, J CELL MOL MED, V14, P1180, DOI 10.1111/j.1582-4934.2009.00771.x; Leung YM, 1999, JPN J PHARMACOL, V81, P253, DOI 10.1254/jjp.81.253; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Malik M, 2012, FERTIL STERIL, V97, P1287, DOI 10.1016/j.fertnstert.2012.02.037; Marsh EE, 2006, OBSTET GYN CLIN N AM, V33, P59, DOI 10.1016/j.ogc.2005.12.001; Martirosyan A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-103; McFarlane SI, 2002, J CLIN ENDOCR METAB, V87, P1451, DOI 10.1210/jc.87.4.1451; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Muck AO, 2004, INT J CLIN PHARM TH, V42, P695; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Peng L, 2009, FERTIL STERIL, V91, P2664, DOI 10.1016/j.fertnstert.2007.10.083; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Ramakrishna S, 2012, CHEST, V142, p925A; Rao S, 1999, P NATL ACAD SCI USA, V96, P7797, DOI 10.1073/pnas.96.14.7797; Rombouts K, 2003, J HEPATOL, V38, P564, DOI 10.1016/S0168-8278(03)00051-5; ROSSI MJ, 1992, ENDOCRINOLOGY, V130, P1716, DOI 10.1210/en.130.3.1716; Salama SA, 2008, INT J CANCER, V123, P1246, DOI 10.1002/ijc.23653; Salama SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007356; Schmidmaier R, 2007, EUR J HAEMATOL, V79, P240, DOI 10.1111/j.1600-0609.2007.00902.x; Seeger H, 2003, EXP CLIN ENDOCR DIAB, V111, P47, DOI 10.1055/s-2003-37501; Shmigol AV, 1998, J PHYSIOL-LONDON, V511, P803, DOI 10.1111/j.1469-7793.1998.803bg.x; Shozu M, 2004, SEMIN REPROD MED, V22, P51; Shozu M, 2003, FERTIL STERIL, V79, P628, DOI 10.1016/S0015-0282(02)04761-1; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V329, P1067, DOI 10.1016/j.bbrc.2005.02.070; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Sozen I, 2002, FERTIL STERIL, V78, P1, DOI 10.1016/S0015-0282(02)03154-0; Stamm JA, 2005, ONCOLOGY-NY, V19, P739; Steinmann C, 2008, J BIOL CHEM, V283, P13506, DOI 10.1074/jbc.C800029200; Stieren ES, 2011, J BIOL CHEM, V286, P35689, DOI 10.1074/jbc.M111.243147; Tanaka T, 2004, J AM SOC NEPHROL, V15, P2320, DOI 10.1097/01.ASN.0000138287.46849.82; Tong WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018685; van der Spek E, 2006, HAEMATOLOGICA, V91, P542; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; Wassmann S, 2001, HYPERTENSION, V37, P1450, DOI 10.1161/01.HYP.37.6.1450; Wildburger NC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-44; Wozniak AL, 2006, J CELL BIOL, V175, P709, DOI 10.1083/jcb.200608035; Xia Z, 2001, LEUKEMIA, V15, P1398, DOI 10.1038/sj.leu.2402196	71	48	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35075	35086		10.1074/jbc.M114.583575	http://dx.doi.org/10.1074/jbc.M114.583575			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25359773	Green Published, hybrid			2022-12-28	WOS:000346660200003
J	Gray, EJ; Petsalaki, E; James, DA; Bagshaw, RD; Stacey, MM; Rocks, O; Gingras, AC; Pawson, T				Gray, Elizabeth J.; Petsalaki, Evangelia; James, D. Andrew; Bagshaw, Richard D.; Stacey, Melissa M.; Rocks, Oliver; Gingras, Anne-Claude; Pawson, Tony			Src Homology 2 Domain Containing Protein 5 (SH2D5) Binds the Breakpoint Cluster Region Protein, BCR, and Regulates Levels of Rac1-GTP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mass Spectrometry (MS); Phosphotyrosine; Ras-related C3 Botulinum Toxin Substrate 1 (Rac1); Signal Transduction; Src Homology 2 Domain (SH2 Domain); BCR Signaling; PTB Domain; Rho GTPases; SH2D5 Signaling; Adaptor Proteins	GTPASE-ACTIVATING PROTEINS; DYNAMIC CONTROL; PTB DOMAINS; ABR; PROTEOMICS; NUMB; PHOSPHORYLATION; PHOSPHATASES; MAINTENANCE; SOFTWARE	SH2D5 is a mammalian-specific, uncharacterized adaptor-like protein that contains an N-terminal phosphotyrosine-binding domain and a C-terminal Src homology 2 (SH2) domain. We show that SH2D5 is highly enriched in adult mouse brain, particularly in Purkinjie cells in the cerebellum and the cornu ammonis of the hippocampus. Despite harboring two potential phosphotyrosine (Tyr(P)) recognition domains, SH2D5 binds minimally to Tyr(P) ligands, consistent with the absence of a conserved Tyr(P)-binding arginine residue in the SH2 domain. Immunoprecipitation coupled to mass spectrometry (IP-MS) from cultured cells revealed a prominent association of SH2D5 with breakpoint cluster region protein, a RacGAP that is also highly expressed in brain. This interaction occurred between the phosphotyrosine-binding domain of SH2D5 and an NxxF motif located within the N-terminal region of the breakpoint cluster region. siRNA-mediated depletion of SH2D5 in a neuroblastoma cell line, B35, induced a cell rounding phenotype correlated with low levels of activated Rac1-GTP, suggesting that SH2D5 affects Rac1-GTP levels. Taken together, our data provide the first characterization of the SH2D5 signaling protein.	[Gray, Elizabeth J.; Gingras, Anne-Claude; Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Gray, Elizabeth J.; Petsalaki, Evangelia; James, D. Andrew; Bagshaw, Richard D.; Stacey, Melissa M.; Rocks, Oliver; Gingras, Anne-Claude; Pawson, Tony] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [James, D. Andrew] Sanofi Pasteur, Toronto, ON M2R 3T4, Canada; [Rocks, Oliver] Max Delbruck Ctr Mol Med Berlin Buch, D-13125 Berlin, Germany	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Sanofi-Aventis; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Gray, EJ (corresponding author), Ctr Addict & Mental Hlth Hosp, 33 Russell St,Rm 4038, Toronto, ON M5S 2S1, Canada.	elizabeth.gray@camh.ca; gingras@lunenfeld.ca	Gingras, Anne-Claude/ABA-8341-2020; Pawson, Tony J/E-4578-2013; Bagshaw, Rick/B-7739-2009; Gingras, Anne-Claude/E-9982-2010; Rocks, Oliver/AFI-7418-2022; Petsalaki, Evangelia/ABC-3561-2020; Rocks, Oliver/ABG-3341-2020	Gingras, Anne-Claude/0000-0002-6090-4437; Bagshaw, Rick/0000-0001-5013-4291; Gingras, Anne-Claude/0000-0002-6090-4437; Petsalaki, Evangelia/0000-0002-8294-2995; Rocks, Oliver/0000-0001-6349-9193	Canadian Institutes of Health Research [MOP-6849, MOP-13466, MOP-84314]; Natural Sciences and Engineering Research Council of Canada; Ontario Graduate Scholarship award; Canadian Institute Health Research award; Human Frontier Science Program Long Term Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship award(Ontario Graduate Scholarship); Canadian Institute Health Research award; Human Frontier Science Program Long Term Fellowship(Human Frontier Science Program)	This work was supported by Canadian Institutes of Health Research Grants MOP-6849 and MOP-13466 (to T. P.) and Grant MOP-84314 (to A.-C. G.).; A recipient of the Natural Sciences and Engineering Research Council of Canada graduate award and an Ontario Graduate Scholarship award. To whom correspondence may be addressed: Centre for Addiction and Mental Health Hospital, 33 Russell St., Rm. 4038, Toronto, ON M5S 2S1, Canada. E-mail: elizabeth.gray@camh.ca.; A recipient of the Canadian Institute Health Research award.; A recipient of the Human Frontier Science Program Long Term Fellowship.	Caron E, 2003, NAT CELL BIOL, V5, P185, DOI 10.1038/ncb0303-185; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Chien CT, 1998, MOL CELL BIOL, V18, P598, DOI 10.1128/MCB.18.1.598; Cho YJ, 2007, MOL CELL BIOL, V27, P899, DOI 10.1128/MCB.00756-06; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; Corbetta S, 2009, FASEB J, V23, P1347, DOI 10.1096/fj.08-121574; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; Kaartinen V, 2001, DEVELOPMENT, V128, P4217; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Liu BA, 2012, PHILOS T R SOC B, V367, P2556, DOI 10.1098/rstb.2012.0107; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Ma GZ, 1997, ONCOGENE, V14, P2367, DOI 10.1038/sj.onc.1201053; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Qin HJ, 2004, J BIOL CHEM, V279, P11304, DOI 10.1074/jbc.M311733200; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; TAN EC, 1993, J BIOL CHEM, V268, P27291; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Um K, 2014, DEV CELL, V29, P701, DOI 10.1016/j.devcel.2014.05.011	30	8	12	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35397	35408		10.1074/jbc.M114.615112	http://dx.doi.org/10.1074/jbc.M114.615112			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25331951	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000346660200030
J	Korkegian, A; Roberts, DM; Blair, R; Parish, T				Korkegian, Aaron; Roberts, David M.; Blair, Rachel; Parish, Tanya			Mutations in the Essential Arabinosyltransferase EmbC Lead to Alterations in Mycobacterium tuberculosis Lipoarabinomannan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Wall; Glycolipid; Infectious Disease; Mycobacteria; Mycobacterium tuberculosis; Arabinosyltransferase; Essential Gene; Ethambutol	TERMINAL HEXAARABINOFURANOSYL MOTIF; CELL-WALL; BIOSYNTHESIS; BIOGENESIS; ETHAMBUTOL; GENES; ARABINOGALACTAN; RECOGNITION; EXTENSION; ARABINAN	The Mycobacterium tuberculosis cell wall is a complex structure essential for the viability of the organism and its interaction with the host. The glycolipid lipoarabinomannan (LAM) plays an important role in mediating host-bacteria interactions and is involved in modulation of the immune response. The arabinosyltransferase EmbC required for LAM biosynthesis is essential. We constructed recombinant strains of M. tuberculosis expressing a variety of alleles of EmbC. We demonstrated that EmbC has a functional signal peptide in M. tuberculosis. Over- or underexpression of EmbC resulted in reduced or increased sensitivity to ethambutol, respectively. The C-terminal domain of EmbC was essential for activity because truncated alleles were unable to mediate LAM production in Mycobacterium smegmatis and were unable to complement an embC deletion in M. tuberculosis. The C-terminal domain of the closely related arabinosyltransferase EmbB was unable to complement the function of the EmbC C-terminal domain. Two functional motifs were identified. The GT-C motif contains two aspartate residues essential for function in the DDX motif. The proline-rich region contains two highly conserved asparagines (Asn-638 and Asn-652). Mutation of these residues was tolerated, but loss of Asn-638 resulted in the synthesis of truncated LAM, which appeared to lack arabinose branching. All embC alleles that were incapable of complementing LAM production in M. smegmatis were not viable in M. tuberculosis, supporting the hypothesis that LAM itself is essential in M. tuberculosis.	[Korkegian, Aaron; Roberts, David M.; Blair, Rachel; Parish, Tanya] Infect Dis Res Inst, TB Discovery Res, Seattle, WA 98102 USA		Parish, T (corresponding author), Infect Dis Res Inst, TB Discovery Res, Seattle, WA 98102 USA.	tanya.parish@idri.org			NIAID/National Institutes of Health [R21AI81111]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081111] Funding Source: NIH RePORTER	NIAID/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NIAID/National Institutes of Health Grant R21AI81111.	Alderwick LJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001299; Amin AG, 2008, MICROBIOL-SGM, V154, P240, DOI 10.1099/mic.0.2007/012153-0; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; Berg S, 2005, J BIOL CHEM, V280, P5651, DOI 10.1074/jbc.M411418200; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6234; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; DENG LY, 1995, ANTIMICROB AGENTS CH, V39, P694, DOI 10.1128/AAC.39.3.694; Escuyer VE, 2001, J BIOL CHEM, V276, P48854, DOI 10.1074/jbc.M102272200; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Goude R, 2009, ANTIMICROB AGENTS CH, V53, P4138, DOI 10.1128/AAC.00162-09; Goude R, 2008, J BACTERIOL, V190, P4335, DOI 10.1128/JB.01825-07; Goude Renan, 2008, V465, P203, DOI [10.1007/978-1-59745-207-6_13, 10.3791/761]; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jankute M, 2012, FUTURE MICROBIOL, V7, P129, DOI [10.2217/fmb.11.123, 10.2217/FMB.11.123]; Kaur D, 2002, MICROBIOL-SGM, V148, P3049, DOI 10.1099/00221287-148-10-3049; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEMASSU A, 1994, BIOCHEM J, V297, P351, DOI 10.1042/bj2970351; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Ollinger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060531; Pashley CA, 2003, FEMS MICROBIOL LETT, V229, P211, DOI 10.1016/S0378-1097(03)00823-1; Rademacher C, 2007, J AM CHEM SOC, V129, P10489, DOI 10.1021/ja0723380; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Shi LB, 2006, J BIOL CHEM, V281, P19512, DOI 10.1074/jbc.M513846200; Shi Libin, 2008, V465, P23, DOI 10.1007/978-1-59745-207-6_3; Sirgel Frederick A., 2008, V465, P173, DOI 10.1007/978-1-59745-207-6_11; STOKES RW, 1995, J IMMUNOL, V155, P1361; Strohmeier GR, 1999, MICROBES INFECT, V1, P709, DOI 10.1016/S1286-4579(99)80072-0; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Torrelles JB, 2004, J BIOL CHEM, V279, P41227, DOI 10.1074/jbc.M405180200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Verbelen C, 2006, FEMS MICROBIOL LETT, V264, P192, DOI 10.1111/j.1574-6968.2006.00443.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zhang N, 2003, MOL MICROBIOL, V50, P69, DOI 10.1046/j.1365-2958.2003.03681.x	41	12	12	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35172	35181		10.1074/jbc.M114.583112	http://dx.doi.org/10.1074/jbc.M114.583112			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25352598	Green Published, hybrid			2022-12-28	WOS:000346660200011
J	Parua, PK; Dombek, KM; Young, ET				Parua, Pabitra K.; Dombek, Kenneth M.; Young, Elton T.			Yeast 14-3-3 Protein Functions as a Comodulator of Transcription by Inhibiting Coactivator Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						14-3-3 Protein; Gene Regulation; Gene Transcription; RNA Polymerase II; Transcription Coactivator; Adr1; Cat8; Oaf1; Pip2; Combinatorial Regulation	GLUCOSE-REPRESSED GENES; MESSENGER-RNA SYNTHESIS; DNA-BINDING DOMAIN; SACCHAROMYCES-CEREVISIAE; ADH2 EXPRESSION; PEROXISOME PROLIFERATION; ACTIVATE TRANSCRIPTION; GLUCONEOGENIC GENES; MEDIATOR COMPLEX; IDENTIFY GENES	In eukaryotes combinatorial activation of transcription is an important component of gene regulation. In the budding yeast Saccharomyces cerevisiae, Adr1-Cat8 and Adr1-Oaf1/Pip2 are pairs of activators that act together to regulate two diverse sets of genes. Transcription activation of both sets is regulated positively by the yeast AMP-activated protein kinase homolog, Snf1, in response to low glucose or the presence of a non-fermentable carbon source and negatively by two redundant 14-3-3 isoforms, Bmh1 and Bmh2. Bmh regulates the function of these pairs at a post-promoter binding step by direct binding to Adr1. However, how Bmh regulates transcription after activator binding remains unknown. In the present study we analyzed Bmh-mediated regulation of two sets of genes activated independently by these pairs of activators. We report that Bmh inhibits mRNA synthesis when the second activator is absent. Using gene fusions we show that Bmh binding to the Adr1 regulatory domain inhibits an Adr1 activation domain but not a heterologous activation domain or artificially recruited Mediator, consistent with Bmh acting at a step in transcription downstream of activator binding. Bmh inhibits the assembly and the function of a preinitiation complex (PIC). Gene expression studies suggest that Bmh regulates Adr1 activity through the coactivators Mediator and Swi/Snf. Mediator recruitment appeared to occur normally, but PIC formation and function were defective, suggesting that Bmh inhibits a step between Mediator recruitment and PIC activation.	[Parua, Pabitra K.; Dombek, Kenneth M.; Young, Elton T.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Young, ET (corresponding author), Univ Washington, Dept Biochem, 1705 NE Pacific St, Seattle, WA 98195 USA.	ety@uw.edu		Parua, Pabitra/0000-0002-1125-4052	National Institutes of Health Grant [GM26079]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026079] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM26079 (to E. T. Y.).	Abate G, 2012, BBA-GENE REGUL MECH, V1819, P419, DOI 10.1016/j.bbagrm.2012.01.009; Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Biddick RK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001436; Biddick RK, 2008, J BIOL CHEM, V283, P33101, DOI 10.1074/jbc.M805258200; Braun KA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005000; Braun KA, 2013, MOL CELL BIOL, V33, P712, DOI 10.1128/MCB.01226-12; Bridges D., 2005, SCI STKE, V296, pre10, DOI DOI 10.1126/STKE.2962005RE10; Candau R, 1997, ONCOGENE, V15, P807, DOI 10.1038/sj.onc.1201244; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Collart M. A., 2001, CURRENT PROTOCOLS MO; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; COUSENS DJ, 1989, EMBO J, V8, P2337, DOI 10.1002/j.1460-2075.1989.tb08361.x; DENIS CL, 1992, MOL CELL BIOL, V12, P1507, DOI 10.1128/MCB.12.4.1507; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Dombek KM, 2004, J BIOL CHEM, V279, P39165, DOI 10.1074/jbc.M400433200; Dombek KM, 1997, MOL CELL BIOL, V17, P1450, DOI 10.1128/MCB.17.3.1450; DOMBEK KM, 1993, MOL CELL BIOL, V13, P4391, DOI 10.1128/MCB.13.7.4391; DONOVIEL MS, 1995, MOL CELL BIOL, V15, P3442; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Karpichev IV, 2008, J BIOL CHEM, V283, P10264, DOI 10.1074/jbc.M708215200; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lottersberger F, 2003, GENETICS, V165, P1717; Luo Y, 1996, J BIOL CHEM, V271, P12068, DOI 10.1074/jbc.271.20.12068; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Morris DP, 2005, J BIOL CHEM, V280, P31368, DOI 10.1074/jbc.M501546200; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Parua PK, 2010, MOL CELL BIOL, V30, P5273, DOI 10.1128/MCB.00715-10; Parua PK, 2014, EUKARYOT CELL, V13, P21, DOI 10.1128/EC.00240-13; Parua PK, 2012, MOL MICROBIOL, V85, P282, DOI 10.1111/j.1365-2958.2012.08112.x; Rahner A, 1996, NUCLEIC ACIDS RES, V24, P2331, DOI 10.1093/nar/24.12.2331; RandezGil F, 1997, MOL CELL BIOL, V17, P2502, DOI 10.1128/MCB.17.5.2502; Ratnakumar S, 2010, J BIOL CHEM, V285, P10703, DOI 10.1074/jbc.M109.079848; Ratnakumar S, 2009, GENETICS, V182, P735, DOI 10.1534/genetics.109.103432; Rottensteiner H, 1996, EMBO J, V15, P2924, DOI 10.1002/j.1460-2075.1996.tb00655.x; Rottensteiner H, 2003, J BIOL CHEM, V278, P27605, DOI 10.1074/jbc.M304097200; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; SIMON M, 1992, YEAST, V8, P303, DOI 10.1002/yea.320080407; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Tachibana C, 2007, J BIOL CHEM, V282, P37308, DOI 10.1074/jbc.M707363200; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; UNGER T, 1992, EMBO J, V11, P1383, DOI 10.1002/j.1460-2075.1992.tb05183.x; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204; Vincent O, 1998, EMBO J, V17, P7002, DOI 10.1093/emboj/17.23.7002; Walther K, 2001, MICROBIOL-SGM, V147, P2037, DOI 10.1099/00221287-147-8-2037; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Young ET, 2008, MOL CELL BIOL, V28, P2509, DOI 10.1128/MCB.00658-07; Young ET, 2012, J BIOL CHEM, V287, P29021, DOI 10.1074/jbc.M112.380147; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200	60	8	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35542	35560		10.1074/jbc.M114.592287	http://dx.doi.org/10.1074/jbc.M114.592287			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25355315	Green Published, hybrid			2022-12-28	WOS:000346660200042
J	Bailey-Elkin, BA; Knaap, RCM; Johnson, GG; Dalebout, TJ; Ninaber, DK; van Kasteren, PB; Bredenbeek, PJ; Snijder, EJ; Kikkert, M; Mark, BL				Bailey-Elkin, Ben A.; Knaap, Robert C. M.; Johnson, Garrett G.; Dalebout, Tim J.; Ninaber, Dennis K.; van Kasteren, Puck B.; Bredenbeek, Peter J.; Snijder, Eric J.; Kikkert, Marjolein; Mark, Brian L.			Crystal Structure of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Papain-like Protease Bound to Ubiquitin Facilitates Targeted Disruption of Deubiquitinating Activity to Demonstrate Its Role in Innate Immune Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cysteine Protease; Deubiquitylation (Deubiquitination); Innate Immunity; Structural Biology; Viral Immunology; X-ray Crystallography; Middle East Respiratory Syndrome Coronavirus; PLpro	NF-KAPPA-B; RIG-I; SARS CORONAVIRUS; RNA VIRUSES; DOMAIN; RECOGNITION; ENZYME; PATHOGENESIS; INHIBITION; INDUCTION	Background: MERS-CoV papain-like protease (PLpro) processes viral polyproteins and has deubiquitinating activity. Results: A crystal structure of MERS-CoV PLpro bound to ubiquitin guided mutagenesis to disrupt PLpro deubiquitinating activity without affecting polyprotein cleavage. Conclusion: The deubiquitinating activity of MERS-CoV PLpro suppresses the induction of interferon- expression. Significance: Our strategy to selectively disable PLpro deubiquitinating activity enables the study of its specific functions in infection. Middle East respiratory syndrome coronavirus (MERS-CoV) is a newly emerging human pathogen that was first isolated in 2012. MERS-CoV replication depends in part on a virus-encoded papain-like protease (PLpro) that cleaves the viral replicase polyproteins at three sites releasing non-structural protein 1 (nsp1), nsp2, and nsp3. In addition to this replicative function, MERS-CoV PLpro was recently shown to be a deubiquitinating enzyme (DUB) and to possess deISGylating activity, as previously reported for other coronaviral PLpro domains, including that of severe acute respiratory syndrome coronavirus. These activities have been suggested to suppress host antiviral responses during infection. To understand the molecular basis for ubiquitin (Ub) recognition and deconjugation by MERS-CoV PLpro, we determined its crystal structure in complex with Ub. Guided by this structure, mutations were introduced into PLpro to specifically disrupt Ub binding without affecting viral polyprotein cleavage, as determined using an in trans nsp34 cleavage assay. Having developed a strategy to selectively disable PLpro DUB activity, we were able to specifically examine the effects of this activity on the innate immune response. Whereas the wild-type PLpro domain was found to suppress IFN- promoter activation, PLpro variants specifically lacking DUB activity were no longer able to do so. These findings directly implicate the DUB function of PLpro, and not its proteolytic activity per se, in the inhibition of IFN- promoter activity. The ability to decouple the DUB activity of PLpro from its role in viral polyprotein processing now provides an approach to further dissect the role(s) of PLpro as a viral DUB during MERS-CoV infection.	[Bailey-Elkin, Ben A.; Johnson, Garrett G.; Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Knaap, Robert C. M.; Dalebout, Tim J.; Ninaber, Dennis K.; van Kasteren, Puck B.; Bredenbeek, Peter J.; Snijder, Eric J.; Kikkert, Marjolein] Leiden Univ, Med Ctr, Dept Med Microbiol, Mol Virol Lab, NL-2333 ZA Leiden, Netherlands	University of Manitoba; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kikkert, M (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Mol Virol Lab, NL-2333 ZA Leiden, Netherlands.	m.kikkert@lumc.nl; brian.mark@umanitoba.ca	Snijder, Eric J./E-6073-2018; van Kasteren, Puck/H-6203-2019; Kikkert, Marjolein/AAK-5514-2020	Snijder, Eric J./0000-0003-3297-2309; van Kasteren, Puck/0000-0003-4369-6055; Mark, Brian/0000-0002-7344-1355; Kikkert, Marjolein/0000-0002-5779-7386; /0000-0002-6829-8312; Johnson, Garrett/0000-0001-5507-9543	Natural Sciences and Engineering Research Council of Canada; National Research Council; Canadian Institutes of Health Research; University of Saskatchewan	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan	We are grateful to Diede Oudshoorn for generating MERS-CoV nsp3-4 expression constructs and Kathleen C. Lehmann for excellent technical assistance. Wekindly thank the following people for providing reagents: John Hiscott, Craig E. Cameron, Michaela U. Gack, and Adolfo Garcia-Sastre. We thank Veronica Larmour for technical assistance and Shaun Labiuk and the staff of the Canadian Light Source (CLS) beamline 08B1-1 for assistance with data collection. The CLS is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council, the Canadian Institutes of Health Research, and the University of Saskatchewan.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baez-Santos YM, 2014, J VIROL, V88, P12511, DOI 10.1128/JVI.01294-14; Bailey-Elkin BA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003894; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Chan RWY, 2013, J VIROL, V87, P6604, DOI 10.1128/JVI.00009-13; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Chou CY, 2014, ACTA CRYSTALLOGR D, V70, P572, DOI 10.1107/S1399004713031040; Chu H, 2014, VIROLOGY, V454, P197, DOI 10.1016/j.virol.2014.02.018; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Eletr ZM, 2014, BBA-MOL CELL RES, V1843, P114, DOI 10.1016/j.bbamcr.2013.06.027; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faesen AC, 2012, BIOCHEM SOC T, V40, P539, DOI 10.1042/BST20120004; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; HADARI T, 1992, J BIOL CHEM, V267, P719; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kilianski A, 2013, J VIROL, V87, P11955, DOI 10.1128/JVI.02105-13; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Lau SKP, 2013, J GEN VIROL, V94, P2679, DOI 10.1099/vir.0.055533-0; Lei J, 2014, ANTIVIR RES, V109, P72, DOI 10.1016/j.antiviral.2014.06.011; Lin MH, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-54; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Lindner HA, 2007, ARCH BIOCHEM BIOPHYS, V466, P8, DOI 10.1016/j.abb.2007.07.006; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Mielech AM, 2014, VIRUS RES, V194, P184, DOI 10.1016/j.virusres.2014.01.025; Mielech AM, 2014, VIROLOGY, V450, P64, DOI 10.1016/j.virol.2013.11.040; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Ratia K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004113; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reusken CB, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.23.20829; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; Spiegel M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-17; Sun Z, 2010, J VIROL, V84, P7832, DOI 10.1128/JVI.00217-10; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; van Kasteren PB, 2013, P NATL ACAD SCI USA, V110, pE838, DOI 10.1073/pnas.1218464110; van Kasteren PB, 2012, J VIROL, V86, P773, DOI 10.1128/JVI.06277-11; Velthuis AJWT, 2010, NUCLEIC ACIDS RES, V38, P203, DOI 10.1093/nar/gkp904; Wojdyla JA, 2010, J VIROL, V84, P10063, DOI 10.1128/JVI.00898-10; World Health Organization, 2014, MIDDL E RESP SYNDR C; World Health Organization (WHO), 2003, SUMM PROB SARS CAS O; Xing YL, 2013, J GEN VIROL, V94, P1554, DOI 10.1099/vir.0.051169-0; Yang XX, 2014, J GEN VIROL, V95, P614, DOI 10.1099/vir.0.059014-0; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zheng DH, 2008, CELL RES, V18, P1105, DOI 10.1038/cr.2008.294	70	113	116	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34667	34682		10.1074/jbc.M114.609644	http://dx.doi.org/10.1074/jbc.M114.609644			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25320088	hybrid, Green Published			2022-12-28	WOS:000346260800024
J	Huang, GC; Stock, C; Bommelje, CC; Weeda, VB; Shah, K; Bains, S; Buss, E; Shaha, M; Rechler, W; Ramanathan, SY; Singh, B				Huang, Guochang; Stock, Cameron; Bommelje, Claire C.; Weeda, Viola B.; Shah, Kushyup; Bains, Sarina; Buss, Elizabeth; Shaha, Manish; Rechler, Willi; Ramanathan, Suresh Y.; Singh, Bhuvanesh			SCCRO3 (DCUN1D3) Antagonizes the Neddylation and Oncogenic Activity of SCCRO (DCUN1D1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Head and Neck Cancer; Lung Cancer; Oncogene; Tumor Suppressor Gene; Ubiquitin	SQUAMOUS-CELL-CARCINOMA; CULLIN-RING LIGASES; PROTEIN UBIQUITINATION; NEDD8; MECHANISMS; METHYLATION; CONJUGATION; PROGRESSION; ACTIVATION; SYSTEM	Background: SCCRO3/DCUN1D3 is proposed to function as a tumor suppressor. However, the mechanisms are not well defined. Results: SCCRO3 inhibits SCCRO-promoted nuclear translocation and neddylation of cullins by sequestering them to the cell membrane. Conclusion: SCCRO3 putatively functions as a tumor suppressor by antagonizing the activity of SCCRO. Significance: Understanding how SCCRO and its family members cooperatively regulate cullin neddylation is important for neddylation-targeted cancer therapy. The activity of cullin-RING type ubiquitination E3 ligases is regulated by neddylation, a process analogous to ubiquitination that culminates in covalent attachment of the ubiquitin-like protein Nedd8 to cullins. As a component of the E3 for neddylation, SCCRO/DCUN1D1 plays a key regulatory role in neddylation and, consequently, cullin-RING ligase activity. The essential contribution of SCCRO to neddylation is to promote nuclear translocation of the cullin-ROC1 complex. The presence of a myristoyl sequence in SCCRO3, one of four SCCRO paralogues present in humans that localizes to the membrane, raises questions about its function in neddylation. We found that although SCCRO3 binds to CAND1, cullins, and ROC1, it does not efficiently bind to Ubc12, promote cullin neddylation, or conform to the reaction processivity paradigms, suggesting that SCCRO3 does not have E3 activity. Expression of SCCRO3 inhibits SCCRO-promoted neddylation by sequestering cullins to the membrane, thereby blocking its nuclear translocation. Moreover, SCCRO3 inhibits SCCRO transforming activity. The inhibitory effects of SCCRO3 on SCCRO-promoted neddylation and transformation require both an intact myristoyl sequence and PONY domain, confirming that membrane localization and binding to cullins are required for in vivo functions. Taken together, our findings suggest that SCCRO3 functions as a tumor suppressor by antagonizing the neddylation activity of SCCRO.	[Huang, Guochang; Stock, Cameron; Bommelje, Claire C.; Weeda, Viola B.; Shah, Kushyup; Bains, Sarina; Buss, Elizabeth; Shaha, Manish; Rechler, Willi; Ramanathan, Suresh Y.; Singh, Bhuvanesh] Mem Sloan Kettering Canc Ctr, Lab Epithelial Canc Biol, Dept Surg, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Singh, B (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	singhb@mskcc.org	Buss, Elizabeth J./AAN-8932-2021	Buss, Elizabeth/0000-0002-5635-3513	National Institutes of Health/NCI Cancer Center Support Grant [P30 CA008748]; Catherine van Tussenbroek Fonds; foundation Vrijvrouwe van Renswoude; Fulbright, The Dutch Cancer Society; Prins Bernhard Culture Foundation; Flight Attendants Medical Research Institute; Hackers for Hope; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health/NCI Cancer Center Support Grant; Catherine van Tussenbroek Fonds; foundation Vrijvrouwe van Renswoude; Fulbright, The Dutch Cancer Society; Prins Bernhard Culture Foundation; Flight Attendants Medical Research Institute; Hackers for Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health/NCI Cancer Center Support Grant P30 CA008748 (to B. S.). This work was also supported in part by grants from the Catherine van Tussenbroek Fonds and the foundation Vrijvrouwe van Renswoude (to C. C. B.); Fulbright, The Dutch Cancer Society, and the Prins Bernhard Culture Foundation (to V. B. W.); and the Clinical Innovator Award from the Flight Attendants Medical Research Institute and a research grant from the Hackers for Hope.	Bommelje CC, 2014, CLIN CANCER RES, V20, P372, DOI 10.1158/1078-0432.CCR-13-1252; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Broderick SR, 2010, NEOPLASIA, V12, P476, DOI 10.1593/neo.10202; Chen K, 2007, GENOME RES, V17, P659, DOI 10.1101/gr.6151507; Chen M, 2009, INT J CANCER, V125, P2342, DOI 10.1002/ijc.24642; Desouki MM, 2011, J CANCER RES CLIN, V137, P795, DOI 10.1007/s00432-010-0937-1; DOBROVIC A, 1988, SOMAT CELL MOLEC GEN, V14, P55, DOI 10.1007/BF01535049; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Estilo CL, 2003, CLIN CANCER RES, V9, P2300; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Huang GC, 2013, CLIN CANCER RES, V19, P5549, DOI 10.1158/1078-0432.CCR-13-2117; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jung SH, 2009, EXP MOL MED, V41, P462, DOI 10.3858/emm.2009.41.7.051; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Ma T, 2008, CANCER SCI, V99, P2128, DOI 10.1111/j.1349-7006.2008.00929.x; Major JE, 2007, BIOINFORMATICS, V23, P3091, DOI 10.1093/bioinformatics/btm339; Meyer-Schaller N, 2009, P NATL ACAD SCI USA, V106, P12365, DOI 10.1073/pnas.0812528106; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Wang J, 2013, CLIN CANCER RES, V19, P5580, DOI 10.1158/1078-0432.CCR-13-0594; Wu K, 2011, J BIOL CHEM, V286, P34060, DOI 10.1074/jbc.M111.273045; Yang XY, 2007, J BIOL CHEM, V282, P24490, DOI 10.1074/jbc.C700038200	39	14	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34728	34742		10.1074/jbc.M114.585505	http://dx.doi.org/10.1074/jbc.M114.585505			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25349211	Green Published, hybrid			2022-12-28	WOS:000346260800028
J	Veena, MS; Wilken, R; Zheng, JY; Gholkar, A; Venkatesan, N; Vira, D; Ahmed, S; Basak, SK; Dalgard, CL; Ravichandran, S; Batra, RK; Kasahara, N; Elashoff, D; Fishbein, MC; Whitelegge, JP; Torres, JZ; Wang, MB; Srivatsan, ES				Veena, Mysore S.; Wilken, Reason; Zheng, Jun-Ying; Gholkar, Ankur; Venkatesan, Natarajan; Vira, Darshni; Ahmed, Sameer; Basak, Saroj K.; Dalgard, Clifton L.; Ravichandran, Sandhiya; Batra, Raj K.; Kasahara, Noriyuki; Elashoff, David; Fishbein, Michael C.; Whitelegge, Julian P.; Torres, Jorge Z.; Wang, Marilene B.; Srivatsan, Eri S.			p16 Protein and Gigaxonin Are Associated with the Ubiquitination of NF kappa B in Cisplatin-induced Senescence of Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Stem Cells; Cellular Senescence; Chemoresistance; Head and Neck Cancer; Ubiquitination; Cisplatin; Gigaxonin; NFB; p16 Suppressor Gene	CURCUMIN SUPPRESSES GROWTH; TRANSCRIPTION FACTOR; NECK-CANCER; HUMAN-PAPILLOMAVIRUS; INDUCTION CHEMOTHERAPY; HUMAN HEAD; CARCINOMA; P53; INHIBITION; EXPRESSION	Background: Molecular mechanism of p16-mediated cellular senescence in cisplatin-treated cells is not known. Results: Cisplatin treatment leads to p16 nuclear transport and association with gigaxonin for the ubiquitination of NFB. Conclusion: A protein associated with neural diseases is involved in cisplatin-mediated cellular senescence. Significance: Nuclear expression of p16 and gigaxonin is a useful marker of cancer cell chemosensitivity. The molecular mechanism of p16-mediated senescence in cisplatin-treated cancer cells is not fully understood. Here we show that cisplatin treatment of head and neck cancer cells results in nuclear transport of p16 leading to a molecular modification of NFB. Chromatin immunoprecipitation assays show that this modification is associated with the inhibition of NFB interacting with its DNA binding sequences, leading to decreased expression of NFB-transcribed proteins. LCMS proteomic analysis of LAP-TAP-purified proteins from HeLa cells containing a tetracycline-inducible GFP-S peptide-NFB expression system identified gigaxonin, an ubiquitin E3 ligase adaptor, as an NFB-interacting protein. Immunoblotting and siRNA studies confirmed the NFB-gigaxonin interaction and the dependence of this binding on p16-NFB binding. Using gel shift assays, we have confirmed p16-NFB and gigaxonin-NFB interactions. Furthermore, we have observed increased NFB ubiquitination with cisplatin treatment that is abolished in the absence of p16 and gigaxonin expression. Analysis of 103 primary tumors has shown that increased nuclear p16 expression correlates with enhanced survival of head and neck cancer patients (p < 0.0000542), indicating the importance of nuclear p16 expression in prognosis. Finally, p16 expression is associated with reduced cytokine expression and the presence of human papilloma virus in chemoradiation-sensitive basaloid tumors. However, the absence of p16 expression is associated with enhanced cytokine expression and the absence of human papilloma virus in aggressive tumors. These results clearly demonstrate that nuclear p16 and gigaxonin play an important role in chemosensitivity of head and neck cancers through ubiquitination of NF kappa B.	[Veena, Mysore S.; Wilken, Reason; Zheng, Jun-Ying; Venkatesan, Natarajan; Vira, Darshni; Basak, Saroj K.; Ravichandran, Sandhiya; Wang, Marilene B.; Srivatsan, Eri S.] UCLA, David Geffen Sch Med, VAGLAHS, Dept Surg, Los Angeles, CA 90073 USA; [Gholkar, Ankur; Torres, Jorge Z.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Vira, Darshni; Ahmed, Sameer; Wang, Marilene B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA; [Dalgard, Clifton L.] Uniformed Serv Univ Hlth Sci, Dept Anat, Bethesda, MD 20814 USA; [Dalgard, Clifton L.] Uniformed Serv Univ Hlth Sci, Dept Physiol, Bethesda, MD 20814 USA; [Dalgard, Clifton L.] Uniformed Serv Univ Hlth Sci, Dept Genet, Bethesda, MD 20814 USA; [Batra, Raj K.] Vet Affairs Greater Los Angeles Healthcare Syst, Div Pulm & Crit Care Med, Dept Med, Los Angeles, CA 90073 USA; [Batra, Raj K.; Kasahara, Noriyuki; Elashoff, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Fishbein, Michael C.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.] UCLA, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Batra, Raj K.; Torres, Jorge Z.; Wang, Marilene B.; Srivatsan, Eri S.] UCLA, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Srivatsan, ES (corresponding author), UCLA, David Geffen Sch Med, VAGLAHS, Dept Surg, Bldg 304,Rm E2-218,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	esrivats@ucla.edu		Batra, Raj K./0000-0002-1126-543X; Kasahara, Noriyuki/0000-0002-6069-9082; Dalgard, Clifton/0000-0003-2025-8239; Torres, Jorge/0000-0002-2158-889X	National Institutes of Health [R21 CA116826-01]; Veterans Affairs, Washington, D. C.; Veterans Affairs Greater Los Angeles Healthcare System; West Los Angeles Surgical Education Research Center; UCLA Academic Senate grant; NATIONAL CANCER INSTITUTE [R21CA116826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs, Washington, D. C.(US Department of Veterans Affairs); Veterans Affairs Greater Los Angeles Healthcare System; West Los Angeles Surgical Education Research Center; UCLA Academic Senate grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 CA116826-01 (to M. W.). This work was also supported by a merit grant from Veterans Affairs, Washington, D. C. (to E. S. S.), by funds from Veterans Affairs Greater Los Angeles Healthcare System, West Los Angeles Surgical Education Research Center, and by a UCLA Academic Senate grant (to M. W.).	Aderhold C, 2013, ANTICANCER RES, V33, P5385; Al-Mohanna MA, 2004, ONCOGENE, V23, P201, DOI 10.1038/sj.onc.1206927; Al-Swiahb JN, 2010, ARCH OTOLARYNGOL, V136, P502, DOI 10.1001/archoto.2010.47; Altekruse S. F., 1975, SEER CANC STAT REV 1; Andrews GA, 2004, HEAD NECK-J SCI SPEC, V26, P870, DOI 10.1002/hed.20029; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Basak SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073195; Becker TM, 2005, BIOCHEM BIOPH RES CO, V332, P873, DOI 10.1016/j.bbrc.2005.05.032; Benasso M, 2013, ORAL ONCOL, V49, P747, DOI 10.1016/j.oraloncology.2013.04.007; Braakhuis BJM, 2012, ANN ONCOL, V23, P173, DOI 10.1093/annonc/mds299; Bradford CR, 2003, HEAD NECK-J SCI SPEC, V25, P654, DOI 10.1002/hed.10274; Capece D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/187204; Chang CP, 2013, AUTOPHAGY, V9, P619, DOI 10.4161/auto.23546; Cleveland DW, 2009, HUM MOL GENET, V18, P1384, DOI 10.1093/hmg/ddp044; Cohen AN, 2009, ARCH OTOLARYNGOL, V135, P190, DOI 10.1001/archotol.135.2.190; Sempere MC, 2008, CLIN TRANSL ONCOL, V10, P143, DOI 10.1007/s12094-008-0171-3; Delston RB, 2006, CURR MOL MED, V6, P713; Duarte VM, 2010, MOL CANCER THER, V9, P2665, DOI 10.1158/1535-7163.MCT-10-0064; Fang K, 2007, ONCOL RES, V16, P479, DOI 10.3727/096504007783338331; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fouret P, 2002, BRIT J CANCER, V87, P1390, DOI 10.1038/sj.bjc.6600648; Gallagher WM, 1997, ONCOGENE, V14, P185; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Gupta S, 2013, DRUG DISCOV THER, V7, P36, DOI 10.5582/ddt.2013.v7.1.36; Hauser U, 2002, HEAD NECK-J SCI SPEC, V24, P868, DOI 10.1002/hed.10128; Havelka AM, 2007, MINI-REV MED CHEM, V7, P1035, DOI 10.2174/138955707782110196; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; KATO J, 1993, GENE DEV, V7, P331; Kato T, 2000, HEAD NECK-J SCI SPEC, V22, P748, DOI 10.1002/1097-0347(200012)22:8<748::AID-HED2>3.3.CO;2-Y; Kordes U, 2000, LEUKEMIA, V14, P399, DOI 10.1038/sj.leu.2401705; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kudoh K, 2002, INT J CANCER, V99, P579, DOI 10.1002/ijc.10331; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Lassen P, 2010, RADIOTHER ONCOL, V94, P30, DOI 10.1016/j.radonc.2009.10.008; Lefebvre JL, 2013, J CLIN ONCOL, V31, P853, DOI 10.1200/JCO.2012.42.3988; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; LoTempio MM, 2005, CLIN CANCER RES, V11, P6994, DOI 10.1158/1078-0432.CCR-05-0301; Lucs AV, 2013, HEAD NECK-J SCI SPEC, V35, P294, DOI 10.1002/hed.21975; Mahammad S, 2013, J CLIN INVEST, V123, P1964, DOI 10.1172/JCI66387; Martins RG, 2013, J CLIN ONCOL, V31, P1415, DOI 10.1200/JCO.2012.46.3299; Mooren JJ, 2014, INT J CANCER, V134, P2108, DOI 10.1002/ijc.28534; Namazie A, 2002, LARYNGOSCOPE, V112, P472, DOI 10.1097/00005537-200203000-00013; Ondrey FG, 1999, MOL CARCINOGEN, V26, P119, DOI 10.1002/(SICI)1098-2744(199910)26:2<119::AID-MC6>3.0.CO;2-N; Shapiro GI, 1998, MOL CELL BIOL, V18, P378, DOI 10.1128/MCB.18.1.378; SORENSON CM, 1990, JNCI-J NATL CANCER I, V82, P749, DOI 10.1093/jnci/82.9.749; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Trimmer EE, 1999, ESSAYS BIOCHEM, V34, P191, DOI 10.1042/bse0340191; Urban D, 2014, CANCER-AM CANCER SOC, V120, P1462, DOI 10.1002/cncr.28595; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; Wang D, 2008, CLIN CANCER RES, V14, P6228, DOI 10.1158/1078-0432.CCR-07-5177; Wang WX, 1999, CLIN CANCER RES, V5, P119; Xu JH, 2014, HEAD NECK-J SCI SPEC, V36, P1474, DOI 10.1002/hed.23487; Yang JM, 2010, J CLIN INVEST, V120, P2563, DOI 10.1172/JCI42358; Yip HT, 2006, ARCH OTOLARYNGOL, V132, P317, DOI 10.1001/archotol.132.3.317	59	25	28	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34921	34937		10.1074/jbc.M114.568543	http://dx.doi.org/10.1074/jbc.M114.568543			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25331947	Green Published, hybrid			2022-12-28	WOS:000346260800042
J	Dikopoltsev, E; Foltyn, VN; Zehl, M; Jensen, ON; Mori, H; Radzishevsky, I; Wolosker, H				Dikopoltsev, Elena; Foltyn, Veronika N.; Zehl, Martin; Jensen, Ole N.; Mori, Hisashi; Radzishevsky, Inna; Wolosker, Herman			FBXO22 Protein Is Required for Optimal Synthesis of the N-Methyl-D-Aspartate (NMDA) Receptor Coagonist D-Serine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutamate Receptor; Neurotransmitter; Neurotransmitter Receptor; Ubiquitin; Ubiquitylation (Ubiquitination); d-Serine; F-box Proteins; FBXO22; NMDA Receptor; Serine Racemase	F-BOX PROTEINS; NEUROMODULATOR D-SERINE; PROTEASOMAL DEGRADATION; MOUSE-BRAIN; RACEMASE; NEURONS; RELEASE; NEUROTRANSMISSION; SCHIZOPHRENIA; INHIBITION	Background: Serine racemase produces d-serine, which is required for optimal NMDA receptor activity. Results: FBXO22 interacts with and activates serine racemase by preventing its targeting to membranes. Conclusion: The data suggest an atypical role of FBXO22 in regulating d-serine synthesis unrelated to its effects on the ubiquitin system. Significance: The results provide a new mechanism affecting d-serine synthesis with implications for the regulation of NMDA receptors. d-Serine is a physiological activator of NMDA receptors (NMDARs) in the nervous system that mediates several NMDAR-mediated processes ranging from normal neurotransmission to neurodegeneration. d-Serine is synthesized from l-serine by serine racemase (SR), a brain-enriched enzyme. However, little is known about the regulation of d-serine synthesis. We now demonstrate that the F-box only protein 22 (FBXO22) interacts with SR and is required for optimal d-serine synthesis in cells. Although FBXO22 is classically associated with the ubiquitin system and is recruited to the Skip1-Cul1-F-box E3 complex, SR interacts preferentially with free FBXO22 species. In vivo ubiquitination and SR half-life determination indicate that FBXO22 does not target SR to the proteasome system. FBXO22 primarily affects SR subcellular localization and seems to increase d-serine synthesis by preventing the association of SR to intracellular membranes. Our data highlight an atypical role of FBXO22 in enhancing d-serine synthesis that is unrelated to its classical effects as a component of the ubiquitin-proteasome degradation pathway.	[Dikopoltsev, Elena; Foltyn, Veronika N.; Radzishevsky, Inna; Wolosker, Herman] Technion Israel Inst Technol, Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel; [Dikopoltsev, Elena; Foltyn, Veronika N.; Radzishevsky, Inna; Wolosker, Herman] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; [Zehl, Martin] Univ Vienna, Dept Pharmacognosy, A-1090 Vienna, Austria; [Jensen, Ole N.] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; [Mori, Hisashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Neurosci, Toyama 9300194, Japan	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; University of Vienna; University of Southern Denmark; University of Toyama	Wolosker, H (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel.	hwolosker@tx.technion.ac.il	Zehl, Martin/B-5901-2008; Jensen, Ole N/J-1763-2012	Zehl, Martin/0000-0001-9685-0373; Jensen, Ole N/0000-0003-1862-8528; Radzishevsky, Inna/0000-0001-7748-7599; Wolosker, Herman/0000-0001-5508-9194	Israel Science Foundation; Legacy Heritage Fund; Allen and Jewel Prince Center for Neurodegenerative Disorders of the Brain; Herbert N. Goldman Medical Research Fund	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Fund; Allen and Jewel Prince Center for Neurodegenerative Disorders of the Brain; Herbert N. Goldman Medical Research Fund	This work was supported by the Israel Science Foundation, by the Legacy Heritage Fund, by the Allen and Jewel Prince Center for Neurodegenerative Disorders of the Brain, and by the Herbert N. Goldman Medical Research Fund (to H. W.).	Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Balan L, 2009, P NATL ACAD SCI USA, V106, P7589, DOI 10.1073/pnas.0809442106; Balu DT, 2014, CELL MOL NEUROBIOL, V34, P419, DOI 10.1007/s10571-014-0027-z; Balu DT, 2013, P NATL ACAD SCI USA, V110, pE2400, DOI 10.1073/pnas.1304308110; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Benneyworth MA, 2012, CELL MOL NEUROBIOL, V32, P613, DOI 10.1007/s10571-012-9808-4; Borziak K, 2007, BIOINFORMATICS, V23, P2518, DOI 10.1093/bioinformatics/btm384; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; de Miranda J, 2002, P NATL ACAD SCI USA, V99, P14542, DOI 10.1073/pnas.222421299; Dumin E, 2006, J BIOL CHEM, V281, P20291, DOI 10.1074/jbc.M601971200; Ehmsen JT, 2013, J NEUROSCI, V33, P12464, DOI 10.1523/JNEUROSCI.4914-12.2013; Foltyn VN, 2005, J BIOL CHEM, V280, P1754, DOI 10.1074/jbc.M405726200; Fujii K, 2006, MOL PSYCHIATR, V11, P150, DOI 10.1038/sj.mp.4001776; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Harlow E., 1988, ANTIBODIES LAB MANUA, P343; Haskin J, 2013, HUM MOL GENET, V22, P2083, DOI 10.1093/hmg/ddt058; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hermand D, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-30; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Ito T, 2007, ANAL BIOCHEM, V371, P167, DOI 10.1016/j.ab.2007.07.030; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Jonkers W, 2009, EUKARYOT CELL, V8, P677, DOI 10.1128/EC.00386-08; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261; Laman H, 2005, EMBO J, V24, P3104, DOI 10.1038/sj.emboj.7600775; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Ma TM, 2013, MOL PSYCHIATR, V18, P557, DOI 10.1038/mp.2012.97; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Mothet JP, 2006, AGING CELL, V5, P267, DOI 10.1111/j.1474-9726.2006.00216.x; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Mustafa AK, 2007, P NATL ACAD SCI USA, V104, P2950, DOI 10.1073/pnas.0611620104; Mustafa AK, 2010, J NEUROSCI, V30, P1413, DOI 10.1523/JNEUROSCI.4297-09.2010; Mustafaa AK, 2009, P NATL ACAD SCI USA, V106, P2921, DOI 10.1073/pnas.0813105106; Nelson DE, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130131; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Panizzutti R, 2001, P NATL ACAD SCI USA, V98, P5294, DOI 10.1073/pnas.091002298; Pilar AVC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002773; Radzishevsky I, 2012, METHODS MOL BIOL, V794, P291, DOI 10.1007/978-1-61779-331-8_19; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Rosenberg D, 2013, J NEUROSCI, V33, P3533, DOI 10.1523/JNEUROSCI.3836-12.2013; Rosenberg D, 2010, FASEB J, V24, P2951, DOI 10.1096/fj.09-147967; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Tan MKM, 2011, MOL CELL BIOL, V31, P3687, DOI 10.1128/MCB.05746-11; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Yoshida Y, 2007, J BIOL CHEM, V282, P7137, DOI 10.1074/jbc.M611168200; Zielke N, 2006, EMBO REP, V7, P1266, DOI 10.1038/sj.embor.7400851; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	57	12	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33904	33915		10.1074/jbc.M114.618405	http://dx.doi.org/10.1074/jbc.M114.618405			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25336657	hybrid, Green Published			2022-12-28	WOS:000346077600020
J	Mayerhofer, H; Panneerselvam, S; Kaljunen, H; Tuukkanen, A; Mertens, HDT; Mueller-Dieckmann, J				Mayerhofer, Hubert; Panneerselvam, Saravanan; Kaljunen, Heidi; Tuukkanen, Anne; Mertens, Haydyn D. T.; Mueller-Dieckmann, Jochen			Structural Model of the Cytosolic Domain of the Plant Ethylene Receptor 1 (ETR1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; Crystal Structure; Histidine Kinase; Plant Hormone; Small Angle X-ray Scattering (SAXS); Ethylene Receptor; Two-component System	RAF-LIKE KINASE; HISTIDINE KINASE; PROTEIN-KINASE; BIOLOGICAL MACROMOLECULES; ENDOPLASMIC-RETICULUM; RESOLUTION STRUCTURE; MUTATIONAL ANALYSIS; SOLUTION SCATTERING; CATALYTIC DOMAIN; ARABIDOPSIS	Background: Signaling of the phytohormone ethylene is initiated by ethylene receptors. Results: We present two crystal structures and a solution model of the entire cytosolic domain of ETR1. Conclusion: This first structural model of the cytosolic domains reveals a flexible receiver domain and asymmetry of the central dimerization domain. Significance: The molecular architecture of the isolated cytosolic domain forms the basis to understand receptor assembly and interaction. Ethylene initiates important aspects of plant growth and development through disulfide-linked receptor dimers located in the endoplasmic reticulum. The receptors feature a small transmembrane, ethylene binding domain followed by a large cytosolic domain, which serves as a scaffold for the assembly of large molecular weight complexes of different ethylene receptors and other cellular participants of the ethylene signaling pathway. Here we report the crystallographic structures of the ethylene receptor 1 (ETR1) catalytic ATP-binding and the ethylene response sensor 1 dimerization histidine phosphotransfer (DHp) domains and the solution structure of the entire cytosolic domain of ETR1, all from Arabidopsis thaliana. The isolated dimeric ethylene response sensor 1 DHp domain is asymmetric, the result of different helical bending angles close to the conserved His residue. The structures of the catalytic ATP-binding, DHp, and receiver domains of ethylene receptors and of a homologous, but dissimilar, GAF domain were refined against experimental small angle x-ray scattering data, leading to a structural model of the entire cytosolic domain of the ethylene receptor 1. The model illustrates that the cytosolic domain is shaped like a dumbbell and that the receiver domain is flexible and assumes a position different from those observed in prokaryotic histidine kinases. Furthermore the cytosolic domain of ETR1 plays a key role, interacting with all other receptors and several participants of the ethylene signaling pathway. Our model, therefore, provides the first step toward a detailed understanding of the molecular mechanics of this important signal transduction process in plants.	[Mayerhofer, Hubert; Panneerselvam, Saravanan; Kaljunen, Heidi; Tuukkanen, Anne; Mertens, Haydyn D. T.; Mueller-Dieckmann, Jochen] Deutsch Elektronen Synchrotron DESY, European Mol Biol Lab EMBL Hamburg, D-22603 Hamburg, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Mueller-Dieckmann, J (corresponding author), Univ Hamburg, Biozentrum Klein Flottbek, Abt Mikrobiol & Biotechnol, Ohnhorststr 18, D-22609 Hamburg, Germany.	jochen.mueller-dieckmann@uni-hamburg.de		Mertens, Haydyn/0000-0002-5664-744X; Mayerhofer, Hubert/0000-0002-3291-2376	EMBL Interdisciplinary Postdocs program	EMBL Interdisciplinary Postdocs program	Supported by fellowships from the EMBL Interdisciplinary Postdocs program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008640; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Dunin-Horkawicz S, 2010, J STRUCT BIOL, V170, P226, DOI 10.1016/j.jsb.2010.01.023; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswar N., 2002, CURRENT PROTOCOLS BI; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferris HU, 2012, STRUCTURE, V20, P56, DOI 10.1016/j.str.2011.11.014; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gamble RL, 2002, PLANT PHYSIOL, V128, P1428, DOI 10.1104/pp.010777; Gao Z, 2008, J BIOL CHEM, V283, P23801, DOI 10.1074/jbc.M800641200; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Hahn A, 2009, PLANT PHYSIOL, V149, P1207, DOI 10.1104/pp.108.132241; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Marina A, 2001, J BIOL CHEM, V276, P41182, DOI 10.1074/jbc.M106080200; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Mayerhofer H, 2013, ACTA CRYSTALLOGR F, V69, P1029, DOI 10.1107/S1744309113021751; Mayerhofer H, 2012, J MOL BIOL, V415, P768, DOI 10.1016/j.jmb.2011.11.046; McDaniel BK, 2012, J BIOL CHEM, V287, P26094, DOI 10.1074/jbc.M112.383034; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; Muller-Dieckmann HJ, 1999, STRUCT FOLD DES, V7, P1547, DOI 10.1016/S0969-2126(00)88345-8; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Panneerselvam S, 2013, ACTA CRYSTALLOGR F, V69, P1307, DOI 10.1107/S174430911302842X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Qiu LP, 2012, PLANT PHYSIOL, V159, P1263, DOI 10.1104/pp.112.193979; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stepanova AN, 2009, CURR OPIN PLANT BIOL, V12, P548, DOI 10.1016/j.pbi.2009.07.009; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Yamada S, 2009, STRUCTURE, V17, P1333, DOI 10.1016/j.str.2009.07.016; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057; Zhao Q, 2011, MOL PLANT, V4, P626, DOI 10.1093/mp/ssr042; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244	65	22	23	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2644	2658		10.1074/jbc.M114.587667	http://dx.doi.org/10.1074/jbc.M114.587667			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25451923	hybrid, Green Published			2022-12-28	WOS:000349310700010
J	Song, WJ; Song, EAC; Jung, MS; Choi, SH; Baik, HH; Jin, BK; Kim, JH; Chung, SH				Song, Woo-Joo; Song, Eun-Ah Christine; Jung, Min-Su; Choi, Sun-Hee; Baik, Hyung-Hwan; Jin, Byung Kwan; Kim, Jeong Hee; Chung, Sul-Hee			Phosphorylation and Inactivation of Glycogen Synthase Kinase 3 beta (GSK3 beta) by Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-SYNDROME; FUNCTIONAL-LINK; ALZHEIMERS-DISEASE; OBESITY-PRONE; MICE; KINASE-3-BETA; PROTEIN; TAU; CHROMOSOME-21; ADIPOGENESIS	Glycogen synthase kinase 3 beta (GSK3 beta) participates in many cellular processes, and its dysregulation has been implicated in a wide range of diseases such as obesity, type 2 diabetes, cancer, and Alzheimer disease. Inactivation of GSK3 beta by phosphorylation at specific residues is a primary mechanism by which this constitutively active kinase is controlled. However, the regulatory mechanism of GSK3 beta is not fully understood. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) has multiple biological functions that occur as the result of phosphorylation of diverse proteins that are involved in metabolism, synaptic function, and neurodegeneration. Here we show that GSK3 beta directly interacts with and is phosphorylated by Dyrk1A. Dyrk1A-mediated phosphorylation at the Thr(356) residue inhibits GSK3 beta activity. Dyrk1A transgenic (TG) mice are lean and resistant to diet-induced obesity because of reduced fat mass, which shows an inverse correlation with the effect of GSK3 beta on obesity. This result suggests a potential in vivo association between GSK3 beta and Dyrk1A regarding the mechanism underlying obesity. The level of Thr(P)(356)-GSK3 beta was higher in the white adipose tissue of Dyrk1A TG mice compared with control mice. GSK3 beta activity was differentially regulated by phosphorylation at different sites in adipose tissue depending on the type of diet the mice were fed. Furthermore, overexpression of Dyrk1A suppressed the expression of adipogenic proteins, including peroxisome proliferator-activated receptor gamma, in 3T3-L1 cells and in young Dyrk1A TG mice fed a chow diet. Taken together, these results reveal a novel regulatory mechanism for GSK3 beta activity and indicate that overexpression of Dyrk1A may contribute to the obesity-resistant phenotype through phosphorylation and inactivation of GSK3 beta.	[Song, Woo-Joo; Song, Eun-Ah Christine; Baik, Hyung-Hwan; Jin, Byung Kwan; Chung, Sul-Hee] Kyung Hee Univ, Dept Biochem & Mol Biol, Neurodegenerat Control Res Ctr, Sch Med, Seoul 130701, South Korea; [Kim, Jeong Hee] Kyung Hee Univ, Sch Dent, Dept Oral Biochem & Mol Biol, Seoul 130701, South Korea; [Kim, Jeong Hee] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 130701, South Korea; [Song, Woo-Joo; Song, Eun-Ah Christine; Jung, Min-Su; Choi, Sun-Hee; Chung, Sul-Hee] Inje Univ, Inst Brain Sci & Technol, Pusan 614735, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Inje University	Chung, SH (corresponding author), Kyung Hee Univ, Sch Med, 1 Hoegi Dong, Seoul 130701, South Korea.	sulchung@khu.ac.kr		Kim, Jeong Hee/0000-0002-3884-4503	Ministry of Health, Welfare and Family Affairs, Republic of Korea [A092004]; National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology [2011-0014085, 2011-0023401, 2012R1A1A2040129, 2011-0030072, 2012-0000495]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [2008-0061888]	Ministry of Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology; National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by Korea Healthcare Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea Grant A092004 and by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science and Technology (Grants 2011-0014085, 2011-0023401, 2012R1A1A2040129, 2011-0030072, and 2012-0000495). This work was also supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2008-0061888).	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; CHANG S, 1990, AM J PHYSIOL, V259, pR1103, DOI 10.1152/ajpregu.1990.259.6.R1103; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Hong SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002857; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee S, 2013, BIOCHEM PHARMACOL, V85, P965, DOI 10.1016/j.bcp.2012.12.023; MacAulay K, 2005, J BIOL CHEM, V280, P9509, DOI 10.1074/jbc.M411648200; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Park JH, 2012, J NEUROCHEM, V122, P1081, DOI 10.1111/j.1471-4159.2012.07861.x; Pearce NJ, 2004, METABOLISM, V53, P1322, DOI 10.1016/j.metabol.2004.05.008; Rachdi L, 2014, DIABETOLOGIA, V57, P960, DOI 10.1007/s00125-014-3174-3; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Ryu YS, 2010, J NEUROCHEM, V115, P574, DOI 10.1111/j.1471-4159.2010.06769.x; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Steuber-Buchberger P, 2008, GENESIS, V46, P144, DOI 10.1002/dvg.20376; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yang TTC, 2006, MOL CELL BIOL, V26, P7372, DOI 10.1128/MCB.00580-06; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	37	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2321	2333		10.1074/jbc.M114.594952	http://dx.doi.org/10.1074/jbc.M114.594952			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25477508	hybrid, Green Published			2022-12-28	WOS:000348588000037
J	Ding, XF; Zhou, J; Hu, QY; Liu, SC; Chen, G				Ding, Xiao-Fei; Zhou, Jun; Hu, Qiong-Ying; Liu, Shuang-Chun; Chen, Guang			The Tumor Suppressor pVHL Down-regulates Never-in-Mitosis A-related Kinase 8 via Hypoxia-inducible Factors to Maintain Cilia in Human Renal Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-HIPPEL-LINDAU; KIDNEY-DISEASE; NEK FAMILY; PROTEIN; LOCALIZATION; CILIOGENESIS; MUTATIONS; CYSTS; LINKS; CYCLE	NEK8 (never in mitosis gene A (NIMA)-related kinase 8) is involved in cytoskeleton, cilia, and DNA damage response/repair. Abnormal expression and/or dysfunction of NEK8 are related to cancer development and progression. However, the mechanisms that regulate NEK8 are not well declared. We demonstrated here that pVHL may be involved in regulating NEK8. We found that CAK-I cells with wild-type vhl expressed a lower level of NEK8 than the cells loss of vhl, such as 786-O, 769-P, and A-498 cells. Moreover, pVHL overexpression down-regulated the NEK8 protein in 786-O cells, whereas pVHL knockdown up-regulated NEK8 in CAK-I cells. In addition, we found that the positive hypoxia response elements (HREs) are located in the promoter of the nek8 sequence and hypoxia could induce nek8 expression in different cell types. Consistent with this, down-regulation of hypoxia-inducible factors alpha (HIF-1 alpha or HIF-2 alpha) by isoform-specific siRNA reduced the ability of hypoxia inducing nek8 expression. In vivo, NEK8 and HIF-1 alpha expression were increased in kidneys of rats subjected to an experimental hypoxia model of ischemia and reperfusion. Furthermore, NEK8 siRNA transfection significantly blocked pVHL-knockdown-induced cilia disassembling, through impairing the pVHL-knockdown-up-regulated NEK8 expression. These results support that nek8 may be a novel hypoxia-inducible gene. In conclusion, our findings show that nek8 may be a new HIF target gene and pVHL can down-regulate NEK8 via HIFs to maintain the primary cilia structure in human renal cancer cells.	[Ding, Xiao-Fei; Zhou, Jun; Hu, Qiong-Ying; Chen, Guang] Taizhou Univ, Sch Med, Taizhou 318000, Zhejiang, Peoples R China; [Zhou, Jun; Chen, Guang] Taizhou Univ, Inst Tumor, Taizhou 318000, Zhejiang, Peoples R China; [Chen, Guang] Taizhou Univ, Sch Pharmaceut & Chem Engn, Taizhou 318000, Zhejiang, Peoples R China; [Liu, Shuang-Chun] Taizhou Municipal Hosp, Taizhou 318000, Zhejiang, Peoples R China	Taizhou University; Taizhou University; Taizhou University; Taizhou University	Chen, G (corresponding author), 1139 Shi Fu Ave, Taizhou 318000, Zhejiang, Peoples R China.	9220229@qq.com			National Natural Science Foundation of China [81201530]; Zhejiang Provincial Natural Science Foundation of China [Y15H310005, Y15H310006]; Foundation of Zhejiang Educational Committee [Y201121896]; Key Disciplines of Applied Chemistry of Zhejiang Providence, Taizhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Foundation of Zhejiang Educational Committee; Key Disciplines of Applied Chemistry of Zhejiang Providence, Taizhou University	This work was supported by National Natural Science Foundation of China Grant 81201530, Zhejiang Provincial Natural Science Foundation of China Grants Y15H310005 and Y15H310006, Foundation of Zhejiang Educational Committee Grant Y201121896, and Key Disciplines of Applied Chemistry of Zhejiang Providence, Taizhou University.	Bowers AJ, 2004, GENE, V328, P135, DOI 10.1016/j.gene.2003.12.002; Cai YQ, 2008, J AM SOC NEPHROL, V19, P418, DOI 10.1681/ASN.2008010084; Chen G, 2012, J BIOL CHEM, V287, P12132, DOI 10.1074/jbc.M111.302299; Choi HJC, 2013, MOL CELL, V51, P423, DOI 10.1016/j.molcel.2013.08.006; Frank V, 2013, HUM MOL GENET, V22, P2177, DOI 10.1093/hmg/ddt070; Frew IJ, 2007, CURR OPIN CELL BIOL, V19, P685, DOI 10.1016/j.ceb.2007.10.001; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Holland PM, 2002, J BIOL CHEM, V277, P16229, DOI 10.1074/jbc.M108662200; Jackson PK, 2013, MOL CELL, V51, P407, DOI 10.1016/j.molcel.2013.08.013; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kuehn EW, 2007, CANCER RES, V67, P4537, DOI 10.1158/0008-5472.CAN-07-0391; Li MQ, 2011, J CELL MOL MED, V15, P187, DOI 10.1111/j.1582-4934.2010.01238.x; Mahjoub MR, 2005, J AM SOC NEPHROL, V16, P3485, DOI 10.1681/ASN.2005080824; Manning DK, 2013, J AM SOC NEPHROL, V24, P100, DOI 10.1681/ASN.2012050490; Moniz L, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-18; Natoli TA, 2008, AM J PHYSIOL-RENAL, V294, pF73, DOI 10.1152/ajprenal.00362.2007; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Sohara E, 2008, J AM SOC NEPHROL, V19, P469, DOI 10.1681/ASN.2006090985; Trapp ML, 2008, PEDIATR NEPHROL, V23, P377, DOI 10.1007/s00467-007-0692-y; Valkova N, 2005, MOL CELL PROTEOMICS, V4, P1009, DOI 10.1074/mcp.M500091-MCP200; Xu J., 2010, J AM SOC NEPHROL, V21, P2041; Xu JY, 2010, J AM SOC NEPHROL, V21, P2041, DOI 10.1681/ASN.2010040345; Zalli D, 2012, HUM MOL GENET, V21, P1155, DOI 10.1093/hmg/ddr544	29	25	25	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1389	1394		10.1074/jbc.M114.589226	http://dx.doi.org/10.1074/jbc.M114.589226			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451921	Green Published, hybrid			2022-12-28	WOS:000348056400008
J	Golebiewska, EM; Harper, MT; Williams, CM; Savage, JS; Goggs, R; von Mollard, GF; Poole, AW				Golebiewska, Ewelina M.; Harper, Matthew T.; Williams, Christopher M.; Savage, Joshua S.; Goggs, Robert; von Mollard, Gabriele Fischer; Poole, Alastair W.			Syntaxin 8 Regulates Platelet Dense Granule Secretion, Aggregation, and Thrombus Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISMS; SNARE; PROTEIN; EXOCYTOSIS; SNAP-23; RELEASE; TRAFFICKING; LOCALIZATION; FUSION; CELLS	Platelet secretion not only drives thrombosis and hemostasis, but also mediates a variety of other physiological and pathological processes. The ubiquitous SNARE machinery and a number of accessory proteins have been implicated in regulating secretion in platelet. Although several platelet SNAREs have been identified, further members of the SNARE family may be needed to fine-tune platelet secretion. In this study we identified expression of the t-SNARE syntaxin 8 (STX8) (Qc SNARE) in mouse and human platelets. In mouse studies, whereas STX8 was not essential for alpha-granule or lysosome secretion, Stx8(-/-) platelets showed a significant defect in dense granule secretion in response to thrombin and CRP. This was most pronounced at intermediate concentrations of agonists. They also showed an aggregation defect that could be rescued with exogenous ADP and increased embolization in Stx8(-/-) mice in vivo consistent with an important autocrine and paracrine role for ADP in aggregation and thrombus stabilization. STX8 therefore specifically contributes to dense granule secretion and represents another member of a growing family of genes that play distinct roles in regulating granule release from platelets and thus platelet function in thrombosis and hemostasis.	[Golebiewska, Ewelina M.; Harper, Matthew T.; Williams, Christopher M.; Poole, Alastair W.] Univ Walk, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Savage, Joshua S.] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Goggs, Robert] Cornell Univ, Dept Clin Sci, Coll Vet Med, Ithaca, NY 14853 USA; [von Mollard, Gabriele Fischer] Univ Bielefeld, Fak Chem, D-33501 Bielefeld, Germany	University of Bristol; University of Birmingham; Cornell University; University of Bielefeld	Poole, AW (corresponding author), Univ Walk, Sch Physiol & Pharmacol, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	a.poole@bris.ac.uk	von Mollard, Gabriele Fischer/A-3935-2012; von Mollard, Gabriele Fischer/O-9778-2019; Savage, Joshua/A-8738-2008; Harper, Matthew T/G-5630-2013	von Mollard, Gabriele Fischer/0000-0003-3236-1401; von Mollard, Gabriele Fischer/0000-0003-3236-1401; Savage, Joshua/0000-0003-0599-0245; Harper, Matthew T/0000-0002-4740-637X; Goggs, Robert/0000-0001-7446-6987; Poole, Alastair/0000-0002-0868-297X	British Heart Foundation [RG/10/006/28299, PG/12/25/29488, FS/09/009/26444]	British Heart Foundation(British Heart Foundation)	This work was supported by grants from the British Heart Foundation to A. W. P. (RG/10/006/28299, PG/12/25/29488, FS/09/009/26444).	Al Hawas R, 2012, BLOOD, V120, P2493, DOI 10.1182/blood-2012-05-430629; Ambrosio AL, 2012, BLOOD, V120, P4072, DOI 10.1182/blood-2012-04-420745; Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; Atlashkin V, 2003, MOL CELL BIOL, V23, P5198, DOI 10.1128/MCB.23.15.5198-5207.2003; Bilan F, 2004, J CELL SCI, V117, P1923, DOI 10.1242/jcs.01070; Bilan F, 2008, EXP CELL RES, V314, P2199, DOI 10.1016/j.yexcr.2008.04.012; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Chen B, 2014, J BIOL CHEM, V289, P19556, DOI 10.1074/jbc.M114.567925; Chen D, 2000, BLOOD, V96, P1782, DOI 10.1182/blood.V96.5.1782.h8001782_1782_1788; Chen D, 2000, BLOOD, V95, P921, DOI 10.1182/blood.V95.3.921.003k17_921_929; Clemetson KJ, 2012, THROMB RES, V129, P220, DOI 10.1016/j.thromres.2011.11.036; Cosemans JMEM, 2013, CARDIOVASC RES, V99, P342, DOI 10.1093/cvr/cvt110; Flaumenhaft R, 1999, J BIOL CHEM, V274, P2492, DOI 10.1074/jbc.274.4.2492; Gilio K, 2010, J BIOL CHEM, V285, P23408, DOI 10.1074/jbc.M110.136176; Goggs R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054663; Golebiewska EM, 2014, BRIT J HAEMATOL, V165, P204, DOI 10.1111/bjh.12682; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Jonnalagadda D, 2012, BLOOD, V120, P5209, DOI 10.1182/blood-2012-07-445080; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; Kasai K, 2001, J CELL SCI, V114, P3115; Kawato M, 2008, J BIOL CHEM, V283, P166, DOI 10.1074/jbc.M705340200; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; King SM, 2009, CIRCULATION, V120, P785, DOI 10.1161/CIRCULATIONAHA.108.845461; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Kreykenbohm V, 2002, EUR J CELL BIOL, V81, P273, DOI 10.1078/0171-9335-00247; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lemons PP, 1997, BLOOD, V90, P1490, DOI 10.1182/blood.V90.4.1490.1490_1490_1500; Lemons PP, 2000, BIOCHEM BIOPH RES CO, V267, P875, DOI 10.1006/bbrc.1999.2039; Lewandrowski U, 2009, BLOOD, V114, pE10, DOI 10.1182/blood-2009-02-203828; Mollinedo F, 2006, J IMMUNOL, V177, P2831, DOI 10.4049/jimmunol.177.5.2831; Neumuller O, 2009, BLOOD, V114, P1396, DOI 10.1182/blood-2008-05-155234; Offenhauser C, 2011, TRAFFIC, V12, P762, DOI 10.1111/j.1600-0854.2011.01189.x; Pattu V, 2012, EUR J IMMUNOL, V42, P470, DOI 10.1002/eji.201141915; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; Ren QS, 2007, MOL BIOL CELL, V18, P24, DOI 10.1091/mbc.E06-09-0785; Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739; Stefanini L, 2009, BLOOD, V114, P2506, DOI 10.1182/blood-2009-04-218768; Tang BL, 1998, BIOCHEM BIOPH RES CO, V245, P627, DOI 10.1006/bbrc.1998.8490; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; van den Bosch MTJ, 2014, J THROMB HAEMOST, V12, P726, DOI 10.1111/jth.12542; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Ye SJ, 2012, BLOOD, V120, P2484, DOI 10.1182/blood-2012-05-430603; zur Stadt U, 2009, AM J HUM GENET, V85, P482, DOI 10.1016/j.ajhg.2009.09.005	50	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1536	1545		10.1074/jbc.M114.602615	http://dx.doi.org/10.1074/jbc.M114.602615			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25404741	hybrid, Green Published			2022-12-28	WOS:000348056400023
J	Park, M; Lee, BS; Jeon, SH; Nam, HJ; Lee, G; Kim, CH; Cho, H; Lee, JH				Park, Minseon; Lee, Bok-Soon; Jeon, Soung-Hoo; Nam, Hyun-Ja; Lee, Gwang; Kim, Chul-Ho; Cho, Hyeseong; Lee, Jae-Ho			A Novel Isoform of Met Receptor Tyrosine Kinase Blocks Hepatocyte Growth Factor/Met Signaling and Stimulates Skeletal Muscle Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SATELLITE CELLS; SCATTER FACTOR; MYOGENIC DIFFERENTIATION; GENE-EXPRESSION; IGF-I; REGENERATION; PROLIFERATION; ACTIVATION; CANCER; MIGRATION	Hepatocyte growth factor (HGF) and its receptor, Met, regulate skeletal muscle differentiation. In the present study, we identified a novel alternatively spliced isoform of Met lacking exon 13 (designated Delta 13Met), which is expressed mainly in human skeletal muscle. Alternative splicing yielded a truncated Met having extracellular domain only, suggesting an inhibitory role. Indeed, Delta 13Met expression led to a decrease in HGF-induced tyrosine phosphorylation of Met and ERK phosphorylation, as well as cell proliferation and migration via sequestration of HGF. Interestingly, in human primary myoblasts undergoing differentiation, Delta 13Met mRNA and protein levels were rapidly increased, concomitantly with a decrease in wild type Met mRNA and protein. Inhibition of Delta 13Met with siRNA led to a decreased differentiation, whereas its overexpression potentiated differentiation of human primary myoblasts. Furthermore, in notexin-induced mouse injury model, exogenous Delta 13Met expression enhanced regeneration of skeletal muscle, further confirming a stimulatory role of the isoform in muscle cell differentiation. In summary, we identified a novel alternatively spliced inhibitory isoform of Met that stimulates muscle cell differentiation, which confers a new means to control muscle differentiation and/or regeneration.	[Park, Minseon; Jeon, Soung-Hoo; Nam, Hyun-Ja; Cho, Hyeseong; Lee, Jae-Ho] Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 443721, South Korea; [Lee, Bok-Soon; Kim, Chul-Ho] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 443721, South Korea; [Lee, Gwang] Ajou Univ, Sch Med, Dept Physiol, Suwon 443721, South Korea	Ajou University; Ajou University; Ajou University	Lee, JH (corresponding author), Ajou Univ, Sch Med, Dept Biochem & Mol Biol, 5 Woncheon Dong, Suwon 443721, South Korea.	jhlee64@ajou.ac.kr		Cho, Hyeseong/0000-0002-4672-8887	National Research Foundation of Korea - Korean government (Ministry of Science, ICT, and Future Planning) [2011-0030043]	National Research Foundation of Korea - Korean government (Ministry of Science, ICT, and Future Planning)	This work was supported by National Research Foundation of Korea Grant 2011-0030043 funded by the Korean government (Ministry of Science, ICT, and Future Planning).	ALLEN RE, 1990, P SOC EXP BIOL MED, V194, P81; Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; AUSTIN L, 1991, J NEUROL SCI, V101, P193, DOI 10.1016/0022-510X(91)90045-9; BHARGAVA M, 1992, CELL GROWTH DIFFER, V3, P11; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Chernyavsky AI, 2005, J BIOL CHEM, V280, P39220, DOI 10.1074/jbc.M504407200; Christ B, 2002, INT J DEV BIOL, V46, P905; Collesi C, 1996, MOL CELL BIOL, V16, P5518; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cross JC, 2003, PLACENTA, V24, P123, DOI 10.1053/plac.2002.0887; Fiaschi T, 2014, CELL MOL LIFE SCI, V71, P1917, DOI 10.1007/s00018-013-1537-4; Flann KL, 2014, J CELL PHYSIOL, V229, P572, DOI 10.1002/jcp.24479; FLORINI JR, 1991, MOL ENDOCRINOL, V5, P718, DOI 10.1210/mend-5-5-718; Foulstone EJ, 2004, EXP CELL RES, V294, P223, DOI 10.1016/j.yexcr.2003.10.034; Gal-Levi R, 1998, BBA-MOL CELL RES, V1402, P39, DOI 10.1016/S0167-4889(97)00124-9; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; JENNISCHE E, 1993, AM J PHYSIOL, V265, pC122, DOI 10.1152/ajpcell.1993.265.1.C122; Karalaki M, 2009, IN VIVO, V23, P779; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; LEE CC, 1994, J BIOL CHEM, V269, P19457; Lee JH, 2006, EXP MOL MED, V38, P565, DOI 10.1038/emm.2006.66; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; Lin JC, 1998, ONCOGENE, V16, P833, DOI 10.1038/sj.onc.1201599; Liu YH, 1998, GENE, V215, P159, DOI 10.1016/S0378-1119(98)00264-9; Liu YH, 2002, CURR OPIN NEPHROL HY, V11, P23, DOI 10.1097/00041552-200201000-00004; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Reiser J, 2000, GENE THER, V7, P910, DOI 10.1038/sj.gt.3301188; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; RODRIGUES GA, 1991, MOL CELL BIOL, V11, P2962, DOI 10.1128/MCB.11.6.2962; Schertzer JD, 2006, GENE THER, V13, P1657, DOI 10.1038/sj.gt.3302817; SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shinomiya N, 2004, CANCER RES, V64, P7962, DOI 10.1158/0008-5472.CAN-04-1043; Tatsumi R, 2002, MOL BIOL CELL, V13, P2909, DOI 10.1091/mbc.E02-01-0062; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Webster MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081757; Yamane A, 2003, DEV GROWTH DIFFER, V45, P1; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	45	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1804	1817		10.1074/jbc.M114.596957	http://dx.doi.org/10.1074/jbc.M114.596957			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25471370	hybrid, Green Published			2022-12-28	WOS:000348056400045
J	Shen, S; Berry, GE; Rivera, RMC; Cheung, RY; Troupes, AN; Brown, SM; Kafri, T; Asokan, A				Shen, Shen; Berry, Garrett E.; Rivera, Ruth M. Castellanos; Cheung, Roland Y.; Troupes, Andrew N.; Brown, Sarah M.; Kafri, Tal; Asokan, Aravind			Functional Analysis of the Putative Integrin Recognition Motif on Adeno-associated Virus 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; GENE-TRANSFER; TYPE-2 INFECTION; RNAI PHENOTYPES; BINDING DOMAIN; TRANSDUCTION; CORECEPTOR; IDENTIFICATION; DATABASE; SEROTYPE	Adeno-associated viruses (AAVs) display a highly conserved NGR motif on the capsid surface. Earlier studies have established this tripeptide motif as being essential for integrin-mediated uptake of recombinant AAV serotype 2 (AAV2) in cultured cells. However, functional attributes of this putative integrin recognition motif in other recombinant AAV serotypes displaying systemic transduction in vivo remain unknown. In this study, we dissect the biology of an integrin domain capsid mutant derived from the human isolate AAV9 in mice. The AAV9/NGA mutant shows decreased systemic transduction in mice. This defective phenotype was accompanied by rapid clearance of mutant virions from the blood circulation and nonspecific sequestration by the spleen. Transient vascular hyperpermeability, induced by histamine coinjection, exacerbated AAV9/NGA uptake by the spleen but not the liver. However, such treatment did not affect AAV9 virions, suggesting a potential entry/post-entry defect for the mutant in different tissues. Further characterization revealed modestly decreased cell surface binding but a more pronounced defect in the cellular entry of mutant virions. These findings were corroborated by the observation that blocking multiple integrins adversely affected recombinant AAV9 transduction in different cell types, albeit with variable efficiencies. From a structural perspective, we observed that the integrin recognition motif is located in close proximity to the galactose binding footprint on AAV9 capsids and postulate that this feature could influence cell surface attachment, cellular uptake at the tissue level, and systemic clearance by the reticuloendothelial system.	[Shen, Shen; Berry, Garrett E.; Rivera, Ruth M. Castellanos; Cheung, Roland Y.; Troupes, Andrew N.; Brown, Sarah M.; Kafri, Tal; Asokan, Aravind] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Berry, Garrett E.; Asokan, Aravind] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Asokan, Aravind] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Asokan, A (corresponding author), Univ N Carolina, Gene Therapy Ctr, CB 7352,5123 Thurston Bldg, Chapel Hill, NC 27599 USA.	aravind@med.unc.edu	, BRIC Small Animal Imaging Facility/AEV-1023-2022	, BRIC Small Animal Imaging Facility/0000-0002-0535-3214	National Institutes of Health [R01HL089221, P01HL112761, R01-DK058702-10]; NATIONAL CANCER INSTITUTE [F31CA165891] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089221, P01HL112761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01HL089221 and P01HL112761 (to A. A.) and R01-DK058702-10 (to T. K.).	Adachi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4075; Asokan A, 2006, J VIROL, V80, P8961, DOI 10.1128/JVI.00843-06; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bell CL, 2012, J VIROL, V86, P7326, DOI 10.1128/JVI.00448-12; Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Bowles D.E., 2006, PARVOVIRUSES, P15; Burns K, 2007, FIELDS VIROLOGY, P2437; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; DiMattia MA, 2012, J VIROL, V86, P6947, DOI 10.1128/JVI.07232-11; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gilsdorf M, 2010, NUCLEIC ACIDS RES, V38, pD448, DOI 10.1093/nar/gkp1038; Greelish JP, 1999, NAT MED, V5, P439, DOI 10.1038/7439; Hauck B, 2004, J VIROL, V78, P13678, DOI 10.1128/JVI.78.24.13678-13686.2004; Horn T, 2007, NUCLEIC ACIDS RES, V35, pD492, DOI 10.1093/nar/gkl906; Kaminsky PM, 2012, MOL THER, V20, P972, DOI 10.1038/mt.2011.295; Kashiwakura Y, 2005, J VIROL, V79, P609, DOI 10.1128/JVI.79.1.609-614.2005; Kern A, 2003, J VIROL, V77, P11072, DOI 10.1128/JVI.77.20.11072-11081.2003; Levy HC, 2009, J STRUCT BIOL, V165, P146, DOI 10.1016/j.jsb.2008.12.002; Ling C, 2010, HUM GENE THER, V21, P1741, DOI 10.1089/hum.2010.075; Neu U, 2011, CURR OPIN STRUC BIOL, V21, P610, DOI 10.1016/j.sbi.2011.08.009; O'Donnell J, 2009, VIROLOGY, V385, P434, DOI 10.1016/j.virol.2008.11.037; Opie SR, 2003, J VIROL, V77, P6995, DOI 10.1128/JVI.77.12.6995-7006.2003; Petrov M, 2011, METHODS MOL BIOL, V709, P277, DOI 10.1007/978-1-61737-982-6_18; Pulicherla N, 2011, MOL THER, V19, P1070, DOI 10.1038/mt.2011.22; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; Schmidt EE, 2013, NUCLEIC ACIDS RES, V41, pD1021, DOI 10.1093/nar/gks1170; Shen S, 2013, J BIOL CHEM, V288, P28814, DOI 10.1074/jbc.M113.482380; Shen S, 2012, J VIROL, V86, P10408, DOI 10.1128/JVI.01155-12; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Summerford C, 1999, NAT MED, V5, P78, DOI 10.1038/4768; Thomas CE, 2004, J VIROL, V78, P3110, DOI 10.1128/JVI.78.6.3110-3122.2004; Wang JH, 2007, P NATL ACAD SCI USA, V104, P13104, DOI 10.1073/pnas.0702778104; Weller ML, 2010, NAT MED, V16, P662, DOI 10.1038/nm.2145; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Yang B, 2014, MOL THER, V22, P1299, DOI 10.1038/mt.2014.68	36	16	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1496	1504		10.1074/jbc.M114.608281	http://dx.doi.org/10.1074/jbc.M114.608281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25404742	Green Published, hybrid			2022-12-28	WOS:000348056400020
J	Guo, L; Li, X; Tang, QQ				Guo, Liang; Li, Xi; Tang, Qi-Qun			Transcriptional Regulation of Adipocyte Differentiation: A Central Role for CCAAT/Enhancer-binding Protein (C/EBP) beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MITOTIC CLONAL EXPANSION; 3T3-L1 PREADIPOCYTE DIFFERENTIATION; H3K9 METHYLTRANSFERASE G9A; FACILITATE ADIPOGENESIS; GENE-TRANSCRIPTION; DNA-REPLICATION; CELL; ACTIVATION; PHOSPHORYLATION; AUTOPHAGY	A detailed understanding of the processes controlling adipogenesis is instrumental in the fight against the obesity epidemic. Adipogenesis is controlled by a transcriptional cascade composed of a large number of transcriptional factors, among which CCAAT/enhancer-binding protein (C/EBP) beta plays an essential role. During 3T3-L1 adipocyte differentiation, C/EBP beta is induced early to transactivate the expression of C/EBP alpha and peroxisome proliferator-activated receptor gamma (PPAR gamma), two master transcription factors for terminal adipocyte differentiation. Studies in recent years have revealed many new target genes of C/EBP beta, implicating its participation inmanyother processes during adipogenesis, such as mitotic clonal expansion, epigenetic regulation, unfolded protein response, and autophagy. Moreover, the function of C/EBP beta is highly regulated by post-translational modifications, which are crucial for the proper activation of the adipogenic program. Advances toward elucidation of the function and roles of the post-translational modification of C/EBP beta during adipogenesis will greatly improve our understanding of the molecular mechanisms governing adipogenesis.	[Tang, Qi-Qun] Fudan Univ, Shanghai Med Coll, Key Lab Metab & Mol Med, Minist Educ, Shanghai 200032, Peoples R China; Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Tang, QQ (corresponding author), Fudan Univ, Shanghai Med Coll, Key Lab Metab & Mol Med, Minist Educ, Shanghai 200032, Peoples R China.	qqtang@shmu.edu.cn			Shanghai Leading Academic Discipline Project [B110]; 985 Project [985 III-YFX0302]	Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); 985 Project(Jilin UniversityXiamen University)	The Department of Biochemistry and Molecular Biology is supported by Shanghai Leading Academic Discipline Project B110 and 985 Project 985 III-YFX0302.	Aparicio T, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-18; Baerga R, 2009, AUTOPHAGY, V5, P1118, DOI 10.4161/auto.5.8.9991; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Cesena TI, 2008, MOL CELL ENDOCRINOL, V289, P94, DOI 10.1016/j.mce.2008.03.009; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Chung SS, 2012, OBESITY, V20, P482, DOI 10.1038/oby.2011.212; Chung SS, 2010, MOL CELL BIOL, V30, P2135, DOI 10.1128/MCB.00852-09; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Greenwel P, 2000, MOL CELL BIOL, V20, P912, DOI 10.1128/MCB.20.3.912-918.2000; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Guo L, 2012, CELL DEATH DIFFER, V19, P1917, DOI 10.1038/cdd.2012.75; Guo L, 2013, MOL CELL BIOL, V33, P3180, DOI 10.1128/MCB.00193-13; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; Iyer VV, 2004, EXP CELL RES, V295, P128, DOI 10.1016/j.yexcr.2004.01.004; Jiang Y, 2014, J PROTEOME RES, V13, P1307, DOI 10.1021/pr401292p; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Johmura Y, 2008, J BIOL CHEM, V283, P2265, DOI 10.1074/jbc.M707880200; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; Kim J, 2002, J BIOL CHEM, V277, P38037, DOI 10.1074/jbc.M207235200; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Li SF, 2013, AM J PHYSIOL-ENDOC M, V304, pE990, DOI 10.1152/ajpendo.00608.2012; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; Li X, 2009, J BIOL CHEM, V284, P19248, DOI 10.1074/jbc.M109.005678; Liu YF, 2013, STAT INTERFACE, V6, P1; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Ma D, 2011, EMBO J, V30, P4642, DOI 10.1038/emboj.2011.322; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Park SW, 2013, SEMIN IMMUNOPATHOL, V35, P351, DOI 10.1007/s00281-013-0370-z; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Pless O, 2008, J BIOL CHEM, V283, P26357, DOI 10.1074/jbc.M802132200; Qiu ZL, 2001, J BIOL CHEM, V276, P11988, DOI 10.1074/jbc.M011729200; Reichert M, 1999, ONCOGENE, V18, P459, DOI 10.1038/sj.onc.1202308; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Turowski P, 2003, MOL BIOL CELL, V14, P2984, DOI 10.1091/mbc.E02-08-0515; Wang LF, 2013, EMBO J, V32, P45, DOI 10.1038/emboj.2012.306; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Xu M, 2003, EMBO J, V22, P893, DOI 10.1093/emboj/cdg094; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101; Zhang YY, 2011, MOL BIOL CELL, V22, P2165, DOI 10.1091/mbc.E10-11-0912; Zhang YY, 2012, BIOCHEM BIOPH RES CO, V419, P550, DOI 10.1016/j.bbrc.2012.02.058; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	69	189	202	2	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					755	761		10.1074/jbc.R114.619957	http://dx.doi.org/10.1074/jbc.R114.619957			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451943	Green Published, hybrid			2022-12-28	WOS:000347778200006
J	Couceiro, JR; Gallardo, R; De Smet, F; De Baets, G; Baatsen, P; Annaert, W; Roose, K; Saelens, X; Schymkowitz, J; Rousseau, F				Couceiro, Jose R.; Gallardo, Rodrigo; De Smet, Frederik; De Baets, Greet; Baatsen, Pieter; Annaert, Wim; Roose, Kenny; Saelens, Xavier; Schymkowitz, Joost; Rousseau, Frederic			Sequence-dependent Internalization of Aggregating Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aggresome; Amyloid; Molecular Chaperone; Peptide Transport; Protein Aggregation; Internalization; Peptide; Prionoid	EXTRACELLULAR ALPHA-SYNUCLEIN; AMYLOID-BETA-PROTEIN; NEURONAL CELL-DEATH; HEAT-SHOCK PROTEINS; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; INTRACELLULAR ACCUMULATION; MICROGLIAL ACTIVATION; SCAVENGER RECEPTOR; HEPARAN-SULFATE	Background: Prionoid propagation requires cell internalization of aggregated polypeptides. Results: Aggregates of different sequence are internalized through different endocytic pathways. Only phagocytosed aggregates (>1 m) elicit an HSF1-dependent proteostatic response. Conclusion: Proteostatic response upon aggregate internalization differs markedly depending on the sequence. Significance: The characterization of mechanisms of cell penetration is fundamental for the understanding of aggregate transmission in disease. Recently, a number of aggregation disease polypeptides have been shown to spread from cell to cell, thereby displaying prionoid behavior. Studying aggregate internalization, however, is often hampered by the complex kinetics of the aggregation process, resulting in the concomitant uptake of aggregates of different sizes by competing mechanisms, which makes it difficult to isolate pathway-specific responses to aggregates. We designed synthetic aggregating peptides bearing different aggregation propensities with the aim of producing modes of uptake that are sufficiently distinct to differentially analyze the cellular response to internalization. We found that small acidic aggregates (500 nm in diameter) were taken up by nonspecific endocytosis as part of the fluid phase and traveled through the endosomal compartment to lysosomes. By contrast, bigger basic aggregates (>1 m) were taken up through a mechanism dependent on cytoskeletal reorganization and membrane remodeling with the morphological hallmarks of phagocytosis. Importantly, the properties of these aggregates determined not only the mechanism of internalization but also the involvement of the proteostatic machinery (the assembly of interconnected networks that control the biogenesis, folding, trafficking, and degradation of proteins) in the process; whereas the internalization of small acidic aggregates is HSF1-independent, the uptake of larger basic aggregates was HSF1-dependent, requiring Hsp70. Our results show that the biophysical properties of aggregates determine both their mechanism of internalization and proteostatic response. It remains to be seen whether these differences in cellular response contribute to the particular role of specific aggregated proteins in disease.	[Couceiro, Jose R.; Gallardo, Rodrigo; De Smet, Frederik; De Baets, Greet; Schymkowitz, Joost; Rousseau, Frederic] VIB, SWITCH Lab, Leuven, Belgium; [Baatsen, Pieter] Katholieke Univ Leuven, Leuven Ctr Human Genet, Electron Microscopy Facil EMoNe, B-3000 Louvain, Belgium; [Annaert, Wim] VIB Ctr Biol Dis, Lab Membrane Trafficking, B-3000 Louvain, Belgium; [Annaert, Wim] VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Roose, Kenny; Saelens, Xavier] VIB Inflammat Res Ctr, B-9052 Ghent, Belgium; [Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Ghent University	Rousseau, F (corresponding author), SWITCH Lab, Dept Cellular & Mol Med, Gasthuisberg Campus O&N1,Herestr 49 Bus, B-3000 Leuven, Belgium.	frederic.rousseau@switch.vib-kuleuven.be	Rousseau, Frederic/J-9044-2016; De Smet, Frederik/Q-7808-2016; De Baets, Greet/J-1881-2014; Saelens, Xavier/N-5728-2015; Rodríguez Couceiro, Jose/F-1497-2016; Schymkowitz, Joost/AAV-3680-2021; Bustelo, Xose R./A-9526-2010; Schymkowitz, Joost/K-7764-2016	Rousseau, Frederic/0000-0002-9189-7399; De Smet, Frederik/0000-0002-6669-3335; De Baets, Greet/0000-0001-8844-800X; Rodríguez Couceiro, Jose/0000-0002-5742-1071; Bustelo, Xose R./0000-0001-9398-6072; , Xavier/0000-0002-3861-6965; Gallardo, Rodrigo/0000-0003-1584-3564; Schymkowitz, Joost/0000-0003-2020-0168	VIB, University of Leuven [GOA/11/009]; Funds for Scientific Research Flanders (FWO); Flanders Institute for Science and Technology (IWT); Federal Office for Scientific Affairs of Belgium (Belspo) Grant [IUAP P7/16]; Hercules Foundation [AKUL/09/037, AKUL/11/30]	VIB, University of Leuven; Funds for Scientific Research Flanders (FWO)(FWO); Flanders Institute for Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Federal Office for Scientific Affairs of Belgium (Belspo) Grant; Hercules Foundation	This work was supported in part by VIB, University of Leuven, Grant GOA/11/009 (to W. A.), the Funds for Scientific Research Flanders (FWO), the Flanders Institute for Science and Technology (IWT), Federal Office for Scientific Affairs of Belgium (Belspo) Grant IUAP P7/16, and Hercules Foundation Grants AKUL/09/037 and AKUL/11/30.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Avrahami D, 2008, J NEUROSCI RES, V86, P2753, DOI 10.1002/jnr.21720; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Cortese K, 2013, MOL BIOL CELL, V24, P129, DOI 10.1091/mbc.E12-04-0282; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gehrmann M, 2005, CELL DEATH DIFFER, V12, P38, DOI 10.1038/sj.cdd.4401510; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Hofmann JP, 2013, P NATL ACAD SCI USA, V110, P5951, DOI 10.1073/pnas.1217321110; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Kandimalla KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004627; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kiachopoulos S, 2004, TRAFFIC, V5, P426, DOI 10.1111/j.1398-9219.2004.00185.x; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Laramie JM, 2008, SHOCK, V29, P623, DOI 10.1097/SHK.0b013e318157f33c; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Luo K, 2010, BIOCHEM BIOPH RES CO, V394, P493, DOI 10.1016/j.bbrc.2010.02.159; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Magenau A, 2011, TRAFFIC, V12, P1730, DOI 10.1111/j.1600-0854.2011.01272.x; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nagao G, 2010, ANTICANCER RES, V30, P3167; Nakamura K, 2006, J NEUROSCI RES, V84, P874, DOI 10.1002/jnr.20992; Novoselova TV, 2005, J NEUROCHEM, V94, P597, DOI 10.1111/j.1471-4159.2005.03119.x; Omtri RS, 2012, MOL PHARMACEUT, V9, P1887, DOI 10.1021/mp200530q; Otsuka A, 2009, BIOCHEM BIOPH RES CO, V378, P478, DOI 10.1016/j.bbrc.2008.11.066; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Park JY, 2009, J NEUROCHEM, V110, P400, DOI 10.1111/j.1471-4159.2009.06150.x; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Santa-Maria I, 2012, J BIOL CHEM, V287, P20522, DOI 10.1074/jbc.M111.323279; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Singh TD, 2010, FEBS LETT, V584, P3936, DOI 10.1016/j.febslet.2010.08.050; Song M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-92; Soura V, 2012, BIOCHEM J, V441, P579, DOI 10.1042/BJ20110749; Sousa R, 2006, TRAFFIC, V7, P1596, DOI 10.1111/j.1600-0854.2006.00497.x; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Trevino RS, 2012, J BIOL CHEM, V287, P29722, DOI 10.1074/jbc.M112.372474; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Wang RB, 2006, J SURG RES, V136, P58, DOI 10.1016/j.jss.2006.06.003; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Yerbury JJ, 2010, CELL STRESS CHAPERON, V15, P115, DOI 10.1007/s12192-009-0122-0	72	17	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					242	258		10.1074/jbc.M114.586636	http://dx.doi.org/10.1074/jbc.M114.586636			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25391649	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000347231200023
J	Goswami, S; Tarapore, RS; Poenitzsch Strong, AM; TeSlaa, JJ; Grinblat, Y; Setaluri, V; Spiegelman, VS				Goswami, Srikanta; Tarapore, Rohinton S.; Poenitzsch Strong, Ashley M.; TeSlaa, Jessica J.; Grinblat, Yevgenya; Setaluri, Vijayasaradhi; Spiegelman, Vladimir S.			MicroRNA-340-mediated Degradation of Microphthalmia-associated Transcription Factor (MITF) mRNA Is Inhibited by Coding Region Determinant-binding Protein (CRD-BP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Melanogenesis; Melanoma; MicroRNA (miRNA); mRNA; mRNA Decay; Ribonuclear Protein (RNP); MITF; CRD-BP; IGF2BP1; Melanoma; miRNA; Alternative Cleavage and Polyadenylation	MELANOMA-CELL LINES; MASTER REGULATOR; EXPRESSION; MELANOCYTES; FAMILY; GENE; PROLIFERATION; TRANSLATION; ACTIVATION; BETA-TRCP1	Background: MITF is paramount for melanocyte development and melanoma pathogenesis. Results: CRD-BP restricts the action of miR-340 by preventing its access to the mRNA of MITF, thereby establishing a novel mode for the regulation of MITF. Conclusion: Regulation of MITF by CRD-BP contributes to the effects of CRD-BP on melanoma survival and progression. Significance: CRD-BP is a potential target for the prevention and treatment of melanoma. Alternative cleavage and polyadenylation generates multiple transcript variants producing mRNA isoforms with different length 3-UTRs. Alternative cleavage and polyadenylation enables differential post-transcriptional regulation via the availability of different cis-acting elements in 3-UTRs. Microphthalmia-associated transcription factor (MITF) is a master regulator of melanocyte development and melanogenesis. This central transcription factor is also implicated in melanoma development. Here, we show that melanoma cells favor the expression of MITF mRNA with a shorter 3-UTR. We also establish that this isoform is regulated by a micro RNA (miRNA/miR), miR-340. miR-340 interacts with two of its target sites on the MITF 3-UTR, causing mRNA degradation as well as decreased expression and activity of MITF. Conversely, the RNA-binding protein, coding region determinant-binding protein, was shown to be highly expressed in melanoma, directly binds to the 3-UTR of MITF mRNA, and prevents the binding of miR-340 to its target sites, resulting in the stabilization of MITF transcripts, elevated expression, and transcriptional activity of MITF. This regulatory interplay between RNA-binding protein and miRNA highlights an important mechanism for the regulation of MITF in melanocytes and malignant melanomas.	[Goswami, Srikanta; Tarapore, Rohinton S.; Poenitzsch Strong, Ashley M.; Setaluri, Vijayasaradhi; Spiegelman, Vladimir S.] Univ Wisconsin, Dept Dermatol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Goswami, Srikanta; Tarapore, Rohinton S.; Poenitzsch Strong, Ashley M.; Setaluri, Vijayasaradhi; Spiegelman, Vladimir S.] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Tarapore, Rohinton S.; Poenitzsch Strong, Ashley M.; Grinblat, Yevgenya; Spiegelman, Vladimir S.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Sch Med & Publ Hlth, Madison, WI 53706 USA; [TeSlaa, Jessica J.] Univ Wisconsin, Dept Zool, Sch Med & Publ Hlth, Madison, WI 53706 USA; [TeSlaa, Jessica J.] Univ Wisconsin, Dept Anat, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Spiegelman, VS (corresponding author), Univ Wisconsin, Dept Dermatol, Sch Med & Publ Hlth, 1300 Univ Ave,MSC 417, Madison, WI 53706 USA.	spiegelman@dermatology.wisc.edu		Spiegelman, Vladimir S/0000-0003-4847-155X	National Institutes of Health, NCI [AR063361, CA191550, CA121851, CA12509]; National Institutes of Health [GM076244]; NATIONAL CANCER INSTITUTE [R01CA121851, R21CA191550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076244] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants AR063361, CA191550, and CA121851 (to V. S. S.) and CA12509 (to V. S.) and National Institutes of Health Grant GM076244 (to Y. G.).	Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Craig EA, 2012, J CELL SCI, V125, P5950, DOI 10.1242/jcs.115204; Craig EA, 2012, PIGM CELL MELANOMA R, V25, P83, DOI 10.1111/j.1755-148X.2011.00921.x; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dorsky RI, 2000, GENE DEV, V14, P158; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Elcheva I, 2008, ONCOGENE, V27, P5069, DOI 10.1038/onc.2008.141; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Fang D, 2002, NUCLEIC ACIDS RES, V30, P3096, DOI 10.1093/nar/gkf424; Hallsson JH, 2004, GENETICS, V167, P233, DOI 10.1534/genetics.167.1.233; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Kawakami Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1811, DOI 10.1271/bbb.90185; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Khaled M, 2002, J BIOL CHEM, V277, P33690, DOI 10.1074/jbc.M202939200; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McGill GG, 2006, J BIOL CHEM, V281, P10365, DOI 10.1074/jbc.M513094200; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Munro TP, 2006, J CELL BIOL, V172, P577, DOI 10.1083/jcb.200510044; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Saito H, 2003, PIGM CELL RES, V16, P261, DOI 10.1034/j.1600-0749.2003.00039.x; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; Strong AMP, 2014, ARCH BIOCHEM BIOPHYS, V563, P118, DOI 10.1016/j.abb.2014.07.012; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Watanabe A, 1998, NAT GENET, V18, P283, DOI 10.1038/ng0398-283; Wu M, 2000, GENE DEV, V14, P301; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; Yasumoto K, 1997, J BIOL CHEM, V272, P503; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058	51	41	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					384	395		10.1074/jbc.M114.590158	http://dx.doi.org/10.1074/jbc.M114.590158			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25414259	Green Published, hybrid			2022-12-28	WOS:000347231200034
J	Rossi, G; Watson, K; Demonch, M; Temple, B; Brennwald, P				Rossi, Guendalina; Watson, Kelly; Demonch, Mallory; Temple, Brenda; Brennwald, Patrick			In Vitro Reconstitution of Rab GTPase-dependent Vesicle Clustering by the Yeast Lethal Giant Larvae/Tomosyn Homolog, Sro7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Exocytosis; Membrane Reconstitution; Rab; Trafficking; Vesicles	GDP DISSOCIATION INHIBITOR; POST-GOLGI VESICLES; SECRETORY PATHWAY; PLASMA-MEMBRANE; BINDING-PROTEIN; SEC15 PROTEIN; EXOCYTOSIS; FAMILY; SNARE; COMPONENT	Background: The mechanism by which Rab GTPases and their effectors act in tethering is not well understood. Results: An in vitro assay was developed to study vesicle clustering by the Lgl family member Sro7. Conclusion: Clustering in vitro and in vivo depends on the conformation of the Rab GTPase and Sro7. Significance: This assay provides a new tool to dissect the role of Rab and Lgl family function. Intracellular traffic in yeast between the Golgi and the cell surface is mediated by vesicular carriers that tether and fuse in a fashion that depends on the function of the Rab GTPase, Sec4. Overexpression of either of two Sec4 effectors, Sro7 or Sec15, results in the formation of a cluster of post-Golgi vesicles within the cell. Here, we describe a novel assay that recapitulates post-Golgi vesicle clustering in vitro utilizing purified Sro7 and vesicles isolated from late secretory mutants. We show clustering in vitro closely replicates the in vivo clustering process as it is highly dependent on both Sro7 and GTP-Sec4. We also make use of this assay to characterize a novel mutant form of Sro7 that results in a protein that is specifically defective in vesicle clustering both in vivo and in vitro. We show that this mutation acts by effecting a conformational change in Sro7 from the closed to a more open structure. Our analysis demonstrates that the N-terminal propeller needs to be able to engage the C-terminal tail for vesicle clustering to occur. Consistent with this, we show that occupancy of the N terminus of Sro7 by the t-SNARE Sec9, which results in the open conformation of Sro7, also acts to inhibit vesicle cluster formation by Sro7. This suggests a model by which a conformational switch in Sro7 acts to coordinate Rab-mediated vesicle tethering with SNARE assembly by requiring a single conformational state for both of these processes to occur.	[Rossi, Guendalina; Watson, Kelly; Demonch, Mallory; Brennwald, Patrick] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Temple, Brenda] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Brennwald, P (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, 522 Taylor Hall, Chapel Hill, NC 27599 USA.	pjbrennw@med.unc.edu			National Institutes of Health [GM-054712]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-054712.	Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; BOWSER R, 1991, J CELL BIOL, V112, P1117, DOI 10.1083/jcb.112.6.1117; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Forsmark A, 2011, TRAFFIC, V12, P740, DOI 10.1111/j.1600-0854.2011.01186.x; Gangar A, 2005, CURR BIOL, V15, P1136, DOI 10.1016/j.cub.2005.05.046; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; Grosshans BL, 2006, J CELL BIOL, V172, P55, DOI 10.1083/jcb.200510016; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Jantti J, 2002, J CELL SCI, V115, P409; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Lipatova Z, 2008, MOL BIOL CELL, V19, P4177, DOI 10.1091/mbc.E08-02-0220; Lo SY, 2012, NAT STRUCT MOL BIOL, V19, P40, DOI 10.1038/nsmb.2162; Mulholland J, 1997, MOL BIOL CELL, V8, P1481, DOI 10.1091/mbc.8.8.1481; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Rossi G, 2011, MOL BIOL CELL, V22, P842, DOI 10.1091/mbc.E10-07-0570; SALMINEN A, 1989, J CELL BIOL, V109, P1023, DOI 10.1083/jcb.109.3.1023; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; WALWORTH NC, 1987, J CELL BIOL, V105, P163, DOI 10.1083/jcb.105.1.163; Zhang XY, 2005, J CELL BIOL, V170, P273, DOI 10.1083/jcb.200502055	24	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					612	624		10.1074/jbc.M114.595892	http://dx.doi.org/10.1074/jbc.M114.595892			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25404740	Green Published, hybrid			2022-12-28	WOS:000347231200053
J	Smrt, ST; Draney, AW; Lorieau, JL				Smrt, Sean T.; Draney, Adrian W.; Lorieau, Justin L.			The Influenza Hemagglutinin Fusion Domain Is an Amphipathic Helical Hairpin That Functions by Inducing Membrane Curvature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Influenza; Membrane Fusion; Membrane Protein; Nuclear Magnetic Resonance (NMR); Structural Biology; Fusion Peptide	MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; VIRUS HEMAGGLUTININ; PHASE-TRANSITIONS; DIPOLAR COUPLINGS; NEGATIVE-CURVATURE; BACKBONE DYNAMICS; PEPTIDE ANALOGS; SIALIC-ACID; BILAYER	Background: The influenza hemagglutinin fusion peptide is responsible for fusion of viral and endosomal membranes upon infection. Results: Negatively induced curvature and fusion activity were significantly reduced by changing the shape of the fusion peptide. Conclusion: The hemagglutinin fusion peptide structure promotes negative membrane curvature. Significance: This work enables elucidates how a crucial component of influenza infection functions and can be targeted. The highly conserved N-terminal 23 residues of the hemagglutinin glycoprotein, known as the fusion peptide domain (HAfp23), is vital to the membrane fusion and infection mechanism of the influenza virus. HAfp23 has a helical hairpin structure consisting of two tightly packed amphiphilic helices that rest on the membrane surface. We demonstrate that HAfp23 is a new class of amphipathic helix that functions by leveraging the negative curvature induced by two tightly packed helices on membranes. The helical hairpin structure has an inverted wedge shape characteristic of negative curvature lipids, with a bulky hydrophobic region and a relatively small hydrophilic head region. The F3G mutation reduces this inverted wedge shape by reducing the volume of its hydrophobic base. We show that despite maintaining identical backbone structures and dynamics as the wild type HAfp23, the F3G mutant has an attenuated fusion activity that is correlated to its reduced ability to induce negative membrane curvature. The inverted wedge shape of HAfp23 is likely to play a crucial role in the initial stages of membrane fusion by stabilizing negative curvature in the fusion stalk.	[Smrt, Sean T.; Draney, Adrian W.; Lorieau, Justin L.] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lorieau, JL (corresponding author), Univ Illinois, Dept Chem, 845 W Taylor St,4500SES, Chicago, IL 60607 USA.	Justin@lorieau.com		Draney, Adrian/0000-0002-2247-4667	Department of Chemistry at the University of Illinois at Chicago (UIC); UIC Campus Research Board grant	Department of Chemistry at the University of Illinois at Chicago (UIC); UIC Campus Research Board grant	This work was supported by the Department of Chemistry at the University of Illinois at Chicago (UIC) and a UIC Campus Research Board grant. Portions of this work were carried out in the Center for Structural Biology via the Research Resources Center at UIC.	[Anonymous], 2006, Wkly Epidemiol Rec, V81, P249; Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303; Best RB, 2006, STRUCTURE, V14, P97, DOI 10.1016/j.str.2005.09.012; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; Chernomordik L, 1996, CHEM PHYS LIPIDS, V81, P203, DOI 10.1016/0009-3084(96)02583-2; CHERNOMORDIK L, 1995, BIOPHYS J, V69, P922, DOI 10.1016/S0006-3495(95)79966-0; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; CHERNOMORDIK LV, 1985, BIOCHIM BIOPHYS ACTA, V812, P643, DOI 10.1016/0005-2736(85)90257-3; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; Clancy S, 2008, NAT ED, V1, P1, DOI DOI https://doi.org/10.1038/nrm2351.pdf; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cross KJ, 2009, PROTEIN PEPTIDE LETT, V16, P766, DOI 10.2174/092986609788681715; Cross KJ, 2001, EMBO J, V20, P4432, DOI 10.1093/emboj/20.16.4432; Davies SMA, 1998, BIOCHEMISTRY-US, V37, P5720, DOI 10.1021/bi980227v; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Donald JE, 2011, P NATL ACAD SCI USA, V108, P3958, DOI 10.1073/pnas.1019668108; Draney AW, 2014, LANGMUIR, V30, P11723, DOI 10.1021/la5030668; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Dubovskii PV, 2000, PROTEIN SCI, V9, P786; Durrer P, 1996, J BIOL CHEM, V271, P13417, DOI 10.1074/jbc.271.23.13417; ELLENS H, 1989, BIOCHEMISTRY-US, V28, P3692, DOI 10.1021/bi00435a011; EPAND RF, 1994, BIOCHEM BIOPH RES CO, V205, P1938, DOI 10.1006/bbrc.1994.2897; EPAND RM, 1990, CHEM PHYS LIPIDS, V52, P227, DOI 10.1016/0009-3084(90)90118-B; EPAND RM, 1991, CHEM PHYS LIPIDS, V57, P75, DOI 10.1016/0009-3084(91)90051-C; EPAND RM, 1995, BIOPOLYMERS, V37, P319, DOI 10.1002/bip.360370504; EPAND RM, 1985, BIOCHEMISTRY-US, V24, P7092, DOI 10.1021/bi00346a011; EPAND RM, 1994, BIOCHEM BIOPH RES CO, V202, P1420, DOI 10.1006/bbrc.1994.2089; Epand RM, 2001, BIOCHEMISTRY-US, V40, P8800, DOI 10.1021/bi0107187; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fitzkee NC, 2011, PROTEIN SCI, V20, P500, DOI 10.1002/pro.582; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fuhrmans M, 2012, J AM CHEM SOC, V134, P1543, DOI 10.1021/ja207290b; GARTEN W, 1983, J GEN VIROL, V64, P2127, DOI 10.1099/0022-1317-64-10-2127; Goddard TD, 2008, SPARKY VERSION 3; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Hallock KJ, 2003, BIOPHYS J, V84, P3052, DOI 10.1016/S0006-3495(03)70031-9; Hallock KJ, 2002, BIOPHYS J, V83, P1004, DOI 10.1016/S0006-3495(02)75226-0; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Haque ME, 2004, BIOCHEMISTRY-US, V43, P3507, DOI 10.1021/bi035794j; HAY AJ, 1974, VIROLOGY, V60, P398, DOI 10.1016/0042-6822(74)90335-3; Jordanova A, 2003, EUR BIOPHYS J BIOPHY, V31, P626, DOI 10.1007/s00249-002-0263-x; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; Koenig BW, 2003, J BIOMOL NMR, V26, P193, DOI 10.1023/A:1023887412387; KOYNOVA R, 1994, CHEM PHYS LIPIDS, V69, P1, DOI 10.1016/0009-3084(94)90024-8; KOZLOV MM, 1989, EUR BIOPHYS J BIOPHY, V17, P121; Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200; Lai AL, 2007, J BIOL CHEM, V282, P23946, DOI 10.1074/jbc.M704008200; Larsson P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002950; LEAR JD, 1987, J BIOL CHEM, V262, P6500; Leikin S, 1996, BIOPHYS J, V71, P2623, DOI 10.1016/S0006-3495(96)79454-7; Li YL, 2005, J VIROL, V79, P12065, DOI 10.1128/JVI.79.18.12065-12076.2005; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lorieau JL, 2013, BIOPOLYMERS, V99, P189, DOI 10.1002/bip.22102; Lorieau JL, 2012, P NATL ACAD SCI USA, V109, P19994, DOI 10.1073/pnas.1213801109; Lorieau JL, 2011, J AM CHEM SOC, V133, P14184, DOI 10.1021/ja2045309; Lorieau JL, 2011, J AM CHEM SOC, V133, P2824, DOI 10.1021/ja1099775; Lorieau JL, 2010, P NATL ACAD SCI USA, V107, P11341, DOI 10.1073/pnas.1006142107; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Markin VS, 2002, BIOPHYS J, V82, P693, DOI 10.1016/S0006-3495(02)75432-5; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Ottiger M, 1999, J BIOMOL NMR, V13, P187, DOI 10.1023/A:1008395916985; Pomorski TG, 2014, ADV COLLOID INTERFAC, V205, P207, DOI 10.1016/j.cis.2013.10.028; Qiang W, 2009, P NATL ACAD SCI USA, V106, P15314, DOI 10.1073/pnas.0907360106; Risselada HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038302; SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Schmick SD, 2010, BIOCHEMISTRY-US, V49, P10623, DOI 10.1021/bi101389r; Siegel DP, 2000, BBA-BIOMEMBRANES, V1468, P87, DOI 10.1016/S0005-2736(00)00246-7; SIEGEL DP, 1993, BIOPHYS J, V65, P2124, DOI 10.1016/S0006-3495(93)81256-6; Siegel DP, 1997, BIOPHYS J, V73, P3089, DOI 10.1016/S0006-3495(97)78336-X; SKEHEL JJ, 1978, J GEN VIROL, V39, P1, DOI 10.1099/0022-1317-39-1-1; Smith PES, 2009, J AM CHEM SOC, V131, P4470, DOI 10.1021/ja809002a; STEGMANN T, 1986, J BIOL CHEM, V261, P966; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Tenchov BG, 2008, BBA-BIOMEMBRANES, V1778, P2405, DOI 10.1016/j.bbamem.2008.07.022; Tenchov BG, 2013, BIOPHYS J, V104, P1029, DOI 10.1016/j.bpj.2012.12.034; TYTLER EM, 1993, J BIOL CHEM, V268, P22112; WHARTON SA, 1988, J GEN VIROL, V69, P1847, DOI 10.1099/0022-1317-69-8-1847; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354; Yao HW, 2014, J AM CHEM SOC, V136, P2611, DOI 10.1021/ja4121956; Zhang Y.Z., 1995, THESIS U PENNSYLVANI; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	87	28	28	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					228	238		10.1074/jbc.M114.611657	http://dx.doi.org/10.1074/jbc.M114.611657			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25398882	Green Published, hybrid			2022-12-28	WOS:000347231200019
J	Choi, YJ; Lai, WS; Fedic, R; Stumpo, DJ; Huang, WC; Li, LP; Perera, L; Brewer, BY; Wilson, GM; Mason, JM; Blackshear, PJ				Choi, Youn-Jeong; Lai, Wi S.; Fedic, Robert; Stumpo, Deborah J.; Huang, Weichun; Li, Leping; Perera, Lalith; Brewer, Brandy Y.; Wilson, Gerald M.; Mason, James M.; Blackshear, Perry J.			The Drosophila Tis11 Protein and Its Effects on mRNA Expression in Flies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; mRNA Decay; Post-transcriptional Regulation; RNA-binding Protein; Zinc Finger; AU-rich Elements; Deadenylation	ZINC-FINGER PROTEINS; AU-RICH ELEMENT; TRISTETRAPROLIN FAMILY; SCHIZOSACCHAROMYCES-POMBE; GENE-EXPRESSION; FORCE-FIELD; BINDING; DEGRADATION; DEADENYLATION; STABILITY	Members of the mammalian tristetraprolin family of CCCH tandem zinc finger proteins can bind to certain AU-rich elements (AREs) in mRNAs, leading to their deadenylation and destabilization. Mammals express three or four members of this family, but Drosophila melanogaster and other insects appear to contain a single gene, Tis11. We found that recombinant Drosophila Tis11 protein could bind to ARE-containing RNA oligonucleotides with low nanomolar affinity. Remarkably, co-expression in mammalian cells with target RNAs demonstrated that Tis11 could promote destabilization of ARE-containing mRNAs and that this was partially dependent on a conserved C-terminal sequence resembling the mammalian NOT1 binding domain. Drosophila Tis11 promoted both deadenylation and decay of a target transcript in this heterologous cell system. We used chromosome deletion/duplication and P element insertion to produce two types of Tis11 deficiency in adult flies, both of which were viable and fertile. To address the hypothesis that Tis11 deficiency would lead to the abnormal accumulation of potential target transcripts, we analyzed gene expression in adult flies by deep mRNA sequencing. We identified 69 transcripts from 56 genes that were significantly up-regulated more than 1.5-fold in both types of Tis11-deficient flies. Ten of the up-regulated transcripts encoded probable proteases, but many other functional classes of proteins were represented. Many of the up-regulated transcripts contained potential binding sites for tristetraprolin family member proteins that were conserved in other Drosophila species. Tis11 is thus an ARE-binding, mRNA-destabilizing protein that may play a role in post-transcriptional gene expression in Drosophila and other insects.	[Choi, Youn-Jeong; Lai, Wi S.; Stumpo, Deborah J.; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Fedic, Robert; Mason, James M.] NIEHS, Lab Mol Genet, NIH, Res Triangle Pk, NC 27709 USA; [Huang, Weichun; Li, Leping] NIEHS, Lab Biostat, NIH, Res Triangle Pk, NC 27709 USA; [Perera, Lalith] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Brewer, Brandy Y.; Wilson, Gerald M.] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University System of Maryland; University of Maryland Baltimore; Duke University; Duke University	Blackshear, PJ (corresponding author), NIEHS, NIH, 111 Alexander Dr,F1-13, Res Triangle Pk, NC 27709 USA.	black009@niehs.nih.gov	perera, Lalith/B-6879-2012; Perera, Lalith/ABB-9995-2021; Wilson, Gerald/AAF-3874-2019; Li, Leping/F-6497-2019; Blackshear, Perry J./C-6206-2019	perera, Lalith/0000-0003-0823-1631; Li, Leping/0000-0003-4208-0259; Blackshear, Perry J./0000-0002-9561-8529; Wilson, Gerald/0000-0002-1273-7507	National Institutes of Health (NIH), NIEHS, Intramural Research Program; NIH [R01 CA102428]; Oliver Smithies Visiting Professorship at Balliol College, Oxford; NATIONAL CANCER INSTITUTE [R01CA102428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZICES043010, ZIAES101765, ZIAES090080] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIEHS, Intramural Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oliver Smithies Visiting Professorship at Balliol College, Oxford; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health (NIH), NIEHS, Intramural Research Program and by NIH Grant R01 CA102428 (to G. M. W.). This work was also supported by an Oliver Smithies Visiting Professorship at Balliol College, Oxford (to P. J. B.).	Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Blackshear PJ, 2014, J INTERF CYTOK RES, V34, P297, DOI 10.1089/jir.2013.0150; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Cairrao F, 2009, MOL CELL BIOL, V29, P2636, DOI 10.1128/MCB.01506-08; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen HH, 2007, BIOCHEM BIOPH RES CO, V357, P56, DOI 10.1016/j.bbrc.2007.03.113; Chen HX, 2004, FEBS LETT, V561, P181, DOI 10.1016/S0014-5793(04)00161-9; Ciais D, 2013, CELL MOL LIFE SCI, V70, P2031, DOI 10.1007/s00018-012-1150-y; Cuthbertson BJ, 2008, J BIOL CHEM, V283, P2586, DOI 10.1074/jbc.M707154200; De J, 1999, GENE, V228, P133, DOI 10.1016/S0378-1119(98)00617-9; Dorner S, 2006, P NATL ACAD SCI USA, V103, P11880, DOI 10.1073/pnas.0605210103; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Elgin SCR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017780; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian MR, 2013, NAT STRUCT MOL BIOL, V20, P735, DOI 10.1038/nsmb.2572; Fortina P, 2008, NAT BIOTECHNOL, V26, P293, DOI 10.1038/nbt0308-293; Frederick ED, 2008, J BIOL CHEM, V283, P14792, DOI 10.1074/jbc.M801234200; Huang WC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr592; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAMESON DM, 1995, METHOD ENZYMOL, V246, P283; Kedar VP, 2012, J BIOL CHEM, V287, P5459, DOI 10.1074/jbc.M111.312652; Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2013, AM J PHYSIOL-REG I, V305, pR689, DOI 10.1152/ajpregu.00310.2013; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1998, J BIOL CHEM, V273, P506, DOI 10.1074/jbc.273.1.506; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lauwers A, 2009, J BIOL CHEM, V284, P8973, DOI 10.1074/jbc.M806778200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MA QF, 1994, ONCOGENE, V9, P3329; NAKANISHI Y, 1986, GENE, V46, P79; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; RAHA D, 1990, DEV GENET, V11, P310, DOI 10.1002/dvg.1020110410; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Soller M, 2005, MOL CELL BIOL, V25, P7580, DOI 10.1128/MCB.25.17.7580-7591.2005; Spasic M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002433; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4; Toba G, 2002, J CELL SCI, V115, P2413; Twyffels L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071686; Wei YH, 2009, NUCLEIC ACIDS RES, V37, P6550, DOI 10.1093/nar/gkp693; Wells ML, 2012, MOL CELL BIOL, V32, P4206, DOI 10.1128/MCB.00325-12; WILSON GM, 2005, REV FLUORESC, P223; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200; Yeh PA, 2012, INT J BIOL SCI, V8, P606, DOI 10.7150/ijbs.3782	60	16	16	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35042	35060		10.1074/jbc.M114.593491	http://dx.doi.org/10.1074/jbc.M114.593491			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25342740	Green Published, hybrid			2022-12-28	WOS:000346660200001
J	Klop, B; van der Pol, P; van Bruggen, R; Wang, YA; de Vries, MA; van Santen, S; O'Flynn, J; van de Geijn, GJM; Njo, TL; Janssen, HW; de Man, P; Jukema, JW; Rabelink, TJ; Rensen, PCN; van Kooten, C; Cabezas, MC				Klop, Boudewijn; van der Pol, Pieter; van Bruggen, Robin; Wang, Yanan; de Vries, Marijke A.; van Santen, Selvetta; O'Flynn, Joseph; van de Geijn, Gert-Jan M.; Njo, Tjin L.; Janssen, Hans W.; de Man, Peter; Jukema, J. Wouter; Rabelink, Ton J.; Rensen, Patrick C. N.; van Kooten, Cees; Cabezas, Manuel Castro			Differential Complement Activation Pathways Promote C3b Deposition on Native and Acetylated LDL thereby Inducing Lipoprotein Binding to the Complement Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Complement; Erythrocyte; Leukocyte; Lipoprotein; Low-density Lipoprotein (LDL); C3b; CR1; Complement Activation; Receptor	RED-BLOOD-CELLS; LECTIN PATHWAY; IMMUNOLOGY; CLEARANCE; CR-1; C1Q	Lipoproteins can induce complement activation resulting in opsonization and binding of these complexes to complement receptors. We investigated the binding of opsonized native LDL and acetylated LDL (acLDL) to the complement receptor 1 (CR1). Binding of complement factors C3b, IgM, C1q, mannose-binding lectin (MBL), and properdin to LDL and acLDL were investigated by ELISA. Subsequent binding of opsonized LDL and acLDL to CR1 on CR1-transfected Chinese Hamster Ovarian cells (CHO-CR1) was tested by flow cytometry. Both native LDL and acLDL induced complement activation with subsequent C3b opsonization upon incubation with normal human serum. Opsonized LDL and acLDL bound to CR1. Binding to CHO-CR1 was reduced by EDTA, whereas MgEGTA only reduced the binding of opsonized LDL, but not of acLDL suggesting involvement of the alternative pathway in the binding of acLDL to CR1. In vitro incubations showed that LDL bound C1q, whereas acLDL bound to C1q, IgM, and properdin. MBL did neither bind to LDL nor to acLDL. The relevance of these findings was demonstrated by the fact that ex vivo up-regulation of CR1 on leukocytes was accompanied by a concomitant increased binding of apolipoprotein B-containing lipoproteins to leukocytes without changes in LDL-receptor expression. In conclusion, CR1 is able to bind opsonized native LDL and acLDL. Binding of LDL to CR1 is mediated via the classical pathway, whereas binding of acLDL is mediated via both the classical and alternative pathways. Binding of lipoproteins to CR1 may be of clinical relevance due to the ubiquitous cellular distribution of CR1.	[Klop, Boudewijn; de Vries, Marijke A.; van Santen, Selvetta] St Franciscus Gasthuis, Dept Internal Med, Diabet & Vasc Ctr, NL-3004 BA Rotterdam, Netherlands; [van de Geijn, Gert-Jan M.; Njo, Tjin L.; Janssen, Hans W.] St Franciscus Gasthuis, Dept Clin Chem, NL-3004 BA Rotterdam, Netherlands; [de Man, Peter] St Franciscus Gasthuis, Dept Med Microbiol, NL-3004 BA Rotterdam, Netherlands; [van der Pol, Pieter; O'Flynn, Joseph; Rabelink, Ton J.; van Kooten, Cees] Leiden Univ, Med Ctr, Dept Nephrol, NL-1006 AN Leiden, Netherlands; [Wang, Yanan; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-1006 AN Leiden, Netherlands; [Wang, Yanan; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, NL-1006 AN Leiden, Netherlands; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, NL-1006 AN Leiden, Netherlands; [van Bruggen, Robin] Sanquin Res, NL-1006 AN Amsterdam, Netherlands	Franciscus Gasthuis; Franciscus Gasthuis; Franciscus Gasthuis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Cabezas, MC (corresponding author), Sint Franciscus Gasthuis Rotterdam, Dept Internal Med, Ctr Diabet & Vasc Med, POB 10900, NL-3004 BA Rotterdam, Netherlands.	m.castrocabezas@sfg.nl	van Kooten, Cees/E-5694-2018; Wang, Yanan/C-4143-2019; Rabelink, Ton J./A-5316-2008; Jukema, J. Wouter/ABD-6503-2021; Rensen, Patrick C.N./D-7176-2018	van Kooten, Cees/0000-0002-6257-0899; Wang, Yanan/0000-0002-0327-0458; Rabelink, Ton J./0000-0001-6780-5186; Jukema, J. Wouter/0000-0002-3246-8359; Rensen, Patrick C.N./0000-0002-8455-4988				Alipour A, 2009, ATHEROSCLEROSIS, V206, P444, DOI 10.1016/j.atherosclerosis.2009.03.007; Alipour A, 2008, ARTERIOSCL THROM VAS, V28, P792, DOI 10.1161/ATVBAHA.107.159749; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Biro A, 2007, MOL IMMUNOL, V44, P1169, DOI 10.1016/j.molimm.2006.06.013; Bovenberg SA, 2010, ATHEROSCLEROSIS SUPP, V11, P25, DOI 10.1016/j.atherosclerosissup.2010.04.003; Bovenberg SA, 2012, EUR J CLIN INVEST, V42, P365, DOI 10.1111/j.1365-2362.2011.02591.x; CORNACOFF JB, 1983, J CLIN INVEST, V71, P236, DOI 10.1172/JCI110764; Ebrahimi KB, 2013, J PATHOL, V229, P729, DOI 10.1002/path.4128; Faro J, 2008, CLIN EXP IMMUNOL, V151, P275, DOI 10.1111/j.1365-2249.2007.03538.x; FEARON DT, 1983, ANNU REV IMMUNOL, V1, P243, DOI 10.1146/annurev.iy.01.040183.001331; FEARON DT, 1979, P NATL ACAD SCI USA, V76, P5867, DOI 10.1073/pnas.76.11.5867; Fraser DA, 2010, J IMMUNOL, V185, P3932, DOI 10.4049/jimmunol.1002080; Gaarkeuken H, 2008, AM J PHYSIOL-RENAL, V295, pF1397, DOI 10.1152/ajprenal.90313.2008; Gauvreau D, 2012, MOL IMMUNOL, V51, P73, DOI 10.1016/j.molimm.2012.02.110; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Hinderling PH, 1997, PHARMACOL REV, V49, P279; Hung KT, 2012, ARTERIOSCL THROM VAS, V32, P1460, DOI 10.1161/ATVBAHA.112.248971; Klop B, 2013, INT J LAB HEMATOL, V35, P644, DOI 10.1111/ijlh.12103; Klop B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075573; Kojima M, 2003, ADV EXP MED BIOL, V535, P229; Langeggen H, 2002, INFLAMMATION, V26, P103, DOI 10.1023/A:1015585530204; MAKRIDES SC, 1992, J BIOL CHEM, V267, P24754; Mitra S, 2011, CARDIOVASC DRUG THER, V25, P419, DOI 10.1007/s10557-011-6341-5; Nauta AJ, 2002, EUR J IMMUNOL, V32, P1726, DOI 10.1002/1521-4141(200206)32:6<1726::AID-IMMU1726>3.0.CO;2-R; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; Nickells M, 1998, CLIN EXP IMMUNOL, V112, P27; Oksjoki R, 2003, CURR OPIN LIPIDOL, V14, P477, DOI 10.1097/00041433-200310000-00008; QUADRI RA, 1992, SCAND J IMMUNOL, V36, P125, DOI 10.1111/j.1365-3083.1992.tb02948.x; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roos A, 2003, MOL IMMUNOL, V39, P655, DOI 10.1016/S0161-5890(02)00254-7; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; van Oostrom AJHHM, 2007, ATHEROSCLEROSIS, V190, P167, DOI 10.1016/j.atherosclerosis.2006.01.009; VANBERKEL TJC, 1982, BIOCHEM J, V208, P493, DOI 10.1042/bj2080493; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WAXMAN FJ, 1984, J CLIN INVEST, V74, P1329, DOI 10.1172/JCI111543; WILSON JG, 1982, NEW ENGL J MED, V307, P981, DOI 10.1056/NEJM198210143071604; Ye Q, 2014, INFLAMMATION, V37, P555, DOI 10.1007/s10753-013-9769-x	39	16	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35421	35430		10.1074/jbc.M114.573840	http://dx.doi.org/10.1074/jbc.M114.573840			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	25349208	hybrid, Green Published			2022-12-28	WOS:000346660200032
J	Goel, S; Muthusamy, A; Miao, J; Cui, LW; Salanti, A; Winzeler, EA; Gowda, DC				Goel, Suchi; Muthusamy, Arivalagan; Miao, Jun; Cui, Liwang; Salanti, Ali; Winzeler, Elizabeth A.; Gowda, D. Channe			Targeted Disruption of a Ring-infected Erythrocyte Surface Antigen (RESA)-like Export Protein Gene in Plasmodium falciparum Confers Stable Chondroitin 4-Sulfate Cytoadherence Capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Cell Surface Protein; Chondroitin Sulfate; Glycosaminoglycan; Malaria; Parasite; Plasmodium	MUTUALLY EXCLUSIVE EXPRESSION; MALARIA PARASITE; SULFATE PROTEOGLYCANS; MEMBRANE PROTEIN-1; VIRULENCE GENES; HUMAN PLACENTA; ADHERENCE; VAR2CSA; BINDING; PFEMP1	Background: Factors that influence the cytoadherence property of P. falciparum are not completely understood. Results: Targeted disruption of the gene that encodes a RESA-like protein in P. falciparum results in stable and increased chondroitin 4-sulfate-dependent cytoadherence capacity. Conclusion: A RESA-like protein gene regulates PfEMP1 expression and cytoadherence of P. falciparum. Significance: Our findings provide a significant insight into the regulation of P. falciparum cytoadherence. The Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) family proteins mediate the adherence of infected erythrocytes to microvascular endothelia of various organs, including the placenta, thereby contributing to cerebral, placental, and other severe malaria pathogenesis. Several parasite proteins, including KAHRP and PfEMP3, play important roles in the cytoadherence by mediating the clustering of PfEMP1 in rigid knoblike structures on the infected erythrocyte surface. The lack of a subtelomeric region of chromosome 2 that contains kahrp and pfemp3 causes reduced cytoadherence. In this study, microarray transcriptome analysis showed that the absence of a gene cluster, comprising kahrp, pfemp3, and four other genes, results in the loss of parasitized erythrocytes adhering to chondroitin 4-sulfate (C4S). The role of one of these genes, PF3D7_0201600/PFB0080c, which encodes PHISTb (Plasmodium helical interspersed subtelomeric b) domain-containing RESA-like protein 1 expressed on the infected erythrocyte surface, was investigated. Disruption of PFB0080c resulted in increased var2csa transcription and VAR2CSA surface expression, leading to higher C4S-binding capacity of infected erythrocytes. Further, PFB0080c-knock-out parasites stably maintained the C4S adherence through many generations of growth. Although the majority of PFB0080c-knock-out parasites bound to C4S even after culturing for 6 months, a minor population bound to both C4S and CD36. These results strongly suggest that the loss of PFB0080c markedly compromises the var gene switching process, leading to a marked reduction in the switching rate and additional PfEMP1 expression by a minor population of parasites. PFB0080c interacts with VAR2CSA and modulates knob-associated Hsp40 expression. Thus, PFB0080c may regulate VAR2CSA expression through these processes. Overall, we conclude that PFB0080c regulates PfEMP1 expression and the parasite's cytoadherence.	[Goel, Suchi; Muthusamy, Arivalagan; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Miao, Jun; Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Salanti, Ali] Copenhagen Univ Hosp, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, DK-2014 Copenhagen, Denmark; [Winzeler, Elizabeth A.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Copenhagen; University of California System; University of California San Diego	Goel, S (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17165 Stockholm, Sweden.	suchigoel@gmail.com; gowda@psu.edu	Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113; Gowda, Channe/0000-0002-6860-5108; MIAO, JUN/0000-0001-9374-6749; Salanti, Ali/0000-0003-2207-5575	National Institutes of Health, NIAID [R01 AI45086, R01 AI10358]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045086] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grants R01 AI45086 (to D. C. G.) and R01 AI10358 (to E. A. W.).	Acharya P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044605; Achur RN, 2008, BIOCHEMISTRY-US, V47, P12635, DOI 10.1021/bi801643m; Achur RN, 2003, J BIOL CHEM, V278, P11705, DOI 10.1074/jbc.M211015200; Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; Barfod L, 2006, INFECT IMMUN, V74, P4357, DOI 10.1128/IAI.01617-05; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Brolin KJM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r117; Cooke BM, 2002, BRIT J HAEMATOL, V117, P203, DOI 10.1046/j.1365-2141.2002.03404.x; Cowman A F, 1984, Mol Biol Med, V2, P207; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dzikowski R, 2007, EMBO REP, V8, P959, DOI 10.1038/sj.embor.7401063; Flick K, 2004, MOL BIOCHEM PARASIT, V134, P3, DOI 10.1016/j.molbiopara.2003.09.010; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Goel S, 2010, P NATL ACAD SCI USA, V107, P16643, DOI 10.1073/pnas.1002568107; Gowda ASP, 2007, J BIOL CHEM, V282, P916, DOI 10.1074/jbc.M604741200; GREENWALT DE, 1992, BLOOD, V80, P1105; Grover M, 2013, PARASITE, V20, DOI 10.1051/parasite/2012002; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Horrocks P, 2005, J CELL SCI, V118, P2507, DOI 10.1242/jcs.02381; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; Kilili GK, 2011, EUKARYOT CELL, V10, P1439, DOI 10.1128/EC.05180-11; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; LANZER M, 1994, NUCLEIC ACIDS RES, V22, P4176, DOI 10.1093/nar/22.20.4176; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Le Roch KG, 2002, AM J TROP MED HYG, V67, P233, DOI 10.4269/ajtmh.2002.67.233; Madhunapantula SV, 2007, INFECT IMMUN, V75, P4409, DOI 10.1128/IAI.00478-07; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051; Mayer C, 2012, J BIOL CHEM, V287, P7182, DOI 10.1074/jbc.M111.330779; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; Parish LA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-160; Pei XH, 2007, BLOOD, V110, P1036, DOI 10.1182/blood-2007-02-076919; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Silva MD, 2005, MOL MICROBIOL, V56, P990, DOI 10.1111/j.1365-2958.2005.04603.x; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; Waller KL, 1999, J BIOL CHEM, V274, P23808, DOI 10.1074/jbc.274.34.23808; Waller KL, 2003, BLOOD, V102, P1911, DOI 10.1182/blood-2002-11-3513; Weatherall David J, 2002, Hematology Am Soc Hematol Educ Program, P35; World Heath Organization, 2012, WORLD MAL REP 2013; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Zhang QF, 2011, CELL HOST MICROBE, V10, P451, DOI 10.1016/j.chom.2011.09.013; Zhou YY, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-3	58	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34408	34421		10.1074/jbc.M114.615393	http://dx.doi.org/10.1074/jbc.M114.615393			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25342752	Green Published, hybrid			2022-12-28	WOS:000346077600059
J	Wang, Y				Wang, Yu			RING Finger Protein 4 (RNF4) Derepresses Gene Expression from DNA Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Methylation; Protein Turnover; RING Finger Protein 4 (RNF4); Transcription; Ubiquitylation (Ubiquitination); Methyl CpG-binding Protein 2 (MeCP2)	MAMMALIAN DNA; TET PROTEINS; 5-METHYLCYTOSINE; DEMETHYLATION; 5-HYDROXYMETHYLCYTOSINE; 5-CARBOXYLCYTOSINE; IDENTIFICATION; TRANSCRIPTION; COREGULATOR; CONVERSION	Background: RNF4 is a transcription activator, yet the mechanism is unknown. Results: RNF4 mediates ubiquitination and turnover of MeCP2 and thus derepresses transcription from DNA methylation. Conclusion: RNF4 regulates transcription by creating a permissive epigenetic environment. Significance: This study lays the basis for better understanding the role of RNF4 in epigenetics and transcription. RNF4 is an E3 ubiquitin ligase originally identified as a transcription co-activator. The mechanism by which RNF4 promotes transcription remains unclear. In this study, I found that RNF4 antagonizes transcriptional repression mediated by DNA methylation. RNF4 does not promote DNA demethylation, but mediates the ubiquitination of MeCP2, a methyl-CpG-binding domain (MBD) protein. Removal of MeCP2 from gene promoters activates transcription. This study thus not only uncovers how RNF4 functions as a transcription activator, but also reveals the mechanism by which MeCP2 protein stability is regulated.	[Wang, Yu] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Wang, Yu] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Wang, Y (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, WAB 164,200 Longwood Ave, Boston, MA 02115 USA.	yu.wang@childrens.harvard.edu			American Heart Association	American Heart Association(American Heart Association)	Supported by a postdoctoral fellowship from American Heart Association. To whom correspondence should be addressed: Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, WAB-164, 200 Longwood Ave., Boston, MA 02115. E-mail: yu.wang@childrens.harvard.edu.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Fatemi M, 2006, J CELL SCI, V119, P3033, DOI 10.1242/jcs.03099; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hakli M, 2004, FEBS LETT, V560, P56, DOI 10.1016/S0014-5793(04)00070-5; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hu XYV, 2010, P NATL ACAD SCI USA, V107, P15087, DOI 10.1073/pnas.1009025107; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Moilanen AM, 1998, MOL CELL BIOL, V18, P5128, DOI 10.1128/MCB.18.9.5128; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Samaco RC, 2008, HUM MOL GENET, V17, P1718, DOI 10.1093/hmg/ddn062; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wang Y, 2014, CELL REP, V6, P278, DOI 10.1016/j.celrep.2013.12.031; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	21	9	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33808	33813		10.1074/jbc.C114.611558	http://dx.doi.org/10.1074/jbc.C114.611558			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25355316	Green Published, hybrid			2022-12-28	WOS:000346077600008
J	Karuppiah, V; Thistlethwaite, A; Dajani, R; Warwicker, J; Derrick, JP				Karuppiah, Vijaykumar; Thistlethwaite, Angela; Dajani, Rana; Warwicker, Jim; Derrick, Jeremy P.			Structure and Mechanism of the Bifunctional CinA Enzyme from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE MONONUCLEOTIDE DEAMIDASE; ASPARAGINASE-II; REFINEMENT; SUBSTRATE; SYMMETRY; REVEALS; SYSTEM; PHENIX; RECA; DNA	CinA is a widely distributed protein in Gram-positive and Gram-negative bacteria. It is associated with natural competence and is proposed to have a function as an enzyme participating in the pyridine nucleotide cycle, which recycles products formed by non-redox uses of NAD. Here we report the determination of the crystal structure of CinA from Thermus thermophilus, in complex with several ligands. CinA was shown to have both nicotinamide mononucleotide deamidase and ADP-ribose pyrophosphatase activities. The crystal structure shows an unusual asymmetric dimer, with three domains for each chain; the C-terminal domain harbors the nicotinamide mononucleotide deamidase activity, and the structure of a complex with the product nicotinate mononucleotide suggests a mechanism for deamidation. The N-terminal domain belongs to the COG1058 family and is associated with the ADP-ribose pyrophosphatase activity. The asymmetry in the CinA dimer arises from two alternative orientations of the COG1058 domains, only one of which forms a contact with the KH-type domain from the other chain, effectively closing the active site into, we propose, a catalytically competent state. Structures of complexes with Mg2+/ADP-ribose, Mg2+/ATP, and Mg2+/AMP suggest a mechanism for the ADP-ribose pyrophosphatase reaction that involves a rotation of the COG1058 domain dimer as part of the reaction cycle, so that each active site oscillates between open and closed forms, thus promoting catalysis.	[Karuppiah, Vijaykumar; Thistlethwaite, Angela; Dajani, Rana; Warwicker, Jim; Derrick, Jeremy P.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Derrick, JP (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Jeremy.Derrick@manchester.ac.uk		Derrick, Jeremy/0000-0002-4350-5354; Warwicker, Jim/0000-0002-1302-0815; Karuppiah, Vijaykumar/0000-0002-9645-7958	Wellcome Trust [093388]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grant 093388.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Averhoff B, 2009, FEMS MICROBIOL REV, V33, P611, DOI 10.1111/j.1574-6976.2008.00160.x; Brown JH, 2006, PROTEIN SCI, V15, P1, DOI 10.1110/ps.051658406; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG WL, 1995, J BACTERIOL, V177, P6711, DOI 10.1128/jb.177.23.6711-6717.1995; Cialabrini L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065595; DERST C, 1992, PROTEIN ENG, V5, P785, DOI 10.1093/protein/5.8.785; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gabelli SB, 2001, NAT STRUCT BIOL, V8, P467, DOI 10.1038/87647; Galeazzi L, 2011, J BIOL CHEM, V286, P40365, DOI 10.1074/jbc.M111.275818; Gesto DS, 2013, J AM CHEM SOC, V135, P7146, DOI 10.1021/ja310165u; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaimer C, 2010, ARCH MICROBIOL, V192, P549, DOI 10.1007/s00203-010-0583-7; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V24, P946; Mair RW, 2012, FEMS MICROBIOL LETT, V331, P44, DOI 10.1111/j.1574-6968.2012.02550.x; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; Masure HR, 1998, MOL MICROBIOL, V27, P845, DOI 10.1046/j.1365-2958.1998.00732.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Michalska K, 2006, ACTA BIOCHIM POL, V53, P627, DOI 10.18388/abp.2006_3291; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Sanchez-Carron G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082705; Seitz P, 2013, FEMS MICROBIOL REV, V37, P336, DOI 10.1111/j.1574-6976.2012.00353.x; SWAIN AL, 1993, P NATL ACAD SCI USA, V90, P1474, DOI 10.1073/pnas.90.4.1474; Swift RV, 2009, EXPERT OPIN DRUG DIS, V4, P1281, DOI 10.1517/17460440903373617; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Wakamatsu T, 2008, J BACTERIOL, V190, P1108, DOI 10.1128/JB.01522-07; Warwicker J, 2004, PROTEIN SCI, V13, P2793, DOI 10.1110/ps.04785604; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yoshiba S, 2004, J BIOL CHEM, V279, P37163, DOI 10.1074/jbc.M403817200	36	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33187	33197		10.1074/jbc.M114.608448	http://dx.doi.org/10.1074/jbc.M114.608448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25313401	Green Published, hybrid			2022-12-28	WOS:000345636600013
J	Soares, JSM; Gentile, A; Scorsato, V; Lima, AD; Kiyota, E; dos Santos, ML; Piattoni, CV; Huber, SC; Aparicio, R; Menossi, M				Soares, Jose Sergio M.; Gentile, Agustina; Scorsato, Valeria; Lima, Aline da C.; Kiyota, Eduardo; dos Santos, Marcelo Leite; Piattoni, Claudia V.; Huber, Steven C.; Aparicio, Ricardo; Menossi, Marcelo			Oligomerization, Membrane Association, and in Vivo Phosphorylation of Sugarcane UDP-glucose Pyrophosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUCROSE-PHOSPHATE SYNTHASE; BIOLOGICAL MACROMOLECULES; PROTEOMIC ANALYSIS; STRUCTURAL BASIS; GENE-EXPRESSION; PROTEIN; ACCUMULATION; SCATTERING; RESISTANCE; INVERTASE	Sugarcane is a monocot plant that accumulates sucrose to levels of up to 50% of dry weight in the stalk. The mechanisms that are involved in sucrose accumulation in sugarcane are not well understood, and little is known with regard to factors that control the extent of sucrose storage in the stalks. UDPglucose pyrophosphorylase (UGPase; EC 2.7.7.9) is an enzyme that produces UDP-glucose, a key precursor for sucrose metabolism and cell wall biosynthesis. The objective of this work was to gain insights into the ScUGPase-1 expression pattern and regulatory mechanisms that control protein activity. ScUGPase-1 expression was negatively correlated with the sucrose content in the internodes during development, and only slight differences in the expression patterns were observed between two cultivars that differ in sucrose content. The intracellular localization of ScUGPase-1 indicated partial membrane association of this soluble protein in both the leaves and internodes. Using a phospho-specific antibody, we observed that ScUGPase-1 was phosphorylated in vivo at the Ser-419 site in the soluble and membrane fractions from the leaves but not from the internodes. The purified recombinant enzyme was kinetically characterized in the direction of UDP-glucose formation, and the enzyme activity was affected by redox modification. Preincubation with H2O2 strongly inhibited this activity, which could be reversed by DTT. Small angle x-ray scattering analysis indicated that the dimer interface is located at the C terminus and provided the first structural model of the dimer of sugarcane UGPase in solution.	[Soares, Jose Sergio M.; Gentile, Agustina; Menossi, Marcelo] Univ Estadual Campinas, Inst Biol, Dept Genet Evolucao & Bioagentes, BR-6109 Campinas, SP, Brazil; [Scorsato, Valeria; Lima, Aline da C.; Kiyota, Eduardo; Aparicio, Ricardo] Univ Estadual Campinas, Inst Quim, Lab Biol Estrutural & Cristalog, BR-6154 Campinas, SP, Brazil; [dos Santos, Marcelo Leite] Univ Fed Sergipe, Nucleo Quim, Ctr Ciencias Exatas & Tecnol, BR-49500000 Itabaiana, SE, Brazil; [Piattoni, Claudia V.] Univ Nacl Litoral, Inst Agrobiotecnol Litoral UNL CONICET, Santa Fe, Argentina; [Huber, Steven C.] Univ Illinois, Dept Agr Agr Res Serv, Urbana, IL 61801 USA; [Huber, Steven C.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal de Sergipe; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Menossi, M (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Genet Evolucao & Bioagentes, Rua Monteiro Lobato 255,CP 6109, BR-6109 Campinas, SP, Brazil.	menossi@lgf.ib.unicamp.br	Soares, Jose Sergio/D-6450-2014; Menossi, Marcelo/A-4364-2012	Soares, Jose Sergio/0000-0003-3908-0741; Menossi, Marcelo/0000-0002-9211-3787; Piattoni, Claudia Vanesa/0000-0003-1613-1112; Scorsato, Valeria/0000-0001-5497-0908; da Costa Lima Moraes, Aline/0000-0002-6985-4392	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/06767-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [BEX 0095/10-9]; CONICET; National Science Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Science Foundation(National Science Foundation (NSF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP Grant 2008/06767-3) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES Grant BEX 0095/10-9).; Supported by CONICET and the National Science Foundation.; Recipient of a research fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Alexander RD, 2006, PROTEOMICS, V6, P1886, DOI 10.1002/pmic.200500548; AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Arruda P, 2012, CURR OPIN BIOTECH, V23, P315, DOI 10.1016/j.copbio.2011.10.012; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; BECKER M, 1995, PLANTA, V195, P331, DOI 10.1007/BF00202589; Begcy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044697; Botha FC, 2000, AUST J PLANT PHYSIOL, V27, P81, DOI 10.1071/TT99098; Cheeseman JM, 2006, J EXP BOT, V57, P2435, DOI 10.1093/jxb/erl004; Chen RZ, 2007, PLANT CELL, V19, P847, DOI 10.1105/tpc.106.044123; Ciereszko I, 2005, J PLANT PHYSIOL, V162, P343, DOI 10.1016/j.jplph.2004.08.003; Ciereszko I, 2001, BIOCHEM J, V354, P67, DOI 10.1042/0264-6021:3540067; Ciereszko I, 2001, PLANTA, V212, P598, DOI 10.1007/s004250000424; Coleman HD, 2007, J EXP BOT, V58, P4257, DOI 10.1093/jxb/erm287; Decker D, 2012, PHYTOCHEMISTRY, V79, P39, DOI 10.1016/j.phytochem.2012.04.002; Dixon DP, 2005, PLANT PHYSIOL, V138, P2233, DOI 10.1104/pp.104.058917; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; dos Reis MA, 2011, BIOPHYS J, V101, P2770, DOI 10.1016/j.bpj.2011.10.046; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fusari C, 2006, ANAL BIOCHEM, V352, P145, DOI 10.1016/j.ab.2006.01.024; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Grose JH, 2007, EMBO J, V26, P4824, DOI 10.1038/sj.emboj.7601914; Gupta SK, 2008, J PLANT PHYSIOL, V165, P679, DOI 10.1016/j.jplph.2007.09.001; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Kellermann G, 1997, J APPL CRYSTALLOGR, V30, P880, DOI 10.1107/S0021889897001829; Kleczkowski LA, 2004, PLANT PHYSIOL, V134, P912, DOI 10.1104/pp.103.036053; Kleczkowski LA, 2010, CRIT REV PLANT SCI, V29, P191, DOI 10.1080/07352689.2010.483578; Kolodziejski PJ, 2003, P NATL ACAD SCI USA, V100, P14263, DOI 10.1073/pnas.2435290100; Koo JH, 2004, J NEUROCHEM, V90, P102, DOI 10.1111/j.1471-4159.2004.02463.x; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; Martinez LI, 2011, BIOCHIMIE, V93, P260, DOI 10.1016/j.biochi.2010.09.019; Martz F, 2002, BIOCHEM J, V367, P295, DOI 10.1042/BJ20020772; Matsuoka S, 2009, IN VITRO CELL DEV-PL, V45, P372, DOI 10.1007/s11627-009-9220-z; Mccoy JG, 2007, J MOL BIOL, V366, P830, DOI 10.1016/j.jmb.2006.11.059; Meng M, 2008, BBA-PROTEINS PROTEOM, V1784, P967, DOI 10.1016/j.bbapap.2008.02.021; Meng M, 2007, GENE, V389, P186, DOI 10.1016/j.gene.2006.11.006; Meng M, 2009, BBA-PROTEINS PROTEOM, V1794, P1734, DOI 10.1016/j.bbapap.2009.08.009; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Mikami S, 2001, PLANT SCI, V161, P665, DOI 10.1016/S0168-9452(01)00455-1; MOORE PH, 1995, AUST J PLANT PHYSIOL, V22, P661, DOI 10.1071/PP9950661; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Papini-Terzi FS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-120; Park JI, 2010, PLANT CELL PHYSIOL, V51, P981, DOI 10.1093/pcp/pcq057; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pua EC, 2000, AUST J PLANT PHYSIOL, V27, P1151, DOI 10.1071/PP00016; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Roeben A, 2006, J MOL BIOL, V364, P551, DOI 10.1016/j.jmb.2006.08.079; Rutter J, 2002, CELL, V111, P17, DOI 10.1016/S0092-8674(02)00974-1; Salahpour A, 2003, BIOL CHEM, V384, P117, DOI 10.1515/BC.2003.012; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Semisotnov GV, 1996, J MOL BIOL, V262, P559, DOI 10.1006/jmbi.1996.0535; Steiner T, 2007, J BIOL CHEM, V282, P13003, DOI 10.1074/jbc.M609984200; STITT M, 1988, PLANTA, V174, P217, DOI 10.1007/BF00394774; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Toroser D, 1998, FEBS LETT, V435, P110, DOI 10.1016/S0014-5793(98)01048-5; Van den Ende W, 2009, J EXP BOT, V60, P9, DOI 10.1093/jxb/ern297; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; Yu Q, 2012, BIOCHEM J, V442, P283, DOI 10.1042/BJ20111598; Zhu YJ, 1997, PLANT PHYSIOL, V115, P609, DOI 10.1104/pp.115.2.609; ZRENNER R, 1993, PLANTA, V190, P247, DOI 10.1007/BF00196618	69	8	9	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33364	33377		10.1074/jbc.M114.590125	http://dx.doi.org/10.1074/jbc.M114.590125			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25320091	hybrid, Green Published			2022-12-28	WOS:000345636600027
J	Chung, JH; Larsen, AR; Chen, E; Bunz, F				Chung, Jon H.; Larsen, Andrew R.; Chen, Evan; Bunz, Fred			A PTCH1 Homolog Transcriptionally Activated by p53 Suppresses Hedgehog Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSION; DRUG-SENSITIVITY; CANCER-CELLS; HUMAN GENOME; MEDULLOBLASTOMA; GENE; TUMORIGENESIS; ENCYCLOPEDIA; PATTERNS; SUGGESTS	The p53-mediated responses to DNA damage and the Hedgehog (Hh) signaling pathway are each recurrently dysregulated in many types of human cancer. Here we describe PTCH53, a p53 target gene that is homologous to the tumor suppressor gene PTCH1 and can function as a repressor of Hh pathway activation. PTCH53 (previously designated PTCHD4) was highly responsive to p53 in vitro and was among a small number of genes that were consistently expressed at reduced levels in diverse TP53 mutant cell lines and human tumors. Increased expression of PTCH53 inhibited canonical Hh signaling by the G protein-coupled receptor SMO. PTCH53 thus delineates a novel, inducible pathway by which p53 can repress tumorigenic Hh signals.	[Chung, Jon H.; Larsen, Andrew R.; Chen, Evan; Bunz, Fred] Kimmel Canc Ctr Johns Hopkins, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Bunz, F (corresponding author), Kimmel Canc Ctr Johns Hopkins, Dept Radiat Oncol & Mol Radiat Sci, 1550 Orleans St, Baltimore, MD 21231 USA.	fredbunz@jhmi.edu		Chung, Jon/0000-0003-0526-3670	National Institutes of Health [R01CA157535, P30CA006973, P50CA062924]; AACR-Fight Colorectal Cancer fellowship; NATIONAL CANCER INSTITUTE [R01CA157535, P30CA006973, P50CA062924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AACR-Fight Colorectal Cancer fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA157535 (to F. B.), P30CA006973 (to the Johns Hopkins gastro-intestinal cancer SPORE), and P50CA062924 (to the Sidney Kimmel Comprehensive Cancer Center).; Supported in part by the AACR-Fight Colorectal Cancer fellowship.	Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Chung JH, 2013, ONCOTARGET, V4, P2208, DOI 10.18632/oncotarget.1651; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Hausmann G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000146; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee Y, 2006, CANCER RES, V66, P6964, DOI 10.1158/0008-5472.CAN-06-0505; Mazza D, 2013, CELL DEATH DIFFER, V20, P1688, DOI 10.1038/cdd.2013.120; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; MIYASHITA T, 1995, CELL, V80, P293; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Pandolfi S, 2013, ONCOGENE, V32, P4737, DOI 10.1038/onc.2012.502; Parikh N, 2014, J PATHOL, V232, P522, DOI 10.1002/path.4321; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Sasai K, 2006, CANCER RES, V66, P4215, DOI 10.1158/0008-5472.CAN-05-4505; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Triscott J, 2013, CANCER RES, V73, P6734, DOI 10.1158/0008-5472.CAN-12-4331; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wanshura LEC, 2011, CANCER RES, V71, P5336, DOI 10.1158/0008-5472.CAN-10-2633; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	35	24	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.597203	http://dx.doi.org/10.1074/jbc.M114.597203			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25296753	Green Published, hybrid			2022-12-28	WOS:000345335000052
